<SEC-DOCUMENT>0001628280-22-004539.txt : 20220301
<SEC-HEADER>0001628280-22-004539.hdr.sgml : 20220301
<ACCEPTANCE-DATETIME>20220301163922
ACCESSION NUMBER:		0001628280-22-004539
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		100
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220301
DATE AS OF CHANGE:		20220301

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUTERA INC
		CENTRAL INDEX KEY:			0001162461
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				770492262
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50644
		FILM NUMBER:		22698839

	BUSINESS ADDRESS:	
		STREET 1:		3240 BAYSHORE BOULEVARD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		94005

	MAIL ADDRESS:	
		STREET 1:		3240 BAYSHORE BOULEVARD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALTUS MEDICAL INC
		DATE OF NAME CHANGE:	20011119
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>cutr-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:1ebe9035-7f15-449f-b887-5ea51f412a9f,g:8ea03665-a689-4990-8029-94d26fa40407,d:dabc87e13e174d3c9f17fa6963046f56--><html xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:cutr="http://cutera.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cutr-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl80L2ZyYWc6OTA1NTkzZjJlMWYxNGNkYjhlYmE2Y2Y3NmVhYTc4YTEvdGFibGU6NTNhNDQ0MTE4NDJjNDQ1Y2I5YTc5NWFmMThkYzQ5MjgvdGFibGVyYW5nZTo1M2E0NDQxMTg0MmM0NDVjYjlhNzk1YWYxOGRjNDkyOF8xLTEtMS0xLTI4NjIx_f7e347b6-a73a-426d-a997-9a64c4748c14">0001162461</ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl80L2ZyYWc6OTA1NTkzZjJlMWYxNGNkYjhlYmE2Y2Y3NmVhYTc4YTEvdGFibGU6NTNhNDQ0MTE4NDJjNDQ1Y2I5YTc5NWFmMThkYzQ5MjgvdGFibGVyYW5nZTo1M2E0NDQxMTg0MmM0NDVjYjlhNzk1YWYxOGRjNDkyOF8yLTEtMS0xLTI4NjIx_7d9a87e9-83a1-403b-a596-dee71328af9f">false</ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl80L2ZyYWc6OTA1NTkzZjJlMWYxNGNkYjhlYmE2Y2Y3NmVhYTc4YTEvdGFibGU6NTNhNDQ0MTE4NDJjNDQ1Y2I5YTc5NWFmMThkYzQ5MjgvdGFibGVyYW5nZTo1M2E0NDQxMTg0MmM0NDVjYjlhNzk1YWYxOGRjNDkyOF80LTEtMS0xLTI4NjIx_efa2c213-1167-42eb-bd5a-a40e9f62f708">FY</ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl80L2ZyYWc6OTA1NTkzZjJlMWYxNGNkYjhlYmE2Y2Y3NmVhYTc4YTEvdGFibGU6NTNhNDQ0MTE4NDJjNDQ1Y2I5YTc5NWFmMThkYzQ5MjgvdGFibGVyYW5nZTo1M2E0NDQxMTg0MmM0NDVjYjlhNzk1YWYxOGRjNDkyOF81LTEtMS0xLTI4NjIx_be44fcba-afd9-4348-9e5b-f53770a0c2e0">2021</ix:nonNumeric><ix:nonNumeric contextRef="i58319883bced4affb153fc42b9f6a7ab_D20210101-20211231" name="cutr:ExtendedServiceContractOptionOneTerm" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzOTA_48951eca-9684-4911-930c-c47a406efd42">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i58319883bced4affb153fc42b9f6a7ab_D20210101-20211231" name="cutr:ExtendedServiceContractOptionTwoTerm" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzOTE_82f81123-597c-470d-8503-057d2c5ae78b">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="i78e6939cb0a445dd8e3548b14d70b125_I20211231" name="us-gaap:CapitalizedContractCostAmortizationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzNTI_f9af2b31-c814-4dab-886d-badea997b8a1">P2Y</ix:nonNumeric><ix:nonFraction unitRef="reporting_unit" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportingUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNzQ3L2ZyYWc6NzNiOGQyZjhiYTdjNDViY2I1ZjQwNzlmZjhmMzcxZDgvdGV4dHJlZ2lvbjo3M2I4ZDJmOGJhN2M0NWJjYjVmNDA3OWZmOGYzNzFkOF8yMDM0MDk2NTExMzk2Nw_caa49acf-c26e-43a6-9487-d83bb8e90cc3">1</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="0" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNzQ3L2ZyYWc6NzNiOGQyZjhiYTdjNDViY2I1ZjQwNzlmZjhmMzcxZDgvdGV4dHJlZ2lvbjo3M2I4ZDJmOGJhN2M0NWJjYjVmNDA3OWZmOGYzNzFkOF8zODQ4MjkwNjk3NTg3_d9643029-01a4-4d9b-9884-4a8258b0931c">0</ix:nonFraction><ix:nonNumeric contextRef="ia36d0816ebaf4b43aa977f986877b067_D20210101-20211231" name="cutr:ExtendedServiceContractOptionOneTerm" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzM4NDgyOTA2OTc5OTU_298632bb-c8d5-4a4a-94e5-1559caf89ce1">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i5897798beb29443aae3381f60fa7cc05_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDAw_eb99cd2f-e555-49f7-b0bf-9cc8cd023330">P4Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i1aa834f5b84048cd91d2b5b6dba22f64_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjcvZnJhZzozY2EyNjE3ZGNiNzA0Nzk3YmM3M2U1MTc4ZmU4NjYxNy90YWJsZTowMWJiMmY3NTg2YzQ0MTAwOTg0OGMwMjk3MDRlYzZlYS90YWJsZXJhbmdlOjAxYmIyZjc1ODZjNDQxMDA5ODQ4YzAyOTcwNGVjNmVhXzYtMS0xLTEtMjg2MjE_4f3d124b-2060-4679-96f5-e0a31bcaed99">25</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i2b6ae716d54948428783d4f61fd518f5_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjcvZnJhZzozY2EyNjE3ZGNiNzA0Nzk3YmM3M2U1MTc4ZmU4NjYxNy90YWJsZTowMWJiMmY3NTg2YzQ0MTAwOTg0OGMwMjk3MDRlYzZlYS90YWJsZXJhbmdlOjAxYmIyZjc1ODZjNDQxMDA5ODQ4YzAyOTcwNGVjNmVhXzItMS0xLTEtNDc1NjI_87cc82e8-967c-4744-9de5-fff4d7eef96e">50</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i254106ff63ec411e9d2da0f175830fa6_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjcvZnJhZzozY2EyNjE3ZGNiNzA0Nzk3YmM3M2U1MTc4ZmU4NjYxNy90YWJsZTowMWJiMmY3NTg2YzQ0MTAwOTg0OGMwMjk3MDRlYzZlYS90YWJsZXJhbmdlOjAxYmIyZjc1ODZjNDQxMDA5ODQ4YzAyOTcwNGVjNmVhXzMtMS0xLTEtNDc1NjI_5b24d466-acb0-4d3c-9785-30ee8c67ff1f">50</ix:nonFraction><ix:nonNumeric contextRef="ibd3302b52f4a41409e34c024834c102a_D20210101-20211231" name="cutr:LesseeLeasesRemainingTerm" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzM1OQ_c3159409-b458-460d-9242-9f6a751b81b3">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMS0xLTEtMzkwMjA_971a5a0e-7d36-4fb8-a69f-ab6296ab5451">http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMS0xLTEtMzkwMjA_9d781c61-1f10-40e0-a3f0-691f77491d63">http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMS0xLTEtMzkwMjI_8092eb31-ac1f-4f22-979c-32b815b92382">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMS0xLTEtMzkwMjI_e0e19b97-1369-4d4a-bbc4-18c6459ed777">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMS0xLTEtMzkwMjQ_28244cd5-3898-471f-8e2b-ae37ea29760a">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMS0xLTEtMzkwMjQ_7df8c095-3d4f-4603-b7c7-f49c99ce82b6">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="ia7b49d8dae1a41d7955cdd82cd7c50ab_D20210301-20210331" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNjMxL2ZyYWc6MTA5YzA1MDMxNWYxNGM0NGEzY2JiYjczNGRlYTIyZTIvdGFibGU6ZjIyNTljNDI2ODJhNDViOTg5MjEzZDZiM2JlY2JmOGYvdGFibGVyYW5nZTpmMjI1OWM0MjY4MmE0NWI5ODkyMTNkNmIzYmVjYmY4Zl8xLTMtMS0xLTM4NzM3_0f12cb4a-a834-4f29-bcce-2f2c4e5f62ac">0.0301427</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cutr-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12806cd82e1f4ceeac75fc20c9308310_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i6fea2b1966df49cfa5b8b7da99a4521a_I20220222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb8194a480bb4178ad9ccc279fa71d86_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i099f3e3620924202a8039a0d27597652_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b500e632e0846a6a33e6a7ac55f88ad_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7098bcdf6ed0484fab59d24d26f26f8b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58319883bced4affb153fc42b9f6a7ab_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a72612f34ee4319a9bb7d59ecf28bee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4cf1c8552b845c08ebb68573b2cdd62_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a7631525a4f45cd84f88a123b5d2213_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if99ac849105d4a778abc890967e8354d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if092c9ece84f49e7896488564096ae3e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6093d26609ac4a2082bc74145688a81e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84bd95534d8f493aa7e53067a3785115_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ef35ea9019a46839254540bd96f8f38_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37fa040d9517485c9e505b0a87f68f29_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee23395883004f20bda4e3cba945dd71_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63061c421e784fa784a49973a94456b2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50e9b99ce0334c7d9a579aa4a855f45e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b37d87a7edd4cbba072cd040d20302b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icee9c162557a4530b5abeb514f96a6c5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84dc3075f0c942e99a266d7512c300d6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id274c268168b47e082c04e17dfbb9eb6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4131053e935748729079966449ab7c37_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i960574069b78413a924873ab23554fb4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcae67fe77484d66aac559d41cdd4a97_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8720e5d165746398e865e8ff2bf37ba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i196713f133464fccbcbe95ca1be37452_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04a8f1192895498a8fbd198d78451ecd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i952540da797a438c883313a189c55038_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8344555ed6a476481db2825ccec753c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90ee30efe67b4fb49e2d5f54e0fafe89_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f16a2afdae64f2daab7448314a752d3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19a4ef1cc484429daba4d25230ec7aad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id52c81a523b740df9a58c7f26a6f5f9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5865f24ced8c4abe92e8e3142a113547_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcc9ffcaa06a4dbd9843701a556e4a0a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="country"><xbrli:measure>cutr:country</xbrli:measure></xbrli:unit><xbrli:context id="i29493bf694aa41e4961175a5d0e9712c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i9f3add778c6d42e2904c632bb4379750_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27ed0b55b74e49509122ed86b0f52309_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i307d65a514094556a1c3cb6702122693_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:LoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id09c2b6d4b444a11a61afbefef850c5f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:LoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78e6939cb0a445dd8e3548b14d70b125_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a9ce53bcd874cb38a5dbc24e4ea3583_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29b9e3b28d734adeb076ece7de227b71_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49f345cd25654a7f84873131ed305500_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3577892be364d588b4ee6707f9426df_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic835d94700e34147a128f7c43a99ba8f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7d8ca402cf64fa095821119515012f0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i046ed111439c42409c5114869295fb0b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib426205ae11e4aa1879843b606c79fd5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d16dd05655a48cea0d5421c014cf5b5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc042179d3e042a49fe526aad8eb50c6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22da8abdff7f43e49f27b03708dc3882_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SecretAndSecretProMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="supplier"><xbrli:measure>cutr:supplier</xbrli:measure></xbrli:unit><xbrli:context id="id4151927442041dd92c39ebf707b54a4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea5dc3d35fa7491281eebabd4744ca45_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:LeasedEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i687140e91bb9469bb4be1621b92c9b8b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:EquipmentAndFurnitureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16179899e1fd49b2884edc3604740025_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac4da192d3c340da971b19d3ab991663_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:CapitalizedCloudComputingSetupCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bfb0aae8e4f42c682a5274dacefb148_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:CapitalizedCloudComputingSetupCostMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f6b3f16760744dc9103390169175d8f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffa27261393c4ab8ba5e3794d9147c89_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cutr:segment</xbrli:measure></xbrli:unit><xbrli:context id="i541d48bf023c4fe7aae98ff86b967101_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cutr:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d7848312e9548839319d5ac37eca97c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bc9b22641b0417da7e8a81fcaf59a1b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="reporting_unit"><xbrli:measure>cutr:reporting_unit</xbrli:measure></xbrli:unit><xbrli:context id="i6f352492b09240419cedf42adcbed4e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if050ebe27c6a45b6afb9c2a998414be2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4550dd7ebeeb4ea9baad304474ac9979_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:LeasedEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i116594d0783a424a8fafeb1b4f59c8e1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:LeasedEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95e3d048dc634a71897f460779f082a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:EquipmentAndFurnitureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4d4966eb9a940dfa6db6a00a25b33db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:EquipmentAndFurnitureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcea864f6da04951ab895dcc2436d3cf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06d8947881bc48feaed989df52b60b1a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7c26e3ef9c442a8832ed31ed63f16e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i314e69e3501a4ea3a3bc04ee5a0601b0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic330d4e7bda4436ea9b5a447faa2ab15_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf1149b9e76a4c089deaa8f058629d53_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia36d0816ebaf4b43aa977f986877b067_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54949609fd0c4fddb72cfc46650cb0e8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib79906570e2049eabe51c068e7921170_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id019adf1333c43ce9cd8acf7e5ea0991_D20200421-20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cutr:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-21</xbrli:startDate><xbrli:endDate>2020-04-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e364a947a114dddb1671e44b0467847_I20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cutr:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b9ef969fb964e68bc041b81228d55de_D20200421-20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cutr:UnderwriterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cutr:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-21</xbrli:startDate><xbrli:endDate>2020-04-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b5f16c096554bfebc0977f38bdab2e3_I19981231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>1998-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bdd524cbef74fc18d573d1100d86374_I20040112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2004-01-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5327f49a62ea40d690f0899c454a9fbd_D20120101-20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-01</xbrli:startDate><xbrli:endDate>2012-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51d5c987d168444995a56ee832d422f1_D20190614-20190614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-14</xbrli:startDate><xbrli:endDate>2019-06-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19b58bf2da1b4bdf82f22bbae4a7f3a2_I20190614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e8bdcbd064d4597b255647bff9cba1a_D20190614-20190614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-14</xbrli:startDate><xbrli:endDate>2019-06-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd9fd5d526a04b80a20fe10491260caa_D20190611-20190611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-11</xbrli:startDate><xbrli:endDate>2019-06-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief9071943aa645caa5dade84cd3e061d_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TheAmendedAndRestated2019EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id927e8d4f38a47a0828d8a646057aed3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3195dfbe94d477e88a888e893f44d1e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d42d4ffa3bd4f0b875d22a9ab203d5c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81aa92e174864f29b74e30628a31ecd2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88b4ab1b779d43ed8ae859fa48628f89_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i713579da903a47a29c2bbc3556a11854_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5f5df8bc21945d8be1f01c615e620b9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5897798beb29443aae3381f60fa7cc05_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsAnnualGrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd9c28c8d501405da659af62fb7475e6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsNewHireMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5046b58bcd594937807a5b3727f16519_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57973c7f0bd94f19b5e2a50196d96324_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55b1792fc2364767a5f64cd1cdf6808c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64db2b3b978b414a8c02290468f928b5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5a5db0c5f0d46b380a0b79f965a62ea_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01a61b6023fb48d7be1011c161d39845_D20210701-20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="tranche"><xbrli:measure>cutr:tranche</xbrli:measure></xbrli:unit><xbrli:context id="i6293b26e539849e09ccfdc96cb5059bb_D20190701-20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6d4b50d303d423099ba57b50833b756_D20190701-20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e2fb7f83d5a4d3797c1641e79c2cb8e_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaba873dc2f8c4fb8bb139aa82a0e3219_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d1404685416410cbcd6e1f275b3fd2d_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1344f4c17c7449aba2397d6f715ba6f_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8e0ec5e57d6453db52240a4631277a9_D20040112-20040112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2004-01-12</xbrli:startDate><xbrli:endDate>2004-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3406523d56248b489c3b7541fdf6711_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4edea0c28014a2d93054c7ca5e19937_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d790cb4f5784d80b7d9b71df630a022_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc61de97e6f5442cae47ea43a50a646f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3df46276971c4ed0986a5e859e637064_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i243cda497d0443fd8d3e77f6c4b77778_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i918b5c66b5b64f319346190d60ad103d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24d00f09f70e46dd88668566228e1cdf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ba69d99c6bf476e8d15c9c79b2a6df2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id228189a9c344696a5059d6861067108_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d5d0bdf4f0d4a1883472cfe8d0f4ca7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e4c6cb41dca483993cf3fb92041cc1f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i062444d03896452f9251a408fa65500b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8ddcd5085f543b5aacaf7518aba284a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e4d0f435f2844b291dd5ea2a0f001f0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20b036dbcc074c4a90dad931e7f4bb6c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40475f7443d64415ba295a8050683744_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7ae52da7abe49da93b5d02df9962d86_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idafa75464bf1482bbe39438ca2a1fbb3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide3c7b9ba1e1465085e27b6fb0183fac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange8Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86f5d1782ee64b31bfb15fc1735484b3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange8Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79619c0d0304473a9a05f38376df1ca5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5787bf9bc4b840c8b9474232abd18822_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i187150c65510432d854fe82b6fb23a3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange10Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice72d61a300545aeb3844e67957f9576_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange10Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08b960d0e6e645c39e84cc857ec13e6b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i192be0f1705145908aa6ad70700cddf7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice6c8183a7fa4570a3f044c0f1d54f9c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32524a5704d848b69d401dc8de11ebf9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35da96289dd949498eddb1768dd19192_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3adb16d3075942348f225b70cf90f3a4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cf974c819a34839aa1bfe59802e71ba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66107087f3fd4a20b6cb4d48e7f3033a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0689b0010d214af6bd1356f9f93a1141_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:ESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i246ec24176874e33b14c7fda30f63bfc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:ESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacfb1ac9741f4b3db30f8728b64a645e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:ESPPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i199effaf47f34a41a806c1a1a7e53aa1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ea32c98f4b44fd4982e248bedf6cead_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i053b35b2d01d445ea80dee2b47dbb5fb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i866b9eac79cc4cecbfb1b078c5693146_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d3833836ada4a39873f0f32f69266d9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia001d3ced3134020b6fbcd0bdba96369_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16b8707c22974632a641c57e2b86817c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc44a2bdb221436a8375e04e1ea9bb79_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4499ceba300a402e858712b9c26ba787_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9d312fc584843e38678f9ffd58f8a01_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:StockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac80237e6ee945ac8a0c0ba713b41438_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:StockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide91ed10ffb54702b454c8e2a5cad1d1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:StockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aa834f5b84048cd91d2b5b6dba22f64_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsNewHireMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b6ae716d54948428783d4f61fd518f5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i254106ff63ec411e9d2da0f175830fa6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e6fd16be09042c6be9c81d3d9e1c187_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55e82d33e5544074a2aac447d7824467_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b4a1f39d65147fcac2e81a5c60fcdb4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifade32131fd14ec1926f12852d497aed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3598dca90d534ae0a8d4aaf1b13b56c1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4c6391b6a824369a52a92dbea8b9166_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i908d24eef82248b3b0c5e24ce67d7620_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2673044451384aab8b4c321ea6b9f8a2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia643c91cedb04d559d547cfeceee8809_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9eb3b54c6e9341a299439438dca1b02c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cutr:CappedCallSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i637b3d70c182413ba3e75aa2bef9320b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cutr:CappedCallSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id943a7c916e04296aa697a2d261b63c9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cutr:CappedCallSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c1a042e66a646cf876664c9b9e32ccf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69439113ac644761bbfd84226a430cdc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9751faf680174024a66bfd73c40bb6ae_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i827ff77fcef14e9c82c96fe8afe59e6f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5e396b1a03c446faf5e013cd334d63a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia86ce17804314cdfb7203658a2fa825c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26a28b3231d24fbd9da85098c345597f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d3b04419de146f79e0830d4f8e5fc88_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67dd4dfa6fb84a8d803fd3e4686012df_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49698c4c16fa448aa1199cdea0f0db3f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadd6424f69774b75aa9f2d8c176bfc58_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82424323bc6746ac95ae7b4f28e7db6e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id80c93e18ea14c80a7c54a7919d9e363_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3d8659c50814d9ba9e908c0fdd94d23_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied686aef55a948f5bdf73f5ebd34b570_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b29467be6564d3f96a00ec95fc5f71b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45b5e0fc162b498a9929672c4fb7e999_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9f2c0dfb22b430f8f1dad0b71274edb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if27b2a1100724a6ba26c08b984a74d73_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabe1ad421e2e4777bc58f953183a58d8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85ccedc5cc084701a241de78d69d915f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0e98db9695641d48b2985be4ab15c8d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f06a616963d42bbb1bef44c8cff5a12_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb36f34a3d6443f59cb889c5f55426a4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe6666768fb24f969d5783ef26a323af_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21f225eac6b24108b1ebbc248f11ac03_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9b8210b31c544628b9091d412a30501_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ead9548c13b4a1e8a2ca967452a46ea_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bf9f04fa0584c609bf017b7f800a291_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a47c8db3d4c4730995fc63329813d86_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idac1466cf9104c8e9357f38e1e4b2c30_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib265219876bc4426a1d87eaf7ec84fe5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i646d72085053489e80492d5e31a5abb2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60121f9d6c17406fa91d2087e5266a1b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:HandPieceRefillsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85aa042e4c004dc8a331aa0e27b9dd03_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:HandPieceRefillsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i007f7a487e97481d9f1957cd82a932d8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:HandPieceRefillsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbb6461561444b40bb9d9d51b6f1aff8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e98acc9c5eb4f31a71cdbb2d1a1a1d5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd3302b52f4a41409e34c024834c102a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5c79f3c61274db4a3f2eb8ce9d31f70_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i399c8e27879e4205838eba2cd2b55bed_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7416b6bdf4a48dcad826a2a1430ea9a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i764ce0cbc59940f481fdec67f544e264_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib80ff99676a24f1f8527cc2a3aa4d119_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cutr:FormerExecutiveVPAndCFOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37f97a9d284443ad97ec8c981fcd7f08_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d1c6d926fe34c69ad511dec85a63fd4_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a6e8339dfdb4cd39eddb0d8191da2b2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b661e68d3614dd8a0389a329265b3bd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7cfa6c72662462f90fcfd77f387c2c3_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026FirstConversionTriggerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>cutr:day</xbrli:measure></xbrli:unit><xbrli:context id="i8b0a2bfb03104efeadd77a4412bae006_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026SecondConversionTriggerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58a47170b8054a0ba5cca87aa0a800de_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74ccf35a513f4cfd8630d93546df6f20_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i130b34c8fd4f434eb30d4d656ae2c907_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerItem"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>cutr:item</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i46277ffbd52b4aaf98c02564d8aa2124_I20210304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i453b9f386c004d948258fe7bc2b71f9c_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6bca201b74942348baa93e457128a05_D20200709-20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-09</xbrli:startDate><xbrli:endDate>2020-07-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77d3c70ae7304fa7a266e0d9e1db39cd_I20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd0e36b6f7714fe981a44e99c804b27b_D20200709-20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-09</xbrli:startDate><xbrli:endDate>2020-07-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9781cc48038047a79264ddaf70b44230_D20200422-20200422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-22</xbrli:startDate><xbrli:endDate>2020-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d2cac1cd2a7480690ed521729608228_I20200422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fe8bd55b1e94cda888bad51642d2ccf_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7b49d8dae1a41d7955cdd82cd7c50ab_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia14ca8fcae0b4aefa76cad9866090d78_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53f708f1ad434a6ebaec1f96b1e10a2a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ee1cde4537a457a88a3ef970508acf5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07d7ed87182941cdbdd83dbfbedf27c2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90d8a65714d14212b8f93aae06688452_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b7116ac1a764bada7c667ee90614aee_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbfb1453521848d4a478c1bab5686392_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54116f7e632d4168b0ea901ff7e1d220_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied6bc4de4307436da39a837d8e641a54_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib07203e94f374a45ab7a8e8c3f66b67b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dbc469745e840208e864df19cadabc3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica83547bfc21466aaad3b5d34df18cb4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb9f62bf502f487d80c5e7ec032cdc88_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia314f34942bd40c09b7937fff3f63589_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162461</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="idabc87e13e174d3c9f17fa6963046f56_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzI5_57952c4e-9732-4d06-952b-59f91dd0037a">10-K</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6MDllZjg1MWJiYjA5NDkxYjgyNDViMjIyOTA4YzljOGQvdGFibGVyYW5nZTowOWVmODUxYmJiMDk0OTFiODI0NWIyMjI5MDhjOWM4ZF8wLTEtMS0xLTI4NjIx_d859e93b-c228-488b-83d0-11ff0c9583aa">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center;text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For fiscal year ended <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zODQ4MjkwNzAxMzc4_3ed1a8a9-8307-4612-ba13-fbb6ff402b12"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zODQ4MjkwNzAxMzc4_e4c1fdc5-b1dd-40b0-8240-8cbdaf1eb2ef">December 31</ix:nonNumeric>, 2021</ix:nonNumeric></span></div><div style="margin-top:2pt;text-align:center;text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.443%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6MWM0NGEwOTA4Nzg5NDE3MmFjYjkwZGUzMDZiMjVmOTEvdGFibGVyYW5nZToxYzQ0YTA5MDg3ODk0MTcyYWNiOTBkZTMwNmIyNWY5MV8wLTEtMS0xLTI4NjIx_baac1c65-0af5-42a0-a1ef-14d6c7366b68">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from ____ to ____</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzI0_e30ab3e5-993f-4b6d-bc80-ad21f5f86172">000-50644</ix:nonNumeric></span></div><div style="margin-top:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzMw_06d8c7ad-5d48-4b10-87a2-2b2b4d1c7e87">CUTERA, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6YzFhMTIxYTBhMTAzNGFkNGE0ZWMwYWIyZjFkMGVhN2QvdGFibGVyYW5nZTpjMWExMjFhMGExMDM0YWQ0YTRlYzBhYjJmMWQwZWE3ZF8wLTEtMS0xLTM2OTU0_73d1f6ce-2e40-4023-a9a1-06ab75917200">Delaware</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6YzFhMTIxYTBhMTAzNGFkNGE0ZWMwYWIyZjFkMGVhN2QvdGFibGVyYW5nZTpjMWExMjFhMGExMDM0YWQ0YTRlYzBhYjJmMWQwZWE3ZF8wLTMtMS0xLTI4NjIx_1425858d-39e6-4c8a-ab1a-464491c0a374">77-0492262</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(I.R.S. Employer<br/>Identification No.)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzI1_3a48fa93-b25a-4cf4-aac9-20241edd685c">3240 Bayshore Blvd.</ix:nonNumeric>, <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzI2_8aca0a6f-5965-447c-9d0b-c0ad992e894d">Brisbane</ix:nonNumeric>, <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zODQ4MjkwNzAxMzU3_3fe087fc-b1ad-4204-b6cd-51a6e5b23a4c">California</ix:nonNumeric> <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzI3_3e4a5c29-c311-4ae4-bfe1-b61f88b8ffe8">94005</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzE4_0d83fd6e-151e-489e-bf39-465fa51b000a">415</ix:nonNumeric>) <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzE5_8900d40d-bdf9-42cb-a0f5-d167e29173cb">657-5500</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6OTU1NGI1ZDUxZWQ5NGEzNmE3MThlZDE4M2Q0NWZkZjcvdGFibGVyYW5nZTo5NTU0YjVkNTFlZDk0YTM2YTcxOGVkMTgzZDQ1ZmRmN18xLTAtMS0xLTI4NjIx_3597ea62-b10e-4b9d-8386-116647168deb"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6OTU1NGI1ZDUxZWQ5NGEzNmE3MThlZDE4M2Q0NWZkZjcvdGFibGVyYW5nZTo5NTU0YjVkNTFlZDk0YTM2YTcxOGVkMTgzZDQ1ZmRmN18xLTAtMS0xLTI4NjIx_55643608-f33e-4acf-b9ec-c6fda10ee93b">Common Stock ($0.001 par value)</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6OTU1NGI1ZDUxZWQ5NGEzNmE3MThlZDE4M2Q0NWZkZjcvdGFibGVyYW5nZTo5NTU0YjVkNTFlZDk0YTM2YTcxOGVkMTgzZDQ1ZmRmN18xLTEtMS0xLTI4NjIx_05d55ca5-cbc7-4517-8517-be5261acbc67">CUTR</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6OTU1NGI1ZDUxZWQ5NGEzNmE3MThlZDE4M2Q0NWZkZjcvdGFibGVyYW5nZTo5NTU0YjVkNTFlZDk0YTM2YTcxOGVkMTgzZDQ1ZmRmN18xLTItMS0xLTM2OTQ5_ce508f8c-ccd2-489d-abb4-5ddc550f3385">The NASDAQ Stock Market, LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzIw_e15bc585-f8bb-4e28-bb56-afb60377b87d">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzIx_2e4eac0e-ff02-4bea-a038-dc7e137a9307">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzIy_7c512963-042e-4faf-9095-f201cf21c28b">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzIz_d85913c4-939e-479f-92bd-0d3aee102890">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-indent:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.290%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6ZThiM2U5ZjY2ODI0NDRiY2JkM2QyZDFjNTU4NTY0MGQvdGFibGVyYW5nZTplOGIzZTlmNjY4MjQ0NGJjYmQzZDJkMWM1NTg1NjQwZF8wLTAtMS0xLTM5MzM0_64355106-2702-4cd5-944f-83a70521c1d4">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6ZThiM2U5ZjY2ODI0NDRiY2JkM2QyZDFjNTU4NTY0MGQvdGFibGVyYW5nZTplOGIzZTlmNjY4MjQ0NGJjYmQzZDJkMWM1NTg1NjQwZF8wLTctMS0xLTI4NjIx_b0651c83-5b5e-46c7-86f7-be1d661be580">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6ZThiM2U5ZjY2ODI0NDRiY2JkM2QyZDFjNTU4NTY0MGQvdGFibGVyYW5nZTplOGIzZTlmNjY4MjQ0NGJjYmQzZDJkMWM1NTg1NjQwZF8wLTktMS0xLTI4NjIx_e7370a26-5aee-46d8-8bf3-61fb1ff8a60a">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zODQ4MjkwNzAxMzk2_1b8afd8a-16ff-4285-9ead-c059f5b0ed24">x</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzI4_9798bfe5-19e9-45a4-a984-0ffc34f5810f">&#9744;</ix:nonNumeric> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:10pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the registrant&#8217;s common stock, held by non-affiliates of the registrant as of June 30, 2021 (which is the last business day of registrant&#8217;s most recently completed second fiscal quarter) based upon the closing price of such stock on the NASDAQ Global Select Market on June 30, 2021, was approximately $<ix:nonFraction unitRef="usd" contextRef="i12806cd82e1f4ceeac75fc20c9308310_I20210630" decimals="-6" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8yODg3_6629fcc8-1be4-45b9-98f2-db161c7c63d3">796</ix:nonFraction>&#160;million.</span></div><div style="margin-top:10pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of Registrant&#8217;s common stock issued and outstanding as of February&#160;22, 2022 was <ix:nonFraction unitRef="shares" contextRef="i6fea2b1966df49cfa5b8b7da99a4521a_I20220222" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zODQ4MjkwNzAxMzU4_d520c207-00c1-4f0a-85a6-0139fbfdde70">18,060,261</ix:nonFraction>.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zODQ4MjkwNzAxMzk3_ecee2dbe-448d-4e32-a4d2-64e61a9a977c" escape="true">Part III incorporates by reference certain information from the registrant&#8217;s definitive proxy statement for the 2022 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission not later than 120 days after December 31, 2021.</ix:nonNumeric></span></div><div style="text-indent:6.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.673%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_13">PART&#160;I</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_16">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_16">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_19">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_19">Risk&#160;Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_19">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_22">Item&#160;1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_22">Unresolved&#160;Staff&#160;Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_22">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_25">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_25">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_25">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_28">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_28">Legal&#160;Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_28">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_31">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_31">Mine&#160;Safety&#160;Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_31">56</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_34">PART&#160;II</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_37">Item&#160;5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_37">Market&#160;for&#160;Registrant&#8217;s&#160;Common&#160;Equity,&#160;Related&#160;Stockholder&#160;Matters&#160;and&#160;Issuer&#160;Purchases&#160;of&#160;Equity&#160;Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_37">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_40">Item&#160;6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_40">Reserved</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_40">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_43">Item&#160;7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_43">Management&#8217;s&#160;Discussion&#160;and&#160;Analysis&#160;of&#160;Financial&#160;Condition&#160;and&#160;Results&#160;of&#160;Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_43">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_70">Item&#160;7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_70">Quantitative&#160;and&#160;Qualitative&#160;Disclosures&#160;About&#160;Market&#160;Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_70">71</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_73">Item&#160;8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_73">Financial&#160;Statements&#160;and&#160;Supplementary&#160;Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_73">73</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_160">Item&#160;9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_160">Changes&#160;in&#160;and&#160;Disagreements&#160;with&#160;Accountants&#160;on&#160;Accounting&#160;and&#160;Financial&#160;Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_160">113</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_163">Item&#160;9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_163">Controls&#160;and&#160;Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_163">113</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_166">Item&#160;9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_166">Other&#160;Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_166">114</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_3298534885100">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_166">114</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_169">PART&#160;III</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_172">Item&#160;10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_172">Directors,&#160;Executive&#160;Officers&#160;and&#160;Corporate&#160;Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_172">114</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_175">Item&#160;11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_175">Executive&#160;Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_175">114</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_178">Item&#160;12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_178">Security&#160;Ownership&#160;of&#160;Certain&#160;Beneficial&#160;Owners&#160;and&#160;Management&#160;and&#160;Related&#160;Stockholder&#160;Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_178">115</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_181">Item&#160;13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_181">Certain&#160;Relationships&#160;and&#160;Related&#160;Transactions,&#160;and&#160;Director&#160;Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_181">115</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_184">Item&#160;14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_184">Principal&#160;Accounting&#160;Fees&#160;and&#160;Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_184">115</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_187">PART&#160;IV</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_190">Item&#160;15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_190">Exhibits,&#160;Financial&#160;Statement&#160;Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_190">116</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_193">Item&#160;16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_193">Form&#160;10K&#160;Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_193">119</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K contains &#8220;forward-looking statements&#8221; that involve risks and uncertainties. The Company&#8217;s actual results could differ materially from those discussed in the forward-looking statements. The statements contained in this report that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Forward-looking statements are often identified by the use of words such as, but not limited to, &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;can,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;might,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;strategy,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would&#8221; or variations of these terms and similar expressions, or the negative of these terms or similar expressions intended to identify forward-looking statements. Forward-looking statements are necessarily based on estimates and assumptions that, while considered reasonable by the Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. Forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the section titled &#8220;Risk Factors&#8221; included under Part I, Item 1A below. Furthermore, such forward-looking statements speak only as of the date of this report. Except as required by law, the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis should be read in conjunction with and are qualified in their entirety by reference to the discussions included in Item 1A - Risk Factors, Item 7 - Management&#8217;s Discussion &amp; Analysis of Financial Condition and Results of Operations, and elsewhere in this Annual Report on Form 10-K.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Annual Report on Form 10-K, unless the context otherwise requires, references to the &#8220;Company,&#8221; &#8220;Cutera,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;the Company&#8217;s&#8221; refers to Cutera, Inc.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_16"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;BUSINESS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Annual Report on Form 10-K, &#8220;Cutera,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;the Company&#8217;s&#8221; refer to Cutera, Inc. and its consolidated subsidiaries.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Background</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cutera was formed in 1988 as a Delaware corporation and is a global provider of laser and energy-based aesthetic systems for practitioners worldwide. The Company designs, develops, manufactures, distributes, and markets light and energy-based product platforms for use by physicians and other qualified practitioners (collectively, &#8220;practitioners&#8221;), enabling them to offer safe and effective aesthetic treatments to their customers. In addition, the Company distributes third-party manufactured skincare products. The Company currently offers easy-to-use products based on the following key platforms: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten&#174;, enlighten SR&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel&#174; HR, excel&#174; V, excel&#174; V+,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt&#174; iD, truSculpt&#174; flex,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF&#174;,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; each of which enables physicians and other qualified practitioners to perform safe and effective aesthetic procedures, including treatment for body contouring, skin resurfacing and revitalization, tattoo removal, removal of benign pigmented lesions, vascular conditions, hair removal, and toenail fungus. The Company&#8217;s platforms are designed to be easily upgraded to add additional applications and hand pieces, which provide flexibility for the Company&#8217;s customers as they expand their practices. The Company&#8217;s ongoing research and development activities primarily focus on developing new products and improving and enhancing the Company&#8217;s portfolio of existing products. The Company also explores ways to expand the Company&#8217;s product offerings through alternative arrangements with other companies, such as distribution arrangements. The Company introduced </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a fractional RF microneedling device for skin revitalization, in January 2018, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten SR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in April 2018, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in July 2018, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in February 2019 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in June 2019, Secret PRO in July 2020, and a product extension of excel V+ during the fourth quarter of 2020. In 2021 the Company introduced</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> truSculpt flex+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a treatment mode that decreased the treatment time from approximately 45 minutes to 15 minutes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s trademarks include: "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cutera&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">," "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AccuTip 500&#174;,"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;CoolGlide&#174;,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;CoolGlide</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel&#174;,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;enlighten&#174;,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HR&#174;,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V&#174;,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V+&#174;,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;LimeLight&#174;,&#8221; "MyQ&#174;," &#8220;Pearl&#174;,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;PICO Genesis&#174;,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;ProWave 770&#174;,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Solera&#174;,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Titan&#174;,&#8221; &#8220;truSculpt&#174;,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,&#8221;"Secret PRO,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Secret</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RF&#174;,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;xeo&#174;.&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s logo and other trade names, trademarks, and service marks appearing in this document are the Company&#8217;s property. Other trade names, trademarks, and service marks appearing in this Annual Report on Form 10-K are the property of their respective owners. Solely for convenience, the Company&#8217;s trademarks and trade names referred to in this Annual Report on Form 10-K appear without the &#174; or symbols, but those references are not intended to indicate, in any way, that the Company will not assert, to the fullest extent under applicable law, the Company&#8217;s rights, or the right of the applicable licensor to these trademarks and trade names.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of each of the Company&#8217;s devices and a summary of the features of the Company&#8217;s primary platforms are as follows:</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In 2020, the Company expanded its distribution of the Secret PRO device. Secret PRO features two proven technologies &#8211; RF microneedling and fractional CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Secret PRO utilizes fractional CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for skin resurfacing and radio frequency microneedling for deep dermal remodeling. The pairing of technologies provides practitioners the ability to tailor each treatment for a patients individual skin concerns. Used individually or in combination for best outcomes with minimal downtime. Each time a procedure is performed, the physician must use a new handpiece tip. The sale of the replacement tip results in recurring revenue.</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In June 2019, the Company introduced the truSculpt flex for the muscle-sculpting market. This product is a bio-electrical muscle stimulation device designed to strengthen, firm and tone the abdomen, buttocks and thighs, and can treat patients at all fitness levels. The truSculpt flex delivers Multi-Direction Stimulation with truControl, inducing muscle hypertrophy and hyperplasia. Johari Digital Healthcare Ltd. (the Company&#8217;s contract manufacturing organization) received 510(k) clearance from the United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;) for muscle conditioning in 2013. It is sold in the USA, Canada, Japan, certain Asia Pacific markets, and the European Union (&#8220;EU&#8221;) and is expected to be sold to a broader international customer base upon required regulatory approvals. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes a consumable handpiece that needs to be "refilled" after a set number of treatments are performed, resulting in recurring revenue. In 2021, the company introduced</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> truSculpt flex+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a treatment mode that decreased the treatment time from approximately 45 minutes to 15 minutes.</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In February 2019, the Company introduced the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a new iteration of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vascular platform originally introduced in 2011. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, is a high-performance, vascular and benign pigmented lesion treatment platform </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">explicitly designed for the market of dermatologists and plastic surgeons. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has 50% more power than its predecessor and provides a greater range of parameters for faster, more customizable treatments. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are solid-state laser platforms providing a combination of the 532 nanometers (&#8220;nm&#8221;) green laser with 1064 nm Nd:YAG technology to provide a single, compact and efficient system that treats the entire range of cosmetic vascular and benign pigmented lesion conditions. In Q4 of 2020, the Company introduced a product extension to its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V+ platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which included a new, 1 mm Dermastat handpiece and expanded specifications. The new</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, expanded treatment capabilities and provided dermatologists and aesthetic providers a higher level of precision and versatility for vascular and pigmented lesions. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> continues to boast 50% more power than its predecessor (excel V) and provides a greater range of parameters for faster, more customizable treatments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a solid-state laser platform combining the 532 nanometers (&#8220;nm&#8221;) green laser with 1064 nm Nd:YAG technology to provide a single, compact and efficient system that treats the entire range of cosmetic vascular and benign pigmented lesion conditions. The excel V+ device includes Cutera&#8217;s signature laser genesis treatment, and introduced the &#8216;green genesis&#8217; treatment &#8211; a micro-pulsed 532 treatment.  </span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In July 2018, the Company introduced a hands-free version of the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the non-surgical body sculpting market. It includes consumable cycles that need to be ordered by the practitioner after a set number of treatments are performed, resulting in recurring revenue. This product is a high-powered radio frequency (&#8220;RF&#8221;) system designed for circumferential reduction, lipolysis, and deep tissue heating and can treat all body and skin types. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> delivers targeted energy at 2 MHz, causing subcutaneous adipose tissue lipolysis. The Company received 510(k) clearance from the FDA for lipolysis of abdominal fat in 2018. Prior </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platforms include the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a 2 MHz device for tissue heating and circumferential reduction of fat in the abdomen and flank, and the original </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform launched in August 2012 and delivered treatments at 1 MHz. In December 2016, the Company received 510(k) clearance from the FDA to market the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform for the temporary reduction in circumference of the abdomen. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes a consumable handpiece that needs to be &#8220;refilled&#8221; after a set number of treatments are performed, resulting in recurring revenue.</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Secret</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In January 2018, the Company introduced a new fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy. The targeted energy revitalizes the tissue, via hemostasis, and coagulation of the tissue, minimizing downtime. Each time a procedure is performed, the physician must use a new handpiece tip. The sale of the replacement tip results in recurring revenue. The Company is the distributor of Secret RF.</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">enlighten </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; In December 2014, the Company introduced the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> laser platform with a dual wavelength (1064 nm + 532 nm). In December 2016, the Company introduced a three wavelength model (1064 nm + 532 nm + 670 nm)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> system is a dual pulse duration (750 picoseconds, or &#8220;ps,&#8221; and two nanoseconds, or &#8220;ns&#8221;) laser system cleared for multi-colored tattoo removal and the treatment of benign pigmented lesions and acne scars. In 2018, the Company introduced an expanded performance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and in April 2018, the Company introduced </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SR,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a lighter version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with reduced optical performance. Clinical studies were conducted to support an FDA clearance in October 2018 for treatment of acne scars on patients with Fitzpatrick skin types II-V when used with the PICO Genesis FX Micro Lens Array (&#8220;MLA&#8221;) handpiece attachment.</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In June 2014, the Company introduced the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform, a premium hair removal solution for all skin types, combining the Company&#8217;s proven long-pulse 1064 nm Nd:YAG laser and a high-power 755 nm Alexandrite laser with sapphire contact cooling.</span></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In 2003, the Company introduced the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which combines intense pulsed light technology with laser applications in a single system. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a multi-application platform on which a customer can purchase hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above-mentioned primary systems, the Company generates revenue from the distribution of skincare products, which are manufactured by ZO Skin Health, Inc. (&#8220;ZO&#8221;), and sold in the Japanese market. The Company also generates revenue from the sale of post-warranty services.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers its customers the ability to select the systems and applications that best fit their practice and subsequently upgrade their systems to add new applications. This upgrade path allows the Company&#8217;s customers to cost-effectively build their aesthetic practices and provides the Company with a source of incremental revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Market for Non-Surgical Aesthetic Procedures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes several factors are contributing to the global growth of aesthetic treatment procedures and aesthetic laser equipment sales, including:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Growing Improvement in Economic Environment, Aesthetic Accessibility, and Expanded Practitioner Base</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The improvements in overall global economic conditions since the financial crisis of 2007-2008&#160;have created an increased demand for aesthetic procedures, which has resulted in an expanding practitioner base to satisfy the demand. An expanding practitioner base paired with digital and mobile advancements has led to a broader range of accessibility options for potential patients.</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%;padding-left:14.5pt">Aging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Demographics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Industrialized</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Countries</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> The aging population of industrialized countries, the amount of discretionary income available to the &#8220;baby boomer&#8221; demographic segment &#9472; ages 57 to 75 as of 2021 &#9472; and their desire to retain a youthful appearance contribute to the increased demand for aesthetic procedures. With millennials entering their 40's the demand and preference for non-invasive aesthetic treatments are also rising. Millennials who are currently entering their 30's, including those in their 30's, have been earlier adopters of aesthetic treatments in comparison to older generations.</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Broader</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Range</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Safe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effective</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treatments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Technical developments and an increase in treatable conditions due to new product introductions, have led to safe, effective, easy-to-use, and low-cost treatments with fewer side effects, resulting in broader adoption of aesthetic procedures by practitioners. In addition, technical advancements enable practitioners to offer a broader range of treatments. These technical developments reduce treatment and recovery times, leading to greater patient demand.</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Broader</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Base</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Managed care and government payor reimbursement restrictions motivate physicians to establish or expand their elective aesthetic practices with procedures paid for directly by patients. As a result, in addition to core practitioners such as dermatologists and plastic surgeons, many other practitioners, such as gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners (&#8220;non-core practitioners&#8221;) expanded their practices to offer aesthetic procedures.</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Reductions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">per</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Procedure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Due partly to increased competition in the aesthetic market, the cost per procedure has decreased in the past few years. This attracts a broader base of customers and patients seeking aesthetic procedures.</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Wide</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acceptance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aesthetic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Focus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">on</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Body</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Image</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Appearance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> According to the American Society for Aesthetic Plastic Surgery survey in 2019, both surgical and non-surgical procedures increased compared to 2015. Surgical procedures increased by 6.2%, while non-surgical procedures increased by 13.3% over this four-year period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Surgical Aesthetic Procedures for Improving the Body and/or Skin&#8217;s Appearance and Their Limitations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many alternative therapies are available for improving a person&#8217;s appearance by treating specific structures within the skin. These procedures utilize injections or abrasive agents to reach different depths of the dermis and the epidermis. In addition, non-invasive and minimally invasive treatments have been developed that employ laser and other energy-based technologies to achieve similar therapeutic results. Some of these common aesthetic procedures and their limitations are described below.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Invasive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Body</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contouring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Treatments for non-invasive body sculpting can be done utilizing a variety of technologies, including radio frequency, laser, cooling, and ultrasound. Procedures address the reduction of unwanted fat on the abdomen, flanks, arms, thighs, submentum, and back and can require one or more treatments. Systems with the ability to induce non-invasive lipolysis (breakdown of fat) offer a more permanent solution with an average fat reduction of more than 20%. Common side effects of this approach may include paradoxical hyperplasia with cooling devices, and nodules which typically resolve over time and the risk of burning the treatment area with radiofrequency devices. In June 2019, the Company introduced the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a bio-electrical muscle stimulation device designed to strengthen, firm, and tone the abdomen, buttocks, and thighs. In 2021 the Company introduced</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> truSculpt flex+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a treatment mode that decreased the treatment time from approximately 45 minutes to 15 minutes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tattoo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">removal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The most effective way to remove tattoos on the body is to utilize laser systems that deliver very short pulse durations with high peak power in order to break up the ink particles that comprise tattoos.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global tattoo removal market was valued at $122.8&#160;million in 2019&#160;and is projected to reach $219.0 million by 2026. According to market research, people tend to remove their tattoos due to career choices, social conditions, personal situations, and more, which have been the key drivers for the tattoo removal market. Despite the effectiveness of lasers for tattoo removal, common complaints concerning laser tattoo removal include a low rate of complete clearance (sometimes no better than 50% after several treatments) as well as the high number of treatments for satisfactory clearance (often 10 or more treatments spaced four to eight weeks apart). However, the latest generation of tattoo removal lasers produce picosecond pulse durations, (a trillionth of a second) and thereby, can meaningfully improve tattoo clearance and reduce the total number of treatments. The Company introduced the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> system, a dual pulse duration laser system, that was cleared for multi-colored tattoo removal.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hair Removal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Techniques for hair removal include waxing, depilatories, tweezing, shaving, electrolysis, laser as well as other energy-based hair removal modalities. The only techniques that provide a long-lasting solution are electrolysis, laser, and other </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">energy-based technology such as Intense Pulsed Light (&#8220;IPL&#8221;). Electrolysis is usually painful, time-consuming and expensive for large areas, but is the most common method for removing light-colored hair. During electrolysis, an electrologist inserts a needle directly into a hair follicle and activates an electric current in the needle. Since electrolysis only treats one hair follicle at a time, the treatment of an area as small as an upper lip may require numerous visits and many hours of treatment. In addition, electrolysis can cause blemishes and infection related to needle use. In comparison, lasers can quickly treat large areas with a high degree of safety and efficacy. In 2003, the Company introduced the xeo system platform utilized for hair removal, which combines intense pulse light technology with laser applications in a single system. In 2014, the Company introduced the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform, a premium hair removal solution for all skin types, combining the Company&#8217;s proven long-pulse 1064 nm Nd:YAG laser and a high-power 755 nm Alexandrite laser with sapphire contact cooling.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revitalization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Skin revitalization treatments include a broad range of popular alternatives, including Botox and collagen injections, chemical peels, microdermabrasion, radio frequency treatment and laser and other energy-based treatments. With these treatments, patients hope to improve overall skin tone and texture, reduce pore size, tighten skin and remove other signs of aging, including mottled pigmentation, diffuse redness and wrinkles. All of these procedures are temporary solutions and must be repeated within several weeks or months to sustain their effect, thereby increasing the cost and inconvenience to patients. For example, the body absorbs Botox and collagen, and patients require supplemental injections every three to six months to maintain the benefits of these treatments.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other skin revitalization treatments, such as chemical peels and microdermabrasion, can have undesirable side effects. Chemical peels use acidic or caustic solutions to peel away the epidermis, and microdermabrasion generally utilizes sand crystals to resurface the skin. These techniques can lead to stinging, redness, irritation and scabbing. In addition, more serious complications, such as changes in skin color, can result from deeper chemical peels.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With many modalities available today for skin revitalization and resurfacing, the Company has developed a range of clinically proven solutions uniquely paired with a patient&#8217;s lifestyle and skin concerns, such as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which utilizes fractional CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for skin resurfacing and radio frequency microneedling for deep dermal remodeling and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a novel fractional RF microneedling system for tissue coagulation and hemostasis designed to stimulate and remodel collagen and address the common signs of aging.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RF Microneedling</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Also known as collagen induction therapy, microneedling is a minimally invasive revitalization treatment that involves using fine needles to create hundreds of tiny, invisible puncture wounds in the top layer of the skin, which stimulates the body's natural wound healing processes, resulting in cell turnover and increased collagen and elastin production via hemostasis and tissue coagulation. In January 2018, the Company introduced </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product, a RF fractional microneedling system. In 2020, the Company released the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which included the dual modality treatment options of RF microneedling and CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> laser.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Facial</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Veins</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Current aesthetic treatment methods for leg and facial veins include sclerotherapy, as well as laser and other energy-based treatments. With these treatments, patients seek to eliminate visible veins, and improve overall skin appearance. Sclerotherapy requires a skilled practitioner to inject a saline or detergent-based solution into the target vein, which breaks down the vessel causing it to collapse and be absorbed into the body. The need to correctly position the needle on the inside of the vein makes it difficult to treat smaller veins, which limits the treatment of facial vessels and small leg veins. In 2019, the Company introduced the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a high-performance, vascular and benign pigmented lesion treatment platform designed specifically for the core-market of dermatologists and plastic surgeons, which treats the entire range of cosmetic vascular and benign pigmented lesion conditions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laser and other energy-based non-surgical treatments for hair removal, veins, skin revitalization and body contouring are discussed in the following section.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Laser and Other Energy-Based Aesthetic Treatments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laser and other energy-based aesthetic treatments can achieve therapeutic results by affecting structures within the skin. The development of safe and effective aesthetic treatments has resulted in a well-established market for these procedures.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Practitioners can use laser and other energy-based technologies to selectively target hair follicles, veins, melanin as well as other chromophores within the epidermis and dermis, without damaging surrounding tissue. Practitioners can also use these technologies to safely remove portions of the epidermis and deliver heat to the dermis as a means of generating new collagen growth. Ablative skin resurfacing improves the appearance of the skin by removing the outer layers of the skin. Ablative skin resurfacing procedures are considered invasive or minimally invasive, depending on how much of the epidermis is removed during a treatment. Non-ablative skin resurfacing improves the appearance of the skin by treating the underlying structure of the skin.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Safe and effective laser and energy-based treatments require an appropriate combination of four parameters:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Energy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the amount of light or radio frequency emitted to heat a target;</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Pulse</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Duration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the time interval over which the energy is delivered;</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Spot Size</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Electrode</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Size</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the diameter of the energy beam, which affects treatment depth and area; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Wavelength</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Frequency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the position in the electromagnetic spectrum which impacts the absorption and the effective depth of the energy delivered.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, in the case of hair removal, by utilizing the correct combination of these parameters, a practitioner can use a laser or other light source to selectively target melanin within the hair follicle to absorb the laser energy and destroy the follicle, without damaging other delicate structures in the surrounding tissue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Technology and Design of the Company&#8217;s Systems</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten, excel, Secret PRO, Secret RF, truSculpt and xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platforms provide the long-lasting benefits of laser and other energy- based aesthetic treatments. The Company&#8217;s technology allows for a wide variety of applications in a single system. Key features of the Company&#8217;s solutions include:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Multiple</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Applications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Available</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Single</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Many of the Company&#8217;s platforms feature multiple-applications that enable practitioners to perform a variety of aesthetic procedures using a single device. These procedures include hair removal, vascular treatments and skin revitalization, which address discoloration, fine lines, and uneven texture. Because practitioners can use the Company&#8217;s systems for multiple indications, the investment in a unit is spread across a greater number of patients and procedures, and the acquisition cost may be more rapidly recovered.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Technology</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Design</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leadership</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s innovative laser technology combines multiple wavelengths, adjustable energy levels, variable spot sizes and a wide range of pulse durations, allowing practitioners to customize treatments for each patient and condition. The Company&#8217;s proprietary pulsed light hand pieces for the treatment of discoloration, hair removal and vascular treatments optimize the wavelength used for treatments and incorporate a monitoring system to increase safety. The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece utilizes a novel light source not previously used for aesthetic treatments. The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces, with proprietary YSGG technology, represent the first application of the 2790 nm wavelength for minimally invasive cosmetic dermatology.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Upgradeable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo, excel V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">trusculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products allow the Company&#8217;s customers to upgrade their system to the Company&#8217;s newest technologies or add new applications to their system, each of which provide the Company with a source of incremental revenue. The Company believes that product upgradeability allows customers to take advantage of the Company&#8217;s latest product offerings and provide additional treatment options to their patients, thereby expanding the opportunities for their aesthetic practices.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Treatments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Broad</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Range</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Types</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conditions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For hair removal, the Company&#8217;s products are safe and effective on patients of all skin types, including harder-to-treat patients with dark or tanned skin. In addition, the wide parameter range of the Company&#8217;s systems allows practitioners to effectively treat patients with both fine and coarse hair. Practitioners may use the Company&#8217;s products to treat spider veins on the leg; to treat facial veins; and perform skin revitalization procedures for discoloration, texture, fine lines and wrinkles on any type of skin. The ability to customize treatment parameters based on skin type enables practitioners to offer safe and effective therapies to a broad base of their patients.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Ease of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company designs its products to be easy to use. The Company&#8217;s proprietary hand pieces are lightweight and ergonomic, minimize user fatigue, and facilitate clear views of the treatment area, reducing the possibility of unintended damage and increasing the speed of application. The Company&#8217;s control console contains an intuitive user interface with simple, independently adjustable controls from which to select a wide range of treatment parameters to suit each patient&#8217;s profile. For instance, the clinical navigation user interface on the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform provides recommended clinical treatment parameter ranges based on patient criteria entered. The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces include a scanner with multiple scan patterns to allow simple and fast treatments of the face. Finally, the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> embodies the best of many of the above features. Unlike other body sculpting treatments on the market that require certain body types, or pinchable fat, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is &#8220;body agnostic&#8221; with the ability to customize treatments to the patient's needs and body type. In addition, the Company&#8217;s proprietary algorithms and navigation enable the practitioner to treat a 300cm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> area in only 15 minutes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Strategy</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s goal is to maintain and expand its position as a leading worldwide provider of light and energy-based aesthetic devices and complementary aesthetic products by executing the following strategies:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Continue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">to Expand</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Though the Company believes that its current portfolio of products is comprehensive, the Company&#8217;s research and development group has a pipeline of potential products under development. The Company launched </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2011, t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ruSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2012, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ProWave LX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2013, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2014. In addition, the Company continues to expand offerings on the Company&#8217;s current platforms with further enhancement such as the enlighten III launched in 2016, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> launched in 2017, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten SR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> launched in April 2018, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> launched in July 2018, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> launched in February 2019 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> launched in June 2019. The Company also introduced </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in January 2018, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a fractional CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and RF microneedling device, in September 2020. In 2021, the company introduced</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> truSculpt flex+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a treatment mode that decreased the treatment time from approximately 45 minutes to 15 minutes.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Improve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Productivity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company believes that the market for aesthetic systems will continue to offer growth opportunities. The Company continues to build brand recognition, add additional products to the Company&#8217;s international distribution channels, and focus on enhancing the Company&#8217;s global distribution network, all of which the Company expects will contribute to increased revenue.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Focus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">on</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Practitioners</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">with</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Established</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offices</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company believes there is growth opportunity in targeting the Company&#8217;s products to a broad customer base. The Company also believes that its customers&#8217; success is largely dependent upon having an existing medical practice, for which the Company&#8217;s systems provide incremental revenue sources to augment a customer&#8217;s existing practice revenue.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Leverage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Installed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Base</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; With the introduction of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company is able to effectively offer additional platforms into the existing installed base. In addition, each of these platforms allows for potential future upgrades that offer additional capabilities. The Company believes this program aligns the Company&#8217;s interest in generating revenue with the Company&#8217;s customers&#8217; interest in improving the return on their investment by expanding the range of treatments that can be performed in their practice.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Generate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Refillable,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consumable,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hand</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pieces</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt 3D, truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cycle and pulsed-light handpieces are refillable products, while the Company&#8217;s single use disposable tips applicable to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO, and Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are consumable products. Each provides the Company with the opportunity to participate in the procedure-based revenue from the Company&#8217;s existing customers. The Company offers post-warranty services to its customers either through extended service contracts to cover preventive maintenance or through direct billing for parts and labor. These post-warranty services serve as additional sources of revenue.</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.5pt">Generate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skincare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company generates revenue from distribution of third party manufactured skincare products in Japan. These skincare products are purchased from a third-party manufacturer and sold to licensed physicians and other end users.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO, Secret RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo platforms</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> allow for the delivery of laser light and/or RF energy for aesthetic applications from a single system. With the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform, practitioners can purchase customized systems with a variety of the Company&#8217;s multi-technology applications. Each of the Company&#8217;s products consists of a control console and one or more hand pieces, depending on the model.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table lists the Company&#8217;s currently offered products. Each checked box represents the applications included in the product in the years noted.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.712%"></td><td style="width:0.1%"></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applications:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Skin Revitalization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noninvasive<br/>Body<br/>Contouring*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">System<br/>Platforms</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Energy<br/>Source</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Hair<br/>Removal</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Vascular<br/>Lesions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BPL&#8217;s<br/>Dyschromia<br/>&amp; Melasma</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Texture,<br/>Lines and<br/>Wrinkles</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acne Scars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tattoo<br/>Removal</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lipolysis*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">xeo</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Nd:YAG</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">ProWave 770</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2005</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">AcuTip 500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2005</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Titan XL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">LimeLight</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2006</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Pearl</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2007</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Pearl Fractional</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2008</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">ProWave LX</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2013</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">excel V</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2012</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">excel HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(g)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">enlighten(dual wavelength)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2014</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(h)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">enlighten III&#160;(MLA)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">truSculpt 3D</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Secret RF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(j)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">truSculpt iD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x*</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">truSculpt flex</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x*</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">excel V+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Secret</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">PRO</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(k)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x**</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">EnergySources:</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.34pt">1064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nd:YAG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">laser;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.34pt">Visible</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">near-infrared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pulsed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Light;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.91pt">Infrared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pulsed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Light;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.34pt">2790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Er:YSGG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">laser;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.91pt">Combined</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">frequency-doubled</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nd:YAG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">laser;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:17.57pt">Radio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">frequency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">at</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&amp;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MHz</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">mono-polar</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.34pt">Combined</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">755</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Alexandrite</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">laser</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nd:YAG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">laser;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.34pt">Dual</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">wavelength</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nd:YAG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">picosecond</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">laser;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:17.57pt">Three</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">wavelength</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">532</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">670</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nd:YAG</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">picosecond</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">laser;</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:17.57pt">Radio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">frequency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">at</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MHz</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">mono-polar; and</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(k)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:15.91pt">Radio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">frequency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">at</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MHz</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bi-polar.</span></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mark</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">allows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">it</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">market</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Union,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Australia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">certain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">countries</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">outside</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">fat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">reduction,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">body</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">shaping</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">body</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">contouring.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">has</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">510(k)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">clearance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">reduction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">circumference</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">abdomen,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">non-invasive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">lipolysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(breakdown</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">fat)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">abdomen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">elevating</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">tissue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">temperature</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">treatment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">selected</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">medical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">conditions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">such</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">as</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">relief</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pain,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">muscle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">spasms,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">local</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">circulation,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">temporary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">improvement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">appearance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cellulite.</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">**Via Hemostasis and Coagulation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Upgrades</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo, excel V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">trusculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products, are designed to allow customers to cost-effectively upgrade to the Company&#8217;s newest technologies or add applications to their system, each of which provides the Company with a source of additional revenue.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Extended Contract Services and Support</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for terms of one to four years. The Company also offers services on a time-and-materials basis for systems and detachable hand piece replacements. Revenue related to services performed on a time-and-materials basis is recognized when performed. These post-warranty services serve as additional sources of recurring revenue from the Company&#8217;s installed product base.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s products are engineered to enable quick and efficient service and support. There are several separate components of the Company&#8217;s products, each of which can be removed and replaced. The Company believes that quick and effective delivery of service is important to its customers. As of December&#160;31, 2021, the Company had 40 Field Service employees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In countries where the Company is represented by distribution partners, customers are serviced through the distributor. Distributors are generally provided warranty coverage for parts only, with labor customarily provided to the end customer by the distributor. The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces generally include a warranty for a set number of shots, rather than for a period of time.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Training</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of systems to customers, except system sales through distributors, include training on the use of the system to be provided within 180 days of purchase. Training is also sold separately from systems. The Company recognizes revenue for training once the training has been provided.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consumables (Other accessories)</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company treats its customers' purchases of replacement cycles for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as replacement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces, as consumable revenue, which provides the Company with a source of recurring revenue from existing customers. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products have single use disposable tips, which must be replaced after every treatment. Sales of these consumable tips further enhance the Company&#8217;s recurring revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Applications and Procedures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s products are designed to allow the practitioner to select an appropriate combination of energy level, spot size and pulse duration for each treatment. The ability to manipulate the combinations of these parameters allows the Company&#8217;s customers to treat the broadest range of conditions available with a single energy-based system.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Invasive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Body</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contouring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology allows practitioners to apply a hand piece directly to the skin and deliver high-powered RF energy that results in the deep and uniform heating of the subcutaneous fat tissue at sustained therapeutic temperatures. This heating can cause selective destruction of fat cells, which are eliminated from the treatment area through the body&#8217;s natural wound healing processes. The treatment takes approximately 15 minutes and two or more treatments may be required to obtain the desired aesthetic results. The Company&#8217;s CE Mark allows the Company to market </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the EU, Australia and certain other countries outside the U.S. for fat reduction, body shaping, body contouring and circumferential reduction. In the U.S., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has 510(k) clearance for topical heating for the purpose of elevating tissue temperature for the treatment of selected medical conditions, such as relief of pain and muscle spasms and increase in local circulation. Additionally, the 2 MHz setting for the 40 cm2 hand piece is indicated for reduction in circumference of the abdomen and non-invasive lipolysis (breakdown of fat) of the abdomen. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> massage device is intended to provide a temporary reduction in the appearance of cellulite.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tattoo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Removal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> systems, delivering picosecond or dual picosecond and nanosecond pulse durations are used for tattoo removal, the treatment of benign pigmented lesions, and a laser skin toning procedure that the Company refers to as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PICO Genesis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hair</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Removal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company has two platforms, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which address hair removal for all skin types as well as hair thicknesses. The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform allows practitioners to select between the 1064 nm mode for darker, course hair, and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ProWave</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece designed to address finer, vellus hair. Contact cooling is present on both hand pieces for epidermal protection. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> employs both a 1064 nm Nd:YAG as well as a 755 nm Alexandrite for hair removal. Like the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the 1064 nm wavelength addresses darker, course hair while the 755 nm wavelength is used for finer, lighter hair. Both wavelengths are transmitted through the same </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CoolView</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece with spot sizes up to 18 mm for the 755 nm wavelength and up to 18 mm for the 1064 nm wavelength. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CoolView</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece employs sapphire as a means of contact cooling &#8211; epidermal protection. Both platforms are cleared for treating all skin types.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vascular</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lesions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Both the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as well as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V and excel V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platforms are capable of treating a wide range of aesthetic vein conditions, including spider and reticular veins, and small facial veins. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> employs the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LimeLight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece for addressing small veins as well as vascular lesions while the Nd:YAG is appropriate for deeper, larger vessels. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LimeLight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a fixed spot size IPL while the Nd:YAG has adjustable spot sizes up to 10mm. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel V+ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">devices are is a dual wavelength laser &#8211; 1064 nm and 532 nm &#8211; with adjustable spot sizes ranging from 2 mm to 12 mm for excel V and 1 mm - 16 mm for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The 532 nm and 1064 wavelength can be used to treat over 20 conditions ranging from small veins and vessels to a variety of vascular lesions. For both of these devices, patients receive on average between one and six treatments, with six weeks or longer between treatments.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revitalization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and enlighten platforms, utilizing an Nd:YAG laser, allow the Company&#8217;s customers to perform non-invasive and minimally-invasive treatments that reduce redness, dyschromia, fine lines, improve skin texture, and treat other aesthetic conditions. When using a 1064 nm Nd:YAG laser to improve skin texture and treat fine lines, cooling is not applied and the hand piece is held directly above the skin. A large number of pulses are directed at the treatment site, repeatedly covering an area, such as the cheek. By delivering many pulses of laser light to a treatment area, a gentle heating of the dermis occurs and collagen growth is stimulated to rejuvenate the skin and reduce wrinkles. Patients typically receive four to six treatments for this procedure. The treatment typically takes less than a half hour with a spacing of two to four weeks between treatments. Skin revitalization was expanded with introduction of 'green genesis', a micro-pulsed 532 nm treatment on the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excelV+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Texture,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lines</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wrinkles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform can address fine lines and wrinkles using the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces. When treating fine lines, texture and wrinkles with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece, the hand piece is held at a controlled distance from the skin and the scanner delivers a preset pattern of spots to the treatment area. Cooling is not applied to the epidermis during the treatment. The energy delivered by the hand piece ablates a portion of the epidermis while leaving a coagulated portion that will gently peel off over the course of a few days. Heat is also delivered into the dermis, which can result in the production of new collagen. Treatment of the full face can usually be performed in approximately 15 to 30 minutes. Patients receive on average between one and three treatments at monthly intervals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RF </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platforms feature Radio Frequency microneedling device that employs fractionated RF energy (2 MHz) delivered at different pre-programmed depths in the dermis to produce new collagen. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret devices</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> come with four treatment tips: a 25-pin tip, both insulated and semi-insulated, and a semi-insulated 64-pin tip. The treatment has minimal side effects, negligible downtime and results in improved skin tone and texture as well as improvement in acne scars.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dyschromia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s pulsed-light technologies allow the Company&#8217;s customers to safely and effectively treat red and brown dyschromia (skin discoloration), benign pigmented lesions, and rosacea. The practitioner delivers a narrow spectrum of light to the surface of the skin through the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LimeLight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces. These hand pieces include one of the Company&#8217;s proprietary wavelength filters, which reduce the energy level required for therapeutic effect and minimize the risk of skin injury.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 532 nm wavelength green laser option of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> systems, as well as the 755 nm infrared wavelength of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HR,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> can be used to treat benign pigmented lesions in substantially the same way.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In treating benign pigmented lesions, the hand piece is placed directly on the skin and then the pulse is triggered. The cells forming the pigmented lesion absorb the light energy, darken and then flake off over the course of two to three weeks. Several treatments may be required to completely remove the lesion. The treatment takes a few minutes per area treated and there are typically three to four weeks between treatments.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Practitioners can also treat dyschromia and other skin conditions with the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece. During these treatments, the heat delivered by the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece will remove the outer layer of the epidermis while coagulating a portion of the epidermis. That coagulated portion will gently peel off over the course of a few days, revealing a new layer of skin underneath. Treatment of the full face can usually be performed in 15 to 30 minutes. Patients receive on average between one and three treatments at monthly intervals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quality</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology allows the Company&#8217;s customers to use deep dermal heating to tighten lax skin. The practitioner delivers a spectrum of light to the skin through the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand piece. This hand piece includes the Company&#8217;s proprietary light source and wavelength filter which tailors the delivered spectrum of light to provide heating at the desired depth in the skin.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In treating compromised skin, the hand piece is placed directly on the skin and then the light pulse is triggered. A sustained pulse causes significant heating in the dermis. This heating can cause immediate collagen contraction while also stimulating </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">long-term collagen regrowth. Several treatments may be required to obtain the desired degree of tightening of the skin. The treatment of a full face can take over an hour and there are typically four weeks between treatments.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s CE Mark allows the Company to market the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the EU, Australia and certain other countries outside the U.S. for the treatment of wrinkles through skin tightening. However, in the U.S. the Company has a 510(k) clearance only for deep dermal heating.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company markets, sells, and services the Company&#8217;s products through direct sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, Spain, Switzerland and the United Kingdom. International sales and services outside of these direct markets are made through a network of distributors in over 42 countries, as well as a direct international sales force. The Company internally manages its U.S. and Canadian sales organization as one North American sales region.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also sells certain items like hand piece refills, cycle refills, consumable tips, and marketing brochures through the Company&#8217;s web site www.mycutera.com.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers generally demand quality, performance, ease of use and high productivity in relation to the cost of ownership. The Company responds to these customer demands by introducing new products focused on these requirements in the markets it serves. Specifically, the Company believes it introduces new products and applications that are innovative, address the specific aesthetic procedures in demand, and are upgradeable on its customers&#8217; existing systems. In addition, the Company provides attractive upgrade pricing to new product families. To increase market penetration, the Company also markets to non-core practitioners in addition to the Company&#8217;s core specialties of plastic surgeons and dermatologists.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company seeks to establish strong ongoing relationships with its customers through the upgradeability of the Company&#8217;s products, sales of extended service contracts, hand piece refills and replacement disposable tips, ongoing training and support, and by distributing skincare products in Japan. The Company primarily targets its marketing efforts to practitioners through office visits, workshops, trade shows, webinars and trade journals. The Company also markets to potential patients through brochures, workshops and its website. In addition, the Company offers clinical forums with recognized expert panelists to promote advanced treatment techniques using the Company&#8217;s products to further enhance customer loyalty and uncover new sales opportunities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The industry in which the Company operates is subject to intense competition. The Company&#8217;s products compete against conventional non-energy-based treatments, such as electrolysis, Botox and collagen injections, chemical peels, microdermabrasion and sclerotherapy. The products also compete against laser and other energy-based products offered by other public companies, such as Abbvie (acquired Allergan and its division Zeltiq), Bausch Health (formerly Valeant Pharmaceuticals), Vieve, Soliton, InMode and Lutronic, as well as private companies, including Sisram, Candela (formerly Syneron Candela, acquired in 2017 by an affiliate of private equity funds advised by Apax Partners), Sciton, BTL Industries and several others. In late 2019, Clayton, Dubilier &amp; Rice entered into an agreement under which its managed funds acquired Cynosure, LLC, a leader in medical aesthetics systems and technologies, from Hologic, Inc. Cynosure develops, manufactures, and markets medical aesthetic treatment systems for dermatologists, plastic surgeons, medical spas and other healthcare practitioners, with sales and distribution worldwide. In early 2020, the affiliated private equity funds of Baring Private Equity Asia completed the acquisition of Lumenis, a provider of specialty energy-based medical devices across the fields of aesthetics, urology, ophthalmology, ENT and gynecology, with an international presence. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition among providers of laser and other energy-based devices for the aesthetic market is characterized by extensive research and development efforts, and innovative technology. While the Company attempts to protect its products through patents and other intellectual property rights, there are few barriers to entry that would prevent new entrants or existing competitors from developing products that would compete directly with the Company. There are many companies, both public and private, that are developing devices that use both energy-based and alternative technologies. Some of these competitors have greater resources than the Company does or product applications for certain sub-markets in which the Company does not participate. Additional competitors may enter the market, and the Company is likely to compete with new companies in the future. To compete effectively, the Company has to demonstrate that the Company&#8217;s products are attractive alternatives to other devices and treatments by differentiating the Company&#8217;s products on the basis of performance, brand name, service and price. The Company has encountered, and expects to continue to encounter, potential customers who, due to existing relationships with the Company&#8217;s competitors, are committed to, or prefer, the products offered by these competitors. Competitive pressures may result in price reductions and reduced margins for the Company&#8217;s products.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also sells skincare products in Japan under the exclusive distribution agreement with ZO which granted the Company the exclusive right to promote, market, sell, and distribute the products produced by ZO in Japan. ZO&#8217;s skincare products compete against other Physician-dispensed skincare brands developed and marketed by other companies, such as Environ, Navision and Revision Skincare, among others.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company focuses its research and development efforts on innovation and improvement for products and services that align with its mission. The Company consistently strives to understand its customers&#8217; expectations for total excellence. The Company accomplishes this by its commitment to continuous improvement in design, manufacturing, and service, which the Company believes provides for superior products and services to ensure on going customer satisfaction, trust and loyalty. The Company seeks to comply with all applicable domestic and international regulations to maintain the highest quality.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s research and development activities are conducted by employees with a broad base of experience in lasers, optoelectronics, software, and other related disciplines. The Company develops working relationships with outside contract engineering and design consultants, giving the Company&#8217;s team additional technical and creative breadth. The Company works closely with thought leaders and customers, to understand unmet needs and emerging applications in aesthetic medicine.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions, Investments, and Distribution Agreements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s strategy of providing a broad range of therapeutic capabilities requires a wide variety of technologies, products, and capabilities. The rapid pace of technological development in the aesthetic device industry and the specialized expertise required in different areas make it challenging for the Company to develop a broad portfolio of technological solutions. In addition to internally generated growth through research and development efforts, the Company has considered, and expects to continue to consider, acquisitions, investments, and distribution agreements to provide access to new products and technologies in both new and existing markets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to further the Company&#8217;s strategic objectives and strengthen its existing businesses by making future acquisitions and investments, or by entering into new distribution agreements in areas that the Company believes it can acquire or stimulate the development of new technologies and products. Mergers and acquisitions of medical technology companies, as well as distribution relationships, are inherently risky and no assurance can be given that any acquisition will be successful or will not materially adversely affect the Company&#8217;s consolidated operations, financial condition and cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manufactures its products with components and subassemblies supplied by vendors and assembles and tests each of its products at the Brisbane, California facility, and at third party contract manufacturers&#8217; facilities. Quality control, cost reduction and inventory management are top priorities of the manufacturing operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases certain components, subassemblies, and assembled systems from a limited number of suppliers. All Secret RF systems are manufactured by Ilooda Co. Ltd, who also manages all related regulatory activities. The Company has flexibility with its suppliers to adjust the number of components and subassemblies as well as the delivery schedules. The forecasts are based on historical demands and sales projections. Lead times for components and subassemblies may vary significantly depending on the size of the order, time required to fabricate and test the components or subassemblies, specific supplier requirements and current market demand for the components and subassemblies. The potential for disruption of supply is reduced by maintaining sufficient inventories and identifying additional suppliers. The time required to qualify new suppliers for some components, or to redesign them, could cause delays in the Company&#8217;s manufacturing. To date, the Company has not experienced significant delays in obtaining any of its components or subassemblies.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patents and Proprietary Technology</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on a combination of patent, copyright, trademark and trade secret laws, and non-disclosure, confidentiality, and invention assignment agreements to protect the Company&#8217;s intellectual property rights. As of January 19, 2022, the Company had 28 issued and unexpired U.S. patents, eight pending U.S. patent applications, and four pending international applications under the Patent Cooperation Treaty (PCT). The Company intends to file for additional patents and trademarks to continue to strengthen the Company&#8217;s intellectual property rights. Patents typically have a 20-year term from the application filing date. There can be no assurance that pending patent applications will result in the issuance of patents, that patents issued to or licensed by the Company will not be challenged or circumvented by competitors, or that these patents will be found to be valid or sufficiently broad to protect the Company&#8217;s technology or to provide the Company with a competitive advantage.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also obtained certain trademarks and trade names for the Company&#8217;s products and maintain certain details about the Company&#8217;s processes, products, and strategies as trade secrets. In the U.S. and several foreign countries, the Company registers its Company name and certain of its product names as trademarks, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cutera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AcuTip, CoolGlide, CoolGlide excel, enlighten, excel V+, LimeLight, myQ, Pearl, PICO Genesis, ProWave 770, truSculpt, truSculpt iD, truSculpt flex, Secret PRO, SecretRF, and xeo. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may have common law rights in other product names, including</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> excel V, Solera, Titan and excel HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company intends to file for additional trademarks to continue to strengthen the Company&#8217;s intellectual property rights.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on non-disclosure and non-competition agreements with employees, technical consultants, and other parties to protect, in part, trade secrets and other proprietary technology. The Company also requires them to agree to disclose and assign to the Company all inventions conceived in connection with the relationship. There can be no assurance that these agreements will not be breached, that the Company will have adequate remedies for any breach, that others will not independently develop equivalent proprietary information or that third parties will not otherwise gain access to the Company&#8217;s trade secrets and proprietary knowledge.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information, please refer to Item 1A. Risk Factors of this Annual Report on Form 10-K, under the section entitled &#8220;Risk Factors - Intellectual property rights may not provide adequate protection for some or all of the Company&#8217;s products, which may permit third parties to compete against the Company more effectively, and the Company may be involved in future costly intellectual property litigation, which could impact the Company&#8217;s future business and financial performance.&#8221;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s products are medical devices subject to regulation by numerous government agencies, including the FDA and counterpart agencies outside the U.S. To varying degrees, each of these agencies require the Company to comply with laws and regulations governing the research, development, testing, manufacturing, labeling, pre-market clearance or approval, marketing, distribution, advertising, promotion, record keeping, reporting, tracking, and importing and exporting of medical devices. In the U.S., FDA regulations govern the following activities that the Company performs and will continue to perform to ensure that medical products distributed domestically or exported internationally are safe and effective for their intended uses:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product design and development;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product testing;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product manufacturing;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product safety;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product labeling;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product storage;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">record keeping;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">pre-market clearance or approval;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">advertising and promotion;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">production;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product sales and distribution; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">complaint handling.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA&#8217;s Pre-market Clearance Requirements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless an exemption applies, each medical device the Company wishes to commercially distribute in the U.S. will require either prior 510(k) clearance, or de novo approval from the FDA. The FDA classifies medical devices into one of three classes. Devices deemed to pose lower risks are placed in either Class I or II. For Class II, the manufacturer must submit to the FDA a pre-market notification requesting permission to commercially distribute the device. This process is known as 510(k) clearance. Some low risk devices are exempted from this requirement. Devices deemed by the FDA to pose the greatest risk, such as life-sustaining, life-supporting or implantable devices, or devices deemed not substantially equivalent to a previously cleared 510(k) device, are placed in Class III, requiring more rigorous pre-market approval. All of the Company&#8217;s current products are Class II devices.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">510(k) Clearance Pathway</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When 510(k) clearance is required, the Company must submit a pre-market notification demonstrating that the Company&#8217;s proposed device is substantially equivalent to a previously cleared 510(k) device or a device that was in commercial distribution before May 28, 1976 for which the FDA has not yet called for the submission of Pre-Market Approval, or "PMA", applications. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By regulation, the FDA is required to clear or deny 510(k), pre-market notification within 90 days of submission of the application. As a practical matter, clearance may take significantly longer, as FDA may require additional information. Laser devices used for aesthetic procedures, such as hair removal, have generally qualified for clearance under 510(k) procedures.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the indications for which the Company received a 510(k) clearance for the Company&#8217;s products and when these clearances were received.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:83.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.563%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FDA Marketing Clearances:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Received:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Laser-based products:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">- treatment of vascular lesions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June&#160;1999</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">- hair removal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March&#160;2000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">- permanent hair reduction</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January&#160;2001</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">- treatment of benign pigmented lesions and pseudo folliculitis barbae, commonly referred to as razor bumps, and for the reduction of red pigmentation in scars</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June&#160;2002</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">- treatment of wrinkles</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October&#160;2002</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- treatment to increase clear nail in patients with onychomycosis</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- expanded spot size to 5 mm for clear nail in patients with onychomycosis</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2013</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- addition of Alexandrite 755 nm laser wavelength for hair removal, permanent hair reduction, treatment of vascular, benign pigmented lesions and treatment of wrinkles</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2013</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- addition of treatment of mild to moderate inflammatory acne vulgaris</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-  enlighten picosecond and nanosecond 532/1064 nm for the treatment of benign pigmented lesions</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2014</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- enlighten picosecond and nanosecond 532/1064 nm for multi-colored tattoo removal</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2014</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- enlighten III picosecond and nanosecond 532/1064 nm for multi-colored tattoo removal and treatment of benign pigmented lesion and picosecond 670 nm for benign pigmented lesions</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- enlighten III higher performance specifications for 532/1064 nm; addition of nanosecond mode for 670nm</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- enlighten III addition of tattoo removal for lighter colored inks (green and blue) for 670 nm</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- enlighten Micro Lens Array (MLA) for treatment of acne scars</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 2018</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pulsed-light technologies:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- treatment of pigmented lesions</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March&#160;2003</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;- hair removal and vascular treatments</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March&#160;2005</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Infrared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">technology</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for deep dermal heating for the temporary relief of minor muscle and joint pain and for the temporary increase in local circulation where applied</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;2004</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Solera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">tabletop console:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- for use with the Titan hand piece</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October&#160;2004</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- for use with the Company&#8217;s pulsed-light hand pieces</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January&#160;2005</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">product for the treatment of wrinkles</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2007</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Pearl Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">product for skin resurfacing and coagulation</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2008</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">radio frequency product:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- for topical heating to elevate tissue temperature for the treatment of selected medical conditions such as relief of pain and muscle spasms and increase in local circulation; massage device for temporary reduction in the appearance of cellulite</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2008</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- Temporary reduction in circumference of the abdomen</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Reduction in circumference of the abdomen</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2017</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-4.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">- truSculpt 3D and iD: For non-invasive lipolysis of the abdomen and for reduction in circumference of the abdomen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:22.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- truSculpt flex: for improvement of abdominal tone, strengthening of abdominal muscles, and development of firmer abdomen; and strengthening, toning, and firming of buttocks and thighs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2019</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Modifications</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to FDA regulations, after a device receives 510(k) clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, labeling and biocompatibility, requires a new clearance. The FDA requires manufacturers to make this determination initially, but the FDA can review any such decision and may disagree with a manufacturer&#8217;s determination. To date, the Company has modified aspects of the Company&#8217;s products after receiving regulatory clearance and determined that new 510(k) clearances are not required for these modifications. If the FDA disagrees with the Company&#8217;s determination not to seek a new 510(k) clearance, the FDA may retroactively require the Company to seek 510(k) clearance.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical Trials</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When FDA approval of a Class II device requires human clinical trials, only approval from the Institutional Review Board (&#8220;IRB&#8221;) is required to proceed with the planned and IRB approved clinical trial/study.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to manufacture the Company&#8217;s products in compliance with the FDA&#8217;s Quality System Regulation (&#8220;QSR&#8221;) and the international quality management standard for medical systems ISO 13485:2016. The QSR and ISO 13485 cover the methods and documentation of the design, testing, control, manufacturing, labeling, quality assurance, packaging, storage and shipping of the Company&#8217;s products. Since 2017, the Company has been enrolled in the Medical Device Single Audit Program (&#8220;MDSAP&#8221;). The MDSAP allows a single audit of a medical device manufacturer&#8217;s Quality Management System (&#8220;QMS&#8221;), which satisfies the requirements of five&#160;regulatory jurisdictions (FDA - US, Health Canada - Canada, Therapeutic Goods Administration (&#8220;TGA&#8221;) - Australia, Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;) - Japan, and Ag&#234;ncia Nacional de Vigilancia Sanit&#225;ria (&#8220;ANVISA&#8221;) - Brazil); and for the EU under Europ&#228;ische Norm (&#8220;EN&#8221;) International Standards Organization (&#8220;ISO&#8221;) 13485:2016 and Medical Device Directive (MDD)/EU Medical Device Regulation MDR&#8221;).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MDSAP re-certification occurs every three years with a surveillance audit taking place annually. Major findings during these audits or an increase in field reportable events could trigger regulatory enforcement action including by the FDA. The Company&#8217;s manufacturing facility is ISO 13485 certified. The Company had a successful MDSAP re-certification audit in January 2021. There were no significant findings or observations as a result of this audit. However, the Company&#8217;s failure to maintain compliance with the QSR requirements could result in the shutdown of the Company&#8217;s manufacturing operations and the recall of the Company&#8217;s products, which would have a material adverse effect on the Company&#8217;s business. In the event that one of the Company&#8217;s suppliers fails to maintain compliance with specified quality requirements, the Company may have to qualify a new supplier and could experience manufacturing delays as a result. The Company has opted to maintain quality assurance and quality management certifications to enable the Company to market the Company&#8217;s products in the U.S., the member states of the EU, the European Free Trade Association and countries which have entered into Mutual Recognition Agreements with the EU.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pervasive and Continuing Regulation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a device is placed on the market, numerous regulatory requirements apply. These include:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Quality system regulations, which require manufacturers, including third-party manufacturers, to follow stringent design, testing, control, documentation and other quality assurance procedures during all aspects of the manufacturing process;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Labeling regulations and FDA prohibitions against the promotion of products for un-cleared, unapproved or &#8220;off-label&#8221; uses;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Medical device reporting regulations, which require that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction were to recur; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Post-market surveillance regulations, which apply when necessary to protect the public health or to provide additional safety and effectiveness data for the device.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has broad post-market and regulatory enforcement powers. The Company is subject to unannounced inspections by the FDA and the Food and Drug Branch of the California Department of Health Services (or &#8220;CDHS&#8221;), to determine the Company&#8217;s compliance with the QSR and other applicable regulations, which may include the manufacturing facilities of the Company&#8217;s subcontractors. In the past, the Company&#8217;s current manufacturing facility has been inspected by the FDA and the CDHS. The FDA and the CDHS noted observations, but there were no findings that involved a material violation of regulatory requirements. The Company&#8217;s responses to those observations have been accepted by the FDA and CDHS.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also regulated under the Radiation Control for Health and Safety Act, which requires laser products to comply with performance standards, including design and operation requirements, and manufacturers to certify in product labeling and in reports to the FDA that their products comply with all such standards. The regulations also require laser manufacturers to file </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">new product and annual reports, maintain manufacturing, testing and sales records, and report product defects. Various warning labels must be affixed and certain protective devices installed, depending on the class of the product.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with applicable regulatory requirements can result in enforcement action by the FDA, which may include any of the following sanctions:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Warning letters, fines, injunctions, consent decrees and civil penalties;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Repair, replacement, recall or seizure of the Company&#8217;s products;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Operating restrictions or partial suspension or total shutdown of production;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Refusing the Company&#8217;s requests for 510(k) clearance of new products, new intended uses, or modifications to existing products;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Withdrawing 510(k) clearance that have already been granted; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Criminal prosecution and penalties.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA also has the authority to require the Company to repair, replace or refund the cost of any medical device that it has manufactured or distributed. If any of these events were to occur, they could have a material adverse effect on the Company&#8217;s business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to a wide range of federal, state and local laws and regulations, including those related to the environment, health and safety, land use and quality assurance. The Company believes that compliance with these laws and regulations as currently in effect will not have a material adverse effect on the Company&#8217;s capital expenditures, earnings and competitive and financial position.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International sales of medical devices are subject to foreign governmental regulations, which vary substantially from country to country. The time required to obtain clearance or approval by a foreign country may be different than that required for FDA clearance. And the clearance or approval requirements may be different from those in the U.S.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Japan, the Company is actively seeking approvals for products to supplement the Company&#8217;s existing approvals for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">V,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> , </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LimeLight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ProWave</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Solera,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Economic Area (&#8220;EEA&#8221;), which is composed of the 27 Member States of the EU plus Norway, Liechtenstein and Iceland, a single regulatory approval process exists, and conformity with the legal requirements is represented by the CE mark. From January 1, 2021 the UK Conformity Assessed (UKCA) mark replaced the CE mark as the new product comfomity marking requirement in England, Wales, and Scotland. Medical devices will have until July 1, 2023 to comply. The CE mark continues to be required for goods sold in Northern Ireland. Other countries, such as Switzerland, have entered into Mutual Recognition Agreements and allow the marketing of medical devices that meet EU requirements. The EU has adopted numerous directives and European Standardization Committees have promulgated voluntary standards regulating the design, manufacture, clinical trials, labeling and adverse event reporting for medical devices. Devices that comply with the requirements of a relevant directive will be entitled to bear CE conformity marking, indicating that the device conforms to the essential requirements of the applicable directives and, accordingly, can be commercially distributed throughout the EEA and countries which have entered into a Mutual Recognition Agreement. The method of assessing conformity varies depending on the type and class of the product, but normally involves a combination of self-assessment by the manufacturer and a third-party assessment by a Notified Body, an independent and neutral institution appointed by a country to conduct the conformity assessment. This third-party assessment may consist of an audit of the manufacturer&#8217;s quality system and specific testing of the manufacturer&#8217;s device. An assessment by a Notified Body in one member state of the EEA, or one country which has entered into a Mutual Recognition Agreement is required in order for a manufacturer to commercially distribute the product throughout these countries. ISO 9001 and ISO 13845 certification are voluntary harmonized standards. Compliance establishes the presumption of conformity with the essential requirements for a CE Marking. In February 2000, the Company&#8217;s facility was awarded the ISO 9001 and EN 46001 certification.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the Company conducted the Company&#8217;s recertification audit to the requirements of ISO 13485:2003 under the MDSAP for the five regulatory jurisdictions signatory to MDSAP (FDA - US, Health Canada - Canada, TGA - Australia, PMDA - Japan, and ANVISA - Brazil); and for the EU under EN ISO 13485:2016 and MDD 93/42/EEC. In January 2021, the Company passed the recertification audit re-confirming compliance with ISO13485:2016 and MDSAP. The MDSAP and EU certification can be used to demonstrate compliance with GMP/QSR/QMS requirements for all five regulatory jurisdictions, replacing routine audits from each regulatory jurisdiction. For cause audits can still occur.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Applicability of Anti-Corruption Laws and Regulations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s worldwide business is subject to the U.S. Foreign Corrupt Practices Act of 1977 (the &#8220;FCPA&#8221;), the United Kingdom Bribery Act of 2010 (the &#8220;UK Bribery Act&#8221;) and other anti-corruption laws and regulations applicable in the jurisdictions where the Company operates. The FCPA can be used to prosecute companies in the U.S. for arrangements with physicians, or other parties outside the U.S., if the physician or party is a government official of another country and the arrangement violates the law of that country. The UK Bribery Act prohibits both domestic and international bribery, as well as bribery across both public and private sectors. There are similar laws and regulations applicable to the Company outside the U.S., all of which are subject to evolving interpretations. For additional information, please refer to Item 1A. Risk Factors of this Annual Report on Form 10-K, under the sections entitled &#8220;Risk Factors &#8211; the Company&#8217;s failure to comply with rules relating to bribery, foreign corrupt practices and privacy and security laws may subject the Company to penalties and adversely impact the Company&#8217;s reputation and business operations.&#8221;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patient Privacy and Security Laws</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various laws worldwide protect the confidentiality of certain patient health and other consumer information, including patient medical records, and restrict the use and disclosure of patient health information by healthcare providers. Privacy standards in Europe and Asia are becoming increasingly strict, enforcement action and financial penalties related to privacy in the EU are growing, and new laws and restrictions are being passed. The management of cross-border transfers of information among and outside of EU member countries is becoming more complex, which may complicate the Company&#8217;s clinical research and commercial activities, as well as product offerings that involve transmission or use of data. The Company will continue its efforts to comply with those requirements and to adapt the Company&#8217;s business processes to those standards.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), as amended by the Health Information Technology and Clinical Health Act (&#8220;HITECH&#8221;) and their respective implementing regulations, including the final omnibus rule published on January 25, 2013, imposes specified requirements relating to the privacy, security and transmission of individually identifiable health information. Among other things, HITECH makes HIPAA&#8217;s privacy and security standards directly applicable to &#8220;business associates,&#8221; defined as independent contractors or agents of covered entities that create, receive, maintain or transmit protected health information in connection with providing a service for or on behalf of a covered entity. HITECH also increased the civil and criminal penalties that may be imposed against covered entities, business associates and possibly other persons, and gave state attorneys new general authority to file civil actions for damages or injunctions in federal court to enforce the federal HIPAA laws and seek attorney&#8217;s fees and costs associated with pursuing federal civil actions. In addition, state laws govern the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways, thus complicating compliance efforts. The Company potentially operates as a business associate to covered entities in a limited number of instances. In those cases, the patient data that the Company receives may include protected health information, as defined under HIPAA. Enforcement actions can be costly and interrupt regular operations of its business. While the Company has not been named in any such actions, if a substantial breach or loss of data from the Company&#8217;s records were to occur, the Company could become a target of such litigation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU, Regulation 2016/679 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (&#8220;General Data Protection Regulation&#8221; or &#8220;GDPR&#8221;) came into effect on May 25, 2018. The GDPR replaces Directive 95/46/EC (&#8220;Data Protection Directive&#8221;). While many of the principles of the GDPR reflect those of the Data Protection Directive, for example in relation to the requirements relating to the privacy, security and transmission of individually identifiable health information, there are a number of changes. In particular: (1) pro-active compliance measures are introduced, such as the requirement to carry out a Privacy Impact Assessment and to appoint a Data Protection Officer where health data is processed on a &#8220;large scale;&#8221; and (2) the administrative fines that can be levied are significantly increased, the maximum being the higher of &#8364;20 million, or 4%, of the total worldwide annual turnover of the group in the previous financial year. The Company will continue its efforts to comply with the GDPR requirements and to adapt the Company&#8217;s business processes to those requirements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental Health and Safety Laws</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to various environmental health and safety laws and regulations worldwide. Like other medical device companies, the Company&#8217;s manufacturing and other operations involve the use and transportation of substances regulated under environmental health and safety laws including those related to the transportation of hazardous materials. To the best of the Company&#8217;s knowledge at this time, the Company does not expect that compliance with environmental protection laws will have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employees and Human Capital</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company had 461 employees, compared to 323 employees as of December 31, 2020. The Company believes that its future success will depend in part on the Company&#8217;s continued ability to attract, hire and retain qualified personnel. None of the Company&#8217;s employees are represented by a labor union, and the Company believes its employee relations are good.&#160;The Company is committed to fostering a diverse and inclusive workplace that attracts and retains exceptional talent. Through ongoing employee development, comprehensive compensation and benefits, and a focus on health, safety and employee wellbeing, the Company strives to help its employees in all aspects of their lives so they can do their best work.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversity, Equity and Inclusion</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is committed to create and maintain a diverse and safe work environment to capture the ideas and perspectives that fuel innovation and enable its workforce, customers, and communities to succeed in creating the future of medical aesthetics. The Company strives to create an inclusive workplace where people can design, manufacture, and market a comprehensive portfolio of aesthetic laser and energy-based products that enable its customers (the practitioner) to provide safe and effective treatments.&#160;Its commitment to diversity and inclusion starts at the highest levels of the Company.&#160;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Engagement</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly collects feedback to better understand and improve the employee experience and identify opportunities to continually strengthen its culture. The Company wants to know what is working well, what the Company can do better and how well its employees understand and practice the Company's cultural values. In 2021, nearly 93% of its employees participated in its annual employee survey.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leadership development and training</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At Cutera, the Company believes that the best leaders are the ones who come from within. These leaders learn with Cutera, grow with Cutera and reach their potential through challenging job experiences. The Company provides learning opportunities by offering valuable training resources for employees in order to ensure its people have everything they need to succeed both personally and professionally. The Company&#8217;s employees are encouraged to take responsibility for their own development and create learning plans that best fit their needs and development goals.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health, Safety and Wellness</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The physical health, financial well-being, life balance and mental health of its employees is vital to its success. The Company sponsors wellness initiatives designed to enhance physical, financial, and mental well-being for all employees. The Company has successfully implemented a number of safety and social distancing measures within its premises to protect the health and safety of associates who are required to be on-premise to support its business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes its periodic and current reports, including the Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports, filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as well as its charters for the Company's Audit, Compensation, Nominating and Corporate Governance, and Enterprise Risk Committees and its Code of Ethics, Corporate Governance Guidelines, By-Laws, and Certificate of Incorporation, available free of charge, on the Company&#8217;s website as soon as practicable after such material is electronically filed or furnished with the Securities and Exchange Commission (the &#8220;SEC&#8221;). The Company&#8217;s website address is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.cutera.com </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the reports are filed under &#8220;SEC Filings,&#8221; under &#8220;Financials&#8221; on the Investor Relations portion of the Company&#8217;s website. These reports and other information concerning the Company may be accessed through the SEC&#8217;s website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a rapidly changing economic and technological environment that presents numerous risks, many of which are driven by factors that the Company cannot control or predict. The Company&#8217;s business, financial condition and results of operations may be impacted by a number of factors. In addition to the factors discussed elsewhere in this report, the following risks and uncertainties could materially harm the Company&#8217;s business, financial condition or results of operations, including causing the Company&#8217;s actual results to differ materially from those projected in any forward-looking statements. The following list of significant risk factors is not all-inclusive or necessarily in order of importance. Additional risks and uncertainties not presently known to the Company, or that the Company currently deems immaterial, also may materially adversely affect the Company in future periods. You should carefully consider these risks and uncertainties before investing in the Company&#8217;s securities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Risk Factors</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business, financial condition, operating results and cash flows are subject to numerous risks and uncertainties that are summarized below. The below summary of risk factors should be read together with the more detailed discussion of risks set forth following this section under the heading &#8220;Risk Factors,&#8221; as well as elsewhere in this Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">s Business and its Industry</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Global Supply Chain Disruption and Inflation may have a material adverse effect on the Company's business, financial condition and results of operations.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company&#8217;s business, financial condition, liquidity, capital, and results of operations have been, and may continue to be, adversely affected by the COVID-19 pandemic.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The increase in sales of skincare products in Japan may be temporarily caused by the change in its customer&#8217;s spending habits due to the COVID-19 pandemic.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">The increase in sales of skincare products in Japan may be temporary and sales of Skincare products may decline in the future.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.46pt">The trading price of the Company&#8217;s notes and common stock may fluctuate substantially.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company&#8217;s ability to report timely and accurate information could be negatively impacted by its plan to implement a new accounting and enterprise resource planning (&#8220;ERP&#8221;) system</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Reliance on contract manufacturers increases the risk that we will not have sufficient supply or that such supply will not be available to us at an acceptable cost</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Any defects in the design, material or workmanship of its products, defective design, material or workmanship or misuse of its products will cause additional costs, including product recalls and product liability suits, and harm the Company&#8217;s reputation.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Failure in hiring, training and retaining sales professionals and skilled and experienced personnel, or changes to management will cause adversely affects the Company&#8217;s operation and operation results.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Inability to obtain regulatory clearance for our new energy-based solution for the treatment of Acne or that the device will be widely adopted by customers or their patients.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The aesthetic equipment market is characterized by rapid innovation and high competition, which may adversely affect the Company if it does not continue to innovate and develop new products and applications.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company competes against companies that offer alternative solutions to its products, have greater resources, or have a larger customer base and broader product offerings than the Company&#8217;s offerings.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company&#8217;s business is subject to regulatory requirements, laser performance standards, federal regulatory reforms, FDA and other government agencies&#8217; regulation and oversight which may negatively affect its business, financial condition and results of operations if the Company fails to comply with them.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company's products may cause or contribute to adverse medical events or be subject to failures or malfunctions that would be subject to sanctions that could harm its reputation, business, financial condition and results of operations.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company may be unable to obtain or maintain international regulatory qualifications or approvals for its current or future products and indications, which could harm its business.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Failure in International expansion and economic and other risks associated with international sales and operations could adversely affect the Company&#8217;s business.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Some of the Company&#8217;s manufacturing operations are dependent upon third-party suppliers, making its vulnerable to supply shortages and price fluctuations, which could harm its business.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Reduction or interruption in supply and an inability to develop alternative sources for supply may adversely affect the Company&#8217;s manufacturing operations and related product sales.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">If customers are not trained and/or the Company&#8217;s products are used by non-licensed practitioners, it could result in product misuse and adverse treatment outcomes, which could harm the Company&#8217;s reputation, result in product liability litigation, distract management and result in additional costs, all of which could harm the Company&#8217;s business.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company&#8217;s products are subject to clinical trial process which is lengthy and expensive with uncertain outcomes. Delays or failures in the Company's clinical trials will prevent it from commercializing any modified or new products.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Intellectual property rights may not provide adequate protection for some or all the Company&#8217;s products, or the Company may be involved in future costly intellectual property litigation.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The expense and potential unavailability of insurance coverage for the Company&#8217;s customers could adversely affect its ability to sell its products, and therefore adversely affect its financial condition.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Any acquisitions that the Company makes could result in operating difficulties, dilution, and other consequences that may adversely impact the Company&#8217;s business and results of operations.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Inability to access credit on favorable terms for the funding of the Company&#8217;s operations and capital projects may be limited due to changes in credit markets.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Security breaches, cyber-security incidents and other disruptions could compromise the Company&#8217;s information and impact the Company&#8217;s business, financial condition or results of operations.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Macroeconomic political and market conditions, and catastrophic events may adversely affect the Company&#8217;s business, results of operations, financial condition and the trading price of the notes and the stock.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company has a relatively limited number of shares of common stock outstanding, which could result in the increase in volatility of its stock price and the trading price of the notes.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Disaster or other similar event could cause damage to its facilities and equipment, which might require the Company to cease or curtail sales of these sole sourced platforms.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Income tax audits or similar proceedings or changes in accounting standards may have a material adverse effect on the Company&#8217;s results of operations and financial position.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Notes</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Although the notes are referred to as convertible senior notes, they are effectively subordinated to any of the Company's secured debt and any liabilities of its subsidiaries.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Regulatory actions and other events may adversely affect the trading price and liquidity of the notes.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Volatility in the market price and trading volume of the Company's common stock could adversely impact the trading price of the notes.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company may still incur substantially more debt or take other actions which would intensify the risks discussed above.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company may not have the ability to raise the funds necessary to settle conversions of the notes in cash or to repurchase the notes upon a fundamental change, and its future debt may contain limitations on its ability to pay cash upon conversion or repurchase of the notes.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The conditional conversion feature of the notes, if triggered, may adversely affect the Company's financial condition and operating results.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Holders of notes will not be entitled to any rights with respect to the Company's common stock, but they will be subject to all changes made with respect to the Company's common stock to the extent the Company satisfies its conversion obligation, in whole or in part, with shares of its common stock.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The conditional conversion feature of the notes could result in holders receiving less than the value of the Company's common stock into which the notes would otherwise be convertible.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Upon conversion of the notes, holders may receive less valuable consideration than expected because the value of the Company's common stock may decline after holders exercise their conversion right but before the Company satisfies it conversion obligation.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The notes are not protected by restrictive covenants.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The increase in the conversion rate for notes converted in connection with a make-whole fundamental change or during a redemption period may not adequately compensate holders for any lost value of their notes as a result of such transaction or redemption.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The conversion rate of the notes may not be adjusted for all dilutive events.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Provisions in the indenture governing the notes may deter or prevent a business combination that may be favorable to the holders. </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The capped call transactions may affect the value of the notes and the Company's common stock.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company is subject to counterparty risk with respect to the capped call transactions.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Some significant restructuring transactions may not constitute a fundamental change, in which case the Company would not be obligated to offer to repurchase the notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company has not registered the notes or the common stock issuable upon conversion, if any, which will limit the ability of holders to resell them.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company cannot assure the holders of the notes that an active trading market will develop for the notes.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Any adverse rating of the notes may cause their trading price to fall.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The holders of the notes may be subject to tax if the Company makes or fails to make certain adjustments to the conversion rate of the notes even though the holders do not receive a corresponding cash distribution.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company may redeem the notes at its option, which may adversely affect the holders' return.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The notes will initially be held in book-entry form and, therefore, holders must rely on the procedures and the relevant clearing systems to exercise their rights and remedies.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of the Company's</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Anti-takeover provisions contained in the Company's amended and restated certificate of incorporation and amended and restated bylaws, as well as provisions of Delaware law, could impair a takeover attempt.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company's business could be negatively affected by activist shareholders.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">If securities or industry analysts do not publish or cease publishing research or reports about the Company, its business, its market or its competitors, or if they adversely change their recommendations regarding the Company's common stock, the market price and trading volume of its notes and common stock could decline.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Company does not expect to declare any dividends on its common stock in the foreseeable future.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">If the Company raises additional capital through the sale of shares of the Company&#8217;s common stock, convertible securities or debt in the future, its stockholders&#8217; ownership in the Company could be diluted and restrictions could be imposed on the Company&#8217;s business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to&#160;the Company&#8217;s Business and its Industry</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Global Supply Chain Disruption and Inflation may have a material adverse effect on the Company's business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disruptions to the global economy in 2020 and 2021 impeded global supply chains and resulted in longer lead times and increased component costs and freight expenses. In some instances, the Company depends on a sole source supplier arrangement, and alternative suppliers may not be readily available. The supply of these components is critical to the Company's manufacturing needs. Despite the actions the Company has undertaken to minimize the impacts from disruptions to the global economy, there can be no assurances that unforeseen future events in the global supply chain, and inflationary pressures, will not have a material adverse effect on its business, financial condition, and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The effects of the COVID-19 pandemic have affected how</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">its</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">customers are operating</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">its</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">businesses, and the duration and extent to which this will impact</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">its</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">future results of operations and overall financial performance remains uncertain.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and related public health measures have affected how the Company and its customers are operating their businesses and have materially and adversely affected the Company&#8217;s business and the Company&#8217;s financial results. To date, the impact includes: a) the deferral of procedures using its&#160;products, b) disruptions or restrictions on the ability of many of&#160;the Company&#8217;s&#160;employees and of third parties on which the Company&#160;relies, to work effectively, including&#160;&#8220;stay-at-home&#8221;&#160;orders and similar government actions; and c) temporary closures of its&#160;facilities and of the facilities of&#160;the Company&#8217;s&#160;customers and suppliers. If the pandemic has a substantial impact on its employees&#8217; or customers&#8217; businesses and productivity, the Company&#8217;s results of operations and overall financial performance may be materially and adversely affected. The global macroeconomic effects of the pandemic may persist for an indefinite period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As jurisdictions throughout the world continue to respond to the pandemic, the degree of the foregoing impacts may increase in scope or magnitude or&#160;the Company&#160;may experience additional adverse effects in one or more regions. Any other outbreaks of contagious diseases or other adverse public health developments in countries where&#160;the Company&#160;operates or where&#160;its customers or suppliers are located could also have a material and adverse effect on&#160;its business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the COVID-19 pandemic,&#160;customers and their patients have been, and in certain regions continue to be, required, or are choosing, to defer elective procedures in which&#160;the Company's&#160;products otherwise could be used, and many facilities that specialize in the procedures in which&#160;the Company's&#160;products otherwise could be used have temporarily closed and in some cases continue to be temporarily closed or operating at reduced hours. In addition, even after the pandemic subsides or governmental orders no longer prohibit or recommend against performing such procedures, patients may continue to defer such procedures due to personal concerns. Further, facilities at which&#160;its products typically are used may not reopen or, even if they reopen, patients may elect to have procedures performed at facilities that are, or are perceived to be, lower-risk, such as private surgery centers, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and&#160;the Company's&#160;products may not be approved at such facilities, and&#160;the Company&#160;may be unable to have&#160;the Company's&#160;products approved for use at such facilities on a timely basis, or at all. The effect of the pandemic on the broader economy could also negatively affect demand for elective procedures using&#160;its products, both in the near- and long-term. Workforce limitations and travel restrictions resulting from government actions taken to contain the spread of COVID-19 have and will continue to adversely affect almost every aspect of&#160;its business. If a significant percentage of&#160;the Company's&#160;workforce, or of the workforce of third parties on which&#160;the Company&#160;relies, cannot work, including because of illness or travel or government restrictions,&#160;its operations will be negatively affected. Due to government restrictions and social distancing guidelines in many countries around the world, there is an increased reliance on working from home for&#160;the Company's&#160;workforce and on the workforce of third parties on which&#160;the Company&#160;rely. For example, most of&#160;the Company's&#160;sales personnel and third-party agents currently are working largely using virtual and online engagement tools and tactics, which may be less effective than&#160;its typical in-person sales and marketing programs. In addition,&#160;the Company&#160;reduced access to&#160;its hands-on customer trainings, which, in turn, adversely impacted&#160;the Company's&#160;ability to educate and train customers on the proper use of&#160;the Company's&#160;products, which may make surgeons less comfortable using, and therefore less likely to use,&#160;the Company's&#160;products. The Company&#160;believes that interruptions resulting from the COVID-19 pandemic may limit&#160;its ability to develop, and therefore launch, the products&#160;the Company&#160;believes will drive the Company&#8217;s future revenue growth on the timelines&#160;the Company&#160;anticipated previously, or at all, and could also delay the planned launch of products in 2022 and beyond. It may also cause&#160;the Company&#160;not to submit required filings on&#160;its previous timelines, including with the FDA, or other regulatory bodies, both in the U.S. and outside the U.S. The COVID-19 pandemic has adversely impacted&#160;the Company's&#160;clinical trial operations in the United States. In addition, changes impacting workforce function at the FDA and other regulatory bodies, as well as changes impacting workforce function at the facilities at which&#160;the Company&#160;seeks to have new products approved for use, could adversely impact the timing of when&#160;the Company's&#160;new products are cleared for marketing and approved for use, either of which would adversely impact the timing of&#160;its ability to sell these new products and would have a material and adverse effect on&#160;the Company's&#160;revenue growth.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the&#160;COVID-19&#160;outbreak, some of the Company&#8217;s customers are being required to&#160;shelter-in-place&#160;and are not working. In cases where&#160;the Company&#8217;s&#160;customers are working, they are performing fewer procedures. When they are performing procedures, customers are mostly focused on medically necessary procedures that should not be delayed.&#160;Non-urgent,&#160;non-essential&#160;procedures are getting cancelled or delayed. As a result of fewer aesthetic procedures being performed and anxiety about the economic future, the Company&#8217;s customers may cancel orders for laser systems or will use less consumables. Some of&#160;the Company&#8217;s&#160;customers will feel less confident about making investments in their practices and focus on retaining their cash. As a result of cash conservation efforts by&#160;the Company&#8217;s&#160;customers,&#160;the Company&#160;may also encounter problems collecting on its receivables, which will impact&#160;the Company&#8217;s&#160;cash position and could result in negative cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, disruptions in the manufacture and distribution of&#160;the Company's&#160;products or in&#160;its supply chain may occur as a result of the COVID-19 pandemic, including for the reasons above, or other events that result in staffing shortages, production slowdowns, stoppages, or disruptions in delivery systems, any of which could materially and adversely affect&#160;the Company's&#160;ability to manufacture or distribute&#160;its products, or to obtain the raw materials and supplies necessary to manufacture and distribute the Company&#8217;s products, in a timely manner, or at all.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also experience other unknown adverse impacts from COVID-19 that cannot be predicted. For example,&#160;customers and other facilities at which&#160;the Company&#160;sells its products may renegotiate their purchase prices, including as a result of, or the perception that they may be suffering, financial difficulty as a result of the pandemic. Similarly, facilities at which&#160;the Company&#160;seeks to sell&#160;its products in the future may require price reductions relative to the price at which&#160;the Company&#160;previously expected to sell&#160;its products. Reduction in the prices at which&#160;the Company&#160;sells products to existing customers may have a material and adverse effect on&#160;its future financial results and reductions in the prices at which&#160;the Company&#160;expected to sell products would have a material and adverse effect on&#160;its expectations for revenue growth.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the global capital markets experienced, and&#160;the Company&#160;expects will continue to experience, disruption and volatility due to the COVID-19 pandemic, adversely impacting access to capital for the Company's customers and suppliers who need access to capital. Their inability to access capital in a timely manner, or at all, could adversely impact demand for&#160;its products and/or adversely impact&#160;its ability to manufacture or supply&#160;its products, any of which could have a material and adverse effect on&#160;the Company's&#160;business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The extent to which the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">pandemic will impact the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s business going forward will depend on numerous evolving factors that cannot be reliably predicted, including the duration and scope of the pandemic; governmental, business, and individuals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">actions in response to the pandemic; and the impact on economic activity including the possibility of recession or financial market instability.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects the customers will return and&#160;the amount of revenue&#160;to&#160;increase in 2022&#160;compared to 2021 as the economic environment outlook due to the&#160;COVID-19&#160;pandemic improves. However, the&#160;COVID-19&#160;outbreak continues to be fluid and the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aftermath of the business and economic disruptions due to the&#160;COVID-19 pandemic is still uncertain, making it difficult to forecast the final impact it could have on&#160;the Company&#8217;s&#160;future operations.&#160;The spread of the coronavirus, which caused a broad impact in 2020 and 2021 globally, including restrictions on travel, shifting work force to work remotely and quarantine policies put into place by businesses and governments, had a material economic effect on the Company&#8217;s business. Notably, healthcare facilities in many countries effectively banned elective procedures. Many of the Company&#8217;s products are used in aesthetic elective procedures and as such, the bans on elective procedures substantially reduced the Company&#8217;s sales and marketing efforts in the early months of the pandemic. The Company&#160;cannot presently predict the scope and severity of any impacts in future periods from the business shutdowns or disruptions due to the&#160;COVID-19&#160;pandemic, but the impact on economic activity such as the possibility of recession or financial market instability could have a material adverse effect on the Company&#8217;s business, revenue, operating results, cash flows and financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The increase in sales of skincare products in Japan may be temporary and sales of Skincare products may decline in the future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020 and 2021, the Company experienced a significant increase in sales of skincare products under the exclusive distribution agreement with ZO which allows&#160;the Company to sell ZO&#8217;s skincare products in Japan. The reason for the increase in skincare products sales might have been the&#160;result of changes in customers&#8217; spending habits to purchase more aesthetic treatments which could be applied at home due to limitations on&#160;in-person&#160;aesthetic procedures, social distancing and mask wearing requirements due to the&#160;COVID-19&#160;pandemic. Future growth in sales of skincare products depends on the customers&#8217; spending habits, which may change back to original spending habits after the&#160;COVID-19&#160;pandemic. Such changes may have a material adverse effect on the Company&#8217;s revenue, operating results and cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The trading price of the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s notes and common stock may fluctuate substantially due to several factors, some of which are discussed below. Further, the Company has a relatively limited number of shares of common stock outstanding, a large portion of which is held by a small number of investors, which could result in the increase in volatility of its stock price and the trading price of the notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been recent volatility in the price of the Company&#8217;s common stock. The Company believes this is due in part to the overall impact of&#160;COVID-19&#160;on the aesthetic industry and its partial recovery, the remaining open territories associated with the Company&#8217;s North America salesforce, and other factors. As a result of the Company&#8217;s relatively limited public float, its common stock may be less liquid than the stock of companies with broader public ownership. Among other things, trading of a relatively small volume of the Company&#8217;s common stock may have a greater impact on the trading price for the Company&#8217;s notes and shares than would be the case if the Company&#8217;s public float were larger. The public market price of the Company&#8217;s common stock has in the past fluctuated substantially and, due to the current concentration of stockholders, the trading price of the notes and the common stock may continue to do so in the future. The market price for the Company&#8217;s notes and common stock could also be affected by a number of other factors, including the general market conditions unrelated to the Company&#8217;s operating performance, including market volatility as a result of the&#160;COVID-19&#160;outbreak.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price for the Company&#8217;s notes and&#160;common stock could also be affected by a number of other factors, including:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the general market conditions unrelated to the Company&#8217;s operating performance;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">sales of large blocks of the Company&#8217;s common stock, including sales by the Company&#8217;s executive officers, directors and large institutional investors;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">quarterly variations in the Company&#8217;s, or the Company&#8217;s competitors&#8217;, results of operations;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">actual or anticipated changes or fluctuations in the Company&#8217;s results of operations;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">actual or anticipated changes in analysts&#8217; estimates, investors&#8217; perceptions, recommendations by securities analysts or the Company&#8217;s failure to achieve analysts &#8216;estimates;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the announcement of new products, service enhancements, distributor relationships or acquisitions by the Company or the Company&#8217;s competitors;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the announcement of the departure of a key employee or executive officer by the Company or the Company&#8217;s competitors;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">regulatory developments or delays concerning the Company&#8217;s, or the Company&#8217;s competitors&#8217; products; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the initiation of any litigation by the Company or against the Company, including the lawsuit initiated by the Company on January 31, 2020 in Federal District Court in California against Lutronic Aesthetics, Inc. as previously disclosed on February 3, 2020, or against the Company.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual or perceived instability and / or volatility in the Company&#8217;s stock price could reduce demand from potential buyers of the Company&#8217;s stock, thereby causing the trading price of the Company&#8217;s notes and stock to either remain depressed or to decline further. In addition, if the market for medical-device company stocks or the stock market in general experiences a loss of investor confidence, the trading price of the Company&#8217;s notes and stock could decline for reasons unrelated to the Company&#8217;s business, results of operations or financial condition. The trading price of the Company&#8217;s notes and common stock might also decline in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reaction to events that affect other companies in the Company&#8217;s industry even if these events do not directly affect us. In the past, following periods of volatility in the market price of a company&#8217;s securities, securities class action litigation has often been brought against that company. Any future securities litigation could result in substantial costs and divert the Company&#8217;s management&#8217;s attention and resources from the Company&#8217;s business. This could have a material adverse effect on the Company&#8217;s business, results of operations and financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s ability to report timely and accurate information could be negatively impacted by its plan to implement a new accounting and enterprise resource planning (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ERP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">) system.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently completing the implementation of a new accounting and ERP system. If aspects of the implementation are not executed successfully, then its ability to report timely and accurate information could be negatively impacted. Failure to report required information in a timely and accurate fashion could result in financial penalties, fines and other administrative actions. Such events could have a material adverse effect on the Company&#8217;s total enterprise value and stock price.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We currently rely on third-party contract manufacturers (&#8220;CMs&#8221;) to produce certain systems. This reliance on CMs increases the risk that we will not have sufficient supply or that such supply will not be available to us at an acceptable cost, which may have a material adverse effect on our business</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into arrangements with third-party contract manufacturers to produce and deliver fully assembled systems ready for direct shipment to our customers. We may experience supply shortfalls or delays in shipping products to our customers if our contract manufacturers experience delays, disruptions, quality control problems in their manufacturing operations, or if we have to change or add manufacturers or contract manufacturing locations. Even if products are available, we may be unable to obtain sufficient quantities at an acceptable cost or quality. Although we have contracts with our manufacturers that include terms to protect us in the event of early termination, we may not have adequate time to transition all of our manufacturing needs to an alternative manufacturer under comparable commercial terms.  As well, a significant portion of our manufacturing is performed in foreign countries and is therefore subject to risks associated with doing business outside of the U.S., including import restrictions, export restrictions, disruptions to our supply chain, cyberattacks, pandemics, regional climate-related events, or regional conflicts. The failure by us or our CMs to produce sufficient quantities at acceptable cost and quality may have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company&#8217;s annual and quarterly operating results may fluctuate in the future, which may cause the Company&#8217;s trading&#160;price for the notes and shares to&#160;decline.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net sales, expenses and operating results may vary significantly from year to year and quarter to quarter for several reasons, including, without limitation:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the ability of the Company&#8217;s sales force to effectively market and promote the Company&#8217;s products, and the extent to which those products gain market acceptance;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the inability to meet the Company&#8217;s debt repayment obligations under its senior credit facility due to insufficient cash;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the possibility that cybersecurity breaches, data breaches, and other disruptions could compromise the Company&#8217;s information or result in the unauthorized disclosure of confidential information;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the existence and timing of any product approvals or changes;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the rate and size of expenditures incurred on the Company&#8217;s clinical, manufacturing, sales, marketing, and product development efforts;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company&#8217;s ability to attract and retain personnel;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the availability of key components, materials and contract services, which depends on the Company&#8217;s ability to forecast sales, among other things;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">investigations of the Company&#8217;s business and business-related activities by regulatory or other governmental authorities;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">variations in timing and quantity of product orders;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">temporary manufacturing interruptions or disruptions;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the timing and success of new product and new market introductions, as well as delays in obtaining domestic or foreign regulatory approvals for such introductions;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">increased competition, patent expirations or new technologies or treatments;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product recalls or safety alerts;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">litigation, including product liability, patent, employment, securities class action, stockholder derivative, general commercial and other lawsuits;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">volatility in the global market and worldwide economic conditions;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in tax laws, including changes domestically and internationally, or exposure to additional income tax liabilities;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the impact of the EU privacy regulations (GDPR) on the Company&#8217;s resources;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the financial health of the Company&#8217;s customers and their ability to purchase the Company&#8217;s products in the current economic environment;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">other unusual or non-operating expenses, such as expenses related to mergers or acquisitions, may cause operating results to vary; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">an epidemic or pandemic, such as the current&#160;COVID-19&#160;pandemic.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of any of these factors, the Company&#8217;s consolidated results of operations may fluctuate significantly, which may in turn cause the&#160;trading price&#160;of the notes and the shares to fluctuate.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If defects are discovered in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s products, the Company may incur additional unforeseen costs, customers may not purchase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">product and the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s reputation may suffer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s success depends on the quality and reliability of its products. While the Company&#8217;s subject components are sources and products manufactured to stringent quality specifications and processes, the Company&#8217;s products incorporate different components including optical components, and other medical device software, any of which may contain errors or exhibit failures, especially when products are first introduced. In addition, new products or enhancements may contain undetected errors or performance problems that, despite testing, are discovered only after commercial shipment. Because the Company&#8217;s products are designed to be used to perform complex surgical procedures, due to the serious and costly consequences of product failure, the Company and its customers have an increased sensitivity to such defects. In the past, the Company has voluntarily recalled certain products. Although the Company&#8217;s products are subject to stringent quality processes and controls, the Company cannot provide&#160;assurance that its products will not experience component aging, errors, or performance problems. If the Company experiences product flaws or performance problems, any or all of the following could occur:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">delays in product shipments;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">loss of revenue;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">delay in market acceptance;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">diversion of the Company&#8217;s resources;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">damage to the Company&#8217;s reputation;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product recalls;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">regulatory actions;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">increased service or warranty costs; or</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product liability claims.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs associated with product flaws or performance problems could have a material adverse effect on the Company&#8217;s business, financial condition, results of operations&#160;or cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The success and continuing development of the Company&#8217;s products depends, in part, upon maintaining strong relationships with physicians and other healthcare professionals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company fails to maintain the Company&#8217;s working relationships with physicians and other ancillary healthcare and aesthetic professionals, the Company&#8217;s products may not be developed and marketed in line with the needs and expectations of the professionals who use and support the Company&#8217;s products. Physicians assist the Company as researchers, marketing consultants, product consultants, and public speakers, and the Company relies on these professionals to provide the Company with considerable knowledge and experience. If the Company is unable to maintain these strong relationships, the development and marketing of the Company&#8217;s products could suffer, which could have a material adverse effect on the Company&#8217;s consolidated financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company relies heavily on its sales professionals to market and sell its products worldwide. If the Company is unable to hire, effectively train, manage, improve the productivity of, and retain the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s sales professionals, the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s business will be harmed, which would impair its future revenue and profitability.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s success largely depends on the Company&#8217;s ability to hire, train, manage, and improve the productivity levels of the Company&#8217;s sales professionals worldwide. Because of the Company&#8217;s focus on&#160;non-core&#160;practitioners in the past, several of its sales professionals do not have established relationships with the core market, consisting of dermatologists and plastic surgeons, or where those relationships exist, they are not appropriately strong.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition for sales professionals who are familiar with, and trained to sell in, the aesthetic equipment market continues to be robust. As a result, the Company occasionally loses its sales people to competitors. The Company&#8217;s industry is characterized by a few established companies that compete vigorously for talented sales professionals. Some of its sales professionals leave the Company for jobs that they perceive to be better opportunities, both within and outside of the aesthetic industry. For instance, in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, the&#160;Company experienced significant turnover of the Company&#8217;s sales professionals, including several people in key sales leadership positions. Most of these sales professionals went to work for a competitor and the loss of these sales professionals negatively impacted the Company&#8217;s sales performance until the Company was able to hire and train replacement personnel. The Company believes it has adequate measures in place to protect the Company&#8217;s proprietary and confidential information when employees leave the Company, however the ability to enforce these measures varies from jurisdiction to jurisdiction and the Company&#160;must make a&#160;case-by-case&#160;decision regarding legal enforcement action. For instance, covenants&#160;not-to-compete&#160;are not allowed in many states, and if allowed, are difficult to enforce in many jurisdictions. Furthermore, such legal enforcement actions are expensive and the Company&#160;cannot give any assurance that these enforcement actions will be successful.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, the Company also continues to hire and train new sales people, including several from the Company&#8217;s competitors. Several of the Company&#8217;s sales employees and sales management are recently hired or transferred into different roles, and it will take time for them to be fully trained to improve their productivity. In addition, due to the competition for sales professionals in the Company&#8217;s industry, the Company also recruits sales professionals from outside the industry. Sales professionals from outside the industry typically take longer to train and become familiar with the Company&#8217;s products and the procedures in which they are used. As a result of a lack of industry knowledge, these sales professionals may take longer to become productive members of the Company&#8217;s sales force.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company trains its existing and recently recruited sales professionals to better understand the Company&#8217;s existing and new product technologies and how they can be positioned against the Company&#8217;s competitors&#8217; products. These initiatives are intended to improve the productivity of the Company&#8217;s sales professionals and the Company&#8217;s revenue and profitability. It takes time for the sales professionals to become productive following their training and there can be no assurance that the newly recruited sales professionals will be adequately trained in a timely manner, or that the Company direct sales productivity will improve, or that the Company will not experience significant levels of attrition in the future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Measures the Company implements in an effort to recruit, retain, train and manage the Company&#8217;s sales professionals, strengthen their relationships with core market physicians, and improve their productivity may not be successful and may instead contribute to instability in its operations, additional departures from the Company&#8217;s sales organization, or further reduce the Company&#8217;s revenue and harm the Company&#8217;s business. If the Company is not able to improve the productivity and retention of the Company&#8217;s North American and international sales professionals, then the Company&#8217;s total revenue, profitability and stock price may be adversely impacted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company is planning to launch an energy-based solution for the treatment of Acne and can provide no assurance that the Company will obtain regulatory clearance for this Acne device or that the device will be widely adopted by customers or their patients.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has recently announced plans to bring an energy-based device for Acne to market. The Company has spent several years working on this program, fine-tuning the product, and designing and developing the procedure to deliver a safe, comfortable and effective solution for Acne patients. Despite these efforts, the Company may not be successful in obtaining final approval from the FDA. Additionally, the Company may be unable to establish and manage a sufficient or effective sales force in a timely or cost-effective manner, and any sales force the Company does establish may not be capable of generating demand for this device, therefore hindering the Company&#8217;s ability to generate revenues and achieve or sustain profitability from this Acne device.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The aesthetic equipment market is characterized by rapid innovation. To compete effectively, the Company must develop and/or acquire new products, seek regulatory clearance, market them successfully, and identify new markets for the Company&#8217;s technology.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aesthetic light and energy-based treatment system industry is subject to continuous technological development and product innovation. If the Company does not continue to innovate and develop new products and applications, the Company&#8217;s competitive position will likely deteriorate as other companies successfully design and commercialize new products and applications or enhancements to the Company&#8217;s current products. The Company created products to apply the Company&#8217;s technology to body contouring, hair removal, treatment of veins, tattoo removal and skin revitalization, including the treatment of diffuse redness, fine lines and wrinkles via hemostasis and coagulation, skin texture, pore size and benign pigmented lesions, etc. For example, the Company introduced Secret RF, a fractional RF microneedling device for skin revitalization, in January 2018, enlighten SR in April 2018, truSculpt iD in July 2018, excel V+ in February 2019, truSculpt flex in June 2019, and the Secret Pro, a device combining the benefits of RF microneedling with the capabilities of a fractional, ablative CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> laser in September of 2020. In 2021, the Company introduced truSculpt flex+, a treatment mode that decreased the treatment time from approximately 45 minutes to 15 minutes. To grow in the future, the Company must continue to develop and/or acquire new and innovative aesthetic products and applications, identify new markets, and successfully launch the newly acquired or developed product offerings.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To successfully expand the Company&#8217;s product offerings, the Company must, among other things:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">develop or otherwise acquire new products that either add to or significantly improve the Company&#8217;s current product offerings;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">obtain regulatory clearance for these new products;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">convince the Company&#8217;s existing and prospective customers that the Company&#8217;s product offerings are an attractive revenue-generating addition to their practice;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">sell the Company&#8217;s product offerings to a broad customer base;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">identify new markets and alternative applications for the Company&#8217;s technology;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">protect the Company&#8217;s existing and future products with defensible intellectual property; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">satisfy and maintain all regulatory requirements for commercialization.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, product introductions have been a significant component of the Company&#8217;s financial performance. To be successful in the aesthetics industry, the Company believes it needs to continue to innovate. The Company&#8217;s business strategy is based, in part, on its expectation that the Company will continue to increase or enhance its product offerings. The Company needs to continue to devote substantial research and development resources to make new product introductions, which can be costly and time consuming to its organization.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also believes that, to increase revenue from sales of new products, the Company needs to continue to develop its clinical support, further expand and nurture relationships with industry thought leaders, and increase market awareness of the benefits of its new products. However, even with a significant investment in research and development, the Company may be unable to continue to develop, acquire or effectively launch and market new products and technologies regularly, or at all. If the Company fails to successfully commercialize new products or enhancements, its business may be harmed.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company attempts to protect its products through patents and other intellectual property, there are few barriers to entry that would prevent new entrants or existing competitors from developing products that compete directly with the Company&#8217;s. The Company expects that any competitive advantage the Company may enjoy from current and future innovations may diminish over time as companies successfully respond to the Company&#8217;s, or create their own, innovations. Consequently, the Company believes that it will have to continuously innovate and improve the Company&#8217;s products and technology to compete successfully. If the Company is unable to innovate successfully, its products could become obsolete and its revenue could decline as its customers and prospective customers purchase its competitors&#8217; products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Demand for the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s products in any of the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s markets could be weakened by several factors, including:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">inability to develop and market the Company&#8217;s products to the core market specialties of dermatologists and plastic surgeons;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">poor financial performance of market segments that attempt to introduce aesthetic procedures to their businesses;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the inability to differentiate the Company&#8217;s products from those of the Company&#8217;s competitors;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">competitive threat from new innovations and product introductions;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">reduced patient demand for elective aesthetic procedures;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">failure to build and maintain relationships with opinion leaders within the various market segments; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the lack of credit financing, or an increase in the cost of borrowing, for some of the Company&#8217;s potential customers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company does not achieve anticipated demand for the Company&#8217;s products, there could be a material adverse effect on its total revenue, profitability, employee retention and stock price.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company depends on skilled and experienced personnel to operate its global business effectively. Changes to management or the inability to recruit, hire, train and retain qualified personnel, could harm the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s ability to successfully manage, develop and expand its business, which would impair the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s future revenue and profitability.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s success largely depends on the skills, experience and efforts of the Company&#8217;s officers and other key employees. The loss of any of the Company&#8217;s executive officers could weaken its management expertise and harm the Company&#8217;s business, and it may not be able to find adequate replacements on a timely basis, or at all. Except for Change of Control and Severance Agreements for the Company&#8217;s executive officers and a few key employees, the Company does not have employment contracts with any of its officers or other key employees. Any of the Company&#8217;s officers and other key employees may terminate their employment at any time and their knowledge of the Company&#8217;s business and industry may be difficult to replace. The Company does not have a succession plan in place for each of its officers and key employees. In addition, the Company does not maintain &#8220;key person&#8221; life insurance policies covering any of the Company&#8217;s employees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to dependence on the Company&#8217;s officers and key employees, the Company is highly dependent on other sales and scientific personnel. For example, in the first quarter of 2020 the Company experienced turnover of its sales professionals, including several people in key sales leadership positions. Most of these sales professionals went to work for a competitor. Additionally, the Company&#8217;s product development plans depend, in part, on the Company&#8217;s ability to attract and retain engineers with experience in medical devices. Attracting and retaining qualified personnel will be critical to the Company&#8217;s success, and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">competition for qualified personnel is intense. The Company may not be able to attract and retain personnel on acceptable terms given the competition for such personnel among technology and healthcare companies and universities. The loss of any of these persons or the Company&#8217;s inability to attract, train and retain qualified personnel could harm the Company&#8217;s business and the Company&#8217;s ability to compete and become profitable.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security breaches, cyber-security incidents and other disruptions could compromise the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s information and impact the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s business, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on networks, information management software and other technology, or information systems, including the Internet and third-party hosted services, to support a variety of business processes and activities, including procurement and supply chain, manufacturing, distribution, invoicing, order processing and collection of payments. The Company uses information systems to process financial information and results of operations for internal reporting purposes and to comply with regulatory financial reporting, legal and tax requirements. In addition, the Company depends on information systems for digital marketing activities and&#160;electronic communications among the Company&#8217;s locations around the world and between company personnel as well as customers and suppliers. Because information systems are critical to many of the Company&#8217;s operating activities, the Company&#8217;s business processes may be impacted by system shutdowns or service disruptions. These disruptions may be caused by failures during routine operations such as system upgrades or user errors, as well as network or hardware failures, malicious or disruptive software, computer hackers, geopolitical events, natural disasters, failures or impairments of telecommunications networks, or other catastrophic events. These events could result in unauthorized disclosure of material confidential information. If the Company&#8217;s information systems suffer severe damage, disruption or shutdown and the Company business continuity plans do not effectively resolve the issues in a timely manner, the Company could experience delays in reporting the Company&#8217;s financial results and the Company&#160;may lose revenue and profits as a result of the Company&#8217;s inability to timely manufacture, distribute, invoice and collect payments. Misuse, leakage or falsification of information could result in a violation of data privacy laws and regulations and damage the Company&#8217;s reputation and credibility, and could expose the Company&#160;to liability. The Company may also be required to spend significant financial and other resources to remedy the damage caused by a security breach or to repair or replace networks and information systems. Like most major corporations, the Company&#8217;s information systems are a target of attacks.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A cyber security attack or other incident that bypasses the Company&#8217;s information systems security could cause a security breach which may lead to a material disruption to the Company&#8217;s information systems infrastructure or business and may involve a significant loss of business or patient health information. If a cyber security attack or other unauthorized attempt to access the Company&#8217;s systems or facilities were successful, it could result in the theft, destruction, loss, misappropriation or release of confidential information or intellectual property, and could cause operational or business delays that may materially impact the Company&#8217;s ability to provide various healthcare services. Any successful cyber security attack or other unauthorized attempt to access the Company&#8217;s systems or facilities also could result in negative publicity which could damage the Company&#8217;s reputation or brand with the Company&#8217;s patients, referral sources, payors or other third parties and could subject the Company&#160;to a number of adverse consequences, the vast majority of which are not insurable, including but not limited to disruptions in the Company&#8217;s operations, regulatory and other civil and criminal penalties, fines, investigations and enforcement actions (including, but not limited to, those arising from the SEC, Federal Trade Commission, Office of Civil Rights, the Office of Inspector General or state attorneys general), fines, private litigation with those affected by the data breach, loss of customers, disputes with payors and increased operating expense, which either individually or in the aggregate could have a material adverse effect on the Company&#8217;s business, financial position, results of operations and liquidity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not had any disruptions to its information systems that have materially affected its business, financial condition or results of operations. However, there can be no assurance that such disruptions may occur and have a material adverse effect on the Company&#160;in the future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in accounting standards and estimates could have a material adverse effect on the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s results of operations and financial position.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally accepted accounting principles and the related authoritative guidance for many aspects of the Company&#8217;s business, including revenue recognition, inventories, warranties, leases, income taxes, expected credit losses, fair-value measurements, and stock-based compensation, are complex and involve subjective judgments. Changes in these rules or changes in the underlying estimates, assumptions or judgments by the Company&#8217;s management could have a material adverse effect on the Company&#8217;s results of operations and may retroactively affect previously reported results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s ability to access credit on favorable terms, if necessary, for the funding of the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s operations and capital projects may be limited due to changes in credit markets.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;9, 2020, the Company terminated its Wells Fargo Revolving Line of Credit and subsequently entered into a Loan and Security Agreement with Silicon Valley Bank (the &#8220;SVB Revolving Line of Credit&#8221;). The agreement provides for a four-year secured revolving loan facility in an aggregate principal amount of up to $30.0&#160;million. The SVB Revolving Line of Credit matures on July&#160;9, 2024. As of December&#160;31, 2021, the Company had not drawn on this credit facility.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A violation of any of the covenants could result in a default under the SVB Revolving Line of Credit that would permit Silicon Valley Bank to restrict the Company&#8217;s ability to further access the revolving line of credit for loans and letters of credit and require the immediate repayment of any outstanding loans under the agreement. In addition, these covenants are subject to renegotiation at the beginning of each fiscal year, which further reduces the Company&#8217;s ability to anticipate whether this source of capital will continue to be available in the near term.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in the past, the credit markets and the financial services industry have experienced disruption characterized by the bankruptcy, failure, collapse or sale of various financial institutions, increased volatility in securities prices, diminished liquidity and credit availability and intervention from the U.S. and other governments. Continued concerns about the systemic impact of potential long-term or widespread downturn, energy costs, geopolitical issues, the availability and cost of credit, the global commercial and residential real estate markets and related mortgage markets and reduced consumer confidence have contributed to increased market volatility. The cost and availability of credit has been and may continue to be adversely affected by these conditions. The Company cannot be certain that funding for the Company&#8217;s capital needs will be available from the Company&#8217;s existing financial institutions and the credit markets if needed, and if available, to the extent required and on acceptable terms. The SVB Revolving Line of Credit terminates on July&#160;9, 2024 and if the Company cannot renew or refinance this facility or obtain funding when needed, in each case on acceptable terms, such conditions may have an adverse effect on the Company&#8217;s revenues and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covenants in the Loan and Security Agreement governing the Company's&#160;revolving credit facility may restrict its&#160;operations, and if the Company does&#160;not effectively manage its business to comply with these covenants, its&#160;financial condition could be adversely impacted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into a Loan and Security Agreement with Silicon Valley Bank in July 2020, which provides for a four-year secured revolving loan facility in an aggregate principal amount of up to $30.0&#160;million (the &#8220;senior credit facility&#8221;). The senior credit facility contains various restrictive covenants, including, among other things, minimum liquidity and revenue requirements, restrictions on the Company's&#160;ability to dispose of assets, make acquisitions or investments, incur debt or liens, make distributions to its&#160;stockholders, or enter into certain types of related party transactions. These restrictions may restrict the Company's current and future operations, particularly the Company's&#160;ability to respond to certain changes in its&#160;business or industry, or take future actions. Pursuant to the senior credit facility, the Company&#160;granted the parties thereto a security interest in substantially all of its&#160;assets. See Note 12 of the notes to the Company's&#160;consolidated financial statements and the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources Loan and Security Agreement&#8221; in Part II, Item 8&#160;of the Company's Annual Report on Form 10-K&#160;for the fiscal year ended December 31,&#160;2021.&#160;The Company&#8217;s ability to meet these restrictive covenants can be impacted by events beyond the Company&#8217;s control and the Company&#160;may be unable to do so. The Company&#8217;s senior credit facility provides that its breaches or failure to satisfy certain covenants constitutes an event of default. Upon the occurrence of an event of default, the Company&#8217;s lenders could elect to declare all amounts outstanding under its debt agreements to be immediately due and payable. In addition, the Company's&#160;lenders would have the right to proceed against the assets the Company&#160;provided as collateral pursuant to the senior credit facility. If the debt under its&#160;senior credit facility was to be accelerated, the Company&#160;may not have sufficient cash on hand or be able to sell sufficient collateral to repay it, which would have an immediate adverse effect on the Company's&#160;business and operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Macroeconomic political and market conditions, and catastrophic events may adversely affect the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s business, results of operations, financial condition and the trading price of the notes and the stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business is influenced by a range of factors that are beyond the Company&#8217;s control, including:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">general macro-economic and business conditions in the Company&#8217;s key markets of North America, Japan, Asia Pacific, the Middle East, Europe and Australia;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the lack of credit financing, or an increase in the cost of borrowing, for some of the Company&#8217;s potential customers due to increasing interest rates and lending requirements;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the overall demand for the Company&#8217;s products by the core market specialties of dermatologists and plastic surgeons;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the timing and success of new product introductions by the Company or the Company&#8217;s competitors or any other change in the competitive landscape of the market for non-surgical aesthetic procedures, including consolidation among the Company&#8217;s competitors;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the level of awareness of aesthetic procedures and the market adoption of the Company&#8217;s products;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in the Company&#8217;s pricing policies or those of the Company&#8217;s competitors;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">governmental budgetary constraints or shifts in government spending priorities;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">general political developments, both domestic and in the Company&#8217;s foreign markets, including economic and political uncertainty caused by elections;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">natural disasters;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">tax law changes;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">currency exchange rate fluctuations; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">any trade restrictions or higher import taxes that may be imposed by foreign countries against products sold internationally by U.S. companies.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Macroeconomic developments, like global recessions and financial crises could negatively affect the Company&#8217;s business, operating results, or financial condition which, in turn, could adversely affect the Company&#8217;s stock price. A general weakening of, and related declining corporate confidence in, the global economy or the curtailment in government or corporate spending could cause current or potential customers to reduce their budgets or be unable to fund product or upgrade application purchases, which could cause customers to delay, decrease or cancel purchases of the Company&#8217;s products and services or cause customers not to pay the Company or to delay paying the Company for previously purchased products and services.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, political unrest in regions like the Middle East, terrorist attacks around the globe and the potential for other hostilities in various parts of the world, potential public health crises and natural disasters continue to contribute to a climate of economic and political uncertainty that could adversely affect the Company&#8217;s results of operations and financial condition, including the Company&#8217;s revenue growth and profitability.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Macroeconomic declines, negative political developments, including volatile market conditions due to investor concerns regarding inflation and potential hostilities between Russian and Ukraine, adverse market conditions and catastrophic events may cause a decline in the Company&#8217;s revenue, negatively affect the Company&#8217;s operating results, adversely affect the Company&#8217;s cash flow and could result in a decline in the Company&#8217;s stock price.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">To successfully market and sell the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s products internationally, the Company must address many issues that are unique to the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s international business. Furthermore, international expansion is a key component of the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s growth strategy, although the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s international operations and foreign transactions expose the Company&#160;to additional operational challenges that the Company might not otherwise face.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is focused on international expansion as a key component of its growth strategy and has identified specific areas of opportunity in various international markets. Revenue from customers outside of North America is a material component of the Company&#8217;s business strategy and represented 52% of its total revenue in 2021 compared to 53% of the Company&#8217;s total revenue in 2020. The Company employs a direct sales force in the major markets&#160;throughout Europe as well as Canada, Japan and Australia/New Zealand while using third-party distributors to sell its products in several other country in the Middle East, Asia, and South America in particular. The Company may be unable to increase or maintain its level of international revenue due to supply chain disruptions or loss of distributor relationship.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company experienced significant turnover of the Company&#8217;s North America sales team during the first quarter of 2020. Though these departures did not have an adverse effect on the Company&#8217;s international sales, they added additional pressure on the global sales team. While the Company continues to have a direct sales and service organization in Australia, New Zealand, Japan, France, Belgium, Spain, Germany, Switzerland and the United Kingdom, a significant portion of its international revenue is generated through its network of distributors. Though the Company continues to evaluate and replace&#160;non-performing&#160;distributors and has recently brought greater focus to collaboration with its distribution partners, there can be no assurance given that these initiatives will result in improved international revenue or profitability in the future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To grow the Company&#8217;s business, it is essential to improve productivity in current sales territories and expand into new territories. However, direct sales productivity may not improve and distributors may not accept the Company&#8217;s business or commit the necessary resources to market and sell the Company&#8217;s products at the Company&#8217;s expectations. If the Company is not able to increase or maintain international revenue growth, the Company&#8217;s total revenue, profitability and stock price may be adversely impacted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the Company&#160;fails to renew any of its&#160;distribution agreements as they expire under the terms of the particular agreement, its&#160;revenues and cash flow may be adversely affected.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's business may suffer if any of its&#160;distribution partners terminates or otherwise fails to renew its distribution agreement with the Company&#160;and the Company is&#160;otherwise unable to replace such agreement with a distribution agreement containing similar terms.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Economic and other risks associated with international sales and operations could adversely affect the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, 52% of the Company&#8217;s total revenue was from customers outside of North America. The Company expects its sales from international operations and export sales to continue to be a significant portion of the Company&#8217;s revenue. The Company has placed a particular emphasis on increasing its growth and presence in international markets. The Company&#8217;s international operations and sales are subject, in varying degrees, to risks inherent in doing business outside the U.S. These risks include:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in trade protection measures, including embargoes, tariffs and other trade barriers, and import and export regulations and licensing requirements;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">instability and uncertainties arising from the global geopolitical environment, such as economic nationalism, populism, protectionism and anti-global sentiment;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in tax laws and potential negative consequences from the interpretation, application and enforcement by governmental tax authorities of tax laws and policies;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">unanticipated changes in other laws and regulations or in how such provisions are interpreted or administered;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">reduced protection for intellectual property rights in some countries and practical difficulties of enforcing intellectual property and contract rights abroad;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">possibility of unfavorable circumstances arising from host country laws or regulations, including those related to infrastructure and data transmission, security and privacy;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">currency exchange rate fluctuations and restrictions on currency repatriation;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">difficulties and expenses related to implementing internal control over financial reporting and disclosure controls and procedures;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">disruption of sales from labor and political disturbances;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">regional safety and security considerations;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">increased costs and risks in developing, staffing and simultaneously managing global sales operations as a result of distance as well as language and cultural differences;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">increased management, travel, infrastructure and legal compliance costs associated with having multiple international operations;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">lengthy payment cycles and difficulty in collecting accounts receivable;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">preference for locally-produced products, as well as protectionist laws and business practices that favor local companies;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">outbreak or escalation of insurrection, armed conflict, terrorism or war; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">supply chain disruption or the loss of distributor relationships.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the geopolitical or economic environments in the countries in which the Company operates could have a material adverse effect on the Company&#8217;s financial condition, results of operations or cash flows. For example, changes in U.S. policy regarding international trade, including import and export regulation and international trade agreements, could also negatively impact the Company&#8217;s business. In 2018, the U.S. imposed tariffs on certain goods imported from China and certain other countries, which has resulted in retaliatory tariffs by China and other countries. Additional tariffs imposed by the U.S. on a broader range of imports, or further retaliatory trade measures taken by China or other countries in response, could adversely impact the Company&#8217;s financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s global operations are required to comply with the U.S. Foreign Corrupt Practices Act of 1977, as amended (&#8220;FCPA&#8221;), Chinese anti- corruption laws, U.K. Bribery Law, and similar anti-bribery laws in other jurisdictions, and with U.S. and foreign export control, trade embargo and customs laws. If the Company fails to comply with any of these laws, the Company could suffer civil and criminal sanctions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2021, the Medicines and Healthcare Products Regulatory Agency (&#8220;MHRA&#8221;) has been responsible for the UK medical device market. New regulations require medical devices to be registered with the MHRA. Manufacturers based outside the UK need to appoint a UK Responsible Person to register devices with the MHRA. By July 1, 2023, in the United Kingdom, all medical devices will require a UKCA (UK Conformity Assessed) mark, but CE marks issued by EU notified bodies will remain valid until this time. However, UKCA marking alone will not be recognized in the EU.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the general risks that the Company faces outside the U.S., the Company&#8217;s operations in emerging markets could involve additional uncertainties for us, including risks that governments may impose withholding or other taxes on remittances and other payments to us, or the amount of any such taxes may increase; governments may seek to nationalize the Company&#8217;s assets; or governments may impose or increase investment barriers or other restrictions affecting the Company&#8217;s business. In addition, emerging markets pose other uncertainties, including the difficulty of enforcing agreements, challenges collecting receivables, protection of the Company&#8217;s intellectual property and other assets, pressure on the pricing of the Company&#8217;s products and services, higher business conduct risks, ability to hire and retain qualified talent and risks of political instability. The Company cannot predict the impact such events might have on the Company&#8217;s business, financial condition and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, compliance with laws and regulations applicable to the Company&#8217;s international operations increases the Company&#8217;s cost of doing business in foreign jurisdictions. The Company may be unable to keep current with changes in foreign government requirements and laws as they change from time to time. Failure to comply with these regulations could have adverse effects on the Company&#8217;s business. In many foreign countries it is common for others to engage in business practices that are prohibited by the Company&#8217;s internal policies and procedures or U.S. regulations applicable to us. In addition, although the Company has implemented policies and procedures designed to ensure compliance with these laws and policies, there can be no assurance that all of the Company&#8217;s employees, contractors, distributors and agents will comply with these laws and policies. Violations of laws or key control policies by the Company&#8217;s employees, contractors, distributors or agents could result in delays in revenue recognition, financial reporting misstatements, fines, penalties, or the prohibition of the importation or&#160;exportation of the Company&#8217;s offerings and could have a material adverse effect on the Company&#8217;s business operations and financial results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">To successfully market and sell third party products internationally, the Company must address many issues that are unique to the related distribution arrangements which could reduce the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s available cash reserves and negatively impact the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s profitability.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into distribution arrangements pursuant to which the Company utilizes its sales force and distributors to sell products manufactured by other companies. In Japan, the Company has a&#160;non-exclusive&#160;right to distribute a&#160;Q-switched&#160;laser product manufactured by a third party OEM. The Company also has an exclusive agreement with ZO to distribute certain of their proprietary skincare products in Japan. Each of these agreements requires the Company&#160;to purchase annual minimum dollar amounts of their products. Additionally, the Company has entered into distribution arrangements with other companies to promote and sell the&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of these distribution agreements presents its own unique risks and challenges. For example, to sell skincare products the Company needs to invest in creating a sales structure that is experienced in the sale of such products and not in capital equipment. The Company needs to commit resources to train the Company&#8217;s sales force, obtain regulatory licenses, and develop new marketing materials to promote the sale of these products. In addition, the minimum commitments and other costs of distributing products manufactured by these companies may exceed the incremental revenue that the Company derives from the sale of their products, thereby negatively impacting the Company&#8217;s profitability and reducing the Company&#8217;s available cash reserves.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company does not make the minimum purchases required in the distribution contracts, or if the third party manufacturer revokes the Company&#8217;s distribution rights, the Company could lose the distribution rights of the products, which would adversely affect the Company&#8217;s future revenue, results of operations, cash flows and its stock price.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company offers credit terms to some qualified customers and also to leasing companies to finance the purchase of its products. In the event that any of these customers default on the amounts payable to the Company, its earnings may be adversely affected.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally offers credit terms of 30 to 90 days to qualified customers. In addition, from time to time, it offers certain key international distributors, with whom the Company has had an extended period of relationship and payment history, payment terms that are significantly longer than the regular 30 to 90 day terms. This allows such international distribution partners to have its products in stock and provide its products to customers on a timely basis.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes it has an adequate basis to ensure that it collects its accounts receivable, the Company cannot provide any assurance that the financial position of customers to whom it has provided payment terms will not change adversely before the Company receives payment. In the event that there is a default by any of the customers to whom the Company has provided credit terms, the Company may recognize a credit loss provision&#160;write-off&#160;charge in the Company&#8217;s general and administrative expenses. If this&#160;write-off&#160;charge is material, it could negatively affect the Company&#8217;s future results of operations, cash flows and its stock price.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in the event of deterioration of general business conditions or the availability of credit, the financial strength and stability of the Company&#8217;s customers and potential customers may deteriorate over time, which may cause them to cancel or delay their purchase of its products. In addition, the Company may be subject to increased risk of&#160;non-payment&#160;of its accounts receivables. The Company may also be adversely affected by bankruptcies or other business failures of the Company&#8217;s customers and potential customers. A significant delay in the collection of funds or a reduction of funds collected may impact the Company&#8217;s liquidity or result in credit losses.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s ability to effectively compete and generate additional revenue from new and existing products depends upon the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s ability to distinguish the Company and its products from the competitors and their products, and to develop and effectively market new and existing products. The Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s success is dependent on many factors, including the following:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">speed of new and innovative product development;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">effective strategy and execution of new product launches;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">identification and development of clinical support for new indications of the Company&#8217;s existing products;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product performance;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product pricing;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">quality of customer support;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">development of successful distribution channels, both domestically and internationally; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">intellectual property protection.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To compete effectively, the Company has to demonstrate that its new and existing products are attractive alternatives to other devices and treatments, by differentiating the Company&#8217;s products on the basis of such factors as innovation, performance, brand name, service, and price. This is difficult to do, especially in a crowded aesthetic market. Some of the Company&#8217;s competitors have newer or different products and more established customer relationships than the Company does, which could inhibit the Company&#8217;s market penetration efforts. For example, the Company has encountered, and expects to continue to encounter, situations where, due to&#160;pre-existing&#160;relationships, potential customers decide to purchase additional products from the Company&#8217;s competitors. Potential customers also may need to recoup the cost of products that they have already purchased from the Company&#8217;s competitors and may decide not to purchase the Company&#8217;s products, or to delay such purchases. If the Company is unable to increase the Company&#8217;s market penetration or compete effectively, its revenue and profitability will be adversely impacted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company competes against companies that offer alternative solutions to its products, have greater resources, or have a larger installed base of customers and broader product offerings than the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s. In addition, increased consolidation in the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s industry may lead to increased competition. If the Company is not able to effectively compete with these companies, it may harm its business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical technology and aesthetic product markets are highly competitive and dynamic and are characterized by rapid and substantial technology development and product innovations. The Company&#8217;s products compete against conventional&#160;non-energy-based&#160;treatments, such as electrolysis, Botox and collagen injections, chemical peels, microdermabrasion and sclerotherapy. The Company&#8217;s products also compete against laser and other energy- based products offered by other companies. Further, other companies could introduce new products that are in direct competition with the Company&#8217;s products. The Company may also face competition from manufacturers of pharmaceutical and other products that have not yet been developed. Competition with these companies could result in reduced selling prices, reduced profit margins and loss of market share, any of which would harm the Company&#8217;s business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been consolidation in the aesthetic industry leading to companies combining their resources, which increases competition and could result in increased downward pressure on the Company&#8217;s product prices. Consolidations have created newly-combined entities with greater financial resources, deeper sales channels and greater pricing flexibility than the Company. Rumored or actual consolidation of the Company&#8217;s partners and competitors could cause uncertainty and disruption to the Company&#8217;s business and can cause the Company&#8217;s stock price to fluctuate.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If there is not sufficient consumer demand for the procedures performed with the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s products, practitioner demand for its products could be inhibited, resulting in unfavorable operating results and reduced growth potential.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Continued expansion of the global market for laser and other-energy-based aesthetic procedures is a material assumption of the Company&#8217;s business strategy. Most procedures performed using the Company&#8217;s products are elective procedures not reimbursable through government or private health insurance, with the costs borne by the patient. The decision to utilize the Company&#8217;s products may therefore be influenced by a number of factors, including:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">consumer disposable income and access to consumer credit, which as a result of an unstable economy, may be significantly impacted;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the cost, safety and effectiveness of alternative treatments, including treatments which are not based upon laser or other energy-based technologies and treatments which use pharmaceutical products;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the success of the Company&#8217;s sales and marketing efforts; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the education of the Company&#8217;s customers and patients on the benefits and uses of the Company&#8217;s products, compared to competitors&#8217; products and technologies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If, as a result of these factors, there is not sufficient demand for the procedures performed with the Company&#8217;s products, practitioner demand for the Company&#8217;s products could be reduced, which could have a material adverse effect on the Company&#8217;s business, financial condition, revenue and result of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company's&#160;products and its operations are subject to extensive government regulation and oversight in the United States. If the Company&#160;fails to obtain or maintain necessary regulatory clearances or approvals for its&#160;products, or if approvals or clearances for future products are delayed or not issued, it will negatively affect its&#160;business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's laser products are medical devices subject to extensive regulation in the United States and elsewhere, including by the FDA and its foreign counterparts. Government regulations specific to medical devices are wide ranging and govern, among other things:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product design, development, manufacture, and release;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">laboratory and clinical testing, labeling, packaging, storage and distribution;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product safety and efficacy;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">pre-marketing clearance or approval;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">service operations;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">record keeping;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product marketing, promotion and advertising, sales and distribution;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">post-marketing surveillance, including reporting of deaths or serious injuries and recalls and correction and removals;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">post-market approval studies; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">product import and export.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA classifies medical devices into one of three classes on the basis of the intended use of the device, the risk associated with the use of the device for that indication, as determined by the FDA, and on the controls deemed by the FDA to be necessary to reasonably ensure their safety and effectiveness.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class&#160;I includes devices with the lowest risk to the patient and are those for which safety and effectiveness can be assured by adherence to the FDA&#8217;s General Controls for medical devices, which include compliance with the applicable portions of the QSR facility registration and product listing, reporting of adverse medical events, and truthful and&#160;non-misleading&#160;labeling, advertising, and promotional materials. Class&#160;II devices are subject to the FDA&#8217;s General Controls, and special controls as deemed necessary by the FDA to ensure the safety and effectiveness of the device. These special controls can include performance standards, post-market surveillance, patient registries and FDA guidance documents.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While most Class&#160;I devices are exempt from the premarket notification requirement, manufacturers of most Class&#160;II devices are required to submit to the FDA a premarket notification under Section&#160;510(k) of the FDCA requesting permission to commercially distribute the device. The FDA&#8217;s permission to commercially distribute a device subject to a 510(k) premarket notification is generally known as 510(k) clearance. Devices deemed by the FDA to pose the greatest risks, such as life sustaining, life supporting or some implantable devices, or devices that have a new intended use, or use advanced technology that is not substantially equivalent to that of a legally marketed device, are placed in Class&#160;III, requiring approval of a PMA application. Some&#160;pre-amendment&#160;devices are unclassified, but are subject to FDA&#8217;s premarket notification and clearance process in order to be commercially distributed. The Company's&#160;currently marketed products are Class&#160;II devices subject to 510(k) clearance, which the Company&#160;has&#160;obtained from the FDA.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before a new medical device, or a new intended use of, claim for, or significant modification to an existing device, can be marketed in the United States, a company must first submit an application for and receive either 510(k) clearance pursuant to a premarket notification submitted under Section&#160;510(k) of the FDCA, or PMA approval from the FDA, unless an exemption applies. The 510(k),&#160;or PMA processes can be expensive, lengthy and unpredictable. The FDA&#8217;s 510(k) clearance process usually takes from three to 12 months, but can last longer. The process of obtaining a PMA approval is much more costly and uncertain than the 510(k) clearance process and generally takes from one to three years, or even longer, from the time the application is filed with the FDA. In addition, a PMA approval generally requires the performance of one or more clinical trials. Despite the time, effort and cost, a device may not be approved or cleared by the FDA. Any delay or failure to obtain necessary regulatory clearances or approvals could harm its&#160;business. Furthermore, even if the Company&#160;is&#160;granted regulatory clearances or approvals, they may include significant limitations on the indicated uses for the device, which may limit the market for the device.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has&#160;obtained 510(k) clearances to market its&#160;products. The FDA or other regulators could delay, limit, or deny clearance or approval of a device for many reasons, including:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">The Company's inability to demonstrate to the satisfaction of the FDA or the applicable regulatory entity or notified body that the Company's currently marketed devices, or any other future device, and any accessories are substantially equivalent to a legally marketed predicate device or safe or effective for their proposed intended uses;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the disagreement of the FDA with the design or implementation of any clinical trials or the interpretation of data from preclinical studies or clinical trials;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">serious and unexpected adverse device effects experienced by participants in its clinical trials;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the insufficiency of the data from preclinical studies or clinical trials to support clearance or approval, where required;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">our inability to demonstrate that the clinical and other benefits of the device outweigh the risks;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the failure of its manufacturing process or facilities to meet applicable requirements; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the potential for approval policies or regulations of the FDA or applicable foreign regulatory bodies to change significantly in a manner rendering its clinical data or regulatory filings insufficient for clearance or approval.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulations to which the Company is&#160;subject are complex and have tended to become more stringent over time. Regulatory changes could result in restrictions on the Company's&#160;ability to carry on or expand its&#160;operations, higher than anticipated costs or lower than anticipated sales. The FDA enforces these regulatory requirements through, among other means, periodic unannounced inspections. The Company does&#160;not know whether it&#160;will be found compliant in connection with any future regulatory inspections. Moreover, the FDA and state authorities have broad enforcement powers. Its&#160;failure to comply with applicable regulatory requirements could result in enforcement action by any such agency. If any of these events were to occur, it would negatively affect the Company's&#160;business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the Company fails to comply with applicable regulatory requirements, it could result in enforcement action by the U.S. FDA, federal and state agencies or international regulatory bodies and the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s commercial operations would be harmed.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s products are medical devices that are subject to extensive regulation in the U.S. by the FDA for manufacturing, labeling, sale, promotion, distribution and shipping. The FDA, state authorities and international regulatory bodies have broad enforcement powers. If the Company fails to comply with any U.S. law or any of the applicable regulatory requirements of the FDA, or federal or state agencies, or one of the international regulatory bodies, it could result in enforcement action by the agencies, which may include any of the following sanctions:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">warning letters, fines, injunctions, consent decrees and civil penalties;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">repair, replacement, recall or seizure of the Company&#8217;s products;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">operating restrictions or partial suspension or total shutdown of production;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">refusing the Company&#8217;s requests for 510(k) clearance of new products, new intended uses, or modifications to existing products;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">withdrawing 510(k) clearance or pre-market approvals that have already been granted; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">criminal prosecution.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal regulatory reforms and changes occurring at the FDA could adversely affect the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s ability to sell its products profitably and financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, legislation is drafted and introduced in Congress that could significantly change the statutory provisions governing the clearance or approval, manufacture and marketing of a device. It is impossible to predict whether legislative changes will be enacted or FDA regulations, guidance or interpretations changed, and what the impact of such changes, if any, may be.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, FDA regulations and guidance are often revised or reinterpreted by the agency in ways that may significantly affect the Company&#8217;s business and the Company&#8217;s products. Changes in FDA regulations may lengthen the regulatory approval process for medical devices and require additional clinical data to support regulatory clearance for the sale and marketing of the Company&#8217;s new products. In addition, it may require additional safety monitoring, labeling changes, restrictions on product distribution or use, or other measures after the introduction of the Company&#8217;s products to market. Either of these changes lengthen the duration to market, increase the Company&#8217;s costs of doing business, adversely affect the future permitted uses of approved products, or otherwise adversely affect the market for its products.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company supports any action that helps ensure patient safety going forward. The Company has a robust, multi-functional process that reviews its promotional claims and materials to ensure they are truthful, not misleading, fair and balanced, and supported by sound scientific evidence.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in funding or disruptions at the FDA and other government agencies caused by funding shortages or global health concerns could hinder their ability to hire and retain key leadership and other personnel, or otherwise prevent new or modified products from being developed, approved or commercialized in a timely manner or at all, or otherwise prevent those agencies </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">from performing normal business functions on which the operation of the Company's&#160;business may rely, which could negatively impact its&#160;business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes, and other events that may otherwise affect the FDA&#8217;s ability to perform routine functions. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of other government agencies on which the Company's&#160;operations may rely, including those that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disruptions at the FDA and other agencies may also slow the time necessary for new product applications to be reviewed and/or approved by necessary government agencies, which would adversely affect its&#160;business. For example, in response to the&#160;COVID-19&#160;pandemic, the FDA has indicated that it will consider alternative methods for inspections and could exercise discretion on a&#160;case-by-case&#160;basis to approve products based on a desk review, if a prolonged government shutdown occurs, or if global health concerns continue to prevent the FDA or other regulatory authorities from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the FDA to timely review and process its&#160;regulatory submissions, which could have a material adverse effect on the Company's&#160;business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the Company fails to comply with the FDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s Quality System Regulation and laser performance standards, the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s manufacturing operations could be halted, and its business would suffer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently required to demonstrate and maintain compliance with the FDA&#8217;s Quality System Regulation (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">QSR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The QSR is a complex regulatory scheme that covers the methods and documentation of the design, testing, control, manufacturing, labeling, quality assurance, packaging, storage and shipping of the Company&#8217;s products. Because the Company&#8217;s products involve the use of lasers, the Company&#8217;s products also are covered by a performance standard for lasers set forth in FDA regulations. The laser performance standard imposes specific record-keeping, reporting, product testing and product labeling requirements. These requirements include affixing warning labels to laser products, as well as incorporating certain safety features in the design of laser products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA enforces the QSR and laser performance standards through periodic unannounced inspections. The Company has had multiple quality system inspections by the FDA, as well as audits the Company&#8217;s Notified Body, and other foreign regulatory agencies, with the most recent inspection by the FDA occurring under the Medical Device Single Audit Program in January 2021. There were no significant findings or observations as a result of this audit. Failure to take satisfactory corrective action in response to an adverse QSR inspection or its failure to comply with applicable laser performance standards could result in enforcement actions, including a public warning letter, a shutdown of the Company&#8217;s manufacturing operations, a recall of its products, civil or criminal penalties, or other sanctions, such as those described in the preceding paragraph, which would cause its sales and business to suffer.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to the FDA's Bioresearch Monitoring (BIMO) program. As such, the BIMO audits the Company and the Company is also subject to FDA regulations relating to the design and conduct of clinical trials. The Company is subject to unannounced BIMO audits, with the most recent inspection by FDA completed over five years ago in August 2016. There were no significant findings and only two observations as a result of this audit. The Company&#8217;s responses to these observations were accepted by the FDA. Failure to take satisfactory corrective action in response to an adverse BIMO inspection or the Company&#8217;s failure to comply with Good Clinical Practices could result in the Company&#160;no longer being able to sponsor Biomedical Research, the reversal of 510(k) clearances previously granted based on the results of clinical trials conducted to gain clinical data to support those 510(k) clearances, or enforcement&#160;actions, including a public warning letter, civil or criminal penalties, or other sanctions, such as those described in the preceding paragraph, which would cause the Company&#8217;s sales and business to suffer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the Company modifies one of its</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA-cleared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">devices, it may need to seek a new clearance, which, if not granted, would prevent the Company from selling its modified products or cause it to redesign its products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any modifications to an&#160;FDA-cleared&#160;device that could significantly affect its safety or effectiveness or that would constitute a major change in its intended use would require a new 510(k) clearance or possibly a&#160;pre-market&#160;approval. The Company may not be able to obtain additional 510(k) clearance or premarket approvals for new products or for modifications to, or additional indications for, its existing products in a timely fashion, or at all. Delays in obtaining future clearance would adversely affect its ability to introduce new or enhanced products in a timely manner, which in turn would harm its revenue and future profitability.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made modifications to its devices in the past and may make additional modifications in the future that it believes do not or will not require additional clearance or approvals. If the FDA disagrees, and requires new clearances or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approvals for the modifications, the Company may be required to recall and to stop marketing the modified devices, which could harm the Company&#8217;s operating results and require it to redesign its products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company may be unable to obtain or maintain international regulatory qualifications or approvals for its current or future products and indications, which could harm its business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of the Company&#8217;s products outside the U.S. are subject to foreign regulatory requirements that vary widely from country to country. In addition, exports of medical devices from the U.S. are regulated by the FDA. Complying with international regulatory requirements can be an expensive and time- consuming process and approval is not certain. The time required for obtaining clearance or approvals, if required by other countries, may be longer than that required for FDA clearance or approvals, and requirements for such clearances or approvals may significantly differ from FDA requirements. The Company may be unable to obtain or maintain regulatory qualifications, clearances or approvals in other countries. The Company may also incur significant costs in attempting to obtain and in maintaining foreign regulatory approvals or qualifications. If the Company experience delays in receiving necessary qualifications, clearances or approvals to market its products outside the U.S., or if the Company fails to receive those qualifications, clearances or approvals, the Company may be unable to market its products or enhancements in international markets effectively, or at all, which could have a material adverse effect on the Company&#8217;s business and growth strategy.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any defects in the design, material or workmanship of its products may not be discovered prior to shipment to customers, which could materially increase its expenses, adversely impact profitability and harm its business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The design of the Company&#8217;s products is complex. To manufacture them successfully, the Company must procure quality components and employ individuals with a significant degree of technical expertise. If the&#160;Company&#8217;s designs are defective, or the material components used in its products are subject to wearing out, or if suppliers fail to deliver components to specification, or if its employees fail to properly assemble, test and package its products, the reliability and performance of its products could be adversely impacted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company&#8217;s products contain defects that cannot be repaired easily, inexpensively, or on a timely basis, the Company may experience:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">damage to the Company&#8217;s brand reputation;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">loss of customer orders and delay in order fulfillment;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">increased costs due to product repair or replacement;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">inability to attract new customers;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">diversion of resources from the Company&#8217;s manufacturing and research and development departments into the Company&#8217;s service department;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in share-based compensation; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">legal action.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of any one or more of the foregoing could materially increase expenses, adversely impact profitability and harm the Company&#8217;s business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company's products may cause or contribute to adverse medical events or be subject to failures or malfunctions that the Company is&#160;required to report to the FDA, and if the Company&#160;fails to do so, the Company&#160;would be subject to sanctions that could harm its&#160;reputation, business, financial condition and results of operations. The discovery of serious safety issues with its&#160;products, or a recall of the Company's&#160;products either voluntarily or at the direction of the FDA or another governmental authority, could have a negative impact on the Company.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is&#160;subject to the FDA&#8217;s medical device reporting regulations and similar foreign regulations, which require the Company&#160;to report to the FDA when the Company&#160;receives or becomes aware of information that reasonably suggests that one or more of its&#160;products may have caused or contributed to a death or serious injury or malfunctioned in a way that, if the malfunction were to recur, it could cause or contribute to a death or serious injury. The timing of its&#160;obligation to report is triggered by the date the Company&#160;becomes aware of the adverse event as well as the nature of the event. The Company&#160;may fail to report adverse events of which it&#160;becomes aware within the prescribed timeframe. The Company&#160;may also fail to recognize that it has&#160;become aware of a reportable adverse event, especially if it is not reported to the Company&#160;as an adverse event or if it is an adverse event that is unexpected or removed in time from the use of the product. If the Company&#160;fails to comply with its&#160;reporting obligations, the FDA could take action, including warning letters, untitled letters, administrative actions, criminal prosecution, imposition of civil monetary penalties, revocation of its&#160;device clearance or approval, seizure of its&#160;products or delay in clearance or approval of future products.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and foreign regulatory bodies have the authority to require the recall of commercialized products in the event of material deficiencies or defects in design or manufacture of a product or in the event that a product poses an unacceptable risk to health. The FDA&#8217;s authority to require a recall must be based on a finding that there is reasonable probability that the device could cause serious injury or death. The Company&#160;may also choose to voluntarily recall a product if any material deficiency is found. A government-mandated or voluntary recall by the Company&#160;could occur as a result of an unacceptable risk to health, component failures, malfunctions, manufacturing defects, labeling or design deficiencies, packaging defects or other deficiencies or failures to comply with applicable regulations. Product defects or other errors may occur in the future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the corrective action the Company&#160;takes to redress a product&#8217;s deficiencies or defects, the FDA may require, or the Company&#160;may decide, that it&#160;will need to obtain new clearances or approvals for the device before the Company&#160;may market or distribute the corrected device. Seeking such clearances or approvals may delay its&#160;ability to replace the recalled devices in a timely manner. Moreover, if the Company does not adequately address problems associated with its&#160;devices, the Company&#160;may face additional regulatory enforcement action, including FDA warning letters, product seizure, injunctions, administrative penalties or civil or criminal fines.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Companies are required to maintain certain records of recalls and corrections, even if they are not reportable to the FDA. The Company may initiate voluntary withdrawals or corrections for its&#160;products in the future that the Company&#160;determines do not require notification of the FDA. If the FDA disagrees with its determinations, it could require the Company&#160;to report those actions as recalls and the Company may be subject to enforcement action. A future recall announcement could harm its&#160;reputation with customers, potentially lead to product liability claims against the Company&#160;and negatively affect its&#160;sales. Any corrective action, whether voluntary or involuntary, as well as defending itself&#160;in a lawsuit, will require the dedication of its&#160;time and capital, will distract management from operating its&#160;business and may harm its reputation and financial results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products may in the future be subject to product recalls that could harm its&#160;reputation, business and financial results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical devices can experience performance problems in the field that require review and possible corrective action. The occurrence of component failures, manufacturing errors, software errors, design defects or labeling inadequacies affecting a medical device could lead to a government-mandated or voluntary recall by the device manufacturer, in particular when such deficiencies may endanger health. The FDA requires that certain classifications of recalls be reported to the FDA within 10 working days after the recall is initiated. Companies are required to maintain certain records of recalls, even if they are not reportable to the FDA. The Company&#160;may initiate voluntary recalls involving its&#160;products in the future that the Company&#160;determines do not require notification of the FDA. If the FDA disagrees with its determinations, they could require the Company&#160;to report those actions as recalls. Product recalls may divert management attention and financial resources, expose the Company to product liability or other claims, harm its&#160;reputation with customers and adversely impact its&#160;business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical trials may be necessary to support future product submissions to the FDA. The clinical trial process is lengthy and expensive with uncertain outcomes, and often requires the enrollment of large numbers of patients, and suitable patients may be difficult to identify and recruit. Delays or failures in the Company's&#160;clinical trials will prevent it&#160;from commercializing any modified or new products and will adversely affect its&#160;business, operating results and prospects.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has&#160;conducted clinical trials in the past and will likely conduct clinical trials in the future. Initiating and completing clinical trials necessary to support any future product candidates, will be time-consuming and expensive and the outcome, uncertain. Moreover, the results of early clinical trials are not necessarily predictive of future results, and any product the Company&#160;advances into clinical trials may not have favorable results in later clinical trials. The results of preclinical studies and clinical trials of its&#160;products conducted to date and ongoing or future studies and trials of its current, planned or future products may not be predictive of the results of later clinical trials, and interim results of a clinical trial do not necessarily predict final results. The Company's&#160;interpretation of data and results from its&#160;clinical trials do not ensure that the Company&#160;will achieve similar results in future clinical trials. In addition, preclinical and clinical data are often susceptible to various interpretations and analyses, and many companies that have believed their products performed satisfactorily in preclinical studies and earlier clinical trials have nonetheless failed to replicate results in later clinical trials. Products in later stages of clinical trials may fail to show the desired safety and efficacy despite having progressed through nonclinical studies and earlier clinical trials. Failure can occur at any stage of clinical testing. The Company's&#160;clinical studies may produce negative or inconclusive results, and it&#160;may decide, or regulators may require us, to conduct additional clinical and&#160;non-clinical&#160;testing in addition to those the Company has&#160;planned.</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company may be required to submit an IDE application to the FDA, which must become effective prior to commencing certain human clinical trials of medical devices, and the FDA may reject the Company's IDE application and notify the Company that it may not begin clinical trials;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">regulators and other comparable foreign regulatory authorities may disagree as to the design or implementation of its clinical trials;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">regulators and/or an IRB, or other reviewing bodies may not authorize the Company or its investigators to commence a clinical trial, or to conduct or continue a clinical trial at a prospective or specific trial site;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company may not reach agreement on acceptable terms with prospective contract research organizations, or CROs, and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">clinical trials may produce negative or inconclusive results, and the Company may decide, or regulators may require the Company to conduct additional clinical trials or abandon product development programs;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the number of subjects or patients required for clinical trials may be larger than the Company anticipates, enrollment in these clinical trials may be insufficient or slower than the Company anticipates, and the number of clinical trials being conducted at any given time may be high and result in fewer available patients for any given clinical trial, or patients may drop out of these clinical trials at a higher rate than the Company anticipates;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company's third-party contractors, including those manufacturing products or conducting clinical trials on the Company's behalf, may fail to comply with regulatory requirements or meet their contractual obligations to the Company in a timely manner, or at all;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company might have to suspend or terminate clinical trials for various reasons, including a finding that the subjects are being exposed to unacceptable health risks;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company may have to amend clinical trial protocols or conduct additional studies to reflect changes in regulatory requirements or guidance, which it may be required to submit to an IRB and/or regulatory authorities for re-examination;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">regulators, IRBs, or other parties may require or recommend that the Company or its investigators suspend or terminate clinical research for various reasons, including safety signals or noncompliance with regulatory requirements;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the cost of clinical trials may be greater than the Company anticipates;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">clinical sites may not adhere to the clinical protocol or may drop out of a clinical trial;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company may be unable to recruit a sufficient number of clinical trial sites;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">regulators, IRBs, or other reviewing bodies may fail to approve or subsequently find fault with its manufacturing processes or facilities of third-party manufacturers with which the Company enters into agreement for clinical and commercial supplies, the supply of devices or other materials necessary to conduct clinical trials may be insufficient, inadequate or not available at an acceptable cost, or the Company may experience interruptions in supply;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">approval policies or regulations of the FDA or applicable foreign regulatory agencies may change in a manner rendering the Company's clinical data insufficient for approval;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the Company's current or future products may have undesirable side effects or other unexpected characteristics; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">impacts of regional or global public health crises including the ongoing COVID-19 pandemic could adversely affect any clinical trials the Company is conducting or plan to conduct, including delays or difficulties in enrolling or onboarding patients, initiating clinical sites, or obtaining the requisite regulatory approvals, interruption of key clinical trial activities, or supply chain disruptions that delay or make it more difficult or costly to obtain the supplies and materials the Company needs for clinical trials.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these occurrences may significantly harm the Company's&#160;business, financial condition and prospects. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of its&#160;product candidates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials must be conducted in accordance with the laws and regulations of the FDA and other applicable regulatory authorities&#8217; legal requirements, regulations or guidelines, and are subject to oversight by these governmental agencies and IRBs at the medical institutions where the clinical trials are conducted. Conducting successful clinical studies will require the enrollment of large numbers of patients, and suitable patients may be difficult to identify and recruit. Patient enrollment in clinical trials and completion of patient participation and&#160;follow-up&#160;depends on many factors, including the size of the patient population, the nature of the trial protocol, the attractiveness of, or the discomforts and risks associated with, the treatments received by enrolled subjects, the availability of appropriate clinical trial investigators, support staff, and proximity of patients to clinical sites and able to comply with the eligibility and exclusion criteria for participation in the clinical trial and patient compliance. For example, patients may be discouraged from enrolling in its&#160;clinical trials if the trial protocol requires them to undergo extensive post-treatment procedures or&#160;follow-up&#160;to assess the safety and effectiveness of its&#160;products or if they determine that the treatments received under the trial protocols are not attractive or involve unacceptable risks or discomforts.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#160;depends on its&#160;collaborators and on medical institutions and CROs to conduct its clinical trials in compliance with good clinical practice ("GCP") requirements. To the extent its&#160;collaborators or the CROs fail to enroll participants for its&#160;clinical trials, fail to conduct the study to GCP standards or are delayed for a significant time in the execution of trials, including achieving full enrollment, the Company&#160;may be affected by increased costs, program delays or both. In addition, clinical trials that are conducted in countries outside the United States may subject the Company to further delays and expenses as a result of increased shipment costs, additional regulatory requirements and the engagement of&#160;non-U.S.&#160;CROs, as well as expose the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company&#160;to risks associated with clinical investigators who are unknown to the FDA, and different standards of diagnosis, screening and medical care.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development of sufficient and appropriate clinical protocols to demonstrate safety and efficacy are required and the Company&#160;may not adequately develop such protocols to support clearance and approval. Further, the FDA may require the Company&#160;to submit data on a greater number of patients than the Company&#160;originally anticipated and/or for a longer&#160;follow-up&#160;period or change the data collection requirements or data analysis applicable to the Company's&#160;clinical trials. Delays in patient enrollment or failure of patients to continue to participate in a clinical trial may cause an increase in costs and delays in the approval and attempted commercialization of its&#160;products or result in the failure of the clinical trial. In addition, despite considerable time and expense invested in its&#160;clinical trials, the FDA may not consider the Company's&#160;data adequate to demonstrate safety and efficacy. Such increased costs and delays or failures could adversely affect its business, operating results and prospects.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The results of the Company's&#160;clinical trials may not support its&#160;product candidate claims or may result in the discovery of adverse side effects.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot be certain that the results of its&#160;future clinical trials will support its&#160;future product claims or that the FDA will agree with its&#160;conclusions regarding them. Success in&#160;pre-clinical&#160;studies and early clinical trials does not ensure that later clinical trials will be successful, and the Company&#160;cannot be sure that the later trials will replicate the results of prior trials and&#160;pre-clinical&#160;studies. The clinical trial process may fail to demonstrate that its&#160;product candidates are safe and effective for the proposed indicated uses, which could cause the Company&#160;to abandon a product candidate and may delay development of others. Any delay or termination of the Company's&#160;clinical trials will delay the filing of its&#160;product submissions and, ultimately, its&#160;ability to commercialize its&#160;product candidates and generate revenues. It is also possible that patients enrolled in clinical trials will experience adverse side effects that are not currently part of the future product&#8217;s profile.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product liability suits could be brought against the Company due to a defective design, material or workmanship or misuse of its products and could result in expensive and time-consuming litigation, payment of substantial damages and an increase in its insurance rates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company&#8217;s products are defectively designed, manufactured or labeled, contain defective components or are misused, the Company may become subject to substantial and costly litigation by the Company&#8217;s customers or their patients. Misusing the Company&#8217;s products or failing to adhere to operating guidelines could cause significant eye and skin damage, and underlying tissue damage. In addition, if its operating guidelines are found to be inadequate, the Company may be subject to liability. The Company has been involved, and may in the future be involved, in litigation related to the use of its products. Product liability claims could divert management&#8217;s attention from its core business, be expensive to defend and result in sizable damage awards against the Company. The Company may not have sufficient insurance coverage for all future claims. The Company may not be able to obtain insurance in amounts or scope sufficient to provide the Company with adequate coverage against all potential liabilities. Any product liability claims brought against the Company, with or without merit, could increase the Company&#8217;s product liability insurance rates or prevent the Company from securing continuing coverage, could harm its reputation in the industry and could reduce product sales. In addition, the Company historically experienced steep increases in its product liability insurance premiums as a percentage of revenue. If its premiums continue to rise, the Company may no longer be able to afford adequate insurance coverage.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If customers are not trained and/or the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s products are used by</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">non-licensed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">practitioners, it could result in product misuse and adverse treatment outcomes, which could harm the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s reputation, result in product liability litigation, distract management and result in additional costs, all of which could harm the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company's products&#160;are used by&#160;non-licensed or untrained&#160;practitioners, it could result in product misuse and adverse treatment outcomes, which could harm the Company&#8217;s reputation and the Company&#8217;s business. U.S. federal regulations allow the Company&#160;to sell the Company&#8217;s products to or on the order of &#8220;licensed practitioners.&#8221; The definition of &#8220;licensed practitioners&#8221; varies from state to state. As a result, the Company&#8217;s products may be purchased or operated by physicians with&#160;varying levels of training, and in many states, by&#160;non-physicians,&#160;including nurse practitioners, chiropractors and technicians. Outside the U.S., many jurisdictions do not require specific qualifications or training for purchasers or operators of its products. The Company does not supervise the procedures performed with the Company&#8217;s products, nor does the Company require that direct medical supervision occur that is determined by state law. The Company and its distributors generally offer but do not require product training to the purchasers or operators of the Company&#8217;s products. In addition, the Company sometimes sells its systems to companies that rent its systems to third parties and that provide a technician to perform the procedures. The lack of training and the purchase and use of its products by&#160;non-physicians&#160;may result in product misuse and adverse treatment outcomes, which could harm the Company&#8217;s reputation and its business, and, in the event these actions result in product liability litigation, distract management and subject the Company&#160;to liability, including legal expenses.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s manufacturing operations are dependent upon third-party suppliers, making its vulnerable to supply shortages and price fluctuations, which could harm its business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the components and materials that comprise the Company&#8217;s products are currently manufactured by a limited number of suppliers. In addition, all of the Company&#8217;s skincare products are manufactured by its sole supplier, ZO. A supply interruption or an increase in demand beyond the Company&#8217;s current suppliers&#8217; capabilities could harm the Company&#8217;s ability to manufacture its products until a new source of supply is identified and qualified. The Company&#8217;s reliance on these suppliers subjects the Company to a number of risks that could harm its business, including:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">interruption of supply resulting from modifications to or discontinuation of a supplier&#8217;s operations;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">delays in product shipments resulting from uncorrected defects, reliability issues or a supplier&#8217;s variation in a component;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">lack of long-term supply arrangements for key components with the Company&#8217;s suppliers;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">inability to obtain adequate supply in a timely manner, or on reasonable terms;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">inability to redesign one or more components in the Company&#8217;s systems in the event that a supplier discontinues manufacturing such components and the Company&#8217;s inability to sources it from other suppliers on reasonable terms;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">difficulty locating and qualifying alternative suppliers for the Company&#8217;s components in a timely manner;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">production delays related to the evaluation and testing of products from alternative suppliers and corresponding regulatory qualifications; and delay in supplier deliveries.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any interruption in the supply of components or materials, or the Company&#8217;s inability to obtain substitute components or materials from alternate sources at acceptable prices in a timely manner, could impair its ability to meet the demand of the Company&#8217;s customers, which would have an adverse effect on the Company&#8217;s business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks related to the reduction or interruption in supply and an inability to develop alternative sources for supply may adversely affect the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s manufacturing operations and related product sales.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains manufacturing operations at its facility in Brisbane, California, and purchases many of the components and raw materials used in manufacturing these products from numerous suppliers in various countries. Any problem affecting a supplier (whether due to external or internal causes) could have a negative impact on the Company.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a few limited cases, specific components and raw materials are purchased from primary or main suppliers (or in some cases, a single supplier) for reasons related to quality assurance, cost-effectiveness ratio and availability. While the Company works closely with its suppliers to ensure supply continuity, the Company cannot guarantee that its efforts will always be successful. Moreover, due to strict standards and regulations governing the manufacture and marketing its products, it may not be able to quickly locate new supply sources in response to a supply reduction or interruption, with negative effects on its ability to manufacture its products effectively and in a timely fashion.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company manufactures its goods at the Brisbane, California site, as well as dual sourcing several product platforms at contract manufacturing shops for redundancy. A few of the product platforms such as Enlighten and excel HR are only capable of being produced at the single site in Brisbane, and as such the occurrence of a catastrophic disaster or other similar event could cause damage to its facilities and equipment, which might require the Company to cease or curtail sales of these sole sourced platforms.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is vulnerable to damage from various types of disasters, including fires, earthquakes, terrorist acts, floods, power losses, communications failures, pandemics and similar events. If any such disaster were to occur, the Company may not be able to operate the Company&#8217;s business at the Company&#8217;s facility in Brisbane, California. Before the Company could manufacture products from a replacement facility, the Company&#8217;s manufacturing facilities which require regulatory agency approval, could require significant delays to obtain regulatory agency&#8217;s approval. The insurance the Company maintains may not be adequate to cover the Company&#8217;s losses resulting from disasters or other business interruptions. Therefore, any such catastrophe could seriously harm the Company&#8217;s business and consolidated results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual property rights may not provide adequate protection for some or all of the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s products, which may permit third parties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">to compete against the Company&#160;more effectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on patent, copyright, trade secret and trademark laws and confidentiality agreements to protect the Company&#8217;s technology and products. As of January&#160;19, 2022, the Company had 28 issued and unexpired U.S. patents, eight pending U.S. patent applications, and four pending international applications under the Patent Cooperation Treaty ("PCT"). Some of the Company&#8217;s components, such as the Company&#8217;s laser module, electronic control system and high-voltage electronics, are not, and in the future may not be, protected by patents. Additionally, the Company&#8217;s patent applications may not issue as patents or, if issued, may not issue in a form that will be advantageous to us. Any patents the Company obtains may be challenged, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">invalidated or legally circumvented by third parties. Consequently, competitors could market products and use manufacturing processes that are substantially similar to, or superior to, the Company&#8217;s. The Company may not be able to prevent the unauthorized disclosure or use of the Company&#8217;s technical knowledge or other trade secrets by consultants, vendors, former employees or current employees, despite the existence generally of confidentiality agreements and other contractual restrictions. Monitoring unauthorized uses and disclosures of the Company&#8217;s intellectual property is difficult, and the Company does not know whether the steps it has taken to protect the Company&#8217;s intellectual property will be effective. Moreover, the laws of many foreign countries will not protect the Company&#8217;s intellectual property rights to the same extent as the laws of the U.S.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The absence of complete intellectual property protection exposes the Company&#160;to a greater risk of direct competition. Competitors could purchase one of the Company&#8217;s products and attempt to replicate some or all of the competitive advantages the Company derives from the Company&#8217;s development efforts, design around the&#160;Company&#8217;s protected technology, or develop their own competitive technologies that fall outside of the Company&#8217;s intellectual property rights. If the Company&#8217;s intellectual property is not adequately protected against competitors&#8217; products and methods, the Company&#8217;s competitive position and its business could be adversely affected.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company may be involved in future costly intellectual property litigation, which could impact its future business and financial performance.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s competitors or other patent holders may assert that the Company&#8217;s present or future products and the methods the Company employs are covered by their patents. In addition, the Company does not know whether its competitors own or will obtain patents that they may claim prevent, limit or interfere with the Company&#8217;s ability to make, use, sell or import the Company&#8217;s products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may become involved in litigation not only as a result of alleged infringement of a third party&#8217;s intellectual property rights but also to protect the Company&#8217;s own intellectual property. For example, the Company has been involved in litigation to protect the trademark rights associated with its company name or the names of its products. Infringement and other intellectual property claims, with or without merit, can be expensive and time- consuming to litigate, and could divert management&#8217;s attention from its core business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The expense and potential unavailability of insurance coverage for the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s customers could adversely affect its ability to sell its products, and therefore adversely affect its financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s customers and prospective customers have had difficulty procuring or maintaining liability insurance to cover their operation and use of its products. Medical malpractice carriers are withdrawing coverage in certain states or substantially increasing premiums. If this trend continues or worsens, the Company&#8217;s customers may discontinue using the Company&#8217;s products and potential customers may opt against purchasing laser-based products due to the cost or inability to procure insurance coverage. The unavailability of insurance coverage for the Company&#8217;s customers and prospects could adversely affect its ability to sell its products, and that could harm its financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">From time to time the Company may become subject to income tax audits or similar proceedings, and as a result the Company may incur additional costs and expenses or owe additional taxes, interest and penalties that may negatively impact its operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes in the U.S. and certain foreign jurisdictions where it operates through a subsidiary, including Australia, Belgium, Canada, France, Germany, Hong Kong, Japan, Spain, Switzerland, Italy and the United Kingdom. The Company&#8217;s determination of its tax liability is subject to review by applicable domestic and foreign tax authorities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has gone through sales and income tax audits in the past. Although these&#160;audits did not result in any material adjustments, the final timing and resolution of any future tax examinations are subject to significant&#160;uncertainty and could result in the Company&#8217;s having to pay amounts to the applicable tax authority in order to resolve examination of its tax positions. An increase or decrease of tax related to tax examination resolution could result in a change in the Company&#8217;s income tax accrual and could negatively impact its financial position, results of operations or cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company may be adversely affected by changes in U.S. tax laws, importation taxes and other changes that may be imposed by the current administration.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to taxes in the U.S. and other jurisdictions. Tax rates in these jurisdictions may be subject to significant change due to economic and/or political conditions. A number of other factors may also impact the Company&#8217;s future effective tax rate including:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the jurisdictions in which profits are determined to be earned and taxed;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the resolution of issues arising from tax audits with various tax authorities;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in valuation of the Company&#8217;s deferred tax assets and liabilities;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">increases in expenses not deductible for tax purposes, including write-offs and impairment of goodwill in connection with acquisitions;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in availability of tax credits, tax holidays, and tax deductions;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in share-based compensation; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">changes in tax laws or the interpretation of such tax laws and changes in generally accepted accounting principles.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any acquisitions that the Company makes could result in operating difficulties, dilution, and other consequences that may adversely impact the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s business and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company from time to time evaluates potential acquisitions of businesses, products and technologies, and anticipates continuing to make these evaluations, the Company has no present understandings, commitments or agreements with respect to any material acquisitions or collaborative projects. The Company may not be able to identify appropriate acquisition candidates or strategic partners, or successfully negotiate, finance or integrate any businesses, products or technologies that the Company acquire.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has limited experience as a team with acquiring companies and products. Furthermore, the integration of any acquisition and management of any collaborative project may divert management&#8217;s time and resources from the Company&#8217;s core business and disrupt the Company&#8217;s operations and it may incur significant legal, accounting and banking fees in connection with such a transaction. Acquisitions could diminish the Company&#8217;s available cash balances for other uses, result in the incurrence of debt, contingent liabilities, or amortization expenses, and restructuring charges. Also, the anticipated benefits or value of its acquisitions or investments may not materialize and could result in an impairment of goodwill and/or purchased long-lived assets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s failure to address these risks or other problems encountered in connection with the Company&#8217;s past or future acquisitions and investments could cause the Company to fail to realize the anticipated benefits of such acquisitions or investments, incur unanticipated liabilities, and harm the Company&#8217;s business and the Company&#8217;s financial condition or results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s failure to comply with rules relating to bribery, foreign corrupt practices, and privacy and security laws may subject the Company to penalties and adversely impact its reputation and business operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business is subject to regulation and oversight worldwide including:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the FCPA, which prohibits corporations and individuals from paying, offering to pay or authorizing the payment of anything of value to any foreign government official, government staff member, political party or political candidate in an attempt to obtain or retain business or to otherwise influence a person working in an official capacity;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">the UK Bribery Act, which prohibits both domestic and international bribery, as well as bribery across both public and private sectors; and bribery provisions contained in the German Criminal Code, which, pursuant to draft legislation being prepared by the German government, may make the corruption and corruptibility of physicians in private practice and other healthcare professionals a criminal offense;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Health Insurance Portability and Accountability Act of 1996, as amended by The Health Information Technology for Economic and Clinical Health Act, which governs the conduct of certain electronic healthcare transactions and protects the security and privacy of protected health information; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">analogous state and foreign law equivalents of each of the above laws, such as state laws that require device companies to comply with the industry&#8217;s voluntary compliance guidelines and the applicable compliance guidance promulgated by the federal government; and state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk of being found in violation of these laws is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available under such laws, it is possible that some of the Company&#8217;s business activities, including the Company&#8217;s&#160;relationships with practitioners and thought leaders worldwide, some of whom recommend, purchase and/or use the Company&#8217;s devices, as well as the Company&#8217;s sales agents and distributors, could be subject to challenge under one or more of such laws. The Company is also exposed to the risk that the Company&#8217;s employees, independent contractors, principal investigators, consultants, vendors, independent sales agents and distributors may engage in fraudulent or other illegal activity. While the Company has policies and procedures in place prohibiting such activity, misconduct by these parties could include, among other infractions or violations, intentional, reckless and/or negligent conduct or unauthorized activity that violates FDA regulations, including those laws that require the reporting of true, complete and accurate information to the FDA, manufacturing standards, laws that require the true, complete and accurate reporting of financial information or data or other commercial or regulatory laws or requirements. It is not always possible to identify and deter </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">misconduct by the Company&#8217;s employees and other third parties, and the precautions the Company takes to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting the Company from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are similar laws and regulations applicable to the Company&#160;outside the U.S., all of which are subject to evolving interpretations. Global enforcement of anti- corruption laws, including but not limited to the UK Bribery Act, the Brazil Clean Companies Act, and continued enforcement in the Europe, Middle East and Asia Pacific has increased substantially in recent years, with more frequent voluntary self-disclosures by companies, aggressive investigations and enforcement proceedings by governmental agencies, and assessment of significant fines and penalties against companies and individuals. The Company&#8217;s operations create the risk of unauthorized payments or offers of payments by one of its employees, consultants, sales agents, or distributors because these parties are not always subject to its control. It is the Company&#8217;s policy to implement safeguards to discourage these practices; however, its existing safeguards and any future improvements may prove to be less than effective, and its employees, consultants, sales agents, or distributors may engage in conduct for which the Company might be held responsible. Any alleged or actual violations of these regulations may subject the Company&#160;to government scrutiny, severe criminal or civil sanctions and other liabilities, and could negatively affect its business, reputation, operating results, and financial condition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;27, 2017, the United Kingdom&#8217;s Financial Conduct Authority announced that it intends to stop persuading or compelling banks to submit LIBOR rates after 2021. These reforms may cause LIBOR to cease to exist, new methods of calculating LIBOR to be established or the establishment of an alternative reference rate(s). These consequences cannot be entirely predicted and could have an adverse impact on the market value for or value of LIBOR-linked securities, loans, and other financial obligations or extensions of credit held by the Company. Changes in market interest rates may influence returns on financial investments and could reduce its earnings and cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes it has a strong culture of compliance and adequate systems of control, and it seeks continuously to improve its systems of internal controls and to remedy any weaknesses identified, there can be no assurance that the policies and procedures will be followed at all times or will effectively detect and prevent violations of the applicable laws by one or more of its employees, consultants, agents or partners and, as a result, the Company may be subject to penalties and material adverse consequences on its business, financial condition or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company has identified a material weakness in its internal control over financial reporting at its Japan subsidiary, which could, if not remediated, result in material misstatements in the Company's financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Securities Exchange Act. As disclosed in Item 9A of this Annual Report on Form 10-K, the Company identified a material weakness in its internal control over financial reporting relating to user access and segregation of duties conflicts at the Company's Japan subsidiary. A material weakness is defined as a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements will not be prevented or detected on a timely basis. As a result of this material weakness, the Company concluded that its internal control over financial reporting was not effective based on criteria set forth by the Committee of Sponsoring Organization of the Treadway Commission in Internal Control-An Integrated Framework (2013). </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To implement remedial measures as disclosed in Item 9A, the Company has begun the process of designing and implementing additional controls to detect potential unauthorized entries or transactions that may arise as a result of the user access and segregation of duties conflicts at the Company's Japan subsidiary. If these remedial measures are insufficient to address the material weakness, or if additional material weaknesses or significant deficiencies in the Company's internal control over financial reporting are discovered or occur in the future, the Company's consolidated financial statements may contain material misstatements, and the Company could be required to restate its financial results. In addition, if the Company is unable to successfully remediate the material weakness and is unable to produce accurate and timely financial statements, its stock price may be adversely affected. </span></div><div style="margin-top:10pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Notes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Although the notes are referred to as convertible senior notes, they are effectively subordinated to any of the Company's&#160;secured debt and any liabilities of its&#160;subsidiaries.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will be the Company's&#160;senior unsecured obligations and will rank:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">senior in right of payment to all of its indebtedness that is expressly subordinated in right of payment to the notes;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">equal in right of payment to all of its unsecured indebtedness that is not so subordinated;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">effectively junior to any of its secured indebtedness to the extent of the value of the assets securing such indebtedness, including any amount outstanding under the Company's senior credit facility; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">structurally junior to all indebtedness and other liabilities of its current or future subsidiaries (including trade payables).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of the Company's&#160;bankruptcy, liquidation reorganization or other winding up, the Company's&#160;assets that secure secured indebtedness will be available to pay obligations on the notes only after all such secured indebtedness has been repaid in full from such assets. There may not be sufficient assets remaining to pay amounts due on any or all of the notes then outstanding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition the notes are the Company's&#160;obligations exclusively and are not guaranteed by any of its subsidiaries. A portion of the Company's&#160;operations are conducted through, and a portion of its&#160;consolidated assets are held by its&#160;subsidiaries. Accordingly, the Company's&#160;ability to service its&#160;debt, including the notes, depends, in part, on the results of operations of its subsidiaries and upon the ability of such subsidiaries to provide the Company&#160;with cash, whether in the form of dividends, loans or otherwise, to pay amounts due on its obligations, including the notes. The Company's&#160;subsidiaries are separate and distinct legal entities and have no obligation contingent or otherwise, to make payments on the notes or to make any funds available for that purpose. The Company's&#160;right to receive any assets of any of its&#160;subsidiaries upon such subsidiary&#8217;s bankruptcy, liquidation or reorganization and, therefore, the right of the holders of notes to participate in those assets, will be subject to prior claims of creditors of the subsidiary, including trade creditors, and such subsidiary may not have sufficient assets remaining to make any payments to the Company&#160;as a shareholder or otherwise. In addition, dividends, loans or other distributions to the Company&#160;from such subsidiaries may be subject to contractual and other restrictions and are subject to other business and tax considerations. The indenture governing the notes will not prohibit the Company&#160;from incurring additional senior debt or secured debt, nor will it prohibit any of the Company's&#160;current or future subsidiaries from incurring additional liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory actions and other events may adversely affect the trading price and liquidity of the notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that many investors in, and potential purchasers of, the notes will employ or seek to employ, a convertible arbitrage strategy with respect to the notes. Investors would typically implement such a strategy by selling short the common stock underlying the notes and dynamically adjusting their short position while continuing to hold the notes. Investors may also implement this type of strategy by entering into swaps on its common stock in lieu of or in addition to short selling the common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC and other regulatory and self-regulatory authorities have implemented various rules and taken certain actions, and may in the future adopt additional rules and take other actions, that may impact those engaging in short selling activity involving equity securities (including its&#160;common stock). Such rules and actions include Rule&#160;201 of SEC Regulation&#160;SHO, the adoption by the Financial Industry Regulatory Authority, Inc. and the national securities exchanges of a &#8220;Limit&#160;Up-Limit&#160;Down&#8221; program, the imposition of market-wide circuit breakers that halt trading of securities for certain periods following specific market declines, and the implementation of certain regulatory reforms required by the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. Any governmental or regulatory action that restricts the ability of investors in or potential purchasers of, the notes to effect short sales of the Company's common stock, borrow its&#160;common stock or enter into swaps on the Company's&#160;common stock could adversely affect the trading price and the liquidity of the notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Volatility in the market price and trading volume of the Company's&#160;common stock could adversely impact the trading price of the notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that the trading price of the notes will be significantly affected by the market price of its&#160;common stock. The stock market in recent years has experienced significant price and volume fluctuations that have often been unrelated to the operating performance of companies. The market price of the Company's&#160;common stock could fluctuate significantly for many reasons, including in response to the risks described in this section, elsewhere in this offering memorandum or the documents incorporated by reference in this offering memorandum or for reasons unrelated to its&#160;operations, many of which are beyond the Company's&#160;control, such as reports by industry analysts, investor perceptions or negative announcements by its&#160;customers, competitors or suppliers regarding their own performance, as well as industry conditions and general financial, economic and political instability. A decrease in the market price of the Company's&#160;common stock would likely adversely impact the trading </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">price of the notes. The market price of the Company's&#160;common stock could also be affected by possible sales of its&#160;common stock by investors who view the notes as a more attractive means of equity participation in the Company&#160;and by hedging or arbitrage trading activity that the Company&#160;expects to develop involving its common stock. This trading activity could, in turn, affect the trading price of the notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company may still incur substantially more debt or take other actions which would intensify the risks discussed above.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its&#160;subsidiaries may incur substantial additional debt in the future, subject to the restrictions contained in its&#160;existing and future debt agreements, some of which may be secured debt. The Company&#160;will not be restricted under the terms of the indenture governing the notes from incurring additional debt, securing existing&#160;or future debt, recapitalizing its&#160;debt, repurchasing its&#160;stock, pledging its&#160;assets, making investments, paying dividends, guaranteeing debt or taking a number of other actions that are not limited by the terms of the indenture governing the notes that could have the effect of diminishing the Company's ability to make payments on the notes when due.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company may not have the ability to raise the funds necessary to settle conversions of the notes in cash or to repurchase the notes upon a fundamental change, and its future debt may contain limitations on its&#160;ability to pay cash upon conversion or repurchase of the notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the notes will have the right to require the Company&#160;to repurchase all or a portion of their notes upon the occurrence of a fundamental change before the maturity date at a repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest, if any.&#160;In addition, upon conversion of the notes, unless the Company&#160;elects to deliver solely shares of its&#160;common stock to settle such conversion (other than paying cash in lieu of delivering any fractional share), the Company&#160;will be required to settle a portion or all of its&#160;conversion obligation in respect of the notes being converted in cash.&#160;Moreover, the Company will be required to repay the notes in cash at their maturity unless earlier converted, redeemed or repurchased. However, the Company&#160;may not have enough available cash or be able to obtain financing at the time the Company is&#160;required to make repurchases of notes surrendered therefor or pay cash with respect to notes being converted or at their maturity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company's&#160;ability to repurchase notes or to pay cash upon conversions of notes or at their maturity may be limited by law, regulatory authority or agreements governing its&#160;future indebtedness. The Company's&#160;failure to repurchase notes at a time when the repurchase is required by the indenture or to pay cash upon conversions of notes or at their maturity as required by the indenture would constitute a default under the indenture. A default under the indenture or the fundamental change itself could also lead to a default under agreements governing the Company's&#160;existing and future indebtedness. Moreover, the occurrence of a fundamental change under the indenture could constitute an event of default under any such agreement. If the payment of the related indebtedness were to be accelerated after any applicable notice or grace periods, the Company&#160;may not have sufficient funds to repay the indebtedness.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The conditional conversion features of the notes, if triggered, may adversely affect the Company's financial condition and operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second and third quarters of 2021, a conversion feature related to the sale price of the Company&#8217;s common stock was triggered. No conversion requests were submitted by the holders of the notes related to these triggering events. In the event the conditional conversion features of the notes are triggered, holders of the notes will be entitled to convert their notes at any time during specified periods at their option.&#160;If one or more holders elect to convert their notes, unless the Company&#160;elects to satisfy the Company's&#160;conversion obligation by delivering solely shares of its&#160;common stock, the Company would be required to settle a portion or all of its conversion obligation in cash, which could adversely affect the company's&#160;liquidity. In addition, even if holders of notes do not elect to convert their notes, the Company could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the notes as a current rather than long-term liability, which would result in a material reduction of its&#160;net working capital.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders of notes will not be entitled to any rights with respect to the Company's&#160;common stock, but they will be subject to all changes made with respect to the Company's&#160;common stock to the extent the Company satisfies&#160;its conversion obligation, in whole or in part, with shares of its&#160;common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of notes will not be entitled to any rights with respect to the Company's&#160;common stock (including, without limitation, voting rights and rights to receive any dividends or other distributions on its common stock) prior to the conversion date relating to such notes (if the Company has&#160;elected to settle the conversion by delivering solely shares of its&#160;common stock (other than paying cash in lieu of delivering any fractional share)) or the last trading day of the observation period (if the Company elects to pay and deliver, as the case may be, a combination of cash and shares of its&#160;common stock in respect of the relevant conversion), but holders of notes will be subject to all changes affecting the Company's&#160;common stock. For example, if an amendment is </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proposed to the Company's&#160;certificate of incorporation or bylaws requiring stockholder approval and the record date for determining the stockholders of record entitled to vote on the amendment occurs prior to the conversion date related to a holder&#8217;s conversion of its notes (if the Company&#160;has&#160;elected to settle the relevant conversion by delivering solely shares of its common stock (other than paying cash in lieu of delivering any fractional share)) or the last trading day of the observation period (if the Company&#160;elects to pay and deliver, as the case may be, a combination of cash and shares of its&#160;common stock in respect of the relevant conversion), such holder will not be entitled to vote on the amendment, although such holder will nevertheless be subject to any changes affecting its&#160;common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The conditional conversion feature of the notes could result in holders&#160;receiving less than the value of the Company's&#160;common stock into which the notes would otherwise be convertible.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the close of business on the business day immediately preceding December&#160;15, 2025, holders may convert their&#160;notes only if specified conditions are met. If the specific conditions for conversion are not met, holders will not be able to convert their notes, and holders&#160;may be unable to receive the value of the cash, common stock or a combination of cash and common stock, as applicable, into which their&#160;notes would otherwise be convertible.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Upon conversion of the notes, holders&#160;may receive less valuable consideration than expected because the value of the Company's&#160;common stock may decline after holders&#160;exercise their&#160;conversion right but before the Company&#160;satisfies it&#160;conversion obligation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the notes, a converting holder will be exposed to fluctuations in the value of the Company's&#160;common stock during the period from the date such holder surrenders notes for conversion until the date the Company&#160;satisfies its&#160;conversion obligation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion of the notes, the Company&#160;will satisfy its conversion obligation by paying or delivering, as the case may be, cash, shares of its&#160;common stock, or a combination of cash and shares of its&#160;common stock, at the Company's&#160;option. If the Company satisfies its&#160;conversion obligation solely in cash or through payment and delivery, as the case may be, of a combination of cash and shares of its&#160;common stock, the amount of cash and shares of common stock, if any, due upon conversion will be based on a daily conversion value calculated on a proportionate basis for each trading day in a 40 trading day observation period. This period would be: (i)&#160;subject to clause (ii), if the relevant conversion date occurs prior to December&#160;15, 2025, the 40 consecutive trading day period beginning on and including, the second trading day immediately succeeding such conversion date; (ii)&#160;if the relevant conversion date occurs during a redemption period, the 40 consecutive trading days beginning on and including, the 41st scheduled trading day immediately preceding the date that is specified as the redemption date in the related notice of redemption; and (iii)&#160;subject to clause (ii), if the relevant conversion date occurs on or after December&#160;15, 2025, the 40 consecutive trading days beginning on and including, the 41st scheduled trading day immediately preceding the maturity date. Accordingly, if the price of the Company's&#160;common stock decreases during this period, the value of consideration holders&#160;receive will be adversely affected. In addition, if the market price of the Company's&#160;common stock at the end of such period is below the average of the daily volume weighted-average prices of the Company's&#160;common stock during such period, the value of any shares of the Company's&#160;common stock that holders&#160;will receive in satisfaction of its&#160;conversion obligation will be less than the value used to determine the number of shares that holders&#160;will receive.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company&#160;elects to satisfy its&#160;conversion obligation solely in shares of the Company's&#160;common stock upon conversion of the notes, the Company&#160;will be required to deliver the shares of its&#160;common stock, together with cash for any fractional share, on the second business day following the relevant conversion date. Accordingly, if the price of the Company's&#160;common stock decreases during this period, the value of the shares that holders&#160;receive will be adversely affected and would be less than the conversion value of the notes on the conversion date.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The notes are not protected by restrictive covenants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indenture governing the notes will not contain any financial or operating covenants or restrictions on the payments of dividends, the incurrence of indebtedness or the issuance or repurchase of securities by the Company&#160;or any of its subsidiaries. The indenture will not contain any covenants or other provisions to afford protection to holders of the notes in the event of a fundamental change or other corporate transaction involving the Company subject to certain exceptions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The increase in the conversion rate for notes converted in connection with a make-whole fundamental change or during a redemption period may not adequately compensate holders&#160;for any lost value of their notes as a result of such transaction or redemption.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a make-whole fundamental change occurs prior to the maturity date or upon its issuance of a notice of redemption the Company&#160;will, under certain circumstances, increase the conversion rate by a number of additional shares of its&#160;common stock for notes converted in connection with such make-whole fundamental change or during the related redemption period. The increase in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the conversion rate will be determined based on the date on which the&#160;specified corporate transaction becomes effective or the redemption notice date, as applicable, and the price paid (or deemed to be paid) per share of the Company's&#160;common stock in such transaction or on such redemption notice date.&#160;The increase in the conversion rate for notes converted in connection with a make-whole fundamental change or during a redemption period may not adequately compensate holders&#160;for any lost value of their notes as a result of such transaction or redemption. Furthermore, if the Company calls only a portion of the outstanding notes for redemption, only those notes called (or deemed called) for redemption will become convertible as a result of such call for redemption and only the conversion rate of notes converted in connection with such notice of redemption will be increased. Accordingly, notes not called for redemption will not become convertible if not otherwise convertible at such time and will remain outstanding, and may have reduced liquidity and a resulting reduced trading price.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligation to increase the conversion rate for notes converted in connection with a make-whole fundamental change or during a redemption period could be considered a penalty, in which case the enforceability thereof would be subject to general principles of reasonableness and equitable remedies.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The conversion rate of the notes may not be adjusted for all dilutive events.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion rate of the notes is subject to adjustment for certain events, including, but not limited to, the issuance of certain stock dividends on the Company's&#160;common stock, the issuance of certain rights or warrants, subdivisions, combinations, distributions of capital stock, indebtedness, or assets, cash dividends and certain issuer tender or exchange offers.&#160;However, the conversion rate will not be adjusted for other events, such as a third-party tender or exchange offer or an issuance of the Company's common stock for cash, that may adversely affect the trading price of the notes or its&#160;common stock. An event that adversely affects the value of the notes may occur, and that event may not result in an adjustment to the conversion rate.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions in the indenture governing the notes may deter or prevent a business combination that may be favorable to holders.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a fundamental change occurs prior to the maturity date, holders of the notes will have the right, at their option, to require the Company&#160;to repurchase all or a portion of their notes. In addition, if a make-whole fundamental change occurs prior the maturity date, the Company&#160;will in some cases be required to increase the conversion rate for a holder that elects to convert its notes in connection with such make-whole fundamental change. Furthermore, the indenture governing the notes will prohibit the Company&#160;from engaging in certain mergers or acquisitions unless, among other things, the surviving entity assumes the Company's&#160;obligations under the notes. These and other provisions in the indenture could deter or prevent a third party from acquiring the Company&#160;even when the acquisition may be favorable to holders.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The capped call transactions may affect the value of the notes and the Company's&#160;common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the pricing of the notes, the Company&#160;entered into capped call transactions with the counterparties. The capped call transactions cover, subject to customary adjustments, the number of shares of the Company's&#160;common stock initially underlying the notes. The capped call transactions generally reduce the potential dilution to the Company's&#160;common stock upon any conversion of the notes.&#160;If the initial purchasers exercise their option to purchase additional notes, the Company&#160;expects to enter into additional capped call transactions with the counterparties.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#160;believes that, in connection with establishing their initial hedge of the capped call transactions, the counterparties or their respective affiliates may have entered into various derivative transactions with respect to the Company's&#160;common stock and/or purchase shares of its&#160;common stock concurrently with or shortly after the pricing of the notes, including with certain investors in the notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#160;expects that the counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to its&#160;common stock and/or purchasing or selling the Company's&#160;common stock or other securities&#160;in secondary market transactions following the pricing of the notes and prior to the maturity of the notes and are likely to do so on each exercise date of the capped call transactions. This activity could also cause or prevent an increase or a decrease in the market price of the Company's common stock or the notes, which could affect their ability to convert the notes and, to the extent the activity occurs during any observation period related to a conversion of notes, it could affect the amount and value of the consideration that holders&#160;will receive upon conversion of the notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if any such capped call transactions fail to become effective, whether or not this offering of notes is completed, the counterparties (or their respective affiliates) may unwind their hedge positions with respect to the Company's&#160;common stock, which could adversely affect the price of the Company's&#160;common stock and the value of the notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does&#160;not make any representation or prediction as to the direction or magnitude of any potential effect that the transactions described above may have on the price of the notes or the shares of the Company's common stock. In addition, the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company does&#160;not make any representation that the counterparties will engage in these transactions or that these transactions, once commenced, will not be discontinued without notice.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company is&#160;subject to counterparty risk with respect to the capped call transactions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The counterparties to the capped call transactions that the Company enter into are financial institutions, and the Company&#160;will be subject to the risk that one or more of the counterparties may default or otherwise fail to perform, or may exercise certain rights to terminate, their obligations under the capped call transactions. The Company's&#160;exposure to the credit risk of the counterparties will not be secured by any collateral.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global economic conditions have in the past resulted in the actual or perceived failure or financial difficulties of many financial institutions. If a counterparty to one or more capped call transactions becomes subject to insolvency proceedings, the Company&#160;will become an unsecured creditor in those proceedings with a claim equal to its&#160;exposure at the time under such transaction. the Company's&#160;exposure will depend on many factors but, generally, its&#160;exposure will increase if the market price or the volatility of the Company's&#160;common stock increases. In addition, upon a default or other failure to perform, or a termination of obligations, by a counterparty, the counterparty may fail to deliver the&#160;consideration required to be delivered to the Company&#160;under the capped call transactions and it&#160;may experience more dilution than the Company currently anticipates with respect to its&#160;common stock. The Company&#160;can provide no assurances as to the financial stability or viability of the counterparties.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some significant restructuring transactions may not constitute a fundamental change, in which case the Company&#160;would not be obligated to offer to repurchase the notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the occurrence of a fundamental change, holders have the right to require the Company&#160;to repurchase all or a portion of their notes. However, the fundamental change provisions will not afford protection to holders of notes in the event of other transactions that could adversely affect the notes. For example, transactions such as leveraged recapitalizations, refinancings, restructurings or acquisitions initiated by the Company&#160;may not constitute a fundamental change requiring the Company&#160;to offer to repurchase the notes. In the event of any such transaction the holders would not have the right to require the Company&#160;to repurchase the notes, even though each of these transactions could increase the amount of its&#160;indebtedness, or otherwise adversely affect its&#160;capital structure or any credit ratings, thereby adversely affecting the holders of notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company has&#160;not registered the notes or the common stock issuable upon conversion, if any, which will limit their ability to resell them.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes and the shares of common stock issuable upon conversion of the notes, if any, have not been registered under the Securities Act or any state securities laws. Unless the notes and any shares of common stock issuable upon conversion of the notes, if any, have been registered, they may not be transferred or resold except in a transaction exempt from or not subject to the registration requirements of the Securities Act and applicable state securities laws. The Company does&#160;not intend to file a registration statement for the resale of the notes and the common stock, if any, into which the notes are convertible.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company cannot assure holders&#160;that an active trading market will develop for the notes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to this offering, there has been no trading market for the notes, and the Company does&#160;not intend to apply to list the notes on any securities exchange or to arrange for quotation on any automated dealer quotation system. The Company has&#160;been informed by the initial purchasers that they intend to make a market in the notes after the offering is completed. However, the initial purchasers may cease their market-making at any time without notice. In addition, the liquidity of the trading market in the notes, and the market price quoted for the notes, may be adversely affected by changes in the overall market for this type of security and by changes in the Company's financial performance or prospects or in the prospects for companies in its&#160;industry generally. As a result, the Company&#160;cannot assure holders&#160;that an active trading market will develop for the notes. If an active trading market does not develop or is not maintained, the market price and liquidity of the notes may be adversely affected. In that case holders&#160;may not be able to sell their&#160;notes at a particular time or holders may not be able to sell their&#160;notes at a favorable price.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any adverse rating of the notes may cause their trading price to fall.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does&#160;not intend to seek a rating on the notes. However, if a rating service were to rate the notes and if such rating service were to lower its rating on the notes below the rating initially assigned to the notes or otherwise announces its intention to put the notes on credit watch, the trading price of the notes could decline.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders may be subject to tax if the Company&#160;makes or fails to make certain adjustments to the conversion rate of the notes even though holders&#160;do not receive a corresponding cash distribution.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion rate of the notes is subject to adjustment in certain circumstances, including the payment of cash dividends. If the conversion rate is adjusted as a result of a distribution that is taxable to the Company's&#160;common stockholders, such as a cash dividend, holders&#160;may be deemed to have received a dividend subject to U.S. federal income tax without the receipt of any cash. In addition, a failure to adjust (or to adjust adequately) the conversion rate after an event that increases their&#160;proportionate interest in the Company&#160;could be treated as a deemed taxable dividend to holders if the failure to adjust (or to adjust adequately) is made in connection with a distribution of cash or other property to the Company's common stockholders. If a make-whole fundamental change occurs prior to the maturity date or the Company&#160;issues a notice of redemption under some circumstances, the Company&#160;will increase the conversion rate for notes converted in connection with the make-whole fundamental change or during the related redemption period. Such increase may also be treated as a distribution subject to U.S. federal income tax as a dividend. It is unclear whether any such deemed dividend would be eligible for the preferential tax treatment generally available for dividends paid by U.S. corporations to certain U.S. holders. If holders&#160;are a&#160;non-U.S.&#160;holders, any deemed dividend generally would be subject to U.S. federal withholding tax at a 30% rate, or such lower rate as may be specified by an applicable treaty, which may be set off against subsequent payments with respect to the notes (or common stock into which the notes convert). The Company&#160;do not currently expect to make distributions on its&#160;common stock, although no assurance can be given in this regard.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company&#160;may redeem the notes at its&#160;option, which may adversely affect their&#160;return.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#160;may not redeem the notes prior to March&#160;20, 2024. On or after March&#160;20, 2024 it&#160;may redeem for cash all or any portion of the notes, at its&#160;option if the last reported sale price of its&#160;common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on and including, the trading day immediately preceding the date on which the Company&#160;provides notice of redemption at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company&#160;calls any note for redemption, holders&#160;may convert their&#160;note called for redemption (or any portion thereof) at any time prior to the close of business on the second scheduled trading day immediately preceding the applicable redemption date. Prevailing interest rates at the time the Company&#160;redeem the notes may be lower than the interest rate on the notes. Upon such redemption or conversion, the cash comprising the redemption price, in the case of a redemption, or the applicable conversion consideration, in the case of a conversion in connection with a redemption notice, in either case, may not fully compensate holders&#160;for any future interest payments that holders&#160;would have otherwise received or for any other lost time value of their notes.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The notes will initially be held in book-entry form and, therefore, holders must rely on the procedures and the relevant clearing systems to exercise their rights and remedies.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless and until certificated notes are issued in exchange for book-entry interests in the notes, owners of the book-entry interests will not be considered owners or holders of notes. Instead, DTC, or its nominee, will be the sole holder of the notes. Payments of principal, interest (including any additional interest), cash amounts due upon conversion and other amounts owing on or in respect of the notes in global form will be made to the paying agent, which will make the payments to DTC. Thereafter, such payments will be credited to DTC participants&#8217; accounts that hold book-entry interests in the notes in global form and credited by such participants to indirect participants. Unlike holders of the notes themselves, owners of book-entry interests will not have the direct right to act upon the Company's solicitations for consents or requests for waivers or other actions from holders of the notes. Instead, if a holder owns a book-entry interest, such holder will be permitted to act only to the extent such holder has received appropriate proxies to do so from DTC or, if applicable, a participant. The Company&#160;cannot assure holders that the procedures implemented for the granting of such proxies will be sufficient to enable holders to vote on any requested actions on a timely basis.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of the Company's&#160;Common Stock</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover provisions contained in the Company's&#160;amended and restated certificate of incorporation and amended and restated bylaws, as well as provisions of Delaware law, could impair a takeover attempt.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's&#160;amended and restated certificate of incorporation, amended and restated bylaws and Delaware law contain provisions which could have the effect of rendering more difficult, delaying or preventing an acquisition deemed undesirable by the Company's&#160;board of directors. Among other things, the Company's&#160;amended and restated certificate of incorporation and amended and restated bylaws include provisions:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">authorizing a classified board of directors whose members serve staggered three-year terms;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">authorizing &#8220;blank check&#8221; preferred stock, which could be issued by the Company's board of directors without stockholder approval and may contain voting, liquidation, dividend and other rights superior to its common stock;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">limiting the liability of, and providing indemnification to, its directors and officers;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">limiting the ability of its stockholders to call and bring business before special meetings;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">requiring advance notice of stockholder proposals for business to be conducted at meetings of the Company's stockholders and for nominations of candidates for election to its board of directors; and</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">controlling the procedures for the conduct and scheduling of board of directors and stockholder meetings.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in the Company's&#160;management.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a Delaware corporation, the Company is&#160;also subject to provisions of Delaware law, including Section&#160;203 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;), which prevents certain stockholders holding more than 15% of its&#160;outstanding capital stock from engaging in certain business combinations without approval of the holders of at least&#160;two-thirds&#160;of the Company's&#160;outstanding common stock not held by such stockholder.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of the Company's&#160;amended and restated certificate of incorporation, amended and restated bylaws or Delaware law that has the effect of delaying, preventing or deterring a change in control could limit the opportunity for its&#160;stockholders to receive a premium for their shares of the Company's&#160;capital stock, and could also affect the price that some investors are willing to pay for its&#160;common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company's business could be negatively affected by activist shareholders.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Responding to actions by activist shareholders could be costly and time-consuming, disrupt the Company's operations and divert the attention of management and its&#160;employees. Additionally, perceived uncertainties as to the Company's&#160;future direction as a result of shareholder activism or changes to the composition of its&#160;board of directors may lead to the perception of a change in the direction of its&#160;business or other instability, which may be exploited by its&#160;competitors, cause concern to the Company's&#160;current or potential customers, and make it more difficult to attract and retain qualified personnel. If customers choose to delay, defer or reduce transactions with the Company&#160;or do business with its&#160;competitors instead of the Company, then the Company's&#160;business, financial condition and operating results would be adversely affected. In addition, the share price of its&#160;common stock and the trading price of the notes could experience periods of increased volatility as a result of shareholder activism.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish or cease publishing research or reports about the Company, its&#160;business, its&#160;market or its&#160;competitors, or if they adversely change their recommendations regarding the Company's common stock, the market price and trading volume of its&#160;notes and common stock could decline.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for the Company's&#160;notes and common stock will be influenced, to some extent, by the research and reports that securities or industry analysts publish about the Company, its business, its&#160;market or its&#160;competitors. If any of the analysts who cover the Company&#160;adversely change their recommendations regarding its&#160;common stock or provide more favorable recommendations about its&#160;competitors, the market price of the Company's&#160;notes and common stock would likely decline. If any of the analysts who cover the Company&#160;cease coverage of the company or fail to regularly publish reports on it, the Company&#160;could lose visibility in the financial markets, which in turn could cause the market price and trading volume of its&#160;notes and common stock to decline.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company does&#160;not expect to declare any dividends on its&#160;common stock in the foreseeable future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does&#160;not anticipate declaring any cash dividends to holders of its&#160;common stock in the foreseeable future. Consequently, investors may need to rely on sales of its&#160;common stock after price appreciation, which may never occur, as the only way to realize any future gains on their investment. Investors seeking cash dividends should not purchase shares of its&#160;common stock.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the Company raises additional capital through the sale of shares of the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s common stock, convertible securities or debt in the future, its stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ownership in the Company could be diluted and restrictions could be imposed on the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">s business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may issue shares of its common stock or securities convertible into its common stock to raise additional capital in the future. To the extent the Company issues such securities, its stockholders may experience substantial dilution and the trading price of the Company&#8217;s common stock could decline. If the Company obtains funds through a credit facility or through the issuance of debt or preferred securities, such debt or preferred securities could have rights senior to the existing stockholders&#8217; rights as a common shareholder, which could impair the value of the Company&#8217;s common stock.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B.&#160;&#160;&#160;&#160;UNRESOLVED STAFF COMMENTS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;PROPERTIES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company occupies 66,000 square feet for its U.S. corporate office in Brisbane, California, under a lease which extends through January 31, 2028. The original lease expired on December 31, 2017, and the Company entered into a Second Amendment on July 6, 2017 that extended the term of the lease to January 31, 2023 and a Third Amendment on July 9, 2020 that extended the term of the lease to January 31, 2028. The amendment provides for the following: a) the extension of the lease term, with the extended term to begin on February 1, 2023 and continue until January 31, 2028; b) the abatement of the monthly base rent for the four month period beginning September 1, 2020 and ending December 31, 2020; c) the amendment of monthly base rent during the extension term to approximately $0.2 million for January 2021 with annual increases of 3.5% thereafter; and d) the waiver by the Company of its early termination right in the lease. Pursuant to the terms of the Third Amendment to the Lease Agreement, the Company has the option to extend the term of the lease by an additional 60 months.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has leased office facilities in certain countries as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:57.908%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Country</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Square Footage</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease termination or Expiration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately&#160;5,896</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Two leases: The first lease expires in March 2024 and the second lease expires in December 2023.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">France</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 2,239</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One lease, which expires in June 2024.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 3,584</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One lease, which expires in January 2023.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Belgium</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 151</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One lease, which expires in November 2023.</span></td></tr></table></div><div id="idabc87e13e174d3c9f17fa6963046f56_28"></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;3.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may be involved in legal and administrative proceedings and claims of various types. For a description of material pending legal and regulatory proceedings and settlements as of December 31, 2021, please see Note 11 to the Company&#8217;s consolidated financial statements entitled &#8220;Commitments and Contingencies,&#8221; Part II Item 8, included in this Annual Report on Form 10-K.</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_31"></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_37"></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;5.&#160;&#160;&#160;&#160;MARKET FOR THE REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Exchange Listing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s common stock trades on The NASDAQ Global Select Market under the symbol &#8220;CUTR.&#8221; As of February 22, 2022, the closing sale price of its common stock was $33.45 per share.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stockholders</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had five&#160;stockholders of record as of February 22, 2022.&#160;The Company believes the actual number of stockholders is greater than this number of record holders and includes stockholders who are beneficial owners, but whose shares are held in &#8220;street&#8221; name by brokers and other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust by other entities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no repurchases of the Company&#8217;s common stock in 2021 under the Company&#8217;s Stock Repurchase Program.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales of Unregistered Securities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued $138.3 million aggregate principal amount of convertible notes in a private placement offering on March 5, 2021. The notes bear interest at a rate of 2.25% per year.&#160;In connection with issuance of the notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally expected to reduce the potential dilution of the Company's&#160;common stock upon any conversion of the notes.&#160;The capped calls were purchased for $16.1 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion regarding the Company&#8217;s intentions with respect to dividends, see the section titled &#8220;Stock-based Compensation Expense&#8221; set forth in Part II Item 7 of this Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Authorized for Issuance under Equity Compensation Plans</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item regarding equity compensation plans is incorporated by reference to the information set forth in Part III Item 12 of this Annual Report on Form 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Graph</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below compares Cutera, Inc.'s cumulative 5-Year total shareholder return on common stock with the cumulative total returns of the NASDAQ Composite index and the NASDAQ Health Care index. The graph tracks the performance of a $100 investment in the Company&#8217;s common stock and in each index (with the reinvestment of all dividends) from December 31, 2016 to December 31, 2021.</span></div><div style="margin-top:10pt;text-align:center"><img src="cutr-20211231_g1.jpg" alt="cutr-20211231_g1.jpg" style="height:466px;margin-bottom:5pt;vertical-align:text-bottom;width:600px"/></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">*$100 invested on December 31, 2016 in stock or index, including reinvestment of dividends.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with SEC rules, the information contained under &#8220;Performance Graph&#8221; shall not be deemed to be &#8220;soliciting material,&#8221; or to be &#8220;filed&#8221; with the SEC or subject to the SEC&#8217;s Regulation 14A or 14C, other than as provided under Item 201(e) of Regulation S-K, or to the liabilities of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the Company specifically request that the information be treated as soliciting material or specifically incorporate it by reference into a document filed under the Securities Act, or the Securities Exchange Act of 1934, as amended.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;6. [Reserved]</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;7.&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">following</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">discussion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">should</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">be</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">read</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">conjunction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">with</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">audited</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">financial</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">thereto</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">fiscal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">December</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">31,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Annual</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Report</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Form</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">10-K,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">including</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">following</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">sections,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">contains</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">forward-looking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">within</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">meaning</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Private</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1995.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Throughout</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">this</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Report,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">particularly</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">this</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">7,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">forward-looking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">based</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">upon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">current</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">expectations,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">projections</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">that</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">reflect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">beliefs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">assumptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">based</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">upon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">available</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">at</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">this Report. In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">some</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cases,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">you can identify these statements by words such as &#8220;may,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;might,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;could,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;will,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;should,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;expects,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;plans,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;anticipates,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;likely,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;believes,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;estimates,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;intends,&#8221; &#8220;forecasts,&#8221; &#8220;foresees,&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;predicts,&#8221; &#8220;potential&#8221; or &#8220;continue,&#8221; and other similar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">terms.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">These</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">forward-looking statements are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">guarantees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">future</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">performance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">subject</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">risks,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">uncertainties,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">assumptions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">that</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">difficult</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">predict.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">actual</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">results,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">performance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">achievements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">could</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">differ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">materially</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">those</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">expressed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">implied</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">by</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">forward-looking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">forward-looking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">include,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">but</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">limited</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">relating</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">future</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">financial</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">performance,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">grow</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">business,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">revenue,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">manage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">expenses, generate additional cash,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">achieve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">maintain</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">profitability,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">develop</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">commercialize existing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">new</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">applications,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">improve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">performance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">worldwide</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">sales</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">distribution</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">network,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">outlook regarding</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">long</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">term prospects. The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cautions you</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">place</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">undue reliance on these forward-looking statements,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">which</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">reflect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">management&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">analysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">only</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">this</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Annual</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Report</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on Form 10-K. The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">undertakes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">no obligation to update forward-looking statements to reflect events or circumstances occurring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">after</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">this</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Some</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">important</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">that</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">could</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cause</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">differ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">materially</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">those</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">forward-looking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">statements,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">discussion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">uncertainties,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">discussed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1A&#8212;Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Factors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">encourages</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">you</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">read</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">that</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">section</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">carefully</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">as</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">well</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">as</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">detailed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">time</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">time</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the Company&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">filings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">with</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SEC.</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_46"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Introduction</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Management&#8217;s Discussion and Analysis (&#8220;MD&amp;A&#8221;) is organized as follows:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:5.5pt">Executive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This section provides a general description and history of the Company&#8217;s business, a brief discussion of the Company&#8217;s product lines and the opportunities, trends, challenges and risks the Company focuses on in the operation of the Company&#8217;s business.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:5.5pt">Critical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This section describes the key accounting policies that are affected by critical accounting estimates.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:5.5pt">Recent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guidance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This section describes the issuance and effect of new accounting pronouncements that are or may be applicable to us.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:5.5pt">Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This section provides the Company&#8217;s analysis and outlook for the significant line items on the Company&#8217;s Consolidated Statements of Operations.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:5.5pt">Liquidity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This section provides an analysis of the Company&#8217;s liquidity and cash flows, as well as a discussion of the Company&#8217;s commitments that existed as of December 31, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We have omitted discussion of 2019 results where it would be redundant to the discussion previously included in Management's Discussion and Analysis of Financial Condition and Results of Operations on Form 10-K for the year ended December 31, 2020, which has been filed with the SEC.</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_49"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company Description</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company is a leading medical device company specializing in the research, development, manufacture, marketing and servicing of light and other energy-based aesthetics systems for practitioners worldwide. In addition to internal development of products, the Company distributes third party sourced products under the Company&#8217;s own brand names. The Company offers easy-to-use products which enable practitioners to perform safe and effective aesthetic procedures, including treatment for body contouring, skin resurfacing and revitalization, tattoo removal, removal of benign pigmented lesions, vascular conditions, hair removal, and toenail fungus. The Company&#8217;s platforms are designed to be easily upgraded to add additional applications and hand pieces, which provide flexibility for the Company&#8217;s customers as they expand their practices. In addition to systems and upgrade revenue, the Company generates revenue from the sale of post warranty service contracts, providing services for products that are out of warranty, hand piece refills and other per procedure related revenue on select systems and distribution of third-party manufactured skincare products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company&#8217;s ongoing research and development activities primarily focus on developing new products, as well as improving and enhancing the Company&#8217;s portfolio of existing products. The Company also explores ways to expand the Company&#8217;s product offerings through alternative arrangements with other companies, such as distribution arrangements. The Company introduced </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">, a fractional RF microneedling device for skin revitalization, in January 2018, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">enlighten SR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> in April 2018, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> in July 2018, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">excel V+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> in February 2019 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> in June 2019, Secret PRO in July 2020 and excel V+III during the fourth quarter of 2020. In 2021, the Company introduced</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"> truSculpt flex+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">, a treatment mode that decreased the treatment time from approximately 45 minutes to 15 minutes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Company&#8217;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company markets sells and services the Company&#8217;s products through direct sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, Spain, Switzerland and the United Kingdom. Sales and Services outside of these direct markets are made through a worldwide distributor network in over 42 countries.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Products and Services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company derives revenue from the sale of products and services. Product revenue includes revenue from the sale of systems, hand pieces and upgrade of systems (collectively &#8220;Systems&#8221; revenue), replacement hand pieces, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cycle refills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cycle refills, as well as single use disposable tips applicable to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Consumables&#8221; revenue), the sale of third party manufactured skincare products (&#8220;Skincare&#8221; revenue); and the leasing of equipment through a membership program. A system consists of a console that incorporates a universal graphic user interface, a laser and (or) an energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. However, depending on the application, the laser or other energy-based module is sometimes contained in the hand piece such as with the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> applications instead of within the console.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue. The Company&#8217;s primary system platforms include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">excel,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skincare revenue relates to the distribution of ZO&#8217;s skincare products in Japan. The skincare products are purchased from a third-party manufacturer and sold to medical offices and licensed physicians. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service includes prepaid service contracts, and labor, time and material on out-of-warranty products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Business Trends</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that the ability to grow revenue will be primarily impacted by the following:</span></div><div style="margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">continuing to expand the Company&#8217;s product offerings, both through internal development and sourcing from other vendors;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">ongoing investment in the Company&#8217;s global sales and marketing infrastructure;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">use of clinical results to support new aesthetic products and applications;</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">enhanced luminary development and reference selling efforts (to develop a location where Company&#8217;s products can be displayed and used to assist in selling efforts);</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">customer demand for the Company&#8217;s products;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">consumer demand for the application of the Company&#8217;s products;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">marketing to physicians in the core dermatology and plastic surgeon specialties, as well as outside those specialties; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">generating recurring revenue from the Company&#8217;s growing installed base of customers through the sale of system upgrades, services, hand piece refills, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cycles, skincare products and replacement tips for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a detailed discussion of the significant business trends impacting the Company&#8217;s business, please see the section titled &#8220;Results of Operations&#8221; below.</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_52"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting policies, significant judgments and use of estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s audited consolidated financial statements and related notes requires the Company to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The Company has based its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. The Company periodically reviews its </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates and makes adjustments when facts and circumstances dictate. To the extent that there are material differences between these estimates and actual results, its financial condition or results of operations will be affected.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An accounting policy is considered to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made, and if different estimates that reasonably could have been used, or changes in the accounting estimates that are reasonably likely to occur periodically, could materially impact the consolidated financial statements. The Company believes that its critical accounting policies reflect the more significant estimates and assumptions used in the preparation of its audited consolidated financial statements. The critical accounting policies, judgments and estimates should be read in conjunction with the Company&#8217;s audited consolidated financial statements and the notes thereto and other disclosures included in this report.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For an analysis of the Company&#8217;s Critical Accounting Policies and Estimates please refer to Note 1 &#8220;Summary of significant accounting policies&#8221; to the Company&#8217;s audited consolidated financial statements included in Part II, Item 8 of this report.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the following critical accounting policies, estimates and assumptions may have a material impact on reported financial condition and operating performance and may involve significant levels of judgment to account for highly uncertain matters or are susceptible to significant change:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See "Part II, Item 8. Revenue Recognition, Note&#160;1" to the consolidated financial statements for the year ended December&#160;31, 2021, included in this Annual Report on Form 10-K for additional information about the Company&#8217;s revenue recognition policy, significant judgement and criteria for recognizing revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into contracts with multiple performance obligations where customers purchase a combination of systems and services. Determining whether systems and services are considered distinct performance obligations that should be accounted for separately requires judgment. The Company determines the transaction price for a contract based on the consideration it expects to receive in exchange for the transferred goods or services. To the extent the transaction price includes variable consideration, such as expected price adjustments for returns, the Company applies judgment when estimating variable consideration and when estimating the extent to which the transaction price is subject to the constraint on variable consideration. The Company evaluates constraints based on its historical and projected experience with similar customer contracts.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocates revenue to each performance obligation in proportion to the relative standalone selling prices (&#8220;SSP&#8221;) and recognizes revenue when control of the related goods or services is transferred for each performance obligation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes the observable standalone selling price when available, which represents the price charged for the performance obligation when sold separately. When standalone selling prices for systems or services are not directly observable, the Company determines the standalone selling prices using relevant information available and applies suitable estimation methods including, but not limited to, the cost plus a margin approach.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the SSP for systems based on directly observable sales in similar circumstances to similar customers. The SSPs for extended service contracts are based on observable prices when sold on a standalone basis.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract, including sales commissions, are allocated to the distinct goods and services to which they relate based on the relative stand-alone selling prices. Incremental costs related to obligations delivered at inception are recognized at contract inception. Those related to obligations delivered over time are capitalized and amortized on a straight-line basis over the expected period of benefit if the Company expects to recover those costs. The Company uses the portfolio method to recognize the amortization expense related to these capitalized costs related to initial contracts and such expense is recognized over a period associated with the revenue of the related portfolio, which is generally two to three years for the Company&#8217;s product and service arrangements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to certain operating and finance leases for vehicles, office space and storages. The Company&#8217;s material operating leases consist of office space, as well as storage facilities. The Company&#8217;s leases generally have remaining terms of one to ten years, some of which include options to renew the leases for up to five years.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract contains a lease at inception. Right of use assets and lease liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease right of use assets represent the right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, the Company estimates the incremental secured borrowing rates corresponding to the maturities of the leases. The Company bases the rate estimates on prevailing financial market conditions, credit analysis and management judgment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes expense for operating leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce the Company&#8217;s right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Inventories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost and net realizable value, cost being determined on a standard cost basis which approximates actual cost on a first-in, first-out basis. Net realizable value is the estimated selling prices in the ordinary course of the Company&#8217;s business, less reasonably predictable costs of completion, disposal, and transportation. Standard costs are monitored and updated quarterly or as necessary, to reflect changes in raw material costs, labor to manufacture the product and overhead rates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost basis of the Company&#8217;s inventory is reduced for any products that are considered excess or obsolete based upon assumptions about future demand and market conditions. The Company provides for excess and obsolete inventories when conditions indicate that the inventory cost is not recoverable due to physical deterioration, forecast usage, obsolescence, reductions in estimated future demand and reductions in selling prices. Inventory provisions are measured as the difference between the cost of inventory and net realizable value to establish a lower cost basis for the inventories. The Company balances the need to maintain strategic inventory levels with the risk of obsolescence due to changing technology, timing of new product introductions and customer demand levels.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes demonstration units within inventories. Demonstration units are carried at cost and amortized over an estimated economic life of two years. Amortization expense related to demonstration units is recorded in Products cost of revenue or in the respective operating expense line based on which function and purpose for which the demonstration units are being used. Proceeds from the sale of demonstration units are recorded as revenue and all costs incurred to refurbish the systems prior to sale are charged to cost of revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See "Part II, Item 8. Financial Statements, Note 1" in the accompanying Notes to consolidated financial statements&#160;for more information.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the estimated future tax effects of temporary differences between book and tax treatment of assets and liabilities and carryforwards to the extent they are realizable.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to taxes on earnings in both the U.S. and various foreign jurisdictions. On a quarterly basis, the Company assesses the realizability of its deferred tax assets. For those jurisdictions where tax carryforwards are likely to expire unused or the projected operating results indicate that realization is not more likely than not, a valuation allowance is recorded to offset the deferred tax asset within that jurisdiction. In assessing the need for a valuation allowance, the Company considers future taxable income and ongoing prudent and feasible tax planning strategies. In the event that the Company determines that it would be able to realize its deferred tax assets in the future in excess of the net recorded amount, a reduction of the valuation allowance would increase income in the period such determination was made. Likewise, should the Company determine that it would not be able to realize all or part of its net deferred tax asset in the future, a reduction to the deferred tax asset would be charged to income in the period such determination was made.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net taxable temporary differences and tax carryforwards are recorded using the enacted tax rates expected to apply to taxable income in the periods in which the deferred tax liability or asset is expected to be settled or realized. Should the expected applicable tax rates change in the future, an adjustment to the Company&#8217;s deferred taxes would be credited or charged, as appropriate, to income in the period such determination was made.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rates differ from the statutory rate primarily due to changes in the valuation allowance, foreign operations, research and development tax credits, state taxes, and certain benefits realized related to stock option activity. The </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company&#8217;s current effective tax rate does not assume U.S. taxes on undistributed profits of foreign subsidiaries. These earnings could become subject to incremental foreign withholding or U.S. state taxes, should they either be deemed or actually remitted to the U.S. The Company&#8217;s future effective tax rates could be adversely affected by earnings being lower in countries where the Company has lower statutory rates and being higher in countries where the Company has higher statutory rates, or by changes in tax laws, accounting principles, interpretations thereof, net operating loss carryback, research, and development tax credits, and due to changes in the valuation allowance applied to its U.S. deferred tax assets. In addition, the Company is subject to the examination of the Company&#8217;s income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#8217;s provision for income taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undistributed earnings of the Company&#8217;s foreign subsidiaries as of December 31, 2021 are considered to be indefinitely reinvested and, accordingly, no provision for income taxes has been provided thereon. Due to the Transition Tax and Global Intangible Low-Tax Income (&#8220;GILTI&#8221;) regimes as enacted by the 2017 Tax Act, those foreign earnings will not be subject to federal income taxes when actually distributed in the form of a dividend or otherwise. The Company, however, could still be subject to state income taxes and withholding taxes payable to various foreign countries. The amounts of taxes which the Company could be subject to are not material to the accompanying financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The CARES Act changed several of the existing U.S. corporate income tax laws by, among other things, increasing the amount of deductible interest, allowing companies to carry back certain Net Operating Losses (&#8220;NOLs&#8221;) and increasing the amount of NOLs that corporations can use to offset income. Further, in December 2020, the Consolidated Appropriations Act, 2021 was signed into law. It clarified that gross income does not include any amount that would otherwise arise from the forgiveness of a PPP loan. The CARES Act did not have a material impact on the Company's income tax provision, deferred tax assets and liabilities, and related taxes payable.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically assesses its exposures related to its global provision for income taxes and believe that it has appropriately accrued taxes for contingencies. Any reduction of these contingent liabilities or additional assessment would increase or decrease income, respectively, in the period such determination was made.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a liability for uncertain tax positions that do not meet the more likely than not standard as prescribed by the authoritative guidance for income tax accounting. The Company records tax benefits for only those positions that it believes will more likely than not be sustained.&#160;For positions that the Company believes that it is more likely than not that it will prevail, the Company records a benefit considering the amounts and probabilities that could be realized upon ultimate settlement.&#160;If the Company judgment as to the likely resolution of the uncertainty changes, if the uncertainty is ultimately settled or if the statute of limitation related to the uncertainty expires, the effects of the change would be recognized in the period in which the change, resolution or expiration occurs. The Company has provided for unrecognized tax benefits of $2.7 million and $1.9 million as of December 31, 2021 and December 31, 2020, respectively. See &#8220;Part II, Item 8. Financial Statements, Note 7. Income Taxes&#8221; in the accompanying Notes to consolidated financial statements&#160;for more information.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been, and may in the future become, subject to a number of legal proceedings involving securities litigation, product liability, intellectual property, contractual disputes, trademark and copyright, and other matters. The Company records a liability and related charge to earnings in its consolidated financial statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The Company&#8217;s assessment is reevaluated each accounting period and is based on all available information, including discussion with any outside legal counsel that represents us. If a reasonable estimate of a known or probable loss cannot be made, but a range of probable losses can be estimated, the low-end of the range of losses is recognized if no amount within the range is a better estimate than any other. If a loss is reasonably possible, but not probable and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not participate in transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance, variable interest or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As of December 31, 2021, the Company was not involved in any unconsolidated transactions.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncement</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the impacts from new accounting pronouncements included above see Note 1 &#8212; &#8220;Summary of Significant Accounting Pronouncements&#8221; in the Notes to Consolidated Financial Statements in Part II, Item 8 of this Annual Report on Form 10-K. for a complete discussion of recent accounting pronouncements adopted and not adopted.</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_55"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth selected consolidated financial data expressed as a percentage of net revenue.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 19pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 19pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income/(Loss) from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on extinguishment of PPP loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth selected consolidated revenue by major geographic area and product category with changes thereof.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue mix by geography:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">North America</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">181,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">North America as a percentage of total revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Japan as a percentage of total revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rest of World as a percentage of total revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue mix by product category:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems - North America</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems - Rest of World (including Japan)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total Systems</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,633&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90,766&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140,478&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skincare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total Products</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total Net revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,270&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147,683&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">181,712&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Net Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s total revenue increased by $83.6 million, or 57%, for the year ended December 31, 2021, compared to 2020, due primarily to a significant recovery in sales in the North America market as the U.S. economic outlook improved in 2021 and increase in Skincare products sales in Japan. The increase was driven mainly by increase in volume.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by Geography</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s North America revenue increased by $42.2 million, or 61%, for the year ended December 31, 2021, compared to the same period in 2020, driven primary by a recovery in sales following an improvement in conditions related to the COVID-19 pandemic.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenue in Japan increased $27.0 million, or 62%, for the year ended December 31, 2021, compared to 2020. The increase was due primarily to a significant increase in sales of Skincare products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Rest of World revenue increased $14.5 million, or 41%, for the year ended December 31, 2021, compared to the same period in 2020, driven primarily by a recovery in sales following an improvement in conditions related to the COVID-19 pandemic.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by Product Type</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systems Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems revenue in North America increased by $35.4 million, or 70%, for the year ended December 31, 2021, compared to the same period in 2020, mainly due to the recovery from the business disruptions caused by the COVID-19 pandemic. The Rest of the World systems revenue increased by $13.5 million, or 34%, compared to the same period in 2020. The increase in Rest of the World revenue was primarily due to increased sales in the Company&#8217;s direct businesses in Australia and Europe, partially offset by decreased sales from distributors in the Middle East and Asian regions.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consumables Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumables revenue increased $7.1 million, or 77%, for the year ended December 31, 2021, compared to the same period in 2020. The increase in consumables revenue was primarily due to the increasing installed base of truSculpt iD, Secret RF, truSculpt 3D and truSculpt flex, each of which have a consumable element.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skincare Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue from Skincare products in Japan increased $24.6 million, or 98%, for the year ended December 31, 2021, compared to the same period in 2020. This increase was due primarily to increased marketing and promotional efforts, as well as changes in customers behavior due to the COVID-19 pandemic, as some consumers opted to purchase skincare products rather than go to a doctor's office for treatment, a trend which began in 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Service Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Service revenue increased $3.0 million, or 13%, for the year ended December 31, 2021, compared to the same period in 2020. This increase was due primarily to increased sales of service contracts, as well as support and maintenance services provided on a time and materials basis to the Company's network of international distributors.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.745%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,772&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,391)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a percentage of total net revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit as a percentage of revenue for the year ended December&#160;31, 2021, increased from 51.3% to 57.6%, compared to the same period in 2020. The increase in gross profit as a percentage of revenue was primarily driven by an increase in volumes as a result of the economic recovery. The increase in sales volume improved the Company's leveraging of fixed costs, which improved the Company's gross margin. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:34.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales and marketing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,343)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a percentage of total net revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses consist primarily of personnel expenses, expenses associated with customer-attended workshops and trade shows, post-marketing studies, advertising, and training. Sales and marketing expenses for the year ended  December&#160;31, 2021 increased $24.0 million, or 45%, compared to the same period in 2020. This increase reflected headcount growth and an $11.3 million increase in commission costs due to higher revenue. Also contributing to the increase in sales and marketing expenses was a $4.0 million increase in consulting and outside professional services, a $3.5 million increase in marketing costs related to new business, trade shows and other promotions, and a $2.4 million increase due to resumption in travel activities. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development (&#8220;R&amp;D&#8221;)</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(763)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,085&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a percentage of total net revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses consist primarily of personnel expenses, clinical research, regulatory and material costs. R&amp;D expenses increased by $7.2, or 51%, for the year ended December&#160;31, 2021, compared to the same period in 2020. The increase in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expense was due primarily to a $4.7 million increase&#160;in salaries and benefits, a $1.4 million increase in outside services, and a $0.7 million increase in material and equipment costs used for research and development activities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative (&#8220;G&amp;A&#8221;)</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.354%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,479&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a percentage of total net revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">G&amp;A expenses consist primarily of personnel expenses, legal, accounting, audit and tax consulting fees, as well as other general and administrative expenses. G&amp;A expenses increased by $1.4 million, or 5%, for the year ended December&#160;31, 2021, compared to the same period in 2020. The increase in expenses was due primarily to a $6.2 million increase in labor-related expenses driven by an increase in headcount, partially offset by a $2.1 million decrease in professional fees, consulting services and legal fees, and a $2.1 million decrease in credit loss expense.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest and Other Income (Expense), Net</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income (expense), net, consists of the following:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:33.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.168%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest and other income (expense), net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,134&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(579)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income (expense), net, increased $2.1 million for the year ended December&#160;31, 2021, compared to 2020, due to a $7.2 million gain resulting from the forgiveness of the PPP loan and accrued interest. This gain was partially offset by interest expense of $2.5 million related to the convertible notes issued in March 2021, and $1.8 million due to foreign exchange fluctuations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Provision</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:27.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax provision</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax provision increased $0.9 million, or 181%, for the year ended December&#160;31, 2021, compared to the same period in 2020. This increase reflects higher net earnings from the Company's foreign subsidiaries.</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_58"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources and Uses of Cash</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s principal source of liquidity is cash generated from the issuance of convertible notes and common stock through exercise of stock options and the Company&#8217;s employee stock purchasing program. The Company actively manages its cash usage and investment of liquid cash to ensure the maintenance of sufficient funds to meet its daily needs. The majority of the Company&#8217;s cash is held in U.S. banks and its foreign subsidiaries maintain a limited amount of cash in their local banks to cover their short-term operating expenses.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and December 31, 2020, the Company had $175.8 million&#160;and $51.9 million of working capital, respectively. Cash and cash equivalents increased by $117.1 million to $164.2 million as of December&#160;31, 2021, from $47.0 million as of December 31, 2020, primarily due to net proceeds from the issuance of the convertible notes, partially offset by $16.1 million in premiums paid for separate capped call transactions related to the issuance of the convertible notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s cash, cash equivalents and restricted cash (in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Cash Flow Data</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, the Company&#8217;s cash flows were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Dollars in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16,934)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,217)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(944)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,526&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,276&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,414&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net increase in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,731&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Net cash provided by operating activities for the year ended December 31, 2021, was $1.2 million, which reflected net income, adjusted for non-cash items of $14.4 million, offset by changes in assets and liabilities of $13.2 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Cash Flows from Investing Activities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Net cash used in investing activities for the year ended December 31, 2021, was $0.9 million, which was primarily due to purchases of property, equipment and software.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Cash Flows from Financing Activities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Net cash provided by financing activities for the year ended December 31, 2021 was $117.5 million, which was primarily due to the proceeds from the issuance of convertible notes, net of issuance costs, and cash used for the purchase of capped calls of $117.4 million</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adequacy of Cash Resources to Meet Future Needs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had cash and cash equivalents of $164.2 million as of December&#160;31, 2021. For fiscal year 2021, the Company&#8217;s principal source of liquidity was $133.5 million of net proceeds from the issuance of the convertible notes, partially offset by $16.1 million in premiums paid concurrently for a separate capped call transaction. The Company believes that the existing cash resources are sufficient to meet the Company&#8217;s anticipated cash needs for working capital and capital expenditures through at least the next 12 months from the date the financial statements are issued, but there can be no assurances.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company issued $138.3 million aggregate principal amount of convertible notes due on March 15, 2026 in a private placement offering. The convertible notes bear interest at a rate of 2.25% per year payable semiannually in arrears on March 15 and September 15 of each year. The convertible notes are presented as long-term debt, net of debt discount. Proceeds from the offering were $133.5 million, net of issuance costs, including underwriters&#8217; fees, which were recorded in the consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 9, 2020, the Company terminated its undrawn revolving line of credit with Wells Fargo and subsequently entered into a Loan and Security Agreement with Silicon Valley Bank. The agreement provides for a four-year secured revolving loan facility (&#8220;SVB Revolving Line of Credit&#8221;) in an aggregate principal amount of up to $30.0 million. See Note 12&#160;&#8211; Debt in the accompanying notes to consolidated financial statements&#160;for more information.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan and Security Agreement with Silicon Valley Bank contains customary affirmative covenants, such as financial statement reporting requirements and delivery of borrowing base certificates, as well as customary covenants that restrict the Company&#8217;s ability to, among other things, incur additional indebtedness, sell certain assets, guarantee obligations of third parties, declare dividends, or make certain distributions, and undergo a merger or consolidation or certain other transactions. The Loan and Security Agreement also contains certain financial condition covenants. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 4, 2021, the Loan and Security Agreement dated July 9, 2020 was amended to (i)&#160;permit the Company to issue the convertible notes, and (ii) to&#160;permit the capped call transactions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or about May 28, 2021, the Loan and Security Agreement was amended. The amendment removed the quarterly minimum revenue requirement but kept the in place the other financial covenants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had not drawn on the SVB Revolving Line of Credit and the Company is in compliance with all financial covenants of the SVB Revolving Line of Credit.</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_64"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchase Commitments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains certain open inventory purchase commitments with its suppliers to ensure a smooth and continuous supply for key components. The Company&#8217;s liability in these purchase commitments is generally restricted to an agreed-upon period. Such time periods can vary among different suppliers. The Company believes it has adequate funds to fulfill any such commitments in the future using the sources discussed in this Item 7 &#8211; Management&#8217;s Discussion &amp; Analysis of Financial Condition and Results of Operations.</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_67"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company enters into agreements that contain a variety of representations, warranties, and indemnification obligations. For example, the Company has entered into indemnification agreements with each of the Company&#8217;s directors and executive officers. The Company&#8217;s exposure under the various indemnification obligations is unknown and not reasonably estimable as they involve future claims that may be made against us. As such, the Company has not accrued any amounts for such obligations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The conditional conversion feature of the convertible notes, if triggered, may adversely affect our financial condition and operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their Notes at their option prior to the close of business on the business day immediately preceding December 15, 2025, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-top:10pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During any fiscal quarter commencing after the fiscal quarter ended on June 30, 2021 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to 130% of the conversion price for the convertible notes on each applicable trading day;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the five-business day period after any five consecutive trading day period (the &#8220;measurement period&#8221;) in which the &#8220;trading price&#8221;&#160;per $1,000 principal amount of convertible notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's&#160;common stock and the conversion rate on each such trading day;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company calls such convertible notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Upon the occurrence of specified corporate events.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after December 15, 2025, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The circumstances described in the first bullet of the paragraph above were met during the second and third quarters of 2021 as the Company's stock traded at a price in excess of the conversion price for the required number of days during each of those quarters. These circumstances were not met during the fourth quarter of 2021. As a result, holders of the Notes had the right to convert their Notes beginning July 1, 2021 and ending on December 31, 2021. As of December 31, 2021, the Notes are not convertible and this condition will remain until March 31, 2022. The Notes may become convertible in future periods.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If one or more holders elect to convert their convertible notes, unless the Company elects to satisfy its conversion obligation by delivering solely shares of its common stock, the Company would be required to settle a portion or all of its conversion obligation through the payment of cash, which could adversely affect the Company&#8217;s liquidity.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 the Company had not drawn on the SVB Revolving Line of Credit. Overall interest rate sensitivity is primarily influenced by any amount borrowed on the line of credit and the prevailing interest rate on the line of credit facility. The effective interest rate on the line of credit facility is based on a floating per annum rate equal to the greater of either 1.75% above the Prime Rate or 5%. The Prime Rate was 3.25% as of December 31, 2021, and accordingly the Company may incur additional expenses if the Company has an outstanding balance on the line of credit and the Prime Rate increases in future periods.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inflation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain production-related costs, including freight expense and components costs, were subject to inflationary pressure in 2021. During the year ended December&#160;31, 2021, we were generally able to offset the inflationary impact by managing our sales mix and leveraging our fixed cost base. If the Company&#8217;s costs were to become subject to significant inflationary pressures, the Company might not be able to fully mitigate such higher costs. The Company&#8217;s inability or failure to do so could harm the Company&#8217;s business, financial condition, and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Exchange Fluctuations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates revenue in Japanese Yen, Euros, Australian Dollars, Canadian Dollars, British Pounds and Swiss Francs. The Company&#8217;s skincare revenue, which was $49.7 million in 2021, is denominated in Japanese Yen and the related product costs to the Company denominated in U.S. dollars. Additionally, approximately 14% of expenses, 15% of assets and 7% of liabilities are denominated in non-U.S. dollar currencies. Therefore, fluctuations in these currencies against the U.S. dollar could materially and adversely affect the Company&#8217;s results of operations upon translation of the Company&#8217;s revenue denominated in these currencies, as well as the re-measurement of the Company&#8217;s international subsidiaries&#8217; financial </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">statements into U.S. dollars. The Company has historically not engaged in hedging activities relating to the Company&#8217;s foreign currency denominated transactions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INC.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUBSIDIARY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPANIES</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10-K</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATEMENTS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Consolidated Financial Statements of the Registrant and its subsidiaries are required to be included in Item 8:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:89.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_76">Reports of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (<ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83My9mcmFnOmMzYThmYTM5YTEwNzRkY2FhZDc4YzM3Y2Q4YTc5OGFiL3RhYmxlOjllMWMwMDM0YWZkMTRjMzNhOWE4YjcwYmFlYjEzMDQyL3RhYmxlcmFuZ2U6OWUxYzAwMzRhZmQxNGMzM2E5YThiNzBiYWViMTMwNDJfMS0wLTEtMS01MDI2MS90ZXh0cmVnaW9uOmJiMWQwMjZkZWY5YzQwOTlhNTAwNDc2N2VlOTNmZDBkXzM4NDgyOTA2OTczNTI_391681b6-c1c4-4c2e-a2d9-cbd14cbd9e12">BDO USA, LLP</ix:nonNumeric>; <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83My9mcmFnOmMzYThmYTM5YTEwNzRkY2FhZDc4YzM3Y2Q4YTc5OGFiL3RhYmxlOjllMWMwMDM0YWZkMTRjMzNhOWE4YjcwYmFlYjEzMDQyL3RhYmxlcmFuZ2U6OWUxYzAwMzRhZmQxNGMzM2E5YThiNzBiYWViMTMwNDJfMS0wLTEtMS01MDI2MS90ZXh0cmVnaW9uOmJiMWQwMjZkZWY5YzQwOTlhNTAwNDc2N2VlOTNmZDBkXzM4NDgyOTA2OTczODA_3f02c65f-897f-4bf2-a9a4-d627c6f74999">San Francisco, California</ix:nonNumeric>; PCAOB ID#<ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83My9mcmFnOmMzYThmYTM5YTEwNzRkY2FhZDc4YzM3Y2Q4YTc5OGFiL3RhYmxlOjllMWMwMDM0YWZkMTRjMzNhOWE4YjcwYmFlYjEzMDQyL3RhYmxlcmFuZ2U6OWUxYzAwMzRhZmQxNGMzM2E5YThiNzBiYWViMTMwNDJfMS0wLTEtMS01MDI2MS90ZXh0cmVnaW9uOmJiMWQwMjZkZWY5YzQwOTlhNTAwNDc2N2VlOTNmZDBkXzM4NDgyOTA2OTczMzc_8fe3c917-74ed-4b66-91c4-f7799ae2f45b">243</ix:nonNumeric>)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_76">74</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_79">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_79">78</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_85">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_85">79</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_88">Consolidated Statements of Comprehensive </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_88">Income (</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_88">Loss</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_88">80</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_91">Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_91">81</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_97">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_97">82</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_100">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_100">83</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_157">Schedule II -Valuation and Qualifying Accounts</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#idabc87e13e174d3c9f17fa6963046f56_157">112</a></span></div></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other required schedules are omitted because of the absence of conditions under which they are required or because the required information is given in the Consolidated Financial Statements or the Notes thereto.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders and Board of Directors</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cutera, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brisbane, California</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Consolidated Financial Statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Cutera, Inc. (the &#8220;Company&#8221;) as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive income (loss), stockholders&#8217; equity, and cash flows for each of the three years in the period ended December 31, 2021, and the related notes and schedule&#160;(collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;), the Company's internal control over financial reporting as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;) and our report dated March&#160;1, 2022 expressed an adverse opinion thereon.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized total net revenue of approximately $231.3 million for the year ended December 31, 2021. As described in Note 1 to the consolidated financial statements, the Company recognizes revenue in a manner that best depicts the transfer of control of promised products or services to the customer, in an amount that reflects the consideration to which the Company expects to be entitled.  The Company&#8217;s contracts with customers may include, individually, or in combination, systems, extended service contracts, training, marketing support and accessories.  Certain of the Company&#8217;s contracts, which include some with international distributors, can include non-standard payment and other sales terms that can impact management&#8217;s conclusions as to whether it is probable at contract inception that the Company will collect substantially all of the consideration to which it will be entitled or whether control has transferred to the customer.  Management applies significant effort and judgment in evaluating the impact of these non-standard payment and sales terms on revenue recognition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the evaluation of non-standard payment and other sales terms in the Company&#8217;s contracts with international distributors as a critical audit matter.  Auditing the impact of non-standard payment and other sales terms on management&#8217;s conclusions of whether the transfer of control has occurred requires significant auditor effort and increased auditor judgment in performing procedures to evaluate management&#8217;s judgment.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary procedures we performed to address this critical audit matter included:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Examining certain international distributor contracts, including any amendments or modifications, for non-standard payment terms and, where such terms are present, evaluating management&#8217;s assessment of whether collection is probable, based on a consideration of indicators of the international distributor&#8217;s liquidity and of the collection and credit memo history with the international distributor and with similar international distributors with similar payment terms.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">Examining certain international distributor contracts, including any amendments or modifications, for non-standard terms governing transfer of control and, where such terms are present, evaluating management&#8217;s conclusions regarding the transfer of control based on an assessment of considerations including whether the international distributor has physical possession and legal title to the product, whether the Company has a present right to payment, and other factors relevant to the determination of whether the international distributor has the ability to direct the use of and obtain substantially all of the remaining benefit from the product.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ BDO USA, LLP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 2014.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Francisco, California</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;1, 2022</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders and Board of Directors</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cutera, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Brisbane, California</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Cutera, Inc.&#8217;s (the &#8220;Company&#8217;s&#8221;) internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (the &#8220;COSO criteria&#8221;). In our opinion, the Company did not maintain, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on the COSO criteria. We do not express an opinion or any other form of assurance on management&#8217;s statements referring to any corrective actions taken by the Company after the date of management&#8217;s assessment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;), the consolidated balance sheets of the Company as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive income (loss), stockholders&#8217; equity, and cash flows for each of the three years in the period ended December 31, 2021, and the related notes and schedule (collectively referred to as the "financial statements") and our report dated March&#160;1, 2022 expressed an unqualified opinion thereon.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Item 9A, Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit of internal control over financial reporting in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis. A material weakness regarding ineffective information technology general controls (&#8220;ITGCs&#8221;) in the areas of user access and segregation of duties related to certain information technology (&#8220;IT&#8221;) systems that support the Company&#8217;s financial reporting process at its Japan subsidiary has been identified and described in management&#8217;s assessment.  This material weakness was considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2021 financial statements, and this report does not affect our report dated March&#160;1, 2022 on those financial statements. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. </span></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ BDO USA, LLP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Francisco, California</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;1, 2022</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">thousands,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">except</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">per</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">data)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNC0xLTEtMS0yODYyMQ_144fe4fb-6af2-4921-b6b5-6754c6879cbb">164,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNC0zLTEtMS0yODYyMQ_7da5bd89-c803-4204-a1bb-cb7ca1865743">47,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNi0wLTEtMS0yODYyMS90ZXh0cmVnaW9uOmFhZGYzZWMwOTA1OTQwMDhhNjc0MzIzNDFjOTA2ZWM4XzYz_fdd53d42-d688-4eaf-abe0-79a9268903f1">899</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNi0wLTEtMS0yODYyMS90ZXh0cmVnaW9uOmFhZGYzZWMwOTA1OTQwMDhhNjc0MzIzNDFjOTA2ZWM4Xzcw_5f116bbf-0ae9-403e-9736-93758afafe11">1,598</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNi0xLTEtMS0yODYyMQ_448407a4-dfd2-497a-bd45-23c74d5f6d35">31,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNi0zLTEtMS0yODYyMQ_3f7c8261-4056-47c0-9651-cef2faf6ae59">21,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNy0xLTEtMS0yODYyMQ_f0f5eb82-4856-4cd6-8265-adf4f549382f">39,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNy0zLTEtMS0yODYyMQ_cf915db9-27e4-42ff-a495-82ea5733b161">28,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets and prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfOC0xLTEtMS0yODYyMQ_3bc1a832-c822-48ce-ba4a-1a46c1c6877c">14,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfOC0zLTEtMS0yODYyMQ_bece210a-59eb-4841-a577-d713df587712">8,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfOS0xLTEtMS0yODYyMQ_ff8de0c5-f7a1-4aff-92c3-b33e18b2d3fe">249,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfOS0zLTEtMS0yODYyMQ_826258dd-4b73-4b27-b0c8-698f96f1bd67">106,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTAtMS0xLTEtMjg2MjE_14401383-e111-4618-8120-c2e129d839fa">3,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTAtMy0xLTEtMjg2MjE_baf04dc1-d3a3-4329-a38a-c5d2c48a8263">2,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTEtMS0xLTEtMjg2MjE_e7e6f9f6-e5bd-49b5-b3fe-2d4e380e2b6e">778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTEtMy0xLTEtMjg2MjE_173fc580-1193-4316-8d1a-3a0fbf38b3b3">643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTItMS0xLTEtMjg2MjE_afdc85a0-9f89-4405-93a0-bf32d44db7cb">14,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTItMy0xLTEtMjg2MjE_d75fa147-d62a-4afc-86a0-e8b0e263a254">17,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTMtMS0xLTEtMjg2MjE_9386d898-6a6a-4ba7-8f95-e35708bf6534">1,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTMtMy0xLTEtMjg2MjE_04e37753-c5ec-43f2-ad0c-e99d24e3c155">1,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTQtMS0xLTEtMjg2MjE_5f504ded-15db-461d-8c62-8bfbf0b1279c">10,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTQtMy0xLTEtMjg2MjE_14330cd5-efcc-4861-ac42-2c22dc15e887">5,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTQtMS0xLTEtNDY3NzM_add9b43e-3704-4b25-a4aa-93fd074afef2">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTQtMy0xLTEtNDY3NzM_17a42276-fe01-4894-b0d4-96bdec9b349d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTUtMS0xLTEtMjg2MjE_278258de-ea94-427a-b78a-f2a58b9bf7ea">280,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTUtMy0xLTEtMjg2MjE_72412393-4c22-4e31-ae65-d5775a302975">132,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTgtMS0xLTEtMjg2MjE_ead127d3-17e6-433e-9ae5-7dd3198e9297">7,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTgtMy0xLTEtMjg2MjE_8b17f90b-556a-4083-b35c-c0f0918ab087">6,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTktMS0xLTEtMjg2MjE_bfdfa6ad-b1d9-4c48-8436-5e4c37af7061">54,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTktMy0xLTEtMjg2MjE_bd6920b7-f521-4ff9-8c8f-363c48cc885f">32,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjAtMS0xLTEtMjg2MjE_c950f17c-6bc4-45d7-8ec0-1bfa630f60e9">2,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjAtMy0xLTEtMjg2MjE_f1e6c8df-99b6-40e9-9343-8823c371fa7c">2,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP loan payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:NotesPayableCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjEtMS0xLTEtMjg2MjE_3c0d7475-a93f-48b1-aec3-d666ae3975dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:NotesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjEtMy0xLTEtMjg2MjE_b5c31d09-48fb-4a67-8e5a-091fb67e77e5">3,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjMtMS0xLTEtMjg2MjE_b8c751cc-f6f5-4374-8c08-cf9ab673eaeb">9,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredRevenueCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjMtMy0xLTEtMjg2MjE_3c39bddd-5b88-4c05-b9d9-a748349ee302">9,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjQtMS0xLTEtMjg2MjE_cab1ebc2-d316-4ca9-bc0c-e45574910f27">73,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjQtMy0xLTEtMjg2MjE_43ba9c5c-c079-4ac2-9c12-bc21105329a0">54,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredRevenueNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjUtMS0xLTEtMjg2MjE_476eb636-f2a5-4f7c-8a09-51431000a0ef">1,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredRevenueNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjUtMy0xLTEtMjg2MjE_f3f4f70f-fa30-40bb-878c-1748b0aa4040">1,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjctMS0xLTEtMjg2MjE_c26ba285-5228-4ce9-a11f-bd1fd744fe4c">13,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjctMy0xLTEtMjg2MjE_0eda44b0-32c2-40bf-8f4d-ebf144223d97">15,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP loan payable, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjgtMS0xLTEtMjg2MjE_66351aec-704e-4145-9c1b-d38720b55472">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjgtMy0xLTEtMjg2MjE_11995aed-11d1-4038-8a24-c471eff3ab93">3,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes, net of unamortized debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjctMC0xLTEtMzY4NTMvdGV4dHJlZ2lvbjoxNDIyZjFlMTMyZWY0NzhkOGExY2JmYjhhZjc5Njg4N18yNzQ4Nzc5MDY5NTE1_81d61143-8138-4400-b0e9-3dd266b96bf3">4,007</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjctMS0xLTEtMzY5NzM_452b95cc-6ab6-4471-83e3-d57f4d63c557">134,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjctMy0xLTEtMzY4NDI_49e7214b-c6d4-49d4-a42c-623dbd5742cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjktMS0xLTEtMjg2MjE_205ec28f-03df-417f-ab45-a9f2b0394e6c">763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjktMy0xLTEtMjg2MjE_b54a054e-edf3-4adf-8f41-d380ba475c59">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzAtMS0xLTEtMjg2MjE_b32b3756-edab-4e0e-ab1e-a66af6db4804">223,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzAtMy0xLTEtMjg2MjE_5fcd939d-6317-4fee-b445-489af04e1567">75,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 11).</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzEtMS0xLTEtMjg2MjE_00b7d2a2-4270-4825-98c4-055e82dcea52"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzEtMy0xLTEtMjg2MjE_f4f1f702-bbb7-413f-9062-5a877cfb2b57"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF8xOA_22cd485c-a056-4b65-ae74-516b77a660f0"><ix:nonFraction unitRef="usdPerShare" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF8xOA_804fd363-3039-49ae-adfd-90fa26dc74be">0.001</ix:nonFraction></ix:nonFraction> par value: Authorized: <ix:nonFraction unitRef="shares" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF80NA_4718ad5b-45b3-44e4-b443-94e7d1a86314"><ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF80NA_f5e59d7b-0cc7-4408-b064-a24c3c03fda7">50,000,000</ix:nonFraction></ix:nonFraction> shares; Issued and outstanding: <ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF83OQ_8a7c77b9-951b-445d-9811-909d3aefd2ed"><ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF83OQ_e4346be6-70bd-45bc-884a-5f31fc3b4b3d">17,995,344</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF84Ng_1daca060-ecb9-4de1-b0a6-9291976b4c27"><ix:nonFraction unitRef="shares" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF84Ng_1ef62906-be89-4b3f-93eb-d71b0725cabe">17,679,232</ix:nonFraction></ix:nonFraction> shares at December&#160;31, 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMS0xLTEtMjg2MjE_4e3d227c-afe0-4b57-b6dd-0e332023516c">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMy0xLTEtMjg2MjE_4935164f-2bd8-469d-b2cd-e638c7171761">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzQtMS0xLTEtMjg2MjE_35e3300e-3abe-4506-9d3e-a6b53612d9c1">114,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzQtMy0xLTEtMjg2MjE_15c0d8d9-024f-4bbe-9cb6-5ecc98c9d81f">117,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzUtMS0xLTEtMjg2MjE_65ec5b07-8674-45f5-9350-7d501fd473e5">58,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzUtMy0xLTEtMjg2MjE_088aa345-d923-420e-a2da-a31f89d9e23a">60,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzctMS0xLTEtMjg2MjE_449e382d-d661-449e-952f-f20cf2d282cf">56,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzctMy0xLTEtMjg2MjE_221ff7cb-3e52-4ed2-839b-9a6db1e213ba">56,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzgtMS0xLTEtMjg2MjE_5bda8143-1ab6-4f53-ab84-a1d9482534f1">280,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzgtMy0xLTEtMjg2MjE_e8e7ed7b-c1da-40d2-83c7-47b5625794e1">132,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">thousands,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">except</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">per</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">data)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i099f3e3620924202a8039a0d27597652_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMy0xLTEtMS0yODYyMQ_08042f34-9dc9-4546-afca-24a69576f3d0">205,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b500e632e0846a6a33e6a7ac55f88ad_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMy0zLTEtMS0yODYyMQ_85d7d360-8d6c-4df0-9366-b482a9e9f8b2">125,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7098bcdf6ed0484fab59d24d26f26f8b_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMy01LTEtMS0yODYyMQ_ce8aea85-fc2c-4cab-aeda-9f8d8b0b84fc">158,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58319883bced4affb153fc42b9f6a7ab_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNC0xLTEtMS0yODYyMQ_6a0ca0a8-0617-46ca-8dcc-8d2c26f62e44">25,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a72612f34ee4319a9bb7d59ecf28bee_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNC0zLTEtMS0yODYyMQ_2b41cd33-5217-48da-8531-a000d09dd11d">22,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4cf1c8552b845c08ebb68573b2cdd62_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNC01LTEtMS0yODYyMQ_1ee5e9af-f54d-4c9f-9d00-ef40e2de0117">23,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNS0xLTEtMS0yODYyMQ_840ed111-e498-4f84-8d28-5eb8a47a0cd1">231,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNS0zLTEtMS0yODYyMQ_d572f8ce-a4d6-4e64-aafa-7b4c4e230b18">147,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNS01LTEtMS0yODYyMQ_385fc24e-6f10-494e-bec7-06d3ae653cf7">181,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i099f3e3620924202a8039a0d27597652_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNy0xLTEtMS0yODYyMQ_96544847-f776-45c1-9196-651810f76b93">83,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b500e632e0846a6a33e6a7ac55f88ad_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNy0zLTEtMS0yODYyMQ_10ebc45b-78d1-490d-8c06-298b2ec64d9d">58,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7098bcdf6ed0484fab59d24d26f26f8b_D20190101-20191231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNy01LTEtMS0yODYyMQ_9a2ab23c-e872-4ff6-9d4c-4b987ce138ae">64,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58319883bced4affb153fc42b9f6a7ab_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfOC0xLTEtMS0yODYyMQ_d5b40f87-04fc-440a-9944-a07a2a52c50f">15,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a72612f34ee4319a9bb7d59ecf28bee_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfOC0zLTEtMS0yODYyMQ_083abd23-0761-4b82-abcc-e1977224d8de">13,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4cf1c8552b845c08ebb68573b2cdd62_D20190101-20191231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfOC01LTEtMS0yODYyMQ_d9c9ddd2-95f2-4f5b-a18a-209d857349ff">18,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfOS0xLTEtMS0yODYyMQ_db62b47c-58bf-4c1f-9242-28793d71e837">98,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfOS0zLTEtMS0yODYyMQ_385c6224-e60e-4ce3-85c0-8cb085c65ac6">71,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfOS01LTEtMS0yODYyMQ_f757f9db-6b3d-4304-b324-3285fbb5726a">83,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTAtMS0xLTEtMjg2MjE_7d3e6d76-679e-46a3-907b-6d5c8072de36">133,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTAtMy0xLTEtMjg2MjE_6bb6e59b-2db1-4e8a-9e9c-9fae469a5784">75,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTAtNS0xLTEtMjg2MjE_a9263a92-379f-45e7-bb34-3709d2a5a658">98,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTItMS0xLTEtMjg2MjE_07b4e66c-29c4-40c7-98d0-0bed10366347">76,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTItMy0xLTEtMjg2MjE_212291c9-46d0-4a0d-93fd-b2ff81ea199b">52,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTItNS0xLTEtMjg2MjE_19d1bb3d-a633-4ae4-8b45-43e9df510e5e">71,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTMtMS0xLTEtMjg2MjE_02381f87-977c-458b-adad-51169d446e8b">21,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTMtMy0xLTEtMjg2MjE_f8ff5abc-7314-42e6-857f-912b6f895667">14,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTMtNS0xLTEtMjg2MjE_5a2ccdbb-5f0e-47b0-8369-5e814d4e5fd1">15,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTQtMS0xLTEtMjg2MjE_3a41af5f-726a-4174-82c3-0ca868faa65d">32,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTQtMy0xLTEtMjg2MjE_6997332f-28f0-4c0e-ba65-039c87bb5970">31,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTQtNS0xLTEtMjg2MjE_afd7c899-3d0d-4501-9a25-c3dab5163957">24,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTUtMS0xLTEtMjg2MjE_fa989e34-5259-4933-ba05-6ef7ae51977a">131,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTUtMy0xLTEtMjg2MjE_571b01ce-bc37-4633-91ee-c5d7bff72d25">98,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTUtNS0xLTEtMjg2MjE_565ad919-c5b2-49f7-826c-06e09bc64413">110,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTYtMS0xLTEtMjg2MjE_1f95565c-5b2f-4a01-810e-12c4f2ff6141">1,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTYtMy0xLTEtMjg2MjE_90035f00-258d-4ff0-9e74-3acd053600ec">22,828</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTYtNS0xLTEtMjg2MjE_f9428c50-fc71-482c-b498-ea61fe1148b0">12,064</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income (expense), net:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Amortization of debt issuance costs   </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTgtMS0xLTEtMzY5OTY_7fb451a0-1009-4fe4-ac7f-b54873b97994">710</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTgtMy0xLTEtMzE4NDc_df21f0d2-184a-455f-a101-40ccbca32bb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTgtNS0xLTEtMzE4NDc_57a7f61f-b6f7-4fe9-8a02-cc9e12c0b651">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Interest on convertible notes  </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTktMS0xLTEtMzY5OTY_3240bb7f-015c-4de9-a272-801a2215f725">2,514</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTktMy0xLTEtMzE4NDc_51749c28-8cbc-42cf-a8b7-572c049be0fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTktNS0xLTEtMzE4NDc_ba4b876e-8520-4df6-865c-23176fd746db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Gain on extinguishment of PPP loan  </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjAtMS0xLTEtMzE4Njk_bc22154e-6ea8-41ff-9d8b-188833bc83ac">7,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjAtMy0xLTEtMzE4NDc_5be4cb4c-6e4c-4bdb-9bd7-1f3774f0a94e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjAtNS0xLTEtMzE4NDc_c0e5bcae-fcb1-4a50-bd2b-4aca584e7fcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other expense, net </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjEtMS0xLTEtMzY5OTY_b26c7db3-1a0c-4597-9553-100d897de10f">2,406</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjEtMy0xLTEtMzE4NDc_670c0320-ac56-4fa5-9b46-6493e480d2e1">579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjEtNS0xLTEtMzE4NDc_bf6521b0-5a5a-4437-8212-935f8d002a12">199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total interest and other income (expense), net </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjItMS0xLTEtMzE4NDc_753bf412-c600-465f-a221-4c8dea56dfa8">1,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjItMy0xLTEtMzE4NDc_c1191dee-8840-4005-a364-13e65f67292d">579</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjItNS0xLTEtMzE4NDc_95cab700-ab69-4107-9da2-5706d34676d9">199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTgtMS0xLTEtMjg2MjE_8d0b3ebf-371c-4183-a466-36e4da4ea70a">3,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTgtMy0xLTEtMjg2MjE_ca438835-70cd-4398-86b9-0b113a435146">23,407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTgtNS0xLTEtMjg2MjE_f03ab98c-131d-4322-a2a1-89faa8a7cc3b">12,263</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTktMS0xLTEtMjg2MjE_b6c32f35-4c37-445b-bddc-06a8c01cfab0">1,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTktMy0xLTEtMjg2MjE_c4731f9c-d82b-472c-8cea-aece67805ff0">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTktNS0xLTEtMjg2MjE_a479878c-5e76-4d4c-83c2-8597a998e7b7">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjAtMS0xLTEtMjg2MjE_1155ad00-3c2b-4b62-bb76-0ca38f6c3993">2,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjAtMy0xLTEtMjg2MjE_63296fe9-bf4e-4a42-815f-ce537b4670f3">23,877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjAtNS0xLTEtMjg2MjE_efe3ac29-2e73-4f7c-ba0b-604b70d9a5e4">12,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjMtMS0xLTEtMjg2MjE_4ea73a5a-d458-4ee7-82ca-f538031902d6">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjMtMy0xLTEtMjg2MjE_2c3f1a05-a90a-4225-b366-12fb27df1adf">1.43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjMtNS0xLTEtMjg2MjE_1d9ebdd1-d23e-4d00-a3f4-111d04da4c46">0.88</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjQtMS0xLTEtMjk2Nzk_d47ba123-7cdc-4f0b-b198-3963b3668d3d">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjQtMy0xLTEtMjk2NjE_a9f89839-209d-44c3-a464-c0ffff15d0d6">1.43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjQtNS0xLTEtMjk2NjE_0cbcfb6b-dfb6-4c66-bb21-f569e246fcdc">0.88</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of shares used in per share calculations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjUtMS0xLTEtMjg2MjE_fb7fe9fc-7935-4ab6-86a4-777335eb0666">17,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjUtMy0xLTEtMjg2MjE_3798b6a8-5408-44ac-bbbb-5c2c92fee6ec">16,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjUtNS0xLTEtMjg2MjE_d6d3cf4d-e826-4ac8-9d30-06de6b56d557">14,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjgtMS0xLTEtMjk2Nzk_75304f36-df0f-40eb-981d-e4062056f93f">18,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjgtMy0xLTEtMjk2NjE_e724d677-31bc-4a0a-be61-d4f4551997a3">16,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjgtNS0xLTEtMjk2NjE_7a401988-c42e-4887-847e-820de18d9a46">14,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">thousands)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfMi0xLTEtMS0yODYyMQ_c28df3fa-d49b-41bc-bff0-c90d8da7fb78">2,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfMi0zLTEtMS0yODYyMQ_d613ebf9-02e5-45d2-af40-d7f1db7cab74">23,877</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfMi01LTEtMS0yODYyMQ_5f1f521f-4355-4972-86f1-f50d984e11be">12,348</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in unrealized gain (loss) on available-for-sale investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNS0xLTEtMS0yODYyMQ_252d347e-9639-4369-a267-371b3a2f3dff">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNS0zLTEtMS0yODYyMQ_edc497b8-38a6-4039-89e2-109681b1ce5a">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNS01LTEtMS0yODYyMQ_f319cf84-d07b-43cb-950e-3488cc9af041">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reclassification adjustment for net losses on investments recognized during the year</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNi0xLTEtMS0yODYyMQ_4d82d17e-e03f-4c38-aa40-47d29b2b0a98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNi0zLTEtMS0yODYyMQ_03c36499-3eba-4efc-87f7-91cd0c6b4601">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNi01LTEtMS0yODYyMQ_1f7cfccb-b4f7-4d8a-a403-a893cd727732">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total change in unrealized gain (loss) on available-for-sale investments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNy0xLTEtMS0yODYyMQ_915d85b0-0b0b-46c2-9074-edf0e92360c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNy0zLTEtMS0yODYyMQ_24a5da0f-bd9e-497c-9cd3-1bc0bcd149f8">60</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNy01LTEtMS0yODYyMQ_feb5a4a4-0807-4a5c-bfaf-9150cd530354">9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfOC0xLTEtMS0yODYyMQ_c15de2db-75b1-449b-a1a2-b4cc6d6bf4f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfOC0zLTEtMS0yODYyMQ_0f063cea-ec66-4114-8469-14226dd2370c">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfOC01LTEtMS0yODYyMQ_163617f8-40f4-4761-99af-3dea6e50852d">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfOS0xLTEtMS0yODYyMQ_e342bc5a-b3ec-4e36-8e88-e59c6ed82754">2,062</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfOS0zLTEtMS0yODYyMQ_094d2425-5974-423c-87ae-1d01c07b642a">23,817</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfOS01LTEtMS0yODYyMQ_1bbd9837-4382-439b-ae88-b18d450e89a2">12,339</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">thousands,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">except</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">amounts)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:29.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings<br/>(Accumulated <br/>Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive <br/>Income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217; <br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a7631525a4f45cd84f88a123b5d2213_I20181231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMi0xLTEtMS0yODYyMQ_e4e37114-1021-448a-b0c3-35f2a810c346">13,968,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a7631525a4f45cd84f88a123b5d2213_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMi0zLTEtMS0yODYyMQ_5975dcbe-a0b9-4cca-acd5-e5b9dc8a4949">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99ac849105d4a778abc890967e8354d_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMi01LTEtMS0yODYyMQ_c05a3278-f1dc-4e56-9863-ac9b9be90a09">70,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if092c9ece84f49e7896488564096ae3e_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMi03LTEtMS0yODYyMQ_33023857-de5f-4fbc-a5be-cf1ee5742c2e">24,010</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6093d26609ac4a2082bc74145688a81e_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMi05LTEtMS0yODYyMQ_a0e34550-50fb-4e8c-962c-4f5851c339ce">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMi0xMS0xLTEtMjg2MjE_a4f34fec-b632-4223-b5da-6c0491d5145d">46,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock for employee purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ef35ea9019a46839254540bd96f8f38_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNS0xLTEtMS0yODYyMQ_aaac922a-3adc-455a-9d01-5c3ee2ac4bde">82,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37fa040d9517485c9e505b0a87f68f29_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNS01LTEtMS0yODYyMQ_da1b95a7-08f3-424c-8592-ef1fbb49beb9">1,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNS0xMS0xLTEtMjg2MjE_99ae49d3-e355-45c0-83e7-34410aa11025">1,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ef35ea9019a46839254540bd96f8f38_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNi0xLTEtMS0yODYyMQ_8a6fc6a2-737c-4c06-9425-dd9eff824464">160,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37fa040d9517485c9e505b0a87f68f29_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNi01LTEtMS0yODYyMQ_8a7a7af9-5545-46a4-8ce9-259f290050b6">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNi0xMS0xLTEtMjg2MjE_20dd2662-5d46-43f3-b906-076aa40b1624">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ef35ea9019a46839254540bd96f8f38_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNy0xLTEtMS0yODYyMQ_264d58c5-acce-475c-9f15-5ecf6b727dba">103,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37fa040d9517485c9e505b0a87f68f29_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNy01LTEtMS0yODYyMQ_6620d7c0-5f38-4ff4-b042-7bf0bdd77348">831</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNy0xMS0xLTEtMjg2MjE_b94f8c06-6190-4551-bd3f-edd0e6261625">831</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37fa040d9517485c9e505b0a87f68f29_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfOC01LTEtMS0yODYyMQ_bdb9a598-bdda-44b4-9d45-1ac96ac451cc">9,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfOC0xMS0xLTEtMjg2MjE_f01628f5-939f-4a83-bf71-752bde025b5e">9,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee23395883004f20bda4e3cba945dd71_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfOS03LTEtMS0yODYyMQ_0456ccd6-9ef4-4f53-8b68-2942cfe0bca4">12,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfOS0xMS0xLTEtMjg2MjE_840f5b9a-b642-4482-b761-6470ff691733">12,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net change in unrealized gain on available-for-sale investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63061c421e784fa784a49973a94456b2_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTAtOS0xLTEtMjg2MjE_f0c98c8b-511d-444f-b282-8f03c64b1056">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTAtMTEtMS0xLTI4NjIx_a9384239-d8bd-44cd-9093-29f345591248">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i50e9b99ce0334c7d9a579aa4a855f45e_I20191231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTEtMS0xLTEtMjg2MjE_6ab50748-b6de-414a-bb2d-f8e81917b092">14,315,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e9b99ce0334c7d9a579aa4a855f45e_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTEtMy0xLTEtMjg2MjE_3cfecccc-aade-4add-a8ca-f801d4517b69">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b37d87a7edd4cbba072cd040d20302b_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTEtNS0xLTEtMjg2MjE_66135f08-d62c-4713-bce6-6b3efc2628ac">82,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icee9c162557a4530b5abeb514f96a6c5_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTEtNy0xLTEtMjg2MjE_ab36fcbb-24d5-4bc5-83d6-186156b78ddd">36,358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84dc3075f0c942e99a266d7512c300d6_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTEtOS0xLTEtMjg2MjE_3dd035f5-7b6e-4635-8b49-862e8c2c89c2">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTEtMTEtMS0xLTI4NjIx_756717a2-8110-49ed-9e3f-9697db29b35c">45,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock for employee purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTMtMS0xLTEtMjg2MjE_7f7637f4-c6fb-4fb8-b6b8-4f90dca081f8">56,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4131053e935748729079966449ab7c37_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTMtNS0xLTEtMjg2MjE_21c5b15f-ce05-4fe7-8e36-cd4bd6e2ffde">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTMtMTEtMS0xLTI4NjIx_8b7a13ab-77af-4a4c-83f1-028aa79ea7b0">632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTQtMS0xLTEtMjg2MjE_6b0b0c98-bbdc-43bb-824f-0f163693583c">73,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4131053e935748729079966449ab7c37_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTQtNS0xLTEtMjg2MjE_723fe72f-4a16-4916-8e50-a3d4688ee5d2">947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTQtMTEtMS0xLTI4NjIx_17a75f76-3a8c-44bb-b004-d3d68cb90762">947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock in connection with public offering, net of issuance&#160;costs of $<ix:nonFraction unitRef="usd" contextRef="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTMtMC0xLTEtMzgwMzUvdGV4dHJlZ2lvbjo2OGI0OTYwNGZlNzA0NjhmYWQxZjAxZWFlMmY3ZjE4OV8xMDk5NTExNjI3ODc4_19cd12ac-ca4f-478f-a190-6b050ea3b091">2,303</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTUtMS0xLTEtMjg2MjE_289ed398-4aa8-4652-ba27-d2573624e52b">2,742,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTUtMy0xLTEtMjg2MjE_b1ad4619-b9b9-4645-9b20-2852238bb034">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4131053e935748729079966449ab7c37_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTUtNS0xLTEtMjg2MjE_af3e1426-cb2e-4806-95f7-425f5b951c03">26,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTUtMTEtMS0xLTI4NjIx_2daa49de-e73b-43bd-8fb6-8f8f8792277a">26,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTYtMS0xLTEtMjg2MjE_c9446dff-2980-4534-84ab-8009d6d91050">490,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTYtMy0xLTEtMjg2MjE_e91f4d35-d6e2-4015-8033-1dbeba8c61f6">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4131053e935748729079966449ab7c37_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTYtNS0xLTEtMjg2MjE_a0ec7bf2-af10-460d-802a-d3c4b1cdc832">3,429</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTYtMTEtMS0xLTI4NjIx_a245d527-dab7-4555-b809-91e3fececca2">3,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4131053e935748729079966449ab7c37_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTctNS0xLTEtMjg2MjE_6f66e20f-4c45-4f04-931d-5c6d9633386d">10,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTctMTEtMS0xLTI4NjIx_9bbbaf77-68b0-482c-999f-d02617897f09">10,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i960574069b78413a924873ab23554fb4_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTgtNy0xLTEtMjg2MjE_6af6e8a7-52d6-43dd-a7d5-7d0bd0881a74">23,877</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTgtMTEtMS0xLTI4NjIx_77878135-6ff0-4b08-a8e1-80b46ee6f2cf">23,877</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net change in unrealized gain on available-for-sale investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcae67fe77484d66aac559d41cdd4a97_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTktOS0xLTEtMjg2MjE_5cf914bd-7649-4d1c-80bb-849260c807fa">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTktMTEtMS0xLTI4NjIx_0395c168-6854-43fe-b416-1ba6aceb0ebf">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8720e5d165746398e865e8ff2bf37ba_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjAtMS0xLTEtMjg2MjE_d98c70ea-ce78-4935-9212-bb535e256f61">17,679,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8720e5d165746398e865e8ff2bf37ba_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjAtMy0xLTEtMjg2MjE_3a9138f0-fe91-415c-a960-ad3feb7bcc20">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i196713f133464fccbcbe95ca1be37452_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjAtNS0xLTEtMjg2MjE_af62a7ff-195a-4592-be1f-253662dedc0a">117,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04a8f1192895498a8fbd198d78451ecd_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjAtNy0xLTEtMjg2MjE_f1886d27-44d7-4b47-8ec6-49115d7ceb02">60,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i952540da797a438c883313a189c55038_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjAtOS0xLTEtMjg2MjE_07ad34cf-0e0a-4eae-99e0-05ad14140f58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjAtMTEtMS0xLTI4NjIx_9944a9ec-3de4-403e-b8df-99604d8b44c2">56,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock for employee purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8344555ed6a476481db2825ccec753c_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjItMS0xLTEtMjg2MjE_81d86cef-40d8-40e8-824a-fc6dfdbf6d32">59,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90ee30efe67b4fb49e2d5f54e0fafe89_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjItNS0xLTEtMjg2MjE_b5ff24fe-cefc-43dd-9798-91bcbed43b5a">1,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjItMTEtMS0xLTI4NjIx_a6ec1fb6-bd1b-49fb-8535-dfb5b273832b">1,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8344555ed6a476481db2825ccec753c_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjMtMS0xLTEtMjg2MjE_ae279fa6-1c09-4b64-8780-ce9557c7decf">71,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90ee30efe67b4fb49e2d5f54e0fafe89_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjMtNS0xLTEtMjg2MjE_2c0931b3-617b-4f21-9aff-ca9281f67e19">1,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjMtMTEtMS0xLTI4NjIx_d474c18e-2df3-46d5-87cc-4b4a10d5cb98">1,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of capped call</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90ee30efe67b4fb49e2d5f54e0fafe89_D20210101-20211231" decimals="-3" sign="-" name="cutr:PurchaseOfCappedCall" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjItNS0xLTEtNDA2MzI_8ee9d783-26cb-4b01-8920-f2079ff334e6">16,134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" sign="-" name="cutr:PurchaseOfCappedCall" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjItMTEtMS0xLTQwNjMy_25919aea-722c-42a0-a967-1068b7be3a81">16,134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8344555ed6a476481db2825ccec753c_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjQtMS0xLTEtMjg2MjE_c0ef8908-c866-4f97-ada2-d90a1b80a0bd">184,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90ee30efe67b4fb49e2d5f54e0fafe89_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjQtNS0xLTEtMjg2MjE_50106b84-ce5b-4c3b-8d0e-295c89d604cd">2,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjQtMTEtMS0xLTI4NjIx_78e0675e-a884-4de2-93d6-d21f946efe7f">2,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90ee30efe67b4fb49e2d5f54e0fafe89_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjUtNS0xLTEtMjg2MjE_9c8dc0ff-7321-4bf5-b529-892b7ba2b562">13,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjUtMTEtMS0xLTI4NjIx_1dc68cee-72b8-4514-89cf-83c5283643ac">13,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f16a2afdae64f2daab7448314a752d3_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjQtNy0xLTEtMjkzOTc_18728d97-335b-4044-a885-2a509d011b59">2,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjQtMTEtMS0xLTI5Mzk3_d63d0e71-eb00-4a60-8246-769ccbdb9f3f">2,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i19a4ef1cc484429daba4d25230ec7aad_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjYtMS0xLTEtMjkzOTc_0d41139e-5e4e-4307-ac16-a01d4bf76a97">17,995,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19a4ef1cc484429daba4d25230ec7aad_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjYtMy0xLTEtMjkzOTc_f372ea9d-dbe1-49a8-8a4b-9aac9f8f4166">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id52c81a523b740df9a58c7f26a6f5f9f_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjYtNS0xLTEtMjkzOTc_56a3a2f4-dda1-423b-9d1f-5e405e58a79f">114,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5865f24ced8c4abe92e8e3142a113547_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjYtNy0xLTEtMjkzOTc_d6974d6c-2b42-4fa8-a30b-add49365fd49">58,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcc9ffcaa06a4dbd9843701a556e4a0a_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjYtOS0xLTEtMjkzOTc_f32777ab-2065-4ae0-82c5-e37d3baf9a3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjYtMTEtMS0xLTI5Mzk3_93142d88-fd84-4087-88ec-4f62cc1d2f6f">56,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_97"></div><hr style="page-break-after:always"/><div style="min-height:32.4pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMy0xLTEtMS0yODYyMQ_0c65012f-bbf4-40d7-bebc-cc849eeaa6dc">2,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMy0zLTEtMS0yODYyMQ_ae990a8d-315b-453a-99d4-b5eb62646c9d">23,877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMy01LTEtMS0yODYyMQ_fd66c5fe-b7ce-449d-aa55-2f4f72889137">12,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNS0xLTEtMS0yODYyMQ_e7b78a3a-9559-4740-ab99-b80ab97105de">13,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNS0zLTEtMS0yODYyMQ_81ae4ad3-8e83-4093-bc57-e29ddb49e924">10,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNS01LTEtMS0yODYyMQ_7d8e6753-4ca6-4403-ace7-662c7167cf01">9,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNi0xLTEtMS0yODYyMQ_1c108b1b-8bfd-4ba4-af9f-13fb4f52d2b3">1,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNi0zLTEtMS0yODYyMQ_6d7a0f80-65cb-47b6-9615-0c774924f103">1,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNi01LTEtMS0yODYyMQ_156e2960-beaa-469e-ae0e-cc8a5f0d462b">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of contract acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNy0xLTEtMS0yODYyMQ_b8b7d71b-2b1f-465b-85b8-18fe995e3452">1,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNy0zLTEtMS0yODYyMQ_3f8f775c-146a-4e53-9908-25799113a366">2,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNy01LTEtMS0yODYyMQ_059e946e-457e-4d4a-8719-3edf221fd2fa">2,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOC0xLTEtMS00MDg0NQ_f0824c0c-4233-45ea-a3c0-589c3b19382d">710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOC0zLTEtMS00MDg0NQ_9d9f4790-f259-47e6-9ac1-71c3bac37d62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOC01LTEtMS00MDg0NQ_6e7f05e8-3414-4fde-8b0d-bb3b36781a8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of capitalized cloud computing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:HostingArrangementServiceContractImplementationCostImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOC0xLTEtMS0yODYyMQ_1e20d622-b1b0-4632-99e3-a2f352f059f6">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:HostingArrangementServiceContractImplementationCostImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOC0zLTEtMS0yODYyMQ_3abeb660-00d1-4d06-b2b8-f4db9170c159">805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:HostingArrangementServiceContractImplementationCostImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOC01LTEtMS0yODYyMQ_cb39d21d-d95d-4033-974d-f2650e409230">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOS0xLTEtMS0yODYyMQ_e0a59143-2f73-469b-87e8-861659e6c457">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOS0zLTEtMS0yODYyMQ_ed1d13a0-2d05-4c00-85ee-7d8f35f7472c">220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOS01LTEtMS0yODYyMQ_b6575784-8446-4c9e-a28f-783b15839f85">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTAtMS0xLTEtMjg2MjE_bcf164e0-b739-43a2-bc23-2d854c33fce7">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTAtMy0xLTEtMjg2MjE_d21adafa-a01a-4aae-9671-08fe4275c95b">2,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTAtNS0xLTEtMjg2MjE_b85cbbf0-45a9-4d2e-8824-8339e3d0ad91">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on extinguishment of PPP loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTMtMS0xLTEtNDA5MDg_59a4a93e-1061-42ac-b0bd-fd1f21076d06">7,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTMtMy0xLTEtNDA5MDg_618da727-fd7e-4899-8818-f94be9aa0757">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTMtNS0xLTEtNDA5MDg_fceedcd3-19f2-459d-bdc4-59b715010c8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Change in right-of-use asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="cutr:ChangeInRightofuseAssetAndLiabilityDueToModification" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTEtMS0xLTEtMjg2MjE_0fde1555-6e43-4905-a19a-018e4729d9ca">2,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="cutr:ChangeInRightofuseAssetAndLiabilityDueToModification" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTEtMy0xLTEtMjg2MjE_bc8facf0-a3dd-438b-91dc-a974d1a6ee0d">2,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="cutr:ChangeInRightofuseAssetAndLiabilityDueToModification" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTEtNS0xLTEtMjg2MjE_edc4d63c-9e06-4a43-bddd-9209ad7955c2">2,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTItMS0xLTEtMjg2MjE_c9949c8f-4f7b-40c5-b4ac-68911fc41665">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTItMy0xLTEtMjg2MjE_c7cc1ea7-987b-4b99-85d5-17f78e94f2a0">513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTItNS0xLTEtMjg2MjE_e57c14c1-82ce-453d-b410-b444385aee99">83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTQtMS0xLTEtMjg2MjE_fe0ac880-0ed9-408f-919a-404f58819e69">9,574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTQtMy0xLTEtMjg2MjE_3411b86a-6094-4577-8465-378406a90626">2,550</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTQtNS0xLTEtMjg2MjE_8985debd-8c88-4aa5-ac11-edf34de933fd">2,509</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTUtMS0xLTEtMjg2MjE_22937964-6cfe-4e66-88b0-37b80934468d">10,936</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTUtMy0xLTEtMjg2MjE_93cda05b-902c-49df-b953-845f229e9ab8">5,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTUtNS0xLTEtMjg2MjE_fdfd864d-2aa0-40a7-875e-b22e0c149415">5,907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets and prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTYtMS0xLTEtMjg2MjE_bdf0b197-8467-4724-bde4-7eed0ffee705">5,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTYtMy0xLTEtMjg2MjE_e4fb4687-6ac1-4573-b6c8-8f55a6d69972">3,164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTYtNS0xLTEtMjg2MjE_7ecf0907-8e9e-4dba-9854-70b454495ad8">1,762</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTctMS0xLTEtMjg2MjE_9e24d1f4-877c-4e91-ac7a-1e8b7f4093c8">7,128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTctMy0xLTEtMjg2MjE_a87b7394-5b95-4d27-ae8c-3a637d9aa0cb">2,067</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTctNS0xLTEtMjg2MjE_349e0183-20c2-4c58-ab50-15f8c364c72b">3,355</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTgtMS0xLTEtMjg2MjE_d35a6490-e4b3-467e-ba1b-93e76fb01693">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTgtMy0xLTEtMjg2MjE_fe2fa7cf-4767-4279-89ed-7156224d7d04">6,034</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTgtNS0xLTEtMjg2MjE_33757a53-891c-4dea-8d2d-030b8508f4ba">1,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTktMS0xLTEtMjg2MjE_2732ee2a-1ce9-423b-a1a0-51a13aa1c50e">21,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTktMy0xLTEtMjg2MjE_889c7d7d-73ed-4b2a-b3fb-f619aed85ee5">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTktNS0xLTEtMjg2MjE_92f0c47a-d1ae-410b-889a-af7d8fb1814a">5,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjEtMS0xLTEtMjg2MjE_4c840caa-b35a-4acd-81da-e21410e2fec2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjEtMy0xLTEtMjg2MjE_65456464-4536-4f48-8ac2-741547cf0892">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjEtNS0xLTEtMjg2MjE_b87d5b4f-ef50-4704-84b1-59a2d91eab9e">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" sign="-" name="cutr:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjItMS0xLTEtMjg2MjE_e99864e5-d814-4d6c-9379-8277adaeeb16">2,151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="cutr:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjItMy0xLTEtMjg2MjE_4318be7b-8030-4be6-8f84-76773f6464bc">1,598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="cutr:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjItNS0xLTEtMjg2MjE_ae0a78eb-e52c-4f7a-94b7-07246505f6e8">2,292</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjMtMS0xLTEtMjg2MjE_c4d34805-fb78-4baf-82bf-f795f3303534">412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjMtMy0xLTEtMjg2MjE_69b69ae2-bab5-4b5a-8b56-1502705ab40d">2,985</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjMtNS0xLTEtMjg2MjE_cfbdb90a-1eee-4374-9cb2-65fa10820764">1,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjQtMS0xLTEtMjg2MjE_f57dc7f0-57c9-4ad3-b02c-505f08042939">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjQtMy0xLTEtMjg2MjE_de8b9fa7-69f8-468a-bc9b-487e1fb62a92">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjQtNS0xLTEtMjg2MjE_226e3a97-0d04-4c2e-aa7c-b1e7ef44a5d1">301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjUtMS0xLTEtMjg2MjE_1dcfd6c0-f5c1-4bbb-bf63-d042a4aacc75">1,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjUtMy0xLTEtMjg2MjE_11bea1af-edae-4f2f-ab92-0aca20938daf">16,934</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjUtNS0xLTEtMjg2MjE_a5a67d0f-cb90-44ac-9c84-9ae38c3c2d6a">2,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of property and equipment   </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjctMS0xLTEtMjg2MjE_f485567a-568c-4b0a-9d69-557f37c8e341">1,015</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjctMy0xLTEtMjg2MjE_64c2e8a6-8df3-436e-9a19-41d935647ad0">1,279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjctNS0xLTEtMjg2MjE_d8edbfec-0b6d-4c20-83aa-4c070112318d">991</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Disposal of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjgtMS0xLTEtMjg2MjE_53be7048-8673-4e06-8a40-974f191f124a">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjgtMy0xLTEtMjg2MjE_c5097410-609a-4804-bcd8-496292815dc6">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjgtNS0xLTEtMjg2MjE_6344c20a-9159-4667-9062-291c4ec241fa">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sales of marketable investments </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjktMS0xLTEtMjg2MjE_7f572a63-a941-4a7e-a766-d3cde14ce7d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjktMy0xLTEtMjg2MjE_3bc560e8-e416-459f-9685-9142674fa9b2">5,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjktNS0xLTEtMjg2MjE_5aed6856-1cb2-48d3-b960-91086b32f0ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from maturities of marketable investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzAtMS0xLTEtMjg2MjE_0ba75402-6f8d-406b-8305-9d5768103904">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzAtMy0xLTEtMjg2MjE_77f5e65a-ebb6-4026-8ff8-f1917d197200">28,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzAtNS0xLTEtMjg2MjE_ca23c448-4040-45ca-87a4-7953a13ea166">14,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of marketable investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzEtMS0xLTEtMjg2MjE_e6880c97-ea6f-415c-b030-e31d42013621">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzEtMy0xLTEtMjg2MjE_a1e54086-0c71-4b62-8d08-0f8ddd28332f">26,060</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzEtNS0xLTEtMjg2MjE_e9184072-1ca1-44ee-afa5-c338d4ee2375">12,687</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzItMS0xLTEtMjg2MjE_f4c71c3d-f0f5-406d-9ea1-2441631e4f83">944</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzItMy0xLTEtMjg2MjE_dc31af5c-1f3e-46b4-8c95-ba742d97a32e">6,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzItNS0xLTEtMjg2MjE_3eb523b2-2159-4b32-ada3-8885064c90ea">1,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options and employee stock purchase plan  </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzQtMS0xLTEtMjg2MjE_1d172f79-3a68-4132-9659-f88441bd623c">2,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzQtMy0xLTEtMjg2MjE_37088614-b7cc-4e7f-8d66-6d1af8c89695">1,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzQtNS0xLTEtMjg2MjE_f7757543-fd7a-45a1-89c2-09e164c672f3">2,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of capped call</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzUtMS0xLTEtMzUwOTA_e9c2dde1-805d-4a21-92e3-14518565419f">16,134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzUtMy0xLTEtMzUwOTA_db82f186-1aa6-4d2b-9541-b94b5361964f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzUtNS0xLTEtMzUwOTA_63e4f9c7-240f-4f28-aee8-dbefa41cb337">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from PPP loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzUtMS0xLTEtMjg2MjE_aefbf4b4-d7bd-479d-a78f-ef6860726361">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzUtMy0xLTEtMjg2MjE_a31b2e86-45d5-40e6-821d-30c2b3b22d62">7,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzUtNS0xLTEtMjg2MjE_cb6aa14c-f574-44a5-8eed-f64802392755">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzctMS0xLTEtMzUxNjI_fc753279-1280-442a-b59f-76bfec674ed5">138,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzctMy0xLTEtMzUxNzc_c9599d91-9dc1-464c-915e-27e6c7b305b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzctNS0xLTEtMzUxODg_5a7f8613-aae8-4341-b6af-f150736592b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of issuance costs of convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzgtMS0xLTEtMzUxNjI_142b5a77-ac91-4178-b11e-b00c7bc21e25">4,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzgtMy0xLTEtMzUxNzc_eb3417ee-ee93-4bf0-b045-e768af6f1580">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzgtNS0xLTEtMzUxODg_28ef41b5-9b47-4a08-92e8-add4c01a018a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross proceeds from equity offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzYtMS0xLTEtMjg2MjE_cb242aaf-e3e6-4d8d-8e6c-fb9d782a8df2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzYtMy0xLTEtMjg2MjE_305ff98f-bb9c-44c3-91c0-bcaee42b2260">28,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzYtNS0xLTEtMjg2MjE_df917015-bfc5-4aaa-a7a8-3fc5228e755c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance costs on the public&#160;offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzctMS0xLTEtMjg2MjE_7f7b8aeb-6fd9-4879-8995-2dfdd1f43629">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzctMy0xLTEtMjg2MjE_c4366ff2-5d73-4e4b-bf92-33e0714b14d9">2,303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzctNS0xLTEtMjg2MjE_343893d6-6ccd-4c5e-b836-8720578476f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzgtMS0xLTEtMjg2MjE_4b403570-7e57-477b-91a8-b44c4811d320">2,176</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzgtMy0xLTEtMjg2MjE_668c221e-26c2-4dff-a85e-66ba4a6c2db5">3,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzgtNS0xLTEtMjg2MjE_e3c60785-5983-4d8b-a939-db4ddabb766b">831</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on capital lease obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzktMS0xLTEtMjg2MjE_30b25a21-0dea-43c4-8cdb-e956f29f1efd">462</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzktMy0xLTEtMjg2MjE_f88cb3a0-e6bb-4cbd-abd6-d1e6d26cfdaa">537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzktNS0xLTEtMjg2MjE_99314b6f-6fe8-4551-92a3-ac3c0780fc01">649</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by financing activities  </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDAtMS0xLTEtMjg2MjE_1b3ad48e-8497-495d-b103-3fc69f7f21d7">117,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDAtMy0xLTEtMjg2MjE_1db1cd16-319d-432d-a1e1-a18ea984e18b">31,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDAtNS0xLTEtMjg2MjE_59b4ce01-7a50-4683-b887-181ce37d6e79">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDEtMS0xLTEtMjg2MjE_836a7f12-0280-4072-a012-bbd937877c4d">117,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDEtMy0xLTEtMjg2MjE_e7284d1a-7599-46a4-b55c-5709119f599d">20,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDEtNS0xLTEtMjg2MjE_1238372c-6f59-4ee7-9960-9ac26d3fa8b3">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDItMS0xLTEtMjg2MjE_6616367a-de0d-4567-aeb4-af4d1ba56378">47,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDItMy0xLTEtMjg2MjE_ccbd0a0b-d7f0-4dd8-a1a4-b74827cc010c">26,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDItNS0xLTEtMjg2MjE_74a5c47f-0847-4743-9440-1456682d0ae5">26,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDMtMS0xLTEtMjg2MjE_6dc492d5-b632-4c7a-9f57-9b9432312a19">164,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDMtMy0xLTEtMjg2MjE_fd43500f-a937-4664-90ae-c9149df04b85">47,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDMtNS0xLTEtMjg2MjE_ec51597c-9093-440d-b017-cb43f8998f0a">26,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDUtMS0xLTEtMjg2MjE_51edd530-98ef-4683-bd0f-f0fd3c3903b5">1,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDUtMy0xLTEtMjg2MjE_fd84cdee-e5d6-49cb-912e-ad6d7759a4f8">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDUtNS0xLTEtMjg2MjE_ab8d43b2-5987-4d7c-ba94-1f4255dbe8ab">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid (refunded) for income taxes, net of (refunds) payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDYtMS0xLTEtMjg2MjE_40205c28-99ee-4942-bd59-1676e9a8c618">891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDYtMy0xLTEtMjg2MjE_0170b3d6-1b70-4186-a988-e2202ff137be">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDYtNS0xLTEtMjg2MjE_55988f75-8557-4f83-bcd0-8570376498d7">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets acquired under finance lease</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDgtMS0xLTEtMjg2MjE_f338c92e-466e-4d14-83a2-ee18c0972698">828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDgtMy0xLTEtMjg2MjE_d0bcec0a-98c1-41bf-99b8-df0c5f402442">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDgtNS0xLTEtMjg2MjE_97f5f302-b61c-4864-9897-c53435ef2888">738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets acquired under operating lease</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDktMS0xLTEtMjg2MjE_5d9ef889-1b75-4c3e-810a-b1cbbe63fd92">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDktMy0xLTEtMjg2MjE_e77858b3-4cc2-4a93-914d-b7146e10b693">11,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDktNS0xLTEtMjg2MjE_8a274840-edbb-4f85-acb8-5e92309557a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on extinguishment of PPP loan</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:NotesReduction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNTMtMS0xLTEtMzUyNzI_8ca24fda-4fbe-434f-81e8-7a85e315dc79">7,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:NotesReduction" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNTMtMy0xLTEtMzUyODE_4e7b8022-5be8-4da7-b0d3-d7ed1b5f3532">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:NotesReduction" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNTMtNS0xLTEtMzUyODg_bc37fae8-f853-44a9-a3e7-e5863dc64ded">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:32.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_103"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1&#8212;<ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTIw_5915f785-0f50-4522-b05c-51c5fd7b68e3" continuedAt="i816b6492586a4907a43270988d1b8e55" escape="true">SUMMARY</ix:nonNumeric></span><ix:continuation id="i816b6492586a4907a43270988d1b8e55" continuedAt="if8b8df9408134d17a51e9d06e60ac2f8"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNIFICANT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCOUNTING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POLICIES</span></ix:continuation></div><ix:continuation id="if8b8df9408134d17a51e9d06e60ac2f8" continuedAt="iffd2b70e3afe44d788f7dc0976b89cec"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTI4_79672fdc-9a59-4055-a19c-13a0420389cb" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Operations and Principles of Consolidation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cutera, Inc. (&#8220;Cutera&#8221; or the &#8220;Company&#8221;) provides energy-based aesthetic systems for practitioners worldwide. The Company develops, manufactures, distributes, and markets energy-based product platforms for use by physicians and other qualified practitioners, enabling them to offer safe and effective aesthetic treatments to their customers. The Company currently markets the following system platforms: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten, excel,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO, Secret RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Several of the Company&#8217;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The sales of (i) systems, system upgrades, and hand pieces (collectively &#8220;Systems&#8221; revenue); (ii) replacement hand pieces, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">D,truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cycle refills, as well as single use disposable tips applicable to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Consumables&#8221; revenue); (iii) the distribution of third party manufactured skincare products (&#8220;Skincare&#8221; revenue); and (iv) the leasing of equipment through a membership program; are collectively classified as &#8220;Products&#8221; revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt 3D, truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and service labor for the repair and maintenance of products that are out of warranty, all of which are collectively classified as &#8220;Service&#8221; revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#8220;RDCs&#8221;) in selection locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets sells and services the Company&#8217;s products through direct sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over <ix:nonFraction unitRef="country" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzIwMzQwOTY1MTk4Mzgw_25643030-d5a1-4e47-b978-0b33932d2ec9">42</ix:nonFraction> countries. The consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3ODc0NzU_8c75bad4-d3c9-4b7f-80c2-bfd9282dc62d" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements have been prepared in conformity with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;). Certain prior period amounts have been reclassified  to conform to the 2021 presentation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTMw_de5090f8-8ff8-48b8-b790-0bcd0f29cd5d" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commissions, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, assumptions used in operating and sales-type lease classification, implicit and incremental borrowing rates related to the Company&#8217;s leases, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="cutr:RisksAndUncertaintiesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTMz_03f69804-9d98-42bd-96b3-725766df60ce" continuedAt="i524b5e7e36d342b69df62c4ae7a9b3c3" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of global financial markets, cybersecurity breaches and other disruptions that could compromise the Company&#8217;s information or results, business disruptions that are </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="iffd2b70e3afe44d788f7dc0976b89cec" continuedAt="if6ad254d85dc4ab4b6a5b2c2e777641a"><ix:continuation id="i524b5e7e36d342b69df62c4ae7a9b3c3" continuedAt="i738cff4f19954a48be14d6639ba8087b"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caused by natural disasters or pandemic events, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, the successful execution of new product launches, strategic relationships and dependence on key individuals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;the World Health Organization declared the COVID-19&#160;outbreak a pandemic. The COVID-19&#160;outbreak, and lately the Delta and Omicron variants, has negatively affected the United States and global economies. The spread of the coronavirus, which caused a broad impact in 2020 globally, including restrictions on travel, shifting work force to work remotely and quarantine policies put into place by businesses and governments, had a material economic effect on the Company&#8217;s business during the year ended December 31, 2020. Notably, healthcare facilities in many countries effectively banned elective procedures. Many of the Company&#8217;s products are used in aesthetic elective procedures and as such, the bans on elective procedures substantially reduced the Company&#8217;s sales and marketing efforts in the early months of the pandemic and led the Company to implement cost control measures. Although the Company&#8217;s operation and results of operations have significantly improved as the economic outlook due to the&#160;COVID-19&#160;pandemic improved in 2021, the&#160;COVID-19&#160;outbreak continues to be fluid and the aftermath of the business and economic disruptions due to the&#160;COVID-19 is still uncertain, making it difficult to forecast the final impact it could have on&#160;the Company&#8217;s&#160;future operations, including disruptions in the Company's supply chain and contract manufacturing operations. The Company&#160;cannot presently predict the scope and severity of any impacts in future periods from the business shutdowns or disruptions due to the&#160;COVID-19&#160;pandemic, but the impact on economic activity including the possibility of recession or financial market instability could have a material adverse effect on the Company&#8217;s business, revenue, operating results, cash flows and financial condition. </span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i738cff4f19954a48be14d6639ba8087b">The Company continues to assess whether any impairment of its goodwill or its long-lived assets has occurred, and has determined that no&#160;charges were necessary during the years ended December&#160;31, 2021, and 2020, other than an impairment loss of $<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzI3NDg3NzkxNTY0MTk_7a9abe5b-3e77-4313-8459-03441c30850e">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzI3NDg3NzkxNTY0ODk_a2083415-a1d0-41ee-9a98-73d009f41d23">0.8</ix:nonFraction> million on capitalized implementation costs of&#160;cloud-based CRM software, respectively.&#160;The Company&#8217;s assumptions about future conditions important to its assessment of potential impairment of its long-lived assets, and goodwill, including the impacts of the&#160;COVID-19&#160;pandemic and other ongoing impacts to its business, are subject to uncertainty, and the Company will continue to monitor these conditions in future periods as new information becomes available.</ix:continuation>&#160;</span></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTMx_fc1c4d44-d20b-4ffa-a28d-0df437c66945" continuedAt="ic388cbc716f946ec8dbde1cfe2cabe11" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-13, Financial Instruments-Credit Losses (Topic 326):"Measurement of Credit Losses on Financial Instruments", which replaces the incurred loss methodology with an expected credit loss methodology that is referred to as the current expected credit loss (CECL) methodology. ASU 2016-13 is effective for fiscal years beginning after December&#160;15, 2019, with early adoption permitted. The amendments in this update are required to be applied using the modified retrospective method with an adjustment to accumulated deficit and are effective for the Company beginning with fiscal year 2020, including interim periods. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost, including loan receivables, available for sale securities and held-to-maturity debt securities. An entity with available for sale securities and trade receivables will be required to use historical loss information, current conditions, and reasonable and supportable forecasts to determine expected lifetime credit losses. Pooling of assets with similar risk characteristics is also required. The Company adopted ASU 2016-13 on January&#160;1, 2020 on a modified retrospective basis. Upon adoption, the standard did not have a material impact on the consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company identified trade receivables and available-for-sale debt securities as impacted by the new guidance. However, the Company determined that the historical losses related to these available-for-sale debt securities are not material as the Company invests in high grade short-term securities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes an allowance for credit losses on trade receivables based on the credit quality of clients, current economic conditions, the age of the accounts receivable balances, historical loss information, and current conditions and forecasted information, and write-off amounts against the allowance when they are deemed uncollectible.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13, &#8220;Fair Value Measurement (Topic 820): Disclosure Framework- Changes to the Disclosure Requirements for Fair Value Measurement&#8221;, to improve the fair value measurement reporting of financial instruments. The amendments in this update require, among other things, added disclosure of the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this update eliminate, among other things, disclosure of the reasons for and amounts of transfers between Level 1 and Level 2 for assets and liabilities that are measured at fair value on a recurring basis and an entity's valuation processes for Level 3 fair value measurements. The amendments in this update became effective for the Company beginning with fiscal year 2020. Retrospective application is required for all amendments in this update except the added disclosures, which should be applied prospectively. The adoption </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="if6ad254d85dc4ab4b6a5b2c2e777641a" continuedAt="i1ed3f54ff3e745d9a4412087e1b04c02"><ix:continuation id="ic388cbc716f946ec8dbde1cfe2cabe11"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the amendments in this update did not have a material impact on the Company&#8217;s consolidated financial position and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">No.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The Company adopted this guidance starting January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial position and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the&#160;FASB&#160;issued ASU No. 2020-6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt &#8211; Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to simplify the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the amendment, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the computation of diluted earnings per share. The Company early adopted the guidance on a prospective basis effective January 1, 2021. See section Computation of Net Income (Loss) per Share.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted by the Company</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed all recently issued, but not yet effective, accounting pronouncements and does not expect the future adoption of any such pronouncements will have a material impact on the Company&#8217;s consolidated financial statements.</span></div></ix:continuation><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQ1_22301dbd-2fde-40ca-9d09-38ed339bf40b" continuedAt="i4fdb03a7ad694bafb71af1533adf3ed9" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company&#8217;s performance obligations are satisfied either over time or at a point in time. Revenue from performance obligations that are transferred to customers over time accounted for approximately <ix:nonFraction unitRef="number" contextRef="i29493bf694aa41e4961175a5d0e9712c_D20210101-20211231" decimals="2" name="cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE1NjA0_5cff5be2-4a93-469b-b77c-dd40d64ac3fb">11</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i9f3add778c6d42e2904c632bb4379750_D20200101-20201231" decimals="2" name="cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE1NjA4_bc33f6b8-3b78-4861-afc3-587dbd70d442">15</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i27ed0b55b74e49509122ed86b0f52309_D20190101-20191231" decimals="2" name="cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE1NjE1_e2bbfc6c-b804-44f2-a581-2ae9a46dcbfd">13</ix:nonFraction>%,&#160;respectively, of the Company&#8217;s total revenue for the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain system sale arrangements that contain multiple products and services. For these bundled sale arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct. The Company&#8217;s products and services are distinct if a customer can benefit from the product or service on its own or with other resources that are readily available to the customer, and if the Company&#8217;s promise to transfer the products or service to the customer is separately identifiable from other promises in the sale arrangements. The Company&#8217;s system sale arrangements can include all or a combination of the following performance obligations: the system and software license (considered as one performance obligation), system accessories (hand pieces), training, other accessories, extended service contracts, marketing services, and time and materials services.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s system sale arrangements that include an extended service contract, the period of service commences at the expiration of the Company&#8217;s standard warranty offered at the time of the system sale. The Company considers the extended service contracts terms in the arrangements that are legally enforceable to be performance obligations. Other than extended service contracts and marketing services, which are satisfied over time, the Company generally satisfies all performance obligations at a point in time. Systems, system accessories (hand pieces), service contracts, training, and time and materials services are also sold on a stand-alone basis, and these performance obligations are satisfied at a point in time. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation on a relative standalone selling price basis.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Products and Services</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systems</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems revenue is generated from the sale of systems and from the sale of upgrades to existing systems. A system consists of a console that incorporates a universal graphic user interface, a laser or other energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. In certain applications, the laser or other energy-based module is contained in the hand piece, such as with the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> applications, rather than within the console.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="i1ed3f54ff3e745d9a4412087e1b04c02" continuedAt="icd91fa4a3b8f42a78de69744e2a25f94"><ix:continuation id="i4fdb03a7ad694bafb71af1533adf3ed9" continuedAt="i5e05873718114b54a7c045bc05933e12"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The system or upgrade and the right to use the embedded software represent a single performance obligation as the software license is integral to the functionality of the system or upgrade.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For systems sold directly to end-customers that are credit approved, revenue is recognized when the Company transfers control to the end-customer, which occurs when the product is shipped to the customer or when the customer receives the product, depending on the nature of the arrangement. When collectability is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> established in advance of receipt of payment from the customer, revenue is recognized upon the later of the receipt of payment or the satisfaction of the performance obligation. For systems sold through credit approved distributors, revenue is recognized at the time of shipment to the distributor.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company typically receives payment for its system consoles and other accessories within 30 days of shipment. Certain international distributor arrangements allow for longer payment terms.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skincare products</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells third-party manufactured skincare products in Japan. The skincare products are purchased from a third-party manufacturer and sold to medical offices and licensed physicians. The Company warrants that the skincare products are free of significant defects in workmanship and materials for 90 days from shipment. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer. The Company recognizes revenue for skincare products at a point in time upon shipment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consumables and other accessories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its customers' purchases of replacement cycles for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt iD </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as replacement hand pieces, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces, and single use disposable tips applicable to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as Consumable revenue, which provides the Company with a source of recurring revenue from existing customers. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products&#8217; single use disposable tips must be replaced after every treatment. Sales of these consumable tips further enhance the Company&#8217;s recurring revenue. The Company&#8217;s systems offer multiple hand pieces and applications, which allow customers to upgrade their systems.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equipment leasing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases equipment to customers through membership programs and receives a fixed monthly fee over the term of the arrangement. The Company classifies its lease income as product revenue. The Company recognizes lease income over the term of the lease if the lease is classified as an operating lease. For agreements that grant customers the right to purchase the leased system, the Company typically classifies the lease as a sales-type lease as the Company has determined it is reasonably certain that the customer will exercise the purchase option. On the commencement of sales-type leases, the Company recognizes revenue upfront in product revenue and the corresponding receivables recorded in Other current assets and prepaid expenses on the consolidated balance sheets (Notes 1 and 11). Revenue from equipment leases was not material in the years ended December&#160;31, 2021 and 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Extended service contract </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for a term of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzOTA_48951eca-9684-4911-930c-c47a406efd42">one</span>, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzOTE_82f81123-597c-470d-8503-057d2c5ae78b">two</span>, or <ix:nonNumeric contextRef="i58319883bced4affb153fc42b9f6a7ab_D20210101-20211231" name="cutr:ExtendedServiceContractOptionThreeTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjE0Mjc_b01f0ce1-d093-479a-ab9b-b1f99e1e9c36">three years</ix:nonNumeric>. Service contract revenue is recognized over time, using a time-based measure of progress, as customers benefit from the service throughout the service period. The Company also offers services on a time-and-materials basis for systems and detachable hand piece replacements. Revenue related to services performed on a time-and-materials basis is recognized when performed.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Training</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of systems to customers include training on the use of the system to be provided within <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="cutr:ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjE0Mjg_47bfd5c9-b6c7-4b12-a1c0-de76806b9ab8">180</ix:nonNumeric> days of purchase. The Company considers training a separate performance obligation as customers can immediately benefit from the training together with the customer&#8217;s system. Training is also sold separately from systems. The Company recognizes revenue for training when the training is provided. Training is not required for customers to use the systems.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Judgments</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="icd91fa4a3b8f42a78de69744e2a25f94" continuedAt="i774b7d5ef7214279ac99058e74ad97f7"><ix:continuation id="i5e05873718114b54a7c045bc05933e12"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of whether two or more contracts entered into at or near the same time with the same customer should be combined and accounted for as one contract may require the use of significant judgment. In making this determination, the Company considers whether the contracts are negotiated as a package with a single commercial objective, have price interdependencies, or promise goods or services that represent a single performance obligation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company&#8217;s purchase agreements do </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provide customers with a contractual right of return, the Company maintains a sales allowance to account for potential returns or refunds as a reduction in transaction price at the time of sale.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines standalone selling price ("SSP") for each performance obligation as follows:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Systems: The SSPs for systems are based on directly observable sales in similar circumstances to similar customers.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Extended service contracts: SSP is based on observable price when sold on a standalone basis to similar customers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loyalty Program</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company launched a customer loyalty program during the third quarter of 2018 for qualified customers located in the U.S. and Canada. Under the loyalty program, customers accumulate points based on their purchasing levels which can be redeemed for such rewards as the right to attend the Company&#8217;s advanced training event for a product, or a ticket for the Company&#8217;s annual forum. A customer&#8217;s account must be in good standing to receive the benefits of the rewards program. Rewards are earned on a quarterly basis and must be used in the following quarter.&#160;All unused rewards are forfeited. The fair value of the reward earned by loyalty program members is included in accrued liabilities and recorded as a reduction. of net revenue at the time the reward is earned. As of December&#160;31, 2021, and December 31, 2020, the accrual for the loyalty program included in accrued liabilities was $<ix:nonFraction unitRef="usd" contextRef="i307d65a514094556a1c3cb6702122693_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzEwOTk1MTE2OTgyNTk_86f9f467-b005-4b34-aae1-d6f043967c3f">0.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="id09c2b6d4b444a11a61afbefef850c5f_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzIwMzQwOTY1MTk4Mzg0_425eab50-5e6b-4352-b1aa-1cdce0d39bd8">0.3</ix:nonFraction>&#160;million, respectively. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Sales Commissions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract, which consist primarily of commissions and related payroll taxes, are capitalized, and amortized on a straight-line basis over the expected period of benefit, except for costs that are recognized when product is sold. The Company uses the portfolio method to recognize the amortization expense related to these capitalized costs related to initial contracts and such expense is recognized over a period associated with the revenue of the related portfolio, which is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzNTI_f9af2b31-c814-4dab-886d-badea997b8a1">two</span> to <ix:nonNumeric contextRef="i8a9ce53bcd874cb38a5dbc24e4ea3583_I20211231" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzNzA_ba6a2a37-679f-4336-b868-6f9415cd707a">three years</ix:nonNumeric>.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total capitalized costs for the year ended December&#160;31, 2021 and December&#160;31, 2020 were $<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-5" name="us-gaap:CapitalizedContractCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzI2MTc4_3f139fe7-53fa-42cf-a945-3f124d91636f">4.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-5" name="us-gaap:CapitalizedContractCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzI2MTg1_90ce4cb3-cc07-4a3d-85ec-5482d850596b">3.4</ix:nonFraction> million, respectively, and are included in Other long-term assets in the Company&#8217;s consolidated balance sheet. Amortization expenses for these assets were&#160;$<ix:nonFraction unitRef="usd" contextRef="i29b9e3b28d734adeb076ece7de227b71_D20210101-20211231" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzI2MzM1_ebf50871-abe8-4a5c-9501-2fc0ae615054">1.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i49f345cd25654a7f84873131ed305500_D20200101-20201231" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzI2MzM5_71659b8f-404a-4f38-b889-0ef32fc246bb">2.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia3577892be364d588b4ee6707f9426df_D20190101-20191231" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzI2MzQ2_c915378e-94e3-4f8d-a9c8-5770e98ce4b6">2.9</ix:nonFraction> million, respectively, during the years&#160;ended December&#160;31, 2021, 2020 and 2019 and were&#160;included in sales and marketing expense in the Company&#8217;s consolidated statement of operations.</span></div></ix:continuation><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTI0_78070c22-92aa-43d3-8508-e148fab14a58" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests its cash primarily in money market funds. All highly liquid investments with stated maturities of three months or less from date of purchase are classified as cash equivalents; all highly liquid investments with stated maturities of greater than three months are classified as marketable investments. The majority of the Company&#8217;s cash and investments are held in U.S. banks and the Company's foreign subsidiaries maintain a limited amount of cash in their local banks to cover short term operating expenses.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTIx_b67a9d44-54dd-4881-98f1-840f3f892540" continuedAt="i0a98e016385447759c65546eeaf6cba4" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy contains three levels of inputs that may be used to measure fair value, in accordance with ASC 820, as follows:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 1: inputs, which include quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 2: inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. For available-for-sale securities, the Company reviews trading activity and pricing as of the measurement date. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="i774b7d5ef7214279ac99058e74ad97f7" continuedAt="ia238bf16469d40579202774dee01c5db"><ix:continuation id="i0a98e016385447759c65546eeaf6cba4"><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 3: inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.</span></div></ix:continuation><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="cutr:AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTM3_68ce8b62-7d5c-4c5c-bdd8-f5717f5f30f7" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Sales Returns and Credit Losses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for sales returns is based on the Company&#8217;s estimates of potential future product returns and other allowances related to current period product revenue. The Company analyzes historical returns, current economic trends and changes in customer demand and acceptance of the Company's products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses on trade receivables is based on the credit quality of clients, current economic conditions, the age of the accounts receivable balances, historical loss information, and current conditions and forecasted information. The Company writes off amounts against the allowance when they are deemed uncollectible.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTM4_e5f060db-a73b-4f21-b797-c734c319b7a2" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities and other factors could negatively impact the Company&#8217;s operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to risks related to changes in the value of the Company&#8217;s significant balance of financial instruments. Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents, and accounts receivable. The Company&#8217;s cash and cash equivalents are primarily invested in deposits and money market accounts with three major financial institutions in the U.S. In addition, the Company has operating cash balances in banks in each of the international locations in which it operates. Deposits in these banks may exceed the federally insured limits or any other&#160;insurance&#160;provided on such deposits, if any. Management believes that these financial institutions are financially sound and, accordingly, believes that minimal credit risk exists. To date, the Company has not experienced any losses on its deposits of cash and cash equivalents.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded net of an allowance for credit losses and are typically unsecured and are derived from revenue earned from worldwide customers. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers and maintains an allowance for potential credit losses. As of December&#160;31, 2021, and 2020, no customer represented more than 10% of the Company&#8217;s net accounts receivable. During the years ended December&#160;31, 2021, 2020, and 2019, domestic revenue accounted for <ix:nonFraction unitRef="number" contextRef="ic835d94700e34147a128f7c43a99ba8f_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM0MzMx_0f2654ad-ff19-43d5-8986-703e4f9d5967">42</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ia7d8ca402cf64fa095821119515012f0_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM0MzM1_33cfd1dc-9d27-42ae-8913-1be09b615b0c">41</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i046ed111439c42409c5114869295fb0b_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM0MzQy_d28aebb7-f348-44b5-8618-a9672316a55d">58</ix:nonFraction>%, respectively, of total revenue, while international revenue accounted for <ix:nonFraction unitRef="number" contextRef="ib426205ae11e4aa1879843b606c79fd5_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM0NDIw_d1dbda8b-f720-4298-8956-f4431c96ab32">58</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i6d16dd05655a48cea0d5421c014cf5b5_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM0NDI0_2ed9b0fc-551c-4ee7-a4f8-1da30016deb5">59</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="icc042179d3e042a49fe526aad8eb50c6_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM0NDMx_52822917-424c-478a-bb57-6ba20aafc0bb">42</ix:nonFraction>%, respectively, of total revenue. No single customer represented more than 10% of total revenue for any of the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplier concentration</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on third parties for the supply of components of its products, as well as third-party logistics providers. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers or satisfactorily deliver its products to its customers. The Company relies on <ix:nonFraction unitRef="supplier" contextRef="i22da8abdff7f43e49f27b03708dc3882_D20210101-20211231" decimals="INF" name="cutr:NumberOfMajorSuppliers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzIwMzQwOTY1MTk4NDE2_70a70f7f-c94a-4489-9173-c666ec058489">one</ix:nonFraction> supplier for its Secret and Secret PRO products and <ix:nonFraction unitRef="supplier" contextRef="id4151927442041dd92c39ebf707b54a4_D20210101-20211231" decimals="INF" name="cutr:NumberOfMajorSuppliers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzIwMzQwOTY1MTk4NDI0_259ae073-737e-4f87-bebc-214fc7a946ad">one</ix:nonFraction> supplier for its skincare products.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQx_aba7ae94-4eb9-40a8-90b0-899f29d16a18" continuedAt="i2626db3c688049219f0c1180bdf301d6" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost and net realizable value, cost being determined on a standard cost basis which approximates actual cost on a first-in, first-out basis. Net realizable value is the estimated selling prices in the ordinary course of the Company&#8217;s business, less reasonably predictable costs of completion, disposal, and transportation. The cost basis of the Company&#8217;s inventory is reduced for any products that are considered excessive or obsolete based upon assumptions about future demand and market conditions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes demonstration units within inventories. Demonstration units are carried at cost and amortized over an estimated economic life of <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="cutr:DemonstrationUnitsAmortizationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzNTE_9e439893-b65a-4076-ad68-166928b1e54f">two years</ix:nonNumeric>. Amortization expense related to demonstration units is recorded in products cost of revenue or in the respective operating expense line based on which function and purpose for which the demonstration units are being used. Proceeds from the sale of demonstration units are recorded as revenue and all costs incurred to refurbish the </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="ia238bf16469d40579202774dee01c5db" continuedAt="i7c3ae9bb4cdd46ec8e00feed1c5369ad"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2626db3c688049219f0c1180bdf301d6">systems prior to sale are charged to product cost of revenue. As of December&#160;31, 2021 and 2020, demonstration inventories, net of accumulated depreciation, included in finished goods inventory was $<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-5" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzEwOTk1MTE2OTg5MDQ_17a721d7-8791-404a-9338-1b2a83df6e50">3.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-5" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzEwOTk1MTE2OTg5MTI_b5306017-c37f-42c7-8506-40b523e731ee">3.6</ix:nonFraction> million, respectively.</ix:continuation></span></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQ2_b73141ed-b625-4c3a-9591-cc7502d2d233" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, net of accumulated depreciation. <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTM5_1ef0954d-2fb9-43f1-b3f4-5b4445f74190" continuedAt="ica8c7ec514d34d8c9ef41fcf8842ee41" escape="true">Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ica8c7ec514d34d8c9ef41fcf8842ee41" continuedAt="i3ea4a7a531d847e08ad30ff4c7b6864b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of useful life or term of lease</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iea5dc3d35fa7491281eebabd4744ca45_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90YWJsZTozYzYzMTVkMjc2YWI0YTQ3ODZjNTBmNWU2YWE5MmE3Ny90YWJsZXJhbmdlOjNjNjMxNWQyNzZhYjRhNDc4NmM1MGY1ZTZhYTkyYTc3XzItMS0xLTEtMjg2MjE_392c77b9-c0a7-4edf-ab44-dc17f1f9e8e4">4.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i687140e91bb9469bb4be1621b92c9b8b_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90YWJsZTozYzYzMTVkMjc2YWI0YTQ3ODZjNTBmNWU2YWE5MmE3Ny90YWJsZXJhbmdlOjNjNjMxNWQyNzZhYjRhNDc4NmM1MGY1ZTZhYTkyYTc3XzMtMS0xLTEtMjg2MjE_4d5bde80-35b2-4ed0-8eb0-487b178fa525">3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i16179899e1fd49b2884edc3604740025_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90YWJsZTozYzYzMTVkMjc2YWI0YTQ3ODZjNTBmNWU2YWE5MmE3Ny90YWJsZXJhbmdlOjNjNjMxNWQyNzZhYjRhNDc4NmM1MGY1ZTZhYTkyYTc3XzQtMS0xLTEtMjg2MjE_686ee5e3-aa03-4677-8a0a-2abb307ae252">3</ix:nonNumeric></span></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon sale or retirement of property and equipment, the costs and related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operating expenses. Maintenance and repairs are charged to operations as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense related to property and equipment for 2021, 2020 and 2019, was $<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM3MTkw_a60d651a-33f7-4ae8-bd28-e433db4ccd27">1.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM3MTk0_cea4511f-035b-4fcd-9b06-ba7b4c0a4969">1.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM3MjAy_4deae9dc-2483-428e-9b52-328d8b6890d9">1.5</ix:nonFraction> million, respectively. Amortization expense for vehicles leased under capital leases is included in depreciation expense. Amortization expense related to equipment leasing accounted for as sales type is included in cost of revenue and was immaterial as of December&#160;31, 2021 and 2020.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEyODA_ac85b091-87b4-4fa0-9b75-6b25f699b47f" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized Cloud Computing Set-up Cost</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain set-up costs for the Company&#8217;s cloud computing arrangements. The capitalized implementation costs are then amortized over the term of the cloud computing arrangement inclusive of expected contract renewals, which are generally <ix:nonNumeric contextRef="iac4da192d3c340da971b19d3ab991663_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzEwOTk1MTE2OTgzNTA_9927e39e-7c8c-46c4-9fee-41bc1207dda2">three years</ix:nonNumeric> to <ix:nonNumeric contextRef="i5bfb0aae8e4f42c682a5274dacefb148_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM3NzYy_700e58a7-0bcc-49f8-a44c-deffa8698f75">ten years</ix:nonNumeric>. As of December&#160;31, 2021, the Company had capitalized cloud computing set-up costs with a carrying amount of $<ix:nonFraction unitRef="usd" contextRef="i5f6b3f16760744dc9103390169175d8f_I20211231" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE3MDQyNDMwMzE0OTg4_4b6f2d10-59f0-4c0a-82f4-36f8134f4bc4">0.4</ix:nonFraction>&#160;million in Other current assets and prepaid expenses and $<ix:nonFraction unitRef="usd" contextRef="iffa27261393c4ab8ba5e3794d9147c89_I20211231" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE3MDQyNDMwMzE1MDAy_83f89296-a639-4b49-be82-f4adcfd3a3df">3.5</ix:nonFraction>&#160;million in Other long-term assets. As of and during the year ended December&#160;31, 2021 there was <ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostExpenseAmortization" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE3MDQyNDMwMzE1MDE5_b4dd2c4a-7b1a-467e-a1fe-7d515e75f15e"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE3MDQyNDMwMzE1MDE5_b56e574f-91fe-4f25-93f4-c78fa22cd658">no</ix:nonFraction></ix:nonFraction> accumulated amortization and amortization expense recorded. The Company periodically assesses the capitalized asset for impairment and, when required, will record an associated impairment loss.&#160;During the year ended December&#160;31, 2021, the Company recognized in general and administrative expense an impairment loss of $<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-5" name="us-gaap:HostingArrangementServiceContractImplementationCostImpairment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4MDE1_7a9abe5b-3e77-4313-8459-03441c30850e">0.2</ix:nonFraction> million for capitalized cloud computing costs related to a cloud-based&#160;enterprise resource planning software.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTI1_df954999-403a-4c4d-bc23-daf8fe5a2cbe" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and intangible assets with indefinite useful lives are not amortized but are tested for impairment at least annually during the fourth quarter of the Company&#8217;s fiscal year, or if circumstances indicate their value may no longer be recoverable. Goodwill represents the excess of the purchase price over the fair value of net identifiable assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to operate in <ix:nonFraction unitRef="segment" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NTU3_a352c42b-7f4b-48db-b48d-bb22e372a602">one</ix:nonFraction> segment, which is considered to be the sole reporting unit and, therefore, goodwill was tested for impairment at the enterprise level. As of December&#160;31, 2021, there has been <ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NzIw_c0a2dccd-927d-4561-959a-05f80d7df03b">no</ix:nonFraction> impairment of goodwill. All acquired intangible assets have been fully amortized as of December&#160;31, 2021.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:StandardProductWarrantyPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQy_a92cf0d1-f253-4731-9a91-be5737cb6aab" continuedAt="i73485b714ad847aea7845b3750989cc8" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranty Obligations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides a <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="cutr:StandardProductWarrantyTermDirectSales" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3ODc1MDY_dd242158-bd7d-41ec-af77-bdef54efae9d">12</ix:nonNumeric>-month warranty for direct sales to customers. For sales to distributors, the Company generally provides a <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="cutr:StandardProductWarrantyTermDistributorSales" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE3MDQyNDMwMzE1MDQ4_6245af46-430e-48eb-9e43-dafcbb5641cd">14</ix:nonNumeric>-month warranty for parts only, with labor being provided to the end customer by the distributor.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i73485b714ad847aea7845b3750989cc8">After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis.</ix:continuation> </span></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTIy_edf1345c-a4d5-4e83-b4bd-2e7726f3e43c" continuedAt="ia88cc2dfe1254ec2b39f8eec21b48f48" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January&#160;1, 2019, the Company adopted ASC 842, which established a right-of-use ("ROU") model requiring lessees to record a right-of-use asset ("ROU asset") and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding ROU asset. Lease liabilities represent the present value of the Company&#8217;s future lease payments over the </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="i7c3ae9bb4cdd46ec8e00feed1c5369ad" continuedAt="iecc55d77596b46f0a4addf9796a1a686"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia88cc2dfe1254ec2b39f8eec21b48f48">expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company&#8217;s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.</ix:continuation></span></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:LessorLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTI2_dd1df88b-0319-4929-9035-c002487e2aa6" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for Leases as a Lessor</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases equipment to customers through membership programs and receives a fixed monthly fee over the term of the arrangement. The Company classifies its lease income as product revenue. The Company recognizes lease income over the term of the lease if the lease is classified as an operating lease. For agreements that grant customers the right to purchase the leased system, the Company typically classifies the lease as a sales-type lease as the Company has determined it is reasonably certain that the customer will exercise the purchase option. On the commencement of sales-type leases, the Company recognizes revenue upfront in product revenue and the corresponding receivables is classified in Other current assets and prepaid expenses on the condensed consolidated balance sheets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 to the consolidated financial statements for more information regarding leasing arrangements.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTIz_2a25b236-ac3c-452f-830d-bdaaef317805" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists primarily of material, finished and semi-finished products purchased from third-party manufacturers, labor, stock-based compensation expenses, overhead involved in the Company's internal manufacturing processes, service contracts, technology license amortization and royalties, costs associated with equipment leasing, costs associated with product warranties and any inventory write-downs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's system sales include a control console, universal graphic user interface, control system software, high voltage electronics and a combination of applications (referred to as &#8220;hand pieces&#8221;). Hand pieces are programmed to have a limited number of uses to ensure the safety of the device to patients. The Company sells refurbished hand pieces, or "refills," of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products and provides for the cost of refurbishment of these hand pieces as part of cost of revenue. When customers purchase a replacement hand piece or are provided a replacement hand piece under a warranty or service contract, the Company ships the customer a previously refurbished unit. Upon the receipt of the expended hand piece from the customer, the Company capitalizes the expended hand piece as inventory at the estimated fair value. Cost of service revenue includes the costs incurred to refurbish hand pieces.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQ3_7a7ff275-2ece-4bcb-bd56-28be86d98d45" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenditures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred and include costs related to research, design, development, testing of products, salaries, benefits and other headcount related costs, facilities, material, third party contractors, regulatory affairs, clinical and development costs.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTM0_9c8cfee6-0202-40ef-83f4-48dd1ae565d6" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are included as part of sales and marketing expense and are expensed as incurred. Advertising expenses for 2021, 2020 and 2019 were $<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzQ3MDk1_251ffafe-fce8-4be8-9fc4-35890b9d0674">2.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzQ3MDk5_c3df6e30-1c08-4733-8d5c-b5156bfbdfd9">1.2</ix:nonFraction> million&#160;and $<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzQ3MTA2_069fd835-0650-463e-bbd7-a27308505b3f">2.8</ix:nonFraction> million, respectively.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQ4_be4f053b-3071-4c6a-a652-5dc80416dcdb" continuedAt="icc6b6550b4ba48bb9498052a85c4b68a" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for share-based employee compensation plans using the fair value recognition and measurement provisions under U.S. GAAP. The Company&#8217;s share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as expense on a straight- line basis over the requisite service period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The expected term represents the weighted-average period that the stock options are expected to be outstanding prior to being exercised. The Company determines expected term based on historical exercise patterns and its expectation of the time it will take for employees to exercise options still outstanding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For the underlying stock price volatility of the Company&#8217;s stock,&#160;the Company estimates volatility solely based on the Company&#8217;s historical volatility of its stock price.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="iecc55d77596b46f0a4addf9796a1a686" continuedAt="i1fdd6bae9eb5419d9a24f3a5b82394bf"><ix:continuation id="icc6b6550b4ba48bb9498052a85c4b68a"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forfeitures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company has made an accounting policy to estimate forfeitures at the time awards are granted and revises, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The risk-free interest rate is based on the U.S. treasury yield curve in effect at the time of grant for the expected term of the stock option.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options ("options") on the grant date using the closing price of the Company's common shares on the grant date is estimated using the Black-Scholes option-pricing model using the single-option approach. The Black-Scholes option pricing model requires the use of highly subjective and complex assumptions, including the option's expected term and the price volatility of the underlying stock, to determine the fair value of award. The Company recognizes the expense associated with options using a single award approach over the requisite service period. The Company accounts for all stock options awarded to non-employees at the fair value of the award issued on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock units (&#8220;RSUs&#8221;) granted are measured on the grant date. The quantity of the RSUs units granted is calculated by dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#8217;s common stock over the <ix:nonNumeric contextRef="i541d48bf023c4fe7aae98ff86b967101_D20210101-20211231" name="cutr:ShareBasedPaymentAwardPeriodToDetermineGrantAmount" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3ODc0ODA_7bcaf0cc-5155-4029-ae4b-399909457de5">50</ix:nonNumeric>-day period ending on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Performance Stock Units (&#8220;PSUs&#8221;) that have operational measurement goals are measured on the grant date using the closing price of the Company&#8217;s common shares on the grant date. The quantity of the PSUs granted is calculated by dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#8217;s common stock over the <ix:nonNumeric contextRef="i541d48bf023c4fe7aae98ff86b967101_D20210101-20211231" name="cutr:ShareBasedPaymentAwardPeriodToDetermineGrantAmount" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3ODc0OTM_52e58909-c005-43c5-9a2b-3d876316ff4b">50</ix:nonNumeric>-day period ending on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 - "Stockholders&#8217; Equity, Stock Plans and Stock-Based Compensation Expense" for a detailed discussion of the Company&#8217;s stock plans and share-based compensation expense.</span></div></ix:continuation><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQz_bc257625-1ff9-4383-abca-a7d0270a185a" continuedAt="i21cfc5464aa247298973f0a29ea872f0" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes in the United States and several foreign jurisdictions. Significant judgment is required in determining the Company&#8217;s provision (benefit) for income taxes and income tax assets and liabilities, including evaluating uncertainties in the application of accounting principles and complex tax laws.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a provision (benefit) for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as for loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company recognizes the deferred income tax effects of a change in tax rates in the period of enactment. The Company records a valuation allowance to reduce the Company&#8217;s deferred tax assets to the net amount that the Company believes is more likely than </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to be realized.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes tax benefits from uncertain tax positions if the Company believes that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. Although the Company believes it has adequately reserved for the Company&#8217;s uncertain tax positions (including net interest and penalties), the Company can provide no assurance that the final tax outcome of these matters will not be different. The Company makes adjustments to these reserves in accordance with income tax accounting guidance when facts and circumstances change, such as the closing of a tax audit. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences may impact the provision (benefit) for income taxes in the period in which such determination is made. The Company records interest and penalties related to the Company&#8217;s uncertain tax positions in the Company&#8217;s provision (benefit) for income taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rates have differed from the statutory rate primarily due to changes in the valuation allowance, foreign operations, research and development tax credits, state taxes, and certain benefits realized related to stock option activity. The Company&#8217;s current effective tax rate does not assume U.S. taxes on undistributed profits of foreign subsidiaries. These earnings could become subject to incremental foreign withholding or U.S. federal and state taxes, should they either be deemed or actually remitted to the U.S. The Company&#8217;s future effective tax rates could be adversely affected by earnings being lower in countries where the Company has lower statutory rates and being higher in countries where the Company has higher statutory rates, or by changes in tax laws, accounting principles, interpretations thereof, net operating loss carryback, research and development tax credits, and due to changes in the valuation allowance of its U.S. deferred tax assets. In addition, the </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="i1fdd6bae9eb5419d9a24f3a5b82394bf"><ix:continuation id="i21cfc5464aa247298973f0a29ea872f0"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company is subject to the examination of the Company&#8217;s income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#8217;s provision for income taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undistributed earnings of the Company&#8217;s foreign subsidiaries at December&#160;31, 2021 are considered to be indefinitely reinvested and, accordingly, no provision for state income taxes has been provided thereon. Due to the Transition Tax and Global Intangible Low-Tax Income (&#8220;GILTI&#8221;) regimes as enacted by the 2017 Tax Act, those foreign earnings will not be subject to federal income taxes when actually distributed in the form of a dividend or otherwise. The Company, however, could still be subject to state income taxes and withholding taxes payable to various foreign countries. The amounts of taxes which the Company could be subject to are not material to the accompanying financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;27, 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The CARES Act changed several of the existing U.S. corporate income tax laws by, among other things, increasing the amount of deductible interest, allowing companies to carry back certain Net Operating Losses (&#8220;NOLs&#8221;) and increasing the amount of NOLs that corporations can use to offset income. The CARES Act did not have a material impact on the Company's income tax provision, deferred tax assets and liabilities, and related taxes payable. The Company is currently assessing the future implications of these provisions within the CARES Act on the Company's consolidated financial statements but does not expect the impact to be material.</span></div></ix:continuation><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTI3_541a3579-a7f9-4305-8223-d762f46623bd" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Computation of Net Income (Loss) per Share</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method and the if-converted method. Dilutive potential common shares include outstanding stock options, restricted stock units, performance stock units, employee stock purchase plan (ESPP) shares and conversion shares under the convertible notes. On January 1, 2021, the Company adopted the accounting standard update to simplify the accounting for convertible debt instruments. The Company now uses the if-converted method for its convertible notes in calculating the diluted net income (loss) per share, and includes the effect of potential share settlement for the convertible notes, if the effect is dilutive. The diluted net income per share is computed with the assumption that the Company will settle the convertible debt in shares, rather than cash.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share is the same as basic earnings per share for the periods in which the Company had a net loss because the inclusion of outstanding common stock equivalents would be anti-dilutive.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTMy_9b2fd460-897d-4644-8d27-97e14e9e84c0" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes all changes in stockholders&#8217; equity except those resulting from investments or contributions by stockholders. For the periods presented, the accumulated other comprehensive income (loss) consisted solely of the unrealized gains or losses on the Company's available-for- sale investments, net of tax.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQ0_fdf5371e-0a2f-4587-88a4-52a58dc4c081" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s foreign subsidiaries are translated in accordance with ASC 830, Foreign Currency Matters. The U.S. Dollar is the functional currency of the Company&#8217;s subsidiaries and the Company&#8217;s reporting currency. Monetary assets and liabilities are re-measured into U.S. Dollars at the applicable period end exchange rate. Sales and operating expenses are re-measured at average exchange rates in effect during each period. Gains or losses resulting from foreign currency transactions are included in net income (loss) are $<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3ODc1Nzk_971ad417-a59b-4657-995f-4e357bdfcf0f">1.8</ix:nonFraction>&#160;million in the year ended December&#160;31, 2021 and were insignificant for each of the two years ended December&#160;31, 2020. The effect of exchange rate changes on cash and cash equivalents was insignificant for each of the three years ended December&#160;31, 2021.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTM1_bee10051-afe3-4fb0-92c1-e382c35cd085" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in <ix:nonFraction unitRef="segment" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU3NjI2_a2994e08-224f-4ec8-b9e9-d721f6a787ab">one</ix:nonFraction> segment and reports segment information in accordance with ASC 280, Segment Reporting. Management uses one measurement of profitability and does not segregate its business for internal reporting. As of December&#160;31, 2021&#160;and 2020, <ix:nonFraction unitRef="number" contextRef="i5d7848312e9548839319d5ac37eca97c_I20211231" decimals="2" name="cutr:PercentageOfAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU3ODQy_7ec4f4a0-9520-486e-aba4-d425ff6ae524">99.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i4bc9b22641b0417da7e8a81fcaf59a1b_I20201231" decimals="2" name="cutr:PercentageOfAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU3ODQ5_db703cb7-c0bc-4cc5-8c82-8c5cb3dfd70b">98.0</ix:nonFraction>% of long-lived assets were in the United States, respectively. Revenue is attributed to a geographic region based on the location of the end customer. See Note 10 &#8211; "Segment Information and Revenue by Geography and Products" for details relating to revenue by geography.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2-<ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90ZXh0cmVnaW9uOjk0NzJjMjhmMTA4NTQ0NTU4MjU5Yzk3Y2MyOWE5MWIxXzE5MzQ_6ec5d864-2e5c-46ef-a47f-9ef1ef65cba7" continuedAt="i87ba4625a0d84ed2b55a70a3853fb6ee" escape="true">CASH, CASH EQUIVALENTS AND RESTRICTED CASH</ix:nonNumeric></span></div><ix:continuation id="i87ba4625a0d84ed2b55a70a3853fb6ee"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90ZXh0cmVnaW9uOjk0NzJjMjhmMTA4NTQ0NTU4MjU5Yzk3Y2MyOWE5MWIxXzE5MzE_64ae7c03-9778-429b-bea2-a58c9cf6b6c2" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize cash, cash equivalents and marketable securities (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90YWJsZTo0ZDI4YzZmYjc5N2I0MmY0YTkyMzk4OTUyYmUxY2E1YS90YWJsZXJhbmdlOjRkMjhjNmZiNzk3YjQyZjRhOTIzOTg5NTJiZTFjYTVhXzMtMS0xLTEtMjg2MjE_41903ba8-bf3b-4a82-ad91-ffcf958482e7">164,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90YWJsZTo0ZDI4YzZmYjc5N2I0MmY0YTkyMzk4OTUyYmUxY2E1YS90YWJsZXJhbmdlOjRkMjhjNmZiNzk3YjQyZjRhOTIzOTg5NTJiZTFjYTVhXzMtMy0xLTEtMjg2MjE_cf3ee0fd-1fec-4fc2-b9cd-d1841805fcf7">47,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90YWJsZTo0ZDI4YzZmYjc5N2I0MmY0YTkyMzk4OTUyYmUxY2E1YS90YWJsZXJhbmdlOjRkMjhjNmZiNzk3YjQyZjRhOTIzOTg5NTJiZTFjYTVhXzMtMS0xLTEtNDY4MjM_7e6c4d17-670a-4f7c-9235-d5d55ef6e2a0">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90YWJsZTo0ZDI4YzZmYjc5N2I0MmY0YTkyMzk4OTUyYmUxY2E1YS90YWJsZXJhbmdlOjRkMjhjNmZiNzk3YjQyZjRhOTIzOTg5NTJiZTFjYTVhXzMtMy0xLTEtNDY4MjM_1d9b95b7-f34c-45eb-a46a-46a46dde4d74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents and restricted cash as reported within the Consolidated Statement of Cash Flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90YWJsZTo0ZDI4YzZmYjc5N2I0MmY0YTkyMzk4OTUyYmUxY2E1YS90YWJsZXJhbmdlOjRkMjhjNmZiNzk3YjQyZjRhOTIzOTg5NTJiZTFjYTVhXzQtMS0xLTEtNDY4MjM_bf936f2e-c4d7-4221-9c3f-5328bdd2745b">164,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90YWJsZTo0ZDI4YzZmYjc5N2I0MmY0YTkyMzk4OTUyYmUxY2E1YS90YWJsZXJhbmdlOjRkMjhjNmZiNzk3YjQyZjRhOTIzOTg5NTJiZTFjYTVhXzQtMy0xLTEtNDY4MjM_74280b8d-c055-4e0c-9a4c-10e79e5cf416">47,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had <ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="INF" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90ZXh0cmVnaW9uOjk0NzJjMjhmMTA4NTQ0NTU4MjU5Yzk3Y2MyOWE5MWIxXzEwOTk1MTE2MzAyMDY_699353c3-0a1a-489b-bedf-7deb2d1e87eb"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:MarketableSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90ZXh0cmVnaW9uOjk0NzJjMjhmMTA4NTQ0NTU4MjU5Yzk3Y2MyOWE5MWIxXzEwOTk1MTE2MzAyMDY_eca06360-68db-446d-8714-90be7a0339b3">no</ix:nonFraction></ix:nonFraction> marketable securities as of December&#160;31, 2021 and December&#160;31, 2020. The cash is restricted to support an outstanding letter of credit for $<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-5" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90ZXh0cmVnaW9uOjk0NzJjMjhmMTA4NTQ0NTU4MjU5Yzk3Y2MyOWE5MWIxXzE3MDQyNDMwMjM4ODY0_7782c610-810a-4329-b0cd-fae65faa9fca">0.7</ix:nonFraction> million provided to a supplier.</span></div></ix:continuation><div style="margin-top:10pt"><span><br/></span></div><div id="idabc87e13e174d3c9f17fa6963046f56_112"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3&#8212;<ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzI3NTY_bc79bdf7-47d7-4568-993c-3c71a82a3b73" continuedAt="i9dcaa31d53c5478597413d1b3f81170f" escape="true">BALANCE SHEET DETAIL</ix:nonNumeric></span></div><ix:continuation id="i9dcaa31d53c5478597413d1b3f81170f" continuedAt="ia546177f03324121ace3da0242ddf902"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation adjustments for excess and obsolete inventory, reflected as a reduction of inventory at December&#160;31, 2021 and 2020, were $<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzE1OQ_55f47a40-d572-4da7-bc72-7077539d3705">4.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzE2Ng_8e91f000-d639-4280-a02d-f34a479490fc">3.9</ix:nonFraction> million, respectively. <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzI3NTc_946cca96-d649-4683-b18f-dca9b30554d9" continuedAt="ie75f852f21ac43caa87af8c25efa4599" escape="true">Inventories, net of these adjustments, consist of the following (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ie75f852f21ac43caa87af8c25efa4599"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzItMS0xLTEtMjg2MjE_ad4ec401-8843-4e12-832b-824bc3905288">24,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzItMy0xLTEtMjg2MjE_ea2a9a33-238d-4908-b1ec-275e0854a192">14,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzMtMS0xLTEtMjg2MjE_90d00f66-b2f9-4367-bd38-d47d49640abe">2,124</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzMtMy0xLTEtMjg2MjE_846f9bff-306c-44af-901f-390068e8583d">1,030</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzQtMS0xLTEtMjg2MjE_c6f0436f-8676-4ca8-95fa-67f066ed095e">13,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzQtMy0xLTEtMjg2MjE_19673591-60f5-49e7-b9a7-8116a17e23ff">12,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzUtMS0xLTEtMjg2MjE_3b2a8161-6b35-46ca-b7b9-1b8534036f99">39,503</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzUtMy0xLTEtMjg2MjE_f1c80550-83a5-4c75-8c21-b30979b78bbc">28,508</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, net</span></div><ix:continuation id="i3ea4a7a531d847e08ad30ff4c7b6864b"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, consists of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f352492b09240419cedf42adcbed4e3_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzItMS0xLTEtMjg2MjE_96d7742a-cc65-48e0-8f75-abac5825d06e">826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if050ebe27c6a45b6afb9c2a998414be2_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzItMy0xLTEtMjg2MjE_365eae17-c19d-41f9-b25b-abb01675a8bf">1,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4550dd7ebeeb4ea9baad304474ac9979_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzMtMS0xLTEtMjg2MjE_f318f861-f294-4875-a2fe-82ff6a8c1331">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i116594d0783a424a8fafeb1b4f59c8e1_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzMtMy0xLTEtMjg2MjE_81120c4d-9057-4526-a97d-2b904bcb9191">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95e3d048dc634a71897f460779f082a8_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzQtMS0xLTEtMjg2MjE_f30a5a13-4d14-49da-9e2f-b9341ebc58a4">1,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d4966eb9a940dfa6db6a00a25b33db_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzQtMy0xLTEtMjg2MjE_eaf00988-3cb5-477d-98b4-eb03392b04ae">3,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcea864f6da04951ab895dcc2436d3cf_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzUtMS0xLTEtMjg2MjE_d2ac6751-75fa-4fce-b12e-2bfbeb9143b1">3,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06d8947881bc48feaed989df52b60b1a_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzUtMy0xLTEtMjg2MjE_0a54a0d3-269d-47c0-a22e-694450b307ea">7,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzYtMS0xLTEtMjg2MjE_1a70a0a1-c508-4e9c-bb02-8abf52c67be0">6,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzYtMy0xLTEtMjg2MjE_1756aef2-01c5-493e-bceb-f0bd47cc3901">12,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzctMS0xLTEtMjg2MjE_8762e57b-5abe-4056-acb4-960589973e32">3,424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzctMy0xLTEtMjg2MjE_eaa83f31-3147-4b28-8708-dd8b57741f42">10,028</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzgtMS0xLTEtMjg2MjE_d94f5dc1-be16-4cf5-8ec2-d4ec2f1729ea">3,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzgtMy0xLTEtMjg2MjE_f801c9b8-fac2-493c-8562-1ae9885a6c9a">2,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in machinery and equipment are financed vehicles used by the Company&#8217;s sales employees. As of December&#160;31, 2021 and&#160;2020, the gross capitalized value of the leased vehicles was $<ix:nonFraction unitRef="usd" contextRef="ib7c26e3ef9c442a8832ed31ed63f16e7_I20211231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzUzNg_7f0b1649-c568-482d-997a-72df1a004121">2.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i314e69e3501a4ea3a3bc04ee5a0601b0_I20201231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzU0Mw_9b3fd3f6-c71f-49ec-add5-4efede283677">1.8</ix:nonFraction> million, respectively, and the related accumulated depreciation was $<ix:nonFraction unitRef="usd" contextRef="ib7c26e3ef9c442a8832ed31ed63f16e7_I20211231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzYwNg_97037d5e-2c29-477e-9977-b82156ea73a9">1.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i314e69e3501a4ea3a3bc04ee5a0601b0_I20201231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzI3NDg3NzkwNzQwNjk_e1fe65bd-0492-469b-8f7b-c6b1708c827d">1.4</ix:nonFraction> million at December&#160;31, 2021 and 2020, respectively. Included in Property and equipment as of December&#160;31, 2021 and&#160;2020 is construction in progress of $<ix:nonFraction unitRef="usd" contextRef="ic330d4e7bda4436ea9b5a447faa2ab15_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzcxMw_f0ead761-5cfe-4b4a-ad90-a7f07201a160">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaf1149b9e76a4c089deaa8f058629d53_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzI3NDg3NzkwNzQwOTY_ebdf0227-621a-491c-b8cc-d4344d4efd29">0.4</ix:nonFraction> million, respectively, which is yet to be depreciated.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is related to the acquisition of Iridex&#8217;s aesthetic business unit, and customer relationships in the Benelux countries acquired from a former distributor in 2013. Goodwill was $<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzEwOTk1MTE2MzE3OTg_47cbef42-e2dd-42ef-bb27-b72ce4fbc2ca"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzEwOTk1MTE2MzE3OTg_7457ab6b-f471-48c6-9871-b38bab268d64">1.3</ix:nonFraction></ix:nonFraction> million as of December&#160;31, 2021 and 2020. There were <ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="INF" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzE0MTQ_59f93b30-d276-45bb-8d6c-ef6433b5cc93"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="INF" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzE0MTQ_6558adc9-e2b6-4ddf-a660-dbeb87aa36ec"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="INF" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzE0MTQ_98ae1cfd-7b23-48b4-8e84-c1e4e74e0643"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="INF" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzE0MTQ_c34395cb-5896-4029-b9c4-a2811337005d">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> impairments or additions to goodwill during the years ended December&#160;31, 2021 or 2020.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="ia546177f03324121ace3da0242ddf902"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities</span></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzI3NTk_2d6e3027-8013-422d-94df-4114d2040eeb" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bonus and payroll-related accruals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzItMS0xLTEtMjg2MjE_724b320f-f6d3-433a-a9c3-35c9f65f3af3">21,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzItMy0xLTEtMjg2MjE_be818384-ef8e-434a-ae07-4de609d4e918">12,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing accruals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="cutr:AccruedSalesAndMarketingCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzMtMS0xLTEtMjg2MjE_5b673765-4be3-4969-b790-8d850e3e8f51">4,808</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="cutr:AccruedSalesAndMarketingCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzMtMy0xLTEtMjg2MjE_dc16df21-d816-427b-93cf-5badc34320a9">2,352</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued inventory in transit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="cutr:AccruedInventoryInTransitCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzQtMS0xLTEtNDM3MjM_aaaba44a-5263-4e34-ae1c-c068f1399999">4,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="cutr:AccruedInventoryInTransitCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzQtMy0xLTEtNDM3MTI_9dfcdef8-5132-4785-b8d5-96c4b046c224">2,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product warranty</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzQtMS0xLTEtMjg2MjE_b72f61b2-995e-42b6-a547-f9eb49631823">3,947</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzQtMy0xLTEtMjg2MjE_d8214529-3b0c-44c7-8eb2-dee6a614bc3d">4,124</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzUtMS0xLTEtMjg2MjE_d955273e-7320-42b0-8f8f-f120a685f84c">9,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzUtMy0xLTEtMjg2MjE_7fda6524-cf27-418f-b008-bfd45c721315">5,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzYtMS0xLTEtMjg2MjE_6d3a7a11-916b-4fef-97bc-9e03959d6403">10,321</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzYtMy0xLTEtMjg2MjE_27cc7d1c-e308-4f13-a4ec-e35525a3afd2">5,803</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzctMS0xLTEtMjg2MjE_b9eea191-fc8a-40e9-aa79-e678ac1de1fc">54,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzctMy0xLTEtMjg2MjE_2235ffd7-ddd3-47c1-8969-b1d415dfdebd">32,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="idabc87e13e174d3c9f17fa6963046f56_118"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4&#8212; <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ProductWarrantyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90ZXh0cmVnaW9uOjQxZjBkMmUwMjI0ZjRiNDY5ZjczYzRhZWE5ZTk5MWVjXzE1MDg_93fa9311-bc9d-4d15-b3e7-8cc307b90ca1" continuedAt="i7789c0ad944f49569ccbe2a02196b5ec" escape="true">PRODUCT WARRANTY </ix:nonNumeric></span></div><ix:continuation id="i7789c0ad944f49569ccbe2a02196b5ec"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a direct field service organization in North America (including Canada). Internationally, the Company provides direct service support in Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, and Switzerland, as well as through third-party service providers in Spain and the United Kingdom. In several other countries, where the Company does not have a direct presence, the Company provides service through a network of distributors and third-party service providers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis. The Company provides the estimated cost to repair or replace products under standard warranty at the time of sale. Costs&#160;in connection with extended service contracts are recognized at the time when costs are incurred. <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90ZXh0cmVnaW9uOjQxZjBkMmUwMjI0ZjRiNDY5ZjczYzRhZWE5ZTk5MWVjXzE1MDc_76dad24e-382e-4305-8550-8704023f1dd3" continuedAt="i99f3a895b99f4011954e2079e8cb85ee" escape="true">The following table provides the changes in the product standard warranty accrual for the years ended December&#160;31, 2021 and 2020 (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i99f3a895b99f4011954e2079e8cb85ee"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzItMS0xLTEtMjg2MjE_88070e7d-ad87-4144-bebc-626b553c7f61">4,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzItMy0xLTEtMjg2MjE_1e303f82-eeac-4448-8bc4-b24a2d950d44">6,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accruals for warranties issued during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzMtMS0xLTEtMjg2MjE_9764e33f-8070-4ca2-a239-01ee19b9ef3f">5,135</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualWarrantiesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzMtMy0xLTEtMjg2MjE_c81cd32c-3fe9-49dc-9423-a6d1a26a3653">4,475</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzQtMS0xLTEtMjg2MjE_2e8662b8-c514-4639-aebc-b01ee95f8e02">5,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrualPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzQtMy0xLTEtMjg2MjE_92b06879-4b72-470b-899b-2982d25eaa7a">6,751</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzUtMS0xLTEtMjg2MjE_d1618a3e-810e-45aa-a6f5-7959a2639b52">3,947</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:StandardProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzUtMy0xLTEtMjg2MjE_8c53cad3-7066-4702-b504-a7c2969d084d">4,124</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="idabc87e13e174d3c9f17fa6963046f56_121"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="cutr:ContractWithCustomerLiabilityTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2Xzc3NA_2e982f07-e0c6-49cd-af1f-f80dc6a10390" continuedAt="i3a32f00048404cbca304f549025bb573" escape="true">DEFERRED REVENUE</ix:nonNumeric></span></div><ix:continuation id="i3a32f00048404cbca304f549025bb573"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records deferred revenue when revenue is to be recognized subsequent to invoicing. For extended service contracts, the Company generally invoices customers at the beginning of the extended service contract term. The Company&#8217;s extended service contracts typically have <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzM4NDgyOTA2OTc5OTU_298632bb-c8d5-4a4a-94e5-1559caf89ce1">one</span> to <ix:nonNumeric contextRef="i54949609fd0c4fddb72cfc46650cb0e8_D20210101-20211231" name="cutr:ExtendedServiceContractOptionTwoTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzE3MDQyNDMwMjMxNDI3_d0322fe0-a8ce-4dc0-8208-d1f1f8c19b47">three-year</ix:nonNumeric> terms. Deferred revenue also includes payments for training. Approximately <ix:nonFraction unitRef="number" contextRef="ib79906570e2049eabe51c068e7921170_I20211231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzQ0Nw_7d119df3-05fc-4985-bf3b-77801aef3a44">86</ix:nonFraction>% of the Company&#8217;s deferred revenue balance of $<ix:nonFraction unitRef="usd" contextRef="ib79906570e2049eabe51c068e7921170_I20211231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzQ5NQ_3664d09f-b008-4221-bca6-8806bf86c67d">10.8</ix:nonFraction> million as of December&#160;31, 2021, will be recognized over the next <ix:nonNumeric contextRef="ib79906570e2049eabe51c068e7921170_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzU0MA_e26054bc-b97a-40fa-adb5-e3be4c1a741f">12</ix:nonNumeric> months.</span></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2Xzc3NQ_55093805-5148-48a4-a3ad-50bbe6651ad0" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in the deferred contract revenue balance for the years ended December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzItMS0xLTEtMjg2MjE_7bab343a-0c76-4ca4-bda1-830e23c1ad62">11,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzItMy0xLTEtMjg2MjE_36b68a56-9cb7-44a5-9b75-68c7271a37da">14,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Payments received</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzMtMS0xLTEtMjg2MjE_3e6e9762-aae5-4ab7-8d99-63e79eab59a9">17,139</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzMtMy0xLTEtMjg2MjE_2746047c-4fd0-4d61-928f-a62dabb7e2be">14,131</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Revenue recognized from current period sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="cutr:ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzQtMS0xLTEtMjg2MjE_d4fb3f6a-781f-4a69-a44c-719f4588906a">7,006</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="cutr:ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzQtMy0xLTEtMjg2MjE_23d1aa72-48c3-4704-8171-45bfefb84088">6,337</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Revenue recognized from beginning balance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzUtMS0xLTEtMjg2MjE_aa747d6a-ed7b-403a-86a5-3c6223f9d06c">10,545</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzUtMy0xLTEtMjg2MjE_714d715a-5a03-421f-b05d-28a761349fdc">10,779</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzYtMS0xLTEtMjg2MjE_4fb81e94-154f-423c-b661-4c4a6812238d">10,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzYtMy0xLTEtMjg2MjE_945e6586-aa8f-4acf-9ced-9a1f3450fb25">11,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs for extended service contracts were $<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-5" name="cutr:DeferredRevenueCostsIncurred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzcxMg_2be2be4e-96a2-437b-a33a-fff991457e59">8.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-5" name="cutr:DeferredRevenueCostsIncurred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzcxNg_0a0833c4-1b4d-47bb-8973-06862a0305f3">8.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-5" name="cutr:DeferredRevenueCostsIncurred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzcyMw_ca853bfb-7184-4af9-93e6-78723c90b89f">9.3</ix:nonFraction> million, respectively, for the years&#160;ended December&#160;31, 2021, 2020 and 2019.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6&#8212;<ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE1NDgw_2f41d232-df16-4cd2-8fe8-01941e957ce4" continuedAt="i9e92518d6d044d4c804687b9fbc2e192" escape="true">STOCKHOLDERS&#8217; EQUITY, STOCK PLANS AND STOCK-BASED COMPENSATION EXPENSE</ix:nonNumeric></span></div><ix:continuation id="i9e92518d6d044d4c804687b9fbc2e192" continuedAt="i1bf3f76c84a64899910a36a5f95be118"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had one class of issued common stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE2Mg_cb815ac7-227d-4fee-9a2c-78eb06e542da">0.001</ix:nonFraction>. Authorized capital stock consists of <ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="cutr:CapitalStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzIwMw_de203ccf-cdeb-4a75-96a8-8698696ddb0b">55,000,000</ix:nonFraction> shares comprised of two classes: (i) <ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI0Mw_4c72e452-383b-40bb-8eca-0a74a780b909">50,000,000</ix:nonFraction> shares of Common Stock, of which <ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI3OQ_23f920c5-e311-4fc4-8f24-d37a7fc80505"><ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI3OQ_a7c5a6f6-aa8f-4d20-8950-34cb5952e99c">17,995,344</ix:nonFraction></ix:nonFraction> shares are issued and outstanding as of December&#160;31, 2021, and (ii) <ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzMzNQ_aed1fb25-12b0-414c-a1b6-8c7081f77257">5,000,000</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzM3NQ_66b2d4ec-8b5f-4f9d-8017-0b910f6d1e3d">0.001</ix:nonFraction> per share (&#8220;Preferred Stock&#8221;), of which <ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzQxOA_0324c974-fd06-4595-ad8c-7cbd2a6bf09e"><ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzQxOA_c0f7f502-fcc6-4078-b493-65616893f857">no</ix:nonFraction></ix:nonFraction> shares are issued and outstanding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuances of Common Stock</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;21, 2020, the Company issued and sold an aggregate of <ix:nonFraction unitRef="shares" contextRef="id019adf1333c43ce9cd8acf7e5ea0991_D20200421-20200421" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzUzMw_f54f6ead-42a5-4d00-9061-6ad6296c7b73">2,742,750</ix:nonFraction> shares of the Company&#8217;s common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i5e364a947a114dddb1671e44b0467847_I20200421" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzU4NA_b230cb21-d671-4fcb-956f-13fbb9f06016">0.001</ix:nonFraction> per share at a price to the public of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5e364a947a114dddb1671e44b0467847_I20200421" decimals="INF" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzYyNQ_1de6ff9f-2e7f-41b9-b727-e3249c8603fd">10.50</ix:nonFraction> per share. The shares include the full exercise of the underwriter&#8217;s option to purchase an additional <ix:nonFraction unitRef="shares" contextRef="i9b9ef969fb964e68bc041b81228d55de_D20200421-20200421" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzczMA_291ae7b2-b777-4394-b39f-e7a2f28d6247">357,750</ix:nonFraction> shares of common stock. The Company received net proceeds from the offering of approximately $<ix:nonFraction unitRef="usd" contextRef="id019adf1333c43ce9cd8acf7e5ea0991_D20200421-20200421" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzgyNg_ab8f9006-cca3-4f78-a1d0-a239005e3082">26.5</ix:nonFraction> million, after deducting underwriting discounts, commissions and offering expenses of $<ix:nonFraction unitRef="usd" contextRef="id019adf1333c43ce9cd8acf7e5ea0991_D20200421-20200421" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzkwNw_14e88bcd-27a8-4abc-9da9-531e04a4c3e4">2.3</ix:nonFraction> million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had the following stock-based employee compensation plans:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2004 Equity Incentive Plan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1998, the Company adopted the 1998 Stock Plan, or 1998 Plan, under which <ix:nonFraction unitRef="shares" contextRef="i7b5f16c096554bfebc0977f38bdab2e3_I19981231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwODk_9104726d-b340-4e37-a56d-2d10756dcc8f">4,650,000</ix:nonFraction> shares of the Company&#8217;s common stock were reserved for issuance to employees, directors and consultants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;12, 2004, the Board of Directors (&#8220;the Board&#8221;) adopted the 2004 Equity Incentive Plan. A total of <ix:nonFraction unitRef="shares" contextRef="i6bdd524cbef74fc18d573d1100d86374_I20040112" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEyOTI_8b72c2de-18e8-4050-b808-44f5af7fe253">1,750,000</ix:nonFraction> shares of common stock were originally reserved for issuance pursuant to the 2004 Equity Incentive Plan. In addition, the shares reserved for issuance under the 2004 Equity Incentive Plan included shares reserved but un-issued under the 1998 Plan and shares returned to the 1998 Plan as the result of termination of options or the repurchase of shares. In 2012 the stockholders approved a &#8220;fungible share&#8221; provision whereby each full-value award issued under the 2004 Equity Incentive Plan results in a requirement to subtract <ix:nonFraction unitRef="shares" contextRef="i5327f49a62ea40d690f0899c454a9fbd_D20120101-20121231" decimals="INF" name="cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE4MjA_cb136fb9-89a3-487c-923f-de6df4d9e6f3">2.12</ix:nonFraction> shares from the shares reserved under the Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Equity Incentive Plan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Company&#8217;s Annual Meeting of Stockholders on June&#160;14, 2019, the Company&#8217;s stockholders approved the 2019 Equity Incentive Plan, which is an amendment and restatement of the 2004 Equity Incentive Plan. The 2004 Equity Incentive Plan was amended to: (i) increase the number of shares available for future grant by <ix:nonFraction unitRef="shares" contextRef="i51d5c987d168444995a56ee832d422f1_D20190614-20190614" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzIyMDM_b66e4d0f-6a68-4984-9884-53fdc192fad0">700,000</ix:nonFraction> (in addition to the <ix:nonFraction unitRef="shares" contextRef="i19b58bf2da1b4bdf82f22bbae4a7f3a2_I20190614" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzIyMjY_18d68691-c617-4c1a-9627-6157840378b4">9,701,192</ix:nonFraction> shares provided under the 2004 Equity Incentive Plan; (ii) extend the term of the 2004 Equity Incentive Plan to the date of the Annual Meeting of the Company&#8217;s stockholders in 2029; (iii) amend the 2004 Equity Incentive Plan to eliminate the requirement for awards granted on or after June&#160;14, 2019 that any shares subject to awards with an exercise price less than fair market value on the date of such grant will be counted against the Plan as <ix:nonFraction unitRef="shares" contextRef="i51d5c987d168444995a56ee832d422f1_D20190614-20190614" decimals="INF" name="cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI2NjQ_d96b4b9e-2478-4776-b9c0-9c20392ed313">2.12</ix:nonFraction> shares for each full value share awarded in accordance with the 2004 Equity Incentive Plan; (iv) amend the 2004 Equity Incentive Plan to remove the requirement that any shares subject to awards with an exercise price less than fair market value on the date of such grant will be counted against the Plan as <ix:nonFraction unitRef="shares" contextRef="i51d5c987d168444995a56ee832d422f1_D20190614-20190614" decimals="INF" name="cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI5NzQ_a76c7532-2d1a-4d86-af91-81ffc32cc003">2.12</ix:nonFraction> shares for each full value share awarded; (v) amend the 2004 Equity Incentive Plan to remove certain provisions relating to the &#8220;performance based compensation&#8221; exception under Section 162(m) of the Internal Revenue Code of 1986, as amended; (vi) include a minimum <ix:nonNumeric contextRef="i2e8bdcbd064d4597b255647bff9cba1a_D20190614-20190614" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMTU0_5de9f439-243c-491a-bb81-1b28765c6c27">one-year</ix:nonNumeric> vesting period with respect to awards granted under the 2004 Equity Incentive Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;11, 2019, the Board also approved, amended and restated the Company&#8217;s Stock Ownership Guidelines adopted on July&#160;28, 2017 in their entirety, to require all officers (as defined by Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) to hold at least <ix:nonFraction unitRef="number" contextRef="ifd9fd5d526a04b80a20fe10491260caa_D20190611-20190611" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzM1OTM_3e552a77-5e40-4467-93af-e282aacbed0e">50</ix:nonFraction>% of any shares received pursuant to stock options, stock appreciation rights, vested restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;), or performance stock units (&#8220;PSUs&#8221;) (net of taxes) for a minimum of one year following vesting and delivery.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;11, 2019, the Board also adopted a clawback policy to permit recovery of certain compensation paid to Named Executive Officers (as defined in Item 402 of Regulation S-K) of the Company if the Compensation Committee of the Board determines that a Named Executive Officer (i) has violated law, the Company&#8217;s Code of Business Conduct and Ethics, or any significant ethics or compliance policies, and (ii) such conduct results in material financial or reputational harm, or results in a need for a restatement of the Company&#8217;s consolidated financial statements. The Amended and Restated Plan provides for the grant of incentive stock options, non-statutory stock options, RSAs, RSUs, stock appreciation rights, PSUs, and other stock or cash awards.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, stockholders approved an amendment and restatement of the 2019 Equity Incentive Plan (the &#8220;Prior Plan&#8221;) as the Amended and Restated 2019 Equity Incentive Plan (the &#8220;Restated Plan&#8221;) and approved an additional <ix:nonFraction unitRef="shares" contextRef="ief9071943aa645caa5dade84cd3e061d_D20200601-20200630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzQ4NjE_19ce9bb7-5729-46fc-8109-6e247c38c988">600,000</ix:nonFraction> shares, available for future grants. The Restated Plan provides for the grant of incentive stock options, non-statutory stock options, RSAs, RSUs, stock appreciation rights, PSUs, and other stock or cash awards.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="i1bf3f76c84a64899910a36a5f95be118" continuedAt="i5937d7644dd945dd81acd1a21dc6bf45"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s non-employee directors are granted $<ix:nonFraction unitRef="usd" contextRef="id927e8d4f38a47a0828d8a646057aed3_I20211231" decimals="INF" name="cutr:ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwOTk1MTE2NTYzNzc_bdbee4e5-5e76-4aae-b353-bacca94e2024">60,000</ix:nonFraction> of RSUs annually on the date of the Company&#8217;s Annual Meeting of stockholders. These RSUs cliff-vest on the <ix:nonNumeric contextRef="ie3195dfbe94d477e88a888e893f44d1e_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMTI0_0d1cdaa2-2438-4ac8-8b3a-60524859e389">one-year</ix:nonNumeric> anniversary of the grant date. In the years ended December&#160;31, 2021, 2020 and 2019, the Company issued <ix:nonFraction unitRef="shares" contextRef="ie3195dfbe94d477e88a888e893f44d1e_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwOTk1MTE2NTY5NTE_5f5b1337-f755-4682-a6f5-1d2a68c6f0c3">41,301</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i3d42d4ffa3bd4f0b875d22a9ab203d5c_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwOTk1MTE2NTY5NTY_a4d50e63-18bf-492c-bf6e-206b0c6ad7a1">35,735</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i81aa92e174864f29b74e30628a31ecd2_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwOTk1MTE2NTY5NjQ_a873461b-86ed-4355-83ec-f836ddb51a1a">42,236</ix:nonFraction> RSUs, respectively, to its non-employee directors.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the years ended December&#160;31, 2021, 2020&#160;and 2019, the Company&#8217;s Board of Directors granted <ix:nonFraction unitRef="shares" contextRef="i88b4ab1b779d43ed8ae859fa48628f89_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzU4OTg_052503af-b110-4f1c-9746-71dd36df05a3">219,686</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i713579da903a47a29c2bbc3556a11854_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzU5MDI_8cc54e17-4072-4823-84ee-318657a26c2a">405,248</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="if5f5df8bc21945d8be1f01c615e620b9_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzU5MDk_bb6b12f2-dc28-4cff-b207-c15568b71e11">475,166</ix:nonFraction> RSUs, respectively, to its executive officers, directors and certain members of the Company&#8217;s management related to annual grants and new hire grants. The annual grant RSUs vest quarterly on each of the first <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDAw_eb99cd2f-e555-49f7-b0bf-9cc8cd023330">four</span> anniversaries of the vest date and the new hire RSUs vest one quarter on the first anniversary and monthly thereafter for <ix:nonNumeric contextRef="ibd9c28c8d501405da659af62fb7475e6_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgwOTcy_44cdd439-67b9-42ff-b224-531024593b6e">36</ix:nonNumeric> months. The Company measured the fair market values of the underlying stock on the dates of grant and recognizes the stock-based compensation expense over the vesting period. On the vesting date, the Company issues common stock, net of stock withheld to settle the recipient&#8217;s minimum statutory tax liability. In addition to the 2020 annual RSU grants, on April 1, 2020, the Company issued RSUs to settle bonuses owed to management under the 2019 Management Bonus Program. In the past, the Company has paid these bonuses with cash. However, due to the economic conditions resulting from COVID-19, fully vested shares were issued in lieu of cash. The Company issued <ix:nonFraction unitRef="shares" contextRef="i5046b58bcd594937807a5b3727f16519_D20200401-20200401" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI3NDg3NzkxMTkwODM_e478f1f6-dbbf-4cf0-bc76-fed1b3329c43">209,981</ix:nonFraction> shares related to this bonus payment to management and recognized $<ix:nonFraction unitRef="usd" contextRef="i5046b58bcd594937807a5b3727f16519_D20200401-20200401" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgwOTc5_ad6d4fb3-0348-42d7-9479-bd847851c32c">2.6</ix:nonFraction>&#160;million in stock-based compensation expense. The Company also recorded an equivalent reduction in bonus expense as a result of the settlement of the bonus in shares.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the years ended December 31, 2021, 2020 and 2019 the Company&#8217;s Board of Directors granted its executive officers and certain senior management employees <ix:nonFraction unitRef="shares" contextRef="i57973c7f0bd94f19b5e2a50196d96324_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI3NDg3NzkxMDY3NzI_58c9bf5b-0721-4715-a5a8-3131cafbe5cd">178,222</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i55b1792fc2364767a5f64cd1cdf6808c_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI3NDg3NzkxMDY3Nzc_90515482-6dc9-42ca-86b5-68996fad995d">76,157</ix:nonFraction>, and <ix:nonFraction unitRef="shares" contextRef="i64db2b3b978b414a8c02290468f928b5_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI3NDg3NzkxMDY3ODY_53688f42-e707-4e0e-b1f3-37189dadfc09">319,275</ix:nonFraction> PSUs, respectively, related to its annual grants. The 2019 and 2020 grants vested on the first anniversary subject to the achievement of pre-established performance goals. The 2021 grant quantity vested one half on the first anniversary subject to the achievement of pre-established performance goals and the remaining half vested on the second anniversary subject to the recipient&#8217;s continued service. In addition to the 2021 annual PSU grants, in July 2021, the Company granted <ix:nonFraction unitRef="shares" contextRef="ie5a5db0c5f0d46b380a0b79f965a62ea_D20210701-20210731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI3NDg3NzkxMTkwOTM_800b11d1-cafb-4691-a7b7-d5144b855eab">265,002</ix:nonFraction> PSUs to certain employees. This grant consists of <ix:nonFraction unitRef="tranche" contextRef="i01a61b6023fb48d7be1011c161d39845_D20210701-20210731" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMTMx_6adfa34f-9de0-4d76-b2bf-fd43276661f7">four</ix:nonFraction> separate vesting tranches that will vest from April 2023 through June 2024 upon the achievement of operational milestones associated with each tranche and continued service.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Board awarded its new CEO, David H. Mowry, <ix:nonFraction unitRef="shares" contextRef="i6293b26e539849e09ccfdc96cb5059bb_D20190701-20190731" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDA2_6049b711-faea-4bc7-bec7-92fb6fd0c609">67,897</ix:nonFraction> PSUs, which are scheduled to vest over <ix:nonNumeric contextRef="id6d4b50d303d423099ba57b50833b756_D20190701-20190731" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDMx_175e35c1-9da1-47ef-8769-259c447701ea">four years</ix:nonNumeric> from 2019 through 2022. These PSUs are subject to certain performance-based criteria related to achieving financial metrics in the Board approved annual budgets. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Board awarded its new CFO, Rohan Seth, <ix:nonFraction unitRef="shares" contextRef="i7e2fb7f83d5a4d3797c1641e79c2cb8e_D20200801-20200831" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDM3_c00ed4b0-ed88-4f1c-9b42-506e875b6356">60,000</ix:nonFraction> stock options, which vests over <ix:nonNumeric contextRef="iaba873dc2f8c4fb8bb139aa82a0e3219_D20200801-20200831" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDU4_21f658b2-56c4-49de-ae8c-3638fa381cdd">five years</ix:nonNumeric>, and <ix:nonFraction unitRef="shares" contextRef="i0d1404685416410cbcd6e1f275b3fd2d_D20200801-20200831" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDY0_786344ea-2a5a-4d24-8009-4ac4b86397ae">22,423</ix:nonFraction> PSUs, which vests over <ix:nonNumeric contextRef="ia1344f4c17c7449aba2397d6f715ba6f_D20200801-20200831" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDg2_24b02372-6278-4b6f-9e9a-758a9dd050ed">2.5</ix:nonNumeric> years and is subject to performance-based criteria relating to the achievement of certain department and financial goals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;12, 2004, the Board of Directors adopted the 2004 Employee Stock Purchase Plan. Under the 2004 Employee Stock Purchase Plan, or 2004 ESPP, eligible employees are permitted to purchase common stock at a discount through payroll deductions. The 2004 ESPP offering and purchase periods are for <ix:nonNumeric contextRef="ie8e0ec5e57d6453db52240a4631277a9_D20040112-20040112" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMTA3_54ff3e5e-c063-466c-bfb8-acfbe03f883c">six months</ix:nonNumeric>. The 2004 ESPP has an evergreen provision based on which shares of common stock eligible for purchase are increased on the first day of each fiscal year by an amount equal to the lesser of:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:nonFraction unitRef="shares" contextRef="ie8e0ec5e57d6453db52240a4631277a9_D20040112-20040112" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzk3NTA_b3538dcc-66cd-41da-ab97-5b6574214aee">600,000</ix:nonFraction> shares;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:nonFraction unitRef="number" contextRef="ie8e0ec5e57d6453db52240a4631277a9_D20040112-20040112" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzk3NjE_19f32737-d231-481e-900c-1468245c87a4">2.0</ix:nonFraction>% of the outstanding shares of common stock on such date; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an amount as determined by the Board of Directors.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price of the common stock purchased is the lower of <ix:nonFraction unitRef="number" contextRef="ie3406523d56248b489c3b7541fdf6711_D20210101-20211231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwMDUz_edb6e57d-09c3-4874-8764-811b9066a31b">85</ix:nonFraction>% of the fair market value of the common stock at the beginning or end of the <ix:nonNumeric contextRef="ie8e0ec5e57d6453db52240a4631277a9_D20040112-20040112" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMTQ2_6070a231-b871-4fb4-95d9-ee6d244a863c">six-month</ix:nonNumeric> offering period. In the years ended December&#160;31, 2021, 2020, and 2019, under the 2004 ESPP, the Company issued <ix:nonFraction unitRef="shares" contextRef="ie3406523d56248b489c3b7541fdf6711_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwMjMy_639f8bee-c4c9-41dd-84cb-0e4fea4a8401">59,635</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="ie4edea0c28014a2d93054c7ca5e19937_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwMjM2_50bcd530-7096-40ff-8a78-7a40bcb53b1d">56,751</ix:nonFraction>, and <ix:nonFraction unitRef="shares" contextRef="i9d790cb4f5784d80b7d9b71df630a022_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwMjQ0_916374e4-c57f-4f36-a42c-b147e1b03d93">82,810</ix:nonFraction> shares, respectively. At December&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="idc61de97e6f5442cae47ea43a50a646f_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwMjc2_8aad67f1-0c69-4be4-894f-9e1f5cd3bf01">645,319</ix:nonFraction> shares remained available for future issuance.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="i5937d7644dd945dd81acd1a21dc6bf45" continuedAt="i7afa9ae69e9043faa25c264275b5ddf7"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option and Award Activity</span></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMTQ4_6c83f32c-117c-4026-a1e8-dba2d54045b2" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the 2004 Plan and 2019 Equity Incentive Plan is summarized as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>Available<br/>For Grant</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions ) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzItMS0xLTEtMjg2MjE_eca32dff-9085-47f9-88d2-c85958f335c0">1,141,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzItMy0xLTEtMjg2MjE_2d98a227-06fa-4acd-a6cd-44f0c14faf2f">507,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzItNS0xLTEtMjg2MjE_bebe13a3-f334-4cc5-9c30-3c76e91416cc">20.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3df46276971c4ed0986a5e859e637064_D20180101-20181231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzItNy0xLTEtMjg2MjE_9a6bf017-2378-4cab-83c4-36fa156ba082">3.52</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231" decimals="-4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzItOS0xLTEtMjg2MjE_c19ea88a-2b41-4dd1-b5e7-8199b87b709d">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="INF" name="cutr:AdditionalSharesReservedSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzMtMS0xLTEtMzcxMjY_306e7d85-0d8a-465c-b465-960a27699b41">700,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzQtMy0xLTEtMjg2MjE_6f8fd469-dd69-4895-8e1e-3c0be64e2069">160,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzQtNS0xLTEtMjg2MjE_7493cd2e-4f25-46d6-9a5f-08a095010167">10.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzUtMS0xLTEtMjg2MjE_022f3203-5a1e-4e94-9cbb-60efd172e913">51,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzUtMy0xLTEtMjg2MjE_a40dfbd7-178d-40b3-a886-27559e9bb137">51,208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzUtNS0xLTEtMjg2MjE_6811213f-5ff4-49e7-9f78-b6d44aed5617">24.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzYtMS0xLTEtMjg2MjE_c000febd-f34e-4298-b1b0-6b81d80951d2">1,538,128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzctMS0xLTEtMjg2MjE_63971eac-f703-449d-87b0-f89ccd6a2575">407,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzgtMS0xLTEtMjg2MjE_27168521-64cd-4d39-8daa-de602cb6417a">761,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzgtMy0xLTEtMjg2MjE_5a503e77-c436-494b-a5ff-d86ce97b7ad4">295,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzgtNS0xLTEtMjg2MjE_339fac94-1d69-49cd-b3a1-2bf6a9cb34f4">25.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzgtNy0xLTEtMjg2MjE_4bfea298-1f34-4eb0-88c6-65c5d610edf4">3.19</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231" decimals="-4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzgtOS0xLTEtMjg2MjE_ac1893a8-6e9a-4320-83cc-0b8ec892a249">3.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="INF" name="cutr:AdditionalSharesReservedSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzktMS0xLTEtMjg2MjE_58c3488f-1bdd-4691-a5b0-570d8f64198e">600,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzEwLTEtMS0xLTQwMjU5_c85d0677-b377-4733-92c8-7dea3b05f47f">71,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzEwLTMtMS0xLTQwMjY0_98191985-ef46-4f50-89d1-0c3f48fc9595">71,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzEwLTUtMS0xLTQwMzAx_63d17e35-f7df-482e-ad56-a736cadc8ed7">14.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzEwLTMtMS0xLTI4NjIx_cb7f0228-7aba-4521-81c8-7451b75d22bf">73,227</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzEwLTUtMS0xLTI4NjIx_1223a107-2c83-45bb-9c2f-b4729c79dfb5">12.91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzExLTEtMS0xLTI4NjIx_2131480f-5673-4d28-a693-0a068d5c7dbb">76,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzExLTMtMS0xLTI4NjIx_98f9bd89-5a06-4b84-9f1e-c4e0bf6311dd">76,553</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzExLTUtMS0xLTI4NjIx_4f4988be-d866-4997-a370-b1167c61dfe0">36.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzEyLTEtMS0xLTI4NjIx_c336dbcd-d9f1-4a64-b1c6-9b5f182f18d8">804,949</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzEzLTEtMS0xLTI4NjIx_f7638840-88c2-46ae-9d25-ae37e4b9f336">522,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE0LTEtMS0xLTI4NjIx_d910101c-747e-4221-9b20-41f54090b7ad">1,085,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE0LTMtMS0xLTI4NjIx_d442c2bf-a7f4-481a-a5b8-376d069b6872">217,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE0LTUtMS0xLTI4NjIx_a7fee061-c461-4532-8c76-f27d4cec3514">22.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE0LTctMS0xLTI4NjIx_6955f279-b80c-4199-a342-706f906e3443">3.75</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE0LTktMS0xLTI4NjIx_cab49cc3-0ffa-4253-81aa-2bf8a9d69a78">1.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="INF" name="cutr:AdditionalSharesReservedSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE2LTEtMS0xLTQzMjAw_307b97b4-90f5-4025-998d-b5c301336d41">450,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE2LTEtMS0xLTI4NjIx_e6cf020c-20bb-4b33-8ec3-91fa20f0ad11">172,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE2LTMtMS0xLTI4NjIx_12504669-9561-4733-b21c-2af9c4e0be1a">172,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE2LTUtMS0xLTI4NjIx_93f1bf87-e789-40a1-89a8-e4d504850bea">30.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE3LTMtMS0xLTI4NjIx_394f5660-a470-4bb0-b48b-f680cdc65c59">71,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE3LTUtMS0xLTI4NjIx_6162a93f-d372-4bc4-9a66-76b50d60ec00">22.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE4LTEtMS0xLTI4NjIx_2e5e2ca6-fc4c-40d8-8dc6-4e9632d623bc">30,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE4LTMtMS0xLTI4NjIx_ed550dbb-2c61-46b1-8de8-8ed3ec7b6b77">30,173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE4LTUtMS0xLTI4NjIx_ea9c4662-4765-489e-ab7c-5a3b84b2aac2">37.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE5LTEtMS0xLTI4NjIx_977f1e34-5d05-4c1d-aa9d-ac29a62866d7">744,949</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="INF" name="cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIwLTEtMS0xLTI4NjIx_ec67f87c-0f0e-435e-899e-270c6a5fde76">299,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIxLTEtMS0xLTI4NjIx_4aea090c-e832-4651-ac6c-d5fdeb507fb2">947,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIxLTMtMS0xLTI4NjIx_0944b1f0-8e18-4815-9f88-f972ee36ab2c">287,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIxLTUtMS0xLTI4NjIx_8c35587d-5a41-411b-b57a-f259116b5001">25.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIxLTctMS0xLTI4NjIx_d9a8b36f-eb82-4c2f-be6e-9ecbac777f23">4.92</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIxLTktMS0xLTI4NjIx_17ca47f6-2021-4c59-8539-52a67442e9a5">4.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIyLTMtMS0xLTI4NjIx_120197f0-2ec1-4a12-901e-6f9d119e0219">83,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIyLTUtMS0xLTI4NjIx_965686df-8d4f-4f3a-b230-5d6e6ac13710">24.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIyLTctMS0xLTI4NjIx_5f0f9fd6-72e6-4646-8a40-92df9fb722ba">2.86</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIyLTktMS0xLTI4NjIx_024c0851-3a9c-4366-8efd-c003c7150db7">1.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vested and expected to vest as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIzLTMtMS0xLTI4NjIx_0b256e80-8ac2-4c2f-8612-4b893b799106">287,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIzLTUtMS0xLTI4NjIx_588412cd-f6e6-49f7-8ddb-1d2320f1529f">25.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIzLTctMS0xLTI4NjIx_f00a99c8-6238-42b1-9dae-344a9be24672">4.92</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIzLTktMS0xLTI4NjIx_750bd304-4f85-4529-b7a7-25482bdd8872">4.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Based on the closing stock price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwNDc3_b5d78b6f-8f39-4bb0-bc1f-face03529361">41.32</ix:nonFraction> of the Company&#8217;s stock on December&#160;31, 2021, $<ix:nonFraction unitRef="usdPerShare" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwNTEw_8fbafcd5-eb31-4b14-8e75-d5d8b8bafaa2">24.11</ix:nonFraction> on December&#160;31, 2020, $<ix:nonFraction unitRef="usdPerShare" contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwNTIw_aa68b8c7-722d-4046-b924-e44c2158ac57">35.81</ix:nonFraction> on December&#160;31, 2019 and $<ix:nonFraction unitRef="usdPerShare" contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwNTMz_c9003b0b-7de2-42de-8f35-c1ef9bca5ea4">17.02</ix:nonFraction> on December&#160;31, 2018.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Approved by the board of directors and stockholders in 2021, 2020 and 2019.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="i7afa9ae69e9043faa25c264275b5ddf7" continuedAt="i5e2bec8656684a6dabd49fdb70d25a46"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value and is the aggregate difference between the Company&#8217;s closing stock price on the last trading day of the fiscal year and the exercise price, multiplied by the number of in-the-money options. The aggregate intrinsic amount changes based on the fair market value of the Company&#8217;s common stock. Total intrinsic value of options exercised in 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExMTU5_c8d4130d-1fef-4566-afc1-14386c3ab364">1.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExMTYz_f49a4e49-5096-45dd-a8ea-4f0b8b032756">0.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExMTcx_b29a43c8-736e-4426-b2eb-3ff8db96acb5">1.0</ix:nonFraction> million, respectively. <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE1NDc1_81bab114-9fda-4fe9-a2fa-e5ea3f7f4c33" continuedAt="i697588bfc8a3441fa747eb3e578ed2e7" escape="true">The options outstanding and exercisable at December&#160;31, 2021 were in the following exercise price ranges:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i697588bfc8a3441fa747eb3e578ed2e7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.360%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prices</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>Exercisable</span></td></tr><tr><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i243cda497d0443fd8d3e77f6c4b77778_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEtMC0xLTEtMjg2MjE_6f259867-fe35-49d0-b5b9-0f8e7d6a6241">10.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i243cda497d0443fd8d3e77f6c4b77778_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEtMi0xLTEtMjg2MjE_34de4237-cca0-4526-931c-180d419bc196">14.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i918b5c66b5b64f319346190d60ad103d_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEtNC0xLTEtMjg2MjE_74bac47c-5449-4405-89af-e014d1e14ba9">25,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i243cda497d0443fd8d3e77f6c4b77778_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEtNi0xLTEtMjg2MjE_452e7536-ec47-49ca-bb84-714c3d476efd">1.97</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i918b5c66b5b64f319346190d60ad103d_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEtOC0xLTEtMjg2MjE_aa0b4f00-4be6-4c87-882d-db8360e5c53e">25,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i24d00f09f70e46dd88668566228e1cdf_I20211231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzItMS0xLTEtMjg2MjE_fb10eb78-169a-4f43-b381-1aa75e68ff32">14.10</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24d00f09f70e46dd88668566228e1cdf_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzItNC0xLTEtMjg2MjE_4611b526-0529-4037-a78f-a90e2bf29fc3">60,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6ba69d99c6bf476e8d15c9c79b2a6df2_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzItNi0xLTEtMjg2MjE_c4aba4ef-3975-4664-afb9-be890c0c24b8">3.59</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i24d00f09f70e46dd88668566228e1cdf_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzItOC0xLTEtMjg2MjE_c17607e5-b7a1-491e-818f-24688b7eedc9">16,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="id228189a9c344696a5059d6861067108_I20211231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzMtMS0xLTEtMjg2MjE_8a754613-0993-4705-b7f3-56231040c138">15.32</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id228189a9c344696a5059d6861067108_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzMtNC0xLTEtMjg2MjE_cff62825-fe7f-449c-8377-31e0c85a2339">2,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4d5d0bdf4f0d4a1883472cfe8d0f4ca7_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzMtNi0xLTEtMjg2MjE_4a4556f5-023e-4adf-99ed-cf77b6a839f1">0.56</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id228189a9c344696a5059d6861067108_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzMtOC0xLTEtMjg2MjE_f2b732d2-8641-4b46-a80d-209f25d193d6">2,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i5e4c6cb41dca483993cf3fb92041cc1f_I20211231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzQtMS0xLTEtMjg2MjE_26bbdd0b-9864-4a17-bf2f-ace66ce5c279">18.55</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e4c6cb41dca483993cf3fb92041cc1f_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzQtNC0xLTEtMjg2MjE_2f83eef6-0ef1-4765-8200-ec47001ca674">1,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i062444d03896452f9251a408fa65500b_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzQtNi0xLTEtMjg2MjE_c1547871-66b6-4159-b556-b9e19f1f1507">2.07</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e4c6cb41dca483993cf3fb92041cc1f_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzQtOC0xLTEtMjg2MjE_25e80ce5-45ba-49d2-99d2-c65aeddd1be0">1,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="id8ddcd5085f543b5aacaf7518aba284a_I20211231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzUtMS0xLTEtMjg2MjE_652df95a-48d7-44f2-8e5d-5b2ad1b87e50">18.93</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id8ddcd5085f543b5aacaf7518aba284a_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzUtNC0xLTEtMjg2MjE_c5c35ceb-cf80-451c-a378-23a09601b817">11,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6e4d0f435f2844b291dd5ea2a0f001f0_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzUtNi0xLTEtMjg2MjE_3dd9b50c-183f-4dfe-a123-2c6d786d0e14">8.83</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id8ddcd5085f543b5aacaf7518aba284a_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzUtOC0xLTEtMjg2MjE_f1b77ab9-4136-487b-8eac-25448f40a702">3,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i20b036dbcc074c4a90dad931e7f4bb6c_I20211231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzYtMS0xLTEtMjg2MjE_acca0fb0-0d1e-47d6-b6df-30c42342a53f">25.70</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i20b036dbcc074c4a90dad931e7f4bb6c_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzYtNC0xLTEtMjg2MjE_a218ce8f-6832-4b1b-8436-3bcd941fd786">6,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i40475f7443d64415ba295a8050683744_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzYtNi0xLTEtMjg2MjE_a0ca5673-ed58-42b0-85a3-7bcb7ac896bc">2.59</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i20b036dbcc074c4a90dad931e7f4bb6c_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzYtOC0xLTEtMjg2MjE_af309ba2-2468-4e78-9636-8f5694375054">6,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ic7ae52da7abe49da93b5d02df9962d86_I20211231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzctMS0xLTEtMjg2MjE_46155572-77a1-44ce-b21e-5664639e6a82">29.28</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic7ae52da7abe49da93b5d02df9962d86_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzctNC0xLTEtMjg2MjE_86c7c8a3-9017-467a-9cbe-59988a9fdb57">93,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idafa75464bf1482bbe39438ca2a1fbb3_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzctNi0xLTEtMjg2MjE_8dcc9ad0-c429-4202-a596-92b0af9882be">6.32</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic7ae52da7abe49da93b5d02df9962d86_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzctOC0xLTEtMjg2MjE_dccde7d7-5581-47fd-8e1d-7294faee59ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ide3c7b9ba1e1465085e27b6fb0183fac_I20211231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzgtMS0xLTEtMjg2MjE_5bcc0280-8af9-477c-ae80-bf96fd787d08">32.87</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide3c7b9ba1e1465085e27b6fb0183fac_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzgtNC0xLTEtMjg2MjE_7f6aabe5-11c1-45bd-9feb-4f3e5e82a010">57,622</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i86f5d1782ee64b31bfb15fc1735484b3_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzgtNi0xLTEtMjg2MjE_10f46263-1913-4067-8270-2e80320e64f5">6.12</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide3c7b9ba1e1465085e27b6fb0183fac_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzgtOC0xLTEtMjg2MjE_5b285a62-a83d-4063-921f-862328b19c62">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i79619c0d0304473a9a05f38376df1ca5_I20211231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzktMS0xLTEtMjg2MjE_3c670fc5-fc79-4e20-8986-3427244bf432">39.30</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79619c0d0304473a9a05f38376df1ca5_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzktNC0xLTEtMjg2MjE_41a17faf-e7fc-4d0b-a716-e2eb1a01c6cf">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5787bf9bc4b840c8b9474232abd18822_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzktNi0xLTEtMjg2MjE_714c4784-ca87-49d5-8934-c9de216e0406">2.83</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79619c0d0304473a9a05f38376df1ca5_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzktOC0xLTEtMjg2MjE_9c8ef1b1-80f6-4ad3-8dd8-70e35f081d94">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i187150c65510432d854fe82b6fb23a3c_I20211231" decimals="INF" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEwLTEtMS0xLTI4NjIx_330a62a6-c311-4bf7-bd1b-64349c56f547">47.40</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i187150c65510432d854fe82b6fb23a3c_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEwLTQtMS0xLTI4NjIx_579bffe9-43f0-4774-95fd-5e52f067dab7">4,745</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ice72d61a300545aeb3844e67957f9576_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEwLTYtMS0xLTI4NjIx_df24ee41-111f-4f9d-9ed3-702504539ed8">2.96</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i187150c65510432d854fe82b6fb23a3c_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEwLTgtMS0xLTI4NjIx_d77a7db7-0318-4d9a-aa5d-2a94b87f5768">4,745</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzExLTAtMS0xLTI4NjIx_8cd873fe-211a-4e77-a2e7-8f6f18e41114">10.79</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzExLTItMS0xLTI4NjIx_aac9c02a-084a-42ba-ad20-aa863fe2dfbe">47.40</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzExLTQtMS0xLTI4NjIx_179592d9-9da0-41f3-bc35-afe92b1204cb">287,175</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzExLTYtMS0xLTI4NjIx_1ef9f1cb-535c-4338-8fb9-d1802002fef1">4.92</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzExLTgtMS0xLTI4NjIx_028edcba-5f8c-472e-b4b3-e52e7d759b41">83,855</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Awards (RSU and PSU) Activity Table</span></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE1NDc2_3e71769d-1dfd-4c06-8828-d4b9f6e8b9f0" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to RSUs and PSUs activity is as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant-<br/>Date Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i08b960d0e6e645c39e84cc857ec13e6b_I20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEtMS0xLTEtMjg2MjE_7424375f-7e35-447f-bb53-3aedfb0b6e03">474,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i08b960d0e6e645c39e84cc857ec13e6b_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEtMy0xLTEtMjg2MjE_17709c41-33e6-40cd-9e37-d78d861b2b19">38.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b960d0e6e645c39e84cc857ec13e6b_I20181231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEtOS0xLTEtMjg2MjE_caa36f07-7b3a-4e67-a9ee-903e54f20ef5">8,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzItMS0xLTEtMjg2MjE_33a8b79f-734d-4aa7-95fb-b17fc2cab6bc">963,814</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzItMy0xLTEtMjg2MjE_0d290310-c64e-42e0-a2f0-6df76a201e85">18.68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzMtMS0xLTEtMjg2MjE_e0584a28-282e-4b4c-b522-b34888302d19">172,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzMtMy0xLTEtMjg2MjE_c63ab50b-b94d-4c30-a6dd-a128651e8446">33.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231" decimals="-3" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzMtNS0xLTEtMjg2MjE_68127eb9-322f-42dd-91f6-23e174b3eda8">6,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzQtMS0xLTEtMjg2MjE_279dd172-461e-420b-a5c5-150b4e2ce27f">161,022</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzQtMy0xLTEtMjg2MjE_f64a1bdd-1e81-4c05-92b4-3fa59707448e">37.91</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i192be0f1705145908aa6ad70700cddf7_I20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzUtMS0xLTEtMjg2MjE_9d7f4c14-4441-4d18-bb92-e10d17077d9a">1,104,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i192be0f1705145908aa6ad70700cddf7_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzUtMy0xLTEtMjg2MjE_40d11c73-402b-473b-b98c-32561d03bc6f">22.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192be0f1705145908aa6ad70700cddf7_I20191231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzUtOS0xLTEtMjg2MjE_40eec908-80e9-4419-b5e8-47d05176a020">37,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzYtMS0xLTEtMjg2MjE_af8c1713-94d1-4c5e-9594-51dbe274f4b4">667,694</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzYtMy0xLTEtMjg2MjE_9a36a82d-1f43-4e05-b824-08ceefde69ab">20.66</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzctMS0xLTEtMjg2MjE_53d7d868-526b-4c1f-9cdb-7d79233f7f05">684,491</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzctMy0xLTEtMjg2MjE_eecd28ae-70c8-4cba-9837-89bfd303ed56">17.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231" decimals="-3" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzctNS0xLTEtMjg2MjE_fd3aac23-23a8-42ed-b566-576e08aa2d44">12,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzgtMS0xLTEtMjg2MjE_83c3b8c8-a807-4e1f-ae71-2188ef0e6fa8">308,248</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzgtMy0xLTEtMjg2MjE_9110f2fa-970b-48f8-9042-55206ad4b827">23.24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice6c8183a7fa4570a3f044c0f1d54f9c_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzktMS0xLTEtMjg2MjE_17bc67eb-abc5-4eda-8479-78514e9cc7e8">779,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ice6c8183a7fa4570a3f044c0f1d54f9c_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzktMy0xLTEtMjg2MjE_6fe54d2d-ecee-4ebe-92f7-4afdb25d82f2">23.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice6c8183a7fa4570a3f044c0f1d54f9c_I20201231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzktOS0xLTEtMjg2MjE_28c2b4ea-a028-4c7e-a681-187d3274ffae">18,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEwLTEtMS0xLTI4NjIx_ba119e51-4c4f-4721-aa8f-e0030516195e">744,949</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEwLTMtMS0xLTI4NjIx_9f2a2a1c-fb9e-4587-ad68-6346fb0cea98">40.16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzExLTEtMS0xLTI4NjIx_5f97424c-5244-4cbf-a996-8a06f07b6670">254,946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzExLTMtMS0xLTI4NjIx_a302f639-06a0-4325-afe6-80acac203203">22.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231" decimals="-3" name="cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzExLTUtMS0xLTI4NjIx_26c0bd3a-d319-4aa6-b8be-ce1141d5d33b">8,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEyLTEtMS0xLTI4NjIx_adb6ce63-8c99-414c-8e67-15e87ac367fb">236,856</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEyLTMtMS0xLTI4NjIx_f52d3e38-3950-4934-a6e6-5b84898e4e12">27.33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i32524a5704d848b69d401dc8de11ebf9_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEzLTEtMS0xLTI4NjIx_8df6f8dc-4cf0-4dc9-84d2-59c8bd2e8391">1,032,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32524a5704d848b69d401dc8de11ebf9_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEzLTMtMS0xLTI4NjIx_e3b5d865-6da0-4caa-9bd0-c4ce6267f85d">35.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32524a5704d848b69d401dc8de11ebf9_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEzLTktMS0xLTI4NjIx_40b1bcc7-c35e-4434-b753-11497d078d61">42,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents the value of the Company&#8217;s stock on the date that the restricted stock units and performance stock units vest.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Based on the closing stock price of the Company&#8217;s stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="i32524a5704d848b69d401dc8de11ebf9_I20211231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExNTg5_f0a56a74-e6a4-4611-83a7-876a88e7a882">41.32</ix:nonFraction> on December&#160;31, 2021, $<ix:nonFraction unitRef="usdPerShare" contextRef="ice6c8183a7fa4570a3f044c0f1d54f9c_I20201231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExNTk5_f65adfd4-794f-47e3-80e9-348b038bcd65">24.11</ix:nonFraction> on December&#160;31, 2020, $<ix:nonFraction unitRef="usdPerShare" contextRef="i192be0f1705145908aa6ad70700cddf7_I20191231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExNjA5_2dad0a23-0fa3-42d7-9a95-82b3b12fd877">35.81</ix:nonFraction> on December&#160;31, 2019, and $<ix:nonFraction unitRef="usdPerShare" contextRef="i08b960d0e6e645c39e84cc857ec13e6b_I20181231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExNjIz_6d192be4-8d13-4d36-87cd-9cc96b2a20dd">17.02</ix:nonFraction> on December&#160;31, 2018.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The number of restricted stock units vested includes shares that the Company withheld on behalf of the employees to satisfy the statutory tax withholding requirements.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $<ix:nonFraction unitRef="usd" contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExODYz_33581de7-dabc-41fb-aa03-0b5973106dca">5.9</ix:nonFraction> million.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $<ix:nonFraction unitRef="usd" contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExOTI5_e10b1dff-209b-4f54-8693-5a8b5fc42429">12.2</ix:nonFraction> million.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $<ix:nonFraction unitRef="usd" contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExOTk1_00fc47d3-a65c-4bd0-8172-2be4fbf23a77">5.8</ix:nonFraction> million.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="i5e2bec8656684a6dabd49fdb70d25a46"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE1NDc3_ac0e87de-434d-4317-b304-a1160723e8a8" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense for the years ended December&#160;31, 2021, 2020 and 2019 was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzItMS0xLTEtMjg2MjE_cd6e8c10-9fdb-4d44-9290-a13930c8fcd3">782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzItMy0xLTEtMjg2MjE_b545d451-e7ca-464c-b864-30ef4786d876">370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35da96289dd949498eddb1768dd19192_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzItNS0xLTEtMjg2MjE_f9401111-05f9-4e9f-a633-585b876a608e">622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzMtMS0xLTEtMjg2MjE_3d4eac0a-a48f-4f23-8d83-9835cc19f54f">5,305</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzMtMy0xLTEtMjg2MjE_0904950e-f90a-4c35-83a0-8cfc106358fc">8,849</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzMtNS0xLTEtMjg2MjE_71bb35a2-0589-44e8-b534-53ea7d4a2abc">4,786</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3adb16d3075942348f225b70cf90f3a4_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzQtMS0xLTEtMjg2MjE_c08d2ee3-f89d-4ac3-893d-2963f5d31578">6,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cf974c819a34839aa1bfe59802e71ba_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzQtMy0xLTEtMjg2MjE_5b9f7094-f7ed-4afc-874d-f58e4b9dbfbc">666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66107087f3fd4a20b6cb4d48e7f3033a_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzQtNS0xLTEtMjg2MjE_d01b4d97-3124-43c7-94c2-4a762c63c54f">3,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0689b0010d214af6bd1356f9f93a1141_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzUtMS0xLTEtMjg2MjE_1d7e3014-c5b1-4072-a9bf-61564ee910aa">494</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i246ec24176874e33b14c7fda30f63bfc_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzUtMy0xLTEtMjg2MjE_68cdba27-f07e-407b-8f78-bf025041e12a">224</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacfb1ac9741f4b3db30f8728b64a645e_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzUtNS0xLTEtMjg2MjE_f29c51dc-6631-4b4d-bcd5-5e3131f0177d">476</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzYtMS0xLTEtMjg2MjE_1a28de52-5994-4994-93f9-6c9f2d0c158d">13,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzYtMy0xLTEtMjg2MjE_ab1e2fdf-2c8a-493c-9886-e634c4161d0b">10,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzYtNS0xLTEtMjg2MjE_97bb91b7-6260-485c-9f5e-73dcabe558a7">9,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE1NDc4_22e13f30-6ad4-4a55-9862-b3983049bade" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized during the year ended December&#160;31, 2021, 2020 and 2019 was recorded in the Consolidated Statement of Operations as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i199effaf47f34a41a806c1a1a7e53aa1_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzItMS0xLTEtMjg2MjE_95a81c1a-d920-4d03-ac91-5e33d22ea7c7">1,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea32c98f4b44fd4982e248bedf6cead_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzItMy0xLTEtMjg2MjE_892a5c6c-6a6a-4bd7-b3a6-8f42327a1160">1,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i053b35b2d01d445ea80dee2b47dbb5fb_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzItNS0xLTEtMjg2MjE_b52f8fa5-96aa-4c00-ac2c-48eab86dd422">1,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29b9e3b28d734adeb076ece7de227b71_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzMtMS0xLTEtMjg2MjE_9685196b-a0fa-40f4-bbef-ab0fb651d2b7">3,160</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49f345cd25654a7f84873131ed305500_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzMtMy0xLTEtMjg2MjE_a94b506f-208c-445b-abc4-e7cdf7d06d21">3,385</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3577892be364d588b4ee6707f9426df_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzMtNS0xLTEtMjg2MjE_2077f3e1-4826-4136-97e9-c0a28876d7bb">4,510</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866b9eac79cc4cecbfb1b078c5693146_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzQtMS0xLTEtMjg2MjE_2d82488f-8ff0-489d-adbf-ec92ee01f7d2">2,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d3833836ada4a39873f0f32f69266d9_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzQtMy0xLTEtMjg2MjE_a95c2d89-2ed9-4389-8c3b-a866c7819c34">1,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia001d3ced3134020b6fbcd0bdba96369_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzQtNS0xLTEtMjg2MjE_f85f4798-299e-47fe-92e1-fdcf5ca744cb">1,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16b8707c22974632a641c57e2b86817c_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzUtMS0xLTEtMjg2MjE_5697c701-34f3-419f-9a94-3ff43005b03d">5,820</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc44a2bdb221436a8375e04e1ea9bb79_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzUtMy0xLTEtMjg2MjE_63e87ec8-d942-4c65-b02a-57b50b48cc56">3,390</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4499ceba300a402e858712b9c26ba787_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzUtNS0xLTEtMjg2MjE_1bcf522c-6eab-49b1-ba98-9c259cf70c6d">2,214</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzYtMS0xLTEtMjg2MjE_43c8ddfe-7391-4e60-b78e-e30df5ddacac">13,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzYtMy0xLTEtMjg2MjE_0c2e22fc-60ef-49bd-8240-c35608425a36">10,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzYtNS0xLTEtMjg2MjE_89c221c0-8559-48d4-94e4-3bbd9d2681ad">9,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation Assumptions and Fair Value of Stock Options and ESPP Grants</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes option pricing model to estimate the fair value of options granted under its equity incentive plans and rights to acquire stock granted under its employee stock purchase plan. <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="cutr:ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE1NDc5_2f380117-314b-4870-be56-202448c169b2" continuedAt="i4489d025b78d4b5b8495a586f30a83e5" escape="true">The weighted average estimated fair values of the employee stock options and rights granted under the employee stock purchase plan and the weighted average assumptions used to calculate the grant date fair values, are as follows:</ix:nonNumeric></span></div><ix:continuation id="i4489d025b78d4b5b8495a586f30a83e5"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:23.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.833%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Purchase Plan (ESPP)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzItMS0xLTEtMjg2MjE_985f64e2-7a7a-4063-b70e-2046625a21e1">3.97</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzItMy0xLTEtMjg2MjE_77830a4e-ce63-4d3c-84ac-f438c923bc7b">4.84</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i35da96289dd949498eddb1768dd19192_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzItNS0xLTEtMjg2MjE_b694cea6-706d-407a-9066-18cc79a949e0">3.65</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib9d312fc584843e38678f9ffd58f8a01_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzItNy0xLTEtMjg2MjE_9f13d9b4-eec4-4eda-97c4-802364320141">0.50</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iac80237e6ee945ac8a0c0ba713b41438_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzItOS0xLTEtMjg2MjE_e505e86b-d8e0-44ed-89cb-c44dff50bb7b">0.50</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ide91ed10ffb54702b454c8e2a5cad1d1_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzItMTEtMS0xLTI4NjIx_c0ef2e7c-4709-4e86-ab0d-d003edbeb140">0.50</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzMtMS0xLTEtMjg2MjE_82dbedbb-4f00-490a-a3c1-8610d99f1d38">0.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzMtMy0xLTEtMjg2MjE_39b5e38d-8106-495b-b6ba-c99e72ab3e4b">0.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35da96289dd949498eddb1768dd19192_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzMtNS0xLTEtMjg2MjE_7344c7a6-39cf-4df7-9e3a-ae52103ff2e9">1.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib9d312fc584843e38678f9ffd58f8a01_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzMtNy0xLTEtMjg2MjE_f475cfaf-ba92-449c-ada8-9fbc4ed1b940">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac80237e6ee945ac8a0c0ba713b41438_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzMtOS0xLTEtMjg2MjE_c276d88e-71a0-4079-88b0-46f47f76aa76">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide91ed10ffb54702b454c8e2a5cad1d1_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzMtMTEtMS0xLTI4NjIx_37b56a7c-f09c-4c81-9f59-b7cbbfb0107e">2.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzQtMS0xLTEtMjg2MjE_124110ff-c243-4106-8f74-81334b823259">66</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzQtMy0xLTEtMjg2MjE_c842918d-08f7-441b-8c13-f5ed902b4217">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35da96289dd949498eddb1768dd19192_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzQtNS0xLTEtMjg2MjE_4e288b79-dc55-41db-9d83-646130b69c68">54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib9d312fc584843e38678f9ffd58f8a01_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzQtNy0xLTEtMjg2MjE_caf09100-18b2-4720-8a5c-b73134e5c660">36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac80237e6ee945ac8a0c0ba713b41438_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzQtOS0xLTEtMjg2MjE_4336e4a6-ca6f-4376-9ad4-a6adc3bd059f">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide91ed10ffb54702b454c8e2a5cad1d1_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzQtMTEtMS0xLTI4NjIx_ab564402-7e9f-4b51-b125-3f116d182dc1">70</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzUtMS0xLTEtMjg2MjE_7c0a0bab-f7e9-4bd1-8bdb-41e8b0366661">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzUtMy0xLTEtMjg2MjE_0f44abfb-c3c2-4962-824b-3ce32b21e305">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i35da96289dd949498eddb1768dd19192_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzUtNS0xLTEtMjg2MjE_a394d924-ef8f-4f93-b0d5-aa6dec5d192f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib9d312fc584843e38678f9ffd58f8a01_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzUtNy0xLTEtMjg2MjE_8438ab52-b3b6-4b80-b281-12d6589d4780">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iac80237e6ee945ac8a0c0ba713b41438_D20200101-20201231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzUtOS0xLTEtMjg2MjE_f54ea414-271e-4171-b24d-125134b4be0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide91ed10ffb54702b454c8e2a5cad1d1_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzUtMTEtMS0xLTI4NjIx_590b6e38-7600-42f8-835f-d806564b3869">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average estimated fair value at grant date</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzYtMS0xLTEtMjg2MjE_8a2e56b0-4a0e-4fb8-a3f7-d6f822186e77">15.09</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzYtMy0xLTEtMjg2MjE_9387ca90-8c84-404d-99bd-ae5bc2f45179">7.63</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i35da96289dd949498eddb1768dd19192_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzYtNS0xLTEtMjg2MjE_93ca658f-ef03-4bac-a700-f943805f3c0c">14.83</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib9d312fc584843e38678f9ffd58f8a01_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzYtNy0xLTEtMjg2MjE_494fce7c-f4bc-40e3-ac33-c7d26e34b9a9">9.64</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iac80237e6ee945ac8a0c0ba713b41438_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzYtOS0xLTEtMjg2MjE_ae0f4ec9-8994-4fa8-8b13-838bfe8f2cf5">6.13</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ide91ed10ffb54702b454c8e2a5cad1d1_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzYtMTEtMS0xLTI4NjIx_ececec58-7176-4d58-815d-a7abca2627d8">9.60</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The expected term represents the period during which the Company&#8217;s stock-based awards are expected to be outstanding. The estimated term is based on historical experience of similar awards, giving consideration to the contractual terms of the awards, vesting requirements and expectation of future employee behavior, including post-vesting terminations. The expected term of groups of employees that have similar historical exercise patterns has been considered separately for valuation purposes.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The risk-free interest rate is based on U.S. Treasury debt securities with maturities close to the expected term of the option or ESPP participation right as of the date of grant.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Estimated volatility is based on historical volatility. The Company estimates volatility based on the Company&#8217;s historical volatility of its stock price.&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company has not paid dividends since its inception.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="idabc87e13e174d3c9f17fa6963046f56_130"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7&#8212;<ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzY0Mzc_ac2685aa-0e9e-4dfe-a2a9-f787ddd4dd5c" continuedAt="i14ce4791b7694102ba466ace97dc667f" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i14ce4791b7694102ba466ace97dc667f" continuedAt="i9cb4f361523448d28b35c77487deb4e4"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal and various state and local jurisdictions and foreign jurisdictions. <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzY0Mzg_fdcf84cf-0090-4265-afac-b6fb251e341d" continuedAt="ia255b44acfbd448dac5936e0fea75bc5" escape="true">The Company&#8217;s income (loss) before provision for income taxes consisted of the following (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ia255b44acfbd448dac5936e0fea75bc5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzItMS0xLTEtMjg2MjE_ecb8f0a4-b6e0-4996-925d-e5cc70c26eec">356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzItMy0xLTEtMjg2MjE_546873f6-4d18-4695-b7cd-849f0c9c3526">25,793</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzItNS0xLTEtMjg2MjE_0f83187c-973e-4dd1-981d-13b5620ce350">13,037</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzMtMS0xLTEtMjg2MjE_2c1bb0e4-5b41-4e51-b431-29ff01518907">3,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzMtMy0xLTEtMjg2MjE_ed37119b-62bb-44ea-9556-3f5d6f16522e">2,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzMtNS0xLTEtMjg2MjE_e5674dbb-347f-4cb0-b191-f973fb79287d">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzQtMS0xLTEtMjg2MjE_ae974a19-4035-4050-a5f2-d111fc7529af">3,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzQtMy0xLTEtMjg2MjE_dc6801de-83bf-4960-9ad8-330d3166c96a">23,407</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzQtNS0xLTEtMjg2MjE_c1ad0a51-cb45-4c8e-ab5e-56d929e68af1">12,263</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzY0Mzk_afecc375-8de5-45b3-ab4a-38cb765f9ca5" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the provision for income taxes are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzMtMS0xLTEtMjg2MjE_1b2de645-8c07-426f-82e1-1b81516dc160">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzMtMy0xLTEtMjg2MjE_1fd91d9a-c051-423a-9053-03afd2a7073c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzMtNS0xLTEtMjg2MjE_d9834b5d-8c31-466e-a1f2-5a6dae9d2370">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzQtMS0xLTEtMjg2MjE_7cdf5c08-1a48-403f-8cfe-d8c89bb00e68">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzQtMy0xLTEtMjg2MjE_fd2e8701-5cfb-41ca-ad08-dbb36b45898e">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzQtNS0xLTEtMjg2MjE_f78ec897-23d2-4508-82e7-7f886a7a4330">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzUtMS0xLTEtMjg2MjE_44b54649-f7f9-46c0-8d91-427f04fe89db">1,512</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzUtMy0xLTEtMjg2MjE_a4abbdc1-2f7b-4410-998c-7b92e3504641">747</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzUtNS0xLTEtMjg2MjE_f8410099-d44d-4047-86ff-b6088002580f">76</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzYtMS0xLTEtMjg2MjE_ac551914-dcf3-4d56-90cb-e0c69b382544">1,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzYtMy0xLTEtMjg2MjE_a0520fe0-aa74-4525-92b7-66fec3670963">694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzYtNS0xLTEtMjg2MjE_04cc0494-e650-4691-a0a0-e80f10c87f4e">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzgtMS0xLTEtMjg2MjE_c401fb6b-6f60-4576-b188-3ff5ba7a2978">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzgtMy0xLTEtMjg2MjE_5e73c8f8-05b2-4ab7-8233-34d767b506e1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzgtNS0xLTEtMjg2MjE_d8027e09-e07e-4838-9412-2f65010a1037">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzktMS0xLTEtMjg2MjE_21f2517b-4d66-4cc9-ab27-eafcd707dbd9">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzktMy0xLTEtMjg2MjE_4515127e-07cc-4f16-9fd5-c294290f5bc4">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzktNS0xLTEtMjg2MjE_31869089-8d1f-4d46-ad06-0a67dd175262">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzEwLTEtMS0xLTI4NjIx_65eb204f-1bc5-4737-b595-3c6cd92d527f">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzEwLTMtMS0xLTI4NjIx_fdb05d53-6fc1-4678-a1cd-0af33a526dda">227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzEwLTUtMS0xLTI4NjIx_dbd690de-6c00-4cbf-86af-2cfd2bd40dd6">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzExLTEtMS0xLTI4NjIx_7c53d7fb-9cf5-4bd7-9b4e-1789ec11fde4">102</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzExLTMtMS0xLTI4NjIx_d350d934-632f-45c7-bcb5-20790d6492f5">224</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzExLTUtMS0xLTI4NjIx_b9bdb9c6-ed42-489c-a088-a7448988a1af">60</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzEyLTEtMS0xLTI4NjIx_e20e4c94-e8f0-426c-9f06-613b219fd6f9">1,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzEyLTMtMS0xLTI4NjIx_c47a6570-0dc9-47fd-99f8-4627a8de1751">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzEyLTUtMS0xLTI4NjIx_80954e7a-a996-4793-a5ba-fcec2dc73518">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzY0NDA_b1214c11-9069-4712-b46e-6add611cdf5f" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net deferred tax assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzItMS0xLTEtMjg2MjE_97fd73ab-44c7-41c2-b0f8-dbbee18cd523">18,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzItMy0xLTEtMjg2MjE_d69eb2f2-c096-42b1-827c-9fd44963882e">18,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzMtMS0xLTEtMjg2MjE_d77f84c5-edf2-459c-8702-7de9ebea0915">3,160</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzMtMy0xLTEtMjg2MjE_3859f8b4-ab6c-4956-a2bf-e4d876354d6a">869</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals and reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzQtMS0xLTEtMjg2MjE_ed75946d-cc60-4578-a559-b1dc1b957678">2,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzQtMy0xLTEtMjg2MjE_628832e2-b60b-42fa-8b1f-b25821ee8e33">3,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzUtMS0xLTEtMjg2MjE_3dbc5512-f207-4af8-83ca-afd6435ab82b">13,634</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzUtMy0xLTEtMjg2MjE_a755eeed-f913-4015-b5c5-2cd358a0e8dd">12,653</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzYtMS0xLTEtMjg2MjE_ed541b55-4cbf-4a81-aabc-38485666b3f5">939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzYtMy0xLTEtMjg2MjE_8b0d473f-2276-4970-b6a8-2dc95b586f90">976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzctMS0xLTEtMjg2MjE_eabb8102-59f4-40ab-a142-550d55932a12">2,226</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzctMy0xLTEtMjg2MjE_b6794941-72a3-4a21-a7a8-c78ed1c57c4e">2,191</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzgtMS0xLTEtMjg2MjE_af43d8c2-1300-4e87-9025-96c7ecbb61fa">977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzgtMy0xLTEtMjg2MjE_234dee35-ed08-4d99-9693-5d0780839b8f">979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="cutr:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzktMS0xLTEtMjg2MjE_0dd01592-8371-4654-b96f-1a0054d70fa2">3,784</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="cutr:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzktMy0xLTEtMjg2MjE_e25888d4-852a-4ff9-b057-f441d88e59d7">4,311</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset before valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzEwLTEtMS0xLTI4NjIx_5d6002b7-b646-451f-bf5b-6bcdaa27834c">45,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzEwLTMtMS0xLTI4NjIx_f5ff23de-c958-47b1-8670-9d54000800de">43,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzExLTEtMS0xLTI4NjIx_4f859e8e-f840-4676-9493-1807fc5be1b3">40,485</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzExLTMtMS0xLTI4NjIx_3fa20173-c62b-44a0-8c5a-b837d9c5ac79">38,321</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset after valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzEyLTEtMS0xLTI4NjIx_357880d5-10e1-4aba-a476-6d3b7a6e9d24">5,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzEyLTMtMS0xLTI4NjIx_2fc01150-3190-4bad-accb-277840e22b39">5,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="cutr:DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzEzLTEtMS0xLTI4NjIx_20e67d1b-3474-4830-9930-215981e697ee">990</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="cutr:DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzEzLTMtMS0xLTI4NjIx_651b2d9b-fc09-41b3-bf0c-1c139ddd428e">803</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzE0LTEtMS0xLTI4NjIx_4795072e-d118-4d52-b38f-f8a03cccba2b">124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzE0LTMtMS0xLTI4NjIx_4a867ee8-b773-490e-8249-251ffc94be96">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzE1LTEtMS0xLTI4NjIx_b3b97f8d-02b1-411f-bf24-60839f70da94">3,480</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzE1LTMtMS0xLTI4NjIx_bac0430b-16cd-4e19-a310-a9a57a88b96f">4,042</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset (liability)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzE2LTEtMS0xLTI4NjIx_3733240a-b8df-4c9c-8d3b-641e81fb462c">778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzE2LTMtMS0xLTI4NjIx_9cf2d0ee-ccb9-4a49-8627-a75b9176a843">643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzY0NDE_e178b187-776b-4283-aade-10aff00f247c" continuedAt="ie7c4bd2d4d4d4673aa3fb02e04fab180" escape="true">The differences between the U.S. federal statutory income tax rates to the Company&#8217;s effective tax rate are as follows:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="i9cb4f361523448d28b35c77487deb4e4" continuedAt="ifdd97fe1980d46c6a9fe234f7ffa57f4"><div style="margin-top:5pt"><ix:continuation id="ie7c4bd2d4d4d4673aa3fb02e04fab180"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzItMS0xLTEtMjg2MjE_8b1604e1-9c21-4c0d-8d92-a658371b69b8">21.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzItMy0xLTEtMjg2MjE_b668ddf3-b36f-4214-9235-199907aebfff">21.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzItNS0xLTEtMjg2MjE_3ab35881-b306-412e-a0fe-cac0e61de2f2">21.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State tax rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzMtMS0xLTEtMjg2MjE_b79c054d-cc88-4822-84fa-8f841205cc8d">2.55</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzMtMy0xLTEtMjg2MjE_70c096bc-32c5-4330-aefc-c8fb1b1ae524">2.77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzMtNS0xLTEtMjg2MjE_dcbeadef-3f3b-427c-8fa3-5f30e7c795fc">2.82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Meals and entertainment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzQtMS0xLTEtMjg2MjE_703cd106-6f9f-4a4a-bd00-232fd2c06c98">9.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzQtMy0xLTEtMjg2MjE_036901d7-4611-484a-b67a-d7496aea128e">0.65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzQtNS0xLTEtMjg2MjE_99dc904d-f13b-4a12-a0de-ca17cc183493">2.83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzUtMS0xLTEtMjg2MjE_944dc291-1b15-41ba-8c10-9036abf8c7f4">1.11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzUtMy0xLTEtMjg2MjE_45049a3a-2b94-44c2-840e-53a7ca99ef33">2.87</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzUtNS0xLTEtMjg2MjE_6fd5a0b5-4a40-47c5-a9e3-ceb7cbd793d3">2.58</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzYtMS0xLTEtMjg2MjE_ee84e1bb-2934-4c82-bcbd-0dd41175ecf7">13.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzYtMy0xLTEtMjg2MjE_c7b6fb04-6874-4989-8a06-c0bf54d46e77">1.07</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzYtNS0xLTEtMjg2MjE_66640159-8fb2-4232-911f-7bfd467d41b7">3.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extinguishment of PPP loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzctMS0xLTEtNDgyNjE_3406486a-8be4-43c6-8d47-c075f0496478">44.59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzctMy0xLTEtNDgyNjE_d9603c6f-b69d-4b57-82fc-e95b5b1a9d64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzctNS0xLTEtNDgyNjE_d68b3108-0669-4f85-9ae2-13789130a0b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzgtMS0xLTEtNDkzODU_27ee00a3-8515-4346-b3fa-73679b6abb35">7.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzgtMy0xLTEtNDkzODU_65f4cac4-c2c1-4334-aa5d-d3c97f673ea6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzgtNS0xLTEtNDkzODU_1cabad97-ea22-4d7e-bfde-b6f7ffc42db3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzgtMS0xLTEtMjg2MjE_bcdd3753-7394-43cb-b1d7-791465bd9cee">17.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzgtMy0xLTEtMjg2MjE_a6039839-e177-4641-8920-d4c6e80016db">1.05</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzgtNS0xLTEtMjg2MjE_95f03d38-40fd-4020-82dd-197413e8da1f">0.34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzktMS0xLTEtMjg2MjE_862d718a-1d31-475f-ae5d-b89d2fea62b1">0.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzktMy0xLTEtMjg2MjE_71961ba3-b939-41e0-92ad-e1cc8b3e68c9">0.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzktNS0xLTEtMjg2MjE_5d158b28-5fd0-4ca7-aed3-d561919e4a74">0.33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General business credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEwLTEtMS0xLTI4NjIx_e08d9381-b44f-4729-b06c-faacc4cf94d1">17.95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEwLTMtMS0xLTI4NjIx_abbe8233-420f-4427-930c-6a914025dd2d">2.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEwLTUtMS0xLTI4NjIx_4b3b2a73-6c20-4a4c-8e3f-3da0ab64e201">8.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzExLTEtMS0xLTI4NjIx_8581b44a-97e5-48ae-9314-1b3eb98fdbcf">72.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzExLTMtMS0xLTI4NjIx_15da3df8-bdcd-4185-a4d3-3ef400f77872">25.51</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzExLTUtMS0xLTI4NjIx_42704527-e84c-4ce1-bb7f-435a10a0dbec">38.60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in prior year reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEyLTEtMS0xLTI4NjIx_5b0e73ad-6404-4af8-9ae5-0aae50b5aa59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEyLTMtMS0xLTI4NjIx_2c6cefd7-7978-49e5-8452-58991b5d45fd">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEyLTUtMS0xLTI4NjIx_d4cc7c55-e86c-4174-bf04-dcb048e8c9fb">2.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred true-up</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="4" sign="-" name="cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEzLTEtMS0xLTI4NjIx_f9a1d9e6-b0f8-4606-b2a7-acffe253a31f">11.76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEzLTMtMS0xLTI4NjIx_b802c495-4ac7-478b-ac9a-ffe84fb2ccd8">2.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="4" name="cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEzLTUtMS0xLTI4NjIx_b1c75a01-501b-4378-9b64-55c1eb8ff56d">5.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzE0LTEtMS0xLTI4NjIx_3d7813a2-9743-49ac-b4e1-2c274279dc21">39.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzE0LTMtMS0xLTI4NjIx_62167a3a-0ec3-4482-89c4-aaef29160a51">2.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="4" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzE0LTUtMS0xLTI4NjIx_064ba28d-8f76-48bf-8f52-b1d16f1a4d00">0.70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company recorded a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzYwOQ_a14f0c9b-fb67-419f-abda-89eb5c7378c1">40.5</ix:nonFraction> million for the portion of the deferred tax asset that it does not expect to be realized. The valuation allowance on the Company&#8217;s net deferred taxes increased by $<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzc2Nw_e24027f4-2356-417e-9809-1f8e92fe6d36">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzc3NA_38f950dd-39c0-429b-94d3-829ed68fb46e">6.0</ix:nonFraction> million during the years ended December&#160;31, 2021 and 2020, respectively. The changes in valuation allowance are primarily due to additional U.S. deferred tax assets and liabilities incurred in the respective year. The Company has $<ix:nonFraction unitRef="usd" contextRef="i2e6fd16be09042c6be9c81d3d9e1c187_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzk4Mg_e5fad84d-08c6-4988-ab55-68219dee0866">0.8</ix:nonFraction> million of net deferred tax assets in foreign jurisdictions, which management believes are more-likely-than-not to be realized given the expectation of future earnings in these jurisdictions. The Company continues to monitor the realizability of the U.S. deferred tax assets taking into account multiple factors, including the results of operations and magnitude of excess tax deductions for stock-based compensation. The Company intends to continue maintaining a full valuation allowance on its U.S. deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. Release of all, or a portion, of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i55e82d33e5544074a2aac447d7824467_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzE4MzU_7d3ed1e4-8b0c-4e53-8fc8-d4cbafd2fdc3">75.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7b4a1f39d65147fcac2e81a5c60fcdb4_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzE4NDI_d8ccc631-abaf-48ca-9a9e-31e5774113da">39.3</ix:nonFraction> million of federal and state net operating loss carryforwards, respectively, available to offset future taxable income. The federal and state net operating loss carryforwards, if not utilized will generally begin to expire in 2029&#160;through 2039. Approximately $<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-5" name="cutr:OperatingLossCarryforwardsWithoutExpiration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzI3NDg3NzkwNzYwMDI_6f018495-9419-4011-8199-f57327e3d9ba">35.4</ix:nonFraction> million of total federal net operating loss carryforwards were generated post December 31, 2017 and have no expiration. At December&#160;31, 2021, the Company had research and development tax credits available to offset federal and California tax liabilities in the amount of $<ix:nonFraction unitRef="usd" contextRef="ifade32131fd14ec1926f12852d497aed_I20211231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzIzNDc_43b46d46-934b-4fe4-8819-1a0809101292">6.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3598dca90d534ae0a8d4aaf1b13b56c1_I20211231" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzIzNTE_2b88dbaf-b0a7-40e2-a06b-b9487be6592c">8.5</ix:nonFraction> million, respectively. Federal credits will begin to expire in 2024 and California state tax credits have no expiration.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state laws can impose substantial restrictions on the utilization of net operating loss and tax credit carryforwards in the event of an &#8220;ownership change,&#8221; as defined in Section 382 of the Internal Revenue Code. The Company has determined that no significant limitation would be placed on the utilization of the Company&#8217;s net operating loss and tax credit carryforwards due to prior ownership changes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No deferred tax liabilities have been recorded relating to the earnings of the Company&#8217;s foreign subsidiaries since all such earnings are intended to be indefinitely reinvested. The amount of the unrecognized deferred tax liability associated with these earnings is immaterial.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uncertain Tax Positions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes reserves for uncertain tax positions based on the largest amount that is more-likely-than-not to be sustained. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. The Company performs a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="ifdd97fe1980d46c6a9fe234f7ffa57f4"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes it has adequately reserved for its uncertain tax positions, no assurance can be given that the final tax outcome of these matters will not be different. The Company adjusts these reserves in light of changing facts and circumstances, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate, as well as the related net interest and penalties.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files U.S., state, and foreign income tax returns in jurisdictions with varying statutes of limitations. Tax years after 2006 remain subject to examination by U.S. federal and California state tax authorities due to the Company&#8217;s net operating loss and credit carryforwards. For significant foreign jurisdictions, tax years after 2016 remain subject to examination by their respective tax authorities.</span></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzY0NDI_47497835-2f90-4a24-ade7-a5d31c94c74d" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits, excluding related interest and penalties, in December 31, 2019 to December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzItMS0xLTEtMjg2MjE_d8391899-b99c-4838-9eb1-4f190fcb8f06">1,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzItMy0xLTEtMjg2MjE_b4683404-cc24-46b6-8bb2-4a44565549c7">1,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzItNS0xLTEtMjg2MjE_6c8aed11-fc20-4f18-b5a8-76ac53ad844c">1,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzMtMS0xLTEtMjg2MjE_02c11c98-6e6e-4c0c-8c24-ab0de2ee6810">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzMtMy0xLTEtMjg2MjE_43951ad0-fde1-4211-ad2e-5a9fb87ddcfa">32</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzMtNS0xLTEtMjg2MjE_24f80fe2-312d-40ca-a84b-f7951cc4cc56">291</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzQtMS0xLTEtMjg2MjE_9b5cf40e-8fc0-4f8f-a7c7-15d1a65f8272">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzQtMy0xLTEtMjg2MjE_7569da48-b34f-4dbf-b763-e1ec058a9133">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzQtNS0xLTEtMjg2MjE_8f7fdc4a-567b-4565-b9ba-1c825d21ffed">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzUtMS0xLTEtMjg2MjE_2c6353a4-6443-4a0a-8bfa-143e3b830a73">919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzUtMy0xLTEtMjg2MjE_12a0e5a6-9216-48d0-ab40-aaffbcc535d2">470</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzUtNS0xLTEtMjg2MjE_33f460bc-a88f-4e5a-a012-bb1d951e355b">129</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzYtMS0xLTEtMjg2MjE_f980ed3d-6583-46da-b226-ad5502055549">2,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzYtMy0xLTEtMjg2MjE_4b7d36e1-8808-43dd-acd1-0773ad5e4bb5">1,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzYtNS0xLTEtMjg2MjE_f742a004-60c8-4f2f-8b6a-ff8f5d460d4c">1,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="idabc87e13e174d3c9f17fa6963046f56_136"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8&#8212;<ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90ZXh0cmVnaW9uOmI3NGQyMTViYzQ4NjQyMDk5NTM1NTdjOGI2MzQyNTBkXzE0MDE_fb4e7032-404b-423e-8548-2270f202da76" continuedAt="i41bab07837a542c69e4d6bda7ce417eb" escape="true">NET INCOME (LOSS) PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i41bab07837a542c69e4d6bda7ce417eb" continuedAt="ia56c1281ebf04d09886cfd281f5fd214"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company&#8217;s convertible notes were potentially convertible into <ix:nonFraction unitRef="segment" contextRef="ia4c6391b6a824369a52a92dbea8b9166_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90ZXh0cmVnaW9uOmI3NGQyMTViYzQ4NjQyMDk5NTM1NTdjOGI2MzQyNTBkXzM4NDgyOTA3MDI3MTg_a963ff76-bae7-4fe4-a22b-c5c731f9b894">4,167,232</ix:nonFraction> shares of common stock. The Company used the if-converted method to calculate the potential dilutive effect of the conversion spread on diluted net income per share for the year ended December 31, 2021. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The denominator for diluted net income (loss) per share does not include any effect from the capped call transactions the Company entered into concurrently with the issuance of the convertible notes, as this effect would be anti-dilutive. In the event of conversion of a convertible note, shares delivered to the Company under the capped call will offset the dilutive effect of the shares that the Company would issue under the convertible notes. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the years ended December 31, 2020 and 2019, basic loss per common share and diluted loss per common share are the same in each respective period, as the inclusion of any potentially issuable&#160;shares would be&#160;anti-dilutive.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90ZXh0cmVnaW9uOmI3NGQyMTViYzQ4NjQyMDk5NTM1NTdjOGI2MzQyNTBkXzE0MDI_cc830edf-e0d1-4dbe-ab71-b72ff5a43fef" continuedAt="if33502835dd5473cba487274e746b4da" escape="true">The following table sets forth the computation of basic and diluted net loss and the weighted average number of shares used in computing basic and diluted net loss per share (in thousands, except per share data):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="ia56c1281ebf04d09886cfd281f5fd214"><div style="margin-top:5pt"><ix:continuation id="if33502835dd5473cba487274e746b4da"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzMtMS0xLTEtMjg2MjE_4bbb152c-51b7-4c3b-9db4-83445f71351e">2,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzMtMy0xLTEtMjg2MjE_72723b26-f1c2-437c-8286-d183de583195">23,877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzMtNS0xLTEtMjg2MjE_336ac29b-1f2c-4d0b-8d53-31d557b46ad7">12,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzUtMS0xLTEtMjg2MjE_445db900-fac0-40ac-93ed-0cbaefd937b5">17,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzUtMy0xLTEtMjg2MjE_bc7c8378-4828-453a-9a30-923d791d11a5">16,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzUtNS0xLTEtMjg2MjE_f28a2085-de4d-424d-bd86-567814270cd2">14,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of incremental shares and share equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzctMS0xLTEtMzc0Njg_f5440edc-632d-416d-8d48-62812ee3275f">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzctMy0xLTEtMzQxNDg_2a667648-d681-4f9b-a00a-28eebe7300a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i35da96289dd949498eddb1768dd19192_D20190101-20191231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzctNS0xLTEtMzQxNTk_3934e677-8795-4f06-a407-3db238acbe4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzgtMS0xLTEtMzc0Njg_fab346cc-02a4-4280-936f-072f3ce21d2d">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzgtMy0xLTEtMzQxNDg_afef21d8-dd90-4682-845e-0180c125687e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzgtNS0xLTEtMzQxNTk_f1d69100-df57-4020-b465-c5c0a2005e68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3adb16d3075942348f225b70cf90f3a4_D20210101-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzktMS0xLTEtMzc0Njg_ddfc5bcc-b29b-4baa-8aff-6e49d3d0fb0a">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7cf974c819a34839aa1bfe59802e71ba_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzktMy0xLTEtMzQxNDg_e253eb14-3175-493e-abe8-3d46bd3025e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66107087f3fd4a20b6cb4d48e7f3033a_D20190101-20191231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzktNS0xLTEtMzQxNTk_6efcab22-727a-4442-8251-c388b4099509">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i908d24eef82248b3b0c5e24ce67d7620_D20210101-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzEwLTEtMS0xLTM3NDY4_bd7cc34d-9dc6-4274-b75f-7c178806ef96">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2673044451384aab8b4c321ea6b9f8a2_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzEwLTMtMS0xLTM0MTQ4_f457e6a5-fa01-4be6-9d3d-c0785c51e93c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia643c91cedb04d559d547cfeceee8809_D20190101-20191231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzEwLTUtMS0xLTM0MTU5_fb6c42d6-617f-4b9c-9c41-65651dff1f29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzExLTEtMS0xLTM3NDY4_5fb3f48b-2a0c-4b39-83ea-2e8662bfe704">18,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzExLTMtMS0xLTM0MTQ4_00857283-9062-4216-b71f-025c938a1b30">16,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzExLTUtMS0xLTM0MTU5_1bb19b15-000d-459b-bb4d-3156298e01c3">14,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share, basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzEzLTEtMS0xLTM0MTc0_3033b9b0-9305-44bc-a54b-a89cff7c8abf">0.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzEzLTMtMS0xLTM0MTQ4_a1677975-85c4-466b-9e1d-3c0d3e43e20d">1.43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzEzLTUtMS0xLTM0MTU5_bc8efcfc-121b-44e2-9650-936dffb71b0e">0.88</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzctMS0xLTEtMjg2MjE_1da05d83-1d77-40a1-ba33-870c36d413c3">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzctMy0xLTEtMjg2MjE_ab3e55af-7067-418b-9ca7-3af70ab867bc">1.43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzctNS0xLTEtMjg2MjE_4d08d0da-2144-4bda-b6c3-52ceb9b25421">0.88</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90ZXh0cmVnaW9uOmI3NGQyMTViYzQ4NjQyMDk5NTM1NTdjOGI2MzQyNTBkXzE0MDM_5c9db542-c1f5-49ed-a7b9-db45a96ee80d" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following numbers of shares outstanding, prior to the application of the treasury stock method and the if-converted method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capped call</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9eb3b54c6e9341a299439438dca1b02c_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzItMS0xLTEtMzQzNDc_7484d1c6-cbcc-4429-a0c3-84d443b2c70e">4,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i637b3d70c182413ba3e75aa2bef9320b_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzItMy0xLTEtMzQzNTg_443a1d01-73a2-4a42-9cba-48320b02bdd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id943a7c916e04296aa697a2d261b63c9_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzItNS0xLTEtMzQzNjk_95c837ed-bfef-46fb-9bcc-cd6004fcf844">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c1a042e66a646cf876664c9b9e32ccf_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzMtMS0xLTEtMzQzNDc_60edaa69-8850-47db-a07f-79cf234a8b32">4,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69439113ac644761bbfd84226a430cdc_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzMtMy0xLTEtMzQzNTg_8709041e-2cb7-459c-a718-be21212acad7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9751faf680174024a66bfd73c40bb6ae_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzMtNS0xLTEtMzQzNjk_23c8a578-4471-43d9-8575-dfc441cf8838">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i827ff77fcef14e9c82c96fe8afe59e6f_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzItMS0xLTEtMjg2MjE_8eef38fe-a839-4ea6-9362-6b88ee5d08f9">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5e396b1a03c446faf5e013cd334d63a_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzItMy0xLTEtMjg2MjE_f8c1ce1a-bca2-4593-83e3-76913220b99b">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia86ce17804314cdfb7203658a2fa825c_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzItNS0xLTEtMjg2MjE_c5d6c94a-6de0-4868-b121-a5cd611a085d">417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i26a28b3231d24fbd9da85098c345597f_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzMtMS0xLTEtMjg2MjE_8ba6f6d4-38e0-427f-b538-365b4788f2c4">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d3b04419de146f79e0830d4f8e5fc88_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzMtMy0xLTEtMjg2MjE_fcd6d6c4-50f5-4504-a618-ac1c645d4d7b">724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67dd4dfa6fb84a8d803fd3e4686012df_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzMtNS0xLTEtMjg2MjE_401d7213-85c4-4376-9b17-9f70127c95e4">559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i49698c4c16fa448aa1199cdea0f0db3f_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzQtMS0xLTEtMjg2MjE_306af4ae-cbba-4057-94e2-07eab6001f82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iadd6424f69774b75aa9f2d8c176bfc58_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzQtMy0xLTEtMjg2MjE_0eeb1f3a-3e1f-456e-82b7-a42b73659d3c">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i82424323bc6746ac95ae7b4f28e7db6e_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzQtNS0xLTEtMjg2MjE_7b23bb87-2894-48bc-a938-4ca763891574">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id80c93e18ea14c80a7c54a7919d9e363_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzUtMS0xLTEtMjg2MjE_cb044894-7eda-42ca-855d-58580d6f0909">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id3d8659c50814d9ba9e908c0fdd94d23_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzUtMy0xLTEtMjg2MjE_aa09dff2-9795-451c-8ab1-0ce081bdc0ef">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied686aef55a948f5bdf73f5ebd34b570_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzUtNS0xLTEtMjg2MjE_99ea180c-b150-4c89-97c4-881d90e971d2">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzYtMS0xLTEtMjg2MjE_64dac984-5965-403d-8dec-409040315edb">8,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzYtMy0xLTEtMjg2MjE_06b9b17d-c775-4c5a-9bc3-5a3339a69693">1,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzYtNS0xLTEtMjg2MjE_cf286b4b-88a3-4a15-8e5c-1774c2941eda">1,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="idabc87e13e174d3c9f17fa6963046f56_139"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9&#8212;<ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzkvZnJhZzo3YzZmMDYyNGEzNTA0ZmM3ODJjMDRkOWRiYzM5NzhlMy90ZXh0cmVnaW9uOjdjNmYwNjI0YTM1MDRmYzc4MmMwNGQ5ZGJjMzk3OGUzXzk1Mg_1a2678ce-ce89-46ec-8ffd-977cedc2aa5e" continuedAt="i9451d6070872460e86b112bf3d632dda" escape="true">DEFINED</ix:nonNumeric></span><ix:continuation id="i9451d6070872460e86b112bf3d632dda" continuedAt="i2831549d17a747a4b001379f98dd5f6c"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTRIBUTION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLAN</span></ix:continuation></div><ix:continuation id="i2831549d17a747a4b001379f98dd5f6c"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the Company has an employee savings plan (&#8220;401(k) Plan&#8221;) that qualifies as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Eligible employees may make voluntary contributions to the 401(k) Plan up to <ix:nonFraction unitRef="number" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="0" name="cutr:DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzkvZnJhZzo3YzZmMDYyNGEzNTA0ZmM3ODJjMDRkOWRiYzM5NzhlMy90ZXh0cmVnaW9uOjdjNmYwNjI0YTM1MDRmYzc4MmMwNGQ5ZGJjMzk3OGUzXzI4Mg_6d6fb32f-570a-45e9-8233-fd927441297a">100</ix:nonFraction>% of their annual compensation, subject to statutory annual limitations. In 2021, 2020 and 2019, the Company made discretionary contributions under the 401(k) Plan of $<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzkvZnJhZzo3YzZmMDYyNGEzNTA0ZmM3ODJjMDRkOWRiYzM5NzhlMy90ZXh0cmVnaW9uOjdjNmYwNjI0YTM1MDRmYzc4MmMwNGQ5ZGJjMzk3OGUzXzQ0Mw_15434b0c-d86f-4e43-91bc-444d455dae79">0.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzkvZnJhZzo3YzZmMDYyNGEzNTA0ZmM3ODJjMDRkOWRiYzM5NzhlMy90ZXh0cmVnaW9uOjdjNmYwNjI0YTM1MDRmYzc4MmMwNGQ5ZGJjMzk3OGUzXzQ0Nw_26615c1d-0bc1-4fed-985e-4bcb951fdb60">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzkvZnJhZzo3YzZmMDYyNGEzNTA0ZmM3ODJjMDRkOWRiYzM5NzhlMy90ZXh0cmVnaW9uOjdjNmYwNjI0YTM1MDRmYzc4MmMwNGQ5ZGJjMzk3OGUzXzQ1NA_af11c33e-e1d9-4be8-95ce-3ab203a701dd">0.4</ix:nonFraction> million, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s Japanese subsidiary, a discretionary employee retirement plan has been established. In addition, for some of the Company&#8217;s other foreign subsidiaries, the Company deposits funds with insurance companies, third-party trustees, or into government-managed accounts consistent with the requirements of local laws. The Company has fully funded or accrued for its obligations as of December&#160;31, 2021, and the related expense for each of the three years then ended was not significant.</span></div></ix:continuation><div id="idabc87e13e174d3c9f17fa6963046f56_142"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10&#8212;<ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90ZXh0cmVnaW9uOjE2YzYzNWIyYmZhNjQ5NjY4MmUzYmM0OWU3ZTY2MjViXzE0MDQ_0600680f-0aca-4f67-91d9-e517f670a8e8" continuedAt="ide7e88fd9ac847b9ae70adbe03fc2d67" escape="true">SEGMENT INFORMATION AND REVENUE BY GEOGRAPHY AND PRODUCTS</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ide7e88fd9ac847b9ae70adbe03fc2d67" continuedAt="i620822f3b3f641b19e704cf9f742ea3e">Segment reporting is based on the &#8220;management approach,&#8221; following the method that management organizes the company&#8217;s reportable segments for which separate financial information is made available to, and evaluated regularly by, the chief operating decision maker in allocating resources and in assessing performance. The Company&#8217;s chief operating decision makers ("CODM") are its Chief Executive Officer ("CEO") and Chief Financial Officer (&#8220;CFO&#8221;), who make decisions on allocating resources and in assessing performance. The CEO and CFO review the Company's consolidated results as <ix:nonFraction unitRef="segment" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90ZXh0cmVnaW9uOjE2YzYzNWIyYmZhNjQ5NjY4MmUzYmM0OWU3ZTY2MjViXzQ5NDc4MDIzMjY0MTY_12a21b3a-25df-4d29-a63b-b6815e0784b5">one</ix:nonFraction> operating segment. In making operating decisions, the CODM primarily considers consolidated financial information, accompanied by disaggregated information about revenues by geography and product. All of the Company&#8217;s principal operations and decision-making functions are located in the U.S. Substantially all of the Company's long-lived assets are located in the U.S. </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="i620822f3b3f641b19e704cf9f742ea3e"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90ZXh0cmVnaW9uOjE2YzYzNWIyYmZhNjQ5NjY4MmUzYmM0OWU3ZTY2MjViXzE0MDM_806c4f22-f36b-431f-8fbb-074957c2f1f2" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of revenue by geography for the year ended December&#160;31, 2021, 2020 and 2019 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue mix by geography:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b29467be6564d3f96a00ec95fc5f71b_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzMtMS0xLTEtMjg2MjE_d0b2f625-6b92-41eb-b887-1939737a55b6">96,629</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45b5e0fc162b498a9929672c4fb7e999_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzMtMy0xLTEtMjg2MjE_f0dafc65-85ee-43e8-bd00-8622a0986326">61,238</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f2c0dfb22b430f8f1dad0b71274edb_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzMtNS0xLTEtMjg2MjE_a1288d32-213c-4903-bc7d-e90490e346dd">106,372</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27b2a1100724a6ba26c08b984a74d73_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzQtMS0xLTEtMjg2MjE_45b613f3-1ffc-4ecd-83ef-b334351bd3c7">70,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabe1ad421e2e4777bc58f953183a58d8_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzQtMy0xLTEtMjg2MjE_1481ff70-357c-4366-af2c-68054ebd221d">43,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85ccedc5cc084701a241de78d69d915f_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzQtNS0xLTEtMjg2MjE_75112047-8a20-4a4d-9d09-5ba31c92f71b">24,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia, excluding Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0e98db9695641d48b2985be4ab15c8d_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzUtMS0xLTEtMjg2MjE_83b6afea-a792-485f-896b-af9d2a8693dd">12,649</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f06a616963d42bbb1bef44c8cff5a12_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzUtMy0xLTEtMjg2MjE_03c0a3cc-8381-4f0f-9380-f82a57c52ad0">10,707</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb36f34a3d6443f59cb889c5f55426a4_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzUtNS0xLTEtMjg2MjE_e51a7638-53c1-406b-a223-3050b4db3c5a">14,414</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe6666768fb24f969d5783ef26a323af_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzYtMS0xLTEtMjg2MjE_f632054c-4700-4066-999c-195eba62f45a">19,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21f225eac6b24108b1ebbc248f11ac03_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzYtMy0xLTEtMjg2MjE_632aea7f-957e-46bc-8d77-6dc6a5aa8bd2">11,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9b8210b31c544628b9091d412a30501_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzYtNS0xLTEtMjg2MjE_45513a28-12ea-4e02-909a-a18fe1916be9">11,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the world, other than United States, Asia and Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ead9548c13b4a1e8a2ca967452a46ea_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzctMS0xLTEtMjg2MjE_0e282c7c-d1c9-4e49-bec1-cac47ef2f974">32,313</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bf9f04fa0584c609bf017b7f800a291_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzctMy0xLTEtMjg2MjE_06a1a671-0644-42b8-9960-b6f4e99120b9">21,288</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a47c8db3d4c4730995fc63329813d86_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzctNS0xLTEtMjg2MjE_187e0106-5bdd-4c57-bae8-8f1993b35757">24,846</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzgtMS0xLTEtMjg2MjE_a906176a-59df-4762-ae91-4d62f4505030">231,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzgtMy0xLTEtMjg2MjE_f86b4fb9-ea73-4a0f-a88e-b6e3f9380739">147,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzgtNS0xLTEtMjg2MjE_4f5d9974-aa93-4bc8-b20d-6ee944fe5950">181,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue mix by product category:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac1466cf9104c8e9357f38e1e4b2c30_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEwLTEtMS0xLTI4NjIx_d9419678-7902-4bb5-ba2b-7c34856fd93a">139,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib265219876bc4426a1d87eaf7ec84fe5_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEwLTMtMS0xLTI4NjIx_4f74d16b-8fe2-4905-8882-5bd922f9ed0e">90,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i646d72085053489e80492d5e31a5abb2_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEwLTUtMS0xLTI4NjIx_3f0f36d9-181b-4ccd-9b6b-53b075c7bfa0">140,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60121f9d6c17406fa91d2087e5266a1b_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzExLTEtMS0xLTI4NjIx_be549758-922b-4a33-b4df-7610ab3e16ab">16,401</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85aa042e4c004dc8a331aa0e27b9dd03_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzExLTMtMS0xLTI4NjIx_fc9b4624-cc21-4b08-a00d-165242de1a25">9,287</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007f7a487e97481d9f1957cd82a932d8_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzExLTUtMS0xLTI4NjIx_ef628822-a854-4965-89dc-d843c3f579de">9,648</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skincare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4151927442041dd92c39ebf707b54a4_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEyLTEtMS0xLTI4NjIx_6cb3c92d-a569-40b1-a10a-89b9b023706b">49,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbb6461561444b40bb9d9d51b6f1aff8_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEyLTMtMS0xLTI4NjIx_f95b3681-4c63-4363-9504-61d578b294b3">25,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e98acc9c5eb4f31a71cdbb2d1a1a1d5_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEyLTUtMS0xLTI4NjIx_7e3f14d3-e8e9-4302-b42a-f8534ed1a4f3">8,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i099f3e3620924202a8039a0d27597652_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEzLTEtMS0xLTI4NjIx_2522d0aa-9bd3-467f-95f8-cb9f08ef9064">205,703</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b500e632e0846a6a33e6a7ac55f88ad_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEzLTMtMS0xLTI4NjIx_2edc09c2-dcab-4460-84c9-7fbc7321eb38">125,113</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7098bcdf6ed0484fab59d24d26f26f8b_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEzLTUtMS0xLTI4NjIx_bb04bde5-f791-4d7f-ac56-e4b3fa414f49">158,638</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58319883bced4affb153fc42b9f6a7ab_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzE0LTEtMS0xLTI4NjIx_4293ea48-7615-4d61-a63a-3d9dbb95b8a1">25,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a72612f34ee4319a9bb7d59ecf28bee_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzE0LTMtMS0xLTI4NjIx_06b903cc-69b0-4df5-9b39-3b57c8cc0a52">22,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4cf1c8552b845c08ebb68573b2cdd62_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzE0LTUtMS0xLTI4NjIx_8c1016eb-8a20-4abf-9340-208d0bcb2213">23,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenue</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzE1LTEtMS0xLTI4NjIx_ca869122-009b-48b6-a51c-75aadf542353">231,270</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzE1LTMtMS0xLTI4NjIx_7040cecf-d36a-4278-bfea-1d26485e6963">147,683</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzE1LTUtMS0xLTI4NjIx_5f1acaed-d3c7-4864-ab96-5d4fafc75325">181,712</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="idabc87e13e174d3c9f17fa6963046f56_145"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="cutr:LesseeLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwNDAx_4f1fd29a-bf2e-44c5-a3bd-e1eac34111e8" continuedAt="i5dfc78337d9e473486af9558a90006ef" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i5dfc78337d9e473486af9558a90006ef" continuedAt="ic99d6c122d8a411994048ebe98488574"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEASES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to certain operating and finance leases for vehicles, office space and storage facilities. The Company&#8217;s material operating leases consist of office space, as well as storage facilities and finance leases consist of automobiles. The Company&#8217;s leases generally have remaining terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzM1OQ_c3159409-b458-460d-9242-9f6a751b81b3">one</span> to <ix:nonNumeric contextRef="if5c79f3c61274db4a3f2eb8ce9d31f70_D20210101-20211231" name="cutr:LesseeLeasesRemainingTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzM2NQ_7e49a885-b45c-4128-bd79-fc6289be71d9">10</ix:nonNumeric> years, some of which include options to renew the leases for up to <ix:nonNumeric contextRef="if5c79f3c61274db4a3f2eb8ce9d31f70_D20210101-20211231" name="cutr:LesseeLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzQyOQ_3cdf4452-16d2-4f15-87f5-9ab34c185c9a">five years</ix:nonNumeric>. The Company leases space for operations in the United States, Japan, Belgium, France, and Spain. In addition to the above facility leases, the Company also routinely leases automobiles for certain sales and field service employees under finance leases.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU 2016-2, "Leases," (also known as ASC Topic 842) which requires, among other items, lease accounting to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures are enhanced to better present the amount, timing and uncertainty of cash flows arising from leases.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted ASU 2016-2, as of January&#160;1, 2019, using the modified retrospective method, to all leases existing at the date of initial application. The comparative period information has not been restated and continues to be reported under the accounting standards in effect for the period presented. The new standard provides a number of optional practical expedients in transition. The Company elected the package of practical expedients permitted under the transition guidance within the new standard, which allowed the Company to carry forward the Company&#8217;s historical conclusions about lease identification, lease classification and initial direct costs. The Company also elected the practical expedient related to land easements, allowing the Company to carry forward the Company&#8217;s accounting treatment for land easements on existing agreements. The Company did not elect the practical expedient to use hindsight in determining the lease term.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of the new standard resulted in the recording of additional lease assets and lease liabilities of $<ix:nonFraction unitRef="usd" contextRef="i399c8e27879e4205838eba2cd2b55bed_I20181231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzI2NzI_82ae6ad2-ffb6-451a-88ad-174b3ab2a05f">10.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i399c8e27879e4205838eba2cd2b55bed_I20181231" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzI2Nzk_0335429f-8cc1-47c9-929e-b6cbd6ec5475">10.1</ix:nonFraction> million, respectively, as of January&#160;1, 2019, based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases. The difference between the additional lease assets and lease liabilities resulted from rent-free periods which were previously recorded as deferred rent. The Company&#8217;s accounting for finance leases remained substantially unchanged. The standard had no material impact on the Company&#8217;s consolidated net earnings, results of operations, comprehensive loss, statements of changes in equity, and cash flows. </span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="ic99d6c122d8a411994048ebe98488574" continuedAt="ibb290c492162470db09a27c4f81d04ff"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effect of Adoption of the New Lease Standard (ASC Topic </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">842</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">) on Consolidated Financial Statements</span></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwNDAy_ed75e0ee-fe81-42f5-9629-e58b825dbb5e" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of adopting Topic 842 on the Company&#8217;s consolidated balance sheet as of January&#160;1, 2019 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As reported under<br/>Topic 842</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balances under<br/>Prior GAAP</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzEtMS0xLTEtMjg2MjE_355ca209-3b35-42ea-8bac-100d92388a67">10,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia7416b6bdf4a48dcad826a2a1430ea9a_I20181231" decimals="-3" sign="-" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzEtMy0xLTEtMjg2MjE_2faaedbb-9a07-47f9-80c2-aac8a4d0dace">10,049</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231" decimals="-4" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzItMS0xLTEtMjg2MjE_62b99d1b-9c65-4387-b727-78effee42740">2,430</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia7416b6bdf4a48dcad826a2a1430ea9a_I20181231" decimals="-4" sign="-" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzItMy0xLTEtMjg2MjE_0175838a-0f4c-4333-860f-2b9313e5bc1c">2,430</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia7416b6bdf4a48dcad826a2a1430ea9a_I20181231" decimals="-4" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzMtMy0xLTEtMjg2MjE_6f310e87-f11e-4872-864f-ee4a7598daec">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231" decimals="-4" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzMtNS0xLTEtMjg2MjE_96b5025f-ec63-48b3-9150-0adf3223bfe7">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzQtMS0xLTEtMjg2MjE_840c2b73-dd0c-45bb-9bd2-962ca31d2afc">7,759</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia7416b6bdf4a48dcad826a2a1430ea9a_I20181231" decimals="-3" sign="-" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzQtMy0xLTEtMjg2MjE_487ee3ee-78c3-44a1-885c-d9c6812de0a5">7,759</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">*Deferred rent included in other long-term liabilities</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract contains a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent the right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, the Company estimates the incremental secured borrowing rates corresponding to the maturities of the leases. The Company based the rate estimates on prevailing financial market conditions, credit analysis, and management judgment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce the Company&#8217;s right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term.&#160;</span></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="cutr:LeasesFinancialStatementInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwNDA3_547ca34f-6e23-4041-8db6-300c639957f7" continuedAt="icd407d3184ed4d85a1a4386de06fd377" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is supplemental balance sheet information related to leases (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzMtMi0xLTEtMjg2MjE_edf5c748-0687-4f89-8fd0-717dca37293e">14,627</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzMtNC0xLTEtMjg2MjE_6c736c8d-4ee4-43c0-b521-c7690bbe0f7f">17,076</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMS0xLTEtMzkwMjA_971a5a0e-7d36-4fb8-a69f-ab6296ab5451"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMS0xLTEtMzkwMjA_9d781c61-1f10-40e0-a3f0-691f77491d63">Property and equipment, net</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMi0xLTEtMjg2MjE_a74ea2f1-92b4-4b33-a0c6-beda698a6e8c">392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtNC0xLTEtMjg2MjE_f5efc50b-abd3-471f-93fd-c602507373e6">467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total leased assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="cutr:LeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzUtMi0xLTEtMjg2MjE_1b9c4fca-4e5b-4436-9ea2-37d806666dcf">15,019</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="cutr:LeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzUtNC0xLTEtMjg2MjE_bef2cad8-0dd5-41ec-9005-3b7660d139d5">17,543</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpmYTZmMThjYWViYjM0MmQzYTY3Yjc1NjAxZjlmMWMyNi90YWJsZXJhbmdlOmZhNmYxOGNhZWJiMzQyZDNhNjdiNzU2MDFmOWYxYzI2XzQtMi0xLTEtMjg2MjE_e59d4367-f310-42c6-ac3d-e4d5f4ad2e64">2,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpmYTZmMThjYWViYjM0MmQzYTY3Yjc1NjAxZjlmMWMyNi90YWJsZXJhbmdlOmZhNmYxOGNhZWJiMzQyZDNhNjdiNzU2MDFmOWYxYzI2XzQtNC0xLTEtMjg2MjE_422ee8d7-a586-4e6c-af2b-d4ec2f1db2b9">2,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities , non-current</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpmYTZmMThjYWViYjM0MmQzYTY3Yjc1NjAxZjlmMWMyNi90YWJsZXJhbmdlOmZhNmYxOGNhZWJiMzQyZDNhNjdiNzU2MDFmOWYxYzI2XzUtMi0xLTEtMjg2MjE_ad819d54-04ac-4454-b5b7-5f019a2416a3">13,483</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpmYTZmMThjYWViYjM0MmQzYTY3Yjc1NjAxZjlmMWMyNi90YWJsZXJhbmdlOmZhNmYxOGNhZWJiMzQyZDNhNjdiNzU2MDFmOWYxYzI2XzUtNC0xLTEtMjg2MjE_9600e0d4-563e-4c8f-acf4-95dcb4dbd5a7">15,950</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpmYTZmMThjYWViYjM0MmQzYTY3Yjc1NjAxZjlmMWMyNi90YWJsZXJhbmdlOmZhNmYxOGNhZWJiMzQyZDNhNjdiNzU2MDFmOWYxYzI2XzYtMi0xLTEtMjg2MjE_c70eecf8-c42e-4b45-b8e9-bcc02a5201bd">15,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpmYTZmMThjYWViYjM0MmQzYTY3Yjc1NjAxZjlmMWMyNi90YWJsZXJhbmdlOmZhNmYxOGNhZWJiMzQyZDNhNjdiNzU2MDFmOWYxYzI2XzYtNC0xLTEtMjg2MjE_011eba89-f27e-4092-88fa-296ed00dea3d">18,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><ix:continuation id="icd407d3184ed4d85a1a4386de06fd377" continuedAt="i4e294e2f87724270b47bd3527a5e5990"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, current</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMS0xLTEtMzkwMjI_8092eb31-ac1f-4f22-979c-32b815b92382"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMS0xLTEtMzkwMjI_e0e19b97-1369-4d4a-bbc4-18c6459ed777">Accrued liabilities</span></span></span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMi0xLTEtMjg2MjE_bf7338a2-8465-4a17-97b2-8044997679be">554</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtNC0xLTEtMjg2MjE_3818bfd0-4d59-48a2-8b64-5cf0e28b44f1">370</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMS0xLTEtMzkwMjQ_28244cd5-3898-471f-8e2b-ae37ea29760a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMS0xLTEtMzkwMjQ_7df8c095-3d4f-4603-b7c7-f49c99ce82b6">Other long-term liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMi0xLTEtMjg2MjE_42169c93-6913-4bee-97fd-2d6aa0997840">730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtNC0xLTEtMjg2MjE_5719daa0-ac64-4288-b400-0e3e0173d4ce">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Finance lease liabilities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzUtMi0xLTEtMjg2MjE_4680374c-05a5-46e6-b2a8-9c9322cd3491">1,284</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzUtNC0xLTEtMjg2MjE_beca12e5-adba-435a-8e22-1cf66ade9ec7">611</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">L<ix:continuation id="i4e294e2f87724270b47bd3527a5e5990" continuedAt="i6421f5e04ece4675a0cda6b2fd522fda">ease costs during the twelve months ended&#160; December&#160;31, 2021 and December&#160;31, 2020 (in thousands):&#160;</ix:continuation></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="ibb290c492162470db09a27c4f81d04ff" continuedAt="i6e51d34276104e6d80c94090596383e6"><ix:continuation id="i6421f5e04ece4675a0cda6b2fd522fda"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzItMi0xLTEtMjg2MjE_a2d6e188-98c9-49a5-962b-ad8cdef1a6f3">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzItNC0xLTEtMjg2MjE_42652851-22d2-4bc7-9c74-1726e0d94a15">431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzItNi0xLTEtNDkyNTM_e033d818-7510-4cbe-8096-9866ec747d92">704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest for finance lease</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzMtMi0xLTEtMjg2MjE_93bc2a93-edb8-4d0f-9b66-64c20024b379">59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzMtNC0xLTEtMjg2MjE_1f87a5d0-5e57-47c6-9f9b-24bd652337fd">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzMtNi0xLTEtNDkyNTM_54562963-be5a-47a7-9bce-f09cdbc159c5">88</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzQtMi0xLTEtMjg2MjE_1227bc61-1e4d-4153-99b3-f5f7b7be126f">3,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzQtNC0xLTEtMjg2MjE_df027c7d-1de6-4081-b211-1008fcfdbe58">3,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzQtNi0xLTEtNDkyNTM_0bb876a4-b7e9-4880-8105-169a16431783">2,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities during the twelve months ended December&#160;31, 2021 and December&#160;31, 2020 were as follows&#160;(in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzItMi0xLTEtMjg2MjE_ff4bba19-4765-4075-a720-ff62fa4f1a84">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzItNC0xLTEtMjg2MjE_6c535652-3146-4157-ab19-1b5b8dba1e60">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzItNi0xLTEtNDkyNjE_325f47d4-fd4b-44cb-aa0d-bb748944415d">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzMtMi0xLTEtMjg2MjE_f57689f7-45a7-445c-ada2-d0b264137fa8">462</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzMtNC0xLTEtMjg2MjE_416e3690-1d12-4b7c-b4e7-5b26d8c9c2b2">537</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzMtNi0xLTEtNDkyNjE_31fc4eae-e4fc-474d-8736-5adf4617efc1">649</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzQtMi0xLTEtMjg2MjE_c5a83a7c-6057-416f-91bf-4c02f36a1e54">3,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzQtNC0xLTEtMjg2MjE_9d7098b5-0af1-43ec-bf6e-45e6a8bd5ce5">2,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzQtNi0xLTEtNDkyNjE_09379e1d-63b1-447a-a753-7f571129d61b">2,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maturities of lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwNDEx_a4f2eeee-d701-4cb2-91ba-1e40119f55e5" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities were as follows as of December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzEtMS0xLTEtMjg2MjE_9dfc71f0-5e50-4d7c-a23a-57b8196d5065">3,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzItMS0xLTEtMjg2MjE_ddc2dcf7-4faa-4498-9d2a-b7dc8a105023">3,160</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzMtMS0xLTEtMjg2MjE_8d4ba18d-8fd9-4823-a8d0-4801410a9d22">2,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzQtMS0xLTEtMjg2MjE_29b1a51a-b36b-4ab6-935f-210f252fdc8e">2,875</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzUtMS0xLTEtMjg2MjE_d59e3318-dfc6-4026-ab4c-09a0ebd4c572">2,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="cutr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzYtMS0xLTEtMjg2MjE_9110a54d-cc27-4026-8c83-73577b141b6b">3,338</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzctMS0xLTEtMjg2MjE_f4104f0b-3c14-478f-9e21-c7a2fb77141d">18,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzgtMS0xLTEtMjg2MjE_1c1a5099-ac3c-44ef-b718-e77f72efa4dd">2,436</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzktMS0xLTEtMjg2MjE_c064fcd6-eb00-49e5-8b5b-e62ad940108b">15,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vehicle Leases</span></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwNDEy_b494923c-6791-4c28-81a4-075b9be51c8b" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable finance leases as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTphOTgyYmZkMmE0NGE0NDEzOTE2NWJkOTVlMTM0NWM1NS90YWJsZXJhbmdlOmE5ODJiZmQyYTQ0YTQ0MTM5MTY1YmQ5NWUxMzQ1YzU1XzEtMS0xLTEtMjg2MjE_eadcca8c-2d2c-4d59-be3d-ed10b9268c3c">601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTphOTgyYmZkMmE0NGE0NDEzOTE2NWJkOTVlMTM0NWM1NS90YWJsZXJhbmdlOmE5ODJiZmQyYTQ0YTQ0MTM5MTY1YmQ5NWUxMzQ1YzU1XzItMS0xLTEtMjg2MjE_b283e8eb-cb84-4301-b515-edf53d3a5669">347</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTphOTgyYmZkMmE0NGE0NDEzOTE2NWJkOTVlMTM0NWM1NS90YWJsZXJhbmdlOmE5ODJiZmQyYTQ0YTQ0MTM5MTY1YmQ5NWUxMzQ1YzU1XzMtMS0xLTEtMjg2MjE_a930563b-4256-4ecb-b7bf-0bde7269d34b">409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTphOTgyYmZkMmE0NGE0NDEzOTE2NWJkOTVlMTM0NWM1NS90YWJsZXJhbmdlOmE5ODJiZmQyYTQ0YTQ0MTM5MTY1YmQ5NWUxMzQ1YzU1XzQtMS0xLTEtNDMxNzM_79621598-9d68-4b56-ade8-8e21bd6d2466">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTphOTgyYmZkMmE0NGE0NDEzOTE2NWJkOTVlMTM0NWM1NS90YWJsZXJhbmdlOmE5ODJiZmQyYTQ0YTQ0MTM5MTY1YmQ5NWUxMzQ1YzU1XzQtMS0xLTEtMjg2MjE_dde7f701-6cc3-4736-8e54-f01f06f763b6">1,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTphOTgyYmZkMmE0NGE0NDEzOTE2NWJkOTVlMTM0NWM1NS90YWJsZXJhbmdlOmE5ODJiZmQyYTQ0YTQ0MTM5MTY1YmQ5NWUxMzQ1YzU1XzUtMS0xLTEtMjg2MjE_2db006b9-2448-42df-ba1b-dde673010d11">95</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTphOTgyYmZkMmE0NGE0NDEzOTE2NWJkOTVlMTM0NWM1NS90YWJsZXJhbmdlOmE5ODJiZmQyYTQ0YTQ0MTM5MTY1YmQ5NWUxMzQ1YzU1XzYtMS0xLTEtMjg2MjE_f54ccb03-16d4-4e6e-96e4-943d02bdbe70">1,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="i6e51d34276104e6d80c94090596383e6" continuedAt="i6e8518b23f304b9f93bc25a93d3c3e26"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwNDA2_1397cb13-1b57-4168-995e-5b834814cad6" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term and discount rate, as of December&#160;31, 2021, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Term and Discount Rate</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo5OTZkZGFmYzY3ZGY0OWZlOTA3ODNlZDU0ZTRmNjQyOC90YWJsZXJhbmdlOjk5NmRkYWZjNjdkZjQ5ZmU5MDc4M2VkNTRlNGY2NDI4XzItMS0xLTEtMjg2MjE_c4794853-c7d0-40c2-93dd-abaf11819b3f">5.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo5OTZkZGFmYzY3ZGY0OWZlOTA3ODNlZDU0ZTRmNjQyOC90YWJsZXJhbmdlOjk5NmRkYWZjNjdkZjQ5ZmU5MDc4M2VkNTRlNGY2NDI4XzMtMS0xLTEtMjg2MjE_49fba651-fe41-48b2-8163-49c3486a05af">2.1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo5OTZkZGFmYzY3ZGY0OWZlOTA3ODNlZDU0ZTRmNjQyOC90YWJsZXJhbmdlOjk5NmRkYWZjNjdkZjQ5ZmU5MDc4M2VkNTRlNGY2NDI4XzUtMS0xLTEtMjg2MjE_381fa5ae-2b91-4fa2-8997-1ce232167afc">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo5OTZkZGFmYzY3ZGY0OWZlOTA3ODNlZDU0ZTRmNjQyOC90YWJsZXJhbmdlOjk5NmRkYWZjNjdkZjQ5ZmU5MDc4M2VkNTRlNGY2NDI4XzYtMS0xLTEtMjg2MjE_0bdef79f-13ea-419b-989c-8f585749283a">6.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessor Information related to the Company&#8217;s system leasing</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year ended December 31, 2020, the Company entered into leasing transactions, in which the Company is the lessor, offered through the Company's membership program. The Company's leases for equipment rentals were all accounted for as operating leases during the second and third quarters of 2020.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter ended December 31, 2020, certain&#160;of the membership program agreements were amended, granting the customers the exclusive right and option to purchase the leased system from the Company, at any time during the period of <ix:nonNumeric contextRef="i764ce0cbc59940f481fdec67f544e264_D20201001-20201231" name="cutr:LessorOptionToPurchaseGrantedPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzE3MDQyNDMwMjQ5NTY2_5a00e24e-fc72-49d2-9ae4-a205c5422515">twelve months</ix:nonNumeric> from signing the amended agreement. For contracts signed under the amended membership agreement,&#160;the Company classified and accounted for the arrangements as sales-type leases as of December 31, 2020, as the Company determined it is reasonably certain that the customer will exercise the purchase option.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the sales-type leases, the net investment of the Company&#8217;s lease receivable is measured at the commencement date and is included in the consolidated balance sheets as a component of Other current assets and prepaid expenses. As of December&#160;31, 2020, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-5" name="us-gaap:SalesTypeLeaseRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzE3MDQyNDMwMjQ5NTc1_bd3d71b1-e35b-46a3-ae11-251214c98f63">0.7</ix:nonFraction>&#160;million of revenue for the sales-type leases in the consolidated statement of operations and the related lease receivable in other current assets of the consolidated balance sheet. There was <ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-5" name="us-gaap:SalesTypeLeaseRevenue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzMyOTg1MzQ4OTg1MjA_377a16b1-00a4-43d5-9ef0-26aebfb51c14">no</ix:nonFraction> revenue recognized from the sales-type lease arrangement in fiscal year 2021. During fiscal year 2021 the company received a full payment of $<ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-5" name="cutr:ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzMyOTg1MzQ5MDE1MTI_611e64a5-9076-4c6c-a80e-98cb76b1ed58">0.4</ix:nonFraction>&#160;million from customers who exercised the purchase option. As of December 31, 2021, the lease receivable balance included in Other current assets of the consolidated balance sheet was $<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-5" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzIwMzQwOTY1MTMyOTIw_05f24ffb-b615-4953-9189-0705fe3d328e">0.3</ix:nonFraction> million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue related to non-lease components, which comprise service contracts and consumables, are deferred and recognized either over time or at the point of delivery. The non-lease component revenue amount as of December&#160;31, 2021 was immaterial.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment lease revenue for operating lease agreements is recognized over the life of the lease. <ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:OperatingLeaseLeaseIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwNDA1_99b24088-ca5d-485a-8763-978a75d94c5e" continuedAt="i11294fd93a424749ae7aed4d039f1dbb" escape="true">The following table summarizes the amount of operating lease income included in product revenue in the accompanying consolidated statements of operations (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i11294fd93a424749ae7aed4d039f1dbb"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.644%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease income from equipment rentals</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyMmFkNjE2ODgzMDA0NjhlOWY1ZGUwMjVmMTc2NTlmOC90YWJsZXJhbmdlOjIyYWQ2MTY4ODMwMDQ2OGU5ZjVkZTAyNWYxNzY1OWY4XzEtMS0xLTEtMjg2MjE_f3a67b53-1569-4088-8bb2-e85a170330cb">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyMmFkNjE2ODgzMDA0NjhlOWY1ZGUwMjVmMTc2NTlmOC90YWJsZXJhbmdlOjIyYWQ2MTY4ODMwMDQ2OGU5ZjVkZTAyNWYxNzY1OWY4XzEtMy0xLTEtNDI5MTg_2cf309bb-5fbe-4558-9a55-1556e70ff412">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains certain open inventory purchase commitments with its suppliers to ensure a smooth and continuous supply for key components. The Company&#8217;s liability in these purchase commitments is generally restricted to an agreed-upon period. These periods can vary among different suppliers. Although open purchase orders are considered enforceable and legally binding, the terms generally allow the Company the option to cancel, reschedule, and adjust their requirements based on the Company's business needs prior to the delivery of goods or performance of services.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnifications</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of the Company&#8217;s business, the Company enters into agreements that contain a variety of representations, warranties, and indemnification obligations. For example, the Company has entered into indemnification agreements with each of its directors and executive officers and certain key employees. The Company&#8217;s exposure under its various indemnification obligations is unknown and not reasonably estimable as they involve future claims that may be made against the Company. As such, the Company has not accrued any amounts for such obligations.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="i6e8518b23f304b9f93bc25a93d3c3e26"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named from time to time as a party to other legal proceedings, product liability, commercial disputes, employee disputes, and contractual lawsuits in the normal course of business. A liability and related charge are recorded to earnings in the Company&#8217;s consolidated financial statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including discussion with outside legal counsel. If a reasonable estimate of a known or probable loss cannot be made, but a range of probable losses can be estimated, the low-end of the range of losses is recognized if no amount within the range is a better estimate than any other. If a material loss is reasonably possible, but not probable and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. The Company expenses legal fees as incurred.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the Company&#8217;s former Executive Vice President and CFO Sandra A. Gardiner announced her resignation from the Company. On November&#160;7, 2019, Ms. Gardiner filed an arbitration demand against the Company in connection with the terms of her employment and resignation. The Company settled this matter with Ms. Gardiner during the second quarter of 2020 with a cash payment of $<ix:nonFraction unitRef="usd" contextRef="ib80ff99676a24f1f8527cc2a3aa4d119_D20200401-20200630" decimals="-5" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzM4NDgyOTA3MDc4NTI_d9740046-bfd1-4b63-8a32-53feec175fde">0.4</ix:nonFraction>&#160;million and issuance of <ix:nonFraction unitRef="shares" contextRef="ib80ff99676a24f1f8527cc2a3aa4d119_D20200401-20200630" decimals="INF" name="cutr:StockIssuedDuringPeriodSharesLitigationSettlement" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzM4NDgyOTA3MDc4NjY_74c6b542-c88a-4c2c-ad4e-2ec6c8bb257d">15,408</ix:nonFraction> shares of common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021 and&#160;2020, the Company had accrued $<ix:nonFraction unitRef="usd" contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231" decimals="-5" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwMjA2_8b141300-e090-4e0f-bf35-69a1946a169d">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231" decimals="-5" name="us-gaap:LitigationReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzM4NDgyOTA3MDc4MzU_137e3d32-feb3-40fc-b613-eb8884274c1e">0.4</ix:nonFraction>&#160;million, respectively, related to various pending commercial and product liability lawsuits. The Company does not believe that a material loss in excess of accrued amounts is reasonably possible.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2020, Cutera filed a lawsuit against Lutronic Aesthetics in the United States District Court for the Eastern District of California.  Lutronic employs numerous former Cutera employees.  The complaint against Lutronic generally alleges claims for (1) misappropriation of trade secrets in violation of state and federal law; (2) violation of the Racketeer Influenced and Corrupt Organizations Act (RICO); (3) interference with contractual relations; (4) interference with prospective economic advantage; (5) unfair competition; and (6) aiding and abetting.  On March 13, 2020, the court entered a temporary restraining order against Lutronic generally prohibiting it from using or disseminating Cutera confidential, proprietary, or trade secret information.  The order also prohibits Lutronic, for 2 years, from using such information for the purpose of soliciting, or conducting business with, certain specified customers.  At the parties&#8217; request, the Court subsequently entered a preliminary injunction providing for the same restrictions in the restraining order.  On February 9, 2022, Cutera filed a motion seeking leave from the court to file a second amended complaint.  In addition to the above-referenced claims against Lutronic Aesthetics, the proposed amended complaint alleges additional claims against it, including (1) violation of the Lanham Act; (2) unlawful business practices; (3) false advertising; and (4) trademark infringement.  The proposed amended complaint also seeks to add Lutronic Corporation (the Korean parent company of Lutronic Aesthetics) as an additional defendant, and also alleges against it the above-described claims for misappropriation of trade secrets, violation of RICO, interference with contractual relations and prospective economic advantage, unfair competition, and aiding and abetting.  Discovery is ongoing.  No trial date has been scheduled.</span></div></ix:continuation><div id="idabc87e13e174d3c9f17fa6963046f56_148"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzUwNzM_510aca13-ff50-49d1-b97d-f6d597e90e3f" continuedAt="ief6ac58e40874e65b74360353dcf1889" escape="true">DEBT</ix:nonNumeric></span></div><ix:continuation id="ief6ac58e40874e65b74360353dcf1889" continuedAt="i5474738fcae848a3ba97b115f668df4c"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible notes, net of unamortized debt issuance costs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i37f97a9d284443ad97ec8c981fcd7f08_I20210331" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzI5NDg_93c09382-2c78-4870-9f67-f5ecf9aabbb4">138.3</ix:nonFraction> million aggregate principal amount of convertible senior notes ("convertible notes")&#160;due on March 15, 2026 in a private placement offering. The convertible notes bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="i37f97a9d284443ad97ec8c981fcd7f08_I20210331" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzMxMTE_e2bab3b6-93e5-4960-af0d-94d7959f630a">2.25</ix:nonFraction>% per year payable semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2021. Upon conversion, the convertible notes will be convertible into cash, shares of the Company&#8217;s common stock or a combination thereof, at the Company&#8217;s election. The convertible notes are presented as convertible notes, net of unamortized debt issuance costs, on the consolidated balance sheet.&#160;Proceeds from the offering were $<ix:nonFraction unitRef="usd" contextRef="i1d1c6d926fe34c69ad511dec85a63fd4_D20210301-20210331" decimals="-5" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzM1Njc_96e35be0-bf79-4aa2-b03d-de13fdf404fd">133.6</ix:nonFraction> million, net of issuance costs, including initial purchasers fees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initially, each $1,000 principal amount of Notes was convertible into 30.1427 shares of the Company&#8217;s common stock at a conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i2a6e8339dfdb4cd39eddb0d8191da2b2_I20210331" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzM3NjM_ab8468d2-084c-4eb6-86b2-5b1fd4312e06">33.18</ix:nonFraction> per share. The conversion rate for the convertible notes is subject to adjustment for certain events as set forth in the Indenture governing the convertible notes. The convertible notes will mature on March 15, 2026, unless earlier converted, redeemed, or repurchased in accordance with the terms of the convertible notes. No sinking fund is provided for the Notes. As of December 31, 2021, the net carrying amount of the Company&#8217;s convertible notes was $<ix:nonFraction unitRef="usd" contextRef="i3b661e68d3614dd8a0389a329265b3bd_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzIwMzQwOTY1MTQyMzgy_e408b7f2-501b-4d36-b7c3-6dca9630a8f3">134.2</ix:nonFraction> million and the unamortized debt issuance costs were&#160;$<ix:nonFraction unitRef="usd" contextRef="i3b661e68d3614dd8a0389a329265b3bd_I20211231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzE2NDkyNjc0NjYzODg_e33801c7-0f38-440e-a35d-5f4fee5f0940">4.0</ix:nonFraction> million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their Notes at their option prior to the close of business on the business day immediately preceding December 15, 2025, in multiples of $1,000 principal amount, only under the following circumstances:</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="i5474738fcae848a3ba97b115f668df4c" continuedAt="if5af45dfc1d1415e81e823220222bef1"><div style="margin-top:10pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During any fiscal quarter commencing after the fiscal quarter ended on June 30, 2021 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least <ix:nonFraction unitRef="day" contextRef="ic7cfa6c72662462f90fcfd77f387c2c3_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzQ2NzQ_baa1e278-942f-4b35-be54-e27806ba9af6">20</ix:nonFraction> trading days (whether or not consecutive) during a period of <ix:nonFraction unitRef="day" contextRef="ic7cfa6c72662462f90fcfd77f387c2c3_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzQ3Mzk_ffd1f9d8-c199-4d18-900e-1239eaf3d659">30</ix:nonFraction> consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to <ix:nonFraction unitRef="number" contextRef="ic7cfa6c72662462f90fcfd77f387c2c3_D20210301-20210331" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzQ4ODc_f2a7c98d-acb4-4da8-bd04-2a43f7afcf18">130</ix:nonFraction>% of the conversion price for the convertible notes on each applicable trading day;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the <ix:nonFraction unitRef="day" contextRef="i8b0a2bfb03104efeadd77a4412bae006_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzQ5ODQ_3e8f3bc0-3a52-4d00-8624-e517b0038426">five</ix:nonFraction>-business day period after any <ix:nonFraction unitRef="day" contextRef="i8b0a2bfb03104efeadd77a4412bae006_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzUwMTg_a82ff0e7-d4f5-4708-a492-191edf727f28">five</ix:nonFraction> consecutive trading day period (the &#8220;measurement period&#8221;) in which the &#8220;trading price&#8221;&#160;per $1,000 principal amount of convertible notes for each trading day of the measurement period was less than <ix:nonFraction unitRef="number" contextRef="i8b0a2bfb03104efeadd77a4412bae006_D20210301-20210331" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzUyMTY_a0befd7c-76f3-4dec-862a-88a05831ed0c">98</ix:nonFraction>% of the product of the last reported sale price of the Company's&#160;common stock and the conversion rate on each such trading day;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company calls such convertible notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Upon the occurrence of specified corporate events.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after December 15, 2025, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The circumstances described in the first bullet of the paragraph above were met during the second and third quarters of 2021 as the Company's stock traded at a price in excess of the conversion price for the required number of days during each of those quarters. These circumstances were not met during the fourth quarter of 2021. As a result, holders of the Notes had the right to convert their Notes beginning July 1, 2021 and ending on December 31, 2021. As of December 31, 2021, the Notes are not convertible and this condition will remain until March 31, 2022. The Notes may become convertible in future periods. Upon any conversion requests of the convertible notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election with respect to such conversion requests. To the extent there are any conversion requests in the year ending December 31, 2022, the Company intends to settle such conversion requests in shares of common stock. Therefore, as of December&#160;31, 2021, the convertible notes have been included as Long-term debt on the consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may not redeem the convertible notes prior to March 20, 2024. On or after March 20, 2024, the Company may redeem for cash all or any portion of the Notes, at the Company&#8217;s option, if the last reported sale price of the Company&#8217;s common stock has been at least <ix:nonFraction unitRef="number" contextRef="ic7cfa6c72662462f90fcfd77f387c2c3_D20210301-20210331" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzcxNDI_b6ea9f0a-bc4c-4fed-91bb-9969b373652b">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="day" contextRef="ic7cfa6c72662462f90fcfd77f387c2c3_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzcxOTg_9bb10431-3458-422d-a4ef-6ef81224eaf7">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="day" contextRef="ic7cfa6c72662462f90fcfd77f387c2c3_D20210301-20210331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzcyNTU_0d2bf4ce-827d-4096-87c7-26eb1bb0255e">30</ix:nonFraction> consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i1d1c6d926fe34c69ad511dec85a63fd4_D20210301-20210331" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2Mzc0OTM_62f52f46-ca9a-4db0-b149-690155cce520">100</ix:nonFraction>% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding Notes, at least $<ix:nonFraction unitRef="usd" contextRef="i37f97a9d284443ad97ec8c981fcd7f08_I20210331" decimals="-5" name="cutr:DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2Mzc3MDU_0247c2e2-247d-4aa8-9cae-2db53d14e97d">50.0</ix:nonFraction> million aggregate principal amount of Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a fundamental change occurs, note holders have the option to require the Company to repurchase any portion or all of their convertible notes in $<ix:nonFraction unitRef="usd" contextRef="i58a47170b8054a0ba5cca87aa0a800de_I20210331" decimals="INF" name="cutr:DebtInstrumentRedemptionIncrementalRepurchaseAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2Mzc5ODU_f642689d-6492-4cc0-9a73-c9368c626bcb">1,000</ix:nonFraction> principal increments for cash. The price for such repurchase is calculated as <ix:nonFraction unitRef="number" contextRef="i74ccf35a513f4cfd8630d93546df6f20_D20210301-20210331" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzgwNjc_5c28657b-0713-4a31-8b8e-f5d6e6c9df66">100</ix:nonFraction>% of the principal amounts of Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. Additionally, holders of the Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The convertible notes are general senior unsecured obligations that rank senior to any of the Company&#8217;s indebtedness that is explicitly subordinated to the Notes. The Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the Notes. The Notes will be junior to any of the Company&#8217;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the convertible notes was approximately $<ix:nonFraction unitRef="usd" contextRef="i3b661e68d3614dd8a0389a329265b3bd_I20211231" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzE2NDkyNjc0NjYzNTM_a25b2482-d67f-4cb7-8691-cda7c378c692">201.0</ix:nonFraction> million as of December&#160;31, 2021. The fair value is based on observable market prices for this debt, which is traded in active markets and therefore is classified as a Level 2 fair value measurement, as defined in Note 1.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:ConvertibleDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE2NzE_a636d3ef-5165-40cc-b93d-7710d73d749a" continuedAt="i059781b7906e402d84c51375727e2b3a" escape="true">The following table presents the outstanding principal amount and carrying value of the convertible notes (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="if5af45dfc1d1415e81e823220222bef1" continuedAt="i0e166386500b4bdb824dcdef8a3c5b1d"><div style="margin-top:10pt;text-align:justify"><ix:continuation id="i059781b7906e402d84c51375727e2b3a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.076%"><tr><td style="width:1.0%"></td><td style="width:78.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.184%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b661e68d3614dd8a0389a329265b3bd_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90YWJsZTowM2RmNmRjZjkzMmQ0NDE0YjNiMDYzMGIyODRhMDgwNC90YWJsZXJhbmdlOjAzZGY2ZGNmOTMyZDQ0MTRiM2IwNjMwYjI4NGEwODA0XzEtMS0xLTEtMzc2MjE_f403c497-aacf-4c37-a3fc-2e3c491b2bda">138,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b661e68d3614dd8a0389a329265b3bd_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90YWJsZTowM2RmNmRjZjkzMmQ0NDE0YjNiMDYzMGIyODRhMDgwNC90YWJsZXJhbmdlOjAzZGY2ZGNmOTMyZDQ0MTRiM2IwNjMwYjI4NGEwODA0XzItMS0xLTEtMzc2MjE_e593231e-13c2-4715-a083-be96bb14b888">4,007</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b661e68d3614dd8a0389a329265b3bd_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90YWJsZTowM2RmNmRjZjkzMmQ0NDE0YjNiMDYzMGIyODRhMDgwNC90YWJsZXJhbmdlOjAzZGY2ZGNmOTMyZDQ0MTRiM2IwNjMwYjI4NGEwODA0XzMtMS0xLTEtMzc2MDM_1f478e24-e896-4c39-9335-53df50a4b0b2">134,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with issuance of the convertible notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally intended to reduce the potential dilution of the Company's&#160;common stock upon any conversion or settlement of the Notes or to offset any cash payment the Company is required to make in excess of the principal amount upon conversion of the Notes, as the case may be, with such reduction or offset subject to a cap based on the cap price. If the market price per share of the Company&#8217;s common stock exceeds the cap price of the capped calls transaction, then the Company&#8217;s stock would experience some dilution and/or the capped call would not fully offset the potential cash payments, in each case to the extent the then-market price per share of its common stock exceeds the cap price. Under the capped call transactions, the Company purchased from the option counterparties capped call options that in the aggregate relate to the total number of shares of the Company's common stock underlying the convertible notes, with a strike price equal to the conversion price of the convertible notes and with an initial cap price equal to $<ix:nonFraction unitRef="usdPerItem" contextRef="i130b34c8fd4f434eb30d4d656ae2c907_I20210331" decimals="INF" name="us-gaap:DerivativeCapPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2NDA1ODY_6771597a-c4b4-4fa8-8a00-23142670df0e">45.5350</ix:nonFraction>, which represents a <ix:nonFraction unitRef="number" contextRef="i130b34c8fd4f434eb30d4d656ae2c907_I20210331" decimals="2" name="cutr:DerivativeCapPricePremiumOverStockPricePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2NDA2MTA_27365d88-baaa-4914-8cba-2eb26d936651">75</ix:nonFraction>% premium over the last reported sale price of the Company's common stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="i46277ffbd52b4aaf98c02564d8aa2124_I20210304" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2NDA2ODk_97e6fc90-cca1-49df-95a9-ac464411792b">26.02</ix:nonFraction> per share on March&#160;4, 2021, with certain adjustments to the settlement terms that reflect standard anti-dilution provisions. The capped call transactions expire over <ix:nonFraction unitRef="day" contextRef="i453b9f386c004d948258fe7bc2b71f9c_D20210301-20210331" decimals="INF" name="cutr:DerivativeCappedCallTransactionTermConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2NDA4NDk_81d31b12-3747-45a1-ad69-0c17b2ab297d">40</ix:nonFraction> consecutive scheduled trading days ended on March 12, 2026. The capped calls were purchased for $<ix:nonFraction unitRef="usd" contextRef="i453b9f386c004d948258fe7bc2b71f9c_D20210301-20210331" decimals="-5" name="us-gaap:PaymentsForDerivativeInstrumentFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE2NzM_93b5e676-49d2-4614-992f-9c81712239d0">16.1</ix:nonFraction>&#160;million. The Company evaluated the capped call transaction under authoritative accounting guidance and determined that it should be accounted for as a separate transaction and classified as a net reduction to Additional paid-in capital within stockholders&#8217; equity with no recurring fair value measurement recorded.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company early adopted ASU 2020-6, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). In accordance with Subtopic 470-20 and 815-40, as revised by ASU 2020-6, the Company records the convertible notes in long-term debt with no separation between the Notes and the conversion option. Each reporting period, the Company will determine whether any criteria is met for the note holders to have the option to redeem the Notes early, which could&#160;result in a change in the classification of the Notes to current liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Debt Issuance Cost</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance costs related to the convertible notes are presented in the consolidated balance sheet as a direct deduction from the carrying amount of the convertible notes. During the year ended December&#160;31, 2021, the Company incurred direct costs associated with the issuance of convertible notes of $<ix:nonFraction unitRef="usd" contextRef="ia4c6391b6a824369a52a92dbea8b9166_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzE2NDkyNjc0NjYyNjY_2d2a8315-dfa4-47d3-aea5-79dfa7134f9b">4.7</ix:nonFraction> million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance costs are&#160;amortized using&#160;an effective interest method basis over the term of the convertible notes and accordingly the Company recorded approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="ia4c6391b6a824369a52a92dbea8b9166_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzE2NDkyNjc0NjYzMDI_bc655267-04ca-4f78-a373-dc391155b1cb">0.7</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of amortization of debt issuance costs during the year ended December&#160;31, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective interest rate on the convertible notes is <ix:nonFraction unitRef="number" contextRef="ia4c6391b6a824369a52a92dbea8b9166_D20210101-20211231" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE2ODg_5ebd2f51-54d1-4600-912c-7f698500fe85">2.97</ix:nonFraction>%. Interest expense for the year ended December&#160;31, 2021, including the amortization of debt issuance cost, totaled approximately $<ix:nonFraction unitRef="usd" contextRef="ia4c6391b6a824369a52a92dbea8b9166_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzE2NDkyNjc0NjYzMTk_649f9271-e719-4bf1-9c6a-da1827329a1d">3.2</ix:nonFraction> million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan and Security Agreement</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 9, 2020, the Company entered into a Loan and Security Agreement with Silicon Valley Bank for a <ix:nonNumeric contextRef="ic6bca201b74942348baa93e457128a05_D20200709-20200709" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE3NzQ_e58c3bd4-a8e9-43c4-8f3c-99505d36cda4">four-year</ix:nonNumeric> secured revolving loan facility (&#8220;SVB Revolving Line of Credit&#8221;) in an aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="i77d3c70ae7304fa7a266e0d9e1db39cd_I20200709" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE2OTg_52990dfa-e278-4e84-978b-15081c54be79">30.0</ix:nonFraction>&#160;million. The SVB Revolving Line of Credit matures on July 9, 2024.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to draw on the full amount of the SVB Revolving Line of Credit, the Company must satisfy certain liquidity ratios. If the Company is unable to meet these liquidity ratios, then availability under the revolving line is calculated as <ix:nonFraction unitRef="number" contextRef="i77d3c70ae7304fa7a266e0d9e1db39cd_I20200709" decimals="2" name="cutr:DebtInstrumentPercentageOfQualifyingAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE3MTM_17adf308-92ec-4710-9432-b34ca4702c0f">80</ix:nonFraction>% of the Company&#8217;s qualifying accounts receivable. The proceeds of the revolving loans may be used for general corporate purposes. The Company&#8217;s obligations under the Loan and Security Agreement with Silicon Valley Bank are secured by substantially all of the assets of the Company. Interest on principal amount outstanding under the revolving line shall accrue at a floating per annum rate equal to the greater of either <ix:nonFraction unitRef="number" contextRef="icd0e36b6f7714fe981a44e99c804b27b_D20200709-20200709" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE3MTg_848867f1-8387-4672-9ffd-37b61a236d6a">1.75</ix:nonFraction>% above the Prime Rate or five percent (<ix:nonFraction unitRef="number" contextRef="i77d3c70ae7304fa7a266e0d9e1db39cd_I20200709" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE3MjU_610e6e7c-f26a-48c6-ae41-39df75732653">5.0</ix:nonFraction>%). The Company paid a non-refundable revolving line commitment fee of $<ix:nonFraction unitRef="usd" contextRef="ic6bca201b74942348baa93e457128a05_D20200709-20200709" decimals="-5" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE3MzE_1a257314-cfa6-4596-a1b4-2b970ba8d5be">0.3</ix:nonFraction>&#160;million, on the effective date of the Loan and Security Agreement with Silicon Valley Bank of July 9, 2020, and the Company is required to pay an anniversary fee of $<ix:nonFraction unitRef="usd" contextRef="i77d3c70ae7304fa7a266e0d9e1db39cd_I20200709" decimals="-5" name="cutr:DebtInstrumentAnniversaryFeeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE3NjA_320a7a8d-cbe7-452b-a94e-fad8f0c8ba37">0.3</ix:nonFraction>&#160;million on each twelve-month anniversary of the effective date of the Loan and Security Agreement.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:continuation id="i0e166386500b4bdb824dcdef8a3c5b1d"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan and Security Agreement with Silicon Valley Bank contains customary affirmative covenants, such as financial statement reporting requirements and delivery of borrowing base certificates, as well as customary covenants that restrict the Company&#8217;s ability to, among other things, incur additional indebtedness, sell certain assets, guarantee obligations of third parties, declare dividends, or make certain distributions, and undergo a merger or consolidation or certain other transactions. The Loan and Security Agreement also contains certain financial covenants, including maintaining a quarterly minimum revenue of $<ix:nonFraction unitRef="usd" contextRef="ic6bca201b74942348baa93e457128a05_D20200709-20200709" decimals="-5" name="cutr:DebtCovenantQuarterlyMinimumRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE3NDU_859c8a85-0298-45ba-b745-fba1b6d9fead">90.0</ix:nonFraction>&#160;million, determined in accordance with GAAP on a trailing twelve-month basis,  but which is only applicable if the Company has an outstanding balance under the loan facility. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 4, 2021, the Loan and Security Agreement dated July 9, 2020 was amended to (i)&#160;permit the Company to issue the Convertible notes and perform its obligations in connection therewith, and (ii)&#160;permit the Capped Call transactions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or about May 28, 2021, the Loan and Security Agreement was amended. The amendment removed the quarterly minimum revenue requirement but kept in place the other financial covenants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had not drawn on the SVB Revolving Line of Credit and the Company is in compliance with all financial covenants of the SVB Revolving Line of Credit.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Paycheck Protection Program (PPP) Loan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;22, 2020, the Company received loan proceeds of $<ix:nonFraction unitRef="usd" contextRef="i9781cc48038047a79264ddaf70b44230_D20200422-20200422" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2NDUxNDU_826ef431-42ca-4651-b6ce-03ac678bf023">7.2</ix:nonFraction> million pursuant to the Paycheck Protection Program (the &#8220;PPP&#8221;) under the CARES Act. The loan, which was in the form of a promissory note dated April 21, 2020, between the Company and Silicon Valley Bank as the lender, originally matured on April 21, 2022 and bore interest at a fixed rate of <ix:nonFraction unitRef="number" contextRef="i4d2cac1cd2a7480690ed521729608228_I20200422" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2NDU0MzQ_1ae8c42a-ecf0-4a99-ada1-5ef3ca79931b">1.00</ix:nonFraction>% per annum, payable monthly commencing September 2021. There was no prepayment penalty. Under the terms of the PPP, all or a portion of the principal may be forgiven if the loan proceeds were used for qualifying expenses as described in the CARES Act, such as payroll costs, benefits, rent, and utilities. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PPP loan and related accrued interest were forgiven in June 2021 under the provisions of the CARES Act, and a $<ix:nonFraction unitRef="usd" contextRef="i2fe8bd55b1e94cda888bad51642d2ccf_D20210601-20210630" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2NDU4NjU_5291fef2-e34b-44dd-8789-81e2b399e66c">7.2</ix:nonFraction>&#160;million Gain on extinguishment of PPP loan was recorded in the consolidated statement of operations.</span></div></ix:continuation><div id="idabc87e13e174d3c9f17fa6963046f56_151"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTEvZnJhZzoxYWYxZTg0MDY5NDI0N2Y4YmQzOWZhMmRkYzU4MzY2ZC90ZXh0cmVnaW9uOjFhZjFlODQwNjk0MjQ3ZjhiZDM5ZmEyZGRjNTgzNjZkXzMxODA_443b55d5-bc80-452c-9b69-1e42d08a0909" continuedAt="ie5f73ea5e1ca4358a9a7f995f4f87656" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie5f73ea5e1ca4358a9a7f995f4f87656">The Company has evaluated subsequent events through the date the financial statements were issued, and determined that there have been no events that have occurred that would require adjustments to our disclosures in the consolidated financial statements.</ix:continuation></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90ZXh0cmVnaW9uOmRjNmZkNWJkMDE1MDQ1ZmVhODUyYWI1NjhjMGYwZTg1XzExNQ_417e19fa-64d6-40cd-a281-600e26977839" escape="true"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUALIFYING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2021, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></div><ix:nonNumeric contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231" name="us-gaap:SummaryOfValuationAllowanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90ZXh0cmVnaW9uOmRjNmZkNWJkMDE1MDQ1ZmVhODUyYWI1NjhjMGYwZTg1XzExNg_d1e19bc5-12a2-47ea-9987-2d852b9134e2" escape="true"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance<br/>at End of<br/>Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia14ca8fcae0b4aefa76cad9866090d78_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzItMS0xLTEtMjg2MjE_01e56fa6-3164-45cb-b71a-0e90c2b3eb25">38,321</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i53f708f1ad434a6ebaec1f96b1e10a2a_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzItMy0xLTEtMjg2MjE_af01e7c4-efa2-4f6d-8ab1-57566a0f97da">7,503</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i53f708f1ad434a6ebaec1f96b1e10a2a_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzItNS0xLTEtMjg2MjE_f5df7b4e-f124-4c76-be2d-1b0f9c3946b8">5,337</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9ee1cde4537a457a88a3ef970508acf5_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzItNy0xLTEtMjg2MjE_6b395b84-d758-4af1-8d95-9aeba147cc88">40,487</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i07d7ed87182941cdbdd83dbfbedf27c2_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzMtMS0xLTEtMjg2MjE_1643f428-ad39-48b8-a3de-6824ce21c549">32,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i90d8a65714d14212b8f93aae06688452_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzMtMy0xLTEtMjg2MjE_fcd85bf2-d42c-4e81-ba31-cce93a123582">7,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i90d8a65714d14212b8f93aae06688452_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzMtNS0xLTEtMjg2MjE_84caeb23-3732-400c-95ca-1e38a92a9dcb">2,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia14ca8fcae0b4aefa76cad9866090d78_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzMtNy0xLTEtMjg2MjE_d7a30030-cca9-47e1-ab4e-0d79336636d2">38,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2019</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3b7116ac1a764bada7c667ee90614aee_I20181231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzQtMS0xLTEtMjg2MjE_94f0ce4b-091d-488e-940d-673aa46d82bb">27,865</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifbfb1453521848d4a478c1bab5686392_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzQtMy0xLTEtMjg2MjE_5c2cf0eb-245f-425d-8889-69ec4c9394ca">7,396</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifbfb1453521848d4a478c1bab5686392_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzQtNS0xLTEtMjg2MjE_4c0c5dc3-7dec-4d55-98e1-21a3d32a8067">2,911</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i07d7ed87182941cdbdd83dbfbedf27c2_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzQtNy0xLTEtMjg2MjE_b6dd2fe4-b4f5-4a7d-8282-b69de15711ef">32,350</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance<br/>at End of<br/>Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses, accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54116f7e632d4168b0ea901ff7e1d220_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzItMS0xLTEtMjg2MjE_0b269d0f-e97c-4462-b6fe-a2532516dd6a">1,598</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied6bc4de4307436da39a837d8e641a54_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzItMy0xLTEtMjg2MjE_3ba4cd3e-f05d-409c-8c63-21158d1b2ee3">271</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied6bc4de4307436da39a837d8e641a54_D20210101-20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzItNS0xLTEtMjg2MjE_abd7c8dd-ea8a-43dd-bbb6-8c22ff04e03a">970</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib07203e94f374a45ab7a8e8c3f66b67b_I20211231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzItNy0xLTEtMjg2MjE_25b718f4-dfaf-4176-85d5-3f782e814313">899</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dbc469745e840208e864df19cadabc3_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzMtMS0xLTEtMjg2MjE_7ef98774-9784-44af-b567-263abd862f9c">1,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica83547bfc21466aaad3b5d34df18cb4_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzMtMy0xLTEtMjg2MjE_a8f5b7e9-b02e-4ae9-ab80-9f227b5a36e2">2,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica83547bfc21466aaad3b5d34df18cb4_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzMtNS0xLTEtMjg2MjE_9efb68f3-6530-4dff-b8e1-342604d335dc">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54116f7e632d4168b0ea901ff7e1d220_I20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzMtNy0xLTEtMjg2MjE_bb5eeb3e-e553-40ed-afcb-818c51820c98">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2019</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb9f62bf502f487d80c5e7ec032cdc88_I20181231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzQtMS0xLTEtMjg2MjE_99a2e589-50d5-4748-ba7a-08d84cee3155">1,257</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia314f34942bd40c09b7937fff3f63589_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzQtMy0xLTEtMjg2MjE_a9abbb91-0d9d-42b5-83cb-336f261b115b">1,361</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia314f34942bd40c09b7937fff3f63589_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzQtNS0xLTEtMjg2MjE_a104a185-4c23-4b5d-9440-6a0baf9409d4">1,264</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dbc469745e840208e864df19cadabc3_I20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzQtNy0xLTEtMjg2MjE_7ffd5039-9fdd-4089-8b4e-267d40c853d6">1,354</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:12pt;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;CHANGES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DISAGREEMENTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WITH</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCOUNTANTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCOUNTING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DISCLOSURE</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_163"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A. &#160; &#160; &#160;&#160; CONTROLS AND PROCEDURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) that are designed to ensure that information required to be disclosed in the Company&#8217;s Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and that such information is accumulated and communicated to the Company&#8217;s management, including the Company&#8217;s principal executive officer and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by SEC Rule 13a-15(b), the Company carried out an evaluation, under the supervision and with the participation of the Company&#8217;s management, including the Company&#8217;s principal executive officer and principal financial officer, of the effectiveness of the design and operation of the Company&#8217;s disclosure controls and procedures as of the end of the period covered by this Annual Report on Form 10-K. Based on the foregoing, the Company&#8217;s Chief Executive Officer (&#8220;CEO&#8221;) and Chief Financial Officer (&#8220;CFO&#8221;) concluded that the Company&#8217;s disclosure controls and procedures were not effective at the reasonable assurance level as a result of the material weakness disclosed below. Notwithstanding the material weakness, the Company&#8217;s management, including the CEO and CFO, has concluded that the consolidated financial statements, included in the 2021 Annual Report on Form 10-K, fairly present, in all material respects, our financial condition, results of operations and cash-flows for the periods presented in conformity with generally accepted accounting principles.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attached as exhibits to this Annual Report are certifications of the Company&#8217;s CEO and CFO, which are required in accordance with Rule 13a-14 of the Securities Exchange Act of 1934, as amended (Exchange Act). This Controls and Procedures section includes the information concerning the controls evaluation referred to in the certifications, and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inherent Limitations Over Internal Controls</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. The Company&#8217;s internal control over financial reporting includes those policies and procedures that:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company&#8217;s assets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that the Company&#8217;s receipts and expenditures are being made only in accordance with authorizations of the Company&#8217;s management and directors; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management, including the Company&#8217;s CEO and CFO, does not expect that the Company&#8217;s internal controls will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of internal controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Also, any evaluation of the effectiveness of controls in future periods are subject to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) to provide reasonable assurance regarding the reliability </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the Company&#8217;s financial reporting and the preparation of Consolidated Financial Statements for external purposes in accordance with U.S. GAAP.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management, including Company&#8217;s CEO and CFO, assessed the Company&#8217;s internal control over financial reporting as of December&#160;31, 2021. Management based its assessment on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Management&#8217;s assessment included evaluation of elements such as the design and operating effectiveness of key financial reporting controls, process documentation, accounting policies, and the Company's overall control environment. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this assessment, management identified a material weakness in the Company&#8217;s internal control over financial reporting. This material weakness is related to ineffective information technology general controls (&#8220;ITGCs&#8221;) in the areas of user access and segregation of duties related to certain information technology (&#8220;IT&#8221;) systems that support the Company&#8217;s financial reporting process at its Japan subsidiary. Although this material weakness did not result in any material misstatement of the Company's consolidated financial statements for the periods presented, it could lead to a material misstatement of account balances or disclosures. Accordingly, management has concluded that this deficiency constitutes a material weakness.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has begun the process of designing and implementing effective internal control measures to improve its internal controls over financial reporting and remediate this material weakness. The Company's efforts include implementing additional controls designed to detect potential material misstatements that may arise as a result of user access and segregation of duties conflicts at the Company's Japan subsidiary.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of the Company&#8217;s internal control over financial reporting as of December&#160;31, 2021, has been audited by an independent registered public accounting firm, as stated in their attestation report, which is included in their annual report under &#8220;Item 8. Financial Statements and Supplementary Data&#8221; of this Annual Report on Form 10-K.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in the Company&#8217;s internal control over financial reporting during the quarter ended December&#160;31, 2021 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_166"></div><div style="margin-top:12pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_3298534885100"></div><div style="margin-top:12pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9C.&#160;&#160;&#160;&#160;DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_169"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information required by Part III is omitted from this report on Form 10-K and is incorporated herein by reference to the Company&#8217;s definitive Proxy Statement for the Company&#8217;s next Annual Meeting of Stockholders (the &#8220;Proxy Statement&#8221;), which the Company intends to file pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended, within 120 days after December&#160;31, 2021.</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_172"></div><div style="margin-top:12pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10.&#160;&#160;&#160;&#160;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is set forth under the following captions in the Company&#8217;s Proxy Statement, all of which is incorporated herein by reference: &#8220;Proposal No. 1 &#8211; Election of Class I Directors&#8221;, &#8220;Board and Committee Information&#8221;, &#8220;Executive Officers&#8221; and &#8220;Additional Information &#8211; Stockholder Proposals to be Presented at Next Annual Meeting.&#8221;</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_175"></div><div style="margin-top:12pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11.&#160;&#160;&#160;&#160;EXECUTIVE COMPENSATION</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item set forth under the following captions in the Proxy Statement, all of which is incorporated herein by reference: &#8220;Executive Compensation.&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_178"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:12pt;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12.&#160;&#160;&#160;&#160;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is set forth under the following captions in the Proxy Statement, all of which is incorporated herein by reference: &#8220;Security Ownership of Certain Beneficial Owners and Management.&#8221;</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_181"></div><div style="margin-top:12pt;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13.&#160;&#160;&#160;&#160;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is set forth under the following captions in the Proxy Statement, all of which is incorporated herein by reference: &#8220;Certain Relationships and Related-Party Transactions.&#8221;</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_184"></div><div style="margin-top:12pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14.&#160;&#160;&#160;&#160;PRINCIPAL ACCOUNTING FEES AND SERVICES</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is set forth under the following captions in the Proxy Statement, which is incorporated by reference herein by reference: &#8220;Proposal No. 2, Ratification of Independent Registered Public Accounting Firm.&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><div id="idabc87e13e174d3c9f17fa6963046f56_187"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:12pt;text-align:center;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_190"></div><div style="-sec-extract:summary;margin-top:12pt;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;EXHIBITS,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATEMENT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULES</span></div><div style="margin-top:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The following documents are filed in Part II of the Annual Report on the Original&#160;10-K:</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Financial Statements: See "Index to Consolidated Financial Statements" within the Consolidated Financial Statements.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. Financial Statement Schedules:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Financial Statement Schedules; not applicable or the required information is otherwise included in the Consolidated Financial Statements and accompanying notes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The exhibits listed in the accompanying index to exhibits are filed, furnished, or incorporated by reference as part of this Form 10-K. The following is a list of such Exhibits:</span></div><div style="margin-top:10pt;text-align:center;text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit Index</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001162461/000143774917018538/ex_99509.htm">Amended and Restated Certificate of Incorporation of the Registrant (filed as Exhibit 3.5 to the Company&#8217;s Quarterly Report on Form 10-Q filed on November 7, 2017 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774915000466/ex3-4.htm">Bylaws of the Registrant (filed as Exhibit 3.4 to the Company&#8217;s Current Report on Form 8-K filed on January 8, 2015 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312505061000/dex41.htm">Specimen Common Stock certificate of the Registrant (filed as Exhibit 4.1 to the Company&#8217;s Annual Report on Form&#160;10-K filed on March 25, 2005 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920005342/ex_177322.htm">Description of the Registrant&#8217;s Securities (filed as Exhibit 4.2 to the Company&#8217;s Annual Report on Form 10-K filed on March 16, 2020 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774919003050/ex_135490.htm">Form of Indemnification Agreement for directors and executive officers (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 21, 2019 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312504004524/dex102.htm">1998 Stock Plan (filed as Exhibit 10.2 to the Company&#8217;s registration statement on Form S-1 filed on January 15, 2004 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312507056855/dex104.htm">2004 Employee Stock Purchase Plan (filed as Exhibit 10.4 to the Company&#8217;s Annual Report on Form&#160;10-K&#160;filed on March&#160;16, 2007 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312504004524/dex106.htm">Brisbane Technology Park Lease dated August 5, 2003 by and between the Registrant and&#160;Gal-Brisbane,&#160;L.P. for office space located at 3240 Bayshore Boulevard, Brisbane, California (filed as Exhibit 10.6 to the Company&#8217;s registration statement on Form&#160;S-1&#160;filed on January&#160;15, 2004 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312506125125/dex991.htm">Settlement Agreement between the Registrant and Palomar Medical Technologies, Inc. dated June&#160; 2, 2006 (filed as Exhibit 99.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on June&#160;6, 2006 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312506125125/dex992.htm">Non-Exclusive&#160;Patent License between the Registrant and Palomar Medical Technologies, Inc. dated June&#160;2, 2006 (filed as Exhibit 99.2 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on June&#160;6, 2006 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312505225555/dex1011.htm">Form of Performance Unit Award Agreement (filed as Exhibit 10.11 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on November&#160;14, 2005 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774919008339/cutr20190429_def14a.htm">2019 Equity Incentive Plan (filed as Appendix A to the Company&#8217;s definitive proxy statement on Form 14A filed on April&#160; 30, 2019 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000116246110000009/ex10_19.htm">First Amendment to Brisbane Technology Park Lease dated August&#160;11, 2010 by and between the Company and BMR-Bayshore Boulevard LLC, as&#160;successor-in-interest&#160;to&#160;Gal-Brisbane,&#160;L.P., the original landlord, for office space located at 3240 Bayshore Boulevard (filed as Exhibit 10.19 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on November&#160;1, 2010 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774916036089/ex10-20.htm">Change of Control and Severance Agreement between Kevin P. Connors and the Registrant (filed as Exhibit 10.20 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on August&#160;1, 2016 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774916036089/ex10-21.htm">Change of Control and Severance Agreement between Ronald J. Santilli and the Registrant (filed as Exhibit 10.21 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on August&#160;1, 2016 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774916036089/ex10-22.htm">Form of Performance Stock Unit Award Agreement (filed as Exhibit 10.22 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on August&#160;1, 2016 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774917000548/ex10-23.htm">Change of Control and Severance Agreement between James Reinstein and the Registrant (filed as Exhibit 10.23 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on January&#160;11, 2017 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774917013942/ex10-26.htm">Lease Termination Agreement dated July&#160; 6, 2017 by and between the Registrant and SI 28, LLC (filed as Exhibit 10.26 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on August&#160;7, 2017 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774917013942/ex10-27.htm">Second Amendment to Lease dated July&#160; 6, 2017 by and between the Company and BMR-Bayshore Boulevard LP (filed as Exhibit 10.27 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on August&#160;7, 2017 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920005342/ex_177316.htm">First Amendment and Wavier to the Loan and Security Agreement dated November&#160; 2, 2018 by and between the Company and Wells Fargo Bank, N.A. (filed as Exhibit 10.20 to the Company&#8217;s Annual Report on Form 10-K filed on March 16, 2020 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920005342/ex_177317.htm">Second Amendment and Waiver to the Loan and Security Agreement dated March&#160; 11, 2019 by and between the Company and Wells Fargo Bank N.A. (filed as Exhibit 10.2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920005342/ex_177317.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920005342/ex_177317.htm"> to the Company&#8217;s Annual Report on Form 10-K filed on March 16, 2020 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774919013706/ex_149506.htm">Employment Offer Letter dated June&#160; 22, 2019 by and between Cutera, Inc. and David Mowry (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on July&#160;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774919013706/ex_149506.htm">10</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774919013706/ex_149506.htm">, 2019 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774919013706/ex_149509.htm">Change of Control and Severance Agreement dated July&#160; 8, 2019 by and between Cutera, Inc. and David Mowry (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on July&#160;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774919013706/ex_149509.htm">10</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774919013706/ex_149509.htm">, 2019 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774919023101/ex_165060.htm">Consulting Agreement between Cutera, Inc. and FLG Partners, effective November&#160; 11, 2019 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on November&#160;18, 2019 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312520113529/d914244dex11.htm">Purchase Agreement, dated April 16, 2020, by and between Cutera, Inc., and Piper Sandler &amp; Co.  (filed as Exhibit 1.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on April 21, 2020 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312520113529/d914244dex51.htm">Opinion of Wilson Sonsini Goodrich &amp; Rosati, Professional Corporation (filed as Exhibit 5.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on April 21, 2020 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920008472/ex_182753.htm">Promissory Note dated April 21, 2020, between Cutera, Inc. and Silicon Valley Bank (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on April 24, 2020 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920013317/ex_190689.htm">Cutera, Inc. 2019 Equity Incentive Plan (amended and restated as of June 15, 2020) (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on June 17, 2020 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920015031/ex_193496.htm">Loan and Security Agreement, dated as of July 9, 2020, by and among Cutera, Inc., as borrower, and Silicon Valley Bank, as lender (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on July 13, 2020 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920015031/ex_193497.htm">Third Amendment to Lease by and between Cutera, Inc. and BMR-Bayshore Boulevard LP, successor-in-interest Gal-Brisbane, L.P. (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on July 13, 2020 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920017087/ex_198097.htm">Employment Offer Letter dated July 29, 2020 by and between Cutera, Inc. and Rohan Seth (filed as Exhibit 10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920017087/ex_198097.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920017087/ex_198097.htm"> to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on August 7, 2020 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774920017087/ex_198098.htm">Change of Control and Severance Agreement dated July 29, 2020 by and between Cutera, Inc. and Rohan Seth (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on August 7, 2020 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312521074917/d134661dex41.htm">Indenture, dated as of March 9, 2021, between Cutera, Inc. and U.S. Bank National Association, as trustee (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on March&#160;9, 2021 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312521074917/d134661dex101.htm">Purchase Agreement, dated March 4, 2021, between Cutera, Inc. and Stifel, Nicolaus &amp; Company, Incorporated, as representative of the several initial purchasers named in Schedule I thereto (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on March&#160;9, 2021 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312521074917/d134661dex102.htm">Form of Capped Call Transaction Confirmation (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on March&#160;9, 2021 and incorporated herein by reference)</a></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312521074917/d134661dex103.htm">Amendment No. 1, dated March 4, 2021, to the Loan and Security Agreement, dated July 9, 2020 by and between Cutera, Inc., and Silicon Valley Bank ((filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on March&#160;9, 2021 and incorporated herein by reference))</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774921011798/ex_248820.htm">Separation and Release Agreement by and between Cutera, Inc. and Jason Richey (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on May&#160;12, 2021 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312521172458/d188233dex101.htm">Employment Offer Letter dated May 19, 2021 by and between Cutera, Inc. and J. Daniel Plants (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on May&#160;25, 2021 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000119312521172458/d188233dex102.htm">Change of Control and Severance Agreement dated May 19, 2021 by and between Cutera, Inc. and J. Daniel Plants  (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on May&#160;25, 2021 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774921015107/ex_258175.htm">Cutera, Inc. 2019 Equity Incentive Plan (amended and restated as of June 15, 2021) (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K&#160;filed on June </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774921015107/ex_258175.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774921015107/ex_258175.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000143774921015107/ex_258175.htm">, 2021 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828021016106/a1zomedicalandcuteraagreem.htm">ZO Medical and Cutera Agreement 5 Aug 2013 (filed as Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on August 6, 2021 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828021016106/a2zoskinhealthamendment21a.htm">ZO Skin Health Amendment 21 Aug 2013 (filed as Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form&#160;10-Q&#160;filed on August 6, 2021 and incorporated herein by reference)</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828021016106/a3zoskinhealthamendment25j.htm">ZO Skin Health Amendment 25 Jan 2021 (filed as Exhibit 10.3 to the Company&#8217;s Quarterly  Report on Form&#160;10-Q&#160;filed on August 6, 2021 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.40</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1162461/000162828021016106/a4zoskinhealthamendment14j.htm">ZO Skin Health Amendment 14 Jun 2021 (filed as Exhibit 10.4 to the Company&#8217;s Quarterly  Report on Form&#160;10-Q&#160;filed on August 6, 2021 and incorporated herein by reference)</a></span></div><div><span><br/></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.41</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cutr-20211231xexx1041.htm">Amendment, effective January 1, 2022, to Distribution Agreement dated August 5, 2013, between Cutera Inc., and ZO Skin Health, Inc.</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cutr-20211231xexx231.htm">Consent of Independent Registered Public Accounting Firm</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power of Attorney</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cutr-20211231xexx313.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cutr-20211231xexx314.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cutr-20211231xexx321.htm">Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Management contract or compensatory plan</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+&#160;&#160;&#160;&#160;Filed herewith</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_193"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16. FORM 10-K SUMMARY</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="idabc87e13e174d3c9f17fa6963046f56_196"></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, in the city of Brisbane, State of California, on the 1th day of March, 2022.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:45.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.721%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUTERA, INC.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DAVID H. MOWRY</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">David H. Mowry</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Officer</span></div></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Power of Attorney</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL MEN AND WOMEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints David H. Mowry, and Rohan Seth, and each of them, as his or her true and lawful&#160;attorneys-in-fact&#160;and agents, with full power of substitution and resubstitution for him or her and in his or her name, place, and stead, in any and all capacities to sign any and all amendments to this Annual Report on Form&#160;10-K,&#160;and to file the same, with exhibits thereto and other documents in connection therewith, with the U.S. Securities and Exchange Commission, granting unto said&#160;attorneys-in-fact&#160;and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done therewith, as fully to all intents and purposes as they might or could do in person, hereby ratifying and confirming all that said&#160;attorneys-in-fact&#160;and agents, and any of them or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">Table of Conte</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#idabc87e13e174d3c9f17fa6963046f56_7">nts</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:25.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.070%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date</span></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ DAVID H. MOWRY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer and Director (Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 01, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">David H. Mowry</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ROHAN SETH</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer (Principal Financial and Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 1, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rohan Seth</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ J. DANIEL PLANTS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Chairman of the Board of Directors</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 1, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">J. Daniel Plants</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ GREGORY A. BARRETT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 1, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gregory A. Barrett</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ JOSEPH E. WHITTERS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 1, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Joseph E. Whitters</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ TIM J. O&#8217;SHEA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 1, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tim J. O&#8217;Shea</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ KATHERINE S. ZANOTTI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 1, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Katherine S. Zanotti</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ SHEILA A. HOPKINS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 1, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sheila A. Hopkins</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ JANET L. WIDMAN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 1, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Janet L. Widman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">/s/ JULIANE T. PARK</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 1, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Juliane T. Park</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.41
<SEQUENCE>2
<FILENAME>cutr-20211231xexx1041.htm
<DESCRIPTION>EX-10.41
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1fcd438d4d9d49e195d0a12a610e1ba2_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:4.55pt;padding-left:99.82pt;padding-right:99.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTAIN IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS NOT MATERIAL AND (I) WOULD BE COMPETITIVELY HARMFUL TO THE REGISTRANT IF PUBLICLY DISCLOSED OR (II) IS INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SUCH INFORMATION HAS BEEN MARKED WITH &#8220;&#91;***&#93;&#8221; TO INDICATE WHERE OMISSIONS HAVE BEEN MADE.</font></div><div style="margin-bottom:0.12pt;margin-top:0.06pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AMENDMENT TO DISTRIBUTION AGREEMENT</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Amendment (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to the Existing Agreement (as hereinafter defined), is made by and between ZO Skin Health, Inc., a California corporation, having its principal place of business at 9685 Research Drive, Irvine, CA 92618 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ZO SKIN HEALTH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and Cutera, Inc., a Delaware corporation, having its principal place of business at 3240 Bayshore Blvd., Brisbane, CA 94005 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Distributor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#8221; and together with ZO SKIN HEALTH, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Parties,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), effective as of January 1, 2022 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Parties have entered into a Distribution Agreement, dated August 5, 2013 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), as amended by an amendment effective August 21, 2013 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">August 2013 Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), an amendment effective January 25, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">January 2021 Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and an amendment effective June 14, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">June 2021 Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The Agreement as amended by the August 2013 Amendment, the January 2021 Amendment and the June 2021 Amendment are collectively referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Existing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Parties hereto desire to amend the Existing Agreement on the terms and subject to the conditions set forth herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Capitalized terms used and not defined in this Amendment have the respective meanings assigned to them in the Existing Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Amendments to the Existing Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  As of the Amendment Effective Date, the Existing Agreement is hereby amended and modified as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Section 4.1. of the Existing Agreement is hereby modified by adding the following as Section 4.4(e)&#58;</font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;(e) 2022 Minimum Sales Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For calendar year 2022, Distributor must achieve in-Territory sales of Products and Related Products of at least </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">XXX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">% of Distributor&#8217;s actual in-Territory sales of Products and Related Products for the 2021 calendar year (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2022 Minimum Sales Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Should Distributor fail to achieve the 2022 Minimum Sales Requirement, the Parties shall follow the procedures set forth in Section 4.1(c) of the Existing Agreement as if Distributor failed to achieve a Minimum Purchase Requirement, and the Parties shall have the same rights and obligations as set forth therein in connection with such failure to achieve the 2022 Minimum Sales Requirement.&#8221; </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Section 4.4. of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58; </font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;4.4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Business Plan and Reporting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.8pt;text-decoration:underline">Business Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. By March 1, 2022, Distributor shall provide to ZO SKIN HEALTH a business plan (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Business Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) for the promotion, marketing, distribution and sale of Products and Related Products in the Territory during the calendar year of this Amendment.  A Business Plan for each subsequent year shall be provided to ZO by October 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the preceding year. The Business Plan shall include, at a minimum, those items set forth in Exhibit E, which may be modified unilaterally by ZO SKIN HEALTH upon written notice to Distributor.</font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:5.18pt;text-decoration:underline">Reporting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Not later than the tenth business day of each calendar month, Distributor shall provide ZO SKIN HEALTH with updated in-market activity containing sales by account and sales by Product&#47;SKU data for the prior calendar month. Following the end of each calendar year during the term of this Agreement, but no later than February 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the following year, Distributor shall send to ZO SKIN HEALTH a report containing sell in and sell through data by country, to be approved by ZO SKIN HEALTH.&#8221;</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Section 4.8. of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58; </font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;4.8. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Quarterly Notices, Reports and Forecasts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Distributor shall provide ZO SKIN HEALTH with at least three (3) months&#8217; prior notice of all in-market Product and Related Product campaigns and shall provide ZO SKIN HEALTH with such reports of its other activities, competitor activities, and other information regarding the Products and Related Products and the markets for them in the Territory in such detail and with such frequency as ZO SKIN HEALTH shall reasonably require from time to time. In order to help ZO SKIN HEALTH provide inventory on a timely and consistent basis to Distributor, Distributor agrees to provide to ZO SKIN HEALTH on a quarterly basis, a binding three (3) month rolling forward minimum unit-based shipping forecast, as well as an estimated twelve (12) month rolling forecast of Distributor&#8217;s projected purchase orders on the form attached hereto as Exhibit B, which form, including the information to be contained therein, may be amended by ZO from time to time. Distributor&#8217;s provision of the above-mentioned estimated forecast shall not be interpreted as a commitment from Distributor to buy any Products or Related Products in excess of Distributor&#8217;s Minimum Purchase Requirement, unless otherwise agreed to in writing by the Parties&#59; provided, that, ZO may refuse to ship Products to Distributor, in ZO&#8217;s sole discretion, in the event they exceed any forecast in order to ensure availability of Products to other territories, including the United States.&#8221; </font></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Section 4.10. of the Existing Agreement is hereby deleted in its entirety and replaced with the following&#58; </font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;4.10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Free Goods and Discounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  During the term of this Agreement, ZO SKIN HEALTH will provide to Distributor&#58; (a) </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">XXX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">% of Net Sales worth as Free Goods and Related Products and collaterals&#59; and (b) a </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">XXX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">% discount on the Distributor Purchase Prices of Products and Related Products set forth in Exhibit A-1. Free Goods allowances and discounts will be calculated on each order and shall not roll-over from one order to the next, or form one year to the next.</font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In addition to the foregoing, for calendar year 2022 only, ZO SKIN HEALTH will provide Distributor with a one-time, incremental discount in the aggregate of $</font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">XXX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, which shall be calculated as an incremental </font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">XXX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">% discount on Distributor&#8217;s first $</font><font style="background-color:#000000;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">XXX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of purchases made in 2022 for ZO SKIN HEALTH Products and Related Products.&#8221;</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Exhibit A of the Existing Agreement is hereby deleted in its entirety and replaced with Exhibit A as attached hereto.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Date of Effectiveness&#59; Limited Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Amendment will become effective as of the Amendment Effective Date. Except as expressly provided in this Amendment, all of the terms and provisions of the Existing Agreement are and will remain in full force and effect and are hereby ratified and confirmed by the Parties. Without limiting the generality of the foregoing, the amendments contained </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">herein will not be construed as an amendment to or waiver of any other provision of the Existing Agreement or as a waiver of or consent to any further or future action on the part of either Party that would require the waiver or consent of the other Party. On and after the Amendment Effective Date, each reference in the Existing Agreement to &#8220;this Agreement,&#8221; &#8220;the Agreement,&#8221; &#8220;hereunder,&#8221; &#8220;hereof,&#8221; &#8220;herein,&#8221; or words of like import, and each reference to the Existing Agreement in any other agreements, documents, or instruments executed and delivered pursuant to, or in connection with, the Existing Agreement, will mean and be a reference to the Existing Agreement as amended by this Amendment. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.75pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">This Amendment is governed by and construed in accordance with, the laws of the State of California, without regard to the conflict of laws provisions of such State.</font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">This Amendment shall inure to the benefit of and be binding upon each of the Parties and each of their respective permitted successors and permitted assigns.</font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The headings in this Amendment are for reference only and do not affect the interpretation of this Amendment.</font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">This Amendment may be executed in counterparts, each of which is deemed an original, but all of which constitute one and the same agreement. Delivery of an executed counterpart of this Amendment electronically or by facsimile shall be effective as delivery of an original executed counterpart of this Amendment.</font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">This Amendment constitutes the sole and entire agreement between the Parties with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings, agreements, representations, and warranties, both written and oral, with respect to such subject matter.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;REMAINDER OF THIS SECTION SHALL REMAIN BLANK&#93;</font></div><div style="margin-top:6pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Parties have executed this Amendment on the date first written above.</font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ZO SKIN HEALTH, INC.</font></div></td></tr><tr style="height:111pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:6pt;padding-right:2.75pt"><img alt="picturemw.jpg" src="picturemw.jpg" style="height:139px;margin-bottom:5pt;vertical-align:text-bottom;width:189px"></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CUTERA, INC.</font></div></td></tr><tr style="height:114pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:6pt;padding-right:2.75pt"><img alt="picturedm.jpg" src="picturedm.jpg" style="height:142px;margin-bottom:5pt;vertical-align:text-bottom;width:204px"></div></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">PRODUCTS, TERRITORY, MINIMUMS</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;padding-left:25.01pt">Products.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> Attached hereto as Exhibit A-1 shall be a list of the ZO Skin Health products subject to this Distribution Agreement. This product list is non-exhaustive and is subject to modification and change at the sole discretion of ZO at any time pursuant to the terms of this Agreement&#59; further, travel size versions of the foregoing may be available at pricing to be provided by ZO from time to time. Additionally, pricing specified in Exhibit A-1 will be then current pricing at the time the list is provided to Distributor. Pricing is subject to change at ZO&#8217;s sole discretion pursuant to the terms of this Agreement. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;padding-left:25.01pt">Territory.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> The territory shall be Japan and any other territory designated by ZO in writing and agreed to by distributor for the exercise of Distributor&#8217;s rights and obligations in the Distributor Agreement.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">C.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;padding-left:25.01pt">Distributor Minimum Purchase Requirements. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Distributor Minimum Purchase Requirements of Products within the Territory shall be&#58;  </font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:0.08pt;padding-left:31.64pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.538%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Year</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Minimum Purchase Requirement</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023 and beyond</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">XXX</font></div></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">ZO&#8217;s remedies for Distributor&#8217;s failure to meet the Minimum Purchase Requirements of Products and Related Products are set forth in Section 4.1 of this Agreement. The above dollar amounts refer to United States Currency.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div><font><br></font></div><div style="margin-bottom:8pt;padding-left:0.72pt;padding-right:0.72pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:0.72pt;padding-right:0.72pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">EXHIBIT A-1</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">PRODUCT LIST</font></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.418%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.286%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.815%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM NO.</font></td><td colspan="3" style="background-color:#b8cce4;border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PRODUCT DESCRIPTION</font></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SIZE</font></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Suggested Retail Price</font></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Suggested Price to Customers</font></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">DISTRIBUTOR PRICE</font></td></tr><tr><td colspan="6" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GETTING SKIN READY&#174;</font></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">962000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Exfoliating Cleanser </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">Normal to Oily</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200 mL &#47; 6.7 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">965000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Hydrating Cleanser </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">Normal to Dry</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center;text-indent:-1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">200 mL &#47; 6.7 Fl. Oz.</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">900300</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Gentle Cleanser </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">All Skin Types </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200 mL &#47; 6.7 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">900400</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exfoliating Polish</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65 g&#160;&#47; 2.3 Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">900500</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dual Action Scrub</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116 g &#47; 4 Oz</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">928000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complexion Renewal Pads</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60 Pads</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">900800</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oil Control Pads</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60 Pads</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">920500</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Calming Toner </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:125%">pH Balancer</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180 mL &#47; 6 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="6" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PREVENT + CORRECT</font></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">905400</font></td><td colspan="3" style="background-color:#ffffff;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pigment Control Cr&#232;me (4% HQ)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80 mL &#47; 2.7 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">906000</font></td><td colspan="3" style="background-color:#ffffff;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Pigment Control + Brightening Cr&#232;me (4% HQ + 20% Vit C)</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81 mL &#47; 2.8 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">905700</font></td><td colspan="3" style="background-color:#ffffff;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pigment Control &#38; Blending Cr&#232;me (4% HQ)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80 mL &#47; 2.7 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">904200</font></td><td colspan="3" style="background-color:#ffffff;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Daily Power Defense</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 mL &#47; 1.7 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">904400</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Growth Factor Serum</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 mL &#47; 1 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">912700</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Firming Serum</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47 mL &#47; 1.6 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">918400</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Wrinkle + Texture Repair</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 mL &#47; 1.7 FL. Oz</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.418%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.286%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.815%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">904000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Radical Night Repair</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60 mL &#47; 2 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">904000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10% Vitamin C</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 mL &#47; 1.7 Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">905200</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exfoliation Accelerator</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 mL &#47;1.7 FL. Oz</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">941800</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Instant Pore Refiner</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#ff0000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">29 g &#47; 1 Oz.</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">905100</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Enzymatic Peel</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 mL &#47; 1.7 Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">940700</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Brightalive</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 mL &#47; 1.7 Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950500</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retinol Skin Brightener (1%)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 mL &#47;1.7 FL. Oz</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950300</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retinol Skin Brightener (0.5%)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 mL &#47;1.7 FL. Oz</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950400</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retinol Skin Brightener (0.25%)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 mL &#47;1.7 FL. Oz</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">907000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acne Control</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60 mL &#47; 2 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">930700</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complexion Clearing Masque</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85 g &#47; 3 Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">907100</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Correct &#38; Conceal Acne Treatment - Light</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3 g &#47; .09 Oz</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">907200</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Correct &#38; Conceal Acne Treatment - Medium</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.3 g &#47; .09 Oz</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">907400</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Rozatrol</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 mL &#47; 1.7 Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="6" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PROTECT</font></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">919300</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sunscreen + Primer SPF 30</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 mL &#47; 1 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">902700</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smart Tone Broad Spectrum SPF 50</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45 mL &#47; 1.5 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">902400</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Daily Sheer Broad Spectrum SPF 50</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45 mL &#47; 1.5 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">903400</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broad Spectrum Sunscreen SPF 50</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118 g &#47; 4 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">972400</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sunscreen + Powder SPF 30 - Light</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7 g &#47; 0.09 Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">972500</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sunscreen + Powder SPF 30 - Medium</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7 g &#47; 0.09 Oz.</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.418%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.286%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.815%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">972600</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sunscreen + Powder SPF 30 &#8211; Deep</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7 g &#47; 0.09 Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="6" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SUPPLEMENTARY</font></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950200</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Renewal Cr&#232;me</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 mL &#47; 1.7 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950100</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recovery Cr&#232;me</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50 mL &#47; 1.7 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">915300</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hydrating Cr&#232;me</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113 g &#47; 4 Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">907700</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cellulite Control</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150 g &#47; 5.3 Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">907600</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Body Emulsion</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">240 mL &#47; 8 Fl Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">907900</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intense Eye Repair</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 mL &#47; 0.5 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">918300</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eye Brightening Cr&#232;me</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 g &#47; 0.5 Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">940300</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Growth Factor Eye Serum</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 mL &#47; 0.5 Fl. Oz.</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="6" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PROGRAMS + KITS</font></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#000090;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">912100</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;padding-left:2.55pt;padding-right:2.75pt;text-indent:-1.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Daily Skincare Program </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 Product Regimen</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926400</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;padding-left:2.55pt;padding-right:2.75pt;text-indent:-1.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Anti-Aging Program </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 Product Regimen</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926300</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;padding-left:2.55pt;padding-right:2.75pt;text-indent:-1.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Aggressive Anti-Aging Program </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6 Product Regimen</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">909400</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;padding-left:2.55pt;padding-right:2.75pt;text-indent:-1.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Skin Normalizing System</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 Product Regimen</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">926500</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;padding-left:2.55pt;padding-right:2.75pt;text-indent:-1.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Complexion Clearing Program</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 Product Regimen</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">969000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Brightening Program</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 Product Regimen</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">973330</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Skin Brightening Program + Texture</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 Product Regimen</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">913100</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 Step Peel</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6 peels</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">910500</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:8pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">ZO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Controlled Depth Peel</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:125%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%"> Kit</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 peels</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XXX</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">XXX</font></div></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">* This product list is non-exhaustive and is subject to modification and change at the sole discretion of ZO.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:0.72pt;padding-right:0.72pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">EXHIBIT B</font></div><div style="margin-bottom:8pt;padding-left:0.72pt;padding-right:0.72pt;text-align:center"><font><br></font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">PURCHASE ORDER AND ROLLING FORECAST FORM</font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-left:0.72pt;padding-right:0.72pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#91;To be provided by ZO SKIN HEALTH from time to time.&#93;</font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-right:1.45pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-right:1.45pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-right:1.45pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-right:1.45pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-right:1.45pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-right:1.45pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-right:1.45pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-right:1.45pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-right:1.45pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-right:1.45pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-right:1.45pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-right:1.45pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-right:1.45pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-right:1.45pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:9.6pt;padding-right:1.45pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">* Note&#58; Forms are subject to change.</font></div><div style="margin-bottom:8pt;padding-left:0.72pt;padding-right:0.72pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:0.72pt;padding-right:0.72pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%">EXHIBIT E</font></div><div style="margin-bottom:8pt;margin-top:18.5pt;padding-left:0.6pt;padding-right:0.6pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">BUSINESS PLAN GUIDELINES</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:8.84pt">Distributor Mission Statement</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:8.84pt">ZO Brand Positioning in the market and in the Distributors product line, including all Distributor product and service offerings, whether by Distributor or its affiliates</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:8.84pt">Currently Targeted Sales Channels &#8211; </font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">XXX</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:8.84pt">Financial Summary</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:11.4pt">Including without limitation </font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">XXX</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:8.84pt">Strategy</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%">&#9702;</font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:11.4pt">XXX</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:8.84pt">Market Analysis</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%">&#9702;</font><font style="background-color:#000000;color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%;padding-left:11.4pt">XXX</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:11.4pt">Current number of </font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">XXX</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:11.4pt">Distributor estimation of </font><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">XXX</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:8.84pt">Business Expansion Strategy</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%">&#9702;</font><font style="background-color:#000000;color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%;padding-left:11.4pt">XXX</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:8.84pt">Operations</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:11.4pt">Distribution Center and all information pertaining to operations</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:8.84pt">Management Structure</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;padding-left:2.73pt">Organizational Structure</font></div><div style="margin-bottom:8pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%">&#9702;</font><font style="background-color:#000000;color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%;padding-left:11.4pt">XXX</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">If the Distributor&#8217;s Territory includes more than one country, the above information shall be provided separately for each country.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* ZO may update these Business Plan Guidelines from time to time.</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXHIBIT G</font></div><div style="margin-bottom:8pt;margin-top:18.5pt;padding-left:0.6pt;padding-right:0.6pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">MONTHLY REPORTING GUIDELINES</font></div><div style="margin-bottom:10pt;padding-right:-9pt;text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:79px;margin-bottom:5pt;vertical-align:text-bottom;width:672px"></div><div style="margin-bottom:10pt;padding-right:-9pt;text-align:center"><img alt="image_1.jpg" src="image_1.jpg" style="height:179px;margin-bottom:5pt;vertical-align:text-bottom;width:672px"><img alt="image_2.jpg" src="image_2.jpg" style="height:452px;margin-bottom:5pt;vertical-align:text-bottom;width:672px"></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:125%">* This list is non-exhaustive and may be updated by ZO from time to time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>cutr-20211231xexx231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic097dd2bd692484aad4c7e03106aeb80_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 23.1</font></div><div style="margin-bottom:0.04pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Consent of Independent Registered Public Accounting Firm</font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cutera, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brisbane, California</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-237552) and Form S-8 (No. 333-114149, 333-123495, 333-132583, 333-141376, 333-149703, 333-158160, 333-187502, 333-206864, 333-221542, and 333-258283) of Cutera, Inc. of our reports dated March&#160;1, 2022, relating to the consolidated financial statements and schedule, and the effectiveness of Cutera, Inc.&#8217;s internal control over financial reporting, which appear in this Form 10-K. </font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; BDO USA, LLP</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Francisco, California</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March&#160;1, 2022</font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-right:-4.3pt;text-align:justify"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.3
<SEQUENCE>4
<FILENAME>cutr-20211231xexx313.htm
<DESCRIPTION>EX-31.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2f786d0b16d34919a41089ec8a5552df_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.3</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 15 U.S.C. SECTION 7241, AS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David H. Mowry, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this annual report on Form 10-K of Cutera, Inc.&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d- 15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:2.41pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under the Company&#8217;s supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to the Company by others within those entities, particularly during the period in which this annual report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under the Company&#8217;s supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:2.41pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report the Company&#8217;s conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I have disclosed, based on the Company&#8217;s most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.74pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.17pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 1, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#47;s&#47; DAVID H. MOWRY</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">David H. Mowry<br>Chief Executive Officer (Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.4
<SEQUENCE>5
<FILENAME>cutr-20211231xexx314.htm
<DESCRIPTION>EX-31.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ib7a704fdc84d4abeac08bf065e17f6dc_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.4</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 15 U.S.C. SECTION 7241, AS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Rohan Seth, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this annual report on Form 10-K of Cutera, Inc.&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d- 15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:2.41pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under the Company&#8217;s supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to the Company by others within those entities, particularly during the period in which this annual report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under the Company&#8217;s supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:2.41pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report the Company&#8217;s conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I have disclosed, based on the Company&#8217;s most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.74pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.17pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 1, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#47;s&#47; ROHAN SETH</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rohan Seth<br>Chief Financial Officer (Principal Financial and<br>Accounting Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>cutr-20211231xexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5a2484886caf4d82953e90d59147288b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the annual report on Form 10-K of Cutera, Inc. a Delaware corporation, for the period ended December&#160;31, 2021, as filed with the Securities and Exchange Commission, each of the undersigned officers of Cutera, Inc. certifies pursuant to section 1350 of chapter 63 of title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his respective knowledge&#58;</font></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">the annual report of Cutera, Inc. on Form 10-K for the period ended December&#160;31, 2021, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="padding-left:90pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">the information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of Cutera, Inc. for the periods presented therein.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 1, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#47;s&#47; DAVID H. MOWRY</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">David H. Mowry<br>Chief Executive Officer (Principal Executive Officer)</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 1, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#47;s&#47; ROHAN SETH</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rohan Seth<br>Chief Financial Officer (Principal Financial and<br>Accounting Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>cutr-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1ebe9035-7f15-449f-b887-5ea51f412a9f,g:8ea03665-a689-4990-8029-94d26fa40407-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cutr="http://cutera.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://cutera.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cutr-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cutr-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cutr-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cutr-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://cutera.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://cutera.com/role/AuditInformation">
        <link:definition>0002002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://cutera.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001003 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002004 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://cutera.com/role/ConsolidatedStatementsofOperations">
        <link:definition>1003005 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>1004006 - Statement - Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>1005007 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityParenthetical" roleURI="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical">
        <link:definition>1006008 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://cutera.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1007009 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://cutera.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2404401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails">
        <link:definition>2405402 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandRestrictedCash" roleURI="http://cutera.com/role/CashCashEquivalentsandRestrictedCash">
        <link:definition>2106102 - Disclosure - Cash, Cash Equivalents and Restricted Cash</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandRestrictedCashTables" roleURI="http://cutera.com/role/CashCashEquivalentsandRestrictedCashTables">
        <link:definition>2307302 - Disclosure - Cash, Cash Equivalents and Restricted Cash (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails" roleURI="http://cutera.com/role/CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails">
        <link:definition>2408403 - Disclosure - Cash, Cash Equivalents and Restricted Cash - Summary of Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandRestrictedCashNarrativeDetails" roleURI="http://cutera.com/role/CashCashEquivalentsandRestrictedCashNarrativeDetails">
        <link:definition>2409404 - Disclosure - Cash, Cash Equivalents and Restricted Cash - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetail" roleURI="http://cutera.com/role/BalanceSheetDetail">
        <link:definition>2110103 - Disclosure - Balance Sheet Detail</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailTables" roleURI="http://cutera.com/role/BalanceSheetDetailTables">
        <link:definition>2311303 - Disclosure - Balance Sheet Detail (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailInventoriesDetails" roleURI="http://cutera.com/role/BalanceSheetDetailInventoriesDetails">
        <link:definition>2412405 - Disclosure - Balance Sheet Detail - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailPropertyandEquipmentNetDetails" roleURI="http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails">
        <link:definition>2413406 - Disclosure - Balance Sheet Detail - Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailAccruedLiabilitiesDetails" roleURI="http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails">
        <link:definition>2414407 - Disclosure - Balance Sheet Detail - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailNarrativeDetails" roleURI="http://cutera.com/role/BalanceSheetDetailNarrativeDetails">
        <link:definition>2415408 - Disclosure - Balance Sheet Detail - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarranty" roleURI="http://cutera.com/role/ProductWarranty">
        <link:definition>2116104 - Disclosure - Product Warranty</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantyTables" roleURI="http://cutera.com/role/ProductWarrantyTables">
        <link:definition>2317304 - Disclosure - Product Warranty (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantySummaryofWarrantiesDetails" roleURI="http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails">
        <link:definition>2418409 - Disclosure - Product Warranty - Summary of Warranties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenue" roleURI="http://cutera.com/role/DeferredRevenue">
        <link:definition>2119105 - Disclosure - Deferred Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenueTables" roleURI="http://cutera.com/role/DeferredRevenueTables">
        <link:definition>2320305 - Disclosure - Deferred Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenueNarrativeDetails" roleURI="http://cutera.com/role/DeferredRevenueNarrativeDetails">
        <link:definition>2421410 - Disclosure - Deferred Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenueNarrativeDetails_1" roleURI="http://cutera.com/role/DeferredRevenueNarrativeDetails_1">
        <link:definition>2421410 - Disclosure - Deferred Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredRevenueSummaryofDeferredServiceContractRevenueDetails" roleURI="http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails">
        <link:definition>2422411 - Disclosure - Deferred Revenue - Summary of Deferred Service Contract Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpense" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpense">
        <link:definition>2123106 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseTables" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables">
        <link:definition>2324306 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails">
        <link:definition>2425412 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails">
        <link:definition>2426413 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails">
        <link:definition>2427414 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Options Outstanding and Exercisable Price Ranges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails">
        <link:definition>2428415 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails">
        <link:definition>2429416 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails">
        <link:definition>2430417 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense by Department (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails" roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails">
        <link:definition>2431418 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Valuation Assumptions and Fair Value of Stock Option and ESPP Grants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://cutera.com/role/IncomeTaxes">
        <link:definition>2132107 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://cutera.com/role/IncomeTaxesTables">
        <link:definition>2333307 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails" roleURI="http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails">
        <link:definition>2434419 - Disclosure - Income Taxes - Income (Loss) Before Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxProvisionDetails" roleURI="http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails">
        <link:definition>2435420 - Disclosure - Income Taxes - Income Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsDetails" roleURI="http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails">
        <link:definition>2436421 - Disclosure - Income Taxes - Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofEffectiveTaxRateDetails" roleURI="http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails">
        <link:definition>2437422 - Disclosure - Income Taxes - Reconciliation of Effective Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://cutera.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2438423 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
        <link:definition>2439424 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShare" roleURI="http://cutera.com/role/NetIncomeLossPerShare">
        <link:definition>2140108 - Disclosure - Net Income (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareTables" roleURI="http://cutera.com/role/NetIncomeLossPerShareTables">
        <link:definition>2341308 - Disclosure - Net Income (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareNetLossPerShareDetails" roleURI="http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails">
        <link:definition>2442425 - Disclosure - Net Income (Loss) Per Share - Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails" roleURI="http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails">
        <link:definition>2443426 - Disclosure - Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareNarrativeDetails" roleURI="http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails">
        <link:definition>2444427 - Disclosure - Net Income (Loss) Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedContributionPlan" roleURI="http://cutera.com/role/DefinedContributionPlan">
        <link:definition>2145109 - Disclosure - Defined Contribution Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedContributionPlanNarrativeDetails" roleURI="http://cutera.com/role/DefinedContributionPlanNarrativeDetails">
        <link:definition>2446428 - Disclosure - Defined Contribution Plan - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandRevenuebyGeographyandProducts" roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProducts">
        <link:definition>2147110 - Disclosure - Segment Information and Revenue by Geography and Products</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandRevenuebyGeographyandProductsTables" roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsTables">
        <link:definition>2348309 - Disclosure - Segment Information and Revenue by Geography and Products (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails" roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails">
        <link:definition>2449429 - Disclosure - Segment Information and Revenue by Geography and Products - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails" roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails">
        <link:definition>2450430 - Disclosure - Segment Information and Revenue by Geography and Products - Summary of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://cutera.com/role/CommitmentsandContingencies">
        <link:definition>2151111 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://cutera.com/role/CommitmentsandContingenciesTables">
        <link:definition>2352310 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>2453431 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails" roleURI="http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails">
        <link:definition>2454432 - Disclosure - Commitments and Contingencies - Effect of Adoption of the New Standard (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesFinancialStatementInformationDetails" roleURI="http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails">
        <link:definition>2455433 - Disclosure - Commitments and Contingencies - Financial Statement Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails" roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails">
        <link:definition>2456434 - Disclosure - Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1" roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1">
        <link:definition>2456434 - Disclosure - Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails" roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails">
        <link:definition>2457435 - Disclosure - Commitments and Contingencies - Maturities of Finance Leases Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1" roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1">
        <link:definition>2457435 - Disclosure - Commitments and Contingencies - Maturities of Finance Leases Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesLeaseInformationDetails" roleURI="http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails">
        <link:definition>2458436 - Disclosure - Commitments and Contingencies - Lease Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesOperatingLeaseIncomeDetails" roleURI="http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails">
        <link:definition>2459437 - Disclosure - Commitments and Contingencies - Operating Lease Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://cutera.com/role/Debt">
        <link:definition>2160112 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://cutera.com/role/DebtTables">
        <link:definition>2361311 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://cutera.com/role/DebtNarrativeDetails">
        <link:definition>2462438 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtOutstandingDebtandCarryingValueDetails" roleURI="http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails">
        <link:definition>2463439 - Disclosure - Debt - Outstanding Debt and Carrying Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://cutera.com/role/SubsequentEvents">
        <link:definition>2164113 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccounts" roleURI="http://cutera.com/role/ScheduleIIValuationandQualifyingAccounts">
        <link:definition>2165114 - Disclosure - Schedule II - Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsTables" roleURI="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsTables">
        <link:definition>2366312 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails" roleURI="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails">
        <link:definition>2467440 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Summary of the Deferred Tax Assets Valuation Allowance and Allowance for Doubtful Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cutr_LoyaltyMember" abstract="true" name="LoyaltyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_ExercisePriceRange5Member" abstract="true" name="ExercisePriceRange5Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cutr_TwoThousandNineteenEquityIncentivePlanMember" abstract="true" name="TwoThousandNineteenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_PercentageOfAssets" abstract="false" name="PercentageOfAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_AsiaExcludingJapanMember" abstract="true" name="AsiaExcludingJapanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ExercisePriceRange3Member" abstract="true" name="ExercisePriceRange3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_SiliconValleyBankMember" abstract="true" name="SiliconValleyBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ConvertibleSeniorNotesDue2026Member" abstract="true" name="ConvertibleSeniorNotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_LesseeLeaseRenewalTerm" abstract="false" name="LesseeLeaseRenewalTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_ChangeInContractWithCustomerLiabilityRollForward" abstract="true" name="ChangeInContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" abstract="false" name="DebtInstrumentPercentageOfQualifyingAccountsReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_DerivativeCapPricePremiumOverStockPricePercent" abstract="false" name="DerivativeCapPricePremiumOverStockPricePercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" abstract="true" name="ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ExtendedServiceContractOptionTwoTerm" abstract="false" name="ExtendedServiceContractOptionTwoTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" abstract="false" name="DerivativeCappedCallTransactionTermConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cutr_FormerExecutiveVPAndCFOMember" abstract="true" name="FormerExecutiveVPAndCFOMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" abstract="false" name="DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_PurchaseOfCappedCall" abstract="false" name="PurchaseOfCappedCall" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_DebtCovenantQuarterlyMinimumRevenue" abstract="false" name="DebtCovenantQuarterlyMinimumRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_LesseeLeasesRemainingTerm" abstract="false" name="LesseeLeasesRemainingTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" abstract="false" name="AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cutr_ESPPMember" abstract="true" name="ESPPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_LesseeLeasesTextBlock" abstract="false" name="LesseeLeasesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" abstract="false" name="ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cutr_ExtendedServiceContractOptionOneTerm" abstract="false" name="ExtendedServiceContractOptionOneTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_CappedCallSecuritiesMember" abstract="true" name="CappedCallSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" abstract="true" name="RestrictedStockUnitsAndPerformanceShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" abstract="false" name="NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cutr_UnderwrittenPublicOfferingMember" abstract="true" name="UnderwrittenPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_LeasedEquipmentMember" abstract="true" name="LeasedEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_PaycheckProtectionProgramCARESActMember" abstract="true" name="PaycheckProtectionProgramCARESActMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ExercisePriceRange6Member" abstract="true" name="ExercisePriceRange6Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_AdditionalSharesReservedSharesAvailableForGrant" abstract="false" name="AdditionalSharesReservedSharesAvailableForGrant" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" abstract="false" name="ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cutr_OperatingLossCarryforwardsWithoutExpiration" abstract="false" name="OperatingLossCarryforwardsWithoutExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_DeferredRevenueCostsIncurred" abstract="false" name="DeferredRevenueCostsIncurred" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" abstract="false" name="ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_CapitalStockSharesAuthorized" abstract="false" name="CapitalStockSharesAuthorized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" abstract="false" name="RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" abstract="false" name="RisksAndUncertaintiesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cutr_StockPurchasePlanMember" abstract="true" name="StockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ExercisePriceRange4Member" abstract="true" name="ExercisePriceRange4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_SecretAndSecretProMember" abstract="true" name="SecretAndSecretProMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" abstract="false" name="DepreciationAndAmortizationExcludingContractAcquisitionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ExercisePriceRange1Member" abstract="true" name="ExercisePriceRange1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" abstract="false" name="ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_DebtInstrumentAnniversaryFeeAmount" abstract="false" name="DebtInstrumentAnniversaryFeeAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_TwoThousandFourEquityIncentivePlanMember" abstract="true" name="TwoThousandFourEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_LeasesFinancialStatementInformationTableTextBlock" abstract="false" name="LeasesFinancialStatementInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_StockPlanMember" abstract="true" name="StockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" abstract="false" name="ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_StandardProductWarrantyTermDirectSales" abstract="false" name="StandardProductWarrantyTermDirectSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:timeItemType"/>
  <xs:element id="cutr_SystemsMember" abstract="true" name="SystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" abstract="false" name="ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ExtendedServiceContractOptionThreeTerm" abstract="false" name="ExtendedServiceContractOptionThreeTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" abstract="false" name="DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_NumberOfMajorSuppliers" abstract="false" name="NumberOfMajorSuppliers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" abstract="false" name="ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_HandPieceRefillsMember" abstract="true" name="HandPieceRefillsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_RestrictedStockUnitsNewHireMember" abstract="true" name="RestrictedStockUnitsNewHireMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_LoanAndSecurityAgreementMember" abstract="true" name="LoanAndSecurityAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_LessorOptionToPurchaseGrantedPeriod" abstract="false" name="LessorOptionToPurchaseGrantedPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_AccruedSalesAndMarketingCostsCurrent" abstract="false" name="AccruedSalesAndMarketingCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember" abstract="true" name="RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_AccruedInventoryInTransitCurrent" abstract="false" name="AccruedInventoryInTransitCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_DeferredTaxAssetsOperatingLeaseLiability" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ExercisePriceRange8Member" abstract="true" name="ExercisePriceRange8Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_UnderwriterMember" abstract="true" name="UnderwriterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ContractWithCustomerLiabilityTextBlock" abstract="false" name="ContractWithCustomerLiabilityTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cutr_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_ExercisePriceRange9Member" abstract="true" name="ExercisePriceRange9Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" abstract="false" name="ChangeInRightofuseAssetAndLiabilityDueToModification" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_DemonstrationUnitsAmortizationPeriod" abstract="false" name="DemonstrationUnitsAmortizationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount" abstract="false" name="ShareBasedPaymentAwardPeriodToDetermineGrantAmount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:timeItemType"/>
  <xs:element id="cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" abstract="false" name="DebtInstrumentRedemptionIncrementalRepurchaseAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" abstract="true" name="OrganizationConsolidationAndPresentationOfFinancialStatementsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cutr_SkincareMember" abstract="true" name="SkincareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" abstract="false" name="DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_RestrictedStockUnitsAnnualGrantMember" abstract="true" name="RestrictedStockUnitsAnnualGrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_TheAmendedAndRestated2019EquityIncentivePlanMember" abstract="true" name="TheAmendedAndRestated2019EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_LeaseRightOfUseAsset" abstract="false" name="LeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" abstract="true" name="ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_EquipmentAndFurnitureMember" abstract="true" name="EquipmentAndFurnitureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_StandardProductWarrantyTermDistributorSales" abstract="false" name="StandardProductWarrantyTermDistributorSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cutr_StockIssuedDuringPeriodSharesLitigationSettlement" abstract="false" name="StockIssuedDuringPeriodSharesLitigationSettlement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cutr_ExercisePriceRange7Member" abstract="true" name="ExercisePriceRange7Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" abstract="true" name="OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cutr_CapitalizedCloudComputingSetupCostMember" abstract="true" name="CapitalizedCloudComputingSetupCostMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ExercisePriceRange10Member" abstract="true" name="ExercisePriceRange10Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cutr_ExercisePriceRange2Member" abstract="true" name="ExercisePriceRange2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>cutr-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1ebe9035-7f15-449f-b887-5ea51f412a9f,g:8ea03665-a689-4990-8029-94d26fa40407-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cutr-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://cutera.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_37529c06-a973-43ae-a06c-c2af5dad64f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_b80dfaca-60b0-43cc-8980-5c2a359e0274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_37529c06-a973-43ae-a06c-c2af5dad64f4" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_b80dfaca-60b0-43cc-8980-5c2a359e0274" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_ca3bbfc9-a3e6-4a39-b5e8-56199e6d6cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_37529c06-a973-43ae-a06c-c2af5dad64f4" xlink:to="loc_us-gaap_LongTermNotesPayable_ca3bbfc9-a3e6-4a39-b5e8-56199e6d6cc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_08fd0e61-2339-4f7e-9c4e-03fdc757da81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_37529c06-a973-43ae-a06c-c2af5dad64f4" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_08fd0e61-2339-4f7e-9c4e-03fdc757da81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e4851aad-cd9f-4e2d-903b-61d49dcae47c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_37529c06-a973-43ae-a06c-c2af5dad64f4" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e4851aad-cd9f-4e2d-903b-61d49dcae47c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_67d3ee92-4630-4315-a4ba-66e051e85c14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_37529c06-a973-43ae-a06c-c2af5dad64f4" xlink:to="loc_us-gaap_LiabilitiesCurrent_67d3ee92-4630-4315-a4ba-66e051e85c14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b220ddbb-2bf6-4e04-a796-533aa3c241ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_37529c06-a973-43ae-a06c-c2af5dad64f4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b220ddbb-2bf6-4e04-a796-533aa3c241ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ea3e6a3b-2fe1-4fc4-b383-ae315c817ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_f597dfcc-fc1f-40c4-99e7-5e03ae7adf15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ea3e6a3b-2fe1-4fc4-b383-ae315c817ae2" xlink:to="loc_us-gaap_NotesPayableCurrent_f597dfcc-fc1f-40c4-99e7-5e03ae7adf15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_04e8aca8-d5f4-4ac3-8b2a-58ca49a56ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ea3e6a3b-2fe1-4fc4-b383-ae315c817ae2" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_04e8aca8-d5f4-4ac3-8b2a-58ca49a56ae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d3201059-2b8a-4094-a92d-4d263f90eb64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ea3e6a3b-2fe1-4fc4-b383-ae315c817ae2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d3201059-2b8a-4094-a92d-4d263f90eb64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_8de581c2-4af7-4932-8cbe-61d3d7699f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ea3e6a3b-2fe1-4fc4-b383-ae315c817ae2" xlink:to="loc_us-gaap_DeferredRevenueCurrent_8de581c2-4af7-4932-8cbe-61d3d7699f46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_856073df-4d92-49d4-854c-11a5c6d5d16e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ea3e6a3b-2fe1-4fc4-b383-ae315c817ae2" xlink:to="loc_us-gaap_AccountsPayableCurrent_856073df-4d92-49d4-854c-11a5c6d5d16e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6df30870-d8fd-453a-90a0-4ba21985b38f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_012f4208-b6ae-4b12-8cca-28ab563ba71b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6df30870-d8fd-453a-90a0-4ba21985b38f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_012f4208-b6ae-4b12-8cca-28ab563ba71b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_50c4a70d-d181-4d57-b666-a2225efa9c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6df30870-d8fd-453a-90a0-4ba21985b38f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_50c4a70d-d181-4d57-b666-a2225efa9c1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e599e986-2736-46ab-8d95-f64bd16096f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6df30870-d8fd-453a-90a0-4ba21985b38f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e599e986-2736-46ab-8d95-f64bd16096f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b78ff324-373a-4a2a-bb31-1b3537e6fbde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6df30870-d8fd-453a-90a0-4ba21985b38f" xlink:to="loc_us-gaap_InventoryNet_b78ff324-373a-4a2a-bb31-1b3537e6fbde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1cb83bb3-f02e-4b56-85ac-61ccfa87839f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9a1a58a8-2da6-43a2-b8d8-34e52d60afcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1cb83bb3-f02e-4b56-85ac-61ccfa87839f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9a1a58a8-2da6-43a2-b8d8-34e52d60afcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_aaf0844c-5e87-4ee1-b7b0-bd4a3f2bc553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1cb83bb3-f02e-4b56-85ac-61ccfa87839f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_aaf0844c-5e87-4ee1-b7b0-bd4a3f2bc553" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_bed1ea3a-31ac-42d2-bd20-3d60b8ac91bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1cb83bb3-f02e-4b56-85ac-61ccfa87839f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_bed1ea3a-31ac-42d2-bd20-3d60b8ac91bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a0524cca-5730-427e-848b-0faae056d934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1cb83bb3-f02e-4b56-85ac-61ccfa87839f" xlink:to="loc_us-gaap_AssetsCurrent_a0524cca-5730-427e-848b-0faae056d934" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3323c05f-4a49-42bf-882c-36e189a129db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1cb83bb3-f02e-4b56-85ac-61ccfa87839f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3323c05f-4a49-42bf-882c-36e189a129db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8711a558-c16e-4ed0-abc5-68aa7e6c6f15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1cb83bb3-f02e-4b56-85ac-61ccfa87839f" xlink:to="loc_us-gaap_Goodwill_8711a558-c16e-4ed0-abc5-68aa7e6c6f15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_c5bb2f9b-94a3-4850-b591-9a02c7bc2786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_1cb83bb3-f02e-4b56-85ac-61ccfa87839f" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_c5bb2f9b-94a3-4850-b591-9a02c7bc2786" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9c8b193e-10fc-4607-9861-902b25cd5f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d4acf49e-fd02-4252-8d54-3c3e2a2749cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9c8b193e-10fc-4607-9861-902b25cd5f6e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d4acf49e-fd02-4252-8d54-3c3e2a2749cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_caef0df2-702e-44b5-a65f-9e6df97cb928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9c8b193e-10fc-4607-9861-902b25cd5f6e" xlink:to="loc_us-gaap_CommonStockValue_caef0df2-702e-44b5-a65f-9e6df97cb928" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_29897469-3d3d-4096-b001-de12657be51f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9c8b193e-10fc-4607-9861-902b25cd5f6e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_29897469-3d3d-4096-b001-de12657be51f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3259c5f2-f056-48b7-ad59-6a32b6eb20a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e8b0e5d9-af75-4788-afb3-350382cb44fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3259c5f2-f056-48b7-ad59-6a32b6eb20a1" xlink:to="loc_us-gaap_StockholdersEquity_e8b0e5d9-af75-4788-afb3-350382cb44fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a4d72aab-741f-4bd5-bf4a-30cdec13e05b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3259c5f2-f056-48b7-ad59-6a32b6eb20a1" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a4d72aab-741f-4bd5-bf4a-30cdec13e05b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2ff48b5f-510d-4887-9322-109e7ea66670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3259c5f2-f056-48b7-ad59-6a32b6eb20a1" xlink:to="loc_us-gaap_Liabilities_2ff48b5f-510d-4887-9322-109e7ea66670" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cutr-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4fc7a567-e47f-4315-9dce-f09f65381c71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_61234913-48f9-4d44-8540-4c7da452607e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4fc7a567-e47f-4315-9dce-f09f65381c71" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_61234913-48f9-4d44-8540-4c7da452607e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b7c1d168-9a9c-47da-908e-5a590d5738b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4fc7a567-e47f-4315-9dce-f09f65381c71" xlink:to="loc_us-gaap_OperatingIncomeLoss_b7c1d168-9a9c-47da-908e-5a590d5738b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_a426e5fe-d706-4d25-94a9-e635071acd8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_cab40294-dcf0-4ead-accc-6dff9a0e2dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_a426e5fe-d706-4d25-94a9-e635071acd8f" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_cab40294-dcf0-4ead-accc-6dff9a0e2dad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_4a910471-41e6-4220-a864-b4ab5b420aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_a426e5fe-d706-4d25-94a9-e635071acd8f" xlink:to="loc_us-gaap_InterestExpenseDebt_4a910471-41e6-4220-a864-b4ab5b420aa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e41ff5ba-eced-4051-b2e9-f3fec00698b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_a426e5fe-d706-4d25-94a9-e635071acd8f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e41ff5ba-eced-4051-b2e9-f3fec00698b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_68238895-1c1c-4881-8451-3b83332e628e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_a426e5fe-d706-4d25-94a9-e635071acd8f" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_68238895-1c1c-4881-8451-3b83332e628e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a1c8652e-7033-45e1-ba3c-b3c7ad07ec69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_f14cc559-751e-44e6-a9a6-23a70021abdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a1c8652e-7033-45e1-ba3c-b3c7ad07ec69" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_f14cc559-751e-44e6-a9a6-23a70021abdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d72b9cb6-38e5-4181-a91d-4d9652b49c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a1c8652e-7033-45e1-ba3c-b3c7ad07ec69" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d72b9cb6-38e5-4181-a91d-4d9652b49c86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_a98b1fcc-fac4-499f-9f04-55d081f82175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a1c8652e-7033-45e1-ba3c-b3c7ad07ec69" xlink:to="loc_us-gaap_SellingAndMarketingExpense_a98b1fcc-fac4-499f-9f04-55d081f82175" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8a4ba092-f23b-41c8-86b4-bb4d27c645e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_200fb61d-935e-43b7-8eb6-2a4a5dca1072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8a4ba092-f23b-41c8-86b4-bb4d27c645e6" xlink:to="loc_us-gaap_GrossProfit_200fb61d-935e-43b7-8eb6-2a4a5dca1072" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_dd5e8953-208d-4c21-86c2-9362e7a9d3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8a4ba092-f23b-41c8-86b4-bb4d27c645e6" xlink:to="loc_us-gaap_OperatingExpenses_dd5e8953-208d-4c21-86c2-9362e7a9d3a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ba433fc5-46e5-4eaa-94dc-f31d30d6d092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_15dc9648-5bab-40ec-b365-e0a0c110711c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ba433fc5-46e5-4eaa-94dc-f31d30d6d092" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_15dc9648-5bab-40ec-b365-e0a0c110711c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_29bbb277-7fbc-458d-8068-158fe93118b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ba433fc5-46e5-4eaa-94dc-f31d30d6d092" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_29bbb277-7fbc-458d-8068-158fe93118b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_202ac837-155d-4d37-abed-5affc24b15e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b53dbf9a-26aa-4ea4-adf7-f66ab0e4f6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_202ac837-155d-4d37-abed-5affc24b15e6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b53dbf9a-26aa-4ea4-adf7-f66ab0e4f6a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_60acf127-a307-4f57-be02-36876777836b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_202ac837-155d-4d37-abed-5affc24b15e6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_60acf127-a307-4f57-be02-36876777836b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cutr-20211231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_d733fa73-8b7a-47bd-9d60-9710c98b030d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_1e689d47-1aa9-4c08-8d0a-5da61bd99816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_d733fa73-8b7a-47bd-9d60-9710c98b030d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_1e689d47-1aa9-4c08-8d0a-5da61bd99816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_eaeb7003-b383-46b9-b4d7-68d712f57969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_d733fa73-8b7a-47bd-9d60-9710c98b030d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_eaeb7003-b383-46b9-b4d7-68d712f57969" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f8191e15-0f9f-4e3c-8a75-42d63275d23b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f77707b6-c9f9-4bcb-868c-18caadbcb388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f8191e15-0f9f-4e3c-8a75-42d63275d23b" xlink:to="loc_us-gaap_NetIncomeLoss_f77707b6-c9f9-4bcb-868c-18caadbcb388" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1f6449a7-215e-4b51-94ec-b87a0cd73a71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f8191e15-0f9f-4e3c-8a75-42d63275d23b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1f6449a7-215e-4b51-94ec-b87a0cd73a71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0c8557f1-b597-400a-ac02-02d256e48946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_e9351ca1-49c0-4615-a5ba-2a93ca6914fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0c8557f1-b597-400a-ac02-02d256e48946" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_e9351ca1-49c0-4615-a5ba-2a93ca6914fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cutr-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_774482ea-fad0-4090-bd60-e01fc5595984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_0a4f1c10-cf93-4d1a-af9e-c380fb579231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_774482ea-fad0-4090-bd60-e01fc5595984" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_0a4f1c10-cf93-4d1a-af9e-c380fb579231" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_bd9fc149-8194-414c-b2ec-19dedae28321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_774482ea-fad0-4090-bd60-e01fc5595984" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_bd9fc149-8194-414c-b2ec-19dedae28321" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_42a99944-d3a3-41e5-b138-a0735e0d0d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_774482ea-fad0-4090-bd60-e01fc5595984" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_42a99944-d3a3-41e5-b138-a0735e0d0d20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_83f403d9-41d9-4069-90b9-4274e80b92d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_774482ea-fad0-4090-bd60-e01fc5595984" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_83f403d9-41d9-4069-90b9-4274e80b92d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_88cb4648-309e-4cfc-bbcf-30389a5dc37d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_774482ea-fad0-4090-bd60-e01fc5595984" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_88cb4648-309e-4cfc-bbcf-30389a5dc37d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_38e0cc48-fb38-403b-af9d-3545e27a88a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_38e0cc48-fb38-403b-af9d-3545e27a88a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_ce6b12a4-1ab2-4276-a364-0528454e887d" xlink:href="cutr-20211231.xsd#cutr_ChangeInRightofuseAssetAndLiabilityDueToModification"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_ce6b12a4-1ab2-4276-a364-0528454e887d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a25f056a-eb8e-4c1c-beaa-3740316c6099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a25f056a-eb8e-4c1c-beaa-3740316c6099" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfAcquisitionCosts_26407f06-6edc-408d-b7cf-9b9032fcdaf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfAcquisitionCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_AmortizationOfAcquisitionCosts_26407f06-6edc-408d-b7cf-9b9032fcdaf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_0ca74f72-5263-4fd5-a920-082fd0f178cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_0ca74f72-5263-4fd5-a920-082fd0f178cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_be750656-56d8-4925-866f-dac31ed75475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_be750656-56d8-4925-866f-dac31ed75475" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_ad08b856-f809-42dc-926f-e619d388225f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HostingArrangementServiceContractImplementationCostImpairment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_ad08b856-f809-42dc-926f-e619d388225f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c2aa2f35-00eb-4440-838b-05d86a3d1bff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_ShareBasedCompensation_c2aa2f35-00eb-4440-838b-05d86a3d1bff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_57ffff7b-7a57-445a-ae0c-cc918e78f619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_57ffff7b-7a57-445a-ae0c-cc918e78f619" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_5a3e0134-4950-48f8-97f2-2405cd467ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_5a3e0134-4950-48f8-97f2-2405cd467ab2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_feb796c1-7758-4165-a00b-96ff224df7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_NetIncomeLoss_feb796c1-7758-4165-a00b-96ff224df7f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_01bcaefb-ad22-413f-8c6d-0f7e6afe2055" xlink:href="cutr-20211231.xsd#cutr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_01bcaefb-ad22-413f-8c6d-0f7e6afe2055" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_f505b081-43e7-4bf4-8a61-2d09354a6903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_f505b081-43e7-4bf4-8a61-2d09354a6903" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_4bb87e94-56a2-4db0-8df4-747fd09dc133" xlink:href="cutr-20211231.xsd#cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_4bb87e94-56a2-4db0-8df4-747fd09dc133" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_404fa8d8-d48a-4516-afd5-199a22e5cc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_404fa8d8-d48a-4516-afd5-199a22e5cc9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_219019fe-954e-40f2-b2d9-e367a14f7de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_219019fe-954e-40f2-b2d9-e367a14f7de9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5b3ad726-bbce-47b4-9212-b9e1669a6a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5b3ad726-bbce-47b4-9212-b9e1669a6a0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_2d0fa9ae-de06-42db-98a2-900d9adea189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_2d0fa9ae-de06-42db-98a2-900d9adea189" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7c65019b-14e2-42b6-84c5-2e345bff1889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7c65019b-14e2-42b6-84c5-2e345bff1889" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_c3c0b0f8-abc4-4f01-8650-465e7e11ee35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_c3c0b0f8-abc4-4f01-8650-465e7e11ee35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_31bfac63-f190-4e11-ba94-50a5b553147d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="21" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_201b921c-5e39-4930-a6d2-6cec25af7425" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_31bfac63-f190-4e11-ba94-50a5b553147d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3537041c-722b-4bc6-9d69-3a8257d37e67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_a91f1b85-2712-44c7-aa2c-6ff9af008f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3537041c-722b-4bc6-9d69-3a8257d37e67" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_a91f1b85-2712-44c7-aa2c-6ff9af008f65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_7f93437d-99e8-49d0-989c-d97575f1b73a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3537041c-722b-4bc6-9d69-3a8257d37e67" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_7f93437d-99e8-49d0-989c-d97575f1b73a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_08ec42a5-d16d-4a41-a746-ee8b63cf3eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3537041c-722b-4bc6-9d69-3a8257d37e67" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_08ec42a5-d16d-4a41-a746-ee8b63cf3eb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ca05a7f4-04e2-4b87-a45f-75a248f3d389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3537041c-722b-4bc6-9d69-3a8257d37e67" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ca05a7f4-04e2-4b87-a45f-75a248f3d389" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_bc6ed735-5a0a-4df3-82d7-58bac60cd87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3537041c-722b-4bc6-9d69-3a8257d37e67" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_bc6ed735-5a0a-4df3-82d7-58bac60cd87d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_1d2e0225-5b9e-41a4-bac3-201693f6b8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3537041c-722b-4bc6-9d69-3a8257d37e67" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_1d2e0225-5b9e-41a4-bac3-201693f6b8a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_574ffcf9-ebca-4151-a083-bfdc36090a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3537041c-722b-4bc6-9d69-3a8257d37e67" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_574ffcf9-ebca-4151-a083-bfdc36090a94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b9cfe1d6-02f3-4906-8196-82485f54a20a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3537041c-722b-4bc6-9d69-3a8257d37e67" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b9cfe1d6-02f3-4906-8196-82485f54a20a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_61c92fc5-945a-4266-a6c6-79dc09e55bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3537041c-722b-4bc6-9d69-3a8257d37e67" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_61c92fc5-945a-4266-a6c6-79dc09e55bd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_da471007-3982-4fcd-91dc-c9737b6cdc67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e74530c-5938-4643-8235-6a5d1e6ef46c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_da471007-3982-4fcd-91dc-c9737b6cdc67" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5e74530c-5938-4643-8235-6a5d1e6ef46c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d4101cb4-b949-463a-9ceb-a52695edd4f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_da471007-3982-4fcd-91dc-c9737b6cdc67" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d4101cb4-b949-463a-9ceb-a52695edd4f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec5ef5ff-f2d1-4c0b-aefa-5ac02d1ff8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_da471007-3982-4fcd-91dc-c9737b6cdc67" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec5ef5ff-f2d1-4c0b-aefa-5ac02d1ff8ba" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dcef94d8-e911-4f8b-9307-e7ee28df6c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_faf6162f-2f4f-4c6f-a255-d045bb2a5302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dcef94d8-e911-4f8b-9307-e7ee28df6c4a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_faf6162f-2f4f-4c6f-a255-d045bb2a5302" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_3da67132-1f3e-44be-b74a-86507512de9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dcef94d8-e911-4f8b-9307-e7ee28df6c4a" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_3da67132-1f3e-44be-b74a-86507512de9e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailInventoriesDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#BalanceSheetDetailInventoriesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/BalanceSheetDetailInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_29976c07-5215-4f23-b159-c853b3dd9fad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_4e303aa3-277d-4773-9040-b12a5d965be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_29976c07-5215-4f23-b159-c853b3dd9fad" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_4e303aa3-277d-4773-9040-b12a5d965be4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_fcc97df8-6c6d-44c9-bc52-7d8eac0e5ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_29976c07-5215-4f23-b159-c853b3dd9fad" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_fcc97df8-6c6d-44c9-bc52-7d8eac0e5ed0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_077d0ac7-c177-4d6a-8b29-578b6ee901ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_29976c07-5215-4f23-b159-c853b3dd9fad" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_077d0ac7-c177-4d6a-8b29-578b6ee901ed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#BalanceSheetDetailPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_49602b77-4d94-4a7d-a548-a4961c2b601a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_7878d640-c202-44db-9aa9-ca14e2d1b2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_49602b77-4d94-4a7d-a548-a4961c2b601a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_7878d640-c202-44db-9aa9-ca14e2d1b2ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_b600204e-aaa3-4237-8494-2bfeec231358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_49602b77-4d94-4a7d-a548-a4961c2b601a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_b600204e-aaa3-4237-8494-2bfeec231358" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#BalanceSheetDetailAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_05560a10-7147-4403-8fa7-58ecfd30b2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AccruedInventoryInTransitCurrent_275c0264-cc7c-4875-a0c6-c382ad073503" xlink:href="cutr-20211231.xsd#cutr_AccruedInventoryInTransitCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_05560a10-7147-4403-8fa7-58ecfd30b2d7" xlink:to="loc_cutr_AccruedInventoryInTransitCurrent_275c0264-cc7c-4875-a0c6-c382ad073503" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a321d497-8382-4367-a0c8-1c1e684e1570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_05560a10-7147-4403-8fa7-58ecfd30b2d7" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a321d497-8382-4367-a0c8-1c1e684e1570" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_158851af-2684-44ca-8e30-378036af6d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_05560a10-7147-4403-8fa7-58ecfd30b2d7" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_158851af-2684-44ca-8e30-378036af6d19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AccruedSalesAndMarketingCostsCurrent_b54f36bd-2508-4393-82cd-be8a9bf5a4d6" xlink:href="cutr-20211231.xsd#cutr_AccruedSalesAndMarketingCostsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_05560a10-7147-4403-8fa7-58ecfd30b2d7" xlink:to="loc_cutr_AccruedSalesAndMarketingCostsCurrent_b54f36bd-2508-4393-82cd-be8a9bf5a4d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_777dc82c-268c-45f3-9700-b7df879f8310" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_05560a10-7147-4403-8fa7-58ecfd30b2d7" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_777dc82c-268c-45f3-9700-b7df879f8310" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_62e587c4-296f-491c-8955-747b1415e03c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_05560a10-7147-4403-8fa7-58ecfd30b2d7" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_62e587c4-296f-491c-8955-747b1415e03c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fdefdf1a-583f-48cf-9dae-b5d601a9a2af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_2640df7d-a957-4edc-9192-23fd1600a9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fdefdf1a-583f-48cf-9dae-b5d601a9a2af" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_2640df7d-a957-4edc-9192-23fd1600a9cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_f5183cd1-3fba-42e1-af5a-a5bdc7a7ba7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fdefdf1a-583f-48cf-9dae-b5d601a9a2af" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_f5183cd1-3fba-42e1-af5a-a5bdc7a7ba7c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#IncomeTaxesIncomeTaxProvisionDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ce5bf201-f476-4e29-bf81-4838538b7f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_852a35d7-b415-4601-9533-1c61af2210be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ce5bf201-f476-4e29-bf81-4838538b7f1f" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_852a35d7-b415-4601-9533-1c61af2210be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0da39957-6389-4cf5-bbb6-cf153424d852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_ce5bf201-f476-4e29-bf81-4838538b7f1f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0da39957-6389-4cf5-bbb6-cf153424d852" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ae15a8bf-5c20-487b-ad92-be73e66d72cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_62375af3-458d-4651-af3a-a055b161257f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ae15a8bf-5c20-487b-ad92-be73e66d72cd" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_62375af3-458d-4651-af3a-a055b161257f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_d5b44d02-1b1a-4779-94b9-0d6d2259731c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ae15a8bf-5c20-487b-ad92-be73e66d72cd" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_d5b44d02-1b1a-4779-94b9-0d6d2259731c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_0fb22fd4-dec3-433e-b73a-6f8a5ed0613f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ae15a8bf-5c20-487b-ad92-be73e66d72cd" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_0fb22fd4-dec3-433e-b73a-6f8a5ed0613f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d550a96a-0df3-40dc-943d-af6e6e0bf6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a44857ce-b8cb-4123-b220-7cdfd3875fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d550a96a-0df3-40dc-943d-af6e6e0bf6e0" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_a44857ce-b8cb-4123-b220-7cdfd3875fc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a4e71255-788a-40df-b1f8-bbce77f4fc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d550a96a-0df3-40dc-943d-af6e6e0bf6e0" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a4e71255-788a-40df-b1f8-bbce77f4fc7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_fab1f1c9-c64e-4370-9f96-7acc2a92b14f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d550a96a-0df3-40dc-943d-af6e6e0bf6e0" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_fab1f1c9-c64e-4370-9f96-7acc2a92b14f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#IncomeTaxesDeferredTaxAssetsDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_30403815-2fe8-4bf3-871a-0ffa34496f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_1e29c879-d4b2-4198-8dab-c1e119f74093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_30403815-2fe8-4bf3-871a-0ffa34496f4e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_1e29c879-d4b2-4198-8dab-c1e119f74093" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_915ad578-d329-479a-a79b-470d46472a81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_30403815-2fe8-4bf3-871a-0ffa34496f4e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_915ad578-d329-479a-a79b-470d46472a81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts_71c8e23c-3439-4b0b-9da4-4ee39c2c97a8" xlink:href="cutr-20211231.xsd#cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_30403815-2fe8-4bf3-871a-0ffa34496f4e" xlink:to="loc_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts_71c8e23c-3439-4b0b-9da4-4ee39c2c97a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_fecc1251-53a8-4ff2-97d4-07df3b9cb72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_30403815-2fe8-4bf3-871a-0ffa34496f4e" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_fecc1251-53a8-4ff2-97d4-07df3b9cb72b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_3dbddf54-4b62-4cf7-adca-d749c0e0b011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_87efbb82-c1b4-496a-bc1a-4c132326ccca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3dbddf54-4b62-4cf7-adca-d749c0e0b011" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_87efbb82-c1b4-496a-bc1a-4c132326ccca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_5abe8719-1dd6-4f3a-b10d-45c71aadf4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3dbddf54-4b62-4cf7-adca-d749c0e0b011" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_5abe8719-1dd6-4f3a-b10d-45c71aadf4f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_2b8f64d7-0ae9-455e-9743-4b1d996a2c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2a4686a7-4ee9-4253-8a9c-f128de46c58b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2b8f64d7-0ae9-455e-9743-4b1d996a2c50" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2a4686a7-4ee9-4253-8a9c-f128de46c58b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_7a394935-baf9-41ec-bd28-4db65ebe105e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2b8f64d7-0ae9-455e-9743-4b1d996a2c50" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_7a394935-baf9-41ec-bd28-4db65ebe105e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredTaxAssetsOperatingLeaseLiability_5bc403ad-f5da-4a26-abe2-941ad06fd54c" xlink:href="cutr-20211231.xsd#cutr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2b8f64d7-0ae9-455e-9743-4b1d996a2c50" xlink:to="loc_cutr_DeferredTaxAssetsOperatingLeaseLiability_5bc403ad-f5da-4a26-abe2-941ad06fd54c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_8a0cf979-a9a6-4488-8992-9c962febfc22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2b8f64d7-0ae9-455e-9743-4b1d996a2c50" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_8a0cf979-a9a6-4488-8992-9c962febfc22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_78c176e2-3ce7-431e-82aa-9101cf52fb64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2b8f64d7-0ae9-455e-9743-4b1d996a2c50" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_78c176e2-3ce7-431e-82aa-9101cf52fb64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_7ed9bd6d-d376-4636-b954-98d6bb43291b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2b8f64d7-0ae9-455e-9743-4b1d996a2c50" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_7ed9bd6d-d376-4636-b954-98d6bb43291b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_cd1335ba-5f69-443c-863a-a625d5ec0753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2b8f64d7-0ae9-455e-9743-4b1d996a2c50" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_cd1335ba-5f69-443c-863a-a625d5ec0753" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_a80b6741-60f1-4f8a-9f41-5a7de127012c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2b8f64d7-0ae9-455e-9743-4b1d996a2c50" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_a80b6741-60f1-4f8a-9f41-5a7de127012c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#IncomeTaxesReconciliationofEffectiveTaxRateDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d9d4166-65c1-4449-9837-922b7ee1a9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_3dc2c3b8-7785-44e7-b288-fb27aa22ae1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d9d4166-65c1-4449-9837-922b7ee1a9f6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_3dc2c3b8-7785-44e7-b288-fb27aa22ae1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_c9b00aa6-1f7b-4b6b-aad0-8df9960e3f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d9d4166-65c1-4449-9837-922b7ee1a9f6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_c9b00aa6-1f7b-4b6b-aad0-8df9960e3f2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_8a26d563-39b2-4e2e-b4b5-bb0f4d03279d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d9d4166-65c1-4449-9837-922b7ee1a9f6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_8a26d563-39b2-4e2e-b4b5-bb0f4d03279d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2c263c35-20b5-48f4-9d7b-db9b4dbd613b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d9d4166-65c1-4449-9837-922b7ee1a9f6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2c263c35-20b5-48f4-9d7b-db9b4dbd613b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent_3b33390c-cfd6-4f1e-a0dd-890d11b2a6cb" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d9d4166-65c1-4449-9837-922b7ee1a9f6" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent_3b33390c-cfd6-4f1e-a0dd-890d11b2a6cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_62ebc021-3da0-465b-adc4-24b004d02b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d9d4166-65c1-4449-9837-922b7ee1a9f6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_62ebc021-3da0-465b-adc4-24b004d02b7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_da60e959-e438-402d-9f2a-a33d307cd9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d9d4166-65c1-4449-9837-922b7ee1a9f6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_da60e959-e438-402d-9f2a-a33d307cd9fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_145472ec-bb91-47e1-a49d-01fb2a83b949" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d9d4166-65c1-4449-9837-922b7ee1a9f6" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_145472ec-bb91-47e1-a49d-01fb2a83b949" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent_c73da9a9-0427-42e0-94cc-4863f0e419cc" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d9d4166-65c1-4449-9837-922b7ee1a9f6" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent_c73da9a9-0427-42e0-94cc-4863f0e419cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_56eb0be8-e265-4c6d-83de-d0adc86099ac" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d9d4166-65c1-4449-9837-922b7ee1a9f6" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_56eb0be8-e265-4c6d-83de-d0adc86099ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent_4535ef98-2278-4165-a256-926788ae12c3" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d9d4166-65c1-4449-9837-922b7ee1a9f6" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent_4535ef98-2278-4165-a256-926788ae12c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent_186a1f7a-40f7-444e-a2da-ea72d30701d2" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d9d4166-65c1-4449-9837-922b7ee1a9f6" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent_186a1f7a-40f7-444e-a2da-ea72d30701d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent_af9a9527-a6f1-4934-920c-dd83c4b9a793" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0d9d4166-65c1-4449-9837-922b7ee1a9f6" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent_af9a9527-a6f1-4934-920c-dd83c4b9a793" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#NetIncomeLossPerShareNetLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1ba843d9-61d6-4e0c-a1ed-cd50feb30d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ed15299d-db9a-46d1-9ffe-0a543e3f0f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1ba843d9-61d6-4e0c-a1ed-cd50feb30d98" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ed15299d-db9a-46d1-9ffe-0a543e3f0f2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_af6ae4fe-1374-4c7d-9077-ad679737f4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1ba843d9-61d6-4e0c-a1ed-cd50feb30d98" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_af6ae4fe-1374-4c7d-9077-ad679737f4b3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesFinancialStatementInformationDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeaseRightOfUseAsset_9b1fe034-cd99-4d78-b466-c4793fe925e0" xlink:href="cutr-20211231.xsd#cutr_LeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_f3f4277d-96c2-43ef-92d8-75a06223381e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cutr_LeaseRightOfUseAsset_9b1fe034-cd99-4d78-b466-c4793fe925e0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_f3f4277d-96c2-43ef-92d8-75a06223381e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_d89fc5f6-7f4c-4d7d-8f3a-0a9658ff2eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cutr_LeaseRightOfUseAsset_9b1fe034-cd99-4d78-b466-c4793fe925e0" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_d89fc5f6-7f4c-4d7d-8f3a-0a9658ff2eb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_5abb372c-8943-4fba-81de-5f103ab373b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_e4760c4d-3c04-44b4-85f0-b23d7affea5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_5abb372c-8943-4fba-81de-5f103ab373b3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_e4760c4d-3c04-44b4-85f0-b23d7affea5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_303ee060-c489-4f93-a192-e18806ee6ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_5abb372c-8943-4fba-81de-5f103ab373b3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_303ee060-c489-4f93-a192-e18806ee6ba5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_64da5661-21da-4a30-9516-d5bdca8331c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_85b7d987-ed81-46f3-b3cf-f2a636fd6c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_64da5661-21da-4a30-9516-d5bdca8331c5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_85b7d987-ed81-46f3-b3cf-f2a636fd6c48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d3eb8546-e10c-4993-89cf-d822a3ab5799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_64da5661-21da-4a30-9516-d5bdca8331c5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d3eb8546-e10c-4993-89cf-d822a3ab5799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive_9c1e7516-debb-4fcf-9da2-54459a12bdfc" xlink:href="cutr-20211231.xsd#cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_64da5661-21da-4a30-9516-d5bdca8331c5" xlink:to="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive_9c1e7516-debb-4fcf-9da2-54459a12bdfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_86abacde-d411-4b95-b299-15b4a6334a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_64da5661-21da-4a30-9516-d5bdca8331c5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_86abacde-d411-4b95-b299-15b4a6334a1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_cf68c725-5308-4c62-b42b-5fede80dff33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_64da5661-21da-4a30-9516-d5bdca8331c5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_cf68c725-5308-4c62-b42b-5fede80dff33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_60f7ac53-08d2-41db-9bc3-eae5609081be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_64da5661-21da-4a30-9516-d5bdca8331c5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_60f7ac53-08d2-41db-9bc3-eae5609081be" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60d62bb9-b98f-4620-bc9f-ea1bfeece770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a7b678f4-ab2f-4615-b3ae-35077b320571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60d62bb9-b98f-4620-bc9f-ea1bfeece770" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_a7b678f4-ab2f-4615-b3ae-35077b320571" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6c803987-6507-4b0d-b3d5-19f2ec322a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_60d62bb9-b98f-4620-bc9f-ea1bfeece770" xlink:to="loc_us-gaap_OperatingLeaseLiability_6c803987-6507-4b0d-b3d5-19f2ec322a2e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f9a05624-cb25-4526-9186-339ef0e3e37d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_40670829-2a19-40ae-8b26-bba4cea13629" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f9a05624-cb25-4526-9186-339ef0e3e37d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_40670829-2a19-40ae-8b26-bba4cea13629" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2710faa2-473b-4c80-87c9-5a8fc2d013dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f9a05624-cb25-4526-9186-339ef0e3e37d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2710faa2-473b-4c80-87c9-5a8fc2d013dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_08d1cf1a-d8f8-4977-8faa-d06d473a800a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f9a05624-cb25-4526-9186-339ef0e3e37d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_08d1cf1a-d8f8-4977-8faa-d06d473a800a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7bcd92f3-7347-4cbf-84a1-56026de4362d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f9a05624-cb25-4526-9186-339ef0e3e37d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7bcd92f3-7347-4cbf-84a1-56026de4362d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2468bdd8-ed76-4304-a7cd-79e0e74c65ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_4b9ecd5d-d330-49d5-a881-e2201a24970a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2468bdd8-ed76-4304-a7cd-79e0e74c65ab" xlink:to="loc_us-gaap_FinanceLeaseLiability_4b9ecd5d-d330-49d5-a881-e2201a24970a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f2fbb994-714a-4698-a4f9-1b1a37630b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2468bdd8-ed76-4304-a7cd-79e0e74c65ab" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f2fbb994-714a-4698-a4f9-1b1a37630b0c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#DebtOutstandingDebtandCarryingValueDetails"/>
  <link:calculationLink xlink:role="http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_83d80532-20d4-4c20-990a-ff6dd625015b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_8729528d-f53c-40ce-a490-8bb387efd382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_83d80532-20d4-4c20-990a-ff6dd625015b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_8729528d-f53c-40ce-a490-8bb387efd382" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a57773d1-e507-46d1-b868-0f1fec1df2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_83d80532-20d4-4c20-990a-ff6dd625015b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a57773d1-e507-46d1-b868-0f1fec1df2b9" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>cutr-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1ebe9035-7f15-449f-b887-5ea51f412a9f,g:8ea03665-a689-4990-8029-94d26fa40407-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cutr-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofOperations" xlink:type="extended" id="i920c9bb11f254f3baacb438fa6e51ac7_ConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_8991a53b-b236-4f52-a228-34de2aeb5630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_RevenuesAbstract_8991a53b-b236-4f52-a228-34de2aeb5630" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4f207ecf-9167-495a-a757-33ecb6afb7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_8991a53b-b236-4f52-a228-34de2aeb5630" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4f207ecf-9167-495a-a757-33ecb6afb7ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_68df87c5-359d-4428-9fcd-7eab3c6067cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_CostOfRevenueAbstract_68df87c5-359d-4428-9fcd-7eab3c6067cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_929863dd-1315-4f91-9fc5-22516f1136ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_68df87c5-359d-4428-9fcd-7eab3c6067cb" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_929863dd-1315-4f91-9fc5-22516f1136ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_bfea6298-fc82-4449-8b07-99a6e7617d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_GrossProfit_bfea6298-fc82-4449-8b07-99a6e7617d4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_e0645921-8263-49da-a979-c2bcb8d0ce34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_OperatingExpensesAbstract_e0645921-8263-49da-a979-c2bcb8d0ce34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_51c1e1bc-fc7d-4c85-ad91-a215fa8c646c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e0645921-8263-49da-a979-c2bcb8d0ce34" xlink:to="loc_us-gaap_SellingAndMarketingExpense_51c1e1bc-fc7d-4c85-ad91-a215fa8c646c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c759b650-d3e1-444f-bf3a-507bde1a2cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e0645921-8263-49da-a979-c2bcb8d0ce34" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c759b650-d3e1-444f-bf3a-507bde1a2cd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_30d97c9e-a7c6-49ea-9170-66dc88bac956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e0645921-8263-49da-a979-c2bcb8d0ce34" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_30d97c9e-a7c6-49ea-9170-66dc88bac956" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_cb5612bc-6935-4c41-9731-eda593779546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e0645921-8263-49da-a979-c2bcb8d0ce34" xlink:to="loc_us-gaap_OperatingExpenses_cb5612bc-6935-4c41-9731-eda593779546" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b915adde-fefb-4ef3-9d91-1a67ef9b49ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e0645921-8263-49da-a979-c2bcb8d0ce34" xlink:to="loc_us-gaap_OperatingIncomeLoss_b915adde-fefb-4ef3-9d91-1a67ef9b49ad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseAbstract_8ddbe3e1-7448-450d-bd76-99f53703554c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_InterestExpenseAbstract_8ddbe3e1-7448-450d-bd76-99f53703554c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_006e71dc-6321-49f2-b6b5-b3b5f980b154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_8ddbe3e1-7448-450d-bd76-99f53703554c" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_006e71dc-6321-49f2-b6b5-b3b5f980b154" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_4054a01c-13ee-42d4-853f-a85589e402b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_8ddbe3e1-7448-450d-bd76-99f53703554c" xlink:to="loc_us-gaap_InterestExpenseDebt_4054a01c-13ee-42d4-853f-a85589e402b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_004aab79-0768-45cd-93cd-02404cab4c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_8ddbe3e1-7448-450d-bd76-99f53703554c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_004aab79-0768-45cd-93cd-02404cab4c43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7765d3f6-6019-4e3f-9ba2-47733577518f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_8ddbe3e1-7448-450d-bd76-99f53703554c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7765d3f6-6019-4e3f-9ba2-47733577518f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9d084176-87d0-4183-b1cd-2125dd0bf85c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestExpenseAbstract_8ddbe3e1-7448-450d-bd76-99f53703554c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9d084176-87d0-4183-b1cd-2125dd0bf85c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e69952e9-fe9c-45d3-8acd-d7b1318d5247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e69952e9-fe9c-45d3-8acd-d7b1318d5247" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_83c960e9-e27c-427b-a1eb-79799a43ceae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_83c960e9-e27c-427b-a1eb-79799a43ceae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0ff5154a-39c1-47b5-8b86-cf92df61c3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_NetIncomeLoss_0ff5154a-39c1-47b5-8b86-cf92df61c3cd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_39abe3fb-2e58-4b69-926c-991e6debdd98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_EarningsPerShareAbstract_39abe3fb-2e58-4b69-926c-991e6debdd98" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6ce547d8-1edf-4b3e-b618-2ab46d05d93e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_39abe3fb-2e58-4b69-926c-991e6debdd98" xlink:to="loc_us-gaap_EarningsPerShareBasic_6ce547d8-1edf-4b3e-b618-2ab46d05d93e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8fa67e2a-c555-4d5f-9520-3c5952e1f83e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_39abe3fb-2e58-4b69-926c-991e6debdd98" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8fa67e2a-c555-4d5f-9520-3c5952e1f83e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_64f574e2-7333-4967-b8d0-c0c9038a9493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_64f574e2-7333-4967-b8d0-c0c9038a9493" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_16dc32ca-c9d3-4ec8-9442-3a4d29305c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_64f574e2-7333-4967-b8d0-c0c9038a9493" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_16dc32ca-c9d3-4ec8-9442-3a4d29305c0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_39a1f2fa-0d0c-47a7-8692-1f173478a550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_64f574e2-7333-4967-b8d0-c0c9038a9493" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_39a1f2fa-0d0c-47a7-8692-1f173478a550" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cea7dec5-bf4a-4e61-a808-d97afd356482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_StatementTable_cea7dec5-bf4a-4e61-a808-d97afd356482" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4d5ad05c-fead-4e89-af0c-6fa09a73523a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_cea7dec5-bf4a-4e61-a808-d97afd356482" xlink:to="loc_srt_ProductOrServiceAxis_4d5ad05c-fead-4e89-af0c-6fa09a73523a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4d5ad05c-fead-4e89-af0c-6fa09a73523a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4d5ad05c-fead-4e89-af0c-6fa09a73523a" xlink:to="loc_srt_ProductsAndServicesDomain_4d5ad05c-fead-4e89-af0c-6fa09a73523a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_37a0e81c-c823-4ce2-94aa-1f1c978067d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4d5ad05c-fead-4e89-af0c-6fa09a73523a" xlink:to="loc_srt_ProductsAndServicesDomain_37a0e81c-c823-4ce2-94aa-1f1c978067d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_3a9a14ca-a764-439d-a6c2-7bf663c888f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_37a0e81c-c823-4ce2-94aa-1f1c978067d7" xlink:to="loc_us-gaap_ProductMember_3a9a14ca-a764-439d-a6c2-7bf663c888f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_f2429109-a0f9-409f-80cd-23d194a3c9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_37a0e81c-c823-4ce2-94aa-1f1c978067d7" xlink:to="loc_us-gaap_ServiceMember_f2429109-a0f9-409f-80cd-23d194a3c9f5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="cutr-20211231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i04215a09888e467c9280d0ca2ff1ec65_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5bccbd96-99e6-42fd-84ea-7b749d046adb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5bccbd96-99e6-42fd-84ea-7b749d046adb" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_94fd163a-136d-4b51-a0fb-359af9a34e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_94fd163a-136d-4b51-a0fb-359af9a34e5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2e07f08d-01db-4c73-8570-39334249c267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockholdersEquity_2e07f08d-01db-4c73-8570-39334249c267" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_def96536-fbbe-4d8b-90ca-33bf4f1c3c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_def96536-fbbe-4d8b-90ca-33bf4f1c3c9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_81d30c94-90a4-47ed-8cc9-f24d2ba643bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_81d30c94-90a4-47ed-8cc9-f24d2ba643bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2da10bd5-754e-4042-bb5e-b71435620cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2da10bd5-754e-4042-bb5e-b71435620cc4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fad8f8b4-d1d8-4b42-a1d6-7faeb68b37b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fad8f8b4-d1d8-4b42-a1d6-7faeb68b37b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PurchaseOfCappedCall_2e1a631a-09ed-42dd-9c35-f088521cc8de" xlink:href="cutr-20211231.xsd#cutr_PurchaseOfCappedCall"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_cutr_PurchaseOfCappedCall_2e1a631a-09ed-42dd-9c35-f088521cc8de" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0b43e3d3-2943-451d-af82-3d2781498e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0b43e3d3-2943-451d-af82-3d2781498e69" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0e3f1489-e7d8-49fa-9c7c-c8ed73e33eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0e3f1489-e7d8-49fa-9c7c-c8ed73e33eb6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_a7a94593-2cc3-4f90-8e1f-16866d029d63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_a7a94593-2cc3-4f90-8e1f-16866d029d63" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_f71abd2c-85d0-4b50-866d-2a2ab32902ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_f71abd2c-85d0-4b50-866d-2a2ab32902ed" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8420b3e4-b6da-461f-9745-9e0cdbfbb28a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8420b3e4-b6da-461f-9745-9e0cdbfbb28a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_32dd3e41-f42e-4afc-a970-f3139ea96314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_NetIncomeLoss_32dd3e41-f42e-4afc-a970-f3139ea96314" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_92e17845-10f8-4947-bc82-7200ab7c191c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_92e17845-10f8-4947-bc82-7200ab7c191c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f701d36b-8ea4-49e6-bfa9-8a89041852cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_215cda5d-23ab-4f16-85dd-a913fe8b0586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_17f5b0d1-3ec8-4233-b63d-51755fd9ee7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5bccbd96-99e6-42fd-84ea-7b749d046adb" xlink:to="loc_us-gaap_StatementTable_17f5b0d1-3ec8-4233-b63d-51755fd9ee7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f7a7021d-707b-46da-947d-f91982539764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_17f5b0d1-3ec8-4233-b63d-51755fd9ee7e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f7a7021d-707b-46da-947d-f91982539764" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f7a7021d-707b-46da-947d-f91982539764_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f7a7021d-707b-46da-947d-f91982539764" xlink:to="loc_us-gaap_EquityComponentDomain_f7a7021d-707b-46da-947d-f91982539764_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dd570f34-7bad-4de5-b4e4-44b351e65aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f7a7021d-707b-46da-947d-f91982539764" xlink:to="loc_us-gaap_EquityComponentDomain_dd570f34-7bad-4de5-b4e4-44b351e65aae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2a161c10-14cc-4d34-aa45-d70a0451eb51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dd570f34-7bad-4de5-b4e4-44b351e65aae" xlink:to="loc_us-gaap_CommonStockMember_2a161c10-14cc-4d34-aa45-d70a0451eb51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8e401704-534b-44c2-930e-02c451edc822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dd570f34-7bad-4de5-b4e4-44b351e65aae" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8e401704-534b-44c2-930e-02c451edc822" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_def88756-88ab-41eb-b071-c8dd259592c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dd570f34-7bad-4de5-b4e4-44b351e65aae" xlink:to="loc_us-gaap_RetainedEarningsMember_def88756-88ab-41eb-b071-c8dd259592c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef8ada5f-476a-4cec-a985-77f0232a011a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dd570f34-7bad-4de5-b4e4-44b351e65aae" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef8ada5f-476a-4cec-a985-77f0232a011a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="cutr-20211231.xsd#ConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:definitionLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended" id="i17fbe0e51d9a437c8c98e1323716dbc1_ConsolidatedStatementsofStockholdersEquityParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_feb7ace9-5a4c-42b7-8a5f-29f793fa0d15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_6d94e0c8-36d4-4550-a7c9-7e89ba56f39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_feb7ace9-5a4c-42b7-8a5f-29f793fa0d15" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_6d94e0c8-36d4-4550-a7c9-7e89ba56f39d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_40ade2b4-3dc7-4fe6-9566-86b5632d11cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_feb7ace9-5a4c-42b7-8a5f-29f793fa0d15" xlink:to="loc_us-gaap_StatementTable_40ade2b4-3dc7-4fe6-9566-86b5632d11cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_034beb49-1388-412f-a38c-58061d85b89f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_40ade2b4-3dc7-4fe6-9566-86b5632d11cf" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_034beb49-1388-412f-a38c-58061d85b89f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_034beb49-1388-412f-a38c-58061d85b89f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_034beb49-1388-412f-a38c-58061d85b89f" xlink:to="loc_us-gaap_EquityComponentDomain_034beb49-1388-412f-a38c-58061d85b89f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bde2d350-19ea-4ee4-9a93-8a55d39e26e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_034beb49-1388-412f-a38c-58061d85b89f" xlink:to="loc_us-gaap_EquityComponentDomain_bde2d350-19ea-4ee4-9a93-8a55d39e26e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_74c13229-061f-4f41-add5-10211540314b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bde2d350-19ea-4ee4-9a93-8a55d39e26e1" xlink:to="loc_us-gaap_CommonStockMember_74c13229-061f-4f41-add5-10211540314b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i8b2654be459a4005b75c1e2abf46d692_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:href="cutr-20211231.xsd#cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_cfe7adb2-177c-40c3-b70b-da6b383fd3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_cfe7adb2-177c-40c3-b70b-da6b383fd3f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues_bee6adf7-3ab0-48f9-be3e-03a079430980" xlink:href="cutr-20211231.xsd#cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues_bee6adf7-3ab0-48f9-be3e-03a079430980" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionOneTerm_5541edcd-6f31-4095-9320-7ad96838f869" xlink:href="cutr-20211231.xsd#cutr_ExtendedServiceContractOptionOneTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_ExtendedServiceContractOptionOneTerm_5541edcd-6f31-4095-9320-7ad96838f869" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionTwoTerm_c6b992e2-484d-448b-b262-9ad04d8f16c5" xlink:href="cutr-20211231.xsd#cutr_ExtendedServiceContractOptionTwoTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_ExtendedServiceContractOptionTwoTerm_c6b992e2-484d-448b-b262-9ad04d8f16c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionThreeTerm_ff990c25-cee7-44b2-997a-fea3b3dadb9e" xlink:href="cutr-20211231.xsd#cutr_ExtendedServiceContractOptionThreeTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_ExtendedServiceContractOptionThreeTerm_ff990c25-cee7-44b2-997a-fea3b3dadb9e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_4d638e8c-e366-4d23-b5eb-6036d6fa1fb5" xlink:href="cutr-20211231.xsd#cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_4d638e8c-e366-4d23-b5eb-6036d6fa1fb5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_1a2e7f8b-5e8f-4317-8439-0af74f23da42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_ContractWithCustomerLiability_1a2e7f8b-5e8f-4317-8439-0af74f23da42" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_32ab1d2b-7918-434a-a3e5-61961ca10d77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_32ab1d2b-7918-434a-a3e5-61961ca10d77" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_9f967466-b6a7-454d-8c9e-b5087935f8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_CapitalizedContractCostNet_9f967466-b6a7-454d-8c9e-b5087935f8ca" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_7cf368bd-1444-4aa8-b740-e65078159ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_7cf368bd-1444-4aa8-b740-e65078159ddd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c6048007-e9b4-4796-a08b-557319c7175e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c6048007-e9b4-4796-a08b-557319c7175e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NumberOfMajorSuppliers_d7355483-2654-4674-98fb-88d97018796f" xlink:href="cutr-20211231.xsd#cutr_NumberOfMajorSuppliers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_NumberOfMajorSuppliers_d7355483-2654-4674-98fb-88d97018796f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DemonstrationUnitsAmortizationPeriod_6aab9b63-5f25-4853-8b87-0f550ce0ae4f" xlink:href="cutr-20211231.xsd#cutr_DemonstrationUnitsAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_DemonstrationUnitsAmortizationPeriod_6aab9b63-5f25-4853-8b87-0f550ce0ae4f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_f003085d-974f-4191-bd72-e26b46566eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_InventoryFinishedGoods_f003085d-974f-4191-bd72-e26b46566eb7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_6f98dabb-4243-4a91-92b0-a4a36cdbd883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_Depreciation_6f98dabb-4243-4a91-92b0-a4a36cdbd883" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1e0ba001-9eed-463f-9bf0-a0bfe16716f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1e0ba001-9eed-463f-9bf0-a0bfe16716f2" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_fc37c682-1024-4064-acfb-e8ed51875000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_fc37c682-1024-4064-acfb-e8ed51875000" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization_9c2f8cc7-60fd-417e-97a1-f649f99866b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization_9c2f8cc7-60fd-417e-97a1-f649f99866b8" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_da16bdbb-e018-498d-857a-ef9d5f1af261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_da16bdbb-e018-498d-857a-ef9d5f1af261" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_3349bed6-44d6-486a-b1a9-731075a9b7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HostingArrangementServiceContractImplementationCostImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_3349bed6-44d6-486a-b1a9-731075a9b7f2" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_c21ab385-7c02-4e1b-9ba2-59361512f3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_NumberOfOperatingSegments_c21ab385-7c02-4e1b-9ba2-59361512f3c4" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_34cbd461-e13e-4bd0-bbb8-474be1b06a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_NumberOfReportingUnits_34cbd461-e13e-4bd0-bbb8-474be1b06a7a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_788e7fa2-290a-4ed2-8be7-3f5e8dc2eab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_788e7fa2-290a-4ed2-8be7-3f5e8dc2eab4" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StandardProductWarrantyTermDirectSales_b2932d46-317a-42ab-a5e2-af74f8fa2baa" xlink:href="cutr-20211231.xsd#cutr_StandardProductWarrantyTermDirectSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_StandardProductWarrantyTermDirectSales_b2932d46-317a-42ab-a5e2-af74f8fa2baa" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StandardProductWarrantyTermDistributorSales_c251cceb-6856-418e-be9e-6324d118b5c2" xlink:href="cutr-20211231.xsd#cutr_StandardProductWarrantyTermDistributorSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_StandardProductWarrantyTermDistributorSales_c251cceb-6856-418e-be9e-6324d118b5c2" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_61c65bd2-b605-4e85-b166-ac94d9b6f011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_AdvertisingExpense_61c65bd2-b605-4e85-b166-ac94d9b6f011" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_84240b8d-8338-4f15-87b8-a55ac9cc9ca7" xlink:href="cutr-20211231.xsd#cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_84240b8d-8338-4f15-87b8-a55ac9cc9ca7" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_8e9a8734-27f6-4356-a2a5-d5498b80abe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_8e9a8734-27f6-4356-a2a5-d5498b80abe0" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PercentageOfAssets_c671ba36-bdeb-4dec-807c-d4eb78307802" xlink:href="cutr-20211231.xsd#cutr_PercentageOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_PercentageOfAssets_c671ba36-bdeb-4dec-807c-d4eb78307802" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:href="cutr-20211231.xsd#cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_53e9d1a7-7f66-482b-ad5b-ef7143ef10c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_53e9d1a7-7f66-482b-ad5b-ef7143ef10c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_53e9d1a7-7f66-482b-ad5b-ef7143ef10c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_53e9d1a7-7f66-482b-ad5b-ef7143ef10c5" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_53e9d1a7-7f66-482b-ad5b-ef7143ef10c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_6b8f6e23-bcfc-4ba9-a9c3-d0abd8fe3f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_53e9d1a7-7f66-482b-ad5b-ef7143ef10c5" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_6b8f6e23-bcfc-4ba9-a9c3-d0abd8fe3f23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_71110711-9fe8-466a-a88a-341c49498d67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_6b8f6e23-bcfc-4ba9-a9c3-d0abd8fe3f23" xlink:to="loc_us-gaap_TransferredOverTimeMember_71110711-9fe8-466a-a88a-341c49498d67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_38bb1f1b-f52b-4dae-83de-7669feeef9a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_srt_ProductOrServiceAxis_38bb1f1b-f52b-4dae-83de-7669feeef9a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_38bb1f1b-f52b-4dae-83de-7669feeef9a1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_38bb1f1b-f52b-4dae-83de-7669feeef9a1" xlink:to="loc_srt_ProductsAndServicesDomain_38bb1f1b-f52b-4dae-83de-7669feeef9a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_023fe33e-cc71-49f1-a6e5-66933063bd9c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_38bb1f1b-f52b-4dae-83de-7669feeef9a1" xlink:to="loc_srt_ProductsAndServicesDomain_023fe33e-cc71-49f1-a6e5-66933063bd9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoyaltyMember_d11f3b1c-bc7d-4ac8-a451-d7b638adcf72" xlink:href="cutr-20211231.xsd#cutr_LoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_023fe33e-cc71-49f1-a6e5-66933063bd9c" xlink:to="loc_cutr_LoyaltyMember_d11f3b1c-bc7d-4ac8-a451-d7b638adcf72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_5b25252a-401d-43b9-89de-23141363083a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_023fe33e-cc71-49f1-a6e5-66933063bd9c" xlink:to="loc_us-gaap_ServiceMember_5b25252a-401d-43b9-89de-23141363083a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SecretAndSecretProMember_b8f6d0c4-62e2-426b-bc51-c5cee3a3f1ab" xlink:href="cutr-20211231.xsd#cutr_SecretAndSecretProMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_023fe33e-cc71-49f1-a6e5-66933063bd9c" xlink:to="loc_cutr_SecretAndSecretProMember_b8f6d0c4-62e2-426b-bc51-c5cee3a3f1ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SkincareMember_acdb69bb-0064-43be-a57a-cdb5cad1358a" xlink:href="cutr-20211231.xsd#cutr_SkincareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_023fe33e-cc71-49f1-a6e5-66933063bd9c" xlink:to="loc_cutr_SkincareMember_acdb69bb-0064-43be-a57a-cdb5cad1358a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0fdec946-c50d-4a77-b0bc-a9ff476b64c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0fdec946-c50d-4a77-b0bc-a9ff476b64c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0fdec946-c50d-4a77-b0bc-a9ff476b64c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0fdec946-c50d-4a77-b0bc-a9ff476b64c7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0fdec946-c50d-4a77-b0bc-a9ff476b64c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_770c3ca4-7ed8-4bb4-9d2c-7e7788a09b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0fdec946-c50d-4a77-b0bc-a9ff476b64c7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_770c3ca4-7ed8-4bb4-9d2c-7e7788a09b49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_3dc8b3e5-06ce-4d08-bdc3-290a835b19af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_770c3ca4-7ed8-4bb4-9d2c-7e7788a09b49" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_3dc8b3e5-06ce-4d08-bdc3-290a835b19af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_f11dc173-d183-4dab-9129-950d921b872f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_f11dc173-d183-4dab-9129-950d921b872f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f11dc173-d183-4dab-9129-950d921b872f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_f11dc173-d183-4dab-9129-950d921b872f" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f11dc173-d183-4dab-9129-950d921b872f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_47ce640d-e89b-418f-8729-b98e230f64ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_f11dc173-d183-4dab-9129-950d921b872f" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_47ce640d-e89b-418f-8729-b98e230f64ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_2579aa0d-6b77-4368-9b5e-16a6164a1311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_47ce640d-e89b-418f-8729-b98e230f64ab" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_2579aa0d-6b77-4368-9b5e-16a6164a1311" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e08eba7a-bb6f-41dd-b1c2-e3a1e15878a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e08eba7a-bb6f-41dd-b1c2-e3a1e15878a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e08eba7a-bb6f-41dd-b1c2-e3a1e15878a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e08eba7a-bb6f-41dd-b1c2-e3a1e15878a7" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e08eba7a-bb6f-41dd-b1c2-e3a1e15878a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_790f0f1a-a005-425f-8517-e89fb725a3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e08eba7a-bb6f-41dd-b1c2-e3a1e15878a7" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_790f0f1a-a005-425f-8517-e89fb725a3d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_23c4bb19-4cbb-4e20-bda5-1f2544270dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_790f0f1a-a005-425f-8517-e89fb725a3d3" xlink:to="loc_us-gaap_SalesRevenueNetMember_23c4bb19-4cbb-4e20-bda5-1f2544270dd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e080f7fd-90e6-49b5-8331-009cce432337" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_srt_StatementGeographicalAxis_e080f7fd-90e6-49b5-8331-009cce432337" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e080f7fd-90e6-49b5-8331-009cce432337_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e080f7fd-90e6-49b5-8331-009cce432337" xlink:to="loc_srt_SegmentGeographicalDomain_e080f7fd-90e6-49b5-8331-009cce432337_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1702bf1a-dbde-4f52-a907-069226969fea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e080f7fd-90e6-49b5-8331-009cce432337" xlink:to="loc_srt_SegmentGeographicalDomain_1702bf1a-dbde-4f52-a907-069226969fea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8348e060-e0b3-44cb-b042-20fca6ddd1b1" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1702bf1a-dbde-4f52-a907-069226969fea" xlink:to="loc_country_US_8348e060-e0b3-44cb-b042-20fca6ddd1b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_720f654c-6b7d-436a-8f6b-d2d6087bb215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1702bf1a-dbde-4f52-a907-069226969fea" xlink:to="loc_us-gaap_NonUsMember_720f654c-6b7d-436a-8f6b-d2d6087bb215" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_53d68039-c547-48a0-8785-835cabd1ec21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_53d68039-c547-48a0-8785-835cabd1ec21" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_53d68039-c547-48a0-8785-835cabd1ec21_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_53d68039-c547-48a0-8785-835cabd1ec21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_53d68039-c547-48a0-8785-835cabd1ec21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad09ba6f-cf4c-4dc4-b111-189caba3eedc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_53d68039-c547-48a0-8785-835cabd1ec21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad09ba6f-cf4c-4dc4-b111-189caba3eedc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CapitalizedCloudComputingSetupCostMember_978067ab-0367-48ea-83fa-15c43d9d1a1f" xlink:href="cutr-20211231.xsd#cutr_CapitalizedCloudComputingSetupCostMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad09ba6f-cf4c-4dc4-b111-189caba3eedc" xlink:to="loc_cutr_CapitalizedCloudComputingSetupCostMember_978067ab-0367-48ea-83fa-15c43d9d1a1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d7e7147c-ae76-4a51-9b73-4ac994e41bc4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_srt_RangeAxis_d7e7147c-ae76-4a51-9b73-4ac994e41bc4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d7e7147c-ae76-4a51-9b73-4ac994e41bc4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d7e7147c-ae76-4a51-9b73-4ac994e41bc4" xlink:to="loc_srt_RangeMember_d7e7147c-ae76-4a51-9b73-4ac994e41bc4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_696aff30-4a11-481a-b619-26439f3bdf0c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d7e7147c-ae76-4a51-9b73-4ac994e41bc4" xlink:to="loc_srt_RangeMember_696aff30-4a11-481a-b619-26439f3bdf0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b94d465a-990f-4f12-8c17-d9cbb59f63fb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_696aff30-4a11-481a-b619-26439f3bdf0c" xlink:to="loc_srt_MinimumMember_b94d465a-990f-4f12-8c17-d9cbb59f63fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d86a870e-396a-4e90-ab9b-0d23217211bc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_696aff30-4a11-481a-b619-26439f3bdf0c" xlink:to="loc_srt_MaximumMember_d86a870e-396a-4e90-ab9b-0d23217211bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1371a5e8-2a2f-4c32-903d-7d933c4550c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1371a5e8-2a2f-4c32-903d-7d933c4550c0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1371a5e8-2a2f-4c32-903d-7d933c4550c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1371a5e8-2a2f-4c32-903d-7d933c4550c0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1371a5e8-2a2f-4c32-903d-7d933c4550c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_cd2146ed-3a4b-482d-bab9-b633c4e8ff16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1371a5e8-2a2f-4c32-903d-7d933c4550c0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_cd2146ed-3a4b-482d-bab9-b633c4e8ff16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_e2057156-37d1-44f2-b3a1-14ef197db5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cd2146ed-3a4b-482d-bab9-b633c4e8ff16" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_e2057156-37d1-44f2-b3a1-14ef197db5c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_44c55921-7449-43ac-b043-caa889908178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cd2146ed-3a4b-482d-bab9-b633c4e8ff16" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_44c55921-7449-43ac-b043-caa889908178" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_8e12391a-1c2e-40b0-82a8-283fa32baefa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_us-gaap_StatementClassOfStockAxis_8e12391a-1c2e-40b0-82a8-283fa32baefa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8e12391a-1c2e-40b0-82a8-283fa32baefa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8e12391a-1c2e-40b0-82a8-283fa32baefa" xlink:to="loc_us-gaap_ClassOfStockDomain_8e12391a-1c2e-40b0-82a8-283fa32baefa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_960ca6ff-9353-4523-b1f2-aedc635616a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8e12391a-1c2e-40b0-82a8-283fa32baefa" xlink:to="loc_us-gaap_ClassOfStockDomain_960ca6ff-9353-4523-b1f2-aedc635616a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_82772c2f-32c9-49fc-b5cb-9f27198aa7af" xlink:href="cutr-20211231.xsd#cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_960ca6ff-9353-4523-b1f2-aedc635616a4" xlink:to="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_82772c2f-32c9-49fc-b5cb-9f27198aa7af" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended" id="i7f3102f5daa849dea6920c86f1a58f5e_SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_51ffc23b-7131-4d15-9643-c0f576164b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2dd11ebd-ae6d-402b-b7e0-daabac51ea72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_51ffc23b-7131-4d15-9643-c0f576164b2d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2dd11ebd-ae6d-402b-b7e0-daabac51ea72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2382c7fc-4688-4bab-b2bb-3166f494bb56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_51ffc23b-7131-4d15-9643-c0f576164b2d" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2382c7fc-4688-4bab-b2bb-3166f494bb56" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_15458968-a44c-4fed-b31f-5c226dcab6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2382c7fc-4688-4bab-b2bb-3166f494bb56" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_15458968-a44c-4fed-b31f-5c226dcab6fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_15458968-a44c-4fed-b31f-5c226dcab6fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_15458968-a44c-4fed-b31f-5c226dcab6fa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_15458968-a44c-4fed-b31f-5c226dcab6fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb1bced6-9b90-4d81-ad18-de2dc792d753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_15458968-a44c-4fed-b31f-5c226dcab6fa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb1bced6-9b90-4d81-ad18-de2dc792d753" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasedEquipmentMember_bb005897-b55f-4984-9677-cd1349ee8b09" xlink:href="cutr-20211231.xsd#cutr_LeasedEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb1bced6-9b90-4d81-ad18-de2dc792d753" xlink:to="loc_cutr_LeasedEquipmentMember_bb005897-b55f-4984-9677-cd1349ee8b09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EquipmentAndFurnitureMember_cc2ceea6-93ef-4ad6-b4a7-be85ca49eb8a" xlink:href="cutr-20211231.xsd#cutr_EquipmentAndFurnitureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb1bced6-9b90-4d81-ad18-de2dc792d753" xlink:to="loc_cutr_EquipmentAndFurnitureMember_cc2ceea6-93ef-4ad6-b4a7-be85ca49eb8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_55c03911-cd13-4703-be5c-d37f38f00bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb1bced6-9b90-4d81-ad18-de2dc792d753" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_55c03911-cd13-4703-be5c-d37f38f00bec" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#BalanceSheetDetailPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails" xlink:type="extended" id="i58ddfb67a95f462bade07849e1441ce4_BalanceSheetDetailPropertyandEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5849de6a-fea8-4274-98cd-d5185823eb42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f4922520-9543-4951-8af8-82406c702871" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5849de6a-fea8-4274-98cd-d5185823eb42" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f4922520-9543-4951-8af8-82406c702871" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_29819e1f-2534-4aee-9ef7-5c5436c6311d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5849de6a-fea8-4274-98cd-d5185823eb42" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_29819e1f-2534-4aee-9ef7-5c5436c6311d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_ddb003a0-ca6f-4651-91d1-ce8af6c7e56d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5849de6a-fea8-4274-98cd-d5185823eb42" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_ddb003a0-ca6f-4651-91d1-ce8af6c7e56d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7f3ce9c0-7014-44ca-80be-7d4192aab218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5849de6a-fea8-4274-98cd-d5185823eb42" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7f3ce9c0-7014-44ca-80be-7d4192aab218" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_09b5f75d-4af8-4883-9da6-80f42954b109" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5849de6a-fea8-4274-98cd-d5185823eb42" xlink:to="loc_us-gaap_StatementTable_09b5f75d-4af8-4883-9da6-80f42954b109" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65565ebc-3924-4f63-b20b-968fde57cb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_09b5f75d-4af8-4883-9da6-80f42954b109" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65565ebc-3924-4f63-b20b-968fde57cb8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_65565ebc-3924-4f63-b20b-968fde57cb8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65565ebc-3924-4f63-b20b-968fde57cb8d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_65565ebc-3924-4f63-b20b-968fde57cb8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff865fa5-ca8b-4609-8230-82f1ddc72ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65565ebc-3924-4f63-b20b-968fde57cb8d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff865fa5-ca8b-4609-8230-82f1ddc72ddf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_70eecff9-59f4-47f9-b1fd-29ecc3841462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff865fa5-ca8b-4609-8230-82f1ddc72ddf" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_70eecff9-59f4-47f9-b1fd-29ecc3841462" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasedEquipmentMember_9ea4ea5e-bf4a-4a88-9e22-79077668c715" xlink:href="cutr-20211231.xsd#cutr_LeasedEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff865fa5-ca8b-4609-8230-82f1ddc72ddf" xlink:to="loc_cutr_LeasedEquipmentMember_9ea4ea5e-bf4a-4a88-9e22-79077668c715" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EquipmentAndFurnitureMember_4ca95af3-874d-4e7c-af7b-71a2418ac2d0" xlink:href="cutr-20211231.xsd#cutr_EquipmentAndFurnitureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff865fa5-ca8b-4609-8230-82f1ddc72ddf" xlink:to="loc_cutr_EquipmentAndFurnitureMember_4ca95af3-874d-4e7c-af7b-71a2418ac2d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_8d06c5a3-1ddb-40f9-8c3c-a1212480ad8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff865fa5-ca8b-4609-8230-82f1ddc72ddf" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_8d06c5a3-1ddb-40f9-8c3c-a1212480ad8e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#BalanceSheetDetailNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/BalanceSheetDetailNarrativeDetails" xlink:type="extended" id="i2fc7fa4abc184ea2b4f00faf2e6ef894_BalanceSheetDetailNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_83ac27f0-3f3b-401d-9671-5bc6ce03e07c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:to="loc_us-gaap_InventoryValuationReserves_83ac27f0-3f3b-401d-9671-5bc6ce03e07c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_76612d4f-de9b-48f5-92e7-a0deae73da70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_76612d4f-de9b-48f5-92e7-a0deae73da70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_88074ab7-317d-4a15-82c4-731f5794a8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_88074ab7-317d-4a15-82c4-731f5794a8e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_37af265f-a347-407b-a844-d0fbecbab05a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_37af265f-a347-407b-a844-d0fbecbab05a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_52acf6fd-e01b-4043-bdfa-0400194781a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:to="loc_us-gaap_Goodwill_52acf6fd-e01b-4043-bdfa-0400194781a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_fa76e6c1-e882-4f4b-ab46-bdcffcc345c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_fa76e6c1-e882-4f4b-ab46-bdcffcc345c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_64bc4628-b31d-40bf-97ad-731d9b6846a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_64bc4628-b31d-40bf-97ad-731d9b6846a1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4bf94650-289f-460d-a48c-f5473647cb50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:to="loc_us-gaap_StatementTable_4bf94650-289f-460d-a48c-f5473647cb50" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_abe430e5-20bd-4489-87a6-028d84a63684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4bf94650-289f-460d-a48c-f5473647cb50" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_abe430e5-20bd-4489-87a6-028d84a63684" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_abe430e5-20bd-4489-87a6-028d84a63684_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_abe430e5-20bd-4489-87a6-028d84a63684" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_abe430e5-20bd-4489-87a6-028d84a63684_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5bb90f6b-43d5-4d21-829b-e2ac0996ff3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_abe430e5-20bd-4489-87a6-028d84a63684" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5bb90f6b-43d5-4d21-829b-e2ac0996ff3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_ed383b70-2275-49e5-886f-a351d897bf36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5bb90f6b-43d5-4d21-829b-e2ac0996ff3e" xlink:to="loc_us-gaap_VehiclesMember_ed383b70-2275-49e5-886f-a351d897bf36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_6cd0c306-415e-4a9e-b764-7c3d2b4d6ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5bb90f6b-43d5-4d21-829b-e2ac0996ff3e" xlink:to="loc_us-gaap_ConstructionInProgressMember_6cd0c306-415e-4a9e-b764-7c3d2b4d6ac0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/DeferredRevenueNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#DeferredRevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/DeferredRevenueNarrativeDetails" xlink:type="extended" id="i027bb514221d4815874582d6c2679259_DeferredRevenueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionOneTerm_1add49b8-bbee-4820-83ed-fc255480b09c" xlink:href="cutr-20211231.xsd#cutr_ExtendedServiceContractOptionOneTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_cutr_ExtendedServiceContractOptionOneTerm_1add49b8-bbee-4820-83ed-fc255480b09c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionTwoTerm_5942e102-83de-40de-9ff2-f0db3ef9bdf5" xlink:href="cutr-20211231.xsd#cutr_ExtendedServiceContractOptionTwoTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_cutr_ExtendedServiceContractOptionTwoTerm_5942e102-83de-40de-9ff2-f0db3ef9bdf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_08df709e-d98d-47ba-a859-e66a8d9d0777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_08df709e-d98d-47ba-a859-e66a8d9d0777" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_a0abbc55-39ae-4628-b300-ca6617185868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_a0abbc55-39ae-4628-b300-ca6617185868" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_bdc03ee3-9836-4a3f-9947-4a579fbbcbbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_bdc03ee3-9836-4a3f-9947-4a579fbbcbbb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredRevenueCostsIncurred_741bfded-10ca-460d-9dcb-d15b6b91c70a" xlink:href="cutr-20211231.xsd#cutr_DeferredRevenueCostsIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_cutr_DeferredRevenueCostsIncurred_741bfded-10ca-460d-9dcb-d15b6b91c70a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_56b5f1b2-aa56-4df9-95d6-95387a1a247e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_56b5f1b2-aa56-4df9-95d6-95387a1a247e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0d86dee5-5fb8-4342-8dff-8b249e2239f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_56b5f1b2-aa56-4df9-95d6-95387a1a247e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0d86dee5-5fb8-4342-8dff-8b249e2239f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_92e72082-52af-445f-a0e8-08cb978bc28d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_56b5f1b2-aa56-4df9-95d6-95387a1a247e" xlink:to="loc_srt_ProductOrServiceAxis_92e72082-52af-445f-a0e8-08cb978bc28d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_92e72082-52af-445f-a0e8-08cb978bc28d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_92e72082-52af-445f-a0e8-08cb978bc28d" xlink:to="loc_srt_ProductsAndServicesDomain_92e72082-52af-445f-a0e8-08cb978bc28d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fd86644f-c17e-4f04-aad1-e3dde18e3ec6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_92e72082-52af-445f-a0e8-08cb978bc28d" xlink:to="loc_srt_ProductsAndServicesDomain_fd86644f-c17e-4f04-aad1-e3dde18e3ec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_e6249ceb-114f-44ee-b5c2-7572b918a7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_fd86644f-c17e-4f04-aad1-e3dde18e3ec6" xlink:to="loc_us-gaap_ServiceMember_e6249ceb-114f-44ee-b5c2-7572b918a7f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8407e28a-3d57-4aed-9909-419a48e55797" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_56b5f1b2-aa56-4df9-95d6-95387a1a247e" xlink:to="loc_srt_RangeAxis_8407e28a-3d57-4aed-9909-419a48e55797" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8407e28a-3d57-4aed-9909-419a48e55797_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8407e28a-3d57-4aed-9909-419a48e55797" xlink:to="loc_srt_RangeMember_8407e28a-3d57-4aed-9909-419a48e55797_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3c1610bc-1bd7-4f0d-b830-f3a132077ec2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8407e28a-3d57-4aed-9909-419a48e55797" xlink:to="loc_srt_RangeMember_3c1610bc-1bd7-4f0d-b830-f3a132077ec2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5954d62b-0e2a-4529-a2e7-d43b4cd3982f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3c1610bc-1bd7-4f0d-b830-f3a132077ec2" xlink:to="loc_srt_MinimumMember_5954d62b-0e2a-4529-a2e7-d43b4cd3982f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_46a4112a-bd02-41f6-b50a-f300c99ab366" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3c1610bc-1bd7-4f0d-b830-f3a132077ec2" xlink:to="loc_srt_MaximumMember_46a4112a-bd02-41f6-b50a-f300c99ab366" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/DeferredRevenueNarrativeDetails_1" xlink:type="simple" xlink:href="cutr-20211231.xsd#DeferredRevenueNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://cutera.com/role/DeferredRevenueNarrativeDetails_1" xlink:type="extended" id="ib636c85722bd4fdab070f79fa44a96a5_DeferredRevenueNarrativeDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionOneTerm_1add49b8-bbee-4820-83ed-fc255480b09c" xlink:href="cutr-20211231.xsd#cutr_ExtendedServiceContractOptionOneTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_cutr_ExtendedServiceContractOptionOneTerm_1add49b8-bbee-4820-83ed-fc255480b09c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionTwoTerm_5942e102-83de-40de-9ff2-f0db3ef9bdf5" xlink:href="cutr-20211231.xsd#cutr_ExtendedServiceContractOptionTwoTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_cutr_ExtendedServiceContractOptionTwoTerm_5942e102-83de-40de-9ff2-f0db3ef9bdf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_08df709e-d98d-47ba-a859-e66a8d9d0777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_08df709e-d98d-47ba-a859-e66a8d9d0777" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_a0abbc55-39ae-4628-b300-ca6617185868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_a0abbc55-39ae-4628-b300-ca6617185868" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_bdc03ee3-9836-4a3f-9947-4a579fbbcbbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_bdc03ee3-9836-4a3f-9947-4a579fbbcbbb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredRevenueCostsIncurred_741bfded-10ca-460d-9dcb-d15b6b91c70a" xlink:href="cutr-20211231.xsd#cutr_DeferredRevenueCostsIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_cutr_DeferredRevenueCostsIncurred_741bfded-10ca-460d-9dcb-d15b6b91c70a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_56b5f1b2-aa56-4df9-95d6-95387a1a247e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_56b5f1b2-aa56-4df9-95d6-95387a1a247e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_92e72082-52af-445f-a0e8-08cb978bc28d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_56b5f1b2-aa56-4df9-95d6-95387a1a247e" xlink:to="loc_srt_ProductOrServiceAxis_92e72082-52af-445f-a0e8-08cb978bc28d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_92e72082-52af-445f-a0e8-08cb978bc28d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_92e72082-52af-445f-a0e8-08cb978bc28d" xlink:to="loc_srt_ProductsAndServicesDomain_92e72082-52af-445f-a0e8-08cb978bc28d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fd86644f-c17e-4f04-aad1-e3dde18e3ec6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_92e72082-52af-445f-a0e8-08cb978bc28d" xlink:to="loc_srt_ProductsAndServicesDomain_fd86644f-c17e-4f04-aad1-e3dde18e3ec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_e6249ceb-114f-44ee-b5c2-7572b918a7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_fd86644f-c17e-4f04-aad1-e3dde18e3ec6" xlink:to="loc_us-gaap_ServiceMember_e6249ceb-114f-44ee-b5c2-7572b918a7f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8407e28a-3d57-4aed-9909-419a48e55797" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_56b5f1b2-aa56-4df9-95d6-95387a1a247e" xlink:to="loc_srt_RangeAxis_8407e28a-3d57-4aed-9909-419a48e55797" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8407e28a-3d57-4aed-9909-419a48e55797_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8407e28a-3d57-4aed-9909-419a48e55797" xlink:to="loc_srt_RangeMember_8407e28a-3d57-4aed-9909-419a48e55797_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3c1610bc-1bd7-4f0d-b830-f3a132077ec2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8407e28a-3d57-4aed-9909-419a48e55797" xlink:to="loc_srt_RangeMember_3c1610bc-1bd7-4f0d-b830-f3a132077ec2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5954d62b-0e2a-4529-a2e7-d43b4cd3982f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3c1610bc-1bd7-4f0d-b830-f3a132077ec2" xlink:to="loc_srt_MinimumMember_5954d62b-0e2a-4529-a2e7-d43b4cd3982f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_46a4112a-bd02-41f6-b50a-f300c99ab366" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3c1610bc-1bd7-4f0d-b830-f3a132077ec2" xlink:to="loc_srt_MaximumMember_46a4112a-bd02-41f6-b50a-f300c99ab366" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails" xlink:type="extended" id="ib7833213fa3c4b2da296b5dda72084f2_StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_69812d4b-7ba0-4acd-8a7b-f3aef7f834a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_69812d4b-7ba0-4acd-8a7b-f3aef7f834a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CapitalStockSharesAuthorized_827cc450-0c81-46cf-bbdf-40bdb5d60247" xlink:href="cutr-20211231.xsd#cutr_CapitalStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_cutr_CapitalStockSharesAuthorized_827cc450-0c81-46cf-bbdf-40bdb5d60247" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_61dfd280-4e61-43e9-a6c7-7aca9ede1238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_61dfd280-4e61-43e9-a6c7-7aca9ede1238" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_7650501d-0bc3-4336-956c-3f4720908830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_CommonStockSharesIssued_7650501d-0bc3-4336-956c-3f4720908830" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_74f68e6b-ddf8-405b-a9b9-1f17ce1b6121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_74f68e6b-ddf8-405b-a9b9-1f17ce1b6121" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_45f57282-6e1b-448f-a03f-fce11cf9a3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_45f57282-6e1b-448f-a03f-fce11cf9a3d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_fa6cd513-6412-4cf4-854d-509e1347c125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_fa6cd513-6412-4cf4-854d-509e1347c125" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_cd7d34c1-bfe8-42c4-a63e-be45ea543498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_PreferredStockSharesIssued_cd7d34c1-bfe8-42c4-a63e-be45ea543498" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_df9a7eb6-085f-4054-9045-2c2244929cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_df9a7eb6-085f-4054-9045-2c2244929cb6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_be4bd19e-6b8c-40c6-a520-23445279958c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_be4bd19e-6b8c-40c6-a520-23445279958c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_fc47d976-0278-492a-adf3-e026c73b9e99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_fc47d976-0278-492a-adf3-e026c73b9e99" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f6c78f2a-0275-4107-a5f1-23225f3783e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f6c78f2a-0275-4107-a5f1-23225f3783e3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_871974f7-fd20-40d1-a4a3-46c4860f5850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_871974f7-fd20-40d1-a4a3-46c4860f5850" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0bcf7452-c0e8-4baf-882b-27c4e961ac75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0bcf7452-c0e8-4baf-882b-27c4e961ac75" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled_74aa7112-c007-4cd5-b8b0-13da550c9261" xlink:href="cutr-20211231.xsd#cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled_74aa7112-c007-4cd5-b8b0-13da550c9261" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7c6e2c1b-028a-442d-96f3-18cc25c92d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7c6e2c1b-028a-442d-96f3-18cc25c92d6b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_406e95f7-84fc-4885-bdce-67a8356cbf5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_406e95f7-84fc-4885-bdce-67a8356cbf5f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear_5ef68e9d-5644-4c4e-bb5e-be5dac160a1a" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear_5ef68e9d-5644-4c4e-bb5e-be5dac160a1a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue_ac109c77-8f30-47cd-b07e-30e90460c2be" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue_ac109c77-8f30-47cd-b07e-30e90460c2be" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f36c89a7-c998-4380-b6b1-7f6030a666c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f36c89a7-c998-4380-b6b1-7f6030a666c0" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_77b8e5b1-9a9e-4fba-9df9-fcaebcbd7ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_77b8e5b1-9a9e-4fba-9df9-fcaebcbd7ea6" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_9f0f34c7-31c4-4a20-b416-f3a38173f951" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_9f0f34c7-31c4-4a20-b416-f3a38173f951" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_fcca0735-117c-4701-873e-532bfaa08481" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_fcca0735-117c-4701-873e-532bfaa08481" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage_4e6b6864-360d-4326-a775-40a7bb9a27d1" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage_4e6b6864-360d-4326-a775-40a7bb9a27d1" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_fe19ad75-db4f-4c9d-9a5c-a31aaa94165b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_fe19ad75-db4f-4c9d-9a5c-a31aaa94165b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_4abd77c5-bda9-4e8e-b507-0b6bff5798fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_4abd77c5-bda9-4e8e-b507-0b6bff5798fd" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_8920030d-db5a-4c5b-b9dc-78376a9ae1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_8920030d-db5a-4c5b-b9dc-78376a9ae1a8" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f709fe37-6070-41af-a1e3-cdc399b087dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f709fe37-6070-41af-a1e3-cdc399b087dd" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_f999c1ab-3980-43bd-99f6-db9fbb65fd07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_f999c1ab-3980-43bd-99f6-db9fbb65fd07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f999c1ab-3980-43bd-99f6-db9fbb65fd07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f999c1ab-3980-43bd-99f6-db9fbb65fd07" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f999c1ab-3980-43bd-99f6-db9fbb65fd07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7fb75221-933e-4bfa-8073-2cf637f3206a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f999c1ab-3980-43bd-99f6-db9fbb65fd07" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7fb75221-933e-4bfa-8073-2cf637f3206a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_UnderwrittenPublicOfferingMember_3858987e-43e1-42cb-89be-4b22447abce2" xlink:href="cutr-20211231.xsd#cutr_UnderwrittenPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7fb75221-933e-4bfa-8073-2cf637f3206a" xlink:to="loc_cutr_UnderwrittenPublicOfferingMember_3858987e-43e1-42cb-89be-4b22447abce2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1454241f-4d61-4abd-9780-c1daf39e65b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:to="loc_srt_CounterpartyNameAxis_1454241f-4d61-4abd-9780-c1daf39e65b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1454241f-4d61-4abd-9780-c1daf39e65b6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_1454241f-4d61-4abd-9780-c1daf39e65b6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1454241f-4d61-4abd-9780-c1daf39e65b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d8d4e1e0-0355-4d48-8eec-f49647bd0433" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_1454241f-4d61-4abd-9780-c1daf39e65b6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d8d4e1e0-0355-4d48-8eec-f49647bd0433" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_UnderwriterMember_18734cba-40ff-4ac7-b21d-f58a568a6ee3" xlink:href="cutr-20211231.xsd#cutr_UnderwriterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d8d4e1e0-0355-4d48-8eec-f49647bd0433" xlink:to="loc_cutr_UnderwriterMember_18734cba-40ff-4ac7-b21d-f58a568a6ee3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_af99adf9-52ff-4d0d-9d84-e4810960a3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:to="loc_us-gaap_PlanNameAxis_af99adf9-52ff-4d0d-9d84-e4810960a3e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_af99adf9-52ff-4d0d-9d84-e4810960a3e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_af99adf9-52ff-4d0d-9d84-e4810960a3e0" xlink:to="loc_us-gaap_PlanNameDomain_af99adf9-52ff-4d0d-9d84-e4810960a3e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_73850d92-1ffa-4b16-a8b4-a74764ed3916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_af99adf9-52ff-4d0d-9d84-e4810960a3e0" xlink:to="loc_us-gaap_PlanNameDomain_73850d92-1ffa-4b16-a8b4-a74764ed3916" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StockPlanMember_b950db9c-7100-4ec0-be60-bb3bdbbd9fbd" xlink:href="cutr-20211231.xsd#cutr_StockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_73850d92-1ffa-4b16-a8b4-a74764ed3916" xlink:to="loc_cutr_StockPlanMember_b950db9c-7100-4ec0-be60-bb3bdbbd9fbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TwoThousandFourEquityIncentivePlanMember_48daed0f-a2bf-4e2c-b091-055950381d40" xlink:href="cutr-20211231.xsd#cutr_TwoThousandFourEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_73850d92-1ffa-4b16-a8b4-a74764ed3916" xlink:to="loc_cutr_TwoThousandFourEquityIncentivePlanMember_48daed0f-a2bf-4e2c-b091-055950381d40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember_143483c3-3cfb-4953-bb1e-f259aeba47b1" xlink:href="cutr-20211231.xsd#cutr_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_73850d92-1ffa-4b16-a8b4-a74764ed3916" xlink:to="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember_143483c3-3cfb-4953-bb1e-f259aeba47b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember_c80ce9f1-d133-422c-bb00-2f76b261bccc" xlink:href="cutr-20211231.xsd#cutr_TheAmendedAndRestated2019EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_73850d92-1ffa-4b16-a8b4-a74764ed3916" xlink:to="loc_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember_c80ce9f1-d133-422c-bb00-2f76b261bccc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EmployeeStockPurchasePlanMember_8703681a-3ba4-4cd4-95c7-8bb685a8c031" xlink:href="cutr-20211231.xsd#cutr_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_73850d92-1ffa-4b16-a8b4-a74764ed3916" xlink:to="loc_cutr_EmployeeStockPurchasePlanMember_8703681a-3ba4-4cd4-95c7-8bb685a8c031" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4e393d61-5d6c-47c9-92e1-036060f1ae3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:to="loc_us-gaap_AwardTypeAxis_4e393d61-5d6c-47c9-92e1-036060f1ae3d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4e393d61-5d6c-47c9-92e1-036060f1ae3d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4e393d61-5d6c-47c9-92e1-036060f1ae3d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4e393d61-5d6c-47c9-92e1-036060f1ae3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7194472-b0a0-4c3d-add7-04ff0668df01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4e393d61-5d6c-47c9-92e1-036060f1ae3d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7194472-b0a0-4c3d-add7-04ff0668df01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b00ff4a7-744e-4ead-a09f-c5815076307e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7194472-b0a0-4c3d-add7-04ff0668df01" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b00ff4a7-744e-4ead-a09f-c5815076307e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAnnualGrantMember_4a2cfe01-7638-43ec-a7d2-4b94c17a8e6a" xlink:href="cutr-20211231.xsd#cutr_RestrictedStockUnitsAnnualGrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_b00ff4a7-744e-4ead-a09f-c5815076307e" xlink:to="loc_cutr_RestrictedStockUnitsAnnualGrantMember_4a2cfe01-7638-43ec-a7d2-4b94c17a8e6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsNewHireMember_243ad02b-4936-4362-ab2d-19b73fff0aff" xlink:href="cutr-20211231.xsd#cutr_RestrictedStockUnitsNewHireMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_b00ff4a7-744e-4ead-a09f-c5815076307e" xlink:to="loc_cutr_RestrictedStockUnitsNewHireMember_243ad02b-4936-4362-ab2d-19b73fff0aff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_85f1ad77-28e1-45e5-b729-847301ea65a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7194472-b0a0-4c3d-add7-04ff0668df01" xlink:to="loc_us-gaap_PerformanceSharesMember_85f1ad77-28e1-45e5-b729-847301ea65a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_ae6add91-634b-47e1-a1fa-e8fb428d35a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:to="loc_us-gaap_GranteeStatusAxis_ae6add91-634b-47e1-a1fa-e8fb428d35a2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_ae6add91-634b-47e1-a1fa-e8fb428d35a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_ae6add91-634b-47e1-a1fa-e8fb428d35a2" xlink:to="loc_us-gaap_GranteeStatusDomain_ae6add91-634b-47e1-a1fa-e8fb428d35a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_b1901e64-cd37-4eec-b8f4-2aabb00cd487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_ae6add91-634b-47e1-a1fa-e8fb428d35a2" xlink:to="loc_us-gaap_GranteeStatusDomain_b1901e64-cd37-4eec-b8f4-2aabb00cd487" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_c39da69d-dfab-47d8-8be4-b072c36307f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_b1901e64-cd37-4eec-b8f4-2aabb00cd487" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_c39da69d-dfab-47d8-8be4-b072c36307f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_ccc5390a-b978-49e5-93e3-b10b35a2edbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_b1901e64-cd37-4eec-b8f4-2aabb00cd487" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_ccc5390a-b978-49e5-93e3-b10b35a2edbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_09e2d13f-0fe4-4361-97e4-9f065461d40a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:to="loc_us-gaap_VestingAxis_09e2d13f-0fe4-4361-97e4-9f065461d40a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_09e2d13f-0fe4-4361-97e4-9f065461d40a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_09e2d13f-0fe4-4361-97e4-9f065461d40a" xlink:to="loc_us-gaap_VestingDomain_09e2d13f-0fe4-4361-97e4-9f065461d40a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_3939b514-b753-4d01-8d76-8a9754097448" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_09e2d13f-0fe4-4361-97e4-9f065461d40a" xlink:to="loc_us-gaap_VestingDomain_3939b514-b753-4d01-8d76-8a9754097448" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_8b537e18-ef19-46bd-b749-2542b18f920b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_3939b514-b753-4d01-8d76-8a9754097448" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_8b537e18-ef19-46bd-b749-2542b18f920b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_3c09fe02-8705-4229-8419-35d040d605f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_3939b514-b753-4d01-8d76-8a9754097448" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_3c09fe02-8705-4229-8419-35d040d605f6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails" xlink:type="extended" id="i12440d6eba22462ba9c1082145ed940b_StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_67aae299-8e1e-4df1-92a1-e765daf7353b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_67aae299-8e1e-4df1-92a1-e765daf7353b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_a0b87e1a-da06-4b4d-9a07-dfb8228b9fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_a0b87e1a-da06-4b4d-9a07-dfb8228b9fa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_7535b2c5-907d-4966-8123-45472fc73f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_7535b2c5-907d-4966-8123-45472fc73f65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_eeee092c-7e28-42b4-9639-5c754e7504ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_eeee092c-7e28-42b4-9639-5c754e7504ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_1561d2e8-4ed2-4d30-a78e-ee6d4051c72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_1561d2e8-4ed2-4d30-a78e-ee6d4051c72b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_36de897d-9553-46e1-9fa2-69e59268b076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_36de897d-9553-46e1-9fa2-69e59268b076" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed287fcd-8def-41b5-9043-fa78fe62871b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed287fcd-8def-41b5-9043-fa78fe62871b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1ca9bc53-4b3f-4881-8979-84697dab1fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed287fcd-8def-41b5-9043-fa78fe62871b" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1ca9bc53-4b3f-4881-8979-84697dab1fff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1ca9bc53-4b3f-4881-8979-84697dab1fff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1ca9bc53-4b3f-4881-8979-84697dab1fff" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1ca9bc53-4b3f-4881-8979-84697dab1fff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1ca9bc53-4b3f-4881-8979-84697dab1fff" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange1Member_cdf96e94-8f68-4bf2-8cfd-f05f932d2dc6" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange1Member_cdf96e94-8f68-4bf2-8cfd-f05f932d2dc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange2Member_99f975e1-6b9b-4c8d-a71e-cdef1df192f5" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange2Member_99f975e1-6b9b-4c8d-a71e-cdef1df192f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange3Member_f2b81bdd-b94d-45bb-ad64-980d4307b99e" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange3Member_f2b81bdd-b94d-45bb-ad64-980d4307b99e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange4Member_7362ea7b-5283-4ab1-8529-d6649a131421" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange4Member_7362ea7b-5283-4ab1-8529-d6649a131421" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange5Member_55dc8709-f4e0-4844-a696-f55f940d975e" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange5Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange5Member_55dc8709-f4e0-4844-a696-f55f940d975e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange6Member_8fcec1b5-a7af-4a6e-aa0c-5574fa9344e4" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange6Member_8fcec1b5-a7af-4a6e-aa0c-5574fa9344e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange7Member_1768b43c-c1e5-4124-bc01-cd996363e490" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange7Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange7Member_1768b43c-c1e5-4124-bc01-cd996363e490" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange8Member_19178a97-6f6c-4614-83cc-87c95c3bb1ed" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange8Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange8Member_19178a97-6f6c-4614-83cc-87c95c3bb1ed" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange9Member_0028d60e-9b77-4caa-a6f0-c287eb733499" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange9Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange9Member_0028d60e-9b77-4caa-a6f0-c287eb733499" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange10Member_49e1b50d-edd3-4d07-9583-5b8cf1c2cb80" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange10Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange10Member_49e1b50d-edd3-4d07-9583-5b8cf1c2cb80" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails" xlink:type="extended" id="ib9bd26856d0549d497793548d6dd92d3_StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f5d8fc79-0209-4bf9-ae64-7103d9bc8eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f5d8fc79-0209-4bf9-ae64-7103d9bc8eb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8af5f51a-06f2-47f0-8aed-16425527c1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f5d8fc79-0209-4bf9-ae64-7103d9bc8eb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8af5f51a-06f2-47f0-8aed-16425527c1e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_462b0fb7-c100-46d1-8b06-46a2ea71d836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f5d8fc79-0209-4bf9-ae64-7103d9bc8eb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_462b0fb7-c100-46d1-8b06-46a2ea71d836" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8375895d-9db8-47de-817b-473fd25ed660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f5d8fc79-0209-4bf9-ae64-7103d9bc8eb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8375895d-9db8-47de-817b-473fd25ed660" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3b5840a6-d3e1-4de1-93c1-769950448ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f5d8fc79-0209-4bf9-ae64-7103d9bc8eb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3b5840a6-d3e1-4de1-93c1-769950448ca7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_308a9c88-92b3-44b9-860f-9bef975ac79b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9aaa5ebe-5dc3-42c2-8068-7c1996ddf7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9aaa5ebe-5dc3-42c2-8068-7c1996ddf7a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_957fef1e-f0f9-4714-b848-2ac6cb8535e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9aaa5ebe-5dc3-42c2-8068-7c1996ddf7a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_957fef1e-f0f9-4714-b848-2ac6cb8535e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4121f5fe-7bd1-4681-8917-99ac588ad07a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9aaa5ebe-5dc3-42c2-8068-7c1996ddf7a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4121f5fe-7bd1-4681-8917-99ac588ad07a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3c968ec4-c478-4be1-b9a8-4d9252b3345c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9aaa5ebe-5dc3-42c2-8068-7c1996ddf7a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3c968ec4-c478-4be1-b9a8-4d9252b3345c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_3b543431-35f9-4dc8-a226-8a1df524a379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9aaa5ebe-5dc3-42c2-8068-7c1996ddf7a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_3b543431-35f9-4dc8-a226-8a1df524a379" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2d30c45f-c347-44c8-bf67-69ad4df6825b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue_f4880258-9bc8-4606-aad7-1f3c9682d984" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue_f4880258-9bc8-4606-aad7-1f3c9682d984" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_a4aab501-b526-4220-bc3e-0278b098f8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_a4aab501-b526-4220-bc3e-0278b098f8c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_0d1de9ab-778c-4498-8ac0-f6d7949bf5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_0d1de9ab-778c-4498-8ac0-f6d7949bf5f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_d41f4919-aca7-44f1-a550-0c35603b148b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:to="loc_us-gaap_SharePrice_d41f4919-aca7-44f1-a550-0c35603b148b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93820c84-9b6e-4624-96a7-38e8ddd973e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93820c84-9b6e-4624-96a7-38e8ddd973e1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1f260291-6399-4a06-a103-cd7e429210d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93820c84-9b6e-4624-96a7-38e8ddd973e1" xlink:to="loc_us-gaap_AwardTypeAxis_1f260291-6399-4a06-a103-cd7e429210d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f260291-6399-4a06-a103-cd7e429210d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1f260291-6399-4a06-a103-cd7e429210d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1f260291-6399-4a06-a103-cd7e429210d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2abd88d7-6f49-49a9-91fc-9fb328913949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1f260291-6399-4a06-a103-cd7e429210d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2abd88d7-6f49-49a9-91fc-9fb328913949" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4df1ccfb-91f5-435a-92f6-8096522ac1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2abd88d7-6f49-49a9-91fc-9fb328913949" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4df1ccfb-91f5-435a-92f6-8096522ac1a5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails" xlink:type="extended" id="id469bedfbb9343d3a137d214e56212ff_StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7b30d4a-ce08-4059-b458-2297e6598483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3f07c214-d355-470d-93a8-7bdf3b6dce80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7b30d4a-ce08-4059-b458-2297e6598483" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3f07c214-d355-470d-93a8-7bdf3b6dce80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e6c54899-6be8-416b-ace1-d46a65147b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7b30d4a-ce08-4059-b458-2297e6598483" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e6c54899-6be8-416b-ace1-d46a65147b8b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_466858ba-1f86-40bc-a11e-2d9d6fe8ef7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e6c54899-6be8-416b-ace1-d46a65147b8b" xlink:to="loc_us-gaap_AwardTypeAxis_466858ba-1f86-40bc-a11e-2d9d6fe8ef7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_466858ba-1f86-40bc-a11e-2d9d6fe8ef7b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_466858ba-1f86-40bc-a11e-2d9d6fe8ef7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_466858ba-1f86-40bc-a11e-2d9d6fe8ef7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e0a0399-258e-4f93-ad4d-7c9fc4be6f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_466858ba-1f86-40bc-a11e-2d9d6fe8ef7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e0a0399-258e-4f93-ad4d-7c9fc4be6f67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_43dd39d0-877b-4ee9-b652-00d08ba2e37c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e0a0399-258e-4f93-ad4d-7c9fc4be6f67" xlink:to="loc_us-gaap_EmployeeStockOptionMember_43dd39d0-877b-4ee9-b652-00d08ba2e37c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_00ac9f2d-dbda-4dfa-8ab7-1865e6cb696f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e0a0399-258e-4f93-ad4d-7c9fc4be6f67" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_00ac9f2d-dbda-4dfa-8ab7-1865e6cb696f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_d9c0c7fc-4ee8-417a-8d19-7f3593916aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e0a0399-258e-4f93-ad4d-7c9fc4be6f67" xlink:to="loc_us-gaap_PerformanceSharesMember_d9c0c7fc-4ee8-417a-8d19-7f3593916aab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ESPPMember_2d0a60a0-ac97-476f-a120-bf10482d7651" xlink:href="cutr-20211231.xsd#cutr_ESPPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e0a0399-258e-4f93-ad4d-7c9fc4be6f67" xlink:to="loc_cutr_ESPPMember_2d0a60a0-ac97-476f-a120-bf10482d7651" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails" xlink:type="extended" id="i0c0120c8988c47929f4807890107a260_StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5758ea9d-b674-4faa-afd7-f2855411df88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_c987758c-1d95-4743-8580-7152791c24ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5758ea9d-b674-4faa-afd7-f2855411df88" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_c987758c-1d95-4743-8580-7152791c24ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eb178851-4c7a-4db1-9c7a-ac5772160401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5758ea9d-b674-4faa-afd7-f2855411df88" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eb178851-4c7a-4db1-9c7a-ac5772160401" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ecd4b66d-092b-49b4-a915-8982819b78b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eb178851-4c7a-4db1-9c7a-ac5772160401" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ecd4b66d-092b-49b4-a915-8982819b78b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ecd4b66d-092b-49b4-a915-8982819b78b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ecd4b66d-092b-49b4-a915-8982819b78b6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ecd4b66d-092b-49b4-a915-8982819b78b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_01fc78a3-9c5e-44b1-83df-afb3f21c49e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ecd4b66d-092b-49b4-a915-8982819b78b6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_01fc78a3-9c5e-44b1-83df-afb3f21c49e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_1a242f99-fd5d-4d91-a474-326e088dabee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_01fc78a3-9c5e-44b1-83df-afb3f21c49e8" xlink:to="loc_us-gaap_CostOfSalesMember_1a242f99-fd5d-4d91-a474-326e088dabee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_51469c7c-41d1-4c59-94b0-8d9746f6f127" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_01fc78a3-9c5e-44b1-83df-afb3f21c49e8" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_51469c7c-41d1-4c59-94b0-8d9746f6f127" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4d3a23a3-9f07-4364-9782-ae604e8c5704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_01fc78a3-9c5e-44b1-83df-afb3f21c49e8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4d3a23a3-9f07-4364-9782-ae604e8c5704" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_455d898c-ce1c-4f2d-8f78-6c53f0c29c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_01fc78a3-9c5e-44b1-83df-afb3f21c49e8" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_455d898c-ce1c-4f2d-8f78-6c53f0c29c99" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails" xlink:type="extended" id="ie3b9eed446c84ebdad6386d355f5bede_StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_cae5f371-cec5-42f9-9086-1751fbd35590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b368f37c-2259-4712-babe-ff8fc49fb965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cae5f371-cec5-42f9-9086-1751fbd35590" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b368f37c-2259-4712-babe-ff8fc49fb965" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_023a09b3-6385-475c-9481-1ecc0b189d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cae5f371-cec5-42f9-9086-1751fbd35590" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_023a09b3-6385-475c-9481-1ecc0b189d7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_54835035-495c-45e1-973a-ed8dd774831d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cae5f371-cec5-42f9-9086-1751fbd35590" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_54835035-495c-45e1-973a-ed8dd774831d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4d68361c-5099-4cbd-a9dd-695e3460fa6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cae5f371-cec5-42f9-9086-1751fbd35590" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4d68361c-5099-4cbd-a9dd-695e3460fa6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0c0ff973-fd84-48d4-ae13-fdba7ab5996e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cae5f371-cec5-42f9-9086-1751fbd35590" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0c0ff973-fd84-48d4-ae13-fdba7ab5996e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0b686958-022a-4087-97fa-775077eb23b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_cae5f371-cec5-42f9-9086-1751fbd35590" xlink:to="loc_us-gaap_StatementTable_0b686958-022a-4087-97fa-775077eb23b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fb34d36f-6cf3-465a-af03-1aa86106c135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0b686958-022a-4087-97fa-775077eb23b9" xlink:to="loc_us-gaap_AwardTypeAxis_fb34d36f-6cf3-465a-af03-1aa86106c135" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fb34d36f-6cf3-465a-af03-1aa86106c135_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_fb34d36f-6cf3-465a-af03-1aa86106c135" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fb34d36f-6cf3-465a-af03-1aa86106c135_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b43fe0f-e695-41bf-bb3a-512db3f626cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_fb34d36f-6cf3-465a-af03-1aa86106c135" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b43fe0f-e695-41bf-bb3a-512db3f626cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e3123576-bd1d-4527-bc44-f398e384cfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b43fe0f-e695-41bf-bb3a-512db3f626cb" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e3123576-bd1d-4527-bc44-f398e384cfd0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StockPurchasePlanMember_f3ab3ab7-fbfb-40e6-9875-dc6717c32d80" xlink:href="cutr-20211231.xsd#cutr_StockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b43fe0f-e695-41bf-bb3a-512db3f626cb" xlink:to="loc_cutr_StockPurchasePlanMember_f3ab3ab7-fbfb-40e6-9875-dc6717c32d80" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i097469a961de42ca9500e4d673b19746_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_01c23f7c-3e3e-488a-ad83-02b47f5ab8af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_01c23f7c-3e3e-488a-ad83-02b47f5ab8af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_8a49bf75-2118-4b13-bf04-b6fb7c382415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_8a49bf75-2118-4b13-bf04-b6fb7c382415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_dff75c23-538a-49ab-8fca-62d688e3df5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_dff75c23-538a-49ab-8fca-62d688e3df5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_b8b6b6b7-9437-4392-822b-1712e480dfaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:to="loc_us-gaap_OperatingLossCarryforwards_b8b6b6b7-9437-4392-822b-1712e480dfaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OperatingLossCarryforwardsWithoutExpiration_fb3fe860-3f4e-4673-a69f-2f301438210d" xlink:href="cutr-20211231.xsd#cutr_OperatingLossCarryforwardsWithoutExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:to="loc_cutr_OperatingLossCarryforwardsWithoutExpiration_fb3fe860-3f4e-4673-a69f-2f301438210d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_6c549e91-ed61-4b73-a9b9-b50cdaaf6cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_6c549e91-ed61-4b73-a9b9-b50cdaaf6cee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_5d120704-f8f9-4cc0-8a91-d8cf4ff31eb2" xlink:href="cutr-20211231.xsd#cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:to="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_5d120704-f8f9-4cc0-8a91-d8cf4ff31eb2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_fba1e5ab-0f0c-468b-a109-a5c9377fb7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:to="loc_us-gaap_StatementTable_fba1e5ab-0f0c-468b-a109-a5c9377fb7d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_59ba4ebe-99ce-465c-b3d2-10b581aba9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_fba1e5ab-0f0c-468b-a109-a5c9377fb7d3" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_59ba4ebe-99ce-465c-b3d2-10b581aba9c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_59ba4ebe-99ce-465c-b3d2-10b581aba9c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_59ba4ebe-99ce-465c-b3d2-10b581aba9c2" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_59ba4ebe-99ce-465c-b3d2-10b581aba9c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_bbc5fea9-1297-46a1-99b3-b3492241eec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_59ba4ebe-99ce-465c-b3d2-10b581aba9c2" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_bbc5fea9-1297-46a1-99b3-b3492241eec8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_a1a5a63e-2d69-4fc8-8ea2-6e7abe866bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_bbc5fea9-1297-46a1-99b3-b3492241eec8" xlink:to="loc_us-gaap_ForeignCountryMember_a1a5a63e-2d69-4fc8-8ea2-6e7abe866bfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_7c48b4ae-9ed1-42c9-be90-a776c533cdb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_bbc5fea9-1297-46a1-99b3-b3492241eec8" xlink:to="loc_us-gaap_DomesticCountryMember_7c48b4ae-9ed1-42c9-be90-a776c533cdb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f7001bbf-280a-4a19-9647-3e7a53a6467d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_bbc5fea9-1297-46a1-99b3-b3492241eec8" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f7001bbf-280a-4a19-9647-3e7a53a6467d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_a3c06451-c2cd-47f9-aa69-b25792f612de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_fba1e5ab-0f0c-468b-a109-a5c9377fb7d3" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_a3c06451-c2cd-47f9-aa69-b25792f612de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_a3c06451-c2cd-47f9-aa69-b25792f612de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_a3c06451-c2cd-47f9-aa69-b25792f612de" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_a3c06451-c2cd-47f9-aa69-b25792f612de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_30c2c522-12d8-4a34-9c2b-52f0de3cd7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_a3c06451-c2cd-47f9-aa69-b25792f612de" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_30c2c522-12d8-4a34-9c2b-52f0de3cd7b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_44af4895-03dc-496f-a421-5023dedd0b54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_30c2c522-12d8-4a34-9c2b-52f0de3cd7b0" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_44af4895-03dc-496f-a421-5023dedd0b54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_039adf03-b68d-4593-b4b9-13f7e72d1912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_30c2c522-12d8-4a34-9c2b-52f0de3cd7b0" xlink:to="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_039adf03-b68d-4593-b4b9-13f7e72d1912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_0fdb3547-87ce-4607-bff7-820352269150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_fba1e5ab-0f0c-468b-a109-a5c9377fb7d3" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_0fdb3547-87ce-4607-bff7-820352269150" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_0fdb3547-87ce-4607-bff7-820352269150_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_0fdb3547-87ce-4607-bff7-820352269150" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_0fdb3547-87ce-4607-bff7-820352269150_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_59f819fd-fabc-4026-a87c-425e83fe37d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_0fdb3547-87ce-4607-bff7-820352269150" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_59f819fd-fabc-4026-a87c-425e83fe37d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_ba52b9be-2ecb-4fe8-ac35-82c2d2a9afe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_59f819fd-fabc-4026-a87c-425e83fe37d0" xlink:to="loc_us-gaap_ResearchMember_ba52b9be-2ecb-4fe8-ac35-82c2d2a9afe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ae94a1f5-ad63-4653-8fc3-c218cbca9e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_fba1e5ab-0f0c-468b-a109-a5c9377fb7d3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ae94a1f5-ad63-4653-8fc3-c218cbca9e30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ae94a1f5-ad63-4653-8fc3-c218cbca9e30_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ae94a1f5-ad63-4653-8fc3-c218cbca9e30" xlink:to="loc_us-gaap_ClassOfStockDomain_ae94a1f5-ad63-4653-8fc3-c218cbca9e30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_468cee07-195f-4028-9683-aeb8715f9934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ae94a1f5-ad63-4653-8fc3-c218cbca9e30" xlink:to="loc_us-gaap_ClassOfStockDomain_468cee07-195f-4028-9683-aeb8715f9934" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_21c9b7b1-6b95-4319-b680-d87d8a0758b5" xlink:href="cutr-20211231.xsd#cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_468cee07-195f-4028-9683-aeb8715f9934" xlink:to="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_21c9b7b1-6b95-4319-b680-d87d8a0758b5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#NetIncomeLossPerShareNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails" xlink:type="extended" id="icf193f7319884002874de18e6c580882_NetIncomeLossPerShareNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_d51ebd6b-58c5-49d1-93a8-c4a0912ef927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_4329d180-26a3-4acf-8474-a554872023c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_d51ebd6b-58c5-49d1-93a8-c4a0912ef927" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_4329d180-26a3-4acf-8474-a554872023c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2ad56719-0957-4a30-9f3e-d9d1b614b26a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_4329d180-26a3-4acf-8474-a554872023c5" xlink:to="loc_us-gaap_NetIncomeLoss_2ad56719-0957-4a30-9f3e-d9d1b614b26a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8218ab3c-56e7-475c-8acb-1041a3a0f0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_d51ebd6b-58c5-49d1-93a8-c4a0912ef927" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8218ab3c-56e7-475c-8acb-1041a3a0f0b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_97240075-29c6-4069-a4b0-589f2e7c310c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8218ab3c-56e7-475c-8acb-1041a3a0f0b1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_97240075-29c6-4069-a4b0-589f2e7c310c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_c86c834b-00de-46a9-b4a3-8fada00855c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_d51ebd6b-58c5-49d1-93a8-c4a0912ef927" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_c86c834b-00de-46a9-b4a3-8fada00855c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a1d2b13e-09b2-4543-b71d-2b259acf9ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_c86c834b-00de-46a9-b4a3-8fada00855c9" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a1d2b13e-09b2-4543-b71d-2b259acf9ca7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d2780fca-2160-4803-9bac-649fd87445fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_c86c834b-00de-46a9-b4a3-8fada00855c9" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d2780fca-2160-4803-9bac-649fd87445fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_350a459e-d301-471f-9709-4920c128ef83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_d51ebd6b-58c5-49d1-93a8-c4a0912ef927" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_350a459e-d301-471f-9709-4920c128ef83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c0923b57-0a34-4f66-80ab-d2481b305f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_350a459e-d301-471f-9709-4920c128ef83" xlink:to="loc_us-gaap_EarningsPerShareBasic_c0923b57-0a34-4f66-80ab-d2481b305f4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0f696b65-97e0-4c64-92c1-2e2e67b7d682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_350a459e-d301-471f-9709-4920c128ef83" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0f696b65-97e0-4c64-92c1-2e2e67b7d682" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_9e11383d-12a5-40c9-9f3a-c7bc2471e702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_d51ebd6b-58c5-49d1-93a8-c4a0912ef927" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_9e11383d-12a5-40c9-9f3a-c7bc2471e702" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7eb537f6-1448-4932-852e-9456003f4e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_9e11383d-12a5-40c9-9f3a-c7bc2471e702" xlink:to="loc_us-gaap_AwardTypeAxis_7eb537f6-1448-4932-852e-9456003f4e3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7eb537f6-1448-4932-852e-9456003f4e3f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7eb537f6-1448-4932-852e-9456003f4e3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7eb537f6-1448-4932-852e-9456003f4e3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_62dc2517-e0ba-4b18-a745-13c4f0810cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7eb537f6-1448-4932-852e-9456003f4e3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_62dc2517-e0ba-4b18-a745-13c4f0810cfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5dc008d3-fe86-47e5-bca4-bf7b0559fba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_62dc2517-e0ba-4b18-a745-13c4f0810cfa" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5dc008d3-fe86-47e5-bca4-bf7b0559fba7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f38a4855-8389-43a9-a49e-ead7d4879ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_62dc2517-e0ba-4b18-a745-13c4f0810cfa" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f38a4855-8389-43a9-a49e-ead7d4879ca9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_a27fa309-9f75-4b80-b8c1-55f2aafc3f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_62dc2517-e0ba-4b18-a745-13c4f0810cfa" xlink:to="loc_us-gaap_PerformanceSharesMember_a27fa309-9f75-4b80-b8c1-55f2aafc3f07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_4f68f246-ac09-4f43-b40b-136aaf56da14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_62dc2517-e0ba-4b18-a745-13c4f0810cfa" xlink:to="loc_us-gaap_EmployeeStockMember_4f68f246-ac09-4f43-b40b-136aaf56da14" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails" xlink:type="extended" id="i3a7d2b58cbd245ffbce5f1b8c7ce193e_NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5e77a988-5d8c-45cd-a7e1-4665893c8f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b6f196f8-642d-4d42-84a7-5706b4fcb4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5e77a988-5d8c-45cd-a7e1-4665893c8f2e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b6f196f8-642d-4d42-84a7-5706b4fcb4ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_105ea10f-626b-49b6-97d1-04ec8563ac7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5e77a988-5d8c-45cd-a7e1-4665893c8f2e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_105ea10f-626b-49b6-97d1-04ec8563ac7c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_13a0e32a-7a7a-4567-94c6-7e21623fa012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_105ea10f-626b-49b6-97d1-04ec8563ac7c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_13a0e32a-7a7a-4567-94c6-7e21623fa012" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_13a0e32a-7a7a-4567-94c6-7e21623fa012_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_13a0e32a-7a7a-4567-94c6-7e21623fa012" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_13a0e32a-7a7a-4567-94c6-7e21623fa012_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_13a0e32a-7a7a-4567-94c6-7e21623fa012" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CappedCallSecuritiesMember_01788609-4565-47de-972a-f9d341a7c94a" xlink:href="cutr-20211231.xsd#cutr_CappedCallSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:to="loc_cutr_CappedCallSecuritiesMember_01788609-4565-47de-972a-f9d341a7c94a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_47badc69-0426-495a-beb4-2d30d86c93ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_47badc69-0426-495a-beb4-2d30d86c93ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_578527e6-7a81-44c3-b22f-e8c704826c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:to="loc_us-gaap_EmployeeStockOptionMember_578527e6-7a81-44c3-b22f-e8c704826c2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_aef19b28-9e6d-449f-b0da-1ffb0597d702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_aef19b28-9e6d-449f-b0da-1ffb0597d702" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_27073746-4dbb-49ab-8820-41f4b688afb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:to="loc_us-gaap_EmployeeStockMember_27073746-4dbb-49ab-8820-41f4b688afb1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_d433b274-f160-4aec-86f9-138e9b114fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:to="loc_us-gaap_PerformanceSharesMember_d433b274-f160-4aec-86f9-138e9b114fc6" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#NetIncomeLossPerShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails" xlink:type="extended" id="i8caf92558f844ea7939deaf8a43ea048_NetIncomeLossPerShareNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4df9f467-fe16-4dd4-b7b9-c87b46a80770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_24134b50-5447-4064-a535-e32f2554b62b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4df9f467-fe16-4dd4-b7b9-c87b46a80770" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_24134b50-5447-4064-a535-e32f2554b62b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b6f3f2a4-6a55-4897-a6b5-d0d774bbf8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4df9f467-fe16-4dd4-b7b9-c87b46a80770" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b6f3f2a4-6a55-4897-a6b5-d0d774bbf8c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_344d6d1c-0251-4f59-88eb-50a6a105319b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b6f3f2a4-6a55-4897-a6b5-d0d774bbf8c2" xlink:to="loc_us-gaap_DebtInstrumentAxis_344d6d1c-0251-4f59-88eb-50a6a105319b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_344d6d1c-0251-4f59-88eb-50a6a105319b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_344d6d1c-0251-4f59-88eb-50a6a105319b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_344d6d1c-0251-4f59-88eb-50a6a105319b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1f060dac-3aa7-45a7-ac28-4cede8af2962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_344d6d1c-0251-4f59-88eb-50a6a105319b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1f060dac-3aa7-45a7-ac28-4cede8af2962" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_3b1fcdba-1978-4ab9-aad8-c6cf46bdab9d" xlink:href="cutr-20211231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1f060dac-3aa7-45a7-ac28-4cede8af2962" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_3b1fcdba-1978-4ab9-aad8-c6cf46bdab9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_eb380404-2429-4df1-b78c-387aa79f9dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b6f3f2a4-6a55-4897-a6b5-d0d774bbf8c2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_eb380404-2429-4df1-b78c-387aa79f9dbb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_eb380404-2429-4df1-b78c-387aa79f9dbb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_eb380404-2429-4df1-b78c-387aa79f9dbb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_eb380404-2429-4df1-b78c-387aa79f9dbb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_eed32bdc-e143-4189-89a9-1f5bc21870e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_eb380404-2429-4df1-b78c-387aa79f9dbb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_eed32bdc-e143-4189-89a9-1f5bc21870e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_3fbbfedc-7e09-4f30-bc2c-3e123558a22c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eed32bdc-e143-4189-89a9-1f5bc21870e9" xlink:to="loc_us-gaap_ConvertibleDebtMember_3fbbfedc-7e09-4f30-bc2c-3e123558a22c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails" xlink:type="extended" id="i8dafdfb1f774489887b261fb6bdff018_SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_71165396-d664-4b42-95db-3552e760318a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_0c71936a-8a21-4357-babb-fb6f1aad5241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71165396-d664-4b42-95db-3552e760318a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_0c71936a-8a21-4357-babb-fb6f1aad5241" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_503a2c28-2b8c-451d-b2c6-71846618018b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71165396-d664-4b42-95db-3552e760318a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_503a2c28-2b8c-451d-b2c6-71846618018b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c343ba10-4ae8-4138-8376-05d764c9c3a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_503a2c28-2b8c-451d-b2c6-71846618018b" xlink:to="loc_srt_StatementGeographicalAxis_c343ba10-4ae8-4138-8376-05d764c9c3a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c343ba10-4ae8-4138-8376-05d764c9c3a4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c343ba10-4ae8-4138-8376-05d764c9c3a4" xlink:to="loc_srt_SegmentGeographicalDomain_c343ba10-4ae8-4138-8376-05d764c9c3a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7de37ede-e80a-4352-89bc-b42a704af9f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c343ba10-4ae8-4138-8376-05d764c9c3a4" xlink:to="loc_srt_SegmentGeographicalDomain_7de37ede-e80a-4352-89bc-b42a704af9f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_53a44b63-50d1-4d8c-94c9-254c8ff6f38e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7de37ede-e80a-4352-89bc-b42a704af9f0" xlink:to="loc_country_US_53a44b63-50d1-4d8c-94c9-254c8ff6f38e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_008c50fc-36dc-4acf-82ab-75480460213a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7de37ede-e80a-4352-89bc-b42a704af9f0" xlink:to="loc_country_JP_008c50fc-36dc-4acf-82ab-75480460213a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AsiaExcludingJapanMember_467b8c7e-c16d-4713-b54c-33502dae3d12" xlink:href="cutr-20211231.xsd#cutr_AsiaExcludingJapanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7de37ede-e80a-4352-89bc-b42a704af9f0" xlink:to="loc_cutr_AsiaExcludingJapanMember_467b8c7e-c16d-4713-b54c-33502dae3d12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_0ce1fb9e-27ff-40c8-a964-efbe351e8c5c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7de37ede-e80a-4352-89bc-b42a704af9f0" xlink:to="loc_srt_EuropeMember_0ce1fb9e-27ff-40c8-a964-efbe351e8c5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember_47c03028-2530-4e5c-920f-fd5eebaf62c8" xlink:href="cutr-20211231.xsd#cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7de37ede-e80a-4352-89bc-b42a704af9f0" xlink:to="loc_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember_47c03028-2530-4e5c-920f-fd5eebaf62c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_69f5aed6-c20f-4de7-9686-25029903b7e2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_503a2c28-2b8c-451d-b2c6-71846618018b" xlink:to="loc_srt_ProductOrServiceAxis_69f5aed6-c20f-4de7-9686-25029903b7e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_69f5aed6-c20f-4de7-9686-25029903b7e2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_69f5aed6-c20f-4de7-9686-25029903b7e2" xlink:to="loc_srt_ProductsAndServicesDomain_69f5aed6-c20f-4de7-9686-25029903b7e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5c0e09bc-3a91-4164-9caa-49fccffb2a93" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_69f5aed6-c20f-4de7-9686-25029903b7e2" xlink:to="loc_srt_ProductsAndServicesDomain_5c0e09bc-3a91-4164-9caa-49fccffb2a93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_d024b73e-9145-438f-9c0f-3f47b2f66f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5c0e09bc-3a91-4164-9caa-49fccffb2a93" xlink:to="loc_us-gaap_ProductMember_d024b73e-9145-438f-9c0f-3f47b2f66f6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SystemsMember_cf969e90-511f-4066-8987-fdf0ab6be948" xlink:href="cutr-20211231.xsd#cutr_SystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductMember_d024b73e-9145-438f-9c0f-3f47b2f66f6a" xlink:to="loc_cutr_SystemsMember_cf969e90-511f-4066-8987-fdf0ab6be948" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_HandPieceRefillsMember_e8469ed7-4b40-4cd9-8913-927ccba3740c" xlink:href="cutr-20211231.xsd#cutr_HandPieceRefillsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductMember_d024b73e-9145-438f-9c0f-3f47b2f66f6a" xlink:to="loc_cutr_HandPieceRefillsMember_e8469ed7-4b40-4cd9-8913-927ccba3740c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SkincareMember_3317e7ee-917c-4fde-80ab-43bdfa67df04" xlink:href="cutr-20211231.xsd#cutr_SkincareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductMember_d024b73e-9145-438f-9c0f-3f47b2f66f6a" xlink:to="loc_cutr_SkincareMember_3317e7ee-917c-4fde-80ab-43bdfa67df04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_522906d6-027c-4143-b5c3-a2f312c3c597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5c0e09bc-3a91-4164-9caa-49fccffb2a93" xlink:to="loc_us-gaap_ServiceMember_522906d6-027c-4143-b5c3-a2f312c3c597" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended" id="i422cc58aa99744c5b9aca6365afd9fd4_CommitmentsandContingenciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeasesRemainingTerm_3f04f348-beba-4111-9ae8-595066979016" xlink:href="cutr-20211231.xsd#cutr_LesseeLeasesRemainingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_cutr_LesseeLeasesRemainingTerm_3f04f348-beba-4111-9ae8-595066979016" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeaseRenewalTerm_7c5fc107-caf6-4fa5-81b4-93625d6a75af" xlink:href="cutr-20211231.xsd#cutr_LesseeLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_cutr_LesseeLeaseRenewalTerm_7c5fc107-caf6-4fa5-81b4-93625d6a75af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_dc0cb023-9c96-4993-bb45-9ea4a3e0db29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_dc0cb023-9c96-4993-bb45-9ea4a3e0db29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e71ac535-3019-4f78-bf07-b464fe6426a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_us-gaap_OperatingLeaseLiability_e71ac535-3019-4f78-bf07-b464fe6426a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LessorOptionToPurchaseGrantedPeriod_af2bb707-6a20-435e-aee6-2d36c610a68d" xlink:href="cutr-20211231.xsd#cutr_LessorOptionToPurchaseGrantedPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_cutr_LessorOptionToPurchaseGrantedPeriod_af2bb707-6a20-435e-aee6-2d36c610a68d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue_b4972173-291f-4890-8f34-88fe9e0c5b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_us-gaap_SalesTypeLeaseRevenue_b4972173-291f-4890-8f34-88fe9e0c5b6a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease_8975cca4-5282-465f-928f-b05e3c2be884" xlink:href="cutr-20211231.xsd#cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease_8975cca4-5282-465f-928f-b05e3c2be884" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_c5ea8323-8c2d-42fa-b553-46f1b2b6f828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_c5ea8323-8c2d-42fa-b553-46f1b2b6f828" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_fd253b16-fb0d-40a5-bc2c-2aec1a451a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_fd253b16-fb0d-40a5-bc2c-2aec1a451a1c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StockIssuedDuringPeriodSharesLitigationSettlement_ad3108a3-85cb-434d-9b1b-5607bf8d713c" xlink:href="cutr-20211231.xsd#cutr_StockIssuedDuringPeriodSharesLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_cutr_StockIssuedDuringPeriodSharesLitigationSettlement_ad3108a3-85cb-434d-9b1b-5607bf8d713c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_051b72f4-73e3-4f31-a2c5-7f6178324e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_us-gaap_LitigationReserve_051b72f4-73e3-4f31-a2c5-7f6178324e1e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_aaa11002-6965-4ef2-aa1b-e268e5d6d788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_aaa11002-6965-4ef2-aa1b-e268e5d6d788" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9aaa0f55-bc8f-451c-b89d-aa690482b767" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_aaa11002-6965-4ef2-aa1b-e268e5d6d788" xlink:to="loc_srt_RangeAxis_9aaa0f55-bc8f-451c-b89d-aa690482b767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9aaa0f55-bc8f-451c-b89d-aa690482b767_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9aaa0f55-bc8f-451c-b89d-aa690482b767" xlink:to="loc_srt_RangeMember_9aaa0f55-bc8f-451c-b89d-aa690482b767_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7389cee5-3325-421f-b4e2-394fd0f9eaf1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9aaa0f55-bc8f-451c-b89d-aa690482b767" xlink:to="loc_srt_RangeMember_7389cee5-3325-421f-b4e2-394fd0f9eaf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0fddb6d0-642f-4323-84a7-7cee07290d70" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7389cee5-3325-421f-b4e2-394fd0f9eaf1" xlink:to="loc_srt_MinimumMember_0fddb6d0-642f-4323-84a7-7cee07290d70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_590fe737-6761-46a9-9d92-dfd4748ff8f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7389cee5-3325-421f-b4e2-394fd0f9eaf1" xlink:to="loc_srt_MaximumMember_590fe737-6761-46a9-9d92-dfd4748ff8f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c196839f-0519-4e9c-ab4f-3bcf5cf7d433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_aaa11002-6965-4ef2-aa1b-e268e5d6d788" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c196839f-0519-4e9c-ab4f-3bcf5cf7d433" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_c196839f-0519-4e9c-ab4f-3bcf5cf7d433_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c196839f-0519-4e9c-ab4f-3bcf5cf7d433" xlink:to="loc_us-gaap_TypeOfAdoptionMember_c196839f-0519-4e9c-ab4f-3bcf5cf7d433_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_469171d6-f17a-410c-9a51-c7fb3bf339cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c196839f-0519-4e9c-ab4f-3bcf5cf7d433" xlink:to="loc_us-gaap_TypeOfAdoptionMember_469171d6-f17a-410c-9a51-c7fb3bf339cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_35809d46-c941-4756-b76b-6ee19a732f74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_469171d6-f17a-410c-9a51-c7fb3bf339cd" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_35809d46-c941-4756-b76b-6ee19a732f74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_0ff7f369-e2e7-458c-a6ea-9770db6953bc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_aaa11002-6965-4ef2-aa1b-e268e5d6d788" xlink:to="loc_srt_CounterpartyNameAxis_0ff7f369-e2e7-458c-a6ea-9770db6953bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0ff7f369-e2e7-458c-a6ea-9770db6953bc_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_0ff7f369-e2e7-458c-a6ea-9770db6953bc" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0ff7f369-e2e7-458c-a6ea-9770db6953bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d1d4d2-3cda-4c14-bd99-0bbc71a7e09c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_0ff7f369-e2e7-458c-a6ea-9770db6953bc" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d1d4d2-3cda-4c14-bd99-0bbc71a7e09c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_FormerExecutiveVPAndCFOMember_b8f1457c-e8ae-4f05-8ceb-613e4efb2df7" xlink:href="cutr-20211231.xsd#cutr_FormerExecutiveVPAndCFOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d1d4d2-3cda-4c14-bd99-0bbc71a7e09c" xlink:to="loc_cutr_FormerExecutiveVPAndCFOMember_b8f1457c-e8ae-4f05-8ceb-613e4efb2df7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails" xlink:type="extended" id="i2e87c54f295448c9bb2ed507d09e9010_CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9a5b03b5-1a0f-45ed-997e-812fc7f4fd2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0eb43110-13c1-4011-b21e-7069a0ef2f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9a5b03b5-1a0f-45ed-997e-812fc7f4fd2e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0eb43110-13c1-4011-b21e-7069a0ef2f04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_675ec288-45ed-4748-a525-50e3d9a13b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9a5b03b5-1a0f-45ed-997e-812fc7f4fd2e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_675ec288-45ed-4748-a525-50e3d9a13b98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_852c25dd-c2c6-435f-a6f0-0cf2eb0a4c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9a5b03b5-1a0f-45ed-997e-812fc7f4fd2e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_852c25dd-c2c6-435f-a6f0-0cf2eb0a4c7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0084bfab-aea1-4b1d-9401-cd29029d582b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9a5b03b5-1a0f-45ed-997e-812fc7f4fd2e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0084bfab-aea1-4b1d-9401-cd29029d582b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7ee242b2-3993-4a95-b798-5e0a03b97d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9a5b03b5-1a0f-45ed-997e-812fc7f4fd2e" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7ee242b2-3993-4a95-b798-5e0a03b97d7d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7eb0f39d-be1f-40ed-a1f8-c031acea4c6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7ee242b2-3993-4a95-b798-5e0a03b97d7d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7eb0f39d-be1f-40ed-a1f8-c031acea4c6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7eb0f39d-be1f-40ed-a1f8-c031acea4c6b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7eb0f39d-be1f-40ed-a1f8-c031acea4c6b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7eb0f39d-be1f-40ed-a1f8-c031acea4c6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7621eac6-872c-4b53-ac17-49138ddf8d0a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7eb0f39d-be1f-40ed-a1f8-c031acea4c6b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7621eac6-872c-4b53-ac17-49138ddf8d0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9b4d3b87-2d3f-43ce-99a7-433f1389fe23" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7621eac6-872c-4b53-ac17-49138ddf8d0a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9b4d3b87-2d3f-43ce-99a7-433f1389fe23" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/DebtNarrativeDetails" xlink:type="extended" id="i4af18d742f2c4c9f92c71d49a8c1987d_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ee584188-e88c-4ece-9d3d-c6a020091f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ee584188-e88c-4ece-9d3d-c6a020091f05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a20fcdfc-0b60-4339-8736-92b4d5c12241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a20fcdfc-0b60-4339-8736-92b4d5c12241" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_4c68f234-d5a8-4b59-a8a5-f0efb2c68a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_4c68f234-d5a8-4b59-a8a5-f0efb2c68a1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_1e62f887-b8f3-4aaf-9545-1df440f75bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_1e62f887-b8f3-4aaf-9545-1df440f75bf7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e1bc0b94-584e-4ef0-a0c8-401ffa405e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e1bc0b94-584e-4ef0-a0c8-401ffa405e5e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_d00e1e5c-424a-412f-952b-f9fbf2225539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_d00e1e5c-424a-412f-952b-f9fbf2225539" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_94e3ef88-84e3-4097-a3c6-e5b8466ea0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_94e3ef88-84e3-4097-a3c6-e5b8466ea0dd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_bb370ab0-053f-4be9-8324-34503c6cb49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_bb370ab0-053f-4be9-8324-34503c6cb49f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_8dd00b65-45b5-4b97-86f5-8b6908b18bad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_8dd00b65-45b5-4b97-86f5-8b6908b18bad" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_15671d83-40e2-4d0a-8ebe-5f48367aee23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_15671d83-40e2-4d0a-8ebe-5f48367aee23" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_52cf2d58-3cbe-43c9-b348-2a84101e9434" xlink:href="cutr-20211231.xsd#cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_52cf2d58-3cbe-43c9-b348-2a84101e9434" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_23a4061f-f7a4-4f47-98a2-4d1017a3d56c" xlink:href="cutr-20211231.xsd#cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_23a4061f-f7a4-4f47-98a2-4d1017a3d56c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_8862ab24-2b03-4d18-9eb4-2339ca43d359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentFairValue_8862ab24-2b03-4d18-9eb4-2339ca43d359" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCapPrice_2c6ecd95-61af-42b3-94f9-eb3d7835961d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCapPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DerivativeCapPrice_2c6ecd95-61af-42b3-94f9-eb3d7835961d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent_7a6eea35-5196-487d-80a0-b68a9914bb28" xlink:href="cutr-20211231.xsd#cutr_DerivativeCapPricePremiumOverStockPricePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent_7a6eea35-5196-487d-80a0-b68a9914bb28" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_cdf6268f-39cc-490c-a9b0-4c065e66df8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_SharePrice_cdf6268f-39cc-490c-a9b0-4c065e66df8e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_4a89647d-7ca4-44b5-bf0e-3be4d316d5ba" xlink:href="cutr-20211231.xsd#cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_4a89647d-7ca4-44b5-bf0e-3be4d316d5ba" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_74f79d24-0bb2-4959-9d1f-37ef51dbe874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_74f79d24-0bb2-4959-9d1f-37ef51dbe874" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8093144c-3fb9-409a-a223-3301514f9f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8093144c-3fb9-409a-a223-3301514f9f3a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_6f186c0a-7aff-49a5-b0de-c30fa7b827cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_6f186c0a-7aff-49a5-b0de-c30fa7b827cc" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_1bb0c22d-795d-46a3-98d0-17b0405688ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_1bb0c22d-795d-46a3-98d0-17b0405688ea" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_f87f6a05-60cb-4eb8-b2ca-0ab609c68c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_InterestExpenseDebt_f87f6a05-60cb-4eb8-b2ca-0ab609c68c5e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_57f196ea-8ef8-4d10-9c10-be06e9605ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentTerm_57f196ea-8ef8-4d10-9c10-be06e9605ba4" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5451ee9e-875b-4592-82ff-627b72b63a73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5451ee9e-875b-4592-82ff-627b72b63a73" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_2b5b733b-c896-4e9d-9d1c-abee2f32fbf9" xlink:href="cutr-20211231.xsd#cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_2b5b733b-c896-4e9d-9d1c-abee2f32fbf9" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_30d7a31e-46cd-433a-b3d4-af1469b4b4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_30d7a31e-46cd-433a-b3d4-af1469b4b4b7" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_c7c261cf-3a7a-4f70-8604-785a76c15172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_c7c261cf-3a7a-4f70-8604-785a76c15172" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentAnniversaryFeeAmount_a38c1e85-2fb1-494c-840e-e5e9bdae8d12" xlink:href="cutr-20211231.xsd#cutr_DebtInstrumentAnniversaryFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_cutr_DebtInstrumentAnniversaryFeeAmount_a38c1e85-2fb1-494c-840e-e5e9bdae8d12" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtCovenantQuarterlyMinimumRevenue_14e45bc4-ba33-4fba-bcf4-1488185b16b7" xlink:href="cutr-20211231.xsd#cutr_DebtCovenantQuarterlyMinimumRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_cutr_DebtCovenantQuarterlyMinimumRevenue_14e45bc4-ba33-4fba-bcf4-1488185b16b7" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7c662d81-5511-4ea0-9e23-de27c335dd21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7c662d81-5511-4ea0-9e23-de27c335dd21" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_06539175-e5ae-4928-9393-f7240b385a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_06539175-e5ae-4928-9393-f7240b385a2c" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6dbf876f-3019-46fb-bacc-5d1f6c2b9f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:to="loc_us-gaap_DebtInstrumentAxis_6dbf876f-3019-46fb-bacc-5d1f6c2b9f7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6dbf876f-3019-46fb-bacc-5d1f6c2b9f7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6dbf876f-3019-46fb-bacc-5d1f6c2b9f7d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6dbf876f-3019-46fb-bacc-5d1f6c2b9f7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a6835bf0-90f4-422a-ad83-47fc84118d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6dbf876f-3019-46fb-bacc-5d1f6c2b9f7d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a6835bf0-90f4-422a-ad83-47fc84118d92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_e296e124-0b58-4c26-8af8-24631c8a71a1" xlink:href="cutr-20211231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a6835bf0-90f4-422a-ad83-47fc84118d92" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_e296e124-0b58-4c26-8af8-24631c8a71a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_e6d55e46-d5b4-4c7f-8255-65b024589199" xlink:href="cutr-20211231.xsd#cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2026Member_e296e124-0b58-4c26-8af8-24631c8a71a1" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_e6d55e46-d5b4-4c7f-8255-65b024589199" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_321e693a-0e34-4cd1-8a4d-f0eb51b85d26" xlink:href="cutr-20211231.xsd#cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a6835bf0-90f4-422a-ad83-47fc84118d92" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_321e693a-0e34-4cd1-8a4d-f0eb51b85d26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PaycheckProtectionProgramCARESActMember_4906a77b-8767-47d4-9b32-ef85157604b3" xlink:href="cutr-20211231.xsd#cutr_PaycheckProtectionProgramCARESActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a6835bf0-90f4-422a-ad83-47fc84118d92" xlink:to="loc_cutr_PaycheckProtectionProgramCARESActMember_4906a77b-8767-47d4-9b32-ef85157604b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoanAndSecurityAgreementMember_11624cac-67a2-48ea-9f7a-5b78b1cbb7d4" xlink:href="cutr-20211231.xsd#cutr_LoanAndSecurityAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a6835bf0-90f4-422a-ad83-47fc84118d92" xlink:to="loc_cutr_LoanAndSecurityAgreementMember_11624cac-67a2-48ea-9f7a-5b78b1cbb7d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a9bd1b3c-0b0e-4410-a10c-5968a9d7c816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a9bd1b3c-0b0e-4410-a10c-5968a9d7c816" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a9bd1b3c-0b0e-4410-a10c-5968a9d7c816_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a9bd1b3c-0b0e-4410-a10c-5968a9d7c816" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a9bd1b3c-0b0e-4410-a10c-5968a9d7c816_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8eac2610-c163-44c8-8338-593bac7af08c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a9bd1b3c-0b0e-4410-a10c-5968a9d7c816" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8eac2610-c163-44c8-8338-593bac7af08c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_4fb42080-5690-49c4-af5c-16d54fdec499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8eac2610-c163-44c8-8338-593bac7af08c" xlink:to="loc_us-gaap_ConvertibleDebtMember_4fb42080-5690-49c4-af5c-16d54fdec499" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ca57cbce-2d5c-48f5-aec3-6d854f572335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ca57cbce-2d5c-48f5-aec3-6d854f572335" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ca57cbce-2d5c-48f5-aec3-6d854f572335_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ca57cbce-2d5c-48f5-aec3-6d854f572335" xlink:to="loc_us-gaap_ClassOfStockDomain_ca57cbce-2d5c-48f5-aec3-6d854f572335_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_045ff5db-29ea-437d-9ca7-136a788d72d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ca57cbce-2d5c-48f5-aec3-6d854f572335" xlink:to="loc_us-gaap_ClassOfStockDomain_045ff5db-29ea-437d-9ca7-136a788d72d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8c604701-da9b-4c3a-a20a-1031771ea1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_045ff5db-29ea-437d-9ca7-136a788d72d9" xlink:to="loc_us-gaap_CommonStockMember_8c604701-da9b-4c3a-a20a-1031771ea1ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_28a90d1d-b150-42f0-9376-c371bcbc476e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_28a90d1d-b150-42f0-9376-c371bcbc476e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_28a90d1d-b150-42f0-9376-c371bcbc476e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_28a90d1d-b150-42f0-9376-c371bcbc476e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_28a90d1d-b150-42f0-9376-c371bcbc476e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9df4e24a-eac8-48ab-ae28-f391b809bc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_28a90d1d-b150-42f0-9376-c371bcbc476e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9df4e24a-eac8-48ab-ae28-f391b809bc5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_9aa7c8af-1408-4c63-98a5-7955458313a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9df4e24a-eac8-48ab-ae28-f391b809bc5c" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_9aa7c8af-1408-4c63-98a5-7955458313a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b9b7e465-9c7b-46b4-92f7-763a7613b7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:to="loc_us-gaap_CreditFacilityAxis_b9b7e465-9c7b-46b4-92f7-763a7613b7e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b9b7e465-9c7b-46b4-92f7-763a7613b7e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b9b7e465-9c7b-46b4-92f7-763a7613b7e4" xlink:to="loc_us-gaap_CreditFacilityDomain_b9b7e465-9c7b-46b4-92f7-763a7613b7e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_483c7e6b-f838-4213-84cd-0e7b8025eef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b9b7e465-9c7b-46b4-92f7-763a7613b7e4" xlink:to="loc_us-gaap_CreditFacilityDomain_483c7e6b-f838-4213-84cd-0e7b8025eef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_6b28b59c-7a10-4353-98db-0a856bfea457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_483c7e6b-f838-4213-84cd-0e7b8025eef3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_6b28b59c-7a10-4353-98db-0a856bfea457" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_9640aa84-bfe9-4d60-9aaf-f5d74c6de9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_9640aa84-bfe9-4d60-9aaf-f5d74c6de9fd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_9640aa84-bfe9-4d60-9aaf-f5d74c6de9fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_9640aa84-bfe9-4d60-9aaf-f5d74c6de9fd" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_9640aa84-bfe9-4d60-9aaf-f5d74c6de9fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_929e87ad-81cb-4ee2-a4b3-fffc38add964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_9640aa84-bfe9-4d60-9aaf-f5d74c6de9fd" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_929e87ad-81cb-4ee2-a4b3-fffc38add964" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SiliconValleyBankMember_bbe3565e-174d-470b-bba6-cb5688167a30" xlink:href="cutr-20211231.xsd#cutr_SiliconValleyBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_929e87ad-81cb-4ee2-a4b3-fffc38add964" xlink:to="loc_cutr_SiliconValleyBankMember_bbe3565e-174d-470b-bba6-cb5688167a30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ec9d0724-9aae-4a6e-bc26-74651f0437e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:to="loc_us-gaap_VariableRateAxis_ec9d0724-9aae-4a6e-bc26-74651f0437e3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ec9d0724-9aae-4a6e-bc26-74651f0437e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_ec9d0724-9aae-4a6e-bc26-74651f0437e3" xlink:to="loc_us-gaap_VariableRateDomain_ec9d0724-9aae-4a6e-bc26-74651f0437e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_bd8a389f-62e2-493c-9b07-4eff505144a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_ec9d0724-9aae-4a6e-bc26-74651f0437e3" xlink:to="loc_us-gaap_VariableRateDomain_bd8a389f-62e2-493c-9b07-4eff505144a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_e0dc0f8b-b873-4d90-b485-83327b7dc375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_bd8a389f-62e2-493c-9b07-4eff505144a7" xlink:to="loc_us-gaap_PrimeRateMember_e0dc0f8b-b873-4d90-b485-83327b7dc375" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#DebtOutstandingDebtandCarryingValueDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="extended" id="i317b04c2cfb84ae8a39a9132f4134119_DebtOutstandingDebtandCarryingValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2d81442c-e625-4e77-8a58-14974ccee406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_5335f696-2705-4a3d-b23b-cec3dfdb9609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d81442c-e625-4e77-8a58-14974ccee406" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_5335f696-2705-4a3d-b23b-cec3dfdb9609" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_1266b8bb-6c49-40f5-8fcc-052369ec5cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d81442c-e625-4e77-8a58-14974ccee406" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_1266b8bb-6c49-40f5-8fcc-052369ec5cb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_397f2afb-800a-41db-82f2-7198625100bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d81442c-e625-4e77-8a58-14974ccee406" xlink:to="loc_us-gaap_LongTermDebt_397f2afb-800a-41db-82f2-7198625100bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_38f7ee19-4471-4da8-b877-508d09608cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d81442c-e625-4e77-8a58-14974ccee406" xlink:to="loc_us-gaap_DebtInstrumentTable_38f7ee19-4471-4da8-b877-508d09608cb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d958748a-07a9-45d8-9f59-7d569c3a9550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_38f7ee19-4471-4da8-b877-508d09608cb4" xlink:to="loc_us-gaap_DebtInstrumentAxis_d958748a-07a9-45d8-9f59-7d569c3a9550" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d958748a-07a9-45d8-9f59-7d569c3a9550_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d958748a-07a9-45d8-9f59-7d569c3a9550" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d958748a-07a9-45d8-9f59-7d569c3a9550_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8f090d60-6925-4009-92aa-74655b874523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d958748a-07a9-45d8-9f59-7d569c3a9550" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8f090d60-6925-4009-92aa-74655b874523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_b2c794f7-29a9-4d22-b9f1-061a787d2063" xlink:href="cutr-20211231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f090d60-6925-4009-92aa-74655b874523" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_b2c794f7-29a9-4d22-b9f1-061a787d2063" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d821a426-6655-4736-bf67-61e6b31d4cff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_38f7ee19-4471-4da8-b877-508d09608cb4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d821a426-6655-4736-bf67-61e6b31d4cff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d821a426-6655-4736-bf67-61e6b31d4cff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d821a426-6655-4736-bf67-61e6b31d4cff" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d821a426-6655-4736-bf67-61e6b31d4cff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9eef66b8-14d7-43d9-8cdc-d09f08c6470f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d821a426-6655-4736-bf67-61e6b31d4cff" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9eef66b8-14d7-43d9-8cdc-d09f08c6470f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_16392571-8311-4819-a731-9bbfe342e3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9eef66b8-14d7-43d9-8cdc-d09f08c6470f" xlink:to="loc_us-gaap_ConvertibleDebtMember_16392571-8311-4819-a731-9bbfe342e3f7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"/>
  <link:definitionLink xlink:role="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails" xlink:type="extended" id="i85aaa3535a4e4c6aa9aeb5d60ec65f97_ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e5adaf38-62ff-4f5b-8dd8-2a936e71b570" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_08d3396a-37f0-4ffd-b51a-47ef9bd0ab38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e5adaf38-62ff-4f5b-8dd8-2a936e71b570" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_08d3396a-37f0-4ffd-b51a-47ef9bd0ab38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_687067fc-191a-464a-83b5-eb83159b1104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e5adaf38-62ff-4f5b-8dd8-2a936e71b570" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_687067fc-191a-464a-83b5-eb83159b1104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_57dec96e-7932-45a6-8e47-c71a6cddc65b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e5adaf38-62ff-4f5b-8dd8-2a936e71b570" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_57dec96e-7932-45a6-8e47-c71a6cddc65b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_7f9dd567-b85e-4957-87e2-574ffc8958df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1b94f23a-2d43-494e-ba03-0a9ae5be740e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e5adaf38-62ff-4f5b-8dd8-2a936e71b570" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1b94f23a-2d43-494e-ba03-0a9ae5be740e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2a9a2d42-6a0e-40a5-b9b7-c923e51665fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1b94f23a-2d43-494e-ba03-0a9ae5be740e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2a9a2d42-6a0e-40a5-b9b7-c923e51665fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_2a9a2d42-6a0e-40a5-b9b7-c923e51665fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2a9a2d42-6a0e-40a5-b9b7-c923e51665fd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_2a9a2d42-6a0e-40a5-b9b7-c923e51665fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_7971c7ca-cc38-4051-a71f-2503373977b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2a9a2d42-6a0e-40a5-b9b7-c923e51665fd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_7971c7ca-cc38-4051-a71f-2503373977b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_7913c2be-1fe7-4e59-913e-bf9d30351193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_7971c7ca-cc38-4051-a71f-2503373977b8" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_7913c2be-1fe7-4e59-913e-bf9d30351193" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_30ebec97-e3c7-4e96-aedf-0b72d631f991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForLoanAndLeaseLossesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_7971c7ca-cc38-4051-a71f-2503373977b8" xlink:to="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_30ebec97-e3c7-4e96-aedf-0b72d631f991" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>cutr-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1ebe9035-7f15-449f-b887-5ea51f412a9f,g:8ea03665-a689-4990-8029-94d26fa40407-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTextBlock_c727d3d0-b3b7-4ea2-9d30-a4b087927bef_terseLabel_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTextBlock_label_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer Liability [Text Block]</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTextBlock_documentation_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure of contract with customer liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityTextBlock" xlink:href="cutr-20211231.xsd#cutr_ContractWithCustomerLiabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ContractWithCustomerLiabilityTextBlock" xlink:to="lab_cutr_ContractWithCustomerLiabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_4c6be896-d860-48f3-8e6a-786e72303e29_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_a3477c4a-7c31-4b50-9c79-0a40a5e34810_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal statutory income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_d792bf27-c810-4ca2-abef-a40b5bf4041b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Net Income (Loss) per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_b4fb0ad4-74f3-4ce2-ac0b-573796f55a1d_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9016e894-5c31-4d86-a771-623bdaf1d44b_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_45993940-79fe-4663-a409-153339c23d2c_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_732fd75f-f594-4b81-ab11-8eb7fee3efb3_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_8b88341a-52f4-4e80-9d1a-b02a339102b4_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_aa7dab42-4be7-4b45-bfda-56c2fe60b211_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_c8b212ca-06c6-4e9a-bb03-198154c242bc_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_UnderwrittenPublicOfferingMember_b0348038-44ad-4e93-816d-62d3f5102882_terseLabel_en-US" xlink:label="lab_cutr_UnderwrittenPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwritten Public Offering</link:label>
    <link:label id="lab_cutr_UnderwrittenPublicOfferingMember_label_en-US" xlink:label="lab_cutr_UnderwrittenPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwritten Public Offering [Member]</link:label>
    <link:label id="lab_cutr_UnderwrittenPublicOfferingMember_documentation_en-US" xlink:label="lab_cutr_UnderwrittenPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the underwritten public offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_UnderwrittenPublicOfferingMember" xlink:href="cutr-20211231.xsd#cutr_UnderwrittenPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_UnderwrittenPublicOfferingMember" xlink:to="lab_cutr_UnderwrittenPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_36673ce8-5b58-489b-9e3a-aa18079b061c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_61eb2752-0c0f-4c45-9ce3-b35fe97e1a87_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_50f04b1c-845e-4be0-868a-1d2f90dd5f7a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_56374a9e-969d-4ed5-a457-2f717534357a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bonus and payroll-related accruals</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_44490bb4-f07e-478b-918c-cf37d4a71701_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_0ed8a6af-93dc-4024-b4e8-33b7aaf9aaf1_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_71109c31-8cbf-4dd4-9724-3bde8eb8d9cc_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in prior year reserves</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_225286f3-ab28-4f6c-a544-35e500311d56_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Geography</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_abbe1e54-61e6-4256-b357-21c9d1fadfff_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_f935d0a0-0660-4628-b5bb-59b9db4e3bd9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonemployee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonemployee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_2768610d-9aab-4862-959f-cf2b3d2582e7_terseLabel_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued sales tax</link:label>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_label_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Excise Tax Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="lab_us-gaap_SalesAndExciseTaxPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_82d07963-cf00-47b7-8e23-69bcca54315e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b216057b-e688-43d3-a177-59721bc3585e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_8cb4629e-a7f0-4e5d-a08a-28473b96ecd2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_6434edec-9205-4233-be14-ff5c4380900a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_93ba8e18-998f-4032-8d79-1e44fd651907_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_8282c8ba-72dc-4a30-a90a-acaa085b9094_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Deferred Service Contract Revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_b0dc2c43-f282-4995-b0ac-8a2511c0bd51_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f26f3a29-583f-4f85-b4ba-0137b0a53ce7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_e2228a82-e3a6-47c5-b6a4-3ec3a1c3e716_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_1770b25f-651a-4fa3-bfa4-c2d59b835152_terseLabel_en-US" xlink:label="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance Share Units</link:label>
    <link:label id="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_label_en-US" xlink:label="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance Share Units [Member]</link:label>
    <link:label id="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_documentation_en-US" xlink:label="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents restricted stock units and performance share units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:href="cutr-20211231.xsd#cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:to="lab_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_e449450d-244d-46ea-b7ca-1be4dd9f5c99_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3eac63c1-a4ba-4e44-a63e-d4a39837d504_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled_08f147d4-bd35-494e-afa7-10219c8d0a5c_terseLabel_en-US" xlink:label="lab_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share subtraction (in shares)</link:label>
    <link:label id="lab_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled_label_en-US" xlink:label="lab_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Stock Awards Counted For Every Share Granted Or Canceled</link:label>
    <link:label id="lab_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled_documentation_en-US" xlink:label="lab_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of stack awards counted for every share granted or canceled when computed shares available for grant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" xlink:href="cutr-20211231.xsd#cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" xlink:to="lab_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1086e03b-1fb5-434e-a9a3-62671bc11fef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_496f0220-b2b0-407b-ad60-4f219ed280f4_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_6bca5ebf-9a31-4516-914e-3d564c2c85bf_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease_74be4dd9-4426-47b7-9dee-50ecd9f438b3_terseLabel_en-US" xlink:label="lab_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from purchase option</link:label>
    <link:label id="lab_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease_label_en-US" xlink:label="lab_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Exercise Of Purchase Option, Sales-Type Lease</link:label>
    <link:label id="lab_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease_documentation_en-US" xlink:label="lab_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Exercise Of Purchase Option, Sales-Type Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" xlink:href="cutr-20211231.xsd#cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" xlink:to="lab_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dfaaa92b-bf7c-44d6-9a12-f55a8cd4b994_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a32d7a1e-f764-463d-a8ca-1e76cda46be6_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_6a670211-32ec-473a-96b5-84f23a4fdc26_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_3aaadc57-c41a-443f-91f8-93e84c78813b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease income from equipment rentals</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_ee406e75-58e4-4264-b16c-b0ba503490dd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt convertible to common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Number of Equity Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:to="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1472f195-3608-4769-b065-4c3defade7ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_831faf05-3c7e-4c88-807c-a3ce7a74a455_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_82236965-55bd-48ee-a641-3bde5a49a4de_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_6520ba88-ede5-4fa3-96a2-e324a11ea37b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_af952a8d-9f54-43b9-a084-5c1f3b710098_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LesseeLeasesTextBlock_3d08934d-6bff-4c14-9aff-b42e9f763dbb_terseLabel_en-US" xlink:label="lab_cutr_LesseeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_cutr_LesseeLeasesTextBlock_label_en-US" xlink:label="lab_cutr_LesseeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Text Block]</link:label>
    <link:label id="lab_cutr_LesseeLeasesTextBlock_documentation_en-US" xlink:label="lab_cutr_LesseeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for operating and finance leases of lessee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeasesTextBlock" xlink:href="cutr-20211231.xsd#cutr_LesseeLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LesseeLeasesTextBlock" xlink:to="lab_cutr_LesseeLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_852f9f41-6a01-48ed-9a9c-dbf1dcdd4f49_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options cancelled (expired or forfeited) (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_806ea3a2-9b12-4717-96f6-1bbe5527cc92_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options cancelled (expired or forfeited) (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_0f164ed2-ccb2-4671-8630-4b051c005339_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_68e3fca5-5279-40f7-bcaa-6f22eba53385_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price, lower range limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_4dfbb6bc-93f3-4322-980a-5b25a67b69d6_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_038659c8-827e-431d-8bb5-9d7d38d607e8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_e1dd4c1f-7456-42b2-8064-377a1096827f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AdditionalSharesReservedSharesAvailableForGrant_e7abc12c-a97c-4c20-bbc5-1e494e89d61e_terseLabel_en-US" xlink:label="lab_cutr_AdditionalSharesReservedSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares reserved (in shares)</link:label>
    <link:label id="lab_cutr_AdditionalSharesReservedSharesAvailableForGrant_label_en-US" xlink:label="lab_cutr_AdditionalSharesReservedSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares reserved, shares available for grant</link:label>
    <link:label id="lab_cutr_AdditionalSharesReservedSharesAvailableForGrant_documentation_en-US" xlink:label="lab_cutr_AdditionalSharesReservedSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For presentations that combine terminations, the number of shares available for grant under options that were reserved as additional shares by the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AdditionalSharesReservedSharesAvailableForGrant" xlink:href="cutr-20211231.xsd#cutr_AdditionalSharesReservedSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AdditionalSharesReservedSharesAvailableForGrant" xlink:to="lab_cutr_AdditionalSharesReservedSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_7cb04a2a-d652-4283-9f7c-15b20728b147_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_8745ef2c-3a1d-45b6-8467-dfbf9108c2da_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EmployeeStockPurchasePlanMember_6ee5db7e-d72b-4a23-8c00-782c88cf13f8_terseLabel_en-US" xlink:label="lab_cutr_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2004 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_cutr_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_cutr_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2004 Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EmployeeStockPurchasePlanMember" xlink:href="cutr-20211231.xsd#cutr_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EmployeeStockPurchasePlanMember" xlink:to="lab_cutr_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_331777be-0cb3-40d7-8103-671c4f84be6c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_000e6d60-da9e-42e5-b170-02ecf66b1184_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1d0f851b-1f97-4e70-9f17-f4858f1cf4fd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_28d4fe9c-3c86-4d80-ac7f-d3c27b7cb554_negatedLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Revenue recognized from beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_e240e8e5-b3b9-4cc5-9dbf-7295d70359d3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_3e47668c-ac04-460d-bb2c-74b9a23313ba_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_7c7b9076-a73d-4d2c-ab61-e61c6f7c9357_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_a490f5f0-c2f1-4845-841c-4c99844c668b_terseLabel_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent differences</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_label_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent differences</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_documentation_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to permanent differences.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:to="lab_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_40d976e5-5db7-4216-b984-3efbd96128d7_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset after valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_f61756e7-a5cc-4807-9709-77da73ef7e41_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value of awards vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c61052f6-9810-4d3f-b571-d551f5d28390_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_SiliconValleyBankMember_c9b5dd80-85b6-4b45-b331-5a42ae6b237b_terseLabel_en-US" xlink:label="lab_cutr_SiliconValleyBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Silicon Valley Bank</link:label>
    <link:label id="lab_cutr_SiliconValleyBankMember_label_en-US" xlink:label="lab_cutr_SiliconValleyBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Silicon Valley Bank [Member]</link:label>
    <link:label id="lab_cutr_SiliconValleyBankMember_documentation_en-US" xlink:label="lab_cutr_SiliconValleyBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information related to Silicon Valley Bank.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SiliconValleyBankMember" xlink:href="cutr-20211231.xsd#cutr_SiliconValleyBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_SiliconValleyBankMember" xlink:to="lab_cutr_SiliconValleyBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EquipmentAndFurnitureMember_9564aabf-4252-484a-929e-27e83a48bad0_terseLabel_en-US" xlink:label="lab_cutr_EquipmentAndFurnitureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office equipment and furniture</link:label>
    <link:label id="lab_cutr_EquipmentAndFurnitureMember_label_en-US" xlink:label="lab_cutr_EquipmentAndFurnitureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment and Furniture [Member]</link:label>
    <link:label id="lab_cutr_EquipmentAndFurnitureMember_documentation_en-US" xlink:label="lab_cutr_EquipmentAndFurnitureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents office equipment and furniture.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EquipmentAndFurnitureMember" xlink:href="cutr-20211231.xsd#cutr_EquipmentAndFurnitureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EquipmentAndFurnitureMember" xlink:to="lab_cutr_EquipmentAndFurnitureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LesseeLeasesRemainingTerm_d20e6897-fcee-4b48-a924-5b50199d1a7e_terseLabel_en-US" xlink:label="lab_cutr_LesseeLeasesRemainingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease terms of operating leases</link:label>
    <link:label id="lab_cutr_LesseeLeasesRemainingTerm_label_en-US" xlink:label="lab_cutr_LesseeLeasesRemainingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Leases Remaining Term</link:label>
    <link:label id="lab_cutr_LesseeLeasesRemainingTerm_documentation_en-US" xlink:label="lab_cutr_LesseeLeasesRemainingTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The remaining term of operating and finance leases for the lessee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeasesRemainingTerm" xlink:href="cutr-20211231.xsd#cutr_LesseeLeasesRemainingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LesseeLeasesRemainingTerm" xlink:to="lab_cutr_LesseeLeasesRemainingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_fcfba266-b99a-4f77-a2e5-eafb73e473a8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment and finance lease right-of-use asset, before accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_55bb97f7-059e-421c-a116-e48b42c5a589_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of marketable investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock_4c8c26fe-b155-46ea-adfd-d05a90461831_terseLabel_en-US" xlink:label="lab_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Assumptions and Fair Value of Stock Options and ESPP Grants</link:label>
    <link:label id="lab_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock_label_en-US" xlink:label="lab_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Assumptions and Fair Value of Stock Options and ESPP Grants [Table Text Block]</link:label>
    <link:label id="lab_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock_documentation_en-US" xlink:label="lab_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options and employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" xlink:href="cutr-20211231.xsd#cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" xlink:to="lab_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_6d84a7fb-f63e-4905-9d6c-f01abb47927b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_82f8db18-c0f4-4c5f-bbab-9e3ae0a60182_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4f01d884-491f-4ea8-ade5-5c2938bec4dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent_b8a38527-5004-400c-8e08-228d4710fc58_terseLabel_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General business credit</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent_label_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General business credit</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent_documentation_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" xlink:to="lab_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_05aaf18c-17a4-4066-92a0-ef707786a65b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_8d30911e-0f54-4c74-8fa2-02350b7c1537_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_54d96197-eb71-4965-ae03-94752b8de185_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP loan payable, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_fe426995-de16-4898-877c-c4accd33dcb4_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:to="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_46d9e574-321f-4875-af58-6ea30fbc798c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_1e87ca7a-02f5-44fc-aebb-22bba50cad20_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_95a9a911-2e95-4403-b95c-454faa1d94f5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_fef3de69-448d-4e67-99cb-2f765785d5b0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fe1c8af0-d157-4c5b-98ae-35a4b6d4121c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_be988be2-78fe-4384-9042-24ffdf693e2f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_StockIssuedDuringPeriodSharesLitigationSettlement_40b7c9d8-21cc-4f14-b46d-af0826bac113_terseLabel_en-US" xlink:label="lab_cutr_StockIssuedDuringPeriodSharesLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration settlement (in shares)</link:label>
    <link:label id="lab_cutr_StockIssuedDuringPeriodSharesLitigationSettlement_label_en-US" xlink:label="lab_cutr_StockIssuedDuringPeriodSharesLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period Shares Litigation Settlement</link:label>
    <link:label id="lab_cutr_StockIssuedDuringPeriodSharesLitigationSettlement_documentation_en-US" xlink:label="lab_cutr_StockIssuedDuringPeriodSharesLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of shares issued during the period resulting from the judgment or settlement of litigation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StockIssuedDuringPeriodSharesLitigationSettlement" xlink:href="cutr-20211231.xsd#cutr_StockIssuedDuringPeriodSharesLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_StockIssuedDuringPeriodSharesLitigationSettlement" xlink:to="lab_cutr_StockIssuedDuringPeriodSharesLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_ed126156-7f18-4e24-b91e-c996ddc3ea4f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_d29bb009-8fbd-4932-99d2-80ba557b6580_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets acquired under finance lease</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_c0843f47-b6bd-4753-bdd7-c1e891946327_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_TwoThousandFourEquityIncentivePlanMember_d7703627-ff1a-4e20-81f3-c50bf1dd832d_terseLabel_en-US" xlink:label="lab_cutr_TwoThousandFourEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2004 Equity Incentive Plan</link:label>
    <link:label id="lab_cutr_TwoThousandFourEquityIncentivePlanMember_label_en-US" xlink:label="lab_cutr_TwoThousandFourEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Four Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_cutr_TwoThousandFourEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_cutr_TwoThousandFourEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information pertaining to the equity incentive plan adopted by the Board of Directors in 2004.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TwoThousandFourEquityIncentivePlanMember" xlink:href="cutr-20211231.xsd#cutr_TwoThousandFourEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_TwoThousandFourEquityIncentivePlanMember" xlink:to="lab_cutr_TwoThousandFourEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_81bf9202-01b2-448b-8859-8e3af2695e55_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6952aba8-45c6-428a-9159-96a6c99fee3a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_0e7e4155-9793-4bd2-99db-ceb22b2f7b05_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseRevenue_75a0d772-aa96-4214-837c-a7f9db598c9e_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue for sales-type leases</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseRevenue_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseRevenue" xlink:to="lab_us-gaap_SalesTypeLeaseRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_26cb1918-5188-4008-8253-7d6bd5a374c5_terseLabel_en-US" xlink:label="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation And Presentation Of Financial Statements [Line Items]</link:label>
    <link:label id="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_label_en-US" xlink:label="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation And Presentation Of Financial Statements [Line Items]</link:label>
    <link:label id="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_documentation_en-US" xlink:label="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation And Presentation Of Financial Statements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:href="cutr-20211231.xsd#cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_b3633e7b-3500-4dfe-a6e9-ae0f21540161_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1df62605-49a7-441a-be12-29b0bc4eef40_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ef839531-81bf-493c-881f-7ff5e1bba425_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options and employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_b0c25ca0-4a7b-4b8c-8ee2-dae693778995_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_04e6dfd1-c614-417b-aa32-01a98ffda339_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0283d42c-e5c0-4833-b398-485db3ebdad2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_ebff9c3f-84b8-43bb-8b26-e6aa8f4b16bf_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_6f7f9aaf-02b9-4809-9d35-8f94f3bfdd4e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_4a6e7ef1-9ad3-4bb1-923f-810fba531c33_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued, price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_53a652f3-d090-4527-ac17-b94fd49563c7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_46f6c1a4-aceb-45e1-8398-9dc76d1ac1b3_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentAnniversaryFeeAmount_63553983-f191-4b2c-940b-9a83779d940d_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anniversary fee amount</link:label>
    <link:label id="lab_cutr_DebtInstrumentAnniversaryFeeAmount_label_en-US" xlink:label="lab_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Anniversary Fee Amount</link:label>
    <link:label id="lab_cutr_DebtInstrumentAnniversaryFeeAmount_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents anniversary fee amount for debt instrument.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:href="cutr-20211231.xsd#cutr_DebtInstrumentAnniversaryFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:to="lab_cutr_DebtInstrumentAnniversaryFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ESPPMember_064132e9-b163-4ceb-a16a-0d3e863bd2f5_terseLabel_en-US" xlink:label="lab_cutr_ESPPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_cutr_ESPPMember_label_en-US" xlink:label="lab_cutr_ESPPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP [Member]</link:label>
    <link:label id="lab_cutr_ESPPMember_documentation_en-US" xlink:label="lab_cutr_ESPPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information pertaining to the Company's employee stock purchase plan (ESPP).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ESPPMember" xlink:href="cutr-20211231.xsd#cutr_ESPPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ESPPMember" xlink:to="lab_cutr_ESPPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_335852d6-ae9a-4235-89d6-57b2da03745d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a5d303a8-dad3-461f-abe9-c99390b99711_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets and prepaid expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_7b57c0d4-57a4-4f0c-a069-79d4b6834acd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_fe366c2e-421e-434e-92d4-a738dfb61d1c_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseAbstract_739238e6-be98-4292-a682-1ecc26faec5c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other income (expense), net:</link:label>
    <link:label id="lab_us-gaap_InterestExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_InterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseAbstract" xlink:to="lab_us-gaap_InterestExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_016ba031-1cba-461d-b9b7-d429102c300c_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_36e1fabe-65a6-48ea-9ea0-c5432758b449_negatedLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Settlements made during the period</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d155a3bb-89e6-47d1-be30-83573639850e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_2d1dfae6-5e38-4e41-957d-8b4beea602fe_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent_c14344f7-7608-4dcb-a660-17608c8e0740_terseLabel_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Meals and entertainment</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent_label_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Meals and entertainment</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent_documentation_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" xlink:to="lab_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_90c7ccae-fbf2-4086-a594-3da9e78f3e44_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets acquired under operating lease</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange9Member_fc23039b-f357-47fa-86e4-aaeb46cba625_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange9Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 9</link:label>
    <link:label id="lab_cutr_ExercisePriceRange9Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange9Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 9 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange9Member" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange9Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange9Member" xlink:to="lab_cutr_ExercisePriceRange9Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_488f8193-4f6c-43c6-a4ac-73ecbbab5a67_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_aa494254-5cf7-4d8d-8305-5f0c0bfcb964_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_b0bf8b8f-8eed-4ae1-a8f7-37a2dcca7673_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_b4fbcce4-92d1-4cd1-8677-5d952d0c367b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_80588cb4-6ceb-47fb-8e9a-272c0ac0c328_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on capital lease obligation</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_6b31cb8f-f551-43fc-bd12-60255cdd154b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flow</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrimeRateMember_9291e713-2910-4b11-93de-898e0c247f07_terseLabel_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate</link:label>
    <link:label id="lab_us-gaap_PrimeRateMember_label_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrimeRateMember" xlink:to="lab_us-gaap_PrimeRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_430c25ee-81f2-48f5-a9da-b619943291bc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_95498728-f5ff-4320-8a39-de653ffb3d98_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_327df3a3-f0d6-48e4-bdf4-d313743efed4_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_56a92709-5810-43d9-8848-aa1278259750_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share, basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_b7f35345-f85b-44e3-bc7d-986b6c1c0a81_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_54d43ef9-86c7-466c-a70a-bf745422cd2b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a66f2fe1-a64f-429e-bef8-48393c6daa48_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f5f9c449-4f6d-4658-be7b-6d4a8f88b2cd_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_e8a122e6-f364-482b-808c-9707446c5e99_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_27eb7912-5917-4139-aa16-b7c2b79746e5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on convertible notes</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_fab648a2-2d3a-49f9-b23d-da22c6dd4c21_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on convertible notes</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_243b1df0-ec58-4481-8a3c-deca1994939b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ab334f53-4056-4322-ad78-e5a1b5550404_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_e4bfcfbc-3a06-4c26-b1e3-16d741dd2be1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of incremental shares and share equivalents:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_SkincareMember_2102c0d2-4950-4f1f-a649-064dd44340ad_terseLabel_en-US" xlink:label="lab_cutr_SkincareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skincare</link:label>
    <link:label id="lab_cutr_SkincareMember_label_en-US" xlink:label="lab_cutr_SkincareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skincare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SkincareMember" xlink:href="cutr-20211231.xsd#cutr_SkincareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_SkincareMember" xlink:to="lab_cutr_SkincareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1245d8bb-e281-4271-8f8e-97d6fe64649a_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule II - Valuation and Qualifying Accounts</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_2cd2a323-7328-4710-8195-0edaf6fab7c7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_11261d77-3ec5-469c-84b4-a3aea7246d8f_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total capitalized costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNet" xlink:to="lab_us-gaap_CapitalizedContractCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_968b2b83-7b90-4abd-83a0-15dca94f9a6e_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_465381f5-4184-4f65-9b47-a43f2670cc2f_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_16e1c802-c3dc-4889-9ec0-e277fde5e57b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flow</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0028af0a-961a-4a9f-a206-f53c15e653c7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_c5835a61-ffc9-4a46-9591-c587560b9347_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted calculation, grant period (in days)</link:label>
    <link:label id="lab_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_label_en-US" xlink:label="lab_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Award, Period To Determine Grant Amount</link:label>
    <link:label id="lab_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_documentation_en-US" xlink:label="lab_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Award, Period To Determine Grant Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount" xlink:href="cutr-20211231.xsd#cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount" xlink:to="lab_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_eb98ec41-1905-4a77-bab6-c9cebdc30c72_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expenditures</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_abe465aa-d56d-4885-aa86-59fa670bd0d0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue_73a21cce-5841-4bae-9c0e-685d8feffafe_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, aggregate fair value</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, aggregate fair value</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate fair value of equity-based payment equity instruments, excluding stock or unit options, granted during the reporting period as calculated by applying the disclosed option pricing methodology.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LeasesFinancialStatementInformationTableTextBlock_e7cef63f-9918-47ae-b7a7-613770c78389_terseLabel_en-US" xlink:label="lab_cutr_LeasesFinancialStatementInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Financial Statement Information</link:label>
    <link:label id="lab_cutr_LeasesFinancialStatementInformationTableTextBlock_label_en-US" xlink:label="lab_cutr_LeasesFinancialStatementInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Financial Statement Information [Table Text Block]</link:label>
    <link:label id="lab_cutr_LeasesFinancialStatementInformationTableTextBlock_documentation_en-US" xlink:label="lab_cutr_LeasesFinancialStatementInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the financial statement information for leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasesFinancialStatementInformationTableTextBlock" xlink:href="cutr-20211231.xsd#cutr_LeasesFinancialStatementInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LeasesFinancialStatementInformationTableTextBlock" xlink:to="lab_cutr_LeasesFinancialStatementInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_149562e1-307a-4f69-8368-6a04a51061e7_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for credit losses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_a564ce1e-1565-463d-b142-57533f793b88_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_b125ba17-8a07-47a9-a037-2662de362de0_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_11dc29df-681f-41ed-900e-6f6fbbd6fe1e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of capped call</link:label>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_8c56427b-69c1-47c0-98f4-6023e1897126_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of capped call</link:label>
    <link:label id="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Derivative Instrument, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:to="lab_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_fadb2b20-cf1e-4f2a-8a34-5d6ae8d0aaa4_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_a2a3a52f-d738-4953-8dca-cd1ec343899e_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_5a3654c9-b096-4a5e-81cd-1eeab812e3bf_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_614cbad7-bfec-466c-9098-3be4f1834ad5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_fad3b146-15c5-4619-ab3b-6d6bd4d92a99_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_69ba7de2-76b2-4992-8947-42b2f6dcd694_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_ae57ec09-e6ea-40f1-85f9-88a1457749d1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_12704f74-154c-45cb-aec6-bc1a56dcfccb_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Accruals for warranties issued during the period</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_01837ce2-75f2-4af0-ba30-52bd4715c6ca_verboseLabel_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostImpairment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of capitalized cloud computing costs</link:label>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_0857edd8-c43b-4705-935b-d94267e6562c_terseLabel_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized computing impairment loss</link:label>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_label_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Service Contract, Implementation Cost, Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HostingArrangementServiceContractImplementationCostImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment" xlink:to="lab_us-gaap_HostingArrangementServiceContractImplementationCostImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_a0b7f738-994b-4b75-9d5e-202d4a7c4892_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LeasedEquipmentMember_82856cd5-931e-4f68-973d-ba4be56c4d1c_terseLabel_en-US" xlink:label="lab_cutr_LeasedEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment leasing</link:label>
    <link:label id="lab_cutr_LeasedEquipmentMember_label_en-US" xlink:label="lab_cutr_LeasedEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased Equipment [Member]</link:label>
    <link:label id="lab_cutr_LeasedEquipmentMember_documentation_en-US" xlink:label="lab_cutr_LeasedEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasedEquipmentMember" xlink:href="cutr-20211231.xsd#cutr_LeasedEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LeasedEquipmentMember" xlink:to="lab_cutr_LeasedEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LoyaltyMember_c911ee81-dc32-4fa8-872e-6806feb650b1_terseLabel_en-US" xlink:label="lab_cutr_LoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loyalty</link:label>
    <link:label id="lab_cutr_LoyaltyMember_label_en-US" xlink:label="lab_cutr_LoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loyalty [Member]</link:label>
    <link:label id="lab_cutr_LoyaltyMember_documentation_en-US" xlink:label="lab_cutr_LoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information related to loyalty</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoyaltyMember" xlink:href="cutr-20211231.xsd#cutr_LoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LoyaltyMember" xlink:to="lab_cutr_LoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_36ebfc79-5ceb-45b2-b30a-83c01a178783_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_19d2f165-db47-4c86-8c68-8f0158c49214_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_20c5a822-2459-4fab-9154-ff74486c5a10_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_d0456cd2-76ab-4cd2-9132-d5790cee2421_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_a339e064-c941-4596-9a91-52098628987d_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Operations and Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_958d741b-79a1-4d86-a2f6-a967ccaa442e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4e0fbba7-0e1f-4fa2-9c71-dc30935d20ee_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_bc4cd481-c44b-4797-88a1-7766db5361ee_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total change in unrealized gain (loss) on available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2ae519b6-6896-44ae-8108-1c6d4ee42d39_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_a2ee9bdc-de5e-46ad-8249-63d4c0ae487d_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_24aef758-3ab4-4f36-9d02-f10fa003852b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent_bcfce076-b27a-416d-8af0-2a77c75d3f3f_terseLabel_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess compensation</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent_label_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Excess Compensation, Percent</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent_documentation_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Excess Compensation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" xlink:to="lab_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod_91a804c8-4af1-4b5f-b9ea-dc7630deaffb_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards canceled (expired or forfeited) (in shares)</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards canceled (in shares)</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For presentations that combine terminations, the number of available for grant restricted stock shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LeaseRightOfUseAsset_21629e48-3403-4562-a499-b0bc5fc03aae_totalLabel_en-US" xlink:label="lab_cutr_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total leased assets</link:label>
    <link:label id="lab_cutr_LeaseRightOfUseAsset_label_en-US" xlink:label="lab_cutr_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Right of Use Asset</link:label>
    <link:label id="lab_cutr_LeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_cutr_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of lessee's right to use underlying asset under finance and operating lease.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeaseRightOfUseAsset" xlink:href="cutr-20211231.xsd#cutr_LeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LeaseRightOfUseAsset" xlink:to="lab_cutr_LeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c3ab2e12-2010-494f-967f-fa846ac819b8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_d453a93e-8363-4587-8ce4-b0ff1d7ce7e3_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_StandardProductWarrantyTermDirectSales_85a65d9d-1507-42c1-936f-f877ad8c7024_terseLabel_en-US" xlink:label="lab_cutr_StandardProductWarrantyTermDirectSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty term, direct sales</link:label>
    <link:label id="lab_cutr_StandardProductWarrantyTermDirectSales_label_en-US" xlink:label="lab_cutr_StandardProductWarrantyTermDirectSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Term, Direct Sales</link:label>
    <link:label id="lab_cutr_StandardProductWarrantyTermDirectSales_documentation_en-US" xlink:label="lab_cutr_StandardProductWarrantyTermDirectSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Term, Direct Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StandardProductWarrantyTermDirectSales" xlink:href="cutr-20211231.xsd#cutr_StandardProductWarrantyTermDirectSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_StandardProductWarrantyTermDirectSales" xlink:to="lab_cutr_StandardProductWarrantyTermDirectSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_c0c8fd50-cf01-43af-ba04-14daee36d83e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_e6461291-1e4f-4489-afd1-aa6d55615169_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear_83085cf4-5f2d-4dca-a92d-6ee117dd3ade_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of awards officers are required to hold for a minimum of one year</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Officers Percentage To Be Held For A Minimum Of One Year</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Officers Percentage To Be Held For A Minimum Of One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_4e469eb9-d517-4ea9-9395-1a2acefe0dd2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_46f0f060-89af-4229-b772-be47219ce98a_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_8de3cf45-d61c-4576-a4a6-bfb6e2eedd52_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_3ff8550d-5935-41af-8682-dbf8d8c80559_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_7a550cb2-a772-46b3-bdc3-13a31481a857_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4e24caf2-7672-4b9e-8de3-87ed9f7da819_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_b3b75d66-5fd8-435a-a79d-41ed5a215739_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt, conversion ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_a961dfb7-a125-45e1-869e-41f3213ae083_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_ff528530-364a-47f0-9c35-1c69eaed8677_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options cancelled (expired or forfeited) (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_21d6c47a-2546-4467-934f-d5bc093f4727_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_91fa2924-8eab-401a-9e76-a5c8ee8d478b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from PPP loan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromNotesPayable" xlink:to="lab_us-gaap_ProceedsFromNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_7deb6f34-63fc-4ba6-8056-dfeabe057aa7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_3f41a908-9360-4076-97f9-aee85bcdd3aa_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_186774d2-ec1a-4d51-ac82-8188c00d023a_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_bafa65b9-fe03-4482-807e-45ef79db88c4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_c9daa760-f375-414b-a079-960dc49b8eca_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset before valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_9a13c9ee-6e55-4a14-bae1-2df0c4bbca88_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_CappedCallSecuritiesMember_72637fbf-8ff9-4862-8ca5-8b763046de49_terseLabel_en-US" xlink:label="lab_cutr_CappedCallSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped call</link:label>
    <link:label id="lab_cutr_CappedCallSecuritiesMember_label_en-US" xlink:label="lab_cutr_CappedCallSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped Call Securities [Member]</link:label>
    <link:label id="lab_cutr_CappedCallSecuritiesMember_documentation_en-US" xlink:label="lab_cutr_CappedCallSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped Call Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CappedCallSecuritiesMember" xlink:href="cutr-20211231.xsd#cutr_CappedCallSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_CappedCallSecuritiesMember" xlink:to="lab_cutr_CappedCallSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4a3e8743-be33-4db1-be21-7558685cf5dd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_4a571620-b76f-490b-bb2a-806bc1295d6d_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_UnderwriterMember_343822f2-1e40-4fdd-8d65-678b1b21b252_terseLabel_en-US" xlink:label="lab_cutr_UnderwriterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriter</link:label>
    <link:label id="lab_cutr_UnderwriterMember_label_en-US" xlink:label="lab_cutr_UnderwriterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriter [Member]</link:label>
    <link:label id="lab_cutr_UnderwriterMember_documentation_en-US" xlink:label="lab_cutr_UnderwriterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the underwriter.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_UnderwriterMember" xlink:href="cutr-20211231.xsd#cutr_UnderwriterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_UnderwriterMember" xlink:to="lab_cutr_UnderwriterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_06bd0d2f-e8a3-458d-8ca3-a3fac60f6cbd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_0a9c9bbb-2353-4cd6-803d-a3fc8efb4f8a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember_06ec18c7-a195-4723-a27b-779f9485e51a_terseLabel_en-US" xlink:label="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Equity Incentive Plan</link:label>
    <link:label id="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember_label_en-US" xlink:label="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to the 2019 equity incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:href="cutr-20211231.xsd#cutr_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:to="lab_cutr_TwoThousandNineteenEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_c9e11979-3258-4077-8458-93ce989111a4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with public offering, net of issuance&#160;costs of $2,303</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_44f194ec-30eb-400f-bad2-fa9beca4ad2c_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_e9cfd2c5-a1e6-4e21-9695-bb953f8cd75e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_ba26fec4-fa18-4d1b-9177-6b461b04b390_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering period</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Offering Period</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Offering Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_f8bcfbfd-882f-46ac-895a-da78c9b7190f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a4586ad4-bc24-47ca-8f81-c6bb71efec82_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_609456e4-aee1-4c87-881d-557322b70dae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_32d5b522-5b17-4357-84f6-b594294e5c11_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Stock Plans and Stock-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_53d1ee5d-957b-4c01-a762-94dd6f082fdc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_f29897e4-75f4-4702-bb2f-f8929265062c_negatedLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b3b97f93-f8e5-4630-a4b2-514d7f634eac_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_27b09da1-7d35-4228-ab02-9d7da1343f4a_terseLabel_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized computing set-up costs</link:label>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:to="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_9305ef78-31b4-4a89-a5dc-f76cf8da9487_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued, offering cost</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_edc70d2e-af92-4488-a1b2-ae27f33748b2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance costs on the public&#160;offering</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2857f3c1-cfa2-40e1-a50f-2a2de9ce9674_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with public offering, net of issuance costs of $2,303 (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d8c9289f-a0e8-4262-a6db-83a3eac08db3_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_a9eb4eee-16a4-4100-a0c0-38b3add1c1d9_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized costs, amortization period</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:to="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_205633d5-01e4-4d92-a429-139b59e3b26a_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_0b61b948-c2be-471b-8055-896f99d2e04b_terseLabel_en-US" xlink:label="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_label_en-US" xlink:label="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_documentation_en-US" xlink:label="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets, excluding contract acquisition costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:href="cutr-20211231.xsd#cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:to="lab_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_8a2f2e42-1d36-49ce-bcf5-9d7f61ed4d46_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_d115eccf-4aac-4627-b5d8-59db306852d1_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_98c3756d-dab2-4e45-8beb-1bce2bd01912_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_57d0dc6f-a773-4cb4-b99d-2d0a9f6e3c47_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_f3382527-616d-4a3e-8f2c-e2baa916b6cc_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_19b1a0bf-8644-45fe-a4e6-897208cfe5f2_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency transaction gains</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_b61a9a01-8d07-4e15-a5c0-936aa5db9ab0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value: Authorized: 50,000,000 shares; Issued and outstanding: 17,995,344 and 17,679,232 shares at December&#160;31, 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_64269b39-5411-4d43-8aa4-c4350405f9c8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_5a9c1ab2-6921-4f73-b369-9b52a2e759b1_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_52c0a5fc-3979-431f-902e-873648bf0bc3_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest and other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f0f9a501-b068-4ca7-9c68-839a740bea31_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c857e17e-ed71-4aa8-a3de-ca51970c412e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_f561a840-fc62-45a4-99b3-e8551b5f92c5_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_dcb05831-81fd-4c1b-b975-c99e1eed829d_terseLabel_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_label_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Valuation Allowance Percent</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_documentation_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to valuation allowance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:to="lab_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_e0801659-55cb-43be-b9c8-1cfb23854159_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill additions during the year</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_994ded02-d2cb-4217-afa8-5b40caf901a6_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_a5795f75-0364-4148-89c7-cfd25558a865_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSUs</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_94422bd3-d546-4295-ae24-352e8bd901b6_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 11).</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_8251dba2-eb86-4805-867e-cf459bbe239e_terseLabel_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026, Second Conversion Trigger</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_label_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026, Second Conversion Trigger [Member]</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_documentation_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to the second conversion trigger feature of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:href="cutr-20211231.xsd#cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:to="lab_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_PurchaseOfCappedCall_1f0a9ca9-4ee3-4797-963d-850737f0b662_terseLabel_en-US" xlink:label="lab_cutr_PurchaseOfCappedCall" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of capped call</link:label>
    <link:label id="lab_cutr_PurchaseOfCappedCall_label_en-US" xlink:label="lab_cutr_PurchaseOfCappedCall" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of Capped Call</link:label>
    <link:label id="lab_cutr_PurchaseOfCappedCall_documentation_en-US" xlink:label="lab_cutr_PurchaseOfCappedCall" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of Capped Call</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PurchaseOfCappedCall" xlink:href="cutr-20211231.xsd#cutr_PurchaseOfCappedCall"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_PurchaseOfCappedCall" xlink:to="lab_cutr_PurchaseOfCappedCall" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_819f8ea5-dce7-4ac1-9027-94b02a0dcb42_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_c96d3037-013e-49a7-874b-0fdb1bef0706_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_d9761866-6a7a-4b2e-8a11-f6f614608563_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from convertible notes, net of unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_234b85f2-7ba2-47a2-a61a-14bcf8b80c53_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss, current</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_70db96de-8b87-4bbd-9c1f-8923933d9f72_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Life</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Contractual Term [Abstract]</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent_b8977bed-5c1c-478d-be68-abe2bc60e437_terseLabel_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred true-up</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent_label_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred true-up</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent_documentation_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deferred true-up.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" xlink:to="lab_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_11c0de0f-a886-4122-8c31-bcca22b1da5b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of issuance costs of convertible notes</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_9bb1249c-0163-41cd-888d-e8aa57bf2ee6_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of issuance costs of convertible notes</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_0f0975eb-d8a3-48ea-8be7-fb97de90fe7a_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_77951e89-7c1a-48a5-9cbd-05f58b307e2c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_98135f08-2c03-4d89-b412-a049e8aaf75d_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LoanAndSecurityAgreementMember_364d152b-f1f4-48d1-af2d-59f9e2c60946_terseLabel_en-US" xlink:label="lab_cutr_LoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan and Security Agreement</link:label>
    <link:label id="lab_cutr_LoanAndSecurityAgreementMember_label_en-US" xlink:label="lab_cutr_LoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan and Security Agreement [Member]</link:label>
    <link:label id="lab_cutr_LoanAndSecurityAgreementMember_documentation_en-US" xlink:label="lab_cutr_LoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information pertaining to the Loan and Security Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoanAndSecurityAgreementMember" xlink:href="cutr-20211231.xsd#cutr_LoanAndSecurityAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LoanAndSecurityAgreementMember" xlink:to="lab_cutr_LoanAndSecurityAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_eca36c85-0a7e-4eed-b695-94def6ccc0cf_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6f9ec363-02ef-43e2-b0d1-7a607c486ea4_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of share-based payment arrangements (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_0a2bab02-037c-45fb-955f-0f13963bc42e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued warranty</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Warranty Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_777023eb-3265-4aa3-83b6-617ed13ca872_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_980a283a-0515-4642-853e-55642b930dcf_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_ef1d186d-1094-494c-a2ba-cc4f307c1379_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_9ab0c983-191e-4dcf-b9eb-33eda0513a9c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_212056ee-0a7b-4399-b6a8-efef7534798b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_f029b43a-ba8d-488e-82a6-9f6569f71792_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_359a7710-22b7-4a6a-8959-cca4c3068706_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExtendedServiceContractOptionThreeTerm_a799fa31-542c-4e61-90ac-f71bd3e8cc85_terseLabel_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionThreeTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended service contract, option three, term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionThreeTerm_label_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionThreeTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option Three, Term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionThreeTerm_documentation_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionThreeTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option Three, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionThreeTerm" xlink:href="cutr-20211231.xsd#cutr_ExtendedServiceContractOptionThreeTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExtendedServiceContractOptionThreeTerm" xlink:to="lab_cutr_ExtendedServiceContractOptionThreeTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock_37aed90a-41d0-417a-910a-3b51866a6579_terseLabel_en-US" xlink:label="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties</link:label>
    <link:label id="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties, Policy [Policy Text Block]</link:label>
    <link:label id="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for risks and uncertainties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:href="cutr-20211231.xsd#cutr_RisksAndUncertaintiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:to="lab_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_877b40c3-d9dc-4c0c-979f-e032bfeb5064_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets and prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_c81adbe7-db9b-4c76-9c2b-c3fe677f41c7_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_d8871d8c-9d72-4755-b680-a31ca0705a26_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_c6e45a21-0c48-4c4b-9918-7e596dd1e746_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_0a409cc1-eac0-4eaf-a2c9-937fa6cdd21f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_4be8bde2-f6e4-42a5-b1d6-910c4822ee16_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_c700a405-d45e-412e-b275-d136b636c2f0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_bcd76554-efed-4f99-9c3e-69c57643281b_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_79ebccf3-71e2-447a-b2dc-61a5efc280e0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_StandardProductWarrantyTermDistributorSales_e066400d-67d9-4923-8127-a92a7f84705a_terseLabel_en-US" xlink:label="lab_cutr_StandardProductWarrantyTermDistributorSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty term, distributor sales</link:label>
    <link:label id="lab_cutr_StandardProductWarrantyTermDistributorSales_label_en-US" xlink:label="lab_cutr_StandardProductWarrantyTermDistributorSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Term, Distributor Sales</link:label>
    <link:label id="lab_cutr_StandardProductWarrantyTermDistributorSales_documentation_en-US" xlink:label="lab_cutr_StandardProductWarrantyTermDistributorSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Term, Distributor Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StandardProductWarrantyTermDistributorSales" xlink:href="cutr-20211231.xsd#cutr_StandardProductWarrantyTermDistributorSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_StandardProductWarrantyTermDistributorSales" xlink:to="lab_cutr_StandardProductWarrantyTermDistributorSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_10f240cb-3d5b-43f5-9d48-d9eba5024533_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_c3bfb2d8-29e2-4a34-9478-1e8d72e87d65_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_b58652ed-8973-4308-97e1-d987861b1e25_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty Obligations</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_84ce7de1-58b5-4319-92f9-eb805c132b56_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_032d5f6f-8d21-44b8-965f-316795af59c5_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_815f1534-4ed5-413a-a28b-89088bb8ec70_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_727346f5-866d-45ae-9d6a-bdcf25aad124_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_32dcffae-9c60-456d-a9c9-c6b2e3d016c2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information and Revenue by Geography and Products</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_07bb2c80-a0b2-4326-84ac-f9b36c438965_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_45b3b152-2bb4-4c08-b859-60784f673c06_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer 401(k) discretionary contribution</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_085da943-cbcc-4c8c-808c-61c0c67aeac8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_fb602f59-f072-4fe6-9569-135036933afb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_490bde99-6ec9-4dcc-b0e6-3356d86a9775_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_64ce4b2e-8ea7-4c92-aadc-be463d2779ba_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_d99cfab2-9c2e-4021-b0d6-e3c875047a9f_terseLabel_en-US" xlink:label="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capped-call transaction term, consecutive trading days</link:label>
    <link:label id="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_label_en-US" xlink:label="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Capped Call Transaction Term, Consecutive Trading Days</link:label>
    <link:label id="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_documentation_en-US" xlink:label="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Capped Call Transaction Term, Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:href="cutr-20211231.xsd#cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:to="lab_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantiesDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:to="lab_us-gaap_ProductWarrantiesDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6ab7fef0-1d9d-4c74-8be8-c3ade18d37ed_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_89648df0-2870-46ac-82e3-05a9bf8a7f28_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_992eec3e-4872-4c1c-921e-b1de5e6fdc49_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_314735ab-22b3-4845-8a9b-04ff70d7d4d9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_4605846d-ee79-4e3e-949e-975f4264758e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4c7f7785-a8c9-4d18-bb0e-10c02ea057e4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_940a6091-44e0-40c9-826a-3854b1fe8caa_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross_42257968-b7c3-46e8-bd56-28bfbe6e7d4c_negatedLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards granted (in shares)</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refers to the number of shares available for grant reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding as of the balance sheet date, including vested options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReduction_36e26c21-4c8d-443c-9fa9-e75cb8fb77f6_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of PPP loan</link:label>
    <link:label id="lab_us-gaap_NotesReduction_label_en-US" xlink:label="lab_us-gaap_NotesReduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReduction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReduction" xlink:to="lab_us-gaap_NotesReduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_b0ccb03e-2364-4644-859c-419f1988db76_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_95aa454e-d24d-445c-b8a1-b391a9793f96_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in deferred tax assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_c655893a-8877-467f-b923-15b5798a75e2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_a2f12231-1569-4d2e-b044-92943461f08a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Accrual</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_68717624-481e-4032-9ff5-31b97faeafbe_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_b62478d2-a2b2-4a72-bc32-78d62adfe14e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_09f5ae53-7926-4ddb-87a1-4ee8bb8c3cd7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d12adda7-933d-491f-b63b-add2e9f865a0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_ccb622aa-da60-4f8e-8c4f-fb709b412d79_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward_57b00797-ae96-4262-aaff-cd684113a35d_terseLabel_en-US" xlink:label="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:href="cutr-20211231.xsd#cutr_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:to="lab_cutr_ChangeInContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_c6fc166f-b1bc-41c2-a7cf-b493f3c3e098_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_7770667e-39d1-46ca-a410-840fd547475b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_country_JP_3e9f50dc-8780-4784-af9b-c5b190c7d2c4_terseLabel_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan</link:label>
    <link:label id="lab_country_JP_label_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JAPAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_JP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_JP" xlink:to="lab_country_JP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_edd2997d-6b36-4c09-9b56-62d8eb0eb9d9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_7976a836-10a1-484b-aad4-0ed02ed2c718_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_98773f5a-11fc-456b-899e-2bd60f05ecad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4675be7e-4406-4249-a355-52446edf315d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_db1c4e24-49d4-4ff0-9dd4-3e6a0fd6aab1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_b13872b1-84b1-45dd-a2c9-013e4c1afb6d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_1f0ad160-8779-4b31-831d-a68c2e0a8747_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_8a233cde-eda3-4a1f-9ea2-75bef055ab77_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_e92673d8-5c5e-4b5b-9603-df0d19e455b3_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred_feaf32e8-e346-4dc5-9a6d-5de097e8ca67_negatedLabel_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Revenue recognized from current period sales</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred_label_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Decrease From Revenue Deferred</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred_documentation_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of decrease in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from revenue deferred.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" xlink:href="cutr-20211231.xsd#cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" xlink:to="lab_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_dc474d08-a4e5-463d-a299-2b17e482c1ba_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_e1c06305-fa0c-427c-abec-b6a05468476d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_a4714f70-61c7-4a26-acef-61cbb2edd730_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5c96323b-4e80-49ee-8052-be997cbf6e1a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ffd6f433-614d-47a5-b29e-2ef4477a1f5c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization_a02a0f24-8c5c-4dee-b2d8-c1bcf37f0bfd_terseLabel_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized computing accumulated amortization</link:label>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization" xlink:to="lab_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_7af7d075-b9c3-4381-a389-58f89c239e88_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_deee6e67-4fef-4874-b8f5-e3caf33ddd1e_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of PPP loan</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_dbc0d8bb-3589-4793-84ed-2ced48fffb3c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of PPP loan</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_5452246f-6801-464b-b593-5f17acbe842b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_6722a526-2dd8-4e5a-9e03-11e1a9624295_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accruals and reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_47eb2d18-8ca5-4767-a9a3-435197db5a3f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_5236909f-c990-493a-a53d-1920f99d7355_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP loan payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LessorOptionToPurchaseGrantedPeriod_ad3556fa-6cca-4666-8efa-8aa8ed31d5ab_terseLabel_en-US" xlink:label="lab_cutr_LessorOptionToPurchaseGrantedPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option granted to purchase leased system, period</link:label>
    <link:label id="lab_cutr_LessorOptionToPurchaseGrantedPeriod_label_en-US" xlink:label="lab_cutr_LessorOptionToPurchaseGrantedPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Option To Purchase Granted, Period</link:label>
    <link:label id="lab_cutr_LessorOptionToPurchaseGrantedPeriod_documentation_en-US" xlink:label="lab_cutr_LessorOptionToPurchaseGrantedPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Option To Purchase Granted, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LessorOptionToPurchaseGrantedPeriod" xlink:href="cutr-20211231.xsd#cutr_LessorOptionToPurchaseGrantedPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LessorOptionToPurchaseGrantedPeriod" xlink:to="lab_cutr_LessorOptionToPurchaseGrantedPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_NumberOfMajorSuppliers_efe77448-529b-4d93-89ba-2500a9c6de55_terseLabel_en-US" xlink:label="lab_cutr_NumberOfMajorSuppliers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of major suppliers</link:label>
    <link:label id="lab_cutr_NumberOfMajorSuppliers_label_en-US" xlink:label="lab_cutr_NumberOfMajorSuppliers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Major Suppliers</link:label>
    <link:label id="lab_cutr_NumberOfMajorSuppliers_documentation_en-US" xlink:label="lab_cutr_NumberOfMajorSuppliers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Major Suppliers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NumberOfMajorSuppliers" xlink:href="cutr-20211231.xsd#cutr_NumberOfMajorSuppliers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_NumberOfMajorSuppliers" xlink:to="lab_cutr_NumberOfMajorSuppliers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_932f56e8-b061-438e-9cfb-f7e48b0fcb2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_d97d32b7-d7bf-4938-90ec-4b10a6cd2db3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_fbb5c362-80ea-48f9-94a8-73d5a0cf5bb4_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk and Other Risks and Uncertainties</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_ddc426cd-8af5-4926-b6fb-ea2915878481_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_2f6b266e-8e14-4264-a6d9-b4091b11e1ca_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_a5466579-d690-43b6-9fc3-03100a58ba9a_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ca8e8385-b80e-4c5c-8d7c-af7e0200364f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities , non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_e02e0a2b-f513-410c-a3d9-1f1690812e67_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1997d974-6339-40b6-8ff0-ad2c85278990_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_4d7b4d34-0b58-4c14-853f-9753ee77b1b9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_38a47e36-bfb7-4788-a56f-b1bcbb39d68f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_e9f35529-3d0a-4c47-994e-a184eaf551b2_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7b3257fc-93cc-46b4-a34e-6d31d38c44e8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_StockPurchasePlanMember_61f7ec30-9d9d-4866-9a0d-958195891264_terseLabel_en-US" xlink:label="lab_cutr_StockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Purchase Plan</link:label>
    <link:label id="lab_cutr_StockPurchasePlanMember_label_en-US" xlink:label="lab_cutr_StockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StockPurchasePlanMember" xlink:href="cutr-20211231.xsd#cutr_StockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_StockPurchasePlanMember" xlink:to="lab_cutr_StockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bd601e67-86d6-4a7d-b09c-ae0b118ad408_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts_c09f81eb-ec48-4847-b8a0-6b58a27f6105_negatedLabel_en-US" xlink:label="lab_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred contract acquisition costs</link:label>
    <link:label id="lab_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts_label_en-US" xlink:label="lab_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Deferred Contract Acquisition Costs</link:label>
    <link:label id="lab_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts_documentation_en-US" xlink:label="lab_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of deferred tax liability attributable to taxable temporary differences from deferred contract acquisition costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" xlink:href="cutr-20211231.xsd#cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" xlink:to="lab_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_2bc83bc3-e21d-4772-83b6-f77038391ed5_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of capitalized contract costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortization" xlink:to="lab_us-gaap_CapitalizedContractCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_b8e9f910-4be5-422e-933d-319d94d38de2_verboseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_41a30b64-7db8-43f2-a228-b846b177d060_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_e1dc6636-ca4c-44ec-a03c-5650a8dea7c7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Cloud Computing Set-up Cost</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, Development, and Computer Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_437873c7-cc5f-4a6d-910d-803224bb230a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_0021419a-26e5-467a-a32f-7e207cc59c4f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_54767f68-044b-4dc2-8403-eece1f3e322a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for employee purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_c459396a-f7ea-4c2e-a90f-2ef003878708_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_6817c0ef-70fe-41f2-b010-bd3d0ea7b209_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_2293a317-6eb1-46a4-af1d-36ac91b50730_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCapPrice_f85688b1-c7df-42d8-9304-273b43c29b86_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCapPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cap price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_DerivativeCapPrice_label_en-US" xlink:label="lab_us-gaap_DerivativeCapPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cap Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCapPrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCapPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCapPrice" xlink:to="lab_us-gaap_DerivativeCapPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExtendedServiceContractOptionOneTerm_44cef66d-4123-4f66-a380-d3344a70aeca_terseLabel_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionOneTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended service contract, option one, term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionOneTerm_label_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionOneTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option One, Term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionOneTerm_documentation_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionOneTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option One, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionOneTerm" xlink:href="cutr-20211231.xsd#cutr_ExtendedServiceContractOptionOneTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExtendedServiceContractOptionOneTerm" xlink:to="lab_cutr_ExtendedServiceContractOptionOneTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1850bf39-17fb-4935-a632-81cd9218d255_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_ba5bbc65-9f09-4c3e-a67d-b3069dc62e27_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_e208fe18-db77-4a61-adb0-0ef1cc73ef51_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_d82f1e5a-a58d-4bfb-a80f-b6db9b58811f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_adbfbe53-37c0-4799-9557-cfd63d5985eb_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which entity operates</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_3b9f9e02-d6b5-4f41-8bca-59d85bb374f2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_63cd6e96-75f4-4c5d-a335-25aceb9eeb69_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_CapitalStockSharesAuthorized_fcee5091-9a65-4c3b-a100-347e8819adf1_terseLabel_en-US" xlink:label="lab_cutr_CapitalStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized capital (in shares)</link:label>
    <link:label id="lab_cutr_CapitalStockSharesAuthorized_label_en-US" xlink:label="lab_cutr_CapitalStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock Shares Authorized</link:label>
    <link:label id="lab_cutr_CapitalStockSharesAuthorized_documentation_en-US" xlink:label="lab_cutr_CapitalStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maximum number of capital shares permitted to be issued by an entity's charter and bylaws.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CapitalStockSharesAuthorized" xlink:href="cutr-20211231.xsd#cutr_CapitalStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_CapitalStockSharesAuthorized" xlink:to="lab_cutr_CapitalStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_f0e72705-3429-49a4-b722-735c739f484b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AuditInformationAbstract_label_en-US" xlink:label="lab_cutr_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_cutr_AuditInformationAbstract_documentation_en-US" xlink:label="lab_cutr_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AuditInformationAbstract" xlink:href="cutr-20211231.xsd#cutr_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AuditInformationAbstract" xlink:to="lab_cutr_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_214ea53e-3c5e-4dd4-8028-bcb1cba4c96d_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3ea8c642-29f4-4e44-aea3-6e04045a0c3f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_ba77ef5c-6623-46ff-9c45-1cac498380dd_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c49abb3c-2b54-40ee-9c78-6c6ff9e6b308_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_13e884b3-7d27-46a6-87df-cc31b631e354_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9ae27089-e60a-4adc-a537-aa2caf2ea02d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_06928fd9-ee10-431f-a4e1-3878fcdd0d34_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Ownership Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e0955835-66c0-42b0-a7ee-484198ee4c53_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $899 and $1,598, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_21cbd46b-06cc-4fb4-ae4d-4737dbb37db2_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_3239c1b8-5a37-4cdd-aa72-56e86fd5cdd2_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan proceeds</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_55816fb2-558a-45dd-bacf-c8c2474d11f5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange5Member_c2be68fe-c81c-4b9a-95e1-c2de00fcd711_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange5Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 5</link:label>
    <link:label id="lab_cutr_ExercisePriceRange5Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange5Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 5 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange5Member" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange5Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange5Member" xlink:to="lab_cutr_ExercisePriceRange5Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_68946124-869b-4773-8c69-e39b921373d1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DemonstrationUnitsAmortizationPeriod_bb1d18ea-5fa7-499f-9159-78c0167848a1_terseLabel_en-US" xlink:label="lab_cutr_DemonstrationUnitsAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated economic life of demonstration units</link:label>
    <link:label id="lab_cutr_DemonstrationUnitsAmortizationPeriod_label_en-US" xlink:label="lab_cutr_DemonstrationUnitsAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demonstration Units, Amortization Period</link:label>
    <link:label id="lab_cutr_DemonstrationUnitsAmortizationPeriod_documentation_en-US" xlink:label="lab_cutr_DemonstrationUnitsAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demonstration Units, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DemonstrationUnitsAmortizationPeriod" xlink:href="cutr-20211231.xsd#cutr_DemonstrationUnitsAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DemonstrationUnitsAmortizationPeriod" xlink:to="lab_cutr_DemonstrationUnitsAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_69f5f7cf-da99-4808-8f9c-0ba7047226e9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3b4dbedf-a7af-490d-978f-b5411c3043d5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_200681dd-b947-46c4-81ab-cf0848fe8336_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_2035a1a3-9db1-4e66-920d-667bf65865f6_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_2f163fe3-3b0f-4713-9050-9eb22be6f04a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_e9411dbb-5e85-4329-89da-dbbbfa74d558_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bfc2d258-9ddc-4c93-9154-9f6c9fcaf2f2_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_a0b227a7-83ff-49c5-ab3e-a99d46ea3412_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_2918b40a-50af-4d23-a701-b24238d89c02_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_2fc4bb94-df99-4ff4-9584-b7826f14190f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_02328693-927a-4d7f-a5a9-1c931005dca2_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited(in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_759257f0-1446-47d3-8c24-54f8ce86fb56_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_e1562121-cea2-4704-9809-c77fc4d6ba11_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_31238a2a-9ee5-47d7-a347-b09745fbc94c_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_9887006e-fb95-4bee-9275-9f80198a55c3_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c29de886-0d90-471c-a7ea-3b6e33204929_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_5db52ecb-b444-4bab-be37-b92d2b2b58b2_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_fb90310c-985d-4f06-8c72-daa0c3f4bf66_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_72ec6e1c-8e75-42b6-afa8-609e4aaac117_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_08caef2d-8368-4125-a0ca-56179aa1d22d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_7691163d-0766-4135-a7e2-0470c2f849fa_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental repurchase amount</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_label_en-US" xlink:label="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Incremental Repurchase Amount</link:label>
    <link:label id="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Incremental Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:href="cutr-20211231.xsd#cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:to="lab_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues_0425a8a3-43b3-4d21-b0e9-137ee42a1575_terseLabel_en-US" xlink:label="lab_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of total revenues</link:label>
    <link:label id="lab_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues_label_en-US" xlink:label="lab_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Including Assessed Tax Percent Of Total Revenues</link:label>
    <link:label id="lab_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues_documentation_en-US" xlink:label="lab_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount, expressed as a percent, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" xlink:href="cutr-20211231.xsd#cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" xlink:to="lab_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_e3a63be6-9871-4a05-8e07-e96d7bd360f6_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_73cca655-7f0e-4b33-99b8-a30c25e98569_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_dbd467e3-7f38-4df8-a042-84f21dcc4530_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_8fa4af04-2128-4100-a91b-4bb2dff9d4f4_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualifying accounts receivable</link:label>
    <link:label id="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_label_en-US" xlink:label="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable</link:label>
    <link:label id="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents percentage of qualifying accounts receivable for debt instrument.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:href="cutr-20211231.xsd#cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:to="lab_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_c92dc96b-c15f-4415-8d55-ce650eca5935_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_79a5647c-be4b-49ef-8968-d82d05d92a21_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_955c46fb-680b-42e9-a902-e6c3da710d77_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:to="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_FormerExecutiveVPAndCFOMember_c8a94b07-4f9c-4da5-a92c-61a8d5e8837b_terseLabel_en-US" xlink:label="lab_cutr_FormerExecutiveVPAndCFOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Executive VP and CFO</link:label>
    <link:label id="lab_cutr_FormerExecutiveVPAndCFOMember_label_en-US" xlink:label="lab_cutr_FormerExecutiveVPAndCFOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Executive VP and CFO [Member]</link:label>
    <link:label id="lab_cutr_FormerExecutiveVPAndCFOMember_documentation_en-US" xlink:label="lab_cutr_FormerExecutiveVPAndCFOMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the former Executive Vice President and CFO Sandra A. Gardiner.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_FormerExecutiveVPAndCFOMember" xlink:href="cutr-20211231.xsd#cutr_FormerExecutiveVPAndCFOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_FormerExecutiveVPAndCFOMember" xlink:to="lab_cutr_FormerExecutiveVPAndCFOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_207cee22-66a4-4a2f-a2a1-b0fb39f1aeea_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_57cb103d-b04a-4d6d-a3c4-1b73f5a44060_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_f0001dd3-8658-4da5-bd72-9c068bf334f0_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_2aa53bea-784a-4f17-9e0a-4bd3f3cc9af4_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_fd5d90ee-d6f9-415f-a99b-792acb6ad326_terseLabel_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026, First Conversion Trigger</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_label_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026, First Conversion Trigger [Member]</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_documentation_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to the first conversion trigger of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:href="cutr-20211231.xsd#cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:to="lab_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_SystemsMember_a24a9fb7-1607-4fd9-bdfc-8c5c6e0cd0a8_terseLabel_en-US" xlink:label="lab_cutr_SystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Systems</link:label>
    <link:label id="lab_cutr_SystemsMember_label_en-US" xlink:label="lab_cutr_SystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Systems [Member]</link:label>
    <link:label id="lab_cutr_SystemsMember_documentation_en-US" xlink:label="lab_cutr_SystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents systems.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SystemsMember" xlink:href="cutr-20211231.xsd#cutr_SystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_SystemsMember" xlink:to="lab_cutr_SystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1a8c53ec-51cb-4c46-8ec0-83818bfe29ff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average estimated fair value at grant date (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_c9ee73f0-4915-4e82-9d45-0bd783f39bd0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_ddb39172-6eb1-4f71-acf9-5c63d1e83193_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_fcd6ff77-7a9b-4254-b33d-15781c13666d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_7c5d6200-af19-4869-9095-9835dafa205c_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Intrinsic Value [Abstract]</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_44650553-87bf-4beb-bac0-0973a7afb711_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, net of unamortized debt issuance costs of $4,007</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_cf44704c-a1d9-4f4f-bb44-a86773a137e0_terseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_65f7e9f2-cae2-485a-b144-35866759059d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_085dbafa-8abd-4120-bba4-3405262abc0d_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted_17749138-3b1e-484a-b331-50d858beb473_negatedLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Options Granted</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For presentations that combine terminations, the number of shares available for grant under options that were granted during the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_6ec39128-c2d6-48d0-9097-29935a11fe4a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_e0b1d83a-0ec8-403a-a85e-23b72030a2dd_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_e00c8c15-955d-4d05-9afb-5d24020daf22_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_96516da8-ce91-4a58-b352-5a39a1f4f704_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fd011010-e749-4a9f-bf01-149c87270b16_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_9835ab2e-9923-4c29-ad7c-0ae695d9ab72_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue balance, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue_a87c8982-2c8e-4d7a-a5e1-6bd8ccca4733_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation By Share Based Payment Fully Vested Stock Awards Grant Date Fair Value</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refers to Share based compensation by share based payment fully vested stock awards grant date fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" xlink:to="lab_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_ff8de690-ba4f-4e51-944b-bfe5b3906a55_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_87cd66b0-6385-48f2-a78f-8c6d6b4cb29d_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_0db1f801-d105-4f01-8dd3-3ca7eda39c86_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_92c94618-82d7-4435-bbc6-c2151891a008_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_b0db1b70-b53f-4a92-88cb-5399955652dd_terseLabel_en-US" xlink:label="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required outstanding amount not subject to redemption</link:label>
    <link:label id="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_label_en-US" xlink:label="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible Required, Outstanding Amount Not Subject To Redemption</link:label>
    <link:label id="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_documentation_en-US" xlink:label="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of required outstanding amount not subject to redemption of a convertible debt instrument.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:href="cutr-20211231.xsd#cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:to="lab_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_8449e842-70b4-4abd-96d2-d56036a8ffce_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1cacdb97-a0b3-4fe9-8dfe-b45db25a3fe3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfAcquisitionCosts_63d87437-479a-4028-b532-542f9e2f7601_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of contract acquisition costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfAcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Acquisition Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfAcquisitionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfAcquisitionCosts" xlink:to="lab_us-gaap_AmortizationOfAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember_71110f5d-f3fd-455d-a94a-96b8ae62bd65_terseLabel_en-US" xlink:label="lab_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Amended and Restated 2019 Equity Incentive Plan</link:label>
    <link:label id="lab_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember_label_en-US" xlink:label="lab_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Amended and Restated 2019 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related to the Amended and Restated 2019 Equity Incentive Plan (the "Restarted Plan").</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember" xlink:href="cutr-20211231.xsd#cutr_TheAmendedAndRestated2019EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember" xlink:to="lab_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_142b5a13-99a0-40bc-8132-2a8f97340ee8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExtendedServiceContractOptionTwoTerm_b284154a-9d18-488c-829a-cdc2f4cc3095_terseLabel_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionTwoTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended service contract, option two, term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionTwoTerm_label_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionTwoTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option Two, Term</link:label>
    <link:label id="lab_cutr_ExtendedServiceContractOptionTwoTerm_documentation_en-US" xlink:label="lab_cutr_ExtendedServiceContractOptionTwoTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Service Contract, Option Two, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionTwoTerm" xlink:href="cutr-20211231.xsd#cutr_ExtendedServiceContractOptionTwoTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExtendedServiceContractOptionTwoTerm" xlink:to="lab_cutr_ExtendedServiceContractOptionTwoTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_8023258a-aa15-48fa-ba28-048e08df7968_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_e446a1c7-0eda-4c98-8791-789dadd10a61_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of stock, percent of market value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fa30ae92-290a-482a-9888-cafebc5b8a71_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_1b3ea30a-d3fd-4761-ad24-fa646b21fcae_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9fe7bdb1-8b1b-46f2-977e-d8453cc113fd_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_378a9fea-4531-470c-93c0-5e1d2ff6ca76_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_9ab02540-82e8-4fd9-947b-5871025aa533_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_e352862d-65c8-49ec-807f-3004f89af3f1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_636c3f50-4db3-4172-b27b-84689834466c_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AsiaExcludingJapanMember_ba6c8aa7-eddf-459e-94b8-9b9c15cc27aa_terseLabel_en-US" xlink:label="lab_cutr_AsiaExcludingJapanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia, excluding Japan</link:label>
    <link:label id="lab_cutr_AsiaExcludingJapanMember_label_en-US" xlink:label="lab_cutr_AsiaExcludingJapanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia, Excluding Japan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AsiaExcludingJapanMember" xlink:href="cutr-20211231.xsd#cutr_AsiaExcludingJapanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AsiaExcludingJapanMember" xlink:to="lab_cutr_AsiaExcludingJapanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8b0a0067-4b38-45b9-afa5-badc9b1f3216_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cloud computing arrangement expected contract renewals</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_aa49fead-b0d6-460a-981a-1d25375d751c_verboseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease receivable</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_b4e899a6-6aed-4bb8-a3e5-b913add1edae_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_2b59f78d-80ad-41a4-bfe3-b0a5b3560a1c_terseLabel_en-US" xlink:label="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in right-of-use asset</link:label>
    <link:label id="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_label_en-US" xlink:label="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in right-of-use asset</link:label>
    <link:label id="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_documentation_en-US" xlink:label="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the change in right-of-use asset and liability due to modification during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:href="cutr-20211231.xsd#cutr_ChangeInRightofuseAssetAndLiabilityDueToModification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:to="lab_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_28fe719f-1649-4208-8a05-13a5fc1ae7b0_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_e13914a4-b8fc-4adc-8660-a48a3cde0e33_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_8ed85858-8c1f-4b26-9ac1-6c0499e4bcd2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_caa16514-a7ff-4e68-a785-1b52a9f1d287_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Basic and Diluted Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_fe26aa42-a3a3-445c-acdb-7e17b95e75c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3f32a5d9-4884-423e-a6ae-f81b497acc42_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution_4b8ba285-1dab-41ed-963c-528c96034723_terseLabel_en-US" xlink:label="lab_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum 401(k) employee contribution percentage</link:label>
    <link:label id="lab_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution_label_en-US" xlink:label="lab_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Maximum Percentage Of Employee Voluntary Contribution</link:label>
    <link:label id="lab_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution_documentation_en-US" xlink:label="lab_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refers to defined contribution plan maximum percentage of voluntary contribution by the employee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" xlink:href="cutr-20211231.xsd#cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" xlink:to="lab_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_600e5965-9354-45dd-8a47-9c95d3571f2f_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_546590a6-e340-4ecb-be34-822c53bec45d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_dc120d8f-00b1-47e8-92b3-10174d0fc896_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized gain on available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_4dbdddc1-0b7e-482f-92e5-ddd0848cf667_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_debdbb03-b3a2-43f2-b9b5-2a045dedcaab_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_46b30ab1-40d1-43d1-98a2-4fd940e693de_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b0be7ca8-be8c-42e8-8808-8befb4adee49_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_ebcbab31-3a1b-45cd-b35e-4b9530745cbc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from equity offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_ebfc7e57-9e2a-46c4-b1c2-1ec8bf51b750_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_b0285540-6aff-4e95-bcba-5204d26d2da4_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_b193d45f-73dc-43ad-8b98-9a35c9d95b0c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_4874261c-0b7e-4241-b85c-780e5ec26f85_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_f1002c17-1a6a-43ec-bd01-fcfe8593cc3b_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_9eb9cd15-d68c-4cfa-aa23-0b7a02caf84b_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_bcc44d4f-b909-4b28-9a58-7cba98632bd1_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_f90f81d0-6d5a-42bb-a183-32dc6e801c37_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent_7c3b32a3-f55f-45f0-b3bb-c17d761401f8_terseLabel_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of PPP loan</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent_label_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Debt Extinguishment, Percent</link:label>
    <link:label id="lab_cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent_documentation_en-US" xlink:label="lab_cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Debt Extinguishment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent" xlink:to="lab_cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_1a691175-a031-4247-bb40-d847b59d5cda_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Detail</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_StockPlanMember_ed915209-78f5-4e54-a8b9-e55147bdec31_terseLabel_en-US" xlink:label="lab_cutr_StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1998 Stock Plan</link:label>
    <link:label id="lab_cutr_StockPlanMember_label_en-US" xlink:label="lab_cutr_StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1998 Stock Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StockPlanMember" xlink:href="cutr-20211231.xsd#cutr_StockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_StockPlanMember" xlink:to="lab_cutr_StockPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_56b82cba-b8eb-47ec-940b-4c409b115dc6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RestrictedStockUnitsAnnualGrantMember_fd1a3798-4d76-4040-acaa-88ebdcf43298_terseLabel_en-US" xlink:label="lab_cutr_RestrictedStockUnitsAnnualGrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Annual Grant</link:label>
    <link:label id="lab_cutr_RestrictedStockUnitsAnnualGrantMember_label_en-US" xlink:label="lab_cutr_RestrictedStockUnitsAnnualGrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Annual Grant [Member]</link:label>
    <link:label id="lab_cutr_RestrictedStockUnitsAnnualGrantMember_documentation_en-US" xlink:label="lab_cutr_RestrictedStockUnitsAnnualGrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, Annual Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAnnualGrantMember" xlink:href="cutr-20211231.xsd#cutr_RestrictedStockUnitsAnnualGrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RestrictedStockUnitsAnnualGrantMember" xlink:to="lab_cutr_RestrictedStockUnitsAnnualGrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_1e0c870d-d503-4b05-a1ff-d410d4a5979a_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reclassification adjustment for net losses on investments recognized during the year</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66422dfe-a10b-49ec-ac3c-b0c43a314c09_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_2f3b937f-fb39-40bd-b986-8e8737b315a0_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_46f5e0a8-d8f4-4453-ac80-e20c55d82f2c_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_68e05e3e-32ed-4aee-8adc-7f4bf09069ce_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue balance, recognition period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c5ae8a0-d54b-4ac2-a8ab-db55792fddc1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_a0657dbc-d3e1-4e78-aac8-3f3de4bd6375_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:to="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_7f62a9b3-5196-4a15-8402-43b021687be7_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_27bf1e9e-34e7-417f-80a0-08b0792a2c11_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DebtCovenantQuarterlyMinimumRevenue_0d154f34-2d5a-4ee8-961b-56ecddb4b5bd_terseLabel_en-US" xlink:label="lab_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly minimum revenue</link:label>
    <link:label id="lab_cutr_DebtCovenantQuarterlyMinimumRevenue_label_en-US" xlink:label="lab_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Quarterly Minimum Revenue</link:label>
    <link:label id="lab_cutr_DebtCovenantQuarterlyMinimumRevenue_documentation_en-US" xlink:label="lab_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents quarterly minimum revenue under debt covenant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:href="cutr-20211231.xsd#cutr_DebtCovenantQuarterlyMinimumRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:to="lab_cutr_DebtCovenantQuarterlyMinimumRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_4278bf51-98bb-498a-81c0-94120a163827_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_869bbb32-42c1-49ea-9900-f9abd97e9760_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_ac77d1b0-0203-4041-9af1-9ac642f078f3_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_e6a96119-db59-464e-bf54-d05d5d1ed6bc_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4610e810-df38-4756-bb82-49e5ab00120a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0e96ac5e-961f-4222-b5dd-53041a708a7a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5a1f5b4f-9bab-438a-ab4b-2c228f29aab2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c6190d30-12f3-4777-9cb3-594bedec0688_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share, diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_3314eca1-a95d-400d-854e-ede3c22334a9_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_962d2b87-9a68-4c65-b076-2489a1e3bf7f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_0156bfae-233e-4585-9339-0bc1901afb0b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion threshold percentage of stock price trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_PaycheckProtectionProgramCARESActMember_e2e38917-3d4e-4146-bd6f-6e76f359034d_terseLabel_en-US" xlink:label="lab_cutr_PaycheckProtectionProgramCARESActMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program CARES Act</link:label>
    <link:label id="lab_cutr_PaycheckProtectionProgramCARESActMember_label_en-US" xlink:label="lab_cutr_PaycheckProtectionProgramCARESActMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program CARES Act [Member]</link:label>
    <link:label id="lab_cutr_PaycheckProtectionProgramCARESActMember_documentation_en-US" xlink:label="lab_cutr_PaycheckProtectionProgramCARESActMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents loan designed to provide funds for small businesses to keep their employees on the payroll.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PaycheckProtectionProgramCARESActMember" xlink:href="cutr-20211231.xsd#cutr_PaycheckProtectionProgramCARESActMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_PaycheckProtectionProgramCARESActMember" xlink:to="lab_cutr_PaycheckProtectionProgramCARESActMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_5e9e744a-bba0-4f2a-8459-053729d3fcd7_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_3ae96da4-6085-451b-91db-ffd0af0b2f61_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_583d6798-5b58-494c-9318-e72a26026c0d_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total product revenue</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_b5dea338-6688-4b9d-b4d9-bee27d138851_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration settlement</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:to="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_bea4b5fe-7995-41e2-98f2-4ce8caf5af43_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid (refunded) for income taxes, net of (refunds) payments</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AccruedSalesAndMarketingCostsCurrent_3ee475d5-5194-47ec-8bef-119732d9eeec_terseLabel_en-US" xlink:label="lab_cutr_AccruedSalesAndMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing accruals</link:label>
    <link:label id="lab_cutr_AccruedSalesAndMarketingCostsCurrent_label_en-US" xlink:label="lab_cutr_AccruedSalesAndMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing accruals</link:label>
    <link:label id="lab_cutr_AccruedSalesAndMarketingCostsCurrent_documentation_en-US" xlink:label="lab_cutr_AccruedSalesAndMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of the obligations incurred through that date and payable for sales and marketing costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AccruedSalesAndMarketingCostsCurrent" xlink:href="cutr-20211231.xsd#cutr_AccruedSalesAndMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AccruedSalesAndMarketingCostsCurrent" xlink:to="lab_cutr_AccruedSalesAndMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_1961de57-d9cc-450e-98a5-262611f072c8_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_118660e4-2692-4137-8a22-a5e3686ec4e6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_7c78d7ab-8195-4d06-afaf-3d2ac6352ad6_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_a25cb112-7696-4728-8cc2-4e7a8335c3c7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for loyalty program</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_43e7e696-9a78-4c4b-bc7a-1e75fda080d8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_96479141-5859-422c-a051-830d5ef245ce_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_6432c5dc-2bda-44b4-97da-8514bef3a734_terseLabel_en-US" xlink:label="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation And Presentation Of Financial Statements [Table]</link:label>
    <link:label id="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_label_en-US" xlink:label="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation And Presentation Of Financial Statements [Table]</link:label>
    <link:label id="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_documentation_en-US" xlink:label="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation And Presentation Of Financial Statements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:href="cutr-20211231.xsd#cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:to="lab_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_deff8b98-fe13-472a-b028-2e7431cb7e5d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0dad81c5-23e6-4d89-bcf0-b700c6388392_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_75618e1c-d390-4b22-94bd-275b63ecf3d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_CapitalizedCloudComputingSetupCostMember_ce7ad1df-200e-4e67-bb98-5c0b12a3f05c_terseLabel_en-US" xlink:label="lab_cutr_CapitalizedCloudComputingSetupCostMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Cloud Computing Set-up Cost</link:label>
    <link:label id="lab_cutr_CapitalizedCloudComputingSetupCostMember_label_en-US" xlink:label="lab_cutr_CapitalizedCloudComputingSetupCostMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Cloud Computing Set-up Cost [Member]</link:label>
    <link:label id="lab_cutr_CapitalizedCloudComputingSetupCostMember_documentation_en-US" xlink:label="lab_cutr_CapitalizedCloudComputingSetupCostMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the capitalized cloud computing set-up cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CapitalizedCloudComputingSetupCostMember" xlink:href="cutr-20211231.xsd#cutr_CapitalizedCloudComputingSetupCostMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_CapitalizedCloudComputingSetupCostMember" xlink:to="lab_cutr_CapitalizedCloudComputingSetupCostMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_5ee497d1-0045-4546-8378-bb3021b2bd9f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_c7eb485f-1060-4837-833d-504e158a968b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_bc3118ac-428a-4cb7-b125-9665ef0d0ce2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_4b11e543-fd1f-4626-9d34-aba37dd484ba_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange10Member_41083459-dab0-4188-8d2d-e7ef6e2835c9_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange10Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 10</link:label>
    <link:label id="lab_cutr_ExercisePriceRange10Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange10Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 10 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange10Member" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange10Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange10Member" xlink:to="lab_cutr_ExercisePriceRange10Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_adc9f594-c874-4361-8d21-0766688dc144_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_14b57bc7-37e4-44ca-b91a-a03095b48eed_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_a3b4318c-294b-4667-a3b8-62513320727b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of convertible notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c5230eb8-1578-47f2-9168-f570acd9e47b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_555b8b28-4e53-4838-8acb-51453249e482_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ea5c373b-ec40-4931-b0c9-3b9207972926_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9cde0ff5-a830-4e0c-9b46-ee2702ade1bf_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_fe3058ba-e374-4090-bacc-d3336c23fde0_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_6522fdef-948c-47ea-867d-07b4ffdb0bef_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_0a618ddc-8311-400b-89f4-2424070d3908_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_8202fa11-5c4a-4d04-8d2b-b87fb9d551f4_terseLabel_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized computing amortization expense</link:label>
    <link:label id="lab_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_label_en-US" xlink:label="lab_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Service Contract, Implementation Cost, Expense, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization" xlink:to="lab_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_54fd2089-19fc-4305-b628-dfa1a6650031_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_f9ac0c5d-fe87-42ff-a9a7-541ceb7d9921_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_aa284da5-e1ee-404c-93b1-10a5150a03e2_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product warranty</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_8cc4616e-6293-482b-8293-614dd6c5edeb_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_12515ae9-4480-429b-a4b5-68cbea957035_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_960d01e2-a977-4fcd-bbd4-ec64ed1a03ed_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_9c697c62-2eb0-492f-950e-1d97fbaec4c7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_fcb5765e-8da0-494f-b74a-b02539bde359_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_af96d32a-0cd1-4606-bd6b-465adf4bd577_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_50907447-2bc7-4eb7-982d-5063116a8cc9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_ee09425b-bbeb-42eb-baaa-46b65cfba0a2_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_fe90d860-adf9-4df4-bfad-edffa613200e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_27fb6a6c-b843-4697-b574-e80d08984b33_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_47f95ec3-a77b-4e63-a252-c4b55c5743b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_b479ffa3-976c-46ec-8667-6e81052c8e7c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_3fe7c169-60ac-4a71-8bad-98227948a739_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_ecb828d4-2312-40be-9956-3b7eca564e2b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price, upper range limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_070ee6ea-83f8-4946-a976-1f1a2c7b1c24_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decreases related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_289fcba9-439a-436f-8190-190c28fd2769_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_fec04bac-9598-4031-b91d-353fa8d1f87f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional stock available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_2162b609-b6b2-4c74-8c59-ebbbca0fa51f_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress to be depreciated</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_12a508f5-c9fd-41fa-b351-777342c2405d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange8Member_782cb644-c1a4-4bd3-aab9-33ee7660529b_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange8Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 8</link:label>
    <link:label id="lab_cutr_ExercisePriceRange8Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange8Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 8 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange8Member" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange8Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange8Member" xlink:to="lab_cutr_ExercisePriceRange8Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_326bf66c-341d-40a4-b989-e16fa5b09aa9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_cb672407-a75d-402f-90c1-15afa4b02f7b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Employee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RestrictedStockUnitsNewHireMember_ab883830-468b-47f1-a76e-65171ebc8b41_terseLabel_en-US" xlink:label="lab_cutr_RestrictedStockUnitsNewHireMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, New Hire</link:label>
    <link:label id="lab_cutr_RestrictedStockUnitsNewHireMember_label_en-US" xlink:label="lab_cutr_RestrictedStockUnitsNewHireMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, New Hire [Member]</link:label>
    <link:label id="lab_cutr_RestrictedStockUnitsNewHireMember_documentation_en-US" xlink:label="lab_cutr_RestrictedStockUnitsNewHireMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units, New Hire</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsNewHireMember" xlink:href="cutr-20211231.xsd#cutr_RestrictedStockUnitsNewHireMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RestrictedStockUnitsNewHireMember" xlink:to="lab_cutr_RestrictedStockUnitsNewHireMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_31f5e974-da49-46d2-b0f7-6ed3daecbf8f_verboseLabel_en-US" xlink:label="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Operating Lease Liabilities</link:label>
    <link:label id="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of increase (decrease) in operating lease liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="cutr-20211231.xsd#cutr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_cutr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_d62a5d0c-b249-4537-9861-6248c6a6dc32_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_5e4a520d-4720-4e48-b5c8-2603e58914ae_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_85bf42bc-4413-4085-80a1-52f22e211b6a_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_d42a93c7-5f24-4405-bb38-950dc3b6d154_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_4aad685a-0988-4671-ba77-b5a643d307a5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange2Member_f0ac562f-6440-4e85-85b0-5e73dd1032c3_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 2</link:label>
    <link:label id="lab_cutr_ExercisePriceRange2Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange2Member" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange2Member" xlink:to="lab_cutr_ExercisePriceRange2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_77671263-ff47-4b94-af08-6a3b942af6a9_terseLabel_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Training on use of system term (in days)</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_label_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Training Provided With Sale Of System, Period</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_documentation_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Training Provided With Sale Of System, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:href="cutr-20211231.xsd#cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:to="lab_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive_7741dcc9-c4bf-4cda-9ca3-56b7b0d4efde_terseLabel_en-US" xlink:label="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive_label_en-US" xlink:label="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Liability To Be Paid After Year Five</link:label>
    <link:label id="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive_documentation_en-US" xlink:label="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of lessee's undiscounted obligation for lease payment for operating lease due after third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" xlink:href="cutr-20211231.xsd#cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" xlink:to="lab_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_0c1378f4-1367-43c0-8164-78debed49c15_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange7Member_6bbd2b35-1a28-48ac-b9f0-2bcf0495876b_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange7Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 7</link:label>
    <link:label id="lab_cutr_ExercisePriceRange7Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange7Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 7 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange7Member" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange7Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange7Member" xlink:to="lab_cutr_ExercisePriceRange7Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026Member_ff10b54c-39b3-4e10-9202-a8f5af0d175c_terseLabel_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026Member_label_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Due 2026 [Member]</link:label>
    <link:label id="lab_cutr_ConvertibleSeniorNotesDue2026Member_documentation_en-US" xlink:label="lab_cutr_ConvertibleSeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to convertible senior notes due 2026.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member" xlink:href="cutr-20211231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2026Member" xlink:to="lab_cutr_ConvertibleSeniorNotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_ba0f9faf-a509-47d9-b106-a47ead42d6ca_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue balance, percentage</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_e30bf722-9a7a-4e16-ba5d-55debed920e9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_8477ab20-8a65-4d68-8226-7d0909e6e3fc_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demonstration inventories included in finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c9c123c2-862b-4807-b370-df1bae1ef626_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2fb84db5-90d8-4e99-8d79-0e6ca7f8857d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorLeasesPolicyTextBlock_aa8850ae-32e0-4f1c-b617-955ddcd55003_terseLabel_en-US" xlink:label="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Leases as a Lessor</link:label>
    <link:label id="lab_us-gaap_LessorLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_77293174-cbe3-4be7-8a31-53ecdeb4e169_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_fb3a0e49-8643-4062-bc6b-04d752576429_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_580a71e2-4c7a-4058-8fa4-4e9a1b335b14_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AccruedInventoryInTransitCurrent_db93b1e9-e8ea-48fe-bdc2-3fee4708cf5c_terseLabel_en-US" xlink:label="lab_cutr_AccruedInventoryInTransitCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued inventory in transit</link:label>
    <link:label id="lab_cutr_AccruedInventoryInTransitCurrent_label_en-US" xlink:label="lab_cutr_AccruedInventoryInTransitCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory In Transit, Current</link:label>
    <link:label id="lab_cutr_AccruedInventoryInTransitCurrent_documentation_en-US" xlink:label="lab_cutr_AccruedInventoryInTransitCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory In Transit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AccruedInventoryInTransitCurrent" xlink:href="cutr-20211231.xsd#cutr_AccruedInventoryInTransitCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AccruedInventoryInTransitCurrent" xlink:to="lab_cutr_AccruedInventoryInTransitCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a5773fe4-d160-45df-a243-e3de9a525649_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage_0d91cf4d-8fda-4a7c-b547-2a21f68169e8_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares authorized, percentage</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized, Percentage</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_dd2d600f-d461-4b1c-a2d5-2e61394a8839_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased vehicles, accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_03c19be8-2be8-479d-8058-768ff2b72c1c_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchMember_3bb4a1a2-6188-43a8-9905-adf5d44dbc0b_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward</link:label>
    <link:label id="lab_us-gaap_ResearchMember_label_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_f7b3f9cf-0e52-4159-a82f-db14fa4581b4_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e1f09d30-5751-4627-8c9b-8e53f6038a92_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69c7f0df-2b79-4803-b9b4-549b87a901d2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant- Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange1Member_54cd55e9-d4f9-4633-90ba-cea7f3c42f9e_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 1</link:label>
    <link:label id="lab_cutr_ExercisePriceRange1Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange1Member" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange1Member" xlink:to="lab_cutr_ExercisePriceRange1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bd18de16-06ab-47e8-8e9c-55232c92e296_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived_864e8e9e-1db8-4a7d-9956-7f4ff3f9aa81_terseLabel_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Payments received</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived_label_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Increase Advance Payments Received</link:label>
    <link:label id="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived_documentation_en-US" xlink:label="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from advance payments received.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:href="cutr-20211231.xsd#cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:to="lab_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_SecretAndSecretProMember_859289cf-a6e3-4106-94a5-03bfb851e736_terseLabel_en-US" xlink:label="lab_cutr_SecretAndSecretProMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secret and Secret Pro</link:label>
    <link:label id="lab_cutr_SecretAndSecretProMember_label_en-US" xlink:label="lab_cutr_SecretAndSecretProMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secret and Secret Pro [Member]</link:label>
    <link:label id="lab_cutr_SecretAndSecretProMember_documentation_en-US" xlink:label="lab_cutr_SecretAndSecretProMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secret and Secret Pro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SecretAndSecretProMember" xlink:href="cutr-20211231.xsd#cutr_SecretAndSecretProMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_SecretAndSecretProMember" xlink:to="lab_cutr_SecretAndSecretProMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_fea040f0-aeee-4789-9098-52e40e4dce74_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_609d5e69-71c2-401a-b62e-349dfc0ed596_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_2c0c84bf-3f71-4f41-9555-c05063507cd5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of marketable investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_090acefa-9648-4169-a193-e169df1b69d6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation adjustment for excess and obsolete inventory</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_8c648a79-1493-46a8-a035-bb9b8393a273_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_d7132023-05ee-4c79-b522-d26e5cc2e0bc_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c58a324f-8774-497b-9d16-154fa7496d5d_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents and restricted cash as reported within the Consolidated Statement of Cash Flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_bda3548c-c9ee-46c5-9646-b7b8e44bf0ac_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_01d39a3d-6ef4-4056-9368-8a1bb2041dc0_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_b71caff2-b324-4580-a58d-556532a1149a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_96570947-27a9-4546-990d-762b5bec57a0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_559d0b60-1edc-4811-a407-2875f6c0e9b4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_12313fdc-bae3-4e60-bc50-fed95148cc2c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_699a77fd-ba36-484f-8567-c696be35501d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_1acc0858-a51d-428c-8d6a-3499b15b65ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_fa286843-b2fc-4a2c-8c86-2610e7770b7d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_18482f30-1504-4f97-9126-8dd7619e1286_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_94839cef-64d9-48d9-a20f-66d940eb1e7b_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS)</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_fdd57bc9-7d5b-437c-ab2a-f2d44ec47716_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_c491f6a9-d6d8-41fa-8deb-b45df6653713_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of vesting tranches</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Number Of Vesting Tranches</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Number Of Vesting Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_5a191b95-9681-43d1-86a8-2ea0bd57e75c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5db86323-a792-4fd0-a16e-2d29e44f2085_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c46af545-9ab6-4e0f-abfc-6821d6fd7af3_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_31239646-d7ea-425f-872b-cce8345ef11e_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0f36d103-826c-4407-9713-7ab220920596_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding used in computing net loss per share, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_01c11e03-f84c-44da-bc82-8c8aa434784f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_99c90619-ebc1-4978-b41b-ad8a58a542a6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_451a8b32-b1cb-481c-8f43-aa60bf089467_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated product liability</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_2e689ae8-1b89-4271-86a1-f0191be3481e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_5df4a4bc-165f-421c-8ffc-7ebb09fe6f5e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_84d17961-a62e-489b-94d2-4357328079f2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_73bea304-8eb8-4141-840d-a9b2ee70124e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_eabf1ef4-e7bc-46a0-8cee-fcae986247bc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_7357f3c0-b653-4c4f-9fe8-0560b917f7a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DeferredTaxAssetsOperatingLeaseLiability_16922300-ccf1-49d8-9872-a35e1b0cf6e5_terseLabel_en-US" xlink:label="lab_cutr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_cutr_DeferredTaxAssetsOperatingLeaseLiability_label_en-US" xlink:label="lab_cutr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Lease Liability</link:label>
    <link:label id="lab_cutr_DeferredTaxAssetsOperatingLeaseLiability_documentation_en-US" xlink:label="lab_cutr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from operating lease liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredTaxAssetsOperatingLeaseLiability" xlink:href="cutr-20211231.xsd#cutr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DeferredTaxAssetsOperatingLeaseLiability" xlink:to="lab_cutr_DeferredTaxAssetsOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_LesseeLeaseRenewalTerm_ab4cb119-159b-4adb-9aeb-8dff982c2859_terseLabel_en-US" xlink:label="lab_cutr_LesseeLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease terms of finance leases</link:label>
    <link:label id="lab_cutr_LesseeLeaseRenewalTerm_label_en-US" xlink:label="lab_cutr_LesseeLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Renewal Term</link:label>
    <link:label id="lab_cutr_LesseeLeaseRenewalTerm_documentation_en-US" xlink:label="lab_cutr_LesseeLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The renewal term for leases of lessee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeaseRenewalTerm" xlink:href="cutr-20211231.xsd#cutr_LesseeLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_LesseeLeaseRenewalTerm" xlink:to="lab_cutr_LesseeLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_ac174687-8b5d-42bc-bc5a-06821c80535f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_73617dd6-fa75-49a6-8d08-df02ea91b05b_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange6Member_5510eea7-81dd-4288-802b-1e3b587f7b04_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange6Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 6</link:label>
    <link:label id="lab_cutr_ExercisePriceRange6Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange6Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 6 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange6Member" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange6Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange6Member" xlink:to="lab_cutr_ExercisePriceRange6Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_b40601ec-d25a-404c-a963-0b11b8c8adf8_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in unrealized gain (loss) on available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_a883afae-cda7-46b4-8019-06e041cbf370_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_PercentageOfAssets_e94a4948-62b1-499b-89e5-135851e7cf28_terseLabel_en-US" xlink:label="lab_cutr_PercentageOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of assets in the United States</link:label>
    <link:label id="lab_cutr_PercentageOfAssets_label_en-US" xlink:label="lab_cutr_PercentageOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Assets</link:label>
    <link:label id="lab_cutr_PercentageOfAssets_documentation_en-US" xlink:label="lab_cutr_PercentageOfAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage amount of assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PercentageOfAssets" xlink:href="cutr-20211231.xsd#cutr_PercentageOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_PercentageOfAssets" xlink:to="lab_cutr_PercentageOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_98572f92-5683-45e6-9041-6df3e695b0d7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_12094f04-98b7-432b-b943-b6a647c9d3f5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_e2601bc6-82c1-4baf-878e-f85ccec7c0cc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_59588d90-4e32-4731-bb76-37cd274c3b44_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_cf5dad75-46b2-46ff-b97c-853a9b62f5cb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for employee purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_db1f6326-2049-4caa-9fe0-97deaa29473d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_3b6d709f-9e6f-4d59-98dd-a14d3531b6f1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate during period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_dbf1f3da-0461-4451-94cf-896af7e4b498_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_3971429a-6e55-4417-9f01-001bd03a187a_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b50a39ee-dc6f-4654-bf6e-b86249b0defe_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_48a161c1-5872-455f-8cd3-b573176dee1d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_95ae98b6-382b-40b2-811c-5f79baba03cb_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_f84703ac-da68-45a1-adc0-d2264317b0da_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_dc7b80b6-1318-4e39-9633-595bcc12f4b6_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_38e01547-4b40-4e54-b7fd-48bc6ec7271f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent_86ff25d4-5d07-4e80-9635-ef31e7200f9b_terseLabel_en-US" xlink:label="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium over stock price (percent)</link:label>
    <link:label id="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent_label_en-US" xlink:label="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cap Price, Premium Over Stock Price, Percent</link:label>
    <link:label id="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent_documentation_en-US" xlink:label="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percent premium over the stock price for derivative caps.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:href="cutr-20211231.xsd#cutr_DerivativeCapPricePremiumOverStockPricePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:to="lab_cutr_DerivativeCapPricePremiumOverStockPricePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_4ede4c52-13e1-42d8-966a-041cbfbf4615_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_27705ff3-1541-4b31-b7ce-0e8cde1c2dbb_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_f396cd23-9a34-4636-be88-6db9a64aa7a5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flow</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_fb11d2ed-06aa-4894-99f3-e1a20cb239c2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b987515d-fdb7-4f42-82b9-04e4f53e68be_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_5af2c46e-b8af-4227-8380-7a009a74e638_terseLabel_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Available For Grant</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_label_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Options, Available For Grant [Roll Forward]</link:label>
    <link:label id="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_documentation_en-US" xlink:label="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Options, Available For Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:to="lab_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3848f496-4f8b-47d0-8c89-5c369b599ebd_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_43526605-09fe-4b7d-b6e4-34654e810010_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_b08f2590-1db1-49f8-a21e-26b3239bac91_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_HandPieceRefillsMember_94c5b77e-210a-4d1e-a8b1-8a8541278849_terseLabel_en-US" xlink:label="lab_cutr_HandPieceRefillsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables</link:label>
    <link:label id="lab_cutr_HandPieceRefillsMember_label_en-US" xlink:label="lab_cutr_HandPieceRefillsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hand Piece Refills [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_HandPieceRefillsMember" xlink:href="cutr-20211231.xsd#cutr_HandPieceRefillsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_HandPieceRefillsMember" xlink:to="lab_cutr_HandPieceRefillsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_a7b3d76c-b294-4717-996c-e6bd22875cb7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CaliforniaFranchiseTaxBoardMember_1c14af52-abf6-4bfb-8308-2b4bd354e9d2_terseLabel_en-US" xlink:label="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California Franchise Tax Board</link:label>
    <link:label id="lab_us-gaap_CaliforniaFranchiseTaxBoardMember_label_en-US" xlink:label="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California Franchise Tax Board [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:to="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember_8bcc0574-8bd1-4e49-b20b-e10ae596b9d0_terseLabel_en-US" xlink:label="lab_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of the world, other than United States, Asia and Europe</link:label>
    <link:label id="lab_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember_label_en-US" xlink:label="lab_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of the World, Excluding United States, Asia and Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember" xlink:href="cutr-20211231.xsd#cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember" xlink:to="lab_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_adeab4b1-a3be-440e-b15b-deb97d4f2951_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_3ffeb5fa-13c0-4810-9152-3506d6f8cc51_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising expense</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0fa2ea27-28e7-4da2-bb0a-a9dbb15596d4_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted by the Company</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_ab8c5a5f-df13-4a32-84c6-cb6937babac0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_6bf74931-3746-46b4-87a1-bcf7abb40825_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_OperatingLossCarryforwardsWithoutExpiration_b1024086-35e6-41dc-b09b-40f9120e629d_terseLabel_en-US" xlink:label="lab_cutr_OperatingLossCarryforwardsWithoutExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards without expiration</link:label>
    <link:label id="lab_cutr_OperatingLossCarryforwardsWithoutExpiration_label_en-US" xlink:label="lab_cutr_OperatingLossCarryforwardsWithoutExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards Without Expiration</link:label>
    <link:label id="lab_cutr_OperatingLossCarryforwardsWithoutExpiration_documentation_en-US" xlink:label="lab_cutr_OperatingLossCarryforwardsWithoutExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of operating loss carryforwards that have no expiration.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OperatingLossCarryforwardsWithoutExpiration" xlink:href="cutr-20211231.xsd#cutr_OperatingLossCarryforwardsWithoutExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_OperatingLossCarryforwardsWithoutExpiration" xlink:to="lab_cutr_OperatingLossCarryforwardsWithoutExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_db0b9ba5-0c91-457c-9378-2ce49cf3ab9a_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange4Member_9ee6b6ed-710f-4d73-a334-0239134a40db_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 4</link:label>
    <link:label id="lab_cutr_ExercisePriceRange4Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 4 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange4Member" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange4Member" xlink:to="lab_cutr_ExercisePriceRange4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a0addfde-7193-46f7-93b5-9969d188368e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets and prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_e81ff695-ea51-4966-86fb-f5d4bdf1dfe6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_6f23e22d-d6b5-420c-9c19-7b668a0c4771_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6d921b7f-57b7-457a-b4a3-f04840489c0d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_12344b86-c3bd-40c5-a27f-95053b70d4b9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_a264e4e1-90f1-4766-800b-1ef421b3aeff_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_cc9e681a-2491-4797-aba3-38473bc5c0fc_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_23bf684d-15f8-4729-93df-99f779449b2e_periodStartLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_39baaef8-0d4b-42b3-a185-35576e692585_periodEndLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_a2f94f15-f1cc-49fd-aae6-e74deba0cc5e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_26630c81-7108-4f27-bed7-e6732d0c36a2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at Beginning of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_62cd04a8-1243-4313-9bc9-119aec0184be_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at End of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_af37f5b0-0fbf-425b-bb46-d51539c3ac10_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_DeferredRevenueCostsIncurred_3c917294-5af9-4b91-a93e-1cf17b3e16d0_terseLabel_en-US" xlink:label="lab_cutr_DeferredRevenueCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs for extended service contracts</link:label>
    <link:label id="lab_cutr_DeferredRevenueCostsIncurred_label_en-US" xlink:label="lab_cutr_DeferredRevenueCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue Costs Incurred</link:label>
    <link:label id="lab_cutr_DeferredRevenueCostsIncurred_documentation_en-US" xlink:label="lab_cutr_DeferredRevenueCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs incurred under service contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredRevenueCostsIncurred" xlink:href="cutr-20211231.xsd#cutr_DeferredRevenueCostsIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_DeferredRevenueCostsIncurred" xlink:to="lab_cutr_DeferredRevenueCostsIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_4adb317e-9f3f-4721-87d1-a36d78d6a0a1_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock_ad758f19-44a9-4b16-bc29-a7a9748fd31e_terseLabel_en-US" xlink:label="lab_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances for Sales Returns and Credit Losses</link:label>
    <link:label id="lab_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock_label_en-US" xlink:label="lab_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances for Sales Returns and Doubtful Accounts [Policy Text Block]</link:label>
    <link:label id="lab_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock_documentation_en-US" xlink:label="lab_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for allowances for sales returns and doubtful accounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" xlink:href="cutr-20211231.xsd#cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" xlink:to="lab_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember_0149fb47-6156-4a03-9bed-3a767516df0a_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses, accounts receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Loan and Lease Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForLoanAndLeaseLossesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:to="lab_us-gaap_AllowanceForLoanAndLeaseLossesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_aa8b3736-7d82-442f-a4a9-947142e22970_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_3fe9a712-dd3a-4d4f-a180-12190dd5f291_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cutr_ExercisePriceRange3Member_20cab15d-58e3-42da-bcbf-63d1d307bf11_terseLabel_en-US" xlink:label="lab_cutr_ExercisePriceRange3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 3</link:label>
    <link:label id="lab_cutr_ExercisePriceRange3Member_label_en-US" xlink:label="lab_cutr_ExercisePriceRange3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange3Member" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cutr_ExercisePriceRange3Member" xlink:to="lab_cutr_ExercisePriceRange3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5bcca856-62e2-4038-b9db-fb4f8c23d57e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_6d9a6fa7-339c-4363-943c-d1b65abd157f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_73d3cc6c-109d-4ee4-98d9-f28ba0cb3c95_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_fd71c9ee-11fe-4b6a-aae2-c5202c75c4f0_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_29cd3758-1d6b-4b80-87eb-949946ec713b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>cutr-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:1ebe9035-7f15-449f-b887-5ea51f412a9f,g:8ea03665-a689-4990-8029-94d26fa40407-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cutera.com/role/Cover" xlink:type="simple" xlink:href="cutr-20211231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://cutera.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_aeb8adb7-3247-49a4-8ee7-34596dfff544" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_DocumentType_aeb8adb7-3247-49a4-8ee7-34596dfff544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_f74687d3-29c9-4c8d-ab92-ade35ccd89ee" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_DocumentAnnualReport_f74687d3-29c9-4c8d-ab92-ade35ccd89ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0c49745b-4b75-4d00-b963-59aee2c8baf0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_DocumentPeriodEndDate_0c49745b-4b75-4d00-b963-59aee2c8baf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_207e26ef-0265-4a07-a86c-ef274f33e857" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_CurrentFiscalYearEndDate_207e26ef-0265-4a07-a86c-ef274f33e857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_62d2c492-8ba9-448d-a4db-ad2c8841c862" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_DocumentTransitionReport_62d2c492-8ba9-448d-a4db-ad2c8841c862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5dd8842a-1143-4136-a4a2-c691ed4da131" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityFileNumber_5dd8842a-1143-4136-a4a2-c691ed4da131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_243836fe-08ac-43b2-b06d-60020f4f7ed7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityRegistrantName_243836fe-08ac-43b2-b06d-60020f4f7ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8f82c8fb-a9e7-4c3d-8801-a5c476957eff" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8f82c8fb-a9e7-4c3d-8801-a5c476957eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_0099b3e1-dd01-4879-bbbc-1a7edb7c2493" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityTaxIdentificationNumber_0099b3e1-dd01-4879-bbbc-1a7edb7c2493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_37ebb25a-ce1b-415f-944d-4cdd86950826" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityAddressAddressLine1_37ebb25a-ce1b-415f-944d-4cdd86950826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_7c18e0df-8d05-4c1b-bf6c-bd83aa3503b0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityAddressCityOrTown_7c18e0df-8d05-4c1b-bf6c-bd83aa3503b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0dffa48a-08e7-4615-9810-9173ef430605" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityAddressStateOrProvince_0dffa48a-08e7-4615-9810-9173ef430605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d7b6f12e-b560-423f-b2b3-4ffe9b6d90cf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityAddressPostalZipCode_d7b6f12e-b560-423f-b2b3-4ffe9b6d90cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f7a602b0-0e29-4cbf-8ef9-557615fd986b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_CityAreaCode_f7a602b0-0e29-4cbf-8ef9-557615fd986b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2989caa6-c182-4c63-ae2e-9caf6575d26d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_LocalPhoneNumber_2989caa6-c182-4c63-ae2e-9caf6575d26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8db3c38a-5179-4238-a1ff-1901cf1ac9a0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_Security12bTitle_8db3c38a-5179-4238-a1ff-1901cf1ac9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b31f852e-50ca-4e06-a277-20e77b5d03b9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_TradingSymbol_b31f852e-50ca-4e06-a277-20e77b5d03b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f7bdf08a-60f8-4c1d-83e6-d8ec01da1b9b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_SecurityExchangeName_f7bdf08a-60f8-4c1d-83e6-d8ec01da1b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_57e810a4-eacf-49ad-945a-84b3eae19761" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_57e810a4-eacf-49ad-945a-84b3eae19761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_e4b88534-8024-41ae-9912-fe3b5295c792" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityVoluntaryFilers_e4b88534-8024-41ae-9912-fe3b5295c792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_78239ff3-fbb9-4ade-80a5-a17cebd06ec3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityCurrentReportingStatus_78239ff3-fbb9-4ade-80a5-a17cebd06ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_7e3a6517-4ebe-4de2-bd70-592f834a0cc1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityInteractiveDataCurrent_7e3a6517-4ebe-4de2-bd70-592f834a0cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a9e960e6-99f2-4a32-9986-6468cfb46463" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityFilerCategory_a9e960e6-99f2-4a32-9986-6468cfb46463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_410b943f-8cfe-49b2-a5d7-92cf09f0af40" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntitySmallBusiness_410b943f-8cfe-49b2-a5d7-92cf09f0af40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d05fce7c-2aa3-457f-b6b5-3b00f29c9759" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityEmergingGrowthCompany_d05fce7c-2aa3-457f-b6b5-3b00f29c9759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_941108e0-5507-4d92-b353-ab3203ff06f2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_IcfrAuditorAttestationFlag_941108e0-5507-4d92-b353-ab3203ff06f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_2750ee53-db8f-47d0-acd7-6f379f6f0813" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityShellCompany_2750ee53-db8f-47d0-acd7-6f379f6f0813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_26738e3e-13a1-4306-808c-970ebaeecaf3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityPublicFloat_26738e3e-13a1-4306-808c-970ebaeecaf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_7a061f93-fdea-454a-b0fe-24ef299bc7f6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_7a061f93-fdea-454a-b0fe-24ef299bc7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_7cedeaab-a8a8-4b55-a0d1-7af826480eb7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_7cedeaab-a8a8-4b55-a0d1-7af826480eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_369fc99e-8572-46e8-b882-07b74a587f30" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_EntityCentralIndexKey_369fc99e-8572-46e8-b882-07b74a587f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a229885d-9ed4-4608-87b0-0c8486e2440e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_AmendmentFlag_a229885d-9ed4-4608-87b0-0c8486e2440e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_9da8ef75-039b-4752-b43d-6f7fd6ae8ec5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_DocumentFiscalPeriodFocus_9da8ef75-039b-4752-b43d-6f7fd6ae8ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_3b99ea68-3ccf-459a-a220-94620c275f1f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5448b73e-1c44-4c4b-b29f-05e06db3c607" xlink:to="loc_dei_DocumentFiscalYearFocus_3b99ea68-3ccf-459a-a220-94620c275f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/AuditInformation" xlink:type="simple" xlink:href="cutr-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://cutera.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AuditInformationAbstract_e22f3407-6526-4129-a366-499952b472b8" xlink:href="cutr-20211231.xsd#cutr_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_1ee03909-25b7-4b34-b8d6-4a67f532ca04" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_AuditInformationAbstract_e22f3407-6526-4129-a366-499952b472b8" xlink:to="loc_dei_AuditorName_1ee03909-25b7-4b34-b8d6-4a67f532ca04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_9e64f1e4-cb22-48e5-af6d-54cc050e3560" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_AuditInformationAbstract_e22f3407-6526-4129-a366-499952b472b8" xlink:to="loc_dei_AuditorLocation_9e64f1e4-cb22-48e5-af6d-54cc050e3560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_e11978e2-92fc-4ca6-836f-45e253a51deb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_AuditInformationAbstract_e22f3407-6526-4129-a366-499952b472b8" xlink:to="loc_dei_AuditorFirmId_e11978e2-92fc-4ca6-836f-45e253a51deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cutr-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_b356650c-b584-4c12-a0af-2171d70bce45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_98cb9383-c61c-40e0-a614-197a3a5be2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b356650c-b584-4c12-a0af-2171d70bce45" xlink:to="loc_us-gaap_AssetsAbstract_98cb9383-c61c-40e0-a614-197a3a5be2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_b1498574-3954-4dd3-bfbb-de23120e2e53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_98cb9383-c61c-40e0-a614-197a3a5be2f5" xlink:to="loc_us-gaap_AssetsCurrentAbstract_b1498574-3954-4dd3-bfbb-de23120e2e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c4e573a0-6366-49c1-83e9-33c3426620f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b1498574-3954-4dd3-bfbb-de23120e2e53" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c4e573a0-6366-49c1-83e9-33c3426620f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f167f594-867c-49c3-b115-ca44acf42c13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b1498574-3954-4dd3-bfbb-de23120e2e53" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f167f594-867c-49c3-b115-ca44acf42c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_95e17166-759d-416f-a87d-446dbe114993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b1498574-3954-4dd3-bfbb-de23120e2e53" xlink:to="loc_us-gaap_InventoryNet_95e17166-759d-416f-a87d-446dbe114993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bf17c077-cae2-47b0-9815-eac9eb09e815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b1498574-3954-4dd3-bfbb-de23120e2e53" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bf17c077-cae2-47b0-9815-eac9eb09e815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b3b32065-c709-49b9-87f6-af43d0e2bde9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b1498574-3954-4dd3-bfbb-de23120e2e53" xlink:to="loc_us-gaap_AssetsCurrent_b3b32065-c709-49b9-87f6-af43d0e2bde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a8e0d252-5a10-4896-b1f6-d3a26e816dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_98cb9383-c61c-40e0-a614-197a3a5be2f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_a8e0d252-5a10-4896-b1f6-d3a26e816dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_706f2ecb-d756-4621-a516-4daa642bed6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_98cb9383-c61c-40e0-a614-197a3a5be2f5" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_706f2ecb-d756-4621-a516-4daa642bed6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_12e364df-5bff-457d-b5c2-7cc164c4c515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_98cb9383-c61c-40e0-a614-197a3a5be2f5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_12e364df-5bff-457d-b5c2-7cc164c4c515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_38016383-1fb2-4928-adcd-68d656dd5ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_98cb9383-c61c-40e0-a614-197a3a5be2f5" xlink:to="loc_us-gaap_Goodwill_38016383-1fb2-4928-adcd-68d656dd5ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bfd0b483-3cd4-417f-b571-e9eee5b1700d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_98cb9383-c61c-40e0-a614-197a3a5be2f5" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_bfd0b483-3cd4-417f-b571-e9eee5b1700d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_75c54d3b-26f9-495b-ba09-92237b258789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_98cb9383-c61c-40e0-a614-197a3a5be2f5" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_75c54d3b-26f9-495b-ba09-92237b258789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c07b4ae9-5b36-40bd-bb46-db072b66d16a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_98cb9383-c61c-40e0-a614-197a3a5be2f5" xlink:to="loc_us-gaap_Assets_c07b4ae9-5b36-40bd-bb46-db072b66d16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_891b374c-4b94-48db-8dca-8bb79a564ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b356650c-b584-4c12-a0af-2171d70bce45" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_891b374c-4b94-48db-8dca-8bb79a564ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b1bcb439-8e5e-477e-b035-23dc8a1305ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_891b374c-4b94-48db-8dca-8bb79a564ed4" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b1bcb439-8e5e-477e-b035-23dc8a1305ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c4533575-3a35-44b3-b390-c89b64f9733f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1bcb439-8e5e-477e-b035-23dc8a1305ac" xlink:to="loc_us-gaap_AccountsPayableCurrent_c4533575-3a35-44b3-b390-c89b64f9733f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_30339e4e-6956-41df-8961-912b97ac87ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1bcb439-8e5e-477e-b035-23dc8a1305ac" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_30339e4e-6956-41df-8961-912b97ac87ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_007661e8-01db-46ff-aa10-450160316234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1bcb439-8e5e-477e-b035-23dc8a1305ac" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_007661e8-01db-46ff-aa10-450160316234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_0314ba21-7586-42ce-bcbe-71bd009b3871" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1bcb439-8e5e-477e-b035-23dc8a1305ac" xlink:to="loc_us-gaap_NotesPayableCurrent_0314ba21-7586-42ce-bcbe-71bd009b3871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_aa2affd0-a956-45d2-a45b-df1ff57871a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1bcb439-8e5e-477e-b035-23dc8a1305ac" xlink:to="loc_us-gaap_DeferredRevenueCurrent_aa2affd0-a956-45d2-a45b-df1ff57871a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_24e6cd82-2ff5-49ba-801b-0c5d381a73e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1bcb439-8e5e-477e-b035-23dc8a1305ac" xlink:to="loc_us-gaap_LiabilitiesCurrent_24e6cd82-2ff5-49ba-801b-0c5d381a73e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_5d1b73bc-f0f0-4d02-b6db-f945cfcf67e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_891b374c-4b94-48db-8dca-8bb79a564ed4" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_5d1b73bc-f0f0-4d02-b6db-f945cfcf67e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_be4f5c36-4c3b-4931-a5fe-ae1d96ad0f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_891b374c-4b94-48db-8dca-8bb79a564ed4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_be4f5c36-4c3b-4931-a5fe-ae1d96ad0f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_be095859-3938-41df-ac2e-5ec53bbac91f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_891b374c-4b94-48db-8dca-8bb79a564ed4" xlink:to="loc_us-gaap_LongTermNotesPayable_be095859-3938-41df-ac2e-5ec53bbac91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_8d0f5d44-0e2f-4dd0-b05c-9a92d194e67e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_891b374c-4b94-48db-8dca-8bb79a564ed4" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_8d0f5d44-0e2f-4dd0-b05c-9a92d194e67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c1de9072-5b22-4189-be24-8180e177d360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_891b374c-4b94-48db-8dca-8bb79a564ed4" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c1de9072-5b22-4189-be24-8180e177d360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_7114c1d9-436a-4569-bd22-8e2bf5a74040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_891b374c-4b94-48db-8dca-8bb79a564ed4" xlink:to="loc_us-gaap_Liabilities_7114c1d9-436a-4569-bd22-8e2bf5a74040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_126b80c3-fcfe-4817-8478-88c6f1399645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_891b374c-4b94-48db-8dca-8bb79a564ed4" xlink:to="loc_us-gaap_CommitmentsAndContingencies_126b80c3-fcfe-4817-8478-88c6f1399645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_5f94f37b-11e1-444d-ac12-1b1f02e943c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_891b374c-4b94-48db-8dca-8bb79a564ed4" xlink:to="loc_us-gaap_StockholdersEquityAbstract_5f94f37b-11e1-444d-ac12-1b1f02e943c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_21dcd98c-c275-4b0f-8c36-2bf5e0e64589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5f94f37b-11e1-444d-ac12-1b1f02e943c5" xlink:to="loc_us-gaap_CommonStockValue_21dcd98c-c275-4b0f-8c36-2bf5e0e64589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2f812bd4-fbcc-46c4-a3b0-7bc7ff52a0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5f94f37b-11e1-444d-ac12-1b1f02e943c5" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2f812bd4-fbcc-46c4-a3b0-7bc7ff52a0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4215f67e-fe18-4b0e-b4d7-066f1bd5a114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5f94f37b-11e1-444d-ac12-1b1f02e943c5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4215f67e-fe18-4b0e-b4d7-066f1bd5a114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_65dca886-2bc5-40b1-be4a-d7db8b17b520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5f94f37b-11e1-444d-ac12-1b1f02e943c5" xlink:to="loc_us-gaap_StockholdersEquity_65dca886-2bc5-40b1-be4a-d7db8b17b520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_02df0332-d577-41c4-9166-97ea608c3768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_891b374c-4b94-48db-8dca-8bb79a564ed4" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_02df0332-d577-41c4-9166-97ea608c3768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="cutr-20211231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0532d810-2da6-488f-801d-6483ae49a28a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_355c97a1-6947-42b7-9f25-b0f2d457da21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0532d810-2da6-488f-801d-6483ae49a28a" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_355c97a1-6947-42b7-9f25-b0f2d457da21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_ca6faefc-4911-442b-8e4f-72a8df1744a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0532d810-2da6-488f-801d-6483ae49a28a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_ca6faefc-4911-442b-8e4f-72a8df1744a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_31f3d510-4e25-472c-a444-5562a8c156ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0532d810-2da6-488f-801d-6483ae49a28a" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_31f3d510-4e25-472c-a444-5562a8c156ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_882f63c8-7acc-4da1-a19a-60a4301fef9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0532d810-2da6-488f-801d-6483ae49a28a" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_882f63c8-7acc-4da1-a19a-60a4301fef9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_0fd96c38-e34a-42d5-b128-96b60a5b93c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0532d810-2da6-488f-801d-6483ae49a28a" xlink:to="loc_us-gaap_CommonStockSharesIssued_0fd96c38-e34a-42d5-b128-96b60a5b93c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_48965b73-1abd-438c-80be-4bdb2629d980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0532d810-2da6-488f-801d-6483ae49a28a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_48965b73-1abd-438c-80be-4bdb2629d980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cutr-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_decdd166-03be-48d2-a36c-613336e94969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cea7dec5-bf4a-4e61-a808-d97afd356482" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_decdd166-03be-48d2-a36c-613336e94969" xlink:to="loc_us-gaap_StatementTable_cea7dec5-bf4a-4e61-a808-d97afd356482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4d5ad05c-fead-4e89-af0c-6fa09a73523a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cea7dec5-bf4a-4e61-a808-d97afd356482" xlink:to="loc_srt_ProductOrServiceAxis_4d5ad05c-fead-4e89-af0c-6fa09a73523a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_37a0e81c-c823-4ce2-94aa-1f1c978067d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4d5ad05c-fead-4e89-af0c-6fa09a73523a" xlink:to="loc_srt_ProductsAndServicesDomain_37a0e81c-c823-4ce2-94aa-1f1c978067d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_3a9a14ca-a764-439d-a6c2-7bf663c888f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_37a0e81c-c823-4ce2-94aa-1f1c978067d7" xlink:to="loc_us-gaap_ProductMember_3a9a14ca-a764-439d-a6c2-7bf663c888f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_f2429109-a0f9-409f-80cd-23d194a3c9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_37a0e81c-c823-4ce2-94aa-1f1c978067d7" xlink:to="loc_us-gaap_ServiceMember_f2429109-a0f9-409f-80cd-23d194a3c9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cea7dec5-bf4a-4e61-a808-d97afd356482" xlink:to="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_8991a53b-b236-4f52-a228-34de2aeb5630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_RevenuesAbstract_8991a53b-b236-4f52-a228-34de2aeb5630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4f207ecf-9167-495a-a757-33ecb6afb7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_8991a53b-b236-4f52-a228-34de2aeb5630" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4f207ecf-9167-495a-a757-33ecb6afb7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_68df87c5-359d-4428-9fcd-7eab3c6067cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_CostOfRevenueAbstract_68df87c5-359d-4428-9fcd-7eab3c6067cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_929863dd-1315-4f91-9fc5-22516f1136ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_68df87c5-359d-4428-9fcd-7eab3c6067cb" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_929863dd-1315-4f91-9fc5-22516f1136ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_bfea6298-fc82-4449-8b07-99a6e7617d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_GrossProfit_bfea6298-fc82-4449-8b07-99a6e7617d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_e0645921-8263-49da-a979-c2bcb8d0ce34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_OperatingExpensesAbstract_e0645921-8263-49da-a979-c2bcb8d0ce34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_51c1e1bc-fc7d-4c85-ad91-a215fa8c646c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e0645921-8263-49da-a979-c2bcb8d0ce34" xlink:to="loc_us-gaap_SellingAndMarketingExpense_51c1e1bc-fc7d-4c85-ad91-a215fa8c646c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c759b650-d3e1-444f-bf3a-507bde1a2cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e0645921-8263-49da-a979-c2bcb8d0ce34" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c759b650-d3e1-444f-bf3a-507bde1a2cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_30d97c9e-a7c6-49ea-9170-66dc88bac956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e0645921-8263-49da-a979-c2bcb8d0ce34" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_30d97c9e-a7c6-49ea-9170-66dc88bac956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_cb5612bc-6935-4c41-9731-eda593779546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e0645921-8263-49da-a979-c2bcb8d0ce34" xlink:to="loc_us-gaap_OperatingExpenses_cb5612bc-6935-4c41-9731-eda593779546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b915adde-fefb-4ef3-9d91-1a67ef9b49ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e0645921-8263-49da-a979-c2bcb8d0ce34" xlink:to="loc_us-gaap_OperatingIncomeLoss_b915adde-fefb-4ef3-9d91-1a67ef9b49ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseAbstract_8ddbe3e1-7448-450d-bd76-99f53703554c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_InterestExpenseAbstract_8ddbe3e1-7448-450d-bd76-99f53703554c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_006e71dc-6321-49f2-b6b5-b3b5f980b154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_8ddbe3e1-7448-450d-bd76-99f53703554c" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_006e71dc-6321-49f2-b6b5-b3b5f980b154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_4054a01c-13ee-42d4-853f-a85589e402b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_8ddbe3e1-7448-450d-bd76-99f53703554c" xlink:to="loc_us-gaap_InterestExpenseDebt_4054a01c-13ee-42d4-853f-a85589e402b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_004aab79-0768-45cd-93cd-02404cab4c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_8ddbe3e1-7448-450d-bd76-99f53703554c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_004aab79-0768-45cd-93cd-02404cab4c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7765d3f6-6019-4e3f-9ba2-47733577518f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_8ddbe3e1-7448-450d-bd76-99f53703554c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7765d3f6-6019-4e3f-9ba2-47733577518f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9d084176-87d0-4183-b1cd-2125dd0bf85c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestExpenseAbstract_8ddbe3e1-7448-450d-bd76-99f53703554c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9d084176-87d0-4183-b1cd-2125dd0bf85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e69952e9-fe9c-45d3-8acd-d7b1318d5247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e69952e9-fe9c-45d3-8acd-d7b1318d5247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_83c960e9-e27c-427b-a1eb-79799a43ceae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_83c960e9-e27c-427b-a1eb-79799a43ceae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0ff5154a-39c1-47b5-8b86-cf92df61c3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_NetIncomeLoss_0ff5154a-39c1-47b5-8b86-cf92df61c3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_39abe3fb-2e58-4b69-926c-991e6debdd98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_EarningsPerShareAbstract_39abe3fb-2e58-4b69-926c-991e6debdd98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6ce547d8-1edf-4b3e-b618-2ab46d05d93e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_39abe3fb-2e58-4b69-926c-991e6debdd98" xlink:to="loc_us-gaap_EarningsPerShareBasic_6ce547d8-1edf-4b3e-b618-2ab46d05d93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8fa67e2a-c555-4d5f-9520-3c5952e1f83e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_39abe3fb-2e58-4b69-926c-991e6debdd98" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8fa67e2a-c555-4d5f-9520-3c5952e1f83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_64f574e2-7333-4967-b8d0-c0c9038a9493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_134fea01-7e6e-436b-9d88-fca33a1f4018" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_64f574e2-7333-4967-b8d0-c0c9038a9493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_16dc32ca-c9d3-4ec8-9442-3a4d29305c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_64f574e2-7333-4967-b8d0-c0c9038a9493" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_16dc32ca-c9d3-4ec8-9442-3a4d29305c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_39a1f2fa-0d0c-47a7-8692-1f173478a550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_64f574e2-7333-4967-b8d0-c0c9038a9493" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_39a1f2fa-0d0c-47a7-8692-1f173478a550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cutr-20211231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d3b604b7-2857-4355-93ed-0dd186be02b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_48d256a7-efa2-4a1b-b653-1b7375c78423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d3b604b7-2857-4355-93ed-0dd186be02b3" xlink:to="loc_us-gaap_NetIncomeLoss_48d256a7-efa2-4a1b-b653-1b7375c78423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4d2c1c74-8b52-42aa-b0d8-520923267dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d3b604b7-2857-4355-93ed-0dd186be02b3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4d2c1c74-8b52-42aa-b0d8-520923267dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_8f9cff63-f5ca-4c4c-9088-ff54e0e0c799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4d2c1c74-8b52-42aa-b0d8-520923267dfb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_8f9cff63-f5ca-4c4c-9088-ff54e0e0c799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_deb87597-ae0e-4a0e-a9c9-cca81333ad8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_8f9cff63-f5ca-4c4c-9088-ff54e0e0c799" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_deb87597-ae0e-4a0e-a9c9-cca81333ad8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_c4c58d16-c1e5-484d-becf-459243be76c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_8f9cff63-f5ca-4c4c-9088-ff54e0e0c799" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_c4c58d16-c1e5-484d-becf-459243be76c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_81e7edfb-0be8-4e6e-b9a1-4e5d78be8ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_8f9cff63-f5ca-4c4c-9088-ff54e0e0c799" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_81e7edfb-0be8-4e6e-b9a1-4e5d78be8ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_be70d693-027a-40fb-aaf9-10bea2005d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4d2c1c74-8b52-42aa-b0d8-520923267dfb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_be70d693-027a-40fb-aaf9-10bea2005d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_bd88c838-631a-422d-b1a1-2f3bbdef3452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d3b604b7-2857-4355-93ed-0dd186be02b3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_bd88c838-631a-422d-b1a1-2f3bbdef3452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="cutr-20211231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_5aaa2591-a044-4aaa-972d-a4dc6adbdbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_17f5b0d1-3ec8-4233-b63d-51755fd9ee7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_5aaa2591-a044-4aaa-972d-a4dc6adbdbd3" xlink:to="loc_us-gaap_StatementTable_17f5b0d1-3ec8-4233-b63d-51755fd9ee7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f7a7021d-707b-46da-947d-f91982539764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_17f5b0d1-3ec8-4233-b63d-51755fd9ee7e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f7a7021d-707b-46da-947d-f91982539764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dd570f34-7bad-4de5-b4e4-44b351e65aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f7a7021d-707b-46da-947d-f91982539764" xlink:to="loc_us-gaap_EquityComponentDomain_dd570f34-7bad-4de5-b4e4-44b351e65aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2a161c10-14cc-4d34-aa45-d70a0451eb51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dd570f34-7bad-4de5-b4e4-44b351e65aae" xlink:to="loc_us-gaap_CommonStockMember_2a161c10-14cc-4d34-aa45-d70a0451eb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8e401704-534b-44c2-930e-02c451edc822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dd570f34-7bad-4de5-b4e4-44b351e65aae" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8e401704-534b-44c2-930e-02c451edc822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_def88756-88ab-41eb-b071-c8dd259592c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dd570f34-7bad-4de5-b4e4-44b351e65aae" xlink:to="loc_us-gaap_RetainedEarningsMember_def88756-88ab-41eb-b071-c8dd259592c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef8ada5f-476a-4cec-a985-77f0232a011a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dd570f34-7bad-4de5-b4e4-44b351e65aae" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ef8ada5f-476a-4cec-a985-77f0232a011a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5bccbd96-99e6-42fd-84ea-7b749d046adb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_17f5b0d1-3ec8-4233-b63d-51755fd9ee7e" xlink:to="loc_us-gaap_StatementLineItems_5bccbd96-99e6-42fd-84ea-7b749d046adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5bccbd96-99e6-42fd-84ea-7b749d046adb" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_94fd163a-136d-4b51-a0fb-359af9a34e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_94fd163a-136d-4b51-a0fb-359af9a34e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2e07f08d-01db-4c73-8570-39334249c267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockholdersEquity_2e07f08d-01db-4c73-8570-39334249c267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_def96536-fbbe-4d8b-90ca-33bf4f1c3c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_def96536-fbbe-4d8b-90ca-33bf4f1c3c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_81d30c94-90a4-47ed-8cc9-f24d2ba643bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_81d30c94-90a4-47ed-8cc9-f24d2ba643bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2da10bd5-754e-4042-bb5e-b71435620cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2da10bd5-754e-4042-bb5e-b71435620cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fad8f8b4-d1d8-4b42-a1d6-7faeb68b37b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fad8f8b4-d1d8-4b42-a1d6-7faeb68b37b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PurchaseOfCappedCall_2e1a631a-09ed-42dd-9c35-f088521cc8de" xlink:href="cutr-20211231.xsd#cutr_PurchaseOfCappedCall"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_cutr_PurchaseOfCappedCall_2e1a631a-09ed-42dd-9c35-f088521cc8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0b43e3d3-2943-451d-af82-3d2781498e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0b43e3d3-2943-451d-af82-3d2781498e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0e3f1489-e7d8-49fa-9c7c-c8ed73e33eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_0e3f1489-e7d8-49fa-9c7c-c8ed73e33eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_a7a94593-2cc3-4f90-8e1f-16866d029d63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_a7a94593-2cc3-4f90-8e1f-16866d029d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_f71abd2c-85d0-4b50-866d-2a2ab32902ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_f71abd2c-85d0-4b50-866d-2a2ab32902ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8420b3e4-b6da-461f-9745-9e0cdbfbb28a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8420b3e4-b6da-461f-9745-9e0cdbfbb28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_32dd3e41-f42e-4afc-a970-f3139ea96314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_NetIncomeLoss_32dd3e41-f42e-4afc-a970-f3139ea96314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_92e17845-10f8-4947-bc82-7200ab7c191c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_92e17845-10f8-4947-bc82-7200ab7c191c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f701d36b-8ea4-49e6-bfa9-8a89041852cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f701d36b-8ea4-49e6-bfa9-8a89041852cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_215cda5d-23ab-4f16-85dd-a913fe8b0586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_787787d4-9803-4fa1-9ef6-a2a8d698af68" xlink:to="loc_us-gaap_StockholdersEquity_215cda5d-23ab-4f16-85dd-a913fe8b0586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="cutr-20211231.xsd#ConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_688e2835-05f2-43d1-9dfb-f2851bcbb09c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_40ade2b4-3dc7-4fe6-9566-86b5632d11cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_688e2835-05f2-43d1-9dfb-f2851bcbb09c" xlink:to="loc_us-gaap_StatementTable_40ade2b4-3dc7-4fe6-9566-86b5632d11cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_034beb49-1388-412f-a38c-58061d85b89f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_40ade2b4-3dc7-4fe6-9566-86b5632d11cf" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_034beb49-1388-412f-a38c-58061d85b89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bde2d350-19ea-4ee4-9a93-8a55d39e26e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_034beb49-1388-412f-a38c-58061d85b89f" xlink:to="loc_us-gaap_EquityComponentDomain_bde2d350-19ea-4ee4-9a93-8a55d39e26e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_74c13229-061f-4f41-add5-10211540314b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bde2d350-19ea-4ee4-9a93-8a55d39e26e1" xlink:to="loc_us-gaap_CommonStockMember_74c13229-061f-4f41-add5-10211540314b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_feb7ace9-5a4c-42b7-8a5f-29f793fa0d15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_40ade2b4-3dc7-4fe6-9566-86b5632d11cf" xlink:to="loc_us-gaap_StatementLineItems_feb7ace9-5a4c-42b7-8a5f-29f793fa0d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_6d94e0c8-36d4-4550-a7c9-7e89ba56f39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_feb7ace9-5a4c-42b7-8a5f-29f793fa0d15" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_6d94e0c8-36d4-4550-a7c9-7e89ba56f39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cutr-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_64395c28-aaec-43ac-a65a-847e4d7cbd95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_24aa9630-e4f5-4e82-bf8d-e81b9f581a22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_64395c28-aaec-43ac-a65a-847e4d7cbd95" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_24aa9630-e4f5-4e82-bf8d-e81b9f581a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2d1f98f6-38b7-4b61-9cb1-f3fef08e1562" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_24aa9630-e4f5-4e82-bf8d-e81b9f581a22" xlink:to="loc_us-gaap_NetIncomeLoss_2d1f98f6-38b7-4b61-9cb1-f3fef08e1562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a083267-9079-425e-a179-ddc4408209a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_24aa9630-e4f5-4e82-bf8d-e81b9f581a22" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a083267-9079-425e-a179-ddc4408209a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2605c57b-d9ca-44c2-8d8d-7cae0ef23a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a083267-9079-425e-a179-ddc4408209a1" xlink:to="loc_us-gaap_ShareBasedCompensation_2605c57b-d9ca-44c2-8d8d-7cae0ef23a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_9754a47b-2db1-48a9-a6bd-391efd2d59ca" xlink:href="cutr-20211231.xsd#cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a083267-9079-425e-a179-ddc4408209a1" xlink:to="loc_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts_9754a47b-2db1-48a9-a6bd-391efd2d59ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfAcquisitionCosts_786545e2-7924-40d5-8b73-56892c8c98c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfAcquisitionCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a083267-9079-425e-a179-ddc4408209a1" xlink:to="loc_us-gaap_AmortizationOfAcquisitionCosts_786545e2-7924-40d5-8b73-56892c8c98c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_bf7b7f90-5276-4bc9-b177-efc29674df59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a083267-9079-425e-a179-ddc4408209a1" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_bf7b7f90-5276-4bc9-b177-efc29674df59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_3266f163-8342-4706-a224-1fd16d8c2615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HostingArrangementServiceContractImplementationCostImpairment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a083267-9079-425e-a179-ddc4408209a1" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_3266f163-8342-4706-a224-1fd16d8c2615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_68e41c80-bbde-4123-8498-0b78f0d41bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a083267-9079-425e-a179-ddc4408209a1" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_68e41c80-bbde-4123-8498-0b78f0d41bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_5a9a58b1-a46b-4213-bb95-7b55212d38d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a083267-9079-425e-a179-ddc4408209a1" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_5a9a58b1-a46b-4213-bb95-7b55212d38d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dcfca9e3-4c51-4eb7-96a9-37eedbb582dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a083267-9079-425e-a179-ddc4408209a1" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dcfca9e3-4c51-4eb7-96a9-37eedbb582dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_2154cf1e-2a18-45d7-ba15-7c2eb37bb22a" xlink:href="cutr-20211231.xsd#cutr_ChangeInRightofuseAssetAndLiabilityDueToModification"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a083267-9079-425e-a179-ddc4408209a1" xlink:to="loc_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification_2154cf1e-2a18-45d7-ba15-7c2eb37bb22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_b1db0a2c-5110-4192-8fbd-7e1892a44c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a083267-9079-425e-a179-ddc4408209a1" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_b1db0a2c-5110-4192-8fbd-7e1892a44c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_58d1e78d-0e53-4f41-80b4-6ceff54f44d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5a083267-9079-425e-a179-ddc4408209a1" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_58d1e78d-0e53-4f41-80b4-6ceff54f44d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e9fca1e7-eb54-48bd-babe-7837187e17e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_58d1e78d-0e53-4f41-80b4-6ceff54f44d4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e9fca1e7-eb54-48bd-babe-7837187e17e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a7519f2a-73a4-4cc1-8c51-d3644a290eef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_58d1e78d-0e53-4f41-80b4-6ceff54f44d4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a7519f2a-73a4-4cc1-8c51-d3644a290eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1426f472-11ca-48ae-918a-7ec296c77418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_58d1e78d-0e53-4f41-80b4-6ceff54f44d4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1426f472-11ca-48ae-918a-7ec296c77418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_df245744-0ac7-4f2d-bcd1-c61501e5a65f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_58d1e78d-0e53-4f41-80b4-6ceff54f44d4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_df245744-0ac7-4f2d-bcd1-c61501e5a65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5d2df82e-b923-4ce7-b1d6-978823d8ccd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_58d1e78d-0e53-4f41-80b4-6ceff54f44d4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5d2df82e-b923-4ce7-b1d6-978823d8ccd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9ba621f8-67d1-488e-ae07-6e928baf5126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_58d1e78d-0e53-4f41-80b4-6ceff54f44d4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9ba621f8-67d1-488e-ae07-6e928baf5126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_765db75b-75d4-432a-b60f-3f2fa351c996" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_58d1e78d-0e53-4f41-80b4-6ceff54f44d4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_765db75b-75d4-432a-b60f-3f2fa351c996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_46832b87-1aca-4f34-9195-0aebe5f8c4bd" xlink:href="cutr-20211231.xsd#cutr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_58d1e78d-0e53-4f41-80b4-6ceff54f44d4" xlink:to="loc_cutr_IncreaseDecreaseInOperatingLeaseLiabilities_46832b87-1aca-4f34-9195-0aebe5f8c4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_5fb860c3-3d2d-4a3e-9817-0713a4f6000a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_58d1e78d-0e53-4f41-80b4-6ceff54f44d4" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_5fb860c3-3d2d-4a3e-9817-0713a4f6000a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_be27f439-76c0-43a9-836e-68e6017fd4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_58d1e78d-0e53-4f41-80b4-6ceff54f44d4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_be27f439-76c0-43a9-836e-68e6017fd4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c71e7d76-9f65-4f49-9031-c388762b2283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_24aa9630-e4f5-4e82-bf8d-e81b9f581a22" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c71e7d76-9f65-4f49-9031-c388762b2283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e4ed263-c17c-4026-8bb7-97475f05b4db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_64395c28-aaec-43ac-a65a-847e4d7cbd95" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e4ed263-c17c-4026-8bb7-97475f05b4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cbc6f814-5283-497d-b2c3-d61d1f3ff4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e4ed263-c17c-4026-8bb7-97475f05b4db" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cbc6f814-5283-497d-b2c3-d61d1f3ff4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3d0c23b9-ef5e-4526-84a3-61616f984569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e4ed263-c17c-4026-8bb7-97475f05b4db" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3d0c23b9-ef5e-4526-84a3-61616f984569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_ce1fd74f-ab29-4db4-8d20-22b1c2e21666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e4ed263-c17c-4026-8bb7-97475f05b4db" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_ce1fd74f-ab29-4db4-8d20-22b1c2e21666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_147d6add-20f2-4f86-a8ad-10d2cf82e6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e4ed263-c17c-4026-8bb7-97475f05b4db" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_147d6add-20f2-4f86-a8ad-10d2cf82e6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_d24eaaef-54fd-4b90-9a4d-9b00d5e99a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e4ed263-c17c-4026-8bb7-97475f05b4db" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_d24eaaef-54fd-4b90-9a4d-9b00d5e99a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b4872700-2253-42b2-8c12-e0c17ca95ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e4ed263-c17c-4026-8bb7-97475f05b4db" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b4872700-2253-42b2-8c12-e0c17ca95ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15c39e14-f43d-463e-a473-b5dfcf49ee98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_64395c28-aaec-43ac-a65a-847e4d7cbd95" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15c39e14-f43d-463e-a473-b5dfcf49ee98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_41b4cc74-e354-4bb6-bdaf-4713a8352fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15c39e14-f43d-463e-a473-b5dfcf49ee98" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_41b4cc74-e354-4bb6-bdaf-4713a8352fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_9767eab1-53c7-4b6d-9d62-7cf7d88e7b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15c39e14-f43d-463e-a473-b5dfcf49ee98" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_9767eab1-53c7-4b6d-9d62-7cf7d88e7b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_73f4ae52-d179-4ffd-ad2e-4a27732ca494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15c39e14-f43d-463e-a473-b5dfcf49ee98" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_73f4ae52-d179-4ffd-ad2e-4a27732ca494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_03c356f3-ec08-4057-bb0a-b4437192027e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15c39e14-f43d-463e-a473-b5dfcf49ee98" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_03c356f3-ec08-4057-bb0a-b4437192027e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_01030e13-aea6-4f79-afe2-2953c55e0701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15c39e14-f43d-463e-a473-b5dfcf49ee98" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_01030e13-aea6-4f79-afe2-2953c55e0701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_81e823ed-0fb0-459f-98c2-ff9abb64ea28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15c39e14-f43d-463e-a473-b5dfcf49ee98" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_81e823ed-0fb0-459f-98c2-ff9abb64ea28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_a3a2a839-5c62-4cd4-90e0-da4fbc4adcdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15c39e14-f43d-463e-a473-b5dfcf49ee98" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_a3a2a839-5c62-4cd4-90e0-da4fbc4adcdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_d99c18d7-02b3-4421-8820-5af2f3bbdb03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15c39e14-f43d-463e-a473-b5dfcf49ee98" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_d99c18d7-02b3-4421-8820-5af2f3bbdb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_ab9da698-ffd1-4590-bf8c-e3eaf1c870b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15c39e14-f43d-463e-a473-b5dfcf49ee98" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_ab9da698-ffd1-4590-bf8c-e3eaf1c870b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_220d5c0a-b5d2-4430-bd65-27f846e07c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15c39e14-f43d-463e-a473-b5dfcf49ee98" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_220d5c0a-b5d2-4430-bd65-27f846e07c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c13830b1-0b03-4a13-83b0-d4c27c1f0c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_64395c28-aaec-43ac-a65a-847e4d7cbd95" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c13830b1-0b03-4a13-83b0-d4c27c1f0c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_e01932c2-82ef-49f7-916d-2eec0ff18a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_64395c28-aaec-43ac-a65a-847e4d7cbd95" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_e01932c2-82ef-49f7-916d-2eec0ff18a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0627c127-d58d-4463-b1d4-64e445f75d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_64395c28-aaec-43ac-a65a-847e4d7cbd95" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0627c127-d58d-4463-b1d4-64e445f75d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_0e53973c-5b6a-4c50-a1f2-e9697e06e1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_64395c28-aaec-43ac-a65a-847e4d7cbd95" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_0e53973c-5b6a-4c50-a1f2-e9697e06e1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_75e76811-e1f9-4ff6-a393-0381ad2265fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0e53973c-5b6a-4c50-a1f2-e9697e06e1c5" xlink:to="loc_us-gaap_InterestPaidNet_75e76811-e1f9-4ff6-a393-0381ad2265fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_ea9953b5-e583-4ee4-bc50-3fbdb9984547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_0e53973c-5b6a-4c50-a1f2-e9697e06e1c5" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_ea9953b5-e583-4ee4-bc50-3fbdb9984547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7fc7cfae-5b72-4261-9f43-da8d9a9dde36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_64395c28-aaec-43ac-a65a-847e4d7cbd95" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7fc7cfae-5b72-4261-9f43-da8d9a9dde36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_127f3cad-ff42-4cdf-bca9-8e5edf7c6e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7fc7cfae-5b72-4261-9f43-da8d9a9dde36" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_127f3cad-ff42-4cdf-bca9-8e5edf7c6e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f5c5c825-2976-40d0-af9e-a1e4afa74605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7fc7cfae-5b72-4261-9f43-da8d9a9dde36" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f5c5c825-2976-40d0-af9e-a1e4afa74605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReduction_18a2c7df-57f0-4e76-bd58-a31610efde91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReduction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_7fc7cfae-5b72-4261-9f43-da8d9a9dde36" xlink:to="loc_us-gaap_NotesReduction_18a2c7df-57f0-4e76-bd58-a31610efde91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="cutr-20211231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0de35142-d811-4e25-a47e-5c491170a18d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_dda40726-43f3-46e1-80b0-cef8bec4644b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0de35142-d811-4e25-a47e-5c491170a18d" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_dda40726-43f3-46e1-80b0-cef8bec4644b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cutr-20211231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_f82af159-a56b-4892-81cf-242f48af5f33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_f82af159-a56b-4892-81cf-242f48af5f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_cde3abd8-a7c1-4b7f-9f0f-141ecd4d102d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_cde3abd8-a7c1-4b7f-9f0f-141ecd4d102d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_86bedcaa-9d11-4057-b928-887181439243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_UseOfEstimates_86bedcaa-9d11-4057-b928-887181439243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock_5b77d475-f29e-47de-b891-55171d426ae5" xlink:href="cutr-20211231.xsd#cutr_RisksAndUncertaintiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock_5b77d475-f29e-47de-b891-55171d426ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_dad136f3-b164-48a3-a8cc-5708ebd1f9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_dad136f3-b164-48a3-a8cc-5708ebd1f9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_77768932-333c-46a9-92dc-52e8c9de638e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_77768932-333c-46a9-92dc-52e8c9de638e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_8795ef95-fbe1-4167-9bf3-282c9cb9518c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_8795ef95-fbe1-4167-9bf3-282c9cb9518c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4086fb12-3d54-4d02-8eca-6095b18f86a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_4086fb12-3d54-4d02-8eca-6095b18f86a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock_75a7699b-abef-4d47-8d79-cd5b0120e12f" xlink:href="cutr-20211231.xsd#cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock_75a7699b-abef-4d47-8d79-cd5b0120e12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_be4dc366-421f-4fe6-827f-07c298544df3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_be4dc366-421f-4fe6-827f-07c298544df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_0a0a13f2-d4e3-4d01-9532-6b9a15cce7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_0a0a13f2-d4e3-4d01-9532-6b9a15cce7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_53086c88-a090-4241-92a0-33d13bb40a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_53086c88-a090-4241-92a0-33d13bb40a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_e1451459-ffa7-42fb-94a5-d43e5005d5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_e1451459-ffa7-42fb-94a5-d43e5005d5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_f1d85725-03c6-4cac-9727-c107d8a0491b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_f1d85725-03c6-4cac-9727-c107d8a0491b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_f99af2a1-1ba4-4372-8483-ee49066eb15f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_f99af2a1-1ba4-4372-8483-ee49066eb15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_43999ae1-eb2b-4e4b-81be-bcc7dba4e27e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_43999ae1-eb2b-4e4b-81be-bcc7dba4e27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeasesPolicyTextBlock_b0681df1-02b8-4a02-9ffe-ba44a34a2697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorLeasesPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_LessorLeasesPolicyTextBlock_b0681df1-02b8-4a02-9ffe-ba44a34a2697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_2969d1c6-c3c8-425b-a284-3b6e0b03445f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_2969d1c6-c3c8-425b-a284-3b6e0b03445f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_77e6669e-4a11-4d77-af59-f66ed228d426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_77e6669e-4a11-4d77-af59-f66ed228d426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_e5def93d-b810-4318-8bfd-549cbb9e23b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_e5def93d-b810-4318-8bfd-549cbb9e23b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1f37b082-8207-42ca-9766-02a686f106f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1f37b082-8207-42ca-9766-02a686f106f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_c6aedb90-0dba-45f5-b903-248dd34cc5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_c6aedb90-0dba-45f5-b903-248dd34cc5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_38e6d09e-10bb-4c65-9fbf-ce5e8fa9e01d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_38e6d09e-10bb-4c65-9fbf-ce5e8fa9e01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_20d2296f-c3c1-441d-9990-299b4c717ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_20d2296f-c3c1-441d-9990-299b4c717ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_e8d2a648-7f45-4180-9863-c385091e45ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_e8d2a648-7f45-4180-9863-c385091e45ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_c27dbf97-b4ea-4f43-8125-9b8ad5a92dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_235ef40e-9973-4e2a-85cb-f9064cd8efe4" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_c27dbf97-b4ea-4f43-8125-9b8ad5a92dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cutr-20211231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c995c295-22d1-44c0-a6e5-0ab5d32eda19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_67560fce-ff2e-4822-814d-72e9952db5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c995c295-22d1-44c0-a6e5-0ab5d32eda19" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_67560fce-ff2e-4822-814d-72e9952db5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a7b97296-4550-49a5-8480-1fa5b51761cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:href="cutr-20211231.xsd#cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a7b97296-4550-49a5-8480-1fa5b51761cf" xlink:to="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_53e9d1a7-7f66-482b-ad5b-ef7143ef10c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_53e9d1a7-7f66-482b-ad5b-ef7143ef10c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_6b8f6e23-bcfc-4ba9-a9c3-d0abd8fe3f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_53e9d1a7-7f66-482b-ad5b-ef7143ef10c5" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_6b8f6e23-bcfc-4ba9-a9c3-d0abd8fe3f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_71110711-9fe8-466a-a88a-341c49498d67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_6b8f6e23-bcfc-4ba9-a9c3-d0abd8fe3f23" xlink:to="loc_us-gaap_TransferredOverTimeMember_71110711-9fe8-466a-a88a-341c49498d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_38bb1f1b-f52b-4dae-83de-7669feeef9a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_srt_ProductOrServiceAxis_38bb1f1b-f52b-4dae-83de-7669feeef9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_023fe33e-cc71-49f1-a6e5-66933063bd9c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_38bb1f1b-f52b-4dae-83de-7669feeef9a1" xlink:to="loc_srt_ProductsAndServicesDomain_023fe33e-cc71-49f1-a6e5-66933063bd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoyaltyMember_d11f3b1c-bc7d-4ac8-a451-d7b638adcf72" xlink:href="cutr-20211231.xsd#cutr_LoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_023fe33e-cc71-49f1-a6e5-66933063bd9c" xlink:to="loc_cutr_LoyaltyMember_d11f3b1c-bc7d-4ac8-a451-d7b638adcf72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_5b25252a-401d-43b9-89de-23141363083a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_023fe33e-cc71-49f1-a6e5-66933063bd9c" xlink:to="loc_us-gaap_ServiceMember_5b25252a-401d-43b9-89de-23141363083a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SecretAndSecretProMember_b8f6d0c4-62e2-426b-bc51-c5cee3a3f1ab" xlink:href="cutr-20211231.xsd#cutr_SecretAndSecretProMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_023fe33e-cc71-49f1-a6e5-66933063bd9c" xlink:to="loc_cutr_SecretAndSecretProMember_b8f6d0c4-62e2-426b-bc51-c5cee3a3f1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SkincareMember_acdb69bb-0064-43be-a57a-cdb5cad1358a" xlink:href="cutr-20211231.xsd#cutr_SkincareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_023fe33e-cc71-49f1-a6e5-66933063bd9c" xlink:to="loc_cutr_SkincareMember_acdb69bb-0064-43be-a57a-cdb5cad1358a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0fdec946-c50d-4a77-b0bc-a9ff476b64c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0fdec946-c50d-4a77-b0bc-a9ff476b64c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_770c3ca4-7ed8-4bb4-9d2c-7e7788a09b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0fdec946-c50d-4a77-b0bc-a9ff476b64c7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_770c3ca4-7ed8-4bb4-9d2c-7e7788a09b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_3dc8b3e5-06ce-4d08-bdc3-290a835b19af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_770c3ca4-7ed8-4bb4-9d2c-7e7788a09b49" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_3dc8b3e5-06ce-4d08-bdc3-290a835b19af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_f11dc173-d183-4dab-9129-950d921b872f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_f11dc173-d183-4dab-9129-950d921b872f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_47ce640d-e89b-418f-8729-b98e230f64ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_f11dc173-d183-4dab-9129-950d921b872f" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_47ce640d-e89b-418f-8729-b98e230f64ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_2579aa0d-6b77-4368-9b5e-16a6164a1311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_47ce640d-e89b-418f-8729-b98e230f64ab" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_2579aa0d-6b77-4368-9b5e-16a6164a1311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e08eba7a-bb6f-41dd-b1c2-e3a1e15878a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e08eba7a-bb6f-41dd-b1c2-e3a1e15878a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_790f0f1a-a005-425f-8517-e89fb725a3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e08eba7a-bb6f-41dd-b1c2-e3a1e15878a7" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_790f0f1a-a005-425f-8517-e89fb725a3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_23c4bb19-4cbb-4e20-bda5-1f2544270dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_790f0f1a-a005-425f-8517-e89fb725a3d3" xlink:to="loc_us-gaap_SalesRevenueNetMember_23c4bb19-4cbb-4e20-bda5-1f2544270dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e080f7fd-90e6-49b5-8331-009cce432337" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_srt_StatementGeographicalAxis_e080f7fd-90e6-49b5-8331-009cce432337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1702bf1a-dbde-4f52-a907-069226969fea" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e080f7fd-90e6-49b5-8331-009cce432337" xlink:to="loc_srt_SegmentGeographicalDomain_1702bf1a-dbde-4f52-a907-069226969fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8348e060-e0b3-44cb-b042-20fca6ddd1b1" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1702bf1a-dbde-4f52-a907-069226969fea" xlink:to="loc_country_US_8348e060-e0b3-44cb-b042-20fca6ddd1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_720f654c-6b7d-436a-8f6b-d2d6087bb215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1702bf1a-dbde-4f52-a907-069226969fea" xlink:to="loc_us-gaap_NonUsMember_720f654c-6b7d-436a-8f6b-d2d6087bb215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_53d68039-c547-48a0-8785-835cabd1ec21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_53d68039-c547-48a0-8785-835cabd1ec21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad09ba6f-cf4c-4dc4-b111-189caba3eedc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_53d68039-c547-48a0-8785-835cabd1ec21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad09ba6f-cf4c-4dc4-b111-189caba3eedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CapitalizedCloudComputingSetupCostMember_978067ab-0367-48ea-83fa-15c43d9d1a1f" xlink:href="cutr-20211231.xsd#cutr_CapitalizedCloudComputingSetupCostMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad09ba6f-cf4c-4dc4-b111-189caba3eedc" xlink:to="loc_cutr_CapitalizedCloudComputingSetupCostMember_978067ab-0367-48ea-83fa-15c43d9d1a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d7e7147c-ae76-4a51-9b73-4ac994e41bc4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_srt_RangeAxis_d7e7147c-ae76-4a51-9b73-4ac994e41bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_696aff30-4a11-481a-b619-26439f3bdf0c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d7e7147c-ae76-4a51-9b73-4ac994e41bc4" xlink:to="loc_srt_RangeMember_696aff30-4a11-481a-b619-26439f3bdf0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b94d465a-990f-4f12-8c17-d9cbb59f63fb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_696aff30-4a11-481a-b619-26439f3bdf0c" xlink:to="loc_srt_MinimumMember_b94d465a-990f-4f12-8c17-d9cbb59f63fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d86a870e-396a-4e90-ab9b-0d23217211bc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_696aff30-4a11-481a-b619-26439f3bdf0c" xlink:to="loc_srt_MaximumMember_d86a870e-396a-4e90-ab9b-0d23217211bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1371a5e8-2a2f-4c32-903d-7d933c4550c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1371a5e8-2a2f-4c32-903d-7d933c4550c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_cd2146ed-3a4b-482d-bab9-b633c4e8ff16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1371a5e8-2a2f-4c32-903d-7d933c4550c0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_cd2146ed-3a4b-482d-bab9-b633c4e8ff16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_e2057156-37d1-44f2-b3a1-14ef197db5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cd2146ed-3a4b-482d-bab9-b633c4e8ff16" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_e2057156-37d1-44f2-b3a1-14ef197db5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_44c55921-7449-43ac-b043-caa889908178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cd2146ed-3a4b-482d-bab9-b633c4e8ff16" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_44c55921-7449-43ac-b043-caa889908178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_8e12391a-1c2e-40b0-82a8-283fa32baefa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_us-gaap_StatementClassOfStockAxis_8e12391a-1c2e-40b0-82a8-283fa32baefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_960ca6ff-9353-4523-b1f2-aedc635616a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8e12391a-1c2e-40b0-82a8-283fa32baefa" xlink:to="loc_us-gaap_ClassOfStockDomain_960ca6ff-9353-4523-b1f2-aedc635616a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_82772c2f-32c9-49fc-b5cb-9f27198aa7af" xlink:href="cutr-20211231.xsd#cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_960ca6ff-9353-4523-b1f2-aedc635616a4" xlink:to="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_82772c2f-32c9-49fc-b5cb-9f27198aa7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:href="cutr-20211231.xsd#cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_13b95914-8f19-468e-a2ff-096fed21b488" xlink:to="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_cfe7adb2-177c-40c3-b70b-da6b383fd3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_cfe7adb2-177c-40c3-b70b-da6b383fd3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues_bee6adf7-3ab0-48f9-be3e-03a079430980" xlink:href="cutr-20211231.xsd#cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues_bee6adf7-3ab0-48f9-be3e-03a079430980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionOneTerm_5541edcd-6f31-4095-9320-7ad96838f869" xlink:href="cutr-20211231.xsd#cutr_ExtendedServiceContractOptionOneTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_ExtendedServiceContractOptionOneTerm_5541edcd-6f31-4095-9320-7ad96838f869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionTwoTerm_c6b992e2-484d-448b-b262-9ad04d8f16c5" xlink:href="cutr-20211231.xsd#cutr_ExtendedServiceContractOptionTwoTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_ExtendedServiceContractOptionTwoTerm_c6b992e2-484d-448b-b262-9ad04d8f16c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionThreeTerm_ff990c25-cee7-44b2-997a-fea3b3dadb9e" xlink:href="cutr-20211231.xsd#cutr_ExtendedServiceContractOptionThreeTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_ExtendedServiceContractOptionThreeTerm_ff990c25-cee7-44b2-997a-fea3b3dadb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_4d638e8c-e366-4d23-b5eb-6036d6fa1fb5" xlink:href="cutr-20211231.xsd#cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod_4d638e8c-e366-4d23-b5eb-6036d6fa1fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_1a2e7f8b-5e8f-4317-8439-0af74f23da42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_ContractWithCustomerLiability_1a2e7f8b-5e8f-4317-8439-0af74f23da42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_32ab1d2b-7918-434a-a3e5-61961ca10d77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_32ab1d2b-7918-434a-a3e5-61961ca10d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_9f967466-b6a7-454d-8c9e-b5087935f8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_CapitalizedContractCostNet_9f967466-b6a7-454d-8c9e-b5087935f8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_7cf368bd-1444-4aa8-b740-e65078159ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_7cf368bd-1444-4aa8-b740-e65078159ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c6048007-e9b4-4796-a08b-557319c7175e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c6048007-e9b4-4796-a08b-557319c7175e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NumberOfMajorSuppliers_d7355483-2654-4674-98fb-88d97018796f" xlink:href="cutr-20211231.xsd#cutr_NumberOfMajorSuppliers"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_NumberOfMajorSuppliers_d7355483-2654-4674-98fb-88d97018796f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DemonstrationUnitsAmortizationPeriod_6aab9b63-5f25-4853-8b87-0f550ce0ae4f" xlink:href="cutr-20211231.xsd#cutr_DemonstrationUnitsAmortizationPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_DemonstrationUnitsAmortizationPeriod_6aab9b63-5f25-4853-8b87-0f550ce0ae4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_f003085d-974f-4191-bd72-e26b46566eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_InventoryFinishedGoods_f003085d-974f-4191-bd72-e26b46566eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_6f98dabb-4243-4a91-92b0-a4a36cdbd883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_Depreciation_6f98dabb-4243-4a91-92b0-a4a36cdbd883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1e0ba001-9eed-463f-9bf0-a0bfe16716f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1e0ba001-9eed-463f-9bf0-a0bfe16716f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_fc37c682-1024-4064-acfb-e8ed51875000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization_fc37c682-1024-4064-acfb-e8ed51875000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization_9c2f8cc7-60fd-417e-97a1-f649f99866b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization_9c2f8cc7-60fd-417e-97a1-f649f99866b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_da16bdbb-e018-498d-857a-ef9d5f1af261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization_da16bdbb-e018-498d-857a-ef9d5f1af261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_3349bed6-44d6-486a-b1a9-731075a9b7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HostingArrangementServiceContractImplementationCostImpairment"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_HostingArrangementServiceContractImplementationCostImpairment_3349bed6-44d6-486a-b1a9-731075a9b7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_c21ab385-7c02-4e1b-9ba2-59361512f3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_NumberOfOperatingSegments_c21ab385-7c02-4e1b-9ba2-59361512f3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_34cbd461-e13e-4bd0-bbb8-474be1b06a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_NumberOfReportingUnits_34cbd461-e13e-4bd0-bbb8-474be1b06a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_788e7fa2-290a-4ed2-8be7-3f5e8dc2eab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_788e7fa2-290a-4ed2-8be7-3f5e8dc2eab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StandardProductWarrantyTermDirectSales_b2932d46-317a-42ab-a5e2-af74f8fa2baa" xlink:href="cutr-20211231.xsd#cutr_StandardProductWarrantyTermDirectSales"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_StandardProductWarrantyTermDirectSales_b2932d46-317a-42ab-a5e2-af74f8fa2baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StandardProductWarrantyTermDistributorSales_c251cceb-6856-418e-be9e-6324d118b5c2" xlink:href="cutr-20211231.xsd#cutr_StandardProductWarrantyTermDistributorSales"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_StandardProductWarrantyTermDistributorSales_c251cceb-6856-418e-be9e-6324d118b5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_61c65bd2-b605-4e85-b166-ac94d9b6f011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_AdvertisingExpense_61c65bd2-b605-4e85-b166-ac94d9b6f011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_84240b8d-8338-4f15-87b8-a55ac9cc9ca7" xlink:href="cutr-20211231.xsd#cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_84240b8d-8338-4f15-87b8-a55ac9cc9ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_8e9a8734-27f6-4356-a2a5-d5498b80abe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_8e9a8734-27f6-4356-a2a5-d5498b80abe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PercentageOfAssets_c671ba36-bdeb-4dec-807c-d4eb78307802" xlink:href="cutr-20211231.xsd#cutr_PercentageOfAssets"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_77434618-1beb-47c2-b318-0634eec6736b" xlink:to="loc_cutr_PercentageOfAssets_c671ba36-bdeb-4dec-807c-d4eb78307802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bfe92d9b-16dc-46a4-8677-ed9e6e92940d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2382c7fc-4688-4bab-b2bb-3166f494bb56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bfe92d9b-16dc-46a4-8677-ed9e6e92940d" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2382c7fc-4688-4bab-b2bb-3166f494bb56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_15458968-a44c-4fed-b31f-5c226dcab6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2382c7fc-4688-4bab-b2bb-3166f494bb56" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_15458968-a44c-4fed-b31f-5c226dcab6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb1bced6-9b90-4d81-ad18-de2dc792d753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_15458968-a44c-4fed-b31f-5c226dcab6fa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb1bced6-9b90-4d81-ad18-de2dc792d753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasedEquipmentMember_bb005897-b55f-4984-9677-cd1349ee8b09" xlink:href="cutr-20211231.xsd#cutr_LeasedEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb1bced6-9b90-4d81-ad18-de2dc792d753" xlink:to="loc_cutr_LeasedEquipmentMember_bb005897-b55f-4984-9677-cd1349ee8b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EquipmentAndFurnitureMember_cc2ceea6-93ef-4ad6-b4a7-be85ca49eb8a" xlink:href="cutr-20211231.xsd#cutr_EquipmentAndFurnitureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb1bced6-9b90-4d81-ad18-de2dc792d753" xlink:to="loc_cutr_EquipmentAndFurnitureMember_cc2ceea6-93ef-4ad6-b4a7-be85ca49eb8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_55c03911-cd13-4703-be5c-d37f38f00bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb1bced6-9b90-4d81-ad18-de2dc792d753" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_55c03911-cd13-4703-be5c-d37f38f00bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_51ffc23b-7131-4d15-9643-c0f576164b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2382c7fc-4688-4bab-b2bb-3166f494bb56" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_51ffc23b-7131-4d15-9643-c0f576164b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2dd11ebd-ae6d-402b-b7e0-daabac51ea72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_51ffc23b-7131-4d15-9643-c0f576164b2d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2dd11ebd-ae6d-402b-b7e0-daabac51ea72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CashCashEquivalentsandRestrictedCash" xlink:type="simple" xlink:href="cutr-20211231.xsd#CashCashEquivalentsandRestrictedCash"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CashCashEquivalentsandRestrictedCash" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_6875cae7-442e-4bda-b0db-88d1ae8cfd11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_4835596c-f875-4737-ba7a-cde400cca800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_6875cae7-442e-4bda-b0db-88d1ae8cfd11" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_4835596c-f875-4737-ba7a-cde400cca800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CashCashEquivalentsandRestrictedCashTables" xlink:type="simple" xlink:href="cutr-20211231.xsd#CashCashEquivalentsandRestrictedCashTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CashCashEquivalentsandRestrictedCashTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_98b26901-3851-4e05-80fd-2f64a2776243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_a81ccf95-216b-4d08-9cfc-d92f3718b762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_98b26901-3851-4e05-80fd-2f64a2776243" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_a81ccf95-216b-4d08-9cfc-d92f3718b762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_425b9913-ab03-4a1b-8cb6-2836ebf7e713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ed5dc7a9-45bb-4a80-adb8-129f0f6b922d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_425b9913-ab03-4a1b-8cb6-2836ebf7e713" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ed5dc7a9-45bb-4a80-adb8-129f0f6b922d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_82fcc802-3f4e-40e3-a7fb-2cacfa679b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_425b9913-ab03-4a1b-8cb6-2836ebf7e713" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_82fcc802-3f4e-40e3-a7fb-2cacfa679b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6563e2d3-28b5-4c35-aebd-2e4d1bbbeffd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_425b9913-ab03-4a1b-8cb6-2836ebf7e713" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6563e2d3-28b5-4c35-aebd-2e4d1bbbeffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CashCashEquivalentsandRestrictedCashNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#CashCashEquivalentsandRestrictedCashNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CashCashEquivalentsandRestrictedCashNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_3ed7aa08-39ee-4855-9550-83e33e3415e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_fefabfd1-b3cf-47bd-8b1a-102676f8c109" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_3ed7aa08-39ee-4855-9550-83e33e3415e5" xlink:to="loc_us-gaap_MarketableSecurities_fefabfd1-b3cf-47bd-8b1a-102676f8c109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetail" xlink:type="simple" xlink:href="cutr-20211231.xsd#BalanceSheetDetail"/>
  <link:presentationLink xlink:role="http://cutera.com/role/BalanceSheetDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5a8826a1-795b-4414-ab2b-aa9bf016d250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_a7cea9e9-3d07-4ce0-b787-4e6adf048881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5a8826a1-795b-4414-ab2b-aa9bf016d250" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_a7cea9e9-3d07-4ce0-b787-4e6adf048881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailTables" xlink:type="simple" xlink:href="cutr-20211231.xsd#BalanceSheetDetailTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/BalanceSheetDetailTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c456591a-9663-453e-8d8f-9d332fff2348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b41959ba-1c7b-45c3-8983-18068d0a6bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c456591a-9663-453e-8d8f-9d332fff2348" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b41959ba-1c7b-45c3-8983-18068d0a6bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_518b4c61-1e74-493b-89d7-f1e7bf31d0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c456591a-9663-453e-8d8f-9d332fff2348" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_518b4c61-1e74-493b-89d7-f1e7bf31d0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_9f214d26-03f4-4825-8041-954ef0ace427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c456591a-9663-453e-8d8f-9d332fff2348" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_9f214d26-03f4-4825-8041-954ef0ace427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailInventoriesDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#BalanceSheetDetailInventoriesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/BalanceSheetDetailInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_79c1746e-11c2-4f30-9a2b-047f3d32f5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7c253616-d9d1-4a22-bb7b-33be1de103f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_79c1746e-11c2-4f30-9a2b-047f3d32f5a9" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7c253616-d9d1-4a22-bb7b-33be1de103f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9e05a989-6894-415f-a2a2-2e31b8b77326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_79c1746e-11c2-4f30-9a2b-047f3d32f5a9" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9e05a989-6894-415f-a2a2-2e31b8b77326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_b5c3e357-c126-461f-a55d-dd083a22edd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_79c1746e-11c2-4f30-9a2b-047f3d32f5a9" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_b5c3e357-c126-461f-a55d-dd083a22edd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cbdf6479-325e-4184-b7e1-f4c6b153cf96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_79c1746e-11c2-4f30-9a2b-047f3d32f5a9" xlink:to="loc_us-gaap_InventoryNet_cbdf6479-325e-4184-b7e1-f4c6b153cf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#BalanceSheetDetailPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ba965de2-62c5-4e2b-8805-0bf98d5fa444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_09b5f75d-4af8-4883-9da6-80f42954b109" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ba965de2-62c5-4e2b-8805-0bf98d5fa444" xlink:to="loc_us-gaap_StatementTable_09b5f75d-4af8-4883-9da6-80f42954b109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65565ebc-3924-4f63-b20b-968fde57cb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_09b5f75d-4af8-4883-9da6-80f42954b109" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65565ebc-3924-4f63-b20b-968fde57cb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff865fa5-ca8b-4609-8230-82f1ddc72ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65565ebc-3924-4f63-b20b-968fde57cb8d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff865fa5-ca8b-4609-8230-82f1ddc72ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_70eecff9-59f4-47f9-b1fd-29ecc3841462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff865fa5-ca8b-4609-8230-82f1ddc72ddf" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_70eecff9-59f4-47f9-b1fd-29ecc3841462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasedEquipmentMember_9ea4ea5e-bf4a-4a88-9e22-79077668c715" xlink:href="cutr-20211231.xsd#cutr_LeasedEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff865fa5-ca8b-4609-8230-82f1ddc72ddf" xlink:to="loc_cutr_LeasedEquipmentMember_9ea4ea5e-bf4a-4a88-9e22-79077668c715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EquipmentAndFurnitureMember_4ca95af3-874d-4e7c-af7b-71a2418ac2d0" xlink:href="cutr-20211231.xsd#cutr_EquipmentAndFurnitureMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff865fa5-ca8b-4609-8230-82f1ddc72ddf" xlink:to="loc_cutr_EquipmentAndFurnitureMember_4ca95af3-874d-4e7c-af7b-71a2418ac2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_8d06c5a3-1ddb-40f9-8c3c-a1212480ad8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ff865fa5-ca8b-4609-8230-82f1ddc72ddf" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_8d06c5a3-1ddb-40f9-8c3c-a1212480ad8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5849de6a-fea8-4274-98cd-d5185823eb42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_09b5f75d-4af8-4883-9da6-80f42954b109" xlink:to="loc_us-gaap_StatementLineItems_5849de6a-fea8-4274-98cd-d5185823eb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f4922520-9543-4951-8af8-82406c702871" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5849de6a-fea8-4274-98cd-d5185823eb42" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f4922520-9543-4951-8af8-82406c702871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_29819e1f-2534-4aee-9ef7-5c5436c6311d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5849de6a-fea8-4274-98cd-d5185823eb42" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_29819e1f-2534-4aee-9ef7-5c5436c6311d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_ddb003a0-ca6f-4651-91d1-ce8af6c7e56d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5849de6a-fea8-4274-98cd-d5185823eb42" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_ddb003a0-ca6f-4651-91d1-ce8af6c7e56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7f3ce9c0-7014-44ca-80be-7d4192aab218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5849de6a-fea8-4274-98cd-d5185823eb42" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7f3ce9c0-7014-44ca-80be-7d4192aab218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#BalanceSheetDetailAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cd5f59a1-27e8-4de5-abf7-fa33a337805e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_569bbab6-f83b-493a-9d66-2094a76c1520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cd5f59a1-27e8-4de5-abf7-fa33a337805e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_569bbab6-f83b-493a-9d66-2094a76c1520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AccruedSalesAndMarketingCostsCurrent_daecc2eb-f073-4d74-918d-c06e9a4d77cc" xlink:href="cutr-20211231.xsd#cutr_AccruedSalesAndMarketingCostsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cd5f59a1-27e8-4de5-abf7-fa33a337805e" xlink:to="loc_cutr_AccruedSalesAndMarketingCostsCurrent_daecc2eb-f073-4d74-918d-c06e9a4d77cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AccruedInventoryInTransitCurrent_7b634967-c24e-48e4-9e5c-01b2ec83a5a3" xlink:href="cutr-20211231.xsd#cutr_AccruedInventoryInTransitCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cd5f59a1-27e8-4de5-abf7-fa33a337805e" xlink:to="loc_cutr_AccruedInventoryInTransitCurrent_7b634967-c24e-48e4-9e5c-01b2ec83a5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_d384479e-529f-4f1c-a7e5-fb7b2398ee5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cd5f59a1-27e8-4de5-abf7-fa33a337805e" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_d384479e-529f-4f1c-a7e5-fb7b2398ee5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_f1704580-019c-4d85-a2c8-f99ed3b6954d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cd5f59a1-27e8-4de5-abf7-fa33a337805e" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_f1704580-019c-4d85-a2c8-f99ed3b6954d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_eaa6a063-e43b-496f-abdf-3ee824977f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cd5f59a1-27e8-4de5-abf7-fa33a337805e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_eaa6a063-e43b-496f-abdf-3ee824977f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_bcc480ac-eb6a-42f0-a34b-454aa44613b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cd5f59a1-27e8-4de5-abf7-fa33a337805e" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_bcc480ac-eb6a-42f0-a34b-454aa44613b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/BalanceSheetDetailNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#BalanceSheetDetailNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/BalanceSheetDetailNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ae30163d-dc28-42d8-b675-77e2f6e63180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4bf94650-289f-460d-a48c-f5473647cb50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ae30163d-dc28-42d8-b675-77e2f6e63180" xlink:to="loc_us-gaap_StatementTable_4bf94650-289f-460d-a48c-f5473647cb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_abe430e5-20bd-4489-87a6-028d84a63684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4bf94650-289f-460d-a48c-f5473647cb50" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_abe430e5-20bd-4489-87a6-028d84a63684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5bb90f6b-43d5-4d21-829b-e2ac0996ff3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_abe430e5-20bd-4489-87a6-028d84a63684" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5bb90f6b-43d5-4d21-829b-e2ac0996ff3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_ed383b70-2275-49e5-886f-a351d897bf36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5bb90f6b-43d5-4d21-829b-e2ac0996ff3e" xlink:to="loc_us-gaap_VehiclesMember_ed383b70-2275-49e5-886f-a351d897bf36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_6cd0c306-415e-4a9e-b764-7c3d2b4d6ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5bb90f6b-43d5-4d21-829b-e2ac0996ff3e" xlink:to="loc_us-gaap_ConstructionInProgressMember_6cd0c306-415e-4a9e-b764-7c3d2b4d6ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4bf94650-289f-460d-a48c-f5473647cb50" xlink:to="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_83ac27f0-3f3b-401d-9671-5bc6ce03e07c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:to="loc_us-gaap_InventoryValuationReserves_83ac27f0-3f3b-401d-9671-5bc6ce03e07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_76612d4f-de9b-48f5-92e7-a0deae73da70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_76612d4f-de9b-48f5-92e7-a0deae73da70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_88074ab7-317d-4a15-82c4-731f5794a8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_88074ab7-317d-4a15-82c4-731f5794a8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_37af265f-a347-407b-a844-d0fbecbab05a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_37af265f-a347-407b-a844-d0fbecbab05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_52acf6fd-e01b-4043-bdfa-0400194781a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:to="loc_us-gaap_Goodwill_52acf6fd-e01b-4043-bdfa-0400194781a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_fa76e6c1-e882-4f4b-ab46-bdcffcc345c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_fa76e6c1-e882-4f4b-ab46-bdcffcc345c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_64bc4628-b31d-40bf-97ad-731d9b6846a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_85df4537-60f5-4342-9a03-b196456e767d" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_64bc4628-b31d-40bf-97ad-731d9b6846a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ProductWarranty" xlink:type="simple" xlink:href="cutr-20211231.xsd#ProductWarranty"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ProductWarranty" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_2b161bbd-d708-4a52-8361-510e530676ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock_b28d20ef-a00c-4d32-9fca-509988ab4c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_2b161bbd-d708-4a52-8361-510e530676ad" xlink:to="loc_us-gaap_ProductWarrantyDisclosureTextBlock_b28d20ef-a00c-4d32-9fca-509988ab4c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ProductWarrantyTables" xlink:type="simple" xlink:href="cutr-20211231.xsd#ProductWarrantyTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ProductWarrantyTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_111a8134-de0c-4696-80b7-985b0a8314b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_342eb980-e723-48a4-82ff-014e99c525d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_111a8134-de0c-4696-80b7-985b0a8314b9" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_342eb980-e723-48a4-82ff-014e99c525d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#ProductWarrantySummaryofWarrantiesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_ddb21fc9-7ea8-44fb-be54-1ca062a266fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantiesDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_d642f7f6-8400-4ddf-8661-b72d33939af4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductWarrantiesDisclosuresAbstract_ddb21fc9-7ea8-44fb-be54-1ca062a266fc" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_d642f7f6-8400-4ddf-8661-b72d33939af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_ac4dccfb-d444-403c-ac43-70a71e8d8cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_d642f7f6-8400-4ddf-8661-b72d33939af4" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_ac4dccfb-d444-403c-ac43-70a71e8d8cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_e900f9ef-b8cc-4af9-85b9-262f6146add3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_d642f7f6-8400-4ddf-8661-b72d33939af4" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_e900f9ef-b8cc-4af9-85b9-262f6146add3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments_4b78d4b0-c761-4352-a26d-e73691b5f9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_d642f7f6-8400-4ddf-8661-b72d33939af4" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualPayments_4b78d4b0-c761-4352-a26d-e73691b5f9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_e7f02714-7c24-4c3d-9930-8ba88ecc3c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_d642f7f6-8400-4ddf-8661-b72d33939af4" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_e7f02714-7c24-4c3d-9930-8ba88ecc3c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DeferredRevenue" xlink:type="simple" xlink:href="cutr-20211231.xsd#DeferredRevenue"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DeferredRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_64fd1c3c-627a-440c-9901-6811041d384e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityTextBlock_4cbe4e4f-a101-4cc7-a2d6-f87f10ebb8fb" xlink:href="cutr-20211231.xsd#cutr_ContractWithCustomerLiabilityTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_64fd1c3c-627a-440c-9901-6811041d384e" xlink:to="loc_cutr_ContractWithCustomerLiabilityTextBlock_4cbe4e4f-a101-4cc7-a2d6-f87f10ebb8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DeferredRevenueTables" xlink:type="simple" xlink:href="cutr-20211231.xsd#DeferredRevenueTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DeferredRevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fc4a35e4-1ad1-4c0f-9909-2eb132b8f925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_2a1f0338-96e2-4c4c-8f25-71c64f18e4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fc4a35e4-1ad1-4c0f-9909-2eb132b8f925" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_2a1f0338-96e2-4c4c-8f25-71c64f18e4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DeferredRevenueNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#DeferredRevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DeferredRevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8afc436c-5d60-4079-8426-d08bc4423757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_56b5f1b2-aa56-4df9-95d6-95387a1a247e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8afc436c-5d60-4079-8426-d08bc4423757" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_56b5f1b2-aa56-4df9-95d6-95387a1a247e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0d86dee5-5fb8-4342-8dff-8b249e2239f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_56b5f1b2-aa56-4df9-95d6-95387a1a247e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0d86dee5-5fb8-4342-8dff-8b249e2239f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_92e72082-52af-445f-a0e8-08cb978bc28d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_56b5f1b2-aa56-4df9-95d6-95387a1a247e" xlink:to="loc_srt_ProductOrServiceAxis_92e72082-52af-445f-a0e8-08cb978bc28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fd86644f-c17e-4f04-aad1-e3dde18e3ec6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_92e72082-52af-445f-a0e8-08cb978bc28d" xlink:to="loc_srt_ProductsAndServicesDomain_fd86644f-c17e-4f04-aad1-e3dde18e3ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_e6249ceb-114f-44ee-b5c2-7572b918a7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_fd86644f-c17e-4f04-aad1-e3dde18e3ec6" xlink:to="loc_us-gaap_ServiceMember_e6249ceb-114f-44ee-b5c2-7572b918a7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8407e28a-3d57-4aed-9909-419a48e55797" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_56b5f1b2-aa56-4df9-95d6-95387a1a247e" xlink:to="loc_srt_RangeAxis_8407e28a-3d57-4aed-9909-419a48e55797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3c1610bc-1bd7-4f0d-b830-f3a132077ec2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8407e28a-3d57-4aed-9909-419a48e55797" xlink:to="loc_srt_RangeMember_3c1610bc-1bd7-4f0d-b830-f3a132077ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5954d62b-0e2a-4529-a2e7-d43b4cd3982f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3c1610bc-1bd7-4f0d-b830-f3a132077ec2" xlink:to="loc_srt_MinimumMember_5954d62b-0e2a-4529-a2e7-d43b4cd3982f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_46a4112a-bd02-41f6-b50a-f300c99ab366" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3c1610bc-1bd7-4f0d-b830-f3a132077ec2" xlink:to="loc_srt_MaximumMember_46a4112a-bd02-41f6-b50a-f300c99ab366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_56b5f1b2-aa56-4df9-95d6-95387a1a247e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionOneTerm_1add49b8-bbee-4820-83ed-fc255480b09c" xlink:href="cutr-20211231.xsd#cutr_ExtendedServiceContractOptionOneTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_cutr_ExtendedServiceContractOptionOneTerm_1add49b8-bbee-4820-83ed-fc255480b09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExtendedServiceContractOptionTwoTerm_5942e102-83de-40de-9ff2-f0db3ef9bdf5" xlink:href="cutr-20211231.xsd#cutr_ExtendedServiceContractOptionTwoTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_cutr_ExtendedServiceContractOptionTwoTerm_5942e102-83de-40de-9ff2-f0db3ef9bdf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_08df709e-d98d-47ba-a859-e66a8d9d0777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_08df709e-d98d-47ba-a859-e66a8d9d0777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_a0abbc55-39ae-4628-b300-ca6617185868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_a0abbc55-39ae-4628-b300-ca6617185868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_bdc03ee3-9836-4a3f-9947-4a579fbbcbbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_bdc03ee3-9836-4a3f-9947-4a579fbbcbbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredRevenueCostsIncurred_741bfded-10ca-460d-9dcb-d15b6b91c70a" xlink:href="cutr-20211231.xsd#cutr_DeferredRevenueCostsIncurred"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_fa661b39-79c1-40e8-8b82-62ec1a838c90" xlink:to="loc_cutr_DeferredRevenueCostsIncurred_741bfded-10ca-460d-9dcb-d15b6b91c70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DeferredRevenueNarrativeDetails_1" xlink:type="simple" xlink:href="cutr-20211231.xsd#DeferredRevenueNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DeferredRevenueNarrativeDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#DeferredRevenueSummaryofDeferredServiceContractRevenueDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_525dae6f-7f59-455b-a7bf-686d9d0d3be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_42f2652f-1d84-4924-89c9-2476bd790bcd" xlink:href="cutr-20211231.xsd#cutr_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_525dae6f-7f59-455b-a7bf-686d9d0d3be4" xlink:to="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_42f2652f-1d84-4924-89c9-2476bd790bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_073e41d0-e547-48d7-966b-e18b3c66e1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_42f2652f-1d84-4924-89c9-2476bd790bcd" xlink:to="loc_us-gaap_ContractWithCustomerLiability_073e41d0-e547-48d7-966b-e18b3c66e1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived_a685df7c-7b13-4059-8faa-9221a7b71310" xlink:href="cutr-20211231.xsd#cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_42f2652f-1d84-4924-89c9-2476bd790bcd" xlink:to="loc_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived_a685df7c-7b13-4059-8faa-9221a7b71310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred_973c6f3b-32ef-4497-8ae5-955e0c74d21d" xlink:href="cutr-20211231.xsd#cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_42f2652f-1d84-4924-89c9-2476bd790bcd" xlink:to="loc_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred_973c6f3b-32ef-4497-8ae5-955e0c74d21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_89197d62-e0cf-42eb-ab6a-e211a085c6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_42f2652f-1d84-4924-89c9-2476bd790bcd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_89197d62-e0cf-42eb-ab6a-e211a085c6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_8da763c0-f403-4516-9e5e-3e25772d686f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ChangeInContractWithCustomerLiabilityRollForward_42f2652f-1d84-4924-89c9-2476bd790bcd" xlink:to="loc_us-gaap_ContractWithCustomerLiability_8da763c0-f403-4516-9e5e-3e25772d686f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpense" xlink:type="simple" xlink:href="cutr-20211231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpense"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpense" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52382a17-7ea1-4d1c-8de6-1cf690ab953a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ac2c5ea3-e2e4-41c0-9bb5-a6728a003b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_52382a17-7ea1-4d1c-8de6-1cf690ab953a" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ac2c5ea3-e2e4-41c0-9bb5-a6728a003b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables" xlink:type="simple" xlink:href="cutr-20211231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a0f0d897-ee71-4efa-9537-59fa7bf8bfcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2d78ba27-3d38-4e7a-ac25-a992c5587745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a0f0d897-ee71-4efa-9537-59fa7bf8bfcc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2d78ba27-3d38-4e7a-ac25-a992c5587745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_831e05ef-e4f6-46a4-804a-f747f18bb40e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a0f0d897-ee71-4efa-9537-59fa7bf8bfcc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_831e05ef-e4f6-46a4-804a-f747f18bb40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_57c2572b-e759-4588-8860-059450ae3a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a0f0d897-ee71-4efa-9537-59fa7bf8bfcc" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_57c2572b-e759-4588-8860-059450ae3a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_d870c94e-b884-4c65-a02a-e2d1fe5ee898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a0f0d897-ee71-4efa-9537-59fa7bf8bfcc" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_d870c94e-b884-4c65-a02a-e2d1fe5ee898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_274c8fbe-961c-4dd7-afb6-37c86f127579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a0f0d897-ee71-4efa-9537-59fa7bf8bfcc" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_274c8fbe-961c-4dd7-afb6-37c86f127579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock_439ccd16-9279-480d-98f9-c50513641801" xlink:href="cutr-20211231.xsd#cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a0f0d897-ee71-4efa-9537-59fa7bf8bfcc" xlink:to="loc_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock_439ccd16-9279-480d-98f9-c50513641801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5ecdc641-c188-4373-94ca-11b28e12d28e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5ecdc641-c188-4373-94ca-11b28e12d28e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_f999c1ab-3980-43bd-99f6-db9fbb65fd07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_f999c1ab-3980-43bd-99f6-db9fbb65fd07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7fb75221-933e-4bfa-8073-2cf637f3206a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f999c1ab-3980-43bd-99f6-db9fbb65fd07" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7fb75221-933e-4bfa-8073-2cf637f3206a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_UnderwrittenPublicOfferingMember_3858987e-43e1-42cb-89be-4b22447abce2" xlink:href="cutr-20211231.xsd#cutr_UnderwrittenPublicOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7fb75221-933e-4bfa-8073-2cf637f3206a" xlink:to="loc_cutr_UnderwrittenPublicOfferingMember_3858987e-43e1-42cb-89be-4b22447abce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1454241f-4d61-4abd-9780-c1daf39e65b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:to="loc_srt_CounterpartyNameAxis_1454241f-4d61-4abd-9780-c1daf39e65b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d8d4e1e0-0355-4d48-8eec-f49647bd0433" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_1454241f-4d61-4abd-9780-c1daf39e65b6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d8d4e1e0-0355-4d48-8eec-f49647bd0433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_UnderwriterMember_18734cba-40ff-4ac7-b21d-f58a568a6ee3" xlink:href="cutr-20211231.xsd#cutr_UnderwriterMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d8d4e1e0-0355-4d48-8eec-f49647bd0433" xlink:to="loc_cutr_UnderwriterMember_18734cba-40ff-4ac7-b21d-f58a568a6ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_af99adf9-52ff-4d0d-9d84-e4810960a3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:to="loc_us-gaap_PlanNameAxis_af99adf9-52ff-4d0d-9d84-e4810960a3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_73850d92-1ffa-4b16-a8b4-a74764ed3916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_af99adf9-52ff-4d0d-9d84-e4810960a3e0" xlink:to="loc_us-gaap_PlanNameDomain_73850d92-1ffa-4b16-a8b4-a74764ed3916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StockPlanMember_b950db9c-7100-4ec0-be60-bb3bdbbd9fbd" xlink:href="cutr-20211231.xsd#cutr_StockPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_73850d92-1ffa-4b16-a8b4-a74764ed3916" xlink:to="loc_cutr_StockPlanMember_b950db9c-7100-4ec0-be60-bb3bdbbd9fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TwoThousandFourEquityIncentivePlanMember_48daed0f-a2bf-4e2c-b091-055950381d40" xlink:href="cutr-20211231.xsd#cutr_TwoThousandFourEquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_73850d92-1ffa-4b16-a8b4-a74764ed3916" xlink:to="loc_cutr_TwoThousandFourEquityIncentivePlanMember_48daed0f-a2bf-4e2c-b091-055950381d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember_143483c3-3cfb-4953-bb1e-f259aeba47b1" xlink:href="cutr-20211231.xsd#cutr_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_73850d92-1ffa-4b16-a8b4-a74764ed3916" xlink:to="loc_cutr_TwoThousandNineteenEquityIncentivePlanMember_143483c3-3cfb-4953-bb1e-f259aeba47b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember_c80ce9f1-d133-422c-bb00-2f76b261bccc" xlink:href="cutr-20211231.xsd#cutr_TheAmendedAndRestated2019EquityIncentivePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_73850d92-1ffa-4b16-a8b4-a74764ed3916" xlink:to="loc_cutr_TheAmendedAndRestated2019EquityIncentivePlanMember_c80ce9f1-d133-422c-bb00-2f76b261bccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EmployeeStockPurchasePlanMember_8703681a-3ba4-4cd4-95c7-8bb685a8c031" xlink:href="cutr-20211231.xsd#cutr_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_73850d92-1ffa-4b16-a8b4-a74764ed3916" xlink:to="loc_cutr_EmployeeStockPurchasePlanMember_8703681a-3ba4-4cd4-95c7-8bb685a8c031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4e393d61-5d6c-47c9-92e1-036060f1ae3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:to="loc_us-gaap_AwardTypeAxis_4e393d61-5d6c-47c9-92e1-036060f1ae3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7194472-b0a0-4c3d-add7-04ff0668df01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4e393d61-5d6c-47c9-92e1-036060f1ae3d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7194472-b0a0-4c3d-add7-04ff0668df01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b00ff4a7-744e-4ead-a09f-c5815076307e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7194472-b0a0-4c3d-add7-04ff0668df01" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b00ff4a7-744e-4ead-a09f-c5815076307e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAnnualGrantMember_4a2cfe01-7638-43ec-a7d2-4b94c17a8e6a" xlink:href="cutr-20211231.xsd#cutr_RestrictedStockUnitsAnnualGrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_b00ff4a7-744e-4ead-a09f-c5815076307e" xlink:to="loc_cutr_RestrictedStockUnitsAnnualGrantMember_4a2cfe01-7638-43ec-a7d2-4b94c17a8e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsNewHireMember_243ad02b-4936-4362-ab2d-19b73fff0aff" xlink:href="cutr-20211231.xsd#cutr_RestrictedStockUnitsNewHireMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_b00ff4a7-744e-4ead-a09f-c5815076307e" xlink:to="loc_cutr_RestrictedStockUnitsNewHireMember_243ad02b-4936-4362-ab2d-19b73fff0aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_85f1ad77-28e1-45e5-b729-847301ea65a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7194472-b0a0-4c3d-add7-04ff0668df01" xlink:to="loc_us-gaap_PerformanceSharesMember_85f1ad77-28e1-45e5-b729-847301ea65a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_ae6add91-634b-47e1-a1fa-e8fb428d35a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:to="loc_us-gaap_GranteeStatusAxis_ae6add91-634b-47e1-a1fa-e8fb428d35a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_b1901e64-cd37-4eec-b8f4-2aabb00cd487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_ae6add91-634b-47e1-a1fa-e8fb428d35a2" xlink:to="loc_us-gaap_GranteeStatusDomain_b1901e64-cd37-4eec-b8f4-2aabb00cd487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_c39da69d-dfab-47d8-8be4-b072c36307f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_b1901e64-cd37-4eec-b8f4-2aabb00cd487" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_c39da69d-dfab-47d8-8be4-b072c36307f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_ccc5390a-b978-49e5-93e3-b10b35a2edbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_b1901e64-cd37-4eec-b8f4-2aabb00cd487" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_ccc5390a-b978-49e5-93e3-b10b35a2edbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_09e2d13f-0fe4-4361-97e4-9f065461d40a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:to="loc_us-gaap_VestingAxis_09e2d13f-0fe4-4361-97e4-9f065461d40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_3939b514-b753-4d01-8d76-8a9754097448" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_09e2d13f-0fe4-4361-97e4-9f065461d40a" xlink:to="loc_us-gaap_VestingDomain_3939b514-b753-4d01-8d76-8a9754097448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_8b537e18-ef19-46bd-b749-2542b18f920b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_3939b514-b753-4d01-8d76-8a9754097448" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_8b537e18-ef19-46bd-b749-2542b18f920b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_3c09fe02-8705-4229-8419-35d040d605f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_3939b514-b753-4d01-8d76-8a9754097448" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_3c09fe02-8705-4229-8419-35d040d605f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_57dad214-3c6c-4326-b96f-09c027a79fb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_69812d4b-7ba0-4acd-8a7b-f3aef7f834a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_69812d4b-7ba0-4acd-8a7b-f3aef7f834a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CapitalStockSharesAuthorized_827cc450-0c81-46cf-bbdf-40bdb5d60247" xlink:href="cutr-20211231.xsd#cutr_CapitalStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_cutr_CapitalStockSharesAuthorized_827cc450-0c81-46cf-bbdf-40bdb5d60247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_61dfd280-4e61-43e9-a6c7-7aca9ede1238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_61dfd280-4e61-43e9-a6c7-7aca9ede1238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_7650501d-0bc3-4336-956c-3f4720908830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_CommonStockSharesIssued_7650501d-0bc3-4336-956c-3f4720908830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_74f68e6b-ddf8-405b-a9b9-1f17ce1b6121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_74f68e6b-ddf8-405b-a9b9-1f17ce1b6121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_45f57282-6e1b-448f-a03f-fce11cf9a3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_45f57282-6e1b-448f-a03f-fce11cf9a3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_fa6cd513-6412-4cf4-854d-509e1347c125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_fa6cd513-6412-4cf4-854d-509e1347c125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_cd7d34c1-bfe8-42c4-a63e-be45ea543498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_PreferredStockSharesIssued_cd7d34c1-bfe8-42c4-a63e-be45ea543498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_df9a7eb6-085f-4054-9045-2c2244929cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_df9a7eb6-085f-4054-9045-2c2244929cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_be4bd19e-6b8c-40c6-a520-23445279958c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_be4bd19e-6b8c-40c6-a520-23445279958c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_fc47d976-0278-492a-adf3-e026c73b9e99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_fc47d976-0278-492a-adf3-e026c73b9e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f6c78f2a-0275-4107-a5f1-23225f3783e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f6c78f2a-0275-4107-a5f1-23225f3783e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_871974f7-fd20-40d1-a4a3-46c4860f5850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_871974f7-fd20-40d1-a4a3-46c4860f5850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0bcf7452-c0e8-4baf-882b-27c4e961ac75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0bcf7452-c0e8-4baf-882b-27c4e961ac75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled_74aa7112-c007-4cd5-b8b0-13da550c9261" xlink:href="cutr-20211231.xsd#cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled_74aa7112-c007-4cd5-b8b0-13da550c9261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7c6e2c1b-028a-442d-96f3-18cc25c92d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7c6e2c1b-028a-442d-96f3-18cc25c92d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_406e95f7-84fc-4885-bdce-67a8356cbf5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_406e95f7-84fc-4885-bdce-67a8356cbf5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear_5ef68e9d-5644-4c4e-bb5e-be5dac160a1a" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear_5ef68e9d-5644-4c4e-bb5e-be5dac160a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue_ac109c77-8f30-47cd-b07e-30e90460c2be" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue_ac109c77-8f30-47cd-b07e-30e90460c2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f36c89a7-c998-4380-b6b1-7f6030a666c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f36c89a7-c998-4380-b6b1-7f6030a666c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_77b8e5b1-9a9e-4fba-9df9-fcaebcbd7ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_77b8e5b1-9a9e-4fba-9df9-fcaebcbd7ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_9f0f34c7-31c4-4a20-b416-f3a38173f951" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_9f0f34c7-31c4-4a20-b416-f3a38173f951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_fcca0735-117c-4701-873e-532bfaa08481" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_fcca0735-117c-4701-873e-532bfaa08481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage_4e6b6864-360d-4326-a775-40a7bb9a27d1" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage_4e6b6864-360d-4326-a775-40a7bb9a27d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_fe19ad75-db4f-4c9d-9a5c-a31aaa94165b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_fe19ad75-db4f-4c9d-9a5c-a31aaa94165b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_4abd77c5-bda9-4e8e-b507-0b6bff5798fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_4abd77c5-bda9-4e8e-b507-0b6bff5798fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_8920030d-db5a-4c5b-b9dc-78376a9ae1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_8920030d-db5a-4c5b-b9dc-78376a9ae1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f709fe37-6070-41af-a1e3-cdc399b087dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d05797f-b0ce-47c1-87c9-395a2f94a0a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f709fe37-6070-41af-a1e3-cdc399b087dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e7a84faa-e630-4a87-8d96-2d7151ded7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_44730a5a-2671-4e22-a931-e20571efb95e" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e7a84faa-e630-4a87-8d96-2d7151ded7fe" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_44730a5a-2671-4e22-a931-e20571efb95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_cc2d84b8-0245-4256-ac24-1c50a8834e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_44730a5a-2671-4e22-a931-e20571efb95e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_cc2d84b8-0245-4256-ac24-1c50a8834e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AdditionalSharesReservedSharesAvailableForGrant_4bb5d07d-b0af-41b0-ba07-42b994b431a9" xlink:href="cutr-20211231.xsd#cutr_AdditionalSharesReservedSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_44730a5a-2671-4e22-a931-e20571efb95e" xlink:to="loc_cutr_AdditionalSharesReservedSharesAvailableForGrant_4bb5d07d-b0af-41b0-ba07-42b994b431a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted_af2c7f37-725e-48cc-bd44-ea55eb9c1e24" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_44730a5a-2671-4e22-a931-e20571efb95e" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted_af2c7f37-725e-48cc-bd44-ea55eb9c1e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_6f8f7821-039d-43ce-91c3-112046615442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_44730a5a-2671-4e22-a931-e20571efb95e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_6f8f7821-039d-43ce-91c3-112046615442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross_1c0b05a4-cdc8-4f17-ad78-d4a6eadacf23" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_44730a5a-2671-4e22-a931-e20571efb95e" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross_1c0b05a4-cdc8-4f17-ad78-d4a6eadacf23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod_830fd0be-7867-41d8-806d-d9e693bcb5de" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_44730a5a-2671-4e22-a931-e20571efb95e" xlink:to="loc_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod_830fd0be-7867-41d8-806d-d9e693bcb5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_725cf019-f306-4bb3-b285-27f9e89962ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward_44730a5a-2671-4e22-a931-e20571efb95e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_725cf019-f306-4bb3-b285-27f9e89962ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4735c204-95f1-4f22-8da3-9452df4218a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e7a84faa-e630-4a87-8d96-2d7151ded7fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4735c204-95f1-4f22-8da3-9452df4218a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8974c8b7-fbe6-4b18-90ec-bcdc58a6c07a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4735c204-95f1-4f22-8da3-9452df4218a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8974c8b7-fbe6-4b18-90ec-bcdc58a6c07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_361957ec-677f-4d10-af83-fc2750ae832d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4735c204-95f1-4f22-8da3-9452df4218a7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_361957ec-677f-4d10-af83-fc2750ae832d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_66f82075-561f-416f-9893-987a9b361807" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4735c204-95f1-4f22-8da3-9452df4218a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_66f82075-561f-416f-9893-987a9b361807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_322c0fd8-81a4-4399-9d69-49791b9f3553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4735c204-95f1-4f22-8da3-9452df4218a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_322c0fd8-81a4-4399-9d69-49791b9f3553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c8d50540-5fc7-42b1-b604-f08fcaa73a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4735c204-95f1-4f22-8da3-9452df4218a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c8d50540-5fc7-42b1-b604-f08fcaa73a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0076ded8-f55d-4dec-8eaa-81f88453bdf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e7a84faa-e630-4a87-8d96-2d7151ded7fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0076ded8-f55d-4dec-8eaa-81f88453bdf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_65199f31-e295-447f-b0a2-932d41ed328f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e7a84faa-e630-4a87-8d96-2d7151ded7fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_65199f31-e295-447f-b0a2-932d41ed328f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_75a88a5e-04f4-4df5-b114-e88b7a3817ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e7a84faa-e630-4a87-8d96-2d7151ded7fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_75a88a5e-04f4-4df5-b114-e88b7a3817ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_95e8c463-81a2-4fe3-a665-a5e9ad4a6ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_75a88a5e-04f4-4df5-b114-e88b7a3817ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_95e8c463-81a2-4fe3-a665-a5e9ad4a6ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a4d91220-b9a1-4272-b3aa-d5d6761004d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_75a88a5e-04f4-4df5-b114-e88b7a3817ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a4d91220-b9a1-4272-b3aa-d5d6761004d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a03a0b29-a029-46f5-b872-7f21fc1e97aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_75a88a5e-04f4-4df5-b114-e88b7a3817ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a03a0b29-a029-46f5-b872-7f21fc1e97aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_885557e1-b134-486d-b4c7-d6a819150101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_75a88a5e-04f4-4df5-b114-e88b7a3817ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_885557e1-b134-486d-b4c7-d6a819150101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_efacb8b8-af71-49f5-9285-236d769e538f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_75a88a5e-04f4-4df5-b114-e88b7a3817ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_efacb8b8-af71-49f5-9285-236d769e538f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_977aee8b-a86a-41b7-a7d2-943584de144c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e7a84faa-e630-4a87-8d96-2d7151ded7fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_977aee8b-a86a-41b7-a7d2-943584de144c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_186dc8ac-c5fd-4015-b288-43bf2c6623ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e7a84faa-e630-4a87-8d96-2d7151ded7fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_186dc8ac-c5fd-4015-b288-43bf2c6623ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_be9e63e6-9f0a-46f2-82b7-f300300d8bf8" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e7a84faa-e630-4a87-8d96-2d7151ded7fe" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_be9e63e6-9f0a-46f2-82b7-f300300d8bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dda2564b-d131-4c82-be9a-b1760b518acd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_be9e63e6-9f0a-46f2-82b7-f300300d8bf8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dda2564b-d131-4c82-be9a-b1760b518acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a337cdc2-7517-43cc-9d81-3078d30ddaf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_be9e63e6-9f0a-46f2-82b7-f300300d8bf8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a337cdc2-7517-43cc-9d81-3078d30ddaf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_78ca71c8-ed52-40f2-9f2c-6a43535c2d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract_be9e63e6-9f0a-46f2-82b7-f300300d8bf8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_78ca71c8-ed52-40f2-9f2c-6a43535c2d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_62621bdc-31e6-4f2c-827d-df5fad05650b" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e7a84faa-e630-4a87-8d96-2d7151ded7fe" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_62621bdc-31e6-4f2c-827d-df5fad05650b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_81f33f28-4069-4386-a23f-ab350e47635a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_62621bdc-31e6-4f2c-827d-df5fad05650b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_81f33f28-4069-4386-a23f-ab350e47635a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_8892adfa-e657-4a8c-a0ae-68962eef5dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_62621bdc-31e6-4f2c-827d-df5fad05650b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_8892adfa-e657-4a8c-a0ae-68962eef5dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_4105a5d8-fa33-4e80-a753-efe315f5d689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_62621bdc-31e6-4f2c-827d-df5fad05650b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_4105a5d8-fa33-4e80-a753-efe315f5d689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e743ee1-d34f-4fcc-b6a0-87b1dd1447f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e7a84faa-e630-4a87-8d96-2d7151ded7fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1e743ee1-d34f-4fcc-b6a0-87b1dd1447f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c41cd271-36ec-485f-9b89-c8dec8ea81f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed287fcd-8def-41b5-9043-fa78fe62871b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c41cd271-36ec-485f-9b89-c8dec8ea81f5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed287fcd-8def-41b5-9043-fa78fe62871b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1ca9bc53-4b3f-4881-8979-84697dab1fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed287fcd-8def-41b5-9043-fa78fe62871b" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1ca9bc53-4b3f-4881-8979-84697dab1fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1ca9bc53-4b3f-4881-8979-84697dab1fff" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange1Member_cdf96e94-8f68-4bf2-8cfd-f05f932d2dc6" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange1Member_cdf96e94-8f68-4bf2-8cfd-f05f932d2dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange2Member_99f975e1-6b9b-4c8d-a71e-cdef1df192f5" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange2Member_99f975e1-6b9b-4c8d-a71e-cdef1df192f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange3Member_f2b81bdd-b94d-45bb-ad64-980d4307b99e" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange3Member_f2b81bdd-b94d-45bb-ad64-980d4307b99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange4Member_7362ea7b-5283-4ab1-8529-d6649a131421" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange4Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange4Member_7362ea7b-5283-4ab1-8529-d6649a131421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange5Member_55dc8709-f4e0-4844-a696-f55f940d975e" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange5Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange5Member_55dc8709-f4e0-4844-a696-f55f940d975e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange6Member_8fcec1b5-a7af-4a6e-aa0c-5574fa9344e4" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange6Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange6Member_8fcec1b5-a7af-4a6e-aa0c-5574fa9344e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange7Member_1768b43c-c1e5-4124-bc01-cd996363e490" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange7Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange7Member_1768b43c-c1e5-4124-bc01-cd996363e490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange8Member_19178a97-6f6c-4614-83cc-87c95c3bb1ed" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange8Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange8Member_19178a97-6f6c-4614-83cc-87c95c3bb1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange9Member_0028d60e-9b77-4caa-a6f0-c287eb733499" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange9Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange9Member_0028d60e-9b77-4caa-a6f0-c287eb733499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ExercisePriceRange10Member_49e1b50d-edd3-4d07-9583-5b8cf1c2cb80" xlink:href="cutr-20211231.xsd#cutr_ExercisePriceRange10Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f8a524d2-e861-4f8a-bb6e-3e1657a87344" xlink:to="loc_cutr_ExercisePriceRange10Member_49e1b50d-edd3-4d07-9583-5b8cf1c2cb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed287fcd-8def-41b5-9043-fa78fe62871b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_67aae299-8e1e-4df1-92a1-e765daf7353b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_67aae299-8e1e-4df1-92a1-e765daf7353b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_a0b87e1a-da06-4b4d-9a07-dfb8228b9fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_a0b87e1a-da06-4b4d-9a07-dfb8228b9fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_7535b2c5-907d-4966-8123-45472fc73f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_7535b2c5-907d-4966-8123-45472fc73f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_eeee092c-7e28-42b4-9639-5c754e7504ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_eeee092c-7e28-42b4-9639-5c754e7504ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_1561d2e8-4ed2-4d30-a78e-ee6d4051c72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_1561d2e8-4ed2-4d30-a78e-ee6d4051c72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_36de897d-9553-46e1-9fa2-69e59268b076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac75493b-bea5-4b79-90e9-b04eb25176da" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_36de897d-9553-46e1-9fa2-69e59268b076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2480150b-c878-4bce-aeeb-f492f8dd3105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93820c84-9b6e-4624-96a7-38e8ddd973e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2480150b-c878-4bce-aeeb-f492f8dd3105" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93820c84-9b6e-4624-96a7-38e8ddd973e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1f260291-6399-4a06-a103-cd7e429210d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93820c84-9b6e-4624-96a7-38e8ddd973e1" xlink:to="loc_us-gaap_AwardTypeAxis_1f260291-6399-4a06-a103-cd7e429210d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2abd88d7-6f49-49a9-91fc-9fb328913949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1f260291-6399-4a06-a103-cd7e429210d6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2abd88d7-6f49-49a9-91fc-9fb328913949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4df1ccfb-91f5-435a-92f6-8096522ac1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2abd88d7-6f49-49a9-91fc-9fb328913949" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4df1ccfb-91f5-435a-92f6-8096522ac1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_93820c84-9b6e-4624-96a7-38e8ddd973e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f5d8fc79-0209-4bf9-ae64-7103d9bc8eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f5d8fc79-0209-4bf9-ae64-7103d9bc8eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8af5f51a-06f2-47f0-8aed-16425527c1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f5d8fc79-0209-4bf9-ae64-7103d9bc8eb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8af5f51a-06f2-47f0-8aed-16425527c1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_462b0fb7-c100-46d1-8b06-46a2ea71d836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f5d8fc79-0209-4bf9-ae64-7103d9bc8eb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_462b0fb7-c100-46d1-8b06-46a2ea71d836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8375895d-9db8-47de-817b-473fd25ed660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f5d8fc79-0209-4bf9-ae64-7103d9bc8eb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8375895d-9db8-47de-817b-473fd25ed660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3b5840a6-d3e1-4de1-93c1-769950448ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f5d8fc79-0209-4bf9-ae64-7103d9bc8eb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3b5840a6-d3e1-4de1-93c1-769950448ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_308a9c88-92b3-44b9-860f-9bef975ac79b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f5d8fc79-0209-4bf9-ae64-7103d9bc8eb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_308a9c88-92b3-44b9-860f-9bef975ac79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9aaa5ebe-5dc3-42c2-8068-7c1996ddf7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9aaa5ebe-5dc3-42c2-8068-7c1996ddf7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_957fef1e-f0f9-4714-b848-2ac6cb8535e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9aaa5ebe-5dc3-42c2-8068-7c1996ddf7a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_957fef1e-f0f9-4714-b848-2ac6cb8535e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4121f5fe-7bd1-4681-8917-99ac588ad07a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9aaa5ebe-5dc3-42c2-8068-7c1996ddf7a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4121f5fe-7bd1-4681-8917-99ac588ad07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3c968ec4-c478-4be1-b9a8-4d9252b3345c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9aaa5ebe-5dc3-42c2-8068-7c1996ddf7a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3c968ec4-c478-4be1-b9a8-4d9252b3345c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_3b543431-35f9-4dc8-a226-8a1df524a379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9aaa5ebe-5dc3-42c2-8068-7c1996ddf7a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_3b543431-35f9-4dc8-a226-8a1df524a379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2d30c45f-c347-44c8-bf67-69ad4df6825b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_9aaa5ebe-5dc3-42c2-8068-7c1996ddf7a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2d30c45f-c347-44c8-bf67-69ad4df6825b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue_f4880258-9bc8-4606-aad7-1f3c9682d984" xlink:href="cutr-20211231.xsd#cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:to="loc_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue_f4880258-9bc8-4606-aad7-1f3c9682d984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_a4aab501-b526-4220-bc3e-0278b098f8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_a4aab501-b526-4220-bc3e-0278b098f8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_0d1de9ab-778c-4498-8ac0-f6d7949bf5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_0d1de9ab-778c-4498-8ac0-f6d7949bf5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_d41f4919-aca7-44f1-a550-0c35603b148b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f8305d58-1732-4d3b-a230-f72fe9a02078" xlink:to="loc_us-gaap_SharePrice_d41f4919-aca7-44f1-a550-0c35603b148b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0a0239a3-6db5-4f25-b7ed-caf59c0fbf84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e6c54899-6be8-416b-ace1-d46a65147b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0a0239a3-6db5-4f25-b7ed-caf59c0fbf84" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e6c54899-6be8-416b-ace1-d46a65147b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_466858ba-1f86-40bc-a11e-2d9d6fe8ef7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e6c54899-6be8-416b-ace1-d46a65147b8b" xlink:to="loc_us-gaap_AwardTypeAxis_466858ba-1f86-40bc-a11e-2d9d6fe8ef7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e0a0399-258e-4f93-ad4d-7c9fc4be6f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_466858ba-1f86-40bc-a11e-2d9d6fe8ef7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e0a0399-258e-4f93-ad4d-7c9fc4be6f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_43dd39d0-877b-4ee9-b652-00d08ba2e37c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e0a0399-258e-4f93-ad4d-7c9fc4be6f67" xlink:to="loc_us-gaap_EmployeeStockOptionMember_43dd39d0-877b-4ee9-b652-00d08ba2e37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_00ac9f2d-dbda-4dfa-8ab7-1865e6cb696f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e0a0399-258e-4f93-ad4d-7c9fc4be6f67" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_00ac9f2d-dbda-4dfa-8ab7-1865e6cb696f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_d9c0c7fc-4ee8-417a-8d19-7f3593916aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e0a0399-258e-4f93-ad4d-7c9fc4be6f67" xlink:to="loc_us-gaap_PerformanceSharesMember_d9c0c7fc-4ee8-417a-8d19-7f3593916aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ESPPMember_2d0a60a0-ac97-476f-a120-bf10482d7651" xlink:href="cutr-20211231.xsd#cutr_ESPPMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7e0a0399-258e-4f93-ad4d-7c9fc4be6f67" xlink:to="loc_cutr_ESPPMember_2d0a60a0-ac97-476f-a120-bf10482d7651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7b30d4a-ce08-4059-b458-2297e6598483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e6c54899-6be8-416b-ace1-d46a65147b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7b30d4a-ce08-4059-b458-2297e6598483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3f07c214-d355-470d-93a8-7bdf3b6dce80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7b30d4a-ce08-4059-b458-2297e6598483" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3f07c214-d355-470d-93a8-7bdf3b6dce80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_011e0106-2d7b-4592-83d5-25e235542370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eb178851-4c7a-4db1-9c7a-ac5772160401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_011e0106-2d7b-4592-83d5-25e235542370" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eb178851-4c7a-4db1-9c7a-ac5772160401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ecd4b66d-092b-49b4-a915-8982819b78b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eb178851-4c7a-4db1-9c7a-ac5772160401" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ecd4b66d-092b-49b4-a915-8982819b78b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_01fc78a3-9c5e-44b1-83df-afb3f21c49e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ecd4b66d-092b-49b4-a915-8982819b78b6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_01fc78a3-9c5e-44b1-83df-afb3f21c49e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_1a242f99-fd5d-4d91-a474-326e088dabee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_01fc78a3-9c5e-44b1-83df-afb3f21c49e8" xlink:to="loc_us-gaap_CostOfSalesMember_1a242f99-fd5d-4d91-a474-326e088dabee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_51469c7c-41d1-4c59-94b0-8d9746f6f127" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_01fc78a3-9c5e-44b1-83df-afb3f21c49e8" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_51469c7c-41d1-4c59-94b0-8d9746f6f127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4d3a23a3-9f07-4364-9782-ae604e8c5704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_01fc78a3-9c5e-44b1-83df-afb3f21c49e8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4d3a23a3-9f07-4364-9782-ae604e8c5704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_455d898c-ce1c-4f2d-8f78-6c53f0c29c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_01fc78a3-9c5e-44b1-83df-afb3f21c49e8" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_455d898c-ce1c-4f2d-8f78-6c53f0c29c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5758ea9d-b674-4faa-afd7-f2855411df88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eb178851-4c7a-4db1-9c7a-ac5772160401" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5758ea9d-b674-4faa-afd7-f2855411df88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_c987758c-1d95-4743-8580-7152791c24ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5758ea9d-b674-4faa-afd7-f2855411df88" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_c987758c-1d95-4743-8580-7152791c24ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_865433a0-136a-48ee-857a-958a3cfc81c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0b686958-022a-4087-97fa-775077eb23b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_865433a0-136a-48ee-857a-958a3cfc81c6" xlink:to="loc_us-gaap_StatementTable_0b686958-022a-4087-97fa-775077eb23b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fb34d36f-6cf3-465a-af03-1aa86106c135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0b686958-022a-4087-97fa-775077eb23b9" xlink:to="loc_us-gaap_AwardTypeAxis_fb34d36f-6cf3-465a-af03-1aa86106c135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b43fe0f-e695-41bf-bb3a-512db3f626cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_fb34d36f-6cf3-465a-af03-1aa86106c135" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b43fe0f-e695-41bf-bb3a-512db3f626cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e3123576-bd1d-4527-bc44-f398e384cfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b43fe0f-e695-41bf-bb3a-512db3f626cb" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e3123576-bd1d-4527-bc44-f398e384cfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StockPurchasePlanMember_f3ab3ab7-fbfb-40e6-9875-dc6717c32d80" xlink:href="cutr-20211231.xsd#cutr_StockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b43fe0f-e695-41bf-bb3a-512db3f626cb" xlink:to="loc_cutr_StockPurchasePlanMember_f3ab3ab7-fbfb-40e6-9875-dc6717c32d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_cae5f371-cec5-42f9-9086-1751fbd35590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0b686958-022a-4087-97fa-775077eb23b9" xlink:to="loc_us-gaap_StatementLineItems_cae5f371-cec5-42f9-9086-1751fbd35590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b368f37c-2259-4712-babe-ff8fc49fb965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cae5f371-cec5-42f9-9086-1751fbd35590" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b368f37c-2259-4712-babe-ff8fc49fb965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_023a09b3-6385-475c-9481-1ecc0b189d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cae5f371-cec5-42f9-9086-1751fbd35590" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_023a09b3-6385-475c-9481-1ecc0b189d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_54835035-495c-45e1-973a-ed8dd774831d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cae5f371-cec5-42f9-9086-1751fbd35590" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_54835035-495c-45e1-973a-ed8dd774831d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4d68361c-5099-4cbd-a9dd-695e3460fa6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cae5f371-cec5-42f9-9086-1751fbd35590" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4d68361c-5099-4cbd-a9dd-695e3460fa6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0c0ff973-fd84-48d4-ae13-fdba7ab5996e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cae5f371-cec5-42f9-9086-1751fbd35590" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0c0ff973-fd84-48d4-ae13-fdba7ab5996e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cutr-20211231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f6c988eb-39e2-4106-b5cd-7e98d8460cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1e09a24e-125d-4cbd-ab82-037025b26db1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f6c988eb-39e2-4106-b5cd-7e98d8460cbf" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1e09a24e-125d-4cbd-ab82-037025b26db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cutr-20211231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f8a33c56-bdda-4d74-a3ce-6f56d495bdfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_e165a926-fe03-474d-920a-2af943435c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8a33c56-bdda-4d74-a3ce-6f56d495bdfc" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_e165a926-fe03-474d-920a-2af943435c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_09e46e81-73c9-466f-bd05-918015e96b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8a33c56-bdda-4d74-a3ce-6f56d495bdfc" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_09e46e81-73c9-466f-bd05-918015e96b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_823861fa-9067-492c-9b09-57c0e436ba49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8a33c56-bdda-4d74-a3ce-6f56d495bdfc" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_823861fa-9067-492c-9b09-57c0e436ba49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a546031c-6e17-489f-9369-de073d9ec525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8a33c56-bdda-4d74-a3ce-6f56d495bdfc" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a546031c-6e17-489f-9369-de073d9ec525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_25ed245f-3e5c-4b92-8e5c-160e684adb58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8a33c56-bdda-4d74-a3ce-6f56d495bdfc" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_25ed245f-3e5c-4b92-8e5c-160e684adb58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_edd58275-e18f-47c1-a2ad-5747f33fa71d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_82a550a1-8675-4e3b-b2ac-9ad5639df33a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_edd58275-e18f-47c1-a2ad-5747f33fa71d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_82a550a1-8675-4e3b-b2ac-9ad5639df33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d538f924-74ff-4d77-af3e-af329875ff93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_edd58275-e18f-47c1-a2ad-5747f33fa71d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_d538f924-74ff-4d77-af3e-af329875ff93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fc4e6276-0c32-49af-afc8-87d38a95961a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_edd58275-e18f-47c1-a2ad-5747f33fa71d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fc4e6276-0c32-49af-afc8-87d38a95961a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#IncomeTaxesIncomeTaxProvisionDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c9b4f44d-0977-4798-96b8-d04c6b524f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_87ecc406-4e67-49b6-9033-af16a3466ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c9b4f44d-0977-4798-96b8-d04c6b524f3b" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_87ecc406-4e67-49b6-9033-af16a3466ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_29ea36db-417d-4bea-b743-dca7525a1c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_87ecc406-4e67-49b6-9033-af16a3466ed8" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_29ea36db-417d-4bea-b743-dca7525a1c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2f4417e9-805f-4b89-a81f-211ba5688d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_87ecc406-4e67-49b6-9033-af16a3466ed8" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2f4417e9-805f-4b89-a81f-211ba5688d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_1b65571e-1f51-45bc-a302-2602b2015c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_87ecc406-4e67-49b6-9033-af16a3466ed8" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_1b65571e-1f51-45bc-a302-2602b2015c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bd116f3d-46bf-4276-8107-775835962ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_87ecc406-4e67-49b6-9033-af16a3466ed8" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bd116f3d-46bf-4276-8107-775835962ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_52352b34-3bda-4a84-a9f5-886f724e3ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c9b4f44d-0977-4798-96b8-d04c6b524f3b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_52352b34-3bda-4a84-a9f5-886f724e3ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4973ba52-0f95-49c6-b857-afcaaec6d9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_52352b34-3bda-4a84-a9f5-886f724e3ff4" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4973ba52-0f95-49c6-b857-afcaaec6d9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_3c734836-7f50-439c-920b-d02eee54544f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_52352b34-3bda-4a84-a9f5-886f724e3ff4" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_3c734836-7f50-439c-920b-d02eee54544f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_510334c6-4d30-487c-ba89-3e9e5ae9542f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_52352b34-3bda-4a84-a9f5-886f724e3ff4" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_510334c6-4d30-487c-ba89-3e9e5ae9542f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_835b156b-3e99-4960-b72a-87ec69bdc3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_52352b34-3bda-4a84-a9f5-886f724e3ff4" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_835b156b-3e99-4960-b72a-87ec69bdc3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_496ab805-d79c-41ef-a0f0-4d9a97783ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c9b4f44d-0977-4798-96b8-d04c6b524f3b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_496ab805-d79c-41ef-a0f0-4d9a97783ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#IncomeTaxesDeferredTaxAssetsDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_feba662a-c134-4312-ab84-8bf58c839694" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_feba662a-c134-4312-ab84-8bf58c839694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4f7129bd-f5d1-47e6-a671-4010d5719380" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4f7129bd-f5d1-47e6-a671-4010d5719380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_7ea08b30-0ee9-485b-870d-3899ace77d37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_7ea08b30-0ee9-485b-870d-3899ace77d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ad0b350e-8dac-4440-8522-534d54c8c419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ad0b350e-8dac-4440-8522-534d54c8c419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_ea7eefb2-25c9-4eff-af51-d8f317335374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves_ea7eefb2-25c9-4eff-af51-d8f317335374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_be37845e-6aac-4a30-88d0-7210622ed454" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_be37845e-6aac-4a30-88d0-7210622ed454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_3dfe5630-26a4-46de-ba57-5baf74dc757d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_3dfe5630-26a4-46de-ba57-5baf74dc757d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredTaxAssetsOperatingLeaseLiability_f7ce5ede-23d7-4ac9-881d-3a9212af3d67" xlink:href="cutr-20211231.xsd#cutr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:to="loc_cutr_DeferredTaxAssetsOperatingLeaseLiability_f7ce5ede-23d7-4ac9-881d-3a9212af3d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_93da27d1-f7f6-4405-a3f8-868f93125911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_93da27d1-f7f6-4405-a3f8-868f93125911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_98facd80-677b-4b15-b9c7-c5c1254ec128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_98facd80-677b-4b15-b9c7-c5c1254ec128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_1bbe3694-4dce-4e0e-83aa-e8baa68777f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_1bbe3694-4dce-4e0e-83aa-e8baa68777f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts_bb9bb3b5-bdbc-418a-b708-21ef9cb2aca2" xlink:href="cutr-20211231.xsd#cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:to="loc_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts_bb9bb3b5-bdbc-418a-b708-21ef9cb2aca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_e02b99e2-b77e-424c-b52a-30e81fcc8bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_e02b99e2-b77e-424c-b52a-30e81fcc8bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_902604ce-2db0-4cfe-950f-c5990de3fd73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_902604ce-2db0-4cfe-950f-c5990de3fd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_39410d1d-0827-4e4d-8240-67d07ca23da6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9c8aa27-c290-4e8b-8f61-b57a5ef4ce6c" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_39410d1d-0827-4e4d-8240-67d07ca23da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#IncomeTaxesReconciliationofEffectiveTaxRateDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_39936dcd-8441-4016-845b-ccc4c008d911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c4ffec49-7926-4370-9fd6-6f90306935f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39936dcd-8441-4016-845b-ccc4c008d911" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c4ffec49-7926-4370-9fd6-6f90306935f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1de09bd0-629b-4685-86d9-c623a34ea48d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39936dcd-8441-4016-845b-ccc4c008d911" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1de09bd0-629b-4685-86d9-c623a34ea48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent_34d145dc-dfeb-4c04-b7e9-b5e258eee135" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39936dcd-8441-4016-845b-ccc4c008d911" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent_34d145dc-dfeb-4c04-b7e9-b5e258eee135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_d82fe495-dcd3-4428-ae4e-fd4eed0c509f" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39936dcd-8441-4016-845b-ccc4c008d911" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent_d82fe495-dcd3-4428-ae4e-fd4eed0c509f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_b4445959-3b73-44bd-84a6-10be8c519180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39936dcd-8441-4016-845b-ccc4c008d911" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_b4445959-3b73-44bd-84a6-10be8c519180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent_2c0a4b53-d0c8-4bae-b601-c69869831c49" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39936dcd-8441-4016-845b-ccc4c008d911" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent_2c0a4b53-d0c8-4bae-b601-c69869831c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent_f72c8ccd-8993-4893-bc4f-5cdc7091d7c2" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39936dcd-8441-4016-845b-ccc4c008d911" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent_f72c8ccd-8993-4893-bc4f-5cdc7091d7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_433010a3-74da-4b33-b1d5-0d6f06e2033d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39936dcd-8441-4016-845b-ccc4c008d911" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_433010a3-74da-4b33-b1d5-0d6f06e2033d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_d91ede50-fbab-45ac-82d9-7d8994368bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39936dcd-8441-4016-845b-ccc4c008d911" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_d91ede50-fbab-45ac-82d9-7d8994368bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent_10c094ab-2132-4c97-a1fc-26cba0c5cdd5" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39936dcd-8441-4016-845b-ccc4c008d911" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent_10c094ab-2132-4c97-a1fc-26cba0c5cdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_f675a400-7c94-4748-a33f-252f8b8d1f0d" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39936dcd-8441-4016-845b-ccc4c008d911" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_f675a400-7c94-4748-a33f-252f8b8d1f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_2dd7555f-ebe4-486d-a66c-3b5c9c6eac82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39936dcd-8441-4016-845b-ccc4c008d911" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_2dd7555f-ebe4-486d-a66c-3b5c9c6eac82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent_09652365-c44f-4098-a7e1-be661f12680f" xlink:href="cutr-20211231.xsd#cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39936dcd-8441-4016-845b-ccc4c008d911" xlink:to="loc_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent_09652365-c44f-4098-a7e1-be661f12680f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_87686ce1-46df-4525-8698-adaf800637a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39936dcd-8441-4016-845b-ccc4c008d911" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_87686ce1-46df-4525-8698-adaf800637a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_23a0f0e6-d82c-4519-ba37-edbba8081a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_fba1e5ab-0f0c-468b-a109-a5c9377fb7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_23a0f0e6-d82c-4519-ba37-edbba8081a74" xlink:to="loc_us-gaap_StatementTable_fba1e5ab-0f0c-468b-a109-a5c9377fb7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_59ba4ebe-99ce-465c-b3d2-10b581aba9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fba1e5ab-0f0c-468b-a109-a5c9377fb7d3" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_59ba4ebe-99ce-465c-b3d2-10b581aba9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_bbc5fea9-1297-46a1-99b3-b3492241eec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_59ba4ebe-99ce-465c-b3d2-10b581aba9c2" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_bbc5fea9-1297-46a1-99b3-b3492241eec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_a1a5a63e-2d69-4fc8-8ea2-6e7abe866bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_bbc5fea9-1297-46a1-99b3-b3492241eec8" xlink:to="loc_us-gaap_ForeignCountryMember_a1a5a63e-2d69-4fc8-8ea2-6e7abe866bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_7c48b4ae-9ed1-42c9-be90-a776c533cdb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_bbc5fea9-1297-46a1-99b3-b3492241eec8" xlink:to="loc_us-gaap_DomesticCountryMember_7c48b4ae-9ed1-42c9-be90-a776c533cdb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_f7001bbf-280a-4a19-9647-3e7a53a6467d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_bbc5fea9-1297-46a1-99b3-b3492241eec8" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_f7001bbf-280a-4a19-9647-3e7a53a6467d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_a3c06451-c2cd-47f9-aa69-b25792f612de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fba1e5ab-0f0c-468b-a109-a5c9377fb7d3" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_a3c06451-c2cd-47f9-aa69-b25792f612de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_30c2c522-12d8-4a34-9c2b-52f0de3cd7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_a3c06451-c2cd-47f9-aa69-b25792f612de" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_30c2c522-12d8-4a34-9c2b-52f0de3cd7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_44af4895-03dc-496f-a421-5023dedd0b54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_30c2c522-12d8-4a34-9c2b-52f0de3cd7b0" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_44af4895-03dc-496f-a421-5023dedd0b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_039adf03-b68d-4593-b4b9-13f7e72d1912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_30c2c522-12d8-4a34-9c2b-52f0de3cd7b0" xlink:to="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_039adf03-b68d-4593-b4b9-13f7e72d1912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_0fdb3547-87ce-4607-bff7-820352269150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fba1e5ab-0f0c-468b-a109-a5c9377fb7d3" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_0fdb3547-87ce-4607-bff7-820352269150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_59f819fd-fabc-4026-a87c-425e83fe37d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_0fdb3547-87ce-4607-bff7-820352269150" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_59f819fd-fabc-4026-a87c-425e83fe37d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_ba52b9be-2ecb-4fe8-ac35-82c2d2a9afe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_59f819fd-fabc-4026-a87c-425e83fe37d0" xlink:to="loc_us-gaap_ResearchMember_ba52b9be-2ecb-4fe8-ac35-82c2d2a9afe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ae94a1f5-ad63-4653-8fc3-c218cbca9e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fba1e5ab-0f0c-468b-a109-a5c9377fb7d3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ae94a1f5-ad63-4653-8fc3-c218cbca9e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_468cee07-195f-4028-9683-aeb8715f9934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ae94a1f5-ad63-4653-8fc3-c218cbca9e30" xlink:to="loc_us-gaap_ClassOfStockDomain_468cee07-195f-4028-9683-aeb8715f9934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_21c9b7b1-6b95-4319-b680-d87d8a0758b5" xlink:href="cutr-20211231.xsd#cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_468cee07-195f-4028-9683-aeb8715f9934" xlink:to="loc_cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember_21c9b7b1-6b95-4319-b680-d87d8a0758b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fba1e5ab-0f0c-468b-a109-a5c9377fb7d3" xlink:to="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_01c23f7c-3e3e-488a-ad83-02b47f5ab8af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_01c23f7c-3e3e-488a-ad83-02b47f5ab8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_8a49bf75-2118-4b13-bf04-b6fb7c382415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_8a49bf75-2118-4b13-bf04-b6fb7c382415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_dff75c23-538a-49ab-8fca-62d688e3df5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_dff75c23-538a-49ab-8fca-62d688e3df5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_b8b6b6b7-9437-4392-822b-1712e480dfaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:to="loc_us-gaap_OperatingLossCarryforwards_b8b6b6b7-9437-4392-822b-1712e480dfaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_OperatingLossCarryforwardsWithoutExpiration_fb3fe860-3f4e-4673-a69f-2f301438210d" xlink:href="cutr-20211231.xsd#cutr_OperatingLossCarryforwardsWithoutExpiration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:to="loc_cutr_OperatingLossCarryforwardsWithoutExpiration_fb3fe860-3f4e-4673-a69f-2f301438210d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_6c549e91-ed61-4b73-a9b9-b50cdaaf6cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_6c549e91-ed61-4b73-a9b9-b50cdaaf6cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_5d120704-f8f9-4cc0-8a91-d8cf4ff31eb2" xlink:href="cutr-20211231.xsd#cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a3a22155-91ff-4d16-b146-9a29f6e1bfaa" xlink:to="loc_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount_5d120704-f8f9-4cc0-8a91-d8cf4ff31eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_501ca54b-3e1e-4ff1-b048-f90949150f75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_aac8bc49-7463-40dc-9681-c92762ad92ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_501ca54b-3e1e-4ff1-b048-f90949150f75" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_aac8bc49-7463-40dc-9681-c92762ad92ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_6ba47d69-be60-4343-b4d3-47e1f49d043e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_aac8bc49-7463-40dc-9681-c92762ad92ba" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_6ba47d69-be60-4343-b4d3-47e1f49d043e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_0677a74b-b3f0-4cbf-9bac-a3b5c1d75de7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_aac8bc49-7463-40dc-9681-c92762ad92ba" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_0677a74b-b3f0-4cbf-9bac-a3b5c1d75de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_8ca799b4-925a-477d-8653-dcc1c1dd32c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_aac8bc49-7463-40dc-9681-c92762ad92ba" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_8ca799b4-925a-477d-8653-dcc1c1dd32c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_aafaa6e0-8c4d-4143-8916-31ae8718b46c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_aac8bc49-7463-40dc-9681-c92762ad92ba" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_aafaa6e0-8c4d-4143-8916-31ae8718b46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_00b47ebc-8a98-40cf-b8a3-a373edf33416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_aac8bc49-7463-40dc-9681-c92762ad92ba" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_00b47ebc-8a98-40cf-b8a3-a373edf33416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="cutr-20211231.xsd#NetIncomeLossPerShare"/>
  <link:presentationLink xlink:role="http://cutera.com/role/NetIncomeLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e1863b97-8b4a-45e4-9bb1-10a61d72c531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_55eafb26-5d3c-44e5-87ac-b6814bb57a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e1863b97-8b4a-45e4-9bb1-10a61d72c531" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_55eafb26-5d3c-44e5-87ac-b6814bb57a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="cutr-20211231.xsd#NetIncomeLossPerShareTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e9a97470-7edf-43e6-9a4a-5b9cb128fc48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3a440bbc-8eca-464c-acd3-92fc20664659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e9a97470-7edf-43e6-9a4a-5b9cb128fc48" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3a440bbc-8eca-464c-acd3-92fc20664659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_55ec801d-483d-4baa-a10d-e9c1caa92c63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e9a97470-7edf-43e6-9a4a-5b9cb128fc48" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_55ec801d-483d-4baa-a10d-e9c1caa92c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#NetIncomeLossPerShareNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_fdfedf89-341d-4b66-a9b3-c2346bfc1a96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_9e11383d-12a5-40c9-9f3a-c7bc2471e702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fdfedf89-341d-4b66-a9b3-c2346bfc1a96" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_9e11383d-12a5-40c9-9f3a-c7bc2471e702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7eb537f6-1448-4932-852e-9456003f4e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_9e11383d-12a5-40c9-9f3a-c7bc2471e702" xlink:to="loc_us-gaap_AwardTypeAxis_7eb537f6-1448-4932-852e-9456003f4e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_62dc2517-e0ba-4b18-a745-13c4f0810cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7eb537f6-1448-4932-852e-9456003f4e3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_62dc2517-e0ba-4b18-a745-13c4f0810cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5dc008d3-fe86-47e5-bca4-bf7b0559fba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_62dc2517-e0ba-4b18-a745-13c4f0810cfa" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5dc008d3-fe86-47e5-bca4-bf7b0559fba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f38a4855-8389-43a9-a49e-ead7d4879ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_62dc2517-e0ba-4b18-a745-13c4f0810cfa" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f38a4855-8389-43a9-a49e-ead7d4879ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_a27fa309-9f75-4b80-b8c1-55f2aafc3f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_62dc2517-e0ba-4b18-a745-13c4f0810cfa" xlink:to="loc_us-gaap_PerformanceSharesMember_a27fa309-9f75-4b80-b8c1-55f2aafc3f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_4f68f246-ac09-4f43-b40b-136aaf56da14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_62dc2517-e0ba-4b18-a745-13c4f0810cfa" xlink:to="loc_us-gaap_EmployeeStockMember_4f68f246-ac09-4f43-b40b-136aaf56da14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_d51ebd6b-58c5-49d1-93a8-c4a0912ef927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_9e11383d-12a5-40c9-9f3a-c7bc2471e702" xlink:to="loc_us-gaap_EarningsPerShareDilutedLineItems_d51ebd6b-58c5-49d1-93a8-c4a0912ef927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_4329d180-26a3-4acf-8474-a554872023c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_d51ebd6b-58c5-49d1-93a8-c4a0912ef927" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_4329d180-26a3-4acf-8474-a554872023c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2ad56719-0957-4a30-9f3e-d9d1b614b26a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_4329d180-26a3-4acf-8474-a554872023c5" xlink:to="loc_us-gaap_NetIncomeLoss_2ad56719-0957-4a30-9f3e-d9d1b614b26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8218ab3c-56e7-475c-8acb-1041a3a0f0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_d51ebd6b-58c5-49d1-93a8-c4a0912ef927" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8218ab3c-56e7-475c-8acb-1041a3a0f0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_97240075-29c6-4069-a4b0-589f2e7c310c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8218ab3c-56e7-475c-8acb-1041a3a0f0b1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_97240075-29c6-4069-a4b0-589f2e7c310c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_c86c834b-00de-46a9-b4a3-8fada00855c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_d51ebd6b-58c5-49d1-93a8-c4a0912ef927" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_c86c834b-00de-46a9-b4a3-8fada00855c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a1d2b13e-09b2-4543-b71d-2b259acf9ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_c86c834b-00de-46a9-b4a3-8fada00855c9" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a1d2b13e-09b2-4543-b71d-2b259acf9ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d2780fca-2160-4803-9bac-649fd87445fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_c86c834b-00de-46a9-b4a3-8fada00855c9" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d2780fca-2160-4803-9bac-649fd87445fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_350a459e-d301-471f-9709-4920c128ef83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_d51ebd6b-58c5-49d1-93a8-c4a0912ef927" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_350a459e-d301-471f-9709-4920c128ef83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c0923b57-0a34-4f66-80ab-d2481b305f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_350a459e-d301-471f-9709-4920c128ef83" xlink:to="loc_us-gaap_EarningsPerShareBasic_c0923b57-0a34-4f66-80ab-d2481b305f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0f696b65-97e0-4c64-92c1-2e2e67b7d682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_350a459e-d301-471f-9709-4920c128ef83" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0f696b65-97e0-4c64-92c1-2e2e67b7d682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1b55e3d0-4153-4164-b30e-bc3ba1edee6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_105ea10f-626b-49b6-97d1-04ec8563ac7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1b55e3d0-4153-4164-b30e-bc3ba1edee6a" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_105ea10f-626b-49b6-97d1-04ec8563ac7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_13a0e32a-7a7a-4567-94c6-7e21623fa012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_105ea10f-626b-49b6-97d1-04ec8563ac7c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_13a0e32a-7a7a-4567-94c6-7e21623fa012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_13a0e32a-7a7a-4567-94c6-7e21623fa012" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_CappedCallSecuritiesMember_01788609-4565-47de-972a-f9d341a7c94a" xlink:href="cutr-20211231.xsd#cutr_CappedCallSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:to="loc_cutr_CappedCallSecuritiesMember_01788609-4565-47de-972a-f9d341a7c94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_47badc69-0426-495a-beb4-2d30d86c93ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_47badc69-0426-495a-beb4-2d30d86c93ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_578527e6-7a81-44c3-b22f-e8c704826c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:to="loc_us-gaap_EmployeeStockOptionMember_578527e6-7a81-44c3-b22f-e8c704826c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_aef19b28-9e6d-449f-b0da-1ffb0597d702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_aef19b28-9e6d-449f-b0da-1ffb0597d702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_27073746-4dbb-49ab-8820-41f4b688afb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:to="loc_us-gaap_EmployeeStockMember_27073746-4dbb-49ab-8820-41f4b688afb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_d433b274-f160-4aec-86f9-138e9b114fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fef27a3b-5c5d-4a20-8f97-6b105e52e512" xlink:to="loc_us-gaap_PerformanceSharesMember_d433b274-f160-4aec-86f9-138e9b114fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5e77a988-5d8c-45cd-a7e1-4665893c8f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_105ea10f-626b-49b6-97d1-04ec8563ac7c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5e77a988-5d8c-45cd-a7e1-4665893c8f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b6f196f8-642d-4d42-84a7-5706b4fcb4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5e77a988-5d8c-45cd-a7e1-4665893c8f2e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b6f196f8-642d-4d42-84a7-5706b4fcb4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#NetIncomeLossPerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_70784b96-6498-4a8d-a4ae-d20f9a62f57c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b6f3f2a4-6a55-4897-a6b5-d0d774bbf8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_70784b96-6498-4a8d-a4ae-d20f9a62f57c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b6f3f2a4-6a55-4897-a6b5-d0d774bbf8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_344d6d1c-0251-4f59-88eb-50a6a105319b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b6f3f2a4-6a55-4897-a6b5-d0d774bbf8c2" xlink:to="loc_us-gaap_DebtInstrumentAxis_344d6d1c-0251-4f59-88eb-50a6a105319b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1f060dac-3aa7-45a7-ac28-4cede8af2962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_344d6d1c-0251-4f59-88eb-50a6a105319b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1f060dac-3aa7-45a7-ac28-4cede8af2962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_3b1fcdba-1978-4ab9-aad8-c6cf46bdab9d" xlink:href="cutr-20211231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1f060dac-3aa7-45a7-ac28-4cede8af2962" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_3b1fcdba-1978-4ab9-aad8-c6cf46bdab9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_eb380404-2429-4df1-b78c-387aa79f9dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b6f3f2a4-6a55-4897-a6b5-d0d774bbf8c2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_eb380404-2429-4df1-b78c-387aa79f9dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_eed32bdc-e143-4189-89a9-1f5bc21870e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_eb380404-2429-4df1-b78c-387aa79f9dbb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_eed32bdc-e143-4189-89a9-1f5bc21870e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_3fbbfedc-7e09-4f30-bc2c-3e123558a22c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_eed32bdc-e143-4189-89a9-1f5bc21870e9" xlink:to="loc_us-gaap_ConvertibleDebtMember_3fbbfedc-7e09-4f30-bc2c-3e123558a22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4df9f467-fe16-4dd4-b7b9-c87b46a80770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b6f3f2a4-6a55-4897-a6b5-d0d774bbf8c2" xlink:to="loc_us-gaap_StatementLineItems_4df9f467-fe16-4dd4-b7b9-c87b46a80770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_24134b50-5447-4064-a535-e32f2554b62b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4df9f467-fe16-4dd4-b7b9-c87b46a80770" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_24134b50-5447-4064-a535-e32f2554b62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DefinedContributionPlan" xlink:type="simple" xlink:href="cutr-20211231.xsd#DefinedContributionPlan"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DefinedContributionPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4e0eadc4-8fae-479a-9528-ddae78622de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5e81d3b6-181f-4683-ab7a-5c644280fa6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4e0eadc4-8fae-479a-9528-ddae78622de2" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5e81d3b6-181f-4683-ab7a-5c644280fa6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DefinedContributionPlanNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#DefinedContributionPlanNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DefinedContributionPlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_950266d5-49a9-4e93-a1d4-fd37c1f6a0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution_0d443e56-51b5-41bf-9a87-85b694f05523" xlink:href="cutr-20211231.xsd#cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_950266d5-49a9-4e93-a1d4-fd37c1f6a0ff" xlink:to="loc_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution_0d443e56-51b5-41bf-9a87-85b694f05523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_aa4ee1d4-0df8-49a5-ba39-6fa8cc6ad62b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_950266d5-49a9-4e93-a1d4-fd37c1f6a0ff" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_aa4ee1d4-0df8-49a5-ba39-6fa8cc6ad62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProducts" xlink:type="simple" xlink:href="cutr-20211231.xsd#SegmentInformationandRevenuebyGeographyandProducts"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProducts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e43c07ae-3c66-4075-9709-40b2834f63ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_fd5b0d98-720c-4baa-be13-753aee8917a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e43c07ae-3c66-4075-9709-40b2834f63ae" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_fd5b0d98-720c-4baa-be13-753aee8917a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsTables" xlink:type="simple" xlink:href="cutr-20211231.xsd#SegmentInformationandRevenuebyGeographyandProductsTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2b568854-f509-44c3-a219-927c9e3eea3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_9cfedfbf-fa20-47aa-9445-1bb355fc232a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2b568854-f509-44c3-a219-927c9e3eea3e" xlink:to="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_9cfedfbf-fa20-47aa-9445-1bb355fc232a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3ec4f5ce-d157-4df8-9f07-def28b0c248f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_255a7b96-b292-4398-bed3-3d02f213b605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3ec4f5ce-d157-4df8-9f07-def28b0c248f" xlink:to="loc_us-gaap_NumberOfOperatingSegments_255a7b96-b292-4398-bed3-3d02f213b605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6075f5f8-153c-406e-8b3f-e5f6897d886e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_503a2c28-2b8c-451d-b2c6-71846618018b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6075f5f8-153c-406e-8b3f-e5f6897d886e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_503a2c28-2b8c-451d-b2c6-71846618018b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c343ba10-4ae8-4138-8376-05d764c9c3a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_503a2c28-2b8c-451d-b2c6-71846618018b" xlink:to="loc_srt_StatementGeographicalAxis_c343ba10-4ae8-4138-8376-05d764c9c3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7de37ede-e80a-4352-89bc-b42a704af9f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c343ba10-4ae8-4138-8376-05d764c9c3a4" xlink:to="loc_srt_SegmentGeographicalDomain_7de37ede-e80a-4352-89bc-b42a704af9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_53a44b63-50d1-4d8c-94c9-254c8ff6f38e" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7de37ede-e80a-4352-89bc-b42a704af9f0" xlink:to="loc_country_US_53a44b63-50d1-4d8c-94c9-254c8ff6f38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_008c50fc-36dc-4acf-82ab-75480460213a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_JP"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7de37ede-e80a-4352-89bc-b42a704af9f0" xlink:to="loc_country_JP_008c50fc-36dc-4acf-82ab-75480460213a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_AsiaExcludingJapanMember_467b8c7e-c16d-4713-b54c-33502dae3d12" xlink:href="cutr-20211231.xsd#cutr_AsiaExcludingJapanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7de37ede-e80a-4352-89bc-b42a704af9f0" xlink:to="loc_cutr_AsiaExcludingJapanMember_467b8c7e-c16d-4713-b54c-33502dae3d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_0ce1fb9e-27ff-40c8-a964-efbe351e8c5c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7de37ede-e80a-4352-89bc-b42a704af9f0" xlink:to="loc_srt_EuropeMember_0ce1fb9e-27ff-40c8-a964-efbe351e8c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember_47c03028-2530-4e5c-920f-fd5eebaf62c8" xlink:href="cutr-20211231.xsd#cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7de37ede-e80a-4352-89bc-b42a704af9f0" xlink:to="loc_cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember_47c03028-2530-4e5c-920f-fd5eebaf62c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_69f5aed6-c20f-4de7-9686-25029903b7e2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_503a2c28-2b8c-451d-b2c6-71846618018b" xlink:to="loc_srt_ProductOrServiceAxis_69f5aed6-c20f-4de7-9686-25029903b7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5c0e09bc-3a91-4164-9caa-49fccffb2a93" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_69f5aed6-c20f-4de7-9686-25029903b7e2" xlink:to="loc_srt_ProductsAndServicesDomain_5c0e09bc-3a91-4164-9caa-49fccffb2a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_d024b73e-9145-438f-9c0f-3f47b2f66f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5c0e09bc-3a91-4164-9caa-49fccffb2a93" xlink:to="loc_us-gaap_ProductMember_d024b73e-9145-438f-9c0f-3f47b2f66f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SystemsMember_cf969e90-511f-4066-8987-fdf0ab6be948" xlink:href="cutr-20211231.xsd#cutr_SystemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductMember_d024b73e-9145-438f-9c0f-3f47b2f66f6a" xlink:to="loc_cutr_SystemsMember_cf969e90-511f-4066-8987-fdf0ab6be948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_HandPieceRefillsMember_e8469ed7-4b40-4cd9-8913-927ccba3740c" xlink:href="cutr-20211231.xsd#cutr_HandPieceRefillsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductMember_d024b73e-9145-438f-9c0f-3f47b2f66f6a" xlink:to="loc_cutr_HandPieceRefillsMember_e8469ed7-4b40-4cd9-8913-927ccba3740c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SkincareMember_3317e7ee-917c-4fde-80ab-43bdfa67df04" xlink:href="cutr-20211231.xsd#cutr_SkincareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductMember_d024b73e-9145-438f-9c0f-3f47b2f66f6a" xlink:to="loc_cutr_SkincareMember_3317e7ee-917c-4fde-80ab-43bdfa67df04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_522906d6-027c-4143-b5c3-a2f312c3c597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5c0e09bc-3a91-4164-9caa-49fccffb2a93" xlink:to="loc_us-gaap_ServiceMember_522906d6-027c-4143-b5c3-a2f312c3c597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_71165396-d664-4b42-95db-3552e760318a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_503a2c28-2b8c-451d-b2c6-71846618018b" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_71165396-d664-4b42-95db-3552e760318a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_0c71936a-8a21-4357-babb-fb6f1aad5241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71165396-d664-4b42-95db-3552e760318a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_0c71936a-8a21-4357-babb-fb6f1aad5241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_eabc77bd-7740-4026-b6a4-610949e92b43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeasesTextBlock_82a63e28-5120-4d57-bb97-3f6fcd023eef" xlink:href="cutr-20211231.xsd#cutr_LesseeLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eabc77bd-7740-4026-b6a4-610949e92b43" xlink:to="loc_cutr_LesseeLeasesTextBlock_82a63e28-5120-4d57-bb97-3f6fcd023eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7fc6be6e-53b7-4e5a-9db8-0cecab7ae4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_a4cc916e-0648-4b5d-8486-d5594a35f680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7fc6be6e-53b7-4e5a-9db8-0cecab7ae4ba" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_a4cc916e-0648-4b5d-8486-d5594a35f680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeasesFinancialStatementInformationTableTextBlock_a079ce4c-7f52-440e-af34-8ebc9ec37c1e" xlink:href="cutr-20211231.xsd#cutr_LeasesFinancialStatementInformationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7fc6be6e-53b7-4e5a-9db8-0cecab7ae4ba" xlink:to="loc_cutr_LeasesFinancialStatementInformationTableTextBlock_a079ce4c-7f52-440e-af34-8ebc9ec37c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_775854bc-77ff-44a2-9c01-2091c8f02b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7fc6be6e-53b7-4e5a-9db8-0cecab7ae4ba" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_775854bc-77ff-44a2-9c01-2091c8f02b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_d22ca45e-7894-4997-8bea-6b4ca9a9f418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7fc6be6e-53b7-4e5a-9db8-0cecab7ae4ba" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_d22ca45e-7894-4997-8bea-6b4ca9a9f418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_965cff5b-fc6f-4683-a92f-55287cf1cc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7fc6be6e-53b7-4e5a-9db8-0cecab7ae4ba" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_965cff5b-fc6f-4683-a92f-55287cf1cc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_b0f4b6a7-6935-427f-863e-5e1899d3d0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7fc6be6e-53b7-4e5a-9db8-0cecab7ae4ba" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_b0f4b6a7-6935-427f-863e-5e1899d3d0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_80ff57a7-3514-4b96-b4a6-0bee18945466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_aaa11002-6965-4ef2-aa1b-e268e5d6d788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_80ff57a7-3514-4b96-b4a6-0bee18945466" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_aaa11002-6965-4ef2-aa1b-e268e5d6d788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9aaa0f55-bc8f-451c-b89d-aa690482b767" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_aaa11002-6965-4ef2-aa1b-e268e5d6d788" xlink:to="loc_srt_RangeAxis_9aaa0f55-bc8f-451c-b89d-aa690482b767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7389cee5-3325-421f-b4e2-394fd0f9eaf1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9aaa0f55-bc8f-451c-b89d-aa690482b767" xlink:to="loc_srt_RangeMember_7389cee5-3325-421f-b4e2-394fd0f9eaf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0fddb6d0-642f-4323-84a7-7cee07290d70" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7389cee5-3325-421f-b4e2-394fd0f9eaf1" xlink:to="loc_srt_MinimumMember_0fddb6d0-642f-4323-84a7-7cee07290d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_590fe737-6761-46a9-9d92-dfd4748ff8f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7389cee5-3325-421f-b4e2-394fd0f9eaf1" xlink:to="loc_srt_MaximumMember_590fe737-6761-46a9-9d92-dfd4748ff8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c196839f-0519-4e9c-ab4f-3bcf5cf7d433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_aaa11002-6965-4ef2-aa1b-e268e5d6d788" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c196839f-0519-4e9c-ab4f-3bcf5cf7d433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_469171d6-f17a-410c-9a51-c7fb3bf339cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c196839f-0519-4e9c-ab4f-3bcf5cf7d433" xlink:to="loc_us-gaap_TypeOfAdoptionMember_469171d6-f17a-410c-9a51-c7fb3bf339cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_35809d46-c941-4756-b76b-6ee19a732f74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_469171d6-f17a-410c-9a51-c7fb3bf339cd" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_35809d46-c941-4756-b76b-6ee19a732f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_0ff7f369-e2e7-458c-a6ea-9770db6953bc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_aaa11002-6965-4ef2-aa1b-e268e5d6d788" xlink:to="loc_srt_CounterpartyNameAxis_0ff7f369-e2e7-458c-a6ea-9770db6953bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d1d4d2-3cda-4c14-bd99-0bbc71a7e09c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_0ff7f369-e2e7-458c-a6ea-9770db6953bc" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d1d4d2-3cda-4c14-bd99-0bbc71a7e09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_FormerExecutiveVPAndCFOMember_b8f1457c-e8ae-4f05-8ceb-613e4efb2df7" xlink:href="cutr-20211231.xsd#cutr_FormerExecutiveVPAndCFOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d1d4d2-3cda-4c14-bd99-0bbc71a7e09c" xlink:to="loc_cutr_FormerExecutiveVPAndCFOMember_b8f1457c-e8ae-4f05-8ceb-613e4efb2df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_aaa11002-6965-4ef2-aa1b-e268e5d6d788" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeasesRemainingTerm_3f04f348-beba-4111-9ae8-595066979016" xlink:href="cutr-20211231.xsd#cutr_LesseeLeasesRemainingTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_cutr_LesseeLeasesRemainingTerm_3f04f348-beba-4111-9ae8-595066979016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeLeaseRenewalTerm_7c5fc107-caf6-4fa5-81b4-93625d6a75af" xlink:href="cutr-20211231.xsd#cutr_LesseeLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_cutr_LesseeLeaseRenewalTerm_7c5fc107-caf6-4fa5-81b4-93625d6a75af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_dc0cb023-9c96-4993-bb45-9ea4a3e0db29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_dc0cb023-9c96-4993-bb45-9ea4a3e0db29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e71ac535-3019-4f78-bf07-b464fe6426a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_us-gaap_OperatingLeaseLiability_e71ac535-3019-4f78-bf07-b464fe6426a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LessorOptionToPurchaseGrantedPeriod_af2bb707-6a20-435e-aee6-2d36c610a68d" xlink:href="cutr-20211231.xsd#cutr_LessorOptionToPurchaseGrantedPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_cutr_LessorOptionToPurchaseGrantedPeriod_af2bb707-6a20-435e-aee6-2d36c610a68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseRevenue_b4972173-291f-4890-8f34-88fe9e0c5b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeLeaseRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_us-gaap_SalesTypeLeaseRevenue_b4972173-291f-4890-8f34-88fe9e0c5b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease_8975cca4-5282-465f-928f-b05e3c2be884" xlink:href="cutr-20211231.xsd#cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease_8975cca4-5282-465f-928f-b05e3c2be884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_c5ea8323-8c2d-42fa-b553-46f1b2b6f828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_c5ea8323-8c2d-42fa-b553-46f1b2b6f828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_fd253b16-fb0d-40a5-bc2c-2aec1a451a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_fd253b16-fb0d-40a5-bc2c-2aec1a451a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_StockIssuedDuringPeriodSharesLitigationSettlement_ad3108a3-85cb-434d-9b1b-5607bf8d713c" xlink:href="cutr-20211231.xsd#cutr_StockIssuedDuringPeriodSharesLitigationSettlement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_cutr_StockIssuedDuringPeriodSharesLitigationSettlement_ad3108a3-85cb-434d-9b1b-5607bf8d713c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_051b72f4-73e3-4f31-a2c5-7f6178324e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_4a95e632-4d7b-4423-b2dd-8b053a213ebe" xlink:to="loc_us-gaap_LitigationReserve_051b72f4-73e3-4f31-a2c5-7f6178324e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a5524695-0b70-48f9-9a0b-8150cd845453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7ee242b2-3993-4a95-b798-5e0a03b97d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a5524695-0b70-48f9-9a0b-8150cd845453" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7ee242b2-3993-4a95-b798-5e0a03b97d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7eb0f39d-be1f-40ed-a1f8-c031acea4c6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7ee242b2-3993-4a95-b798-5e0a03b97d7d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7eb0f39d-be1f-40ed-a1f8-c031acea4c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7621eac6-872c-4b53-ac17-49138ddf8d0a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_7eb0f39d-be1f-40ed-a1f8-c031acea4c6b" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7621eac6-872c-4b53-ac17-49138ddf8d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9b4d3b87-2d3f-43ce-99a7-433f1389fe23" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7621eac6-872c-4b53-ac17-49138ddf8d0a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9b4d3b87-2d3f-43ce-99a7-433f1389fe23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9a5b03b5-1a0f-45ed-997e-812fc7f4fd2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_7ee242b2-3993-4a95-b798-5e0a03b97d7d" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9a5b03b5-1a0f-45ed-997e-812fc7f4fd2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0eb43110-13c1-4011-b21e-7069a0ef2f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9a5b03b5-1a0f-45ed-997e-812fc7f4fd2e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0eb43110-13c1-4011-b21e-7069a0ef2f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_675ec288-45ed-4748-a525-50e3d9a13b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9a5b03b5-1a0f-45ed-997e-812fc7f4fd2e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_675ec288-45ed-4748-a525-50e3d9a13b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_852c25dd-c2c6-435f-a6f0-0cf2eb0a4c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9a5b03b5-1a0f-45ed-997e-812fc7f4fd2e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_852c25dd-c2c6-435f-a6f0-0cf2eb0a4c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0084bfab-aea1-4b1d-9401-cd29029d582b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9a5b03b5-1a0f-45ed-997e-812fc7f4fd2e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0084bfab-aea1-4b1d-9401-cd29029d582b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesFinancialStatementInformationDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_83f68dce-fb6d-4217-b2eb-ebed47cc044d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ed4663c0-2877-496b-bcd8-263dcc94f3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_83f68dce-fb6d-4217-b2eb-ebed47cc044d" xlink:to="loc_us-gaap_AssetsAbstract_ed4663c0-2877-496b-bcd8-263dcc94f3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8cca36dc-e36b-4037-8d86-3760edf6d4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ed4663c0-2877-496b-bcd8-263dcc94f3fa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8cca36dc-e36b-4037-8d86-3760edf6d4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_55e4648a-3766-4e93-80b2-e7fd113997b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ed4663c0-2877-496b-bcd8-263dcc94f3fa" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_55e4648a-3766-4e93-80b2-e7fd113997b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f35e6c79-f162-4dd2-882e-f852be26e203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_55e4648a-3766-4e93-80b2-e7fd113997b8" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f35e6c79-f162-4dd2-882e-f852be26e203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LeaseRightOfUseAsset_a061e918-7070-407d-8142-7609b1ec4ad2" xlink:href="cutr-20211231.xsd#cutr_LeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ed4663c0-2877-496b-bcd8-263dcc94f3fa" xlink:to="loc_cutr_LeaseRightOfUseAsset_a061e918-7070-407d-8142-7609b1ec4ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_4c1d8eb6-e4c8-4f80-82da-fd484452d039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_83f68dce-fb6d-4217-b2eb-ebed47cc044d" xlink:to="loc_us-gaap_LiabilitiesAbstract_4c1d8eb6-e4c8-4f80-82da-fd484452d039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_168f74ad-d1f0-4bfe-b2f5-f9042383b489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4c1d8eb6-e4c8-4f80-82da-fd484452d039" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_168f74ad-d1f0-4bfe-b2f5-f9042383b489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_83e1c811-3714-497b-a302-635ff9cd61f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4c1d8eb6-e4c8-4f80-82da-fd484452d039" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_83e1c811-3714-497b-a302-635ff9cd61f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_1c0a5ee2-1139-44fb-b5d0-e91a637e3eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4c1d8eb6-e4c8-4f80-82da-fd484452d039" xlink:to="loc_us-gaap_OperatingLeaseLiability_1c0a5ee2-1139-44fb-b5d0-e91a637e3eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_435a012e-05cc-4fba-b820-9abc2203a2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4c1d8eb6-e4c8-4f80-82da-fd484452d039" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_435a012e-05cc-4fba-b820-9abc2203a2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_5fd8617d-3547-4c44-8f6a-80c6f0aae4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent_435a012e-05cc-4fba-b820-9abc2203a2e3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_5fd8617d-3547-4c44-8f6a-80c6f0aae4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6d460dc3-012e-429b-ae12-87164f4034b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4c1d8eb6-e4c8-4f80-82da-fd484452d039" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6d460dc3-012e-429b-ae12-87164f4034b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_66f7de49-4103-4d49-9f40-91e02ff8abe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6d460dc3-012e-429b-ae12-87164f4034b6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_66f7de49-4103-4d49-9f40-91e02ff8abe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_c521f6c6-b039-4e87-bbe2-3136967ecea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4c1d8eb6-e4c8-4f80-82da-fd484452d039" xlink:to="loc_us-gaap_FinanceLeaseLiability_c521f6c6-b039-4e87-bbe2-3136967ecea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_fc85d992-2add-4a78-98a4-38e9f7c4876c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4c1d8eb6-e4c8-4f80-82da-fd484452d039" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_fc85d992-2add-4a78-98a4-38e9f7c4876c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_3d287e94-020f-44f9-9b5d-9323df91ada6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4c1d8eb6-e4c8-4f80-82da-fd484452d039" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_3d287e94-020f-44f9-9b5d-9323df91ada6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_55246d34-86a2-497a-b455-7fbed32f6bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4c1d8eb6-e4c8-4f80-82da-fd484452d039" xlink:to="loc_us-gaap_OperatingLeaseExpense_55246d34-86a2-497a-b455-7fbed32f6bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_e742837f-c81e-4ee7-958f-ca6960b09bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4c1d8eb6-e4c8-4f80-82da-fd484452d039" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_e742837f-c81e-4ee7-958f-ca6960b09bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_1dd34f12-51b9-4d2e-897d-b44904608b35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4c1d8eb6-e4c8-4f80-82da-fd484452d039" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_1dd34f12-51b9-4d2e-897d-b44904608b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_46a48e9e-1685-405b-ab64-e979ee47fa2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4c1d8eb6-e4c8-4f80-82da-fd484452d039" xlink:to="loc_us-gaap_OperatingLeasePayments_46a48e9e-1685-405b-ab64-e979ee47fa2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_69103d43-1bf5-4070-b54b-6ecc07c75f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0ccd4c8d-b9a0-436d-8f25-9a4e0684d9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_69103d43-1bf5-4070-b54b-6ecc07c75f5f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0ccd4c8d-b9a0-436d-8f25-9a4e0684d9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1266843c-bf5d-4d55-b432-2ee9f21e4837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_69103d43-1bf5-4070-b54b-6ecc07c75f5f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1266843c-bf5d-4d55-b432-2ee9f21e4837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_48b92ad9-c529-4866-a297-814cd0c2a2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_69103d43-1bf5-4070-b54b-6ecc07c75f5f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_48b92ad9-c529-4866-a297-814cd0c2a2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e65f2913-9765-4f5e-9fca-9ab26c13693d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_69103d43-1bf5-4070-b54b-6ecc07c75f5f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e65f2913-9765-4f5e-9fca-9ab26c13693d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_01042afe-75ce-4811-abd2-75c79b1b4054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_69103d43-1bf5-4070-b54b-6ecc07c75f5f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_01042afe-75ce-4811-abd2-75c79b1b4054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive_da51c078-4d3c-4410-9395-5883298b519f" xlink:href="cutr-20211231.xsd#cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_69103d43-1bf5-4070-b54b-6ecc07c75f5f" xlink:to="loc_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive_da51c078-4d3c-4410-9395-5883298b519f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b0aae946-b53f-4810-8fef-92f533618032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_69103d43-1bf5-4070-b54b-6ecc07c75f5f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b0aae946-b53f-4810-8fef-92f533618032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_44f526c5-3866-4117-aff7-bc2ac728e6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_69103d43-1bf5-4070-b54b-6ecc07c75f5f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_44f526c5-3866-4117-aff7-bc2ac728e6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e93ae903-36ad-46e5-87f4-ac1ac3c2147d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_69103d43-1bf5-4070-b54b-6ecc07c75f5f" xlink:to="loc_us-gaap_OperatingLeaseLiability_e93ae903-36ad-46e5-87f4-ac1ac3c2147d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3a7c4f26-aaa8-4f90-b94a-580d986d64cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f9f6f73b-0fd9-46d7-81c3-785b215a79c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3a7c4f26-aaa8-4f90-b94a-580d986d64cf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f9f6f73b-0fd9-46d7-81c3-785b215a79c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_fd707146-3f7d-4ad4-a992-5d9947315a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3a7c4f26-aaa8-4f90-b94a-580d986d64cf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_fd707146-3f7d-4ad4-a992-5d9947315a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c9bd6f6f-5329-4b1a-8cbd-91fc95930ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3a7c4f26-aaa8-4f90-b94a-580d986d64cf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c9bd6f6f-5329-4b1a-8cbd-91fc95930ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_e4fae183-5fe7-42b4-89f0-d9a8836dd8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3a7c4f26-aaa8-4f90-b94a-580d986d64cf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_e4fae183-5fe7-42b4-89f0-d9a8836dd8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_26a6ff56-516d-4100-9497-defdb38862d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3a7c4f26-aaa8-4f90-b94a-580d986d64cf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_26a6ff56-516d-4100-9497-defdb38862d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_bc000c60-90d8-47c1-a6c3-90a368d83cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3a7c4f26-aaa8-4f90-b94a-580d986d64cf" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_bc000c60-90d8-47c1-a6c3-90a368d83cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_45c9d6b8-17a4-4318-933d-95eda2ddffa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3a7c4f26-aaa8-4f90-b94a-580d986d64cf" xlink:to="loc_us-gaap_FinanceLeaseLiability_45c9d6b8-17a4-4318-933d-95eda2ddffa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesLeaseInformationDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_42bf3a19-f378-40b7-905c-48f00ee7407e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a4ac4efe-9bb9-424e-bbbe-3d203dbd9b90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_42bf3a19-f378-40b7-905c-48f00ee7407e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a4ac4efe-9bb9-424e-bbbe-3d203dbd9b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_95388f8a-5df6-4f1c-a7d8-d8489bfcd5ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_42bf3a19-f378-40b7-905c-48f00ee7407e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_95388f8a-5df6-4f1c-a7d8-d8489bfcd5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_597200c4-f064-4f18-8dac-fb3fa116e021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_42bf3a19-f378-40b7-905c-48f00ee7407e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_597200c4-f064-4f18-8dac-fb3fa116e021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_e6e3aff9-34ed-4bff-b011-c74e8076818f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_42bf3a19-f378-40b7-905c-48f00ee7407e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_e6e3aff9-34ed-4bff-b011-c74e8076818f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#CommitmentsandContingenciesOperatingLeaseIncomeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1be335ca-7546-4eec-8324-42e3b9e2f208" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_b2f18927-2bc7-4859-86f7-6345963a71cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1be335ca-7546-4eec-8324-42e3b9e2f208" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_b2f18927-2bc7-4859-86f7-6345963a71cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/Debt" xlink:type="simple" xlink:href="cutr-20211231.xsd#Debt"/>
  <link:presentationLink xlink:role="http://cutera.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e128a6d8-82a4-46c5-b7cd-013cdf0678c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_5b298ab3-5a08-403c-a659-5988494689e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e128a6d8-82a4-46c5-b7cd-013cdf0678c1" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_5b298ab3-5a08-403c-a659-5988494689e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DebtTables" xlink:type="simple" xlink:href="cutr-20211231.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1e289fe4-d3c4-4ece-a0a3-6d6bc2a3ed69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock_be774b32-e15f-407d-9d28-f926441d95c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1e289fe4-d3c4-4ece-a0a3-6d6bc2a3ed69" xlink:to="loc_us-gaap_ConvertibleDebtTableTextBlock_be774b32-e15f-407d-9d28-f926441d95c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_415bf133-4cb2-4e9a-b9d1-2c3fdeac0771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_415bf133-4cb2-4e9a-b9d1-2c3fdeac0771" xlink:to="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6dbf876f-3019-46fb-bacc-5d1f6c2b9f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:to="loc_us-gaap_DebtInstrumentAxis_6dbf876f-3019-46fb-bacc-5d1f6c2b9f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a6835bf0-90f4-422a-ad83-47fc84118d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6dbf876f-3019-46fb-bacc-5d1f6c2b9f7d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a6835bf0-90f4-422a-ad83-47fc84118d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_e296e124-0b58-4c26-8af8-24631c8a71a1" xlink:href="cutr-20211231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a6835bf0-90f4-422a-ad83-47fc84118d92" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_e296e124-0b58-4c26-8af8-24631c8a71a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_e6d55e46-d5b4-4c7f-8255-65b024589199" xlink:href="cutr-20211231.xsd#cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cutr_ConvertibleSeniorNotesDue2026Member_e296e124-0b58-4c26-8af8-24631c8a71a1" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember_e6d55e46-d5b4-4c7f-8255-65b024589199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_321e693a-0e34-4cd1-8a4d-f0eb51b85d26" xlink:href="cutr-20211231.xsd#cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a6835bf0-90f4-422a-ad83-47fc84118d92" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember_321e693a-0e34-4cd1-8a4d-f0eb51b85d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_PaycheckProtectionProgramCARESActMember_4906a77b-8767-47d4-9b32-ef85157604b3" xlink:href="cutr-20211231.xsd#cutr_PaycheckProtectionProgramCARESActMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a6835bf0-90f4-422a-ad83-47fc84118d92" xlink:to="loc_cutr_PaycheckProtectionProgramCARESActMember_4906a77b-8767-47d4-9b32-ef85157604b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_LoanAndSecurityAgreementMember_11624cac-67a2-48ea-9f7a-5b78b1cbb7d4" xlink:href="cutr-20211231.xsd#cutr_LoanAndSecurityAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a6835bf0-90f4-422a-ad83-47fc84118d92" xlink:to="loc_cutr_LoanAndSecurityAgreementMember_11624cac-67a2-48ea-9f7a-5b78b1cbb7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a9bd1b3c-0b0e-4410-a10c-5968a9d7c816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a9bd1b3c-0b0e-4410-a10c-5968a9d7c816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8eac2610-c163-44c8-8338-593bac7af08c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a9bd1b3c-0b0e-4410-a10c-5968a9d7c816" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8eac2610-c163-44c8-8338-593bac7af08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_4fb42080-5690-49c4-af5c-16d54fdec499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8eac2610-c163-44c8-8338-593bac7af08c" xlink:to="loc_us-gaap_ConvertibleDebtMember_4fb42080-5690-49c4-af5c-16d54fdec499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ca57cbce-2d5c-48f5-aec3-6d854f572335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ca57cbce-2d5c-48f5-aec3-6d854f572335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_045ff5db-29ea-437d-9ca7-136a788d72d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ca57cbce-2d5c-48f5-aec3-6d854f572335" xlink:to="loc_us-gaap_ClassOfStockDomain_045ff5db-29ea-437d-9ca7-136a788d72d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8c604701-da9b-4c3a-a20a-1031771ea1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_045ff5db-29ea-437d-9ca7-136a788d72d9" xlink:to="loc_us-gaap_CommonStockMember_8c604701-da9b-4c3a-a20a-1031771ea1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_28a90d1d-b150-42f0-9376-c371bcbc476e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_28a90d1d-b150-42f0-9376-c371bcbc476e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9df4e24a-eac8-48ab-ae28-f391b809bc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_28a90d1d-b150-42f0-9376-c371bcbc476e" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9df4e24a-eac8-48ab-ae28-f391b809bc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_9aa7c8af-1408-4c63-98a5-7955458313a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9df4e24a-eac8-48ab-ae28-f391b809bc5c" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_9aa7c8af-1408-4c63-98a5-7955458313a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b9b7e465-9c7b-46b4-92f7-763a7613b7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:to="loc_us-gaap_CreditFacilityAxis_b9b7e465-9c7b-46b4-92f7-763a7613b7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_483c7e6b-f838-4213-84cd-0e7b8025eef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b9b7e465-9c7b-46b4-92f7-763a7613b7e4" xlink:to="loc_us-gaap_CreditFacilityDomain_483c7e6b-f838-4213-84cd-0e7b8025eef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_6b28b59c-7a10-4353-98db-0a856bfea457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_483c7e6b-f838-4213-84cd-0e7b8025eef3" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_6b28b59c-7a10-4353-98db-0a856bfea457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_9640aa84-bfe9-4d60-9aaf-f5d74c6de9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_9640aa84-bfe9-4d60-9aaf-f5d74c6de9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_929e87ad-81cb-4ee2-a4b3-fffc38add964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_9640aa84-bfe9-4d60-9aaf-f5d74c6de9fd" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_929e87ad-81cb-4ee2-a4b3-fffc38add964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_SiliconValleyBankMember_bbe3565e-174d-470b-bba6-cb5688167a30" xlink:href="cutr-20211231.xsd#cutr_SiliconValleyBankMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_929e87ad-81cb-4ee2-a4b3-fffc38add964" xlink:to="loc_cutr_SiliconValleyBankMember_bbe3565e-174d-470b-bba6-cb5688167a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ec9d0724-9aae-4a6e-bc26-74651f0437e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:to="loc_us-gaap_VariableRateAxis_ec9d0724-9aae-4a6e-bc26-74651f0437e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_bd8a389f-62e2-493c-9b07-4eff505144a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_ec9d0724-9aae-4a6e-bc26-74651f0437e3" xlink:to="loc_us-gaap_VariableRateDomain_bd8a389f-62e2-493c-9b07-4eff505144a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_e0dc0f8b-b873-4d90-b485-83327b7dc375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_bd8a389f-62e2-493c-9b07-4eff505144a7" xlink:to="loc_us-gaap_PrimeRateMember_e0dc0f8b-b873-4d90-b485-83327b7dc375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7a3a747b-e9ae-4048-989a-97170c5a2159" xlink:to="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ee584188-e88c-4ece-9d3d-c6a020091f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ee584188-e88c-4ece-9d3d-c6a020091f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a20fcdfc-0b60-4339-8736-92b4d5c12241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a20fcdfc-0b60-4339-8736-92b4d5c12241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_4c68f234-d5a8-4b59-a8a5-f0efb2c68a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_4c68f234-d5a8-4b59-a8a5-f0efb2c68a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_1e62f887-b8f3-4aaf-9545-1df440f75bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_1e62f887-b8f3-4aaf-9545-1df440f75bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e1bc0b94-584e-4ef0-a0c8-401ffa405e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e1bc0b94-584e-4ef0-a0c8-401ffa405e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_d00e1e5c-424a-412f-952b-f9fbf2225539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_d00e1e5c-424a-412f-952b-f9fbf2225539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_94e3ef88-84e3-4097-a3c6-e5b8466ea0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_94e3ef88-84e3-4097-a3c6-e5b8466ea0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_bb370ab0-053f-4be9-8324-34503c6cb49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_bb370ab0-053f-4be9-8324-34503c6cb49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_8dd00b65-45b5-4b97-86f5-8b6908b18bad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_8dd00b65-45b5-4b97-86f5-8b6908b18bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_15671d83-40e2-4d0a-8ebe-5f48367aee23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_15671d83-40e2-4d0a-8ebe-5f48367aee23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_52cf2d58-3cbe-43c9-b348-2a84101e9434" xlink:href="cutr-20211231.xsd#cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption_52cf2d58-3cbe-43c9-b348-2a84101e9434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_23a4061f-f7a4-4f47-98a2-4d1017a3d56c" xlink:href="cutr-20211231.xsd#cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount_23a4061f-f7a4-4f47-98a2-4d1017a3d56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_8862ab24-2b03-4d18-9eb4-2339ca43d359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentFairValue_8862ab24-2b03-4d18-9eb4-2339ca43d359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCapPrice_2c6ecd95-61af-42b3-94f9-eb3d7835961d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCapPrice"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DerivativeCapPrice_2c6ecd95-61af-42b3-94f9-eb3d7835961d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent_7a6eea35-5196-487d-80a0-b68a9914bb28" xlink:href="cutr-20211231.xsd#cutr_DerivativeCapPricePremiumOverStockPricePercent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_cutr_DerivativeCapPricePremiumOverStockPricePercent_7a6eea35-5196-487d-80a0-b68a9914bb28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_cdf6268f-39cc-490c-a9b0-4c065e66df8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_SharePrice_cdf6268f-39cc-490c-a9b0-4c065e66df8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_4a89647d-7ca4-44b5-bf0e-3be4d316d5ba" xlink:href="cutr-20211231.xsd#cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays_4a89647d-7ca4-44b5-bf0e-3be4d316d5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_74f79d24-0bb2-4959-9d1f-37ef51dbe874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities_74f79d24-0bb2-4959-9d1f-37ef51dbe874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8093144c-3fb9-409a-a223-3301514f9f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8093144c-3fb9-409a-a223-3301514f9f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_6f186c0a-7aff-49a5-b0de-c30fa7b827cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_6f186c0a-7aff-49a5-b0de-c30fa7b827cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_1bb0c22d-795d-46a3-98d0-17b0405688ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_1bb0c22d-795d-46a3-98d0-17b0405688ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_f87f6a05-60cb-4eb8-b2ca-0ab609c68c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_InterestExpenseDebt_f87f6a05-60cb-4eb8-b2ca-0ab609c68c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_57f196ea-8ef8-4d10-9c10-be06e9605ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentTerm_57f196ea-8ef8-4d10-9c10-be06e9605ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5451ee9e-875b-4592-82ff-627b72b63a73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5451ee9e-875b-4592-82ff-627b72b63a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_2b5b733b-c896-4e9d-9d1c-abee2f32fbf9" xlink:href="cutr-20211231.xsd#cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable_2b5b733b-c896-4e9d-9d1c-abee2f32fbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_30d7a31e-46cd-433a-b3d4-af1469b4b4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_30d7a31e-46cd-433a-b3d4-af1469b4b4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_c7c261cf-3a7a-4f70-8604-785a76c15172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_c7c261cf-3a7a-4f70-8604-785a76c15172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtInstrumentAnniversaryFeeAmount_a38c1e85-2fb1-494c-840e-e5e9bdae8d12" xlink:href="cutr-20211231.xsd#cutr_DebtInstrumentAnniversaryFeeAmount"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_cutr_DebtInstrumentAnniversaryFeeAmount_a38c1e85-2fb1-494c-840e-e5e9bdae8d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_DebtCovenantQuarterlyMinimumRevenue_14e45bc4-ba33-4fba-bcf4-1488185b16b7" xlink:href="cutr-20211231.xsd#cutr_DebtCovenantQuarterlyMinimumRevenue"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_cutr_DebtCovenantQuarterlyMinimumRevenue_14e45bc4-ba33-4fba-bcf4-1488185b16b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7c662d81-5511-4ea0-9e23-de27c335dd21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7c662d81-5511-4ea0-9e23-de27c335dd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_06539175-e5ae-4928-9393-f7240b385a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_84afb54e-50b0-4d7f-a0c0-bb76b1be18a4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_06539175-e5ae-4928-9393-f7240b385a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#DebtOutstandingDebtandCarryingValueDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_58ba87a0-35a2-46db-a5ae-de3495a7d728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_38f7ee19-4471-4da8-b877-508d09608cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_58ba87a0-35a2-46db-a5ae-de3495a7d728" xlink:to="loc_us-gaap_DebtInstrumentTable_38f7ee19-4471-4da8-b877-508d09608cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d958748a-07a9-45d8-9f59-7d569c3a9550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_38f7ee19-4471-4da8-b877-508d09608cb4" xlink:to="loc_us-gaap_DebtInstrumentAxis_d958748a-07a9-45d8-9f59-7d569c3a9550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8f090d60-6925-4009-92aa-74655b874523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d958748a-07a9-45d8-9f59-7d569c3a9550" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8f090d60-6925-4009-92aa-74655b874523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cutr_ConvertibleSeniorNotesDue2026Member_b2c794f7-29a9-4d22-b9f1-061a787d2063" xlink:href="cutr-20211231.xsd#cutr_ConvertibleSeniorNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f090d60-6925-4009-92aa-74655b874523" xlink:to="loc_cutr_ConvertibleSeniorNotesDue2026Member_b2c794f7-29a9-4d22-b9f1-061a787d2063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d821a426-6655-4736-bf67-61e6b31d4cff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_38f7ee19-4471-4da8-b877-508d09608cb4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d821a426-6655-4736-bf67-61e6b31d4cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9eef66b8-14d7-43d9-8cdc-d09f08c6470f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d821a426-6655-4736-bf67-61e6b31d4cff" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9eef66b8-14d7-43d9-8cdc-d09f08c6470f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_16392571-8311-4819-a731-9bbfe342e3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9eef66b8-14d7-43d9-8cdc-d09f08c6470f" xlink:to="loc_us-gaap_ConvertibleDebtMember_16392571-8311-4819-a731-9bbfe342e3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2d81442c-e625-4e77-8a58-14974ccee406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_38f7ee19-4471-4da8-b877-508d09608cb4" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2d81442c-e625-4e77-8a58-14974ccee406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_5335f696-2705-4a3d-b23b-cec3dfdb9609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d81442c-e625-4e77-8a58-14974ccee406" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_5335f696-2705-4a3d-b23b-cec3dfdb9609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_1266b8bb-6c49-40f5-8fcc-052369ec5cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d81442c-e625-4e77-8a58-14974ccee406" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_1266b8bb-6c49-40f5-8fcc-052369ec5cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_397f2afb-800a-41db-82f2-7198625100bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2d81442c-e625-4e77-8a58-14974ccee406" xlink:to="loc_us-gaap_LongTermDebt_397f2afb-800a-41db-82f2-7198625100bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/SubsequentEvents" xlink:type="simple" xlink:href="cutr-20211231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://cutera.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_00045ba4-8298-47b0-964a-471bae181700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_397077dd-7ef8-49d4-89b9-cd1dc3801929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_00045ba4-8298-47b0-964a-471bae181700" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_397077dd-7ef8-49d4-89b9-cd1dc3801929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="simple" xlink:href="cutr-20211231.xsd#ScheduleIIValuationandQualifyingAccounts"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ScheduleIIValuationandQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_b8609ac7-722f-41e8-b7c3-539ca17c9c42" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_20f75d65-cb5c-4adb-a2e2-cb4e406d453a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_b8609ac7-722f-41e8-b7c3-539ca17c9c42" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_20f75d65-cb5c-4adb-a2e2-cb4e406d453a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsTables" xlink:type="simple" xlink:href="cutr-20211231.xsd#ScheduleIIValuationandQualifyingAccountsTables"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_4a605f91-bb28-4f88-a004-4e0be89e868b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_f3d28841-5b49-4a9a-ad51-8d731c2f4abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_4a605f91-bb28-4f88-a004-4e0be89e868b" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_f3d28841-5b49-4a9a-ad51-8d731c2f4abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails" xlink:type="simple" xlink:href="cutr-20211231.xsd#ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_4559889a-c6d7-4b63-9fe7-ef59ab4c8fb3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1b94f23a-2d43-494e-ba03-0a9ae5be740e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_4559889a-c6d7-4b63-9fe7-ef59ab4c8fb3" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1b94f23a-2d43-494e-ba03-0a9ae5be740e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2a9a2d42-6a0e-40a5-b9b7-c923e51665fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1b94f23a-2d43-494e-ba03-0a9ae5be740e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2a9a2d42-6a0e-40a5-b9b7-c923e51665fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_7971c7ca-cc38-4051-a71f-2503373977b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_2a9a2d42-6a0e-40a5-b9b7-c923e51665fd" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_7971c7ca-cc38-4051-a71f-2503373977b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_7913c2be-1fe7-4e59-913e-bf9d30351193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_7971c7ca-cc38-4051-a71f-2503373977b8" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_7913c2be-1fe7-4e59-913e-bf9d30351193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_30ebec97-e3c7-4e96-aedf-0b72d631f991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForLoanAndLeaseLossesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_7971c7ca-cc38-4051-a71f-2503373977b8" xlink:to="loc_us-gaap_AllowanceForLoanAndLeaseLossesMember_30ebec97-e3c7-4e96-aedf-0b72d631f991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e5adaf38-62ff-4f5b-8dd8-2a936e71b570" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_1b94f23a-2d43-494e-ba03-0a9ae5be740e" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e5adaf38-62ff-4f5b-8dd8-2a936e71b570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_08d3396a-37f0-4ffd-b51a-47ef9bd0ab38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e5adaf38-62ff-4f5b-8dd8-2a936e71b570" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_08d3396a-37f0-4ffd-b51a-47ef9bd0ab38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_687067fc-191a-464a-83b5-eb83159b1104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e5adaf38-62ff-4f5b-8dd8-2a936e71b570" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_687067fc-191a-464a-83b5-eb83159b1104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_57dec96e-7932-45a6-8e47-c71a6cddc65b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e5adaf38-62ff-4f5b-8dd8-2a936e71b570" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_57dec96e-7932-45a6-8e47-c71a6cddc65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_7f9dd567-b85e-4957-87e2-574ffc8958df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_e5adaf38-62ff-4f5b-8dd8-2a936e71b570" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_7f9dd567-b85e-4957-87e2-574ffc8958df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0.jpg
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M 0           *#48DH8             $HMIH0!            H-1B2A@
M            2BVFA $           "@U&)*&             !*+::$ 0
M         *#48DH8             $HMIH0!            H-1B2A@
M        2BVFA $           "@U&)*&             !*+::$ 0
M     *#48DH8             $HMIH0!            H-1B2A@
M    2BVFA $           "@U&)*&             !*+::$ 0
M *#48DH8             $HMIH0!            H-1B2A@
M2BVFA $           "@U&)*&             !*+::$ 0           *#4
M8DH8             $HMIH0!            H-1B2A@             2BVF
MA $           "@U&)*&             !*+::$ 0           *#48DH8
M             $HMIH0!            H-1B2A@             2BVFA $
M          "@U&)*&             !*+::$ 0           *#48DH8
M         $HMIH0!            H-1B2A@             2BVFA $
M      "@U&)*&             !*+::$ 0           *#48DH8
M     $HMIH0!            H-1B2A@             2BVFA $
M  "@U&)*&             !*+::$ 0           *#48DH8
M $HMIH0!            H-1B2A@             2BVFA $           "@
MU&)*&             !*+::$ 0           *#48DH8             $HM
MIH0!            H-1B2A@             2BVFA $           "@U&)*
M&             !*+::$ 0           *#48DH8             $HMIH0!
M            H-1B2A@             2BVFA $           "@U&)*&
M          !*+::$ 0           *#48DH8             $JM/3DE/'CP
MX%-..67SYLW!#9F1EY<W:-"@(4.&Y.3D!+?M=I]\\LG @0,G3YX<W%"L7(H\
M??ITR<G,F3.#&XK#DB5+VK5KU[!A0_D[9<H4"9DQ8X;L3G8:C%ID&S9L" 9E
M4B9VE[G*2;1MV[:LK*Q@:.&YM.1[[[U7VN'//_\<W%!29>+@_KYD=%@
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MN"$S,K>[3%1.HHT;-U:N7+FXYF@C6_*L6;,D0K5JU8(;2J3,'=S?E\P-"P
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ME1/*[$C:JK2QGCU[]NW;5XHC(<\^^ZS&2=VP5ZY<V:M7+\U)^_;MI0CVC&E
ML;3DM6O7ZE:=2-;'2WNQ.<7KKKM.NIB\D+?2;LU._W]RL:G3/GWZ7'+))?*Z
M7+ER1QUUE#3FEBU;2JEUMGCBQ(DF)ZD+[CO47NC!]=,=!\XXXPR)]N*++YH0
MJ9#CCCM. @<.'*@AZ:4<RGW$T")+"Y<>/7GRY,AAP:6?AHX2Q5@Z
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MICN(,\\\4T)NN>46$Y)>RJ%<1@P]6'7KUC7_\> R+$3V4S])W19CZ0
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M&]AWWWTE>]]\\XTT=6EX]LKA*HV4$Z4]8D0."R[]U _K JI82@<
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ME$))S(T;-^JL=JM6K8*1X@J5<B*7$4,/EGW[M<NPX-)/0T<)6Q%+!P
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M!'(;6>30$2"R#2<Z*_9<29N,Y+HI]?#H)\F#V:J2G3QDKB7[#F.1R]=WY#E
ML7R_IQZ:DM5>,I%Y]ATJ)W4C3T8/:/GRY?6;5QUPP 'VFK=I'-!D?2ITI(T\
M>_$=#GU@Z68YRGI:(B<2IFNX%"1RP D5>=YB!A-]F[K+)ZL]/]W>'1BFBM[>
MMF_?KO=DZV2G?>*A3W26:K13DV\*"?S#'_Y@G\C9,CV@J<B6EKI?.R:21FVD
M;@]^(=M/,B[GD)'?[*%=V"7ER('7Y:>$2Q=.KW(      &K/3 G+#\B##SYX
M].C1V[9M^].?_M2]>W>738D./_QP^1WXR2>?Z-O!@P?K+\,KKKA"0[[__GN]
MHK%BQ0H->>VUU_2"PFFGG39V[-@''GA ?K'+VR%#AFB$4'EY>7_YRU^\V,_[
M.^ZXX_;;;]>'2(G*E2OOVK5+XKSXXHMZ1:->O7K#AP^_[[[[*E6J)&^OO_[Z
M8'(6\SM<4MY___U[]NS9MV_?_?;;3T*>??99C9,ZY94K5_;JU4LST[Y]>\E;
MBLOQ+KN+K"(IK_[FKUBQ8K]^_29-FM2\>7,OMMCFEBU;-(Y>#1%-FC21%"0I
M?>LE7#>Q[=BQ0Y]X)UEJUZ[=/??<T[1I4_W4A D3-,Y;;[VE1:A9LZ84]O33
M3P]$\../9Y-CU+)ERZY=NVH!Z]2I8Y8$S,W-;=BPH01*37;HT&'<N'&Z(_G(
M5U]]I7%"'Q1M+Q4>69G2C.O7K^_%+E5(5NWK+XET=TKR+V774DB%: 27RKGM
MMMM,(G)0!@P8<."!!WJQ#'BQ&NO=N[<F>_311YM=NQS0N^ZZ2T(..>00Z65#
MAP[5G$A\^Y841U)OYJ*>EJ5/GSY2@?+VR2>?U#BIV[Q?^+[O4L8SSCA#0F37
M^E8_==QQQTG@P($#-22R=YA6(>.8[*M!@P;F"+K0Q^QYL4M@UUUWG53[/K')
M;VEX)H[>R"@'UW<KU_CQXS5-R8Q\ZN:;;Y;C*&]KU:JE$22FUO_%%U\\9LP8
M.2*2FKSMW+FSV6EDP4.Y9"^RY;MD+[*WFCC:0Z4OR &2_$1F+U&R?FT71*JZ
M?__^9Y]]MKP^XH@C]#O"I39"198N<BP2:]>NU;SI9=/)DR?K6SF@TGU./OED
M>7W000=Y\6Z8./OK)RROFEZK".0D\LO"I=XB:R#94?O[W_\N@7*F(0.%A&MW
MN^"""^2UWBT=R&UDD4-' )<VG&CDR)$ZR%>I4D7R(Z.W3DA$#H^A>2B0=$RR
MDX?,M>3(L<AW^/J./ <HEN]W$T<E#DW):B]49)Y]A\J);.3)F()(A4C*\G4F
M75C>7GCAA1HAO0.:K$\ECK12S,BS%]_AT-M+-^_<N=-D<NG2I1K!I2"1 TXH
ME_,6,YCX#E];R6HOO=X=&*:*I;WI/=ER'J6WS]HG'O([2%[+1TQJ?OP,ROQ'
M4:),#VB^VWERZG[MF$AA:R.R/?B%;#_)1)Y#NGRS)W9A.6&(3-EEX(W\*>'2
MA=.N'     " VC-3PG[LIEM=:S%QA;$4FP+T*K:N%R<_(\U_+I]__OD:X8$'
M'O!BO_GU[<Z=._7W9XL6+<Q*CR^\\(*$5*]>7=^&>OKII_5G[?SY\S7DG__\
MI^[KU%-/]6-SQKJ(=-NV;?6:J1_[MW<O=H^FO>1L@/X.]V*K9'_^^><:>,,-
M-TB(_.3VW5*6BM)$(O]%.G)W+E4T8<($+_:OW[-FS=(0R:1>V_K7O_[EQZZG
MZ+&X[+++](I/;FZN3C:(5U]]53^52&\!$>^^^ZX)E!J6D&[=NOFQHZS_/-Z\
M>7/SW_IZ#<+<WO&?__S'BU6.R=YKK[VFR9K[N?5NVLJ5*YL#*GFN5Z^>%[\<
MX\>O#@\=.E3?*GNI\,C*%)TZ=;+33$%W)_KTZ:,'VESC^_;;;WV'RO&M^T[T
M0I6XY99;-.2TTT[+B:VKMGCQ8@TQEU<B#ZC0*0&SS.8//_R@$Z[CQHW3$'>F
MWO;??W^S=J7>CJ87Z%W:?&'[ODL9K[[Z:GD[?/AP?>O'UCGT8M??M6>Y] Y3
M.FGP>F^--/YX>M',%;3WWW]?0T:,&*$)FGM-CCGF&"^V2H'O4"ZI'%W[\9QS
MSM$(?FRQ1$U3EVV</7NV%VO&9F')GCU[2H@<!7WK4O!0D=GS'5I^9/9,(BEZ
MJXGCQ2[=RHZD(+I8:.KLA0KMUR9]V:HATDTT1*^]NM1&J,C2N8Q%;[SQAA>[
MG<Z/W?YUQ!%'>+&;G+3.97 P]QWJS8ZA#]>TEU=-NU78.7'YLG"I-Y<:"#UJ
M>N'^\<<?U[=5JE21M_9:EW9N78H<.@*XM.%0#S_\L%>P\[H,CZ%Y,"G80D\>
M,M227<:BR*]OEW. 8OE^-W&\Y$-3:.TE<LFS2^6X-/)06A#[>.D1+%.FC'ZM
MI'= _21]*G&D-?^ DN+L)?+0^];2S?+ZQAMO]&*S5O;=HI$%<1EP0D6>M_@%
M!Q.7+I]8>VGW;GN8*J[V]LPSSWC6/=GVB<>33S[IQ?YUQGQVSIPY7FS^./7R
MZ9D>T%S.DR/[M4LBA:T-E_90V/83*O(<,O*;W0_KPA(Y,F67@3?RIT1D%_:+
M4#D      +7'IH2+A:Z..WGR9'G]WGOO>?&;G!HU:J01].JM1O#C-P?LL\\^
M]G)D^?GY^N_&]L,1 _0W[6VWW69"5JY<Z<7HE;@77WS1BUV<LA=,DY3UG^X3
MGZ5DZ.]PK^!-'GJ9Z<8;;_3=4G[]]=>]^,6@U")WYU)%^N,\<!%P^/#A$BA)
MR>NI4Z=J(G:5ZGR;%[_F$FKLV+&M6K7JTZ>/'=BM6S?YE/S@E]?OO/..%[N.
M::Z'^K%'P)8K5^[BBR_6MTV:-)$XLCL38?OV[?O%F&=6Z0&]\\X[31P_=M.&
M9UVKJEFSIKS][W__:R)D967I;2)Z@3*R,OWX93@SWY""7A3[\Y__;*YQ2.UI
M^NO7K_<=*D?H2G<GGGBBN0ZH%TJJ5*EB_B_AXX\_]F+3G/K6=SB@0N^DL1<.
M[=RYLW0T^Z831Z;>[(=PZ_W-[FV^L'W?I8RZ$J!YZ\=O6C+W>;CTCM!6X4[+
M:"]_+4U=$]35^;9MVZ9W>"Q;MLQW*)?DJD.'#N>>>ZY9*4%LW+A1T_SYYY_]
M^)5W*84IU^+%BT\ZZ:1FS9II:W0I>*C([/D.+3\R>[Y#;_7C.ZI;MZ[I'2[9
M"Q7:KS7]TT\_W4P6_O+++W9!TMY=9.E"6UU@+-)_8SKOO//\^+7^BA4KFJ77
M_?CJEY*L+D*K]Y!)/9L(?GRA49U72+M5V#EQ^;)PJ3>7&D@\:KMV[=+<ZE>#
MF>&S1QX[MRY%#LV)2QL.I9-&/7KT,"$NPV-H'D*%GCQDJ"6[C$617]\NYP#%
M\OWN.PQ-H;67R"7/+I43>E@#C3R4%L1>L49*I'>WZTH;Z1U0/ZQ/^6$CK<O9
M2^2A]^-+-TL7T+Q)3YPY<Z:)[SL4Q&7 "15YWA(83%RZ?&+MI=V[[6&JN-I;
M__[]O?@]V8$3#ZEV+[:VO/FL/J?#++:?3*8'-)>6%MFO(Q-)HS8BVT,:[2=4
MY#EDY#>[']:%?8>470;>R)\2D5W8+T+E      #4[WM*^-IKKY6?A0\__+ ?
MOU5"U_&3WZ5^?**H>O7JNNB9N.:::[S8/\YG%Z3_++]@P0([<>/;;[^-_>;]
M;?5I]:<__4D"__G/?\KK"RZXP"OX4UGI<FTIILWT=WB=.G7L0$U-E[!S25E_
M+>O%H-0B=Q=915]]]976QMRY<^T(^K Z74#L^NNO]ZPE?)4^DU5^PYO[ %+8
ML6.'_-1?NG3I"R^\H"OW:O;Z].GCQ1[<:$?.S\\W:6[9LD7_Y=Q^_)X?NP!J
M7L^;-T^+L&;-&BN*/WWZ="^^:)ZY.FR6.Q,??OBA%YM,U=U%5J9$VR^V\)JY
MH)F,V9V9PO3C^30KDQO)*N>GGW[2<DV9,L5$UB77[/:C-T"<<,()^M;E@(HN
M7;IHM-:M6YLKYNG1>@NL^Z?U]N"##YK7J=M\H?J^8QGULJ.YU4/KOT*%"F:Y
M@LC>X<=+=\PQQ]B7TAR96_$"SS/6AQR_]MIK\GKAPH6:*VD&CN4R-F_>+!]Y
M__WW-9.5*E72\/7KU^OUS4,..>3))Y],S+E+P1.Y9,^EY4=FSZ6WFCBR=XW@
MDKU0H?W:I/_,,\^80"V(YB'MW;F4+G(L$M===YT7?[2V3H&T:=/&CO_((X]X
MUGTVO7OWEK=RZ.TX+5JT,&FFURK\@CF)_+)PK+?(&@@]:N;+7;J&'Y_A.^RP
MPTP$OV!N78H<.@)$MN%D=-)HS)@Q)L1E> S-0ZC$DX?,M61;Z%CD\O4=>0Y0
M7-_O+D-38NV%BLQS0&CE^ Z-/)0IR <??&"'2SI>[&LE[0,:VJ<21UI;LK,7
MET,O6=*4APT;IKWIZ:>?MN(Z#>F1 XX=;HL\;PD,)I%=/K3VTN[=]C!57.WM
MDDLN\>+W9-LG'GZ\L-(1-.877WRAAT9OX4TATP.:D:REN?1K(UDB:=1&9'LH
M;/L)Y7(.&?G-'MJ%(U-V&7C]J)\2+EW83[=R      #&[WM*6'_9WGGGG3DY
M.?OOO[_\B%V^?+F$''GDD;*U8\>.7L%;>_4?GY.1'_F_)6V9-&F2%[82IJXP
M^<8;;\AK78GNT4<?#<316Q533 GKS8[R(]D.U"4]ITV;YKNEK"75BT&I1>XN
MLHK,?^N'NN222_QXGD>-&F7O15<8.^.,,^S @+R\O*%#AS9ITD0?)&;3FP-T
M7;6;;KHI^,DX73U/?/_]]\%M<7I #S[XX$"XSI7JE8N//OK(BUWBL:\U//[X
MXUY\J7#?H3)7K5JEF=%+/"GH[H2]QOA33STE(2>??+*^C:R<=]]]UXNMMV;?
M;*'_N/#<<\^9$'T:G[DDZG) _=@E&+U%P(O=83-@P(!MV[:9- M%KSW9=PD(
MZ;,2^+___<]W:_.%ZON.9=0*-,LDZDV3DI2^]1UZAQ]O%7W[]C6?<J<W]YCK
MC$J.NSZP;?;LV7Y\53V=^78LUX(%"]JW;U^S9LU !/OJMC[@39URRBFZ=+#A
M4O!$+MES:?E^5/9<>JO&*5>NG-X"Z[ME+U1HO];Y)&F']J,W]8D#DF&_"+MS
M*5WD6.3'[\[1QU[J 7W@@0?L^#*\>-955TTS,-5TZ*&'>O'E5=-K%7[!G$1^
M63C66V0-A!XUO=FH1HT:^O;!!Q^4M\V:-3,1_+!Z2R;U")"Z#8<RDT9SY\XU
M@2[#8[(\)$H\><A<2_:CQB*7K^_(<X#B^GYW&9H2:R]49)Y5ZLKQ'1IY*#V@
MU:I5LP-WQ6])E"^=M ]H:)]*'&E]A[,7ET-O5@_6YX:*D2-'VA%<"A(YX"03
M>=X2&$S\J"X?6GMI]VY[F"JN]B:=1=Y.G3K5+WCBX<<FF/4HZ,W6NHBW5%$\
M[7"[84"+;&DN_3HRD?1J(W5[*&S[">5R#AGYS1[:A2-3=AEX_:B?$BY=6*51
M.0      X_<]):P7<+MW[ZZ_.<\^^VP)+%NV;/7JU;=NW:K+XGWVV6<:>=>N
M7?JC77Z%5@JS:M4J.W%#]W+666?9@68=Q35KUIC+ 8$%HB4/^J_6.FT<ZO##
M#_=BZ^"9$)/RUU]_[9BR/N-J[-BQ=IQ0J7?G4D7WWGNO%[M8$-P6H__I7[ER
M98DS:]8LLQ<_OL+>#3?<8 ?:?OWUUS9MVFAFI'22U:9-F]YTTTT:H@]OTROR
M#SWT4/##<7I!X8 ##@ANL.C,A_TP,Z6W5NAE07TFEEX!-Z1TGO70OM25Z<<?
MS";13(1D='?FSEVE-:8KN;E4SF.//>99#P/SK?N&O_GF&Q.H*]H-'CQ8W[H<
M4+5Z]6J=)54-&S:47)FM[K3>[%N93;U)/AW;?*'ZOF,9]7ER^^Z[KW0$R8G$
MESV:M0%<>H<?+YU>(RZL?_WK7UY",Y ,:.5H3K25MFO7SG<KEW1#O?3OQ6Z
M:]"@0?OV[77YS<!-HM)W]+*@%WL&GFG8C@5/Y)*]R)9O),N>[]9;$^.X9"]4
M:+_6].VE(X7>N7[MM=?Z1=A=8L[]A-)%CD5R$+53Z)53O8S[UEMOF?A"&I4$
M]NO73]\FMF3[@8MIMXI 3B*_+!SK+;(&0H^:/G'<7+M/G.&S<^M8Y,1Z,U*T
MX5!FTLC,SCH.CRGR$)!X\I"YEAPY%KE\?4>> Q37][O+T)18>Z$B\^P[5([O
MT,A#:4'.//-,.U#BZP>7+U^>]@$-[5.)=>MR]N)RZ.WI(GV2JWE.A'(I2.2
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M!QUTD 3.FS?/#I3?L:U:M=*UT4+)SWXO]H_,=F#KUJV]^,.Z O<*&/WZ]9/
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MI5Y<&LB0G3MW2O/;OGU[< ,  ''KUZ__[W__NVK5JN"&O5+)J8W,G4-F+F4
M    P)["E#              E%I,"0,           ! J<64,
M  "46DP) P           $"IQ90P             )1:>W)*>/#@P:><<LKF
MS9N#&U)N6K=NW6FGG?;  P\$-SBX]]Y[!PT:]////YN0#1LV6-O]3S[Y9.#
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MKU1%9L.&#;CAGF&N57KVV6>;-FU:H$ !N 2M1C]^?)RU1/L<95NA:P423]W
MF=9=NW:=/W\>-R;]Z:>?%#\*KA6(L'N<<CZ?;Q6(B U9>4EXKA%[^J#/B8]X
M53"%GKXA.B$[^)&++=1@AGF^[S]WFIJ0)DT:(_885]=LTM%Y#!#B: VD=>O6
MLE#!A[I"4Y,13PFEJ0!6=%H]8=$<GQ\G[!HCI;"+V,?):D I=NS8,9^?KAE9
M8>YN#<4*Y8:Y:S'<*X5D YJZ.W;LB+/_^"U42$@(-(Z0E1C!0X<.H6<=)<3%
MCHT:-8+_MV[=0F6@$#3Q;SF5D5]OP( !1MRS464_^!6%:\'4*=VVZ,?1AVRU
MEFC7CJN^?OK0#*&ITL% KJ/DKGGA";\T0[98TUE8JAVA%SO7)!*2Q1?T!(HA
M_%F[=BVYZD0$RWN%"A7^"52JII1%HC+6GJ=F$V!-#5MTDLA5 70"D6L 1%.?
M':H:I9>../BW9<R8,88E=@</'L00<%6W-3&5KIIU-"0T0M:I"1&'NDBG=7 -
MA&$8AF$8AF$8A@DT$KU)^,:-&SC^=#A2\=BQ8X8YE8!?6 \9,@0NJU6K)OO!
M&4!E!@KW4,7M-'&6S?E0KJM7K^*#Z,0X3^#C6K9L*0NK5*D"PJ%#A\+___WO
M?X:Y@&_0H$$T6;-FS1K#G!C"DZMPAV1Y3(X;0BJ[B>(G_PL7+L1+G8C(W+QY
MLU>O7F%A87#7XX\_[C#(IP/SSI\_+\M__?57E!\^?!@N7WCA!<,RW68%DZA+
MERXDT<GKR,A(]+-OWSY9_O333QN6I</"W['35P"<N.S6K1M>+ENVS+!\IF"%
MIJ2W;=M&0GRH8=HG2+AERQ8C=NM(G72S?7-O585X]MEG#7/%AKP0!S=%[->O
MG_#WXZPEVN<HVPI=*Y!XZ@;NT[ADR1)<@U*R9$G%@Q77"H120)[XQDTUJ7[P
MK0(A?9//-02>>^XYPUR8Z'/BR^@73*&A;S(Z(7OR(Q?;=NW:&9:S-@\=.H1Q
MQ\1QS297G;]]^S8&&!$1(<M??OEE$'[UU5>R4,:WND)'DV6Y;4+I*( M.JV>
M57-\?IRP:XR4PDXI)I>CS9LW&][4KK;H1%8&RB86,6#4J%&*J\)T<VD7*![.
MT<^8,4.82P93I4J%3KB,$G%50J!&C1K@IW___O!_QXX=^)+*6D97_%Y."?GU
M.G;L:-AM>XM[/C=NW%AH%$R=TFV+5W$4WF2K;8EV[;CJZZ</S1"^CV(7A(RC
M_SI*[IH7MOBE&;+%-IVMU8[0BYUK$MV(W1,X;]Z\ITZ=JE6KEA%7>W4B@D8^
M1>?7K5L'PHP9,\I"!6O/4Z<)L$T-6W22R%4!= *1:P!$7Y\]535*+YWPY-\6
M7*#\UEMOR<)Y\^:!$&KC.W?NZ'35K*,AH1&R3DTH8UL7Z;0.,K:!, S#, S#
M, S#,(&&H0H2(5FS9H7!Y_;MVV4A#(9KUZZ-&QLN6;+$,"=<T G'^=V[=Y?]
MO_;::T;L)!J!>ZCB:4]X&&WUZM5E#_#0JE6KMFS9$L_DV[1I$_C)ER^?[,<6
M?-SPX<-E88X<.>AQ,/B'_TV:-)$]X @?QMMXB3LDRZ-N7/8G?_U]^_9M//Z*
MIO)U(E*C1HWLV;/+VT+^\,,/AHEB:I615YO)\IX]>QJQ>S#&Q,2D-G=^<]UR
M#9,(Y[()U[Q>NW8MOL.Z=>O(P]&C1S$1=NS8(1(R=OH*\/SSSX//Z=.GX^7@
MP8,-RW($*V2ND*<4\:%T<"""1XW2V<FNZ6;[YCJJ8N7RY<LXQ7GDR!$2GCMW
M#I>_+%JT2/CU<<)#B?8MRK9"UPHDGKK1H4,'PZP-LF3) G_FSY^O^K#@6H'L
MW+G3,&<&9:W J4"J'WRK0# B1MS\/7GR).8OGJ_L6^+[5C!U]$TG9!T_<K'%
MO>A??OEE\B]B3X7,E"D37KIFDZO.0X6)4\\K5ZXD#WOV[,$7^_'''Z7[XN!;
M7:&CR3H)Y:H MNBT>K::X]OC;!LCI;#CX]*E2R>GV*1)DPQO:E=;7".[:M6J
M @4*E"Y=FESOWKV+-FQE]:H5W/*T9LV:Z=.GA^Q&'<B=.S>49:P$Y*-G7950
MQ&XMCJ4)]R6F'-'$7^74%OGU<'TAKI$E+EZ\B&NCO_WV6Z%1,'5*MQ6=./J<
MK;8EVK7C*K3UTX=F"$.63QG [TLR9,B QD)7)1<:>6&+7YHA6VS3V;;:T8F=
M:Q+AUM]0$?WUUU\B]F,.R +YHQ#7B*"ZRDH%U*E3Q[ <8ZQ@[7GJ- &VJ6&+
M3A*Y*H!.('(-@#CKLTY5(S?W.OYM*5NVK&&I2?"L=PA3Z'75;$=#KB&[UH0Z
M=9%KZZ 3",,P#,,P#,,P#!-H) 63,(Z6!PP80!+<+-&(M0OBSE<U:]9$5QRL
M3ILVC?R+V'.;Y&EWVD/UY,F3(G82)&/&C#1/%!455;1H44,:DT^<.!$NWWCC
M#0K$$_@X&$N31'D<GB[6N7-G\K!__W[<D)"^"L<=DF7;)R[[DW<3I>D&6M"C
M$Q&<C^C=NS=> E>N7,'70ZNJ)\+#PXVX:7OZ]&D\J^R33SX1IG46P\$U6 Y@
M$NW:M4L6NN;UR)$C\;)7KU[D!Q+$,$_RPSF7A(N=I@) 7N!&=I [*&G:M*EA
MMQQ! 9=TY,F31Q;B0Y79P$Z=.H&P5:M6>.F:;K9OKJ,J5E#E /F$VG???1>%
M>_;L$7Y]G/!0HGV+LJU0IP*)CVZ@TN*Q?T\^^:3.VCO7"@0M6[*JX#:#AE0_
M^%:!8$2 6;-FD3><?LV;-R]Z\RWQ?2N8.OJF$[*K'Z78XD%]:=*DH:GS??OV
MX60KJ:MK-NGH/&XK*K<%C1LWQD#.GCU+0@6?ZPI7379-**&A +;HM'JVFN/;
MXVP;(Z6PX^/*E"E#'H0EQ7Q[NFMD<5D>J-SUZ]?)#_@WS'UQ26(+%0I#,@G@
M5ADA(2%9LF21O[!Q54*R$D&*B=AU8\H*6E?\54ZM**\W?OQX^)\_?WZY(L5E
M=I"\:(=S+9@ZI=N*3AQ]SE;;$NW:<17:^NE#,X1-H;SO>J-&C0S)Q.BJY$(C
M+VSQ2S-DBVTZVU8[.K%S3:)OOOG&D-:P7KIT":W:\A;]KA%!0S(4[8L7+Z*'
M@P</8CC.QQC;]CQ=FP#;U+!%)XE<%< U$*4&0)SUV;6J49I[5_^>P!<("PNC
MVO78L6/XF=?LV;.%7E?-=C3D&K)K3:A3%[FV#CJ!, S#, S#, S#,(%&4C )
M]^G3QS"7;L#(_.[=N[-FS<)OZDN4*($FP"9-FL!ESYX]T3\.I+_^^FO:@NS2
MI4N&R:E3IRC8GW_^&22//?887L)X&$_8:M6JU?W[]P\>//CVVV_C73"D1S\X
M4RP;(VVAQ\E'?.'C8*".EQA4KERY<$[DCS_^R)<O']X%3D+:(5G>W@V7_<F[
MB<Z8,0,DQ8L7)XE.1'#6 !)JP8(%X.?V[=NX/B9Y\N3PGX*RTJQ9,_#VQ!-/
MX(H'R!'<0RQ;MFPX7[!HT2+TH-X9%TRBD)"0.W?NR'+7O*;IUSQY\AP]>A3\
MC!HU"B7T@7_"Q4Y3 8X<.6*8RU#H<1B.8F6T CEKF%,\\#BZ%U=+0,1EGY4J
M53*D$^Q<T\WVS754Q0I-YWW^^></'CRX=>O69Y]]AA(C=J[<CX\3=B5:^!IE
M6Z%K!2+BIQLX)XA,F#!!=;:@4X$L7;H4_>S9LP?\@R:D3)D2)5@_^%R!H+X9
MIAX>.W8,<FWX\.&X-HY6O?N6^+X53!U]TPG9U8]2;"%;41->>.$%J-;@Z3B3
M#K1KUT[H99..SM>O7]\PVP(()SHZNE^_?N@A2Y8L%*P5G^L*5TUV32BAH0"V
MN+9ZY$?1'-\>9]L8*84='Z><V8PI-F+$"+ST[>FND07]@22%2U )-$P>.G0(
M0X8G*J$I0)@8E"&=H%FZ=&F4?/311[)G5R7$=8VI4Z>.B8D1L?L2#QX\&&__
M^../"Q<N[+JSJ+_*J17E]?[\\T],M__^][_"+*>#!@W"I^ [ZQ1,U])MBTX<
M?<Y6:XG6Z;@*;?WTMAD2L?4)Z.V%"Q?@<O3HT7@[[9.LH^1XZ9 7MOBE&;+%
MFL["0[7C&CNAD42H\W+QP>I%KJ5=([)__WX,%O0-+J'JAO='R=BQ8RD<*[8]
M3]<FP#8U;'%-(AT%< U$J0$09WUVK6J4YM[5ORU0,.D=H#J"S(+:%1<?/_OL
ML_BVKETUV]&03L@Z-:%K7>3:.N@$PC ,PS ,PS ,PP0:2<$D?./&#5S^8IB?
M*N.?'#ERT#09GNY&BPD*%BR(?@ 8S8K8"0@8[5.8(O8+:WD/U2E3IN!=]!0C
M]JMY!*=RY"T9;<''*4=\*8^C;?%"0D)RY\X-?T)#0^$6(_9 *=PA.3P\7 X$
M=TB3=Q/MWKT[2)HU:R;Y<H_(F3-G'GOL,93#V!Z/0U/\V'+RY$GTG#)E2IJU
M@:? VZ*' 0,&&+';FCF 200YI<A=\[I,F3*&>5"B828=[@MJQ#VH+.%BIZD
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M@$TPCP1J]<+"PO+FS9LS9TZ:Z$"J5JVJWI,4"6J3\+OOOBMG.3!TZ%#54Y)
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M.S/ZPSJ'D4B0HS^]HZ_SR-6K5P</'@S=F$:-&GW[[;>@_-A=QRE!Q7.PX>U
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MSF\"6H="&),HY_;!Y>W;M^6@/*&CGY[41O;C"5>3L',<G5M)AQ>S9JZG0@&
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MKEV[0I&C<&C1&[7<3SWUU((%"R!J.%\,O_*)ZPKZZ:R,KI]YYAF([]RY<Z7
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M>\:,&3!LH+&T%?UTIM&ULM3 $U:3,$";^Q.R29@VO:04@[K@L<<>0Z$?3<(
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M?2=[=IW8]#3R9827)AA$<\8 @:PD/];)GZ#%V23\T4<?1<<>9X;H5#6N!2$
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MI"B1&I D&$-/ MG?YS>?;X[#[&830H"POIY_Y+%[YLSL[F3.F=EY[YPY<.#
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MU/3IT^?-F[=Y\V;W9.00SB !@$]$P@             0L(B$ 0
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MRWOTZ"$56K5J-7;LV-.G3YM)NC:^^^Z[^/CXT:-'-V[<."PL;/CPX;)8QP(
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MJU>O_G^G;RVK7+ER&S9LT I;MFS1DD.'#K5NW;IHT:)Y\N2I6K7J@@4+S$*
M"^4G$G[UU5=ET@TWW.#Q2D=^__UW*;?L'/3YYY]_^>672Y8LJ1OMR)$CM<ZM
MM]XJ3\N7+]^C1X^>/7M*37E:JE0I;6Z__OJKE.N8[2U:M)#')T^>]'A%PJM7
MK];%WG'''6^^^>9CCSVF >J++[ZH%3+2O'ESG5$6-7;LV,.'#[MKV+(>":L"
M!0K(>SYSYHP.*6_90<[@P8-E"::.B83KUJTK3Z75=^G29>C0H:9I;]RX42O,
MGCU;2ZI5JR8+:=^^O=Z_V:QG71NJ5JU:LI[EX^C33S[Y1.L ,+9OWZZ-2)IJ
MITZ=EBY=ZOQEE9,.,1T4%/3HHX\.&#! 6JO.6+QX<;VTU]7IK5JU2IN>M,%W
MWGFG:]>N^IN8\/!PK?#IIY_J ILT:2+-N5&C1KK #S[XP+RH3WXB8>DW]$4G
M3)C@+,^T;S&]5K%BQ=Y[[[TA0X;HD SFW69D\^;-^_;MT\=$P@       ,A5
MB(218Y8N76IE(1)>NW:MWI+0.?ZD2DY.+E6JE)Z'O>ZZZYQ#4(H&#1I(>;]^
M_>2Q=R2\?/ERG=&E4*%".W;L\-C77,K3BA4KNJX7# H*FCIUJED.<$%\1L(I
M*2GCQX_7P*-QX\8>KW3DDT\^L>SLQ%QSEIJ:JE?(M6C1PF/_,$*WSU]^^44K
M;-NV34N<=P[VOI>P*Q)^[+''+/MW$CI6L^C6K9MEYQRNRW]=XN+B-)-6>?/F
MK56KUK!APV)C8YW5LAX)RQ*DBSASYHP.T%JF3!G+'LU5$VY98XT:-=+7TDA8
M.@I].GWZ=%V.S%NG3ATI>>*))SSV-86AH:&6?=]3,UBT5-:Y(B,C/8Y(N$V;
M-OI"ITZ=JERYLF4/-J"S '!Z]]UWM=6H&V^\L4.'#@L6+'#U&'__^]]EZL"!
M TW)BA4K=)9=NW9YO#H][=_NNNLNTUJED>:Q;=FR19X^^^RSUOD-LVG3IE8&
M6:^31L(5*E08FN[MM]_NU*F3=%GZ?DJ7+JWCZJM,^Q9/>J\EQRK1T=%:8@9F
MD&,)+<G40P\]9!$) P      (-<@$D:.R4HD?/3HT7+EREGVM8\FHS+V[-FC
MIUPM>^#*SIT[FV$JO_GF&RF\^>:;];IA[TAXPH0).F/'CAWW[MU[\N3)<>/&
M:287%A;F2<^N5(,&#>;/GS]ERA0=4E+^9CJ.+N"31L+Y\N6[+5W9LF7U1P^6
MO1GK96>N=$2VO0<>>$#F=2Y*DYB&#1O*X]V[=^L25JU:92I$1$3(<LPXJY[,
M(F'9JG4A<^;,,16DE14L6# T-#33^V?'Q,3\^]__UB48A0H5<BXMZY'PXX\_
M;BK$Q\=;]LJ1CVD*-V_>K"^AD7"G3ITL.XYRWDQ4/JG.>/KTZ:U;MVK]=>O6
MF0I"<Z"V;=MZ')&P?!93H7?OWI8=))L2 $YCQXZ5IJ=MQZA7KY[9:R<E)4F+
MKERY\J%#AYPS7G?==59ZDW1V>GKC!C%JU"AG?1T11)JD/&[=NK4\?O311\W4
M;=NVC1PY<MFR97_.X(M&PAF1-[EITR9G_4S[%D]ZKV428J57_0X?/MQ9Z >1
M,        '(5(F'DF$PCX>/'C]][[[V6G9_]\,,/[LD>S^G3I^?-F[=RY4H]
M8RO>?OMMCWT%8<6*%>7IE"E3M*9W)+QNW;I77GGEM==><U[)-'#@0%U.7%S<
MQ(D3]?%##SUDZFS?OEUOLYKIT)2 3QH)^U2B1(FOOOI*JWG?5M/IP($#LV;-
MTKOMFJBR>/'BEAW!MF_??M&B13XOZO4?">_8L<.R0P[7?7-]+BHCNW?O'CQX
M\#WWW&,^ES29#S_\4*=F/1+NV[>OJ:!]1:5*E4R)*ENVK)4>">LUA?)WI\.6
M+5MTX.M=NW9)7V'9(V^[%C)RY$C+;N:>]+6A8W<;>K?46K5J.0L!."4G)TOS
M:=6JE0YQKZ0?D)VINZJ][_[QQQ^EH]#;GZ]8L<)S?J=G+LQ=LF2)LT7KOEZ'
M1A@S9HS6"0T-E5;L"IO]T$CXFFNNN?'&&XL5*Z8+4>^^^Z[S^F"5:=_B2>^U
MOOCB"^>,0X8,D<)V[=HY"_T@$@8      $"N0B2,'.,_$C8#,XJ//_[8/=E+
MQXX=I>;UUU^?EI:F5T]6JU9-AW[U^(J$?3IZ]*B^XNK5J^?,F:./O_ON.V>=
M)DV:2&'7KEV=A4 6:21<N'#AY]*]\,(+PX8-D^U--C]3S3L2/G'BQ(0)$^K6
MK5NT:%'=,I6)A,V%[ZI4J5*]>O5RY3'^(^&HJ"C+3J;_G.$B[-V[]_777[_F
MFFLL^_-JKISU2'CBQ(FF@F8_M6O7-B5*+_#52+A2I4KFLWN35JROXGII,6O6
M+"DO6[:L)WUMW';;;<X*4Z=.E<+[[KO/60C IY24%&F2__SG/[7I.>_X$!T=
MW:5+E]MOOUU_665X1\)F1'>?[K__?H]]A_4J5:J8PKQY\S[RR"/FSN)^N.XE
MG)24]/[[[^M]B*6#];X7<J9]BR>]U](/8DR9,D4*:]2HX2ST@T@8
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M]&EC[-BQZ>_"-U<DK$:/'JVS#QTZU%GNR4+?XDGOM;27,[2[<_W$Q \B80
M     .0J1,+(,7XBX>>??UY/SG;OWMT]S;ZYZ9PY<W2T1N/DR9,ZR_+ER_4$
M;D;TWJMQ<7'1T='>MT>]]MIKI<["A0M__?57K7_X\&%GA4&#!DGADT\^Z2P$
MLBA[D7#__OUU:VS9LN6,&3-B8V.E<,"  9:OH'3;MFU]^O31097%P($#S23_
MD?"Z=>LL>^AI,U4E)27Y'SNZ;=NV,F/CQHW=$VSZ3D:/'NU)STBJ5Z_NK* #
MMON)A#_[[#,IJ5JUJBE1>O6>1L(ZUZ1)DUQU#%VE=]QQAZO\XX\_-F^)2!C(
M.MD76[;UZ]>[IZ6WK")%BGCL';1T+/*T7+ER@P</EJXF.3DY)27E&GL4 ;W[
MK[/3TY;H/<R[3[)PZ5C"PL+TXN,"!0K(PMV5''Q&PFEI:?HC&YE]^_;MSDF9
M]BV>]#JN,45&C1IEV5<>.PO](!(&      ! KD(DC!R3420\:=(D^R2SU;%C
M1]<DU;!A0YGZ\LLO.PMW[MRI<^W;M^_55U]M=;YJU:K)I#)ERLCC8<.&2?VZ
M=>M*2>?.G9T+V;MWKR[DEU]^.77J5/[\^2W[7H;..NW:M9/"(4.&. N!+,I>
M)*S7VSW[[+/..D\]]904RB2/O>F.&3,F(B+"3$U-3=4;^CJO:/<?"1\Z=$BW
M_P,'#I@*XA__^$>! @7FSY_O+'1ZYYUW9*YKK[WVS)DS[FD>C[1QF2HOY$F_
M:/CVVV]W5GCNN><LOY'PJE6K+#NJ<5[Q'!\?KRU4(^'P\'#+:T1W:<5OOOGF
ME"E39,:5*U?JFSQ^_+BS3O?NW:6\29,F'B)AX$*DI:7ICZBDE;FG>3R3)T^6
M2=*<Y;'L1BW[0EO909L*>O-R*WTGZ^ST-FW:I).<35XL7+CPW7??7;Y\N3R>
M,V=.W[Y]8V)BS%0=Y\#RNEK7Q6<D+&2Q.KOKURV9]BV>]%[+=8&R]-A2V*%#
M!V>A'T3"        R%6(A)%C?$;"L;&Q-]QP@V5?R^M]2S^E0S?+C,[\Z957
M7I'"ZZZ[SGL$2X^O>PEK,E>F3)F3)T^:0@V'2I4JE9J:*D^;-V\N3\/"PDR%
MQ,3$ZZ^_WO*Z& C(HNQ%PB5+EK3.'T3]]]]_EZU7"FO5JN5)OR O?_[\O_WV
MFZG3OGU[Z_Q(6,=47[!@@2EQAJ#GSIW3*^R=%Q;_]--/ENW@P8.FT&71HD5:
MIUFS9JY46"\+#@H*^N.//SSI24_!@@7UJ<<>>_:FFVZR_$;")TZ<*%:LF.N-
MO?[ZZ_JB&@GK-=/2/&7-F#HZXG2>/'GV[]^?D)!0H$ !>?K^^^^;"L>/'R]<
MN+ 4#AHTR$,D#%P@Z:.D=<A>6W;HSO+3IT_K(/8]>O20I^/'C[?L';2T=U-G
MV+!AVH2CHJ(\YW=ZTC!U.&AIYJ:^=!K%BQ>7PF>>><:3/OS 2R^]9"H<.'!
M%YB]2%A(;ZE+</YN)M.^Q9/>:VG^K9*2DO0C3)@PP13Z1R0,      " 7(5(
M&#G&9R3<IT\?/2';LV?/$5XTOEV_?KW>@+!#AP[)R<GGSIV+B(C0FQ3VZM7+
MN31CA%<DO&;-FCQY\DAABQ8M9+%GSYX=.W:L#CLY<N1(K:/O4/3MVS<E)>78
ML6,-&C20IR5*E$A*2C*+ K(N>Y%PK5JU+/OB6KU^=__^_7K=L @-#962@P</
MZM/FS9OOW+E3-M=OO_U6+^!S9BH5*U:4DO#P\"5+ENC8JJX0=,B0(98]=O27
M7WZ9EI9VZ-"A&C5J2$FU:M7,0GS2R^XM>P3FX<.'+U^^/#(RLFO7KCHPK%[*
M+!(2$K1:TZ9-#Q\^'!L;*ZU22_Q$PF+PX,&6'<#(QY&&*:M1VZ^5'@G'Q\=K
M ",K318KGV[6K%DA(2&6X_[!\G[D:7!P\.S9L^73Q<7%U:Y=V[*3*KW4CT@8
MN" K5JS0EI@_?_X77WQQ^O3I:]>NG3)E2N7*E;5Y+EZ\6*I%147ITU&C1LG>
M5CJHSS[[3'>X0GH;CU>GIUVE+';RY,FRE]^]>[>.BR T?N[8L:-E)[72TD^?
M/KUW[][6K5M;]NV'Y>F?;]&+GTAXTZ9-^G$>?OAA4YB5OD5[+<N.J,^<.9.8
MF"B=O&7?I-S_FW$B$@8      $"N0B2,'.,S$BY?OKR>5_5I]^[=6NVEEU[2
MDD*%"NF965&A0@7G);].WI&PZ-2ID\Y8L&!!/>%KV8'6J5.G3)UFS9II>7!P
ML(Y2&Q04Y+H<"LBZ[$7"$1$1NAWFR9-'QV&V[,O9Y:]L_QKNOO#""UINV9NT
M/BA>O/B1(T?,8LTU<&+KUJT>KQ T*2GIUEMOU0K77W^]9C;RU_]5=T+:IE[L
MZZU*E2K.:Y=UF&@GO7;9?R1\[-@Q#:<-#;R%&=':7'1HTF++;KE;MFS1"K&Q
ML:5+ES9U])<E8NC0H5J!2!BX4)JP^C1FS!BM([OF<N7*:6&Q8L5TKRW=5)$B
M1:ST&S&X.KWX^'AS0W3+T:C;M&FC%6)B8LR.6P< 4/W[]]<*&?$3"7O21P<1
MD9&1IC#3OL5$PI;]N?0W:E)YRI0I9B&9(A(&      ! KD(DC!RS>O5JR[+*
ME2OG+'2>V/5F(N&S9\\.&C1(S[I:]HG7)Y]\,C$QT;DH)Y^1<$I*2O_^_<U"
M@H*"GGCBB1,G3CCKG#MWKENW;B9@DW?[T4<?.2L %T2'.V[8L*%[POEFSIQI
M.=(1V0Y[].AA(LR0D)!>O7K)MJKM19J2QPY=.G?N;.I8]N\;-F[<Z%SLCAT[
M3**L2:IW"!H?'U^W;EV3?)0I4\89C?AQ].C1MFW;ZF7!JEBQ8DV:-(F+BW-6
MD[?=N'%C\P.+L+ P_76(_TC88]^\4QKC;;?=%AP<_.BCCZY:M4H3([VQJ/K\
M\\^+%BUJWD"5*E56K%CA6(;G\.'#M6O7-I^N<.'"GWSRB9GJO38\Z?\+<Z$S
M !=I.";QM>Q[!H>&ADZ:-,E9)SHZ6AJOJ2/-7'HG'9-9FK/'J]/SV'V1= NF
M3Y.^Y>677W;^9FO)DB7.GY%)?R@+U/L^^-&[=V\KXTCXYY]_UJ,"5Y/WW[=H
MKR6')3J>OV4/ICUMVC3' C(GZT%FO* 4&0       +ATB(21BYPX<6+5JE6+
M%BWR$P9GZN3)DVO7KEVZ=*DK#'8Z<^:,O-#FS9O=$X#+*#X^?MFR9>O7K\_H
M-ML>>V1FV5:CHJ+V[MWK\[[:8M^^?8</'W:7GN_HT:/2LK9MV^;GM7Q*24F1
MN>;-F[=KUR[W-(>DI*3%BQ<[[\WIARQSSYX]WA]'+Q3>L&&#LU"JR4M'1D;N
MWKW[W+ESSDF&O*Z\^O;MV[V7"2![CAPY(GO2)4N6'#]^W#W-EIJ:*IV#]$ZN
MGXGX=^S8L>7+E\MNVMR W$F6N6/'C@4+%D1'1_O9B><(/WV+^2&+U)$N^H<?
M?KC0GA,       #(;8B$ 0"7E=XI.20D9,^>/:9PQHP9EGV=\:7.@0# OXS&
M-@        "N7D3" (#+36\^VK)ERX2$A+2TM'7KUNE M0\\\("[*@!<7D3"
M        "#Q$P@" RZUOW[YZA\Z@H* B18KHXZ)%BSJO&P: *X)(&
M (&'2!@ <+F=.7.F6[=N04%!&@;GS9NW1HT:2Y8L<=<#@,N.2!@       "!
MAT@8 '!E'#ER9.G2I7/FS$E(2'!/ X KY,2)$\>.'4M-375/         *Y:
M1,(             $+"(A $            @8!$) P           $# (A(&
M            @(!%) P              8M(&              "%I$P
M          0L(F$             "%A$P@             0L(B$ 0
M     "!@$0D#            0, B$@8           " @$4D#
M   !BT@8              (6D3              !"PB80             (
M6$3"             !"PB(0!            (& 1"0,           ! P"(2
M!@           (" 120,              &+2!@              A:1,
M           $+")A              A81,(             $+"(A $
M       @8!$) P           $# (A(&            @(!%) P
M     8M(&              "%I$P              0L(F$
M"%A$P@             0L(B$ 0           "!@$0D#            0, B
M$@8           " @$4D#              !BT@8              (6D3
M            !"PB80             (6$3"             !"PB(0!
M        (& 1"0,           ! P"(2!@           (" 120,
M      &+2!@              A:1,              $+")A
M  A81,(             $+"(A $            @8!$) P           $#
6^G_.9=CE6'4QP@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_1.jpg
MB5!.1PT*&@H    -24A$4@  "7@   *$" (    XA%=+  "  $E$051X7NS=
M>;Q6T_[ \7/JE.:))BI2:22Y7/I52"&$4$BIR-! N1F2;H9T4[A%F17*D$KD
MYA#%O;<2KB%<35(9;IKK-(_G[-]R5JW6LYYQK_.L9SCG\_ZC5V>MM=?>S[.^
MS]YK[^_S[)WA 0           (!/&68!             $1#HA$
M  " ;R0: 0           /A&HA$           " ;R0: 0           /A&
MHA$           " ;R0: 0           /A&HA$           " ;R0: 0
M         /A&HA$           " ;R0: 0           /A&HA$
M  " ;R0: 0           /A&HA$           " ;R0: 0           /A&
MHA$           " ;R0: 0           /A&HA$           " ;R0: 0
M         /A&HA$           " ;R0: 0           /A&HA$
M  " ;R0: 0           /A&HA$           " ;R0: 0           /A&
MHA$           " ;R0: 0           /A&HA$           " ;R0: 0
M         /A&HA$           " ;R0: 0           /A&HA$
M  " ;R0: 0           /A&HA$           " ;R0: 0           /A&
MHA$           " ;R0: 0           /A&HA$           " ;R0: 0
M         /A&HA$           " ;R0: 0           /A&HA$
M  " ;R0: 0           /A&HA$           " ;R0: 0           /A&
MHA$           " ;R0: 0           /A&HA$           " ;R0: 0
M         /A&HA$           " ;R0: 0           /A&HA$
M  " ;R0: 0           /A&HA$           " ;R0: 0           /A&
MHA$           " ;R0: 0           /A&HA$           " ;R0: 0
M         /A&HA$           " ;R0: 0           /A&HA$
M  " ;R0: 0           /A&HA$           " ;R0: 0           /A&
MHA$           " ;R0: 0           /A&HA$           " ;R0: 0
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M(VMKU*BAO@%MO3J+=0$   #I)9&S9>MU*5]^^66=.G54)PJ)1@  @$*/1",
MX)"GGWY:71'8O'FS69WOY)-/E@TZ=>JD"M>M6Z<6%)UHS0^9.G6J:O#MM]_*
M0KO5V:T+    2"^)G"W;K4N9,F6*^D&D@40C  ! H4>B$0!PR TWW" O!U2I
M4L6L.^SRRR^7;9HU:Z8*IT^?KBXE_/CCCUKS0S9MVJ0://GDD[+0;G5VZP(
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M%VG- W3OWEVV:=2HD5D71LC5.5H7    D%X2.5L.N2YEVK1I\^;-TTM(- (
M !0=)!H! #'9OW]_DR9-Y/6"S,Q,_8DOS9LWE^4]>_8\LD"@08,&R3;''GNL
M61=*N-6Y6!<   "07A(Y6PZWK@A(- (  !0=)!H! #&Y^^Z[Y<4"X<(++]2K
M3CKI)%G>MV]?O5PW=.A0V:92I4IF72CA5N=B70   $!Z2>1L.=RZ(B#1"
M4'20: 0 1#=[]NS,S$QYL:!8L6(+%BS0:VO7KBVK!@X<J)?KA@\?+MN4+%G2
MK L2875Q7Q<   "07A(Y6XZPK@A(- (  !0=)!H! %$L7[Z\:M6J\DJ!,'3H
M4*-!_?KU9=4MM]QB5"DC1XY4/9AU@2*O+K[K @   -)+(F?+D=<5 8E&  "
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MK5JUDLTNOOABL^ZP[MV[RS:-&S<VZ_RLKN#K @   -)+(F?+L:\K A*-
M10>)1@" *3<W]XHKKE 7%S(S,Z=.G6HVTG3MVE6V;-&BA5EW6+MV[62;#ATZ
M&%6^5E? =0$   #I)9&S95_KBH!$(P  0-%!HA$ 8+KUUEO5Q07AN>>>,UL$
M&C)DB&Q9J5*EO+P\LSJ?NM;0IT\?H\K7Z@JX+@   ""])'*V[&M=$9!H!
M*#I(- (  CSWW'/ZQ86___WO9HL@$R9,4.U7K%AA5GO>IDV;5(/QX\?K57Y7
M5Y!U 0   .DED;-EO^N*@$0C  ! T4&B$0!PQ"^__%*^?'EU<6'8L&%FBU"6
M+5NF%@GYK>>I4Z>J!M]]]YTJMUB=];H   " ])+(V;+%NB(@T0@  %!TD&@$
M !QQ_OGGJXL+W;IU,ZO#JU6KEERJ18L6N;FY1NVYYYXK:X\^^FB]UFYU=NL"
M    TDLB9\MVZPJ'1",  $#10:(1 '#(_/GSU<6%8X\]=MNV;6:+\.ZXXPZU
M[%_^\A>]:N3(D2&KK%=GL2X    @O21RMFR]KG!(- (  !0=)!H! (?TZ-%#
M75\0CH_H@@LNT)?][;??2I8LJ9:]^^Z[ERU;]K___6_DR)&9F9FRL%BQ8J)0
M+6*].HMU 0   .DED;-EZW6%0Z(1  "@Z"#1" #X0VYN;NG2I?7K"Y'5JE7+
MZ.'!!Q\T&P6ZZZZ[5.,"KL[7N@   (#TDLC9<@'7%1*)1@  @**#1", X ^_
M_OIKP/6#:(*O+^3EY77ITL5L=]C99Y^]9\\>U;B J_.U+@   ""])'*V7,!U
MA42B$0  H.@@T0@ ^,/WWW\?</T@FI#7%_+R\D:,&%&^?'F]Y5%''=6O7[^]
M>_?J+0N^NMC7!0   *271,Z6"[ZN8"K1^/###YMU    *%Q(- ( XFS[]NTS
M9LQX_/'''WWTT>G3IZ];M\YL$3^)7!<   "07I@M P  P#42C0
M  !\(]$(            P#<2C0            !\(]$(            P#<2
MC0            !\(]$(            P#<2C0            !\(]$(
M        P#<2C0            !\(]$(            P#<2C0
M  !\(]$(            P#<2C0            !\(]$(            P#<2
MC0            !\(]$(            P#<2C0            !\(]$(P+GO
MO_]^<K[77GLM-S?7K ZT>_=NV5A8M6J565VTO?ONN_*=6;]^O5E7E'SXX8<J
M2 QOO?76QQ]__,TWWVS:M,E<#$&(*$<6+UZL8G+[]NUF-8J\G)P<%2$Q,KNP
MQ:<>X:C9FB3V8V:+4)8N7:HO]=MOOYDM4HD^R5R[=JU9C92Q8<,&-5)SYLPQ
MJQ,E9,!LV;)%%6[=NC5P":2$HK W0Q(QSX<C+D*+8U::2I&)$. 7B48 SK5J
MU2KCL(D3)YK5@=:L6:,:O_KJJV9U$?;++[^H=V;>O'EF=5%RSCGGJ+<BG,S,
MS--..VW:M&EY>7GF\LA'1+GSV&./J??VQQ]_-*M1Y#W^^.,J0F)D=F&%3STB
MT&=KPG7776>V"*5GSY[Z4O_XQS_,%JGD?__[G]K4CS_^V*Q&RA@S9HP:J4J5
M*NW;M\]LD1 A ^;;;[]5A=]]]UW@$D@)16%OAB1BG@]'7(06QZPTE2(3H=2Q
M9LV:_OW[FZ5(/?&Y; $ $?S?__V?.D8>=]QQNW;M,EMH2#2&LWKU:O7.%/$+
MQ+$D&A71."<GQ^P"1)1++LX249CH$1*+S,Q,LPLK?.H1@3Y;$ZI5JQ;UFSJB
M08T:-?2E4OS2?,B\$5)0FS9MM+#*>.^]]\P6"1$R8+AHF_J*PMX,2<0\'XZX
M""V.66DJ129"*2([._N88XX11W.S JF'1", YXR3O1$C1I@M-"0:P^$"L>(K
MT2BT:-&"^X0$(Z+<<7&6B,*$1"-2D#%;$[[YYANS42#1P%@DQ2_-A\P;(=6L
M7[^^6+%B6EAE].C1PVR4$"$#AHNVJ:\H[,V01,SSX8B+T.*8E8Y29R*4"MY\
M\TUQ+IR1_[4ALPZIAT0C .>,D[WRY<MOV+#!;'08B<9PN$"LJ$1CE2I5_JH9
M,F1(OW[]NG;M6J]>/?5>2;UZ]3)[*?*(*'=<G"6B,-$C1.RU]/U82,.&#3.[
ML,*G'A$$7YI_Y)%'S$:!1HX<:2R2XI?F0^:-D&HF3)B@Q=0?*E:LF)2;AJU?
MOUYM XG&-%(4]F9((N;Y<,1%:'',2D>I,Q%*!>IS4;UZ=;,.J8=$(P#G@D_V
M(MQ<FT1C.%P@5E2B\:233C+K#ENX<.$))YR@WC&!9V@;B"AW7)PEHC!)5H3P
MJ4<$P;.UMFW;FHT"G7WVV<8B*7YIGD1C6KCDDDOD&/WI3W]2XY6LT/KAAQ^^
MR[=CQPY9PD7;U%<4]F9(HF3-XE#HN0@MCEGI**4F0DE'HC&]D&@$X%SPR5Y6
M5M;RY<O-=OE(-(;#!6(EED2CL'7KUF;-FJDWK5V[=F:+HHV(<L?%62(*DV1%
M")]Z1! \6RM9LN3.G3O-=H?EY.2(Z9RQ2(I?!"'1F/IV[-AQU%%'R3%Z^>67
M*U>N+/_?O7MWLVF2<-$V]16%O1F2*%FS.!1Z+D*+8U;:2?V)4(*1:$PO)!H!
M.!=\LB=<>>659KM\)!K#X0*Q$F.B4?CBBR^*%R\N&V=F9JY8L<)L48014>ZX
M.$M$89*L".%3CPC4;*U.G3HJ3K*SL\UVA\V8,4.V4<?9C)2_-$^B,?5-FS9-
MC='*E2NON>8:^?\*%2KLW;O7;)T,7+1-?45A;X8D2M8L#H6>B]#BF)5V4G\B
ME& D&M,+B48 SJF3O<:-&ZOOY@B??OJIV=1/HG'MVK63)T_NUZ_?Z:>?WJQ9
MLQMOO/&%%UY8M6J5T6SZ].G/YWOGG7>,*F7[]NVRC2#^;U;GR\G)>>NMMP8-
M&M2R94OQ0GKV["D:KUZ]VFSG>?OV[5.]B3]S<W/%7.&RRRX32S5MVO3RRR\7
M_>3EY:GV"Q8LZ-JUZRFGG-*D21,QC7CFF6?$(D>Z.\RX0+QKUZXI4Z;T[MV[
M8<.&9YQQ1H\>/?[UKW^9RP2)_56(_N5+>/_]]\6?BQ8MZM.G3_WZ]2^\\$)1
M>/#@07.!!(H]T2C<?//-ZGT;/GRX6:V)_<W1;=JTZ?777[_]]MO__.<_-VK4
MZ(HKKKC__OM%<)KM@L2^.B(J[<1XEOC?__YW\.#!5U]]M0B>NG7KBOV8B)]1
MHT9MW+C1:&F\>V) 9\Z<V;ESY^;-FXNH$\,]=NS8S9LW&TL)6[9L.1P[SP=W
M:S18OWZ]6>UG(SUM.[V@(<[.SI95$R=.-!?3O/322[+9NG7KS+I"),8(B47L
MGT'/]E,?]<.;K# +N3U$FC4U6^O0H4.M6K7D_P<,&&"V.TP=7CMV["C_DQ'Q
MTGSLHQQYB(WCA:^C<'"B\9___*=HWZ9-&_$IZ-2ITP,//! R1)$PUUUWG1R@
M&C5JB#_%N8 :,G'@,UOG4P$CB..CF,F+R;^(3Q$/8L]V_?77SYT[UUPF7]1(
M4PW$'N/ @0-R*2[:IC[7>S,OYAW:!Q]\($.(0U)A$F$69STCLI[J*[XFA$A-
M$4++LXVND,<L=DVIS&(B9!<;NB^__%(<"ENU:B5F0==>>ZT(##F7?OOMM\4B
M+[SP@MA'R98%7]?RY<N'#!DB#II-FS8]]=13Q:GHL\\^NV3)$K.=Y\V?/U]T
M<M555\F77[Y\>=GM@@4+S*9(&20: 3BG3O8NNNBBN^ZZ2QTFQ238;!ISHG'N
MW+E''WVT:JF4+EW:6*I3ITZRJFS9LN&^ 31UZE35PR>??&)6YS^@Y<033U1M
ME#)ERHA#K]%8'%E5 W&2($Y!M24.Z=*EBZC*R\O[RU_^8M9E9)QWWGG!QVS]
M K&8&@8_2D2X_/++=^_>;2RH^'H5ZF)<5E:6F':4*E5*7T3,!HSVB>0KT?C1
M1Q^IS;[DDDO,ZL-\O3F*>&?4]0M=A0H5GGKJ*;.UQM?JB*BT$_DL41!G:V(&
M7ZQ8,>T].$+LQZ9-FZ:WU]^];=NV77CAA8%+_*%.G3H+%R[4EQ(6+UZL&GSU
MU5=&K9<_B*K!YY]_KE?YW4A/V\[@(18G$NK_8JN,!25Q@J':O/;::V9U(1(U
M0F+DZS/HV7[JHWYXDQ5F(;>'2+.FS];$L,K_-VK4R&QW6.W:M66;IY]^6OXG
M(\RE>;^C''F(]>.%WZ.PGFB<,V=.W[Y]M84.J5JUZJQ9L\PED1#[]NVK6+&B
M' @QL?'R$\GJ1V;777>=N4 ^?5B7+ETJ)H?J3^7BBR\.OG-FU$C3>U8G""$O
MVB*EN-N;>3YW: ,'#E15')(*C0BS..L9D?547_([(41JBA!:GFUTA3QFL6M*
M6783(;O8D/;OW]^]>W=5JU2K5DW$P.FGGR[_?/WUUV7[@JSKX,&#PX8-TW]\
MHHA=WS///*,W%OKUZV>VR]>P84.C)5('B48 SNDG>UNV;%$W&1?>>NLMHW$L
MB<8Q8\;H=[8)=L<==ZB?<+WRRBNJ_(,//@CLZ1!U9!7;IKZPK,R:-:M\^?*J
M$T-F9N;(D2/U]GI:*&361QH]>O1]]]UGEA[6OW]_O4\O\ )QA)=_P047B-F)
ML:SG_U6HLQUQ(GWJJ:<&-L\0DV"]<8+Y2C2*=T.]\*I5JYK5^?R^.=(;;[QA
M7),RA M@OZLCHM).Y+-$L9-ITZ:-]NI#$.^2_@L,_=UKW[Y]8-LCQ*Q=M-16
M97\F8+&1GK:=P4/<IT\?]7\1J_I2BBB7#<29A@A[L[H0B1PA,?+[&?1L/_51
M/[S)"K.0VT.D6=-G:_I=FW[]]5>SJ3:FE2I5^OKKKU7CX$OS%J,<>8C5\<+B
M**SGC:I7KZZU#5"Z=.F07\&&:[-GSU:C\/+++\O"UJU;RQ*QQ]NS9T_  OGT
M80V9993..^\\XQN'42--[UG=:S?D15ND%$=[,\__#NV33SY1Y1R2"HT(LSCK
M&9'U5-^SFA B-44(+<\VND(>L]@UI2R[B9!=;'CYF;\KK[Q251EJU*A1KEPY
M^?^X)!K%ODA5A31HT""]/8G&=$2B$8!S^LF>^//QQQ]71X@&#1KLW[]?;QPU
MT?C99Y^I!AGY7],[__SS.W3H4*%"!;U\TJ1)LKW^#:#;;KLML+,_B(.K^G%D
M\ .6Q?;HW[@1:Q&OHG/GSL<>>ZPJS C\':2>%E*J5:MVQAEGB*W5"]678<69
M[3'''"/F<*JJ5*E2O__^N[8A 1>(E4:-&G7ITN6$$T[0"\>,&:,OZ%F]"OW:
M2K"E2Y=JW2>:KT2C</'%%ZLM#[Z=FL6;(XC1T:]OEBY=NFW;MM=??[W^,!@Q
M$0R^EZ_%ZHBHM!/Y+''(D"':2\\XZZRS>O7JU;5KUV;-FNGE9Y]]MEHDY+M7
ML6+%TTX[S;C.;LS.K<\$+#;2"[.=DEA1E2I5Y/_;M&FC+Z6HDZASSSW7K"M<
M(D=(+"P^@Y[MIS["L&;D?WA3)\PRB+0",+X6IN9.$R9,,)MJ<SD1/-]]]YW\
M?T:H2_,6HQQYB.7QPNXH'+)G$3 B)(X__GB]</#@P?J"2 SU10$QGU%W8M!W
MF"&?@Q \K&+Q"RZX0 RBB J]?-2H49$7U(E((]&8IASMS3S_.[0#!PYP2"I\
M(LSBK&=$(7='L4SU[2:$2$T10LNSC:Z0QRQV32G+;B)D%QO"Q(D35;EPW'''
M77GEE4V:--$+I8(G&I<O7UZR9$E5=?KII]]\\\V]>_<6IZ*J4/C^^^_5(B-&
MC!"'UQHU:LBJK*RL9ODNO?12U0:IAD0C .>,1./>O7OU"YKCQX_7&T=--.HW
M$A%G<3DY.;)<=*O?4O+$$T]4OTT4<R-96+=NW2,='39__GRU5/ O+.^XXPY5
MVZI5*Y6FRLO+TV\#V[9M6[6(D1821U-UKXG5JU<W:-! K\W,S!P^?+A\P-[F
MS9M//OED566\_. +Q&/'CE6U@P</5N5''WWTMFW;M$5M7H5QMB-.T<6<8]2H
M46+&*5Z":I84?A.-ZJ9)0O#-WRW>'.'..^]45:><<HJ(6UF^<^=.<6JGJH8,
M&:(OY5FMCHA*.Q'.$O7SNK)ER\Z;-T^O??GEE]75!#'0:B=FO'MBDBWVG'*4
M=^W:I4=CN7+E]$=RVIT)V&VD%[B=P4/<HT</517\Q5C]2R%Z*!9*>H0L6[8L
M+R)SX7P6GT'/]E,?]<.;Q##+"+4]1)H=8[;6LF5+^:>\<9-!_=[BI9=>BG!I
MWFZ4HPZQ9WL4#NYY].C1ZE,V9LP8<0R5594K5]871 *(@:A9LZ9\_\58J_+E
MRY>K(>O:M:NVQ"'&L(I!?.655U3ML\\^JX:U4J5*^CXA.!Z,2"/1F*9<[,T\
MVQT:AZ3")\(\WVY&Y 7MCF*?ZMM-")&:(H269QM=X8Y9[)I2D/5$R"XV=N_>
MK3^ H'___FI*_.Z[[QI?<2AXHE'LTV2AF)5-F3)%E1\\>/#NN^]6BP1_U4]]
M+JI7KVY4(061: 3@G'&R)[SVVFOJ0%*U:E4]AQ$YT2@.5*I6G#0:SY$2<V[U
MY&3AA1=>D.5B;J0*@_-,]]QSCZP2A](=.W;H5>O7KR]=NK2L;=BP8? -) <-
M&J1Z5D\D-M)"+[[XHKZ(_MH%<4S5:\5165T->>211_0JXP+Q_???K]<*M]QR
MBZH5I\JJW.Y5&&<[^G:*J8#Z?U+X333J5\\_^^PSO<KNS=FX<6/9LF5E8;UZ
M]8PDW/;MV]4O*IHW;ZY7V:V.B$H[$<X2/_[X8U5E?,U"TM^]GW[Z218:[][S
MSS^O+R+>0/6A$/1?\-B="=AMI!>XG<%#/&/&#%7[QAMOJ%II\N3)JG;ERI5&
M;2&C1TA4QHU#/=O/H&?[J8_ZX4UBF&6$VAXBS8XQ6WOPP0?EGU6J5-&O:7KY
MR3SU^XG??_\]PJ5YNU&..L361V&CY^#?ZZL'>PM&MW!MX<*%ZLU_+/"&ZNK;
M[N7*E0M^=+0QK"-&C# :_/6O?U6USS[[K"J/&FDD&M.4B[V99[M#XY!4^$28
MY]O-B+R@W5&,4WWK"2%24X30\FRC*]PQBUU3"K*>"-G%QIMOOJD*NW7K%KA$
MP$U<,^*1:+SQQAME88<.';3F?Q"[.+$'D[7!OZ ET9A>2#0"<"XXT9B7EW?:
M::?)0N&^^^Y3C2,G&GOV[*EJ0SYP44R#U-TCQ2IDH9B+JZ4>??31P"6\QHT;
MRZI++KG$J'KXX8?5@L%GFU[^+\;4I2YU;-;30A4J5-BU:Y>^R/;MVU6M.+,-
MOI.G>I![OW[]]'+] G'Y\N5%/WJM($YH54KIVFNO5>5VKT(_VZE6K9J1@DTN
MOXE&,>CJM1AA8_?F//744VJI)Y]\,G")/PP?/EPUT&]8:K<Z(BKM1#A+5%])
M+E&BQ-:M6_4J:<Z<.6K9K[_^6A8:[Y[QE"E!?P21_A5[NS,!NXWTM.T,.<0[
M=^Y47XT,?I1]ERY=9%6S9LV,JL+'5Z)17=U6[#Z#GNVG/NJ'-UEAEA%F>X@T
M.\9L3?]JUQ=??*&WG#5KEBP_]=13Q9\1+LW;C7+4(;8^"NL]5ZU:U3B>"MG9
MV:I!(;NG=^I3W_S+"#ITZM\8FS%CAE[E!0YKN7+E@O=LZ]:M$Q$H&W3JU$F5
M1XTT$HUIRL7>S+/=H7%(*GPBS//M9D1>T.XHQJF^]800J2E":'FVT17NF,6N
M*0593X3L8J-7KUZR1)S]A9STJH-I1CP2C1T[=I2%[=NWUYH?(EY@O7KU+KOL
MLN"'AI)H3"\D&@$X%YQH] *_$UJZ=.G_'7ZJ>>1$H[I3?*-&C<+=4$X]S;AB
MQ8JJL'GSYK+PG'/..=(T/S$IRS.T7T JZO>15:M6-:J4JZZZ2K8Y\\PS98F>
M%KK^^NL#F_]!/5<OY WQU6O44SM>X 7BVV^_7:]2SC__?-E WV"[5Z&?[>@#
MEPK\)AK'C!FC7DMV=K9>9??FJ!O1E"M7+N0O'L3TZ^*++Q:SI2E3INC7,>U6
M1T2EG0AGB=NW;__LL\\F3IRH_ZA"IT_-Y\^?+POU=R_D8"U9LD0U^/###U6Y
MW9F W49ZVG:&&V)U@E&E2A7]EZS[]^]7S]G5OWI26!4PT6CW&?1L/_51/[S)
M"K.,,-OC$6E6C-F:>-_430(??OAAO67__OUEN;PQ:81+\W:C''6(K8_">L_&
MEV^DI4N7J@8\T2K!U*W@Q23?J-*_XW_--=<8M?JP]NW;UZB5U#53L0=0OVF+
M&FDD&M.4B[V99[M#\S@D%3H1YOEV,R+/=JIO/2%$:HH06IYM=$4X9K%K2C76
M$R&[V%!/<A5G?X'-#YDZ=:I:JN")QJ%#AZKRT:-'BS#3%HJ$1&-Z(=$(P+F0
MB49!_*F.-#?<<(,LC)QHK%V[MJP:,&" 4:4\__SSJ@?U;=,''GA EF1E9>E?
M07WBB2=D>;%BQ=:M6Z?*)96A:=>NG5&E#!LV3+:I6;.F+-'30J(VL/D?U*L(
M>8-U]1!*8P*A7R ./O65U,L4U!T5[%Y%U(MQ2>0WT:C?,LNX=:K=FZ.>!NKW
MA,UN=414VHE\EAA.3D[.M&G3U%<E,K3+W/J[%_RS;*/!N^^^J\JMSP3"B;"1
MGK89X89XPH0):D']&IS^(X!8-B/=Z1%RW'''G1#1IY]^:BQN]QGT;#_U43^\
MR0JSC##;XQ%I5H)G:^I@IS\G1JA7KYXLES^JB'QI/IP(HQQUB*V/PGK/HT:-
M,JL];]NV;:K!].G3S6HXH^]&@A_/DYN;6[UZ=5E;MFQ9XZ9A^K"&BT#]YA:;
M-FV2A5$CC41CFDKPWLR+N$/S."05.A'F^=8S(KNIOO6$$*DI0FAYMM$5X9C%
MKBFE%&0B9!$;>_;L424A+S%Y@==F"YYHU.\:DI&_1QHT:)!^TYIP2#2F%Q*-
M )P+/MF3OO_^>W6;4_$?\:<7,=%XX, !]4CJD)>')'4/'&'1HD6R\)MOOE&%
M4Z=.58W%I%P6MFS94A4J*G^3D7^7N9#4)F5F9LKG(NAIH9!W]#K^^.-E[5UW
MW676>=[%%U\L:R.DA<(=CY]]]EG5YM=??Y6%=J]"/YEY+/ &\4GG-]'8MV]?
M]5KT!WUYMF^.B!99<L455^B]166W.B(J[40^2U0V;-CPWGOO/?C@@YTZ=:I;
MMZZZ9:42\K)[\#<PO/P[(ZD&[[SSCBJW/A-08M](3]O.<$.\;MTZM=O7SZ &
M#APH"\4I1[A?JQ<F,49(.':?0<_V4Q_UPYNL,,L(LST>D68E>+;VTDLOR9*L
MK"SUP\$5*U;(PHH5*XJ)F1?SI?G81SGJ$%L?A?6>)T^>;%9[WMZ]>U6#:=.F
MF=5P9L2($>J=O^...Z8%:=&BA6I@Y(#U80VY"_("'S>U;-DR61@UTD@TIBG7
M>S//SP[-XY!4Z$28Q5G/B.RF^M830J2F"*'EV497A&,6NZ:44I")D$5LB+,\
M5?+<<\^9"^0[>/"@VH$4/-$H#K[Z+DLYZ:23A@T;%N%1H"0:TPN)1@#.!9_L
M*3?<<(,ZP,AG D=(-/[\\\_AJG1Z3E&_X*Z2,>KFD^)0IQ[9$GPK<#VO&2.9
MQ-+30L$/UO:T+;G__OO-NMC20L'/X9/$ZU5M9)+5^E7H9SNI]J5^OXG&SIT[
MJ]>2DY.CRJW?G%JU:LD_0W[_/1SKU1%1:2?R6:(@WLR.'3NJ4[MP0EYVU^^,
MJNA!$J]$H]^-]+3MC##$K5JUDFV:-FVJ"M631&^^^6:M;:$5-4(BL/X,>K:?
M^J@?WF2%64:8[9&(-+^"9VOZ6SUSYDQ9.&[<.%DBCJVR).JE>;^C''6([8["
M7@S[4A*-R?*G/_U)O?-1=>G215]6'U;]D9RZCS[Z2+59L&"!+(P::20:TY2[
MO9GG?X<F<4@J3"+,XJQG1%$/3\%3_8),")&:(H269QM=D8]9[)I21T$F0A:Q
M\?777ZN2D)>8I)HU:\HV!4\T>OFW@%9W,C=D9F9><LDEP6'OD6A,-R0: 3@7
M?+*GB"EUZ=*EU=%E[MRY,28:)TV:I%?IQ,%)-=,O$@T8,$ 65JU:53Z=99KV
M3'7U[69EPX8-JC9&\D"KGP;,FC7+Z-:+1UI(?^"0;O;LV:J-_+6*]:L(>6TE
M1?A--*IO3I4H44(OMWYS*E:L*/^\\\X[]0XCLUX=$95V(I\E?O_]]Y4K5U8-
M=&*&K48S(\QE]Y#O7O#5!\GZ3,!B(SUM.T-NI*2_.2((O<"-?.^]]\P%"J/(
M$1*9]6?0L_W41PV_9(591ICMD8@TOT+.UIHU:R8+54I/'5,F3IPH2R)?FK<8
MY:A#;'<4]F+HF41C4OSRRR_J;8]%F3)EPCUZ<\^>/5K'1_S[W_]6;4(^#31D
M/(1L$/FB+5*!H[V99[5#DS@D%2819G'6,Z*0>QM=\%2_(!-"I*8(H>791E?D
M8Q:[IA11P(F016Q\^>67JN2MM]XR%SA,74F+2Z+1R_]9B#I&!Q.K$SM#8Q$2
MC>F%1", YT*>["GWW7>?.JZT:-'BM]]^4W\:B4;]AB'A?MTO+%BP0#5;N'"A
M*A?G>ZI</JBO1X\>\L_@ARU[^3<*R,K*D@W:MV\_-@9BNN\E)"TD5Q1LTJ1)
MJLWZ]>N] KR*J&<[2>0KT:@GGHV'.5F_.2)@Y%(BA/0.([->'1&5LL2[H>XH
MJ].?!66<)8JWO4:-&JI6$I'<K5NW<>/&B=[TN7OLE]V#KSY(>F__^<]_M"4.
M^?333U4#=29@MY%>;(G&Y<N7JV6?>NHI43)JU"CY9]FR9<-=(RYD(E]'B,SZ
M,^C9?NJCAE^RPBPCS/9(1)I?(6=K=]UUERRL5Z^>E_] ES)ERLB2-6O6R#81
M+LW;C7+4(;8["GLQ]$RB,2G4#\MBIX^./JSB/$+K^ C]RX7R6JH70SR$;!#Y
MHBU2@8N]F6>[0Y,X)*4CBWF^W8S("[.WT05/]0LR(41R68269QM=D8]9[)I2
M1 $G0A:QH7]3X=EGGS47.*QDR9*R3<A$8XSK"K9HT:([[KA#W:%$=^JIIQJ-
M232F%Q*- )P+>;*G;-NV[9ACCE''%36SR0A*- KERI635>&>5RQ,G3I5]:!_
M'>; @0/J=_H///! 7EZ>6F_PPY:E$TXX03:XX88;S+KP$I 66K%BA5ZEJ'>O
M5*E2JM#N540]VTDB7XE&_7EC8MR-6KLWYX(++I!+77CAA6;=83DY.?)Q+SJ[
MU1%1*4B<LXE)L'A;BA4KMG__?J/VP0<?5"]VX\:->I4(0E55HT:-29,F;=Z\
M66^@3\W5&Q7UW0N^^B#I9P+SYLW3ECA$OT^F.A.PVT@OMD2CT*1)$]FL4Z=.
MXL_V[=O+/_T^;BU]%231Z-E^!CW;3WW4\$M6F!GEP8@T7T+.UN;,F2,+A56K
M5JD_FS=OKMI$N#1O-\I1A]CZ*!RU9Q*-2=&V;5OYGF=E97WXX8?_"N.AAQY2
MHZ/N=>D%#NN77WZI=7R$NH0GCMHJ,*+&0\@&D2_:(A6XV)MYMCLTA4-2&K&>
MY]O-B+PP>QM=R*F^]800R6(=6IYM=$4]9K%K2@4%G C9Q4;9LF5E2?!5,FG3
MIDUJJ9")QMC7%5)>7M["A0L'#ARH7Q 6?O[Y9[T9B<;T0J(1@',A3_9T^O=W
MU/?R,D(E&ILV;2JKNG?O;E0ICSSRB.I*WB)5N?[ZZV55Z]:M]4<YRA\X!COW
MW'-E@[/..LNL.VSW[MTK5JS0+V8E("VD)Q)TM]YZJVS0H$$#56CW*J*>[211
M[(E&$0"GG'**>B'!$QV[-Z=W[]YR*?UA!KJ]>_>6*5.F1(D2C1LWUJ]4VJV.
MB$I!^N4J8RKL:=^:%S$@)M!ZE3IYJU"API(E2_0JZ>VWWU8]SYT[5Q9&??="
M7GT0Q"BH\H\^^DA;XI#GGW]>-5 ?$+N-]&).- X9,D0VJURYLOZ3@I=??MEL
M6D@5,-%H]QGT;#_U4<,O66&6$69[%"+-EY"S-7DXD^4OOOBBVKG=>^^]JDV$
M2_-VHQQUB*V/PE%[)M&8>)LV;5*3_[///MNLUFS>O%FU%..[<^=.6:X/JXBH
MP(4.^<M?_B(;U*I52Q5&C8>0#:)>M$72N=B;>;8[-(5#4AJQGN?;S8B\,'L;
M7<BIOO6$$,EB'5J>;71%/6:Q:TJZ@D^$[&)#W5'\\LLO#VQ^R+_^]2^UE$HT
MVJU+VKY]^\*%"]5F*SMV[+CBBBO44L8,G$1C>B'1","YD"=[NOW[]]>O7U\=
M5Y3@1*-*F90M6W;KUJU&K9?_I9B33CI)MCG^^..-VADS9L@J,74;-FR8_'^-
M&C6"IW%2SYX]99N2)4O^\LLO9G6^KEV[9N0G-<5ZY28E("TDYJ!ZE23FA>HG
MF^W:M5/E=J\BZME.$L6>:!3S8_4JJE6K9B2>/=LW1_^RX>+%B\T%/$_,GU2#
M]]]_7Y7;K8Z(2D%+ERY5+\>X.Y8@)NNR2K^@Z>7?)T?]+%M^:338P($#5<^S
M9\^6A5'?O9!7'X2U:]>J\I"/MKWYYIM5 WDF8+V17LR)QB^^^$(M/G[\>/F?
M8L6*!7]UM[ J8*+1[C/HV7[JHX9?LL(L(\SV*$2:+^%F:^H@<NVUUYY\\LGR
M___^][]5@W"7YJU'.>H06Q^%H_9,HC'Q7GGE%?6>/_KHHV9UH//..T\U?O/-
M-V6A/JQBUQ>XQ!_$B4;-FC5E Q'GJCQJ/(1L$/6B+9(N[GLSKP [-(5#4AJQ
MF^=[5C,B*>3>1A=RJF\](42R6(>69QM=48]9[)J2KN 3(;O8N/322V5)\>+%
M0]YY_IIKKE%+J42CW;K6K5O7H$&#S,S,C#"/A!0-U%(//?207J5.G*M5JZ:7
M(S61: 3@7+B3/9W^Z!0E.-$X?/AP53MZ]&BC5GCOO?=4 W$.:=3NW+FS5*E2
MJH%TRRVW&,V4IYYZ2C43QTNSVO/6K%FC[EHNSE=E80+20N)$=^7*E7JM%YA4
M&S5JE"JW>Q51SW:2*,9$XS_^\0]]N)]\\DFSA>V;\_[[[ZNE!@P8$+C$'VZ_
M_7996Z)$"?T;6W:K(Z)2D!A6]7*,?<BV;=NJ5JTJJ\XXXPR]2G_0;-^^??4J
M2;Q+^N-_U'!'??="7GT0=NW:I<K[]^^O+?$'L:GJEBD9A\\$K#=25LG"D!NI
MY.7E'7OLL;*E2FNU;MW:;%=X%3#1:/<9]&P_]5'#+UEAEA%F>Q0BS9=PLS5Q
M])3E2L6*%?7?1H2[-&\]RE&'V/HH'+5G$HV)UZE3)_6>+UVZU*P.I*Z!"E=>
M>:4LU(=5[/K6K5L7N%# 689^?["H\1"R0=2+MDBZN._-O +LT!0.26G$;I[O
M6<V(I)![&UW(J;[UA!#)8AU:GFUT13UFL6M*NH)/A.QB8\J4*:KP[KOO#ES(
M6[5JE7ZW.95HM%O7[MV[U:6YD!=@-V[<J)::.'&B7O7$$T_(<G'VJI<C-9%H
M!.!<N),]PYEGGJD.+5)PHG'KUJWBA%#65JI4:?[\^7KMRI4K3SSQ1%F;F9D9
M<B+5L6/'(RO(EYV=;38Z3!P.U3>@Q5'VW7??U6MS<W/U[Q.IQ&<"TD)"FS9M
M]-_GK5BQ0DT0Q3LC#O"JRNY51#W;2:+(B<;-FS?/GCU;O'OZQ$BT#'X*@F?[
MYHCIN+HCJYA(Z5^%]O)G\VK5QAS=;G5$5&I2SQ(0,?#UUU^K<OVK?\%/3%'G
M;XT:-=JW;Y]>)=YD_4Z_&=IE[JCO7LBK#U+MVK5EN1@L_>%5XA.AO@<MJ3,!
MNXWT8DXT"GWZ]-$[R8CA^YN%20$3C7:?0<_V4Q\U_+PDA5E&^.U1BGBD^1)N
MMK9LV;+ MS#CJJNNTAM$N#1O-\I1A]CZ*!RU9Q*-";9KUZ[2I4O+-[Q>O7IF
M=9#??OM-?AU>$ ONV+'#"QS6C/SK;OJ4[^>??U:/,2M7KIS^4+VH\1"R0=2+
MMD@Z%WLSSW:'IN.0E$;LYOF>U8S("[.WT86<ZEM/")%$UJ'E6457+,<L=DU)
M%)>)D&<5&V(7T;AQ8U7^][__72VU?/ER=8E)4HE&SVI=GO:$=6,I2;];R7_^
M\Q^]2K\7ZT\__:17(061: 3@7+B3/<.\>?/4\4,*3C1Z@4>@4J5*C1LW;N7*
ME9LW;Q:G<VJ>G1'^GC83)DQ0;3+RKSCLW;O7;*117Y_)R+^#Q/WWW[]TZ5)Q
M!/WJJZ]4NDLXZJBCU-T&$I,6D@U6K%@AIB;B3+A6K5JJ_*]__:N^H&?U*J*>
M[221VF8Q1SE><]QQQZGO;.K$2];OG&:P>'.$-]YX0U6).'SFF6=$[;9MVR9/
MGJQRX1FAKC)8K(Z(2DUWWWVW>D7B1/'66V\=.'"@<1=H_>Q1:M6JE:J]]MIK
M-VW:),N_^.(+O4IZX8479&W4=R_DU0=)?^!!G3IU'GOL,3%,TZ=/UT=*4F<"
M=AOI^4DT?O#!!X'=9(CS&;-1X57 1*-G]1GT;#_U4<//2U*8983?'J6(1YHO
M$69K*D\CB:F47AOATKS=*,<RQ'9'X:@]DVA,,/V9=N(8:E:'<L899ZA%IDR9
MX@4E&C/R8UCL:K9OWRYF37KT&K>,CAH/(1O$<M$6R>5B;^;9[M!T')+2B-T\
MW[.:$7EA]C:Z<%-]NPDADL@ZM#RKZ(KEF,6N*8GB,A'RK&+#"YQ.9^0_[770
MH$&=.W>N4*&"7IX1F&BT6Y=^4X$J5:H\^^RS&S=NS,O+^^677\1*BQ<O+JLJ
M5ZXLSDS54E[@1HJ/S(TWWACRJA=2!(E& ,Y%.-DSJ+O22R$3C3DY.?I]:4(2
M,^EOOOG&7#+?^O7KQ11<M10'4;-%H#U[]M2M6U?K.S3]-#5A::&0:M:L&7P_
M?8M7$?5L)XF"9S 1E"A1(O*U0HLWQ\M_4DO3IDW-1H&Z=.FB+R)9K(Z(2DV_
M__Z[V-5H+]?4IDT;<YF@V7Q65E:]>O6J5:NFEZC_]^O73RX5]=T+=_5!F#MW
MKJH*IN;T&=J9@-U&>GX2C?OV[=-/8!HV;&BV*-0*GFBT^ QZMI_ZJ.'G)2G,
M,L)OCU+$(\V7"+.U6V^]5;V'PIHU:_3:")?F[48YEB&V.PI'[9E$8X+UZ-%#
MO>%SYLPQJT/YV]_^IA:YXHHKO%")QI!$X*U=NU;O*FH\A&P0RT5;))>+O9EG
MNT/3<4A*(W;S?,]J1N2%V=OHPDWU[2:$2"+KT/*LHBN68Q:[IB2*RT3(LXH-
M(3<W]\(++]0:AC5UZE2UE-VZ1)@U;]Y<:_@'_=JL-'GR9+6(]/777QMM2I0H
MH=^5!RF%1", YR*<[!F6+EVJGZ&%3#1Z^;<+T+_%8SCVV&/UXUFPUJU;J\:O
MO?::61UDPX8-D3-;QJW)$Y 6>N211]3_=2>==))HIB^E^'T54<]VDBCR"]&)
M6?+LV;/-Y8/X?7.D39LV15CJE%-.$=V:R^3SNSHB*F4-&S9,>\4!JE>O;MST
M0U$C$JQ6K5H+%BSHTJ6+_%.,K%PDZKL7[NJ#=----ZE:P]___O<&#1K(_^M[
M3HN-]/PD&KW &P3=<\\]9G6A5O!$H^?_,^C9?NJCAI^4^##+B+@]2E&.-%\B
MS-;T;UN+HYM1&_G2O,4HQSC$%D?AJ#V3:$RD P<.J'M1EB]?WK@793A+EBQ1
M8U2J5*GMV[?KPWK666>I_^OJUZ\??+NMJ/$0LD$L%VV17([V9I[5#LW (2F-
MV,WS/:L94<B]C2["5-]B0HCDL@XMSW]TQ7C,8M>4%/&:",ERO[$AB6T(OG=N
M1OZ/#K.SL]6?Q@.G[-;UW__^MURY<H'- W3OWEUO+^7FYK9KU\YH^>NOOYKM
MD!I(- )P3IWL&7F.D/3OF89+-'KYW]V[Y99;Q,%8-19*EBS9H4,'X]O*P=05
MWJRLK*U;MYK5H8BC[YUWWEFY<F5]=1GY%V2#[\FY:]<N]24UX[E!DDH+/?[X
MXV:=YUU[[;6R-EQ:2&RV>/G#AP_7MT<4BM<>_,LSG:]7(4YF5-(WY-E.$EUZ
MZ:6!K^ (\<Z?>.*);=JTZ=6KEZ_-]O7F*/OW[^_7KY\1A\6+%Q\Z=&CD::*O
MU1%1J6S2I$EERI0)? /^>"J8\1UYG8B-!QYXH$2)$OHBE2I5ZMJUJWS#]9L@
MK5^_WHOAW8MP]<'+GYT_^."#QK2^1HT:\IL6ZDQ G+2H12PVTM.V,^1&&EY^
M^675PX(%"\SJ0BTNB4;/YV?0L_W41PT_*?%AEA%Q>Y2B'&F^1)BMY>3DJ/=\
M\.#!1FWD2_,6HQS[$/L]"D?M64\TQO)%)13$?__[7_5N&X_*BZQAPX9JP;ES
MYQH7Z/_VM[_I.R(QXA=<<$%PUMF+(1Y"-EBU:I7J/-R7L9!<CO9FGM4.S< A
M*;U8S/,]JQE1R+V-+O)4W^^$$$EG%UJ>_^B*\9C%KBDIXC41DH5^8T,W??KT
MFVZZJ7'CQF)'=.:99XJ)]/+ERW_[[3?5CW$9RGI=HL^KK[Y:7TJJ5:O6C!DS
MC,:*F,6U;=OVJ*..4OO)SS[[S&R$U$"B$4 :$X>W[[___L477QP_?OSGGW\>
M^6F+<;%BQ8K77W_]L<<>>_OMMY<N77KPX$&S10*)M<^?/__QQQ_/SLY63X&.
M14J]BE1C\>:(-M]^^^USSSWWU%-/B7EY^HX%$65GUZY=8O_SP@LOC!HUZKWW
MWHMZ?BAMW+CQXX\_%C'S[+//BOU8 N[^L6G3IEFS9CWQQ!/CQHU[__WW8]EA
M.MU(==>7:M6JQ;?G(LCZ,VC]J0\GU<+,(])2@]-1+LA1&(5 \"^!]NW;]\]_
M_E/L$L5>B'A W!5DA\8A*>W8S?,]JQE1P5E/")%XUJ'E.8@N=DV%1AQCXZNO
MOE+SJY#/#;5>UZ^__OK11Q^-'S]>!/^,&3,6+UZ\?_]^LU&0/7OVB%W<%U]\
ML67+%K,.*8-$(P   !+M]--/E^<M??OV->N ^"'2@,(M.-$(I"P.20!2$+NF
M(FCRY,F]>_<>-V[<HD6+S+I\K[_^NII?B;F660V$0J(1    ";5RY4IUWL)U
M8;A#I &%'HE&I L.20!2$+NFHNG..^^4@]ZH42.S+E_'CAUE@YHU:YIU0!@D
M&@$  ) X!P\>O.222^1Y2[5JU;BM$QPATH"B@$0CT@*')  IB%U3D?7<<\^I
MZ=,GGWQBU,Z:-:M8L6*RME.G3D8M$ Z)1@   #@G3F"Z=^]^YYUW_OG/?U9G
M-8,'#S;; 05#I %%"HE&I#(.20!2$+LF?/[YYVKHCSGFF)=>>FG[]NVB?,V:
M-<.'#R];MJRJ?>>==\R%@3!(- (  ,"Y<>/&J=,5J7CQXC___+/9#B@8(@TH
M4D@T(I5Q2 *0@M@U0>C<N;,1!EE9649)V[9MS<6 \$@T @  P+EITZ89YRU/
M/OFDV0@H,"(-*%)(-"*5<4@"D(+8-<'+__%BS9HUC4C0_?G/?]ZT:9.Y&! >
MB48    X-V_>//V\I7___F8+(!Z(-*!(V;)E2_'BQ>7GG40C4@V')  IB%T3
MI)R<'#'ZZG&,2N7*E>^[[[Z=.W>:"P 1D6@$  " <P<.'/CLL\_&CAW[XHLO
M_O;;;V8U$"=$&E#4[#\L+R_/K .2BD,2@!3$K@FZC1LWSI\_?\*$"0\__+#X
M=^[<N:0888=$(P            #?2#0"            \(U$(P
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MV-$;VA9" QT%[D)'@>LX;BI#1V]H6P@-CMO),G;TAK:%D.&XJ0P=O:%MH;1
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M?KQ:M6IBMGKUZFO7KE5GDY*2&C5J)&;MPY5_Z%'BQ:@\]-!#LE@P:=(DO0@
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MCBK;T%'@+G04N([CIG)V]'14V<9Q.UE.CYZ.*O,X;BIG1T]'@1\(&@TB@\8
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MJLW:I*2DE"]?7A2T;MU:#*Y:M4JN>O311XNN^)5''GE$S$9'1\M; YT]EA5
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M1Q$1$1$1$1$1$1$141<(&@$               #  02-
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MO0(              ."<(6@$*&ODY.1LV+!ARI0I;[[YYH$#!_1I
M        -R!H!                ("@(6@$                @* A: 0
M              " H"%H!                ("@(6@$
M@* A: 0               " H"%H!                ("@(6@$
M        @* A: 0               " H"%H!                ("@(6@$
M                @* A: 0               " H"%H!
M ("@(6@$                @* A: 0               " H"%H!
M         ("@(6@$                @* A: 0               " H"%H
M!                ("@(6@$                @* A: 0
M  " H"%H!                ("@(6@$                @* A: 0
M          " H"%H!                ("@(6@$                @* A
M: 0               " H"%H!                ("@(6@$
M    @* A: 0               " H"%H!           @/_/WGF VU&4??S<
M])#<=$(Z*1#2("$D)"&%$$("">FA"4@1E"(@8 -!!/P$]!.D"(* @-*+TE1
M441$!!01Y$,0440@A%Y39+XWF<.<N3ME9]X]>\H]___S>WC"G-V=\K[SSLS.
MWET(@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (
M@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (
M@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (
M@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1
M@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H
M8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (
M@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (
M@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (
M@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (
M@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (
M@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (
M@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1
M@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H
M8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (
M@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (
M@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (
M@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (
M@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (
M@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (
M@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1
M@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H
M8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (
M@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (
M@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (
M@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (
M@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (
M@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (
M@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1
M@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H
M8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (
M@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (@B (
M@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (@B (
M@B (@B (@J!H8:,1@B (@B (@B (@B (@B (@B (@J!H8:,1@B (@B (@B (
M@B (@B (@B (@J!HU=Y&XW_/                     *"F@6IRHW$E
M                 #4-A(U&                     **!L-$(
M            0#00-AH!                    B ;"1B,
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M*R.1;9+#**2+D%CM<AAK2UH34W%ED<4G761?:T1U6()R4<<\\H>=S0/(H.J
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M/F?%*X_5@M9$HFO7=C+1^L5CR?77E8;A?W_\;(O^F<8_/C*7JB#_K=Z,.F!
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ME9VG\'X8!A(!-O+XC)_ C49BR>(!*HN"8Z.15SM%E.$85A.YS1@K.5T4 ?[
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M\0%%5.M1]Z&KR0,2'QB3J!G&_WYK&_/7O?<JSG%=,XPL<<.%O_LKHDSL:?-
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M                    @)H PD8C                     -% V&@$
M                (!H(&XT                     1 -AHQ$
M          " :"!L- (                    0#82-1@
M      "B@;#1"                    $ T$#8: 0
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M%Q8>><0(,[U!^.L3\PH?Z_>_FV,>4 '^_:^%J@PTD)L'Y 3;]-4J<"W ;C0
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M0%?6?Z4 >]JI8V4<>.W5Q5MOW5W]5*[;H,N6EOX2C@*(Y]L>^F[6I=_?SCS
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M*9WSI[1:1$1$;%!"B08:7WLE]R:$$GN*%A$13:;4L:>T6D3$!N,)Q_>7G>3
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M$1$1$1'16?A"!AI_C(B(B(B(B(B(B(B(B/B%%KZ(@48
M^,)#H!$                 G"'0"                 #.$&@$
M         &<(- (               " ,P0: 0               , 9 HT
M                X R!1@                !PAD C
M #A#H!$                 G"'0"                 #.$&@$
M         &<(- (               " ,P0: 0               , 9 HT
M                X R!1@                !PAD C
M #A#H!$                 G"'0"                 #.$&@$
M         &<(- (               " ,P0: 0               , 9 HT
M                X R!1@                !PAD C
M #A#H!$                 G"'0"                 #.$&@$
M         &<(- (               " ,P0: 0               , 9 HT
M                X R!1@                !PAD C
M #A#H!$                 G"'0"                 #.$&@$
M         &<(- (               " ,P0: 0               , 9 HT
M                X R!1@                !PAD C
M #A#H!$                 G"'0"                 #.$&@$
M         &<(- (               " ,P0: 0               , 9 HT
M                X R!1@                !PAD C
M #A#H!$                 G"'0"                 #._#\.;MO5?_^K
-:     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_2.jpg
MB5!.1PT*&@H    -24A$4@  "<8   :2" (   ")>RE4  "  $E$051X7NS=
M>7P41=K \20DR'VM0$ $D4- $/ 5D150//!64%A!$1!/8!7$@U46Q0@('JC@
MB@?WXL'EL1A$ =<%!!45104B B)RR17.0*Y^BY0I:FJF9Y)*9M*3_+Y_\"%5
M3W7/=-=T5_4STQWC              !<Q)@%             (!<I%0!
M        P!4I50            !P14H5             %R14@4
M    5Z14 0           , 5*54             <$5*%0            !<
MD5(%             %>D5 $           # %2E5             '!%2A4
M            7)%2!0            !7I%0!            P!4I50
M      !P14H5             %R14@4             5Z14 0
M , 5*54             <$5*%0            !<D5(%             %>D
M5 $           # %2E5             '!%2A4             7)%2!0
M          !7I%0!            P!4I50            !P14H5
M     %R14@4             5Z14 0           , 5*54
M<$5*%0            !<D5(%             %>D5 $           # %2E5
M             '!%2A4             7)%2!0            !7I%0!
M        P!4I50            !P14H5             %R14@4
M    5Z14 0           , 5*54             <$5*%0            !<
MD5(%             %>D5 $           # %2E5             '!%2A4
M            7)%2!0            !7I%0!            P!4I50
M      !P14H5             %R14@4             5Z14 0
M , 5*54             <$5*%0            !<D5(%             %>D
M5 $           # %2E5             '!%2A4             7)%2!0
M          !7I%0!            P!4I50            !P14H5
M     %R14@4             5Z14 0           , 5*54
M<$5*%0            !<D5(%             %>D5 $           # %2E5
M             '!%2A4             7)%2!0            !7I%0!
M        P!4I50            !P14H5             %R14@4
M    5Z14 0           , 5*54             <$5*%0            !<
MD5(%             %>D5 $           # %2E5             '!%2A4
M            7)%2!0            !7I%0!            P!4I50
M      !P14H5  #3H4.'OOCBBS?>>..99YY)3D[>OGV[&1%(:FKJ^^^__\(+
M+TR8,.&[[[[+SLXV(UQ$>'4   ! M+ ;*CNVHV7KU4E965ECQXX=.7+D9Y]]
M9M8!   @RI%2!0#@I ,'#MQQQQVQL;$QONK5J[=TZ5(S.E=65M;PX<,K5JRH
M-ZE6K=JP8</,4%\17AT    0+>R&RH[M:-EZ=;IITZ;)5O_\YS_-.@   $0Y
M4JH  /SIBR^^J%.GCL\5%$U\?/R$"1/,-CF7;&ZZZ28S.M?]]]]O-L@5X=4!
M    T<)NJ.S8CI:M5Z?;OW__Z:>?+IN04@4  "A^2*D" '#"L6/'&C9LZ'OQ
M)("//_[8:#ANW#@SR-<CCSQB-'$BOCH    @6E@/E1VKT7)!5J=D965===55
M*IB4*@  0/%#2A4 @!.>>.()=06D8L6*;[SQQK9MVPX?/KQX\>*SSSY;59U[
M[KGZ<YAV[]Y=MFQ953MTZ-"??_[YQQ]__,<__J$*$Q(2-F_>?')-.2*\.@
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MRQ][]^XUJW.T:-%"!G3ITD66[-RY4[422_ -/V'6K%DJX+OOOE/E$5X=
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M\@T_J5>O7C*F29,F9IV["*\.    B!8!A\I.V$;+;JL39L^>O73I4KV$E"H
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MIYYZRJP#  ! E".E"@! X3AX\."\>?.>>^ZY9YYY9LZ<.3MW[C0C"E6$5P<
M  !$$4;+    *%RD5 $           # %2E5             '!%2A4
M        7)%2!0            !7I%0!            P!4I50
M  !P14H5             %R14@4             5Z14 0           , 5
M*54             <$5*%0            !<D5(%             %>D5 $
M          # %2E5             '!%2A4             7)%2!0
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MN7)I:6DB<LF2)4:5_[9MV+"A'C!SYDPCP(U*J39JU.C;;[]U_%X\*54
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M;MVZ>H#^&U8IORE5_U7HKKGF&CUXS)@QLORKK[[2RQLV;.C;+M](J0(
M     $08*=428<B0(7H>KGSY\F9$GK5MVU9?U$LOO61&.,[.G3OU&"$U-54/
M")E2K5V[MAX0,J6Z=.E2(Z!ITZ9ZP.>??VX$Y#>E*I^QZL9X8&JG3IUD^:A1
MH_3R!QYXP+==OI%2!0          B#!2JB6"<;=>X?#APV:0)CT]W2S*U;!A
M0WTY\^;-,R,<)SL[NW3ITGK8JE6K]  CI7K@P &]5JA>O;H>$#*EJFZTJ[1L
MV5(/*'A*=>/&C7J 8<>.';&QL2I8O'VYA2^^^.*3BXB)^?333\V6^41*%0
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M^>>?-^."VKIUJ[&$@J=4QXP9HP<H]]Y[KV.;4A7NOOMNO:'4J%$C,\X6*54
M         ( ((Z5:LAP]>M3(R07QZJNOFNUSS9PYLU2I4F8#/P,'#C1;YMB]
M>W?=NG7-Z%QBR4;&-!R_4EVQ8H4>H'3MVM4I0$HU.3E9;R@-&3+$C+-%2A4
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M/4SHUJV;XY=2K5BQHMG8W7777:>WK5*E2D9&AAEDJTN7+OK"ER]?;D8
M      "@4)%2+=&V;-DR=^[<"1,FC!HUZJVWWOKNN^_2TM+,H%"RLK)^_/''
MJ5.G/O?<<^^^^^[:M6O-"'='CASYSW_^\^*++XX?/W[APH7'CATS(\(L/3T]
M.3GYI9=>&C=NW*Q9LW[YY1<S(O_:MFVK9SUOOOEF,P(           #1@Y0J
M4)A^^>47X[>___[WO\T@            1 ]2JD"A24]/O^***_1\:EQ<W)X]
M>\PX            1 ]2JD!!C1DS9MBP84\^^62K5JWT?*IP^>67F]$
M      "(*J14@8)JU*B1D4E5YLR98T8#           @JI!2!0JJ0X<.9BHU
M1[-FS3(R,LQH            1!52JD!!=>O6S<RFQL14JU;MBR^^,$,!
M       0;4BI @4U<.! (Y_:HD6+C1LWFG$           "(0J14@8+:MFU;
M<G+RA D31H\>_?[[[V_9LL6,            0-0BI0H             KDBI
M @           ( K4JH             X(J4*@            "X(J4*
M         *Y(J0(           " *U*J             ."*E"H
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MWS[YY),)$R:(GC]OWKR??OHI/3W=# HD+2U-'.6^_/++??OVF74H(J14 0
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M/GZ/QWON<V\A3(4WB%0!            P"TB50            !PBT@5
M         -PB4@4             MXA4 0           , M(E4
M    <(M(%0            #<(E(%             +>(5 $           #
M+2+5HA(;&[NH@#[XX -]EP*Z<N6*W.W,F3-ZV6J_\\M9*#$Q4;[SSS__7"\#
M            UQ&I%I6! P?Z%%! 0("^2P&=.G5*[O;%%U_H9;-.GSX]>/!@
M?;7(7NYW,'WZ=/G.*U:L>/7J5;T#WG%W-@           &X81*I%Y8:)5#=L
MV%"E2I6J5:OJA:)YN=_'/??<(]^Y8?WZ]7H'O.#A;            -PPB%2+
MRHT1J2Y?OMS7U]?8S65L9OG+_3[.G3OGY^<GW[FA?__^>A/RX_EL
M    W#"(5(N*C%1]?7W_Z9U77WU5WZ6 SIT[)V-"2S+.J5.GBMUNN>46O58$
M+_?[F#]_OGS;0EA8&+_]6U">SP8          , -@TBUJ,A(U<_/3Z\5I9]^
M^NF'/&EI:7JMX/*-S:Q]N=_'HX\^*CY4RY8MQ3\,GWSRB=X'C_(]&P
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M%Y2)7^7FYM:O7U_TW';;;6+QS)DS<C>7#V$=-&B0;+ V4G4^&X4Y<@
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MWD\0J_?+:FK4J"%C4=4SSSRCMUXW;=JT>O7JB7];$JEZ/AMVLT<.
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MU*E3>AD            H D2J*"Y&C!@AXM+P\'"]EN>QQQX3#=6K5]=K
M        0-$@4D5Q,7?N7'D3ZI=??JE5UZU;Y^?G)ZI=NW;5J@
M $ 1(5)%<;%CQPX9J5:I4N7==]^]=.F2L7[Z].GQX\<'!P?+ZIHU:_1A
M        H&@0J:(8Z=&CA\Q-A8"  &VE0X<.^A@           !09(A448R<
M/GVZ>O7J6H:JNNNNNY*3D_4Q            H,@0J:)XN7CQXN#!@^5C4Z5*
ME2J]_/++ER]?U@<           " HD2DBN(H*2GIVV^_G3]__FNOO6;\OUNV
M;"%,!0          P/\$D2H             N$6D"@            !N$:D"
M            @%M$J@            #@%I$J             +A%I H
M        ;A&I @           (!;1*H             X!:1:LFP<^?.17D^
M__QSO79#2TQ,%!^\%'YV            % =$JB5#G3IU?/(\^."#>JV8.7WZ
M].#!@_55LZ9/GRX^N*%BQ8I7KU[5.^ %:R\*          ! J4*D6C+<?OOM
M)2)2W;!A0Y4J5:I6K:H7S+KGGGMDI&I8OWZ]WH'\6'Y1            2A4B
MU9*A1$2JRY<O]_7U-=ZD5>G=N7/G_/S\U$BU?__^>A,\LORB
ME#9$JB5#B8A4ITZ=*M[D+;?<HM=,F3]_O@Q3A;"P,'[[MT LOR@
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M&% L7;JT7+ER<MR9RZ33W)2)K[>0D:J?GY]Q!F2#)C PT.@4(UY>%!.7&P
M        H%0A4BT9S$6JV[=O5[.Q\N7+/_300YTZ=:I0H8*ZOG#A0CD2'Q]?
MMFQ966K5JM6@08,&#AP8'AZN3/@<.'! >1W[A D3&C=N7*U:-5$-" AHG*=+
MERYJF_>>>^XYL96?GY_\=5SY6%##FC5K'"=^]<LOOZC):%!04(<.'9YZZJG:
MM6O+Q=#04.U7><U-F?AZ[86.5%5A86$M6K30DF"9@'IS4<Q=;@
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MKM.F39O*=7-3YKY>NT61:DQ,C#IB7)I[[[U75M6[:3U?E,)<;@
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M].S94YVM6;.F6(^*BE+7/3,Q59BOM_"1JOJ[OM+Y\^=E@_>1JKT0EQL
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M9<J4:=BPH7S_YJ9,?[U'CAP1BX;-FS<[3EP3$Q,C&WZ'2-7TY08
M "@EB%1+!A.1:N?.G<5(<'#PA0L7]'+>_8CUZ]<7/;?==INQ<O;LV7KUZOGZ
M^AHK'W[XH3Z0UR#Z#>/&C=.J,KVK6K6J5O+&^^^_+S>?,F6*7G9T__WWR^;E
MRY>+Q;%CQ\K%@P</.DY<$QL;*QLV;MPH%LU-F?AZA3-GSLC=7#Z'=="@0;+!
MPDC5^:(4\G(#          "4$D2J)8.)2'7\^/$R#YL\>;)>MMO7KU\O&WKW
M[FVL7+ERI5RY<F+EV6>?U0?L]J2D)#FR8,$"K?K66V^)4DA(B%;R1M>N7>7F
MAPX=TLN.9LV:)9N[=>LF%C=NW"@77WCA!<>):X8,&2*J9<J4D?=EFILR\?4*
MZ>GI<GWPX,'*Q#6IJ:G!P<&RH?"1JH>+4LC+#0          4$H0J98,)B+5
M"Q<NA(6%B:F*%2M^^^VW:C4A(:%.G3JBZNOK^\,//XAU^6#1@(" 7;MVJ2-V
MQQLZO__^>ZVJ_F+MSS__K%4]2T]/#PH*$K-UZ];5RTY.GCPI;J\T&(-I:6GV
MO!M#FS1I(A:#@X._^>8;=63__OWRYX+;M6LGU\U-F?MZA5JU:HF2]B5G964-
M&#! E(3"1ZJ>+TIA+C<          $ I0:1:,LA(M5RY<K?E9^G2I6)*C<2,
MP9DS9R8D)*2DI*Q<N;)Z]>JRU+5K5_E",V;,D.N5*U>>,V=.4E)2;F[N\>/'
MAP\?[N_O+TJ5*E5*3T^74X+QNG(V.#@X,C+RE5=>T7K<^>BCC^3LT*%#];(K
M=]YYIQQ9MFR96%3?@_&1WW[[[9,G3Z:FIBY:M$@FH#Y.3P8U-V7BZQ749Y36
MKEU[ZM2INW?O7K5JU;WWWBO7A<)'JIXO2F$N-P          0"E!I%HRR$C5
M&S$Q,6+JXL6+U:I5T\N. @,#]^[=*U_HZM6K39LVU7K\_/RTE46+%LD1:<^>
M/5I;F3)E;#:;WN=*__[]Y=3GGW^NEUV9.'&B'(F(B!"+.3DYC1HUDNLN]>S9
MTW$GDU,FOEYARY8M>I]"!ID^5D2JGB]*82XW          ! *4&D6C*8BU3M
M>3^0J][-J:E1HX8,[:0??_PQ)"1$;U7TZ]=/&Q%L-ML##SR@-9\X<4+O<Y*=
MG5VY<F71'QH:>O7J5;W#E;BX./DJY<J5NW3IDEA/3DYVOMU3:M*D26)BHN-.
MYJ=,?+W",\\\HW=?-VW:M'KUZHE_%SY2S?>BF+[<            I021:LE0
MH$A5_@JND)&1\>RSSX:&AJH]9<N6[=2ITYDS9]1.Z>3)DT\\\83:+]2L67/U
MZM5ZMR(Q,;%#APZ!@8'R^:/;MV_7FYS\^../\B6Z=^^NE]UKT*"!'-RR98M<
MS\K*BHJ*TCZRO[__F#%C/.2UYJ9,?+WVO*1S[-BQ6I99K5JU#S[XP*C*2#4N
M+D[TGS]_7GZE!8I4[5Y<%-.7&P          H#0@4BTM;#;;@0,'WGGGG5FS
M9NW8L2,S,U/O<'+BQ(G-FS<;_9,F35J]>O7!@P>SLK+T)E<R,C*.'#FR<^?.
M\^?/Z[7?44Y.SO[]^^?.G3M[]NQMV[:EI:7I':Z8FS+Q]=KS;HU=MV[=6V^]
M-7/FS(T;-WHY94Z^%\7TY08          +BQ$:D"            @%M$J@
M          #@%I$J             +A%I H             ;A&I @
M     (!;1*H             X!:1*@            "X1:0*
M &X1J0(           " 6T2J             . 6D2H             N$6D
M"@            !N$:D"            @%M$J@            #@%I$J
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M0T-#$Q,3]:;K;KQ(=?[\^<JGOR8L+(S?_BVHJ5.GBF_OEEMNT6L
M  !P@TBU9- B58.'QV'>>)'JHX\^*CY.RY8MY4?[Y)-/]#YX1*0*
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M86+%DDAUR) ARL2OXN+B9,.F39ODNN=(=<R8,7)J\N3)V@-Z 0
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MG)9$JNKO^DKGSY^7#=Y'JO:\7PRN7+FRG%7Y^OH^^NBCVA-M 0
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MZ6-1I+IGSQZY+I0I4\9FLXGJU:M7FS9MJC7X^?EI*XL6+9(; @
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M @           (!;1*H             X!:1*@            "X1:0*
M         &X1J0(           " 6T2J             . 6D2H
M    N$6D"@            !N$:D"            @%M$J@            #@
M%I$J             +A%I H             ;A&I @           (!;1*H
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M<." &0$$@XQ":)%1""TR"J%%1B&TR"B$%AF%T"*C$%ID%$*+C$+@**D"
M        @"U*J@            !@BY(J             -BBI H
M    MBBI @           ( M2JH             8(N2*@            #8
MHJ0*             +8HJ0(           " +4JJ             &"+DBH
M            V**D"@            "V**D"            @"U*J@
M      !@BY(J             -BBI H             MBBI @
M ( M2JH             8(N2*@            #8HJ0*             +8H
MJ0(           " +4JJ             &"+DBH             V**D"@
M          "V**D"            @"U*J@            !@BY(J
M     -BBI H             MBBI @           ( M2JH
M8(N2*@            #8HJ0*             +8HJ0(           " +4JJ
M             &"+DBH             V**D"@            "V**D"
M        @"U*J@            !@BY(J             -BBI H
M    MBBI @           ( M2JH             8(N2*@            #8
MHJ0*             +8HJ0(           " +4JJ             &"+DBH
M            V**D"@            "V**D"            @"U*J@
M      !@BY(J             -BBI H             MBBI @
M ( M2JH             8(N2*@            #8HJ0*             +8H
MJ0(           " +4JJ             &"+DBH             V**D"@
M          "V**D"            @"U*J@            !@BY(J
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M8A8O7GSII9<:,9TZ==(6DZ>XOZ0Z?_Y\_1E&145]_/''LFO[]NW&QLK#6PH
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MJ6C1HF?.G%FY<J71[KENJU6KI@?,G#G3"'"F>_?N^F)[].AA1@
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M&,9EA L4*+![]VXCYOKKK]=CKKWV6B,@Y"75WKU[Z[UI:6DQ,3%ZP.;-F_4
MRV.U^"VI&C\_54Z<.%&H4"$]\MMOOY5=Z>GIQF]AMV[=FG5TT,:-&Z<O,"*S
MUKMCQPXS#@           $&BI)I_]>[=6Z_ 5:E2Q8P(1H<.'?2EW7OOO6:$
M92U8L$"/\;S4<,A+JM.F33,"*E>NK ?HOV&5@BVI>CZ$TJ9-&SURV+!ALOWK
MK[_6VZM5JY9U7-"6+5MFE(J%EUYZR8P#          ! \"BIYE\#!P[4*W#%
MBA4S(X)Q]=57ZTL;-6J4&6%9!PX<T&.$Y.1D/<!O2;5BQ8IZ@-^2ZJI5JXR
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MJ8H7I0<8A@\?K@</&#!@\>+%>HMX.'-,P 8-&J0O2HB.CEZX<*$9!P
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M'[TQ'"55H6O7KGJ,U*Q9,\MI2?7LV;.>%R[^[W__:\8%8/WZ]<9R?*.D"@
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MZ>JKK]8KG9T[=S8C            X$J45(&PV[%CA_';W_???]\, @
M    @"M14@7"*R4EI56K5GH]-2HJZM"A0V8<            7(F2*A 6PX8-
M>_;99U]^^>6&#1OJ]53AUEMO-:,!          #@5I14@;"H7KVZ44E5/OKH
M(S,:            ;D5)%0B+%BU:F*743'7JU$E-336C 0          X%:4
M5(&PZ-BQHUE-C8@H4Z;,^O7KS5            "X&"55("SZ]^]OU%/KUZ^_
M<^=.,PX           #N1DD5"(N]>_<F)"2,&3/FM==>^_333__XXP\S @
M         +D!)54             L$5)%0            !L45(%
M     %N45 $           # %B55             +!%214
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MD)*J(H*3DY/-18","J=PG \C+]$S)!"1D9'F(H+'6QX^Z%,U(2XNSN\7DD1
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M5<-KWKRY&9=W9;.DZNQMZ.PM;P6P91UD&FGF-G93-7'HE.U*R9(E]=^[^*A
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M^?GGGX\9,T9D_OSY\W_^^>>4E!0SR)LS9\Z(O=R&#1N.'#EB]B&'4%(%
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M,/N ',51"8#;L%^"(2DI:?7JU9,F37KEE5?$ORM6K*"8BD!04@4
M    6Y14 0           , 6)54             L$5)%0            !L
M45(%             %N45 $           # %B55             +!%214
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M$A,359DP)#7.-]]\4RZM?/GR9E\8'N[BF#1IDGK:4LF2);GV;[!\YP8
M     $">04DU7%1)-2HJRNP+IY]^^NF'3"=.G##[@N>W;!;:A[LXVK1I(U_4
ME5=>*?\C?/;99V8<?/*;&P           'D#)=5PR:F2:FCEO;+9B1,G"A4J
M)%_4U*E32Y<N+?_?O7MW,Q0^Y;W<            \(J2:KA04G6GN7/GRE<D
M[-RYLW/GSO+_)4J4.'OVK!D->WDO-P           +RBI!HNV2FI;MBP8<(%
MGW_^N=EM61D9&9,G3Y8!\^;-4^VG3IV2C5.F3$E-3=5&_&7;MFU//_UT^_;M
MZ]:MV[!A0_$DQX\?OV7+%C/.LE:O7BV6<_?==\M74;QX<;GD-6O6J!BO#Z<:
M%R]>+/Y,3T__]--/.W;LV*!!@UJU:G7MVO7MM]\^?/BP6HA7&S=N?/#!!Z^[
M[KIJU:IUZ=)%O-C]^_>+]H\__E@L>>+$B>)1S#&!Z=:MFWQ%\?'QXL_WWW]?
M_BF(YVE&>SATZ-"L6;,>>>21JZZZ2KP<L29?>.$%^=Q\<#9*$#$S9LSHUZ]?
MDR9-ZM6KU[MW;_':=^W:9<99UI$C1^1J%Y*2DLSNK &)B8FRT=G&"B0WE,!3
M#@          P)THJ89+=DJJRY8M4W6^HD6+>M;>)D^>K (:-6J4GIXNV_?L
MV:/:O_CB"WU(6EK:\\\_KZYYJXN)B1DW;IP>+/3KU\^,RU2S9DT5X_7A5*-8
M[+%CQUJU:J5BE,J5*Z]=NU8M1Y>2DM*]>W=S0$1$7%S<EBU;FC1I(O^<-6N6
M.3( Y\Z=*UFRI%Q"ITZ=K,QB9W1TM&SIUJV;.2"KC1LW5JI420;K2I0H,7;L
M6#/Z F>CA!4K5OSC'_\PAT5$%"E2Y/WWWS>"?_[Y9Q6P:=,FH]?*O.NM"EB_
M?KUL=+:Q LD-*_B4 P          <"=*JN&2G9*JT+9M6U5_ZM.GC]Z5G)P<
M%Q<GNR(C(]>M6Z>Z]!KGRI4KM4'6:Z^]IKJ\&CAPH!X?2-G,Z\.I1O'";[GE
M%A5@*%2HD(A4BY+2TM(Z=.A@AEX0'Q\?&QLK_^^LI+ITZ5*UM*E3I\K&YLV;
MRY;BQ8N?.7,FRP#-!Q]\4+AP837<DV>9T_$H8>3(D:K6Z]5CCSVF2NE6MDNJ
M06VL0'+#"C[E            W(F2:KADLZ3ZZZ^_%BQ84"XA)B9FV[9MJNOQ
MQQ]71:G>O7MK@[S7.*W,BZ^JI0E-FC1Y\,$'Q3.L5:N6:A0V;]ZLA@P=.K1>
MO7KQ\?&R2SR'>IG:MFVK8KP^G-ZHE"Q9LG'CQD9QT;.BIO_Z5KCDDDLZ=.A0
MITX=O5%R5E+MTZ>/'"XVBKHZKKHGJ/#))Y]D'?&7??OVZ4^^2)$B+5NVO.^^
M^RI7KJP:BQ<O;ER2U]DH8=VZ=2H@(O.7RK?>>NOMM]]>HD0)O7WZ].EJ2#9+
MJCJ_&RN0W'"0<@           .Y$235<])+JW@!XWK'RB2>>4)6GCAT[RL8M
M6[;$Q,3(QM*E2QMWS?1:XQ3&C!DC&R,C(V?/GJW:T]+2GGSR235D\.#!JDM2
MY<;RY<L;79;-PQE5.O%LQ:-G9&18F7?N'#1HD.J*C8W5?V=Y^O1I_0*Y_?OW
MEZ.$!0L6&!4^!R55L;0*%2K(X<V;-U?MV[9M4XOMVK6K-N)O^M.^XHHKQ/:2
M[2=/GA2;1G4]_?33V1\EZ!?@O?[ZZY.3DV7[V;-G[[GG'M5U^>67JUO8AJ2D
M&OC&LOSEAN.4 P          <!M*JN&B2JH!*E*DR-&C1_4E'#MV3%W@5_CZ
MZZ]%XVVWW:9:/.]&Z;7&*?3NW5LVWG[[[5KX>6EI:35KUI2]-]YXH]'KNVSF
M]>&,*MV$"1/T(>+A;KCA!M6K_T#SPP\_5.WWWGNO-N@\_9J]$8Y*JFO7KE7#
MQ>O2N]1/)V-C8T^?/JUW"4E)2<6*%9,!5:M6%=M%[SU^_+CZU6F#!@U4N[-1
MPOKUZV6[T*Q9,^/YI*>G=^O6305,G#A1MH>DI!KXQK+\Y8;CE ,
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MK9OKE2Q.":=.G:I>O;K9ZBHT-'3;MFWZU/KUZ\TFC4HQ VR*5'WOAN65 P
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M#0\/5]45*U:8PP           ,#%0:2*$J1KUZXJ-Y5"0D*,D[9MVYIC
M        P$5#I(H2Y.C1HS5JU# R5-T--]R0DI)BC@$            7#9$J
M2I93ITX-&C1(?6VJ4J5*E>>>>^[,F3/F             ' Q$:FB)$I.3O[^
M^^_GS)GS\LLOB_^[?OUZPE0           #\3Q"I @           (!71*H
M            X!61*@            !X1:0*             %X1J0(
M      " 5T2J             . 5D2H             >$6D"@
M  !>$:F6#ILV;5I0X(LOOC!KE[2DI"3YBY?!WQT            E 9%JZ5"W
M;MV  G?==9=9*V&.'CTZ:- @\]2JUU]_7?[B0N7*E<^=.V=VP _VWA0
M     ( RA4BU=+CJJJM*1:2Z>O7JJE6K5JM6S2Q8=<LMMZA(5?CTTT_-#A3&
M]IL"          !0IA"IE@ZE(E+]X(,/ @,#Q8NT*[T[<>)$4%"0'JGVZ=/'
M;()/MM\4          " LH9(M70H%9'JY,F3Y8N\_/++S9HE<^;,46&J%!45
MQ6?_%HGM-P4          *"L(5(M'<IFI'K__??+"UY[[;7R#\(GGWQB]L$[
MVV\*          ! 64.D6CJ4P4@U(R,C-#147G#NW+E5JE21?^[=N[?9"N_L
MO2D           !E$)%JZ5 &(]6E2Y?*JPD)"0G=NW>7?ZY4J5)V=K;9#2_L
MO2D           !E$)%JZ5#,2/78L6,+%BP8.'#@====U[1ITW[]^KW]]ML'
M#APP^S1[]NP9.7)D3$Q,DR9-6K1HT;]__UFS9L7'QYM]!;[__OO8V-@N7;K(
M%QD9&1E;8,.&#6:KWWKUZB6O5KUZ=?'7]]Y[3_Y5^/CCC\UN-RDI*>^___[@
MP8-ON.&&1HT:B5_DQ1=?%.^#V>?*VE21WMZTM#3YY@C)R<EFV;7AQ(D3\C S
M,U.>K%FS1OS5X7"(-Z%KUZ[-FS<7K[-GSYYOO/%&:FJJ?ITBW90BW6X
M     ( RA4BU="A.I+I^_?J__.4O*H]4*E2H\-Y[[YG=3F=>7MZH4:/4A^[J
M0D)"WGKK+7/ Z1PX<*#96J!APX9FJW_.G3L7%14E+]*M6S=G0=@9'!PL3WKU
MZF4.N-J\>7.M6K7^>!T75*I4:>;,F6;W!=:FBOKV[MJU2_5LV;+%+#N=O_[Z
MJVK8N'&C/#QRY(@\$;<@/3W]WGOO53U*G3IUXN+BU'7\O"D6;C<
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MRTV%J*@H>3Y\^'#MJH6P,%6<M[?XD>J77W[I.G&>Y4C5:?5V P
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M8X?ZN. V;=JH<VM3UMY>J7;MVK)DO,DY.3E]^_:5):GXD:KOFU*<VPT
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MSREK"KTIEF\W          # I8U(%0            "\(E(%
M *^(5 $           # *R)5             /"*2!4             O")2
M!0            "OB%0!            P"LB50            #PBD@5
M         +PB4@4             KXA4 0           , K(E4
M    \(I(%0            "\(E(%             *^(5 $           #
M*R)5             /"*2!4             O")2+1UV[MRYH,#"A0L=#H=9
M=G7V[%G9+!PX<, LETY)24GJE_KBBR_,,@           '!Q$*F6#C???'/
M!>^^^ZY9=G7TZ%'5_-Y[[YGETNGUUU]7OU3ERI7/G3MG=L _8CT&#1IDG@(
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M6CJX1ZHA(2%[]NPQ^PI<8I%J1D9&:&BH_'7FSIU;I4H5^>?>O7N;K?")2!4
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M8TY;(E7]<WV5M+0TU>!_I.HL^,3@Z.AH-:L+# R\__[[C6^T!0
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MZ]=/W'U5G39MFJI&1T?/FC4K.3DY/S__T*%#PX8-"PX.EJ4J5:ID9F:J*0
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M24M+4ZEYD2)59\'M:]NV;6AHJ+K"CS_^J#<D)B8^^."#:ERI5:O6\N7+]4X
M         ( R@DBUK-NW;]_[[[\_>?+DCS[Z:/?NW7EY>69'Z2=^J1T[=LR>
M/7OFS)D;-FS(R,@P.[RP-NAP.';NW/G..^_,F#%CX\:-V=G99H>;E)245:M6
M39TZ=?KTZ6O6K/%GI#BRLK+$?=^T:5-:6II9*W#X\.%UZ]:)US]APH3ERY?O
MVK4K)R?'; (          "@;B%0!            P"LB50            #P
MBD@5             +PB4@4             KXA4 0           , K(E4
M            \(I(%0            "\(E(%             *^(5 $
M      # *R)5             /"*2!4             O")2!0
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ML_[L1H\>/?2J^.W4^/KUZ\4;HE?UW4!IU[IU:_WFSIPY4Z^*Y=&K%2I4T*N
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M[MPY\4NM6K5J6H'//OM,+(GZ%&A<VLZ<.;-BQ8HI4Z9,F#!A\>+%QX\?-SN
MHF"C8"\V"O9BHV O-@KV8J-@+S8*]F*C8"\V"O9BH^ _(E4
M\(I(%0            "\(E(%             *^(5 $           # *R)5
M             /"*2!4             O")2!0            "OB%0!
M        P"LB50            #PBD@5             +PB4@4
M    KXA4 0           , K(E4             \(I(%0            "\
M(E(%             *^(5 $           # *R)5             /"*2!4
M            O")2!0            "OB%0!            P"LB50
M      #PBD@5             +PB4@4             KXA4 0
M , K(E4             \(I(%0            "\(E(%             *^(
M5 $           # *R)5             /"*2!4             O")2!0
M     (#_S]Z=Q^E4_H\?GQECG;&6,9;(3H2*Y!-*"9%")DNBC]*G^(BH_-1'
M2A0M*OHFRIHE6R5+"2V(9"N%) I99S"68<QV?I>Y<KGNZU[FOL_,;<[,O)Y_
M>)CK>E_GW.><ZS[G.N=]GW,   "\(J4*             %Z14@4
M    KTBI @           (!7I%0!            P"M2J@            #@
M%2E5             /"*E"H             >$5*%0            "\(J4*
M             %Z14@4             KTBI @           (!7I%0!
M        P"M2J@            #@%2E5             /"*E"H
M    >$5*%0            "\(J4*             %Z14@4
MKTBI @           (!7I%0!            P"M2J@            #@%2E5
M             /"*E"H             >$5*%0            "\(J4*
M         %Z14@4             KTBI @           (!7I%0!
M    P"M2J@            #@%2E5             /"*E"H
M>$5*%0            "\(J4*             %Z14H6+0X<.C1\_/B8FIFG3
MIC5KUKSMMML&#!@P9<J4G3MWFJ%PAOW[]R];MNS--]^<,&'"CS_^F)B8:$8
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M"9]^^JD>4[QX<;'JS"#O1/!//_TT;=HTO=6Q8\?T:8:&AB8F)FJ-
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M].C1LOS''W_4RZM5J^;:+C"QL;&5*E5JV;)EFS9MC!58LF1)46LV
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M5;%0>H!AS)@Q>O"  0.6+5NFEXC9F6TR)S4U-5^^?/HL?OGE%S,(
M    ?B.EFG>EIJ86*U9,S[U5J5(E+2W-C$LW;MPX/5)8L&"!'M"[=V^]=N3(
MD7JMM'OW;CU&.'GRI!Y@I%2-C.FY<^?T6O< RRVENG?O7B,@RU.J*2DI>H#A
MM]]^TX-KU:KUU%-/Z26S9LTRVV1D\^;-,V?.?.&%%\1';=FRI5&;F)BH/VU8
MV+IUJQ$#            _Y%2S=-B8F+TW)NP;-DR,\BR3IPX$145I8=%1D:>
M.W=.CS%>X5F_?GV]5GKEE5?TF)(E2QH!$1$1>L#//_^LU^[:M4NO#0E.2K5;
MMVYZP.3)D_5:(Z4:&AJJUWI4JU8MO8F>QLZ7+Y]8MV:#C)0O7UZ;GGDG[J^_
M_JK7BD^8D)"@!P           " @I%3SM!4K5NCI-Z%X\>*K5Z_68Y*2DHPL
MH_#@@P_J,<*L6;.,F"^^^$(/.'_^?-FR9?6 7KUZZ0%"N7+E](#Y\^?KM4\_
M_;1>&Q*<E&K/GCWU@ D3)NBU1DHU?_[\>JU'0X8,T9OHFC=O;D;[H4V;-OI$
M_O>__^FU__WO?_7::Z^]5J\%          ! H$BIYFEI:6DU:M30,W!"X<*%
M1XX<N7[]^KBXN)4K5]Y\\\U&@+!X\6)C4K&QL<9CA$N5*K5V[5I9>_KTZ18M
M6NBUPM*E2UVG8=6N75L/:-"@@7H0\<\__QP>'J[7A@0GI?KHHX_J 4\\\80H
MO'#A@E@$RRVE6J!  :.Y.[$F]2:ZUU]_W8SVPZA1H_2)B.TE-I.L^NRSSPH6
M+*C7MFW;UK4U             D-*-:_[ZJNO] R</VK4J''AP@5S0I8U8L0(
M(S)__OPM6K3HW+ESF3)EC*KJU:LG)2494[CWWGN-L+ONNNNEEUYZ^.&'(R,C
MC:J0X*14^_?OKP<(UU]_O9C[BR^^:-E*J::FID9'1^NME-]^^\V,]H-[CC9?
MOGQWW'%'LV;-Q'^,JL\^^\QL#P          @$"04H7U\,,/&WDX'PH5*O33
M3S^9DTAW]NQ9]]2I-ZM6K3+;6]:;;[YIQOETX, !8PJ93ZF.'CU:#U >?_QQ
MRU9*57CLL<?T5E+UZM7-.+]U[MS9G)PGW*(*          "0>:1489T[=^Z.
M.^XPTW%>O/_^^V9[S<R9,]UOE'37KU\_LV6ZV-C8BA4KFM&7B"D;&=-@W*6Z
M;MTZ/4#IV+&C93>ENG3I4KV5-&C0(#/.;T>/'KWJJJO,*;HJ5*C0'W_\8;8$
M          ! @$BIXJ*$A(28F!@S*><J,C+RS3??-%NZ^?KKKWW?J_KLL\^J
M-Z2ZV[1I4Z%"A<PV(2&AH:$S9LSX[W__JQ<&(Z4J=.O638^1FC1I8ME-J28F
M)KH_N/B;;[XQXP(AUG/9LF6-:2J5*U?>N'&CV08           "!(Z6*RQ8M
M6G3++;>$AH8:^;FPL+!NW;H=/'C0;.#%H4.'[KWW7O<D8I,F318O7FQ&NYD[
M=^[55U^M-XR.CIXV;9JH>NZYYU1A>'CXB1,GC+;777>="A ?^^C1HT: <3_N
MIDV;C #A[[__KERYLAXF=.[<V7)+J18M6M1L[$7[]NWUAB5*E$A.3C:# G3\
M^/$N7;KHDPU)?W_M P\\</+D23,:            MI!2A6G?OGT+%BP8/W[\
MJ%&C9L^>_=-//YT_?]X,\D-J:NJOO_XZ=>K4-]YXXY-//MFQ8X<9X5U"0L+G
MGW_^]MMOCQLW[LLOOTQ,3#0C@BPI*6GITJ7OO//.V+%CY\Z=F_DGZ#9NW%A/
M?';ITL6,L"L^/O[;;[\5'U6LKN^__][>Q@(          ( WI%2!H/OCCS^,
M>W\_^N@C,P@           ".1$H5"*ZDI*36K5OK^=2PL+"XN#@S#@
M     (Y$2A4(BM&C1S___/,OO?12@P8-]'RJ<-===YG1            <"I2
MJD!05*]>W<BD*O/GSS>C 0          X%2D5(&@:-:LF9E*37?===<E)R>;
MT0           ' J4JI 4'3NW-G,IH:$E"I5ZH<??C!# 0          X&"D
M5(&@Z->OGY%/O?[ZZ_?LV6/& 0          P-E(J0)!<?#@P:5+EXX?/_Z5
M5U[Y[+//]NW;9T8            @)R"E"@            !>D5(%
M     *](J0(           " 5Z14 0           , K4JH
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MR5$R,PJRUS'.GS^O"CU>8K)<K\UF,J6J/PDF)'V/-&C0(/4X!]](J3H9*54
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M]M-//S4; ^E(J0(   !!-&[<.'5B)N7+E^^OO_XRXX!,H)L!>0TI53@91R4
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MJ@            #@%2E5             /"*E"H             >$5*%0
M          "\(J4*             %Z14@4             KTBI @
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M+=S%JZ^^*F/$!TY-314ENW?OEB7"5U]]93:PK(D3)ZJ *Y-2M=?E
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MJ;?<<DMTRUYZZ:7P6W7S6;APX80)$ZZ[[KH1(T9,G#BQ,B-5L=G=*&SE
M    MA(B5;868\>.[=NW[X@1(]YXXXUTK=1==]V51*ISYLQ)EP$      .!+
M(%)E:W'!!1?$<6G[]NW3M5+'''-,W-"R9<MT#0       +X<(E6V%J-&C4H>
M0GWVV6=3U0D3)A07%\?5XX\_/E4%      " +XE(E:W%2R^]E$2J.^VTTQ_^
M\(?//OLL.O_XXX^OO/+*!@T:)-6''GHH/0P       !?#I$J6Y%>O7HEN6FL
M5JU:J9-NW;JEQP       .!+(U)E*_+QQQ^W;-DRE:&&#CSPP(4+%Z;'
M    X$LC4F7KLG3ITO[]^R=?FYIHVK3II9=>NF+%BO0         ?)E$JFR-
M%BQ8\/SSS]]ZZZV_^M6OHO\[:=(D82H       #_$2)5        @+Q$J@
M      !YB50!        \A*I @       .0E4@4       #(2Z0*
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M@;OOOKM>O7K)>'F;3#H+FRK@[:UBI%I<7!SM0-*04K=NW:@S'JGD32G@=@,
M     &Q71*K50V&1ZHLOOAAF8SOLL,,11QS1O7OW'7?<,3P?,V9,,C)CQHPZ
M=>HDI0,..."<<\[IV[=O^_;M@XD:4Z=.#7Y.;LB0(7OOO7>+%BWB:JU:M?8N
M=>RQQX9ME??C'_\XOE1Q<7'RZ;C)UX)&'GKHH;(3__3))Y^$R6C]^O6[=>MV
MYIEGMF[=.CELU*A1ZE-Y"YLJX.W-53E2#35NW+ASY\ZI)#A)0"MS4PJ[W0
M     -L5D6KU4%BD&GX\[*&''KITZ=+X?,V:-2>==%)2VF.//=:O7Q^7;KCA
MAOBPJ*CHGGON22ZU8<.&BRZZ*!FY^.*+DU(BB3QWV667=&U+;-RXL67+EO&E
MNG;MFIS/F#$C>0&GGGIJ,/$O%UQP0=*SSS[[?/SQQ_'YBA4K>O7JE90NN>22
MJD\5\/;F,HI4:]6J%=VIZ(W*E7[-:OCZ&S9L&#X76_%-J<KM!@      V$Z(
M5*N' B+5EUYZ*8G$NG3ILFK5JK!:4E)RVFFG)0TWWWQS?-ZG3Y_XI'OW[F%_
MKC1F:]>N75S]SG>^DZKF-I?>5=Z4*5/BZT2B:X:EY.G)A@T;IGZCR((%"QHT
M:! WM&G39MFR96'UL\\^2YXZ[=2I4W)>V%1A;V\NHTAU].C1X4AT:PX[[+"D
M&CY-6_%-J<KM!@      V$Z(5*N' B+5WKU[QR.1QQ]_/%W.Y6;-FE5<7!PW
M=.[<.3X\YIAC*OA!%U]\<9LV;8X[[KAAPX:E:YM+[RKO9S_[67R=R+OOOAN6
MHA>0E,:/'Q^6(B-'CDRJUU]_?:H:N?+**Y.&3S[Y)#XL;*JPMS>71:3:O'GS
M-6O6E!W*C1LW+FEX[KGGDO.*;TI5;C<      ,!V0J1:/100J7;MVC4>:=^^
M??P)L>7U[-DS[FG<N'%\<MEEE\4GD6'#AJU;MZ[L1$4J3N\JKVW;MO%UHE>>
M*H4/L)Y\\LFIZH477AB7&C9LF'K8-#9MVK2CCCKJXHLOON>>>U:N7!D?%C95
MV-N;RR)2'3!@0-F)STV?/CUI>/+))Y/SBF]*56XW      # =D*D6CT4$*GN
MMMMN\<A/?_K3=.T+HT>/3A*U)4N61">//?98<A)IV;+EH$&#7GOMM?3DIE2<
MWE52F#B6_PK/DI*2Z.)QM4&#!JF/VTV^P?2@@PX*SRM6V%1A;V\NBTCUZJNO
M+CN1;GCXX8>3\XIO2E5N-P      P'9"I%H];&FDNG[]^IHU:\8C0X<.39>_
M,&'"A"1.>^.--Z*39<N6)6%A:*^]]AH\>/"L6;/2EPA4G-Y5TI A0Y(?.G#@
MP''E[+???DG#_???'\YVZ=(E/N_1HT=X7K$"I@I^>W-91*I__.,?RTY\;M&B
M14G#0P\]E)Q7?%.J<KL!      "V$R+5ZF%+(]4//O@@B<<VF<#%7G_]]:0M
MR>&F3Y_>K%FSY#Q45%1T]-%'I[[?-%%Q>E=)^^^_?]F?69$33SPQG&W5JE5\
MWJ]?O_"\8@5,5>7MK7JD&GZN;V+QXL5)0^4CU5P5;C<      ,!V0J1:/50E
M4ATS9DRZ_(5WWWTW:1LW;EQR_OKKKQ]\\,%)*66WW7:;,V=.<)E_VFQZMUD?
M?OAAV1^U&3OLL$/RY::1QHT;Q^<77'!!<-7-*&"J*F]OU2/59YYYINS$YPJ.
M5'.%WFX      (#MA$BU>MC22#7\&-A1HT:ERU^8/'ERTC9ERI14]8TWWA@X
M<&#R$&=HWWWW337G*I?>56S$B!%E?\[FA4EP^_;MX\.SSCHKN.IF%#!5E;<W
MC%3_]K>_E9WXW LOO) T_'LBU=B6WFX      (#MA$BU>MC22#72L&'#>&3P
MX,'IVA?NN^^^)#;+]R3BQHT;ITR9<O[YY^^TTTY)<^2##SY(=58^O<NG6[=N
M\15JU:KUY)-/_B6/*ZZX(GD9O7KU2L:///+(^/#[W_]^<-4REBY=NG[]^O"D
ML*F"W]XP4GWNN>?*3GSNH8<>2AK^G9%JK/*W&P      8#LA4JT>"HA4.W;L
M&(^<<<89Z=H7?O.;W\0]M6K5*BDIB0\_^^RS*5.FK%BQHFQO;OGRY3UZ](C[
M:Y1]/#2VI>E=RL*%"Z.7$5_AT$,/39<#BQ8M2CIWV&&'Y*7V[=LW/HQ^][(3
M_[1FS9JHOW;MVATZ=$A>?V%3!;^],V?.C \C3SWU5-F)SXT>/3II^#=$J@7?
M;@      @.V$2+5Z*"!2/>JHH^*1!@T:+%FR)%TN?1YQK[WVBGN^]K6O12>?
M?OIIV[9MBXJ*HI,''G@@/5#:$/='KKCBBE0U2>^:-V^>*E7&'7?<D5S\ZJNO
M3I?+.OSPPY/F>^^]-SZ\_/++D\-ITZ:5G?C<E"E3DH:)$R?&AX5-%?#VQN;.
MG9M<;9/?PWK..><D#1E&JN5O2A5O-P      P'9"I%H]%!"I7GGEE4D>-FS8
ML'0YEWOTT4>3AE-..24Z6;5J5;UZ]>*3<\\]-SV0RRU8L" 9N>VVVU+5ZZZ[
M+BXU;-@P5:J,XX\_/KGX.^^\DRZ7=<,--R3-/7OVC \G3IR8'/[TIS\M._&Y
M 0,&Q-7:M6LGSV46-E7 VQM;N7)E<MZ_?_]@XG/+EBUKT*!!TE#U2+6"FU+%
MVPT      +"=$*E6#P5$JDN6+&G<N'$\U:1)D^>??SZLSIHU:X\]]HBK145%
M?__[W^/SY(M%:]6J]<HKKX0CN;(/=/[M;W]+5<-/K'WOO?=2U8JM7+FR?OWZ
M\6R;-FW2Y7)FSYX=/UX9B0:7+U^>*WTP=)]]]HD/&S1H\->__C4<>?/--Y./
M"^[:M6MR7MA486]O;+?==HM+J3=YW;IUO7OWCDNQJD>J%=^4JMQN      "
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M        \A*I @       .0E4@4       #(2Z0*        D)=(%0
M " OD2H       ! 7B)5        @+Q$J@        !YB50!        \A*I
M @       .0E4@4       #(2Z0*        D)=(%0       " OD2H
M  ! 7B)5        @+Q$J@        !YB52KAZE3IXXM=>>==Y:4E*3+9:U:
MM2INCKS__OOI<O4T?_[\Y)=Z^NFGTV4       #X<HA4JX=##CFDQA=NN^VV
M=+FLCS_^.&G^XQ__F"Y73]=>>VWR2S5ITF3MVK7I#BHG6H_^_?NG3P$
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M/E*-].S9,]U7:AN+5,>-&Y?\.K-FS3KYY)/C/^^XXXYKUJQ)=Y.?2!4
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M?%ZK5JV]2QU[[+')96?,F%&G3IUD]H ##CCGG'/Z]NW;OGW[Y# R=>K49 0
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MIW'CQO%))I'J@ $#@HE_FCY]>M+PY)-/)N<51ZJ77799,C5LV+#4%_0"
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MF42JUUUW77S8L&'#H/USJU:MJE>O7EP]]]QS4]7(@@4+DFO>=MMMZ3(
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M2!4        @+Y$J        0%XB50       ("\1*H         >8E4 0
M     /(2J0(       #D)5(%        R$ND"@       )"72!4        @
M+Y$J        0%XB50       ("\1*H         >8E4 0       /(2J0(
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M@"UAH\B6C2);-HILV2BR9:/(EHTB6S:*;-DHLF6CJ#R1*@       $!>(E4
M      " O$2J         'F)5 $       #R$JD"        Y"52!0
M ,A+I H       "0ET@5        ("^1*@       $!>(E4       " O$2J
M         'F)5 $       #R$JD"        Y"52!0       ,A+I H
M  "0ET@5        ("^1*@       $!>(E4       " O$2J         'F)
M5 $       #R$JD"        Y"52!0       ,A+I H       "0ET@5
M    ("^1*@       $!>(E4       " O$2J         'F)5 $       #R
M$JD"        Y"52!0       ,A+I H       "0ET@5        ("^1*@
M     $!>(E4       " O$2J         'F)5 $       #R$JD"
MY"52!0       ,A+I H       "0ET@5        ("^1*@       $!>(E4
M      " O$2J         'F)5 $       #R$JD"        Y"52!0
M ,A+I H       "0ET@5        ("^1*@       $!>(E4       " O$2J
M         'F)5 $       #R$JD"        Y"52!0       ,A+I H
M  "0ET@5        ("^1*@       $!>(E4       " O$2J         'F)
M5 $       #R$JD"        Y"52!0       ,A+I H       "0ET@5
M    ("^1*@       $!>(E4       " O$2J         'F)5 $       #R
M$JD"        Y"52!0       ,A+I H       "0ET@5        ("^1*@
M     $!>(E4       " O$2J         'F)5 $       #R$JD"
MY"52!0       ,A+I H       "0ET@5        ("^1*@       $!>(E4
M      " O$2J         'F)5 $       #R$JD"        Y"52!0
M ,A+I H       "0ET@5        ("^1*@       $!>(E4       " O$2J
M         'F)5 $       #R$JD"        Y"52!0       ,A+I H
M  "0ET@5     .#_LW?G<3J5_^/'9\989QA\&$.BK".*BJ2HM%!)(;(D2NE3
M?(JHCY_ZB$31HL(W2Y;(DJV2I6PMR)*M%)I$(?M@+&.9[?PN<^5RW=>]SIFY
M9\[,O)Y_>)CK>E_GW/<YUWW.=9WW?9\#  #@%2E5             /"*E"H
M            >$5*%0            "\(J4*             %Z14@4
M        KTBI @           (!7I%0!            P"M2J@
M  #@%2E5             /"*E"H             >$5*%0            "\
M(J4*             %Z14@4             KTBI @           (!7I%0!
M            P"M2JG!QX,"!4:-&M6O7KG'CQC5KUKS]]MM[]>HU:=*D'3MV
MF*%PGI4K5PZYY)UWWC&K 0          D'&D5/&/X\>//_WTTV%A82&>B/(7
M7GCAW+ES9K.\*SDY>># @5NV;#$KG$KLG<J5*ZM=5K)D23,"
M&4=*%1=MW[Z]0H4*6@K5L]C8V T;-IB-\Z(__OBC8<.&XBU/F3+%K'.J8<.&
MZ3N+E"H          $"6(*4*Z_???X^)B=&S<3Z4+EWZP($#YB+REDF3)D5&
M1LKWFUM2JD>.'"E1HH2^ITBI @          9 E2JOE=:FJJ_#EFX.Z[[SYS
M*7G(*Z^\HK_9W))2[=&CA_ZR0TBI @          9!%2JOG=R)$CC52<5+ER
MY?OOO[]6K5IF1;HOOOC"7%!>T:%#!_V=YHJ4ZO;MV\/#P_67'4)*%0
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MQ'_&C1LGE]:Y<V<]H%.G3FI%POCQX_7:VVZ[3:\-Q!-//*$O8?[\^:*0E"H
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MR'A@:M.F367YT*%#]?(77GC!M9TOR<G)L;&QJFVA0H7T>Q>34@4
M ,ARI%3S+^-6O<*9,V?,($U24I)9I*E6K9J^J'GSYID1EI66EE:H4"$];,.&
M#7J D5(]>?*D7BN4+5M6#_";4E7WVE7JUJVK!V0^I;IKURX]0'?PX,'0T% 5
M*=Z[W,)WW'''Y?8A(=]\\XW9TKL//_Q0;]NB18LX3514E*HJ7KRX+'1_7BP
M           "1THU__KXXX\OI^;2Q<7%F4&:ZZ^_ODZ=.N^]]][1HT?-.LNJ
M4:.&OBB/*56A5*E2>IB13312JL>.'=-KA9(E2^H!?E.JV[=O-P+JUZ^O!V0^
MI>J>]]4U:M1(#UZT:)%8@IY7%N\H.3G9;.;=XX\_?GEQ@;GJJJO,I0
M     "!@I%3SK^W;MQNYMZ%#AYI!E^S9LT>%%2I4J%V[=K_^^JL>8/SR<NK4
MJ7JM=.[<.3TFQ"WE::14#Q\^K-<*Q8H5TP/\IE3=?T*:Y2E5\:;T ,/PX</U
MX%Z]>BU>O%@OT9^$&@A2J@           -F,E&K^E9J:6J)$"3WW5J5*E;2T
M-#,NW<B1(_5(8>[<N7I MV[=]-HA0X;HM=+.G3OU&.'$B1-Z@)%2-3*F9\^>
MU6O= RRWE*K[/6^S/*6:DI*B!QA^^^TW/3@V-O:%%U[02Z9/GVZV\8F4*@
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M=]\UXWS:MV^?L83,IU2'#1NF!RC///.,92NE*CS]]--Z*ZEZ]>IF7*:14@4
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MDI(6+5KTP0<?C!@Q8M:L67_\\8<9D4$-&S:\G% -"6G?OKT9 0
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M__[]BQ8M&C5JU!MOO/'%%U_LV;/'C            $!N0$H5
M +PBI0H             7I%2!0            "O2*D"            @%>D
M5 $           # *U*J             . 5*54             \(J4*@
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MZ-^B$JL0;Z%MV[85*E10A2%N/VS5$V!*='1T@P8-Q*O5"]47G,4<ODR9,F+
MJJJ*%"ERX, !?;'ZU7 E-C:V7;MV5UUUE5XX8L0(O:&]=Z%?2'*W8\<./3B;
M92BE*MQ___WJE;O?#-#>]A%[1[^26[1HT:9-FS[VV&/Z0YO$J->X$[6]==&C
M<AW?\^'^_?MK;SWDYIMO?OSQQSMV[%BG3AV]_+;;;E--/&Z]J*BH&VZXP<@H
MZ%,1VQ,>*^M>I"+65;IT:?G_)DV::*NZ3,T8[[CC#K,N;_'=0P)AXV-H^R/O
M>\^*#Z_MGD8W<P[CVV]JX#1AP@0S5!O(B<[S\\\_R_^'>,E 9/E>EN<+&V=A
MCXL5'49TB<J5*^N%_?KU4ZV0G=2W(L1X1MU=0S]@>GR*A_N>%<V;-6LF]J/H
M%7KYL&'#?+32B6Y&2C7W<LX!+3DYF;-2WN-C%&=O1.3Q<.1WG&_9&@W"R7QT
M+<MN[W(_9W%<<BQ[HR!['4.:.'&BJA*NN.**-FW:7'/--7JAE,F4:EQ<7*%"
MA51Y_?KUNW?O_N233XJIJ"H4MF[=JB]JR) AXO0:$Q,C:\/#P^ND:]FRI1Z&
M'$1*%0""R$BIGC]_7K]Z.VK4*#W8;TI5OQ..F*\F)"3(<K%8_8:H5:I44;\W
M%0-!67CUU5=?7M EJU:M4JV,7\WV[MU;5=UZZZTJ&Y>6EJ;?P;AITZ9Z*R,!
M)H8.ZF8I?_[Y9_7JU?7:T-#0P8,'RP=A'CMV[-IKKU55QMMWOQK^WGOOJ=I^
M_?JI\G_]ZU\G3YY45?;>A3&U*U"@@!A=#1LV3 ROQ5O0([-?1E.JZI9?@OMS
M&NQMG[Y]^ZJJZZZ[3O1;67[FS!DQCU55_?OWUUO96Q<]*M?Q,1_6)[$1$1$K
M5Z[4:R=/GJPNG8@=K0YBQM83TPEQY)1[.3$Q4>^-D9&1ZC?Z]B8\5A:]2/==
MW*5+%U7E_GUG_>LO>E?,D_0>\MMOOZ7Y9#9.9^-C:/LC[W?/VNMI=#-',89J
MC1HUDG_*VXX9U&]H)DV:Y#L#$:2];-DZ"[LO=OCPX>HC-F+$"'$"E56E2I52
MK9!MQ+XH7[Z\W 5B7ZORN+@XM=<Z=NRHM?B'L6?%?OSXXX]5[9@Q8]2>+5FR
MI#HLN/<'HYN14LV]''5 XZR4]_@8Y]L;$=D;YUNV1H-P,A]=R[+;NSR>LS@N
M.9#M49"]CB&</7M6?WQ&SYX]U:AX_OSYQO<Y,IE2%<<T62*&9#-GSE3!*2DI
M+[WTDHKW^*5&];DH5ZZ<68><1DH5 (+(F-8*TZ9-4V?-LF7+ZI=N?:=4Q2E9
MU8KIL?'(-S'!4(]S%\:/'R_+Q4!0%;IGU/[[W__**C%H.'WZM"H_?/APT:)%
M957-FC7=[WW:IT\?M5C] >E& NRCCS[2&KF\=T$,(/1:,?Y0UWW>?/--O<JX
M&O[JJZ_JM<+33S^M:B=-FB0+;;\+8VJGOTXQ[E'_SQ$93:GJJ8*U:]?J5?:V
MS]&C1R,B(F1AU:I5]0XLG#IU2OU*IF[=NJK<WKHL>E0NY&,^O&+%"E5E?*%$
MTC?@'W_\(0N-K3=NW#B]B=B ZD,AJ%]EV9OP6%GT(MUW\;QY\U3MC!DS5*TT
M=>I45;MKURZC-H_1>XA?^@U1)7L?0WL?>2N /6NOI]'-',48J@T:-$C^6;IT
M:?WJK96>LU2_B3EPX(#O#$20]K*]L["Q6./7V$*K5JU4K;%,9(,U:]:H[?^V
MZ^, U(\8(B,C?3SO61HR9(@1\+___4_5CADS1A;Z[6:D5',O1QW0."OE/3[&
M^?9&1/;&^?9&@W R'UW+LMN[/)ZS."XYD.U1D+V.(7SZZ:>J_-%'']5:7*3?
MA3@DTRG5;MVZR9)[[[W7-?SB(4X<P62MQU]%DU)U,E*J !!$[BG5M+2T&VZX
M018*+[_\L@KVG5+MVK6KJO7X8%0QYE/W/A6KD(5BXJ%:O?766ZXMK%JU:LFJ
M%BU:Z.6OO_ZZ:N4^J;;2?P*HKNCI0Q ] 5:B1(G$Q$2MT<4K?:I6S.'=[T-;
MI4H56=NC1P^]7+\:7KQX<;$<O5804W>5/.O0H8,LM/TN]*E=='2TGFS.<1E-
MJ8J=KMZ+T6WL;9_1HT>K5A]\\(%KBXL&#QZL M3M=NVMRZ)'Y4(^YL/JF^8%
M"Q8\<>*$7B4M6[9,M=VT:9,L-+:>_C0X27]4F/K9A+T)CY5%+])]%Y\Y<T9]
MW;53ITY&;;MV[615G3IUC*J\)T,I5?U2OF3O8VCO(V\%L&?M]32ZF:,80S7]
M&VSKUZ_7(Q<L6"#+Z]6K)_[TG8$(TEZV=Q;6%UNV;%GC9"HL6K1(!>2QV]'G
M"NH[CB%NIT[]NW'SYLW3JRS7/1L9&>E^<#MTZ)#H@3*@5:M6LM!O-R.EFGLY
MZH#&62GO\3'.MS<BLC?.MS<:A)/YZ%J6W=[E\9S%<<F!;(^"['4,X?'''Y>%
M8@+H<=RK3J8AF4ZI/O#  [+D[KOO=@V_2+S!JE6K/OC@@QX?[DM*U<E(J0)
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MD[!ERQ99N'GS9E4X:]8L%2QF(+*P4:-&JE!2::J0]'LD>J1>3VAHJ'I^B9X
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M=_GRY213$0A2J@            #@%2E5             /"*E"H
M    >$5*%0            "\(J4*             %Z14@4
MKTBI @           (!7I%0!            P"M2J@            #@%2G5
M8%FS9LW4#)HV;9JYE PZ>_:L6MK!@P?-ZJR6S:O+0D>.'%&O?-FR968U
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MG3Y]VJS+.+]ILZQ=7?9HT:*%?%,WWGBC_(_PY9=?FG'PR6_?
MR!M(J09+3J54LU;>2YN=/GVZ<.'"\DU-GCRY5*E2\O^=.W<V0^%3WNL;
M        'I%2#192JLXT>_9L^8Z$7;MVM6_?7OZ_1(D2Y\^?-Z/A7=[K&P
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M7BNA:]>NJORKK[[26OQCUZY=86%A,N"&&VZ0A9E/J69H9UG^^H;M+@<
M     . TI%2#)4M2JJFIJ==??[T9EYYT7+]^O1%L><EQ"J^\\HHJ'SY\>%)2
MDM;(%]]I,X^KTPN?>^XYUQ87;=^^704L6;)$E5>H4$$6WG///5KX9;-FS5(-
M;:14JU>O+MO&QL8:5?H/6-NW;V_4JCLP1T9&&C\VE;9MVW;__??WZ]=OYLR9
MB8F)LM!>*Z%QX\:RH7B=ZM;'AC9MVLB8J*@H69+YE&J&=I;EKV_8[G(
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M4OVPUTJ_T:ZW&R +JU>O5F%KUJRQ7%.J/_[XH]G LG[XX0<5D&TI52E#70X
M         ,!I2*D&2U:E5#_^^&.7'%2ZJZ^^^MRY<V9H !DR)2TM;<V:-;UZ
M]2I3IHRVX)"__OI+#_.=-O.X.H^%.F]9NHB("%DX<.# R]&:^/AXU3!#*=6F
M39O*5N'AX4N6+/G.B]=>>TTMOVW;MJIYLV;-9&'SYLVUI;I(2$A(3D[62^RU
M$B(C(V7# 0,&&%7*K%FS9(P@?^BIIU17KEQI-K LL:E50#:G5*4 NQP
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M%UJU:J6WTA]0*OK,VV^_O7'CQCESYMQ^^^VJ7,J2E*KOOF&[RP$
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M<$1$A*K]_///S<8           ! <)!2A8.T;=M6Y4VE\/!PHZ1ITZ9F,P
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MS]MS+P      Y"52!0       ,A+I H       "0ET@5        ("^1*@
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MX,'CQHTK*2F)%PO;5=CES641J0X8,*#LCL_,F#$C:7CBB2>2]8IORM;<;@
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M?__[P5G+6+ITZ;IUZ\*5PG85?'G#2/799Y\MN^,S#SSP0-+PWXQ48Y6_W0
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M)IV77GII*LMLV;+E'7?<$5632'7&C!EQ_^+%BY-+ND61:JX2-Z7@VPT
M % =B%2KB]+2TFG3IMU\\\W777?=BR^^N'KUZG1'.1]^^.&33SX9]0\;-FS"
MA G3IT]?NW9MNFE35JU:]<X[[[STTDN+%R].U_Z+UJ]?__KKK]]XXXVC1HV:
M/'GR\N7+TQV;4MBN BYO;N.CL0\__/ UUUPS<N3(B1,G5G)7839[4PJ^W0
M     -LWD2H       ! 7B)5        @+Q$J@        !YB50!
M\A*I @       .0E4@4       #(2Z0*        D)=(%0       " OD2H
M      ! 7B)5        @+Q$J@        !YB50!        \A*I @
M .0E4@4       #(2Z0*        D)=(%0       " OD2H       ! 7B+5
MJF':M&EC-[KCCCM*2TO3Y;)6KEP9-T?>>^^]=+EJFC]_?O*FGGKJJ709
M    OA@BU:KAH(,.JO&Y6V^]-5TNZZ.//DJ:__SG/Z?+5=/55U^=O*FF39NN
M6;,FW4'E1./1OW__]"H       !YB%2KA@,//# )%+_\Y2^7E)2D.P+;9:3Z
M[6]_.WE3D4<>>23=024\^NBC.^ZX8XL6+=(%        \A"I5@UAI!H9.G1H
MNB.P_46J\^;-*RXN#BY C3/.."/=Q.;<???=145%T=43J0(      %2>2+5J
M2$6JC1LWGC]_?KKI<]M?I'K++;<$[_XS39HT\=F_6VK$B!'QU=MYYYW3-0
M     /(0J58-J4@U4L'786Y_D>I11QT5OYW]]MLO>6L//?10NH\*B50!
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M__WO)VV)MFW;AAEVOW[]TAT;M6_?/NF)K%^_?LB0(6%FGXC^UO777Q\V P
M    5!,BU:HAC%07+UZ<?)]HY+[[[DLU;S92??CAAQLW;ISTI!05%?WVM[\-
M^[_VM:_%I2...")<C_SUKW]--A87%R]?OCRLEI:6-FW:-*Z.&#$B+%72XX\_
MGIS_MMMNBQ>[=>L6KT3O8M6J564V!.ZZZZYZ]>HEV\O;Y,7)%;KQZJNO3K+>
M31HX<&!T09+^K8]4HPO^O>]]+^E)J5NW;M09;ZEDI!K=]W1'68,&#0K[ 0
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M8--GPJ>*GWWVV62]XDCUZ*./CJO?^][WTK6-%WSWW7<_]MACAP\?GJX!
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M)J6; DF*62.C2/655UY)UF.U:]<N+2V-JVO6K.G<N7.JH;BX.+4R=NS8Y(0
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MIIL       "J!Y$J        0%XB50       ("\1*H         >8E4 0
M     /(2J0(       #D)5(%        R$ND"@       )"72!4        @
M+Y$J        0%XB50       ("\1*H         >8E4 0       /(2J0(
M      #D)5(%        R$ND"@       )"72!4        @+Y$J
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MHLB6B2);)HILF2BR9:*H/)$J        0%XB50       ("\1*H
M>8E4 0       /(2J0(       #D)5(%        R$ND"@       )"72!4
M       @+Y$J        0%XB50       ("\1*H         >8E4 0
M /(2J0(       #D)5(%        R$ND"@       )"72!4        @+Y$J
M        0%XB50       ("\1*H         >8E4 0       /(2J0(
M  #D)5(%        R$ND"@       )"72!4        @+Y$J        0%XB
M50       ("\1*H         >8E4 0       /(2J0(       #D)5(%
M    R$ND"@       )"72!4        @+Y$J        0%XB50       ("\
M1*H         >8E4 0       /(2J0(       #D)5(%        R$ND"@
M     )"72!4        @+Y$J        0%XB50       ("\1*H
M>8E4 0       /(2J0(       #D)5(%        R$ND"@       )"72!4
M       @+Y$J        0%XB50       ("\1*H         >8E4 0
M /(2J0(       #D)5(%        R$ND"@       )"72!4        @+Y$J
M        0%XB50       ("\1*H         >8E4 0       /(2J0(
M  #D)5(%        R$ND"@       )"72!4        @+Y$J        0%XB
M50       ("\1*H         >8E4 0       /(2J0(       #D)5(%
M    R$ND"@       )"72!4        @+Y$J        0%XB50       ("\
M1*H         >8E4 0       /(2J0(       #D)5(%        R$ND"@
M     )"72!4        @+Y$J        0%XB50       ("\1*H
M>8E4 0       /(2J0(       #D)5(%        R$ND"@       )"72!4
M       @+Y$J        0%XB50       ("\1*H         >8E4 0
M /(2J0(       #D)5(%        R$ND"@       )"72!4        @+Y$J
M        0%XB50       ("\1*H         >8E4 0       /(2J0(
M  #D594CU=+S' Z'X[]QY%:E__T#      !4&U4Z4NWE<#@<_XTC5Y+^]P\
M     %!MB%0=#H=C<X=(%0      JC&1JL/A<&SN$*D"     $ U)E)U.!R.
MS1TB50      J,9$J@Z'P[&Y0Z0*      #5F$C5X7 X-G>(5 $     H!H3
MJ3H<#L?F#I$J      !48R)5A\/AV-PA4@4     @&I,I.IP.!R;.T2J
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M_[S9?_]WAV5'?^LO3C\HOW*<W^5$M;]F]5:JDR:-2LUZGCWV:&O:WZJJ5 $
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M:]'*IZU,>H6?_/B5^0E1-EZW,)GSH_NZ\S<6;IV?T,1C-JA2;=R)2EXSE2H
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MGE^@4:D"     , PIE*5H9=\I2K2V*A4 0    !@&%.IRM"+2E4&.RI5
M   8QE2J,O2B4I7!CDH5      "&,96J#+VH5&6PHU(%     (!A3*4J0R\J
M51GLJ%0!     & 84ZG*T(M*508[*E4      !C&5*HR]++UD35M;2TJ51F\
MJ%0!     & 84ZG*D,PS.WKB//=L]I+(P$>E"@      PYA*542D*BI5
M   8QH9RI?K<-2(B@Y'>I[/__P,       P;0[E2!0       &@PE2H
M  ! D$H5        ($BE"@       !"D4@4        (4JD"        !*E4
M 0       ()4J@        !!*E4       " ()4J        0)!*%0
M "!(I0H        0I%(%        "%*I @        2I5 $       ""5*H
M        02I5        @""5*@       $"02A4        @2*4*
M$*12!0        A2J0(        $J50!        @E2J         $$J50
M     ( @E2H       ! D$H5        ($BE"@       !"D4@4        (
M4JD"        !*E4 0       ()4J@        !!*E4       " ()4J
M    0)!*%0       "!(I0H        0I%(%        "%*I @        2I
M5 $       ""5*H         02I5        @""5*@       $"02A4
M   @2*4*        $*12!0        A2J0(        $J50!        @E2J
M         $$J50       ( @E2H       ! D$H5        ($BE"@
M !"D4@4        (4JD"        !*E4 0       ()4J@        !!*E4
M      " ()4J        0)!*%0       "!(I0H        0I%(%
M"%*I @        2I5 $       ""5*H         02I5        @""5*@
M     $"02A4        @2*4*        $*12!0        A2J0(        $
MJ50!        @E2J         $$J50       ( @E2H       ! T/\# PQF
1*,I>3QL     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>picturedm.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 picturedm.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ". ,P# 2(  A$! Q$!_\0
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M?%+3_A=INE/<6TVI:KK6H1:3I.EVQ42WEU)DJ@+'"J%5G9SPJJ3R< G9=_U
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MR'@_1_&FJ?#?P'X)UCP9=Z'<Z,VEC4M5FOK26S86,D4A,'ES-*WF-"H4/&F
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M110 4444 %?.?[=.K6>F?"KPR+G5K;1Y)/&>@F.XN'10FW4(69\,<$* 6.>
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M:U;;6/J,V ./K7;./M[3@ULEJTME;K;L<<)>Q3A)/=[)O=WZ'TA17SYH:_M
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MM[@D19!CEE"L5P6$$YXP,==8>)/B?K7Q:\/>%AXQ31[35/#LWB259]'@FN(
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M/_@?K_7GOIL_GW]EO0=,^-WPQU/QAXYT^#6_%>JZSJ<%XUZN^73%BNI88[6
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$@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>picturemw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 picturemw.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "+ +T# 2(  A$! Q$!_\0
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M;C>A&>4&9AM&_:-_)\JO][NGYVZ7*EO*W=V\U=V^[=?/RM-\;/BQK7PW\?\
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M>UU8;^*GVO\ @CGQ'\-KO;\SU2&%+>)(HD6.)%"JB# 4#@ #L*?17R_^UO\
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MIE]Y1NKC6E*6T2VI5E M_*@7:0AW;D&XL)#4P]Z3C_7G^B]6EUTJ7NQ4N_\
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;YR_SJH/)Z\\UT-% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>cutr-20211231_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 cutr-20211231_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOBG\5-)\-M\:?">DW6E7&GJ\N^6SO=*EFN8XYYXDD6.XCG\O"R?(C[!71_\
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MZ=XCL]:N%T'PWX3>QATJWL-0N+1IY9Y+F9I3BSF<@*H D Y*Y/RI_P 'KO\
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MGPZ^,/PIT[P1\?/#_AN]33A;.9;+6-.E>VEO1I\DF9(B6M;:22U<LVV!'5Y
MC[ #J_\ @LY_P7V\(?\ !-OQKH/[*'[/GPRC^)WQY\7-;)I/A0W+)9Z5]ID$
M=LUV8_G>69R!';(59E.]GC4QF3U;3O@Y_P %IY_@>OC/4OVU_A-!\4'T_P"U
MGP:OPD=O#4=ULW?8#<B^^V&/=\AN0<_Q>4>A_ /X->(-;^/?_!VDFM?%F1KB
M[B_:IU)%CNCN,"Z9?3I90\_\\EM+=%_ZYBOZO* /SG_X(Y?\%\_#O_!0KXH>
M(_V,OVFOA9!\+_C]X-N+RWU7PO%=M)8ZL]I(T5W]D+DO'-"ZMOMG9V"*75Y%
M63R_%/\ @X'_ ."K/_!5O_@D9\3?">L?!CQ%\-?%O@7QY9:K>V,.I_#^[-]H
M LKBSBD2YEBO/+DB)U&S1)L(6=RI4':7_,K]ICQ'KWP,_P"#L^3Q#\*9'@OO
M^&G=$Q':G!N/M]Q:+=PG':5;F>-O42-ZU_0'^V'\(/AK\?O^"AWPA^"OQB\'
MV>O^%_$_[/WQ2T_7-'OX]T5U;R:AX,#*<<J>X8$,K ,I! ( ,?\ X(H_\%=?
MAW_P5P_91C^(%D]CHOQ)\-1QV/Q&\*V[$BQO&4[+N!&)8VL^UGCR25*O&68Q
MEC-\#?'?_!1C7/\ @I-\0_V</B/\?_A]>_#KP!X2\-^(X)-/^'$MOJNJ1:M/
MJ,2VKR&_>.$QMI5UF14;<'C(5>17X(_M)_ []KG_ (-7?^"J6D?&7X+7E[K7
MP[UF::3PQ>WCE;;Q1H+2*;K1KUE&T7,0V L!PP@N%49"#]SO^"9'[8WP0_;V
M_;1^+/[4?[/OB,:AX>\2? ;X8R"*0@7&GW*ZEXS$UG<("?+GB?*,N2#@,I96
M5B ?<]?G3_P6<_X+[>$/^";?C70?V4/V?/AE'\3OCSXN:V32?"AN62STK[3(
M([9KLQ_.\LSD".V0JS*=[/&IC,GZ+5_*'\&O$&M_'O\ X.TDUKXLR-<7<7[5
M.I(L=T=Q@73+Z=+*'G_GDMI;HO\ US% '[^:=\'/^"T\_P #U\9ZE^VO\)H/
MB@^G_:SX-7X2.WAJ.ZV;OL!N1??;#'N^0W(.?XO*/0^3_P#!'+_@OGX=_P""
MA7Q0\1_L9?M-?"R#X7_'[P;<7EOJOA>*[:2QU9[21HKO[(7)>.:%U;?;.SL$
M4NKR*LGE_HQ7\H_[3'B/7O@9_P '9\GB'X4R/!??\-.Z)B.U.#<?;[BT6[A.
M.TJW,\;>HD;UH _4G_@XK_X*R_\ !1'_ () ^)/AUXD^!/C;X?:_X>^)$^LI
M'I/B3P-,;C26LC:,JB>*]43JRW8'**08LY._"^Y_LHZ[_P %E_VM?V,OA]^U
M7X/_ &V/@AIE_P"/_!5CK]OX9U+X!7WDV;7,"RB!KM->+.%+;?,$ SUV]J^#
MO^#Y/_D5/V:O^PCXM_\ 1>D5UWPD_;]_;.^'_P"P_P#\$_\ ]F'1OV'O%'AK
MX?\ C/QO\*])U7XR7^M6-W97EI%JNG3+!##9RRO:FY:%1FZ\IC&'01EFR@!^
MB/\ P28^.W[=WQD\ ?%;PE_P45\/^$M/^(WPW^,-WX68>";.6'3[JP72=*O[
M:YC\V1V<2K?F16.T[&0,BLK"OICQ]XX\+_#'P+K7Q*\<:M'8:+X>TFYU/6+Z
M4_);6L$32RR-[*B,3]*N6&B:+I5W>W^EZ1:VT^IW(N=2FM[=4>[F$4<(DD(&
M9'$44489LG;&B]% 'RY_P6L^!7[6_P"U'_P3I\=?LT_L6Z7IL_B[QXEOH]Y/
MJNL+916VE/('O#O8$,9(D,&WN+ACVH _*34/^"X?_!T;XUOY_&7PD_X)>:D_
MA35YFO?##/\  O7+DG3Y27MB9DF"RGRF3YU #=1P:_8;_@EW\0OVU?BY^Q3X
M2^*G_!0+PCI_ASXF>(1<7FJ>&=/T*;3O[)MS,ZVT$L,TCNLQB5)'#$%3+M(&
MWG^?OQG^T)_P=)?\$.[W3OB-^T-XG\<:[X%MKF*&:;QGJ\?B[P_<)D*EO+=+
M+++9;CA5'FV\AQA>.*_=#]BC_@LC^Q[^U!^P;X(_;B^+'Q=\'?"?3O%%S+I.
MH6?COQ?9Z=#9ZU!N%Q91SW+QK,<(94QAFB96*J<@ 'U3XCM-:U#0+VQ\-ZS'
MIVH36DB6.H2V@G6VF*D)(8BR^8%;!V[AG&,CK7X(?MQ_\' 7_!8#_@G+_P %
M&O\ AC#]J74OA59^$X_$.GR'Q[IWPXNV:[\-7,ZC^U(+<ZAAI$B\T-%N($T$
MD>X[=Q_9_P"%7_!0/]@OX[>.;3X8_!#]MSX1>,O$NH+*UAX>\*?$G2]1OKD1
MQM)(8X+>=Y'"HC.V%.%4DX )KX*_X.M?^"8'_#:?[#Y_:@^&/A[[1\0O@M!/
MJ06WBS-J6@, U];<<L8@HNDSG BF51F6@#],K&75M8^%T-QHOQ#L;B]NM"5[
M7Q5#9I);2R-""MXL0?8T9)$@4/@@XW8YKY+_ .";7Q0_X*,_M8>"?&?QO^+/
MQW\!Q^ M0\1ZIIWP:U#0?AM+;W.N:5;W30V^O3"6_D"Q7 C9HH0/GC*R[PKJ
M*_-W_@A'_P %#_C1_P %(_V%M"_X(U)<ZS!KVCW!T[QKX]@=D-A\,XPIEBCG
M!RM[(7328@!E(9UF!S":_>?POX8\.^"/#.G>#/"&B6VFZ3I%A#9:7IUE"(X;
M6VB01QQ1J.%1455 '   H _"O1_^"['_  5MU_\ X+)W/_!)R'XC_"&SB7XF
M7GA6#QR_PMNIV$<7F,ERUH-40%BJ#*"4 $G#''/U_P#\%&/'_P#P7N_8L_9T
M\4?M&?!C]H7X#?%2T\$:2^K^*- ;X17VCZA#IL:LTMS"@U>Y27RU21V5F0E(
MG*[F&P_CWK7BCQCX+_X.UM<\4_#_ .&=YXRUFR_:!U&33_#&GZC;6DVHR>7*
M/*2:ZDCAC."3EW4<=:_:7_@DI^T/\<?VV?V@_P!KFY_;!_9VE\!WMAXIT7PL
M_P -->ECO38:4FF2[89I /*N5G$\LY9,Q.MS\I9,,0#[ZT:[EO\ 1[2^G WS
MVT<C[1QDJ"<?G7QA_P %U_\ @K%:?\$E/V4]&^+&@Z79ZMXO\3>,[#3?#VA7
M;<7-M',D^HR,."%%JCQ!Q]V6YA//2OM:***")8((U1$4*B*,!0.@%?B?_P %
MS/V,?$__  5M_9J^/G[:WA":\NK;X!:DVB_!FPMY6,.IVFCO+_PE5ZJC*R>=
M<-+ A7)8Z!'MP)3D _9#X1_%3P1\<OA7X;^-'PTUE-1\.^+-"M-7T.^3I/:7
M,*S1/CL2CC(['BOC?_@O9^V-^V1_P3M_8VU/]LS]F#QYX1\G0-4TVRU'PMXJ
M\(27BW*W-QY!ECN([J)HV#21G:58$*W0FOEO_@SG_P""@'_"\_V-=?\ V'?'
M&M^;XB^$-_\ :O#RS29>?0+V1G55SRWD77G(3T5)[=1@ 5[9_P '8O\ RA.^
M(7_8R>'O_3K;T <;_P $C_VTO^"R7_!4_P#8EU#]K?PA^T/\"/#>JQ>)+_1=
M/\(Z[\&M2N+6:6WCA=9)+Z#6T>)7,V#BWD*A<X;.!6_X)(?\'%?Q'_:N_;>U
M[_@F?^WG\!] \"_%K2]4U73-/U#PA<S'3+W4=-,OVRQ:*=Y'A=5@F='\UUD$
M;+\IV[_CS_@AW_P6D^#W_!)C_@C6FN?&[]G#XIZ_9ZM\5M9@T+7O#>CV;:1<
MW[6MLZV<EU+=(T,FV,L<QL=H)0/M8#<_X-T?^"<7Q:_;<_;TU3_@OE\:_%'A
MG3] U7QMXEUK0/"F@ZJ+NZ?6;V2YCEBN%4?Z+% MT[*KD2O^Y8H$;<P!_0)7
MSK_P4X_X*:?L[_\ !*[]FZY_:$^/MW<74EQ<?8O"WA;367[;KM^5++!$&X1%
M +22M\L:C/S,41OHJOY?_P#@\Z^,7C?Q=_P4L\)_!S5+R9?#_@[X86D^CV3,
M?+^TWMS</<W ']YUAMXR?2V6@#]2/^"?WQS_ ."X?_!57X>6W[7EY\5/AS^S
M;\+]?+R^ _#EG\/CXDUG5K,,56YN)+NXB2.-B#LD54,@7<(E5D=NS^.'[77_
M  5<_8Y_:,^"?P!^,WA'X<^/O WQ3^*6E>'&^-/A/2;K2KBP5Y#)+9WFE2S7
M,<<\\4<BQW$<_EX63Y$?:*^T/V;?"'AKX??L[> O 7@RWCBT?1/!>EV&E10@
M!$MH;2*.(+CL$5:WO&/@/P=\0;.RT_QIX>MM1AT[5[35+!+A<^1>6LRS03J1
MR&21%8'Z@Y!((!^2_P#P<4_\%?O^"BO_  2!^)WP^?X'>+_AYK_AOXDV^KS6
MFG>(_ \QN=*:RDM04\Z*\43*RW<8!**08VSG/'WY_P $V/B#^TG\>/V+?A[^
MT9^T/\2M U/6_B3\/M'\206?A[PL;"VTDWUHMTL0#W$K3;5FC4EBN3&2  V!
M^/'_  ?+?\A_]F;_ *\_%_\ Z'HU?L7_ ,$G?^467[-/_9O_ (-_],=G0!Y=
M^SW\2?\ @HOXK_X*4?%']FCXE?'_ .']W\/OAGX=\,:Y#-IGPXEMM4U>/5WO
M0ML[M?O'!Y?]FW*F148MOC8*O(KXO_X+D?\ !7/_ (*Z_P#!*WXWSZ'\(=:^
M&GC3P/%X9T?5;[5-5\ 3Q7>ER:C=:G;0PR^5?;9$W:9)^]P@S,B%<X+??/[/
M/_*77]IP_P#5*OA?_P"CO%5>6?MN_LA>$OV]/VO?CY^R5XR\E(/&?[(OANUL
M+R9-PL;]/$/B"6SNL=_*N8X9,#KLQWH ]:_X(Z?\%!;3_@IK_P $_O!/[4EY
M'8V_B2YADTSQQIVG*5BL]9MFV7"JI9BB2 QSHI9B([B,$DY-?)/_  <1?\%L
M?VJ?^":M]H.@_L:^&O"6HOIGV-OB/J?BG3);N*QDU,7ATJTC6*:/;+(FEZE*
M^XDA$A.,."?@+_@U!_;EN_V$OVQ/BQ_P3V_:CU<>&=+U>VU"_EBU:78FCZ_H
MB2F^C;LN^TAN"YYR;&)1UKT[_@X4\(>(]1_X(@Z)^UA\2-'FLO%WQZ_:;T[Q
MOJ=I>+B?3M-FT/58=&TY\\J;?2X;)'3@"8SG +&@#]%?^")7[57[<7_!1O\
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M,<"+<72PB,32!0&<("=N3DXR<9Q7\OO_  ;/_P#*PYXC_P"O3QE_Z.:OZB:
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M0>$GTNT\46&J_#>2.TU:2ZO5MFFMPE_OM=IGCPC-+E8S\V6R/'_^"./[<?\
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M@3_P4?G\ F\^&USHMUX4\1^"-*GL+'5=(OH;N3[8PN)I"N&MF1@2/+>*5<L
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MKXV?#+6%U#P[XMT&TUC0[U/^6UK<PK+$V.Q*N,CL<CM7Q_\ \%X_VO?VQ/\
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MUB]J+F>.WNAJ\HNI8H]Q"F*+S AV_,51M#_@O]_P4S_;S_X)@?LY_#_]JO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X_?\
M!U!_P14^+?[?7A+PW^V+^R=X3DU_XA^ ](DTK7_"MH ;K7-&\QYXS;#_ ):3
MV\LD["+[TJ3L%RZ(C^A?\$:O^"\7['?C+]D/PA^S_P#MI_'/0O@_\8/AKH5M
MX<\7Z%\4M070S=-9Q+#'=I->F.-FEC16>,L)$DW@IMV,WZ?USWC'X2?"GXB7
M,-[\0/ACX>UV:WQY$NLZ+!=-'CIM,B,1^% 'AOPZ_P""CW@#]I_XT:-\,?V'
MM#;XG^'H;UV\??%+3'9/#.@VJ1N?*@OBOEZE>R2"-%@MC((U9I)70*%?\OO^
M#HS_ ((R_M#?$#XX:1_P56_8A\$W_B/7=,M;)?B#X<T2U:>_26QV_9-5@A4%
M[@+&D<,J("R+!$X4J9&3]S[&QLM,LXM.TVSBM[>",)#!!&$2-0,!54< #T%2
MT ?(7[,'_!<'_@G'^T!^S)IG[0?BC]J[P#X(O$TE9?%_A+Q9XJMK#4]!OD3_
M $BTEMIW69BD@=$*J1+@%-V:_)?X$_L*_%?_ (.!?^"WVO\ _!2CQ5\,]9T+
M]FK1/%%C<:+K'B'3I+4>*+'3(HH;.UM(Y0&E6Y: 33,/EB261-PDV*?W_P!>
M^"WP<\5>(4\6^)_A-X9U+58R#'J=_H-O-<*0, B1T+#\ZZ555%"(H  P !TH
M ^$O^"HO[<W[(/P0_;"_91\ _%3]HOPCHNL:1\<Y]0UW3[W7(5DTBTE\)ZY9
M1W%X-W^B1-/J5FH>7:I$N[.U6(^5/^#K[_@FWJ?[=7P2^$G[8O[+&DVWBCQ-
MIGB&P\*R3Z+*DZ:KI.L74<5C(LJ%@Z1WTL:J5.,7\C9P*_9FB@#\]?V^_"7[
M.G_!-?\ X(#^.?V0->^+.@Z5/:? +6=!T0:OJT4%WXDU::R=)YHHI&#SS7%Y
M<F1PH)#7&3C-?G/_ ,&2WQP^#GP\\5_'_P"&?C[XHZ!H>O\ BN3PC_PB^D:O
MJT-M<:NT3ZM'(ELDC S.KW-NI5,G,R<<U_1%10!_+U_P>0?''X.?&3]O_P"'
MUI\(_BAH'B<^'_A:EIK<GA_5H;Q+*Y;4KQQ!(\3,J2A"K%"=P#J2 &&?Z1_V
M9OCA\'?V@?@SH7Q ^"'Q0T#Q9HTFF6R?VCX>U:&[B20P1OY;M$S!) KJ2C88
M;AD"N^HH ^/O^"S_ /P4\^%/_!.']DS7-1N?BOHND?$OQ38_V7\.=)NKM6N5
MN[EO(74F@!+FUM=S3R.0%/D^7G>Z@\]\ /\ @D;_ ,$KK_\ 9ZTA?A7X]\9>
M*?!UMI!@D\0>'OVFO%G]F7VU3]IG(LM9%JF]S)(ZQJJ NW '%?<5% '\D_P.
M^/GPL_X(5_\ !P9JVJ_!OXG:?XB^#^D>,)=&U/4/#NK#48)O"NI)%-Y1FC9_
MM$MF)868!B6GL"#SD5^N'_!T]^UO^R[X]_X(U:OX<\!_M#>"]=U#QKK6@W?A
M2QT;Q-:W4VJVR7ZR-<0)$[-)$%@ES(!M!0@G/%?K110!^%?_  ;>_"G]CC_@
MH%_P0\\<?\$X_CEXXT"XU;7O'FL22^'!JD"ZSIQ-O:2VNIVT#-YF8W3>L@4H
M3$Z-D;UKY,_X)=_M>_'#_@VS_P""IOBO]AG]L^[GB^&/B'5XK/Q3<I&[6L*M
MQ8>)+1>28FC*B4+\QB+*P,ENJ#^H>B@#\-_^#QO]J?\ 9I^+G_!/_P"&'@+X
M3_'_ ,&^*-8N?BO::S#IWASQ+:WTIT]=(U!?M6V%V(B)N8,.>&\U<$YKU?\
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M^'?P_P#!,\USX,\"Z/I$ER,7$FF:9%;M+SGYC&HW<^M;% 'Q;^Q__P &_?\
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MH"[< <5]QT4 ?R3_  5^/7PL_P""%7_!P;JVK_!CXFZ?XB^#^C^,)-'U*_\
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M[ZV66*0=<,C@AA]10!\B_%;_ (+-_L6>*_A9>:+^Q9\<-"^,_P 3_$6DRP>
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MQ'KNH>!O$OC&RU!'TN3[/=R+IVLB56*>2)4P92VU(;N5R<"OZI+[XD?#O3/
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MC3X9EE&C6<"N+33RZDJTJ^=-)*RDKOEV L(P[?H%X+^%GPQ^&XF'P[^'.@Z
M+C_7C1='AM?,_P![RE7=^-;U 'YC_P#!V'\<?@YX9_X)#?$/X*Z]\4= M?&'
MB*^\/-HGA:;5H5U&]1-9MIFDCM]WF,@CMYF+A=O[MN>*\5_X,NOCE\&[3]@?
MQE\ [[XI:!;^-Y_C/J6HVOA*XU>%-1N+1]'TP+/%;LPDDCS:W'S*"!Y#YQM-
M?M%10!\@_P#!9K_@IY\*/^";?[).OZ[>?%+1-+^)/B73VTWX<:-=W:-<M>W!
M\A=0: 9<VMJ6,\CXVXB\O.]U!YK]GG_@D=_P2QU']GG1O^%5?$+QGXM\)VVD
MF&;Q'X<_::\6?V;J#!2;FX*V.LBU3S',DDBQJJ!G;@#BON.B@#^2;X1?';X5
M_P#!"G_@X.U76_@E\3-/\1_"#1O&$FE:A>^'-7&I02^%-3CBF: S1L_VB6S6
M6(D;B6GL,'G-?KY_P=%?M<_LM>/O^"+7B;0/ ?[1/@K7+[QOJ'A^Z\(V6C^)
MK6YFU:W358I6G@2-RTD2K;SY<#:#$P)R,5^KM% 'X0?\&G/_  4C_8/_ &5_
M^"=7BWX1_M*_M6^"O ?B,_%W4-3ATKQ5K<=E)/9S:;IL<<\?F$!U+P2J<$D%
M.0,C/UUX@_X+/?LZ_MJ?\%2_@%^P-^Q)\5HO%^E0:_JGB?XF^+-!D?[ 8+'1
M;][33HI< 7(:Z:"61DRB^5$H9BSJOZ2T4 %?RR?\'AGQQ^#GQN_X*5>#;CX.
M?%#0/%4&A?!VQT_5[KP[JT-Y#:7?]J:G,;=WB9E$@CEB<KG($BYZU_4W10!^
M1'_!?7_@FO\ !K_@LO\ L0:=^VS^PMXGT#QI\1OASHV_3KWPEJ$-Z/$6E");
MB;2F:%FS<QK()X8S\P9WCVYG!'"?\&O'_!=GP1\3O@E;_L ?MH?%K3-%\8^!
M;1(/A_XA\3ZI';+KND+A$L3+,P5KJVX15SNDAV8!,4C']LJ* /Y0?^"Z_P"T
M9\#O%/\ P<3I\;?!OQ0T;7?"7A[Q'X,DU/Q!H5\E[:(+2*R>YVR0EED,>UE8
M*20RLOW@17[I?&G_ (+3?\$2_@KXCG_:VU3]N#P3KNOVO@^31XM/\%:LFK7U
M_:M.MREN+>V#,)/-4A3(41/-;>5!W#[LHH ^8_\ @D-^T_X\_;=_8FTK]LCQ
M[9W%@WQ*\3Z[JNAZ'<3^8=(TF/4[BSL;4'H2+:UB=BH 9Y'; W&OR$_X/9_C
MC\&_'VI? 7X7>!?BCH&M>(O#-[XI;Q)HVDZM#<7&D[_[,C1;E(V)@9GAF4*^
M"3$_'RFOZ%Z* /CS_@@_\<O@W\5_^"5_P,\-_#7XI:!KNI^&?A7HMAXCTS2]
M6AGN=+N8K<0O%<1(Q>%A)%(N' SM.,UX_P#\'37[#/QI_;B_X)D?V;^S]X1O
M/$/B7X?>-[/Q4OA_383+=ZC:1VMW:W$<$8YDD5;H3!%RS"%E4,Q"G](Z* /Q
MF_X-JO\ @K_^P+\'_P#@F/X8_9&_:2_:0\,_#3QO\,=3UBUU/2_'FI)I?VJ&
MXU.ZO8Y87G*I(1]I,31@^8K0G*@%2WVQ^RGXO;]M#]OO7OV\/ASHFHQ_"GP[
M\*D\"^ ?$NJ:?+:CQ9=7.HK?ZC?V<<RK(UC']FLH4G*A9G$IC+(H8_36L?!3
MX->(?$J^--?^$GAB^UA&#+JUYH-O+<@CH1*R%\_C73T ?SK_ /![3\</@[\1
MO'/[/_PT^'_Q0T#7-?\ " \7_P#"4Z3I.K0W,^DM-)I$<27*1L3"[/:W V/A
MLQ-QQ7U%\1?V /V=_P#@N#_P0#^"7@7X$_$/PMJ_Q<^%'P6\-_\ "+WNG:M!
M+-IFJ1:1!!<Z/?;6+6Z3O;21$/MVRP))R(V#?L-10!_/?_P:[_\ !9Y?V;M<
MU+_@D[^WUXN7PI!H^I747P\U;Q?<BT&C7J2L+K0KEYB!#F7>\(<C;)YL627B
M0?HKX'_X*-?L+ZO_ ,%L?%_@+3/VK? <]U=_ #P]IEG=1^*+4VEQJ,&M:O-+
M81S[_+DN5BO+>0PJQ?:YX^5L??=% 'R;_P %B_\ @E)\)?\ @K/^RE>_!KQ9
M]FTKQCHPEOOAUXP>'+Z1J&W&QR!N:VFVJDT8SD!7 WQH1\G_ /!H_P# +XM?
MLM_LG_'']GWXZ>#;G0/%GA3X_7ECK6EW2\QR+I&F$,K#AXW4JZ2+E71U920P
M-?K%4-OI]A:7$]W:V4,4MTX>YECB"M,P4*&8CEB%55R>P [4 34444 %%%%
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M_M_>%?\ @IY^P)X<\:_&KXA^&3XX\>MXFDUGP/HWB**"_P!.TX:WJ$%M;K'
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M_@HIX _X*C?L6^&_VK?!&D#2;R\DET[Q5X>\_P TZ1JT&WS[??@;D(>.6-B
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXA;XHZ#/I=AKVFW'C7PREK90Z:V_[5]H.J;)$FWJL:IEP4D\Q8P$+H?V"_\
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MXZ\':YI)\/7MGK%A'8O<3SW-W%+9F$K--MEB#-O1<#EJ *W_  ;._M8?$/\
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MKPYK5QXN\.ZE:_V;?2B:"*X%CJ4TT=R,%65(GCRRD28S@ _!+]F?XV?M;?\
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M]X'^#OP^NM!_X1KQ5XEM[5M7\1>(;-X;^=4=N1::4XME?M)JMROWHSC\>/\
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M@?V%OV,M?O=2T[PZVE>+O$=UXR\.:;;ZBUO/NL;BW674UG+A))59I(XV"QP
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M?_@G;^RQX8_90^!-E*-&\.V[&YU&["_:=4O9#OGO)RH ,DCDG X50J+A44
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M:UH_AO1[OQ#XBU:VL-/L+9[B^OKV=8H;>%%+/)([$*BJH)+$@  DU\]^&/\
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MJUC+9ZIIFHVRS6]W;RH4DADC<%71E8JRD$$$@U>HH _,/PC_ ,&T?@_]E/\
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M\>:)Q9V_VV0Q^?&R2/O=5$GEYC /J#X'?\%Q/V4?BK^VS<_\$\/B7\./B/\
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MTZW@7/(\NS3RA_LJ:K_\%08(8?\ @\(^#<D485I?&7P_:0@?>.Z%<G\ !^%
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MCPAX2\1?\$*_B5H?B'2K5K'6_''BBVUK?"N+B!M)LHW$AQ\P\LE>>W%?/O\
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MAOXA^"?B'X=CN9)/#'Q-\,1Z9<W@MWVW"Q*D\I62/(+0RB.4#<=A"/M^'/\
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MU;QQX[_8Y^/ESJ8^)G@WP\+3X?IXAF8/I_A^*]EEU#28(I #;O'>SK-(O+R
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M\=:9:VVN:+<_"Y],N$>U:9K>2&Y&JS*F#/)N5HGW @ J1FOTAHH _(WX]_\
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M+E8Q).P !D<1JJ!F(R=JJN3P .*GH ^$?V]_^"0OQT_;T_X)S>"?^"?/BO\
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MX!X- '>45YQX4_:[_9I\<^([3PCX1^,>CW^I7\OE6=G!*Q>5\9VC*]>*]'H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:)_P4S_;7^+&@^-/B)X,\"1>%? 6F>$O#$NEZ5I40-R9M0=9[FXDFNI3>7(
MW*D2RD .0KK]D4 %9>K>"/!>O7AU#7/"&EWMP5"F>[T^.1R!T&YE)Q6I10!\
M^_M)^&_#OA;XV_!8^&- LM--SXWD2Y^P6J0^:HMV(5M@&X \X-?05>%_M8?\
MEL^!_P#V/<O_ *3-7NE !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >%_M8
M?\EL^!__ &/<O_I,U>Z5X7^UA_R6SX'_ /8]R_\ I,U>Z4 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!X7^UA_R6SX'_\ 8]R_^DS5[I7A?[6'_);/@?\
M]CW+_P"DS5[I0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'A?[6'_);/@?
M_P!CW+_Z3-7NE>%_M8?\EL^!_P#V/<O_ *3-7NE !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^R+XP\!W#6*>+/!.A>$->M[8[([VQU+7=2L#'*HX=4,\<@!Z-!&1RBX_;.@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFZ)J'C+4XM0\37&GP[/MUS%:PVJ2,N=JXA@B7"@ [2Q!9F) /EV[_P""UO\
MP3GE_:X\=?\ !.#]I#QVO@KQ7X8MH[359_BCI]OIF@>)%EMU>1;6XGE,<B%9
M -DXC\T-^[$JY-?(G_!)7_@D1H%IXX_;G\1_#.RDT#X&?'2TU'P5\)$:-UAO
MM+GBNUGOK=&P7LHWN?*MI>1+&K,I*[6?]==9\#^"O$>J6VN>(?!^EW][9?\
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M#Y+&\:910K?5\)S8BK_+27-]\OA2[ZNW8_7^BBBOI#ZX**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \+_:P_Y+9\#_
M /L>Y?\ TF:O=*\+_:P_Y+9\#_\ L>Y?_29J]TH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **K:SK6C>'-*N-=\
M0ZM:V%C:Q&2ZO+V=8HH4'5G=B H'J37Q=^U)_P %Z/V(O@!]HT/X>:U=?$O7
MH<JMKX68"Q5QT#WKCRRI_O0B;Z5Q8W,L!EM/GQ-107F]7Z+=_)'G9CF^6932
M]IC*L8+S>K]%N_DF?;5>3_M)?MQ_LI_LDZ>UU\>?C3H^C77E[X=&68W&H3C'
M!2UB#2D'@;MH49Y(K\V&_:E_X+:?\%0V-E^SIX"N/AKX&O3A=9TW=IT+1'^(
MZE/^^F(SS]E ]TKU?]FW_@W/^$^BZ@OCC]L;XMZGX\UB>7S[S2=)GDM+)Y"<
ML);AC]IN,GG<#">>17S_ /;^99EIE6&;C_S\J>[#U2^*2]+>A\O_ *SYOF_N
MY+A&XO\ Y>U?<AZI?%)>EO0Y/XP?\' GQ@^-/B=OA/\ \$[?V8-4U;4[DE+;
M5=:T][V[<9P7CL;4D(!U#R2,,'YD'-8/AS_@D5_P4Q_;VUNW\??\%#/VD+KP
M_IID$T6ASW2WUS%GG$5G;LMI:9!QD-N'\2<8K]1O@_\  CX,_L_^&%\&_!/X
M8:)X7TU<;[;1M/2'S6 QND91NE?_ &G)8]S764UPW7Q[YLVQ$JO]R/N0^Y:O
MU=F./".)S-J>=XJ5;_IW'W*:^2UEZMIGS/\ LM_\$C?V&OV4?LVK>$OA+#XA
MU^WP5\2^,"M_=*XZ/&K*(8&']Z*-6YZFOIBBBOH\+@\)@:7L\/!0CV2L?6X+
M 8++J/LL+3C"/:*2_P"'?FPHHHKI.L**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH \+_:P_Y+9\#_\ L>Y?_29J]TKP
MO]K#_DMGP/\ ^Q[E_P#29J]TH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ***AU'4=/TBPFU35KZ&UMK>,R7%S<2A(XD R69FP% '<T-
MI(&TE=DU%?&G[4G_  71_89_9U^TZ'X4\6S?$77X<J-/\'E9;5''3S+QB(=O
M8F,RL/[M?)DW[;'_  6?_P""G$SZ5^R?\++CX=^#+IRG]MZ7FU01YY+:K<A2
M[+W^RJC]/E-?.XSBC*\/5]C1;K5/Y::YG\VM%YZ_(^4Q_&6382M]7H-UZO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-\>_@W)\:/B7X<UFW?QN191Z1HS6S1L(27+$DY!3('H>:^NJ "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ7_@H#^W9\%O^"='
M[,6O?M-?&W4,VFFQ^1HVC0RA;G6M1=6\BR@!_C<J26P0B*[GY4->G?$OXD^
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M%C4CG$G>OT _9\_9$_9I_96T7^Q/@#\&]$\.*T82>\M;;?>7"CM+<R%II?\
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M,VD>;&%NIFNXM7@:::8C#.$0"-4C"X4EMW_@FO\ \$.OB=^P?X5^,EM\1/\
M@HWXW^)?BGXI>#X?#VB>.IM*FL=2\'PHEX#+9O/?7A,GFW4<RG*A7MD.&R<?
MH110!\'_ +(7_!//_@JS\"_A_K?[/'QS_P""L%G\2? FI036MOX@USX<S3^+
M[6VE4JZV^HSZ@Z1R88D27,5[M.-J@  =Y^V__P $<OV5?VS/^"?VC_\ !/J"
MPE\%^'_!D%DWPWU?1HO-G\-W5I$T4$ZK(P\\&-Y$E5V#2B1SO5]LB_6E% 'Q
MO\+_ /@EMXH\3_\ !0;1/^"F?[:_Q8T'QI\1/!G@2+PKX"TSPEX8ETO2M*B!
MN3-J#K/<W$DUU*;RY &Y4B64@!R%=?LBBB@ HHHH \+_ &L/^2V? _\ ['N7
M_P!)FKW2O"_VL/\ DMGP/_['N7_TF:O=* "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBOR-_P"#C_\ X+!>)_A+8Q?\$Q/V*KZ[U+XM
M^/TAL/$]SH&Z6[T>TN\)%80!,M]MN@X  ^:.)P0 TL;+[O#G#^/XGS:& PJU
MEJY/:$5\4I/HDOO=DM6C*M5C1IN4CY]_X+(_MW?&G_@M%^V=H_\ P1W_ ."=
M5_\ VAX.L]<"^,O$=I,WV/5KNW?,UQ-*F?\ B76>"V>1-,H*AR("W[$_\$^_
MV$O@O_P3G_9AT']F;X*6 -KIT?GZUK4T(6YUK475?/O9\?Q.5 "Y(1%1!\J"
MOGW_ ((2?\$??#'_  2W_9R&J>.K&TO?B]XUM8I_'.L1[9!8)]Z/2K=Q_P L
MHB<NRG][+ELE5C"_=M?2\9<08"5"GD.3.V"H/?K6J;2JR[]H]EY62QP]*5W5
MJ?$_P78****_/3K"OC?_ (+5?\$G? O_  52_9>G\(VL=IIOQ)\+)->_#KQ)
M.NT17!4;[*=@,_9I]JJW78RQR '85;[(HKT,KS3'9+F%/&X.?+4INZ?Z/NFM
M&MFFTR)PC4@XRV9^-?\ P;A_\%8_'6E>(+C_ () _MX27FB_$/P//-IG@.YU
M]MD\\=ME9-%F+'F> *QA.2'B4H#^[3S/V4K\D_\ @Y"_X(^^(_C=HL7_  4M
M_8TT^[T_XN_#Z*&]\16^@EHKO6K*UP\5Y"8\,;ZT"!E(^>2)-H):*)3[W_P0
M<_X+!>'/^"HO[.(T3Q_J%I9_%_P1:Q0>-]*0+'_:,7W(]5@0<>7*1B15&(I<
MK@*\1;[_ (MRO!9_EBXIRB'+&3MB*:_Y=57]I?W)O5/HWYVCRT)RI3]A4^3[
MK_-'WC1117Y@=H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2[2@]&GK\[I3AZSJ)QEI);_YFQ1117Q1TA1110 4444 %%%% !1110 4444
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M:>W^&"^W+HDNOG9/FK8B-)\L5>3Z'J7_  41_P""^?[3?_!0[XN-_P $\/\
M@B3X3UZ^?69'M-3^(>EP-#?ZA%G;(UFS[?[.M%!R]Y*4?!R/) W/]6_\$;_^
M#=OX(?\ !/=+#X_?M$2V'Q"^-+@3KJDT9ET[PY*>2+%)!F28$G-VX#_W%C!;
M?]1_\$[_ /@F5^RK_P $R_A&OPQ_9T\&!;Z[C0^)/%VIJLFJ:Y,H^_/* ,("
M3LA0+&F3A<LS-]"5Z6><9X6A@)9-PY3=#"_;D_XM;SG+I%](K2V^CY5-/#R<
MO:5G>7X+T"BBBOSDZPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3%^QB]Z--Z.K)=)RVBGM_P"!(X)MXRKR+X%OYOL>K?![X0_#?X!?"[0?@O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX=_\NX/]Y)?WY_9OV7HUU/C']AO_ ((9?LO?LLFS\<?%:"+XC^-(=L@O=9M
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M^DS5[I7A?[6'_);/@?\ ]CW+_P"DS5[I0 4444 %%%% !1110 4444 %%%%
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M8EZU^N%%?'X7CKBS!YM/,J>+E[6;O*[O&7DXOW;):)6T6UCHEA:$J:@XZ(_
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M'_!9?]FS7_$6F1GRK/Q:+>*'5VA4@&6&X0_8]7C P-P='R27F8\5^P7[&/\
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MA**PBOO*<YM>SMVC[O=W/B<5Q7..)E@\IA];J+>WPP_Q3V^2WVNF?<O[3_\
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MXNTN?/3R;^-L_DU:44L4Z>9#*KJ>C*V17RU>?\$N?!CY^P?%C4XO3SM.C?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"_VL/^2V?
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MQ53VLOA6R[^?^1-1117Y,=X4444 %%%% !1110 4444 %%%% !1110 4444
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M+K4]4U*Z2"WM((U+/+)(Y"HBJ"2Q(  R:_"G_@I#_P %J_VHO^"K_P :)/\
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MH,#AH^E?57[#G_!"7]F?]F=K3QW\;5B^)/C*(K*)=4M<:78R]?W-JV1*P/\
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M PA-NK&.;6IT.-TTH+0VD#<A6R0F^<KZU_P<"?\ !3+XK_MG_'FQ_P"")O\
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MI1C'$U4NRE43IP?]ZG9IZVN*3\-<EFIT:-3'55]J;=*G?NHKWWZ2T/QXN_\
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M55D*$KNPN2 2!G&3UH ]0HK\J?VP/^#MK]A7]D']IWQM^S!K'P/^(WB>_P#
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MNB^]J]>WX4U^#1TV\.<BW=3'U%_W"I?K-_BF?,1L?^"A/[2G_'W-+X1T>?\
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ME?&']JW_ (*;?\'.WQJO/V</V1O"U[\.?V?M*OT&OWM[*T=L8@P9)M5N(_\
MCYG( >.PB)4':3NV&=?U]_X)C_\ !)']E+_@EK\,O^$7^"OA_P#M3Q5J-LJ>
M*?B!J\"G4M688)0$9%O;AAE8$.T8!8N^7/N7P&^ 'P8_9?\ A7I7P2^ 'PYT
MSPKX6T6#RM/TC2H-B)_>=B<M)(Q^9I'+.[$LS$DFNPK/B3C2>98197E=+ZM@
M8[4UO-_S59;RD][7:6F[5PHX?DESS=Y=_P#(****^$.H**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** /C/_@N]_P $T_&__!4[]@N[^ 7PK\;6^A^,-!\36GB?PG)?2M':
MW=[;0W$(MIG4$QJ\=S+M< [9!&Q& :_+;_@F?_P6.U[]G3]I/XF_\$V?^"]'
MPMU*V\3_ !'\5Z5%XD\9:V(U6WO(=*T[3[,7Z0X'E206=G,NH0N1N<3'Y6,R
M_M)^WCK7[7W@_P !>$?B%^QE\,CXWUWP[X_LKWQ+X*77[;36US0C;W,%Y;I-
M=.D/FCSHY8P[!?,A0GI7Y7_ML?L ?%;_ (+4_&?XE_"S0?V/_$?P^NV_:*\/
MZUX@^)7Q"_LRVN/"FBIX*T:UO+"-+:[GEO+B=DCD2.+?;'RXF>9",  ^I/\
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MZ] _;P_9*_8:^./PKM;RR\'?$[5M=UN[TN[<,UKJ%G)IMFUNY7AVADGO8MP
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M%W^S[^SUIVJ?#GX%)<>7>2ZB3;ZEXJ56_P!;=1J=Z0<92UX4G#2L3M$78_\
M!-3QW\<OV</ %Q\(?^"4?['<UWXJU6-8?%_Q9U+1#JNL7SC! \QE%IIML&P5
MMV\Q1A2TDCY=OKJ&?<!\ 4%C,RJPQF8/^'AJ;]HH/^:LXWCS+_GW>ZZZZQ^+
MS+C/):-;ZO3J\\NU-<\GY*VB^;1]Y_\ !'3_ ((/? +_ ()9^$D_:/\ VC];
MT7Q+\7GM#+J/BK4)%&F^%T<?/%9--C#8)5[I\.P)"B-68-[#^T5_P7*_8 ^
M?GZ;H_Q&G\>:M#D#3_!%N+J+=VS=.R6Y7/4H[D?W3QGY3T/_ ((M_P#!1K]L
MG5H/&/\ P4!_:QFTVW+^:-&?47U>YMSW5(8V2TML^L3,!S\OK];?LZ_\$2?^
M"?W[/GD:E/\ "MO&VKPX/]J>.9Q>J6]K8*MN!GIF,L/[QK\XSKBKCKC+,)8R
MK34'+[55ZI=%&$?A2Z)Z?,QIX[B[,(<F PD<-3_FK.\O7DCL_P#%='R-JO\
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MX6U^WK^TC^[^'?A63PUI$_W;NWA^RJ4/\7VB;YV^L6/I6UX+_P"";4^KW_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ719;GXU?$"S,R0:KF2X\-:=.?,,+%\L+R?(>=C\R@B+@B7?^H=?9<89WE^
MP,>&<EE?#4G>I-?\OZO63_N1>D5MI?6T6<^'ISG+VU3=[+L@HHHK\W.P****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX%4LWRE\V!Q&L.].7VJ4NSB[VONEN[-F6'K2E>G4^)?CYGH-%%%?!G4%%%%
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ME^!':6EI86Z6=C:QPQ1C"11(%51Z #@5)117VR2BK+8^8;;=V%%%%,04444
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M>3E.3NVW=MOJV]6SK2459!1116(PHHHH **** "BBB@ HHHH **** "BBB@
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M^\3R#91_O[+PPSC"O=A#^]N3D%+53GD-(57:LGS'_P $QO\ @ASK7Q*^(_\
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M-;:_F7K-K$CW6[ZI(2GY**]*TG1='T&S73M#TFVLK=?NP6D"QH/HJ@"OSO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4N"ZX#[$^S;CP!X$NP1=>"M(ESU\S38FS^:U^*7_  <#_L2_M*_L(?&#2O\
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M</>.F4XRIA:^-POM(-J2E2FFFO1_BMUJC>.8>&-:*E]4Q"3[5(O\T>0^,/\
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M?LLL%]J5LK!9+NXNY-TFFZ<,_<!$TP(5@3(+>OUC_P""2/\ P1<_9W_X)8^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH \&_X*/\ ["?[._\ P4A_9CO_
M -DS]HZZDM+'7KU)?#VI65RD=[8:K#'+)%<6N_(>1(Q.60@AHO-!&,D?@C\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#PO]K#_ )+9\#_^Q[E_])FKW2O"_P!K#_DMGP/_ .Q[E_\ 29J]
MTH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#PO]K#_ )+9\#_^Q[E_])FK
MW2O"_P!K#_DMGP/_ .Q[E_\ 29J]TH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#PO]K#_ )+9\#_^Q[E_])FKW2O"_P!K#_DMGP/_ .Q[E_\ 29J]TH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^./&'B*]U?QE\3+?XG:_'<7$]Y=RS>:VD+-9I#!$LBQJL+,1'$,*[#YOLO\
MX.?_ (V?!_P/_P $]_V1_P!C[]C#5;.'X,_$*]6]T6+0KN22VO=%TN"Q2SA9
MY&,DJ$Z@DI\TEVDA5GRZDT ?M%\!_P!L']F/]IR^U'2/@3\:=$\17^DV\%QJ
M6EVLYCO+>WF7=#<-;RA91#(.4EV['YVL<5Z37XF?\%8/CCKW[+/_  =/_LB^
M,/ =PUBGBSP3H7A#7K>V.R.]L=2UW4K QRJ.'5#/'( >C01D<HN/VSH ***X
M/X@_M/? #X5>(V\)?$3XJ:7I&I)"DK6=W(P<(W*MP#P: .'_ &L/^2V? _\
M['N7_P!)FKW2OE?XU_M$_!'XN?'?X,6'PU^)&FZQ-9^.&:YCLW8F,/ 44G('
M5B!7U10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'A?[6'_ "6SX'_]CW+_ .DS
M5[I7A?[6'_);/@?_ -CW+_Z3-7NE !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 >%_M8?\ );/@?_V/<O\ Z3-7NE>%_M8?\EL^!_\ V/<O_I,U>Z4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!X7^UA_P EL^!__8]R_P#I,U>Z5X7^
MUA_R6SX'_P#8]R_^DS5[I0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_@M1_P!'C?"S_P ) _\ R/1_PIC_ (+4?]'C?"S_ ,) _P#R/0!]AT5\>?\
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MCT ?8=%?'G_"F/\ @M1_T>-\+/\ PD#_ /(]'_"F/^"U'_1XWPL_\) __(]
M'V'17QY_PIC_ (+4?]'C?"S_ ,) _P#R/1_PIC_@M1_T>-\+/_"0/_R/0!]A
MT5\>?\*8_P""U'_1XWPL_P#"0/\ \CT?\*8_X+4?]'C?"S_PD#_\CT ?8=%?
M'G_"F/\ @M1_T>-\+/\ PD#_ /(]'_"F/^"U'_1XWPL_\) __(] 'V'17QY_
MPIC_ (+4?]'C?"S_ ,) _P#R/1_PIC_@M1_T>-\+/_"0/_R/0!]AT5\>?\*8
M_P""U'_1XWPL_P#"0/\ \CT?\*8_X+4?]'C?"S_PD#_\CT ?8=%?'G_"F/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-6\"?#OP5>ZIIT5EX8L8KY]/N=0@AU"5$6XFDBC=KB(&8><0&"[0.*_X*/\
MQT_X*N_\$Q_^#?;P)^RA^T_XQN]'^(7B/XCW/A67Q7I/B9;V\;PE%:M=1P?:
MXFW+(S'[-][=]G@*'ALT ?T#V6JZ9J33)IVI07!MY3'.()E<QOUVM@_*?8\U
MD?%+6?&'AWX8^(_$'P]T.+4]?L-!O+C0]-GSLN[Q(7:&%MI!PT@53CG!KXF^
M#?\ P1J^'7PF_P""DOP]_P""C/[%OQAM/ /PX@^%\6A^(_AAX9T%8K3Q7&+2
M:.TNI9HY%1OEFMI27B=R]FC;LR$K][T ? ?_  0"_P""AW[7_P#P4'_X)T:Q
M^U#^U!X)T_4_$MOX[U33O#MMX7LXK#^UK&"&V9/EGE$2NL\EQ#N+J-L(SE@2
MWG/[#_\ P6E_:Z_:M_X+>>./^"<WQ4^ WAKX>>&?A]X7U>6]TNSU,ZKJ%W>V
M\]FL4SWHV1^68YRXCCB4C?AF;''Z"?LS?LU?"C]D?X0VOP.^">BOI_AVRU74
M]0MK61PQ26^OY[Z89 'RB6X<*,9"!5R<9K\9O^"='_*X9^TE_P!BQK/_ +B*
M /U+_P""FW_!3/X#_P#!+KX +\9_C#;7VLZKJ]^-,\$^"M%PVH>(M2896WA!
MSM0<%Y2"$!  9V1'U_V1+;]O'QMHMA\7OVSO$7A?PI=ZE:_:(/A-X(TOS8M&
M21<I!?ZE<-(][<("-S6Z6T0=2 )%&YOR)_X+T6^K_'[_ (.4/V2?V8_'WB+5
MM+\)6^GZ!<Z5)IMUY,L5U=:S=F:Y@<@A)6:SM8]V#@P+Z5ZE^Q=^U-^UU^QK
M_P '(?BS_@DUXQ_:0\<_%'X4^+M*FU+PPWQ'UZ75M0T1CHW]K(R7<V90BE)[
M786VLIC8C<,T ?LS1110 4444 %%%% !1110 4444 %%%% !1110!^>__!Q#
M_P %!/VO/^"7O[*>A_M4_LQ>)_"LWVOQM9^'M0\.^*O##W<;+/;7<WVB.6.X
MB9&!MU7:0P(;/!'/!W?[>_\ P5_\$_\ !*KPI_P5;\.7OP=^)6DW'@:U\6^.
M/AH_@/4-(OK/3&C$ES)9:A'J<T<AA3=(PEMQ^[1V&2 AYO\ X/,_^43.@?\
M9:='_P#3?JE>V?L5:CX<T?\ X-JO"^J^,7B72;;]E2ZEU,S'Y/LZZ-,9-V>V
MW- 'MW_!+?\ X*8_ _\ X*K_ ++5E^TK\&+.YTN6.]?3?%/A?4)EDN=$U*-$
M=[=W4 2H5='CE  ='!*HP9%^B$U'3Y;Z33([Z%KF*-7EMUE!D13G#%>H!P<'
MVK^8[_@WY^//Q[_8I_X)"_MV_MB?#<3P#2M-\.V/@V^DA\R*WUIOMD$MPBL"
MI>!;^RE(((.(]PQP?>/V8OV7/VWOVE/^"9/[,7[4O_!._P#9R:'XX>'OB!<^
M+O$?QRUSQOID5UXPB>XOXM2M+R<SM=W*23);0M%<*5\NV*D8P" ?OSJ&HZ?I
M-G)J.JWT-M;Q+NEGN)0B(/4L>!4L<B2HLL3AE8 JRG((]17XU:Q\:M$_;X_X
M.C?%/[#W[6&D6FN_#+X8_"^[M? _P^UZ)9].N=8FT^QGN+Z6V?,<UQY-W>!)
M""4CAC*[2":^X/\ @C?_ ,$V/B%_P2P_9GU?]FCQC^T_J'Q,TL^,+K4?";WN
MFM;+HFG2)$B6<:M++@%HWE8*50/*VU1EF8 \P_X.*/\ @H?^V7_P3=_9?\ _
M%C]C7PSHE]JGB'XGVF@:K+K6E->J$EMKB6*W6)77!F>'87SD#A<,X8>\_P#!
M1_\ ;$^.7[$'['7B;]I3X<_LTQ>/-0\*^&)M7UVTD\4P:?9:?'"BF5F=PTTV
MT,SB../YUB8%T8J&]._:+_9J^%'[4_@O2_ 7QAT5[W3]&\8:-XEL4C<*4OM,
MOX;VWSD$%&>$1R+CYHY)%R-V1X__ ,%JO^42/[1W_9'M=_\ 2.2@#D?^"$/[
M?/QJ_P""E/[ EK^U;\?;'1+/7=4\8:O:+8^'K)X+2UMH)@D4:+([N<+U9F8D
M]^U?#FL?\%'/^#J/XQ^(O$'Q0_9-_8$\$W/PJO\ 6[VY\ :IXETZVLKBYT,S
MR&RN'%WJL#OOM_+?S/+57!W  $5[K_P:+ '_ ((S^'@1_P SUKW_ *4"O?\
M_@N7^T)XF_9[_P"":GCNR^&(9O&_Q%%K\/\ X?V<#;9;C5M9E%B@B/:1(I)I
ME]X: ,G_ ((,_MA?MA?M\?L%6?[5W[8]CX8M=2\3>)M03PM;^%=*>U@.E6SB
MV$C!YI2[M<Q76&!"E%0@<Y/VC7GO[)?[/7AC]DS]F'P!^S-X-"'3O OA&PT6
M&9$V_:&@@5'G(_O2.&D8]V<FO0J "BBB@ HHHH **** "BBB@ HHHH ****
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M"OB?]K&'P,/$FK65S:Z;X<T:65HX)[^YDV1M.Z\K$@#R-C!8)L!4L&'YB_\
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MUM=TUKD3ROY7V6P3:R^7]HW3Y<?./)&TCFN__P""G'QQ_P""M$&H_P#"G/\
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MJ:YX.^#7C+4A=:KX,F^'UEJ&IPJ,JJP75T\D,5PL9V?:Q "0$WQ/L7'ZFT4
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M<O$DL3.,9X$B^N>Q_/#]AK_@AC\=?V*_^"D'Q)_X*-P?MT^&_$NK?%B35?\
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MS9\*OV/OV>_"7[,GP1T9[#PMX,T:/3M)AFDWRNJY9YI6 &^621GD=L#<\C'
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M:GIEH%WF>ZT^VN5F"JN2Z6XN)$P<H,-M_(#]EOQQJG[7?_!Y1XDUCX[N]X?
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M^(=MHD%C=:EHFE71@NC-#;JD1;:]M+&0 W[UU=GP" #];J*_$3X+_P#!4?\
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M6/\ P,BH_P"(S^&/_0RC_P" U/\ Y /^(:<<_P#0%+_P*'_R1]145\]_"_\
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MOLVE^+M)^$'@.^^'?C!H=TFC:C]O\6##$#<UM-M5)HQU4*P&^.,K^8W[#/\
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M3JN/^"F?P^^"/BOQ%X$L;#5]1U#3$DMK+5(+#3[V>UEG,%S(@W?Z.\AB+!U
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MW:V?B7Q%IF^![P:UJB&\GMK8Q!_FS(88VC5C\@:,'(^A/^";/_!0?]NS0_\
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M7[,?_1N?@/\ \)"R_P#C5=W15_7<9_S\E][_ ,Q<L>QPG_#+7[,?_1N?@/\
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M@ZYL_#OPKC\8Z?JFMZM?R1D&:2Z+P6EK$/E2.-Y S;Y'D\O:B'Y6_P"#6_\
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MZ;'Y$-I9VD$9%[>PR/,RVK.Q5"@W#YB20/V:HH _('_@J?\ L.?\% _VGO\
M@M!^S%^W#\&?V*/$NH^ _A1%X>N/%D]QXP\-6]TC1ZK)?7,,4,FJ@R/%'($)
MR$:16",R[7:S;_L&_M\O_P '09_X*52?L@ZW'\'6L?[%_P"$D?Q;X>,P7^P!
MIWVPV@U$S^1Y_P V-GF^7\WE[ODK]=:* /P%_9M^(?Q+^%O_  =L_M+^-/AE
M\#M3^(<UKX4OO[4\-Z!JEI;:E)9F/1MTEH+V6&WFF5_+_=230AD+E7+JL;_1
M/_!)[_@D1^T!XK_:F_:R_;V_;Q^%DW@ ?M&V.O>'- \!2ZI;W.I66@ZK=&:X
M>Y>W>2*.3RX[6-1N+$I(S*H*[OHOX"?\$68_@/\ \%0?%_\ P5/T_P#:?O=3
M\7>.X[FU\2>';GPG$FG&SF-ONA@VS^;$RK:PA)&=\%26#Y(K[FH _#GX,?\
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M (5_X#_Z$G2/_!;%_P#$UKT5A5PV&KN]2"D_-)_F:TZ]:DK0DUZ-HR/^%?\
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M* /SZ_X*>^#/^"P_[4W_  2Q\6:7^SGX(M? /Q5\5:U9[? &@>,;<ZEIWAW
M6YM/[5+10/>R-^\D,3I&L+- CR,#)+\$?%'_ ()*_P#!6;6/'G["'QD\-?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
<B@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386087304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 22, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-50644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CUTERA, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0492262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3240 Bayshore Blvd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Brisbane<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">657-5500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock ($0.001 par value)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CUTR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,060,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Part III incorporates by reference certain information from the registrant&#8217;s definitive proxy statement for the 2022 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission not later than 120 days after December 31, 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001162461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842571173416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">BDO USA, LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Francisco, California<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386349112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 164,164<span></span>
</td>
<td class="nump">$ 47,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $899 and $1,598, respectively</a></td>
<td class="nump">31,449<span></span>
</td>
<td class="nump">21,962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">39,503<span></span>
</td>
<td class="nump">28,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other current assets and prepaid expenses</a></td>
<td class="nump">14,545<span></span>
</td>
<td class="nump">8,779<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">249,661<span></span>
</td>
<td class="nump">106,296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">3,019<span></span>
</td>
<td class="nump">2,299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">778<span></span>
</td>
<td class="nump">643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">14,627<span></span>
</td>
<td class="nump">17,076<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,339<span></span>
</td>
<td class="nump">1,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">10,169<span></span>
</td>
<td class="nump">5,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">280,293<span></span>
</td>
<td class="nump">132,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">7,891<span></span>
</td>
<td class="nump">6,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">54,100<span></span>
</td>
<td class="nump">32,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">2,419<span></span>
</td>
<td class="nump">2,260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">PPP loan payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">9,490<span></span>
</td>
<td class="nump">9,489<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">73,900<span></span>
</td>
<td class="nump">54,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">1,335<span></span>
</td>
<td class="nump">1,748<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">13,483<span></span>
</td>
<td class="nump">15,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">PPP loan payable, net of current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible notes, net of unamortized debt issuance costs of $4,007</a></td>
<td class="nump">134,243<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">763<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">223,724<span></span>
</td>
<td class="nump">75,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 11).</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value: Authorized: 50,000,000 shares; Issued and outstanding: 17,995,344 and 17,679,232 shares at December&#160;31, 2021 and 2020, respectively</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">114,724<span></span>
</td>
<td class="nump">117,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(58,173)<span></span>
</td>
<td class="num">(60,235)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">56,569<span></span>
</td>
<td class="nump">56,880<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 280,293<span></span>
</td>
<td class="nump">$ 132,733<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386304232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit loss, current</a></td>
<td class="nump">$ 899<span></span>
</td>
<td class="nump">$ 1,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized debt issuance costs</a></td>
<td class="nump">$ 4,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (in shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (in shares)</a></td>
<td class="nump">17,995,344<span></span>
</td>
<td class="nump">17,679,232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="nump">17,995,344<span></span>
</td>
<td class="nump">17,679,232<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842389547016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 231,270<span></span>
</td>
<td class="nump">$ 147,683<span></span>
</td>
<td class="nump">$ 181,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of revenue</a></td>
<td class="nump">98,165<span></span>
</td>
<td class="nump">71,911<span></span>
</td>
<td class="nump">83,549<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">133,105<span></span>
</td>
<td class="nump">75,772<span></span>
</td>
<td class="nump">98,163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">76,762<span></span>
</td>
<td class="nump">52,766<span></span>
</td>
<td class="nump">71,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">21,568<span></span>
</td>
<td class="nump">14,322<span></span>
</td>
<td class="nump">15,085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">32,945<span></span>
</td>
<td class="nump">31,512<span></span>
</td>
<td class="nump">24,033<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">131,275<span></span>
</td>
<td class="nump">98,600<span></span>
</td>
<td class="nump">110,227<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">1,830<span></span>
</td>
<td class="num">(22,828)<span></span>
</td>
<td class="num">(12,064)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseAbstract', window );"><strong>Interest and other income (expense), net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt issuance costs</a></td>
<td class="num">(710)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest on convertible notes</a></td>
<td class="num">(2,514)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="nump">7,185<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(2,406)<span></span>
</td>
<td class="num">(579)<span></span>
</td>
<td class="num">(199)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total interest and other income (expense), net</a></td>
<td class="nump">1,555<span></span>
</td>
<td class="num">(579)<span></span>
</td>
<td class="num">(199)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">3,385<span></span>
</td>
<td class="num">(23,407)<span></span>
</td>
<td class="num">(12,263)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">1,323<span></span>
</td>
<td class="nump">470<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 2,062<span></span>
</td>
<td class="num">$ (23,877)<span></span>
</td>
<td class="num">$ (12,348)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="num">$ (1.43)<span></span>
</td>
<td class="num">$ (0.88)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="num">$ (1.43)<span></span>
</td>
<td class="num">$ (0.88)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">17,891<span></span>
</td>
<td class="nump">16,691<span></span>
</td>
<td class="nump">14,096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">18,362<span></span>
</td>
<td class="nump">16,691<span></span>
</td>
<td class="nump">14,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 205,703<span></span>
</td>
<td class="nump">$ 125,113<span></span>
</td>
<td class="nump">$ 158,638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of revenue</a></td>
<td class="nump">83,048<span></span>
</td>
<td class="nump">58,325<span></span>
</td>
<td class="nump">64,693<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">25,567<span></span>
</td>
<td class="nump">22,570<span></span>
</td>
<td class="nump">23,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of revenue</a></td>
<td class="nump">$ 15,117<span></span>
</td>
<td class="nump">$ 13,586<span></span>
</td>
<td class="nump">$ 18,856<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386301128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 2,062<span></span>
</td>
<td class="num">$ (23,877)<span></span>
</td>
<td class="num">$ (12,348)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Available-for-sale investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax', window );">Net change in unrealized gain (loss) on available-for-sale investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Less: Reclassification adjustment for net losses on investments recognized during the year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Total change in unrealized gain (loss) on available-for-sale investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">$ 2,062<span></span>
</td>
<td class="num">$ (23,817)<span></span>
</td>
<td class="num">$ (12,339)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842389074248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings (Accumulated Deficit)</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (loss)</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,968,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 46,386<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 70,451<span></span>
</td>
<td class="num">$ (24,010)<span></span>
</td>
<td class="num">$ (69)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for employee purchase plan</a></td>
<td class="nump">$ 1,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">160,798<span></span>
</td>
<td class="nump">160,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(831)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(831)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">9,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(12,348)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,348)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net change in unrealized gain on available-for-sale investments</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,315,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">45,942<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">82,346<span></span>
</td>
<td class="num">(36,358)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for employee purchase plan</a></td>
<td class="nump">$ 632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">73,227<span></span>
</td>
<td class="nump">73,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with public offering, net of issuance costs of $2,303 (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,742,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with public offering, net of issuance&#160;costs of $2,303</a></td>
<td class="nump">26,495<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">26,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">490,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(3,428)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(3,429)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">10,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(23,877)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,877)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net change in unrealized gain on available-for-sale investments</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">17,679,232<span></span>
</td>
<td class="nump">17,679,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 56,880<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">117,097<span></span>
</td>
<td class="num">(60,235)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for employee purchase plan</a></td>
<td class="nump">$ 1,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">71,798<span></span>
</td>
<td class="nump">71,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_PurchaseOfCappedCall', window );">Purchase of capped call</a></td>
<td class="num">(16,134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(2,176)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,176)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">13,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">2,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net change in unrealized gain on available-for-sale investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">17,995,344<span></span>
</td>
<td class="nump">17,995,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 56,569<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 114,724<span></span>
</td>
<td class="num">$ (58,173)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_PurchaseOfCappedCall">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of Capped Call</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_PurchaseOfCappedCall</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386315128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issued, offering cost</a></td>
<td class="nump">$ 2,303<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issued, offering cost</a></td>
<td class="nump">$ 2,303<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386439752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 2,062<span></span>
</td>
<td class="num">$ (23,877)<span></span>
</td>
<td class="num">$ (12,348)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">13,172<span></span>
</td>
<td class="nump">10,109<span></span>
</td>
<td class="nump">9,832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts', window );">Depreciation and amortization</a></td>
<td class="nump">1,344<span></span>
</td>
<td class="nump">1,394<span></span>
</td>
<td class="nump">1,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfAcquisitionCosts', window );">Amortization of contract acquisition costs</a></td>
<td class="nump">1,857<span></span>
</td>
<td class="nump">2,593<span></span>
</td>
<td class="nump">2,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">710<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HostingArrangementServiceContractImplementationCostImpairment', window );">Impairment of capitalized cloud computing costs</a></td>
<td class="nump">182<span></span>
</td>
<td class="nump">805<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Change in deferred tax assets</a></td>
<td class="num">(135)<span></span>
</td>
<td class="num">(220)<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">2,144<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="num">(7,185)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification', window );">Change in right-of-use asset</a></td>
<td class="nump">2,292<span></span>
</td>
<td class="nump">2,522<span></span>
</td>
<td class="nump">2,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(9,574)<span></span>
</td>
<td class="num">(2,550)<span></span>
</td>
<td class="num">(2,509)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(10,936)<span></span>
</td>
<td class="nump">5,413<span></span>
</td>
<td class="num">(5,907)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Other current assets and prepaid expenses</a></td>
<td class="num">(5,766)<span></span>
</td>
<td class="num">(3,164)<span></span>
</td>
<td class="num">(1,762)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="num">(7,128)<span></span>
</td>
<td class="num">(2,067)<span></span>
</td>
<td class="num">(3,355)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts payable</a></td>
<td class="nump">1,207<span></span>
</td>
<td class="num">(6,034)<span></span>
</td>
<td class="nump">1,406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">21,608<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="nump">5,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(140)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(2,151)<span></span>
</td>
<td class="num">(1,598)<span></span>
</td>
<td class="num">(2,292)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(412)<span></span>
</td>
<td class="num">(2,985)<span></span>
</td>
<td class="nump">1,656<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="num">(301)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">1,235<span></span>
</td>
<td class="num">(16,934)<span></span>
</td>
<td class="num">(2,217)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Acquisition of property and equipment</a></td>
<td class="num">(1,015)<span></span>
</td>
<td class="num">(1,279)<span></span>
</td>
<td class="num">(991)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Disposal of property and equipment</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales of marketable investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,648<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from maturities of marketable investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,050<span></span>
</td>
<td class="nump">14,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(26,060)<span></span>
</td>
<td class="num">(12,687)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="num">(944)<span></span>
</td>
<td class="nump">6,389<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from exercise of stock options and employee stock purchase plan</a></td>
<td class="nump">2,765<span></span>
</td>
<td class="nump">1,579<span></span>
</td>
<td class="nump">2,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities', window );">Purchase of capped call</a></td>
<td class="num">(16,134)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from PPP loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,167<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes</a></td>
<td class="nump">138,250<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of issuance costs of convertible notes</a></td>
<td class="num">(4,717)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from equity offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,798<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs on the public&#160;offering</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,303)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(2,176)<span></span>
</td>
<td class="num">(3,428)<span></span>
</td>
<td class="num">(831)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments on capital lease obligation</a></td>
<td class="num">(462)<span></span>
</td>
<td class="num">(537)<span></span>
</td>
<td class="num">(649)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">117,526<span></span>
</td>
<td class="nump">31,276<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents, and restricted cash</a></td>
<td class="nump">117,817<span></span>
</td>
<td class="nump">20,731<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents, and restricted cash at beginning of year</a></td>
<td class="nump">47,047<span></span>
</td>
<td class="nump">26,316<span></span>
</td>
<td class="nump">26,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents, and restricted cash at end of year</a></td>
<td class="nump">164,864<span></span>
</td>
<td class="nump">47,047<span></span>
</td>
<td class="nump">26,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">1,663<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid (refunded) for income taxes, net of (refunds) payments</a></td>
<td class="nump">891<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Assets acquired under finance lease</a></td>
<td class="nump">828<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Assets acquired under operating lease</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">11,735<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReduction', window );">Gain on extinguishment of PPP loan</a></td>
<td class="nump">$ 7,185<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ChangeInRightofuseAssetAndLiabilityDueToModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the change in right-of-use asset and liability due to modification during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ChangeInRightofuseAssetAndLiabilityDueToModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets, excluding contract acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HostingArrangementServiceContractImplementationCostImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on capitalized implementation cost from hosting arrangement that is service contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118198657&amp;loc=SL118198666-228104<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HostingArrangementServiceContractImplementationCostImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of notes retired (or transferred to another entity) in noncash investing or financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3505-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387746520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">SUMMARY<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNIFICANT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCOUNTING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POLICIES</span><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Operations and Principles of Consolidation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cutera, Inc. (&#8220;Cutera&#8221; or the &#8220;Company&#8221;) provides energy-based aesthetic systems for practitioners worldwide. The Company develops, manufactures, distributes, and markets energy-based product platforms for use by physicians and other qualified practitioners, enabling them to offer safe and effective aesthetic treatments to their customers. The Company currently markets the following system platforms: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten, excel,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO, Secret RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Several of the Company&#8217;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The sales of (i) systems, system upgrades, and hand pieces (collectively &#8220;Systems&#8221; revenue); (ii) replacement hand pieces, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">D,truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cycle refills, as well as single use disposable tips applicable to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Consumables&#8221; revenue); (iii) the distribution of third party manufactured skincare products (&#8220;Skincare&#8221; revenue); and (iv) the leasing of equipment through a membership program; are collectively classified as &#8220;Products&#8221; revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt 3D, truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and service labor for the repair and maintenance of products that are out of warranty, all of which are collectively classified as &#8220;Service&#8221; revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#8220;RDCs&#8221;) in selection locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets sells and services the Company&#8217;s products through direct sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over 42 countries. The consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements have been prepared in conformity with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;). Certain prior period amounts have been reclassified  to conform to the 2021 presentation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commissions, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, assumptions used in operating and sales-type lease classification, implicit and incremental borrowing rates related to the Company&#8217;s leases, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of global financial markets, cybersecurity breaches and other disruptions that could compromise the Company&#8217;s information or results, business disruptions that are </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caused by natural disasters or pandemic events, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, the successful execution of new product launches, strategic relationships and dependence on key individuals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;the World Health Organization declared the COVID-19&#160;outbreak a pandemic. The COVID-19&#160;outbreak, and lately the Delta and Omicron variants, has negatively affected the United States and global economies. The spread of the coronavirus, which caused a broad impact in 2020 globally, including restrictions on travel, shifting work force to work remotely and quarantine policies put into place by businesses and governments, had a material economic effect on the Company&#8217;s business during the year ended December 31, 2020. Notably, healthcare facilities in many countries effectively banned elective procedures. Many of the Company&#8217;s products are used in aesthetic elective procedures and as such, the bans on elective procedures substantially reduced the Company&#8217;s sales and marketing efforts in the early months of the pandemic and led the Company to implement cost control measures. Although the Company&#8217;s operation and results of operations have significantly improved as the economic outlook due to the&#160;COVID-19&#160;pandemic improved in 2021, the&#160;COVID-19&#160;outbreak continues to be fluid and the aftermath of the business and economic disruptions due to the&#160;COVID-19 is still uncertain, making it difficult to forecast the final impact it could have on&#160;the Company&#8217;s&#160;future operations, including disruptions in the Company's supply chain and contract manufacturing operations. The Company&#160;cannot presently predict the scope and severity of any impacts in future periods from the business shutdowns or disruptions due to the&#160;COVID-19&#160;pandemic, but the impact on economic activity including the possibility of recession or financial market instability could have a material adverse effect on the Company&#8217;s business, revenue, operating results, cash flows and financial condition. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to assess whether any impairment of its goodwill or its long-lived assets has occurred, and has determined that no&#160;charges were necessary during the years ended December&#160;31, 2021, and 2020, other than an impairment loss of $0.2 million and $0.8 million on capitalized implementation costs of&#160;cloud-based CRM software, respectively.&#160;The Company&#8217;s assumptions about future conditions important to its assessment of potential impairment of its long-lived assets, and goodwill, including the impacts of the&#160;COVID-19&#160;pandemic and other ongoing impacts to its business, are subject to uncertainty, and the Company will continue to monitor these conditions in future periods as new information becomes available.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-13, Financial Instruments-Credit Losses (Topic 326):"Measurement of Credit Losses on Financial Instruments", which replaces the incurred loss methodology with an expected credit loss methodology that is referred to as the current expected credit loss (CECL) methodology. ASU 2016-13 is effective for fiscal years beginning after December&#160;15, 2019, with early adoption permitted. The amendments in this update are required to be applied using the modified retrospective method with an adjustment to accumulated deficit and are effective for the Company beginning with fiscal year 2020, including interim periods. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost, including loan receivables, available for sale securities and held-to-maturity debt securities. An entity with available for sale securities and trade receivables will be required to use historical loss information, current conditions, and reasonable and supportable forecasts to determine expected lifetime credit losses. Pooling of assets with similar risk characteristics is also required. The Company adopted ASU 2016-13 on January&#160;1, 2020 on a modified retrospective basis. Upon adoption, the standard did not have a material impact on the consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company identified trade receivables and available-for-sale debt securities as impacted by the new guidance. However, the Company determined that the historical losses related to these available-for-sale debt securities are not material as the Company invests in high grade short-term securities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes an allowance for credit losses on trade receivables based on the credit quality of clients, current economic conditions, the age of the accounts receivable balances, historical loss information, and current conditions and forecasted information, and write-off amounts against the allowance when they are deemed uncollectible.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13, &#8220;Fair Value Measurement (Topic 820): Disclosure Framework- Changes to the Disclosure Requirements for Fair Value Measurement&#8221;, to improve the fair value measurement reporting of financial instruments. The amendments in this update require, among other things, added disclosure of the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this update eliminate, among other things, disclosure of the reasons for and amounts of transfers between Level 1 and Level 2 for assets and liabilities that are measured at fair value on a recurring basis and an entity's valuation processes for Level 3 fair value measurements. The amendments in this update became effective for the Company beginning with fiscal year 2020. Retrospective application is required for all amendments in this update except the added disclosures, which should be applied prospectively. The adoption </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the amendments in this update did not have a material impact on the Company&#8217;s consolidated financial position and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">No.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The Company adopted this guidance starting January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial position and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the&#160;FASB&#160;issued ASU No. 2020-6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt &#8211; Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to simplify the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the amendment, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the computation of diluted earnings per share. The Company early adopted the guidance on a prospective basis effective January 1, 2021. See section Computation of Net Income (Loss) per Share.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted by the Company</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed all recently issued, but not yet effective, accounting pronouncements and does not expect the future adoption of any such pronouncements will have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company&#8217;s performance obligations are satisfied either over time or at a point in time. Revenue from performance obligations that are transferred to customers over time accounted for approximately 11%, 15% and 13%,&#160;respectively, of the Company&#8217;s total revenue for the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain system sale arrangements that contain multiple products and services. For these bundled sale arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct. The Company&#8217;s products and services are distinct if a customer can benefit from the product or service on its own or with other resources that are readily available to the customer, and if the Company&#8217;s promise to transfer the products or service to the customer is separately identifiable from other promises in the sale arrangements. The Company&#8217;s system sale arrangements can include all or a combination of the following performance obligations: the system and software license (considered as one performance obligation), system accessories (hand pieces), training, other accessories, extended service contracts, marketing services, and time and materials services.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s system sale arrangements that include an extended service contract, the period of service commences at the expiration of the Company&#8217;s standard warranty offered at the time of the system sale. The Company considers the extended service contracts terms in the arrangements that are legally enforceable to be performance obligations. Other than extended service contracts and marketing services, which are satisfied over time, the Company generally satisfies all performance obligations at a point in time. Systems, system accessories (hand pieces), service contracts, training, and time and materials services are also sold on a stand-alone basis, and these performance obligations are satisfied at a point in time. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation on a relative standalone selling price basis.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Products and Services</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systems</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems revenue is generated from the sale of systems and from the sale of upgrades to existing systems. A system consists of a console that incorporates a universal graphic user interface, a laser or other energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. In certain applications, the laser or other energy-based module is contained in the hand piece, such as with the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> applications, rather than within the console.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The system or upgrade and the right to use the embedded software represent a single performance obligation as the software license is integral to the functionality of the system or upgrade.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For systems sold directly to end-customers that are credit approved, revenue is recognized when the Company transfers control to the end-customer, which occurs when the product is shipped to the customer or when the customer receives the product, depending on the nature of the arrangement. When collectability is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> established in advance of receipt of payment from the customer, revenue is recognized upon the later of the receipt of payment or the satisfaction of the performance obligation. For systems sold through credit approved distributors, revenue is recognized at the time of shipment to the distributor.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company typically receives payment for its system consoles and other accessories within 30 days of shipment. Certain international distributor arrangements allow for longer payment terms.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skincare products</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells third-party manufactured skincare products in Japan. The skincare products are purchased from a third-party manufacturer and sold to medical offices and licensed physicians. The Company warrants that the skincare products are free of significant defects in workmanship and materials for 90 days from shipment. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer. The Company recognizes revenue for skincare products at a point in time upon shipment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consumables and other accessories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its customers' purchases of replacement cycles for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt iD </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as replacement hand pieces, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces, and single use disposable tips applicable to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as Consumable revenue, which provides the Company with a source of recurring revenue from existing customers. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products&#8217; single use disposable tips must be replaced after every treatment. Sales of these consumable tips further enhance the Company&#8217;s recurring revenue. The Company&#8217;s systems offer multiple hand pieces and applications, which allow customers to upgrade their systems.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equipment leasing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases equipment to customers through membership programs and receives a fixed monthly fee over the term of the arrangement. The Company classifies its lease income as product revenue. The Company recognizes lease income over the term of the lease if the lease is classified as an operating lease. For agreements that grant customers the right to purchase the leased system, the Company typically classifies the lease as a sales-type lease as the Company has determined it is reasonably certain that the customer will exercise the purchase option. On the commencement of sales-type leases, the Company recognizes revenue upfront in product revenue and the corresponding receivables recorded in Other current assets and prepaid expenses on the consolidated balance sheets (Notes 1 and 11). Revenue from equipment leases was not material in the years ended December&#160;31, 2021 and 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Extended service contract </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for a term of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzOTA_48951eca-9684-4911-930c-c47a406efd42">one</span>, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzOTE_82f81123-597c-470d-8503-057d2c5ae78b">two</span>, or three years. Service contract revenue is recognized over time, using a time-based measure of progress, as customers benefit from the service throughout the service period. The Company also offers services on a time-and-materials basis for systems and detachable hand piece replacements. Revenue related to services performed on a time-and-materials basis is recognized when performed.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Training</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of systems to customers include training on the use of the system to be provided within 180 days of purchase. The Company considers training a separate performance obligation as customers can immediately benefit from the training together with the customer&#8217;s system. Training is also sold separately from systems. The Company recognizes revenue for training when the training is provided. Training is not required for customers to use the systems.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of whether two or more contracts entered into at or near the same time with the same customer should be combined and accounted for as one contract may require the use of significant judgment. In making this determination, the Company considers whether the contracts are negotiated as a package with a single commercial objective, have price interdependencies, or promise goods or services that represent a single performance obligation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company&#8217;s purchase agreements do </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provide customers with a contractual right of return, the Company maintains a sales allowance to account for potential returns or refunds as a reduction in transaction price at the time of sale.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines standalone selling price ("SSP") for each performance obligation as follows:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Systems: The SSPs for systems are based on directly observable sales in similar circumstances to similar customers.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Extended service contracts: SSP is based on observable price when sold on a standalone basis to similar customers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loyalty Program</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company launched a customer loyalty program during the third quarter of 2018 for qualified customers located in the U.S. and Canada. Under the loyalty program, customers accumulate points based on their purchasing levels which can be redeemed for such rewards as the right to attend the Company&#8217;s advanced training event for a product, or a ticket for the Company&#8217;s annual forum. A customer&#8217;s account must be in good standing to receive the benefits of the rewards program. Rewards are earned on a quarterly basis and must be used in the following quarter.&#160;All unused rewards are forfeited. The fair value of the reward earned by loyalty program members is included in accrued liabilities and recorded as a reduction. of net revenue at the time the reward is earned. As of December&#160;31, 2021, and December 31, 2020, the accrual for the loyalty program included in accrued liabilities was $0.5 million, and $0.3&#160;million, respectively. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Sales Commissions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract, which consist primarily of commissions and related payroll taxes, are capitalized, and amortized on a straight-line basis over the expected period of benefit, except for costs that are recognized when product is sold. The Company uses the portfolio method to recognize the amortization expense related to these capitalized costs related to initial contracts and such expense is recognized over a period associated with the revenue of the related portfolio, which is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzNTI_f9af2b31-c814-4dab-886d-badea997b8a1">two</span> to three years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total capitalized costs for the year ended December&#160;31, 2021 and December&#160;31, 2020 were $4.2 million and $3.4 million, respectively, and are included in Other long-term assets in the Company&#8217;s consolidated balance sheet. Amortization expenses for these assets were&#160;$1.9 million, $2.6 million and $2.9 million, respectively, during the years&#160;ended December&#160;31, 2021, 2020 and 2019 and were&#160;included in sales and marketing expense in the Company&#8217;s consolidated statement of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests its cash primarily in money market funds. All highly liquid investments with stated maturities of three months or less from date of purchase are classified as cash equivalents; all highly liquid investments with stated maturities of greater than three months are classified as marketable investments. The majority of the Company&#8217;s cash and investments are held in U.S. banks and the Company's foreign subsidiaries maintain a limited amount of cash in their local banks to cover short term operating expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy contains three levels of inputs that may be used to measure fair value, in accordance with ASC 820, as follows:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 1: inputs, which include quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 2: inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. For available-for-sale securities, the Company reviews trading activity and pricing as of the measurement date. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 3: inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Sales Returns and Credit Losses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for sales returns is based on the Company&#8217;s estimates of potential future product returns and other allowances related to current period product revenue. The Company analyzes historical returns, current economic trends and changes in customer demand and acceptance of the Company's products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses on trade receivables is based on the credit quality of clients, current economic conditions, the age of the accounts receivable balances, historical loss information, and current conditions and forecasted information. The Company writes off amounts against the allowance when they are deemed uncollectible.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities and other factors could negatively impact the Company&#8217;s operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to risks related to changes in the value of the Company&#8217;s significant balance of financial instruments. Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents, and accounts receivable. The Company&#8217;s cash and cash equivalents are primarily invested in deposits and money market accounts with three major financial institutions in the U.S. In addition, the Company has operating cash balances in banks in each of the international locations in which it operates. Deposits in these banks may exceed the federally insured limits or any other&#160;insurance&#160;provided on such deposits, if any. Management believes that these financial institutions are financially sound and, accordingly, believes that minimal credit risk exists. To date, the Company has not experienced any losses on its deposits of cash and cash equivalents.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded net of an allowance for credit losses and are typically unsecured and are derived from revenue earned from worldwide customers. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers and maintains an allowance for potential credit losses. As of December&#160;31, 2021, and 2020, no customer represented more than 10% of the Company&#8217;s net accounts receivable. During the years ended December&#160;31, 2021, 2020, and 2019, domestic revenue accounted for 42%, 41% and 58%, respectively, of total revenue, while international revenue accounted for 58%, 59% and 42%, respectively, of total revenue. No single customer represented more than 10% of total revenue for any of the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplier concentration</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on third parties for the supply of components of its products, as well as third-party logistics providers. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers or satisfactorily deliver its products to its customers. The Company relies on one supplier for its Secret and Secret PRO products and one supplier for its skincare products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost and net realizable value, cost being determined on a standard cost basis which approximates actual cost on a first-in, first-out basis. Net realizable value is the estimated selling prices in the ordinary course of the Company&#8217;s business, less reasonably predictable costs of completion, disposal, and transportation. The cost basis of the Company&#8217;s inventory is reduced for any products that are considered excessive or obsolete based upon assumptions about future demand and market conditions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes demonstration units within inventories. Demonstration units are carried at cost and amortized over an estimated economic life of two years. Amortization expense related to demonstration units is recorded in products cost of revenue or in the respective operating expense line based on which function and purpose for which the demonstration units are being used. Proceeds from the sale of demonstration units are recorded as revenue and all costs incurred to refurbish the </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">systems prior to sale are charged to product cost of revenue. As of December&#160;31, 2021 and 2020, demonstration inventories, net of accumulated depreciation, included in finished goods inventory was $3.7 million and $3.6 million, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of useful life or term of lease</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon sale or retirement of property and equipment, the costs and related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operating expenses. Maintenance and repairs are charged to operations as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense related to property and equipment for 2021, 2020 and 2019, was $1.3 million, $1.4 million, and $1.5 million, respectively. Amortization expense for vehicles leased under capital leases is included in depreciation expense. Amortization expense related to equipment leasing accounted for as sales type is included in cost of revenue and was immaterial as of December&#160;31, 2021 and 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized Cloud Computing Set-up Cost</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain set-up costs for the Company&#8217;s cloud computing arrangements. The capitalized implementation costs are then amortized over the term of the cloud computing arrangement inclusive of expected contract renewals, which are generally three years to ten years. As of December&#160;31, 2021, the Company had capitalized cloud computing set-up costs with a carrying amount of $0.4&#160;million in Other current assets and prepaid expenses and $3.5&#160;million in Other long-term assets. As of and during the year ended December&#160;31, 2021 there was no accumulated amortization and amortization expense recorded. The Company periodically assesses the capitalized asset for impairment and, when required, will record an associated impairment loss.&#160;During the year ended December&#160;31, 2021, the Company recognized in general and administrative expense an impairment loss of $0.2 million for capitalized cloud computing costs related to a cloud-based&#160;enterprise resource planning software.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and intangible assets with indefinite useful lives are not amortized but are tested for impairment at least annually during the fourth quarter of the Company&#8217;s fiscal year, or if circumstances indicate their value may no longer be recoverable. Goodwill represents the excess of the purchase price over the fair value of net identifiable assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to operate in one segment, which is considered to be the sole reporting unit and, therefore, goodwill was tested for impairment at the enterprise level. As of December&#160;31, 2021, there has been no impairment of goodwill. All acquired intangible assets have been fully amortized as of December&#160;31, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranty Obligations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides a 12-month warranty for direct sales to customers. For sales to distributors, the Company generally provides a 14-month warranty for parts only, with labor being provided to the end customer by the distributor.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January&#160;1, 2019, the Company adopted ASC 842, which established a right-of-use ("ROU") model requiring lessees to record a right-of-use asset ("ROU asset") and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding ROU asset. Lease liabilities represent the present value of the Company&#8217;s future lease payments over the </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company&#8217;s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for Leases as a Lessor</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases equipment to customers through membership programs and receives a fixed monthly fee over the term of the arrangement. The Company classifies its lease income as product revenue. The Company recognizes lease income over the term of the lease if the lease is classified as an operating lease. For agreements that grant customers the right to purchase the leased system, the Company typically classifies the lease as a sales-type lease as the Company has determined it is reasonably certain that the customer will exercise the purchase option. On the commencement of sales-type leases, the Company recognizes revenue upfront in product revenue and the corresponding receivables is classified in Other current assets and prepaid expenses on the condensed consolidated balance sheets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 to the consolidated financial statements for more information regarding leasing arrangements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists primarily of material, finished and semi-finished products purchased from third-party manufacturers, labor, stock-based compensation expenses, overhead involved in the Company's internal manufacturing processes, service contracts, technology license amortization and royalties, costs associated with equipment leasing, costs associated with product warranties and any inventory write-downs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's system sales include a control console, universal graphic user interface, control system software, high voltage electronics and a combination of applications (referred to as &#8220;hand pieces&#8221;). Hand pieces are programmed to have a limited number of uses to ensure the safety of the device to patients. The Company sells refurbished hand pieces, or "refills," of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products and provides for the cost of refurbishment of these hand pieces as part of cost of revenue. When customers purchase a replacement hand piece or are provided a replacement hand piece under a warranty or service contract, the Company ships the customer a previously refurbished unit. Upon the receipt of the expended hand piece from the customer, the Company capitalizes the expended hand piece as inventory at the estimated fair value. Cost of service revenue includes the costs incurred to refurbish hand pieces.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenditures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred and include costs related to research, design, development, testing of products, salaries, benefits and other headcount related costs, facilities, material, third party contractors, regulatory affairs, clinical and development costs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are included as part of sales and marketing expense and are expensed as incurred. Advertising expenses for 2021, 2020 and 2019 were $2.1 million, $1.2 million&#160;and $2.8 million, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for share-based employee compensation plans using the fair value recognition and measurement provisions under U.S. GAAP. The Company&#8217;s share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as expense on a straight- line basis over the requisite service period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The expected term represents the weighted-average period that the stock options are expected to be outstanding prior to being exercised. The Company determines expected term based on historical exercise patterns and its expectation of the time it will take for employees to exercise options still outstanding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For the underlying stock price volatility of the Company&#8217;s stock,&#160;the Company estimates volatility solely based on the Company&#8217;s historical volatility of its stock price.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forfeitures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company has made an accounting policy to estimate forfeitures at the time awards are granted and revises, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The risk-free interest rate is based on the U.S. treasury yield curve in effect at the time of grant for the expected term of the stock option.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options ("options") on the grant date using the closing price of the Company's common shares on the grant date is estimated using the Black-Scholes option-pricing model using the single-option approach. The Black-Scholes option pricing model requires the use of highly subjective and complex assumptions, including the option's expected term and the price volatility of the underlying stock, to determine the fair value of award. The Company recognizes the expense associated with options using a single award approach over the requisite service period. The Company accounts for all stock options awarded to non-employees at the fair value of the award issued on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock units (&#8220;RSUs&#8221;) granted are measured on the grant date. The quantity of the RSUs units granted is calculated by dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#8217;s common stock over the 50-day period ending on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Performance Stock Units (&#8220;PSUs&#8221;) that have operational measurement goals are measured on the grant date using the closing price of the Company&#8217;s common shares on the grant date. The quantity of the PSUs granted is calculated by dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#8217;s common stock over the 50-day period ending on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 - "Stockholders&#8217; Equity, Stock Plans and Stock-Based Compensation Expense" for a detailed discussion of the Company&#8217;s stock plans and share-based compensation expense.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes in the United States and several foreign jurisdictions. Significant judgment is required in determining the Company&#8217;s provision (benefit) for income taxes and income tax assets and liabilities, including evaluating uncertainties in the application of accounting principles and complex tax laws.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a provision (benefit) for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as for loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company recognizes the deferred income tax effects of a change in tax rates in the period of enactment. The Company records a valuation allowance to reduce the Company&#8217;s deferred tax assets to the net amount that the Company believes is more likely than </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to be realized.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes tax benefits from uncertain tax positions if the Company believes that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. Although the Company believes it has adequately reserved for the Company&#8217;s uncertain tax positions (including net interest and penalties), the Company can provide no assurance that the final tax outcome of these matters will not be different. The Company makes adjustments to these reserves in accordance with income tax accounting guidance when facts and circumstances change, such as the closing of a tax audit. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences may impact the provision (benefit) for income taxes in the period in which such determination is made. The Company records interest and penalties related to the Company&#8217;s uncertain tax positions in the Company&#8217;s provision (benefit) for income taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rates have differed from the statutory rate primarily due to changes in the valuation allowance, foreign operations, research and development tax credits, state taxes, and certain benefits realized related to stock option activity. The Company&#8217;s current effective tax rate does not assume U.S. taxes on undistributed profits of foreign subsidiaries. These earnings could become subject to incremental foreign withholding or U.S. federal and state taxes, should they either be deemed or actually remitted to the U.S. The Company&#8217;s future effective tax rates could be adversely affected by earnings being lower in countries where the Company has lower statutory rates and being higher in countries where the Company has higher statutory rates, or by changes in tax laws, accounting principles, interpretations thereof, net operating loss carryback, research and development tax credits, and due to changes in the valuation allowance of its U.S. deferred tax assets. In addition, the </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company is subject to the examination of the Company&#8217;s income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#8217;s provision for income taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undistributed earnings of the Company&#8217;s foreign subsidiaries at December&#160;31, 2021 are considered to be indefinitely reinvested and, accordingly, no provision for state income taxes has been provided thereon. Due to the Transition Tax and Global Intangible Low-Tax Income (&#8220;GILTI&#8221;) regimes as enacted by the 2017 Tax Act, those foreign earnings will not be subject to federal income taxes when actually distributed in the form of a dividend or otherwise. The Company, however, could still be subject to state income taxes and withholding taxes payable to various foreign countries. The amounts of taxes which the Company could be subject to are not material to the accompanying financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;27, 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The CARES Act changed several of the existing U.S. corporate income tax laws by, among other things, increasing the amount of deductible interest, allowing companies to carry back certain Net Operating Losses (&#8220;NOLs&#8221;) and increasing the amount of NOLs that corporations can use to offset income. The CARES Act did not have a material impact on the Company's income tax provision, deferred tax assets and liabilities, and related taxes payable. The Company is currently assessing the future implications of these provisions within the CARES Act on the Company's consolidated financial statements but does not expect the impact to be material.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Computation of Net Income (Loss) per Share</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method and the if-converted method. Dilutive potential common shares include outstanding stock options, restricted stock units, performance stock units, employee stock purchase plan (ESPP) shares and conversion shares under the convertible notes. On January 1, 2021, the Company adopted the accounting standard update to simplify the accounting for convertible debt instruments. The Company now uses the if-converted method for its convertible notes in calculating the diluted net income (loss) per share, and includes the effect of potential share settlement for the convertible notes, if the effect is dilutive. The diluted net income per share is computed with the assumption that the Company will settle the convertible debt in shares, rather than cash.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share is the same as basic earnings per share for the periods in which the Company had a net loss because the inclusion of outstanding common stock equivalents would be anti-dilutive.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes all changes in stockholders&#8217; equity except those resulting from investments or contributions by stockholders. For the periods presented, the accumulated other comprehensive income (loss) consisted solely of the unrealized gains or losses on the Company's available-for- sale investments, net of tax.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s foreign subsidiaries are translated in accordance with ASC 830, Foreign Currency Matters. The U.S. Dollar is the functional currency of the Company&#8217;s subsidiaries and the Company&#8217;s reporting currency. Monetary assets and liabilities are re-measured into U.S. Dollars at the applicable period end exchange rate. Sales and operating expenses are re-measured at average exchange rates in effect during each period. Gains or losses resulting from foreign currency transactions are included in net income (loss) are $1.8&#160;million in the year ended December&#160;31, 2021 and were insignificant for each of the two years ended December&#160;31, 2020. The effect of exchange rate changes on cash and cash equivalents was insignificant for each of the three years ended December&#160;31, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in one segment and reports segment information in accordance with ASC 280, Segment Reporting. Management uses one measurement of profitability and does not segregate its business for internal reporting. As of December&#160;31, 2021&#160;and 2020, 99.0% and 98.0% of long-lived assets were in the United States, respectively. Revenue is attributed to a geographic region based on the location of the end customer. See Note 10 &#8211; "Segment Information and Revenue by Geography and Products" for details relating to revenue by geography.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387542040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Restricted Cash<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text">CASH, CASH EQUIVALENTS AND RESTRICTED CASH<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize cash, cash equivalents and marketable securities (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents and restricted cash as reported within the Consolidated Statement of Cash Flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no marketable securities as of December&#160;31, 2021 and December&#160;31, 2020. The cash is restricted to support an outstanding letter of credit for $0.7 million provided to a supplier.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387651624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Detail<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Detail</a></td>
<td class="text">BALANCE SHEET DETAIL<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation adjustments for excess and obsolete inventory, reflected as a reduction of inventory at December&#160;31, 2021 and 2020, were $4.9 million and $3.9 million, respectively. Inventories, net of these adjustments, consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,035&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,503&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,508&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, net</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, consists of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,424)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,028)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in machinery and equipment are financed vehicles used by the Company&#8217;s sales employees. As of December&#160;31, 2021 and&#160;2020, the gross capitalized value of the leased vehicles was $2.6 million and $1.8 million, respectively, and the related accumulated depreciation was $1.5 million and $1.4 million at December&#160;31, 2021 and 2020, respectively. Included in Property and equipment as of December&#160;31, 2021 and&#160;2020 is construction in progress of $0.8 million and $0.4 million, respectively, which is yet to be depreciated.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is related to the acquisition of Iridex&#8217;s aesthetic business unit, and customer relationships in the Benelux countries acquired from a former distributor in 2013. Goodwill was $1.3 million as of December&#160;31, 2021 and 2020. There were no impairments or additions to goodwill during the years ended December&#160;31, 2021 or 2020.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.012%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.439%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bonus and payroll-related accruals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,649&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,197&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing accruals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,808&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,352&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued inventory in transit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product warranty</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,295&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387761976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranty<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantiesDisclosuresAbstract', window );"><strong>Product Warranties Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyDisclosureTextBlock', window );">Product Warranty</a></td>
<td class="text">PRODUCT WARRANTY <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a direct field service organization in North America (including Canada). Internationally, the Company provides direct service support in Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, and Switzerland, as well as through third-party service providers in Spain and the United Kingdom. In several other countries, where the Company does not have a direct presence, the Company provides service through a network of distributors and third-party service providers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis. The Company provides the estimated cost to repair or replace products under standard warranty at the time of sale. Costs&#160;in connection with extended service contracts are recognized at the time when costs are incurred. The following table provides the changes in the product standard warranty accrual for the years ended December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accruals for warranties issued during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,135&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,475&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,751)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,124&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantiesDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantiesDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI http://asc.fasb.org/topic&amp;trid=2155896<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387615768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ContractWithCustomerLiabilityTextBlock', window );">Deferred Revenue</a></td>
<td class="text">DEFERRED REVENUE<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records deferred revenue when revenue is to be recognized subsequent to invoicing. For extended service contracts, the Company generally invoices customers at the beginning of the extended service contract term. The Company&#8217;s extended service contracts typically have <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzM4NDgyOTA2OTc5OTU_298632bb-c8d5-4a4a-94e5-1559caf89ce1">one</span> to three-year terms. Deferred revenue also includes payments for training. Approximately 86% of the Company&#8217;s deferred revenue balance of $10.8 million as of December&#160;31, 2021, will be recognized over the next 12 months.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in the deferred contract revenue balance for the years ended December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Payments received</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,131&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Revenue recognized from current period sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,337)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Revenue recognized from beginning balance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,779)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,825&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs for extended service contracts were $8.3 million, $8.2 million and $9.3 million, respectively, for the years&#160;ended December&#160;31, 2021, 2020 and 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ContractWithCustomerLiabilityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of contract with customer liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ContractWithCustomerLiabilityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387754184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stockholders' Equity, Stock Plans and Stock-based Compensation Expense</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY, STOCK PLANS AND STOCK-BASED COMPENSATION EXPENSE<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had one class of issued common stock with a par value of $0.001. Authorized capital stock consists of 55,000,000 shares comprised of two classes: (i) 50,000,000 shares of Common Stock, of which 17,995,344 shares are issued and outstanding as of December&#160;31, 2021, and (ii) 5,000,000 shares of preferred stock, par value $0.001 per share (&#8220;Preferred Stock&#8221;), of which no shares are issued and outstanding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuances of Common Stock</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;21, 2020, the Company issued and sold an aggregate of 2,742,750 shares of the Company&#8217;s common stock, par value $0.001 per share at a price to the public of $10.50 per share. The shares include the full exercise of the underwriter&#8217;s option to purchase an additional 357,750 shares of common stock. The Company received net proceeds from the offering of approximately $26.5 million, after deducting underwriting discounts, commissions and offering expenses of $2.3 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had the following stock-based employee compensation plans:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2004 Equity Incentive Plan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1998, the Company adopted the 1998 Stock Plan, or 1998 Plan, under which 4,650,000 shares of the Company&#8217;s common stock were reserved for issuance to employees, directors and consultants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;12, 2004, the Board of Directors (&#8220;the Board&#8221;) adopted the 2004 Equity Incentive Plan. A total of 1,750,000 shares of common stock were originally reserved for issuance pursuant to the 2004 Equity Incentive Plan. In addition, the shares reserved for issuance under the 2004 Equity Incentive Plan included shares reserved but un-issued under the 1998 Plan and shares returned to the 1998 Plan as the result of termination of options or the repurchase of shares. In 2012 the stockholders approved a &#8220;fungible share&#8221; provision whereby each full-value award issued under the 2004 Equity Incentive Plan results in a requirement to subtract 2.12 shares from the shares reserved under the Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Equity Incentive Plan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Company&#8217;s Annual Meeting of Stockholders on June&#160;14, 2019, the Company&#8217;s stockholders approved the 2019 Equity Incentive Plan, which is an amendment and restatement of the 2004 Equity Incentive Plan. The 2004 Equity Incentive Plan was amended to: (i) increase the number of shares available for future grant by 700,000 (in addition to the 9,701,192 shares provided under the 2004 Equity Incentive Plan; (ii) extend the term of the 2004 Equity Incentive Plan to the date of the Annual Meeting of the Company&#8217;s stockholders in 2029; (iii) amend the 2004 Equity Incentive Plan to eliminate the requirement for awards granted on or after June&#160;14, 2019 that any shares subject to awards with an exercise price less than fair market value on the date of such grant will be counted against the Plan as 2.12 shares for each full value share awarded in accordance with the 2004 Equity Incentive Plan; (iv) amend the 2004 Equity Incentive Plan to remove the requirement that any shares subject to awards with an exercise price less than fair market value on the date of such grant will be counted against the Plan as 2.12 shares for each full value share awarded; (v) amend the 2004 Equity Incentive Plan to remove certain provisions relating to the &#8220;performance based compensation&#8221; exception under Section 162(m) of the Internal Revenue Code of 1986, as amended; (vi) include a minimum one-year vesting period with respect to awards granted under the 2004 Equity Incentive Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;11, 2019, the Board also approved, amended and restated the Company&#8217;s Stock Ownership Guidelines adopted on July&#160;28, 2017 in their entirety, to require all officers (as defined by Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) to hold at least 50% of any shares received pursuant to stock options, stock appreciation rights, vested restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;), or performance stock units (&#8220;PSUs&#8221;) (net of taxes) for a minimum of one year following vesting and delivery.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;11, 2019, the Board also adopted a clawback policy to permit recovery of certain compensation paid to Named Executive Officers (as defined in Item 402 of Regulation S-K) of the Company if the Compensation Committee of the Board determines that a Named Executive Officer (i) has violated law, the Company&#8217;s Code of Business Conduct and Ethics, or any significant ethics or compliance policies, and (ii) such conduct results in material financial or reputational harm, or results in a need for a restatement of the Company&#8217;s consolidated financial statements. The Amended and Restated Plan provides for the grant of incentive stock options, non-statutory stock options, RSAs, RSUs, stock appreciation rights, PSUs, and other stock or cash awards.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, stockholders approved an amendment and restatement of the 2019 Equity Incentive Plan (the &#8220;Prior Plan&#8221;) as the Amended and Restated 2019 Equity Incentive Plan (the &#8220;Restated Plan&#8221;) and approved an additional 600,000 shares, available for future grants. The Restated Plan provides for the grant of incentive stock options, non-statutory stock options, RSAs, RSUs, stock appreciation rights, PSUs, and other stock or cash awards.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s non-employee directors are granted $60,000 of RSUs annually on the date of the Company&#8217;s Annual Meeting of stockholders. These RSUs cliff-vest on the one-year anniversary of the grant date. In the years ended December&#160;31, 2021, 2020 and 2019, the Company issued 41,301, 35,735 and 42,236 RSUs, respectively, to its non-employee directors.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the years ended December&#160;31, 2021, 2020&#160;and 2019, the Company&#8217;s Board of Directors granted 219,686, 405,248 and 475,166 RSUs, respectively, to its executive officers, directors and certain members of the Company&#8217;s management related to annual grants and new hire grants. The annual grant RSUs vest quarterly on each of the first <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDAw_eb99cd2f-e555-49f7-b0bf-9cc8cd023330">four</span> anniversaries of the vest date and the new hire RSUs vest one quarter on the first anniversary and monthly thereafter for 36 months. The Company measured the fair market values of the underlying stock on the dates of grant and recognizes the stock-based compensation expense over the vesting period. On the vesting date, the Company issues common stock, net of stock withheld to settle the recipient&#8217;s minimum statutory tax liability. In addition to the 2020 annual RSU grants, on April 1, 2020, the Company issued RSUs to settle bonuses owed to management under the 2019 Management Bonus Program. In the past, the Company has paid these bonuses with cash. However, due to the economic conditions resulting from COVID-19, fully vested shares were issued in lieu of cash. The Company issued 209,981 shares related to this bonus payment to management and recognized $2.6&#160;million in stock-based compensation expense. The Company also recorded an equivalent reduction in bonus expense as a result of the settlement of the bonus in shares.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the years ended December 31, 2021, 2020 and 2019 the Company&#8217;s Board of Directors granted its executive officers and certain senior management employees 178,222, 76,157, and 319,275 PSUs, respectively, related to its annual grants. The 2019 and 2020 grants vested on the first anniversary subject to the achievement of pre-established performance goals. The 2021 grant quantity vested one half on the first anniversary subject to the achievement of pre-established performance goals and the remaining half vested on the second anniversary subject to the recipient&#8217;s continued service. In addition to the 2021 annual PSU grants, in July 2021, the Company granted 265,002 PSUs to certain employees. This grant consists of four separate vesting tranches that will vest from April 2023 through June 2024 upon the achievement of operational milestones associated with each tranche and continued service.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Board awarded its new CEO, David H. Mowry, 67,897 PSUs, which are scheduled to vest over four years from 2019 through 2022. These PSUs are subject to certain performance-based criteria related to achieving financial metrics in the Board approved annual budgets. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Board awarded its new CFO, Rohan Seth, 60,000 stock options, which vests over five years, and 22,423 PSUs, which vests over 2.5 years and is subject to performance-based criteria relating to the achievement of certain department and financial goals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;12, 2004, the Board of Directors adopted the 2004 Employee Stock Purchase Plan. Under the 2004 Employee Stock Purchase Plan, or 2004 ESPP, eligible employees are permitted to purchase common stock at a discount through payroll deductions. The 2004 ESPP offering and purchase periods are for six months. The 2004 ESPP has an evergreen provision based on which shares of common stock eligible for purchase are increased on the first day of each fiscal year by an amount equal to the lesser of:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">600,000 shares;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">2.0% of the outstanding shares of common stock on such date; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an amount as determined by the Board of Directors.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price of the common stock purchased is the lower of 85% of the fair market value of the common stock at the beginning or end of the six-month offering period. In the years ended December&#160;31, 2021, 2020, and 2019, under the 2004 ESPP, the Company issued 59,635, 56,751, and 82,810 shares, respectively. At December&#160;31, 2021, 645,319 shares remained available for future issuance.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option and Award Activity</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the 2004 Plan and 2019 Equity Incentive Plan is summarized as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>Available<br/>For Grant</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions ) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141,305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.52</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,538,128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,227)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,553)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(804,949)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085,170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,007&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(744,949)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,855&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vested and expected to vest as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Based on the closing stock price of $41.32 of the Company&#8217;s stock on December&#160;31, 2021, $24.11 on December&#160;31, 2020, $35.81 on December&#160;31, 2019 and $17.02 on December&#160;31, 2018.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Approved by the board of directors and stockholders in 2021, 2020 and 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value and is the aggregate difference between the Company&#8217;s closing stock price on the last trading day of the fiscal year and the exercise price, multiplied by the number of in-the-money options. The aggregate intrinsic amount changes based on the fair market value of the Company&#8217;s common stock. Total intrinsic value of options exercised in 2021, 2020 and 2019 was $1.3 million, $0.4 million, and $1.0 million, respectively. The options outstanding and exercisable at December&#160;31, 2021 were in the following exercise price ranges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.360%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.360%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.363%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prices</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>Exercisable</span></td></tr><tr><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15.32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.55</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.07</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.93</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.83</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25.70</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.59</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29.28</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$32.87</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,622&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39.30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.83</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$47.40</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.96</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$10.79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$47.40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">287,175</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.92</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">83,855</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Awards (RSU and PSU) Activity Table</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to RSUs and PSUs activity is as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.156%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.424%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant-<br/>Date Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,814&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172,281)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,022)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,694&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684,491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308,248)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744,949&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236,856)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032,904&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents the value of the Company&#8217;s stock on the date that the restricted stock units and performance stock units vest.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Based on the closing stock price of the Company&#8217;s stock of $41.32 on December&#160;31, 2021, $24.11 on December&#160;31, 2020, $35.81 on December&#160;31, 2019, and $17.02 on December&#160;31, 2018.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The number of restricted stock units vested includes shares that the Company withheld on behalf of the employees to satisfy the statutory tax withholding requirements.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $5.9 million.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $12.2 million.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $5.8 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense for the years ended December&#160;31, 2021, 2020 and 2019 was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,305&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,849&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,786&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,832&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized during the year ended December&#160;31, 2021, 2020 and 2019 was recorded in the Consolidated Statement of Operations as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,510&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,820&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,832&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation Assumptions and Fair Value of Stock Options and ESPP Grants</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes option pricing model to estimate the fair value of options granted under its equity incentive plans and rights to acquire stock granted under its employee stock purchase plan. The weighted average estimated fair values of the employee stock options and rights granted under the employee stock purchase plan and the weighted average assumptions used to calculate the grant date fair values, are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:23.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Purchase Plan (ESPP)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average estimated fair value at grant date</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.09&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.63&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.83&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.64&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.60&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The expected term represents the period during which the Company&#8217;s stock-based awards are expected to be outstanding. The estimated term is based on historical experience of similar awards, giving consideration to the contractual terms of the awards, vesting requirements and expectation of future employee behavior, including post-vesting terminations. The expected term of groups of employees that have similar historical exercise patterns has been considered separately for valuation purposes.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The risk-free interest rate is based on U.S. Treasury debt securities with maturities close to the expected term of the option or ESPP participation right as of the date of grant.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Estimated volatility is based on historical volatility. The Company estimates volatility based on the Company&#8217;s historical volatility of its stock price.&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company has not paid dividends since its inception.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387577400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal and various state and local jurisdictions and foreign jurisdictions. The Company&#8217;s income (loss) before provision for income taxes consisted of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,793)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,037)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,407)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,263)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the provision for income taxes are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net deferred tax assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals and reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,634&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,653&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,784&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,311&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset before valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,857&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,485)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,321)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset after valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(990)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(803)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,480)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,042)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset (liability)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The differences between the U.S. federal statutory income tax rates to the Company&#8217;s effective tax rate are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State tax rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.55)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Meals and entertainment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.87)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.58)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.07)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extinguishment of PPP loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.05)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General business credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in prior year reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred true-up</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.11&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.01)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.70)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company recorded a valuation allowance of $40.5 million for the portion of the deferred tax asset that it does not expect to be realized. The valuation allowance on the Company&#8217;s net deferred taxes increased by $2.2 million and $6.0 million during the years ended December&#160;31, 2021 and 2020, respectively. The changes in valuation allowance are primarily due to additional U.S. deferred tax assets and liabilities incurred in the respective year. The Company has $0.8 million of net deferred tax assets in foreign jurisdictions, which management believes are more-likely-than-not to be realized given the expectation of future earnings in these jurisdictions. The Company continues to monitor the realizability of the U.S. deferred tax assets taking into account multiple factors, including the results of operations and magnitude of excess tax deductions for stock-based compensation. The Company intends to continue maintaining a full valuation allowance on its U.S. deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. Release of all, or a portion, of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, the Company had approximately $75.9 million and $39.3 million of federal and state net operating loss carryforwards, respectively, available to offset future taxable income. The federal and state net operating loss carryforwards, if not utilized will generally begin to expire in 2029&#160;through 2039. Approximately $35.4 million of total federal net operating loss carryforwards were generated post December 31, 2017 and have no expiration. At December&#160;31, 2021, the Company had research and development tax credits available to offset federal and California tax liabilities in the amount of $6.9 million and $8.5 million, respectively. Federal credits will begin to expire in 2024 and California state tax credits have no expiration.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state laws can impose substantial restrictions on the utilization of net operating loss and tax credit carryforwards in the event of an &#8220;ownership change,&#8221; as defined in Section 382 of the Internal Revenue Code. The Company has determined that no significant limitation would be placed on the utilization of the Company&#8217;s net operating loss and tax credit carryforwards due to prior ownership changes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No deferred tax liabilities have been recorded relating to the earnings of the Company&#8217;s foreign subsidiaries since all such earnings are intended to be indefinitely reinvested. The amount of the unrecognized deferred tax liability associated with these earnings is immaterial.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uncertain Tax Positions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes reserves for uncertain tax positions based on the largest amount that is more-likely-than-not to be sustained. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. The Company performs a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes it has adequately reserved for its uncertain tax positions, no assurance can be given that the final tax outcome of these matters will not be different. The Company adjusts these reserves in light of changing facts and circumstances, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate, as well as the related net interest and penalties.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files U.S., state, and foreign income tax returns in jurisdictions with varying statutes of limitations. Tax years after 2006 remain subject to examination by U.S. federal and California state tax authorities due to the Company&#8217;s net operating loss and credit carryforwards. For significant foreign jurisdictions, tax years after 2016 remain subject to examination by their respective tax authorities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits, excluding related interest and penalties, in December 31, 2019 to December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,746&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842391338408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text">NET INCOME (LOSS) PER SHARE<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company&#8217;s convertible notes were potentially convertible into 4,167,232 shares of common stock. The Company used the if-converted method to calculate the potential dilutive effect of the conversion spread on diluted net income per share for the year ended December 31, 2021. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The denominator for diluted net income (loss) per share does not include any effect from the capped call transactions the Company entered into concurrently with the issuance of the convertible notes, as this effect would be anti-dilutive. In the event of conversion of a convertible note, shares delivered to the Company under the capped call will offset the dilutive effect of the shares that the Company would issue under the convertible notes. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the years ended December 31, 2020 and 2019, basic loss per common share and diluted loss per common share are the same in each respective period, as the inclusion of any potentially issuable&#160;shares would be&#160;anti-dilutive.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table sets forth the computation of basic and diluted net loss and the weighted average number of shares used in computing basic and diluted net loss per share (in thousands, except per share data):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,877)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of incremental shares and share equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,362&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,096&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share, basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.43)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.88)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following numbers of shares outstanding, prior to the application of the treasury stock method and the if-converted method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capped call</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,652&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387664616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Defined Contribution Plan</a></td>
<td class="text">DEFINED<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTRIBUTION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLAN</span><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the Company has an employee savings plan (&#8220;401(k) Plan&#8221;) that qualifies as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Eligible employees may make voluntary contributions to the 401(k) Plan up to 100% of their annual compensation, subject to statutory annual limitations. In 2021, 2020 and 2019, the Company made discretionary contributions under the 401(k) Plan of $0.3 million, $0.2 million and $0.4 million, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s Japanese subsidiary, a discretionary employee retirement plan has been established. In addition, for some of the Company&#8217;s other foreign subsidiaries, the Company deposits funds with insurance companies, third-party trustees, or into government-managed accounts consistent with the requirements of local laws. The Company has fully funded or accrued for its obligations as of December&#160;31, 2021, and the related expense for each of the three years then ended was not significant.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387742952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information and Revenue by Geography and Products<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information and Revenue by Geography and Products</a></td>
<td class="text">SEGMENT INFORMATION AND REVENUE BY GEOGRAPHY AND PRODUCTSSegment reporting is based on the &#8220;management approach,&#8221; following the method that management organizes the company&#8217;s reportable segments for which separate financial information is made available to, and evaluated regularly by, the chief operating decision maker in allocating resources and in assessing performance. The Company&#8217;s chief operating decision makers ("CODM") are its Chief Executive Officer ("CEO") and Chief Financial Officer (&#8220;CFO&#8221;), who make decisions on allocating resources and in assessing performance. The CEO and CFO review the Company's consolidated results as one operating segment. In making operating decisions, the CODM primarily considers consolidated financial information, accompanied by disaggregated information about revenues by geography and product. All of the Company&#8217;s principal operations and decision-making functions are located in the U.S. Substantially all of the Company's long-lived assets are located in the U.S. <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of revenue by geography for the year ended December&#160;31, 2021, 2020 and 2019 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue mix by geography:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,629&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,238&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,372&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia, excluding Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,649&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,707&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,414&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the world, other than United States, Asia and Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,288&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,846&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue mix by product category:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,401&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,287&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,648&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skincare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,703&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,113&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,638&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenue</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,270&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,683&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,712&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842391353320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_LesseeLeasesTextBlock', window );">Leases</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEASES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to certain operating and finance leases for vehicles, office space and storage facilities. The Company&#8217;s material operating leases consist of office space, as well as storage facilities and finance leases consist of automobiles. The Company&#8217;s leases generally have remaining terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzM1OQ_c3159409-b458-460d-9242-9f6a751b81b3">one</span> to 10 years, some of which include options to renew the leases for up to five years. The Company leases space for operations in the United States, Japan, Belgium, France, and Spain. In addition to the above facility leases, the Company also routinely leases automobiles for certain sales and field service employees under finance leases.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU 2016-2, "Leases," (also known as ASC Topic 842) which requires, among other items, lease accounting to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures are enhanced to better present the amount, timing and uncertainty of cash flows arising from leases.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted ASU 2016-2, as of January&#160;1, 2019, using the modified retrospective method, to all leases existing at the date of initial application. The comparative period information has not been restated and continues to be reported under the accounting standards in effect for the period presented. The new standard provides a number of optional practical expedients in transition. The Company elected the package of practical expedients permitted under the transition guidance within the new standard, which allowed the Company to carry forward the Company&#8217;s historical conclusions about lease identification, lease classification and initial direct costs. The Company also elected the practical expedient related to land easements, allowing the Company to carry forward the Company&#8217;s accounting treatment for land easements on existing agreements. The Company did not elect the practical expedient to use hindsight in determining the lease term.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of the new standard resulted in the recording of additional lease assets and lease liabilities of $10.2 million and $10.1 million, respectively, as of January&#160;1, 2019, based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases. The difference between the additional lease assets and lease liabilities resulted from rent-free periods which were previously recorded as deferred rent. The Company&#8217;s accounting for finance leases remained substantially unchanged. The standard had no material impact on the Company&#8217;s consolidated net earnings, results of operations, comprehensive loss, statements of changes in equity, and cash flows. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effect of Adoption of the New Lease Standard (ASC Topic </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">842</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">) on Consolidated Financial Statements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of adopting Topic 842 on the Company&#8217;s consolidated balance sheet as of January&#160;1, 2019 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As reported under<br/>Topic 842</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balances under<br/>Prior GAAP</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,049)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,430)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,430&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,759)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,759&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">*Deferred rent included in other long-term liabilities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract contains a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent the right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, the Company estimates the incremental secured borrowing rates corresponding to the maturities of the leases. The Company based the rate estimates on prevailing financial market conditions, credit analysis, and management judgment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce the Company&#8217;s right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term.&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is supplemental balance sheet information related to leases (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,627&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,076&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMS0xLTEtMzkwMjA_971a5a0e-7d36-4fb8-a69f-ab6296ab5451"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMS0xLTEtMzkwMjA_9d781c61-1f10-40e0-a3f0-691f77491d63">Property and equipment, net</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total leased assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,019&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,543&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities , non-current</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,483&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,950&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,902&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,210&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, current</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMS0xLTEtMzkwMjI_8092eb31-ac1f-4f22-979c-32b815b92382"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMS0xLTEtMzkwMjI_e0e19b97-1369-4d4a-bbc4-18c6459ed777">Accrued liabilities</span></span></span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">554&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">370&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMS0xLTEtMzkwMjQ_28244cd5-3898-471f-8e2b-ae37ea29760a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMS0xLTEtMzkwMjQ_7df8c095-3d4f-4603-b7c7-f49c99ce82b6">Other long-term liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Finance lease liabilities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,284&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">611&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs during the twelve months ended&#160; December&#160;31, 2021 and December&#160;31, 2020 (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">704&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest for finance lease</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities during the twelve months ended December&#160;31, 2021 and December&#160;31, 2020 were as follows&#160;(in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">462&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">537&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">649&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maturities of lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities were as follows as of December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,338&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,436)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,902&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vehicle Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable finance leases as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">601&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">347&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,284&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term and discount rate, as of December&#160;31, 2021, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Term and Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessor Information related to the Company&#8217;s system leasing</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year ended December 31, 2020, the Company entered into leasing transactions, in which the Company is the lessor, offered through the Company's membership program. The Company's leases for equipment rentals were all accounted for as operating leases during the second and third quarters of 2020.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter ended December 31, 2020, certain&#160;of the membership program agreements were amended, granting the customers the exclusive right and option to purchase the leased system from the Company, at any time during the period of twelve months from signing the amended agreement. For contracts signed under the amended membership agreement,&#160;the Company classified and accounted for the arrangements as sales-type leases as of December 31, 2020, as the Company determined it is reasonably certain that the customer will exercise the purchase option.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the sales-type leases, the net investment of the Company&#8217;s lease receivable is measured at the commencement date and is included in the consolidated balance sheets as a component of Other current assets and prepaid expenses. As of December&#160;31, 2020, the Company recorded $0.7&#160;million of revenue for the sales-type leases in the consolidated statement of operations and the related lease receivable in other current assets of the consolidated balance sheet. There was no revenue recognized from the sales-type lease arrangement in fiscal year 2021. During fiscal year 2021 the company received a full payment of $0.4&#160;million from customers who exercised the purchase option. As of December 31, 2021, the lease receivable balance included in Other current assets of the consolidated balance sheet was $0.3 million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue related to non-lease components, which comprise service contracts and consumables, are deferred and recognized either over time or at the point of delivery. The non-lease component revenue amount as of December&#160;31, 2021 was immaterial.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment lease revenue for operating lease agreements is recognized over the life of the lease. The following table summarizes the amount of operating lease income included in product revenue in the accompanying consolidated statements of operations (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.644%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease income from equipment rentals</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains certain open inventory purchase commitments with its suppliers to ensure a smooth and continuous supply for key components. The Company&#8217;s liability in these purchase commitments is generally restricted to an agreed-upon period. These periods can vary among different suppliers. Although open purchase orders are considered enforceable and legally binding, the terms generally allow the Company the option to cancel, reschedule, and adjust their requirements based on the Company's business needs prior to the delivery of goods or performance of services.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnifications</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of the Company&#8217;s business, the Company enters into agreements that contain a variety of representations, warranties, and indemnification obligations. For example, the Company has entered into indemnification agreements with each of its directors and executive officers and certain key employees. The Company&#8217;s exposure under its various indemnification obligations is unknown and not reasonably estimable as they involve future claims that may be made against the Company. As such, the Company has not accrued any amounts for such obligations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named from time to time as a party to other legal proceedings, product liability, commercial disputes, employee disputes, and contractual lawsuits in the normal course of business. A liability and related charge are recorded to earnings in the Company&#8217;s consolidated financial statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including discussion with outside legal counsel. If a reasonable estimate of a known or probable loss cannot be made, but a range of probable losses can be estimated, the low-end of the range of losses is recognized if no amount within the range is a better estimate than any other. If a material loss is reasonably possible, but not probable and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. The Company expenses legal fees as incurred.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the Company&#8217;s former Executive Vice President and CFO Sandra A. Gardiner announced her resignation from the Company. On November&#160;7, 2019, Ms. Gardiner filed an arbitration demand against the Company in connection with the terms of her employment and resignation. The Company settled this matter with Ms. Gardiner during the second quarter of 2020 with a cash payment of $0.4&#160;million and issuance of 15,408 shares of common stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021 and&#160;2020, the Company had accrued $0.7 million and $0.4&#160;million, respectively, related to various pending commercial and product liability lawsuits. The Company does not believe that a material loss in excess of accrued amounts is reasonably possible.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2020, Cutera filed a lawsuit against Lutronic Aesthetics in the United States District Court for the Eastern District of California.  Lutronic employs numerous former Cutera employees.  The complaint against Lutronic generally alleges claims for (1) misappropriation of trade secrets in violation of state and federal law; (2) violation of the Racketeer Influenced and Corrupt Organizations Act (RICO); (3) interference with contractual relations; (4) interference with prospective economic advantage; (5) unfair competition; and (6) aiding and abetting.  On March 13, 2020, the court entered a temporary restraining order against Lutronic generally prohibiting it from using or disseminating Cutera confidential, proprietary, or trade secret information.  The order also prohibits Lutronic, for 2 years, from using such information for the purpose of soliciting, or conducting business with, certain specified customers.  At the parties&#8217; request, the Court subsequently entered a preliminary injunction providing for the same restrictions in the restraining order.  On February 9, 2022, Cutera filed a motion seeking leave from the court to file a second amended complaint.  In addition to the above-referenced claims against Lutronic Aesthetics, the proposed amended complaint alleges additional claims against it, including (1) violation of the Lanham Act; (2) unlawful business practices; (3) false advertising; and (4) trademark infringement.  The proposed amended complaint also seeks to add Lutronic Corporation (the Korean parent company of Lutronic Aesthetics) as an additional defendant, and also alleges against it the above-described claims for misappropriation of trade secrets, violation of RICO, interference with contractual relations and prospective economic advantage, unfair competition, and aiding and abetting.  Discovery is ongoing.  No trial date has been scheduled.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LesseeLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating and finance leases of lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LesseeLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842391353320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">DEBT<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible notes, net of unamortized debt issuance costs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company issued $138.3 million aggregate principal amount of convertible senior notes ("convertible notes")&#160;due on March 15, 2026 in a private placement offering. The convertible notes bear interest at a rate of 2.25% per year payable semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2021. Upon conversion, the convertible notes will be convertible into cash, shares of the Company&#8217;s common stock or a combination thereof, at the Company&#8217;s election. The convertible notes are presented as convertible notes, net of unamortized debt issuance costs, on the consolidated balance sheet.&#160;Proceeds from the offering were $133.6 million, net of issuance costs, including initial purchasers fees.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initially, each $1,000 principal amount of Notes was convertible into 30.1427 shares of the Company&#8217;s common stock at a conversion price of $33.18 per share. The conversion rate for the convertible notes is subject to adjustment for certain events as set forth in the Indenture governing the convertible notes. The convertible notes will mature on March 15, 2026, unless earlier converted, redeemed, or repurchased in accordance with the terms of the convertible notes. No sinking fund is provided for the Notes. As of December 31, 2021, the net carrying amount of the Company&#8217;s convertible notes was $134.2 million and the unamortized debt issuance costs were&#160;$4.0 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their Notes at their option prior to the close of business on the business day immediately preceding December 15, 2025, in multiples of $1,000 principal amount, only under the following circumstances:</span></div><div style="margin-top:10pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During any fiscal quarter commencing after the fiscal quarter ended on June 30, 2021 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to 130% of the conversion price for the convertible notes on each applicable trading day;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the five-business day period after any five consecutive trading day period (the &#8220;measurement period&#8221;) in which the &#8220;trading price&#8221;&#160;per $1,000 principal amount of convertible notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's&#160;common stock and the conversion rate on each such trading day;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company calls such convertible notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Upon the occurrence of specified corporate events.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after December 15, 2025, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The circumstances described in the first bullet of the paragraph above were met during the second and third quarters of 2021 as the Company's stock traded at a price in excess of the conversion price for the required number of days during each of those quarters. These circumstances were not met during the fourth quarter of 2021. As a result, holders of the Notes had the right to convert their Notes beginning July 1, 2021 and ending on December 31, 2021. As of December 31, 2021, the Notes are not convertible and this condition will remain until March 31, 2022. The Notes may become convertible in future periods. Upon any conversion requests of the convertible notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#8217;s election with respect to such conversion requests. To the extent there are any conversion requests in the year ending December 31, 2022, the Company intends to settle such conversion requests in shares of common stock. Therefore, as of December&#160;31, 2021, the convertible notes have been included as Long-term debt on the consolidated balance sheet.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may not redeem the convertible notes prior to March 20, 2024. On or after March 20, 2024, the Company may redeem for cash all or any portion of the Notes, at the Company&#8217;s option, if the last reported sale price of the Company&#8217;s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding Notes, at least $50.0 million aggregate principal amount of Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a fundamental change occurs, note holders have the option to require the Company to repurchase any portion or all of their convertible notes in $1,000 principal increments for cash. The price for such repurchase is calculated as 100% of the principal amounts of Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. Additionally, holders of the Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The convertible notes are general senior unsecured obligations that rank senior to any of the Company&#8217;s indebtedness that is explicitly subordinated to the Notes. The Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the Notes. The Notes will be junior to any of the Company&#8217;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the convertible notes was approximately $201.0 million as of December&#160;31, 2021. The fair value is based on observable market prices for this debt, which is traded in active markets and therefore is classified as a Level 2 fair value measurement, as defined in Note 1.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the outstanding principal amount and carrying value of the convertible notes (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.076%"><tr><td style="width:1.0%"/><td style="width:78.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.184%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,007)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,243&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with issuance of the convertible notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally intended to reduce the potential dilution of the Company's&#160;common stock upon any conversion or settlement of the Notes or to offset any cash payment the Company is required to make in excess of the principal amount upon conversion of the Notes, as the case may be, with such reduction or offset subject to a cap based on the cap price. If the market price per share of the Company&#8217;s common stock exceeds the cap price of the capped calls transaction, then the Company&#8217;s stock would experience some dilution and/or the capped call would not fully offset the potential cash payments, in each case to the extent the then-market price per share of its common stock exceeds the cap price. Under the capped call transactions, the Company purchased from the option counterparties capped call options that in the aggregate relate to the total number of shares of the Company's common stock underlying the convertible notes, with a strike price equal to the conversion price of the convertible notes and with an initial cap price equal to $45.5350, which represents a 75% premium over the last reported sale price of the Company's common stock of $26.02 per share on March&#160;4, 2021, with certain adjustments to the settlement terms that reflect standard anti-dilution provisions. The capped call transactions expire over 40 consecutive scheduled trading days ended on March 12, 2026. The capped calls were purchased for $16.1&#160;million. The Company evaluated the capped call transaction under authoritative accounting guidance and determined that it should be accounted for as a separate transaction and classified as a net reduction to Additional paid-in capital within stockholders&#8217; equity with no recurring fair value measurement recorded.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company early adopted ASU 2020-6, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). In accordance with Subtopic 470-20 and 815-40, as revised by ASU 2020-6, the Company records the convertible notes in long-term debt with no separation between the Notes and the conversion option. Each reporting period, the Company will determine whether any criteria is met for the note holders to have the option to redeem the Notes early, which could&#160;result in a change in the classification of the Notes to current liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Debt Issuance Cost</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance costs related to the convertible notes are presented in the consolidated balance sheet as a direct deduction from the carrying amount of the convertible notes. During the year ended December&#160;31, 2021, the Company incurred direct costs associated with the issuance of convertible notes of $4.7 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance costs are&#160;amortized using&#160;an effective interest method basis over the term of the convertible notes and accordingly the Company recorded approximately&#160;$0.7 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of amortization of debt issuance costs during the year ended December&#160;31, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective interest rate on the convertible notes is 2.97%. Interest expense for the year ended December&#160;31, 2021, including the amortization of debt issuance cost, totaled approximately $3.2 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan and Security Agreement</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 9, 2020, the Company entered into a Loan and Security Agreement with Silicon Valley Bank for a four-year secured revolving loan facility (&#8220;SVB Revolving Line of Credit&#8221;) in an aggregate principal amount of up to $30.0&#160;million. The SVB Revolving Line of Credit matures on July 9, 2024.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to draw on the full amount of the SVB Revolving Line of Credit, the Company must satisfy certain liquidity ratios. If the Company is unable to meet these liquidity ratios, then availability under the revolving line is calculated as 80% of the Company&#8217;s qualifying accounts receivable. The proceeds of the revolving loans may be used for general corporate purposes. The Company&#8217;s obligations under the Loan and Security Agreement with Silicon Valley Bank are secured by substantially all of the assets of the Company. Interest on principal amount outstanding under the revolving line shall accrue at a floating per annum rate equal to the greater of either 1.75% above the Prime Rate or five percent (5.0%). The Company paid a non-refundable revolving line commitment fee of $0.3&#160;million, on the effective date of the Loan and Security Agreement with Silicon Valley Bank of July 9, 2020, and the Company is required to pay an anniversary fee of $0.3&#160;million on each twelve-month anniversary of the effective date of the Loan and Security Agreement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan and Security Agreement with Silicon Valley Bank contains customary affirmative covenants, such as financial statement reporting requirements and delivery of borrowing base certificates, as well as customary covenants that restrict the Company&#8217;s ability to, among other things, incur additional indebtedness, sell certain assets, guarantee obligations of third parties, declare dividends, or make certain distributions, and undergo a merger or consolidation or certain other transactions. The Loan and Security Agreement also contains certain financial covenants, including maintaining a quarterly minimum revenue of $90.0&#160;million, determined in accordance with GAAP on a trailing twelve-month basis,  but which is only applicable if the Company has an outstanding balance under the loan facility. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 4, 2021, the Loan and Security Agreement dated July 9, 2020 was amended to (i)&#160;permit the Company to issue the Convertible notes and perform its obligations in connection therewith, and (ii)&#160;permit the Capped Call transactions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or about May 28, 2021, the Loan and Security Agreement was amended. The amendment removed the quarterly minimum revenue requirement but kept in place the other financial covenants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had not drawn on the SVB Revolving Line of Credit and the Company is in compliance with all financial covenants of the SVB Revolving Line of Credit.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Paycheck Protection Program (PPP) Loan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;22, 2020, the Company received loan proceeds of $7.2 million pursuant to the Paycheck Protection Program (the &#8220;PPP&#8221;) under the CARES Act. The loan, which was in the form of a promissory note dated April 21, 2020, between the Company and Silicon Valley Bank as the lender, originally matured on April 21, 2022 and bore interest at a fixed rate of 1.00% per annum, payable monthly commencing September 2021. There was no prepayment penalty. Under the terms of the PPP, all or a portion of the principal may be forgiven if the loan proceeds were used for qualifying expenses as described in the CARES Act, such as payroll costs, benefits, rent, and utilities. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PPP loan and related accrued interest were forgiven in June 2021 under the provisions of the CARES Act, and a $7.2&#160;million Gain on extinguishment of PPP loan was recorded in the consolidated statement of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387769576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">SUBSEQUENT EVENTSThe Company has evaluated subsequent events through the date the financial statements were issued, and determined that there have been no events that have occurred that would require adjustments to our disclosures in the consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387685992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule II - Valuation and Qualifying Accounts</a></td>
<td class="text"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II CUTERA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUALIFYING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACCOUNTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December&#160;31, 2021, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance<br/>at End of<br/>Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,503&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,337&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,487&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2019</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,865&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,396&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,911&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance<br/>at End of<br/>Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses, accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2019</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,361&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,264&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842389359976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Description of Operations and Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Operations and Principles of Consolidation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cutera, Inc. (&#8220;Cutera&#8221; or the &#8220;Company&#8221;) provides energy-based aesthetic systems for practitioners worldwide. The Company develops, manufactures, distributes, and markets energy-based product platforms for use by physicians and other qualified practitioners, enabling them to offer safe and effective aesthetic treatments to their customers. The Company currently markets the following system platforms: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">enlighten, excel,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO, Secret RF,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">xeo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Several of the Company&#8217;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The sales of (i) systems, system upgrades, and hand pieces (collectively &#8220;Systems&#8221; revenue); (ii) replacement hand pieces, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">D,truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cycle refills, as well as single use disposable tips applicable to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Consumables&#8221; revenue); (iii) the distribution of third party manufactured skincare products (&#8220;Skincare&#8221; revenue); and (iv) the leasing of equipment through a membership program; are collectively classified as &#8220;Products&#8221; revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan, truSculpt 3D, truSculpt iD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and service labor for the repair and maintenance of products that are out of warranty, all of which are collectively classified as &#8220;Service&#8221; revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#8220;RDCs&#8221;) in selection locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets sells and services the Company&#8217;s products through direct sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over 42 countries. The consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements have been prepared in conformity with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;). Certain prior period amounts have been reclassified  to conform to the 2021 presentation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commissions, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, assumptions used in operating and sales-type lease classification, implicit and incremental borrowing rates related to the Company&#8217;s leases, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of global financial markets, cybersecurity breaches and other disruptions that could compromise the Company&#8217;s information or results, business disruptions that are </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caused by natural disasters or pandemic events, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, the successful execution of new product launches, strategic relationships and dependence on key individuals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;the World Health Organization declared the COVID-19&#160;outbreak a pandemic. The COVID-19&#160;outbreak, and lately the Delta and Omicron variants, has negatively affected the United States and global economies. The spread of the coronavirus, which caused a broad impact in 2020 globally, including restrictions on travel, shifting work force to work remotely and quarantine policies put into place by businesses and governments, had a material economic effect on the Company&#8217;s business during the year ended December 31, 2020. Notably, healthcare facilities in many countries effectively banned elective procedures. Many of the Company&#8217;s products are used in aesthetic elective procedures and as such, the bans on elective procedures substantially reduced the Company&#8217;s sales and marketing efforts in the early months of the pandemic and led the Company to implement cost control measures. Although the Company&#8217;s operation and results of operations have significantly improved as the economic outlook due to the&#160;COVID-19&#160;pandemic improved in 2021, the&#160;COVID-19&#160;outbreak continues to be fluid and the aftermath of the business and economic disruptions due to the&#160;COVID-19 is still uncertain, making it difficult to forecast the final impact it could have on&#160;the Company&#8217;s&#160;future operations, including disruptions in the Company's supply chain and contract manufacturing operations. The Company&#160;cannot presently predict the scope and severity of any impacts in future periods from the business shutdowns or disruptions due to the&#160;COVID-19&#160;pandemic, but the impact on economic activity including the possibility of recession or financial market instability could have a material adverse effect on the Company&#8217;s business, revenue, operating results, cash flows and financial condition. </span></div>The Company continues to assess whether any impairment of its goodwill or its long-lived assets has occurred, and has determined that no&#160;charges were necessary during the years ended December&#160;31, 2021, and 2020, other than an impairment loss of $0.2 million and $0.8 million on capitalized implementation costs of&#160;cloud-based CRM software, respectively.&#160;The Company&#8217;s assumptions about future conditions important to its assessment of potential impairment of its long-lived assets, and goodwill, including the impacts of the&#160;COVID-19&#160;pandemic and other ongoing impacts to its business, are subject to uncertainty, and the Company will continue to monitor these conditions in future periods as new information becomes available.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted by the Company</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-13, Financial Instruments-Credit Losses (Topic 326):"Measurement of Credit Losses on Financial Instruments", which replaces the incurred loss methodology with an expected credit loss methodology that is referred to as the current expected credit loss (CECL) methodology. ASU 2016-13 is effective for fiscal years beginning after December&#160;15, 2019, with early adoption permitted. The amendments in this update are required to be applied using the modified retrospective method with an adjustment to accumulated deficit and are effective for the Company beginning with fiscal year 2020, including interim periods. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost, including loan receivables, available for sale securities and held-to-maturity debt securities. An entity with available for sale securities and trade receivables will be required to use historical loss information, current conditions, and reasonable and supportable forecasts to determine expected lifetime credit losses. Pooling of assets with similar risk characteristics is also required. The Company adopted ASU 2016-13 on January&#160;1, 2020 on a modified retrospective basis. Upon adoption, the standard did not have a material impact on the consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company identified trade receivables and available-for-sale debt securities as impacted by the new guidance. However, the Company determined that the historical losses related to these available-for-sale debt securities are not material as the Company invests in high grade short-term securities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes an allowance for credit losses on trade receivables based on the credit quality of clients, current economic conditions, the age of the accounts receivable balances, historical loss information, and current conditions and forecasted information, and write-off amounts against the allowance when they are deemed uncollectible.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13, &#8220;Fair Value Measurement (Topic 820): Disclosure Framework- Changes to the Disclosure Requirements for Fair Value Measurement&#8221;, to improve the fair value measurement reporting of financial instruments. The amendments in this update require, among other things, added disclosure of the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this update eliminate, among other things, disclosure of the reasons for and amounts of transfers between Level 1 and Level 2 for assets and liabilities that are measured at fair value on a recurring basis and an entity's valuation processes for Level 3 fair value measurements. The amendments in this update became effective for the Company beginning with fiscal year 2020. Retrospective application is required for all amendments in this update except the added disclosures, which should be applied prospectively. The adoption </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the amendments in this update did not have a material impact on the Company&#8217;s consolidated financial position and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">No.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019-12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The Company adopted this guidance starting January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#8217;s consolidated financial position and results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the&#160;FASB&#160;issued ASU No. 2020-6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt &#8211; Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to simplify the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the amendment, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the computation of diluted earnings per share. The Company early adopted the guidance on a prospective basis effective January 1, 2021. See section Computation of Net Income (Loss) per Share.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted by the Company</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed all recently issued, but not yet effective, accounting pronouncements and does not expect the future adoption of any such pronouncements will have a material impact on the Company&#8217;s consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company&#8217;s performance obligations are satisfied either over time or at a point in time. Revenue from performance obligations that are transferred to customers over time accounted for approximately 11%, 15% and 13%,&#160;respectively, of the Company&#8217;s total revenue for the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain system sale arrangements that contain multiple products and services. For these bundled sale arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct. The Company&#8217;s products and services are distinct if a customer can benefit from the product or service on its own or with other resources that are readily available to the customer, and if the Company&#8217;s promise to transfer the products or service to the customer is separately identifiable from other promises in the sale arrangements. The Company&#8217;s system sale arrangements can include all or a combination of the following performance obligations: the system and software license (considered as one performance obligation), system accessories (hand pieces), training, other accessories, extended service contracts, marketing services, and time and materials services.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company&#8217;s system sale arrangements that include an extended service contract, the period of service commences at the expiration of the Company&#8217;s standard warranty offered at the time of the system sale. The Company considers the extended service contracts terms in the arrangements that are legally enforceable to be performance obligations. Other than extended service contracts and marketing services, which are satisfied over time, the Company generally satisfies all performance obligations at a point in time. Systems, system accessories (hand pieces), service contracts, training, and time and materials services are also sold on a stand-alone basis, and these performance obligations are satisfied at a point in time. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation on a relative standalone selling price basis.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Products and Services</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systems</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems revenue is generated from the sale of systems and from the sale of upgrades to existing systems. A system consists of a console that incorporates a universal graphic user interface, a laser or other energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. In certain applications, the laser or other energy-based module is contained in the hand piece, such as with the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pearl Fractional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> applications, rather than within the console.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The system or upgrade and the right to use the embedded software represent a single performance obligation as the software license is integral to the functionality of the system or upgrade.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For systems sold directly to end-customers that are credit approved, revenue is recognized when the Company transfers control to the end-customer, which occurs when the product is shipped to the customer or when the customer receives the product, depending on the nature of the arrangement. When collectability is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> established in advance of receipt of payment from the customer, revenue is recognized upon the later of the receipt of payment or the satisfaction of the performance obligation. For systems sold through credit approved distributors, revenue is recognized at the time of shipment to the distributor.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company typically receives payment for its system consoles and other accessories within 30 days of shipment. Certain international distributor arrangements allow for longer payment terms.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skincare products</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells third-party manufactured skincare products in Japan. The skincare products are purchased from a third-party manufacturer and sold to medical offices and licensed physicians. The Company warrants that the skincare products are free of significant defects in workmanship and materials for 90 days from shipment. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer. The Company recognizes revenue for skincare products at a point in time upon shipment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consumables and other accessories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its customers' purchases of replacement cycles for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt iD </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt flex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as replacement hand pieces, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hand pieces, and single use disposable tips applicable to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret PRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as Consumable revenue, which provides the Company with a source of recurring revenue from existing customers. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Secret RF</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products&#8217; single use disposable tips must be replaced after every treatment. Sales of these consumable tips further enhance the Company&#8217;s recurring revenue. The Company&#8217;s systems offer multiple hand pieces and applications, which allow customers to upgrade their systems.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equipment leasing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases equipment to customers through membership programs and receives a fixed monthly fee over the term of the arrangement. The Company classifies its lease income as product revenue. The Company recognizes lease income over the term of the lease if the lease is classified as an operating lease. For agreements that grant customers the right to purchase the leased system, the Company typically classifies the lease as a sales-type lease as the Company has determined it is reasonably certain that the customer will exercise the purchase option. On the commencement of sales-type leases, the Company recognizes revenue upfront in product revenue and the corresponding receivables recorded in Other current assets and prepaid expenses on the consolidated balance sheets (Notes 1 and 11). Revenue from equipment leases was not material in the years ended December&#160;31, 2021 and 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Extended service contract </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for a term of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzOTA_48951eca-9684-4911-930c-c47a406efd42">one</span>, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzOTE_82f81123-597c-470d-8503-057d2c5ae78b">two</span>, or three years. Service contract revenue is recognized over time, using a time-based measure of progress, as customers benefit from the service throughout the service period. The Company also offers services on a time-and-materials basis for systems and detachable hand piece replacements. Revenue related to services performed on a time-and-materials basis is recognized when performed.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Training</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of systems to customers include training on the use of the system to be provided within 180 days of purchase. The Company considers training a separate performance obligation as customers can immediately benefit from the training together with the customer&#8217;s system. Training is also sold separately from systems. The Company recognizes revenue for training when the training is provided. Training is not required for customers to use the systems.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Judgments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of whether two or more contracts entered into at or near the same time with the same customer should be combined and accounted for as one contract may require the use of significant judgment. In making this determination, the Company considers whether the contracts are negotiated as a package with a single commercial objective, have price interdependencies, or promise goods or services that represent a single performance obligation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company&#8217;s purchase agreements do </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provide customers with a contractual right of return, the Company maintains a sales allowance to account for potential returns or refunds as a reduction in transaction price at the time of sale.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines standalone selling price ("SSP") for each performance obligation as follows:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Systems: The SSPs for systems are based on directly observable sales in similar circumstances to similar customers.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Extended service contracts: SSP is based on observable price when sold on a standalone basis to similar customers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loyalty Program</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company launched a customer loyalty program during the third quarter of 2018 for qualified customers located in the U.S. and Canada. Under the loyalty program, customers accumulate points based on their purchasing levels which can be redeemed for such rewards as the right to attend the Company&#8217;s advanced training event for a product, or a ticket for the Company&#8217;s annual forum. A customer&#8217;s account must be in good standing to receive the benefits of the rewards program. Rewards are earned on a quarterly basis and must be used in the following quarter.&#160;All unused rewards are forfeited. The fair value of the reward earned by loyalty program members is included in accrued liabilities and recorded as a reduction. of net revenue at the time the reward is earned. As of December&#160;31, 2021, and December 31, 2020, the accrual for the loyalty program included in accrued liabilities was $0.5 million, and $0.3&#160;million, respectively. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Sales Commissions</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract, which consist primarily of commissions and related payroll taxes, are capitalized, and amortized on a straight-line basis over the expected period of benefit, except for costs that are recognized when product is sold. The Company uses the portfolio method to recognize the amortization expense related to these capitalized costs related to initial contracts and such expense is recognized over a period associated with the revenue of the related portfolio, which is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzNTI_f9af2b31-c814-4dab-886d-badea997b8a1">two</span> to three years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total capitalized costs for the year ended December&#160;31, 2021 and December&#160;31, 2020 were $4.2 million and $3.4 million, respectively, and are included in Other long-term assets in the Company&#8217;s consolidated balance sheet. Amortization expenses for these assets were&#160;$1.9 million, $2.6 million and $2.9 million, respectively, during the years&#160;ended December&#160;31, 2021, 2020 and 2019 and were&#160;included in sales and marketing expense in the Company&#8217;s consolidated statement of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests its cash primarily in money market funds. All highly liquid investments with stated maturities of three months or less from date of purchase are classified as cash equivalents; all highly liquid investments with stated maturities of greater than three months are classified as marketable investments. The majority of the Company&#8217;s cash and investments are held in U.S. banks and the Company's foreign subsidiaries maintain a limited amount of cash in their local banks to cover short term operating expenses.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy contains three levels of inputs that may be used to measure fair value, in accordance with ASC 820, as follows:</span></div><div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 1: inputs, which include quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 2: inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. For available-for-sale securities, the Company reviews trading activity and pricing as of the measurement date. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 3: inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock', window );">Allowances for Sales Returns and Credit Losses</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Sales Returns and Credit Losses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for sales returns is based on the Company&#8217;s estimates of potential future product returns and other allowances related to current period product revenue. The Company analyzes historical returns, current economic trends and changes in customer demand and acceptance of the Company's products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses on trade receivables is based on the credit quality of clients, current economic conditions, the age of the accounts receivable balances, historical loss information, and current conditions and forecasted information. The Company writes off amounts against the allowance when they are deemed uncollectible.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and Other Risks and Uncertainties</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities and other factors could negatively impact the Company&#8217;s operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to risks related to changes in the value of the Company&#8217;s significant balance of financial instruments. Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents, and accounts receivable. The Company&#8217;s cash and cash equivalents are primarily invested in deposits and money market accounts with three major financial institutions in the U.S. In addition, the Company has operating cash balances in banks in each of the international locations in which it operates. Deposits in these banks may exceed the federally insured limits or any other&#160;insurance&#160;provided on such deposits, if any. Management believes that these financial institutions are financially sound and, accordingly, believes that minimal credit risk exists. To date, the Company has not experienced any losses on its deposits of cash and cash equivalents.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded net of an allowance for credit losses and are typically unsecured and are derived from revenue earned from worldwide customers. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers and maintains an allowance for potential credit losses. As of December&#160;31, 2021, and 2020, no customer represented more than 10% of the Company&#8217;s net accounts receivable. During the years ended December&#160;31, 2021, 2020, and 2019, domestic revenue accounted for 42%, 41% and 58%, respectively, of total revenue, while international revenue accounted for 58%, 59% and 42%, respectively, of total revenue. No single customer represented more than 10% of total revenue for any of the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplier concentration</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on third parties for the supply of components of its products, as well as third-party logistics providers. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers or satisfactorily deliver its products to its customers. The Company relies on one supplier for its Secret and Secret PRO products and one supplier for its skincare products.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost and net realizable value, cost being determined on a standard cost basis which approximates actual cost on a first-in, first-out basis. Net realizable value is the estimated selling prices in the ordinary course of the Company&#8217;s business, less reasonably predictable costs of completion, disposal, and transportation. The cost basis of the Company&#8217;s inventory is reduced for any products that are considered excessive or obsolete based upon assumptions about future demand and market conditions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes demonstration units within inventories. Demonstration units are carried at cost and amortized over an estimated economic life of two years. Amortization expense related to demonstration units is recorded in products cost of revenue or in the respective operating expense line based on which function and purpose for which the demonstration units are being used. Proceeds from the sale of demonstration units are recorded as revenue and all costs incurred to refurbish the </span></div>systems prior to sale are charged to product cost of revenue. As of December&#160;31, 2021 and 2020, demonstration inventories, net of accumulated depreciation, included in finished goods inventory was $3.7 million and $3.6 million, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of useful life or term of lease</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon sale or retirement of property and equipment, the costs and related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operating expenses. Maintenance and repairs are charged to operations as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense related to property and equipment for 2021, 2020 and 2019, was $1.3 million, $1.4 million, and $1.5 million, respectively. Amortization expense for vehicles leased under capital leases is included in depreciation expense. Amortization expense related to equipment leasing accounted for as sales type is included in cost of revenue and was immaterial as of December&#160;31, 2021 and 2020.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock', window );">Capitalized Cloud Computing Set-up Cost</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized Cloud Computing Set-up Cost</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain set-up costs for the Company&#8217;s cloud computing arrangements. The capitalized implementation costs are then amortized over the term of the cloud computing arrangement inclusive of expected contract renewals, which are generally three years to ten years. As of December&#160;31, 2021, the Company had capitalized cloud computing set-up costs with a carrying amount of $0.4&#160;million in Other current assets and prepaid expenses and $3.5&#160;million in Other long-term assets. As of and during the year ended December&#160;31, 2021 there was no accumulated amortization and amortization expense recorded. The Company periodically assesses the capitalized asset for impairment and, when required, will record an associated impairment loss.&#160;During the year ended December&#160;31, 2021, the Company recognized in general and administrative expense an impairment loss of $0.2 million for capitalized cloud computing costs related to a cloud-based&#160;enterprise resource planning software.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and intangible assets with indefinite useful lives are not amortized but are tested for impairment at least annually during the fourth quarter of the Company&#8217;s fiscal year, or if circumstances indicate their value may no longer be recoverable. Goodwill represents the excess of the purchase price over the fair value of net identifiable assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to operate in one segment, which is considered to be the sole reporting unit and, therefore, goodwill was tested for impairment at the enterprise level. As of December&#160;31, 2021, there has been no impairment of goodwill. All acquired intangible assets have been fully amortized as of December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Warranty Obligations</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warranty Obligations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides a 12-month warranty for direct sales to customers. For sales to distributors, the Company generally provides a 14-month warranty for parts only, with labor being provided to the end customer by the distributor.</span></div>After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January&#160;1, 2019, the Company adopted ASC 842, which established a right-of-use ("ROU") model requiring lessees to record a right-of-use asset ("ROU asset") and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding ROU asset. Lease liabilities represent the present value of the Company&#8217;s future lease payments over the </span></div>expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company&#8217;s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorLeasesPolicyTextBlock', window );">Accounting for Leases as a Lessor</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for Leases as a Lessor</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases equipment to customers through membership programs and receives a fixed monthly fee over the term of the arrangement. The Company classifies its lease income as product revenue. The Company recognizes lease income over the term of the lease if the lease is classified as an operating lease. For agreements that grant customers the right to purchase the leased system, the Company typically classifies the lease as a sales-type lease as the Company has determined it is reasonably certain that the customer will exercise the purchase option. On the commencement of sales-type leases, the Company recognizes revenue upfront in product revenue and the corresponding receivables is classified in Other current assets and prepaid expenses on the condensed consolidated balance sheets.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 to the consolidated financial statements for more information regarding leasing arrangements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Revenue</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists primarily of material, finished and semi-finished products purchased from third-party manufacturers, labor, stock-based compensation expenses, overhead involved in the Company's internal manufacturing processes, service contracts, technology license amortization and royalties, costs associated with equipment leasing, costs associated with product warranties and any inventory write-downs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's system sales include a control console, universal graphic user interface, control system software, high voltage electronics and a combination of applications (referred to as &#8220;hand pieces&#8221;). Hand pieces are programmed to have a limited number of uses to ensure the safety of the device to patients. The Company sells refurbished hand pieces, or "refills," of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Titan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> truSculpt 3D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products and provides for the cost of refurbishment of these hand pieces as part of cost of revenue. When customers purchase a replacement hand piece or are provided a replacement hand piece under a warranty or service contract, the Company ships the customer a previously refurbished unit. Upon the receipt of the expended hand piece from the customer, the Company capitalizes the expended hand piece as inventory at the estimated fair value. Cost of service revenue includes the costs incurred to refurbish hand pieces.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenditures</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenditures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred and include costs related to research, design, development, testing of products, salaries, benefits and other headcount related costs, facilities, material, third party contractors, regulatory affairs, clinical and development costs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are included as part of sales and marketing expense and are expensed as incurred. Advertising expenses for 2021, 2020 and 2019 were $2.1 million, $1.2 million&#160;and $2.8 million, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based Compensation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for share-based employee compensation plans using the fair value recognition and measurement provisions under U.S. GAAP. The Company&#8217;s share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as expense on a straight- line basis over the requisite service period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The expected term represents the weighted-average period that the stock options are expected to be outstanding prior to being exercised. The Company determines expected term based on historical exercise patterns and its expectation of the time it will take for employees to exercise options still outstanding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For the underlying stock price volatility of the Company&#8217;s stock,&#160;the Company estimates volatility solely based on the Company&#8217;s historical volatility of its stock price.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forfeitures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company has made an accounting policy to estimate forfeitures at the time awards are granted and revises, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The risk-free interest rate is based on the U.S. treasury yield curve in effect at the time of grant for the expected term of the stock option.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options ("options") on the grant date using the closing price of the Company's common shares on the grant date is estimated using the Black-Scholes option-pricing model using the single-option approach. The Black-Scholes option pricing model requires the use of highly subjective and complex assumptions, including the option's expected term and the price volatility of the underlying stock, to determine the fair value of award. The Company recognizes the expense associated with options using a single award approach over the requisite service period. The Company accounts for all stock options awarded to non-employees at the fair value of the award issued on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock units (&#8220;RSUs&#8221;) granted are measured on the grant date. The quantity of the RSUs units granted is calculated by dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#8217;s common stock over the 50-day period ending on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Performance Stock Units (&#8220;PSUs&#8221;) that have operational measurement goals are measured on the grant date using the closing price of the Company&#8217;s common shares on the grant date. The quantity of the PSUs granted is calculated by dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#8217;s common stock over the 50-day period ending on the day of the grant.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 - "Stockholders&#8217; Equity, Stock Plans and Stock-Based Compensation Expense" for a detailed discussion of the Company&#8217;s stock plans and share-based compensation expense.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to income taxes in the United States and several foreign jurisdictions. Significant judgment is required in determining the Company&#8217;s provision (benefit) for income taxes and income tax assets and liabilities, including evaluating uncertainties in the application of accounting principles and complex tax laws.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records a provision (benefit) for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as for loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company recognizes the deferred income tax effects of a change in tax rates in the period of enactment. The Company records a valuation allowance to reduce the Company&#8217;s deferred tax assets to the net amount that the Company believes is more likely than </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">not</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to be realized.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes tax benefits from uncertain tax positions if the Company believes that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. Although the Company believes it has adequately reserved for the Company&#8217;s uncertain tax positions (including net interest and penalties), the Company can provide no assurance that the final tax outcome of these matters will not be different. The Company makes adjustments to these reserves in accordance with income tax accounting guidance when facts and circumstances change, such as the closing of a tax audit. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences may impact the provision (benefit) for income taxes in the period in which such determination is made. The Company records interest and penalties related to the Company&#8217;s uncertain tax positions in the Company&#8217;s provision (benefit) for income taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rates have differed from the statutory rate primarily due to changes in the valuation allowance, foreign operations, research and development tax credits, state taxes, and certain benefits realized related to stock option activity. The Company&#8217;s current effective tax rate does not assume U.S. taxes on undistributed profits of foreign subsidiaries. These earnings could become subject to incremental foreign withholding or U.S. federal and state taxes, should they either be deemed or actually remitted to the U.S. The Company&#8217;s future effective tax rates could be adversely affected by earnings being lower in countries where the Company has lower statutory rates and being higher in countries where the Company has higher statutory rates, or by changes in tax laws, accounting principles, interpretations thereof, net operating loss carryback, research and development tax credits, and due to changes in the valuation allowance of its U.S. deferred tax assets. In addition, the </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company is subject to the examination of the Company&#8217;s income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#8217;s provision for income taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Undistributed earnings of the Company&#8217;s foreign subsidiaries at December&#160;31, 2021 are considered to be indefinitely reinvested and, accordingly, no provision for state income taxes has been provided thereon. Due to the Transition Tax and Global Intangible Low-Tax Income (&#8220;GILTI&#8221;) regimes as enacted by the 2017 Tax Act, those foreign earnings will not be subject to federal income taxes when actually distributed in the form of a dividend or otherwise. The Company, however, could still be subject to state income taxes and withholding taxes payable to various foreign countries. The amounts of taxes which the Company could be subject to are not material to the accompanying financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;27, 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The CARES Act changed several of the existing U.S. corporate income tax laws by, among other things, increasing the amount of deductible interest, allowing companies to carry back certain Net Operating Losses (&#8220;NOLs&#8221;) and increasing the amount of NOLs that corporations can use to offset income. The CARES Act did not have a material impact on the Company's income tax provision, deferred tax assets and liabilities, and related taxes payable. The Company is currently assessing the future implications of these provisions within the CARES Act on the Company's consolidated financial statements but does not expect the impact to be material.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Computation of Net Income (Loss) per Share</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Computation of Net Income (Loss) per Share</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method and the if-converted method. Dilutive potential common shares include outstanding stock options, restricted stock units, performance stock units, employee stock purchase plan (ESPP) shares and conversion shares under the convertible notes. On January 1, 2021, the Company adopted the accounting standard update to simplify the accounting for convertible debt instruments. The Company now uses the if-converted method for its convertible notes in calculating the diluted net income (loss) per share, and includes the effect of potential share settlement for the convertible notes, if the effect is dilutive. The diluted net income per share is computed with the assumption that the Company will settle the convertible debt in shares, rather than cash.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share is the same as basic earnings per share for the periods in which the Company had a net loss because the inclusion of outstanding common stock equivalents would be anti-dilutive.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes all changes in stockholders&#8217; equity except those resulting from investments or contributions by stockholders. For the periods presented, the accumulated other comprehensive income (loss) consisted solely of the unrealized gains or losses on the Company's available-for- sale investments, net of tax.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s foreign subsidiaries are translated in accordance with ASC 830, Foreign Currency Matters. The U.S. Dollar is the functional currency of the Company&#8217;s subsidiaries and the Company&#8217;s reporting currency. Monetary assets and liabilities are re-measured into U.S. Dollars at the applicable period end exchange rate. Sales and operating expenses are re-measured at average exchange rates in effect during each period. Gains or losses resulting from foreign currency transactions are included in net income (loss) are $1.8&#160;million in the year ended December&#160;31, 2021 and were insignificant for each of the two years ended December&#160;31, 2020. The effect of exchange rate changes on cash and cash equivalents was insignificant for each of the three years ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in one segment and reports segment information in accordance with ASC 280, Segment Reporting. Management uses one measurement of profitability and does not segregate its business for internal reporting. As of December&#160;31, 2021&#160;and 2020, 99.0% and 98.0% of long-lived assets were in the United States, respectively. Revenue is attributed to a geographic region based on the location of the end customer. See Note 10 &#8211; "Segment Information and Revenue by Geography and Products" for details relating to revenue by geography.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for allowances for sales returns and doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_RisksAndUncertaintiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for risks and uncertainties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_RisksAndUncertaintiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangements entered into by lessor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL117410129-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919352-209981<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL117410129-209981<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL119206284-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19347-109286<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387746520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text">Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of useful life or term of lease</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, consists of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,424)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,028)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387657640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Restricted Cash (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Summary of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize cash, cash equivalents and marketable securities (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents and restricted cash as reported within the Consolidated Statement of Cash Flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842388963400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Detail (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text">Inventories, net of these adjustments, consist of the following (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,035&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,503&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,508&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, net</a></td>
<td class="text">Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Lives</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of useful life or term of lease</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, consists of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment leasing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment and furniture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,424)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,028)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.012%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.439%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bonus and payroll-related accruals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,649&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,197&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing accruals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,808&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,352&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued inventory in transit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product warranty</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,295&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387663208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranty (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantiesDisclosuresAbstract', window );"><strong>Product Warranties Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of Product Warranty Accrual</a></td>
<td class="text">The following table provides the changes in the product standard warranty accrual for the years ended December&#160;31, 2021 and 2020 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accruals for warranties issued during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,135&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,475&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Settlements made during the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,312)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,751)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,124&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantiesDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantiesDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387557976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Summary of Deferred Service Contract Revenue</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides changes in the deferred contract revenue balance for the years ended December&#160;31, 2021 and 2020 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Payments received</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,131&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Revenue recognized from current period sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,337)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Revenue recognized from beginning balance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,779)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,825&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386273224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Payment Arrangement, Option, Activity</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the 2004 Plan and 2019 Equity Incentive Plan is summarized as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares<br/>Available<br/>For Grant</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Value</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions ) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141,305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.52</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,538,128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,227)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,553)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(804,949)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085,170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,007&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional shares reserved</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">450,000&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(744,949)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards cancelled (expired or forfeited)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,855&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vested and expected to vest as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Based on the closing stock price of $41.32 of the Company&#8217;s stock on December&#160;31, 2021, $24.11 on December&#160;31, 2020, $35.81 on December&#160;31, 2019 and $17.02 on December&#160;31, 2018.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Approved by the board of directors and stockholders in 2021, 2020 and 2019.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Share-based Payment Arrangement, Option, Exercise Price Range</a></td>
<td class="text">The options outstanding and exercisable at December&#160;31, 2021 were in the following exercise price ranges:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.360%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.360%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.363%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prices</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number<br/>Exercisable</span></td></tr><tr><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15.32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.55</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.07</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.93</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.83</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25.70</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.59</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29.28</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$32.87</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,622&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39.30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.83</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$47.40</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.96</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,745&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$10.79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$47.40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">287,175</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.92</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">83,855</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to RSUs and PSUs activity is as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.156%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.424%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.826%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant-<br/>Date Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intrinsic Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.44&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,814&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172,281)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,022)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,694&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(684,491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308,248)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744,949&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236,856)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032,904&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents the value of the Company&#8217;s stock on the date that the restricted stock units and performance stock units vest.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Based on the closing stock price of the Company&#8217;s stock of $41.32 on December&#160;31, 2021, $24.11 on December&#160;31, 2020, $35.81 on December&#160;31, 2019, and $17.02 on December&#160;31, 2018.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The number of restricted stock units vested includes shares that the Company withheld on behalf of the employees to satisfy the statutory tax withholding requirements.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $5.9 million.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $12.2 million.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On the grant date, the fair value for these vested awards was $5.8 million.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Share-based Payment Arrangement, Cost by Plan</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense for the years ended December&#160;31, 2021, 2020 and 2019 was as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,305&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,849&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,786&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,832&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Share-based Payment Arrangement, Expensed and Capitalized, Amount</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized during the year ended December&#160;31, 2021, 2020 and 2019 was recorded in the Consolidated Statement of Operations as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,510&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,820&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,109&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,832&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock', window );">Valuation Assumptions and Fair Value of Stock Options and ESPP Grants</a></td>
<td class="text">The weighted average estimated fair values of the employee stock options and rights granted under the employee stock purchase plan and the weighted average assumptions used to calculate the grant date fair values, are as follows:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:23.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Purchase Plan (ESPP)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.97</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.65</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average estimated fair value at grant date</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.09&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.63&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.83&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.64&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.60&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The expected term represents the period during which the Company&#8217;s stock-based awards are expected to be outstanding. The estimated term is based on historical experience of similar awards, giving consideration to the contractual terms of the awards, vesting requirements and expectation of future employee behavior, including post-vesting terminations. The expected term of groups of employees that have similar historical exercise patterns has been considered separately for valuation purposes.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The risk-free interest rate is based on U.S. Treasury debt securities with maturities close to the expected term of the option or ESPP participation right as of the date of grant.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Estimated volatility is based on historical volatility. The Company estimates volatility based on the Company&#8217;s historical volatility of its stock price.&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company has not paid dividends since its inception.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options and employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842388749736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income before Income Tax</a></td>
<td class="text">The Company&#8217;s income (loss) before provision for income taxes consisted of the following (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,793)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,037)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,407)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,263)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the provision for income taxes are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s net deferred tax assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accruals and reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,634&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,653&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued warranty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,784&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,311&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset before valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,857&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,485)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,321)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax asset after valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(990)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(803)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,480)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,042)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax asset (liability)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text">The differences between the U.S. federal statutory income tax rates to the Company&#8217;s effective tax rate are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State tax rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.55)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Meals and entertainment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.87)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.58)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.07)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Extinguishment of PPP loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44.59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.05)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General business credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.82&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in prior year reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred true-up</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.11&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.01)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.70)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the Company&#8217;s gross unrecognized tax benefits, excluding related interest and penalties, in December 31, 2019 to December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,746&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=124434304&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387676616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Net Income (Loss)</a></td>
<td class="text">The following table sets forth the computation of basic and diluted net loss and the weighted average number of shares used in computing basic and diluted net loss per share (in thousands, except per share data):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,877)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of incremental shares and share equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,362&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,691&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,096&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share, basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.43)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.88)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following numbers of shares outstanding, prior to the application of the treasury stock method and the if-converted method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capped call</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,652&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842570841848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information and Revenue by Geography and Products (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Schedule of Revenue by Geography</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of revenue by geography for the year ended December&#160;31, 2021, 2020 and 2019 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue mix by geography:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,629&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,238&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,372&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia, excluding Japan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,649&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,707&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,414&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the world, other than United States, Asia and Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,313&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,288&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,846&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue mix by product category:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,401&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,287&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,648&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skincare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,703&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,113&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,638&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenue</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,270&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,683&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,712&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386243416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Accounting Standards Update and Change in Accounting Principle</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effects of adopting Topic 842 on the Company&#8217;s consolidated balance sheet as of January&#160;1, 2019 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As reported under<br/>Topic 842</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balances under<br/>Prior GAAP</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,049)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,430)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,430&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,759)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,759&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">*Deferred rent included in other long-term liabilities</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_LeasesFinancialStatementInformationTableTextBlock', window );">Leases, Financial Statement Information</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is supplemental balance sheet information related to leases (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,627&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,076&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMS0xLTEtMzkwMjA_971a5a0e-7d36-4fb8-a69f-ab6296ab5451"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMS0xLTEtMzkwMjA_9d781c61-1f10-40e0-a3f0-691f77491d63">Property and equipment, net</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total leased assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,019&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,543&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities , non-current</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,483&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,950&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,902&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,210&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.796%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, current</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMS0xLTEtMzkwMjI_8092eb31-ac1f-4f22-979c-32b815b92382"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMS0xLTEtMzkwMjI_e0e19b97-1369-4d4a-bbc4-18c6459ed777">Accrued liabilities</span></span></span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">554&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">370&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMS0xLTEtMzkwMjQ_28244cd5-3898-471f-8e2b-ae37ea29760a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMS0xLTEtMzkwMjQ_7df8c095-3d4f-4603-b7c7-f49c99ce82b6">Other long-term liabilities</span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Finance lease liabilities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,284&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">611&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>ease costs during the twelve months ended&#160; December&#160;31, 2021 and December&#160;31, 2020 (in thousands):&#160;<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">704&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest for finance lease</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities during the twelve months ended December&#160;31, 2021 and December&#160;31, 2020 were as follows&#160;(in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">462&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">537&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">649&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities were as follows as of December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,338&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,436)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,902&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Finance Lease, Liability, Fiscal Year Maturity</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable finance leases as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">601&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">347&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,284&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term and discount rate, as of December&#160;31, 2021, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Term and Discount Rate</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock', window );">Operating Lease, Lease Income</a></td>
<td class="text">The following table summarizes the amount of operating lease income included in product revenue in the accompanying consolidated statements of operations (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.644%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease income from equipment rentals</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LeasesFinancialStatementInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the financial statement information for leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LeasesFinancialStatementInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of income from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387756776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Convertible Debt</a></td>
<td class="text">The following table presents the outstanding principal amount and carrying value of the convertible notes (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.076%"><tr><td style="width:1.0%"/><td style="width:78.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.184%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,007)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying Value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,243&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387553544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Summary of Valuation Allowance</a></td>
<td class="text"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance at<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance<br/>at End of<br/>Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,503&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,337&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,487&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2019</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,865&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,396&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,911&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>Beginning<br/>of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance<br/>at End of<br/>Year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses, accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ended December 31, 2019</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,361&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,264&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842381873928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>segment </div>
<div>supplier </div>
<div>country </div>
<div>reporting_unit</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which entity operates | country</a></td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod', window );">Training on use of system term (in days)</a></td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Accrual for loyalty program</a></td>
<td class="nump">$ 10,825,000<span></span>
</td>
<td class="nump">$ 11,237,000<span></span>
</td>
<td class="nump">$ 14,222,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Total capitalized costs</a></td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DemonstrationUnitsAmortizationPeriod', window );">Estimated economic life of demonstration units</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Demonstration inventories included in finished goods</a></td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization', window );">Capitalized computing accumulated amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization', window );">Capitalized computing amortization expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HostingArrangementServiceContractImplementationCostImpairment', window );">Capitalized computing impairment loss</a></td>
<td class="nump">$ 182,000<span></span>
</td>
<td class="nump">805,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_StandardProductWarrantyTermDirectSales', window );">Warranty term, direct sales</a></td>
<td class="text">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_StandardProductWarrantyTermDistributorSales', window );">Warranty term, distributor sales</a></td>
<td class="text">14 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense</a></td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">$ 2,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains</a></td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember', window );">Restricted Stock Units and Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount', window );">Shares granted calculation, grant period (in days)</a></td>
<td class="text">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Other current assets and prepaid expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization', window );">Capitalized computing set-up costs</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization', window );">Capitalized computing set-up costs</a></td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized costs, amortization period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized costs, amortization period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_CapitalizedCloudComputingSetupCostMember', window );">Capitalized Cloud Computing Set-up Cost | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Cloud computing arrangement expected contract renewals</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_CapitalizedCloudComputingSetupCostMember', window );">Capitalized Cloud Computing Set-up Cost | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Cloud computing arrangement expected contract renewals</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_PercentageOfAssets', window );">Percentage of assets in the United States</a></td>
<td class="nump">99.00%<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Revenue Benchmark | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">58.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Revenue Benchmark | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">58.00%<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of capitalized contract costs</a></td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_LoyaltyMember', window );">Loyalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Accrual for loyalty program</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionOneTerm', window );">Extended service contract, option one, term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionTwoTerm', window );">Extended service contract, option two, term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionThreeTerm', window );">Extended service contract, option three, term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionOneTerm', window );">Extended service contract, option one, term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionTwoTerm', window );">Extended service contract, option two, term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_SecretAndSecretProMember', window );">Secret and Secret Pro</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_NumberOfMajorSuppliers', window );">Number of major suppliers | supplier</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_SkincareMember', window );">Skincare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_NumberOfMajorSuppliers', window );">Number of major suppliers | supplier</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Transferred over Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization, Consolidation And Presentation Of Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues', window );">Percent of total revenues</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Training Provided With Sale Of System, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DemonstrationUnitsAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Demonstration Units, Amortization Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DemonstrationUnitsAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ExtendedServiceContractOptionOneTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extended Service Contract, Option One, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ExtendedServiceContractOptionOneTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ExtendedServiceContractOptionThreeTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extended Service Contract, Option Three, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ExtendedServiceContractOptionThreeTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ExtendedServiceContractOptionTwoTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extended Service Contract, Option Two, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ExtendedServiceContractOptionTwoTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_NumberOfMajorSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Major Suppliers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_NumberOfMajorSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Organization, Consolidation And Presentation Of Financial Statements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_PercentageOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage amount of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_PercentageOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, expressed as a percent, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Payment Award, Period To Determine Grant Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:timeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_StandardProductWarrantyTermDirectSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Standard Product Warranty Term, Direct Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_StandardProductWarrantyTermDirectSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:timeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_StandardProductWarrantyTermDistributorSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Standard Product Warranty Term, Distributor Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_StandardProductWarrantyTermDistributorSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131251-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of capitalized implementation cost from hosting arrangement that is service contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118198657&amp;loc=SL118198666-228104<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of capitalized implementation cost from hosting arrangement that is service contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118198657&amp;loc=SL118198666-228104<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for capitalized implementation cost from hosting arrangement that is service contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118198657&amp;loc=SL118198666-228104<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HostingArrangementServiceContractImplementationCostImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on capitalized implementation cost from hosting arrangement that is service contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118198657&amp;loc=SL118198666-228104<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HostingArrangementServiceContractImplementationCostImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_CapitalizedCloudComputingSetupCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cutr_CapitalizedCloudComputingSetupCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_LoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_LoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_SecretAndSecretProMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_SecretAndSecretProMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_SkincareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_SkincareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386193096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Property and Equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_LeasedEquipmentMember', window );">Equipment leasing</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_EquipmentAndFurnitureMember', window );">Office equipment and furniture</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_LeasedEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_LeasedEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_EquipmentAndFurnitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_EquipmentAndFurnitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386052888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Restricted Cash - Summary of Cash and Cash Equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 164,164<span></span>
</td>
<td class="nump">$ 47,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash equivalents and restricted cash as reported within the Consolidated Statement of Cash Flows</a></td>
<td class="nump">$ 164,864<span></span>
</td>
<td class="nump">$ 47,047<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842388710184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Restricted Cash - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387905832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Detail - Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 24,035<span></span>
</td>
<td class="nump">$ 14,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">2,124<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">13,344<span></span>
</td>
<td class="nump">12,604<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 39,503<span></span>
</td>
<td class="nump">$ 28,508<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386177080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Detail - Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property, plant, and equipment and finance lease right-of-use asset, before accumulated depreciation and amortization</a></td>
<td class="nump">$ 6,443<span></span>
</td>
<td class="nump">$ 12,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less: Accumulated depreciation</a></td>
<td class="num">(3,424)<span></span>
</td>
<td class="num">(10,028)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">3,019<span></span>
</td>
<td class="nump">2,299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">826<span></span>
</td>
<td class="nump">1,051<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_LeasedEquipmentMember', window );">Equipment leasing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_EquipmentAndFurnitureMember', window );">Office equipment and furniture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,527<span></span>
</td>
<td class="nump">3,407<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 3,983<span></span>
</td>
<td class="nump">$ 7,683<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_LeasedEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_LeasedEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_EquipmentAndFurnitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cutr_EquipmentAndFurnitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842381862056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Detail - Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Bonus and payroll-related accruals</a></td>
<td class="nump">$ 21,649<span></span>
</td>
<td class="nump">$ 12,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_AccruedSalesAndMarketingCostsCurrent', window );">Sales and marketing accruals</a></td>
<td class="nump">4,808<span></span>
</td>
<td class="nump">2,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_AccruedInventoryInTransitCurrent', window );">Accrued inventory in transit</a></td>
<td class="nump">4,265<span></span>
</td>
<td class="nump">2,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Product warranty</a></td>
<td class="nump">3,947<span></span>
</td>
<td class="nump">4,124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Accrued sales tax</a></td>
<td class="nump">9,110<span></span>
</td>
<td class="nump">5,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">10,321<span></span>
</td>
<td class="nump">5,803<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 54,100<span></span>
</td>
<td class="nump">$ 32,295<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_AccruedInventoryInTransitCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Inventory In Transit, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_AccruedInventoryInTransitCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_AccruedSalesAndMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for sales and marketing costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_AccruedSalesAndMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12524-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123377177&amp;loc=d3e11281-110244<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386079672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Detail - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Valuation adjustment for excess and obsolete inventory</a></td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="nump">$ 3,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease</a></td>
<td class="nump">392,000<span></span>
</td>
<td class="nump">467,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,339,000<span></span>
</td>
<td class="nump">1,339,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill additions during the year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease</a></td>
<td class="nump">2,600,000<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization', window );">Leased vehicles, accumulated depreciation</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Construction in progress to be depreciated</a></td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842388715928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranty - Summary of Warranties (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Balance at beginning of year</a></td>
<td class="nump">$ 4,124<span></span>
</td>
<td class="nump">$ 6,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued', window );">Add: Accruals for warranties issued during the period</a></td>
<td class="nump">5,135<span></span>
</td>
<td class="nump">4,475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPayments', window );">Less: Settlements made during the period</a></td>
<td class="num">(5,312)<span></span>
</td>
<td class="num">(6,751)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Balance at end of year</a></td>
<td class="nump">$ 3,947<span></span>
</td>
<td class="nump">$ 4,124<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1),(c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842381803096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DeferredRevenueCostsIncurred', window );">Costs for extended service contracts</a></td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 8.2<span></span>
</td>
<td class="nump">$ 9.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionOneTerm', window );">Extended service contract, option one, term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionTwoTerm', window );">Extended service contract, option two, term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionOneTerm', window );">Extended service contract, option one, term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ExtendedServiceContractOptionTwoTerm', window );">Extended service contract, option two, term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Deferred revenue balance, percentage</a></td>
<td class="nump">86.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Deferred revenue balance, amount</a></td>
<td class="nump">$ 10.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Deferred revenue balance, recognition period</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DeferredRevenueCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred under service contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DeferredRevenueCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ExtendedServiceContractOptionOneTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extended Service Contract, Option One, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ExtendedServiceContractOptionOneTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ExtendedServiceContractOptionTwoTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extended Service Contract, Option Two, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ExtendedServiceContractOptionTwoTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842389465544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue - Summary of Deferred Service Contract Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ChangeInContractWithCustomerLiabilityRollForward', window );"><strong>Change in Contract with Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at beginning of year</a></td>
<td class="nump">$ 11,237<span></span>
</td>
<td class="nump">$ 14,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived', window );">Add: Payments received</a></td>
<td class="nump">17,139<span></span>
</td>
<td class="nump">14,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred', window );">Less: Revenue recognized from current period sales</a></td>
<td class="num">(7,006)<span></span>
</td>
<td class="num">(6,337)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Less: Revenue recognized from beginning balance</a></td>
<td class="num">(10,545)<span></span>
</td>
<td class="num">(10,779)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Balance at end of year</a></td>
<td class="nump">$ 10,825<span></span>
</td>
<td class="nump">$ 11,237<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ChangeInContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in Contract with Customer, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ChangeInContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from revenue deferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from advance payments received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842377833192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 21, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 14, 2019 </div>
<div>shares</div>
</th>
<th class="th"><div>Jun. 11, 2019</div></th>
<th class="th">
<div>Jan. 12, 2004 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2021 </div>
<div>tranche </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2012 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 1998 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_CapitalStockSharesAuthorized', window );">Authorized capital (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,995,344<span></span>
</td>
<td class="nump">17,679,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,995,344<span></span>
</td>
<td class="nump">17,679,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from equity offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 28,798,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issued, offering cost | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,303,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear', window );">Percentage of awards officers are required to hold for a minimum of one year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches', window );">Number of vesting tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Share-based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Share-based Payment Arrangement, Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">744,949<span></span>
</td>
<td class="nump">667,694<span></span>
</td>
<td class="nump">963,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Share-based Payment Arrangement, Nonemployee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,301<span></span>
</td>
<td class="nump">35,735<span></span>
</td>
<td class="nump">42,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Share-based Payment Arrangement, Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219,686<span></span>
</td>
<td class="nump">405,248<span></span>
</td>
<td class="nump">475,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsAnnualGrantMember', window );">Restricted Stock Units, Annual Grant | Share-based Payment Arrangement, Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsNewHireMember', window );">Restricted Stock Units, New Hire | Share-based Payment Arrangement, Employee | Share-based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsNewHireMember', window );">Restricted Stock Units, New Hire | Share-based Payment Arrangement, Employee | Share-based Payment Arrangement, Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs | Share-based Payment Arrangement, Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,897<span></span>
</td>
<td class="nump">178,222<span></span>
</td>
<td class="nump">76,157<span></span>
</td>
<td class="nump">319,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs | Share-based Payment Arrangement, Employee | Share-based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs | Share-based Payment Arrangement, Employee | Share-based Payment Arrangement, Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cutr_StockPlanMember', window );">1998 Stock Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,650,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cutr_TwoThousandFourEquityIncentivePlanMember', window );">2004 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled', window );">Share subtraction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cutr_TwoThousandNineteenEquityIncentivePlanMember', window );">2019 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,701,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled', window );">Share subtraction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional stock available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue', window );">Grant date fair value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cutr_TheAmendedAndRestated2019EquityIncentivePlanMember', window );">The Amended and Restated 2019 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional stock available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cutr_EmployeeStockPurchasePlanMember', window );">2004 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional stock available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod', window );">Offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage', window );">Additional shares authorized, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of stock, percent of market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">ESPP stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,635<span></span>
</td>
<td class="nump">56,751<span></span>
</td>
<td class="nump">82,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">645,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cutr_UnderwrittenPublicOfferingMember', window );">Underwritten Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares)</a></td>
<td class="nump">2,742,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Common stock issued, price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from equity offering | $</a></td>
<td class="nump">$ 26,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock issued, offering cost | $</a></td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cutr_UnderwrittenPublicOfferingMember', window );">Underwritten Public Offering | Underwriter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares)</a></td>
<td class="nump">357,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_CapitalStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of capital shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_CapitalStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of stack awards counted for every share granted or canceled when computed shares available for grant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Number Of Vesting Tranches</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Offering Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Officers Percentage To Be Held For A Minimum Of One Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to Share based compensation by share based payment fully vested stock awards grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 25<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109244457&amp;loc=d3e16649-113920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsAnnualGrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsAnnualGrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsNewHireMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cutr_RestrictedStockUnitsNewHireMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cutr_StockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cutr_StockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cutr_TwoThousandFourEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cutr_TwoThousandFourEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cutr_TwoThousandNineteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cutr_TwoThousandNineteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cutr_TheAmendedAndRestated2019EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cutr_TheAmendedAndRestated2019EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cutr_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cutr_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cutr_UnderwrittenPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cutr_UnderwrittenPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cutr_UnderwriterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cutr_UnderwriterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842381975544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward', window );"><strong>Shares Available For Grant</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Balance (in shares)</a></td>
<td class="nump">1,085,170<span></span>
</td>
<td class="nump">761,705<span></span>
</td>
<td class="nump">1,141,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_AdditionalSharesReservedSharesAvailableForGrant', window );">Additional shares reserved (in shares)</a></td>
<td class="nump">450,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted', window );">Options granted (in shares)</a></td>
<td class="num">(172,139)<span></span>
</td>
<td class="num">(71,088)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options cancelled (expired or forfeited) (in shares)</a></td>
<td class="nump">30,173<span></span>
</td>
<td class="nump">76,553<span></span>
</td>
<td class="nump">51,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross', window );">Stock awards granted (in shares)</a></td>
<td class="num">(744,949)<span></span>
</td>
<td class="num">(804,949)<span></span>
</td>
<td class="num">(1,538,128)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod', window );">Stock awards canceled (expired or forfeited) (in shares)</a></td>
<td class="nump">299,092<span></span>
</td>
<td class="nump">522,949<span></span>
</td>
<td class="nump">407,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Balance (in shares)</a></td>
<td class="nump">947,347<span></span>
</td>
<td class="nump">1,085,170<span></span>
</td>
<td class="nump">761,705<span></span>
</td>
<td class="nump">1,141,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance (in shares)</a></td>
<td class="nump">217,007<span></span>
</td>
<td class="nump">295,699<span></span>
</td>
<td class="nump">507,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="num">(71,798)<span></span>
</td>
<td class="num">(73,227)<span></span>
</td>
<td class="num">(160,798)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">172,139<span></span>
</td>
<td class="nump">71,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options cancelled (expired or forfeited) (in shares)</a></td>
<td class="num">(30,173)<span></span>
</td>
<td class="num">(76,553)<span></span>
</td>
<td class="num">(51,208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance (in shares)</a></td>
<td class="nump">287,175<span></span>
</td>
<td class="nump">217,007<span></span>
</td>
<td class="nump">295,699<span></span>
</td>
<td class="nump">507,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">83,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest (in shares)</a></td>
<td class="nump">287,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance (in dollars per share)</a></td>
<td class="nump">$ 22.35<span></span>
</td>
<td class="nump">$ 25.52<span></span>
</td>
<td class="nump">$ 20.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in dollars per share)</a></td>
<td class="nump">30.71<span></span>
</td>
<td class="nump">14.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (in dollars per share)</a></td>
<td class="nump">22.02<span></span>
</td>
<td class="nump">12.91<span></span>
</td>
<td class="nump">10.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Options cancelled (expired or forfeited) (in dollars per share)</a></td>
<td class="nump">37.14<span></span>
</td>
<td class="nump">36.65<span></span>
</td>
<td class="nump">24.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance (in dollars per share)</a></td>
<td class="nump">25.89<span></span>
</td>
<td class="nump">$ 22.35<span></span>
</td>
<td class="nump">$ 25.52<span></span>
</td>
<td class="nump">$ 20.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (in dollars per share)</a></td>
<td class="nump">24.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest (in dollars per share)</a></td>
<td class="nump">$ 25.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract', window );"><strong>Weighted-Average Remaining Contractual Life</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance</a></td>
<td class="text">4 years 11 months 1 day<span></span>
</td>
<td class="text">3 years 9 months<span></span>
</td>
<td class="text">3 years 2 months 8 days<span></span>
</td>
<td class="text">3 years 6 months 7 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable</a></td>
<td class="text">2 years 10 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest</a></td>
<td class="text">4 years 11 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Balance</a></td>
<td class="nump">$ 4,460<span></span>
</td>
<td class="nump">$ 1,470<span></span>
</td>
<td class="nump">$ 3,040<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable</a></td>
<td class="nump">1,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest</a></td>
<td class="nump">$ 4,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_AdditionalSharesReservedSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares available for grant under options that were reserved as additional shares by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_AdditionalSharesReservedSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of available for grant restricted stock shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Options, Available For Grant</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Contractual Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the number of shares available for grant reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding as of the balance sheet date, including vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares available for grant under options that were granted during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842389185128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Options Outstanding and Exercisable Price Ranges (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 47.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">287,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">4 years 11 months 1 day<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">83,855<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange1Member', window );">Exercise Price Range 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 14.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">25,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">1 year 11 months 19 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">25,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange2Member', window );">Exercise Price Range 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 14.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">3 years 7 months 2 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">16,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange3Member', window );">Exercise Price Range 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 15.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">2,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">6 months 21 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">2,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange4Member', window );">Exercise Price Range 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 18.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">2 years 25 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange5Member', window );">Exercise Price Range 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 18.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">11,088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">8 years 9 months 29 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">3,234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange6Member', window );">Exercise Price Range 6</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 25.70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">2 years 7 months 2 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange7Member', window );">Exercise Price Range 7</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 29.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">93,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">6 years 3 months 25 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange8Member', window );">Exercise Price Range 8</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 32.87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">57,622<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">6 years 1 month 13 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange9Member', window );">Exercise Price Range 9</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 39.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">2 years 9 months 29 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange10Member', window );">Exercise Price Range 10</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 47.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">4,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Contractual life</a></td>
<td class="text">2 years 11 months 15 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number exercisable (in shares)</a></td>
<td class="nump">4,745<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange8Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange8Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange9Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange9Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange10Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=cutr_ExercisePriceRange10Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842388897528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Restricted Stock Units Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 04, 2021</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">209,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant- Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41.32<span></span>
</td>
<td class="nump">$ 24.11<span></span>
</td>
<td class="nump">$ 35.81<span></span>
</td>
<td class="nump">$ 26.02<span></span>
</td>
<td class="nump">$ 17.02<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">779,757<span></span>
</td>
<td class="nump">1,104,802<span></span>
</td>
<td class="nump">474,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">744,949<span></span>
</td>
<td class="nump">667,694<span></span>
</td>
<td class="nump">963,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(254,946)<span></span>
</td>
<td class="num">(684,491)<span></span>
</td>
<td class="num">(172,281)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited(in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(236,856)<span></span>
</td>
<td class="num">(308,248)<span></span>
</td>
<td class="num">(161,022)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,032,904<span></span>
</td>
<td class="nump">779,757<span></span>
</td>
<td class="nump">1,104,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant- Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.96<span></span>
</td>
<td class="nump">$ 22.10<span></span>
</td>
<td class="nump">$ 38.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.16<span></span>
</td>
<td class="nump">20.66<span></span>
</td>
<td class="nump">18.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.94<span></span>
</td>
<td class="nump">17.82<span></span>
</td>
<td class="nump">33.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.33<span></span>
</td>
<td class="nump">23.24<span></span>
</td>
<td class="nump">37.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35.00<span></span>
</td>
<td class="nump">$ 23.96<span></span>
</td>
<td class="nump">$ 22.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue', window );">Vested, aggregate fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,287<span></span>
</td>
<td class="nump">$ 12,036<span></span>
</td>
<td class="nump">$ 6,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Aggregate intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,680<span></span>
</td>
<td class="nump">18,800<span></span>
</td>
<td class="nump">37,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,072<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Grant date fair value of awards vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800<span></span>
</td>
<td class="nump">$ 12,200<span></span>
</td>
<td class="nump">$ 5,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41.32<span></span>
</td>
<td class="nump">$ 24.11<span></span>
</td>
<td class="nump">$ 35.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.02<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value of equity-based payment equity instruments, excluding stock or unit options, granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842381750760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="nump">$ 13,172<span></span>
</td>
<td class="nump">$ 10,109<span></span>
</td>
<td class="nump">$ 9,832<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">782<span></span>
</td>
<td class="nump">370<span></span>
</td>
<td class="nump">622<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,305<span></span>
</td>
<td class="nump">8,849<span></span>
</td>
<td class="nump">4,786<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,591<span></span>
</td>
<td class="nump">666<span></span>
</td>
<td class="nump">3,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cutr_ESPPMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
<td class="nump">$ 224<span></span>
</td>
<td class="nump">$ 476<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cutr_ESPPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cutr_ESPPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386137016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense by Department (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="nump">$ 13,172<span></span>
</td>
<td class="nump">$ 10,109<span></span>
</td>
<td class="nump">$ 9,832<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,408<span></span>
</td>
<td class="nump">1,665<span></span>
</td>
<td class="nump">1,572<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,160<span></span>
</td>
<td class="nump">3,385<span></span>
</td>
<td class="nump">4,510<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,784<span></span>
</td>
<td class="nump">1,669<span></span>
</td>
<td class="nump">1,536<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,820<span></span>
</td>
<td class="nump">$ 3,390<span></span>
</td>
<td class="nump">$ 2,214<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842388981336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Valuation Assumptions and Fair Value of Stock Option and ESPP Grants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">3 years 11 months 19 days<span></span>
</td>
<td class="text">4 years 10 months 2 days<span></span>
</td>
<td class="text">3 years 7 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.48%<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
<td class="nump">1.64%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">66.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
<td class="nump">54.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average estimated fair value at grant date (in dollars per share)</a></td>
<td class="nump">$ 15.09<span></span>
</td>
<td class="nump">$ 7.63<span></span>
</td>
<td class="nump">$ 14.83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cutr_StockPurchasePlanMember', window );">Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.14%<span></span>
</td>
<td class="nump">0.11%<span></span>
</td>
<td class="nump">2.49%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average estimated fair value at grant date (in dollars per share)</a></td>
<td class="nump">$ 9.64<span></span>
</td>
<td class="nump">$ 6.13<span></span>
</td>
<td class="nump">$ 9.60<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cutr_StockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cutr_StockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842392007992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income (Loss) Before Provision for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S.</a></td>
<td class="num">$ (356)<span></span>
</td>
<td class="num">$ (25,793)<span></span>
</td>
<td class="num">$ (13,037)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">3,741<span></span>
</td>
<td class="nump">2,386<span></span>
</td>
<td class="nump">774<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">$ 3,385<span></span>
</td>
<td class="num">$ (23,407)<span></span>
</td>
<td class="num">$ (12,263)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386147144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Provision (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">1,512<span></span>
</td>
<td class="nump">747<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total Current</a></td>
<td class="nump">1,425<span></span>
</td>
<td class="nump">694<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(227)<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total Deferred</a></td>
<td class="num">(102)<span></span>
</td>
<td class="num">(224)<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax provision</a></td>
<td class="nump">$ 1,323<span></span>
</td>
<td class="nump">$ 470<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842381948008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 18,274<span></span>
</td>
<td class="nump">$ 18,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">3,160<span></span>
</td>
<td class="nump">869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther', window );">Other accruals and reserves</a></td>
<td class="nump">2,863<span></span>
</td>
<td class="nump">3,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Credits</a></td>
<td class="nump">13,634<span></span>
</td>
<td class="nump">12,653<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves', window );">Accrued warranty</a></td>
<td class="nump">939<span></span>
</td>
<td class="nump">976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Depreciation and amortization</a></td>
<td class="nump">2,226<span></span>
</td>
<td class="nump">2,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">977<span></span>
</td>
<td class="nump">979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DeferredTaxAssetsOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="nump">3,784<span></span>
</td>
<td class="nump">4,311<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax asset before valuation allowance</a></td>
<td class="nump">45,857<span></span>
</td>
<td class="nump">43,919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(40,485)<span></span>
</td>
<td class="num">(38,321)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax asset after valuation allowance</a></td>
<td class="nump">5,372<span></span>
</td>
<td class="nump">5,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts', window );">Deferred contract acquisition costs</a></td>
<td class="num">(990)<span></span>
</td>
<td class="num">(803)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Goodwill</a></td>
<td class="num">(124)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right of use asset</a></td>
<td class="num">(3,480)<span></span>
</td>
<td class="num">(4,042)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset</a></td>
<td class="nump">$ 778<span></span>
</td>
<td class="nump">$ 643<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DeferredTaxAssetsOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DeferredTaxAssetsOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from deferred contract acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from warranty reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123403335&amp;loc=d3e9972-128506<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123403335&amp;loc=d3e9979-128506<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386399080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Effective Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal statutory income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State tax rate</a></td>
<td class="num">(2.55%)<span></span>
</td>
<td class="nump">2.77%<span></span>
</td>
<td class="nump">2.82%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent', window );">Meals and entertainment</a></td>
<td class="nump">9.28%<span></span>
</td>
<td class="num">(0.65%)<span></span>
</td>
<td class="num">(2.83%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent', window );">Permanent differences</a></td>
<td class="nump">1.11%<span></span>
</td>
<td class="num">(2.87%)<span></span>
</td>
<td class="num">(2.58%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="num">(13.08%)<span></span>
</td>
<td class="num">(1.07%)<span></span>
</td>
<td class="nump">3.78%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent', window );">Extinguishment of PPP loan</a></td>
<td class="num">(44.59%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent', window );">Excess compensation</a></td>
<td class="nump">7.88%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="nump">17.03%<span></span>
</td>
<td class="num">(1.05%)<span></span>
</td>
<td class="num">(0.34%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.08%)<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
<td class="num">(0.33%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent', window );">General business credit</a></td>
<td class="num">(17.95%)<span></span>
</td>
<td class="nump">2.74%<span></span>
</td>
<td class="nump">8.14%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent', window );">Valuation allowance</a></td>
<td class="nump">72.82%<span></span>
</td>
<td class="num">(25.51%)<span></span>
</td>
<td class="num">(38.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Change in prior year reserves</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">2.53%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent', window );">Deferred true-up</a></td>
<td class="num">(11.76%)<span></span>
</td>
<td class="nump">2.08%<span></span>
</td>
<td class="nump">5.71%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">39.11%<span></span>
</td>
<td class="num">(2.01%)<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Debt Extinguishment, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deferred true-up.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Excess Compensation, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to permanent differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386078520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">$ 40,485<span></span>
</td>
<td class="nump">$ 38,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Change in valuation allowance</a></td>
<td class="nump">2,200<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset</a></td>
<td class="nump">778<span></span>
</td>
<td class="nump">$ 643<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_OperatingLossCarryforwardsWithoutExpiration', window );">Operating loss carryforwards without expiration</a></td>
<td class="nump">$ 35,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember', window );">Restricted Stock Units and Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount', window );">Shares granted calculation, grant period (in days)</a></td>
<td class="text">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">75,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority | Internal Revenue Service (IRS) | Research Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">6,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">39,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction | California Franchise Tax Board | Research Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward</a></td>
<td class="nump">$ 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_OperatingLossCarryforwardsWithoutExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating loss carryforwards that have no expiration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_OperatingLossCarryforwardsWithoutExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Payment Award, Period To Determine Grant Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:timeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386381608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of year</a></td>
<td class="nump">$ 1,864<span></span>
</td>
<td class="nump">$ 1,426<span></span>
</td>
<td class="nump">$ 1,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decreases related to prior year tax positions</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(291)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increases related to prior year tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current year tax positions</a></td>
<td class="nump">919<span></span>
</td>
<td class="nump">470<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of year</a></td>
<td class="nump">$ 2,746<span></span>
</td>
<td class="nump">$ 1,864<span></span>
</td>
<td class="nump">$ 1,426<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842381771864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 2,062<span></span>
</td>
<td class="num">$ (23,877)<span></span>
</td>
<td class="num">$ (12,348)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic (in shares)</a></td>
<td class="nump">17,891<span></span>
</td>
<td class="nump">16,691<span></span>
</td>
<td class="nump">14,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Dilutive effect of incremental shares and share equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares of common stock outstanding used in computing net loss per share, diluted (in shares)</a></td>
<td class="nump">18,362<span></span>
</td>
<td class="nump">16,691<span></span>
</td>
<td class="nump">14,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net income (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per share, basic (USD per share)</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="num">$ (1.43)<span></span>
</td>
<td class="num">$ (0.88)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per share, diluted (USD per share)</a></td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="num">$ (1.43)<span></span>
</td>
<td class="num">$ (0.88)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Dilutive effect of incremental shares and share equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment arrangements (in shares)</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Dilutive effect of incremental shares and share equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment arrangements (in shares)</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Dilutive effect of incremental shares and share equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment arrangements (in shares)</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Dilutive effect of incremental shares and share equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment arrangements (in shares)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842389176056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">8,652<span></span>
</td>
<td class="nump">1,123<span></span>
</td>
<td class="nump">1,265<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cutr_CappedCallSecuritiesMember', window );">Capped call</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">4,167<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">4,167<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">166<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">724<span></span>
</td>
<td class="nump">559<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember', window );">PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cutr_CappedCallSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cutr_CappedCallSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387672056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>segment</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Debt convertible to common shares (in shares)</a></td>
<td class="nump">4,167,232<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842392263800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plan - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution', window );">Maximum 401(k) employee contribution percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Employer 401(k) discretionary contribution</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to defined contribution plan maximum percentage of voluntary contribution by the employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842387777032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information and Revenue by Geography and Products - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842389611960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information and Revenue by Geography and Products - Summary of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 231,270<span></span>
</td>
<td class="nump">$ 147,683<span></span>
</td>
<td class="nump">$ 181,712<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Total product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">205,703<span></span>
</td>
<td class="nump">125,113<span></span>
</td>
<td class="nump">158,638<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_SystemsMember', window );">Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">139,633<span></span>
</td>
<td class="nump">90,765<span></span>
</td>
<td class="nump">140,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_HandPieceRefillsMember', window );">Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">16,401<span></span>
</td>
<td class="nump">9,287<span></span>
</td>
<td class="nump">9,648<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cutr_SkincareMember', window );">Skincare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">49,669<span></span>
</td>
<td class="nump">25,061<span></span>
</td>
<td class="nump">8,512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">25,567<span></span>
</td>
<td class="nump">22,570<span></span>
</td>
<td class="nump">23,074<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">96,629<span></span>
</td>
<td class="nump">61,238<span></span>
</td>
<td class="nump">106,372<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">70,235<span></span>
</td>
<td class="nump">43,265<span></span>
</td>
<td class="nump">24,143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cutr_AsiaExcludingJapanMember', window );">Asia, excluding Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">12,649<span></span>
</td>
<td class="nump">10,707<span></span>
</td>
<td class="nump">14,414<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">19,444<span></span>
</td>
<td class="nump">11,185<span></span>
</td>
<td class="nump">11,937<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember', window );">Rest of the world, other than United States, Asia and Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total net revenue</a></td>
<td class="nump">$ 32,313<span></span>
</td>
<td class="nump">$ 21,288<span></span>
</td>
<td class="nump">$ 24,846<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_SystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_SystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_HandPieceRefillsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_HandPieceRefillsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cutr_SkincareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cutr_SkincareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cutr_AsiaExcludingJapanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cutr_AsiaExcludingJapanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842377800888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 17,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,627<span></span>
</td>
<td class="nump">$ 17,076<span></span>
</td>
<td class="nump">$ 10,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total Operating lease liabilities</a></td>
<td class="nump">$ 18,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,902<span></span>
</td>
<td class="nump">18,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_LessorOptionToPurchaseGrantedPeriod', window );">Option granted to purchase leased system, period</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseRevenue', window );">Revenue for sales-type leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease', window );">Proceeds from purchase option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived', window );">Lease receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated product liability</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=cutr_FormerExecutiveVPAndCFOMember', window );">Former Executive VP and CFO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Arbitration settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_StockIssuedDuringPeriodSharesLitigationSettlement', window );">Arbitration settlement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_LesseeLeasesRemainingTerm', window );">Remaining lease terms of operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_LesseeLeasesRemainingTerm', window );">Remaining lease terms of operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_LesseeLeaseRenewalTerm', window );">Remaining lease terms of finance leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LesseeLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The renewal term for leases of lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LesseeLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LesseeLeasesRemainingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining term of operating and finance leases for the lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LesseeLeasesRemainingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LessorOptionToPurchaseGrantedPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessor, Option To Purchase Granted, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LessorOptionToPurchaseGrantedPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Exercise Of Purchase Option, Sales-Type Lease</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_StockIssuedDuringPeriodSharesLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period resulting from the judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_StockIssuedDuringPeriodSharesLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sales-type lease revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cutr_FormerExecutiveVPAndCFOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cutr_FormerExecutiveVPAndCFOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842391673240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Effect of Adoption of the New Standard (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 14,627<span></span>
</td>
<td class="nump">$ 17,076<span></span>
</td>
<td class="nump">$ 10,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="num">(2,419)<span></span>
</td>
<td class="num">(2,260)<span></span>
</td>
<td class="num">(2,430)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">763<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="num">$ (13,483)<span></span>
</td>
<td class="num">$ (15,950)<span></span>
</td>
<td class="num">(7,759)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,049)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,759<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842389273016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Financial Statement Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 14,627<span></span>
</td>
<td class="nump">$ 17,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease</a></td>
<td class="nump">$ 392<span></span>
</td>
<td class="nump">$ 467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Property and equipment, net<span></span>
</td>
<td class="text">Property and equipment, net<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_LeaseRightOfUseAsset', window );">Total leased assets</a></td>
<td class="nump">$ 15,019<span></span>
</td>
<td class="nump">$ 17,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">2,419<span></span>
</td>
<td class="nump">2,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities , non-current</a></td>
<td class="nump">13,483<span></span>
</td>
<td class="nump">15,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total Operating lease liabilities</a></td>
<td class="nump">15,902<span></span>
</td>
<td class="nump">18,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities, current</a></td>
<td class="nump">$ 554<span></span>
</td>
<td class="nump">$ 370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, non-current</a></td>
<td class="nump">$ 730<span></span>
</td>
<td class="nump">$ 241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 1,284<span></span>
</td>
<td class="nump">$ 611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance lease cost</a></td>
<td class="nump">484<span></span>
</td>
<td class="nump">431<span></span>
</td>
<td class="nump">$ 704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Finance lease cost</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease cost</a></td>
<td class="nump">3,542<span></span>
</td>
<td class="nump">3,275<span></span>
</td>
<td class="nump">2,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flow</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flow</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">537<span></span>
</td>
<td class="nump">649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flow</a></td>
<td class="nump">$ 3,092<span></span>
</td>
<td class="nump">$ 2,139<span></span>
</td>
<td class="nump">$ 2,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under finance and operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842388859144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 3,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">3,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">2,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">2,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">2,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive', window );">Thereafter</a></td>
<td class="nump">3,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">18,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(2,436)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total Operating lease liabilities</a></td>
<td class="nump">$ 15,902<span></span>
</td>
<td class="nump">$ 18,210<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842388613512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Maturities of Finance Leases Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">1,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 1,284<span></span>
</td>
<td class="nump">$ 611<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842470466632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Lease Information (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases</a></td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">4.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">6.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842391374408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Operating Lease Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Operating lease income from equipment rentals</a></td>
<td class="nump">$ 149<span></span>
</td>
<td class="nump">$ 367<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123420820&amp;loc=SL77919311-209978<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842380509368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 09, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 22, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>day </div>
<div>$ / shares </div>
<div>$ / item</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 04, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,007,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCapPrice', window );">Cap price (in USD per share) | $ / item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.5350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DerivativeCapPricePremiumOverStockPricePercent', window );">Premium over stock price (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41.32<span></span>
</td>
<td class="nump">$ 24.11<span></span>
</td>
<td class="nump">$ 35.81<span></span>
</td>
<td class="nump">$ 26.02<span></span>
</td>
<td class="nump">$ 17.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays', window );">Capped-call transaction term, consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities', window );">Purchase of capped call</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,100,000<span></span>
</td>
<td class="nump">$ 16,134,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of issuance costs of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,717,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">710,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest on convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,514,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,185,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Convertible debt, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0301427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 138,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from convertible notes, net of unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,007,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption', window );">Required outstanding amount not subject to redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of issuance costs of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest on convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026 | Convertible Debt | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount', window );">Incremental repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember', window );">Convertible Senior Notes Due 2026, Second Conversion Trigger | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Conversion threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion threshold percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember', window );">Convertible Senior Notes Due 2026, First Conversion Trigger | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Conversion threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion threshold percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_PaycheckProtectionProgramCARESActMember', window );">Paycheck Protection Program CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Loan proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement | Revolving Credit Facility | Silicon Valley Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable', window );">Qualifying accounts receivable</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Commitment fee amount</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DebtInstrumentAnniversaryFeeAmount', window );">Anniversary fee amount</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cutr_DebtCovenantQuarterlyMinimumRevenue', window );">Quarterly minimum revenue</a></td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_LoanAndSecurityAgreementMember', window );">Loan and Security Agreement | Revolving Credit Facility | Silicon Valley Bank | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtCovenantQuarterlyMinimumRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents quarterly minimum revenue under debt covenant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtCovenantQuarterlyMinimumRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentAnniversaryFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents anniversary fee amount for debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentAnniversaryFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of required outstanding amount not subject to redemption of a convertible debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of qualifying accounts receivable for debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption, Incremental Repurchase Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DerivativeCapPricePremiumOverStockPricePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percent premium over the stock price for derivative caps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DerivativeCapPricePremiumOverStockPricePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative, Capped Call Transaction Term, Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cutr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCapPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cap rate on a price risk derivative such as a cap or collar. A payment or receipt is triggered if the market rate exceeds the cap rate on the contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCapPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3505-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_PaycheckProtectionProgramCARESActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_PaycheckProtectionProgramCARESActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_LoanAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_LoanAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=cutr_SiliconValleyBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=cutr_SiliconValleyBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842386209416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Outstanding Debt and Carrying Value (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized debt issuance costs</a></td>
<td class="num">$ (4,007)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member', window );">Convertible Senior Notes Due 2026 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal amount</a></td>
<td class="nump">138,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized debt issuance costs</a></td>
<td class="num">(4,007)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">$ 134,243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cutr_ConvertibleSeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139842381737816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts - Summary of the Deferred Tax Assets Valuation Allowance and Allowance for Doubtful Accounts Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">Deferred tax assets valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">$ 38,321<span></span>
</td>
<td class="nump">$ 32,350<span></span>
</td>
<td class="nump">$ 27,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions</a></td>
<td class="nump">7,503<span></span>
</td>
<td class="nump">7,986<span></span>
</td>
<td class="nump">7,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="nump">5,337<span></span>
</td>
<td class="nump">2,015<span></span>
</td>
<td class="nump">2,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">40,487<span></span>
</td>
<td class="nump">38,321<span></span>
</td>
<td class="nump">32,350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLoanAndLeaseLossesMember', window );">Allowance for credit losses, accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">1,598<span></span>
</td>
<td class="nump">1,354<span></span>
</td>
<td class="nump">1,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions</a></td>
<td class="nump">271<span></span>
</td>
<td class="nump">2,144<span></span>
</td>
<td class="nump">1,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="nump">970<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="nump">1,264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Year</a></td>
<td class="nump">$ 899<span></span>
</td>
<td class="nump">$ 1,598<span></span>
</td>
<td class="nump">$ 1,354<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLoanAndLeaseLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForLoanAndLeaseLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>cutr-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:cutr="http://cutera.com/20211231"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cutr-20211231.xsd" xlink:type="simple"/>
    <context id="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i12806cd82e1f4ceeac75fc20c9308310_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6fea2b1966df49cfa5b8b7da99a4521a_I20220222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2022-02-22</instant>
        </period>
    </context>
    <context id="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icb8194a480bb4178ad9ccc279fa71d86_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i099f3e3620924202a8039a0d27597652_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1b500e632e0846a6a33e6a7ac55f88ad_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7098bcdf6ed0484fab59d24d26f26f8b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i58319883bced4affb153fc42b9f6a7ab_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3a72612f34ee4319a9bb7d59ecf28bee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia4cf1c8552b845c08ebb68573b2cdd62_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1a7631525a4f45cd84f88a123b5d2213_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if99ac849105d4a778abc890967e8354d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if092c9ece84f49e7896488564096ae3e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6093d26609ac4a2082bc74145688a81e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i84bd95534d8f493aa7e53067a3785115_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8ef35ea9019a46839254540bd96f8f38_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i37fa040d9517485c9e505b0a87f68f29_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iee23395883004f20bda4e3cba945dd71_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i63061c421e784fa784a49973a94456b2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i50e9b99ce0334c7d9a579aa4a855f45e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5b37d87a7edd4cbba072cd040d20302b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icee9c162557a4530b5abeb514f96a6c5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i84dc3075f0c942e99a266d7512c300d6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id274c268168b47e082c04e17dfbb9eb6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4131053e935748729079966449ab7c37_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i960574069b78413a924873ab23554fb4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibcae67fe77484d66aac559d41cdd4a97_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib8720e5d165746398e865e8ff2bf37ba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i196713f133464fccbcbe95ca1be37452_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i04a8f1192895498a8fbd198d78451ecd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i952540da797a438c883313a189c55038_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie8344555ed6a476481db2825ccec753c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i90ee30efe67b4fb49e2d5f54e0fafe89_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6f16a2afdae64f2daab7448314a752d3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i19a4ef1cc484429daba4d25230ec7aad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id52c81a523b740df9a58c7f26a6f5f9f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5865f24ced8c4abe92e8e3142a113547_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idcc9ffcaa06a4dbd9843701a556e4a0a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29493bf694aa41e4961175a5d0e9712c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9f3add778c6d42e2904c632bb4379750_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i27ed0b55b74e49509122ed86b0f52309_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i307d65a514094556a1c3cb6702122693_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:LoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id09c2b6d4b444a11a61afbefef850c5f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:LoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i78e6939cb0a445dd8e3548b14d70b125_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8a9ce53bcd874cb38a5dbc24e4ea3583_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29b9e3b28d734adeb076ece7de227b71_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i49f345cd25654a7f84873131ed305500_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia3577892be364d588b4ee6707f9426df_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic835d94700e34147a128f7c43a99ba8f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia7d8ca402cf64fa095821119515012f0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i046ed111439c42409c5114869295fb0b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib426205ae11e4aa1879843b606c79fd5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6d16dd05655a48cea0d5421c014cf5b5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icc042179d3e042a49fe526aad8eb50c6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i22da8abdff7f43e49f27b03708dc3882_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SecretAndSecretProMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id4151927442041dd92c39ebf707b54a4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iea5dc3d35fa7491281eebabd4744ca45_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:LeasedEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i687140e91bb9469bb4be1621b92c9b8b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:EquipmentAndFurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i16179899e1fd49b2884edc3604740025_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iac4da192d3c340da971b19d3ab991663_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:CapitalizedCloudComputingSetupCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5bfb0aae8e4f42c682a5274dacefb148_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cutr:CapitalizedCloudComputingSetupCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5f6b3f16760744dc9103390169175d8f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iffa27261393c4ab8ba5e3794d9147c89_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i541d48bf023c4fe7aae98ff86b967101_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cutr:RestrictedStockUnitsAndPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5d7848312e9548839319d5ac37eca97c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4bc9b22641b0417da7e8a81fcaf59a1b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6f352492b09240419cedf42adcbed4e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if050ebe27c6a45b6afb9c2a998414be2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4550dd7ebeeb4ea9baad304474ac9979_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:LeasedEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i116594d0783a424a8fafeb1b4f59c8e1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:LeasedEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i95e3d048dc634a71897f460779f082a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:EquipmentAndFurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic4d4966eb9a940dfa6db6a00a25b33db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cutr:EquipmentAndFurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idcea864f6da04951ab895dcc2436d3cf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i06d8947881bc48feaed989df52b60b1a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib7c26e3ef9c442a8832ed31ed63f16e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i314e69e3501a4ea3a3bc04ee5a0601b0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic330d4e7bda4436ea9b5a447faa2ab15_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaf1149b9e76a4c089deaa8f058629d53_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia36d0816ebaf4b43aa977f986877b067_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i54949609fd0c4fddb72cfc46650cb0e8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib79906570e2049eabe51c068e7921170_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id019adf1333c43ce9cd8acf7e5ea0991_D20200421-20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cutr:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-21</startDate>
            <endDate>2020-04-21</endDate>
        </period>
    </context>
    <context id="i5e364a947a114dddb1671e44b0467847_I20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cutr:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-21</instant>
        </period>
    </context>
    <context id="i9b9ef969fb964e68bc041b81228d55de_D20200421-20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cutr:UnderwriterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cutr:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-21</startDate>
            <endDate>2020-04-21</endDate>
        </period>
    </context>
    <context id="i7b5f16c096554bfebc0977f38bdab2e3_I19981231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>1998-12-31</instant>
        </period>
    </context>
    <context id="i6bdd524cbef74fc18d573d1100d86374_I20040112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2004-01-12</instant>
        </period>
    </context>
    <context id="i5327f49a62ea40d690f0899c454a9fbd_D20120101-20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-01-01</startDate>
            <endDate>2012-12-31</endDate>
        </period>
    </context>
    <context id="i51d5c987d168444995a56ee832d422f1_D20190614-20190614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-14</startDate>
            <endDate>2019-06-14</endDate>
        </period>
    </context>
    <context id="i19b58bf2da1b4bdf82f22bbae4a7f3a2_I20190614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-14</instant>
        </period>
    </context>
    <context id="i2e8bdcbd064d4597b255647bff9cba1a_D20190614-20190614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-14</startDate>
            <endDate>2019-06-14</endDate>
        </period>
    </context>
    <context id="ifd9fd5d526a04b80a20fe10491260caa_D20190611-20190611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2019-06-11</startDate>
            <endDate>2019-06-11</endDate>
        </period>
    </context>
    <context id="ief9071943aa645caa5dade84cd3e061d_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TheAmendedAndRestated2019EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id927e8d4f38a47a0828d8a646057aed3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie3195dfbe94d477e88a888e893f44d1e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3d42d4ffa3bd4f0b875d22a9ab203d5c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i81aa92e174864f29b74e30628a31ecd2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i88b4ab1b779d43ed8ae859fa48628f89_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i713579da903a47a29c2bbc3556a11854_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if5f5df8bc21945d8be1f01c615e620b9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5897798beb29443aae3381f60fa7cc05_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsAnnualGrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibd9c28c8d501405da659af62fb7475e6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsNewHireMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5046b58bcd594937807a5b3727f16519_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i57973c7f0bd94f19b5e2a50196d96324_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i55b1792fc2364767a5f64cd1cdf6808c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i64db2b3b978b414a8c02290468f928b5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie5a5db0c5f0d46b380a0b79f965a62ea_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i01a61b6023fb48d7be1011c161d39845_D20210701-20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="i6293b26e539849e09ccfdc96cb5059bb_D20190701-20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="id6d4b50d303d423099ba57b50833b756_D20190701-20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="i7e2fb7f83d5a4d3797c1641e79c2cb8e_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="iaba873dc2f8c4fb8bb139aa82a0e3219_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i0d1404685416410cbcd6e1f275b3fd2d_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="ia1344f4c17c7449aba2397d6f715ba6f_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="ie8e0ec5e57d6453db52240a4631277a9_D20040112-20040112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2004-01-12</startDate>
            <endDate>2004-01-12</endDate>
        </period>
    </context>
    <context id="ie3406523d56248b489c3b7541fdf6711_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie4edea0c28014a2d93054c7ca5e19937_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9d790cb4f5784d80b7d9b71df630a022_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idc61de97e6f5442cae47ea43a50a646f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cutr:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3df46276971c4ed0986a5e859e637064_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i243cda497d0443fd8d3e77f6c4b77778_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i918b5c66b5b64f319346190d60ad103d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i24d00f09f70e46dd88668566228e1cdf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ba69d99c6bf476e8d15c9c79b2a6df2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id228189a9c344696a5059d6861067108_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4d5d0bdf4f0d4a1883472cfe8d0f4ca7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5e4c6cb41dca483993cf3fb92041cc1f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i062444d03896452f9251a408fa65500b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id8ddcd5085f543b5aacaf7518aba284a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e4d0f435f2844b291dd5ea2a0f001f0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i20b036dbcc074c4a90dad931e7f4bb6c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i40475f7443d64415ba295a8050683744_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic7ae52da7abe49da93b5d02df9962d86_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idafa75464bf1482bbe39438ca2a1fbb3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ide3c7b9ba1e1465085e27b6fb0183fac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i86f5d1782ee64b31bfb15fc1735484b3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i79619c0d0304473a9a05f38376df1ca5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5787bf9bc4b840c8b9474232abd18822_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i187150c65510432d854fe82b6fb23a3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice72d61a300545aeb3844e67957f9576_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">cutr:ExercisePriceRange10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i08b960d0e6e645c39e84cc857ec13e6b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i192be0f1705145908aa6ad70700cddf7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ice6c8183a7fa4570a3f044c0f1d54f9c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i32524a5704d848b69d401dc8de11ebf9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i35da96289dd949498eddb1768dd19192_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3adb16d3075942348f225b70cf90f3a4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7cf974c819a34839aa1bfe59802e71ba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i66107087f3fd4a20b6cb4d48e7f3033a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0689b0010d214af6bd1356f9f93a1141_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:ESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i246ec24176874e33b14c7fda30f63bfc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:ESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iacfb1ac9741f4b3db30f8728b64a645e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:ESPPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i199effaf47f34a41a806c1a1a7e53aa1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7ea32c98f4b44fd4982e248bedf6cead_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i053b35b2d01d445ea80dee2b47dbb5fb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i866b9eac79cc4cecbfb1b078c5693146_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8d3833836ada4a39873f0f32f69266d9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia001d3ced3134020b6fbcd0bdba96369_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i16b8707c22974632a641c57e2b86817c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idc44a2bdb221436a8375e04e1ea9bb79_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4499ceba300a402e858712b9c26ba787_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib9d312fc584843e38678f9ffd58f8a01_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:StockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iac80237e6ee945ac8a0c0ba713b41438_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:StockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ide91ed10ffb54702b454c8e2a5cad1d1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:StockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1aa834f5b84048cd91d2b5b6dba22f64_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cutr:RestrictedStockUnitsNewHireMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2b6ae716d54948428783d4f61fd518f5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i254106ff63ec411e9d2da0f175830fa6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2e6fd16be09042c6be9c81d3d9e1c187_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55e82d33e5544074a2aac447d7824467_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7b4a1f39d65147fcac2e81a5c60fcdb4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifade32131fd14ec1926f12852d497aed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3598dca90d534ae0a8d4aaf1b13b56c1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4c6391b6a824369a52a92dbea8b9166_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i908d24eef82248b3b0c5e24ce67d7620_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2673044451384aab8b4c321ea6b9f8a2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia643c91cedb04d559d547cfeceee8809_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9eb3b54c6e9341a299439438dca1b02c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cutr:CappedCallSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i637b3d70c182413ba3e75aa2bef9320b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cutr:CappedCallSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id943a7c916e04296aa697a2d261b63c9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cutr:CappedCallSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8c1a042e66a646cf876664c9b9e32ccf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i69439113ac644761bbfd84226a430cdc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9751faf680174024a66bfd73c40bb6ae_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i827ff77fcef14e9c82c96fe8afe59e6f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if5e396b1a03c446faf5e013cd334d63a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia86ce17804314cdfb7203658a2fa825c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i26a28b3231d24fbd9da85098c345597f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4d3b04419de146f79e0830d4f8e5fc88_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i67dd4dfa6fb84a8d803fd3e4686012df_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i49698c4c16fa448aa1199cdea0f0db3f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iadd6424f69774b75aa9f2d8c176bfc58_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i82424323bc6746ac95ae7b4f28e7db6e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id80c93e18ea14c80a7c54a7919d9e363_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id3d8659c50814d9ba9e908c0fdd94d23_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ied686aef55a948f5bdf73f5ebd34b570_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8b29467be6564d3f96a00ec95fc5f71b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i45b5e0fc162b498a9929672c4fb7e999_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib9f2c0dfb22b430f8f1dad0b71274edb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if27b2a1100724a6ba26c08b984a74d73_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iabe1ad421e2e4777bc58f953183a58d8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i85ccedc5cc084701a241de78d69d915f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic0e98db9695641d48b2985be4ab15c8d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8f06a616963d42bbb1bef44c8cff5a12_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieb36f34a3d6443f59cb889c5f55426a4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:AsiaExcludingJapanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibe6666768fb24f969d5783ef26a323af_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i21f225eac6b24108b1ebbc248f11ac03_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie9b8210b31c544628b9091d412a30501_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7ead9548c13b4a1e8a2ca967452a46ea_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5bf9f04fa0584c609bf017b7f800a291_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9a47c8db3d4c4730995fc63329813d86_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cutr:RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idac1466cf9104c8e9357f38e1e4b2c30_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib265219876bc4426a1d87eaf7ec84fe5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i646d72085053489e80492d5e31a5abb2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i60121f9d6c17406fa91d2087e5266a1b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:HandPieceRefillsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i85aa042e4c004dc8a331aa0e27b9dd03_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:HandPieceRefillsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i007f7a487e97481d9f1957cd82a932d8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:HandPieceRefillsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idbb6461561444b40bb9d9d51b6f1aff8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2e98acc9c5eb4f31a71cdbb2d1a1a1d5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cutr:SkincareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibd3302b52f4a41409e34c024834c102a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if5c79f3c61274db4a3f2eb8ce9d31f70_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i399c8e27879e4205838eba2cd2b55bed_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia7416b6bdf4a48dcad826a2a1430ea9a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i764ce0cbc59940f481fdec67f544e264_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib80ff99676a24f1f8527cc2a3aa4d119_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cutr:FormerExecutiveVPAndCFOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i37f97a9d284443ad97ec8c981fcd7f08_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1d1c6d926fe34c69ad511dec85a63fd4_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2a6e8339dfdb4cd39eddb0d8191da2b2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3b661e68d3614dd8a0389a329265b3bd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic7cfa6c72662462f90fcfd77f387c2c3_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026FirstConversionTriggerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8b0a2bfb03104efeadd77a4412bae006_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026SecondConversionTriggerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i58a47170b8054a0ba5cca87aa0a800de_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i74ccf35a513f4cfd8630d93546df6f20_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i130b34c8fd4f434eb30d4d656ae2c907_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i46277ffbd52b4aaf98c02564d8aa2124_I20210304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <instant>2021-03-04</instant>
        </period>
    </context>
    <context id="i453b9f386c004d948258fe7bc2b71f9c_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic6bca201b74942348baa93e457128a05_D20200709-20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-09</startDate>
            <endDate>2020-07-09</endDate>
        </period>
    </context>
    <context id="i77d3c70ae7304fa7a266e0d9e1db39cd_I20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-09</instant>
        </period>
    </context>
    <context id="icd0e36b6f7714fe981a44e99c804b27b_D20200709-20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">cutr:SiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-09</startDate>
            <endDate>2020-07-09</endDate>
        </period>
    </context>
    <context id="i9781cc48038047a79264ddaf70b44230_D20200422-20200422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-22</startDate>
            <endDate>2020-04-22</endDate>
        </period>
    </context>
    <context id="i4d2cac1cd2a7480690ed521729608228_I20200422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-22</instant>
        </period>
    </context>
    <context id="i2fe8bd55b1e94cda888bad51642d2ccf_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:PaycheckProtectionProgramCARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia7b49d8dae1a41d7955cdd82cd7c50ab_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cutr:ConvertibleSeniorNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia14ca8fcae0b4aefa76cad9866090d78_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i53f708f1ad434a6ebaec1f96b1e10a2a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9ee1cde4537a457a88a3ef970508acf5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07d7ed87182941cdbdd83dbfbedf27c2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i90d8a65714d14212b8f93aae06688452_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3b7116ac1a764bada7c667ee90614aee_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ifbfb1453521848d4a478c1bab5686392_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i54116f7e632d4168b0ea901ff7e1d220_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ied6bc4de4307436da39a837d8e641a54_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib07203e94f374a45ab7a8e8c3f66b67b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1dbc469745e840208e864df19cadabc3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ica83547bfc21466aaad3b5d34df18cb4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibb9f62bf502f487d80c5e7ec032cdc88_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia314f34942bd40c09b7937fff3f63589_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162461</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForLoanAndLeaseLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="country">
        <measure>cutr:country</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="supplier">
        <measure>cutr:supplier</measure>
    </unit>
    <unit id="segment">
        <measure>cutr:segment</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>cutr:reporting_unit</measure>
    </unit>
    <unit id="tranche">
        <measure>cutr:tranche</measure>
    </unit>
    <unit id="day">
        <measure>cutr:day</measure>
    </unit>
    <unit id="usdPerItem">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>cutr:item</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl80L2ZyYWc6OTA1NTkzZjJlMWYxNGNkYjhlYmE2Y2Y3NmVhYTc4YTEvdGFibGU6NTNhNDQ0MTE4NDJjNDQ1Y2I5YTc5NWFmMThkYzQ5MjgvdGFibGVyYW5nZTo1M2E0NDQxMTg0MmM0NDVjYjlhNzk1YWYxOGRjNDkyOF8xLTEtMS0xLTI4NjIx_f7e347b6-a73a-426d-a997-9a64c4748c14">0001162461</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl80L2ZyYWc6OTA1NTkzZjJlMWYxNGNkYjhlYmE2Y2Y3NmVhYTc4YTEvdGFibGU6NTNhNDQ0MTE4NDJjNDQ1Y2I5YTc5NWFmMThkYzQ5MjgvdGFibGVyYW5nZTo1M2E0NDQxMTg0MmM0NDVjYjlhNzk1YWYxOGRjNDkyOF8yLTEtMS0xLTI4NjIx_7d9a87e9-83a1-403b-a596-dee71328af9f">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl80L2ZyYWc6OTA1NTkzZjJlMWYxNGNkYjhlYmE2Y2Y3NmVhYTc4YTEvdGFibGU6NTNhNDQ0MTE4NDJjNDQ1Y2I5YTc5NWFmMThkYzQ5MjgvdGFibGVyYW5nZTo1M2E0NDQxMTg0MmM0NDVjYjlhNzk1YWYxOGRjNDkyOF80LTEtMS0xLTI4NjIx_efa2c213-1167-42eb-bd5a-a40e9f62f708">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl80L2ZyYWc6OTA1NTkzZjJlMWYxNGNkYjhlYmE2Y2Y3NmVhYTc4YTEvdGFibGU6NTNhNDQ0MTE4NDJjNDQ1Y2I5YTc5NWFmMThkYzQ5MjgvdGFibGVyYW5nZTo1M2E0NDQxMTg0MmM0NDVjYjlhNzk1YWYxOGRjNDkyOF81LTEtMS0xLTI4NjIx_be44fcba-afd9-4348-9e5b-f53770a0c2e0">2021</dei:DocumentFiscalYearFocus>
    <cutr:ExtendedServiceContractOptionOneTerm
      contextRef="i58319883bced4affb153fc42b9f6a7ab_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzOTA_48951eca-9684-4911-930c-c47a406efd42">P1Y</cutr:ExtendedServiceContractOptionOneTerm>
    <cutr:ExtendedServiceContractOptionTwoTerm
      contextRef="i58319883bced4affb153fc42b9f6a7ab_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzOTE_82f81123-597c-470d-8503-057d2c5ae78b">P2Y</cutr:ExtendedServiceContractOptionTwoTerm>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i78e6939cb0a445dd8e3548b14d70b125_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzNTI_f9af2b31-c814-4dab-886d-badea997b8a1">P2Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:NumberOfReportingUnits
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNzQ3L2ZyYWc6NzNiOGQyZjhiYTdjNDViY2I1ZjQwNzlmZjhmMzcxZDgvdGV4dHJlZ2lvbjo3M2I4ZDJmOGJhN2M0NWJjYjVmNDA3OWZmOGYzNzFkOF8yMDM0MDk2NTExMzk2Nw_caa49acf-c26e-43a6-9487-d83bb8e90cc3"
      unitRef="reporting_unit">1</us-gaap:NumberOfReportingUnits>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNzQ3L2ZyYWc6NzNiOGQyZjhiYTdjNDViY2I1ZjQwNzlmZjhmMzcxZDgvdGV4dHJlZ2lvbjo3M2I4ZDJmOGJhN2M0NWJjYjVmNDA3OWZmOGYzNzFkOF8zODQ4MjkwNjk3NTg3_d9643029-01a4-4d9b-9884-4a8258b0931c"
      unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <cutr:ExtendedServiceContractOptionOneTerm
      contextRef="ia36d0816ebaf4b43aa977f986877b067_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzM4NDgyOTA2OTc5OTU_298632bb-c8d5-4a4a-94e5-1559caf89ce1">P1Y</cutr:ExtendedServiceContractOptionOneTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i5897798beb29443aae3381f60fa7cc05_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDAw_eb99cd2f-e555-49f7-b0bf-9cc8cd023330">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i1aa834f5b84048cd91d2b5b6dba22f64_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjcvZnJhZzozY2EyNjE3ZGNiNzA0Nzk3YmM3M2U1MTc4ZmU4NjYxNy90YWJsZTowMWJiMmY3NTg2YzQ0MTAwOTg0OGMwMjk3MDRlYzZlYS90YWJsZXJhbmdlOjAxYmIyZjc1ODZjNDQxMDA5ODQ4YzAyOTcwNGVjNmVhXzYtMS0xLTEtMjg2MjE_4f3d124b-2060-4679-96f5-e0a31bcaed99"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i2b6ae716d54948428783d4f61fd518f5_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjcvZnJhZzozY2EyNjE3ZGNiNzA0Nzk3YmM3M2U1MTc4ZmU4NjYxNy90YWJsZTowMWJiMmY3NTg2YzQ0MTAwOTg0OGMwMjk3MDRlYzZlYS90YWJsZXJhbmdlOjAxYmIyZjc1ODZjNDQxMDA5ODQ4YzAyOTcwNGVjNmVhXzItMS0xLTEtNDc1NjI_87cc82e8-967c-4744-9de5-fff4d7eef96e"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i254106ff63ec411e9d2da0f175830fa6_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjcvZnJhZzozY2EyNjE3ZGNiNzA0Nzk3YmM3M2U1MTc4ZmU4NjYxNy90YWJsZTowMWJiMmY3NTg2YzQ0MTAwOTg0OGMwMjk3MDRlYzZlYS90YWJsZXJhbmdlOjAxYmIyZjc1ODZjNDQxMDA5ODQ4YzAyOTcwNGVjNmVhXzMtMS0xLTEtNDc1NjI_5b24d466-acb0-4d3c-9785-30ee8c67ff1f"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <cutr:LesseeLeasesRemainingTerm
      contextRef="ibd3302b52f4a41409e34c024834c102a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzM1OQ_c3159409-b458-460d-9242-9f6a751b81b3">P1Y</cutr:LesseeLeasesRemainingTerm>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMS0xLTEtMzkwMjA_971a5a0e-7d36-4fb8-a69f-ab6296ab5451">http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMS0xLTEtMzkwMjA_9d781c61-1f10-40e0-a3f0-691f77491d63">http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMS0xLTEtMzkwMjI_8092eb31-ac1f-4f22-979c-32b815b92382">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMS0xLTEtMzkwMjI_e0e19b97-1369-4d4a-bbc4-18c6459ed777">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMS0xLTEtMzkwMjQ_28244cd5-3898-471f-8e2b-ae37ea29760a">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMS0xLTEtMzkwMjQ_7df8c095-3d4f-4603-b7c7-f49c99ce82b6">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="ia7b49d8dae1a41d7955cdd82cd7c50ab_D20210301-20210331"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNjMxL2ZyYWc6MTA5YzA1MDMxNWYxNGM0NGEzY2JiYjczNGRlYTIyZTIvdGFibGU6ZjIyNTljNDI2ODJhNDViOTg5MjEzZDZiM2JlY2JmOGYvdGFibGVyYW5nZTpmMjI1OWM0MjY4MmE0NWI5ODkyMTNkNmIzYmVjYmY4Zl8xLTMtMS0xLTM4NzM3_0f12cb4a-a834-4f29-bcce-2f2c4e5f62ac"
      unitRef="number">0.0301427</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzI5_57952c4e-9732-4d06-952b-59f91dd0037a">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6MDllZjg1MWJiYjA5NDkxYjgyNDViMjIyOTA4YzljOGQvdGFibGVyYW5nZTowOWVmODUxYmJiMDk0OTFiODI0NWIyMjI5MDhjOWM4ZF8wLTEtMS0xLTI4NjIx_d859e93b-c228-488b-83d0-11ff0c9583aa">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zODQ4MjkwNzAxMzc4_3ed1a8a9-8307-4612-ba13-fbb6ff402b12">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zODQ4MjkwNzAxMzc4_e4c1fdc5-b1dd-40b0-8240-8cbdaf1eb2ef">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6MWM0NGEwOTA4Nzg5NDE3MmFjYjkwZGUzMDZiMjVmOTEvdGFibGVyYW5nZToxYzQ0YTA5MDg3ODk0MTcyYWNiOTBkZTMwNmIyNWY5MV8wLTEtMS0xLTI4NjIx_baac1c65-0af5-42a0-a1ef-14d6c7366b68">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzI0_e30ab3e5-993f-4b6d-bc80-ad21f5f86172">000-50644</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzMw_06d8c7ad-5d48-4b10-87a2-2b2b4d1c7e87">CUTERA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6YzFhMTIxYTBhMTAzNGFkNGE0ZWMwYWIyZjFkMGVhN2QvdGFibGVyYW5nZTpjMWExMjFhMGExMDM0YWQ0YTRlYzBhYjJmMWQwZWE3ZF8wLTEtMS0xLTM2OTU0_73d1f6ce-2e40-4023-a9a1-06ab75917200">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6YzFhMTIxYTBhMTAzNGFkNGE0ZWMwYWIyZjFkMGVhN2QvdGFibGVyYW5nZTpjMWExMjFhMGExMDM0YWQ0YTRlYzBhYjJmMWQwZWE3ZF8wLTMtMS0xLTI4NjIx_1425858d-39e6-4c8a-ab1a-464491c0a374">77-0492262</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzI1_3a48fa93-b25a-4cf4-aac9-20241edd685c">3240 Bayshore Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzI2_8aca0a6f-5965-447c-9d0b-c0ad992e894d">Brisbane</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zODQ4MjkwNzAxMzU3_3fe087fc-b1ad-4204-b6cd-51a6e5b23a4c">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzI3_3e4a5c29-c311-4ae4-bfe1-b61f88b8ffe8">94005</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzE4_0d83fd6e-151e-489e-bf39-465fa51b000a">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzE5_8900d40d-bdf9-42cb-a0f5-d167e29173cb">657-5500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6OTU1NGI1ZDUxZWQ5NGEzNmE3MThlZDE4M2Q0NWZkZjcvdGFibGVyYW5nZTo5NTU0YjVkNTFlZDk0YTM2YTcxOGVkMTgzZDQ1ZmRmN18xLTAtMS0xLTI4NjIx_3597ea62-b10e-4b9d-8386-116647168deb">Common Stock ($0.001 par value)</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6OTU1NGI1ZDUxZWQ5NGEzNmE3MThlZDE4M2Q0NWZkZjcvdGFibGVyYW5nZTo5NTU0YjVkNTFlZDk0YTM2YTcxOGVkMTgzZDQ1ZmRmN18xLTAtMS0xLTI4NjIx_55643608-f33e-4acf-b9ec-c6fda10ee93b">Common Stock ($0.001 par value)</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6OTU1NGI1ZDUxZWQ5NGEzNmE3MThlZDE4M2Q0NWZkZjcvdGFibGVyYW5nZTo5NTU0YjVkNTFlZDk0YTM2YTcxOGVkMTgzZDQ1ZmRmN18xLTEtMS0xLTI4NjIx_05d55ca5-cbc7-4517-8517-be5261acbc67">CUTR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6OTU1NGI1ZDUxZWQ5NGEzNmE3MThlZDE4M2Q0NWZkZjcvdGFibGVyYW5nZTo5NTU0YjVkNTFlZDk0YTM2YTcxOGVkMTgzZDQ1ZmRmN18xLTItMS0xLTM2OTQ5_ce508f8c-ccd2-489d-abb4-5ddc550f3385">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzIw_e15bc585-f8bb-4e28-bb56-afb60377b87d">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzIx_2e4eac0e-ff02-4bea-a038-dc7e137a9307">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzIy_7c512963-042e-4faf-9095-f201cf21c28b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzIz_d85913c4-939e-479f-92bd-0d3aee102890">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6ZThiM2U5ZjY2ODI0NDRiY2JkM2QyZDFjNTU4NTY0MGQvdGFibGVyYW5nZTplOGIzZTlmNjY4MjQ0NGJjYmQzZDJkMWM1NTg1NjQwZF8wLTAtMS0xLTM5MzM0_64355106-2702-4cd5-944f-83a70521c1d4">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6ZThiM2U5ZjY2ODI0NDRiY2JkM2QyZDFjNTU4NTY0MGQvdGFibGVyYW5nZTplOGIzZTlmNjY4MjQ0NGJjYmQzZDJkMWM1NTg1NjQwZF8wLTctMS0xLTI4NjIx_b0651c83-5b5e-46c7-86f7-be1d661be580">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGFibGU6ZThiM2U5ZjY2ODI0NDRiY2JkM2QyZDFjNTU4NTY0MGQvdGFibGVyYW5nZTplOGIzZTlmNjY4MjQ0NGJjYmQzZDJkMWM1NTg1NjQwZF8wLTktMS0xLTI4NjIx_e7370a26-5aee-46d8-8bf3-61fb1ff8a60a">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zODQ4MjkwNzAxMzk2_1b8afd8a-16ff-4285-9ead-c059f5b0ed24">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zNzI4_9798bfe5-19e9-45a4-a984-0ffc34f5810f">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i12806cd82e1f4ceeac75fc20c9308310_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8yODg3_6629fcc8-1be4-45b9-98f2-db161c7c63d3"
      unitRef="usd">796000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i6fea2b1966df49cfa5b8b7da99a4521a_I20220222"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zODQ4MjkwNzAxMzU4_d520c207-00c1-4f0a-85a6-0139fbfdde70"
      unitRef="shares">18060261</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xL2ZyYWc6OWNkZDVhMTcxOWQ5NDA5YjgyMTI2MWMyNjM4MjZjMGYvdGV4dHJlZ2lvbjo5Y2RkNWExNzE5ZDk0MDliODIxMjYxYzI2MzgyNmMwZl8zODQ4MjkwNzAxMzk3_ecee2dbe-448d-4e32-a4d2-64e61a9a977c">Part III incorporates by reference certain information from the registrant&#x2019;s definitive proxy statement for the 2022 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission not later than 120 days after December 31, 2021.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83My9mcmFnOmMzYThmYTM5YTEwNzRkY2FhZDc4YzM3Y2Q4YTc5OGFiL3RhYmxlOjllMWMwMDM0YWZkMTRjMzNhOWE4YjcwYmFlYjEzMDQyL3RhYmxlcmFuZ2U6OWUxYzAwMzRhZmQxNGMzM2E5YThiNzBiYWViMTMwNDJfMS0wLTEtMS01MDI2MS90ZXh0cmVnaW9uOmJiMWQwMjZkZWY5YzQwOTlhNTAwNDc2N2VlOTNmZDBkXzM4NDgyOTA2OTczNTI_391681b6-c1c4-4c2e-a2d9-cbd14cbd9e12">BDO USA, LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83My9mcmFnOmMzYThmYTM5YTEwNzRkY2FhZDc4YzM3Y2Q4YTc5OGFiL3RhYmxlOjllMWMwMDM0YWZkMTRjMzNhOWE4YjcwYmFlYjEzMDQyL3RhYmxlcmFuZ2U6OWUxYzAwMzRhZmQxNGMzM2E5YThiNzBiYWViMTMwNDJfMS0wLTEtMS01MDI2MS90ZXh0cmVnaW9uOmJiMWQwMjZkZWY5YzQwOTlhNTAwNDc2N2VlOTNmZDBkXzM4NDgyOTA2OTczODA_3f02c65f-897f-4bf2-a9a4-d627c6f74999">San Francisco, California</dei:AuditorLocation>
    <dei:AuditorFirmId
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83My9mcmFnOmMzYThmYTM5YTEwNzRkY2FhZDc4YzM3Y2Q4YTc5OGFiL3RhYmxlOjllMWMwMDM0YWZkMTRjMzNhOWE4YjcwYmFlYjEzMDQyL3RhYmxlcmFuZ2U6OWUxYzAwMzRhZmQxNGMzM2E5YThiNzBiYWViMTMwNDJfMS0wLTEtMS01MDI2MS90ZXh0cmVnaW9uOmJiMWQwMjZkZWY5YzQwOTlhNTAwNDc2N2VlOTNmZDBkXzM4NDgyOTA2OTczMzc_8fe3c917-74ed-4b66-91c4-f7799ae2f45b">243</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNC0xLTEtMS0yODYyMQ_144fe4fb-6af2-4921-b6b5-6754c6879cbb"
      unitRef="usd">164164000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNC0zLTEtMS0yODYyMQ_7da5bd89-c803-4204-a1bb-cb7ca1865743"
      unitRef="usd">47047000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNi0wLTEtMS0yODYyMS90ZXh0cmVnaW9uOmFhZGYzZWMwOTA1OTQwMDhhNjc0MzIzNDFjOTA2ZWM4XzYz_fdd53d42-d688-4eaf-abe0-79a9268903f1"
      unitRef="usd">899000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNi0wLTEtMS0yODYyMS90ZXh0cmVnaW9uOmFhZGYzZWMwOTA1OTQwMDhhNjc0MzIzNDFjOTA2ZWM4Xzcw_5f116bbf-0ae9-403e-9736-93758afafe11"
      unitRef="usd">1598000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNi0xLTEtMS0yODYyMQ_448407a4-dfd2-497a-bd45-23c74d5f6d35"
      unitRef="usd">31449000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNi0zLTEtMS0yODYyMQ_3f7c8261-4056-47c0-9651-cef2faf6ae59"
      unitRef="usd">21962000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNy0xLTEtMS0yODYyMQ_f0f5eb82-4856-4cd6-8265-adf4f549382f"
      unitRef="usd">39503000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfNy0zLTEtMS0yODYyMQ_cf915db9-27e4-42ff-a495-82ea5733b161"
      unitRef="usd">28508000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfOC0xLTEtMS0yODYyMQ_3bc1a832-c822-48ce-ba4a-1a46c1c6877c"
      unitRef="usd">14545000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfOC0zLTEtMS0yODYyMQ_bece210a-59eb-4841-a577-d713df587712"
      unitRef="usd">8779000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfOS0xLTEtMS0yODYyMQ_ff8de0c5-f7a1-4aff-92c3-b33e18b2d3fe"
      unitRef="usd">249661000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfOS0zLTEtMS0yODYyMQ_826258dd-4b73-4b27-b0c8-698f96f1bd67"
      unitRef="usd">106296000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTAtMS0xLTEtMjg2MjE_14401383-e111-4618-8120-c2e129d839fa"
      unitRef="usd">3019000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTAtMy0xLTEtMjg2MjE_baf04dc1-d3a3-4329-a38a-c5d2c48a8263"
      unitRef="usd">2299000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTEtMS0xLTEtMjg2MjE_e7e6f9f6-e5bd-49b5-b3fe-2d4e380e2b6e"
      unitRef="usd">778000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTEtMy0xLTEtMjg2MjE_173fc580-1193-4316-8d1a-3a0fbf38b3b3"
      unitRef="usd">643000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTItMS0xLTEtMjg2MjE_afdc85a0-9f89-4405-93a0-bf32d44db7cb"
      unitRef="usd">14627000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTItMy0xLTEtMjg2MjE_d75fa147-d62a-4afc-86a0-e8b0e263a254"
      unitRef="usd">17076000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTMtMS0xLTEtMjg2MjE_9386d898-6a6a-4ba7-8f95-e35708bf6534"
      unitRef="usd">1339000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTMtMy0xLTEtMjg2MjE_04e37753-c5ec-43f2-ad0c-e99d24e3c155"
      unitRef="usd">1339000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTQtMS0xLTEtMjg2MjE_5f504ded-15db-461d-8c62-8bfbf0b1279c"
      unitRef="usd">10169000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTQtMy0xLTEtMjg2MjE_14330cd5-efcc-4861-ac42-2c22dc15e887"
      unitRef="usd">5080000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTQtMS0xLTEtNDY3NzM_add9b43e-3704-4b25-a4aa-93fd074afef2"
      unitRef="usd">700000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTQtMy0xLTEtNDY3NzM_17a42276-fe01-4894-b0d4-96bdec9b349d"
      unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:Assets
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTUtMS0xLTEtMjg2MjE_278258de-ea94-427a-b78a-f2a58b9bf7ea"
      unitRef="usd">280293000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTUtMy0xLTEtMjg2MjE_72412393-4c22-4e31-ae65-d5775a302975"
      unitRef="usd">132733000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTgtMS0xLTEtMjg2MjE_ead127d3-17e6-433e-9ae5-7dd3198e9297"
      unitRef="usd">7891000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTgtMy0xLTEtMjg2MjE_8b17f90b-556a-4083-b35c-c0f0918ab087"
      unitRef="usd">6684000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTktMS0xLTEtMjg2MjE_bfdfa6ad-b1d9-4c48-8436-5e4c37af7061"
      unitRef="usd">54100000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMTktMy0xLTEtMjg2MjE_bd6920b7-f521-4ff9-8c8f-363c48cc885f"
      unitRef="usd">32295000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjAtMS0xLTEtMjg2MjE_c950f17c-6bc4-45d7-8ec0-1bfa630f60e9"
      unitRef="usd">2419000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjAtMy0xLTEtMjg2MjE_f1e6c8df-99b6-40e9-9343-8823c371fa7c"
      unitRef="usd">2260000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjEtMS0xLTEtMjg2MjE_3c0d7475-a93f-48b1-aec3-d666ae3975dc"
      unitRef="usd">0</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjEtMy0xLTEtMjg2MjE_b5c31d09-48fb-4a67-8e5a-091fb67e77e5"
      unitRef="usd">3630000</us-gaap:NotesPayableCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjMtMS0xLTEtMjg2MjE_b8c751cc-f6f5-4374-8c08-cf9ab673eaeb"
      unitRef="usd">9490000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjMtMy0xLTEtMjg2MjE_3c39bddd-5b88-4c05-b9d9-a748349ee302"
      unitRef="usd">9489000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjQtMS0xLTEtMjg2MjE_cab1ebc2-d316-4ca9-bc0c-e45574910f27"
      unitRef="usd">73900000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjQtMy0xLTEtMjg2MjE_43ba9c5c-c079-4ac2-9c12-bc21105329a0"
      unitRef="usd">54358000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjUtMS0xLTEtMjg2MjE_476eb636-f2a5-4f7c-8a09-51431000a0ef"
      unitRef="usd">1335000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjUtMy0xLTEtMjg2MjE_f3f4f70f-fa30-40bb-878c-1748b0aa4040"
      unitRef="usd">1748000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjctMS0xLTEtMjg2MjE_c26ba285-5228-4ce9-a11f-bd1fd744fe4c"
      unitRef="usd">13483000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjctMy0xLTEtMjg2MjE_0eda44b0-32c2-40bf-8f4d-ebf144223d97"
      unitRef="usd">15950000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjgtMS0xLTEtMjg2MjE_66351aec-704e-4145-9c1b-d38720b55472"
      unitRef="usd">0</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjgtMy0xLTEtMjg2MjE_11995aed-11d1-4038-8a24-c471eff3ab93"
      unitRef="usd">3555000</us-gaap:LongTermNotesPayable>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjctMC0xLTEtMzY4NTMvdGV4dHJlZ2lvbjoxNDIyZjFlMTMyZWY0NzhkOGExY2JmYjhhZjc5Njg4N18yNzQ4Nzc5MDY5NTE1_81d61143-8138-4400-b0e9-3dd266b96bf3"
      unitRef="usd">4007000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjctMS0xLTEtMzY5NzM_452b95cc-6ab6-4471-83e3-d57f4d63c557"
      unitRef="usd">134243000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjctMy0xLTEtMzY4NDI_49e7214b-c6d4-49d4-a42c-623dbd5742cc"
      unitRef="usd">0</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjktMS0xLTEtMjg2MjE_205ec28f-03df-417f-ab45-a9f2b0394e6c"
      unitRef="usd">763000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMjktMy0xLTEtMjg2MjE_b54a054e-edf3-4adf-8f41-d380ba475c59"
      unitRef="usd">242000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzAtMS0xLTEtMjg2MjE_b32b3756-edab-4e0e-ab1e-a66af6db4804"
      unitRef="usd">223724000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzAtMy0xLTEtMjg2MjE_5fcd939d-6317-4fee-b445-489af04e1567"
      unitRef="usd">75853000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzEtMS0xLTEtMjg2MjE_00b7d2a2-4270-4825-98c4-055e82dcea52"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzEtMy0xLTEtMjg2MjE_f4f1f702-bbb7-413f-9062-5a877cfb2b57"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF8xOA_22cd485c-a056-4b65-ae74-516b77a660f0"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF8xOA_804fd363-3039-49ae-adfd-90fa26dc74be"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF80NA_4718ad5b-45b3-44e4-b443-94e7d1a86314"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF80NA_f5e59d7b-0cc7-4408-b064-a24c3c03fda7"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF83OQ_8a7c77b9-951b-445d-9811-909d3aefd2ed"
      unitRef="shares">17995344</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF83OQ_e4346be6-70bd-45bc-884a-5f31fc3b4b3d"
      unitRef="shares">17995344</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF84Ng_1daca060-ecb9-4de1-b0a6-9291976b4c27"
      unitRef="shares">17679232</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMC0xLTEtMjg2MjEvdGV4dHJlZ2lvbjo0ODMwNjQ1YmMxYTY0MDgxYWMxZmU5YzM2MDBmODFiZF84Ng_1ef62906-be89-4b3f-93eb-d71b0725cabe"
      unitRef="shares">17679232</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMS0xLTEtMjg2MjE_4e3d227c-afe0-4b57-b6dd-0e332023516c"
      unitRef="usd">18000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzMtMy0xLTEtMjg2MjE_4935164f-2bd8-469d-b2cd-e638c7171761"
      unitRef="usd">18000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzQtMS0xLTEtMjg2MjE_35e3300e-3abe-4506-9d3e-a6b53612d9c1"
      unitRef="usd">114724000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzQtMy0xLTEtMjg2MjE_15c0d8d9-024f-4bbe-9cb6-5ecc98c9d81f"
      unitRef="usd">117097000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzUtMS0xLTEtMjg2MjE_65ec5b07-8674-45f5-9350-7d501fd473e5"
      unitRef="usd">-58173000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzUtMy0xLTEtMjg2MjE_088aa345-d923-420e-a2da-a31f89d9e23a"
      unitRef="usd">-60235000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzctMS0xLTEtMjg2MjE_449e382d-d661-449e-952f-f20cf2d282cf"
      unitRef="usd">56569000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzctMy0xLTEtMjg2MjE_221ff7cb-3e52-4ed2-839b-9a6db1e213ba"
      unitRef="usd">56880000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzgtMS0xLTEtMjg2MjE_5bda8143-1ab6-4f53-ab84-a1d9482534f1"
      unitRef="usd">280293000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl83OS9mcmFnOmEyMzgwOWU0YWQ3YTRhZTg5NmFjZTBkZDg1YTExMmI2L3RhYmxlOjU5YzA3Y2UyZWI0ZTQxMWZiMzRlNDFkMDMyZTQ4NGEzL3RhYmxlcmFuZ2U6NTljMDdjZTJlYjRlNDExZmIzNGU0MWQwMzJlNDg0YTNfMzgtMy0xLTEtMjg2MjE_e8e7ed7b-c1da-40d2-83c7-47b5625794e1"
      unitRef="usd">132733000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i099f3e3620924202a8039a0d27597652_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMy0xLTEtMS0yODYyMQ_08042f34-9dc9-4546-afca-24a69576f3d0"
      unitRef="usd">205703000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1b500e632e0846a6a33e6a7ac55f88ad_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMy0zLTEtMS0yODYyMQ_85d7d360-8d6c-4df0-9366-b482a9e9f8b2"
      unitRef="usd">125113000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7098bcdf6ed0484fab59d24d26f26f8b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMy01LTEtMS0yODYyMQ_ce8aea85-fc2c-4cab-aeda-9f8d8b0b84fc"
      unitRef="usd">158638000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i58319883bced4affb153fc42b9f6a7ab_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNC0xLTEtMS0yODYyMQ_6a0ca0a8-0617-46ca-8dcc-8d2c26f62e44"
      unitRef="usd">25567000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3a72612f34ee4319a9bb7d59ecf28bee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNC0zLTEtMS0yODYyMQ_2b41cd33-5217-48da-8531-a000d09dd11d"
      unitRef="usd">22570000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia4cf1c8552b845c08ebb68573b2cdd62_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNC01LTEtMS0yODYyMQ_1ee5e9af-f54d-4c9f-9d00-ef40e2de0117"
      unitRef="usd">23074000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNS0xLTEtMS0yODYyMQ_840ed111-e498-4f84-8d28-5eb8a47a0cd1"
      unitRef="usd">231270000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNS0zLTEtMS0yODYyMQ_d572f8ce-a4d6-4e64-aafa-7b4c4e230b18"
      unitRef="usd">147683000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNS01LTEtMS0yODYyMQ_385fc24e-6f10-494e-bec7-06d3ae653cf7"
      unitRef="usd">181712000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i099f3e3620924202a8039a0d27597652_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNy0xLTEtMS0yODYyMQ_96544847-f776-45c1-9196-651810f76b93"
      unitRef="usd">83048000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i1b500e632e0846a6a33e6a7ac55f88ad_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNy0zLTEtMS0yODYyMQ_10ebc45b-78d1-490d-8c06-298b2ec64d9d"
      unitRef="usd">58325000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i7098bcdf6ed0484fab59d24d26f26f8b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfNy01LTEtMS0yODYyMQ_9a2ab23c-e872-4ff6-9d4c-4b987ce138ae"
      unitRef="usd">64693000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i58319883bced4affb153fc42b9f6a7ab_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfOC0xLTEtMS0yODYyMQ_d5b40f87-04fc-440a-9944-a07a2a52c50f"
      unitRef="usd">15117000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3a72612f34ee4319a9bb7d59ecf28bee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfOC0zLTEtMS0yODYyMQ_083abd23-0761-4b82-abcc-e1977224d8de"
      unitRef="usd">13586000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia4cf1c8552b845c08ebb68573b2cdd62_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfOC01LTEtMS0yODYyMQ_d9c9ddd2-95f2-4f5b-a18a-209d857349ff"
      unitRef="usd">18856000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfOS0xLTEtMS0yODYyMQ_db62b47c-58bf-4c1f-9242-28793d71e837"
      unitRef="usd">98165000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfOS0zLTEtMS0yODYyMQ_385c6224-e60e-4ce3-85c0-8cb085c65ac6"
      unitRef="usd">71911000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfOS01LTEtMS0yODYyMQ_f757f9db-6b3d-4304-b324-3285fbb5726a"
      unitRef="usd">83549000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTAtMS0xLTEtMjg2MjE_7d3e6d76-679e-46a3-907b-6d5c8072de36"
      unitRef="usd">133105000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTAtMy0xLTEtMjg2MjE_6bb6e59b-2db1-4e8a-9e9c-9fae469a5784"
      unitRef="usd">75772000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTAtNS0xLTEtMjg2MjE_a9263a92-379f-45e7-bb34-3709d2a5a658"
      unitRef="usd">98163000</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTItMS0xLTEtMjg2MjE_07b4e66c-29c4-40c7-98d0-0bed10366347"
      unitRef="usd">76762000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTItMy0xLTEtMjg2MjE_212291c9-46d0-4a0d-93fd-b2ff81ea199b"
      unitRef="usd">52766000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTItNS0xLTEtMjg2MjE_19d1bb3d-a633-4ae4-8b45-43e9df510e5e"
      unitRef="usd">71109000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTMtMS0xLTEtMjg2MjE_02381f87-977c-458b-adad-51169d446e8b"
      unitRef="usd">21568000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTMtMy0xLTEtMjg2MjE_f8ff5abc-7314-42e6-857f-912b6f895667"
      unitRef="usd">14322000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTMtNS0xLTEtMjg2MjE_5a2ccdbb-5f0e-47b0-8369-5e814d4e5fd1"
      unitRef="usd">15085000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTQtMS0xLTEtMjg2MjE_3a41af5f-726a-4174-82c3-0ca868faa65d"
      unitRef="usd">32945000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTQtMy0xLTEtMjg2MjE_6997332f-28f0-4c0e-ba65-039c87bb5970"
      unitRef="usd">31512000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTQtNS0xLTEtMjg2MjE_afd7c899-3d0d-4501-9a25-c3dab5163957"
      unitRef="usd">24033000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTUtMS0xLTEtMjg2MjE_fa989e34-5259-4933-ba05-6ef7ae51977a"
      unitRef="usd">131275000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTUtMy0xLTEtMjg2MjE_571b01ce-bc37-4633-91ee-c5d7bff72d25"
      unitRef="usd">98600000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTUtNS0xLTEtMjg2MjE_565ad919-c5b2-49f7-826c-06e09bc64413"
      unitRef="usd">110227000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTYtMS0xLTEtMjg2MjE_1f95565c-5b2f-4a01-810e-12c4f2ff6141"
      unitRef="usd">1830000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTYtMy0xLTEtMjg2MjE_90035f00-258d-4ff0-9e74-3acd053600ec"
      unitRef="usd">-22828000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTYtNS0xLTEtMjg2MjE_f9428c50-fc71-482c-b498-ea61fe1148b0"
      unitRef="usd">-12064000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTgtMS0xLTEtMzY5OTY_7fb451a0-1009-4fe4-ac7f-b54873b97994"
      unitRef="usd">710000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTgtMy0xLTEtMzE4NDc_df21f0d2-184a-455f-a101-40ccbca32bb4"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTgtNS0xLTEtMzE4NDc_57a7f61f-b6f7-4fe9-8a02-cc9e12c0b651"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseDebt
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTktMS0xLTEtMzY5OTY_3240bb7f-015c-4de9-a272-801a2215f725"
      unitRef="usd">2514000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTktMy0xLTEtMzE4NDc_51749c28-8cbc-42cf-a8b7-572c049be0fd"
      unitRef="usd">0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTktNS0xLTEtMzE4NDc_ba4b876e-8520-4df6-865c-23176fd746db"
      unitRef="usd">0</us-gaap:InterestExpenseDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjAtMS0xLTEtMzE4Njk_bc22154e-6ea8-41ff-9d8b-188833bc83ac"
      unitRef="usd">7185000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjAtMy0xLTEtMzE4NDc_5be4cb4c-6e4c-4bdb-9bd7-1f3774f0a94e"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjAtNS0xLTEtMzE4NDc_c0e5bcae-fcb1-4a50-bd2b-4aca584e7fcc"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjEtMS0xLTEtMzY5OTY_b26c7db3-1a0c-4597-9553-100d897de10f"
      unitRef="usd">-2406000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjEtMy0xLTEtMzE4NDc_670c0320-ac56-4fa5-9b46-6493e480d2e1"
      unitRef="usd">-579000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjEtNS0xLTEtMzE4NDc_bf6521b0-5a5a-4437-8212-935f8d002a12"
      unitRef="usd">-199000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjItMS0xLTEtMzE4NDc_753bf412-c600-465f-a221-4c8dea56dfa8"
      unitRef="usd">1555000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjItMy0xLTEtMzE4NDc_c1191dee-8840-4005-a364-13e65f67292d"
      unitRef="usd">-579000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjItNS0xLTEtMzE4NDc_95cab700-ab69-4107-9da2-5706d34676d9"
      unitRef="usd">-199000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTgtMS0xLTEtMjg2MjE_8d0b3ebf-371c-4183-a466-36e4da4ea70a"
      unitRef="usd">3385000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTgtMy0xLTEtMjg2MjE_ca438835-70cd-4398-86b9-0b113a435146"
      unitRef="usd">-23407000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTgtNS0xLTEtMjg2MjE_f03ab98c-131d-4322-a2a1-89faa8a7cc3b"
      unitRef="usd">-12263000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTktMS0xLTEtMjg2MjE_b6c32f35-4c37-445b-bddc-06a8c01cfab0"
      unitRef="usd">1323000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTktMy0xLTEtMjg2MjE_c4731f9c-d82b-472c-8cea-aece67805ff0"
      unitRef="usd">470000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMTktNS0xLTEtMjg2MjE_a479878c-5e76-4d4c-83c2-8597a998e7b7"
      unitRef="usd">85000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjAtMS0xLTEtMjg2MjE_1155ad00-3c2b-4b62-bb76-0ca38f6c3993"
      unitRef="usd">2062000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjAtMy0xLTEtMjg2MjE_63296fe9-bf4e-4a42-815f-ce537b4670f3"
      unitRef="usd">-23877000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjAtNS0xLTEtMjg2MjE_efe3ac29-2e73-4f7c-ba0b-604b70d9a5e4"
      unitRef="usd">-12348000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjMtMS0xLTEtMjg2MjE_4ea73a5a-d458-4ee7-82ca-f538031902d6"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjMtMy0xLTEtMjg2MjE_2c3f1a05-a90a-4225-b366-12fb27df1adf"
      unitRef="usdPerShare">-1.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjMtNS0xLTEtMjg2MjE_1d9ebdd1-d23e-4d00-a3f4-111d04da4c46"
      unitRef="usdPerShare">-0.88</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjQtMS0xLTEtMjk2Nzk_d47ba123-7cdc-4f0b-b198-3963b3668d3d"
      unitRef="usdPerShare">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjQtMy0xLTEtMjk2NjE_a9f89839-209d-44c3-a464-c0ffff15d0d6"
      unitRef="usdPerShare">-1.43</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjQtNS0xLTEtMjk2NjE_0cbcfb6b-dfb6-4c66-bb21-f569e246fcdc"
      unitRef="usdPerShare">-0.88</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjUtMS0xLTEtMjg2MjE_fb7fe9fc-7935-4ab6-86a4-777335eb0666"
      unitRef="shares">17891000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjUtMy0xLTEtMjg2MjE_3798b6a8-5408-44ac-bbbb-5c2c92fee6ec"
      unitRef="shares">16691000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjUtNS0xLTEtMjg2MjE_d6d3cf4d-e826-4ac8-9d30-06de6b56d557"
      unitRef="shares">14096000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjgtMS0xLTEtMjk2Nzk_75304f36-df0f-40eb-981d-e4062056f93f"
      unitRef="shares">18362000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjgtMy0xLTEtMjk2NjE_e724d677-31bc-4a0a-be61-d4f4551997a3"
      unitRef="shares">16691000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84NS9mcmFnOjgwM2UzZDI5MGY2NzQ1YjJiZTAwY2EzZGQ5NTFmYmU4L3RhYmxlOjFjOTY5NWU2YjNhZDQ0MTJhNzQ1MjEzZjBiNGQ0M2E1L3RhYmxlcmFuZ2U6MWM5Njk1ZTZiM2FkNDQxMmE3NDUyMTNmMGI0ZDQzYTVfMjgtNS0xLTEtMjk2NjE_7a401988-c42e-4887-847e-820de18d9a46"
      unitRef="shares">14096000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfMi0xLTEtMS0yODYyMQ_c28df3fa-d49b-41bc-bff0-c90d8da7fb78"
      unitRef="usd">2062000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfMi0zLTEtMS0yODYyMQ_d613ebf9-02e5-45d2-af40-d7f1db7cab74"
      unitRef="usd">-23877000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfMi01LTEtMS0yODYyMQ_5f1f521f-4355-4972-86f1-f50d984e11be"
      unitRef="usd">-12348000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNS0xLTEtMS0yODYyMQ_252d347e-9639-4369-a267-371b3a2f3dff"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNS0zLTEtMS0yODYyMQ_edc497b8-38a6-4039-89e2-109681b1ce5a"
      unitRef="usd">-3000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNS01LTEtMS0yODYyMQ_f319cf84-d07b-43cb-950e-3488cc9af041"
      unitRef="usd">9000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNi0xLTEtMS0yODYyMQ_4d82d17e-e03f-4c38-aa40-47d29b2b0a98"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNi0zLTEtMS0yODYyMQ_03c36499-3eba-4efc-87f7-91cd0c6b4601"
      unitRef="usd">-63000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNi01LTEtMS0yODYyMQ_1f7cfccb-b4f7-4d8a-a403-a893cd727732"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNy0xLTEtMS0yODYyMQ_915d85b0-0b0b-46c2-9074-edf0e92360c1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNy0zLTEtMS0yODYyMQ_24a5da0f-bd9e-497c-9cd3-1bc0bcd149f8"
      unitRef="usd">60000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfNy01LTEtMS0yODYyMQ_feb5a4a4-0807-4a5c-bfaf-9150cd530354"
      unitRef="usd">9000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfOC0xLTEtMS0yODYyMQ_c15de2db-75b1-449b-a1a2-b4cc6d6bf4f5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfOC0zLTEtMS0yODYyMQ_0f063cea-ec66-4114-8469-14226dd2370c"
      unitRef="usd">60000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfOC01LTEtMS0yODYyMQ_163617f8-40f4-4761-99af-3dea6e50852d"
      unitRef="usd">9000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfOS0xLTEtMS0yODYyMQ_e342bc5a-b3ec-4e36-8e88-e59c6ed82754"
      unitRef="usd">2062000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfOS0zLTEtMS0yODYyMQ_094d2425-5974-423c-87ae-1d01c07b642a"
      unitRef="usd">-23817000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl84OC9mcmFnOjQ0ZDY3N2VhMTVmYzQ4MmM4OGFmOWE5YmJkNDBkMzRhL3RhYmxlOjBjNWZiMmNhYjAwZDQyZmY5MGJkMDEzNjk4ZDAxZjBiL3RhYmxlcmFuZ2U6MGM1ZmIyY2FiMDBkNDJmZjkwYmQwMTM2OThkMDFmMGJfOS01LTEtMS0yODYyMQ_1bbd9837-4382-439b-ae88-b18d450e89a2"
      unitRef="usd">-12339000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1a7631525a4f45cd84f88a123b5d2213_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMi0xLTEtMS0yODYyMQ_e4e37114-1021-448a-b0c3-35f2a810c346"
      unitRef="shares">13968852</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i1a7631525a4f45cd84f88a123b5d2213_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMi0zLTEtMS0yODYyMQ_5975dcbe-a0b9-4cca-acd5-e5b9dc8a4949"
      unitRef="usd">14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if99ac849105d4a778abc890967e8354d_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMi01LTEtMS0yODYyMQ_c05a3278-f1dc-4e56-9863-ac9b9be90a09"
      unitRef="usd">70451000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if092c9ece84f49e7896488564096ae3e_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMi03LTEtMS0yODYyMQ_33023857-de5f-4fbc-a5be-cf1ee5742c2e"
      unitRef="usd">-24010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6093d26609ac4a2082bc74145688a81e_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMi05LTEtMS0yODYyMQ_a0e34550-50fb-4e8c-962c-4f5851c339ce"
      unitRef="usd">-69000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMi0xMS0xLTEtMjg2MjE_a4f34fec-b632-4223-b5da-6c0491d5145d"
      unitRef="usd">46386000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i8ef35ea9019a46839254540bd96f8f38_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNS0xLTEtMS0yODYyMQ_aaac922a-3adc-455a-9d01-5c3ee2ac4bde"
      unitRef="shares">82810</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i37fa040d9517485c9e505b0a87f68f29_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNS01LTEtMS0yODYyMQ_da1b95a7-08f3-424c-8592-ef1fbb49beb9"
      unitRef="usd">1281000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNS0xMS0xLTEtMjg2MjE_99ae49d3-e355-45c0-83e7-34410aa11025"
      unitRef="usd">1281000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i8ef35ea9019a46839254540bd96f8f38_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNi0xLTEtMS0yODYyMQ_8a6fc6a2-737c-4c06-9425-dd9eff824464"
      unitRef="shares">160798</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i37fa040d9517485c9e505b0a87f68f29_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNi01LTEtMS0yODYyMQ_8a7a7af9-5545-46a4-8ce9-259f290050b6"
      unitRef="usd">1613000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNi0xMS0xLTEtMjg2MjE_20dd2662-5d46-43f3-b906-076aa40b1624"
      unitRef="usd">1613000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i8ef35ea9019a46839254540bd96f8f38_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNy0xLTEtMS0yODYyMQ_264d58c5-acce-475c-9f15-5ecf6b727dba"
      unitRef="shares">103126</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i37fa040d9517485c9e505b0a87f68f29_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNy01LTEtMS0yODYyMQ_6620d7c0-5f38-4ff4-b042-7bf0bdd77348"
      unitRef="usd">-831000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfNy0xMS0xLTEtMjg2MjE_b94f8c06-6190-4551-bd3f-edd0e6261625"
      unitRef="usd">-831000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i37fa040d9517485c9e505b0a87f68f29_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfOC01LTEtMS0yODYyMQ_bdb9a598-bdda-44b4-9d45-1ac96ac451cc"
      unitRef="usd">9832000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfOC0xMS0xLTEtMjg2MjE_f01628f5-939f-4a83-bf71-752bde025b5e"
      unitRef="usd">9832000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="iee23395883004f20bda4e3cba945dd71_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfOS03LTEtMS0yODYyMQ_0456ccd6-9ef4-4f53-8b68-2942cfe0bca4"
      unitRef="usd">-12348000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfOS0xMS0xLTEtMjg2MjE_840f5b9a-b642-4482-b761-6470ff691733"
      unitRef="usd">-12348000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i63061c421e784fa784a49973a94456b2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTAtOS0xLTEtMjg2MjE_f0c98c8b-511d-444f-b282-8f03c64b1056"
      unitRef="usd">9000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTAtMTEtMS0xLTI4NjIx_a9384239-d8bd-44cd-9093-29f345591248"
      unitRef="usd">9000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i50e9b99ce0334c7d9a579aa4a855f45e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTEtMS0xLTEtMjg2MjE_6ab50748-b6de-414a-bb2d-f8e81917b092"
      unitRef="shares">14315586</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i50e9b99ce0334c7d9a579aa4a855f45e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTEtMy0xLTEtMjg2MjE_3cfecccc-aade-4add-a8ca-f801d4517b69"
      unitRef="usd">14000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5b37d87a7edd4cbba072cd040d20302b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTEtNS0xLTEtMjg2MjE_66135f08-d62c-4713-bce6-6b3efc2628ac"
      unitRef="usd">82346000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icee9c162557a4530b5abeb514f96a6c5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTEtNy0xLTEtMjg2MjE_ab36fcbb-24d5-4bc5-83d6-186156b78ddd"
      unitRef="usd">-36358000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i84dc3075f0c942e99a266d7512c300d6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTEtOS0xLTEtMjg2MjE_3dd035f5-7b6e-4635-8b49-862e8c2c89c2"
      unitRef="usd">-60000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTEtMTEtMS0xLTI4NjIx_756717a2-8110-49ed-9e3f-9697db29b35c"
      unitRef="usd">45942000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTMtMS0xLTEtMjg2MjE_7f7637f4-c6fb-4fb8-b6b8-4f90dca081f8"
      unitRef="shares">56751</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i4131053e935748729079966449ab7c37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTMtNS0xLTEtMjg2MjE_21c5b15f-ce05-4fe7-8e36-cd4bd6e2ffde"
      unitRef="usd">632000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTMtMTEtMS0xLTI4NjIx_8b7a13ab-77af-4a4c-83f1-028aa79ea7b0"
      unitRef="usd">632000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTQtMS0xLTEtMjg2MjE_6b0b0c98-bbdc-43bb-824f-0f163693583c"
      unitRef="shares">73227</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4131053e935748729079966449ab7c37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTQtNS0xLTEtMjg2MjE_723fe72f-4a16-4916-8e50-a3d4688ee5d2"
      unitRef="usd">947000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTQtMTEtMS0xLTI4NjIx_17a75f76-3a8c-44bb-b004-d3d68cb90762"
      unitRef="usd">947000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTMtMC0xLTEtMzgwMzUvdGV4dHJlZ2lvbjo2OGI0OTYwNGZlNzA0NjhmYWQxZjAxZWFlMmY3ZjE4OV8xMDk5NTExNjI3ODc4_19cd12ac-ca4f-478f-a190-6b050ea3b091"
      unitRef="usd">2303000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTUtMS0xLTEtMjg2MjE_289ed398-4aa8-4652-ba27-d2573624e52b"
      unitRef="shares">2742750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTUtMy0xLTEtMjg2MjE_b1ad4619-b9b9-4645-9b20-2852238bb034"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i4131053e935748729079966449ab7c37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTUtNS0xLTEtMjg2MjE_af3e1426-cb2e-4806-95f7-425f5b951c03"
      unitRef="usd">26492000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTUtMTEtMS0xLTI4NjIx_2daa49de-e73b-43bd-8fb6-8f8f8792277a"
      unitRef="usd">26495000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTYtMS0xLTEtMjg2MjE_c9446dff-2980-4534-84ab-8009d6d91050"
      unitRef="shares">490918</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTYtMy0xLTEtMjg2MjE_e91f4d35-d6e2-4015-8033-1dbeba8c61f6"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i4131053e935748729079966449ab7c37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTYtNS0xLTEtMjg2MjE_a0ec7bf2-af10-460d-802a-d3c4b1cdc832"
      unitRef="usd">-3429000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTYtMTEtMS0xLTI4NjIx_a245d527-dab7-4555-b809-91e3fececca2"
      unitRef="usd">-3428000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4131053e935748729079966449ab7c37_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTctNS0xLTEtMjg2MjE_6f66e20f-4c45-4f04-931d-5c6d9633386d"
      unitRef="usd">10109000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTctMTEtMS0xLTI4NjIx_9bbbaf77-68b0-482c-999f-d02617897f09"
      unitRef="usd">10109000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i960574069b78413a924873ab23554fb4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTgtNy0xLTEtMjg2MjE_6af6e8a7-52d6-43dd-a7d5-7d0bd0881a74"
      unitRef="usd">-23877000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTgtMTEtMS0xLTI4NjIx_77878135-6ff0-4b08-a8e1-80b46ee6f2cf"
      unitRef="usd">-23877000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibcae67fe77484d66aac559d41cdd4a97_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTktOS0xLTEtMjg2MjE_5cf914bd-7649-4d1c-80bb-849260c807fa"
      unitRef="usd">60000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMTktMTEtMS0xLTI4NjIx_0395c168-6854-43fe-b416-1ba6aceb0ebf"
      unitRef="usd">60000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib8720e5d165746398e865e8ff2bf37ba_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjAtMS0xLTEtMjg2MjE_d98c70ea-ce78-4935-9212-bb535e256f61"
      unitRef="shares">17679232</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib8720e5d165746398e865e8ff2bf37ba_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjAtMy0xLTEtMjg2MjE_3a9138f0-fe91-415c-a960-ad3feb7bcc20"
      unitRef="usd">18000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i196713f133464fccbcbe95ca1be37452_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjAtNS0xLTEtMjg2MjE_af62a7ff-195a-4592-be1f-253662dedc0a"
      unitRef="usd">117097000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i04a8f1192895498a8fbd198d78451ecd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjAtNy0xLTEtMjg2MjE_f1886d27-44d7-4b47-8ec6-49115d7ceb02"
      unitRef="usd">-60235000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i952540da797a438c883313a189c55038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjAtOS0xLTEtMjg2MjE_07ad34cf-0e0a-4eae-99e0-05ad14140f58"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjAtMTEtMS0xLTI4NjIx_9944a9ec-3de4-403e-b8df-99604d8b44c2"
      unitRef="usd">56880000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ie8344555ed6a476481db2825ccec753c_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjItMS0xLTEtMjg2MjE_81d86cef-40d8-40e8-824a-fc6dfdbf6d32"
      unitRef="shares">59635</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i90ee30efe67b4fb49e2d5f54e0fafe89_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjItNS0xLTEtMjg2MjE_b5ff24fe-cefc-43dd-9798-91bcbed43b5a"
      unitRef="usd">1184000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjItMTEtMS0xLTI4NjIx_a6ec1fb6-bd1b-49fb-8535-dfb5b273832b"
      unitRef="usd">1184000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ie8344555ed6a476481db2825ccec753c_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjMtMS0xLTEtMjg2MjE_ae279fa6-1c09-4b64-8780-ce9557c7decf"
      unitRef="shares">71798</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i90ee30efe67b4fb49e2d5f54e0fafe89_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjMtNS0xLTEtMjg2MjE_2c0931b3-617b-4f21-9aff-ca9281f67e19"
      unitRef="usd">1581000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjMtMTEtMS0xLTI4NjIx_d474c18e-2df3-46d5-87cc-4b4a10d5cb98"
      unitRef="usd">1581000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cutr:PurchaseOfCappedCall
      contextRef="i90ee30efe67b4fb49e2d5f54e0fafe89_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjItNS0xLTEtNDA2MzI_8ee9d783-26cb-4b01-8920-f2079ff334e6"
      unitRef="usd">-16134000</cutr:PurchaseOfCappedCall>
    <cutr:PurchaseOfCappedCall
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjItMTEtMS0xLTQwNjMy_25919aea-722c-42a0-a967-1068b7be3a81"
      unitRef="usd">-16134000</cutr:PurchaseOfCappedCall>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ie8344555ed6a476481db2825ccec753c_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjQtMS0xLTEtMjg2MjE_c0ef8908-c866-4f97-ada2-d90a1b80a0bd"
      unitRef="shares">184679</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i90ee30efe67b4fb49e2d5f54e0fafe89_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjQtNS0xLTEtMjg2MjE_50106b84-ce5b-4c3b-8d0e-295c89d604cd"
      unitRef="usd">-2176000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjQtMTEtMS0xLTI4NjIx_78e0675e-a884-4de2-93d6-d21f946efe7f"
      unitRef="usd">-2176000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i90ee30efe67b4fb49e2d5f54e0fafe89_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjUtNS0xLTEtMjg2MjE_9c8dc0ff-7321-4bf5-b529-892b7ba2b562"
      unitRef="usd">13172000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjUtMTEtMS0xLTI4NjIx_1dc68cee-72b8-4514-89cf-83c5283643ac"
      unitRef="usd">13172000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i6f16a2afdae64f2daab7448314a752d3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjQtNy0xLTEtMjkzOTc_18728d97-335b-4044-a885-2a509d011b59"
      unitRef="usd">2062000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjQtMTEtMS0xLTI5Mzk3_d63d0e71-eb00-4a60-8246-769ccbdb9f3f"
      unitRef="usd">2062000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i19a4ef1cc484429daba4d25230ec7aad_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjYtMS0xLTEtMjkzOTc_0d41139e-5e4e-4307-ac16-a01d4bf76a97"
      unitRef="shares">17995344</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i19a4ef1cc484429daba4d25230ec7aad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjYtMy0xLTEtMjkzOTc_f372ea9d-dbe1-49a8-8a4b-9aac9f8f4166"
      unitRef="usd">18000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id52c81a523b740df9a58c7f26a6f5f9f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjYtNS0xLTEtMjkzOTc_56a3a2f4-dda1-423b-9d1f-5e405e58a79f"
      unitRef="usd">114724000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5865f24ced8c4abe92e8e3142a113547_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjYtNy0xLTEtMjkzOTc_d6974d6c-2b42-4fa8-a30b-add49365fd49"
      unitRef="usd">-58173000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idcc9ffcaa06a4dbd9843701a556e4a0a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjYtOS0xLTEtMjkzOTc_f32777ab-2065-4ae0-82c5-e37d3baf9a3a"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85MS9mcmFnOjM1ZGQ5MTdjMDQxNTQ2Yzg5MGUwYmNkMzE3ODczZDc5L3RhYmxlOjU0OTJhYWUyNWU0ZTQxZTdiMDRhMGVlYjk3M2I4ZDA4L3RhYmxlcmFuZ2U6NTQ5MmFhZTI1ZTRlNDFlN2IwNGEwZWViOTczYjhkMDhfMjYtMTEtMS0xLTI5Mzk3_93142d88-fd84-4087-88ec-4f62cc1d2f6f"
      unitRef="usd">56569000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMy0xLTEtMS0yODYyMQ_0c65012f-bbf4-40d7-bebc-cc849eeaa6dc"
      unitRef="usd">2062000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMy0zLTEtMS0yODYyMQ_ae990a8d-315b-453a-99d4-b5eb62646c9d"
      unitRef="usd">-23877000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMy01LTEtMS0yODYyMQ_fd66c5fe-b7ce-449d-aa55-2f4f72889137"
      unitRef="usd">-12348000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNS0xLTEtMS0yODYyMQ_e7b78a3a-9559-4740-ab99-b80ab97105de"
      unitRef="usd">13172000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNS0zLTEtMS0yODYyMQ_81ae4ad3-8e83-4093-bc57-e29ddb49e924"
      unitRef="usd">10109000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNS01LTEtMS0yODYyMQ_7d8e6753-4ca6-4403-ace7-662c7167cf01"
      unitRef="usd">9832000</us-gaap:ShareBasedCompensation>
    <cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNi0xLTEtMS0yODYyMQ_1c108b1b-8bfd-4ba4-af9f-13fb4f52d2b3"
      unitRef="usd">1344000</cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts>
    <cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNi0zLTEtMS0yODYyMQ_6d7a0f80-65cb-47b6-9615-0c774924f103"
      unitRef="usd">1394000</cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts>
    <cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNi01LTEtMS0yODYyMQ_156e2960-beaa-469e-ae0e-cc8a5f0d462b"
      unitRef="usd">1548000</cutr:DepreciationAndAmortizationExcludingContractAcquisitionCosts>
    <us-gaap:AmortizationOfAcquisitionCosts
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNy0xLTEtMS0yODYyMQ_b8b7d71b-2b1f-465b-85b8-18fe995e3452"
      unitRef="usd">1857000</us-gaap:AmortizationOfAcquisitionCosts>
    <us-gaap:AmortizationOfAcquisitionCosts
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNy0zLTEtMS0yODYyMQ_3f8f775c-146a-4e53-9908-25799113a366"
      unitRef="usd">2593000</us-gaap:AmortizationOfAcquisitionCosts>
    <us-gaap:AmortizationOfAcquisitionCosts
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNy01LTEtMS0yODYyMQ_059e946e-457e-4d4a-8719-3edf221fd2fa"
      unitRef="usd">2915000</us-gaap:AmortizationOfAcquisitionCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOC0xLTEtMS00MDg0NQ_f0824c0c-4233-45ea-a3c0-589c3b19382d"
      unitRef="usd">710000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOC0zLTEtMS00MDg0NQ_9d9f4790-f259-47e6-9ac1-71c3bac37d62"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOC01LTEtMS00MDg0NQ_6e7f05e8-3414-4fde-8b0d-bb3b36781a8e"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:HostingArrangementServiceContractImplementationCostImpairment
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOC0xLTEtMS0yODYyMQ_1e20d622-b1b0-4632-99e3-a2f352f059f6"
      unitRef="usd">182000</us-gaap:HostingArrangementServiceContractImplementationCostImpairment>
    <us-gaap:HostingArrangementServiceContractImplementationCostImpairment
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOC0zLTEtMS0yODYyMQ_3abeb660-00d1-4d06-b2b8-f4db9170c159"
      unitRef="usd">805000</us-gaap:HostingArrangementServiceContractImplementationCostImpairment>
    <us-gaap:HostingArrangementServiceContractImplementationCostImpairment
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOC01LTEtMS0yODYyMQ_cb39d21d-d95d-4033-974d-f2650e409230"
      unitRef="usd">0</us-gaap:HostingArrangementServiceContractImplementationCostImpairment>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOS0xLTEtMS0yODYyMQ_e0a59143-2f73-469b-87e8-861659e6c457"
      unitRef="usd">135000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOS0zLTEtMS0yODYyMQ_ed1d13a0-2d05-4c00-85ee-7d8f35f7472c"
      unitRef="usd">220000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfOS01LTEtMS0yODYyMQ_b6575784-8446-4c9e-a28f-783b15839f85"
      unitRef="usd">-34000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTAtMS0xLTEtMjg2MjE_bcf164e0-b739-43a2-bc23-2d854c33fce7"
      unitRef="usd">87000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTAtMy0xLTEtMjg2MjE_d21adafa-a01a-4aae-9671-08fe4275c95b"
      unitRef="usd">2144000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTAtNS0xLTEtMjg2MjE_b85cbbf0-45a9-4d2e-8824-8339e3d0ad91"
      unitRef="usd">590000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTMtMS0xLTEtNDA5MDg_59a4a93e-1061-42ac-b0bd-fd1f21076d06"
      unitRef="usd">7185000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTMtMy0xLTEtNDA5MDg_618da727-fd7e-4899-8818-f94be9aa0757"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTMtNS0xLTEtNDA5MDg_fceedcd3-19f2-459d-bdc4-59b715010c8c"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <cutr:ChangeInRightofuseAssetAndLiabilityDueToModification
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTEtMS0xLTEtMjg2MjE_0fde1555-6e43-4905-a19a-018e4729d9ca"
      unitRef="usd">2292000</cutr:ChangeInRightofuseAssetAndLiabilityDueToModification>
    <cutr:ChangeInRightofuseAssetAndLiabilityDueToModification
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTEtMy0xLTEtMjg2MjE_bc8facf0-a3dd-438b-91dc-a974d1a6ee0d"
      unitRef="usd">2522000</cutr:ChangeInRightofuseAssetAndLiabilityDueToModification>
    <cutr:ChangeInRightofuseAssetAndLiabilityDueToModification
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTEtNS0xLTEtMjg2MjE_edc4d63c-9e06-4a43-bddd-9209ad7955c2"
      unitRef="usd">2502000</cutr:ChangeInRightofuseAssetAndLiabilityDueToModification>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTItMS0xLTEtMjg2MjE_c9949c8f-4f7b-40c5-b4ac-68911fc41665"
      unitRef="usd">1000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTItMy0xLTEtMjg2MjE_c7cc1ea7-987b-4b99-85d5-17f78e94f2a0"
      unitRef="usd">513000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTItNS0xLTEtMjg2MjE_e57c14c1-82ce-453d-b410-b444385aee99"
      unitRef="usd">-83000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTQtMS0xLTEtMjg2MjE_fe0ac880-0ed9-408f-919a-404f58819e69"
      unitRef="usd">9574000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTQtMy0xLTEtMjg2MjE_3411b86a-6094-4577-8465-378406a90626"
      unitRef="usd">2550000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTQtNS0xLTEtMjg2MjE_8985debd-8c88-4aa5-ac11-edf34de933fd"
      unitRef="usd">2509000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTUtMS0xLTEtMjg2MjE_22937964-6cfe-4e66-88b0-37b80934468d"
      unitRef="usd">10936000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTUtMy0xLTEtMjg2MjE_93cda05b-902c-49df-b953-845f229e9ab8"
      unitRef="usd">-5413000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTUtNS0xLTEtMjg2MjE_fdfd864d-2aa0-40a7-875e-b22e0c149415"
      unitRef="usd">5907000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTYtMS0xLTEtMjg2MjE_bdf0b197-8467-4724-bde4-7eed0ffee705"
      unitRef="usd">5766000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTYtMy0xLTEtMjg2MjE_e4fb4687-6ac1-4573-b6c8-8f55a6d69972"
      unitRef="usd">3164000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTYtNS0xLTEtMjg2MjE_7ecf0907-8e9e-4dba-9854-70b454495ad8"
      unitRef="usd">1762000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTctMS0xLTEtMjg2MjE_9e24d1f4-877c-4e91-ac7a-1e8b7f4093c8"
      unitRef="usd">7128000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTctMy0xLTEtMjg2MjE_a87b7394-5b95-4d27-ae8c-3a637d9aa0cb"
      unitRef="usd">2067000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTctNS0xLTEtMjg2MjE_349e0183-20c2-4c58-ab50-15f8c364c72b"
      unitRef="usd">3355000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTgtMS0xLTEtMjg2MjE_d35a6490-e4b3-467e-ba1b-93e76fb01693"
      unitRef="usd">1207000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTgtMy0xLTEtMjg2MjE_fe2fa7cf-4767-4279-89ed-7156224d7d04"
      unitRef="usd">-6034000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTgtNS0xLTEtMjg2MjE_33757a53-891c-4dea-8d2d-030b8508f4ba"
      unitRef="usd">1406000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTktMS0xLTEtMjg2MjE_2732ee2a-1ce9-423b-a1a0-51a13aa1c50e"
      unitRef="usd">21608000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTktMy0xLTEtMjg2MjE_889c7d7d-73ed-4b2a-b3fb-f619aed85ee5"
      unitRef="usd">161000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMTktNS0xLTEtMjg2MjE_92f0c47a-d1ae-410b-889a-af7d8fb1814a"
      unitRef="usd">5997000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjEtMS0xLTEtMjg2MjE_4c840caa-b35a-4acd-81da-e21410e2fec2"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjEtMy0xLTEtMjg2MjE_65456464-4536-4f48-8ac2-741547cf0892"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjEtNS0xLTEtMjg2MjE_b87d5b4f-ef50-4704-84b1-59a2d91eab9e"
      unitRef="usd">-140000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <cutr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjItMS0xLTEtMjg2MjE_e99864e5-d814-4d6c-9379-8277adaeeb16"
      unitRef="usd">-2151000</cutr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <cutr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjItMy0xLTEtMjg2MjE_4318be7b-8030-4be6-8f84-76773f6464bc"
      unitRef="usd">-1598000</cutr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <cutr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjItNS0xLTEtMjg2MjE_ae0a78eb-e52c-4f7a-94b7-07246505f6e8"
      unitRef="usd">-2292000</cutr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjMtMS0xLTEtMjg2MjE_c4d34805-fb78-4baf-82bf-f795f3303534"
      unitRef="usd">-412000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjMtMy0xLTEtMjg2MjE_69b69ae2-bab5-4b5a-8b56-1502705ab40d"
      unitRef="usd">-2985000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjMtNS0xLTEtMjg2MjE_cfbdb90a-1eee-4374-9cb2-65fa10820764"
      unitRef="usd">1656000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjQtMS0xLTEtMjg2MjE_f57dc7f0-57c9-4ad3-b02c-505f08042939"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjQtMy0xLTEtMjg2MjE_de8b9fa7-69f8-468a-bc9b-487e1fb62a92"
      unitRef="usd">-93000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjQtNS0xLTEtMjg2MjE_226e3a97-0d04-4c2e-aa7c-b1e7ef44a5d1"
      unitRef="usd">-301000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjUtMS0xLTEtMjg2MjE_1dcfd6c0-f5c1-4bbb-bf63-d042a4aacc75"
      unitRef="usd">1235000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjUtMy0xLTEtMjg2MjE_11bea1af-edae-4f2f-ab92-0aca20938daf"
      unitRef="usd">-16934000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjUtNS0xLTEtMjg2MjE_a5a67d0f-cb90-44ac-9c84-9ae38c3c2d6a"
      unitRef="usd">-2217000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjctMS0xLTEtMjg2MjE_f485567a-568c-4b0a-9d69-557f37c8e341"
      unitRef="usd">1015000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjctMy0xLTEtMjg2MjE_64c2e8a6-8df3-436e-9a19-41d935647ad0"
      unitRef="usd">1279000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjctNS0xLTEtMjg2MjE_d8edbfec-0b6d-4c20-83aa-4c070112318d"
      unitRef="usd">991000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjgtMS0xLTEtMjg2MjE_53be7048-8673-4e06-8a40-974f191f124a"
      unitRef="usd">71000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjgtMy0xLTEtMjg2MjE_c5097410-609a-4804-bcd8-496292815dc6"
      unitRef="usd">30000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjgtNS0xLTEtMjg2MjE_6344c20a-9159-4667-9062-291c4ec241fa"
      unitRef="usd">45000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjktMS0xLTEtMjg2MjE_7f572a63-a941-4a7e-a766-d3cde14ce7d9"
      unitRef="usd">0</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjktMy0xLTEtMjg2MjE_3bc560e8-e416-459f-9685-9142674fa9b2"
      unitRef="usd">5648000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMjktNS0xLTEtMjg2MjE_5aed6856-1cb2-48d3-b960-91086b32f0ab"
      unitRef="usd">0</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzAtMS0xLTEtMjg2MjE_0ba75402-6f8d-406b-8305-9d5768103904"
      unitRef="usd">0</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzAtMy0xLTEtMjg2MjE_77f5e65a-ebb6-4026-8ff8-f1917d197200"
      unitRef="usd">28050000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzAtNS0xLTEtMjg2MjE_ca23c448-4040-45ca-87a4-7953a13ea166"
      unitRef="usd">14700000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzEtMS0xLTEtMjg2MjE_e6880c97-ea6f-415c-b030-e31d42013621"
      unitRef="usd">0</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzEtMy0xLTEtMjg2MjE_a1e54086-0c71-4b62-8d08-0f8ddd28332f"
      unitRef="usd">26060000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzEtNS0xLTEtMjg2MjE_e9184072-1ca1-44ee-afa5-c338d4ee2375"
      unitRef="usd">12687000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzItMS0xLTEtMjg2MjE_f4c71c3d-f0f5-406d-9ea1-2441631e4f83"
      unitRef="usd">-944000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzItMy0xLTEtMjg2MjE_dc31af5c-1f3e-46b4-8c95-ba742d97a32e"
      unitRef="usd">6389000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzItNS0xLTEtMjg2MjE_3eb523b2-2159-4b32-ada3-8885064c90ea"
      unitRef="usd">1067000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzQtMS0xLTEtMjg2MjE_1d172f79-3a68-4132-9659-f88441bd623c"
      unitRef="usd">2765000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzQtMy0xLTEtMjg2MjE_37088614-b7cc-4e7f-8d66-6d1af8c89695"
      unitRef="usd">1579000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzQtNS0xLTEtMjg2MjE_f7757543-fd7a-45a1-89c2-09e164c672f3"
      unitRef="usd">2894000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzUtMS0xLTEtMzUwOTA_e9c2dde1-805d-4a21-92e3-14518565419f"
      unitRef="usd">16134000</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzUtMy0xLTEtMzUwOTA_db82f186-1aa6-4d2b-9541-b94b5361964f"
      unitRef="usd">0</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzUtNS0xLTEtMzUwOTA_63e4f9c7-240f-4f28-aee8-dbefa41cb337"
      unitRef="usd">0</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzUtMS0xLTEtMjg2MjE_aefbf4b4-d7bd-479d-a78f-ef6860726361"
      unitRef="usd">0</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzUtMy0xLTEtMjg2MjE_a31b2e86-45d5-40e6-821d-30c2b3b22d62"
      unitRef="usd">7167000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzUtNS0xLTEtMjg2MjE_cb6aa14c-f574-44a5-8eed-f64802392755"
      unitRef="usd">0</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzctMS0xLTEtMzUxNjI_fc753279-1280-442a-b59f-76bfec674ed5"
      unitRef="usd">138250000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzctMy0xLTEtMzUxNzc_c9599d91-9dc1-464c-915e-27e6c7b305b6"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzctNS0xLTEtMzUxODg_5a7f8613-aae8-4341-b6af-f150736592b1"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzgtMS0xLTEtMzUxNjI_142b5a77-ac91-4178-b11e-b00c7bc21e25"
      unitRef="usd">4717000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzgtMy0xLTEtMzUxNzc_eb3417ee-ee93-4bf0-b045-e768af6f1580"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzgtNS0xLTEtMzUxODg_28ef41b5-9b47-4a08-92e8-add4c01a018a"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzYtMS0xLTEtMjg2MjE_cb242aaf-e3e6-4d8d-8e6c-fb9d782a8df2"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzYtMy0xLTEtMjg2MjE_305ff98f-bb9c-44c3-91c0-bcaee42b2260"
      unitRef="usd">28798000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzYtNS0xLTEtMjg2MjE_df917015-bfc5-4aaa-a7a8-3fc5228e755c"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzctMS0xLTEtMjg2MjE_7f7b8aeb-6fd9-4879-8995-2dfdd1f43629"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzctMy0xLTEtMjg2MjE_c4366ff2-5d73-4e4b-bf92-33e0714b14d9"
      unitRef="usd">2303000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzctNS0xLTEtMjg2MjE_343893d6-6ccd-4c5e-b836-8720578476f7"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzgtMS0xLTEtMjg2MjE_4b403570-7e57-477b-91a8-b44c4811d320"
      unitRef="usd">2176000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzgtMy0xLTEtMjg2MjE_668c221e-26c2-4dff-a85e-66ba4a6c2db5"
      unitRef="usd">3428000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzgtNS0xLTEtMjg2MjE_e3c60785-5983-4d8b-a939-db4ddabb766b"
      unitRef="usd">831000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzktMS0xLTEtMjg2MjE_30b25a21-0dea-43c4-8cdb-e956f29f1efd"
      unitRef="usd">462000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzktMy0xLTEtMjg2MjE_f88cb3a0-e6bb-4cbd-abd6-d1e6d26cfdaa"
      unitRef="usd">537000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfMzktNS0xLTEtMjg2MjE_99314b6f-6fe8-4551-92a3-ac3c0780fc01"
      unitRef="usd">649000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDAtMS0xLTEtMjg2MjE_1b3ad48e-8497-495d-b103-3fc69f7f21d7"
      unitRef="usd">117526000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDAtMy0xLTEtMjg2MjE_1db1cd16-319d-432d-a1e1-a18ea984e18b"
      unitRef="usd">31276000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDAtNS0xLTEtMjg2MjE_59b4ce01-7a50-4683-b887-181ce37d6e79"
      unitRef="usd">1414000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDEtMS0xLTEtMjg2MjE_836a7f12-0280-4072-a012-bbd937877c4d"
      unitRef="usd">117817000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDEtMy0xLTEtMjg2MjE_e7284d1a-7599-46a4-b55c-5709119f599d"
      unitRef="usd">20731000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDEtNS0xLTEtMjg2MjE_1238372c-6f59-4ee7-9960-9ac26d3fa8b3"
      unitRef="usd">264000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDItMS0xLTEtMjg2MjE_6616367a-de0d-4567-aeb4-af4d1ba56378"
      unitRef="usd">47047000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDItMy0xLTEtMjg2MjE_ccbd0a0b-d7f0-4dd8-a1a4-b74827cc010c"
      unitRef="usd">26316000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDItNS0xLTEtMjg2MjE_74a5c47f-0847-4743-9440-1456682d0ae5"
      unitRef="usd">26052000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDMtMS0xLTEtMjg2MjE_6dc492d5-b632-4c7a-9f57-9b9432312a19"
      unitRef="usd">164864000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDMtMy0xLTEtMjg2MjE_fd43500f-a937-4664-90ae-c9149df04b85"
      unitRef="usd">47047000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDMtNS0xLTEtMjg2MjE_ec51597c-9093-440d-b017-cb43f8998f0a"
      unitRef="usd">26316000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDUtMS0xLTEtMjg2MjE_51edd530-98ef-4683-bd0f-f0fd3c3903b5"
      unitRef="usd">1663000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDUtMy0xLTEtMjg2MjE_fd84cdee-e5d6-49cb-912e-ad6d7759a4f8"
      unitRef="usd">63000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDUtNS0xLTEtMjg2MjE_ab8d43b2-5987-4d7c-ba94-1f4255dbe8ab"
      unitRef="usd">81000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDYtMS0xLTEtMjg2MjE_40205c28-99ee-4942-bd59-1676e9a8c618"
      unitRef="usd">891000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDYtMy0xLTEtMjg2MjE_0170b3d6-1b70-4186-a988-e2202ff137be"
      unitRef="usd">-1000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDYtNS0xLTEtMjg2MjE_55988f75-8557-4f83-bcd0-8570376498d7"
      unitRef="usd">59000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDgtMS0xLTEtMjg2MjE_f338c92e-466e-4d14-83a2-ee18c0972698"
      unitRef="usd">828000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDgtMy0xLTEtMjg2MjE_d0bcec0a-98c1-41bf-99b8-df0c5f402442"
      unitRef="usd">43000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDgtNS0xLTEtMjg2MjE_97f5f302-b61c-4864-9897-c53435ef2888"
      unitRef="usd">738000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDktMS0xLTEtMjg2MjE_5d9ef889-1b75-4c3e-810a-b1cbbe63fd92"
      unitRef="usd">123000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDktMy0xLTEtMjg2MjE_e77858b3-4cc2-4a93-914d-b7146e10b693"
      unitRef="usd">11735000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNDktNS0xLTEtMjg2MjE_8a274840-edbb-4f85-acb8-5e92309557a8"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:NotesReduction
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNTMtMS0xLTEtMzUyNzI_8ca24fda-4fbe-434f-81e8-7a85e315dc79"
      unitRef="usd">7185000</us-gaap:NotesReduction>
    <us-gaap:NotesReduction
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNTMtMy0xLTEtMzUyODE_4e7b8022-5be8-4da7-b0d3-d7ed1b5f3532"
      unitRef="usd">0</us-gaap:NotesReduction>
    <us-gaap:NotesReduction
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl85Ny9mcmFnOjVhN2JkM2M5ZmU5NDRkYmRhMjM4MTAzN2QwMmE1NjgyL3RhYmxlOjNjNjk3MzE4ZjJjYjQ3NTE5YzhmZTRkNWZiZGIzZGU1L3RhYmxlcmFuZ2U6M2M2OTczMThmMmNiNDc1MTljOGZlNGQ1ZmJkYjNkZTVfNTMtNS0xLTEtMzUyODg_bc37fae8-f853-44a9-a3e7-e5863dc64ded"
      unitRef="usd">0</us-gaap:NotesReduction>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTIw_5915f785-0f50-4522-b05c-51c5fd7b68e3">SUMMARY&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;OF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SIGNIFICANT&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ACCOUNTING&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;POLICIES&lt;/span&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Operations and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cutera, Inc. (&#x201c;Cutera&#x201d; or the &#x201c;Company&#x201d;) provides energy-based aesthetic systems for practitioners worldwide. The Company develops, manufactures, distributes, and markets energy-based product platforms for use by physicians and other qualified practitioners, enabling them to offer safe and effective aesthetic treatments to their customers. The Company currently markets the following system platforms: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;enlighten, excel,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret PRO, Secret RF,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;xeo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Several of the Company&#x2019;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The sales of (i) systems, system upgrades, and hand pieces (collectively &#x201c;Systems&#x201d; revenue); (ii) replacement hand pieces, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan, truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;D,truSculpt iD&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt flex&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; cycle refills, as well as single use disposable tips applicable to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret PRO,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;Consumables&#x201d; revenue); (iii) the distribution of third party manufactured skincare products (&#x201c;Skincare&#x201d; revenue); and (iv) the leasing of equipment through a membership program; are collectively classified as &#x201c;Products&#x201d; revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan, truSculpt 3D, truSculpt iD&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt flex)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and service labor for the repair and maintenance of products that are out of warranty, all of which are collectively classified as &#x201c;Service&#x201d; revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#x201c;RDCs&#x201d;) in selection locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets sells and services the Company&#x2019;s products through direct sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over 42 countries. The consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Consolidated Financial Statements have been prepared in conformity with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;). Certain prior period amounts have been reclassified  to conform to the 2021 presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commissions, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, assumptions used in operating and sales-type lease classification, implicit and incremental borrowing rates related to the Company&#x2019;s leases, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of global financial markets, cybersecurity breaches and other disruptions that could compromise the Company&#x2019;s information or results, business disruptions that are &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;caused by natural disasters or pandemic events, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, the successful execution of new product launches, strategic relationships and dependence on key individuals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;the World Health Organization declared the COVID-19&#160;outbreak a pandemic. The COVID-19&#160;outbreak, and lately the Delta and Omicron variants, has negatively affected the United States and global economies. The spread of the coronavirus, which caused a broad impact in 2020 globally, including restrictions on travel, shifting work force to work remotely and quarantine policies put into place by businesses and governments, had a material economic effect on the Company&#x2019;s business during the year ended December 31, 2020. Notably, healthcare facilities in many countries effectively banned elective procedures. Many of the Company&#x2019;s products are used in aesthetic elective procedures and as such, the bans on elective procedures substantially reduced the Company&#x2019;s sales and marketing efforts in the early months of the pandemic and led the Company to implement cost control measures. Although the Company&#x2019;s operation and results of operations have significantly improved as the economic outlook due to the&#160;COVID-19&#160;pandemic improved in 2021, the&#160;COVID-19&#160;outbreak continues to be fluid and the aftermath of the business and economic disruptions due to the&#160;COVID-19 is still uncertain, making it difficult to forecast the final impact it could have on&#160;the Company&#x2019;s&#160;future operations, including disruptions in the Company's supply chain and contract manufacturing operations. The Company&#160;cannot presently predict the scope and severity of any impacts in future periods from the business shutdowns or disruptions due to the&#160;COVID-19&#160;pandemic, but the impact on economic activity including the possibility of recession or financial market instability could have a material adverse effect on the Company&#x2019;s business, revenue, operating results, cash flows and financial condition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to assess whether any impairment of its goodwill or its long-lived assets has occurred, and has determined that no&#160;charges were necessary during the years ended December&#160;31, 2021, and 2020, other than an impairment loss of $0.2 million and $0.8 million on capitalized implementation costs of&#160;cloud-based CRM software, respectively.&#160;The Company&#x2019;s assumptions about future conditions important to its assessment of potential impairment of its long-lived assets, and goodwill, including the impacts of the&#160;COVID-19&#160;pandemic and other ongoing impacts to its business, are subject to uncertainty, and the Company will continue to monitor these conditions in future periods as new information becomes available.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2016-13, Financial Instruments-Credit Losses (Topic 326):"Measurement of Credit Losses on Financial Instruments", which replaces the incurred loss methodology with an expected credit loss methodology that is referred to as the current expected credit loss (CECL) methodology. ASU 2016-13 is effective for fiscal years beginning after December&#160;15, 2019, with early adoption permitted. The amendments in this update are required to be applied using the modified retrospective method with an adjustment to accumulated deficit and are effective for the Company beginning with fiscal year 2020, including interim periods. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost, including loan receivables, available for sale securities and held-to-maturity debt securities. An entity with available for sale securities and trade receivables will be required to use historical loss information, current conditions, and reasonable and supportable forecasts to determine expected lifetime credit losses. Pooling of assets with similar risk characteristics is also required. The Company adopted ASU 2016-13 on January&#160;1, 2020 on a modified retrospective basis. Upon adoption, the standard did not have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company identified trade receivables and available-for-sale debt securities as impacted by the new guidance. However, the Company determined that the historical losses related to these available-for-sale debt securities are not material as the Company invests in high grade short-term securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes an allowance for credit losses on trade receivables based on the credit quality of clients, current economic conditions, the age of the accounts receivable balances, historical loss information, and current conditions and forecasted information, and write-off amounts against the allowance when they are deemed uncollectible.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-13, &#x201c;Fair Value Measurement (Topic 820): Disclosure Framework- Changes to the Disclosure Requirements for Fair Value Measurement&#x201d;, to improve the fair value measurement reporting of financial instruments. The amendments in this update require, among other things, added disclosure of the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this update eliminate, among other things, disclosure of the reasons for and amounts of transfers between Level 1 and Level 2 for assets and liabilities that are measured at fair value on a recurring basis and an entity's valuation processes for Level 3 fair value measurements. The amendments in this update became effective for the Company beginning with fiscal year 2020. Retrospective application is required for all amendments in this update except the added disclosures, which should be applied prospectively. The adoption &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of the amendments in this update did not have a material impact on the Company&#x2019;s consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;No.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2019-12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The Company adopted this guidance starting January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the&#160;FASB&#160;issued ASU No. 2020-6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt &#x2013; Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Topic 815), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to simplify the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the amendment, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#x2019;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the computation of diluted earnings per share. The Company early adopted the guidance on a prospective basis effective January 1, 2021. See section Computation of Net Income (Loss) per Share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted by the Company&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviewed all recently issued, but not yet effective, accounting pronouncements and does not expect the future adoption of any such pronouncements will have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company&#x2019;s performance obligations are satisfied either over time or at a point in time. Revenue from performance obligations that are transferred to customers over time accounted for approximately 11%, 15% and 13%,&#160;respectively, of the Company&#x2019;s total revenue for the years ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain system sale arrangements that contain multiple products and services. For these bundled sale arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct. The Company&#x2019;s products and services are distinct if a customer can benefit from the product or service on its own or with other resources that are readily available to the customer, and if the Company&#x2019;s promise to transfer the products or service to the customer is separately identifiable from other promises in the sale arrangements. The Company&#x2019;s system sale arrangements can include all or a combination of the following performance obligations: the system and software license (considered as one performance obligation), system accessories (hand pieces), training, other accessories, extended service contracts, marketing services, and time and materials services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company&#x2019;s system sale arrangements that include an extended service contract, the period of service commences at the expiration of the Company&#x2019;s standard warranty offered at the time of the system sale. The Company considers the extended service contracts terms in the arrangements that are legally enforceable to be performance obligations. Other than extended service contracts and marketing services, which are satisfied over time, the Company generally satisfies all performance obligations at a point in time. Systems, system accessories (hand pieces), service contracts, training, and time and materials services are also sold on a stand-alone basis, and these performance obligations are satisfied at a point in time. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation on a relative standalone selling price basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Products and Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Systems&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Systems revenue is generated from the sale of systems and from the sale of upgrades to existing systems. A system consists of a console that incorporates a universal graphic user interface, a laser or other energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. In certain applications, the laser or other energy-based module is contained in the hand piece, such as with the Company&#x2019;s &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pearl&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pearl Fractional&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; applications, rather than within the console.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The system or upgrade and the right to use the embedded software represent a single performance obligation as the software license is integral to the functionality of the system or upgrade.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For systems sold directly to end-customers that are credit approved, revenue is recognized when the Company transfers control to the end-customer, which occurs when the product is shipped to the customer or when the customer receives the product, depending on the nature of the arrangement. When collectability is &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;not&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; established in advance of receipt of payment from the customer, revenue is recognized upon the later of the receipt of payment or the satisfaction of the performance obligation. For systems sold through credit approved distributors, revenue is recognized at the time of shipment to the distributor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company typically receives payment for its system consoles and other accessories within 30 days of shipment. Certain international distributor arrangements allow for longer payment terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Skincare products&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sells third-party manufactured skincare products in Japan. The skincare products are purchased from a third-party manufacturer and sold to medical offices and licensed physicians. The Company warrants that the skincare products are free of significant defects in workmanship and materials for 90 days from shipment. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer. The Company recognizes revenue for skincare products at a point in time upon shipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consumables and other accessories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its customers' purchases of replacement cycles for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt iD &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt flex&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as well as replacement hand pieces, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt 3D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hand pieces, and single use disposable tips applicable to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret PRO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as Consumable revenue, which provides the Company with a source of recurring revenue from existing customers. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; products&#x2019; single use disposable tips must be replaced after every treatment. Sales of these consumable tips further enhance the Company&#x2019;s recurring revenue. The Company&#x2019;s systems offer multiple hand pieces and applications, which allow customers to upgrade their systems.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equipment leasing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases equipment to customers through membership programs and receives a fixed monthly fee over the term of the arrangement. The Company classifies its lease income as product revenue. The Company recognizes lease income over the term of the lease if the lease is classified as an operating lease. For agreements that grant customers the right to purchase the leased system, the Company typically classifies the lease as a sales-type lease as the Company has determined it is reasonably certain that the customer will exercise the purchase option. On the commencement of sales-type leases, the Company recognizes revenue upfront in product revenue and the corresponding receivables recorded in Other current assets and prepaid expenses on the consolidated balance sheets (Notes 1 and 11). Revenue from equipment leases was not material in the years ended December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Extended service contract &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for a term of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzOTA_48951eca-9684-4911-930c-c47a406efd42"&gt;one&lt;/span&gt;, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzOTE_82f81123-597c-470d-8503-057d2c5ae78b"&gt;two&lt;/span&gt;, or three years. Service contract revenue is recognized over time, using a time-based measure of progress, as customers benefit from the service throughout the service period. The Company also offers services on a time-and-materials basis for systems and detachable hand piece replacements. Revenue related to services performed on a time-and-materials basis is recognized when performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Training&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales of systems to customers include training on the use of the system to be provided within 180 days of purchase. The Company considers training a separate performance obligation as customers can immediately benefit from the training together with the customer&#x2019;s system. Training is also sold separately from systems. The Company recognizes revenue for training when the training is provided. Training is not required for customers to use the systems.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The determination of whether two or more contracts entered into at or near the same time with the same customer should be combined and accounted for as one contract may require the use of significant judgment. In making this determination, the Company considers whether the contracts are negotiated as a package with a single commercial objective, have price interdependencies, or promise goods or services that represent a single performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company&#x2019;s purchase agreements do &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;not&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; provide customers with a contractual right of return, the Company maintains a sales allowance to account for potential returns or refunds as a reduction in transaction price at the time of sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines standalone selling price ("SSP") for each performance obligation as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Systems: The SSPs for systems are based on directly observable sales in similar circumstances to similar customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Extended service contracts: SSP is based on observable price when sold on a standalone basis to similar customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loyalty Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company launched a customer loyalty program during the third quarter of 2018 for qualified customers located in the U.S. and Canada. Under the loyalty program, customers accumulate points based on their purchasing levels which can be redeemed for such rewards as the right to attend the Company&#x2019;s advanced training event for a product, or a ticket for the Company&#x2019;s annual forum. A customer&#x2019;s account must be in good standing to receive the benefits of the rewards program. Rewards are earned on a quarterly basis and must be used in the following quarter.&#160;All unused rewards are forfeited. The fair value of the reward earned by loyalty program members is included in accrued liabilities and recorded as a reduction. of net revenue at the time the reward is earned. As of December&#160;31, 2021, and December 31, 2020, the accrual for the loyalty program included in accrued liabilities was $0.5 million, and $0.3&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Sales Commissions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incremental costs of obtaining a contract, which consist primarily of commissions and related payroll taxes, are capitalized, and amortized on a straight-line basis over the expected period of benefit, except for costs that are recognized when product is sold. The Company uses the portfolio method to recognize the amortization expense related to these capitalized costs related to initial contracts and such expense is recognized over a period associated with the revenue of the related portfolio, which is generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzNTI_f9af2b31-c814-4dab-886d-badea997b8a1"&gt;two&lt;/span&gt; to three years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total capitalized costs for the year ended December&#160;31, 2021 and December&#160;31, 2020 were $4.2 million and $3.4 million, respectively, and are included in Other long-term assets in the Company&#x2019;s consolidated balance sheet. Amortization expenses for these assets were&#160;$1.9 million, $2.6 million and $2.9 million, respectively, during the years&#160;ended December&#160;31, 2021, 2020 and 2019 and were&#160;included in sales and marketing expense in the Company&#x2019;s consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company invests its cash primarily in money market funds. All highly liquid investments with stated maturities of three months or less from date of purchase are classified as cash equivalents; all highly liquid investments with stated maturities of greater than three months are classified as marketable investments. The majority of the Company&#x2019;s cash and investments are held in U.S. banks and the Company's foreign subsidiaries maintain a limited amount of cash in their local banks to cover short term operating expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy contains three levels of inputs that may be used to measure fair value, in accordance with ASC 820, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 1: inputs, which include quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 2: inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. For available-for-sale securities, the Company reviews trading activity and pricing as of the measurement date. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 3: inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allowance for Sales Returns and Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The allowance for sales returns is based on the Company&#x2019;s estimates of potential future product returns and other allowances related to current period product revenue. The Company analyzes historical returns, current economic trends and changes in customer demand and acceptance of the Company's products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The allowance for credit losses on trade receivables is based on the credit quality of clients, current economic conditions, the age of the accounts receivable balances, historical loss information, and current conditions and forecasted information. The Company writes off amounts against the allowance when they are deemed uncollectible.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities and other factors could negatively impact the Company&#x2019;s operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also subject to risks related to changes in the value of the Company&#x2019;s significant balance of financial instruments. Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents, and accounts receivable. The Company&#x2019;s cash and cash equivalents are primarily invested in deposits and money market accounts with three major financial institutions in the U.S. In addition, the Company has operating cash balances in banks in each of the international locations in which it operates. Deposits in these banks may exceed the federally insured limits or any other&#160;insurance&#160;provided on such deposits, if any. Management believes that these financial institutions are financially sound and, accordingly, believes that minimal credit risk exists. To date, the Company has not experienced any losses on its deposits of cash and cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are recorded net of an allowance for credit losses and are typically unsecured and are derived from revenue earned from worldwide customers. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers and maintains an allowance for potential credit losses. As of December&#160;31, 2021, and 2020, no customer represented more than 10% of the Company&#x2019;s net accounts receivable. During the years ended December&#160;31, 2021, 2020, and 2019, domestic revenue accounted for 42%, 41% and 58%, respectively, of total revenue, while international revenue accounted for 58%, 59% and 42%, respectively, of total revenue. No single customer represented more than 10% of total revenue for any of the years ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Supplier concentration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company relies on third parties for the supply of components of its products, as well as third-party logistics providers. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers or satisfactorily deliver its products to its customers. The Company relies on one supplier for its Secret and Secret PRO products and one supplier for its skincare products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost and net realizable value, cost being determined on a standard cost basis which approximates actual cost on a first-in, first-out basis. Net realizable value is the estimated selling prices in the ordinary course of the Company&#x2019;s business, less reasonably predictable costs of completion, disposal, and transportation. The cost basis of the Company&#x2019;s inventory is reduced for any products that are considered excessive or obsolete based upon assumptions about future demand and market conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company includes demonstration units within inventories. Demonstration units are carried at cost and amortized over an estimated economic life of two years. Amortization expense related to demonstration units is recorded in products cost of revenue or in the respective operating expense line based on which function and purpose for which the demonstration units are being used. Proceeds from the sale of demonstration units are recorded as revenue and all costs incurred to refurbish the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;systems prior to sale are charged to product cost of revenue. As of December&#160;31, 2021 and 2020, demonstration inventories, net of accumulated depreciation, included in finished goods inventory was $3.7 million and $3.6 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lesser of useful life or term of lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment leasing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment and furniture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon sale or retirement of property and equipment, the costs and related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operating expenses. Maintenance and repairs are charged to operations as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense related to property and equipment for 2021, 2020 and 2019, was $1.3 million, $1.4 million, and $1.5 million, respectively. Amortization expense for vehicles leased under capital leases is included in depreciation expense. Amortization expense related to equipment leasing accounted for as sales type is included in cost of revenue and was immaterial as of December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capitalized Cloud Computing Set-up Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain set-up costs for the Company&#x2019;s cloud computing arrangements. The capitalized implementation costs are then amortized over the term of the cloud computing arrangement inclusive of expected contract renewals, which are generally three years to ten years. As of December&#160;31, 2021, the Company had capitalized cloud computing set-up costs with a carrying amount of $0.4&#160;million in Other current assets and prepaid expenses and $3.5&#160;million in Other long-term assets. As of and during the year ended December&#160;31, 2021 there was no accumulated amortization and amortization expense recorded. The Company periodically assesses the capitalized asset for impairment and, when required, will record an associated impairment loss.&#160;During the year ended December&#160;31, 2021, the Company recognized in general and administrative expense an impairment loss of $0.2 million for capitalized cloud computing costs related to a cloud-based&#160;enterprise resource planning software.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and intangible assets with indefinite useful lives are not amortized but are tested for impairment at least annually during the fourth quarter of the Company&#x2019;s fiscal year, or if circumstances indicate their value may no longer be recoverable. Goodwill represents the excess of the purchase price over the fair value of net identifiable assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to operate in one segment, which is considered to be the sole reporting unit and, therefore, goodwill was tested for impairment at the enterprise level. As of December&#160;31, 2021, there has been no impairment of goodwill. All acquired intangible assets have been fully amortized as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warranty Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides a 12-month warranty for direct sales to customers. For sales to distributors, the Company generally provides a 14-month warranty for parts only, with labor being provided to the end customer by the distributor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective January&#160;1, 2019, the Company adopted ASC 842, which established a right-of-use ("ROU") model requiring lessees to record a right-of-use asset ("ROU asset") and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding ROU asset. Lease liabilities represent the present value of the Company&#x2019;s future lease payments over the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company&#x2019;s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting for Leases as a Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases equipment to customers through membership programs and receives a fixed monthly fee over the term of the arrangement. The Company classifies its lease income as product revenue. The Company recognizes lease income over the term of the lease if the lease is classified as an operating lease. For agreements that grant customers the right to purchase the leased system, the Company typically classifies the lease as a sales-type lease as the Company has determined it is reasonably certain that the customer will exercise the purchase option. On the commencement of sales-type leases, the Company recognizes revenue upfront in product revenue and the corresponding receivables is classified in Other current assets and prepaid expenses on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 11 to the consolidated financial statements for more information regarding leasing arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue consists primarily of material, finished and semi-finished products purchased from third-party manufacturers, labor, stock-based compensation expenses, overhead involved in the Company's internal manufacturing processes, service contracts, technology license amortization and royalties, costs associated with equipment leasing, costs associated with product warranties and any inventory write-downs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's system sales include a control console, universal graphic user interface, control system software, high voltage electronics and a combination of applications (referred to as &#x201c;hand pieces&#x201d;). Hand pieces are programmed to have a limited number of uses to ensure the safety of the device to patients. The Company sells refurbished hand pieces, or "refills," of its &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; truSculpt 3D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; products and provides for the cost of refurbishment of these hand pieces as part of cost of revenue. When customers purchase a replacement hand piece or are provided a replacement hand piece under a warranty or service contract, the Company ships the customer a previously refurbished unit. Upon the receipt of the expended hand piece from the customer, the Company capitalizes the expended hand piece as inventory at the estimated fair value. Cost of service revenue includes the costs incurred to refurbish hand pieces.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Expenditures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs are expensed as incurred and include costs related to research, design, development, testing of products, salaries, benefits and other headcount related costs, facilities, material, third party contractors, regulatory affairs, clinical and development costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs are included as part of sales and marketing expense and are expensed as incurred. Advertising expenses for 2021, 2020 and 2019 were $2.1 million, $1.2 million&#160;and $2.8 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for share-based employee compensation plans using the fair value recognition and measurement provisions under U.S. GAAP. The Company&#x2019;s share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as expense on a straight- line basis over the requisite service period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Term&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The expected term represents the weighted-average period that the stock options are expected to be outstanding prior to being exercised. The Company determines expected term based on historical exercise patterns and its expectation of the time it will take for employees to exercise options still outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: For the underlying stock price volatility of the Company&#x2019;s stock,&#160;the Company estimates volatility solely based on the Company&#x2019;s historical volatility of its stock price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Forfeitures:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company has made an accounting policy to estimate forfeitures at the time awards are granted and revises, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-Free Interest Rate:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The risk-free interest rate is based on the U.S. treasury yield curve in effect at the time of grant for the expected term of the stock option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of stock options ("options") on the grant date using the closing price of the Company's common shares on the grant date is estimated using the Black-Scholes option-pricing model using the single-option approach. The Black-Scholes option pricing model requires the use of highly subjective and complex assumptions, including the option's expected term and the price volatility of the underlying stock, to determine the fair value of award. The Company recognizes the expense associated with options using a single award approach over the requisite service period. The Company accounts for all stock options awarded to non-employees at the fair value of the award issued on the day of the grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of restricted stock units (&#x201c;RSUs&#x201d;) granted are measured on the grant date. The quantity of the RSUs units granted is calculated by dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#x2019;s common stock over the 50-day period ending on the day of the grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of Performance Stock Units (&#x201c;PSUs&#x201d;) that have operational measurement goals are measured on the grant date using the closing price of the Company&#x2019;s common shares on the grant date. The quantity of the PSUs granted is calculated by dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#x2019;s common stock over the 50-day period ending on the day of the grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 6 - "Stockholders&#x2019; Equity, Stock Plans and Stock-Based Compensation Expense" for a detailed discussion of the Company&#x2019;s stock plans and share-based compensation expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to income taxes in the United States and several foreign jurisdictions. Significant judgment is required in determining the Company&#x2019;s provision (benefit) for income taxes and income tax assets and liabilities, including evaluating uncertainties in the application of accounting principles and complex tax laws.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records a provision (benefit) for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as for loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company recognizes the deferred income tax effects of a change in tax rates in the period of enactment. The Company records a valuation allowance to reduce the Company&#x2019;s deferred tax assets to the net amount that the Company believes is more likely than &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;not&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes tax benefits from uncertain tax positions if the Company believes that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. Although the Company believes it has adequately reserved for the Company&#x2019;s uncertain tax positions (including net interest and penalties), the Company can provide no assurance that the final tax outcome of these matters will not be different. The Company makes adjustments to these reserves in accordance with income tax accounting guidance when facts and circumstances change, such as the closing of a tax audit. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences may impact the provision (benefit) for income taxes in the period in which such determination is made. The Company records interest and penalties related to the Company&#x2019;s uncertain tax positions in the Company&#x2019;s provision (benefit) for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s effective tax rates have differed from the statutory rate primarily due to changes in the valuation allowance, foreign operations, research and development tax credits, state taxes, and certain benefits realized related to stock option activity. The Company&#x2019;s current effective tax rate does not assume U.S. taxes on undistributed profits of foreign subsidiaries. These earnings could become subject to incremental foreign withholding or U.S. federal and state taxes, should they either be deemed or actually remitted to the U.S. The Company&#x2019;s future effective tax rates could be adversely affected by earnings being lower in countries where the Company has lower statutory rates and being higher in countries where the Company has higher statutory rates, or by changes in tax laws, accounting principles, interpretations thereof, net operating loss carryback, research and development tax credits, and due to changes in the valuation allowance of its U.S. deferred tax assets. In addition, the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company is subject to the examination of the Company&#x2019;s income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#x2019;s provision for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Undistributed earnings of the Company&#x2019;s foreign subsidiaries at December&#160;31, 2021 are considered to be indefinitely reinvested and, accordingly, no provision for state income taxes has been provided thereon. Due to the Transition Tax and Global Intangible Low-Tax Income (&#x201c;GILTI&#x201d;) regimes as enacted by the 2017 Tax Act, those foreign earnings will not be subject to federal income taxes when actually distributed in the form of a dividend or otherwise. The Company, however, could still be subject to state income taxes and withholding taxes payable to various foreign countries. The amounts of taxes which the Company could be subject to are not material to the accompanying financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;27, 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;). The CARES Act changed several of the existing U.S. corporate income tax laws by, among other things, increasing the amount of deductible interest, allowing companies to carry back certain Net Operating Losses (&#x201c;NOLs&#x201d;) and increasing the amount of NOLs that corporations can use to offset income. The CARES Act did not have a material impact on the Company's income tax provision, deferred tax assets and liabilities, and related taxes payable. The Company is currently assessing the future implications of these provisions within the CARES Act on the Company's consolidated financial statements but does not expect the impact to be material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Computation of Net Income (Loss) per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method and the if-converted method. Dilutive potential common shares include outstanding stock options, restricted stock units, performance stock units, employee stock purchase plan (ESPP) shares and conversion shares under the convertible notes. On January 1, 2021, the Company adopted the accounting standard update to simplify the accounting for convertible debt instruments. The Company now uses the if-converted method for its convertible notes in calculating the diluted net income (loss) per share, and includes the effect of potential share settlement for the convertible notes, if the effect is dilutive. The diluted net income per share is computed with the assumption that the Company will settle the convertible debt in shares, rather than cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share is the same as basic earnings per share for the periods in which the Company had a net loss because the inclusion of outstanding common stock equivalents would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) includes all changes in stockholders&#x2019; equity except those resulting from investments or contributions by stockholders. For the periods presented, the accumulated other comprehensive income (loss) consisted solely of the unrealized gains or losses on the Company's available-for- sale investments, net of tax.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company&#x2019;s foreign subsidiaries are translated in accordance with ASC 830, Foreign Currency Matters. The U.S. Dollar is the functional currency of the Company&#x2019;s subsidiaries and the Company&#x2019;s reporting currency. Monetary assets and liabilities are re-measured into U.S. Dollars at the applicable period end exchange rate. Sales and operating expenses are re-measured at average exchange rates in effect during each period. Gains or losses resulting from foreign currency transactions are included in net income (loss) are $1.8&#160;million in the year ended December&#160;31, 2021 and were insignificant for each of the two years ended December&#160;31, 2020. The effect of exchange rate changes on cash and cash equivalents was insignificant for each of the three years ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in one segment and reports segment information in accordance with ASC 280, Segment Reporting. Management uses one measurement of profitability and does not segregate its business for internal reporting. As of December&#160;31, 2021&#160;and 2020, 99.0% and 98.0% of long-lived assets were in the United States, respectively. Revenue is attributed to a geographic region based on the location of the end customer. See Note 10 &#x2013; "Segment Information and Revenue by Geography and Products" for details relating to revenue by geography.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTI4_79672fdc-9a59-4055-a19c-13a0420389cb">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Operations and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cutera, Inc. (&#x201c;Cutera&#x201d; or the &#x201c;Company&#x201d;) provides energy-based aesthetic systems for practitioners worldwide. The Company develops, manufactures, distributes, and markets energy-based product platforms for use by physicians and other qualified practitioners, enabling them to offer safe and effective aesthetic treatments to their customers. The Company currently markets the following system platforms: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;enlighten, excel,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret PRO, Secret RF,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;xeo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Several of the Company&#x2019;s systems offer multiple hand pieces and applications, providing customers the flexibility to upgrade their systems. The sales of (i) systems, system upgrades, and hand pieces (collectively &#x201c;Systems&#x201d; revenue); (ii) replacement hand pieces, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan, truSculpt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;D,truSculpt iD&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt flex&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; cycle refills, as well as single use disposable tips applicable to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret PRO,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;Consumables&#x201d; revenue); (iii) the distribution of third party manufactured skincare products (&#x201c;Skincare&#x201d; revenue); and (iv) the leasing of equipment through a membership program; are collectively classified as &#x201c;Products&#x201d; revenue. In addition to Products revenue, the Company generates revenue from the sale of post-warranty service contracts, parts, detachable hand piece replacements (except for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan, truSculpt 3D, truSculpt iD&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt flex)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and service labor for the repair and maintenance of products that are out of warranty, all of which are collectively classified as &#x201c;Service&#x201d; revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s corporate headquarters and U.S. operations are located in Brisbane, California, where the Company conducts manufacturing, warehousing, research and development, regulatory, sales and marketing, service, and administrative activities. The Company also maintains regional distribution centers (&#x201c;RDCs&#x201d;) in selection locations across the U.S. These RDCs serve as forward warehousing for systems and service parts in various geographies. The Company markets sells and services the Company&#x2019;s products through direct sales and service employees in North America (including Canada), Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, Spain, Switzerland, and the United Kingdom. Sales and services outside of these direct markets are made through a worldwide distributor network in over 42 countries. The consolidated financial statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzIwMzQwOTY1MTk4Mzgw_25643030-d5a1-4e47-b978-0b33932d2ec9"
      unitRef="country">42</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3ODc0NzU_8c75bad4-d3c9-4b7f-80c2-bfd9282dc62d">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Consolidated Financial Statements have been prepared in conformity with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;). Certain prior period amounts have been reclassified  to conform to the 2021 presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTMw_de5090f8-8ff8-48b8-b790-0bcd0f29cd5d">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commissions, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, assumptions used in operating and sales-type lease classification, implicit and incremental borrowing rates related to the Company&#x2019;s leases, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <cutr:RisksAndUncertaintiesPolicyPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTMz_03f69804-9d98-42bd-96b3-725766df60ce">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's future operating results and cause actual results to vary materially from expectations include, but are not limited to, rapid technological change, continued acceptance of the Company's products, stability of global financial markets, cybersecurity breaches and other disruptions that could compromise the Company&#x2019;s information or results, business disruptions that are &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;caused by natural disasters or pandemic events, management of international activities, competition from substitute products and larger companies, ability to obtain and maintain regulatory approvals, government regulations and oversight, patent and other types of litigation, ability to protect proprietary technology from counterfeit versions of the Company's products, the successful execution of new product launches, strategic relationships and dependence on key individuals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;the World Health Organization declared the COVID-19&#160;outbreak a pandemic. The COVID-19&#160;outbreak, and lately the Delta and Omicron variants, has negatively affected the United States and global economies. The spread of the coronavirus, which caused a broad impact in 2020 globally, including restrictions on travel, shifting work force to work remotely and quarantine policies put into place by businesses and governments, had a material economic effect on the Company&#x2019;s business during the year ended December 31, 2020. Notably, healthcare facilities in many countries effectively banned elective procedures. Many of the Company&#x2019;s products are used in aesthetic elective procedures and as such, the bans on elective procedures substantially reduced the Company&#x2019;s sales and marketing efforts in the early months of the pandemic and led the Company to implement cost control measures. Although the Company&#x2019;s operation and results of operations have significantly improved as the economic outlook due to the&#160;COVID-19&#160;pandemic improved in 2021, the&#160;COVID-19&#160;outbreak continues to be fluid and the aftermath of the business and economic disruptions due to the&#160;COVID-19 is still uncertain, making it difficult to forecast the final impact it could have on&#160;the Company&#x2019;s&#160;future operations, including disruptions in the Company's supply chain and contract manufacturing operations. The Company&#160;cannot presently predict the scope and severity of any impacts in future periods from the business shutdowns or disruptions due to the&#160;COVID-19&#160;pandemic, but the impact on economic activity including the possibility of recession or financial market instability could have a material adverse effect on the Company&#x2019;s business, revenue, operating results, cash flows and financial condition. &lt;/span&gt;&lt;/div&gt;The Company continues to assess whether any impairment of its goodwill or its long-lived assets has occurred, and has determined that no&#160;charges were necessary during the years ended December&#160;31, 2021, and 2020, other than an impairment loss of $0.2 million and $0.8 million on capitalized implementation costs of&#160;cloud-based CRM software, respectively.&#160;The Company&#x2019;s assumptions about future conditions important to its assessment of potential impairment of its long-lived assets, and goodwill, including the impacts of the&#160;COVID-19&#160;pandemic and other ongoing impacts to its business, are subject to uncertainty, and the Company will continue to monitor these conditions in future periods as new information becomes available.</cutr:RisksAndUncertaintiesPolicyPolicyTextBlock>
    <us-gaap:HostingArrangementServiceContractImplementationCostImpairment
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzI3NDg3NzkxNTY0MTk_7a9abe5b-3e77-4313-8459-03441c30850e"
      unitRef="usd">200000</us-gaap:HostingArrangementServiceContractImplementationCostImpairment>
    <us-gaap:HostingArrangementServiceContractImplementationCostImpairment
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzI3NDg3NzkxNTY0ODk_a2083415-a1d0-41ee-9a98-73d009f41d23"
      unitRef="usd">800000</us-gaap:HostingArrangementServiceContractImplementationCostImpairment>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTMx_fc1c4d44-d20b-4ffa-a28d-0df437c66945">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2016-13, Financial Instruments-Credit Losses (Topic 326):"Measurement of Credit Losses on Financial Instruments", which replaces the incurred loss methodology with an expected credit loss methodology that is referred to as the current expected credit loss (CECL) methodology. ASU 2016-13 is effective for fiscal years beginning after December&#160;15, 2019, with early adoption permitted. The amendments in this update are required to be applied using the modified retrospective method with an adjustment to accumulated deficit and are effective for the Company beginning with fiscal year 2020, including interim periods. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost, including loan receivables, available for sale securities and held-to-maturity debt securities. An entity with available for sale securities and trade receivables will be required to use historical loss information, current conditions, and reasonable and supportable forecasts to determine expected lifetime credit losses. Pooling of assets with similar risk characteristics is also required. The Company adopted ASU 2016-13 on January&#160;1, 2020 on a modified retrospective basis. Upon adoption, the standard did not have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company identified trade receivables and available-for-sale debt securities as impacted by the new guidance. However, the Company determined that the historical losses related to these available-for-sale debt securities are not material as the Company invests in high grade short-term securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes an allowance for credit losses on trade receivables based on the credit quality of clients, current economic conditions, the age of the accounts receivable balances, historical loss information, and current conditions and forecasted information, and write-off amounts against the allowance when they are deemed uncollectible.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-13, &#x201c;Fair Value Measurement (Topic 820): Disclosure Framework- Changes to the Disclosure Requirements for Fair Value Measurement&#x201d;, to improve the fair value measurement reporting of financial instruments. The amendments in this update require, among other things, added disclosure of the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this update eliminate, among other things, disclosure of the reasons for and amounts of transfers between Level 1 and Level 2 for assets and liabilities that are measured at fair value on a recurring basis and an entity's valuation processes for Level 3 fair value measurements. The amendments in this update became effective for the Company beginning with fiscal year 2020. Retrospective application is required for all amendments in this update except the added disclosures, which should be applied prospectively. The adoption &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of the amendments in this update did not have a material impact on the Company&#x2019;s consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;No.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2019-12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740)-Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; to remove certain exceptions and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The Company adopted this guidance starting January 1, 2021. The adoption of this guidance did not have a material impact on the Company&#x2019;s consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the&#160;FASB&#160;issued ASU No. 2020-6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt &#x2013; Debt with Conversion and Other Options (Topic 470) and Derivatives and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Topic 815), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to simplify the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the amendment, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#x2019;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the computation of diluted earnings per share. The Company early adopted the guidance on a prospective basis effective January 1, 2021. See section Computation of Net Income (Loss) per Share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted by the Company&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviewed all recently issued, but not yet effective, accounting pronouncements and does not expect the future adoption of any such pronouncements will have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQ1_22301dbd-2fde-40ca-9d09-38ed339bf40b">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company&#x2019;s performance obligations are satisfied either over time or at a point in time. Revenue from performance obligations that are transferred to customers over time accounted for approximately 11%, 15% and 13%,&#160;respectively, of the Company&#x2019;s total revenue for the years ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain system sale arrangements that contain multiple products and services. For these bundled sale arrangements, the Company accounts for individual products and services as separate performance obligations if they are distinct. The Company&#x2019;s products and services are distinct if a customer can benefit from the product or service on its own or with other resources that are readily available to the customer, and if the Company&#x2019;s promise to transfer the products or service to the customer is separately identifiable from other promises in the sale arrangements. The Company&#x2019;s system sale arrangements can include all or a combination of the following performance obligations: the system and software license (considered as one performance obligation), system accessories (hand pieces), training, other accessories, extended service contracts, marketing services, and time and materials services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company&#x2019;s system sale arrangements that include an extended service contract, the period of service commences at the expiration of the Company&#x2019;s standard warranty offered at the time of the system sale. The Company considers the extended service contracts terms in the arrangements that are legally enforceable to be performance obligations. Other than extended service contracts and marketing services, which are satisfied over time, the Company generally satisfies all performance obligations at a point in time. Systems, system accessories (hand pieces), service contracts, training, and time and materials services are also sold on a stand-alone basis, and these performance obligations are satisfied at a point in time. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation on a relative standalone selling price basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Products and Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Systems&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Systems revenue is generated from the sale of systems and from the sale of upgrades to existing systems. A system consists of a console that incorporates a universal graphic user interface, a laser or other energy-based module, control system software and high voltage electronics, as well as one or more hand pieces. In certain applications, the laser or other energy-based module is contained in the hand piece, such as with the Company&#x2019;s &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pearl&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pearl Fractional&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; applications, rather than within the console.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers customers the ability to select the system that best fits their practice at the time of purchase and then to cost-effectively add applications to their system as their practice grows. This provides customers the flexibility to upgrade their systems whenever they choose and provides the Company with a source of additional Systems revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The system or upgrade and the right to use the embedded software represent a single performance obligation as the software license is integral to the functionality of the system or upgrade.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For systems sold directly to end-customers that are credit approved, revenue is recognized when the Company transfers control to the end-customer, which occurs when the product is shipped to the customer or when the customer receives the product, depending on the nature of the arrangement. When collectability is &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;not&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; established in advance of receipt of payment from the customer, revenue is recognized upon the later of the receipt of payment or the satisfaction of the performance obligation. For systems sold through credit approved distributors, revenue is recognized at the time of shipment to the distributor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company typically receives payment for its system consoles and other accessories within 30 days of shipment. Certain international distributor arrangements allow for longer payment terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Skincare products&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sells third-party manufactured skincare products in Japan. The skincare products are purchased from a third-party manufacturer and sold to medical offices and licensed physicians. The Company warrants that the skincare products are free of significant defects in workmanship and materials for 90 days from shipment. The Company acts as the principal in this arrangement, as the Company determines the price to charge customers for the skincare products and controls the products before they are transferred to the customer. The Company recognizes revenue for skincare products at a point in time upon shipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consumables and other accessories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its customers' purchases of replacement cycles for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt iD &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt flex&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as well as replacement hand pieces, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;truSculpt 3D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hand pieces, and single use disposable tips applicable to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret PRO&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as Consumable revenue, which provides the Company with a source of recurring revenue from existing customers. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Secret RF&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; products&#x2019; single use disposable tips must be replaced after every treatment. Sales of these consumable tips further enhance the Company&#x2019;s recurring revenue. The Company&#x2019;s systems offer multiple hand pieces and applications, which allow customers to upgrade their systems.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equipment leasing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases equipment to customers through membership programs and receives a fixed monthly fee over the term of the arrangement. The Company classifies its lease income as product revenue. The Company recognizes lease income over the term of the lease if the lease is classified as an operating lease. For agreements that grant customers the right to purchase the leased system, the Company typically classifies the lease as a sales-type lease as the Company has determined it is reasonably certain that the customer will exercise the purchase option. On the commencement of sales-type leases, the Company recognizes revenue upfront in product revenue and the corresponding receivables recorded in Other current assets and prepaid expenses on the consolidated balance sheets (Notes 1 and 11). Revenue from equipment leases was not material in the years ended December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Extended service contract &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers post-warranty services to its customers through extended service contracts that cover parts and labor for a term of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzOTA_48951eca-9684-4911-930c-c47a406efd42"&gt;one&lt;/span&gt;, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzOTE_82f81123-597c-470d-8503-057d2c5ae78b"&gt;two&lt;/span&gt;, or three years. Service contract revenue is recognized over time, using a time-based measure of progress, as customers benefit from the service throughout the service period. The Company also offers services on a time-and-materials basis for systems and detachable hand piece replacements. Revenue related to services performed on a time-and-materials basis is recognized when performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Training&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales of systems to customers include training on the use of the system to be provided within 180 days of purchase. The Company considers training a separate performance obligation as customers can immediately benefit from the training together with the customer&#x2019;s system. Training is also sold separately from systems. The Company recognizes revenue for training when the training is provided. Training is not required for customers to use the systems.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The determination of whether two or more contracts entered into at or near the same time with the same customer should be combined and accounted for as one contract may require the use of significant judgment. In making this determination, the Company considers whether the contracts are negotiated as a package with a single commercial objective, have price interdependencies, or promise goods or services that represent a single performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company&#x2019;s purchase agreements do &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;not&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; provide customers with a contractual right of return, the Company maintains a sales allowance to account for potential returns or refunds as a reduction in transaction price at the time of sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines standalone selling price ("SSP") for each performance obligation as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Systems: The SSPs for systems are based on directly observable sales in similar circumstances to similar customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Extended service contracts: SSP is based on observable price when sold on a standalone basis to similar customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loyalty Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company launched a customer loyalty program during the third quarter of 2018 for qualified customers located in the U.S. and Canada. Under the loyalty program, customers accumulate points based on their purchasing levels which can be redeemed for such rewards as the right to attend the Company&#x2019;s advanced training event for a product, or a ticket for the Company&#x2019;s annual forum. A customer&#x2019;s account must be in good standing to receive the benefits of the rewards program. Rewards are earned on a quarterly basis and must be used in the following quarter.&#160;All unused rewards are forfeited. The fair value of the reward earned by loyalty program members is included in accrued liabilities and recorded as a reduction. of net revenue at the time the reward is earned. As of December&#160;31, 2021, and December 31, 2020, the accrual for the loyalty program included in accrued liabilities was $0.5 million, and $0.3&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Sales Commissions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incremental costs of obtaining a contract, which consist primarily of commissions and related payroll taxes, are capitalized, and amortized on a straight-line basis over the expected period of benefit, except for costs that are recognized when product is sold. The Company uses the portfolio method to recognize the amortization expense related to these capitalized costs related to initial contracts and such expense is recognized over a period associated with the revenue of the related portfolio, which is generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzNTI_f9af2b31-c814-4dab-886d-badea997b8a1"&gt;two&lt;/span&gt; to three years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total capitalized costs for the year ended December&#160;31, 2021 and December&#160;31, 2020 were $4.2 million and $3.4 million, respectively, and are included in Other long-term assets in the Company&#x2019;s consolidated balance sheet. Amortization expenses for these assets were&#160;$1.9 million, $2.6 million and $2.9 million, respectively, during the years&#160;ended December&#160;31, 2021, 2020 and 2019 and were&#160;included in sales and marketing expense in the Company&#x2019;s consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues
      contextRef="i29493bf694aa41e4961175a5d0e9712c_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE1NjA0_5cff5be2-4a93-469b-b77c-dd40d64ac3fb"
      unitRef="number">0.11</cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues>
    <cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues
      contextRef="i9f3add778c6d42e2904c632bb4379750_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE1NjA4_bc33f6b8-3b78-4861-afc3-587dbd70d442"
      unitRef="number">0.15</cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues>
    <cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues
      contextRef="i27ed0b55b74e49509122ed86b0f52309_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE1NjE1_e2bbfc6c-b804-44f2-a581-2ae9a46dcbfd"
      unitRef="number">0.13</cutr:RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues>
    <cutr:ExtendedServiceContractOptionThreeTerm
      contextRef="i58319883bced4affb153fc42b9f6a7ab_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjE0Mjc_b01f0ce1-d093-479a-ab9b-b1f99e1e9c36">P3Y</cutr:ExtendedServiceContractOptionThreeTerm>
    <cutr:ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjE0Mjg_47bfd5c9-b6c7-4b12-a1c0-de76806b9ab8">P180D</cutr:ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i307d65a514094556a1c3cb6702122693_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzEwOTk1MTE2OTgyNTk_86f9f467-b005-4b34-aae1-d6f043967c3f"
      unitRef="usd">500000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="id09c2b6d4b444a11a61afbefef850c5f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzIwMzQwOTY1MTk4Mzg0_425eab50-5e6b-4352-b1aa-1cdce0d39bd8"
      unitRef="usd">300000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i8a9ce53bcd874cb38a5dbc24e4ea3583_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzNzA_ba6a2a37-679f-4336-b868-6f9415cd707a">P3Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedContractCostNet
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzI2MTc4_3f139fe7-53fa-42cf-a945-3f124d91636f"
      unitRef="usd">4200000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostNet
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzI2MTg1_90ce4cb3-cc07-4a3d-85ec-5482d850596b"
      unitRef="usd">3400000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i29b9e3b28d734adeb076ece7de227b71_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzI2MzM1_ebf50871-abe8-4a5c-9501-2fc0ae615054"
      unitRef="usd">1900000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i49f345cd25654a7f84873131ed305500_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzI2MzM5_71659b8f-404a-4f38-b889-0ef32fc246bb"
      unitRef="usd">2600000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="ia3577892be364d588b4ee6707f9426df_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzI2MzQ2_c915378e-94e3-4f8d-a9c8-5770e98ce4b6"
      unitRef="usd">2900000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTI0_78070c22-92aa-43d3-8508-e148fab14a58">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company invests its cash primarily in money market funds. All highly liquid investments with stated maturities of three months or less from date of purchase are classified as cash equivalents; all highly liquid investments with stated maturities of greater than three months are classified as marketable investments. The majority of the Company&#x2019;s cash and investments are held in U.S. banks and the Company's foreign subsidiaries maintain a limited amount of cash in their local banks to cover short term operating expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTIx_b67a9d44-54dd-4881-98f1-840f3f892540">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy contains three levels of inputs that may be used to measure fair value, in accordance with ASC 820, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 1: inputs, which include quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 2: inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. For available-for-sale securities, the Company reviews trading activity and pricing as of the measurement date. When sufficient quoted pricing for identical securities is not available, the Company uses market pricing and other observable market inputs for similar securities obtained from various third-party data providers. These inputs either represent quoted prices for similar assets in active markets or have been derived from observable market data; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 3: inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques, as well as significant management judgment or estimation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <cutr:AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTM3_68ce8b62-7d5c-4c5c-bdd8-f5717f5f30f7">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allowance for Sales Returns and Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The allowance for sales returns is based on the Company&#x2019;s estimates of potential future product returns and other allowances related to current period product revenue. The Company analyzes historical returns, current economic trends and changes in customer demand and acceptance of the Company's products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The allowance for credit losses on trade receivables is based on the credit quality of clients, current economic conditions, the age of the accounts receivable balances, historical loss information, and current conditions and forecasted information. The Company writes off amounts against the allowance when they are deemed uncollectible.&lt;/span&gt;&lt;/div&gt;</cutr:AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTM4_e5f060db-a73b-4f21-b797-c734c319b7a2">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities and other factors could negatively impact the Company&#x2019;s operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also subject to risks related to changes in the value of the Company&#x2019;s significant balance of financial instruments. Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents, and accounts receivable. The Company&#x2019;s cash and cash equivalents are primarily invested in deposits and money market accounts with three major financial institutions in the U.S. In addition, the Company has operating cash balances in banks in each of the international locations in which it operates. Deposits in these banks may exceed the federally insured limits or any other&#160;insurance&#160;provided on such deposits, if any. Management believes that these financial institutions are financially sound and, accordingly, believes that minimal credit risk exists. To date, the Company has not experienced any losses on its deposits of cash and cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are recorded net of an allowance for credit losses and are typically unsecured and are derived from revenue earned from worldwide customers. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers and maintains an allowance for potential credit losses. As of December&#160;31, 2021, and 2020, no customer represented more than 10% of the Company&#x2019;s net accounts receivable. During the years ended December&#160;31, 2021, 2020, and 2019, domestic revenue accounted for 42%, 41% and 58%, respectively, of total revenue, while international revenue accounted for 58%, 59% and 42%, respectively, of total revenue. No single customer represented more than 10% of total revenue for any of the years ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Supplier concentration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company relies on third parties for the supply of components of its products, as well as third-party logistics providers. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers or satisfactorily deliver its products to its customers. The Company relies on one supplier for its Secret and Secret PRO products and one supplier for its skincare products.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic835d94700e34147a128f7c43a99ba8f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM0MzMx_0f2654ad-ff19-43d5-8986-703e4f9d5967"
      unitRef="number">0.42</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia7d8ca402cf64fa095821119515012f0_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM0MzM1_33cfd1dc-9d27-42ae-8913-1be09b615b0c"
      unitRef="number">0.41</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i046ed111439c42409c5114869295fb0b_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM0MzQy_d28aebb7-f348-44b5-8618-a9672316a55d"
      unitRef="number">0.58</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib426205ae11e4aa1879843b606c79fd5_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM0NDIw_d1dbda8b-f720-4298-8956-f4431c96ab32"
      unitRef="number">0.58</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6d16dd05655a48cea0d5421c014cf5b5_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM0NDI0_2ed9b0fc-551c-4ee7-a4f8-1da30016deb5"
      unitRef="number">0.59</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icc042179d3e042a49fe526aad8eb50c6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM0NDMx_52822917-424c-478a-bb57-6ba20aafc0bb"
      unitRef="number">0.42</us-gaap:ConcentrationRiskPercentage1>
    <cutr:NumberOfMajorSuppliers
      contextRef="i22da8abdff7f43e49f27b03708dc3882_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzIwMzQwOTY1MTk4NDE2_70a70f7f-c94a-4489-9173-c666ec058489"
      unitRef="supplier">1</cutr:NumberOfMajorSuppliers>
    <cutr:NumberOfMajorSuppliers
      contextRef="id4151927442041dd92c39ebf707b54a4_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzIwMzQwOTY1MTk4NDI0_259ae073-737e-4f87-bebc-214fc7a946ad"
      unitRef="supplier">1</cutr:NumberOfMajorSuppliers>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQx_aba7ae94-4eb9-40a8-90b0-899f29d16a18">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost and net realizable value, cost being determined on a standard cost basis which approximates actual cost on a first-in, first-out basis. Net realizable value is the estimated selling prices in the ordinary course of the Company&#x2019;s business, less reasonably predictable costs of completion, disposal, and transportation. The cost basis of the Company&#x2019;s inventory is reduced for any products that are considered excessive or obsolete based upon assumptions about future demand and market conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company includes demonstration units within inventories. Demonstration units are carried at cost and amortized over an estimated economic life of two years. Amortization expense related to demonstration units is recorded in products cost of revenue or in the respective operating expense line based on which function and purpose for which the demonstration units are being used. Proceeds from the sale of demonstration units are recorded as revenue and all costs incurred to refurbish the &lt;/span&gt;&lt;/div&gt;systems prior to sale are charged to product cost of revenue. As of December&#160;31, 2021 and 2020, demonstration inventories, net of accumulated depreciation, included in finished goods inventory was $3.7 million and $3.6 million, respectively.</us-gaap:InventoryPolicyTextBlock>
    <cutr:DemonstrationUnitsAmortizationPeriod
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEzNTE_9e439893-b65a-4076-ad68-166928b1e54f">P2Y</cutr:DemonstrationUnitsAmortizationPeriod>
    <us-gaap:InventoryFinishedGoods
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzEwOTk1MTE2OTg5MDQ_17a721d7-8791-404a-9338-1b2a83df6e50"
      unitRef="usd">3700000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzEwOTk1MTE2OTg5MTI_b5306017-c37f-42c7-8506-40b523e731ee"
      unitRef="usd">3600000</us-gaap:InventoryFinishedGoods>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQ2_b73141ed-b625-4c3a-9591-cc7502d2d233">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lesser of useful life or term of lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment leasing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment and furniture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon sale or retirement of property and equipment, the costs and related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operating expenses. Maintenance and repairs are charged to operations as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense related to property and equipment for 2021, 2020 and 2019, was $1.3 million, $1.4 million, and $1.5 million, respectively. Amortization expense for vehicles leased under capital leases is included in depreciation expense. Amortization expense related to equipment leasing accounted for as sales type is included in cost of revenue and was immaterial as of December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTM5_1ef0954d-2fb9-43f1-b3f4-5b4445f74190">Depreciation expense recognized is on a straight-line basis over the estimated useful lives of the assets, generally as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lesser of useful life or term of lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment leasing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment and furniture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net, consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment leasing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment and furniture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iea5dc3d35fa7491281eebabd4744ca45_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90YWJsZTozYzYzMTVkMjc2YWI0YTQ3ODZjNTBmNWU2YWE5MmE3Ny90YWJsZXJhbmdlOjNjNjMxNWQyNzZhYjRhNDc4NmM1MGY1ZTZhYTkyYTc3XzItMS0xLTEtMjg2MjE_392c77b9-c0a7-4edf-ab44-dc17f1f9e8e4">P4Y6M</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i687140e91bb9469bb4be1621b92c9b8b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90YWJsZTozYzYzMTVkMjc2YWI0YTQ3ODZjNTBmNWU2YWE5MmE3Ny90YWJsZXJhbmdlOjNjNjMxNWQyNzZhYjRhNDc4NmM1MGY1ZTZhYTkyYTc3XzMtMS0xLTEtMjg2MjE_4d5bde80-35b2-4ed0-8eb0-487b178fa525">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i16179899e1fd49b2884edc3604740025_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90YWJsZTozYzYzMTVkMjc2YWI0YTQ3ODZjNTBmNWU2YWE5MmE3Ny90YWJsZXJhbmdlOjNjNjMxNWQyNzZhYjRhNDc4NmM1MGY1ZTZhYTkyYTc3XzQtMS0xLTEtMjg2MjE_686ee5e3-aa03-4677-8a0a-2abb307ae252">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:Depreciation
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM3MTkw_a60d651a-33f7-4ae8-bd28-e433db4ccd27"
      unitRef="usd">1300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM3MTk0_cea4511f-035b-4fcd-9b06-ba7b4c0a4969"
      unitRef="usd">1400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM3MjAy_4deae9dc-2483-428e-9b52-328d8b6890d9"
      unitRef="usd">1500000</us-gaap:Depreciation>
    <us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3NjEyODA_ac85b091-87b4-4fa0-9b75-6b25f699b47f">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capitalized Cloud Computing Set-up Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain set-up costs for the Company&#x2019;s cloud computing arrangements. The capitalized implementation costs are then amortized over the term of the cloud computing arrangement inclusive of expected contract renewals, which are generally three years to ten years. As of December&#160;31, 2021, the Company had capitalized cloud computing set-up costs with a carrying amount of $0.4&#160;million in Other current assets and prepaid expenses and $3.5&#160;million in Other long-term assets. As of and during the year ended December&#160;31, 2021 there was no accumulated amortization and amortization expense recorded. The Company periodically assesses the capitalized asset for impairment and, when required, will record an associated impairment loss.&#160;During the year ended December&#160;31, 2021, the Company recognized in general and administrative expense an impairment loss of $0.2 million for capitalized cloud computing costs related to a cloud-based&#160;enterprise resource planning software.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iac4da192d3c340da971b19d3ab991663_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzEwOTk1MTE2OTgzNTA_9927e39e-7c8c-46c4-9fee-41bc1207dda2">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5bfb0aae8e4f42c682a5274dacefb148_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM3NzYy_700e58a7-0bcc-49f8-a44c-deffa8698f75">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization
      contextRef="i5f6b3f16760744dc9103390169175d8f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE3MDQyNDMwMzE0OTg4_4b6f2d10-59f0-4c0a-82f4-36f8134f4bc4"
      unitRef="usd">400000</us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization>
    <us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization
      contextRef="iffa27261393c4ab8ba5e3794d9147c89_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE3MDQyNDMwMzE1MDAy_83f89296-a639-4b49-be82-f4adcfd3a3df"
      unitRef="usd">3500000</us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization>
    <us-gaap:HostingArrangementServiceContractImplementationCostExpenseAmortization
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE3MDQyNDMwMzE1MDE5_b4dd2c4a-7b1a-467e-a1fe-7d515e75f15e"
      unitRef="usd">0</us-gaap:HostingArrangementServiceContractImplementationCostExpenseAmortization>
    <us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE3MDQyNDMwMzE1MDE5_b56e574f-91fe-4f25-93f4-c78fa22cd658"
      unitRef="usd">0</us-gaap:HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization>
    <us-gaap:HostingArrangementServiceContractImplementationCostImpairment
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4MDE1_7a9abe5b-3e77-4313-8459-03441c30850e"
      unitRef="usd">200000</us-gaap:HostingArrangementServiceContractImplementationCostImpairment>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTI1_df954999-403a-4c4d-bc23-daf8fe5a2cbe">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and intangible assets with indefinite useful lives are not amortized but are tested for impairment at least annually during the fourth quarter of the Company&#x2019;s fiscal year, or if circumstances indicate their value may no longer be recoverable. Goodwill represents the excess of the purchase price over the fair value of net identifiable assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to operate in one segment, which is considered to be the sole reporting unit and, therefore, goodwill was tested for impairment at the enterprise level. As of December&#160;31, 2021, there has been no impairment of goodwill. All acquired intangible assets have been fully amortized as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NTU3_a352c42b-7f4b-48db-b48d-bb22e372a602"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NzIw_c0a2dccd-927d-4561-959a-05f80d7df03b"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:StandardProductWarrantyPolicy
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQy_a92cf0d1-f253-4731-9a91-be5737cb6aab">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warranty Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides a 12-month warranty for direct sales to customers. For sales to distributors, the Company generally provides a 14-month warranty for parts only, with labor being provided to the end customer by the distributor.&lt;/span&gt;&lt;/div&gt;After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis.</us-gaap:StandardProductWarrantyPolicy>
    <cutr:StandardProductWarrantyTermDirectSales
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3ODc1MDY_dd242158-bd7d-41ec-af77-bdef54efae9d">12</cutr:StandardProductWarrantyTermDirectSales>
    <cutr:StandardProductWarrantyTermDistributorSales
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzE3MDQyNDMwMzE1MDQ4_6245af46-430e-48eb-9e43-dafcbb5641cd">P14M</cutr:StandardProductWarrantyTermDistributorSales>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTIy_edf1345c-a4d5-4e83-b4bd-2e7726f3e43c">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective January&#160;1, 2019, the Company adopted ASC 842, which established a right-of-use ("ROU") model requiring lessees to record a right-of-use asset ("ROU asset") and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding ROU asset. Lease liabilities represent the present value of the Company&#x2019;s future lease payments over the &lt;/span&gt;&lt;/div&gt;expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company&#x2019;s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LessorLeasesPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTI2_dd1df88b-0319-4929-9035-c002487e2aa6">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting for Leases as a Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases equipment to customers through membership programs and receives a fixed monthly fee over the term of the arrangement. The Company classifies its lease income as product revenue. The Company recognizes lease income over the term of the lease if the lease is classified as an operating lease. For agreements that grant customers the right to purchase the leased system, the Company typically classifies the lease as a sales-type lease as the Company has determined it is reasonably certain that the customer will exercise the purchase option. On the commencement of sales-type leases, the Company recognizes revenue upfront in product revenue and the corresponding receivables is classified in Other current assets and prepaid expenses on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 11 to the consolidated financial statements for more information regarding leasing arrangements.&lt;/span&gt;&lt;/div&gt;</us-gaap:LessorLeasesPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTIz_2a25b236-ac3c-452f-830d-bdaaef317805">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue consists primarily of material, finished and semi-finished products purchased from third-party manufacturers, labor, stock-based compensation expenses, overhead involved in the Company's internal manufacturing processes, service contracts, technology license amortization and royalties, costs associated with equipment leasing, costs associated with product warranties and any inventory write-downs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's system sales include a control console, universal graphic user interface, control system software, high voltage electronics and a combination of applications (referred to as &#x201c;hand pieces&#x201d;). Hand pieces are programmed to have a limited number of uses to ensure the safety of the device to patients. The Company sells refurbished hand pieces, or "refills," of its &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Titan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; truSculpt 3D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; products and provides for the cost of refurbishment of these hand pieces as part of cost of revenue. When customers purchase a replacement hand piece or are provided a replacement hand piece under a warranty or service contract, the Company ships the customer a previously refurbished unit. Upon the receipt of the expended hand piece from the customer, the Company capitalizes the expended hand piece as inventory at the estimated fair value. Cost of service revenue includes the costs incurred to refurbish hand pieces.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQ3_7a7ff275-2ece-4bcb-bd56-28be86d98d45">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Expenditures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs are expensed as incurred and include costs related to research, design, development, testing of products, salaries, benefits and other headcount related costs, facilities, material, third party contractors, regulatory affairs, clinical and development costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTM0_9c8cfee6-0202-40ef-83f4-48dd1ae565d6">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs are included as part of sales and marketing expense and are expensed as incurred. Advertising expenses for 2021, 2020 and 2019 were $2.1 million, $1.2 million&#160;and $2.8 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzQ3MDk1_251ffafe-fce8-4be8-9fc4-35890b9d0674"
      unitRef="usd">2100000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzQ3MDk5_c3df6e30-1c08-4733-8d5c-b5156bfbdfd9"
      unitRef="usd">1200000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzQ3MTA2_069fd835-0650-463e-bbd7-a27308505b3f"
      unitRef="usd">2800000</us-gaap:AdvertisingExpense>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQ4_be4f053b-3071-4c6a-a652-5dc80416dcdb">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for share-based employee compensation plans using the fair value recognition and measurement provisions under U.S. GAAP. The Company&#x2019;s share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as expense on a straight- line basis over the requisite service period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Term&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The expected term represents the weighted-average period that the stock options are expected to be outstanding prior to being exercised. The Company determines expected term based on historical exercise patterns and its expectation of the time it will take for employees to exercise options still outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: For the underlying stock price volatility of the Company&#x2019;s stock,&#160;the Company estimates volatility solely based on the Company&#x2019;s historical volatility of its stock price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Forfeitures:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company has made an accounting policy to estimate forfeitures at the time awards are granted and revises, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-Free Interest Rate:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The risk-free interest rate is based on the U.S. treasury yield curve in effect at the time of grant for the expected term of the stock option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of stock options ("options") on the grant date using the closing price of the Company's common shares on the grant date is estimated using the Black-Scholes option-pricing model using the single-option approach. The Black-Scholes option pricing model requires the use of highly subjective and complex assumptions, including the option's expected term and the price volatility of the underlying stock, to determine the fair value of award. The Company recognizes the expense associated with options using a single award approach over the requisite service period. The Company accounts for all stock options awarded to non-employees at the fair value of the award issued on the day of the grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of restricted stock units (&#x201c;RSUs&#x201d;) granted are measured on the grant date. The quantity of the RSUs units granted is calculated by dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#x2019;s common stock over the 50-day period ending on the day of the grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of Performance Stock Units (&#x201c;PSUs&#x201d;) that have operational measurement goals are measured on the grant date using the closing price of the Company&#x2019;s common shares on the grant date. The quantity of the PSUs granted is calculated by dividing a fixed award amount determined by the Board on the grant date by the average closing price of the Company&#x2019;s common stock over the 50-day period ending on the day of the grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 6 - "Stockholders&#x2019; Equity, Stock Plans and Stock-Based Compensation Expense" for a detailed discussion of the Company&#x2019;s stock plans and share-based compensation expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <cutr:ShareBasedPaymentAwardPeriodToDetermineGrantAmount
      contextRef="i541d48bf023c4fe7aae98ff86b967101_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3ODc0ODA_7bcaf0cc-5155-4029-ae4b-399909457de5">50</cutr:ShareBasedPaymentAwardPeriodToDetermineGrantAmount>
    <cutr:ShareBasedPaymentAwardPeriodToDetermineGrantAmount
      contextRef="i541d48bf023c4fe7aae98ff86b967101_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3ODc0OTM_52e58909-c005-43c5-9a2b-3d876316ff4b">50</cutr:ShareBasedPaymentAwardPeriodToDetermineGrantAmount>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQz_bc257625-1ff9-4383-abca-a7d0270a185a">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to income taxes in the United States and several foreign jurisdictions. Significant judgment is required in determining the Company&#x2019;s provision (benefit) for income taxes and income tax assets and liabilities, including evaluating uncertainties in the application of accounting principles and complex tax laws.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records a provision (benefit) for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as for loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company recognizes the deferred income tax effects of a change in tax rates in the period of enactment. The Company records a valuation allowance to reduce the Company&#x2019;s deferred tax assets to the net amount that the Company believes is more likely than &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;not&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes tax benefits from uncertain tax positions if the Company believes that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. Although the Company believes it has adequately reserved for the Company&#x2019;s uncertain tax positions (including net interest and penalties), the Company can provide no assurance that the final tax outcome of these matters will not be different. The Company makes adjustments to these reserves in accordance with income tax accounting guidance when facts and circumstances change, such as the closing of a tax audit. To the extent that the final tax outcome of these matters is different from the amounts recorded, such differences may impact the provision (benefit) for income taxes in the period in which such determination is made. The Company records interest and penalties related to the Company&#x2019;s uncertain tax positions in the Company&#x2019;s provision (benefit) for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s effective tax rates have differed from the statutory rate primarily due to changes in the valuation allowance, foreign operations, research and development tax credits, state taxes, and certain benefits realized related to stock option activity. The Company&#x2019;s current effective tax rate does not assume U.S. taxes on undistributed profits of foreign subsidiaries. These earnings could become subject to incremental foreign withholding or U.S. federal and state taxes, should they either be deemed or actually remitted to the U.S. The Company&#x2019;s future effective tax rates could be adversely affected by earnings being lower in countries where the Company has lower statutory rates and being higher in countries where the Company has higher statutory rates, or by changes in tax laws, accounting principles, interpretations thereof, net operating loss carryback, research and development tax credits, and due to changes in the valuation allowance of its U.S. deferred tax assets. In addition, the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company is subject to the examination of the Company&#x2019;s income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#x2019;s provision for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Undistributed earnings of the Company&#x2019;s foreign subsidiaries at December&#160;31, 2021 are considered to be indefinitely reinvested and, accordingly, no provision for state income taxes has been provided thereon. Due to the Transition Tax and Global Intangible Low-Tax Income (&#x201c;GILTI&#x201d;) regimes as enacted by the 2017 Tax Act, those foreign earnings will not be subject to federal income taxes when actually distributed in the form of a dividend or otherwise. The Company, however, could still be subject to state income taxes and withholding taxes payable to various foreign countries. The amounts of taxes which the Company could be subject to are not material to the accompanying financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;27, 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;). The CARES Act changed several of the existing U.S. corporate income tax laws by, among other things, increasing the amount of deductible interest, allowing companies to carry back certain Net Operating Losses (&#x201c;NOLs&#x201d;) and increasing the amount of NOLs that corporations can use to offset income. The CARES Act did not have a material impact on the Company's income tax provision, deferred tax assets and liabilities, and related taxes payable. The Company is currently assessing the future implications of these provisions within the CARES Act on the Company's consolidated financial statements but does not expect the impact to be material.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTI3_541a3579-a7f9-4305-8223-d762f46623bd">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Computation of Net Income (Loss) per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method and the if-converted method. Dilutive potential common shares include outstanding stock options, restricted stock units, performance stock units, employee stock purchase plan (ESPP) shares and conversion shares under the convertible notes. On January 1, 2021, the Company adopted the accounting standard update to simplify the accounting for convertible debt instruments. The Company now uses the if-converted method for its convertible notes in calculating the diluted net income (loss) per share, and includes the effect of potential share settlement for the convertible notes, if the effect is dilutive. The diluted net income per share is computed with the assumption that the Company will settle the convertible debt in shares, rather than cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share is the same as basic earnings per share for the periods in which the Company had a net loss because the inclusion of outstanding common stock equivalents would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTMy_9b2fd460-897d-4644-8d27-97e14e9e84c0">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) includes all changes in stockholders&#x2019; equity except those resulting from investments or contributions by stockholders. For the periods presented, the accumulated other comprehensive income (loss) consisted solely of the unrealized gains or losses on the Company's available-for- sale investments, net of tax.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTQ0_fdf5371e-0a2f-4587-88a4-52a58dc4c081">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company&#x2019;s foreign subsidiaries are translated in accordance with ASC 830, Foreign Currency Matters. The U.S. Dollar is the functional currency of the Company&#x2019;s subsidiaries and the Company&#x2019;s reporting currency. Monetary assets and liabilities are re-measured into U.S. Dollars at the applicable period end exchange rate. Sales and operating expenses are re-measured at average exchange rates in effect during each period. Gains or losses resulting from foreign currency transactions are included in net income (loss) are $1.8&#160;million in the year ended December&#160;31, 2021 and were insignificant for each of the two years ended December&#160;31, 2020. The effect of exchange rate changes on cash and cash equivalents was insignificant for each of the three years ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzM4NDgyOTA3ODc1Nzk_971ad417-a59b-4657-995f-4e357bdfcf0f"
      unitRef="usd">1800000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU4MTM1_bee10051-afe3-4fb0-92c1-e382c35cd085">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in one segment and reports segment information in accordance with ASC 280, Segment Reporting. Management uses one measurement of profitability and does not segregate its business for internal reporting. As of December&#160;31, 2021&#160;and 2020, 99.0% and 98.0% of long-lived assets were in the United States, respectively. Revenue is attributed to a geographic region based on the location of the end customer. See Note 10 &#x2013; "Segment Information and Revenue by Geography and Products" for details relating to revenue by geography.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU3NjI2_a2994e08-224f-4ec8-b9e9-d721f6a787ab"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <cutr:PercentageOfAssets
      contextRef="i5d7848312e9548839319d5ac37eca97c_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU3ODQy_7ec4f4a0-9520-486e-aba4-d425ff6ae524"
      unitRef="number">0.990</cutr:PercentageOfAssets>
    <cutr:PercentageOfAssets
      contextRef="i4bc9b22641b0417da7e8a81fcaf59a1b_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDMvZnJhZzozZTI2ZjI2NjdiMTQ0NDgwOWMwZjgyNGMzNTAzYTBlYy90ZXh0cmVnaW9uOjNlMjZmMjY2N2IxNDQ0ODA5YzBmODI0YzM1MDNhMGVjXzU3ODQ5_db703cb7-c0bc-4cc5-8c82-8c5cb3dfd70b"
      unitRef="number">0.980</cutr:PercentageOfAssets>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90ZXh0cmVnaW9uOjk0NzJjMjhmMTA4NTQ0NTU4MjU5Yzk3Y2MyOWE5MWIxXzE5MzQ_6ec5d864-2e5c-46ef-a47f-9ef1ef65cba7">CASH, CASH EQUIVALENTS AND RESTRICTED CASH&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize cash, cash equivalents and marketable securities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents and restricted cash as reported within the Consolidated Statement of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no marketable securities as of December&#160;31, 2021 and December&#160;31, 2020. The cash is restricted to support an outstanding letter of credit for $0.7 million provided to a supplier.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90ZXh0cmVnaW9uOjk0NzJjMjhmMTA4NTQ0NTU4MjU5Yzk3Y2MyOWE5MWIxXzE5MzE_64ae7c03-9778-429b-bea2-a58c9cf6b6c2">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize cash, cash equivalents and marketable securities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents and restricted cash as reported within the Consolidated Statement of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90YWJsZTo0ZDI4YzZmYjc5N2I0MmY0YTkyMzk4OTUyYmUxY2E1YS90YWJsZXJhbmdlOjRkMjhjNmZiNzk3YjQyZjRhOTIzOTg5NTJiZTFjYTVhXzMtMS0xLTEtMjg2MjE_41903ba8-bf3b-4a82-ad91-ffcf958482e7"
      unitRef="usd">164164000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90YWJsZTo0ZDI4YzZmYjc5N2I0MmY0YTkyMzk4OTUyYmUxY2E1YS90YWJsZXJhbmdlOjRkMjhjNmZiNzk3YjQyZjRhOTIzOTg5NTJiZTFjYTVhXzMtMy0xLTEtMjg2MjE_cf3ee0fd-1fec-4fc2-b9cd-d1841805fcf7"
      unitRef="usd">47047000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90YWJsZTo0ZDI4YzZmYjc5N2I0MmY0YTkyMzk4OTUyYmUxY2E1YS90YWJsZXJhbmdlOjRkMjhjNmZiNzk3YjQyZjRhOTIzOTg5NTJiZTFjYTVhXzMtMS0xLTEtNDY4MjM_7e6c4d17-670a-4f7c-9235-d5d55ef6e2a0"
      unitRef="usd">700000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90YWJsZTo0ZDI4YzZmYjc5N2I0MmY0YTkyMzk4OTUyYmUxY2E1YS90YWJsZXJhbmdlOjRkMjhjNmZiNzk3YjQyZjRhOTIzOTg5NTJiZTFjYTVhXzMtMy0xLTEtNDY4MjM_1d9b95b7-f34c-45eb-a46a-46a46dde4d74"
      unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90YWJsZTo0ZDI4YzZmYjc5N2I0MmY0YTkyMzk4OTUyYmUxY2E1YS90YWJsZXJhbmdlOjRkMjhjNmZiNzk3YjQyZjRhOTIzOTg5NTJiZTFjYTVhXzQtMS0xLTEtNDY4MjM_bf936f2e-c4d7-4221-9c3f-5328bdd2745b"
      unitRef="usd">164864000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90YWJsZTo0ZDI4YzZmYjc5N2I0MmY0YTkyMzk4OTUyYmUxY2E1YS90YWJsZXJhbmdlOjRkMjhjNmZiNzk3YjQyZjRhOTIzOTg5NTJiZTFjYTVhXzQtMy0xLTEtNDY4MjM_74280b8d-c055-4e0c-9a4c-10e79e5cf416"
      unitRef="usd">47047000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:MarketableSecurities
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90ZXh0cmVnaW9uOjk0NzJjMjhmMTA4NTQ0NTU4MjU5Yzk3Y2MyOWE5MWIxXzEwOTk1MTE2MzAyMDY_699353c3-0a1a-489b-bedf-7deb2d1e87eb"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90ZXh0cmVnaW9uOjk0NzJjMjhmMTA4NTQ0NTU4MjU5Yzk3Y2MyOWE5MWIxXzEwOTk1MTE2MzAyMDY_eca06360-68db-446d-8714-90be7a0339b3"
      unitRef="usd">0</us-gaap:MarketableSecurities>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMDkvZnJhZzo5NDcyYzI4ZjEwODU0NDU1ODI1OWM5N2NjMjlhOTFiMS90ZXh0cmVnaW9uOjk0NzJjMjhmMTA4NTQ0NTU4MjU5Yzk3Y2MyOWE5MWIxXzE3MDQyNDMwMjM4ODY0_7782c610-810a-4329-b0cd-fae65faa9fca"
      unitRef="usd">700000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzI3NTY_bc79bdf7-47d7-4568-993c-3c71a82a3b73">BALANCE SHEET DETAIL&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation adjustments for excess and obsolete inventory, reflected as a reduction of inventory at December&#160;31, 2021 and 2020, were $4.9 million and $3.9 million, respectively. Inventories, net of these adjustments, consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net, consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment leasing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment and furniture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in machinery and equipment are financed vehicles used by the Company&#x2019;s sales employees. As of December&#160;31, 2021 and&#160;2020, the gross capitalized value of the leased vehicles was $2.6 million and $1.8 million, respectively, and the related accumulated depreciation was $1.5 million and $1.4 million at December&#160;31, 2021 and 2020, respectively. Included in Property and equipment as of December&#160;31, 2021 and&#160;2020 is construction in progress of $0.8 million and $0.4 million, respectively, which is yet to be depreciated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is related to the acquisition of Iridex&#x2019;s aesthetic business unit, and customer relationships in the Benelux countries acquired from a former distributor in 2013. Goodwill was $1.3 million as of December&#160;31, 2021 and 2020. There were no impairments or additions to goodwill during the years ended December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bonus and payroll-related accruals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued inventory in transit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:InventoryValuationReserves
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzE1OQ_55f47a40-d572-4da7-bc72-7077539d3705"
      unitRef="usd">4900000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzE2Ng_8e91f000-d639-4280-a02d-f34a479490fc"
      unitRef="usd">3900000</us-gaap:InventoryValuationReserves>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzI3NTc_946cca96-d649-4683-b18f-dca9b30554d9">Inventories, net of these adjustments, consist of the following (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzItMS0xLTEtMjg2MjE_ad4ec401-8843-4e12-832b-824bc3905288"
      unitRef="usd">24035000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzItMy0xLTEtMjg2MjE_ea2a9a33-238d-4908-b1ec-275e0854a192"
      unitRef="usd">14874000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzMtMS0xLTEtMjg2MjE_90d00f66-b2f9-4367-bd38-d47d49640abe"
      unitRef="usd">2124000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzMtMy0xLTEtMjg2MjE_846f9bff-306c-44af-901f-390068e8583d"
      unitRef="usd">1030000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzQtMS0xLTEtMjg2MjE_c6f0436f-8676-4ca8-95fa-67f066ed095e"
      unitRef="usd">13344000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzQtMy0xLTEtMjg2MjE_19673591-60f5-49e7-b9a7-8116a17e23ff"
      unitRef="usd">12604000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzUtMS0xLTEtMjg2MjE_3b2a8161-6b35-46ca-b7b9-1b8534036f99"
      unitRef="usd">39503000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTo5YjFhMDUyMDA0YTA0MjY2OTU2NjZmZTY4NTYyMGE1OC90YWJsZXJhbmdlOjliMWEwNTIwMDRhMDQyNjY5NTY2NmZlNjg1NjIwYTU4XzUtMy0xLTEtMjg2MjE_f1c80550-83a5-4c75-8c21-b30979b78bbc"
      unitRef="usd">28508000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6f352492b09240419cedf42adcbed4e3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzItMS0xLTEtMjg2MjE_96d7742a-cc65-48e0-8f75-abac5825d06e"
      unitRef="usd">826000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if050ebe27c6a45b6afb9c2a998414be2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzItMy0xLTEtMjg2MjE_365eae17-c19d-41f9-b25b-abb01675a8bf"
      unitRef="usd">1051000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4550dd7ebeeb4ea9baad304474ac9979_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzMtMS0xLTEtMjg2MjE_f318f861-f294-4875-a2fe-82ff6a8c1331"
      unitRef="usd">107000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i116594d0783a424a8fafeb1b4f59c8e1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzMtMy0xLTEtMjg2MjE_81120c4d-9057-4526-a97d-2b904bcb9191"
      unitRef="usd">186000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i95e3d048dc634a71897f460779f082a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzQtMS0xLTEtMjg2MjE_f30a5a13-4d14-49da-9e2f-b9341ebc58a4"
      unitRef="usd">1527000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic4d4966eb9a940dfa6db6a00a25b33db_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzQtMy0xLTEtMjg2MjE_eaf00988-3cb5-477d-98b4-eb03392b04ae"
      unitRef="usd">3407000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="idcea864f6da04951ab895dcc2436d3cf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzUtMS0xLTEtMjg2MjE_d2ac6751-75fa-4fce-b12e-2bfbeb9143b1"
      unitRef="usd">3983000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i06d8947881bc48feaed989df52b60b1a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzUtMy0xLTEtMjg2MjE_0a54a0d3-269d-47c0-a22e-694450b307ea"
      unitRef="usd">7683000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzYtMS0xLTEtMjg2MjE_1a70a0a1-c508-4e9c-bb02-8abf52c67be0"
      unitRef="usd">6443000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzYtMy0xLTEtMjg2MjE_1756aef2-01c5-493e-bceb-f0bd47cc3901"
      unitRef="usd">12327000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzctMS0xLTEtMjg2MjE_8762e57b-5abe-4056-acb4-960589973e32"
      unitRef="usd">3424000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzctMy0xLTEtMjg2MjE_eaa83f31-3147-4b28-8708-dd8b57741f42"
      unitRef="usd">10028000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzgtMS0xLTEtMjg2MjE_d94f5dc1-be16-4cf5-8ec2-d4ec2f1729ea"
      unitRef="usd">3019000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTpkNGIxZDE5YTlkN2M0YjYxOTdhOTlhMDkwNTEwOGUyYi90YWJsZXJhbmdlOmQ0YjFkMTlhOWQ3YzRiNjE5N2E5OWEwOTA1MTA4ZTJiXzgtMy0xLTEtMjg2MjE_f801c9b8-fac2-493c-8562-1ae9885a6c9a"
      unitRef="usd">2299000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ib7c26e3ef9c442a8832ed31ed63f16e7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzUzNg_7f0b1649-c568-482d-997a-72df1a004121"
      unitRef="usd">2600000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i314e69e3501a4ea3a3bc04ee5a0601b0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzU0Mw_9b3fd3f6-c71f-49ec-add5-4efede283677"
      unitRef="usd">1800000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="ib7c26e3ef9c442a8832ed31ed63f16e7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzYwNg_97037d5e-2c29-477e-9977-b82156ea73a9"
      unitRef="usd">1500000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="i314e69e3501a4ea3a3bc04ee5a0601b0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzI3NDg3NzkwNzQwNjk_e1fe65bd-0492-469b-8f7b-c6b1708c827d"
      unitRef="usd">1400000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic330d4e7bda4436ea9b5a447faa2ab15_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzcxMw_f0ead761-5cfe-4b4a-ad90-a7f07201a160"
      unitRef="usd">800000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iaf1149b9e76a4c089deaa8f058629d53_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzI3NDg3NzkwNzQwOTY_ebdf0227-621a-491c-b8cc-d4344d4efd29"
      unitRef="usd">400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzEwOTk1MTE2MzE3OTg_47cbef42-e2dd-42ef-bb27-b72ce4fbc2ca"
      unitRef="usd">1300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzEwOTk1MTE2MzE3OTg_7457ab6b-f471-48c6-9871-b38bab268d64"
      unitRef="usd">1300000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzE0MTQ_59f93b30-d276-45bb-8d6c-ef6433b5cc93"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzE0MTQ_6558adc9-e2b6-4ddf-a660-dbeb87aa36ec"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzE0MTQ_98ae1cfd-7b23-48b4-8e84-c1e4e74e0643"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzE0MTQ_c34395cb-5896-4029-b9c4-a2811337005d"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90ZXh0cmVnaW9uOjhkMjIwNDkyNmIwOTQ2MmFiOGQzOTgzMzJkOWVkYmY3XzI3NTk_2d6e3027-8013-422d-94df-4114d2040eeb">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.439%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bonus and payroll-related accruals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued inventory in transit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzItMS0xLTEtMjg2MjE_724b320f-f6d3-433a-a9c3-35c9f65f3af3"
      unitRef="usd">21649000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzItMy0xLTEtMjg2MjE_be818384-ef8e-434a-ae07-4de609d4e918"
      unitRef="usd">12197000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <cutr:AccruedSalesAndMarketingCostsCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzMtMS0xLTEtMjg2MjE_5b673765-4be3-4969-b790-8d850e3e8f51"
      unitRef="usd">4808000</cutr:AccruedSalesAndMarketingCostsCurrent>
    <cutr:AccruedSalesAndMarketingCostsCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzMtMy0xLTEtMjg2MjE_dc16df21-d816-427b-93cf-5badc34320a9"
      unitRef="usd">2352000</cutr:AccruedSalesAndMarketingCostsCurrent>
    <cutr:AccruedInventoryInTransitCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzQtMS0xLTEtNDM3MjM_aaaba44a-5263-4e34-ae1c-c068f1399999"
      unitRef="usd">4265000</cutr:AccruedInventoryInTransitCurrent>
    <cutr:AccruedInventoryInTransitCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzQtMy0xLTEtNDM3MTI_9dfcdef8-5132-4785-b8d5-96c4b046c224"
      unitRef="usd">2476000</cutr:AccruedInventoryInTransitCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzQtMS0xLTEtMjg2MjE_b72f61b2-995e-42b6-a547-f9eb49631823"
      unitRef="usd">3947000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzQtMy0xLTEtMjg2MjE_d8214529-3b0c-44c7-8eb2-dee6a614bc3d"
      unitRef="usd">4124000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzUtMS0xLTEtMjg2MjE_d955273e-7320-42b0-8f8f-f120a685f84c"
      unitRef="usd">9110000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzUtMy0xLTEtMjg2MjE_7fda6524-cf27-418f-b008-bfd45c721315"
      unitRef="usd">5343000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzYtMS0xLTEtMjg2MjE_6d3a7a11-916b-4fef-97bc-9e03959d6403"
      unitRef="usd">10321000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzYtMy0xLTEtMjg2MjE_27cc7d1c-e308-4f13-a4ec-e35525a3afd2"
      unitRef="usd">5803000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzctMS0xLTEtMjg2MjE_b9eea191-fc8a-40e9-aa79-e678ac1de1fc"
      unitRef="usd">54100000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTIvZnJhZzo4ZDIyMDQ5MjZiMDk0NjJhYjhkMzk4MzMyZDllZGJmNy90YWJsZTozZTBkNjlmYzQyOGM0YTRkYTkxMGIwZDlhNDM0YjQzYy90YWJsZXJhbmdlOjNlMGQ2OWZjNDI4YzRhNGRhOTEwYjBkOWE0MzRiNDNjXzctMy0xLTEtMjg2MjE_2235ffd7-ddd3-47c1-8969-b1d415dfdebd"
      unitRef="usd">32295000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ProductWarrantyDisclosureTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90ZXh0cmVnaW9uOjQxZjBkMmUwMjI0ZjRiNDY5ZjczYzRhZWE5ZTk5MWVjXzE1MDg_93fa9311-bc9d-4d15-b3e7-8cc307b90ca1">PRODUCT WARRANTY &lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a direct field service organization in North America (including Canada). Internationally, the Company provides direct service support in Australia, Austria, Belgium, France, Germany, Hong Kong, Japan, the Netherlands, and Switzerland, as well as through third-party service providers in Spain and the United Kingdom. In several other countries, where the Company does not have a direct presence, the Company provides service through a network of distributors and third-party service providers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After the original warranty period, maintenance and support are offered on an extended service contract basis or on a time and materials basis. The Company provides the estimated cost to repair or replace products under standard warranty at the time of sale. Costs&#160;in connection with extended service contracts are recognized at the time when costs are incurred. The following table provides the changes in the product standard warranty accrual for the years ended December&#160;31, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Accruals for warranties issued during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Settlements made during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90ZXh0cmVnaW9uOjQxZjBkMmUwMjI0ZjRiNDY5ZjczYzRhZWE5ZTk5MWVjXzE1MDc_76dad24e-382e-4305-8550-8704023f1dd3">The following table provides the changes in the product standard warranty accrual for the years ended December&#160;31, 2021 and 2020 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Accruals for warranties issued during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Settlements made during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzItMS0xLTEtMjg2MjE_88070e7d-ad87-4144-bebc-626b553c7f61"
      unitRef="usd">4124000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzItMy0xLTEtMjg2MjE_1e303f82-eeac-4448-8bc4-b24a2d950d44"
      unitRef="usd">6400000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzMtMS0xLTEtMjg2MjE_9764e33f-8070-4ca2-a239-01ee19b9ef3f"
      unitRef="usd">5135000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualWarrantiesIssued
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzMtMy0xLTEtMjg2MjE_c81cd32c-3fe9-49dc-9423-a6d1a26a3653"
      unitRef="usd">4475000</us-gaap:StandardProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzQtMS0xLTEtMjg2MjE_2e8662b8-c514-4639-aebc-b01ee95f8e02"
      unitRef="usd">5312000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrualPayments
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzQtMy0xLTEtMjg2MjE_92b06879-4b72-470b-899b-2982d25eaa7a"
      unitRef="usd">6751000</us-gaap:StandardProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzUtMS0xLTEtMjg2MjE_d1618a3e-810e-45aa-a6f5-7959a2639b52"
      unitRef="usd">3947000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMTgvZnJhZzo0MWYwZDJlMDIyNGY0YjQ2OWY3M2M0YWVhOWU5OTFlYy90YWJsZTo3M2IyNzA0YmVmMjM0NDlhYjRlMDkxNWM3MjEyYjQ3Ny90YWJsZXJhbmdlOjczYjI3MDRiZWYyMzQ0OWFiNGUwOTE1YzcyMTJiNDc3XzUtMy0xLTEtMjg2MjE_8c53cad3-7066-4702-b504-a7c2969d084d"
      unitRef="usd">4124000</us-gaap:StandardProductWarrantyAccrual>
    <cutr:ContractWithCustomerLiabilityTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2Xzc3NA_2e982f07-e0c6-49cd-af1f-f80dc6a10390">DEFERRED REVENUE&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records deferred revenue when revenue is to be recognized subsequent to invoicing. For extended service contracts, the Company generally invoices customers at the beginning of the extended service contract term. The Company&#x2019;s extended service contracts typically have &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzM4NDgyOTA2OTc5OTU_298632bb-c8d5-4a4a-94e5-1559caf89ce1"&gt;one&lt;/span&gt; to three-year terms. Deferred revenue also includes payments for training. Approximately 86% of the Company&#x2019;s deferred revenue balance of $10.8 million as of December&#160;31, 2021, will be recognized over the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides changes in the deferred contract revenue balance for the years ended December&#160;31, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Payments received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Revenue recognized from current period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Revenue recognized from beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,779)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs for extended service contracts were $8.3 million, $8.2 million and $9.3 million, respectively, for the years&#160;ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</cutr:ContractWithCustomerLiabilityTextBlock>
    <cutr:ExtendedServiceContractOptionTwoTerm
      contextRef="i54949609fd0c4fddb72cfc46650cb0e8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzE3MDQyNDMwMjMxNDI3_d0322fe0-a8ce-4dc0-8208-d1f1f8c19b47">P3Y</cutr:ExtendedServiceContractOptionTwoTerm>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ib79906570e2049eabe51c068e7921170_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzQ0Nw_7d119df3-05fc-4985-bf3b-77801aef3a44"
      unitRef="number">0.86</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ib79906570e2049eabe51c068e7921170_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzQ5NQ_3664d09f-b008-4221-bca6-8806bf86c67d"
      unitRef="usd">10800000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ib79906570e2049eabe51c068e7921170_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzU0MA_e26054bc-b97a-40fa-adb5-e3be4c1a741f">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2Xzc3NQ_55093805-5148-48a4-a3ad-50bbe6651ad0">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides changes in the deferred contract revenue balance for the years ended December&#160;31, 2021 and 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Payments received&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Revenue recognized from current period sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Revenue recognized from beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,779)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzItMS0xLTEtMjg2MjE_7bab343a-0c76-4ca4-bda1-830e23c1ad62"
      unitRef="usd">11237000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzItMy0xLTEtMjg2MjE_36b68a56-9cb7-44a5-9b75-68c7271a37da"
      unitRef="usd">14222000</us-gaap:ContractWithCustomerLiability>
    <cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzMtMS0xLTEtMjg2MjE_3e6e9762-aae5-4ab7-8d99-63e79eab59a9"
      unitRef="usd">17139000</cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived>
    <cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzMtMy0xLTEtMjg2MjE_2746047c-4fd0-4d61-928f-a62dabb7e2be"
      unitRef="usd">14131000</cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived>
    <cutr:ContractWithCustomerLiabilityDecreaseFromRevenueDeferred
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzQtMS0xLTEtMjg2MjE_d4fb3f6a-781f-4a69-a44c-719f4588906a"
      unitRef="usd">7006000</cutr:ContractWithCustomerLiabilityDecreaseFromRevenueDeferred>
    <cutr:ContractWithCustomerLiabilityDecreaseFromRevenueDeferred
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzQtMy0xLTEtMjg2MjE_23d1aa72-48c3-4704-8171-45bfefb84088"
      unitRef="usd">6337000</cutr:ContractWithCustomerLiabilityDecreaseFromRevenueDeferred>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzUtMS0xLTEtMjg2MjE_aa747d6a-ed7b-403a-86a5-3c6223f9d06c"
      unitRef="usd">10545000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzUtMy0xLTEtMjg2MjE_714d715a-5a03-421f-b05d-28a761349fdc"
      unitRef="usd">10779000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzYtMS0xLTEtMjg2MjE_4fb81e94-154f-423c-b661-4c4a6812238d"
      unitRef="usd">10825000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90YWJsZTo2NTMxODY3ZDZlZDU0ZGEwYmVjNWZmZjZkYTgyMTRhYi90YWJsZXJhbmdlOjY1MzE4NjdkNmVkNTRkYTBiZWM1ZmZmNmRhODIxNGFiXzYtMy0xLTEtMjg2MjE_945e6586-aa8f-4acf-9ced-9a1f3450fb25"
      unitRef="usd">11237000</us-gaap:ContractWithCustomerLiability>
    <cutr:DeferredRevenueCostsIncurred
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzcxMg_2be2be4e-96a2-437b-a33a-fff991457e59"
      unitRef="usd">8300000</cutr:DeferredRevenueCostsIncurred>
    <cutr:DeferredRevenueCostsIncurred
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzcxNg_0a0833c4-1b4d-47bb-8973-06862a0305f3"
      unitRef="usd">8200000</cutr:DeferredRevenueCostsIncurred>
    <cutr:DeferredRevenueCostsIncurred
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjEvZnJhZzo2ZDZhNDZjZTIyOTI0ZWI4YTcyZDE3MDMxMmVmNTMzNi90ZXh0cmVnaW9uOjZkNmE0NmNlMjI5MjRlYjhhNzJkMTcwMzEyZWY1MzM2XzcyMw_ca853bfb-7184-4af9-93e6-78723c90b89f"
      unitRef="usd">9300000</cutr:DeferredRevenueCostsIncurred>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE1NDgw_2f41d232-df16-4cd2-8fe8-01941e957ce4">STOCKHOLDERS&#x2019; EQUITY, STOCK PLANS AND STOCK-BASED COMPENSATION EXPENSE&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company had one class of issued common stock with a par value of $0.001. Authorized capital stock consists of 55,000,000 shares comprised of two classes: (i) 50,000,000 shares of Common Stock, of which 17,995,344 shares are issued and outstanding as of December&#160;31, 2021, and (ii) 5,000,000 shares of preferred stock, par value $0.001 per share (&#x201c;Preferred Stock&#x201d;), of which no shares are issued and outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Issuances of Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;21, 2020, the Company issued and sold an aggregate of 2,742,750 shares of the Company&#x2019;s common stock, par value $0.001 per share at a price to the public of $10.50 per share. The shares include the full exercise of the underwriter&#x2019;s option to purchase an additional 357,750 shares of common stock. The Company received net proceeds from the offering of approximately $26.5 million, after deducting underwriting discounts, commissions and offering expenses of $2.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company had the following stock-based employee compensation plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2004 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 1998, the Company adopted the 1998 Stock Plan, or 1998 Plan, under which 4,650,000 shares of the Company&#x2019;s common stock were reserved for issuance to employees, directors and consultants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;12, 2004, the Board of Directors (&#x201c;the Board&#x201d;) adopted the 2004 Equity Incentive Plan. A total of 1,750,000 shares of common stock were originally reserved for issuance pursuant to the 2004 Equity Incentive Plan. In addition, the shares reserved for issuance under the 2004 Equity Incentive Plan included shares reserved but un-issued under the 1998 Plan and shares returned to the 1998 Plan as the result of termination of options or the repurchase of shares. In 2012 the stockholders approved a &#x201c;fungible share&#x201d; provision whereby each full-value award issued under the 2004 Equity Incentive Plan results in a requirement to subtract 2.12 shares from the shares reserved under the Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2019 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the Company&#x2019;s Annual Meeting of Stockholders on June&#160;14, 2019, the Company&#x2019;s stockholders approved the 2019 Equity Incentive Plan, which is an amendment and restatement of the 2004 Equity Incentive Plan. The 2004 Equity Incentive Plan was amended to: (i) increase the number of shares available for future grant by 700,000 (in addition to the 9,701,192 shares provided under the 2004 Equity Incentive Plan; (ii) extend the term of the 2004 Equity Incentive Plan to the date of the Annual Meeting of the Company&#x2019;s stockholders in 2029; (iii) amend the 2004 Equity Incentive Plan to eliminate the requirement for awards granted on or after June&#160;14, 2019 that any shares subject to awards with an exercise price less than fair market value on the date of such grant will be counted against the Plan as 2.12 shares for each full value share awarded in accordance with the 2004 Equity Incentive Plan; (iv) amend the 2004 Equity Incentive Plan to remove the requirement that any shares subject to awards with an exercise price less than fair market value on the date of such grant will be counted against the Plan as 2.12 shares for each full value share awarded; (v) amend the 2004 Equity Incentive Plan to remove certain provisions relating to the &#x201c;performance based compensation&#x201d; exception under Section 162(m) of the Internal Revenue Code of 1986, as amended; (vi) include a minimum one-year vesting period with respect to awards granted under the 2004 Equity Incentive Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;11, 2019, the Board also approved, amended and restated the Company&#x2019;s Stock Ownership Guidelines adopted on July&#160;28, 2017 in their entirety, to require all officers (as defined by Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) to hold at least 50% of any shares received pursuant to stock options, stock appreciation rights, vested restricted stock awards (&#x201c;RSAs&#x201d;), restricted stock units (&#x201c;RSUs&#x201d;), or performance stock units (&#x201c;PSUs&#x201d;) (net of taxes) for a minimum of one year following vesting and delivery.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;11, 2019, the Board also adopted a clawback policy to permit recovery of certain compensation paid to Named Executive Officers (as defined in Item 402 of Regulation S-K) of the Company if the Compensation Committee of the Board determines that a Named Executive Officer (i) has violated law, the Company&#x2019;s Code of Business Conduct and Ethics, or any significant ethics or compliance policies, and (ii) such conduct results in material financial or reputational harm, or results in a need for a restatement of the Company&#x2019;s consolidated financial statements. The Amended and Restated Plan provides for the grant of incentive stock options, non-statutory stock options, RSAs, RSUs, stock appreciation rights, PSUs, and other stock or cash awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2020, stockholders approved an amendment and restatement of the 2019 Equity Incentive Plan (the &#x201c;Prior Plan&#x201d;) as the Amended and Restated 2019 Equity Incentive Plan (the &#x201c;Restated Plan&#x201d;) and approved an additional 600,000 shares, available for future grants. The Restated Plan provides for the grant of incentive stock options, non-statutory stock options, RSAs, RSUs, stock appreciation rights, PSUs, and other stock or cash awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s non-employee directors are granted $60,000 of RSUs annually on the date of the Company&#x2019;s Annual Meeting of stockholders. These RSUs cliff-vest on the one-year anniversary of the grant date. In the years ended December&#160;31, 2021, 2020 and 2019, the Company issued 41,301, 35,735 and 42,236 RSUs, respectively, to its non-employee directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the years ended December&#160;31, 2021, 2020&#160;and 2019, the Company&#x2019;s Board of Directors granted 219,686, 405,248 and 475,166 RSUs, respectively, to its executive officers, directors and certain members of the Company&#x2019;s management related to annual grants and new hire grants. The annual grant RSUs vest quarterly on each of the first &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDAw_eb99cd2f-e555-49f7-b0bf-9cc8cd023330"&gt;four&lt;/span&gt; anniversaries of the vest date and the new hire RSUs vest one quarter on the first anniversary and monthly thereafter for 36 months. The Company measured the fair market values of the underlying stock on the dates of grant and recognizes the stock-based compensation expense over the vesting period. On the vesting date, the Company issues common stock, net of stock withheld to settle the recipient&#x2019;s minimum statutory tax liability. In addition to the 2020 annual RSU grants, on April 1, 2020, the Company issued RSUs to settle bonuses owed to management under the 2019 Management Bonus Program. In the past, the Company has paid these bonuses with cash. However, due to the economic conditions resulting from COVID-19, fully vested shares were issued in lieu of cash. The Company issued 209,981 shares related to this bonus payment to management and recognized $2.6&#160;million in stock-based compensation expense. The Company also recorded an equivalent reduction in bonus expense as a result of the settlement of the bonus in shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the years ended December 31, 2021, 2020 and 2019 the Company&#x2019;s Board of Directors granted its executive officers and certain senior management employees 178,222, 76,157, and 319,275 PSUs, respectively, related to its annual grants. The 2019 and 2020 grants vested on the first anniversary subject to the achievement of pre-established performance goals. The 2021 grant quantity vested one half on the first anniversary subject to the achievement of pre-established performance goals and the remaining half vested on the second anniversary subject to the recipient&#x2019;s continued service. In addition to the 2021 annual PSU grants, in July 2021, the Company granted 265,002 PSUs to certain employees. This grant consists of four separate vesting tranches that will vest from April 2023 through June 2024 upon the achievement of operational milestones associated with each tranche and continued service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2019, the Board awarded its new CEO, David H. Mowry, 67,897 PSUs, which are scheduled to vest over four years from 2019 through 2022. These PSUs are subject to certain performance-based criteria related to achieving financial metrics in the Board approved annual budgets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Board awarded its new CFO, Rohan Seth, 60,000 stock options, which vests over five years, and 22,423 PSUs, which vests over 2.5 years and is subject to performance-based criteria relating to the achievement of certain department and financial goals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;12, 2004, the Board of Directors adopted the 2004 Employee Stock Purchase Plan. Under the 2004 Employee Stock Purchase Plan, or 2004 ESPP, eligible employees are permitted to purchase common stock at a discount through payroll deductions. The 2004 ESPP offering and purchase periods are for six months. The 2004 ESPP has an evergreen provision based on which shares of common stock eligible for purchase are increased on the first day of each fiscal year by an amount equal to the lesser of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;600,000 shares;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;2.0% of the outstanding shares of common stock on such date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;an amount as determined by the Board of Directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The price of the common stock purchased is the lower of 85% of the fair market value of the common stock at the beginning or end of the six-month offering period. In the years ended December&#160;31, 2021, 2020, and 2019, under the 2004 ESPP, the Company issued 59,635, 56,751, and 82,810 shares, respectively. At December&#160;31, 2021, 645,319 shares remained available for future issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Option and Award Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the 2004 Plan and 2019 Equity Incentive Plan is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Available&lt;br/&gt;For Grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions ) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,141,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.52&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional shares reserved&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,538,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional shares reserved&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(804,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,085,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional shares reserved&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(744,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;947,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Vested and expected to vest as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Based on the closing stock price of $41.32 of the Company&#x2019;s stock on December&#160;31, 2021, $24.11 on December&#160;31, 2020, $35.81 on December&#160;31, 2019 and $17.02 on December&#160;31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Approved by the board of directors and stockholders in 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value and is the aggregate difference between the Company&#x2019;s closing stock price on the last trading day of the fiscal year and the exercise price, multiplied by the number of in-the-money options. The aggregate intrinsic amount changes based on the fair market value of the Company&#x2019;s common stock. Total intrinsic value of options exercised in 2021, 2020 and 2019 was $1.3 million, $0.4 million, and $1.0 million, respectively. The options outstanding and exercisable at December&#160;31, 2021 were in the following exercise price ranges:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercise&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prices&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$14.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$14.10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$15.32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$25.70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$29.28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$32.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$39.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$47.40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$10.79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$47.40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;287,175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;83,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Awards (RSU and PSU) Activity Table&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information with respect to RSUs and PSUs activity is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.156%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant-&lt;br/&gt;Date Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(684,491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236,856)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents the value of the Company&#x2019;s stock on the date that the restricted stock units and performance stock units vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Based on the closing stock price of the Company&#x2019;s stock of $41.32 on December&#160;31, 2021, $24.11 on December&#160;31, 2020, $35.81 on December&#160;31, 2019, and $17.02 on December&#160;31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The number of restricted stock units vested includes shares that the Company withheld on behalf of the employees to satisfy the statutory tax withholding requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;On the grant date, the fair value for these vested awards was $5.9 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;On the grant date, the fair value for these vested awards was $12.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;On the grant date, the fair value for these vested awards was $5.8 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense for the years ended December&#160;31, 2021, 2020 and 2019 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized during the year ended December&#160;31, 2021, 2020 and 2019 was recorded in the Consolidated Statement of Operations as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Valuation Assumptions and Fair Value of Stock Options and ESPP Grants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the Black-Scholes option pricing model to estimate the fair value of options granted under its equity incentive plans and rights to acquire stock granted under its employee stock purchase plan. The weighted average estimated fair values of the employee stock options and rights granted under the employee stock purchase plan and the weighted average assumptions used to calculate the grant date fair values, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Purchase Plan (ESPP)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average estimated fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The expected term represents the period during which the Company&#x2019;s stock-based awards are expected to be outstanding. The estimated term is based on historical experience of similar awards, giving consideration to the contractual terms of the awards, vesting requirements and expectation of future employee behavior, including post-vesting terminations. The expected term of groups of employees that have similar historical exercise patterns has been considered separately for valuation purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The risk-free interest rate is based on U.S. Treasury debt securities with maturities close to the expected term of the option or ESPP participation right as of the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Estimated volatility is based on historical volatility. The Company estimates volatility based on the Company&#x2019;s historical volatility of its stock price.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The Company has not paid dividends since its inception.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE2Mg_cb815ac7-227d-4fee-9a2c-78eb06e542da"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <cutr:CapitalStockSharesAuthorized
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzIwMw_de203ccf-cdeb-4a75-96a8-8698696ddb0b"
      unitRef="shares">55000000</cutr:CapitalStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI0Mw_4c72e452-383b-40bb-8eca-0a74a780b909"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI3OQ_23f920c5-e311-4fc4-8f24-d37a7fc80505"
      unitRef="shares">17995344</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI3OQ_a7c5a6f6-aa8f-4d20-8950-34cb5952e99c"
      unitRef="shares">17995344</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzMzNQ_aed1fb25-12b0-414c-a1b6-8c7081f77257"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzM3NQ_66b2d4ec-8b5f-4f9d-8017-0b910f6d1e3d"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzQxOA_0324c974-fd06-4595-ad8c-7cbd2a6bf09e"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzQxOA_c0f7f502-fcc6-4078-b493-65616893f857"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="id019adf1333c43ce9cd8acf7e5ea0991_D20200421-20200421"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzUzMw_f54f6ead-42a5-4d00-9061-6ad6296c7b73"
      unitRef="shares">2742750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5e364a947a114dddb1671e44b0467847_I20200421"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzU4NA_b230cb21-d671-4fcb-956f-13fbb9f06016"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i5e364a947a114dddb1671e44b0467847_I20200421"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzYyNQ_1de6ff9f-2e7f-41b9-b727-e3249c8603fd"
      unitRef="usdPerShare">10.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i9b9ef969fb964e68bc041b81228d55de_D20200421-20200421"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzczMA_291ae7b2-b777-4394-b39f-e7a2f28d6247"
      unitRef="shares">357750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="id019adf1333c43ce9cd8acf7e5ea0991_D20200421-20200421"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzgyNg_ab8f9006-cca3-4f78-a1d0-a239005e3082"
      unitRef="usd">26500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="id019adf1333c43ce9cd8acf7e5ea0991_D20200421-20200421"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzkwNw_14e88bcd-27a8-4abc-9da9-531e04a4c3e4"
      unitRef="usd">2300000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i7b5f16c096554bfebc0977f38bdab2e3_I19981231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwODk_9104726d-b340-4e37-a56d-2d10756dcc8f"
      unitRef="shares">4650000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i6bdd524cbef74fc18d573d1100d86374_I20040112"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEyOTI_8b72c2de-18e8-4050-b808-44f5af7fe253"
      unitRef="shares">1750000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled
      contextRef="i5327f49a62ea40d690f0899c454a9fbd_D20120101-20121231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE4MjA_cb136fb9-89a3-487c-923f-de6df4d9e6f3"
      unitRef="shares">2.12</cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i51d5c987d168444995a56ee832d422f1_D20190614-20190614"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzIyMDM_b66e4d0f-6a68-4984-9884-53fdc192fad0"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i19b58bf2da1b4bdf82f22bbae4a7f3a2_I20190614"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzIyMjY_18d68691-c617-4c1a-9627-6157840378b4"
      unitRef="shares">9701192</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled
      contextRef="i51d5c987d168444995a56ee832d422f1_D20190614-20190614"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI2NjQ_d96b4b9e-2478-4776-b9c0-9c20392ed313"
      unitRef="shares">2.12</cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled>
    <cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled
      contextRef="i51d5c987d168444995a56ee832d422f1_D20190614-20190614"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI5NzQ_a76c7532-2d1a-4d86-af91-81ffc32cc003"
      unitRef="shares">2.12</cutr:NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2e8bdcbd064d4597b255647bff9cba1a_D20190614-20190614"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMTU0_5de9f439-243c-491a-bb81-1b28765c6c27">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear
      contextRef="ifd9fd5d526a04b80a20fe10491260caa_D20190611-20190611"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzM1OTM_3e552a77-5e40-4467-93af-e282aacbed0e"
      unitRef="number">0.50</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ief9071943aa645caa5dade84cd3e061d_D20200601-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzQ4NjE_19ce9bb7-5729-46fc-8109-6e247c38c988"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <cutr:ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue
      contextRef="id927e8d4f38a47a0828d8a646057aed3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwOTk1MTE2NTYzNzc_bdbee4e5-5e76-4aae-b353-bacca94e2024"
      unitRef="usd">60000</cutr:ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie3195dfbe94d477e88a888e893f44d1e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMTI0_0d1cdaa2-2438-4ac8-8b3a-60524859e389">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie3195dfbe94d477e88a888e893f44d1e_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwOTk1MTE2NTY5NTE_5f5b1337-f755-4682-a6f5-1d2a68c6f0c3"
      unitRef="shares">41301</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3d42d4ffa3bd4f0b875d22a9ab203d5c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwOTk1MTE2NTY5NTY_a4d50e63-18bf-492c-bf6e-206b0c6ad7a1"
      unitRef="shares">35735</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i81aa92e174864f29b74e30628a31ecd2_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwOTk1MTE2NTY5NjQ_a873461b-86ed-4355-83ec-f836ddb51a1a"
      unitRef="shares">42236</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i88b4ab1b779d43ed8ae859fa48628f89_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzU4OTg_052503af-b110-4f1c-9746-71dd36df05a3"
      unitRef="shares">219686</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i713579da903a47a29c2bbc3556a11854_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzU5MDI_8cc54e17-4072-4823-84ee-318657a26c2a"
      unitRef="shares">405248</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if5f5df8bc21945d8be1f01c615e620b9_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzU5MDk_bb6b12f2-dc28-4cff-b207-c15568b71e11"
      unitRef="shares">475166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ibd9c28c8d501405da659af62fb7475e6_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgwOTcy_44cdd439-67b9-42ff-b224-531024593b6e">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i5046b58bcd594937807a5b3727f16519_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI3NDg3NzkxMTkwODM_e478f1f6-dbbf-4cf0-bc76-fed1b3329c43"
      unitRef="shares">209981</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5046b58bcd594937807a5b3727f16519_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgwOTc5_ad6d4fb3-0348-42d7-9479-bd847851c32c"
      unitRef="usd">2600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i57973c7f0bd94f19b5e2a50196d96324_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI3NDg3NzkxMDY3NzI_58c9bf5b-0721-4715-a5a8-3131cafbe5cd"
      unitRef="shares">178222</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i55b1792fc2364767a5f64cd1cdf6808c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI3NDg3NzkxMDY3Nzc_90515482-6dc9-42ca-86b5-68996fad995d"
      unitRef="shares">76157</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i64db2b3b978b414a8c02290468f928b5_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI3NDg3NzkxMDY3ODY_53688f42-e707-4e0e-b1f3-37189dadfc09"
      unitRef="shares">319275</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie5a5db0c5f0d46b380a0b79f965a62ea_D20210701-20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzI3NDg3NzkxMTkwOTM_800b11d1-cafb-4691-a7b7-d5144b855eab"
      unitRef="shares">265002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches
      contextRef="i01a61b6023fb48d7be1011c161d39845_D20210701-20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMTMx_6adfa34f-9de0-4d76-b2bf-fd43276661f7"
      unitRef="tranche">4</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i6293b26e539849e09ccfdc96cb5059bb_D20190701-20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDA2_6049b711-faea-4bc7-bec7-92fb6fd0c609"
      unitRef="shares">67897</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="id6d4b50d303d423099ba57b50833b756_D20190701-20190731"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDMx_175e35c1-9da1-47ef-8769-259c447701ea">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i7e2fb7f83d5a4d3797c1641e79c2cb8e_D20200801-20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDM3_c00ed4b0-ed88-4f1c-9b42-506e875b6356"
      unitRef="shares">60000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iaba873dc2f8c4fb8bb139aa82a0e3219_D20200801-20200831"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDU4_21f658b2-56c4-49de-ae8c-3638fa381cdd">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0d1404685416410cbcd6e1f275b3fd2d_D20200801-20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDY0_786344ea-2a5a-4d24-8009-4ac4b86397ae"
      unitRef="shares">22423</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia1344f4c17c7449aba2397d6f715ba6f_D20200801-20200831"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMDg2_24b02372-6278-4b6f-9e9a-758a9dd050ed">P2Y6M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod
      contextRef="ie8e0ec5e57d6453db52240a4631277a9_D20040112-20040112"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMTA3_54ff3e5e-c063-466c-bfb8-acfbe03f883c">P6M</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ie8e0ec5e57d6453db52240a4631277a9_D20040112-20040112"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzk3NTA_b3538dcc-66cd-41da-ab97-5b6574214aee"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage
      contextRef="ie8e0ec5e57d6453db52240a4631277a9_D20040112-20040112"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzk3NjE_19f32737-d231-481e-900c-1468245c87a4"
      unitRef="number">0.020</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ie3406523d56248b489c3b7541fdf6711_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwMDUz_edb6e57d-09c3-4874-8764-811b9066a31b"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod
      contextRef="ie8e0ec5e57d6453db52240a4631277a9_D20040112-20040112"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMTQ2_6070a231-b871-4fb4-95d9-ee6d244a863c">P6M</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="ie3406523d56248b489c3b7541fdf6711_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwMjMy_639f8bee-c4c9-41dd-84cb-0e4fea4a8401"
      unitRef="shares">59635</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="ie4edea0c28014a2d93054c7ca5e19937_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwMjM2_50bcd530-7096-40ff-8a78-7a40bcb53b1d"
      unitRef="shares">56751</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="i9d790cb4f5784d80b7d9b71df630a022_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwMjQ0_916374e4-c57f-4f36-a42c-b147e1b03d93"
      unitRef="shares">82810</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="idc61de97e6f5442cae47ea43a50a646f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwMjc2_8aad67f1-0c69-4be4-894f-9e1f5cd3bf01"
      unitRef="shares">645319</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE3MDQyNDMwMjgxMTQ4_6c83f32c-117c-4026-a1e8-dba2d54045b2">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the 2004 Plan and 2019 Equity Incentive Plan is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Available&lt;br/&gt;For Grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions ) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,141,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.52&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional shares reserved&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,538,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional shares reserved&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(804,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,085,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additional shares reserved&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;450,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(744,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards cancelled (expired or forfeited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;947,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Vested and expected to vest as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Based on the closing stock price of $41.32 of the Company&#x2019;s stock on December&#160;31, 2021, $24.11 on December&#160;31, 2020, $35.81 on December&#160;31, 2019 and $17.02 on December&#160;31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Approved by the board of directors and stockholders in 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzItMS0xLTEtMjg2MjE_eca32dff-9085-47f9-88d2-c85958f335c0"
      unitRef="shares">1141305</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzItMy0xLTEtMjg2MjE_2d98a227-06fa-4acd-a6cd-44f0c14faf2f"
      unitRef="shares">507705</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzItNS0xLTEtMjg2MjE_bebe13a3-f334-4cc5-9c30-3c76e91416cc"
      unitRef="usdPerShare">20.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i3df46276971c4ed0986a5e859e637064_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzItNy0xLTEtMjg2MjE_9a6bf017-2378-4cab-83c4-36fa156ba082">P3Y6M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzItOS0xLTEtMjg2MjE_c19ea88a-2b41-4dd1-b5e7-8199b87b709d"
      unitRef="usd">2000000.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <cutr:AdditionalSharesReservedSharesAvailableForGrant
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzMtMS0xLTEtMzcxMjY_306e7d85-0d8a-465c-b465-960a27699b41"
      unitRef="shares">700000</cutr:AdditionalSharesReservedSharesAvailableForGrant>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzQtMy0xLTEtMjg2MjE_6f8fd469-dd69-4895-8e1e-3c0be64e2069"
      unitRef="shares">160798</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzQtNS0xLTEtMjg2MjE_7493cd2e-4f25-46d6-9a5f-08a095010167"
      unitRef="usdPerShare">10.03</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzUtMS0xLTEtMjg2MjE_022f3203-5a1e-4e94-9cbb-60efd172e913"
      unitRef="shares">51208</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzUtMy0xLTEtMjg2MjE_a40dfbd7-178d-40b3-a886-27559e9bb137"
      unitRef="shares">51208</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzUtNS0xLTEtMjg2MjE_6811213f-5ff4-49e7-9f78-b6d44aed5617"
      unitRef="usdPerShare">24.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzYtMS0xLTEtMjg2MjE_c000febd-f34e-4298-b1b0-6b81d80951d2"
      unitRef="shares">1538128</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross>
    <cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzctMS0xLTEtMjg2MjE_63971eac-f703-449d-87b0-f89ccd6a2575"
      unitRef="shares">407320</cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzgtMS0xLTEtMjg2MjE_27168521-64cd-4d39-8daa-de602cb6417a"
      unitRef="shares">761705</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzgtMy0xLTEtMjg2MjE_5a503e77-c436-494b-a5ff-d86ce97b7ad4"
      unitRef="shares">295699</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzgtNS0xLTEtMjg2MjE_339fac94-1d69-49cd-b3a1-2bf6a9cb34f4"
      unitRef="usdPerShare">25.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzgtNy0xLTEtMjg2MjE_4bfea298-1f34-4eb0-88c6-65c5d610edf4">P3Y2M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzgtOS0xLTEtMjg2MjE_ac1893a8-6e9a-4320-83cc-0b8ec892a249"
      unitRef="usd">3040000.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <cutr:AdditionalSharesReservedSharesAvailableForGrant
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzktMS0xLTEtMjg2MjE_58c3488f-1bdd-4691-a5b0-570d8f64198e"
      unitRef="shares">600000</cutr:AdditionalSharesReservedSharesAvailableForGrant>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzEwLTEtMS0xLTQwMjU5_c85d0677-b377-4733-92c8-7dea3b05f47f"
      unitRef="shares">71088</cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzEwLTMtMS0xLTQwMjY0_98191985-ef46-4f50-89d1-0c3f48fc9595"
      unitRef="shares">71088</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzEwLTUtMS0xLTQwMzAx_63d17e35-f7df-482e-ad56-a736cadc8ed7"
      unitRef="usdPerShare">14.85</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzEwLTMtMS0xLTI4NjIx_cb7f0228-7aba-4521-81c8-7451b75d22bf"
      unitRef="shares">73227</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzEwLTUtMS0xLTI4NjIx_1223a107-2c83-45bb-9c2f-b4729c79dfb5"
      unitRef="usdPerShare">12.91</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzExLTEtMS0xLTI4NjIx_2131480f-5673-4d28-a693-0a068d5c7dbb"
      unitRef="shares">76553</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzExLTMtMS0xLTI4NjIx_98f9bd89-5a06-4b84-9f1e-c4e0bf6311dd"
      unitRef="shares">76553</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzExLTUtMS0xLTI4NjIx_4f4988be-d866-4997-a370-b1167c61dfe0"
      unitRef="usdPerShare">36.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzEyLTEtMS0xLTI4NjIx_c336dbcd-d9f1-4a64-b1c6-9b5f182f18d8"
      unitRef="shares">804949</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross>
    <cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzEzLTEtMS0xLTI4NjIx_f7638840-88c2-46ae-9d25-ae37e4b9f336"
      unitRef="shares">522949</cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE0LTEtMS0xLTI4NjIx_d910101c-747e-4221-9b20-41f54090b7ad"
      unitRef="shares">1085170</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE0LTMtMS0xLTI4NjIx_d442c2bf-a7f4-481a-a5b8-376d069b6872"
      unitRef="shares">217007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE0LTUtMS0xLTI4NjIx_a7fee061-c461-4532-8c76-f27d4cec3514"
      unitRef="usdPerShare">22.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE0LTctMS0xLTI4NjIx_6955f279-b80c-4199-a342-706f906e3443">P3Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE0LTktMS0xLTI4NjIx_cab49cc3-0ffa-4253-81aa-2bf8a9d69a78"
      unitRef="usd">1470000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <cutr:AdditionalSharesReservedSharesAvailableForGrant
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE2LTEtMS0xLTQzMjAw_307b97b4-90f5-4025-998d-b5c301336d41"
      unitRef="shares">450000</cutr:AdditionalSharesReservedSharesAvailableForGrant>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE2LTEtMS0xLTI4NjIx_e6cf020c-20bb-4b33-8ec3-91fa20f0ad11"
      unitRef="shares">172139</cutr:ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE2LTMtMS0xLTI4NjIx_12504669-9561-4733-b21c-2af9c4e0be1a"
      unitRef="shares">172139</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE2LTUtMS0xLTI4NjIx_93f1bf87-e789-40a1-89a8-e4d504850bea"
      unitRef="usdPerShare">30.71</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE3LTMtMS0xLTI4NjIx_394f5660-a470-4bb0-b48b-f680cdc65c59"
      unitRef="shares">71798</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE3LTUtMS0xLTI4NjIx_6162a93f-d372-4bc4-9a66-76b50d60ec00"
      unitRef="usdPerShare">22.02</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE4LTEtMS0xLTI4NjIx_2e5e2ca6-fc4c-40d8-8dc6-4e9632d623bc"
      unitRef="shares">30173</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE4LTMtMS0xLTI4NjIx_ed550dbb-2c61-46b1-8de8-8ed3ec7b6b77"
      unitRef="shares">30173</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE4LTUtMS0xLTI4NjIx_ea9c4662-4765-489e-ab7c-5a3b84b2aac2"
      unitRef="usdPerShare">37.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzE5LTEtMS0xLTI4NjIx_977f1e34-5d05-4c1d-aa9d-ac29a62866d7"
      unitRef="shares">744949</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross>
    <cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIwLTEtMS0xLTI4NjIx_ec67f87c-0f0e-435e-899e-270c6a5fde76"
      unitRef="shares">299092</cutr:ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIxLTEtMS0xLTI4NjIx_4aea090c-e832-4651-ac6c-d5fdeb507fb2"
      unitRef="shares">947347</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIxLTMtMS0xLTI4NjIx_0944b1f0-8e18-4815-9f88-f972ee36ab2c"
      unitRef="shares">287175</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIxLTUtMS0xLTI4NjIx_8c35587d-5a41-411b-b57a-f259116b5001"
      unitRef="usdPerShare">25.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIxLTctMS0xLTI4NjIx_d9a8b36f-eb82-4c2f-be6e-9ecbac777f23">P4Y11M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIxLTktMS0xLTI4NjIx_17ca47f6-2021-4c59-8539-52a67442e9a5"
      unitRef="usd">4460000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIyLTMtMS0xLTI4NjIx_120197f0-2ec1-4a12-901e-6f9d119e0219"
      unitRef="shares">83855</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIyLTUtMS0xLTI4NjIx_965686df-8d4f-4f3a-b230-5d6e6ac13710"
      unitRef="usdPerShare">24.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIyLTctMS0xLTI4NjIx_5f0f9fd6-72e6-4646-8a40-92df9fb722ba">P2Y10M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIyLTktMS0xLTI4NjIx_024c0851-3a9c-4366-8efd-c003c7150db7"
      unitRef="usd">1470000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIzLTMtMS0xLTI4NjIx_0b256e80-8ac2-4c2f-8612-4b893b799106"
      unitRef="shares">287175</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIzLTUtMS0xLTI4NjIx_588412cd-f6e6-49f7-8ddb-1d2320f1529f"
      unitRef="usdPerShare">25.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIzLTctMS0xLTI4NjIx_f00a99c8-6238-42b1-9dae-344a9be24672">P4Y11M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpjZWYxZGQxN2M5MGM0MTMyOTdlNjQyZjBjY2M0ODRjMS90YWJsZXJhbmdlOmNlZjFkZDE3YzkwYzQxMzI5N2U2NDJmMGNjYzQ4NGMxXzIzLTktMS0xLTI4NjIx_750bd304-4f85-4529-b7a7-25482bdd8872"
      unitRef="usd">4460000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:SharePrice
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwNDc3_b5d78b6f-8f39-4bb0-bc1f-face03529361"
      unitRef="usdPerShare">41.32</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwNTEw_8fbafcd5-eb31-4b14-8e75-d5d8b8bafaa2"
      unitRef="usdPerShare">24.11</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwNTIw_aa68b8c7-722d-4046-b924-e44c2158ac57"
      unitRef="usdPerShare">35.81</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzEwNTMz_c9003b0b-7de2-42de-8f35-c1ef9bca5ea4"
      unitRef="usdPerShare">17.02</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExMTU5_c8d4130d-1fef-4566-afc1-14386c3ab364"
      unitRef="usd">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExMTYz_f49a4e49-5096-45dd-a8ea-4f0b8b032756"
      unitRef="usd">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExMTcx_b29a43c8-736e-4426-b2eb-3ff8db96acb5"
      unitRef="usd">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE1NDc1_81bab114-9fda-4fe9-a2fa-e5ea3f7f4c33">The options outstanding and exercisable at December&#160;31, 2021 were in the following exercise price ranges:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.360%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercise&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prices&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$14.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$14.10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$15.32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$25.70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.59&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$29.28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$32.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$39.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$47.40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$10.79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$47.40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;287,175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;83,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i243cda497d0443fd8d3e77f6c4b77778_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEtMC0xLTEtMjg2MjE_6f259867-fe35-49d0-b5b9-0f8e7d6a6241"
      unitRef="usdPerShare">10.79</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i243cda497d0443fd8d3e77f6c4b77778_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEtMi0xLTEtMjg2MjE_34de4237-cca0-4526-931c-180d419bc196"
      unitRef="usdPerShare">14.04</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i918b5c66b5b64f319346190d60ad103d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEtNC0xLTEtMjg2MjE_74bac47c-5449-4405-89af-e014d1e14ba9"
      unitRef="shares">25480</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i243cda497d0443fd8d3e77f6c4b77778_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEtNi0xLTEtMjg2MjE_452e7536-ec47-49ca-bb84-714c3d476efd">P1Y11M19D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i918b5c66b5b64f319346190d60ad103d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEtOC0xLTEtMjg2MjE_aa0b4f00-4be6-4c87-882d-db8360e5c53e"
      unitRef="shares">25480</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i24d00f09f70e46dd88668566228e1cdf_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzItMS0xLTEtMjg2MjE_fb10eb78-169a-4f43-b381-1aa75e68ff32"
      unitRef="usdPerShare">14.10</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i24d00f09f70e46dd88668566228e1cdf_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzItNC0xLTEtMjg2MjE_4611b526-0529-4037-a78f-a90e2bf29fc3"
      unitRef="shares">60000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i6ba69d99c6bf476e8d15c9c79b2a6df2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzItNi0xLTEtMjg2MjE_c4aba4ef-3975-4664-afb9-be890c0c24b8">P3Y7M2D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i24d00f09f70e46dd88668566228e1cdf_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzItOC0xLTEtMjg2MjE_c17607e5-b7a1-491e-818f-24688b7eedc9"
      unitRef="shares">16000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="id228189a9c344696a5059d6861067108_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzMtMS0xLTEtMjg2MjE_8a754613-0993-4705-b7f3-56231040c138"
      unitRef="usdPerShare">15.32</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="id228189a9c344696a5059d6861067108_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzMtNC0xLTEtMjg2MjE_cff62825-fe7f-449c-8377-31e0c85a2339"
      unitRef="shares">2396</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i4d5d0bdf4f0d4a1883472cfe8d0f4ca7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzMtNi0xLTEtMjg2MjE_4a4556f5-023e-4adf-99ed-cf77b6a839f1">P0Y6M21D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="id228189a9c344696a5059d6861067108_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzMtOC0xLTEtMjg2MjE_f2b732d2-8641-4b46-a80d-209f25d193d6"
      unitRef="shares">2396</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i5e4c6cb41dca483993cf3fb92041cc1f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzQtMS0xLTEtMjg2MjE_26bbdd0b-9864-4a17-bf2f-ace66ce5c279"
      unitRef="usdPerShare">18.55</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i5e4c6cb41dca483993cf3fb92041cc1f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzQtNC0xLTEtMjg2MjE_2f83eef6-0ef1-4765-8200-ec47001ca674"
      unitRef="shares">1000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i062444d03896452f9251a408fa65500b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzQtNi0xLTEtMjg2MjE_c1547871-66b6-4159-b556-b9e19f1f1507">P2Y25D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i5e4c6cb41dca483993cf3fb92041cc1f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzQtOC0xLTEtMjg2MjE_25e80ce5-45ba-49d2-99d2-c65aeddd1be0"
      unitRef="shares">1000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="id8ddcd5085f543b5aacaf7518aba284a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzUtMS0xLTEtMjg2MjE_652df95a-48d7-44f2-8e5d-5b2ad1b87e50"
      unitRef="usdPerShare">18.93</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="id8ddcd5085f543b5aacaf7518aba284a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzUtNC0xLTEtMjg2MjE_c5c35ceb-cf80-451c-a378-23a09601b817"
      unitRef="shares">11088</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i6e4d0f435f2844b291dd5ea2a0f001f0_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzUtNi0xLTEtMjg2MjE_3dd9b50c-183f-4dfe-a123-2c6d786d0e14">P8Y9M29D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="id8ddcd5085f543b5aacaf7518aba284a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzUtOC0xLTEtMjg2MjE_f1b77ab9-4136-487b-8eac-25448f40a702"
      unitRef="shares">3234</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i20b036dbcc074c4a90dad931e7f4bb6c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzYtMS0xLTEtMjg2MjE_acca0fb0-0d1e-47d6-b6df-30c42342a53f"
      unitRef="usdPerShare">25.70</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i20b036dbcc074c4a90dad931e7f4bb6c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzYtNC0xLTEtMjg2MjE_a218ce8f-6832-4b1b-8436-3bcd941fd786"
      unitRef="shares">6000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i40475f7443d64415ba295a8050683744_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzYtNi0xLTEtMjg2MjE_a0ca5673-ed58-42b0-85a3-7bcb7ac896bc">P2Y7M2D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i20b036dbcc074c4a90dad931e7f4bb6c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzYtOC0xLTEtMjg2MjE_af309ba2-2468-4e78-9636-8f5694375054"
      unitRef="shares">6000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="ic7ae52da7abe49da93b5d02df9962d86_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzctMS0xLTEtMjg2MjE_46155572-77a1-44ce-b21e-5664639e6a82"
      unitRef="usdPerShare">29.28</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ic7ae52da7abe49da93b5d02df9962d86_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzctNC0xLTEtMjg2MjE_86c7c8a3-9017-467a-9cbe-59988a9fdb57"
      unitRef="shares">93844</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="idafa75464bf1482bbe39438ca2a1fbb3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzctNi0xLTEtMjg2MjE_8dcc9ad0-c429-4202-a596-92b0af9882be">P6Y3M25D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ic7ae52da7abe49da93b5d02df9962d86_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzctOC0xLTEtMjg2MjE_dccde7d7-5581-47fd-8e1d-7294faee59ea"
      unitRef="shares">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="ide3c7b9ba1e1465085e27b6fb0183fac_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzgtMS0xLTEtMjg2MjE_5bcc0280-8af9-477c-ae80-bf96fd787d08"
      unitRef="usdPerShare">32.87</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ide3c7b9ba1e1465085e27b6fb0183fac_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzgtNC0xLTEtMjg2MjE_7f6aabe5-11c1-45bd-9feb-4f3e5e82a010"
      unitRef="shares">57622</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i86f5d1782ee64b31bfb15fc1735484b3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzgtNi0xLTEtMjg2MjE_10f46263-1913-4067-8270-2e80320e64f5">P6Y1M13D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ide3c7b9ba1e1465085e27b6fb0183fac_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzgtOC0xLTEtMjg2MjE_5b285a62-a83d-4063-921f-862328b19c62"
      unitRef="shares">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i79619c0d0304473a9a05f38376df1ca5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzktMS0xLTEtMjg2MjE_3c670fc5-fc79-4e20-8986-3427244bf432"
      unitRef="usdPerShare">39.30</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i79619c0d0304473a9a05f38376df1ca5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzktNC0xLTEtMjg2MjE_41a17faf-e7fc-4d0b-a716-e2eb1a01c6cf"
      unitRef="shares">25000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i5787bf9bc4b840c8b9474232abd18822_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzktNi0xLTEtMjg2MjE_714c4784-ca87-49d5-8934-c9de216e0406">P2Y9M29D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i79619c0d0304473a9a05f38376df1ca5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzktOC0xLTEtMjg2MjE_9c8ef1b1-80f6-4ad3-8dd8-70e35f081d94"
      unitRef="shares">25000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="i187150c65510432d854fe82b6fb23a3c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEwLTEtMS0xLTI4NjIx_330a62a6-c311-4bf7-bd1b-64349c56f547"
      unitRef="usdPerShare">47.40</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i187150c65510432d854fe82b6fb23a3c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEwLTQtMS0xLTI4NjIx_579bffe9-43f0-4774-95fd-5e52f067dab7"
      unitRef="shares">4745</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ice72d61a300545aeb3844e67957f9576_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEwLTYtMS0xLTI4NjIx_df24ee41-111f-4f9d-9ed3-702504539ed8">P2Y11M15D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i187150c65510432d854fe82b6fb23a3c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzEwLTgtMS0xLTI4NjIx_d77a7db7-0318-4d9a-aa5d-2a94b87f5768"
      unitRef="shares">4745</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzExLTAtMS0xLTI4NjIx_8cd873fe-211a-4e77-a2e7-8f6f18e41114"
      unitRef="usdPerShare">10.79</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzExLTItMS0xLTI4NjIx_aac9c02a-084a-42ba-ad20-aa863fe2dfbe"
      unitRef="usdPerShare">47.40</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzExLTQtMS0xLTI4NjIx_179592d9-9da0-41f3-bc35-afe92b1204cb"
      unitRef="shares">287175</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzExLTYtMS0xLTI4NjIx_1ef9f1cb-535c-4338-8fb9-d1802002fef1">P4Y11M1D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTowMjgyMzk5OWI1NWY0YzEwYjE2OWQwYjFjY2EzNzdhNi90YWJsZXJhbmdlOjAyODIzOTk5YjU1ZjRjMTBiMTY5ZDBiMWNjYTM3N2E2XzExLTgtMS0xLTI4NjIx_028edcba-5f8c-472e-b4b3-e52e7d759b41"
      unitRef="shares">83855</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE1NDc2_3e71769d-1dfd-4c06-8828-d4b9f6e8b9f0">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information with respect to RSUs and PSUs activity is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.156%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant-&lt;br/&gt;Date Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intrinsic Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161,022)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(684,491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236,856)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Represents the value of the Company&#x2019;s stock on the date that the restricted stock units and performance stock units vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Based on the closing stock price of the Company&#x2019;s stock of $41.32 on December&#160;31, 2021, $24.11 on December&#160;31, 2020, $35.81 on December&#160;31, 2019, and $17.02 on December&#160;31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The number of restricted stock units vested includes shares that the Company withheld on behalf of the employees to satisfy the statutory tax withholding requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;On the grant date, the fair value for these vested awards was $5.9 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;On the grant date, the fair value for these vested awards was $12.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;On the grant date, the fair value for these vested awards was $5.8 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i08b960d0e6e645c39e84cc857ec13e6b_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEtMS0xLTEtMjg2MjE_7424375f-7e35-447f-bb53-3aedfb0b6e03"
      unitRef="shares">474291</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i08b960d0e6e645c39e84cc857ec13e6b_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEtMy0xLTEtMjg2MjE_17709c41-33e6-40cd-9e37-d78d861b2b19"
      unitRef="usdPerShare">38.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="i08b960d0e6e645c39e84cc857ec13e6b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEtOS0xLTEtMjg2MjE_caa36f07-7b3a-4e67-a9ee-903e54f20ef5"
      unitRef="usd">8072000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzItMS0xLTEtMjg2MjE_33a8b79f-734d-4aa7-95fb-b17fc2cab6bc"
      unitRef="shares">963814</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzItMy0xLTEtMjg2MjE_0d290310-c64e-42e0-a2f0-6df76a201e85"
      unitRef="usdPerShare">18.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzMtMS0xLTEtMjg2MjE_e0584a28-282e-4b4c-b522-b34888302d19"
      unitRef="shares">172281</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzMtMy0xLTEtMjg2MjE_c63ab50b-b94d-4c30-a6dd-a128651e8446"
      unitRef="usdPerShare">33.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue
      contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzMtNS0xLTEtMjg2MjE_68127eb9-322f-42dd-91f6-23e174b3eda8"
      unitRef="usd">6169000</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzQtMS0xLTEtMjg2MjE_279dd172-461e-420b-a5c5-150b4e2ce27f"
      unitRef="shares">161022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzQtMy0xLTEtMjg2MjE_f64a1bdd-1e81-4c05-92b4-3fa59707448e"
      unitRef="usdPerShare">37.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i192be0f1705145908aa6ad70700cddf7_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzUtMS0xLTEtMjg2MjE_9d7f4c14-4441-4d18-bb92-e10d17077d9a"
      unitRef="shares">1104802</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i192be0f1705145908aa6ad70700cddf7_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzUtMy0xLTEtMjg2MjE_40d11c73-402b-473b-b98c-32561d03bc6f"
      unitRef="usdPerShare">22.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="i192be0f1705145908aa6ad70700cddf7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzUtOS0xLTEtMjg2MjE_40eec908-80e9-4419-b5e8-47d05176a020"
      unitRef="usd">37442000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzYtMS0xLTEtMjg2MjE_af8c1713-94d1-4c5e-9594-51dbe274f4b4"
      unitRef="shares">667694</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzYtMy0xLTEtMjg2MjE_9a36a82d-1f43-4e05-b824-08ceefde69ab"
      unitRef="usdPerShare">20.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzctMS0xLTEtMjg2MjE_53d7d868-526b-4c1f-9cdb-7d79233f7f05"
      unitRef="shares">684491</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzctMy0xLTEtMjg2MjE_eecd28ae-70c8-4cba-9837-89bfd303ed56"
      unitRef="usdPerShare">17.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue
      contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzctNS0xLTEtMjg2MjE_fd3aac23-23a8-42ed-b566-576e08aa2d44"
      unitRef="usd">12036000</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzgtMS0xLTEtMjg2MjE_83c3b8c8-a807-4e1f-ae71-2188ef0e6fa8"
      unitRef="shares">308248</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzgtMy0xLTEtMjg2MjE_9110f2fa-970b-48f8-9042-55206ad4b827"
      unitRef="usdPerShare">23.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ice6c8183a7fa4570a3f044c0f1d54f9c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzktMS0xLTEtMjg2MjE_17bc67eb-abc5-4eda-8479-78514e9cc7e8"
      unitRef="shares">779757</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ice6c8183a7fa4570a3f044c0f1d54f9c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzktMy0xLTEtMjg2MjE_6fe54d2d-ecee-4ebe-92f7-4afdb25d82f2"
      unitRef="usdPerShare">23.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="ice6c8183a7fa4570a3f044c0f1d54f9c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzktOS0xLTEtMjg2MjE_28c2b4ea-a028-4c7e-a681-187d3274ffae"
      unitRef="usd">18800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEwLTEtMS0xLTI4NjIx_ba119e51-4c4f-4721-aa8f-e0030516195e"
      unitRef="shares">744949</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEwLTMtMS0xLTI4NjIx_9f2a2a1c-fb9e-4587-ad68-6346fb0cea98"
      unitRef="usdPerShare">40.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzExLTEtMS0xLTI4NjIx_5f97424c-5244-4cbf-a996-8a06f07b6670"
      unitRef="shares">254946</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzExLTMtMS0xLTI4NjIx_a302f639-06a0-4325-afe6-80acac203203"
      unitRef="usdPerShare">22.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue
      contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzExLTUtMS0xLTI4NjIx_26c0bd3a-d319-4aa6-b8be-ce1141d5d33b"
      unitRef="usd">8287000</cutr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEyLTEtMS0xLTI4NjIx_adb6ce63-8c99-414c-8e67-15e87ac367fb"
      unitRef="shares">236856</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEyLTMtMS0xLTI4NjIx_f52d3e38-3950-4934-a6e6-5b84898e4e12"
      unitRef="usdPerShare">27.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i32524a5704d848b69d401dc8de11ebf9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEzLTEtMS0xLTI4NjIx_8df6f8dc-4cf0-4dc9-84d2-59c8bd2e8391"
      unitRef="shares">1032904</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i32524a5704d848b69d401dc8de11ebf9_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEzLTMtMS0xLTI4NjIx_e3b5d865-6da0-4caa-9bd0-c4ce6267f85d"
      unitRef="usdPerShare">35.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="i32524a5704d848b69d401dc8de11ebf9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZToxNmU1Mzg3NDBkMTg0NjhkYjkzYzgwMDc1MmE4MmI5NS90YWJsZXJhbmdlOjE2ZTUzODc0MGQxODQ2OGRiOTNjODAwNzUyYTgyYjk1XzEzLTktMS0xLTI4NjIx_40b1bcc7-c35e-4434-b753-11497d078d61"
      unitRef="usd">42680000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:SharePrice
      contextRef="i32524a5704d848b69d401dc8de11ebf9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExNTg5_f0a56a74-e6a4-4611-83a7-876a88e7a882"
      unitRef="usdPerShare">41.32</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="ice6c8183a7fa4570a3f044c0f1d54f9c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExNTk5_f65adfd4-794f-47e3-80e9-348b038bcd65"
      unitRef="usdPerShare">24.11</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i192be0f1705145908aa6ad70700cddf7_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExNjA5_2dad0a23-0fa3-42d7-9a95-82b3b12fd877"
      unitRef="usdPerShare">35.81</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i08b960d0e6e645c39e84cc857ec13e6b_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExNjIz_6d192be4-8d13-4d36-87cd-9cc96b2a20dd"
      unitRef="usdPerShare">17.02</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExODYz_33581de7-dabc-41fb-aa03-0b5973106dca"
      unitRef="usd">5900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExOTI5_e10b1dff-209b-4f54-8693-5a8b5fc42429"
      unitRef="usd">12200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzExOTk1_00fc47d3-a65c-4bd0-8172-2be4fbf23a77"
      unitRef="usd">5800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE1NDc3_ac0e87de-434d-4317-b304-a1160723e8a8">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense for the years ended December&#160;31, 2021, 2020 and 2019 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzItMS0xLTEtMjg2MjE_cd6e8c10-9fdb-4d44-9290-a13930c8fcd3"
      unitRef="usd">782000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzItMy0xLTEtMjg2MjE_b545d451-e7ca-464c-b864-30ef4786d876"
      unitRef="usd">370000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i35da96289dd949498eddb1768dd19192_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzItNS0xLTEtMjg2MjE_f9401111-05f9-4e9f-a633-585b876a608e"
      unitRef="usd">622000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzMtMS0xLTEtMjg2MjE_3d4eac0a-a48f-4f23-8d83-9835cc19f54f"
      unitRef="usd">5305000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzMtMy0xLTEtMjg2MjE_0904950e-f90a-4c35-83a0-8cfc106358fc"
      unitRef="usd">8849000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzMtNS0xLTEtMjg2MjE_71bb35a2-0589-44e8-b534-53ea7d4a2abc"
      unitRef="usd">4786000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3adb16d3075942348f225b70cf90f3a4_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzQtMS0xLTEtMjg2MjE_c08d2ee3-f89d-4ac3-893d-2963f5d31578"
      unitRef="usd">6591000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7cf974c819a34839aa1bfe59802e71ba_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzQtMy0xLTEtMjg2MjE_5b9f7094-f7ed-4afc-874d-f58e4b9dbfbc"
      unitRef="usd">666000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i66107087f3fd4a20b6cb4d48e7f3033a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzQtNS0xLTEtMjg2MjE_d01b4d97-3124-43c7-94c2-4a762c63c54f"
      unitRef="usd">3948000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0689b0010d214af6bd1356f9f93a1141_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzUtMS0xLTEtMjg2MjE_1d7e3014-c5b1-4072-a9bf-61564ee910aa"
      unitRef="usd">494000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i246ec24176874e33b14c7fda30f63bfc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzUtMy0xLTEtMjg2MjE_68cdba27-f07e-407b-8f78-bf025041e12a"
      unitRef="usd">224000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iacfb1ac9741f4b3db30f8728b64a645e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzUtNS0xLTEtMjg2MjE_f29c51dc-6631-4b4d-bcd5-5e3131f0177d"
      unitRef="usd">476000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzYtMS0xLTEtMjg2MjE_1a28de52-5994-4994-93f9-6c9f2d0c158d"
      unitRef="usd">13172000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzYtMy0xLTEtMjg2MjE_ab1e2fdf-2c8a-493c-9886-e634c4161d0b"
      unitRef="usd">10109000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo2ZTRjOTVjMjUzYjM0N2M1OTA1Mzg0MDUwYTQ1ZmNhZS90YWJsZXJhbmdlOjZlNGM5NWMyNTNiMzQ3YzU5MDUzODQwNTBhNDVmY2FlXzYtNS0xLTEtMjg2MjE_97bb91b7-6260-485c-9f5e-73dcabe558a7"
      unitRef="usd">9832000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE1NDc4_22e13f30-6ad4-4a55-9862-b3983049bade">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized during the year ended December&#160;31, 2021, 2020 and 2019 was recorded in the Consolidated Statement of Operations as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i199effaf47f34a41a806c1a1a7e53aa1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzItMS0xLTEtMjg2MjE_95a81c1a-d920-4d03-ac91-5e33d22ea7c7"
      unitRef="usd">1408000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7ea32c98f4b44fd4982e248bedf6cead_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzItMy0xLTEtMjg2MjE_892a5c6c-6a6a-4bd7-b3a6-8f42327a1160"
      unitRef="usd">1665000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i053b35b2d01d445ea80dee2b47dbb5fb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzItNS0xLTEtMjg2MjE_b52f8fa5-96aa-4c00-ac2c-48eab86dd422"
      unitRef="usd">1572000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i29b9e3b28d734adeb076ece7de227b71_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzMtMS0xLTEtMjg2MjE_9685196b-a0fa-40f4-bbef-ab0fb651d2b7"
      unitRef="usd">3160000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i49f345cd25654a7f84873131ed305500_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzMtMy0xLTEtMjg2MjE_a94b506f-208c-445b-abc4-e7cdf7d06d21"
      unitRef="usd">3385000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia3577892be364d588b4ee6707f9426df_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzMtNS0xLTEtMjg2MjE_2077f3e1-4826-4136-97e9-c0a28876d7bb"
      unitRef="usd">4510000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i866b9eac79cc4cecbfb1b078c5693146_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzQtMS0xLTEtMjg2MjE_2d82488f-8ff0-489d-adbf-ec92ee01f7d2"
      unitRef="usd">2784000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8d3833836ada4a39873f0f32f69266d9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzQtMy0xLTEtMjg2MjE_a95c2d89-2ed9-4389-8c3b-a866c7819c34"
      unitRef="usd">1669000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia001d3ced3134020b6fbcd0bdba96369_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzQtNS0xLTEtMjg2MjE_f85f4798-299e-47fe-92e1-fdcf5ca744cb"
      unitRef="usd">1536000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i16b8707c22974632a641c57e2b86817c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzUtMS0xLTEtMjg2MjE_5697c701-34f3-419f-9a94-3ff43005b03d"
      unitRef="usd">5820000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idc44a2bdb221436a8375e04e1ea9bb79_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzUtMy0xLTEtMjg2MjE_63e87ec8-d942-4c65-b02a-57b50b48cc56"
      unitRef="usd">3390000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4499ceba300a402e858712b9c26ba787_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzUtNS0xLTEtMjg2MjE_1bcf522c-6eab-49b1-ba98-9c259cf70c6d"
      unitRef="usd">2214000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzYtMS0xLTEtMjg2MjE_43c8ddfe-7391-4e60-b78e-e30df5ddacac"
      unitRef="usd">13172000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzYtMy0xLTEtMjg2MjE_0c2e22fc-60ef-49bd-8240-c35608425a36"
      unitRef="usd">10109000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTo1YTk2NTU5ZjhjNWQ0ZjNmODNmZGVjZmJhNTgxYmRjZi90YWJsZXJhbmdlOjVhOTY1NTlmOGM1ZDRmM2Y4M2ZkZWNmYmE1ODFiZGNmXzYtNS0xLTEtMjg2MjE_89c221c0-8559-48d4-94e4-3bbd9d2681ad"
      unitRef="usd">9832000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cutr:ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90ZXh0cmVnaW9uOjVjNDYxZTQ1OWUwZDRiZmQ5MjIxZGNjOGMxNTIzMmZkXzE1NDc5_2f380117-314b-4870-be56-202448c169b2">The weighted average estimated fair values of the employee stock options and rights granted under the employee stock purchase plan and the weighted average assumptions used to calculate the grant date fair values, are as follows:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Purchase Plan (ESPP)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average estimated fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The expected term represents the period during which the Company&#x2019;s stock-based awards are expected to be outstanding. The estimated term is based on historical experience of similar awards, giving consideration to the contractual terms of the awards, vesting requirements and expectation of future employee behavior, including post-vesting terminations. The expected term of groups of employees that have similar historical exercise patterns has been considered separately for valuation purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The risk-free interest rate is based on U.S. Treasury debt securities with maturities close to the expected term of the option or ESPP participation right as of the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Estimated volatility is based on historical volatility. The Company estimates volatility based on the Company&#x2019;s historical volatility of its stock price.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The Company has not paid dividends since its inception.&lt;/span&gt;&lt;/div&gt;</cutr:ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzItMS0xLTEtMjg2MjE_985f64e2-7a7a-4063-b70e-2046625a21e1">P3Y11M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzItMy0xLTEtMjg2MjE_77830a4e-ce63-4d3c-84ac-f438c923bc7b">P4Y10M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i35da96289dd949498eddb1768dd19192_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzItNS0xLTEtMjg2MjE_b694cea6-706d-407a-9066-18cc79a949e0">P3Y7M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ib9d312fc584843e38678f9ffd58f8a01_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzItNy0xLTEtMjg2MjE_9f13d9b4-eec4-4eda-97c4-802364320141">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="iac80237e6ee945ac8a0c0ba713b41438_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzItOS0xLTEtMjg2MjE_e505e86b-d8e0-44ed-89cb-c44dff50bb7b">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ide91ed10ffb54702b454c8e2a5cad1d1_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzItMTEtMS0xLTI4NjIx_c0ef2e7c-4709-4e86-ab0d-d003edbeb140">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzMtMS0xLTEtMjg2MjE_82dbedbb-4f00-490a-a3c1-8610d99f1d38"
      unitRef="number">0.0048</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzMtMy0xLTEtMjg2MjE_39b5e38d-8106-495b-b6ba-c99e72ab3e4b"
      unitRef="number">0.0015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i35da96289dd949498eddb1768dd19192_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzMtNS0xLTEtMjg2MjE_7344c7a6-39cf-4df7-9e3a-ae52103ff2e9"
      unitRef="number">0.0164</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ib9d312fc584843e38678f9ffd58f8a01_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzMtNy0xLTEtMjg2MjE_f475cfaf-ba92-449c-ada8-9fbc4ed1b940"
      unitRef="number">0.0014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="iac80237e6ee945ac8a0c0ba713b41438_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzMtOS0xLTEtMjg2MjE_c276d88e-71a0-4079-88b0-46f47f76aa76"
      unitRef="number">0.0011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ide91ed10ffb54702b454c8e2a5cad1d1_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzMtMTEtMS0xLTI4NjIx_37b56a7c-f09c-4c81-9f59-b7cbbfb0107e"
      unitRef="number">0.0249</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzQtMS0xLTEtMjg2MjE_124110ff-c243-4106-8f74-81334b823259"
      unitRef="number">0.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzQtMy0xLTEtMjg2MjE_c842918d-08f7-441b-8c13-f5ed902b4217"
      unitRef="number">0.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i35da96289dd949498eddb1768dd19192_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzQtNS0xLTEtMjg2MjE_4e288b79-dc55-41db-9d83-646130b69c68"
      unitRef="number">0.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ib9d312fc584843e38678f9ffd58f8a01_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzQtNy0xLTEtMjg2MjE_caf09100-18b2-4720-8a5c-b73134e5c660"
      unitRef="number">0.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="iac80237e6ee945ac8a0c0ba713b41438_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzQtOS0xLTEtMjg2MjE_4336e4a6-ca6f-4376-9ad4-a6adc3bd059f"
      unitRef="number">0.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ide91ed10ffb54702b454c8e2a5cad1d1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzQtMTEtMS0xLTI4NjIx_ab564402-7e9f-4b51-b125-3f116d182dc1"
      unitRef="number">0.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzUtMS0xLTEtMjg2MjE_7c0a0bab-f7e9-4bd1-8bdb-41e8b0366661"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzUtMy0xLTEtMjg2MjE_0f44abfb-c3c2-4962-824b-3ce32b21e305"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i35da96289dd949498eddb1768dd19192_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzUtNS0xLTEtMjg2MjE_a394d924-ef8f-4f93-b0d5-aa6dec5d192f"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ib9d312fc584843e38678f9ffd58f8a01_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzUtNy0xLTEtMjg2MjE_8438ab52-b3b6-4b80-b281-12d6589d4780"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="iac80237e6ee945ac8a0c0ba713b41438_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzUtOS0xLTEtMjg2MjE_f54ea414-271e-4171-b24d-125134b4be0f"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ide91ed10ffb54702b454c8e2a5cad1d1_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzUtMTEtMS0xLTI4NjIx_590b6e38-7600-42f8-835f-d806564b3869"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzYtMS0xLTEtMjg2MjE_8a2e56b0-4a0e-4fb8-a3f7-d6f822186e77"
      unitRef="usdPerShare">15.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzYtMy0xLTEtMjg2MjE_9387ca90-8c84-404d-99bd-ae5bc2f45179"
      unitRef="usdPerShare">7.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i35da96289dd949498eddb1768dd19192_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzYtNS0xLTEtMjg2MjE_93ca658f-ef03-4bac-a700-f943805f3c0c"
      unitRef="usdPerShare">14.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib9d312fc584843e38678f9ffd58f8a01_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzYtNy0xLTEtMjg2MjE_494fce7c-f4bc-40e3-ac33-c7d26e34b9a9"
      unitRef="usdPerShare">9.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iac80237e6ee945ac8a0c0ba713b41438_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzYtOS0xLTEtMjg2MjE_ae0f4ec9-8994-4fa8-8b13-838bfe8f2cf5"
      unitRef="usdPerShare">6.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ide91ed10ffb54702b454c8e2a5cad1d1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMjQvZnJhZzo1YzQ2MWU0NTllMGQ0YmZkOTIyMWRjYzhjMTUyMzJmZC90YWJsZTpmMDVjOTYwMWU3N2Y0YmY2YWU1NWNiOGNkNWVlNTk4Mi90YWJsZXJhbmdlOmYwNWM5NjAxZTc3ZjRiZjZhZTU1Y2I4Y2Q1ZWU1OTgyXzYtMTEtMS0xLTI4NjIx_ececec58-7176-4d58-815d-a7abca2627d8"
      unitRef="usdPerShare">9.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzY0Mzc_ac2685aa-0e9e-4dfe-a2a9-f787ddd4dd5c">INCOME TAXES&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the U.S. federal and various state and local jurisdictions and foreign jurisdictions. The Company&#x2019;s income (loss) before provision for income taxes consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,793)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,037)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the provision for income taxes are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s net deferred tax assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accruals and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset before valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,321)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset after valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(990)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(803)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax asset (liability)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The differences between the U.S. federal statutory income tax rates to the Company&#x2019;s effective tax rate are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.87)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.58)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Extinguishment of PPP loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44.59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Excess compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General business credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in prior year reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred true-up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company recorded a valuation allowance of $40.5 million for the portion of the deferred tax asset that it does not expect to be realized. The valuation allowance on the Company&#x2019;s net deferred taxes increased by $2.2 million and $6.0 million during the years ended December&#160;31, 2021 and 2020, respectively. The changes in valuation allowance are primarily due to additional U.S. deferred tax assets and liabilities incurred in the respective year. The Company has $0.8 million of net deferred tax assets in foreign jurisdictions, which management believes are more-likely-than-not to be realized given the expectation of future earnings in these jurisdictions. The Company continues to monitor the realizability of the U.S. deferred tax assets taking into account multiple factors, including the results of operations and magnitude of excess tax deductions for stock-based compensation. The Company intends to continue maintaining a full valuation allowance on its U.S. deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. Release of all, or a portion, of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021, the Company had approximately $75.9 million and $39.3 million of federal and state net operating loss carryforwards, respectively, available to offset future taxable income. The federal and state net operating loss carryforwards, if not utilized will generally begin to expire in 2029&#160;through 2039. Approximately $35.4 million of total federal net operating loss carryforwards were generated post December 31, 2017 and have no expiration. At December&#160;31, 2021, the Company had research and development tax credits available to offset federal and California tax liabilities in the amount of $6.9 million and $8.5 million, respectively. Federal credits will begin to expire in 2024 and California state tax credits have no expiration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal and state laws can impose substantial restrictions on the utilization of net operating loss and tax credit carryforwards in the event of an &#x201c;ownership change,&#x201d; as defined in Section 382 of the Internal Revenue Code. The Company has determined that no significant limitation would be placed on the utilization of the Company&#x2019;s net operating loss and tax credit carryforwards due to prior ownership changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No deferred tax liabilities have been recorded relating to the earnings of the Company&#x2019;s foreign subsidiaries since all such earnings are intended to be indefinitely reinvested. The amount of the unrecognized deferred tax liability associated with these earnings is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Uncertain Tax Positions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company establishes reserves for uncertain tax positions based on the largest amount that is more-likely-than-not to be sustained. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. The Company performs a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company believes it has adequately reserved for its uncertain tax positions, no assurance can be given that the final tax outcome of these matters will not be different. The Company adjusts these reserves in light of changing facts and circumstances, such as the closing of a tax audit or the refinement of an estimate. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate, as well as the related net interest and penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files U.S., state, and foreign income tax returns in jurisdictions with varying statutes of limitations. Tax years after 2006 remain subject to examination by U.S. federal and California state tax authorities due to the Company&#x2019;s net operating loss and credit carryforwards. For significant foreign jurisdictions, tax years after 2016 remain subject to examination by their respective tax authorities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the Company&#x2019;s gross unrecognized tax benefits, excluding related interest and penalties, in December 31, 2019 to December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzY0Mzg_fdcf84cf-0090-4265-afac-b6fb251e341d">The Company&#x2019;s income (loss) before provision for income taxes consisted of the following (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,793)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,037)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzItMS0xLTEtMjg2MjE_ecb8f0a4-b6e0-4996-925d-e5cc70c26eec"
      unitRef="usd">-356000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzItMy0xLTEtMjg2MjE_546873f6-4d18-4695-b7cd-849f0c9c3526"
      unitRef="usd">-25793000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzItNS0xLTEtMjg2MjE_0f83187c-973e-4dd1-981d-13b5620ce350"
      unitRef="usd">-13037000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzMtMS0xLTEtMjg2MjE_2c1bb0e4-5b41-4e51-b431-29ff01518907"
      unitRef="usd">3741000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzMtMy0xLTEtMjg2MjE_ed37119b-62bb-44ea-9556-3f5d6f16522e"
      unitRef="usd">2386000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzMtNS0xLTEtMjg2MjE_e5674dbb-347f-4cb0-b191-f973fb79287d"
      unitRef="usd">774000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzQtMS0xLTEtMjg2MjE_ae974a19-4035-4050-a5f2-d111fc7529af"
      unitRef="usd">3385000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzQtMy0xLTEtMjg2MjE_dc6801de-83bf-4960-9ad8-330d3166c96a"
      unitRef="usd">-23407000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo5NzcwZGZjMTJkYTM0MjI1ODYwMzM1NzRiMTc2ZGRiNi90YWJsZXJhbmdlOjk3NzBkZmMxMmRhMzQyMjU4NjAzMzU3NGIxNzZkZGI2XzQtNS0xLTEtMjg2MjE_c1ad0a51-cb45-4c8e-ab5e-56d929e68af1"
      unitRef="usd">-12263000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzY0Mzk_afecc375-8de5-45b3-ab4a-38cb765f9ca5">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the provision for income taxes are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzMtMS0xLTEtMjg2MjE_1b2de645-8c07-426f-82e1-1b81516dc160"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzMtMy0xLTEtMjg2MjE_1fd91d9a-c051-423a-9053-03afd2a7073c"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzMtNS0xLTEtMjg2MjE_d9834b5d-8c31-466e-a1f2-5a6dae9d2370"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzQtMS0xLTEtMjg2MjE_7cdf5c08-1a48-403f-8cfe-d8c89bb00e68"
      unitRef="usd">-87000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzQtMy0xLTEtMjg2MjE_fd2e8701-5cfb-41ca-ad08-dbb36b45898e"
      unitRef="usd">-53000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzQtNS0xLTEtMjg2MjE_f78ec897-23d2-4508-82e7-7f886a7a4330"
      unitRef="usd">101000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzUtMS0xLTEtMjg2MjE_44b54649-f7f9-46c0-8d91-427f04fe89db"
      unitRef="usd">1512000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzUtMy0xLTEtMjg2MjE_a4abbdc1-2f7b-4410-998c-7b92e3504641"
      unitRef="usd">747000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzUtNS0xLTEtMjg2MjE_f8410099-d44d-4047-86ff-b6088002580f"
      unitRef="usd">-76000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzYtMS0xLTEtMjg2MjE_ac551914-dcf3-4d56-90cb-e0c69b382544"
      unitRef="usd">1425000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzYtMy0xLTEtMjg2MjE_a0520fe0-aa74-4525-92b7-66fec3670963"
      unitRef="usd">694000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzYtNS0xLTEtMjg2MjE_04cc0494-e650-4691-a0a0-e80f10c87f4e"
      unitRef="usd">25000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzgtMS0xLTEtMjg2MjE_c401fb6b-6f60-4576-b188-3ff5ba7a2978"
      unitRef="usd">2000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzgtMy0xLTEtMjg2MjE_5e73c8f8-05b2-4ab7-8233-34d767b506e1"
      unitRef="usd">2000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzgtNS0xLTEtMjg2MjE_d8027e09-e07e-4838-9412-2f65010a1037"
      unitRef="usd">2000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzktMS0xLTEtMjg2MjE_21f2517b-4d66-4cc9-ab27-eafcd707dbd9"
      unitRef="usd">1000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzktMy0xLTEtMjg2MjE_4515127e-07cc-4f16-9fd5-c294290f5bc4"
      unitRef="usd">1000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzktNS0xLTEtMjg2MjE_31869089-8d1f-4d46-ad06-0a67dd175262"
      unitRef="usd">1000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzEwLTEtMS0xLTI4NjIx_65eb204f-1bc5-4737-b595-3c6cd92d527f"
      unitRef="usd">-105000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzEwLTMtMS0xLTI4NjIx_fdb05d53-6fc1-4678-a1cd-0af33a526dda"
      unitRef="usd">-227000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzEwLTUtMS0xLTI4NjIx_dbd690de-6c00-4cbf-86af-2cfd2bd40dd6"
      unitRef="usd">57000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzExLTEtMS0xLTI4NjIx_7c53d7fb-9cf5-4bd7-9b4e-1789ec11fde4"
      unitRef="usd">-102000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzExLTMtMS0xLTI4NjIx_d350d934-632f-45c7-bcb5-20790d6492f5"
      unitRef="usd">-224000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzExLTUtMS0xLTI4NjIx_b9bdb9c6-ed42-489c-a088-a7448988a1af"
      unitRef="usd">60000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzEyLTEtMS0xLTI4NjIx_e20e4c94-e8f0-426c-9f06-613b219fd6f9"
      unitRef="usd">1323000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzEyLTMtMS0xLTI4NjIx_c47a6570-0dc9-47fd-99f8-4627a8de1751"
      unitRef="usd">470000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZToxYzUxN2EzNzkwM2Y0NGM3OGUzYjZkMjMzZDZhM2RkMC90YWJsZXJhbmdlOjFjNTE3YTM3OTAzZjQ0Yzc4ZTNiNmQyMzNkNmEzZGQwXzEyLTUtMS0xLTI4NjIx_80954e7a-a996-4793-a5ba-fcec2dc73518"
      unitRef="usd">85000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzY0NDA_b1214c11-9069-4712-b46e-6add611cdf5f">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s net deferred tax assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accruals and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset before valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,321)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax asset after valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(990)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(803)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax asset (liability)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzItMS0xLTEtMjg2MjE_97fd73ab-44c7-41c2-b0f8-dbbee18cd523"
      unitRef="usd">18274000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzItMy0xLTEtMjg2MjE_d69eb2f2-c096-42b1-827c-9fd44963882e"
      unitRef="usd">18270000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzMtMS0xLTEtMjg2MjE_d77f84c5-edf2-459c-8702-7de9ebea0915"
      unitRef="usd">3160000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzMtMy0xLTEtMjg2MjE_3859f8b4-ab6c-4956-a2bf-e4d876354d6a"
      unitRef="usd">869000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzQtMS0xLTEtMjg2MjE_ed75946d-cc60-4578-a559-b1dc1b957678"
      unitRef="usd">2863000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzQtMy0xLTEtMjg2MjE_628832e2-b60b-42fa-8b1f-b25821ee8e33"
      unitRef="usd">3670000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzUtMS0xLTEtMjg2MjE_3dbc5512-f207-4af8-83ca-afd6435ab82b"
      unitRef="usd">13634000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzUtMy0xLTEtMjg2MjE_a755eeed-f913-4015-b5c5-2cd358a0e8dd"
      unitRef="usd">12653000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzYtMS0xLTEtMjg2MjE_ed541b55-4cbf-4a81-aabc-38485666b3f5"
      unitRef="usd">939000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzYtMy0xLTEtMjg2MjE_8b0d473f-2276-4970-b6a8-2dc95b586f90"
      unitRef="usd">976000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzctMS0xLTEtMjg2MjE_eabb8102-59f4-40ab-a142-550d55932a12"
      unitRef="usd">2226000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzctMy0xLTEtMjg2MjE_b6794941-72a3-4a21-a7a8-c78ed1c57c4e"
      unitRef="usd">2191000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzgtMS0xLTEtMjg2MjE_af43d8c2-1300-4e87-9025-96c7ecbb61fa"
      unitRef="usd">977000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzgtMy0xLTEtMjg2MjE_234dee35-ed08-4d99-9693-5d0780839b8f"
      unitRef="usd">979000</us-gaap:DeferredTaxAssetsOther>
    <cutr:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzktMS0xLTEtMjg2MjE_0dd01592-8371-4654-b96f-1a0054d70fa2"
      unitRef="usd">3784000</cutr:DeferredTaxAssetsOperatingLeaseLiability>
    <cutr:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzktMy0xLTEtMjg2MjE_e25888d4-852a-4ff9-b057-f441d88e59d7"
      unitRef="usd">4311000</cutr:DeferredTaxAssetsOperatingLeaseLiability>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzEwLTEtMS0xLTI4NjIx_5d6002b7-b646-451f-bf5b-6bcdaa27834c"
      unitRef="usd">45857000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzEwLTMtMS0xLTI4NjIx_f5ff23de-c958-47b1-8670-9d54000800de"
      unitRef="usd">43919000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzExLTEtMS0xLTI4NjIx_4f859e8e-f840-4676-9493-1807fc5be1b3"
      unitRef="usd">40485000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzExLTMtMS0xLTI4NjIx_3fa20173-c62b-44a0-8c5a-b837d9c5ac79"
      unitRef="usd">38321000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzEyLTEtMS0xLTI4NjIx_357880d5-10e1-4aba-a476-6d3b7a6e9d24"
      unitRef="usd">5372000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzEyLTMtMS0xLTI4NjIx_2fc01150-3190-4bad-accb-277840e22b39"
      unitRef="usd">5598000</us-gaap:DeferredTaxAssetsNet>
    <cutr:DeferredTaxLiabilitiesDeferredContractAcquisitionCosts
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzEzLTEtMS0xLTI4NjIx_20e67d1b-3474-4830-9930-215981e697ee"
      unitRef="usd">990000</cutr:DeferredTaxLiabilitiesDeferredContractAcquisitionCosts>
    <cutr:DeferredTaxLiabilitiesDeferredContractAcquisitionCosts
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzEzLTMtMS0xLTI4NjIx_651b2d9b-fc09-41b3-bf0c-1c139ddd428e"
      unitRef="usd">803000</cutr:DeferredTaxLiabilitiesDeferredContractAcquisitionCosts>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzE0LTEtMS0xLTI4NjIx_4795072e-d118-4d52-b38f-f8a03cccba2b"
      unitRef="usd">124000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzE0LTMtMS0xLTI4NjIx_4a867ee8-b773-490e-8249-251ffc94be96"
      unitRef="usd">110000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzE1LTEtMS0xLTI4NjIx_b3b97f8d-02b1-411f-bf24-60839f70da94"
      unitRef="usd">3480000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzE1LTMtMS0xLTI4NjIx_bac0430b-16cd-4e19-a310-a9a57a88b96f"
      unitRef="usd">4042000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzE2LTEtMS0xLTI4NjIx_3733240a-b8df-4c9c-8d3b-641e81fb462c"
      unitRef="usd">778000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4ODM4NzAyYzkyZTY0MDNjYjlmYWM2NzQzZjgwMTAxNy90YWJsZXJhbmdlOjg4Mzg3MDJjOTJlNjQwM2NiOWZhYzY3NDNmODAxMDE3XzE2LTMtMS0xLTI4NjIx_9cf2d0ee-ccb9-4a49-8627-a75b9176a843"
      unitRef="usd">643000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzY0NDE_e178b187-776b-4283-aade-10aff00f247c">The differences between the U.S. federal statutory income tax rates to the Company&#x2019;s effective tax rate are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.87)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.58)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Extinguishment of PPP loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44.59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Excess compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.05)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General business credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in prior year reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred true-up&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzItMS0xLTEtMjg2MjE_8b1604e1-9c21-4c0d-8d92-a658371b69b8"
      unitRef="number">0.2100</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzItMy0xLTEtMjg2MjE_b668ddf3-b36f-4214-9235-199907aebfff"
      unitRef="number">0.2100</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzItNS0xLTEtMjg2MjE_3ab35881-b306-412e-a0fe-cac0e61de2f2"
      unitRef="number">0.2100</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzMtMS0xLTEtMjg2MjE_b79c054d-cc88-4822-84fa-8f841205cc8d"
      unitRef="number">-0.0255</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzMtMy0xLTEtMjg2MjE_70c096bc-32c5-4330-aefc-c8fb1b1ae524"
      unitRef="number">0.0277</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzMtNS0xLTEtMjg2MjE_dcbeadef-3f3b-427c-8fa3-5f30e7c795fc"
      unitRef="number">0.0282</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzQtMS0xLTEtMjg2MjE_703cd106-6f9f-4a4a-bd00-232fd2c06c98"
      unitRef="number">0.0928</cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzQtMy0xLTEtMjg2MjE_036901d7-4611-484a-b67a-d7496aea128e"
      unitRef="number">-0.0065</cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzQtNS0xLTEtMjg2MjE_99dc904d-f13b-4a12-a0de-ca17cc183493"
      unitRef="number">-0.0283</cutr:EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzUtMS0xLTEtMjg2MjE_944dc291-1b15-41ba-8c10-9036abf8c7f4"
      unitRef="number">0.0111</cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzUtMy0xLTEtMjg2MjE_45049a3a-2b94-44c2-840e-53a7ca99ef33"
      unitRef="number">-0.0287</cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzUtNS0xLTEtMjg2MjE_6fd5a0b5-4a40-47c5-a9e3-ceb7cbd793d3"
      unitRef="number">-0.0258</cutr:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzYtMS0xLTEtMjg2MjE_ee84e1bb-2934-4c82-bcbd-0dd41175ecf7"
      unitRef="number">-0.1308</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzYtMy0xLTEtMjg2MjE_c7b6fb04-6874-4989-8a06-c0bf54d46e77"
      unitRef="number">-0.0107</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzYtNS0xLTEtMjg2MjE_66640159-8fb2-4232-911f-7bfd467d41b7"
      unitRef="number">0.0378</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <cutr:EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzctMS0xLTEtNDgyNjE_3406486a-8be4-43c6-8d47-c075f0496478"
      unitRef="number">-0.4459</cutr:EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzctMy0xLTEtNDgyNjE_d9603c6f-b69d-4b57-82fc-e95b5b1a9d64"
      unitRef="number">0</cutr:EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzctNS0xLTEtNDgyNjE_d68b3108-0669-4f85-9ae2-13789130a0b6"
      unitRef="number">0</cutr:EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzgtMS0xLTEtNDkzODU_27ee00a3-8515-4346-b3fa-73679b6abb35"
      unitRef="number">0.0788</cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzgtMy0xLTEtNDkzODU_65f4cac4-c2c1-4334-aa5d-d3c97f673ea6"
      unitRef="number">0</cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzgtNS0xLTEtNDkzODU_1cabad97-ea22-4d7e-bfde-b6f7ffc42db3"
      unitRef="number">0</cutr:EffectiveIncomeTaxRateReconciliationExcessCompensationPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzgtMS0xLTEtMjg2MjE_bcdd3753-7394-43cb-b1d7-791465bd9cee"
      unitRef="number">0.1703</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzgtMy0xLTEtMjg2MjE_a6039839-e177-4641-8920-d4c6e80016db"
      unitRef="number">-0.0105</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzgtNS0xLTEtMjg2MjE_95f03d38-40fd-4020-82dd-197413e8da1f"
      unitRef="number">-0.0034</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzktMS0xLTEtMjg2MjE_862d718a-1d31-475f-ae5d-b89d2fea62b1"
      unitRef="number">-0.0008</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzktMy0xLTEtMjg2MjE_71961ba3-b939-41e0-92ad-e1cc8b3e68c9"
      unitRef="number">0.0015</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzktNS0xLTEtMjg2MjE_5d158b28-5fd0-4ca7-aed3-d561919e4a74"
      unitRef="number">-0.0033</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEwLTEtMS0xLTI4NjIx_e08d9381-b44f-4729-b06c-faacc4cf94d1"
      unitRef="number">-0.1795</cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEwLTMtMS0xLTI4NjIx_abbe8233-420f-4427-930c-6a914025dd2d"
      unitRef="number">0.0274</cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEwLTUtMS0xLTI4NjIx_4b3b2a73-6c20-4a4c-8e3f-3da0ab64e201"
      unitRef="number">0.0814</cutr:EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzExLTEtMS0xLTI4NjIx_8581b44a-97e5-48ae-9314-1b3eb98fdbcf"
      unitRef="number">0.7282</cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent>
    <cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzExLTMtMS0xLTI4NjIx_15da3df8-bdcd-4185-a4d3-3ef400f77872"
      unitRef="number">-0.2551</cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent>
    <cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzExLTUtMS0xLTI4NjIx_42704527-e84c-4ce1-bb7f-435a10a0dbec"
      unitRef="number">-0.3860</cutr:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEyLTEtMS0xLTI4NjIx_5b0e73ad-6404-4af8-9ae5-0aae50b5aa59"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEyLTMtMS0xLTI4NjIx_2c6cefd7-7978-49e5-8452-58991b5d45fd"
      unitRef="number">0.0040</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEyLTUtMS0xLTI4NjIx_d4cc7c55-e86c-4174-bf04-dcb048e8c9fb"
      unitRef="number">0.0253</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEzLTEtMS0xLTI4NjIx_f9a1d9e6-b0f8-4606-b2a7-acffe253a31f"
      unitRef="number">-0.1176</cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEzLTMtMS0xLTI4NjIx_b802c495-4ac7-478b-ac9a-ffe84fb2ccd8"
      unitRef="number">0.0208</cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent>
    <cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzEzLTUtMS0xLTI4NjIx_b1c75a01-501b-4378-9b64-55c1eb8ff56d"
      unitRef="number">0.0571</cutr:EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzE0LTEtMS0xLTI4NjIx_3d7813a2-9743-49ac-b4e1-2c274279dc21"
      unitRef="number">0.3911</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzE0LTMtMS0xLTI4NjIx_62167a3a-0ec3-4482-89c4-aaef29160a51"
      unitRef="number">-0.0201</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTpmYmMwZTk3OWVhNTI0YzEyYjJkMzQ5MzFiMjU2MGVkNC90YWJsZXJhbmdlOmZiYzBlOTc5ZWE1MjRjMTJiMmQzNDkzMWIyNTYwZWQ0XzE0LTUtMS0xLTI4NjIx_064ba28d-8f76-48bf-8f52-b1d16f1a4d00"
      unitRef="number">-0.0070</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzYwOQ_a14f0c9b-fb67-419f-abda-89eb5c7378c1"
      unitRef="usd">40500000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzc2Nw_e24027f4-2356-417e-9809-1f8e92fe6d36"
      unitRef="usd">2200000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzc3NA_38f950dd-39c0-429b-94d3-829ed68fb46e"
      unitRef="usd">6000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i2e6fd16be09042c6be9c81d3d9e1c187_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzk4Mg_e5fad84d-08c6-4988-ab55-68219dee0866"
      unitRef="usd">800000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i55e82d33e5544074a2aac447d7824467_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzE4MzU_7d3ed1e4-8b0c-4e53-8fc8-d4cbafd2fdc3"
      unitRef="usd">75900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i7b4a1f39d65147fcac2e81a5c60fcdb4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzE4NDI_d8ccc631-abaf-48ca-9a9e-31e5774113da"
      unitRef="usd">39300000</us-gaap:OperatingLossCarryforwards>
    <cutr:OperatingLossCarryforwardsWithoutExpiration
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzI3NDg3NzkwNzYwMDI_6f018495-9419-4011-8199-f57327e3d9ba"
      unitRef="usd">35400000</cutr:OperatingLossCarryforwardsWithoutExpiration>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="ifade32131fd14ec1926f12852d497aed_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzIzNDc_43b46d46-934b-4fe4-8819-1a0809101292"
      unitRef="usd">6900000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i3598dca90d534ae0a8d4aaf1b13b56c1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzIzNTE_2b88dbaf-b0a7-40e2-a06b-b9487be6592c"
      unitRef="usd">8500000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90ZXh0cmVnaW9uOmRmMDI4NjlmMzZjMTQ4ZGVhOWM5ZmZkOTVhNjNjYzIwXzY0NDI_47497835-2f90-4a24-ade7-a5d31c94c74d">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the Company&#x2019;s gross unrecognized tax benefits, excluding related interest and penalties, in December 31, 2019 to December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzItMS0xLTEtMjg2MjE_d8391899-b99c-4838-9eb1-4f190fcb8f06"
      unitRef="usd">1864000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzItMy0xLTEtMjg2MjE_b4683404-cc24-46b6-8bb2-4a44565549c7"
      unitRef="usd">1426000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzItNS0xLTEtMjg2MjE_6c8aed11-fc20-4f18-b5a8-76ac53ad844c"
      unitRef="usd">1563000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzMtMS0xLTEtMjg2MjE_02c11c98-6e6e-4c0c-8c24-ab0de2ee6810"
      unitRef="usd">37000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzMtMy0xLTEtMjg2MjE_43951ad0-fde1-4211-ad2e-5a9fb87ddcfa"
      unitRef="usd">32000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzMtNS0xLTEtMjg2MjE_24f80fe2-312d-40ca-a84b-f7951cc4cc56"
      unitRef="usd">291000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzQtMS0xLTEtMjg2MjE_9b5cf40e-8fc0-4f8f-a7c7-15d1a65f8272"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzQtMy0xLTEtMjg2MjE_7569da48-b34f-4dbf-b763-e1ec058a9133"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzQtNS0xLTEtMjg2MjE_8f7fdc4a-567b-4565-b9ba-1c825d21ffed"
      unitRef="usd">25000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzUtMS0xLTEtMjg2MjE_2c6353a4-6443-4a0a-8bfa-143e3b830a73"
      unitRef="usd">919000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzUtMy0xLTEtMjg2MjE_12a0e5a6-9216-48d0-ab40-aaffbcc535d2"
      unitRef="usd">470000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzUtNS0xLTEtMjg2MjE_33f460bc-a88f-4e5a-a012-bb1d951e355b"
      unitRef="usd">129000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzYtMS0xLTEtMjg2MjE_f980ed3d-6583-46da-b226-ad5502055549"
      unitRef="usd">2746000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzYtMy0xLTEtMjg2MjE_4b7d36e1-8808-43dd-acd1-0773ad5e4bb5"
      unitRef="usd">1864000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id274c268168b47e082c04e17dfbb9eb6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzAvZnJhZzpkZjAyODY5ZjM2YzE0OGRlYTljOWZmZDk1YTYzY2MyMC90YWJsZTo4NmU1Mjk1MTkwOWY0ZTU0OGM5NzdkOWZiMmY5Njk2ZS90YWJsZXJhbmdlOjg2ZTUyOTUxOTA5ZjRlNTQ4Yzk3N2Q5ZmIyZjk2OTZlXzYtNS0xLTEtMjg2MjE_f742a004-60c8-4f2f-8b6a-ff8f5d460d4c"
      unitRef="usd">1426000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90ZXh0cmVnaW9uOmI3NGQyMTViYzQ4NjQyMDk5NTM1NTdjOGI2MzQyNTBkXzE0MDE_fb4e7032-404b-423e-8548-2270f202da76">NET INCOME (LOSS) PER SHARE&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, the Company&#x2019;s convertible notes were potentially convertible into 4,167,232 shares of common stock. The Company used the if-converted method to calculate the potential dilutive effect of the conversion spread on diluted net income per share for the year ended December 31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The denominator for diluted net income (loss) per share does not include any effect from the capped call transactions the Company entered into concurrently with the issuance of the convertible notes, as this effect would be anti-dilutive. In the event of conversion of a convertible note, shares delivered to the Company under the capped call will offset the dilutive effect of the shares that the Company would issue under the convertible notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For the years ended December 31, 2020 and 2019, basic loss per common share and diluted loss per common share are the same in each respective period, as the inclusion of any potentially issuable&#160;shares would be&#160;anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table sets forth the computation of basic and diluted net loss and the weighted average number of shares used in computing basic and diluted net loss per share (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of incremental shares and share equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net income (loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following numbers of shares outstanding, prior to the application of the treasury stock method and the if-converted method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capped call&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments
      contextRef="ia4c6391b6a824369a52a92dbea8b9166_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90ZXh0cmVnaW9uOmI3NGQyMTViYzQ4NjQyMDk5NTM1NTdjOGI2MzQyNTBkXzM4NDgyOTA3MDI3MTg_a963ff76-bae7-4fe4-a22b-c5c731f9b894"
      unitRef="segment">4167232</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90ZXh0cmVnaW9uOmI3NGQyMTViYzQ4NjQyMDk5NTM1NTdjOGI2MzQyNTBkXzE0MDI_cc830edf-e0d1-4dbe-ab71-b72ff5a43fef">The following table sets forth the computation of basic and diluted net loss and the weighted average number of shares used in computing basic and diluted net loss per share (in thousands, except per share data):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of incremental shares and share equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding used in computing net income (loss) per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Net income (loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzMtMS0xLTEtMjg2MjE_4bbb152c-51b7-4c3b-9db4-83445f71351e"
      unitRef="usd">2062000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzMtMy0xLTEtMjg2MjE_72723b26-f1c2-437c-8286-d183de583195"
      unitRef="usd">-23877000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzMtNS0xLTEtMjg2MjE_336ac29b-1f2c-4d0b-8d53-31d557b46ad7"
      unitRef="usd">-12348000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzUtMS0xLTEtMjg2MjE_445db900-fac0-40ac-93ed-0cbaefd937b5"
      unitRef="shares">17891000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzUtMy0xLTEtMjg2MjE_bc7c8378-4828-453a-9a30-923d791d11a5"
      unitRef="shares">16691000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzUtNS0xLTEtMjg2MjE_f28a2085-de4d-424d-bd86-567814270cd2"
      unitRef="shares">14096000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzctMS0xLTEtMzc0Njg_f5440edc-632d-416d-8d48-62812ee3275f"
      unitRef="shares">68000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i96da2608d0c74b9caa0470c76a5e3299_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzctMy0xLTEtMzQxNDg_2a667648-d681-4f9b-a00a-28eebe7300a9"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i35da96289dd949498eddb1768dd19192_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzctNS0xLTEtMzQxNTk_3934e677-8795-4f06-a407-3db238acbe4c"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie7b82881e10947cb93b085d9ee5177ff_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzgtMS0xLTEtMzc0Njg_fab346cc-02a4-4280-936f-072f3ce21d2d"
      unitRef="shares">294000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ifdb12bdbe74d4a31b24447db518d4288_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzgtMy0xLTEtMzQxNDg_afef21d8-dd90-4682-845e-0180c125687e"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3216a5d8bf854f599b80e4283564ca37_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzgtNS0xLTEtMzQxNTk_f1d69100-df57-4020-b465-c5c0a2005e68"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3adb16d3075942348f225b70cf90f3a4_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzktMS0xLTEtMzc0Njg_ddfc5bcc-b29b-4baa-8aff-6e49d3d0fb0a"
      unitRef="shares">104000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7cf974c819a34839aa1bfe59802e71ba_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzktMy0xLTEtMzQxNDg_e253eb14-3175-493e-abe8-3d46bd3025e8"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i66107087f3fd4a20b6cb4d48e7f3033a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzktNS0xLTEtMzQxNTk_6efcab22-727a-4442-8251-c388b4099509"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i908d24eef82248b3b0c5e24ce67d7620_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzEwLTEtMS0xLTM3NDY4_bd7cc34d-9dc6-4274-b75f-7c178806ef96"
      unitRef="shares">5000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i2673044451384aab8b4c321ea6b9f8a2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzEwLTMtMS0xLTM0MTQ4_f457e6a5-fa01-4be6-9d3d-c0785c51e93c"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia643c91cedb04d559d547cfeceee8809_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzEwLTUtMS0xLTM0MTU5_fb6c42d6-617f-4b9c-9c41-65651dff1f29"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzExLTEtMS0xLTM3NDY4_5fb3f48b-2a0c-4b39-83ea-2e8662bfe704"
      unitRef="shares">18362000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzExLTMtMS0xLTM0MTQ4_00857283-9062-4216-b71f-025c938a1b30"
      unitRef="shares">16691000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzExLTUtMS0xLTM0MTU5_1bb19b15-000d-459b-bb4d-3156298e01c3"
      unitRef="shares">14096000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzEzLTEtMS0xLTM0MTc0_3033b9b0-9305-44bc-a54b-a89cff7c8abf"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzEzLTMtMS0xLTM0MTQ4_a1677975-85c4-466b-9e1d-3c0d3e43e20d"
      unitRef="usdPerShare">-1.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzEzLTUtMS0xLTM0MTU5_bc8efcfc-121b-44e2-9650-936dffb71b0e"
      unitRef="usdPerShare">-0.88</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzctMS0xLTEtMjg2MjE_1da05d83-1d77-40a1-ba33-870c36d413c3"
      unitRef="usdPerShare">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzctMy0xLTEtMjg2MjE_ab3e55af-7067-418b-9ca7-3af70ab867bc"
      unitRef="usdPerShare">-1.43</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo1YjMyMTg5MzhhNGM0MGY0YWExYWRmN2NkMGNlOTQyMi90YWJsZXJhbmdlOjViMzIxODkzOGE0YzQwZjRhYTFhZGY3Y2QwY2U5NDIyXzctNS0xLTEtMjg2MjE_4d08d0da-2144-4bda-b6c3-52ceb9b25421"
      unitRef="usdPerShare">-0.88</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90ZXh0cmVnaW9uOmI3NGQyMTViYzQ4NjQyMDk5NTM1NTdjOGI2MzQyNTBkXzE0MDM_5c9db542-c1f5-49ed-a7b9-db45a96ee80d">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following numbers of shares outstanding, prior to the application of the treasury stock method and the if-converted method, were excluded from the computation of diluted net income (loss) per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capped call&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9eb3b54c6e9341a299439438dca1b02c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzItMS0xLTEtMzQzNDc_7484d1c6-cbcc-4429-a0c3-84d443b2c70e"
      unitRef="shares">4167000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i637b3d70c182413ba3e75aa2bef9320b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzItMy0xLTEtMzQzNTg_443a1d01-73a2-4a42-9cba-48320b02bdd5"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id943a7c916e04296aa697a2d261b63c9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzItNS0xLTEtMzQzNjk_95c837ed-bfef-46fb-9bcc-cd6004fcf844"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8c1a042e66a646cf876664c9b9e32ccf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzMtMS0xLTEtMzQzNDc_60edaa69-8850-47db-a07f-79cf234a8b32"
      unitRef="shares">4167000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i69439113ac644761bbfd84226a430cdc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzMtMy0xLTEtMzQzNTg_8709041e-2cb7-459c-a718-be21212acad7"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9751faf680174024a66bfd73c40bb6ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzMtNS0xLTEtMzQzNjk_23c8a578-4471-43d9-8575-dfc441cf8838"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i827ff77fcef14e9c82c96fe8afe59e6f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzItMS0xLTEtMjg2MjE_8eef38fe-a839-4ea6-9362-6b88ee5d08f9"
      unitRef="shares">166000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if5e396b1a03c446faf5e013cd334d63a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzItMy0xLTEtMjg2MjE_f8c1ce1a-bca2-4593-83e3-76913220b99b"
      unitRef="shares">244000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia86ce17804314cdfb7203658a2fa825c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzItNS0xLTEtMjg2MjE_c5d6c94a-6de0-4868-b121-a5cd611a085d"
      unitRef="shares">417000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i26a28b3231d24fbd9da85098c345597f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzMtMS0xLTEtMjg2MjE_8ba6f6d4-38e0-427f-b538-365b4788f2c4"
      unitRef="shares">32000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4d3b04419de146f79e0830d4f8e5fc88_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzMtMy0xLTEtMjg2MjE_fcd6d6c4-50f5-4504-a618-ac1c645d4d7b"
      unitRef="shares">724000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i67dd4dfa6fb84a8d803fd3e4686012df_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzMtNS0xLTEtMjg2MjE_401d7213-85c4-4376-9b17-9f70127c95e4"
      unitRef="shares">559000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i49698c4c16fa448aa1199cdea0f0db3f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzQtMS0xLTEtMjg2MjE_306af4ae-cbba-4057-94e2-07eab6001f82"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iadd6424f69774b75aa9f2d8c176bfc58_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzQtMy0xLTEtMjg2MjE_0eeb1f3a-3e1f-456e-82b7-a42b73659d3c"
      unitRef="shares">87000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i82424323bc6746ac95ae7b4f28e7db6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzQtNS0xLTEtMjg2MjE_7b23bb87-2894-48bc-a938-4ca763891574"
      unitRef="shares">111000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id80c93e18ea14c80a7c54a7919d9e363_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzUtMS0xLTEtMjg2MjE_cb044894-7eda-42ca-855d-58580d6f0909"
      unitRef="shares">120000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id3d8659c50814d9ba9e908c0fdd94d23_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzUtMy0xLTEtMjg2MjE_aa09dff2-9795-451c-8ab1-0ce081bdc0ef"
      unitRef="shares">68000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ied686aef55a948f5bdf73f5ebd34b570_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzUtNS0xLTEtMjg2MjE_99ea180c-b150-4c89-97c4-881d90e971d2"
      unitRef="shares">178000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzYtMS0xLTEtMjg2MjE_64dac984-5965-403d-8dec-409040315edb"
      unitRef="shares">8652000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzYtMy0xLTEtMjg2MjE_06b9b17d-c775-4c5a-9bc3-5a3339a69693"
      unitRef="shares">1123000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzYvZnJhZzpiNzRkMjE1YmM0ODY0MjA5OTUzNTU3YzhiNjM0MjUwZC90YWJsZTo3MzNmNGJhZWRjZmM0NDVhODMxYjYxNTM2MTZjYWViMy90YWJsZXJhbmdlOjczM2Y0YmFlZGNmYzQ0NWE4MzFiNjE1MzYxNmNhZWIzXzYtNS0xLTEtMjg2MjE_cf286b4b-88a3-4a15-8e5c-1774c2941eda"
      unitRef="shares">1265000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzkvZnJhZzo3YzZmMDYyNGEzNTA0ZmM3ODJjMDRkOWRiYzM5NzhlMy90ZXh0cmVnaW9uOjdjNmYwNjI0YTM1MDRmYzc4MmMwNGQ5ZGJjMzk3OGUzXzk1Mg_1a2678ce-ce89-46ec-8ffd-977cedc2aa5e">DEFINED&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CONTRIBUTION&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PLAN&lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the U.S., the Company has an employee savings plan (&#x201c;401(k) Plan&#x201d;) that qualifies as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Eligible employees may make voluntary contributions to the 401(k) Plan up to 100% of their annual compensation, subject to statutory annual limitations. In 2021, 2020 and 2019, the Company made discretionary contributions under the 401(k) Plan of $0.3 million, $0.2 million and $0.4 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company&#x2019;s Japanese subsidiary, a discretionary employee retirement plan has been established. In addition, for some of the Company&#x2019;s other foreign subsidiaries, the Company deposits funds with insurance companies, third-party trustees, or into government-managed accounts consistent with the requirements of local laws. The Company has fully funded or accrued for its obligations as of December&#160;31, 2021, and the related expense for each of the three years then ended was not significant.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <cutr:DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzkvZnJhZzo3YzZmMDYyNGEzNTA0ZmM3ODJjMDRkOWRiYzM5NzhlMy90ZXh0cmVnaW9uOjdjNmYwNjI0YTM1MDRmYzc4MmMwNGQ5ZGJjMzk3OGUzXzI4Mg_6d6fb32f-570a-45e9-8233-fd927441297a"
      unitRef="number">1</cutr:DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzkvZnJhZzo3YzZmMDYyNGEzNTA0ZmM3ODJjMDRkOWRiYzM5NzhlMy90ZXh0cmVnaW9uOjdjNmYwNjI0YTM1MDRmYzc4MmMwNGQ5ZGJjMzk3OGUzXzQ0Mw_15434b0c-d86f-4e43-91bc-444d455dae79"
      unitRef="usd">300000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzkvZnJhZzo3YzZmMDYyNGEzNTA0ZmM3ODJjMDRkOWRiYzM5NzhlMy90ZXh0cmVnaW9uOjdjNmYwNjI0YTM1MDRmYzc4MmMwNGQ5ZGJjMzk3OGUzXzQ0Nw_26615c1d-0bc1-4fed-985e-4bcb951fdb60"
      unitRef="usd">200000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xMzkvZnJhZzo3YzZmMDYyNGEzNTA0ZmM3ODJjMDRkOWRiYzM5NzhlMy90ZXh0cmVnaW9uOjdjNmYwNjI0YTM1MDRmYzc4MmMwNGQ5ZGJjMzk3OGUzXzQ1NA_af11c33e-e1d9-4be8-95ce-3ab203a701dd"
      unitRef="usd">400000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90ZXh0cmVnaW9uOjE2YzYzNWIyYmZhNjQ5NjY4MmUzYmM0OWU3ZTY2MjViXzE0MDQ_0600680f-0aca-4f67-91d9-e517f670a8e8">SEGMENT INFORMATION AND REVENUE BY GEOGRAPHY AND PRODUCTSSegment reporting is based on the &#x201c;management approach,&#x201d; following the method that management organizes the company&#x2019;s reportable segments for which separate financial information is made available to, and evaluated regularly by, the chief operating decision maker in allocating resources and in assessing performance. The Company&#x2019;s chief operating decision makers ("CODM") are its Chief Executive Officer ("CEO") and Chief Financial Officer (&#x201c;CFO&#x201d;), who make decisions on allocating resources and in assessing performance. The CEO and CFO review the Company's consolidated results as one operating segment. In making operating decisions, the CODM primarily considers consolidated financial information, accompanied by disaggregated information about revenues by geography and product. All of the Company&#x2019;s principal operations and decision-making functions are located in the U.S. Substantially all of the Company's long-lived assets are located in the U.S. &lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of revenue by geography for the year ended December&#160;31, 2021, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue mix by geography:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia, excluding Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of the world, other than United States, Asia and Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue mix by product category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skincare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90ZXh0cmVnaW9uOjE2YzYzNWIyYmZhNjQ5NjY4MmUzYmM0OWU3ZTY2MjViXzQ5NDc4MDIzMjY0MTY_12a21b3a-25df-4d29-a63b-b6815e0784b5"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90ZXh0cmVnaW9uOjE2YzYzNWIyYmZhNjQ5NjY4MmUzYmM0OWU3ZTY2MjViXzE0MDM_806c4f22-f36b-431f-8fbb-074957c2f1f2">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a summary of revenue by geography for the year ended December&#160;31, 2021, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue mix by geography:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia, excluding Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of the world, other than United States, Asia and Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue mix by product category:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skincare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8b29467be6564d3f96a00ec95fc5f71b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzMtMS0xLTEtMjg2MjE_d0b2f625-6b92-41eb-b887-1939737a55b6"
      unitRef="usd">96629000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i45b5e0fc162b498a9929672c4fb7e999_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzMtMy0xLTEtMjg2MjE_f0dafc65-85ee-43e8-bd00-8622a0986326"
      unitRef="usd">61238000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib9f2c0dfb22b430f8f1dad0b71274edb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzMtNS0xLTEtMjg2MjE_a1288d32-213c-4903-bc7d-e90490e346dd"
      unitRef="usd">106372000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if27b2a1100724a6ba26c08b984a74d73_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzQtMS0xLTEtMjg2MjE_45b613f3-1ffc-4ecd-83ef-b334351bd3c7"
      unitRef="usd">70235000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iabe1ad421e2e4777bc58f953183a58d8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzQtMy0xLTEtMjg2MjE_1481ff70-357c-4366-af2c-68054ebd221d"
      unitRef="usd">43265000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i85ccedc5cc084701a241de78d69d915f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzQtNS0xLTEtMjg2MjE_75112047-8a20-4a4d-9d09-5ba31c92f71b"
      unitRef="usd">24143000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic0e98db9695641d48b2985be4ab15c8d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzUtMS0xLTEtMjg2MjE_83b6afea-a792-485f-896b-af9d2a8693dd"
      unitRef="usd">12649000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8f06a616963d42bbb1bef44c8cff5a12_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzUtMy0xLTEtMjg2MjE_03c0a3cc-8381-4f0f-9380-f82a57c52ad0"
      unitRef="usd">10707000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ieb36f34a3d6443f59cb889c5f55426a4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzUtNS0xLTEtMjg2MjE_e51a7638-53c1-406b-a223-3050b4db3c5a"
      unitRef="usd">14414000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibe6666768fb24f969d5783ef26a323af_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzYtMS0xLTEtMjg2MjE_f632054c-4700-4066-999c-195eba62f45a"
      unitRef="usd">19444000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i21f225eac6b24108b1ebbc248f11ac03_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzYtMy0xLTEtMjg2MjE_632aea7f-957e-46bc-8d77-6dc6a5aa8bd2"
      unitRef="usd">11185000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie9b8210b31c544628b9091d412a30501_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzYtNS0xLTEtMjg2MjE_45513a28-12ea-4e02-909a-a18fe1916be9"
      unitRef="usd">11937000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7ead9548c13b4a1e8a2ca967452a46ea_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzctMS0xLTEtMjg2MjE_0e282c7c-d1c9-4e49-bec1-cac47ef2f974"
      unitRef="usd">32313000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5bf9f04fa0584c609bf017b7f800a291_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzctMy0xLTEtMjg2MjE_06a1a671-0644-42b8-9960-b6f4e99120b9"
      unitRef="usd">21288000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9a47c8db3d4c4730995fc63329813d86_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzctNS0xLTEtMjg2MjE_187e0106-5bdd-4c57-bae8-8f1993b35757"
      unitRef="usd">24846000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzgtMS0xLTEtMjg2MjE_a906176a-59df-4762-ae91-4d62f4505030"
      unitRef="usd">231270000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzgtMy0xLTEtMjg2MjE_f86b4fb9-ea73-4a0f-a88e-b6e3f9380739"
      unitRef="usd">147683000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzgtNS0xLTEtMjg2MjE_4f5d9974-aa93-4bc8-b20d-6ee944fe5950"
      unitRef="usd">181712000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idac1466cf9104c8e9357f38e1e4b2c30_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEwLTEtMS0xLTI4NjIx_d9419678-7902-4bb5-ba2b-7c34856fd93a"
      unitRef="usd">139633000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib265219876bc4426a1d87eaf7ec84fe5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEwLTMtMS0xLTI4NjIx_4f74d16b-8fe2-4905-8882-5bd922f9ed0e"
      unitRef="usd">90765000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i646d72085053489e80492d5e31a5abb2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEwLTUtMS0xLTI4NjIx_3f0f36d9-181b-4ccd-9b6b-53b075c7bfa0"
      unitRef="usd">140478000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i60121f9d6c17406fa91d2087e5266a1b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzExLTEtMS0xLTI4NjIx_be549758-922b-4a33-b4df-7610ab3e16ab"
      unitRef="usd">16401000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i85aa042e4c004dc8a331aa0e27b9dd03_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzExLTMtMS0xLTI4NjIx_fc9b4624-cc21-4b08-a00d-165242de1a25"
      unitRef="usd">9287000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i007f7a487e97481d9f1957cd82a932d8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzExLTUtMS0xLTI4NjIx_ef628822-a854-4965-89dc-d843c3f579de"
      unitRef="usd">9648000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id4151927442041dd92c39ebf707b54a4_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEyLTEtMS0xLTI4NjIx_6cb3c92d-a569-40b1-a10a-89b9b023706b"
      unitRef="usd">49669000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idbb6461561444b40bb9d9d51b6f1aff8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEyLTMtMS0xLTI4NjIx_f95b3681-4c63-4363-9504-61d578b294b3"
      unitRef="usd">25061000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2e98acc9c5eb4f31a71cdbb2d1a1a1d5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEyLTUtMS0xLTI4NjIx_7e3f14d3-e8e9-4302-b42a-f8534ed1a4f3"
      unitRef="usd">8512000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i099f3e3620924202a8039a0d27597652_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEzLTEtMS0xLTI4NjIx_2522d0aa-9bd3-467f-95f8-cb9f08ef9064"
      unitRef="usd">205703000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1b500e632e0846a6a33e6a7ac55f88ad_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEzLTMtMS0xLTI4NjIx_2edc09c2-dcab-4460-84c9-7fbc7321eb38"
      unitRef="usd">125113000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7098bcdf6ed0484fab59d24d26f26f8b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzEzLTUtMS0xLTI4NjIx_bb04bde5-f791-4d7f-ac56-e4b3fa414f49"
      unitRef="usd">158638000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i58319883bced4affb153fc42b9f6a7ab_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzE0LTEtMS0xLTI4NjIx_4293ea48-7615-4d61-a63a-3d9dbb95b8a1"
      unitRef="usd">25567000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3a72612f34ee4319a9bb7d59ecf28bee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzE0LTMtMS0xLTI4NjIx_06b903cc-69b0-4df5-9b39-3b57c8cc0a52"
      unitRef="usd">22570000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia4cf1c8552b845c08ebb68573b2cdd62_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzE0LTUtMS0xLTI4NjIx_8c1016eb-8a20-4abf-9340-208d0bcb2213"
      unitRef="usd">23074000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzE1LTEtMS0xLTI4NjIx_ca869122-009b-48b6-a51c-75aadf542353"
      unitRef="usd">231270000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzE1LTMtMS0xLTI4NjIx_7040cecf-d36a-4278-bfea-1d26485e6963"
      unitRef="usd">147683000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDIvZnJhZzoxNmM2MzViMmJmYTY0OTY2ODJlM2JjNDllN2U2NjI1Yi90YWJsZTplYTgwYzUzYjFkNDA0NWE4ODgzMzU1YTExMGRiNDI3Ni90YWJsZXJhbmdlOmVhODBjNTNiMWQ0MDQ1YTg4ODMzNTVhMTEwZGI0Mjc2XzE1LTUtMS0xLTI4NjIx_5f1acaed-d3c7-4864-ab96-5d4fafc75325"
      unitRef="usd">181712000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <cutr:LesseeLeasesTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwNDAx_4f1fd29a-bf2e-44c5-a3bd-e1eac34111e8">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;LEASES&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to certain operating and finance leases for vehicles, office space and storage facilities. The Company&#x2019;s material operating leases consist of office space, as well as storage facilities and finance leases consist of automobiles. The Company&#x2019;s leases generally have remaining terms of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzM1OQ_c3159409-b458-460d-9242-9f6a751b81b3"&gt;one&lt;/span&gt; to 10 years, some of which include options to renew the leases for up to five years. The Company leases space for operations in the United States, Japan, Belgium, France, and Spain. In addition to the above facility leases, the Company also routinely leases automobiles for certain sales and field service employees under finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued ASU 2016-2, "Leases," (also known as ASC Topic 842) which requires, among other items, lease accounting to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures are enhanced to better present the amount, timing and uncertainty of cash flows arising from leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted ASU 2016-2, as of January&#160;1, 2019, using the modified retrospective method, to all leases existing at the date of initial application. The comparative period information has not been restated and continues to be reported under the accounting standards in effect for the period presented. The new standard provides a number of optional practical expedients in transition. The Company elected the package of practical expedients permitted under the transition guidance within the new standard, which allowed the Company to carry forward the Company&#x2019;s historical conclusions about lease identification, lease classification and initial direct costs. The Company also elected the practical expedient related to land easements, allowing the Company to carry forward the Company&#x2019;s accounting treatment for land easements on existing agreements. The Company did not elect the practical expedient to use hindsight in determining the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The adoption of the new standard resulted in the recording of additional lease assets and lease liabilities of $10.2 million and $10.1 million, respectively, as of January&#160;1, 2019, based on the present value of the remaining minimum rental payments under current leasing standards for existing operating leases. The difference between the additional lease assets and lease liabilities resulted from rent-free periods which were previously recorded as deferred rent. The Company&#x2019;s accounting for finance leases remained substantially unchanged. The standard had no material impact on the Company&#x2019;s consolidated net earnings, results of operations, comprehensive loss, statements of changes in equity, and cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Effect of Adoption of the New Lease Standard (ASC Topic &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;842&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;) on Consolidated Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of adopting Topic 842 on the Company&#x2019;s consolidated balance sheet as of January&#160;1, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As reported under&lt;br/&gt;Topic 842&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balances under&lt;br/&gt;Prior GAAP&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(10,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term liabilities*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,759)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;*Deferred rent included in other long-term liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if a contract contains a lease at inception. Operating lease assets and liabilities are recognized at the lease commencement date. Operating lease liabilities represent the present value of lease payments not yet paid. Operating lease assets represent the right to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, the Company estimates the incremental secured borrowing rates corresponding to the maturities of the leases. The Company based the rate estimates on prevailing financial market conditions, credit analysis, and management judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes expense for these leases on a straight-line basis over the lease term. Additionally, tenant incentives used to fund leasehold improvements are recognized when earned and reduce the Company&#x2019;s right-of-use asset related to the lease. These are amortized through the right-of-use asset as reductions of expense over the lease term.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is supplemental balance sheet information related to leases (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMS0xLTEtMzkwMjA_971a5a0e-7d36-4fb8-a69f-ab6296ab5451"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMS0xLTEtMzkwMjA_9d781c61-1f10-40e0-a3f0-691f77491d63"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total leased assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities , non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMS0xLTEtMzkwMjI_8092eb31-ac1f-4f22-979c-32b815b92382"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMS0xLTEtMzkwMjI_e0e19b97-1369-4d4a-bbc4-18c6459ed777"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMS0xLTEtMzkwMjQ_28244cd5-3898-471f-8e2b-ae37ea29760a"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMS0xLTEtMzkwMjQ_7df8c095-3d4f-4603-b7c7-f49c99ce82b6"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease costs during the twelve months ended&#160; December&#160;31, 2021 and December&#160;31, 2020 (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest for finance lease&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities during the twelve months ended December&#160;31, 2021 and December&#160;31, 2020 were as follows&#160;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financing cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Maturities of lease liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of operating lease liabilities were as follows as of December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Vehicle Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable finance leases as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term and discount rate, as of December&#160;31, 2021, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Term and Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lessor Information related to the Company&#x2019;s system leasing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal year ended December 31, 2020, the Company entered into leasing transactions, in which the Company is the lessor, offered through the Company's membership program. The Company's leases for equipment rentals were all accounted for as operating leases during the second and third quarters of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter ended December 31, 2020, certain&#160;of the membership program agreements were amended, granting the customers the exclusive right and option to purchase the leased system from the Company, at any time during the period of twelve months from signing the amended agreement. For contracts signed under the amended membership agreement,&#160;the Company classified and accounted for the arrangements as sales-type leases as of December 31, 2020, as the Company determined it is reasonably certain that the customer will exercise the purchase option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the sales-type leases, the net investment of the Company&#x2019;s lease receivable is measured at the commencement date and is included in the consolidated balance sheets as a component of Other current assets and prepaid expenses. As of December&#160;31, 2020, the Company recorded $0.7&#160;million of revenue for the sales-type leases in the consolidated statement of operations and the related lease receivable in other current assets of the consolidated balance sheet. There was no revenue recognized from the sales-type lease arrangement in fiscal year 2021. During fiscal year 2021 the company received a full payment of $0.4&#160;million from customers who exercised the purchase option. As of December 31, 2021, the lease receivable balance included in Other current assets of the consolidated balance sheet was $0.3 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The revenue related to non-lease components, which comprise service contracts and consumables, are deferred and recognized either over time or at the point of delivery. The non-lease component revenue amount as of December&#160;31, 2021 was immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment lease revenue for operating lease agreements is recognized over the life of the lease. The following table summarizes the amount of operating lease income included in product revenue in the accompanying consolidated statements of operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease income from equipment rentals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchase Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains certain open inventory purchase commitments with its suppliers to ensure a smooth and continuous supply for key components. The Company&#x2019;s liability in these purchase commitments is generally restricted to an agreed-upon period. These periods can vary among different suppliers. Although open purchase orders are considered enforceable and legally binding, the terms generally allow the Company the option to cancel, reschedule, and adjust their requirements based on the Company's business needs prior to the delivery of goods or performance of services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of the Company&#x2019;s business, the Company enters into agreements that contain a variety of representations, warranties, and indemnification obligations. For example, the Company has entered into indemnification agreements with each of its directors and executive officers and certain key employees. The Company&#x2019;s exposure under its various indemnification obligations is unknown and not reasonably estimable as they involve future claims that may be made against the Company. As such, the Company has not accrued any amounts for such obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named from time to time as a party to other legal proceedings, product liability, commercial disputes, employee disputes, and contractual lawsuits in the normal course of business. A liability and related charge are recorded to earnings in the Company&#x2019;s consolidated financial statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including discussion with outside legal counsel. If a reasonable estimate of a known or probable loss cannot be made, but a range of probable losses can be estimated, the low-end of the range of losses is recognized if no amount within the range is a better estimate than any other. If a material loss is reasonably possible, but not probable and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. The Company expenses legal fees as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, the Company&#x2019;s former Executive Vice President and CFO Sandra A. Gardiner announced her resignation from the Company. On November&#160;7, 2019, Ms. Gardiner filed an arbitration demand against the Company in connection with the terms of her employment and resignation. The Company settled this matter with Ms. Gardiner during the second quarter of 2020 with a cash payment of $0.4&#160;million and issuance of 15,408 shares of common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021 and&#160;2020, the Company had accrued $0.7 million and $0.4&#160;million, respectively, related to various pending commercial and product liability lawsuits. The Company does not believe that a material loss in excess of accrued amounts is reasonably possible.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 31, 2020, Cutera filed a lawsuit against Lutronic Aesthetics in the United States District Court for the Eastern District of California.  Lutronic employs numerous former Cutera employees.  The complaint against Lutronic generally alleges claims for (1) misappropriation of trade secrets in violation of state and federal law; (2) violation of the Racketeer Influenced and Corrupt Organizations Act (RICO); (3) interference with contractual relations; (4) interference with prospective economic advantage; (5) unfair competition; and (6) aiding and abetting.  On March 13, 2020, the court entered a temporary restraining order against Lutronic generally prohibiting it from using or disseminating Cutera confidential, proprietary, or trade secret information.  The order also prohibits Lutronic, for 2 years, from using such information for the purpose of soliciting, or conducting business with, certain specified customers.  At the parties&#x2019; request, the Court subsequently entered a preliminary injunction providing for the same restrictions in the restraining order.  On February 9, 2022, Cutera filed a motion seeking leave from the court to file a second amended complaint.  In addition to the above-referenced claims against Lutronic Aesthetics, the proposed amended complaint alleges additional claims against it, including (1) violation of the Lanham Act; (2) unlawful business practices; (3) false advertising; and (4) trademark infringement.  The proposed amended complaint also seeks to add Lutronic Corporation (the Korean parent company of Lutronic Aesthetics) as an additional defendant, and also alleges against it the above-described claims for misappropriation of trade secrets, violation of RICO, interference with contractual relations and prospective economic advantage, unfair competition, and aiding and abetting.  Discovery is ongoing.  No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;</cutr:LesseeLeasesTextBlock>
    <cutr:LesseeLeasesRemainingTerm
      contextRef="if5c79f3c61274db4a3f2eb8ce9d31f70_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzM2NQ_7e49a885-b45c-4128-bd79-fc6289be71d9">P10Y</cutr:LesseeLeasesRemainingTerm>
    <cutr:LesseeLeaseRenewalTerm
      contextRef="if5c79f3c61274db4a3f2eb8ce9d31f70_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzQyOQ_3cdf4452-16d2-4f15-87f5-9ab34c185c9a">P5Y</cutr:LesseeLeaseRenewalTerm>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i399c8e27879e4205838eba2cd2b55bed_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzI2NzI_82ae6ad2-ffb6-451a-88ad-174b3ab2a05f"
      unitRef="usd">10200000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="i399c8e27879e4205838eba2cd2b55bed_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzI2Nzk_0335429f-8cc1-47c9-929e-b6cbd6ec5475"
      unitRef="usd">10100000</us-gaap:OperatingLeaseLiability>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwNDAy_ed75e0ee-fe81-42f5-9629-e58b825dbb5e">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effects of adopting Topic 842 on the Company&#x2019;s consolidated balance sheet as of January&#160;1, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As reported under&lt;br/&gt;Topic 842&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balances under&lt;br/&gt;Prior GAAP&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(10,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term liabilities*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(7,759)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;*Deferred rent included in other long-term liabilities&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzEtMS0xLTEtMjg2MjE_355ca209-3b35-42ea-8bac-100d92388a67"
      unitRef="usd">10049000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia7416b6bdf4a48dcad826a2a1430ea9a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzEtMy0xLTEtMjg2MjE_2faaedbb-9a07-47f9-80c2-aac8a4d0dace"
      unitRef="usd">-10049000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzItMS0xLTEtMjg2MjE_62b99d1b-9c65-4387-b727-78effee42740"
      unitRef="usd">2430000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia7416b6bdf4a48dcad826a2a1430ea9a_I20181231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzItMy0xLTEtMjg2MjE_0175838a-0f4c-4333-860f-2b9313e5bc1c"
      unitRef="usd">-2430000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia7416b6bdf4a48dcad826a2a1430ea9a_I20181231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzMtMy0xLTEtMjg2MjE_6f310e87-f11e-4872-864f-ee4a7598daec"
      unitRef="usd">140000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzMtNS0xLTEtMjg2MjE_96b5025f-ec63-48b3-9150-0adf3223bfe7"
      unitRef="usd">140000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i84bd95534d8f493aa7e53067a3785115_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzQtMS0xLTEtMjg2MjE_840c2b73-dd0c-45bb-9bd2-962ca31d2afc"
      unitRef="usd">7759000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia7416b6bdf4a48dcad826a2a1430ea9a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpjNWFiNzc4MWMxOGU0NmZmYmE4YTkyYjA0NjExOWI3MC90YWJsZXJhbmdlOmM1YWI3NzgxYzE4ZTQ2ZmZiYThhOTJiMDQ2MTE5YjcwXzQtMy0xLTEtMjg2MjE_487ee3ee-78c3-44a1-885c-d9c6812de0a5"
      unitRef="usd">-7759000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <cutr:LeasesFinancialStatementInformationTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwNDA3_547ca34f-6e23-4041-8db6-300c639957f7">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is supplemental balance sheet information related to leases (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMS0xLTEtMzkwMjA_971a5a0e-7d36-4fb8-a69f-ab6296ab5451"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMS0xLTEtMzkwMjA_9d781c61-1f10-40e0-a3f0-691f77491d63"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total leased assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities , non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMS0xLTEtMzkwMjI_8092eb31-ac1f-4f22-979c-32b815b92382"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMS0xLTEtMzkwMjI_e0e19b97-1369-4d4a-bbc4-18c6459ed777"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMS0xLTEtMzkwMjQ_28244cd5-3898-471f-8e2b-ae37ea29760a"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMS0xLTEtMzkwMjQ_7df8c095-3d4f-4603-b7c7-f49c99ce82b6"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;ease costs during the twelve months ended&#160; December&#160;31, 2021 and December&#160;31, 2020 (in thousands):&#160;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest for finance lease&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities during the twelve months ended December&#160;31, 2021 and December&#160;31, 2020 were as follows&#160;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financing cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cutr:LeasesFinancialStatementInformationTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzMtMi0xLTEtMjg2MjE_edf5c748-0687-4f89-8fd0-717dca37293e"
      unitRef="usd">14627000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzMtNC0xLTEtMjg2MjE_6c736c8d-4ee4-43c0-b521-c7690bbe0f7f"
      unitRef="usd">17076000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtMi0xLTEtMjg2MjE_a74ea2f1-92b4-4b33-a0c6-beda698a6e8c"
      unitRef="usd">392000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzQtNC0xLTEtMjg2MjE_f5efc50b-abd3-471f-93fd-c602507373e6"
      unitRef="usd">467000</us-gaap:FinanceLeaseRightOfUseAsset>
    <cutr:LeaseRightOfUseAsset
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzUtMi0xLTEtMjg2MjE_1b9c4fca-4e5b-4436-9ea2-37d806666dcf"
      unitRef="usd">15019000</cutr:LeaseRightOfUseAsset>
    <cutr:LeaseRightOfUseAsset
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTplYmNkYjI2MDZmZWY0NzUwYWE4Zjk5YjQxMjE4NWQ4Mi90YWJsZXJhbmdlOmViY2RiMjYwNmZlZjQ3NTBhYThmOTliNDEyMTg1ZDgyXzUtNC0xLTEtMjg2MjE_bef2cad8-0dd5-41ec-9005-3b7660d139d5"
      unitRef="usd">17543000</cutr:LeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpmYTZmMThjYWViYjM0MmQzYTY3Yjc1NjAxZjlmMWMyNi90YWJsZXJhbmdlOmZhNmYxOGNhZWJiMzQyZDNhNjdiNzU2MDFmOWYxYzI2XzQtMi0xLTEtMjg2MjE_e59d4367-f310-42c6-ac3d-e4d5f4ad2e64"
      unitRef="usd">2419000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpmYTZmMThjYWViYjM0MmQzYTY3Yjc1NjAxZjlmMWMyNi90YWJsZXJhbmdlOmZhNmYxOGNhZWJiMzQyZDNhNjdiNzU2MDFmOWYxYzI2XzQtNC0xLTEtMjg2MjE_422ee8d7-a586-4e6c-af2b-d4ec2f1db2b9"
      unitRef="usd">2260000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpmYTZmMThjYWViYjM0MmQzYTY3Yjc1NjAxZjlmMWMyNi90YWJsZXJhbmdlOmZhNmYxOGNhZWJiMzQyZDNhNjdiNzU2MDFmOWYxYzI2XzUtMi0xLTEtMjg2MjE_ad819d54-04ac-4454-b5b7-5f019a2416a3"
      unitRef="usd">13483000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpmYTZmMThjYWViYjM0MmQzYTY3Yjc1NjAxZjlmMWMyNi90YWJsZXJhbmdlOmZhNmYxOGNhZWJiMzQyZDNhNjdiNzU2MDFmOWYxYzI2XzUtNC0xLTEtMjg2MjE_9600e0d4-563e-4c8f-acf4-95dcb4dbd5a7"
      unitRef="usd">15950000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpmYTZmMThjYWViYjM0MmQzYTY3Yjc1NjAxZjlmMWMyNi90YWJsZXJhbmdlOmZhNmYxOGNhZWJiMzQyZDNhNjdiNzU2MDFmOWYxYzI2XzYtMi0xLTEtMjg2MjE_c70eecf8-c42e-4b45-b8e9-bcc02a5201bd"
      unitRef="usd">15902000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTpmYTZmMThjYWViYjM0MmQzYTY3Yjc1NjAxZjlmMWMyNi90YWJsZXJhbmdlOmZhNmYxOGNhZWJiMzQyZDNhNjdiNzU2MDFmOWYxYzI2XzYtNC0xLTEtMjg2MjE_011eba89-f27e-4092-88fa-296ed00dea3d"
      unitRef="usd">18210000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtMi0xLTEtMjg2MjE_bf7338a2-8465-4a17-97b2-8044997679be"
      unitRef="usd">554000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzMtNC0xLTEtMjg2MjE_3818bfd0-4d59-48a2-8b64-5cf0e28b44f1"
      unitRef="usd">370000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtMi0xLTEtMjg2MjE_42169c93-6913-4bee-97fd-2d6aa0997840"
      unitRef="usd">730000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzQtNC0xLTEtMjg2MjE_5719daa0-ac64-4288-b400-0e3e0173d4ce"
      unitRef="usd">241000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzUtMi0xLTEtMjg2MjE_4680374c-05a5-46e6-b2a8-9c9322cd3491"
      unitRef="usd">1284000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyNDNjYTVlMjVlZTc0OGE3OWVmMzA3ODdkZDlkZGRiNi90YWJsZXJhbmdlOjI0M2NhNWUyNWVlNzQ4YTc5ZWYzMDc4N2RkOWRkZGI2XzUtNC0xLTEtMjg2MjE_beca12e5-adba-435a-8e22-1cf66ade9ec7"
      unitRef="usd">611000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzItMi0xLTEtMjg2MjE_a2d6e188-98c9-49a5-962b-ad8cdef1a6f3"
      unitRef="usd">484000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzItNC0xLTEtMjg2MjE_42652851-22d2-4bc7-9c74-1726e0d94a15"
      unitRef="usd">431000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzItNi0xLTEtNDkyNTM_e033d818-7510-4cbe-8096-9866ec747d92"
      unitRef="usd">704000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzMtMi0xLTEtMjg2MjE_93bc2a93-edb8-4d0f-9b66-64c20024b379"
      unitRef="usd">59000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzMtNC0xLTEtMjg2MjE_1f87a5d0-5e57-47c6-9f9b-24bd652337fd"
      unitRef="usd">63000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzMtNi0xLTEtNDkyNTM_54562963-be5a-47a7-9bce-f09cdbc159c5"
      unitRef="usd">88000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzQtMi0xLTEtMjg2MjE_1227bc61-1e4d-4153-99b3-f5f7b7be126f"
      unitRef="usd">3542000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzQtNC0xLTEtMjg2MjE_df027c7d-1de6-4081-b211-1008fcfdbe58"
      unitRef="usd">3275000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo4NjQ0YjVhMjg5NWU0MWJlYmYwY2E3NjlhMWQzNDY1ZS90YWJsZXJhbmdlOjg2NDRiNWEyODk1ZTQxYmViZjBjYTc2OWExZDM0NjVlXzQtNi0xLTEtNDkyNTM_0bb876a4-b7e9-4880-8105-169a16431783"
      unitRef="usd">2892000</us-gaap:OperatingLeaseExpense>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzItMi0xLTEtMjg2MjE_ff4bba19-4765-4075-a720-ff62fa4f1a84"
      unitRef="usd">56000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzItNC0xLTEtMjg2MjE_6c535652-3146-4157-ab19-1b5b8dba1e60"
      unitRef="usd">63000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzItNi0xLTEtNDkyNjE_325f47d4-fd4b-44cb-aa0d-bb748944415d"
      unitRef="usd">88000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzMtMi0xLTEtMjg2MjE_f57689f7-45a7-445c-ada2-d0b264137fa8"
      unitRef="usd">462000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzMtNC0xLTEtMjg2MjE_416e3690-1d12-4b7c-b4e7-5b26d8c9c2b2"
      unitRef="usd">537000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzMtNi0xLTEtNDkyNjE_31fc4eae-e4fc-474d-8736-5adf4617efc1"
      unitRef="usd">649000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzQtMi0xLTEtMjg2MjE_c5a83a7c-6057-416f-91bf-4c02f36a1e54"
      unitRef="usd">3092000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzQtNC0xLTEtMjg2MjE_9d7098b5-0af1-43ec-bf6e-45e6a8bd5ce5"
      unitRef="usd">2139000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="iaf4d1316c374488a9b0fb076a6693104_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTowYjUxNWZjNTEwMGM0YTg2YWVjMGZhN2YzZGZlOTAzOS90YWJsZXJhbmdlOjBiNTE1ZmM1MTAwYzRhODZhZWMwZmE3ZjNkZmU5MDM5XzQtNi0xLTEtNDkyNjE_09379e1d-63b1-447a-a753-7f571129d61b"
      unitRef="usd">2820000</us-gaap:OperatingLeasePayments>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwNDEx_a4f2eeee-d701-4cb2-91ba-1e40119f55e5">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of operating lease liabilities were as follows as of December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzEtMS0xLTEtMjg2MjE_9dfc71f0-5e50-4d7c-a23a-57b8196d5065"
      unitRef="usd">3121000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzItMS0xLTEtMjg2MjE_ddc2dcf7-4faa-4498-9d2a-b7dc8a105023"
      unitRef="usd">3160000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzMtMS0xLTEtMjg2MjE_8d4ba18d-8fd9-4823-a8d0-4801410a9d22"
      unitRef="usd">2874000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzQtMS0xLTEtMjg2MjE_29b1a51a-b36b-4ab6-935f-210f252fdc8e"
      unitRef="usd">2875000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzUtMS0xLTEtMjg2MjE_d59e3318-dfc6-4026-ab4c-09a0ebd4c572"
      unitRef="usd">2970000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <cutr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFive
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzYtMS0xLTEtMjg2MjE_9110a54d-cc27-4026-8c83-73577b141b6b"
      unitRef="usd">3338000</cutr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzctMS0xLTEtMjg2MjE_f4104f0b-3c14-478f-9e21-c7a2fb77141d"
      unitRef="usd">18338000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzgtMS0xLTEtMjg2MjE_1c1a5099-ac3c-44ef-b718-e77f72efa4dd"
      unitRef="usd">2436000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToxM2JlMzY5YTRhY2E0MmNjYTdiOWRlODcyOTg4YzEzNi90YWJsZXJhbmdlOjEzYmUzNjlhNGFjYTQyY2NhN2I5ZGU4NzI5ODhjMTM2XzktMS0xLTEtMjg2MjE_c064fcd6-eb00-49e5-8b5b-e62ad940108b"
      unitRef="usd">15902000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwNDEy_b494923c-6791-4c28-81a4-075b9be51c8b">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company was committed to minimum lease payments for vehicles leased under long-term non-cancelable finance leases as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTphOTgyYmZkMmE0NGE0NDEzOTE2NWJkOTVlMTM0NWM1NS90YWJsZXJhbmdlOmE5ODJiZmQyYTQ0YTQ0MTM5MTY1YmQ5NWUxMzQ1YzU1XzEtMS0xLTEtMjg2MjE_eadcca8c-2d2c-4d59-be3d-ed10b9268c3c"
      unitRef="usd">601000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTphOTgyYmZkMmE0NGE0NDEzOTE2NWJkOTVlMTM0NWM1NS90YWJsZXJhbmdlOmE5ODJiZmQyYTQ0YTQ0MTM5MTY1YmQ5NWUxMzQ1YzU1XzItMS0xLTEtMjg2MjE_b283e8eb-cb84-4301-b515-edf53d3a5669"
      unitRef="usd">347000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTphOTgyYmZkMmE0NGE0NDEzOTE2NWJkOTVlMTM0NWM1NS90YWJsZXJhbmdlOmE5ODJiZmQyYTQ0YTQ0MTM5MTY1YmQ5NWUxMzQ1YzU1XzMtMS0xLTEtMjg2MjE_a930563b-4256-4ecb-b7bf-0bde7269d34b"
      unitRef="usd">409000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTphOTgyYmZkMmE0NGE0NDEzOTE2NWJkOTVlMTM0NWM1NS90YWJsZXJhbmdlOmE5ODJiZmQyYTQ0YTQ0MTM5MTY1YmQ5NWUxMzQ1YzU1XzQtMS0xLTEtNDMxNzM_79621598-9d68-4b56-ade8-8e21bd6d2466"
      unitRef="usd">22000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTphOTgyYmZkMmE0NGE0NDEzOTE2NWJkOTVlMTM0NWM1NS90YWJsZXJhbmdlOmE5ODJiZmQyYTQ0YTQ0MTM5MTY1YmQ5NWUxMzQ1YzU1XzQtMS0xLTEtMjg2MjE_dde7f701-6cc3-4736-8e54-f01f06f763b6"
      unitRef="usd">1379000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTphOTgyYmZkMmE0NGE0NDEzOTE2NWJkOTVlMTM0NWM1NS90YWJsZXJhbmdlOmE5ODJiZmQyYTQ0YTQ0MTM5MTY1YmQ5NWUxMzQ1YzU1XzUtMS0xLTEtMjg2MjE_2db006b9-2448-42df-ba1b-dde673010d11"
      unitRef="usd">95000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTphOTgyYmZkMmE0NGE0NDEzOTE2NWJkOTVlMTM0NWM1NS90YWJsZXJhbmdlOmE5ODJiZmQyYTQ0YTQ0MTM5MTY1YmQ5NWUxMzQ1YzU1XzYtMS0xLTEtMjg2MjE_f54ccb03-16d4-4e6e-96e4-943d02bdbe70"
      unitRef="usd">1284000</us-gaap:FinanceLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwNDA2_1397cb13-1b57-4168-995e-5b834814cad6">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term and discount rate, as of December&#160;31, 2021, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Term and Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo5OTZkZGFmYzY3ZGY0OWZlOTA3ODNlZDU0ZTRmNjQyOC90YWJsZXJhbmdlOjk5NmRkYWZjNjdkZjQ5ZmU5MDc4M2VkNTRlNGY2NDI4XzItMS0xLTEtMjg2MjE_c4794853-c7d0-40c2-93dd-abaf11819b3f">P5Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo5OTZkZGFmYzY3ZGY0OWZlOTA3ODNlZDU0ZTRmNjQyOC90YWJsZXJhbmdlOjk5NmRkYWZjNjdkZjQ5ZmU5MDc4M2VkNTRlNGY2NDI4XzMtMS0xLTEtMjg2MjE_49fba651-fe41-48b2-8163-49c3486a05af">P2Y1M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo5OTZkZGFmYzY3ZGY0OWZlOTA3ODNlZDU0ZTRmNjQyOC90YWJsZXJhbmdlOjk5NmRkYWZjNjdkZjQ5ZmU5MDc4M2VkNTRlNGY2NDI4XzUtMS0xLTEtMjg2MjE_381fa5ae-2b91-4fa2-8997-1ce232167afc"
      unitRef="number">0.048</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZTo5OTZkZGFmYzY3ZGY0OWZlOTA3ODNlZDU0ZTRmNjQyOC90YWJsZXJhbmdlOjk5NmRkYWZjNjdkZjQ5ZmU5MDc4M2VkNTRlNGY2NDI4XzYtMS0xLTEtMjg2MjE_0bdef79f-13ea-419b-989c-8f585749283a"
      unitRef="number">0.067</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <cutr:LessorOptionToPurchaseGrantedPeriod
      contextRef="i764ce0cbc59940f481fdec67f544e264_D20201001-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzE3MDQyNDMwMjQ5NTY2_5a00e24e-fc72-49d2-9ae4-a205c5422515">P12M</cutr:LessorOptionToPurchaseGrantedPeriod>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzE3MDQyNDMwMjQ5NTc1_bd3d71b1-e35b-46a3-ae11-251214c98f63"
      unitRef="usd">700000</us-gaap:SalesTypeLeaseRevenue>
    <us-gaap:SalesTypeLeaseRevenue
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzMyOTg1MzQ4OTg1MjA_377a16b1-00a4-43d5-9ef0-26aebfb51c14"
      unitRef="usd">0</us-gaap:SalesTypeLeaseRevenue>
    <cutr:ProceedsFromExerciseOfPurchaseOptionSalesTypeLease
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzMyOTg1MzQ5MDE1MTI_611e64a5-9076-4c6c-a80e-98cb76b1ed58"
      unitRef="usd">400000</cutr:ProceedsFromExerciseOfPurchaseOptionSalesTypeLease>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzIwMzQwOTY1MTMyOTIw_05f24ffb-b615-4953-9189-0705fe3d328e"
      unitRef="usd">300000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived>
    <us-gaap:OperatingLeaseLeaseIncomeTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwNDA1_99b24088-ca5d-485a-8763-978a75d94c5e">The following table summarizes the amount of operating lease income included in product revenue in the accompanying consolidated statements of operations (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease income from equipment rentals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OperatingLeaseLeaseIncomeTableTextBlock>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyMmFkNjE2ODgzMDA0NjhlOWY1ZGUwMjVmMTc2NTlmOC90YWJsZXJhbmdlOjIyYWQ2MTY4ODMwMDQ2OGU5ZjVkZTAyNWYxNzY1OWY4XzEtMS0xLTEtMjg2MjE_f3a67b53-1569-4088-8bb2-e85a170330cb"
      unitRef="usd">149000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90YWJsZToyMmFkNjE2ODgzMDA0NjhlOWY1ZGUwMjVmMTc2NTlmOC90YWJsZXJhbmdlOjIyYWQ2MTY4ODMwMDQ2OGU5ZjVkZTAyNWYxNzY1OWY4XzEtMy0xLTEtNDI5MTg_2cf309bb-5fbe-4558-9a55-1556e70ff412"
      unitRef="usd">367000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="ib80ff99676a24f1f8527cc2a3aa4d119_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzM4NDgyOTA3MDc4NTI_d9740046-bfd1-4b63-8a32-53feec175fde"
      unitRef="usd">400000</us-gaap:LossContingencyDamagesPaidValue>
    <cutr:StockIssuedDuringPeriodSharesLitigationSettlement
      contextRef="ib80ff99676a24f1f8527cc2a3aa4d119_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzM4NDgyOTA3MDc4NjY_74c6b542-c88a-4c2c-ad4e-2ec6c8bb257d"
      unitRef="shares">15408</cutr:StockIssuedDuringPeriodSharesLitigationSettlement>
    <us-gaap:LitigationReserve
      contextRef="i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzEwMjA2_8b141300-e090-4e0f-bf35-69a1946a169d"
      unitRef="usd">700000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="icb8194a480bb4178ad9ccc279fa71d86_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDUvZnJhZzowMThmYjBjMDA1NTU0ZjYwYjQzMGEwNmU3ODYyNDk3OC90ZXh0cmVnaW9uOjAxOGZiMGMwMDU1NTRmNjBiNDMwYTA2ZTc4NjI0OTc4XzM4NDgyOTA3MDc4MzU_137e3d32-feb3-40fc-b613-eb8884274c1e"
      unitRef="usd">400000</us-gaap:LitigationReserve>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzUwNzM_510aca13-ff50-49d1-b97d-f6d597e90e3f">DEBT&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible notes, net of unamortized debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, the Company issued $138.3 million aggregate principal amount of convertible senior notes ("convertible notes")&#160;due on March 15, 2026 in a private placement offering. The convertible notes bear interest at a rate of 2.25% per year payable semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2021. Upon conversion, the convertible notes will be convertible into cash, shares of the Company&#x2019;s common stock or a combination thereof, at the Company&#x2019;s election. The convertible notes are presented as convertible notes, net of unamortized debt issuance costs, on the consolidated balance sheet.&#160;Proceeds from the offering were $133.6 million, net of issuance costs, including initial purchasers fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Initially, each $1,000 principal amount of Notes was convertible into 30.1427 shares of the Company&#x2019;s common stock at a conversion price of $33.18 per share. The conversion rate for the convertible notes is subject to adjustment for certain events as set forth in the Indenture governing the convertible notes. The convertible notes will mature on March 15, 2026, unless earlier converted, redeemed, or repurchased in accordance with the terms of the convertible notes. No sinking fund is provided for the Notes. As of December 31, 2021, the net carrying amount of the Company&#x2019;s convertible notes was $134.2 million and the unamortized debt issuance costs were&#160;$4.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders may convert their Notes at their option prior to the close of business on the business day immediately preceding December 15, 2025, in multiples of $1,000 principal amount, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;During any fiscal quarter commencing after the fiscal quarter ended on June 30, 2021 (and only during such fiscal quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter, is greater than or equal to 130% of the conversion price for the convertible notes on each applicable trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;During the five-business day period after any five consecutive trading day period (the &#x201c;measurement period&#x201d;) in which the &#x201c;trading price&#x201d;&#160;per $1,000 principal amount of convertible notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's&#160;common stock and the conversion rate on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Company calls such convertible notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Upon the occurrence of specified corporate events.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after December 15, 2025, and until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The circumstances described in the first bullet of the paragraph above were met during the second and third quarters of 2021 as the Company's stock traded at a price in excess of the conversion price for the required number of days during each of those quarters. These circumstances were not met during the fourth quarter of 2021. As a result, holders of the Notes had the right to convert their Notes beginning July 1, 2021 and ending on December 31, 2021. As of December 31, 2021, the Notes are not convertible and this condition will remain until March 31, 2022. The Notes may become convertible in future periods. Upon any conversion requests of the convertible notes, the Company would be required to pay or deliver, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company&#x2019;s election with respect to such conversion requests. To the extent there are any conversion requests in the year ending December 31, 2022, the Company intends to settle such conversion requests in shares of common stock. Therefore, as of December&#160;31, 2021, the convertible notes have been included as Long-term debt on the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may not redeem the convertible notes prior to March 20, 2024. On or after March 20, 2024, the Company may redeem for cash all or any portion of the Notes, at the Company&#x2019;s option, if the last reported sale price of the Company&#x2019;s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company elects to redeem fewer than all of the outstanding Notes, at least $50.0 million aggregate principal amount of Notes must be outstanding and not subject to redemption as of the relevant redemption notice date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a fundamental change occurs, note holders have the option to require the Company to repurchase any portion or all of their convertible notes in $1,000 principal increments for cash. The price for such repurchase is calculated as 100% of the principal amounts of Notes, plus accrued and unpaid interest to the day immediately preceding the Fundamental Change repurchase date. Additionally, holders of the Notes who convert in connection with a fundamental change are, under certain circumstances, entitled to an increase in conversion rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The convertible notes are general senior unsecured obligations that rank senior to any of the Company&#x2019;s indebtedness that is explicitly subordinated to the Notes. The Notes have equal rank in right of payment with all existing and future unsecured indebtedness that is not subordinated to the Notes. The Notes will be junior to any of the Company&#x2019;s secured indebtedness to the extent of the value of the assets securing such indebtedness. The Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the convertible notes was approximately $201.0 million as of December&#160;31, 2021. The fair value is based on observable market prices for this debt, which is traded in active markets and therefore is classified as a Level 2 fair value measurement, as defined in Note 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the outstanding principal amount and carrying value of the convertible notes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.076%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with issuance of the convertible notes, the Company entered into capped call transactions with certain option counterparties. The capped call transactions are generally intended to reduce the potential dilution of the Company's&#160;common stock upon any conversion or settlement of the Notes or to offset any cash payment the Company is required to make in excess of the principal amount upon conversion of the Notes, as the case may be, with such reduction or offset subject to a cap based on the cap price. If the market price per share of the Company&#x2019;s common stock exceeds the cap price of the capped calls transaction, then the Company&#x2019;s stock would experience some dilution and/or the capped call would not fully offset the potential cash payments, in each case to the extent the then-market price per share of its common stock exceeds the cap price. Under the capped call transactions, the Company purchased from the option counterparties capped call options that in the aggregate relate to the total number of shares of the Company's common stock underlying the convertible notes, with a strike price equal to the conversion price of the convertible notes and with an initial cap price equal to $45.5350, which represents a 75% premium over the last reported sale price of the Company's common stock of $26.02 per share on March&#160;4, 2021, with certain adjustments to the settlement terms that reflect standard anti-dilution provisions. The capped call transactions expire over 40 consecutive scheduled trading days ended on March 12, 2026. The capped calls were purchased for $16.1&#160;million. The Company evaluated the capped call transaction under authoritative accounting guidance and determined that it should be accounted for as a separate transaction and classified as a net reduction to Additional paid-in capital within stockholders&#x2019; equity with no recurring fair value measurement recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company early adopted ASU 2020-6, Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40). In accordance with Subtopic 470-20 and 815-40, as revised by ASU 2020-6, the Company records the convertible notes in long-term debt with no separation between the Notes and the conversion option. Each reporting period, the Company will determine whether any criteria is met for the note holders to have the option to redeem the Notes early, which could&#160;result in a change in the classification of the Notes to current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Debt Issuance Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The issuance costs related to the convertible notes are presented in the consolidated balance sheet as a direct deduction from the carrying amount of the convertible notes. During the year ended December&#160;31, 2021, the Company incurred direct costs associated with the issuance of convertible notes of $4.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The issuance costs are&#160;amortized using&#160;an effective interest method basis over the term of the convertible notes and accordingly the Company recorded approximately&#160;$0.7 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of amortization of debt issuance costs during the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective interest rate on the convertible notes is 2.97%. Interest expense for the year ended December&#160;31, 2021, including the amortization of debt issuance cost, totaled approximately $3.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loan and Security Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 9, 2020, the Company entered into a Loan and Security Agreement with Silicon Valley Bank for a four-year secured revolving loan facility (&#x201c;SVB Revolving Line of Credit&#x201d;) in an aggregate principal amount of up to $30.0&#160;million. The SVB Revolving Line of Credit matures on July 9, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In order to draw on the full amount of the SVB Revolving Line of Credit, the Company must satisfy certain liquidity ratios. If the Company is unable to meet these liquidity ratios, then availability under the revolving line is calculated as 80% of the Company&#x2019;s qualifying accounts receivable. The proceeds of the revolving loans may be used for general corporate purposes. The Company&#x2019;s obligations under the Loan and Security Agreement with Silicon Valley Bank are secured by substantially all of the assets of the Company. Interest on principal amount outstanding under the revolving line shall accrue at a floating per annum rate equal to the greater of either 1.75% above the Prime Rate or five percent (5.0%). The Company paid a non-refundable revolving line commitment fee of $0.3&#160;million, on the effective date of the Loan and Security Agreement with Silicon Valley Bank of July 9, 2020, and the Company is required to pay an anniversary fee of $0.3&#160;million on each twelve-month anniversary of the effective date of the Loan and Security Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Loan and Security Agreement with Silicon Valley Bank contains customary affirmative covenants, such as financial statement reporting requirements and delivery of borrowing base certificates, as well as customary covenants that restrict the Company&#x2019;s ability to, among other things, incur additional indebtedness, sell certain assets, guarantee obligations of third parties, declare dividends, or make certain distributions, and undergo a merger or consolidation or certain other transactions. The Loan and Security Agreement also contains certain financial covenants, including maintaining a quarterly minimum revenue of $90.0&#160;million, determined in accordance with GAAP on a trailing twelve-month basis,  but which is only applicable if the Company has an outstanding balance under the loan facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 4, 2021, the Loan and Security Agreement dated July 9, 2020 was amended to (i)&#160;permit the Company to issue the Convertible notes and perform its obligations in connection therewith, and (ii)&#160;permit the Capped Call transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or about May 28, 2021, the Loan and Security Agreement was amended. The amendment removed the quarterly minimum revenue requirement but kept in place the other financial covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company had not drawn on the SVB Revolving Line of Credit and the Company is in compliance with all financial covenants of the SVB Revolving Line of Credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The Paycheck Protection Program (PPP) Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;22, 2020, the Company received loan proceeds of $7.2 million pursuant to the Paycheck Protection Program (the &#x201c;PPP&#x201d;) under the CARES Act. The loan, which was in the form of a promissory note dated April 21, 2020, between the Company and Silicon Valley Bank as the lender, originally matured on April 21, 2022 and bore interest at a fixed rate of 1.00% per annum, payable monthly commencing September 2021. There was no prepayment penalty. Under the terms of the PPP, all or a portion of the principal may be forgiven if the loan proceeds were used for qualifying expenses as described in the CARES Act, such as payroll costs, benefits, rent, and utilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The PPP loan and related accrued interest were forgiven in June 2021 under the provisions of the CARES Act, and a $7.2&#160;million Gain on extinguishment of PPP loan was recorded in the consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i37f97a9d284443ad97ec8c981fcd7f08_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzI5NDg_93c09382-2c78-4870-9f67-f5ecf9aabbb4"
      unitRef="usd">138300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i37f97a9d284443ad97ec8c981fcd7f08_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzMxMTE_e2bab3b6-93e5-4960-af0d-94d7959f630a"
      unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i1d1c6d926fe34c69ad511dec85a63fd4_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzM1Njc_96e35be0-bf79-4aa2-b03d-de13fdf404fd"
      unitRef="usd">133600000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i2a6e8339dfdb4cd39eddb0d8191da2b2_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzM3NjM_ab8468d2-084c-4eb6-86b2-5b1fd4312e06"
      unitRef="usdPerShare">33.18</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:LongTermDebt
      contextRef="i3b661e68d3614dd8a0389a329265b3bd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzIwMzQwOTY1MTQyMzgy_e408b7f2-501b-4d36-b7c3-6dca9630a8f3"
      unitRef="usd">134200000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i3b661e68d3614dd8a0389a329265b3bd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzE2NDkyNjc0NjYzODg_e33801c7-0f38-440e-a35d-5f4fee5f0940"
      unitRef="usd">4000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="ic7cfa6c72662462f90fcfd77f387c2c3_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzQ2NzQ_baa1e278-942f-4b35-be54-e27806ba9af6"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ic7cfa6c72662462f90fcfd77f387c2c3_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzQ3Mzk_ffd1f9d8-c199-4d18-900e-1239eaf3d659"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="ic7cfa6c72662462f90fcfd77f387c2c3_D20210301-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzQ4ODc_f2a7c98d-acb4-4da8-bd04-2a43f7afcf18"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i8b0a2bfb03104efeadd77a4412bae006_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzQ5ODQ_3e8f3bc0-3a52-4d00-8624-e517b0038426"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i8b0a2bfb03104efeadd77a4412bae006_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzUwMTg_a82ff0e7-d4f5-4708-a492-191edf727f28"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i8b0a2bfb03104efeadd77a4412bae006_D20210301-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzUyMTY_a0befd7c-76f3-4dec-862a-88a05831ed0c"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="ic7cfa6c72662462f90fcfd77f387c2c3_D20210301-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzcxNDI_b6ea9f0a-bc4c-4fed-91bb-9969b373652b"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="ic7cfa6c72662462f90fcfd77f387c2c3_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzcxOTg_9bb10431-3458-422d-a4ef-6ef81224eaf7"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ic7cfa6c72662462f90fcfd77f387c2c3_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzcyNTU_0d2bf4ce-827d-4096-87c7-26eb1bb0255e"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i1d1c6d926fe34c69ad511dec85a63fd4_D20210301-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2Mzc0OTM_62f52f46-ca9a-4db0-b149-690155cce520"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <cutr:DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption
      contextRef="i37f97a9d284443ad97ec8c981fcd7f08_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2Mzc3MDU_0247c2e2-247d-4aa8-9cae-2db53d14e97d"
      unitRef="usd">50000000</cutr:DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption>
    <cutr:DebtInstrumentRedemptionIncrementalRepurchaseAmount
      contextRef="i58a47170b8054a0ba5cca87aa0a800de_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2Mzc5ODU_f642689d-6492-4cc0-9a73-c9368c626bcb"
      unitRef="usd">1000</cutr:DebtInstrumentRedemptionIncrementalRepurchaseAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i74ccf35a513f4cfd8630d93546df6f20_D20210301-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2MzgwNjc_5c28657b-0713-4a31-8b8e-f5d6e6c9df66"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3b661e68d3614dd8a0389a329265b3bd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzE2NDkyNjc0NjYzNTM_a25b2482-d67f-4cb7-8691-cda7c378c692"
      unitRef="usd">201000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE2NzE_a636d3ef-5165-40cc-b93d-7710d73d749a">The following table presents the outstanding principal amount and carrying value of the convertible notes (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.076%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,007)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3b661e68d3614dd8a0389a329265b3bd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90YWJsZTowM2RmNmRjZjkzMmQ0NDE0YjNiMDYzMGIyODRhMDgwNC90YWJsZXJhbmdlOjAzZGY2ZGNmOTMyZDQ0MTRiM2IwNjMwYjI4NGEwODA0XzEtMS0xLTEtMzc2MjE_f403c497-aacf-4c37-a3fc-2e3c491b2bda"
      unitRef="usd">138250000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i3b661e68d3614dd8a0389a329265b3bd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90YWJsZTowM2RmNmRjZjkzMmQ0NDE0YjNiMDYzMGIyODRhMDgwNC90YWJsZXJhbmdlOjAzZGY2ZGNmOTMyZDQ0MTRiM2IwNjMwYjI4NGEwODA0XzItMS0xLTEtMzc2MjE_e593231e-13c2-4715-a083-be96bb14b888"
      unitRef="usd">4007000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i3b661e68d3614dd8a0389a329265b3bd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90YWJsZTowM2RmNmRjZjkzMmQ0NDE0YjNiMDYzMGIyODRhMDgwNC90YWJsZXJhbmdlOjAzZGY2ZGNmOTMyZDQ0MTRiM2IwNjMwYjI4NGEwODA0XzMtMS0xLTEtMzc2MDM_1f478e24-e896-4c39-9335-53df50a4b0b2"
      unitRef="usd">134243000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeCapPrice
      contextRef="i130b34c8fd4f434eb30d4d656ae2c907_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2NDA1ODY_6771597a-c4b4-4fa8-8a00-23142670df0e"
      unitRef="usdPerItem">45.5350</us-gaap:DerivativeCapPrice>
    <cutr:DerivativeCapPricePremiumOverStockPricePercent
      contextRef="i130b34c8fd4f434eb30d4d656ae2c907_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2NDA2MTA_27365d88-baaa-4914-8cba-2eb26d936651"
      unitRef="number">0.75</cutr:DerivativeCapPricePremiumOverStockPricePercent>
    <us-gaap:SharePrice
      contextRef="i46277ffbd52b4aaf98c02564d8aa2124_I20210304"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2NDA2ODk_97e6fc90-cca1-49df-95a9-ac464411792b"
      unitRef="usdPerShare">26.02</us-gaap:SharePrice>
    <cutr:DerivativeCappedCallTransactionTermConsecutiveTradingDays
      contextRef="i453b9f386c004d948258fe7bc2b71f9c_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2NDA4NDk_81d31b12-3747-45a1-ad69-0c17b2ab297d"
      unitRef="day">40</cutr:DerivativeCappedCallTransactionTermConsecutiveTradingDays>
    <us-gaap:PaymentsForDerivativeInstrumentFinancingActivities
      contextRef="i453b9f386c004d948258fe7bc2b71f9c_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE2NzM_93b5e676-49d2-4614-992f-9c81712239d0"
      unitRef="usd">16100000</us-gaap:PaymentsForDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ia4c6391b6a824369a52a92dbea8b9166_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzE2NDkyNjc0NjYyNjY_2d2a8315-dfa4-47d3-aea5-79dfa7134f9b"
      unitRef="usd">4700000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ia4c6391b6a824369a52a92dbea8b9166_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzE2NDkyNjc0NjYzMDI_bc655267-04ca-4f78-a373-dc391155b1cb"
      unitRef="usd">700000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ia4c6391b6a824369a52a92dbea8b9166_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE2ODg_5ebd2f51-54d1-4600-912c-7f698500fe85"
      unitRef="number">0.0297</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:InterestExpenseDebt
      contextRef="ia4c6391b6a824369a52a92dbea8b9166_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzE2NDkyNjc0NjYzMTk_649f9271-e719-4bf1-9c6a-da1827329a1d"
      unitRef="usd">3200000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentTerm
      contextRef="ic6bca201b74942348baa93e457128a05_D20200709-20200709"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE3NzQ_e58c3bd4-a8e9-43c4-8f3c-99505d36cda4">P4Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i77d3c70ae7304fa7a266e0d9e1db39cd_I20200709"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE2OTg_52990dfa-e278-4e84-978b-15081c54be79"
      unitRef="usd">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <cutr:DebtInstrumentPercentageOfQualifyingAccountsReceivable
      contextRef="i77d3c70ae7304fa7a266e0d9e1db39cd_I20200709"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE3MTM_17adf308-92ec-4710-9432-b34ca4702c0f"
      unitRef="number">0.80</cutr:DebtInstrumentPercentageOfQualifyingAccountsReceivable>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="icd0e36b6f7714fe981a44e99c804b27b_D20200709-20200709"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE3MTg_848867f1-8387-4672-9ffd-37b61a236d6a"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i77d3c70ae7304fa7a266e0d9e1db39cd_I20200709"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE3MjU_610e6e7c-f26a-48c6-ae41-39df75732653"
      unitRef="number">0.050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="ic6bca201b74942348baa93e457128a05_D20200709-20200709"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE3MzE_1a257314-cfa6-4596-a1b4-2b970ba8d5be"
      unitRef="usd">300000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <cutr:DebtInstrumentAnniversaryFeeAmount
      contextRef="i77d3c70ae7304fa7a266e0d9e1db39cd_I20200709"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE3NjA_320a7a8d-cbe7-452b-a94e-fad8f0c8ba37"
      unitRef="usd">300000</cutr:DebtInstrumentAnniversaryFeeAmount>
    <cutr:DebtCovenantQuarterlyMinimumRevenue
      contextRef="ic6bca201b74942348baa93e457128a05_D20200709-20200709"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzM4NDgyOTA3MjE3NDU_859c8a85-0298-45ba-b745-fba1b6d9fead"
      unitRef="usd">90000000</cutr:DebtCovenantQuarterlyMinimumRevenue>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i9781cc48038047a79264ddaf70b44230_D20200422-20200422"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2NDUxNDU_826ef431-42ca-4651-b6ce-03ac678bf023"
      unitRef="usd">7200000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4d2cac1cd2a7480690ed521729608228_I20200422"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2NDU0MzQ_1ae8c42a-ecf0-4a99-ada1-5ef3ca79931b"
      unitRef="number">0.0100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i2fe8bd55b1e94cda888bad51642d2ccf_D20210601-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNDgvZnJhZzphNGYxZDI4Yjg0MDc0YmM4OGI1NjkwNjg1ZThmNjQ0OS90ZXh0cmVnaW9uOmE0ZjFkMjhiODQwNzRiYzg4YjU2OTA2ODVlOGY2NDQ5XzEwOTk1MTE2NDU4NjU_5291fef2-e34b-44dd-8789-81e2b399e66c"
      unitRef="usd">7200000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTEvZnJhZzoxYWYxZTg0MDY5NDI0N2Y4YmQzOWZhMmRkYzU4MzY2ZC90ZXh0cmVnaW9uOjFhZjFlODQwNjk0MjQ3ZjhiZDM5ZmEyZGRjNTgzNjZkXzMxODA_443b55d5-bc80-452c-9b69-1e42d08a0909">SUBSEQUENT EVENTSThe Company has evaluated subsequent events through the date the financial statements were issued, and determined that there have been no events that have occurred that would require adjustments to our disclosures in the consolidated financial statements.</us-gaap:SubsequentEventsTextBlock>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90ZXh0cmVnaW9uOmRjNmZkNWJkMDE1MDQ1ZmVhODUyYWI1NjhjMGYwZTg1XzExNQ_417e19fa-64d6-40cd-a281-600e26977839">&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE II CUTERA, INC.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;VALUATION&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;AND&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;QUALIFYING&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;thousands)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;For&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Ended&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;December&#160;31, 2021, 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at&lt;br/&gt;Beginning&lt;br/&gt;of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance&lt;br/&gt;at End of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;Beginning&lt;br/&gt;of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance&lt;br/&gt;at End of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses, accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="i830897d0da8d4889beae5266b3d535b8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90ZXh0cmVnaW9uOmRjNmZkNWJkMDE1MDQ1ZmVhODUyYWI1NjhjMGYwZTg1XzExNg_d1e19bc5-12a2-47ea-9987-2d852b9134e2">&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance at&lt;br/&gt;Beginning&lt;br/&gt;of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Balance&lt;br/&gt;at End of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;Beginning&lt;br/&gt;of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance&lt;br/&gt;at End of&lt;br/&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses, accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia14ca8fcae0b4aefa76cad9866090d78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzItMS0xLTEtMjg2MjE_01e56fa6-3164-45cb-b71a-0e90c2b3eb25"
      unitRef="usd">38321000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i53f708f1ad434a6ebaec1f96b1e10a2a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzItMy0xLTEtMjg2MjE_af01e7c4-efa2-4f6d-8ab1-57566a0f97da"
      unitRef="usd">7503000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i53f708f1ad434a6ebaec1f96b1e10a2a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzItNS0xLTEtMjg2MjE_f5df7b4e-f124-4c76-be2d-1b0f9c3946b8"
      unitRef="usd">5337000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i9ee1cde4537a457a88a3ef970508acf5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzItNy0xLTEtMjg2MjE_6b395b84-d758-4af1-8d95-9aeba147cc88"
      unitRef="usd">40487000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i07d7ed87182941cdbdd83dbfbedf27c2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzMtMS0xLTEtMjg2MjE_1643f428-ad39-48b8-a3de-6824ce21c549"
      unitRef="usd">32350000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i90d8a65714d14212b8f93aae06688452_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzMtMy0xLTEtMjg2MjE_fcd85bf2-d42c-4e81-ba31-cce93a123582"
      unitRef="usd">7986000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i90d8a65714d14212b8f93aae06688452_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzMtNS0xLTEtMjg2MjE_84caeb23-3732-400c-95ca-1e38a92a9dcb"
      unitRef="usd">2015000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia14ca8fcae0b4aefa76cad9866090d78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzMtNy0xLTEtMjg2MjE_d7a30030-cca9-47e1-ab4e-0d79336636d2"
      unitRef="usd">38321000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i3b7116ac1a764bada7c667ee90614aee_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzQtMS0xLTEtMjg2MjE_94f0ce4b-091d-488e-940d-673aa46d82bb"
      unitRef="usd">27865000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ifbfb1453521848d4a478c1bab5686392_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzQtMy0xLTEtMjg2MjE_5c2cf0eb-245f-425d-8889-69ec4c9394ca"
      unitRef="usd">7396000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ifbfb1453521848d4a478c1bab5686392_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzQtNS0xLTEtMjg2MjE_4c0c5dc3-7dec-4d55-98e1-21a3d32a8067"
      unitRef="usd">2911000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i07d7ed87182941cdbdd83dbfbedf27c2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpjMzNiNDFjMDNkMjg0NTAxYmY0NWJkMDA1ODAzYzk3MC90YWJsZXJhbmdlOmMzM2I0MWMwM2QyODQ1MDFiZjQ1YmQwMDU4MDNjOTcwXzQtNy0xLTEtMjg2MjE_b6dd2fe4-b4f5-4a7d-8282-b69de15711ef"
      unitRef="usd">32350000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i54116f7e632d4168b0ea901ff7e1d220_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzItMS0xLTEtMjg2MjE_0b269d0f-e97c-4462-b6fe-a2532516dd6a"
      unitRef="usd">1598000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ied6bc4de4307436da39a837d8e641a54_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzItMy0xLTEtMjg2MjE_3ba4cd3e-f05d-409c-8c63-21158d1b2ee3"
      unitRef="usd">271000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ied6bc4de4307436da39a837d8e641a54_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzItNS0xLTEtMjg2MjE_abd7c8dd-ea8a-43dd-bbb6-8c22ff04e03a"
      unitRef="usd">970000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ib07203e94f374a45ab7a8e8c3f66b67b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzItNy0xLTEtMjg2MjE_25b718f4-dfaf-4176-85d5-3f782e814313"
      unitRef="usd">899000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i1dbc469745e840208e864df19cadabc3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzMtMS0xLTEtMjg2MjE_7ef98774-9784-44af-b567-263abd862f9c"
      unitRef="usd">1354000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ica83547bfc21466aaad3b5d34df18cb4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzMtMy0xLTEtMjg2MjE_a8f5b7e9-b02e-4ae9-ab80-9f227b5a36e2"
      unitRef="usd">2144000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ica83547bfc21466aaad3b5d34df18cb4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzMtNS0xLTEtMjg2MjE_9efb68f3-6530-4dff-b8e1-342604d335dc"
      unitRef="usd">1900000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i54116f7e632d4168b0ea901ff7e1d220_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzMtNy0xLTEtMjg2MjE_bb5eeb3e-e553-40ed-afcb-818c51820c98"
      unitRef="usd">1598000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ibb9f62bf502f487d80c5e7ec032cdc88_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzQtMS0xLTEtMjg2MjE_99a2e589-50d5-4748-ba7a-08d84cee3155"
      unitRef="usd">1257000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ia314f34942bd40c09b7937fff3f63589_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzQtMy0xLTEtMjg2MjE_a9abbb91-0d9d-42b5-83cb-336f261b115b"
      unitRef="usd">1361000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ia314f34942bd40c09b7937fff3f63589_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzQtNS0xLTEtMjg2MjE_a104a185-4c23-4b5d-9440-6a0baf9409d4"
      unitRef="usd">1264000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i1dbc469745e840208e864df19cadabc3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhYmM4N2UxM2UxNzRkM2M5ZjE3ZmE2OTYzMDQ2ZjU2L3NlYzpkYWJjODdlMTNlMTc0ZDNjOWYxN2ZhNjk2MzA0NmY1Nl8xNTcvZnJhZzpkYzZmZDViZDAxNTA0NWZlYTg1MmFiNTY4YzBmMGU4NS90YWJsZTpiZDE3MzUwYmNiMDI0MGY1OWY0M2FmODE5M2QyMmFjNS90YWJsZXJhbmdlOmJkMTczNTBiY2IwMjQwZjU5ZjQzYWY4MTkzZDIyYWM1XzQtNy0xLTEtMjg2MjE_7ffd5039-9fdd-4089-8b4e-267d40c853d6"
      unitRef="usd">1354000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>95
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MH((_3@4'Z(8HD3(9A+B"?U N.4U3)3'EK0'I]P;M7B\(,$9E*@AQ'7\0%K*
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MEH^<^T0 -9%W=:JR!%+5"5FG(D[)6L"2G'.R ,E*X ZVLD/8U@,"R$(TRJK
M!4T8W]"5RI(,1G9#,@D%5T 2.+X0MG#/QCSFKB#<M^6PTTQ4YKFH69Z#V6J8
MW$0F_(F\Y]6["8>"(W\8]FFWC_;LRCP7X5EI"!%(?!2.J4T-0.WN+A-;U+"Q
MM>T>;?M;M_"X,G?4P-U^PUB5J2S"4]!+5KZG=9P3#G:LS=8YZ'*[#.6_%A@2
MN[[&IN&]?[K_(C'T??A.^?KF<\9'YA*<(1E?@&EP.H#PZ<T7@LV-52O?,Y\K
M:U7N+U/.8'.Y%^#WA5)V=^,&V'^GN?H/4$L#!!0    ( .>$850ME4 %' (
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M3.XRLU7IS?OL)NRI1&M-9<I,JGIH23ES!R<9[7 W;=U-[W*W9EJ@S>J:N6X
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M 7B^DM!D]S?FI+[_9F;Y'U!+ P04    " #GA&%4W-_7&=L"  #U!P  &
M 'AL+W=O<FMS:&5E=',O<VAE970T+GAM;(V5WV_:,!#'_Y53U(=6ZLA/"%2
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MK&#" /3_UUQWR/V#^8'AYN_F?U!+ P04    " #GA&%4U]>,T%T#  "U"@
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MPJP?2"'36PQ9,-0:"^0V%N..&7E6PI;M?11&"=+MQ/P09)]\ZRF0VU/8O?4
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MSS_(/\K%+3*>%S>VAOIO@)3%#(KRG:)9?A#Q&JHS,1Z=BCS+L_OEM3@^.CD
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ML["UQF 9<SCW:/*ZWV\CQDW8S^3XZFPL+DB8T@?GZ]L(\0V1?08 0<7,.@*
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M$QR6@ + [UL)&=KX1=W@=#K]ZG]02P,$%     @ YX1A5)U(LDIT*@  >(8
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M_B0AE9RV!TG;,YW!"_!AW8E8@"7S<Y9#U\&#S2$<!+&\=@T(7MR5$1</\AP
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M>KR:6=Z3X%05A3G-L1"M&R)CK(/K$AM41S6Z<2FNBH2OAQVF 2:Z27E-G1W
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M$KAV!EA?*&5W'VZ#]F?'^3]02P,$%     @ YX1A5)2"C)-1!   40D  !D
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M-2YX;6S57&MSV\:2_2M37F57JH)@O$':CJMH6TE\;V)K)3MW;VWM!Y 8DMB
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M.)=??\V9U(EE@VI'9 I$?EEON.11_.0.]H^:?\_&ERA#D+K2DJ<=5F]FB05
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M+NQ)^FZX_7N$7] Z=47 :(FI@9].3T1CS_CM@ZDW?*Z^J(VIUWR[4BB$#0W
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M#'(R=G8M'&L#C1<QU&@-<LIP4:Z#PUL%NS YHP5V"G%J37!JWL1476IIQDD
M/"LE>0<U;:&R%Z &F?@&E-*+<U-0\10@ :\=N6Q+;IJ]BGA&>5\,!P<B2[/!
M*WC#7;##B#=\ >^*@G*$E@IB2@:1!R_^.)G[X- <?[[B8+1S,(H.1O]'-O\#
MZOSS[.+\3)Q^O[BYFDUO;V;?+\3EUY,+,3,BE"1N^]?]@[@ZM54MS4:4T@MI
M!%6UMALBX>5*F:47-0B(-S__<)AEZ=$H';RY>QM)Q9W!T5N R"#N&ZG50A$P
M\.'.)N<0BY<:IU5(YZ19MLEK4%\GKKN#U2':120S,X&<D5I<T8I,P^P*ZHMS
MK99JKFG'SJ.+-_C>D5A9W9C 3O*]O'D1;$3<8RR:FG<':?I3YT\YA&Q ';85
M)I67;'N (3/_"_Q8VP<9FF YAE93JTJ%J.?[G$WNKMAC*30*+ :_/$UL)0L2
MA?*Y([;Z)],V(<_)@N&/:7^(8ZMU) 4IVTK1%39&CZ\=^9KBE-*;OL#0V2?!
MQ1I\//+B5PF1/'&(7A4*; ZX7D_H[7K /;9\; /ND3D1N@1IF6N%R5'$),BB
M4&WJ,.F%MQ5M*_J<@,6F8RU,///( IWS-&L%U=;S$5L@/1YS+91"&=^@CW**
MY9*F,U*N>%=+%S8B.,P\XEVP4 ;E6]H5&HHC>%=)@XNBP"C/+3K&<Q6\@CZB
MB_#LWM%]TX7L.01M<ZZY7*/8-\].RZ+1>A/Y 14. >P:+#D%S-PB0\NV4_A4
M  TCB:HYXM^.I8-8R-:QE@'&],!]2!&$9%YN\QA*AX)L2#K/,DH0W:X!;&P0
M'MG$^<NE"?U_&T7)WI"OR"WC5<8I0";:>;_;W=V6)^TE\:C>7K7?I%NB$D+3
M J9I_^/[GG#M]=4*P=;QRIC;@ LH+DO<^.18 >\7UH:MP YV_R$F?P-02P,$
M%     @ YX1A5#E72B92!0  IPL  !D   !X;"]W;W)K<VAE971S+W-H965T
M,3DN>&ULO59M;^(X$/XK(VYUMRMY(6^$T&V1**7=GM120;NGU>D^F,2 M4F<
MLYU2[M??C!,HW9>>M!_N"SCQS#///#.>^'2K]!>S$<+"4Y&7YJRSL;8ZZ?5,
MNA$%-UU5B1)W5DH7W.*C7O=,I07/G%.1]P+/BWL%EV5G=.K>W>G1J:IM+DMQ
MI\'41<'U[ESD:GO6\3O[%W.YWEAZT1N=5GPM%L(^5'<:GWH'E$P6HC12E:#%
MZJPS]D_.([)W!I^DV)JC-5 F2Z6^T,-U=M;QB)#(16H)@>/?HYB(/"<@I/%W
MB]DYA"3'X_4>_=+ECKDLN1$3E?\A,[LYZR0=R,2*U[F=J^U'T>;3)[Q4Y<;]
MPK:Q[:-Q6ANKBM89&12R;/[Y4ZO#D4/B_< A:!T"Q[L)Y%A><,M'IUIM09,U
MHM'"I>J\D9PLJ2@+JW%7HI\=+<0:);9P738%=DJ5&<S%HRAK <L=7 FUUKS:
M[-S&G599G5ISVK,8GD!Z:1OJO D5_""4'\"-*NW&P+3,1/82H(>\#^2#/?GS
MX%7$"Y%V(?09!%[@OX(7'L0('5[X'V+,1:6TE>4:_APOC=78.G^] A\=X",'
M'_T?6K\:BH[RB:EX*LXZ>%:-T(^B,UI,KVZFM_=P?7LYF]^,[Z]GMS"^O8#Y
M]-/T]F$*YY_A:CJ[FH_O/GYV&W?SV<7#Y'ZQ)ZX/NDCCSD(&F(+="/CUER0(
MO \%+_$D.UM>55KQ=,/<EO\!5BK'"4#.Y% (NU$9+KF%(R^<+KR4_PCCC%)5
M5+S<$8(_^&#:^'R9"S -)8.P&K8;F6[P5<4UMP)6LN1E*GD.\DAII%SP3 !_
MY#)W&%8Q)[-XY'F-CAD&6-<YU_D.:\$:"ALI5H S$)&)>R92Z092P;\(C0&
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M:TF&V"8(&GO!(KTZAEM3C*]RG;%SE2@ZE#2D&)MXUEW0=@+&LPF#MU%KJ@,
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M$MU1IVZWDM) UZSO#-24#.'(B,Q3ZU1I9P4Z"T=<\9TXS6$<WE@2@%-GLZB
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M%81LZ '<7U;(H?T7VB#^.O7E/P!02P,$%     @ YX1A5!(@)M=B$P  SCL
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M(&FI0R/LTM&F5&)UEC29]D.X0[[D6ET_RW.\RQ\*B+]$"KT5A4;,B>9O4D$
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MH?W>Q^,,7#N_K4%VDV9F:8DG,!TK?O+0Q0#VKZREO1$3=(_H]!E02P,$%
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M!/6O^HD#LNW=K:'%P?;+C=#4?>UT3\\=2N- ^ULA]-DP ;H'=/PO4$L#!!0
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M7/OKX;J&3X_\*%F^=V635V52N\VW)Y?G+UY>/,<7Z(E_YNZN,7\GN)5557W
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M;I>O=_>$_PVO8@#^7T8XQ;JJ#Q6".=F!%@G<LVZ1[G&MORYOEDEEA ],7E3
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MX58\'.;.Z4M_3E_. OC7AM#]==/F>]S1V!%]W@AT.@QQ;W+=!]L')X,P!)B
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M$@:")0Z4K#3=L7(&6IH:Q>.L9X'L*I#YMJA WS425_1Y&/:(;@NW!DD)CZX
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M@%5S)A?1)1KOB/#)3Q0%):718@N?H@:*B)4(F8$"Q&H'UVC)FC 5+EK0>#F
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M*IGI*GRP<@@U ;Y%!C,7J_X:_]9^G#8*3E 7UY&$Y1J/DY*.'SQ7G\3 (=7
M,Z%I-=46Z7+&48#ODHC)Z/$4&8W527L\E+X48F/F6"Y$WLU*IXN./+QF_)":
M"S2P8:F72'%D'!GBHI8<3Y0[AV[MF$5U1_^?J$Z6.GT?$N+V+(H97'+'U=KB
M<?6MDTR#$_50ZF&%2FGJB0CZB^O?3A)@8#I'JEL6QY(VL&1HORW]$@GU#8^.
M<+O-"_*5C\VO7/\CK/'?D6-X>,2D/L-<_2='T4$RI#Y2!TGN>54XN]G@.):.
MD$P9DL]#K4=RKA' XVP:U;[#-F>5EXN@O%S,JAF7OA$U419;]^_%O4J:M&V%
M-*K'W'."^XS/9;K1&VR[J,,W[_7.Z&N@ID_PQOB+M?^9#QR&^24A(X#!F-8:
M)!13>3:.# A;'!'/3*<-F6>DCT=;4WTEY:Y('PJL*51':.;VW&C@?MUDER-P
MNT<7DCXP_PLV(NGE0V%#$DJ)^/,=2>:H*]S[=OYXWAZM2JQV##42@NW86-E4
M;']&%^?_U GC(/+!^=K^@4XF5JAOW'O+47AJD,RM#DNL+8]#AF.-DQO3*]6C
M?^E<UFB)MJNW3K#?3C=:EDCJ.-8 K]-#[*]E,M](@VEN)FCZR9KRW8D>FZ%3
M8*]ODL9O.XK:D8N/H&OY2"!QG&&L7WX($!N J>MINF',F[&O^9@\]\-R$EV<
M31VAZSL"MC3:FMOZ9]FV$P\M"/G%P"NQL,%72_,3-S2IBZ _#N=.&D<,>A#8
M?94Y:JD@(MBZ9_RTXKHDSP8Z*7KPPE;2MC<G^2$&Q>,V(2:<.BW4WT8# ["'
M 6M3,?HGQQCGJX8KE#"]DK7'UE,4>M-E1[R>QLF@:'^B$UH*P#<N$^<J;()2
M4LD'0CA/)"JF$/Q&>.*S(S %$>TWA=R"RA3+8]Q9G]O@A^S1QDV!C4(L^A/B
M$T"=Q--"C&$,+1\7O2%)6T)*-TH-9>4A"55DT0P!KT7=W-4_HWT&(8:;]^B@
M'J Q=%IJZ7HDAM253Y$;#--PAY,YR:G>Y)!IU95D[&C: 0D08V&H\UQ"3?1=
MN(-IZL)%36"UL!I-\J8&YKI$PH:%TD6.@I7KY7US93N)!*K]),ZKQ.P(B9*"
MV%OL8_-]( 7=JM=4;S:<Q1&LLK*)_F+F40(@)6? 7.=G7TSQQ]*2O>4VKS[+
M8Z[KP68_&:P$N_N%H%V42O+DXHM%\N2<2[&?/ALMQ;9EUV0O%GV6,#XV#??T
M.8]-$\V/C6VX?<;(_6 XJ @W[;8_KS#\IJ/N3G4L-WJY246NF7-ZTV/N3/HV
MMT(660ZL7)IY(>Z%IO?&3K)N ]0<N NC\1V\+;E-,'%G?U]?X\+4:4XE*X+]
MXBR>+!94%V!ING)BYPHYRUO90RYW'O@JCHK$%EC&6"H7[6>0<-=/YU*04:Z)
MPEA+*B1=V>1-8R)UE/T^^MX@67U6HPWW!I_/W^;[-MQ/-*J>SKX]?LN(&3*Q
M?Y-?A,,9$D4'!J1]*AH&"8?:,=9(QR7V/_V\<M28.W@Q3.9*G<DS%!N6K.C0
M?Z'1ZT/H(7IOD]=->XK=Q?DOO.U%*SQ'UH!J(:FO8H]F<1*15T1(=&+G%F *
M=3.I%(8&UA1!,LFYT@I<;AF2X#O25N%8L9%,]D)J<=&_3HU3@_5D(#$QO5Y*
M=>1(,C?)5U8RO/73%-6C,M,T2#45.1(K6)8F.5&EA+V@A^_0$5O=F,"B[ 6#
ML*>!:\\P>*4J&V5+79FWOM;(7*N%VM?P.<XKJ&LI0O8(9E(+*&Q>FB/UQC V
MF"78W57,4L?#Q-8D&%MK'B<J>\ R%H8[U*@/AD3F?4N@070KT>P'1GVYRD@*
M#-GAW-4'\@)2"9[V9!E;&=^:A(-C:&2)"5VHI#;#VN.IMVV^C,W;QI FXZWO
MFTU)$INN7N4-KVB.<87;'L_G[VF\MG>D^;J&41[V1P9*KD?O8.LQ,6[=K(IG
MU+8:"!G3,(@J7YE/!GE\!D?>W"?1Q>-I_[HX'\S JW#"Y9(F>/4KO_$CO?$C
MIJ[O,/=/V@^RD?DC-KLD;NS'WQ!N:LR$BPV&)21/ED^3=U3F9N&$+IZN!GQ!
MXG\,=LH:Z!:K:V)X/N;.R(QNJ/JT>>C!/74/7KM3YF@SBZ;@;^E>OB $WE=>
MQZ?L-YL7$BJ'R4> VT3'$WGHR<O5:$\DU[NNS<>B8<OA-F5>)][>)ZR)ZN&(
M-NP=QH%J)I'&<YQQX!#QCVA["\X1.[<98?#I22]C[-SFD,498Z,<$&>[=<!K
M"JVWR:1%NB0-::%$+PTO&]G<IYFL&^#>($F<W<M4B-*;LL]U*;.&.ES;=M)C
MMDZHUYCC7.'^T_/YZTNO3#K555%UF71TH^H*UYYV!_BB&6=E?\G(O<M(]!W3
M&8J?C7.]!IX?FF#M)QAV"+)Y8_Y>'#Y<H5Y6[LN^5*8,2Q.IG9F*CY@U$MNT
M7^L$:N"'=V1CA[XM)L>-/$QL-6&,!Y:B\G[*[(W]&UF<'-=;9P1'3:37ZP1#
MVLO?S@(=?EY%DZ3./1V^W4^-TQWA&_>[(NH<'P!H<8E3Q%UC9MKGKE; U5F_
MI3['7L3UPK$PR:ZTD.1X*-D^X<Y3\D^1JU]K7!9<LL8S2:Z+9C^:%Y%E#QP*
MTV9R'.$/4KI4S.$]QY>YZZZIN"B:68XX)#R24VH&;08IH2D_(BU.J-@&S X"
ML93-'D!V4=A4NU+,LJIP&^7Y_'64W\L5M;3AMT"\Y98"GY>$4Z,<ZL\,F$0_
MY^%G>YT#F.]N@TFR+E:$?&J)YR5Z[6/+GN<^-K$4:26/'HW]@"";"BM[;7W"
M& LT7;HI-)YO>A4<V-X.*Q?$22&1^?1H&M%RTA9?$XMN+P\"[P72+EEH>?G&
M$IIF*!V/E&O&20:HF$9=WB8N+AVX+OTU7^+B)A6'*F>VK('Y?&%C&W)%'QD/
M5:$W0).-4>9"O,11,/*W\+<?$W^9/"':><!WRO*:9\[42:CA3)&RLL-5X<IE
MS@"E&WZE;*V':2';!-.&C@:I)G2$67H+5TF=SU_1]"\M[GP7W%FC5/;YP\1,
M6 OQT^3\XI1R1T-'-SP%KE92;:JROJXW/HB/9F_4G\0RSB!D[61/QB;C"M2J
M1 <ID3@7HK*!ZF,@H4M-\)1*DUK;XF3N'$+;UO/YEJMD(HU#?O;%<8<8CY:\
M'F_OJ^WIAW?.7"7/GEPHK=DF-RF7&IU6FU-,6GEP\O[=KR</.9$G"0WAT;?D
M^)Q40L8OLI2EU_GO$^XLSI:>[>HF&06QC:27#6@M-,7LJ&.?\#;V6U](<O)D
M:5[.01NKU"&R2'$[J7CNH$6-COJ+33W=3L[ 9?##8GXNM>)@F-/Z_LM6[]DV
M=>Y#Q8"JE>3)D '+#4QLZ;J'[Y*-[RB/*R3&<?XM_ST;4Q:7&D\L'7*,IV"&
M!"Y"&O_%?.I][X(#P6&JCOJ1>IV,4<>?'?._VU'\=SN*_X+M*.)#^H,]*3+N
M#373G8+;P&.'BN3\W'<\^E0?<[[?OJ(2HG!)>.VV:9TI#@WL]SD6$@HI+N9+
M'J[$XR(M-$89QF>-D%SU?#B^Y654>JC^'(SME"(QL83.[?-3_XWWQO?Z>TUU
M]\)8#:HE>"%WM?X@MAAE,)5-7#VV(.K>X=W4>7E;%7*W;ISK)]'DHG=GK+]U
M:+R=:[A]7+L.#FSQFFI'Y1[VAA-.HXK @1=MZD$E!%'6-/5*2ZXX@L27AM%=
MLQ'G^WO4N3BD*Z>^[:!TE5O<HQWI1*/1Q62745YHO\MTU/;R0>\V3KD"R#1<
MTKM(E\D/M@L3QV!1TNSY9;EX0.N9RHXL W:D<]-6RO:1N,K&A8*KS&F?[@.L
M:M!;6QK:^>B)R^*V74#8)_ CL,EF<:)A]XE^7U&$V:ODZMP+SE&92CDIQ]ZC
M+E0-*>P^;!O(49LT>ID3BN$FVI.1\E6;1*?)!]FIG)J^T_5$GVL/NQUVZ(H$
M"A8I ,2KKJ&FAP&J:*'*'8WL]/=-'MGT/K"OR*QGI(VDG=QZ5:>&2&T@5FU=
M'^0QB>&>[>F&?1](>[O27-3-]M:=8^TAS?QB/@O\/6 %UF%)D2]=)D=']IHV
M2E&?4?OIKQ@WB9[*S%/!K2R\.+,Q%?$J,1\:.-EJ&13;DF+2YL*.O" 7A5SV
M%Q);@&>EW [>]TX(R:DH +@!@\Y"<RXP:]575P59%1)LCAZCI>OG%OVNA"4;
M1 OD[  XKB ;@\#L&8=DYXOYW./+C&[5(>4 ,7#\/#]SC,1^$X[+!VH,=YFK
M<M9,O;%C7D9S1"7=8Q767-E]L3R/ F,7_<KN9Q-QL3E0ARR<B_DLG!NC4EP9
ME6(4XG]LJ%Z#3W,'!]U=I+[E_:&HCL[%B@UZEQMSJ;/Q,MI+:>BH3(E;N-E)
MV#>EZ7Y_>7D]T0+1+"2:G^1,'M^?C.M@&X?S3J/*AV&M58IM.N1BC;A[;N.1
M*H[!)V-!>'*N-.A[5E[,\8PE,2@*/?V"!AUW!/+A*#+R>@Y=O;[S5*_OM/?F
MD:J )RF63F!JZ]:[6JNN]:U<0 %&45Z)UTRMIFS2Z1*OS4//E'-XR^N _6RT
MO@9Y'+\;711!#5'REFVV-OW H6%%)VE=+^/IEH"AXG4@81<&BO^LL!\_^5->
M^*LQ3,$< X>]W[?AV<EK*^#I6$*'RB+S.NJCW,5FNB3)0"B>F++TPK+(+,<F
M-BBR7LC]H!KRF[0A#&9*.,)W]NB7]T3X3;YV<QDGM]+Q*5R8PR W$5DDPIQ\
M[9Z$_L:O]*I>:[SON9-Z=(,76)QK;DXN8-2./7S5GFF2DX:F/D2N(H91#R,K
M)\<P!9H\:7VD:FRLW 4J"W5:["#D!#X[2Y93JU31Q##QR9_IDBIB3M]@=/<M
M]:8#!O(>?N%SP&SL4VJBG.N/'.7H09CX%7:#!:YS3(XY=CT &7-+\1"Y4[/7
M@XQ9DJK5,9%I T1#UV/MC6*Z?W B?YT\U&4%MF=X,M[A&IJ:#4K+T$-"C8SI
M=KOA0'D3)1CIJ"]!%_]P>K/>4?MO7LEI5#AJ'N8\YE.YKHWR+]/UCK<X-E!<
M@:I!7>:.4HPI=4E2[Z)E29P/^=$F&YI[4CD1D[[^>Y_/J2]GBG'T.<PBOH)^
M*%L(O2==?E[U9V=[9%WK 3/\?#L_&M #[SZ29U*PHV^^)T1P<";]$@XRL&?!
MX@FYJ;>8"MIDJ8<78= 8$B-1 8RYVPPN@5,''XB5_?[F5V]>![Y@[VX>H"C/
M\GN7\O6VL@ <2,;68= ;EQ9KR558@=3#*\88R.P*%A@S-S:^20DGO:SPYR&-
MR,\JK^<HSO3=8;KC8]##?'IVBD 4QA[?@7 ?Z%Z;%H6D\ $/M^"]MN E(4 ^
M"I]JAFXGHZAM*VP./P_^>[*:P<8G&,[X:>*Z__\]1^^]_3(Y34[HW# -T]6^
M8SE?R;N0,[TFM9LJ!4A=>#E4ZE\S<SF1_H$ @S3'._BPEK^C[FNS*I%H]N0=
MG5*^-3MOSM )6;L7\\FV]I[L4>/F_J_WJS9-P:;$6*C%G"\1+,DY=]-R/0#Y
M@V\IF4?[%/T&^E:#R?><DGXSTDHVNFL]CQL6C '96T#) W$0/)1K#\T"Q2LA
M7TSD:%CYIG5>E%IARWWUHC1S.3SG)8>;5ZD"5.UJE:-Z__=0CG&$\U[;\#V!
M2F[K0S(7!D8W+^ESZY"MS+DA;N(Z;<-J.$)M87&4EA2AZ2<9AOC59) G4T_O
M)\$\U-PDUCJZ$Y"?58V!?%9%^0=M<T3RU,=C0C8,J2 PVDIO?Y@Z<%,UM=&\
M8WU9BO0HF1!^)!W;-'6<V6#$Y0.@]6)W8S-80R&E,B\,.:4?I3$&03*^D=07
MQ[(Z_HE5]*Q9+KE!T5/KO<RS>M78H;).KC>@1??;1_?:AUZ1_D[Z*=P/;4:B
M/L9<-3-*]-G(*4BPCHH=3=\NBZ^^UA;QN:)[I3XXRE%-2TILB\$T#1O$+?5&
MDG'DF03]IM?9-[T;1GO%OARG'5^(+MT.QY8_WJG=-=(OB J"W,?4]Q$7P0NO
M$2%T@";28R@RN[B?RYJ4E-KTH]6I,'L+7L7H_S@ 6[);P6P%_8)L7DG%R2:3
MF:= ]"!P74JF4W.1_.F .Q1H>]CW_9>^CS8FSC9:SNWAAFR!.J"B\X/3 332
MLB=?B]QHC<!>.<]=>CBZ3S\@)66_==J:SS<8E?TV8]W-+ \,DL'?34[YM1O?
M=S3.9V22"LW$K#9(-$>C KQ:J@AG1MHZB^[WV'O>A"V'0(MV -&T8EF%9;V8
M66DZ/]Q+;,4<P7,P*;>W7?!S=H6,,XIQS.BU?KTWVDTT\;S/AL9=J^%J^< +
MR200\-E;)T%#ZBC:P#<J^,AZUNE53OWF%SW^N/ J59#I"Q]?&80L@CS#B$I+
MZ;+2'!@14 #D69J7$P:VULKU';DF&E9HYYL!1,(E].174/</80G5OODT0TX?
MT%;98WTNM0<:-@T XM .)2M'!Q6KJK[9L@Z$9(J& 5&5>,VE=00KKA9&<GM"
MB\UOI-7:RK? 0:. '&?$ _=Y:W"1AAV#D&@\8RBCN\"FD$"I=)TD/<9&E]\M
M.Z&YO)=*;X!R^:HX+>B./(S\8(QXS'YX(/0"W6\D>;(W%$7*5\<(=47E78RK
MQPLFZ$/M6G\1/,Q7;:3:+V1@H59&:M@J17?1_;"<JS#N24[J6Z8#&U$N9CJ?
MQ&81L^-TW[MW>U@=[ 6$-M82P?U6<U8T'T=NO35!3Q8 7K#WF25&,NM^X0?I
M%_FN8HU,4$O%0V-*\)1'-=$^FJ&/CD7_>C(>$!CID'W^&M&Y1^FI5,RQ)K<@
MZD:*R.)*:M;F0C$#4:CODC-LQ5)6O54S%XADF4]\#TG3A+58@MKYZ^!_P9IQ
MUME^P=."L_N^J%;4B];GP?]8W9WBKV)QJV/I^[<__O+6>Y;@//,]IX20'AU<
M+Q=GYU_1Z)><EB%ER00J#U*KXQ@T5587;8W4$L_+[ GYNP78PYZRFPC3Q+6Y
MZ%W>NT1HD>R X]QBT@9S-(Y$Q<L8@2^5#!KFS-\>TJ/VEM#FF+I5SZZ6)O[#
MN"2[TBKM4'TA'-:L1"M;?)VB'"3B![U%M#&2^D?YD3\1.[KXRMXW$(F4+;JS
M2F)2>HJ\HKHJT]N\AOU<YH".[U&_WC#S>JVE\C?<)_2(!^VQY.KR_>L;_"9D
M4!'T]6MA>L$%XQ-MY(H_6I^_LMIR).39@&0+A"6*1V8Z.\2G!0O3-#@/?+@M
MX_L<5D6(^"R8P7(: D(QETH'Y.4),G.O>F!#B'>>XTMG0]WKS^]^#*Y6<>6,
M+P*?3.3B+=X9,2\T%^AFI@H;W36NE>WV89;E&6&!9)N%&\=8X8VCE7^/V+AG
M'(M1XW3H>3!5U1&.#UJEB3;E.;K/$& = JL^?<*=U_--7H"Y,3OL=+"53^>X
M8JF75]_8L4!CJ#5 S%9!-NO*#&6\%Y\HMJ5Z/2])$4F462**/$23(KE!K^JH
MH_.O&CQY";BV%NN4GRC\$^34Y3(M'*_G1A^^(]Q;4Q.\BSRD-/;<^B8#P53/
M:63J55[0I&:BB559\W]F=IUV$_OC#T4GL3:.R2+%X]345S TMKK_TJUC3,._
M/)5<_*%QQ'QS"LB)V49882".R5>?FMLW\#9KB )UBXGXV2*ZG"KZP6?N"$A\
M@6 !_.7!ZYOKZX<Z/;M^<=6D3,BWG;]#279$[+*L*)S^KHR+EOIELEJTI&))
M%&K?G:<[4.2%KY4"GK Y]A_E2UK"Q)E;M7%O1,MZ2J!6?RW+R"'XMDF#O9 5
M(6$E/>-LB*=](EK8Y,$^LH5S9M1F]Z5OQS *TX6ZWV08<GHPWO!61Q8U3CS^
MFI<0#A]Z%TG7XG4-UB.@%D18H,WDV\AC'[Y R%YUBU9"7H.4BV%6Q(U&GE-
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M/,PV)+.6)-Y#TH_A1DE;&KB4.>;_ X3D<>=VO'5[%A]$O,#L! ;]'L11W#^
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M%BY]!RY)X<IHOW+P65=8O0;H4VY=@NDNP;-T+^(%EL>0)1&D<9KLP<NZ@K.
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M!0  &0   'AL+W=O<FMS:&5E=',O<VAE970R."YX;6R-5-]O&C$,_E>LTQY
M0KT?'*5#@ 3MIDU:)=1VZ\.TAW Q7-1<<DMRI?WOY^3@RC2*]G*Q$_OS9_OL
MZ4Z;)ULB.GBII+*SJ'2NGL2Q+4JLF+W0-2IZV6A3,4>JV<:V-LAX<*IDG"7)
M95PQH:+Y--RMS'RJ&R>%PI4!VU05,Z]+E'HWB]+H<'$GMJ7S%_%\6K,MWJ/[
M7J\,:7&'PD6%R@JMP.!F%BW2R3+W]L'@A\"=/9+!9[+6^LDK7_DL2CPAE%@X
MC\#H>,9KE-(#$8W?>\RH"^D=C^4#^N>0.^6R9A:OM7P4W)6SZ"H"CAO62'>G
M=U]PG\_(XQ5:VO"%76N;9Q$4C76ZVCL3@TJH]F0O^SH<.5PE[SAD>X<L\&X#
M!98WS+'YU.@=&&]-:%X(J09O(B>4;\J],_0JR,_-5T;SIG#PR(QARKU"[X&M
M)=K^-'8$[XWB8@^U;*&R=Z#2#&ZU<J6%3XHC_QL@)EX=N>Q ;IF=1;S!X@*&
MZ0"R)$O/X V[9(<!;_A_R0JT<"-L(;5M#,D_%VOK#/TGO\[$RKM8>8B5OQ/K
MGL:'-Q)!;^"?(B^*PC1,GJKQ650_HA-;LP)G$<V@1?.,T?RA1-AH2?,EU!:<
M[Q_41C\+3DDY>BQ*IK8D"Q74>D_'.J8X,QQV!UZLY45H)EB^(C,6T+<3J!E8
MK=%T#0'R]D("O0"L&TLWMC\Y81K,EDPR52 P!VO<"J4\72J/CP(?(!^D64[G
MY2!/$EAP/CG4R09"N[>N"6L;HL0;$S+V.:$1FL-HD Y'A)2/1_ -K9T K14G
MD=:(LS0W'$\X]4:#89KUH7<Y&(_2_C%/2OV(X7#P,1]W3$_])/'1)%9HMF'?
M6"ATHUP[E-UMM](6[22_F;?[\)89JI$%B1MR32[&HPA,NV-:Q>DZS/5:.]H2
M02QI+:/Q!O2^T=H=%!^@6_3S/U!+ P04    " #GA&%4?"+]S-X"   P!@
M&0   'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6R%5=MN&C$0_971J@\@H>P-
M0H( "4BK5FHD%-+VH>J#=W=@K>S:6]M TJ_OV'N!2H&^X+'WS)DSX_$P/4KU
MHG-$ Z]E(?3,RXVI)KZOTQQ+IF]DA8*^;*4JF:&MVOFZ4L@RYU06?A0$MW[)
MN/#F4W>V5O.IW)N""UPKT/NR9.IMB84\SKS0:P^>^"XW]L"?3RNVPPV:;]5:
MT<[O6#)>HM!<"E"XG7F+<+(<6KP#?.=XU&<VV$P2*5_LYDLV\P(K" M,C65@
MM!QPA45AB4C&[X;3ZT):QW.[9?_D<J=<$J9Q)8L?/#/YS+OS(,,MVQ?F21X_
M8Y//R/*ELM#N%XXU=CCV(-UK(\O&F1247-0K>VWJ<.9P%UQPB!J'R.FN SF5
M#\RP^53)(RB+)C9KN%2=-XGCPE[*QBCZRLG/S!]PBTIA!D]X0+%'Z#VSI$#=
MG_J&Z"W(3QNJ94T57: *(WB4PN0:/HH,LW\)?-+5B8M:<<OH*N,#IC<0AP.(
M@BB\PA=WR<:.+[[ U^:X5;*$%6E5U!14<)/#RI4:%?Q<)-J=_[H2<-@%'+J
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M9/A.%*2.S]&QF[N[;@UX=MH0[@BX]TC*,Q[-6!+[QH\\BYPXRTC?R/K3IYO
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MI<@15=0![^=UK;L;FJ#_V'_Z/U!+ P04    " #GA&%4C?R&[<T&  !I$0
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MF9/%Q^^H#Y86Q: (M^TU='SD)4MR]BML46BWA6IYW86I]TZC"F1)B+4)1-W
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M3/I/1ZC7EH[VDXXJN1(UI^GV%9JN%+6V]M!ZBMVBM]YAXK&HVY+T#)(JHHE
M;R7. '^\IA[O4"9?T!CDA=K/N?TOY[1K7EL\<6I JZIIR"K$WB*'!ITLL>T8
M8U9BSW%"L %6041]&(D#Q)&W6]EU##0+FLZGH9VG<N %!?<?['[)/HQY1P44
M_4!X1 0U39K4_."9OZ(I#SP-\-F0?.;Q,43/#SY_-T*M[$<^%8ZV,=V7\/AT
M_!WAJOM\WB_O?H3XF2O$7&-46&(K6(0!7W4?]MV-D5O[,;V0!I_F]G(M.,HV
M+<#[I91FN"$%XZ\KEW\#4$L#!!0    ( .>$853 L(8C@P0  #$+   9
M>&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;+U666_C-A#^*P-U422 UI;D,ZEM
M(%?1!;I;(\YV411]H*6Q180BM205)_^^0^JH'2?&/A40=' X'^?\-+.=TH\F
M1[3P7 AIYD%N;7G9[YLTQX*9GBI1DF2C=,$L?>IMWY0:6>:5"M%/HFC<+QB7
MP6+FUY9Z,5.5%5SB4H.IBH+IEVL4:C</XJ!=N.?;W+J%_F)6LBVNT'XMEYJ^
M^AU*Q@N4ABL)&C?SX"J^O!ZY_7[#GQQW9N\=G"=KI1[=QZ=L'D3.(!286H?
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M.($P0ZW-^'R &SD8,08W"H,7:/9NP.8-]<:(/\K:)5W' %YAS!A1?<>/1\.
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MH#0':+\40N\#DZ#_YYK\ U!+ P04    " #GA&%4_8:VO; (  !\,   &0
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MMI904+$K:%E$B5=8'L,H/X(B*_((;Q0$&GG>^ #OI4R&1%M!(LQQ8(X]<W2
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MR2U1UAO9[,+5QJ$Q&R;L*4Z-PJ\,<::XHYR*$LC4M<P8#&6<?"$/8@/"2,5
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M-<(!#EODP\_+@X]RWR2BS@:NLX&=O^B$OR<Y)YS^);;"KM%0<"48+4A5<+Q
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MS2WDF@OSGP#2&ICYF1!ZW[%74?WG,?@'4$L#!!0    ( .>$851J /XR+ ,
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M%@# 8A W@,\!NE>J:6Q#%ZD.!]VDYG*#0<]@1])T9J"4P2CX<C><L>ZE+^:
M&YC!4P;C:35_5"SNRES4G<&P*=>-/GT-;<#A /=T$3 #F@RNU3@SW%.' F<M
MC!FT9#!:ZMZMK6.3&1AD_H[$ID%"!B/ARV/SE'7;>"+N894Z]H1$JXT'SJZW
MC<W31M_0V#0 RAR5^,DDUL\7R;+)Y5'$B;A+9+52%:LZ;;/4YZ%>)P.D# ;2
MNLPU$:4R1L3+5I>>6U#6O;0$TD1FX);!R>I7E3X=JP"=J.#1G<FZ!"!TIO&B
MK<0-IO(=N;GD!E&YHY#^\\%RP;L%<08$"S<HRV&0K%EWF1LWJ<\B'T_5RCB]
M8O"3[T@)G!O,Y8X2^,][Y8QW"]F@5PSZ<AA]/R_;@'K)[\RA84!UAQO<Y8ZJ
M1FNMJM5H-?7MP\G[F4,U<>3NO-4OZ:@J+*-VGL?CJA5DV>Y7VZ<_F8G\NRQK
M1+0V3\*/"%TE46Y FL,@_?[VYF:K-C]NZ8Z,V.;-V2?;,,:#C7NX*\NPD(2X
M+W -[/,!G2K%QEZZ7Y0+Q=L#\X=+;JE<^ '%D=VXT'!#".?;WQ0;Y4]Y7)8R
M52!WE\1CM-QI@%-#@_0AW@V8"PV^AS"^OVX;_$GSM(&MKZ$AB!!.L"^6L:$V
MZ;C=^0S'RDEH*4QPGZBC4(]%AA]"F!\L/>/[#;2\=.WJ!X9K_6$'/=74T'!%
M""/]RYMC3QK-:YVO]6&^;_D,982.5'WKMM:31N.:-10RQE!#".,VM/&5-:NO
M)71:#%L-\#M2.PX-+H<P+K]X?W6QF :\N[U&K5\VZI\K7XG\(4X+E,A[)>@=
MZ&PEKW\!7+\ILWGU8\>[K"RS6?5R*H7R@QZ@OK_/LG+Y1O]^<O4[[*/_ E!+
M P04    " #GA&%4,MD_ES@&  #"'   &0   'AL+W=O<FMS:&5E=',O<VAE
M970T.2YX;6RM66UOVS80_BN$46 MT-@BJ=<B"9#$WE9@W8)F;3\S%FT+E427
MHO/R[T=*LO5VHM6A!=)(RG.G>^Z.?$CQ\EG([\6.<X5>LC0OKF8[I?8?%HMB
MO>,9*^9BSW/]EXV0&5/Z5FX7Q5YR%I=&6;H@CN,O,I;DL^O+\MF]O+X4!Y4F
M.;^7J#AD&9.OMSP5SU<S/#L^^)QL=\H\6%Q?[MF6/W#U97\O]=WBY"5.,IX7
MB<B1Y)NKV0W^L**N,2@17Q/^7+2ND:'R*,1W<_,QOIHY)B*>\K4R+IC^]<3O
M>)H:3SJ.'[73V>F=QK!]??3^>TE>DWED!;\3Z;<D5KNK63A#,=^P0ZH^B^<_
M>4W(,_[6(BW*_]%SC75F:'THE,AJ8QU!EN35;_92)Z)E0+P1 U(;D)X!#D8,
M:&U ^V]P1PS<VL"=:N#5!B7U1<6]3-R2*79]*<4SD@:MO9F+,ONEM<Y7DIM&
M>5!2_S71=NKZ08GU]YU(8RZ+W]#JQR%1K^]1^13=IRPO$,OCZO["%"1&=R+3
M75JPLLZK%W/-T45M\L^^?'QCRJ\]H;=+KEB2%N\TXLO#$KU]\PZ]00M4[)CD
M!4IR]"5/5/%>/]37_^[$H=#O*RX72G,S$2[6-8_;B@<9X8$)^B1RM2O0*H]Y
MW'6PT$DY988<,W-+K!Z7?#U'%+]'Q"$8".ANNKD#F"\GF^,(,%]--P\MR:"G
M-J&E/SK6)E6];IYT,=ECRI$>I>@/R7)E<>Z>G+NE<W?$^2W3C;;FZ*UN@:HQ
MWD$-4#GQ2R=F_GNZQD[HX4!G]ZE=ER$N\#7*Z\*6@#OL8MK"=<AX)S*>E<Q-
M'"=F#+#TV.3ZA\LG/7+.\/,& ;F>H__UZ UAOC.$+8>PH OKL/-/['PKNVI\
M%VAK2G^>DC\(X@('!-.HQPG !;JX(1QL< HVF!3LVG17FIIP^<L^D?I"=Z\6
MV0U/-(EWYU@$@^BH@P/:XS!$!;[G]5#+(<K#Q!DA&IZ(AE:BU=S+GIF,)Y<F
M!%+NNI';+PV "YTA;@G@L$=#3$:X12=NT71N527_=R&C08PDBIR(]"@/81XA
M0\9#F.L$E(R,,.PTBNS\BNFP]M)^?^0&U UZ;  <.&\N 2 T<:X@A[:9$[?6
M(MBJ,G\?LD<ND=B@2F\LVH))XY3\DG2287-H\LX@G0 N\ORHWQT SG."8#1)
MC1)C.FE6XR]<KI/B_$BO_?5FUR *^\P@'"4DZ#,#<-AWV@Z[U)IU +8O!'Y2
M73 @X9"Z #B+NN!&Z;%=ZG^5ON"A5E] "@/A((V!<!:5P8WX8[OZ3QU*0SDG
MH>XXK\\'P %#;@GA@"&W G#6(=>L([!](;&JAEJY\#W'?2CP(0V]L1 :A<=V
MB?_*"S,BS&9,]YC>9>L;)="3?GPVI*$T]\K1C:E19AQ9I^MOY2Z<QQ=Z7\ E
MVW)4)XJC>YFLN6T3UJ@AF:Z&L4A3)@NTUR)1$@;YU@[#-E\RI_WN@V#>W.LM
M!I80S&G#NKP:K2/XI^>ZB?SJ';W369#. ]PG"."P.P]'ZDX:125V1845:&+P
M9!B4KH[37X-!.$SF$>Z7!\(Y<X>.D&QDEDR3V4F3^T3N%"A<,,=NGSN$\^=^
M?P<+X8@[]_$(]T:'R?0-^41J+A"*-P_[4ESCSHS-)00;CLT5!+.,S4;8B5W8
M^_/]Q!QX8#E:Y>V&T\@NL<ONN;E_8G@^E--6A;K1->)(@FDJ<!2!S]Q\H$[R
M+;H3N9)LK0XL17\E&ZL@-$I([$I8-R=(T6[IHE=N\H0QRJIOA1C%[!7\MF?W
M1&M/4>T(_+XWS04YQA*:6"!/JXF>_*.G /#4378C\<2^^VZ-!##A=FMR3+AS
M#"TZ%QIM%@;4OC"PC HHU#/>)O5&-])&ZJE]6WNSW4J^98JCCWH\)'F1K-%7
MEAYLXX$V:DPG[6]!SI6EU_Y$X?K]#XH "KN#KP, BCIN#[4"4&3THR-M?7VV
MB_&9-J3#'6F'0?>MC0Q2NPS^;(>Y]FQ742Q:9S49E]ORD$PO,\0A5]7AQ.GI
MZ2#NICQ^ZCV_Q1]6U7%:XZ8ZW?O$Y%9W&4KY1KO4*T,=DJP.S*H;)?;EB="C
M4$IDY>6.LYA+ ]!_WPBACC?F!:=CR^O_ %!+ P04    " #GA&%48&%W-"8&
M  "0*   &0   'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6S-FFMOFT@4AO_*
MR%II6ZFUF2M0.9:2-*NMU&ZC5KO[8;4?B)G8J%Q<&->)M#]^N85#!#/@BU+G
M@P.8.7/FP/LPO)[Y+DF_96LI%7J(PCB[F*R5VKR;S;+E6D9>-DTV,LZ_N4_2
MR%/Y;KJ:99M4>G[9* IGQ++$+/*">+*8E\=NT\4\V:HPB.5MBK)M%'GIXY4,
MD]W%!$^>#GP)5FM5')@MYAMO);]*]>?F-LWW9DT4/XADG 5)C%)Y?S&YQ.^N
MA%LT*,_X*Y"[K+6-BJ'<)<FW8N>#?S&QBHQD*)>J".'E_W[(:QF&1:0\C^]U
MT$G39]&PO?T4_;=R\/E@[KQ,7B?AWX&OUA<39X)\>>]M0_4EV?TNZP'Q(MXR
M";/R$^WJ<ZT)6FXSE41UXSR#*(BK_]Y#78A6 ZIK0.H&I,R[ZJC,\KVGO,4\
M378H+<[.HQ4;Y5#+UGER05Q<E:\JS;\-\G9J\54ERV_K)/1EFOV*;KYO _7X
M!I5'T6WHQ1GR8K_:?UN,WD?7293?$IE7%O7FH=B6Z"WZO"D.9.CS5F4J;Q/$
MJ[+IS8-,ET'FW842W:;!4J(O7KR2&7KU7BHO"+/7\YG*!U*D,UO625]521--
MTIB@3TFLUAFZB7WI/P\PRRO0E($\E>&*&".^E\LIHO@-(A;!OZ 9RM9>*K/J
MTQ"?-F6F97RJ*W,1J*^ EVE:E"._SQ6Z>T3M\VZ]Q_+PY<Y+??3/QSPD^J!D
ME/UK2(@U";$R(:9)J+XL$FV*:_(&Y>J4*2IS06$0!0J]"F+D)V'HI1G:Y-^5
MM7B-_D-0GKXK5W7KE-T62/BQP-;4=N>S'SW9\B9;OE>VV\WF--GR3K;,GK+^
M9$63K# F^\<VNLLS2%I"*+*KDNB]VZMXHI4%<6QL\_X\["8/VYC'=2Z1-*?>
MU@OS(MW+OI[-$1AZE$5!,491I3>,?._1</LY36[.F!K)%AP&:N1T:N10AVM*
MY#9IN./NJQ:9$#:,#UO 5>L\%(];J,<_1_-UOR-%CPDD3'Z.[.M^GR7,II9&
M^!@HC^F)I5\'?*9]SAQ+DPG@'9OY/D;\ R%PJ?ZV^-U"_:;'(0:@8S/1]P=
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M7/SCN'/IQY<6MC]+?J^CUI.?^N!$W?K^R1^^L-<62.3B2W]M)[ZP5^\D@RF
MKTPF*%#"-J6L'NE-:Y-M7IL<ZZ+]1F>A)C,ZTE0I[!?"5U2E)#DL%:7OCM23
MAU=98561;&WRI"<F5=9EBIG*I('K :I_R9@\5/0$36X^_Q]02P,$%     @
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M<J4++=M<Z^(9A 'H[TO.U;YC)NC*\?E_4$L#!!0    ( .>$850?JAB<[P,
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M4O5$7"^,7+NA\E$:&E'=8TY?$:CL 7J_E-*\+*R#YKMD\C=02P,$%     @
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MHH\AJ?)>+SM&KMQ-]RP-WINNN<2G$"@+P/FYE.:]8Q>H'U?CWU!+ P04
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MGJ18W8F,</-D*V2*M5G*G:LR27!2D%+F(L\+W113[LRGQ=Y*SJ<BUXQRLI)
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MTU 7&;2)0%V&83".JY&V[9A^MY^WQ[;-_KJWP_I,=<FD 8Y'%SH9W\\CT.T
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M!J2"%6VYO5>;[]#GXP66BAO_)9O.]S()2-D:JT0/1@6"R>Y/7_I]V '$%P<
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M?]8=)4##L5>RA!#2$< %@S#NOA!.6((CMP#8FBL>-M=[IG19*[UB91,I3\^
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M)A#'ADG'\5])VJE\&N#V]3O[W":ODUE0"1,>_\TBM;[N##LH@B7-8_7(-W]
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MG&U)%L6$@S/P.<ZPO,8)N!=8$ 4$7[)R@:I$?UP1@>.$?Y+8A_L5^/CA$_@
MX@S\V-&<2T8^MX3T4[W-BBJ?KDN?4(]/$(%OTHT=!S?9FJQ/"2PIL%:)CBJO
MT2#CBD3GP(%3@&P$#0XMQYO;!O/5:',X,YC?C#</!X+AU"EW"CZGA^^*<R+X
M )%;$[D%D=M#]'U/&%:K!21$UBI@JBC/Z.8LES?8\)8R526I5Y"J?>QI 5T?
M!7/KJ9T1 RJP _\4=6- V;8[JU$GNKQ:ES>HJUSSI%1E4N!I;W5FJ.._CG']
MP.R77_OEC_+KJ_)K"NZ.X7Z0X2Z2.FT5*=VT:O>6\K@HUW]NGH7:Y1\321-S
M\:])WK 7MTQV*29>BNV"_,KCO7K?%&1$F"KKG<A. A;4 0L&V7]0(<47:5P/
M+,A 7T1>4:DG"36@ L]US"D-:P_#P5K\&N/'.)&Y(4,%.:O99F\JR*2/O=1=
MDODM1<C59!M R+<[96AB<FQS:*#=M";[O\H!<HG0["S*&9/KQ=AB;,TGZ+BA
MTY%G@GDSKRNP@K6S'P1>SSX#6\T7CEB@;TQ;Q=EQV>YN0"98B&!?5E#C,QJ_
M.[9]G8*A=" M@)[G=EW604[0YW#3[J#SEFWS6'(O4[ L_7VG;?,5-ZZBB.5R
M'QK.[O+_LIP&J6GE<+B7#V3UM4+3>W#@V-W,ZB"YU_1DMNG3<%RCUC/[)\VB
M]TWNL"??Q8XPD-!L>R8(2U]-\CNQG<:MF2/@:UV7<!6/)YSD1$5EW+[CZQT0
MA5H-ZR@?]F6Z:>1PN).?+L^(<O-2#+0MS]4=-( <> I:0;W;![;;HZ)I]C!\
M#Q6AYJ#7[<H&C.]T->B8,.R1T$P8\&TC1J\(?21P/%?K4084"KRN$,-X$;8&
M[M-/PF:\0&/'BPCS'=@D]&!2@O0)P>M\ABP-&"T=!DQ?.E S0*#A :+:SE[5
MH,\"\I.K*T('>4[05:&#_+[O+=3,%&AXIAB;"L-\8&M?7@84@LZL*\2 "E%W
MV+!:)RLI8=OB2(O+59]GHCQ^J)_6QV97Q6%1Y_DUO%B5AU\-37D6]PVS;9QQ
M64\;26F?!](E5AYOE3>"[HOSFT<J!$V+RQW!:\(40/Z^H50<;]0+ZD/&Q6]0
M2P,$%     @ YX1A5"UQZ\G# @  +P@  !D   !X;"]W;W)K<VAE971S+W-H
M965T-S N>&ULC99=;]HP%(;_BA7UHI56\D5"J "I!4V;U&I5/[:+:1<&#L2J
M$V?VH;3_?K:3IG0XT!MBQW[?YYR3Y)C15L@GE0,@>2EXJ<9>CEA=^+Y:Y%!0
MU1,5E'IE)61!44_EVE>5!+JTHH+[41"D?D%9Z4U&]MZMG(S$!CDKX582M2D*
M*E^O@(OMV N]MQMW;)VCN>%/1A5=PSW@8W4K]<QO79:L@%(Q41()J[%W&5Y,
M0RNP.WXRV*J=,3&IS(5X,I/OR[$7F(B PP*-!=679Y@"Y\9)Q_&W,?5:IA'N
MCM_<O]KD=3)SJF J^"^VQ'SL91Y9PHIN.-Z)[3=H$DJ,WT)P97_)MMD;>&2Q
M42B*1JPC*%A97^E+4X@=0=CO$$2-(/JL(&X$L4VTCLRF-:-()R,IMD2:W=K-
M#&QMK%IGPTKS&.]1ZE6F=3B9BJ)@J)\+*D++)9F*$EFYAG+!0)%S<D-Q(QF:
MB5B1'Q5(:M;)->C:D6M&YXS7RZ<S0,JX.M.JQ_L9.3TY(R>$E>0A%QNEO=7(
M1QVQX?J+)KJK.KJH([H9+'HD#K^0*(A"AWSZ>7GP4>[K.K7%BMIB1=8O[O"S
M22OR^W*N4.H7\,\!S[CUC*UGO\-3AQ:Y"E.K$JLRW^+S) Y-#9X=K'[+ZA]C
MQ2Y6K4H_L-+ S4I:5G*,U7>QDCU6E WZ;E;:LM)CK,3%2EVLQ,T:M*S!,5;J
M8@WV6<-!1PVSEI4=9#WDH%OS"D&ZB-G^4XOCS$T<ML3A8:) R@FW'W=%7VU?
M<+&'>^PPZX2'P7LS"@[BKT&I"\**:H.PU+U#9PX*G7TCV(O@/.K':4<$.^TP
M_$0!WOM<70K^WN><P81['VN8#(.H#:9I5HYM613^_Y+X.]W<'*4W5*Y9J70H
M*ZT+>@-M(.O3J9Z@J&R#GPO4QX4=YOI$!VDVZ/65$/@V,6=&^Q]A\@]02P,$
M%     @ YX1A5/C]:K6@ @  /@<  !D   !X;"]W;W)K<VAE971S+W-H965T
M-S$N>&ULC97);MLP$(9?A1!R2(#&6KT%MH#$1M ""6!D:0]%#[0\MHA0I$I2
M=O+V'5**ZM:RDXM$BOS_;V;$9;*3ZD7G (:\%ESHJ9<;4U[YOLYR**CNR1($
MCJRE*JC!KMKXNE1 5TY4<#\*@H%?4":\=.*^+50ZD97A3,!"$5T5!55O-\#E
M;NJ%WON'![;)C?W@IY.2;N 1S'.Y4-CS6Y<5*T!H)@51L)YZU^'5;&SGNPG?
M&>ST7IO83)92OMC.M]74"VQ P"$SUH'B:PLSX-P:81B_&T^O15KA?OO=_=;E
MCKDLJ8:9Y#_8RN13;^21%:QIQ<V#W'V%)I^^]<LDU^Y)=LW<P"-9I8TL&C%&
M4#!1O^EK4X<]09@<$42-(/JL(&X$L4NTCLRE-:>&IA,E=T39V>AF&ZXV3HW9
M,&'_XJ-1.,I09]*9+ IF\+<83:A8D9D4AHD-B(R!)I?DGII*,6,[<DUNF: B
M W('6#E-[AA=,EZ/GL_!4,;U!8J>'^?D_.R"G!$FR%,N*XW6>N(;#-AB_:P)
M[J8.+CH2W!RR'HG#+R0*HK!#/ON\//A7[F.9VEI%;:TBYQ<?\6NR_GF]U$;A
M^OMUPC-N/6/GF1SQQ-"BKL+4JKY3V9VX30<!EF#;@4I:5/(1*NY"U:K!'BI.
MAMVH?HOJ?X1*NE#] U02C+M1@Q8U^ C5[T(-#E"VT%VD84L:GB0]24,YX781
MD)*^N3W311X>D,-X>"3+4<L>G63?@=97A!5E96"%N\J  FVZZ*,#^N6XWPT?
MM_#Q2?@"69@LV5)>@3T&ZAKPO[N_*Y#QP0H.HU'21E)OX,-)@_#_9>[OG6[V
M9KFG:L.$QBC6J IZ0Y2K^K2N.T:6[L!;2H/'IVOF>,&!LA-P?"VE>>_8,[2]
M,M,_4$L#!!0    ( .>$851R8"24'P(  )0%   9    >&PO=V]R:W-H965T
M<R]S:&5E=#<R+GAM;*6476O;,!2&_\K!,-A@BVPG<;/B&)J4LL+&0LNVB[$+
MQ3Z)1?7A2<K<_/M)LF,R:+R+WM@ZDM[W/.<(*6^5?C(UHH5GP:591K6US34A
MIJQ14#-1#4JWLE-:4.M"O2>FT4BK(!*<I'&<$4&9C(H\S&UTD:N#Y4SB1H,Y
M"$'U<85<M<LHB4X3#VQ?6S]!BKRA>WQ$^ZW9:!>1P:5B J5A2H+&W3*Z2:Y7
MF=\?-GQGV)JS,?A*MDH]^>"^6D:Q!T*.I?4.U/W^X!HY]T8.XW?O&0TIO?!\
M?'*_"[6[6K;4X%KQ'ZRR]3):1%#ACAZX?5#M)^SKF7N_4G$3OM!V>[,X@O)@
MK!*]V!$()KL_?>[[<"9(YQ<$:2]( W>7*%#>4DN+7*L6M-_MW/P@E!K4#HY)
M?RB/5KM5YG2V6"LAF'5=M@:HK&"MI&5RC[)D:. #?$97,MS+[OA]']_>HJ6,
MFW<YL0[ VY"R3[;JDJ47DMUB.8%I\A[2.$W^E1/'/<"G WP:_*87_ *<@9\W
M6V.U.]]?(Y[3P7,:/&<7/+\VJ*EO ?#@_E*5XPYS."+5!CZ"<,VL#20+J.C1
MC,#-!KC9J/4=DU26.((VKD][M*1#@^Q_8/,!;/[JKHT[S":+^,T(23:09*]L
MT;@^FUR]S$'.+IE_K[Y0O6?2N$0[9Q1/KEQ]NGL#NL"J)MR[K;+N%H=A[9Y-
MU'Z#6]\I94^!O\K#0US\!5!+ P04    " #GA&%4.B,50U "   W!0  &0
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M(E 7B]F/T\8Q:U58[[NVMBFOL\>A>9<R?TXH\\EI3]RU/E[E#07[,&%<^7O
M\[G?CQ1"V]!L8T.ZL7W>Q0X=B^G842S/E_B@1[?=MC4UKG[H\Y$R^D"VB3NB
MU'?EJ>C5^>24;YA.G_SB_*G,N<"\<Q.<CWEB@3X?]S*2\?3<YT(44GO^%5\3
M<^F+WX_&:3?4_&-VOMXG%_;3/"*;'I??\=L9O];_9!\"I \)TH<"Z4.#]&%
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M2P$"% ,4    " #GA&%4!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .>$853;3VD4[P   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M .>$85297)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ YX1A5!@6M1=K!@  LQD  !@
M     ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M .>$850ME4 %' (  &P%   8              " @:\.  !X;"]W;W)K<VAE
M971S+W-H965T,BYX;6Q02P$"% ,4    " #GA&%4QKETMV<&  "E&0  &
M            @($!$0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#
M%     @ YX1A5-S?UQG; @  ]0<  !@              ("!GA<  'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( .>$853[;ODJ9P8   4<
M   8              " @:\:  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q0
M2P$"% ,4    " #GA&%4U]>,T%T#  "U"@  &               @(%,(0
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ YX1A5 YKOO(C
M!P  Y"0  !@              ("!WR0  'AL+W=O<FMS:&5E=',O<VAE970W
M+GAM;%!+ 0(4 Q0    ( .>$850 \R6I+ (  /0$   8              "
M@3@L  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " #GA&%4
M^D<R; L*  "I+@  &               @(&:+@  >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&UL4$L! A0#%     @ YX1A5)U(LDIT*@  >(8  !D
M     ("!VS@  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .>$851Q,B4MNA4  (Y!   9              "
M@89T  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ YX1A
M5$ [?IR+#   ="$  !D              ("!=XH  'AL+W=O<FMS:&5E=',O
M<VAE970Q-BYX;6Q02P$"% ,4    " #GA&%4>K+TA94%   ]#@  &0
M        @($YEP  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0
M   ( .>$8509>S**\0,  $\(   9              " @06=  !X;"]W;W)K
M<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ YX1A5#E72B92!0  IPL
M !D              ("!+:$  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q0
M2P$"% ,4    " #GA&%4Z-RE=EP4  "I.@  &0              @(&VI@
M>&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( .>$8502(";7
M8A,  ,X[   9              " @4F[  !X;"]W;W)K<VAE971S+W-H965T
M,C$N>&UL4$L! A0#%     @ YX1A5+2=A19H @  4 4  !D
M ("!XLX  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " #G
MA&%4-/#LZR$#  !,!P  &0              @(&!T0  >&PO=V]R:W-H965T
M<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( .>$852T@@47MSL   G0   9
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M970R."YX;6Q02P$"% ,4    " #GA&%4?"+]S-X"   P!@  &0
M    @('&'@$ >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (
M .>$850_+^8Q'@L  /@?   9              " @=LA 0!X;"]W;W)K<VAE
M971S+W-H965T,S N>&UL4$L! A0#%     @ YX1A5(W\ANW-!@  :1$  !D
M             ("!,"T! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"
M% ,4    " #GA&%4P+"&(X,$   Q"P  &0              @($T- $ >&PO
M=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( .>$852#/[+8C0,
M '8'   9              " @>XX 0!X;"]W;W)K<VAE971S+W-H965T,S,N
M>&UL4$L! A0#%     @ YX1A5*60U1VA!@  "A0  !D              ("!
MLCP! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " #GA&%4
M/+NRU'8"  !"!0  &0              @(&*0P$ >&PO=V]R:W-H965T<R]S
M:&5E=#,U+GAM;%!+ 0(4 Q0    ( .>$850R# !ZWP(  ,4&   9
M      " @3=& 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%
M  @ YX1A5/V&MKVP"   ?#   !D              ("!34D! 'AL+W=O<FMS
M:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " #GA&%4N9V%HX@"  "O!P
M&0              @($T4@$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+
M 0(4 Q0    ( .>$851SV/-4:@(  #D&   9              " @?-4 0!X
M;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ YX1A5#YZ6%L"
M @  >@0  !D              ("!E%<! 'AL+W=O<FMS:&5E=',O<VAE970T
M,"YX;6Q02P$"% ,4    " #GA&%4#+G>0(L"  !M!@  &0
M@('-60$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( .>$
M853(5<R\(P,   \*   9              " @8]< 0!X;"]W;W)K<VAE971S
M+W-H965T-#(N>&UL4$L! A0#%     @ YX1A5%\_$<<, P  A0@  !D
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M=#0W+GAM;%!+ 0(4 Q0    ( .>$853+Z(E+ZPD  ),]   9
M  " @:MP 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @
MYX1A5#+9/Y<X!@  PAP  !D              ("!S7H! 'AL+W=O<FMS:&5E
M=',O<VAE970T.2YX;6Q02P$"% ,4    " #GA&%48&%W-"8&  "0*   &0
M            @($\@0$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4
M Q0    ( .>$853;,W$! P4  /L4   9              " @9F' 0!X;"]W
M;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ YX1A5+/)71XN P
M^ P  !D              ("!TXP! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX
M;6Q02P$"% ,4    " #GA&%4Q;?+1&0#  !.#0  &0              @($X
MD $ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( .>$852,
MKT'!Z0,  *</   9              " @=.3 0!X;"]W;W)K<VAE971S+W-H
M965T-30N>&UL4$L! A0#%     @ YX1A5'8Q17VQ @  3P<  !D
M     ("!\Y<! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .>$851=WJ(E(@,  &@)   9              "
M@1RK 0!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ YX1A
M5&K2&5$T!   "!(  !D              ("!=:X! 'AL+W=O<FMS:&5E=',O
M<VAE970V,2YX;6Q02P$"% ,4    " #GA&%4Q$\Z*(8#  "]#P  &0
M        @('@L@$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0
M   ( .>$852-<2]L)@(  )$$   9              " @9VV 0!X;"]W;W)K
M<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ YX1A5/'_H42( @  ;@8
M !D              ("!^K@! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q0
M2P$"% ,4    " #GA&%4JEKW\2("  " !   &0              @(&YNP$
M>&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( .>$851J>F,_
MG@0  $D5   9              " @1*^ 0!X;"]W;W)K<VAE971S+W-H965T
M-C8N>&UL4$L! A0#%     @ YX1A5+I$6@J@!   4Q(  !D
M ("!Y\(! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    " #G
MA&%4KI+]%$L#   K"P  &0              @(&^QP$ >&PO=V]R:W-H965T
M<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( .>$850Q_DG,Q00  ' 4   9
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M970W,RYX;6Q02P$"% ,4    " #GA&%4_RKO<64(  #8*0  &0
M    @('JV@$ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    (
M .>$852BRS/1=@(  $H&   9              " @8;C 0!X;"]W;W)K<VAE
M971S+W-H965T-S4N>&UL4$L! A0#%     @ YX1A5 ;.N?C. P  +PT  !D
M             ("!,^8! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"
M% ,4    " #GA&%4F7!#>S@#  #\$P  #0              @ $XZ@$ >&PO
M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( .>$8527BKL<P    !,"   +
M      "  9OM 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( .>$853]_DH<B@4
M $TR   /              "  83N 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " #GA&%4<WQX+%$"  #[+   &@              @ $[] $ >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #GA&%4SA7,7P\"  #J
M*P  $P              @ '$]@$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    5 !4  ,7   $^0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>262</ContextCount>
  <ElementCount>551</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>94</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001003 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002004 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003005 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004006 - Statement - Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005007 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1006008 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1007009 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2106102 - Disclosure - Cash, Cash Equivalents and Restricted Cash</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CashCashEquivalentsandRestrictedCash</Role>
      <ShortName>Cash, Cash Equivalents and Restricted Cash</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2110103 - Disclosure - Balance Sheet Detail</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/BalanceSheetDetail</Role>
      <ShortName>Balance Sheet Detail</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2116104 - Disclosure - Product Warranty</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ProductWarranty</Role>
      <ShortName>Product Warranty</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2119105 - Disclosure - Deferred Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DeferredRevenue</Role>
      <ShortName>Deferred Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2123106 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpense</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2132107 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2140108 - Disclosure - Net Income (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/NetIncomeLossPerShare</Role>
      <ShortName>Net Income (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2145109 - Disclosure - Defined Contribution Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DefinedContributionPlan</Role>
      <ShortName>Defined Contribution Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2147110 - Disclosure - Segment Information and Revenue by Geography and Products</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProducts</Role>
      <ShortName>Segment Information and Revenue by Geography and Products</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2151111 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2160112 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2164113 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2165114 - Disclosure - Schedule II - Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ScheduleIIValuationandQualifyingAccounts</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://cutera.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2307302 - Disclosure - Cash, Cash Equivalents and Restricted Cash (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CashCashEquivalentsandRestrictedCashTables</Role>
      <ShortName>Cash, Cash Equivalents and Restricted Cash (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/CashCashEquivalentsandRestrictedCash</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2311303 - Disclosure - Balance Sheet Detail (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/BalanceSheetDetailTables</Role>
      <ShortName>Balance Sheet Detail (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/BalanceSheetDetail</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2317304 - Disclosure - Product Warranty (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ProductWarrantyTables</Role>
      <ShortName>Product Warranty (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/ProductWarranty</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2320305 - Disclosure - Deferred Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DeferredRevenueTables</Role>
      <ShortName>Deferred Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/DeferredRevenue</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2324306 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpense</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2333307 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/IncomeTaxes</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2341308 - Disclosure - Net Income (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/NetIncomeLossPerShareTables</Role>
      <ShortName>Net Income (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/NetIncomeLossPerShare</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2348309 - Disclosure - Segment Information and Revenue by Geography and Products (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsTables</Role>
      <ShortName>Segment Information and Revenue by Geography and Products (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProducts</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2352310 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/CommitmentsandContingencies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2361311 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/Debt</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2366312 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsTables</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cutera.com/role/ScheduleIIValuationandQualifyingAccounts</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Cash, Cash Equivalents and Restricted Cash - Summary of Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails</Role>
      <ShortName>Cash, Cash Equivalents and Restricted Cash - Summary of Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Cash, Cash Equivalents and Restricted Cash - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CashCashEquivalentsandRestrictedCashNarrativeDetails</Role>
      <ShortName>Cash, Cash Equivalents and Restricted Cash - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Balance Sheet Detail - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/BalanceSheetDetailInventoriesDetails</Role>
      <ShortName>Balance Sheet Detail - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Balance Sheet Detail - Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails</Role>
      <ShortName>Balance Sheet Detail - Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - Balance Sheet Detail - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Detail - Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2415408 - Disclosure - Balance Sheet Detail - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/BalanceSheetDetailNarrativeDetails</Role>
      <ShortName>Balance Sheet Detail - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - Product Warranty - Summary of Warranties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails</Role>
      <ShortName>Product Warranty - Summary of Warranties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2421410 - Disclosure - Deferred Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DeferredRevenueNarrativeDetails</Role>
      <ShortName>Deferred Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2422411 - Disclosure - Deferred Revenue - Summary of Deferred Service Contract Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails</Role>
      <ShortName>Deferred Revenue - Summary of Deferred Service Contract Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2425412 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2427414 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Options Outstanding and Exercisable Price Ranges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Options Outstanding and Exercisable Price Ranges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2428415 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2430417 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense by Department (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense by Department (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2431418 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Valuation Assumptions and Fair Value of Stock Option and ESPP Grants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails</Role>
      <ShortName>Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Valuation Assumptions and Fair Value of Stock Option and ESPP Grants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - Income Taxes - Income (Loss) Before Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Income (Loss) Before Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2435420 - Disclosure - Income Taxes - Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails</Role>
      <ShortName>Income Taxes - Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2436421 - Disclosure - Income Taxes - Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - Income Taxes - Reconciliation of Effective Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Effective Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2438423 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2439424 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2442425 - Disclosure - Net Income (Loss) Per Share - Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails</Role>
      <ShortName>Net Income (Loss) Per Share - Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2443426 - Disclosure - Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails</Role>
      <ShortName>Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2444427 - Disclosure - Net Income (Loss) Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails</Role>
      <ShortName>Net Income (Loss) Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2446428 - Disclosure - Defined Contribution Plan - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DefinedContributionPlanNarrativeDetails</Role>
      <ShortName>Defined Contribution Plan - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2449429 - Disclosure - Segment Information and Revenue by Geography and Products - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails</Role>
      <ShortName>Segment Information and Revenue by Geography and Products - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2450430 - Disclosure - Segment Information and Revenue by Geography and Products - Summary of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails</Role>
      <ShortName>Segment Information and Revenue by Geography and Products - Summary of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2453431 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2454432 - Disclosure - Commitments and Contingencies - Effect of Adoption of the New Standard (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails</Role>
      <ShortName>Commitments and Contingencies - Effect of Adoption of the New Standard (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2455433 - Disclosure - Commitments and Contingencies - Financial Statement Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Financial Statement Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2456434 - Disclosure - Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2457435 - Disclosure - Commitments and Contingencies - Maturities of Finance Leases Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingencies - Maturities of Finance Leases Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2458436 - Disclosure - Commitments and Contingencies - Lease Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Lease Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2459437 - Disclosure - Commitments and Contingencies - Operating Lease Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails</Role>
      <ShortName>Commitments and Contingencies - Operating Lease Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2462438 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2463439 - Disclosure - Debt - Outstanding Debt and Carrying Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails</Role>
      <ShortName>Debt - Outstanding Debt and Carrying Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="cutr-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2467440 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Summary of the Deferred Tax Assets Valuation Allowance and Allowance for Doubtful Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts - Summary of the Deferred Tax Assets Valuation Allowance and Allowance for Doubtful Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="cutr-20211231.htm">cutr-20211231.htm</File>
    <File>cutr-20211231.xsd</File>
    <File>cutr-20211231_cal.xml</File>
    <File>cutr-20211231_def.xml</File>
    <File>cutr-20211231_lab.xml</File>
    <File>cutr-20211231_pre.xml</File>
    <File>cutr-20211231xexx1041.htm</File>
    <File>cutr-20211231xexx231.htm</File>
    <File>cutr-20211231xexx313.htm</File>
    <File>cutr-20211231xexx314.htm</File>
    <File>cutr-20211231xexx321.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cutr-20211231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="1118">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>101
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cutr-20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 33,
   "contextCount": 262,
   "dts": {
    "calculationLink": {
     "local": [
      "cutr-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cutr-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cutr-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cutr-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cutr-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cutr-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 700,
   "entityCount": 1,
   "hidden": {
    "http://cutera.com/20211231": 4,
    "http://fasb.org/us-gaap/2021-01-31": 14,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 22
   },
   "keyCustom": 63,
   "keyStandard": 488,
   "memberCustom": 40,
   "memberStandard": 49,
   "nsprefix": "cutr",
   "nsuri": "http://cutera.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://cutera.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://cutera.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106102 - Disclosure - Cash, Cash Equivalents and Restricted Cash",
     "role": "http://cutera.com/role/CashCashEquivalentsandRestrictedCash",
     "shortName": "Cash, Cash Equivalents and Restricted Cash",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - Balance Sheet Detail",
     "role": "http://cutera.com/role/BalanceSheetDetail",
     "shortName": "Balance Sheet Detail",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116104 - Disclosure - Product Warranty",
     "role": "http://cutera.com/role/ProductWarranty",
     "shortName": "Product Warranty",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:ContractWithCustomerLiabilityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119105 - Disclosure - Deferred Revenue",
     "role": "http://cutera.com/role/DeferredRevenue",
     "shortName": "Deferred Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:ContractWithCustomerLiabilityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123106 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpense",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132107 - Disclosure - Income Taxes",
     "role": "http://cutera.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140108 - Disclosure - Net Income (Loss) Per Share",
     "role": "http://cutera.com/role/NetIncomeLossPerShare",
     "shortName": "Net Income (Loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2145109 - Disclosure - Defined Contribution Plan",
     "role": "http://cutera.com/role/DefinedContributionPlan",
     "shortName": "Defined Contribution Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147110 - Disclosure - Segment Information and Revenue by Geography and Products",
     "role": "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProducts",
     "shortName": "Segment Information and Revenue by Geography and Products",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0002002 - Document - Audit Information",
     "role": "http://cutera.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:LesseeLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151111 - Disclosure - Commitments and Contingencies",
     "role": "http://cutera.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cutr:LesseeLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2160112 - Disclosure - Debt",
     "role": "http://cutera.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2164113 - Disclosure - Subsequent Events",
     "role": "http://cutera.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2165114 - Disclosure - Schedule II - Valuation and Qualifying Accounts",
     "role": "http://cutera.com/role/ScheduleIIValuationandQualifyingAccounts",
     "shortName": "Schedule II - Valuation and Qualifying Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://cutera.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307302 - Disclosure - Cash, Cash Equivalents and Restricted Cash (Tables)",
     "role": "http://cutera.com/role/CashCashEquivalentsandRestrictedCashTables",
     "shortName": "Cash, Cash Equivalents and Restricted Cash (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311303 - Disclosure - Balance Sheet Detail (Tables)",
     "role": "http://cutera.com/role/BalanceSheetDetailTables",
     "shortName": "Balance Sheet Detail (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317304 - Disclosure - Product Warranty (Tables)",
     "role": "http://cutera.com/role/ProductWarrantyTables",
     "shortName": "Product Warranty (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320305 - Disclosure - Deferred Revenue (Tables)",
     "role": "http://cutera.com/role/DeferredRevenueTables",
     "shortName": "Deferred Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001003 - Statement - Consolidated Balance Sheets",
     "role": "http://cutera.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324306 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense (Tables)",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333307 - Disclosure - Income Taxes (Tables)",
     "role": "http://cutera.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341308 - Disclosure - Net Income (Loss) Per Share (Tables)",
     "role": "http://cutera.com/role/NetIncomeLossPerShareTables",
     "shortName": "Net Income (Loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348309 - Disclosure - Segment Information and Revenue by Geography and Products (Tables)",
     "role": "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsTables",
     "shortName": "Segment Information and Revenue by Geography and Products (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352310 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://cutera.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2361311 - Disclosure - Debt (Tables)",
     "role": "http://cutera.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SummaryOfValuationAllowanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2366312 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables)",
     "role": "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsTables",
     "shortName": "Schedule II - Valuation and Qualifying Accounts (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SummaryOfValuationAllowanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfCountriesInWhichEntityOperates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "country",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfCountriesInWhichEntityOperates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "country",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "iea5dc3d35fa7491281eebabd4744ca45_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "role": "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
     "shortName": "Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "iea5dc3d35fa7491281eebabd4744ca45_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Cash, Cash Equivalents and Restricted Cash - Summary of Cash and Cash Equivalents (Details)",
     "role": "http://cutera.com/role/CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails",
     "shortName": "Cash, Cash Equivalents and Restricted Cash - Summary of Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002004 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:MarketableSecurities",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Cash, Cash Equivalents and Restricted Cash - Narrative (Details)",
     "role": "http://cutera.com/role/CashCashEquivalentsandRestrictedCashNarrativeDetails",
     "shortName": "Cash, Cash Equivalents and Restricted Cash - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:MarketableSecurities",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Balance Sheet Detail - Inventories (Details)",
     "role": "http://cutera.com/role/BalanceSheetDetailInventoriesDetails",
     "shortName": "Balance Sheet Detail - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Balance Sheet Detail - Property and Equipment, Net (Details)",
     "role": "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
     "shortName": "Balance Sheet Detail - Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - Balance Sheet Detail - Accrued Liabilities (Details)",
     "role": "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails",
     "shortName": "Balance Sheet Detail - Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryValuationReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415408 - Disclosure - Balance Sheet Detail - Narrative (Details)",
     "role": "http://cutera.com/role/BalanceSheetDetailNarrativeDetails",
     "shortName": "Balance Sheet Detail - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryValuationReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "icb8194a480bb4178ad9ccc279fa71d86_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - Product Warranty - Summary of Warranties (Details)",
     "role": "http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails",
     "shortName": "Product Warranty - Summary of Warranties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "id274c268168b47e082c04e17dfbb9eb6_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "cutr:DeferredRevenueCostsIncurred",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421410 - Disclosure - Deferred Revenue - Narrative (Details)",
     "role": "http://cutera.com/role/DeferredRevenueNarrativeDetails",
     "shortName": "Deferred Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "cutr:DeferredRevenueCostsIncurred",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "icb8194a480bb4178ad9ccc279fa71d86_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422411 - Disclosure - Deferred Revenue - Summary of Deferred Service Contract Revenue (Details)",
     "role": "http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails",
     "shortName": "Deferred Revenue - Summary of Deferred Service Contract Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cutr:ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425412 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Narrative (Details)",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cutr:CapitalStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "icb8194a480bb4178ad9ccc279fa71d86_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock Option Activity (Details)",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cutr:AdditionalSharesReservedSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003005 - Statement - Consolidated Statements of Operations",
     "role": "http://cutera.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427414 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Options Outstanding and Exercisable Price Ranges (Details)",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Options Outstanding and Exercisable Price Ranges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i5046b58bcd594937807a5b3727f16519_D20200401-20200401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428415 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Restricted Stock Units Activity (Details)",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Restricted Stock Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i08b960d0e6e645c39e84cc857ec13e6b_I20181231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i5046b58bcd594937807a5b3727f16519_D20200401-20200401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense (Details)",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i5046b58bcd594937807a5b3727f16519_D20200401-20200401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430417 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense by Department (Details)",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Stock-based Compensation Expense by Department (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i199effaf47f34a41a806c1a1a7e53aa1_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431418 - Disclosure - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Valuation Assumptions and Fair Value of Stock Option and ESPP Grants (Details)",
     "role": "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails",
     "shortName": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense - Valuation Assumptions and Fair Value of Stock Option and ESPP Grants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - Income Taxes - Income (Loss) Before Provision for Income Taxes (Details)",
     "role": "http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes - Income (Loss) Before Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435420 - Disclosure - Income Taxes - Income Tax Provision (Details)",
     "role": "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails",
     "shortName": "Income Taxes - Income Tax Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436421 - Disclosure - Income Taxes - Deferred Tax Assets (Details)",
     "role": "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails",
     "shortName": "Income Taxes - Deferred Tax Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - Income Taxes - Reconciliation of Effective Tax Rate (Details)",
     "role": "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails",
     "shortName": "Income Taxes - Reconciliation of Effective Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438423 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://cutera.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004006 - Statement - Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "icb8194a480bb4178ad9ccc279fa71d86_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439424 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)",
     "role": "http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i84bd95534d8f493aa7e53067a3785115_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442425 - Disclosure - Net Income (Loss) Per Share - Net Loss Per Share (Details)",
     "role": "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails",
     "shortName": "Net Income (Loss) Per Share - Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i2b6f79bd9e214645b06e19082f494df8_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443426 - Disclosure - Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details)",
     "role": "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
     "shortName": "Net Income (Loss) Per Share - Antidilutive Securities Excluded From Computation of Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "ia4c6391b6a824369a52a92dbea8b9166_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444427 - Disclosure - Net Income (Loss) Per Share - Narrative (Details)",
     "role": "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails",
     "shortName": "Net Income (Loss) Per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "ia4c6391b6a824369a52a92dbea8b9166_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "cutr:DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446428 - Disclosure - Defined Contribution Plan - Narrative (Details)",
     "role": "http://cutera.com/role/DefinedContributionPlanNarrativeDetails",
     "shortName": "Defined Contribution Plan - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "cutr:DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449429 - Disclosure - Segment Information and Revenue by Geography and Products - Narrative (Details)",
     "role": "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails",
     "shortName": "Segment Information and Revenue by Geography and Products - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450430 - Disclosure - Segment Information and Revenue by Geography and Products - Summary of Revenue (Details)",
     "role": "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails",
     "shortName": "Segment Information and Revenue by Geography and Products - Summary of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "idac1466cf9104c8e9357f38e1e4b2c30_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cutr:LeasesFinancialStatementInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "icb8194a480bb4178ad9ccc279fa71d86_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453431 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "role": "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i764ce0cbc59940f481fdec67f544e264_D20201001-20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "cutr:LessorOptionToPurchaseGrantedPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cutr:LeasesFinancialStatementInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454432 - Disclosure - Commitments and Contingencies - Effect of Adoption of the New Standard (Details)",
     "role": "http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails",
     "shortName": "Commitments and Contingencies - Effect of Adoption of the New Standard (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i84bd95534d8f493aa7e53067a3785115_I20181231",
      "decimals": "-4",
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cutr:LeasesFinancialStatementInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455433 - Disclosure - Commitments and Contingencies - Financial Statement Information (Details)",
     "role": "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
     "shortName": "Commitments and Contingencies - Financial Statement Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cutr:LeasesFinancialStatementInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cutr:LeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i1a7631525a4f45cd84f88a123b5d2213_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005007 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i1a7631525a4f45cd84f88a123b5d2213_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456434 - Disclosure - Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details)",
     "role": "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails",
     "shortName": "Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457435 - Disclosure - Commitments and Contingencies - Maturities of Finance Leases Liabilities (Details)",
     "role": "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails",
     "shortName": "Commitments and Contingencies - Maturities of Finance Leases Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458436 - Disclosure - Commitments and Contingencies - Lease Information (Details)",
     "role": "http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails",
     "shortName": "Commitments and Contingencies - Lease Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459437 - Disclosure - Commitments and Contingencies - Operating Lease Income (Details)",
     "role": "http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails",
     "shortName": "Commitments and Contingencies - Operating Lease Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462438 - Disclosure - Debt - Narrative (Details)",
     "role": "http://cutera.com/role/DebtNarrativeDetails",
     "shortName": "Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i130b34c8fd4f434eb30d4d656ae2c907_I20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeCapPrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerItem",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i61bbc2cbafa242e2be0c3e31fe1fb2d4_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463439 - Disclosure - Debt - Outstanding Debt and Carrying Value (Details)",
     "role": "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails",
     "shortName": "Debt - Outstanding Debt and Carrying Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i3b661e68d3614dd8a0389a329265b3bd_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "ia14ca8fcae0b4aefa76cad9866090d78_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467440 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Summary of the Deferred Tax Assets Valuation Allowance and Allowance for Doubtful Accounts Receivable (Details)",
     "role": "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails",
     "shortName": "Schedule II - Valuation and Qualifying Accounts - Summary of the Deferred Tax Assets Valuation Allowance and Allowance for Doubtful Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i3b7116ac1a764bada7c667ee90614aee_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i8e54dcaf658240a4871bd05fa7deab9b_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006008 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "role": "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical",
     "shortName": "Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i748e51eb5e014d4fba5760cc2f33825c_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007009 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cutr-20211231.htm",
      "contextRef": "i830897d0da8d4889beae5266b3d535b8_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 94,
   "tag": {
    "country_JP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "JAPAN",
        "terseLabel": "Japan"
       }
      }
     },
     "localname": "JP",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_AccruedInventoryInTransitCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Inventory In Transit, Current",
        "label": "Accrued Inventory In Transit, Current",
        "terseLabel": "Accrued inventory in transit"
       }
      }
     },
     "localname": "AccruedInventoryInTransitCurrent",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_AccruedSalesAndMarketingCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for sales and marketing costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales and marketing accruals",
        "terseLabel": "Sales and marketing accruals"
       }
      }
     },
     "localname": "AccruedSalesAndMarketingCostsCurrent",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_AdditionalSharesReservedSharesAvailableForGrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares available for grant under options that were reserved as additional shares by the entity.",
        "label": "Additional shares reserved, shares available for grant",
        "terseLabel": "Additional shares reserved (in shares)"
       }
      }
     },
     "localname": "AdditionalSharesReservedSharesAvailableForGrant",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cutr_AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for allowances for sales returns and doubtful accounts.",
        "label": "Allowances for Sales Returns and Doubtful Accounts [Policy Text Block]",
        "terseLabel": "Allowances for Sales Returns and Credit Losses"
       }
      }
     },
     "localname": "AllowancesForSalesReturnsAndDoubtfulAccountsPolicyTextBlock",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cutr_AsiaExcludingJapanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia, Excluding Japan [Member]",
        "terseLabel": "Asia, excluding Japan"
       }
      }
     },
     "localname": "AsiaExcludingJapanMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://cutera.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cutr_CapitalStockSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of capital shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Capital Stock Shares Authorized",
        "terseLabel": "Authorized capital (in shares)"
       }
      }
     },
     "localname": "CapitalStockSharesAuthorized",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cutr_CapitalizedCloudComputingSetupCostMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the capitalized cloud computing set-up cost.",
        "label": "Capitalized Cloud Computing Set-up Cost [Member]",
        "terseLabel": "Capitalized Cloud Computing Set-up Cost"
       }
      }
     },
     "localname": "CapitalizedCloudComputingSetupCostMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_CappedCallSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capped Call Securities",
        "label": "Capped Call Securities [Member]",
        "terseLabel": "Capped call"
       }
      }
     },
     "localname": "CappedCallSecuritiesMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ChangeInContractWithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Contract with Customer, Liability",
        "label": "Change in Contract with Customer, Liability [Roll Forward]",
        "terseLabel": "Change in Contract with Customer, Liability [Roll Forward]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityRollForward",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_ChangeInRightofuseAssetAndLiabilityDueToModification": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the change in right-of-use asset and liability due to modification during the period.",
        "label": "Change in right-of-use asset",
        "terseLabel": "Change in right-of-use asset"
       }
      }
     },
     "localname": "ChangeInRightofuseAssetAndLiabilityDueToModification",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ContractWithCustomerLiabilityDecreaseFromRevenueDeferred": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from revenue deferred.",
        "label": "Contract With Customer Liability Decrease From Revenue Deferred",
        "negatedLabel": "Less: Revenue recognized from current period sales"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityDecreaseFromRevenueDeferred",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in obligation to transfer good or service to customer for which consideration from customer has been received or is due, from advance payments received.",
        "label": "Contract With Customer Liability Increase Advance Payments Received",
        "terseLabel": "Add: Payments received"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ContractWithCustomerLiabilityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of contract with customer liability.",
        "label": "Contract with Customer Liability [Text Block]",
        "terseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityTextBlock",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DeferredRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cutr_ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Training Provided With Sale Of System, Period",
        "label": "Contract With Customer, Liability, Training Provided With Sale Of System, Period",
        "terseLabel": "Training on use of system term (in days)"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_ConvertibleSeniorNotesDue2026FirstConversionTriggerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to the first conversion trigger of debt.",
        "label": "Convertible Senior Notes Due 2026, First Conversion Trigger [Member]",
        "terseLabel": "Convertible Senior Notes Due 2026, First Conversion Trigger"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2026FirstConversionTriggerMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ConvertibleSeniorNotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to convertible senior notes due 2026.",
        "label": "Convertible Senior Notes Due 2026 [Member]",
        "terseLabel": "Convertible Senior Notes Due 2026"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2026Member",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ConvertibleSeniorNotesDue2026SecondConversionTriggerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to the second conversion trigger feature of debt.",
        "label": "Convertible Senior Notes Due 2026, Second Conversion Trigger [Member]",
        "terseLabel": "Convertible Senior Notes Due 2026, Second Conversion Trigger"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2026SecondConversionTriggerMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_DebtCovenantQuarterlyMinimumRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents quarterly minimum revenue under debt covenant.",
        "label": "Debt Covenant Quarterly Minimum Revenue",
        "terseLabel": "Quarterly minimum revenue"
       }
      }
     },
     "localname": "DebtCovenantQuarterlyMinimumRevenue",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DebtInstrumentAnniversaryFeeAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents anniversary fee amount for debt instrument.",
        "label": "Debt Instrument Anniversary Fee Amount",
        "terseLabel": "Anniversary fee amount"
       }
      }
     },
     "localname": "DebtInstrumentAnniversaryFeeAmount",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of required outstanding amount not subject to redemption of a convertible debt instrument.",
        "label": "Debt Instrument, Convertible Required, Outstanding Amount Not Subject To Redemption",
        "terseLabel": "Required outstanding amount not subject to redemption"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleRequiredOutstandingAmountNotSubjectToRedemption",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents percentage of qualifying accounts receivable for debt instrument.",
        "label": "cutr_DebtInstrumentPercentageOfQualifyingAccountsReceivable",
        "terseLabel": "Qualifying accounts receivable"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfQualifyingAccountsReceivable",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_DebtInstrumentRedemptionIncrementalRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redemption, Incremental Repurchase Amount",
        "label": "Debt Instrument, Redemption, Incremental Repurchase Amount",
        "terseLabel": "Incremental repurchase amount"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionIncrementalRepurchaseAmount",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DeferredRevenueCostsIncurred": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred under service contracts.",
        "label": "Deferred Revenue Costs Incurred",
        "terseLabel": "Costs for extended service contracts"
       }
      }
     },
     "localname": "DeferredRevenueCostsIncurred",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DeferredTaxAssetsOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from operating lease liability.",
        "label": "Deferred Tax Assets Operating Lease Liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiability",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DeferredTaxLiabilitiesDeferredContractAcquisitionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from deferred contract acquisition costs.",
        "label": "Deferred Tax Liabilities Deferred Contract Acquisition Costs",
        "negatedLabel": "Deferred contract acquisition costs"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredContractAcquisitionCosts",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to defined contribution plan maximum percentage of voluntary contribution by the employee.",
        "label": "Defined Contribution Plan Maximum Percentage Of Employee Voluntary Contribution",
        "terseLabel": "Maximum 401(k) employee contribution percentage"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DefinedContributionPlanNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_DemonstrationUnitsAmortizationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Demonstration Units, Amortization Period",
        "label": "Demonstration Units, Amortization Period",
        "terseLabel": "Estimated economic life of demonstration units"
       }
      }
     },
     "localname": "DemonstrationUnitsAmortizationPeriod",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_DepreciationAndAmortizationExcludingContractAcquisitionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets, excluding contract acquisition costs.",
        "label": "Depreciation and amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortizationExcludingContractAcquisitionCosts",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_DerivativeCapPricePremiumOverStockPricePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percent premium over the stock price for derivative caps.",
        "label": "Derivative, Cap Price, Premium Over Stock Price, Percent",
        "terseLabel": "Premium over stock price (percent)"
       }
      }
     },
     "localname": "DerivativeCapPricePremiumOverStockPricePercent",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_DerivativeCappedCallTransactionTermConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Capped Call Transaction Term, Consecutive Trading Days",
        "label": "Derivative, Capped Call Transaction Term, Consecutive Trading Days",
        "terseLabel": "Capped-call transaction term, consecutive trading days"
       }
      }
     },
     "localname": "DerivativeCappedCallTransactionTermConsecutiveTradingDays",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cutr_ESPPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the Company's employee stock purchase plan (ESPP).",
        "label": "ESPP [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "ESPPMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Debt Extinguishment, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Debt Extinguishment, Percent",
        "terseLabel": "Extinguishment of PPP loan"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDebtExtinguishmentPercent",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deferred true-up.",
        "label": "Deferred true-up",
        "terseLabel": "Deferred true-up"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_EffectiveIncomeTaxRateReconciliationExcessCompensationPercent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Excess Compensation, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Excess Compensation, Percent",
        "terseLabel": "Excess compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationExcessCompensationPercent",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment.",
        "label": "Meals and entertainment",
        "terseLabel": "Meals and entertainment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to permanent differences.",
        "label": "Permanent differences",
        "terseLabel": "Permanent differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development.",
        "label": "General business credit",
        "terseLabel": "General business credit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to valuation allowance.",
        "label": "Effective Income Tax Rate Reconciliation Valuation Allowance Percent",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationValuationAllowancePercent",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "2004 Employee Stock Purchase Plan [Member]",
        "terseLabel": "2004 Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_EquipmentAndFurnitureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents office equipment and furniture.",
        "label": "Equipment and Furniture [Member]",
        "terseLabel": "Office equipment and furniture"
       }
      }
     },
     "localname": "EquipmentAndFurnitureMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange10Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 10 [Member]",
        "terseLabel": "Exercise Price Range 10"
       }
      }
     },
     "localname": "ExercisePriceRange10Member",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 1 [Member]",
        "terseLabel": "Exercise Price Range 1"
       }
      }
     },
     "localname": "ExercisePriceRange1Member",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 2 [Member]",
        "terseLabel": "Exercise Price Range 2"
       }
      }
     },
     "localname": "ExercisePriceRange2Member",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 3 [Member]",
        "terseLabel": "Exercise Price Range 3"
       }
      }
     },
     "localname": "ExercisePriceRange3Member",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 4 [Member]",
        "terseLabel": "Exercise Price Range 4"
       }
      }
     },
     "localname": "ExercisePriceRange4Member",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange5Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 5 [Member]",
        "terseLabel": "Exercise Price Range 5"
       }
      }
     },
     "localname": "ExercisePriceRange5Member",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 6 [Member]",
        "terseLabel": "Exercise Price Range 6"
       }
      }
     },
     "localname": "ExercisePriceRange6Member",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange7Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 7 [Member]",
        "terseLabel": "Exercise Price Range 7"
       }
      }
     },
     "localname": "ExercisePriceRange7Member",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange8Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 8 [Member]",
        "terseLabel": "Exercise Price Range 8"
       }
      }
     },
     "localname": "ExercisePriceRange8Member",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExercisePriceRange9Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range 9 [Member]",
        "terseLabel": "Exercise Price Range 9"
       }
      }
     },
     "localname": "ExercisePriceRange9Member",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ExtendedServiceContractOptionOneTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended Service Contract, Option One, Term",
        "label": "Extended Service Contract, Option One, Term",
        "terseLabel": "Extended service contract, option one, term"
       }
      }
     },
     "localname": "ExtendedServiceContractOptionOneTerm",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_ExtendedServiceContractOptionThreeTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended Service Contract, Option Three, Term",
        "label": "Extended Service Contract, Option Three, Term",
        "terseLabel": "Extended service contract, option three, term"
       }
      }
     },
     "localname": "ExtendedServiceContractOptionThreeTerm",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_ExtendedServiceContractOptionTwoTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended Service Contract, Option Two, Term",
        "label": "Extended Service Contract, Option Two, Term",
        "terseLabel": "Extended service contract, option two, term"
       }
      }
     },
     "localname": "ExtendedServiceContractOptionTwoTerm",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_FormerExecutiveVPAndCFOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the former Executive Vice President and CFO Sandra A. Gardiner.",
        "label": "Former Executive VP and CFO [Member]",
        "terseLabel": "Former Executive VP and CFO"
       }
      }
     },
     "localname": "FormerExecutiveVPAndCFOMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_HandPieceRefillsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hand Piece Refills [Member]",
        "terseLabel": "Consumables"
       }
      }
     },
     "localname": "HandPieceRefillsMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of increase (decrease) in operating lease liabilities.",
        "label": "Increase Decrease In Operating Lease Liabilities",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_LeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under finance and operating lease.",
        "label": "Lease Right of Use Asset",
        "totalLabel": "Total leased assets"
       }
      }
     },
     "localname": "LeaseRightOfUseAsset",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_LeasedEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leased Equipment",
        "label": "Leased Equipment [Member]",
        "terseLabel": "Equipment leasing"
       }
      }
     },
     "localname": "LeasedEquipmentMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_LeasesFinancialStatementInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the financial statement information for leases.",
        "label": "Leases, Financial Statement Information [Table Text Block]",
        "terseLabel": "Leases, Financial Statement Information"
       }
      }
     },
     "localname": "LeasesFinancialStatementInformationTableTextBlock",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cutr_LesseeLeaseRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The renewal term for leases of lessee.",
        "label": "Lessee Lease Renewal Term",
        "terseLabel": "Remaining lease terms of finance leases"
       }
      }
     },
     "localname": "LesseeLeaseRenewalTerm",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_LesseeLeasesRemainingTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining term of operating and finance leases for the lessee.",
        "label": "Lessee Leases Remaining Term",
        "terseLabel": "Remaining lease terms of operating leases"
       }
      }
     },
     "localname": "LesseeLeasesRemainingTerm",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_LesseeLeasesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating and finance leases of lessee.",
        "label": "Lessee, Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesTextBlock",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cutr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability To Be Paid After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFive",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_LessorOptionToPurchaseGrantedPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessor, Option To Purchase Granted, Period",
        "label": "Lessor, Option To Purchase Granted, Period",
        "terseLabel": "Option granted to purchase leased system, period"
       }
      }
     },
     "localname": "LessorOptionToPurchaseGrantedPeriod",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_LoanAndSecurityAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the Loan and Security Agreement.",
        "label": "Loan and Security Agreement [Member]",
        "terseLabel": "Loan and Security Agreement"
       }
      }
     },
     "localname": "LoanAndSecurityAgreementMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_LoyaltyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to loyalty",
        "label": "Loyalty [Member]",
        "terseLabel": "Loyalty"
       }
      }
     },
     "localname": "LoyaltyMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_NumberOfMajorSuppliers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Major Suppliers",
        "label": "Number Of Major Suppliers",
        "terseLabel": "Number of major suppliers"
       }
      }
     },
     "localname": "NumberOfMajorSuppliers",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cutr_NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of stack awards counted for every share granted or canceled when computed shares available for grant.",
        "label": "Number Of Stock Awards Counted For Every Share Granted Or Canceled",
        "terseLabel": "Share subtraction (in shares)"
       }
      }
     },
     "localname": "NumberOfStockAwardsCountedForEveryShareGrantedOrCanceled",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cutr_OperatingLossCarryforwardsWithoutExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of operating loss carryforwards that have no expiration.",
        "label": "Operating Loss Carryforwards Without Expiration",
        "terseLabel": "Operating loss carryforwards without expiration"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsWithoutExpiration",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization, Consolidation And Presentation Of Financial Statements",
        "label": "Organization, Consolidation And Presentation Of Financial Statements [Line Items]",
        "terseLabel": "Organization, Consolidation And Presentation Of Financial Statements [Line Items]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_OrganizationConsolidationAndPresentationOfFinancialStatementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization, Consolidation And Presentation Of Financial Statements",
        "label": "Organization, Consolidation And Presentation Of Financial Statements [Table]",
        "terseLabel": "Organization, Consolidation And Presentation Of Financial Statements [Table]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsTable",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_PaycheckProtectionProgramCARESActMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents loan designed to provide funds for small businesses to keep their employees on the payroll.",
        "label": "Paycheck Protection Program CARES Act [Member]",
        "terseLabel": "Paycheck Protection Program CARES Act"
       }
      }
     },
     "localname": "PaycheckProtectionProgramCARESActMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_PercentageOfAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage amount of assets.",
        "label": "Percentage Of Assets",
        "terseLabel": "Percentage of assets in the United States"
       }
      }
     },
     "localname": "PercentageOfAssets",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_ProceedsFromExerciseOfPurchaseOptionSalesTypeLease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Exercise Of Purchase Option, Sales-Type Lease",
        "label": "Proceeds From Exercise Of Purchase Option, Sales-Type Lease",
        "terseLabel": "Proceeds from purchase option"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfPurchaseOptionSalesTypeLease",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_PurchaseOfCappedCall": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of Capped Call",
        "label": "Purchase of Capped Call",
        "terseLabel": "Purchase of capped call"
       }
      }
     },
     "localname": "PurchaseOfCappedCall",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rest of the World, Excluding United States, Asia and Europe [Member]",
        "terseLabel": "Rest of the world, other than United States, Asia and Europe"
       }
      }
     },
     "localname": "RestOfTheWorldExcludingUnitedStatesAsiaAndEuropeMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_RestrictedStockUnitsAndPerformanceShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents restricted stock units and performance share units.",
        "label": "Restricted Stock Units and Performance Share Units [Member]",
        "terseLabel": "Restricted Stock Units and Performance Share Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsAndPerformanceShareUnitsMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_RestrictedStockUnitsAnnualGrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units, Annual Grant",
        "label": "Restricted Stock Units, Annual Grant [Member]",
        "terseLabel": "Restricted Stock Units, Annual Grant"
       }
      }
     },
     "localname": "RestrictedStockUnitsAnnualGrantMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_RestrictedStockUnitsNewHireMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units, New Hire",
        "label": "Restricted Stock Units, New Hire [Member]",
        "terseLabel": "Restricted Stock Units, New Hire"
       }
      }
     },
     "localname": "RestrictedStockUnitsNewHireMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, expressed as a percent, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.",
        "label": "Revenue From Contract With Customer Including Assessed Tax Percent Of Total Revenues",
        "terseLabel": "Percent of total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTaxPercentOfTotalRevenues",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_RisksAndUncertaintiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for risks and uncertainties.",
        "label": "Risks and Uncertainties, Policy [Policy Text Block]",
        "terseLabel": "Risks and Uncertainties"
       }
      }
     },
     "localname": "RisksAndUncertaintiesPolicyPolicyTextBlock",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cutr_SecretAndSecretProMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secret and Secret Pro",
        "label": "Secret and Secret Pro [Member]",
        "terseLabel": "Secret and Secret Pro"
       }
      }
     },
     "localname": "SecretAndSecretProMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of available for grant restricted stock shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Stock awards canceled (in shares)",
        "terseLabel": "Stock awards canceled (expired or forfeited) (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized, Percentage",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Authorized, Percentage",
        "terseLabel": "Additional shares authorized, percentage"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercentage",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value of equity-based payment equity instruments, excluding stock or unit options, granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Vested, aggregate fair value",
        "terseLabel": "Vested, aggregate fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateFairValue",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Number Of Vesting Tranches",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Number Of Vesting Tranches",
        "terseLabel": "Number of vesting tranches"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Offering Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Offering Period",
        "terseLabel": "Offering period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Officers Percentage To Be Held For A Minimum Of One Year",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Officers Percentage To Be Held For A Minimum Of One Year",
        "terseLabel": "Percentage of awards officers are required to hold for a minimum of one year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Options, Available For Grant",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Options, Available For Grant [Roll Forward]",
        "terseLabel": "Shares Available For Grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAvailableForGrantRollForward",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Contractual Term",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Contractual Term [Abstract]",
        "terseLabel": "Weighted-Average Remaining Contractual Life"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualTermAbstract",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Intrinsic Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the number of shares available for grant reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding as of the balance sheet date, including vested options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross",
        "negatedLabel": "Stock awards granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cutr_ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares available for grant under options that were granted during the reporting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Options Granted",
        "negatedLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cutr_ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to Share based compensation by share based payment fully vested stock awards grant date fair value.",
        "label": "Share Based Compensation By Share Based Payment Fully Vested Stock Awards Grant Date Fair Value",
        "terseLabel": "Grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationByShareBasedPaymentFullyVestedStockAwardsGrantDateFairValue",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cutr_ShareBasedPaymentAwardPeriodToDetermineGrantAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Award, Period To Determine Grant Amount",
        "label": "Share-based Payment Award, Period To Determine Grant Amount",
        "terseLabel": "Shares granted calculation, grant period (in days)"
       }
      }
     },
     "localname": "ShareBasedPaymentAwardPeriodToDetermineGrantAmount",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "timeItemType"
    },
    "cutr_SiliconValleyBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to Silicon Valley Bank.",
        "label": "Silicon Valley Bank [Member]",
        "terseLabel": "Silicon Valley Bank"
       }
      }
     },
     "localname": "SiliconValleyBankMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_SkincareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Skincare [Member]",
        "terseLabel": "Skincare"
       }
      }
     },
     "localname": "SkincareMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_StandardProductWarrantyTermDirectSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Standard Product Warranty Term, Direct Sales",
        "label": "Standard Product Warranty Term, Direct Sales",
        "terseLabel": "Warranty term, direct sales"
       }
      }
     },
     "localname": "StandardProductWarrantyTermDirectSales",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "timeItemType"
    },
    "cutr_StandardProductWarrantyTermDistributorSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Standard Product Warranty Term, Distributor Sales",
        "label": "Standard Product Warranty Term, Distributor Sales",
        "terseLabel": "Warranty term, distributor sales"
       }
      }
     },
     "localname": "StandardProductWarrantyTermDistributorSales",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cutr_StockIssuedDuringPeriodSharesLitigationSettlement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued during the period resulting from the judgment or settlement of litigation.",
        "label": "Stock Issued During Period Shares Litigation Settlement",
        "terseLabel": "Arbitration settlement (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesLitigationSettlement",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cutr_StockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "1998 Stock Plan [Member]",
        "terseLabel": "1998 Stock Plan"
       }
      }
     },
     "localname": "StockPlanMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_StockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Purchase Plan [Member]",
        "terseLabel": "Stock Purchase Plan"
       }
      }
     },
     "localname": "StockPurchasePlanMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_SystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents systems.",
        "label": "Systems [Member]",
        "terseLabel": "Systems"
       }
      }
     },
     "localname": "SystemsMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_TheAmendedAndRestated2019EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to the Amended and Restated 2019 Equity Incentive Plan (the \"Restarted Plan\").",
        "label": "The Amended and Restated 2019 Equity Incentive Plan [Member]",
        "terseLabel": "The Amended and Restated 2019 Equity Incentive Plan"
       }
      }
     },
     "localname": "TheAmendedAndRestated2019EquityIncentivePlanMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_TwoThousandFourEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the equity incentive plan adopted by the Board of Directors in 2004.",
        "label": "Two Thousand Four Equity Incentive Plan [Member]",
        "terseLabel": "2004 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandFourEquityIncentivePlanMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_TwoThousandNineteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related to the 2019 equity incentive plan.",
        "label": "Two Thousand Nineteen Equity Incentive Plan [Member]",
        "terseLabel": "2019 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandNineteenEquityIncentivePlanMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_UnderwriterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the underwriter.",
        "label": "Underwriter [Member]",
        "terseLabel": "Underwriter"
       }
      }
     },
     "localname": "UnderwriterMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_UnderwrittenPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the underwritten public offering.",
        "label": "Underwritten Public Offering [Member]",
        "terseLabel": "Underwritten Public Offering"
       }
      }
     },
     "localname": "UnderwrittenPublicOfferingMember",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cutr_ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options and employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Valuation Assumptions and Fair Value of Stock Options and ESPP Grants [Table Text Block]",
        "terseLabel": "Valuation Assumptions and Fair Value of Stock Options and ESPP Grants"
       }
      }
     },
     "localname": "ValuationAssumptionsAndFairValueOfStockOptionsAndEsppGrantsTableTextBlock",
     "nsuri": "http://cutera.com/20211231",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://cutera.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r66",
      "r68",
      "r136",
      "r137",
      "r315",
      "r354",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r150",
      "r158",
      "r164",
      "r250",
      "r448",
      "r449",
      "r450",
      "r491",
      "r492",
      "r522",
      "r525",
      "r527",
      "r528",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r150",
      "r158",
      "r164",
      "r250",
      "r448",
      "r449",
      "r450",
      "r491",
      "r492",
      "r522",
      "r525",
      "r527",
      "r528",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r150",
      "r158",
      "r164",
      "r250",
      "r448",
      "r449",
      "r450",
      "r491",
      "r492",
      "r522",
      "r525",
      "r527",
      "r528",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of Europe.",
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r314",
      "r353",
      "r404",
      "r405",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r637",
      "r640",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r314",
      "r353",
      "r404",
      "r405",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r637",
      "r640",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r231",
      "r378",
      "r381",
      "r601",
      "r636",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r231",
      "r378",
      "r381",
      "r601",
      "r636",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r314",
      "r353",
      "r390",
      "r404",
      "r405",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r637",
      "r640",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r314",
      "r353",
      "r390",
      "r404",
      "r405",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r637",
      "r640",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r67",
      "r68",
      "r136",
      "r137",
      "r315",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r145",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "Schedule II - Valuation and Qualifying Accounts"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r232",
      "r233",
      "r378",
      "r382",
      "r639",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r681",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r232",
      "r233",
      "r378",
      "r382",
      "r639",
      "r654",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r681",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r143",
      "r144",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r48",
      "r589"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r8",
      "r26",
      "r237",
      "r238"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $899 and $1,598, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r72",
      "r74",
      "r84",
      "r85",
      "r86",
      "r147",
      "r148",
      "r149",
      "r513",
      "r643",
      "r644",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r448",
      "r449",
      "r450",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r151",
      "r152",
      "r153",
      "r154",
      "r164",
      "r241",
      "r242",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r298",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r489",
      "r490",
      "r491",
      "r492",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r586",
      "r603",
      "r604",
      "r605",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r408",
      "r411",
      "r454",
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r459"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising expense"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r411",
      "r441",
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r32",
      "r239",
      "r253"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for credit loss, current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForLoanAndLeaseLossesMember": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r143",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for portion expected to be uncollectible of receivable from loan and lease portfolio.",
        "label": "SEC Schedule, 12-09, Allowance, Loan and Lease Loss [Member]",
        "terseLabel": "Allowance for credit losses, accounts receivable"
       }
      }
     },
     "localname": "AllowanceForLoanAndLeaseLossesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AmortizationOfAcquisitionCosts": {
     "auth_ref": [
      "r117",
      "r269"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Acquisition Costs",
        "terseLabel": "Amortization of contract acquisition costs"
       }
      }
     },
     "localname": "AmortizationOfAcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r93",
      "r117",
      "r334",
      "r556"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r117",
      "r334",
      "r346",
      "r347",
      "r556"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "negatedTerseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r131",
      "r211",
      "r221",
      "r227",
      "r246",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r509",
      "r514",
      "r533",
      "r587",
      "r589",
      "r609",
      "r625"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r64",
      "r131",
      "r246",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r509",
      "r514",
      "r533",
      "r587",
      "r589"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r412",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CaliforniaFranchiseTaxBoardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of the state of California.",
        "label": "California Franchise Tax Board [Member]",
        "terseLabel": "California Franchise Tax Board"
       }
      }
     },
     "localname": "CaliforniaFranchiseTaxBoardMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalizedContractCostAmortization": {
     "auth_ref": [
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Amortization",
        "terseLabel": "Amortization of capitalized contract costs"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortizationPeriod": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Capitalized Contract Cost, Amortization Period",
        "terseLabel": "Capitalized costs, amortization period"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortizationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_CapitalizedContractCostNet": {
     "auth_ref": [
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Net",
        "terseLabel": "Total capitalized costs"
       }
      }
     },
     "localname": "CapitalizedContractCostNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r42",
      "r119"
     ],
     "calculation": {
      "http://cutera.com/role/CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      },
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r16",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "terseLabel": "Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsandRestrictedCash"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r113",
      "r119",
      "r125"
     ],
     "calculation": {
      "http://cutera.com/role/CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "totalLabel": "Cash equivalents and restricted cash as reported within the Consolidated Statement of Cash Flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r113",
      "r119",
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of year",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r113",
      "r546"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r129",
      "r131",
      "r168",
      "r172",
      "r173",
      "r175",
      "r177",
      "r189",
      "r190",
      "r191",
      "r246",
      "r299",
      "r303",
      "r304",
      "r305",
      "r308",
      "r309",
      "r351",
      "r352",
      "r355",
      "r356",
      "r533",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/IncomeTaxesNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r58",
      "r286",
      "r613",
      "r630"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 11)."
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares available for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r147",
      "r148",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r25",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "verboseLabel": "Common stock outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r25",
      "r589"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value: Authorized: 50,000,000 shares; Issued and outstanding: 17,995,344 and 17,679,232 shares at December\u00a031, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r79",
      "r81",
      "r82",
      "r89",
      "r617",
      "r632"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r198",
      "r199",
      "r235",
      "r531",
      "r532",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r198",
      "r199",
      "r235",
      "r531",
      "r532",
      "r653",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r198",
      "r199",
      "r235",
      "r531",
      "r532",
      "r653",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r194",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk and Other Risks and Uncertainties"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r198",
      "r199",
      "r235",
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r198",
      "r199",
      "r235",
      "r531",
      "r532",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Description of Operations and Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Summary of Deferred Service Contract Revenue"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r364",
      "r365",
      "r379"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year",
        "terseLabel": "Accrual for loyalty program"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r380"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "negatedLabel": "Less: Revenue recognized from beginning balance"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueSummaryofDeferredServiceContractRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r314",
      "r324",
      "r325",
      "r326",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r344",
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Convertible notes, net of unamortized debt issuance costs of $4,007"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.",
        "label": "Convertible Debt Securities [Member]",
        "terseLabel": "Convertible debt"
       }
      }
     },
     "localname": "ConvertibleDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.",
        "label": "Convertible Debt [Table Text Block]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r96",
      "r601"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Total cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Cost of revenue:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Revenue"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r132",
      "r485",
      "r495"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r132",
      "r485"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r132",
      "r485",
      "r495",
      "r497"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total Current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r132",
      "r485",
      "r495"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r197",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r128",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r328",
      "r335",
      "r336",
      "r338",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r130",
      "r138",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r318",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r344",
      "r345",
      "r346",
      "r347",
      "r557",
      "r610",
      "r611",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r22",
      "r339",
      "r611",
      "r624"
     ],
     "calculation": {
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Outstanding principal amount"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r313",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r55",
      "r313",
      "r358",
      "r359",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Convertible debt, conversion ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments": {
     "auth_ref": [
      "r55",
      "r313",
      "r358",
      "r359",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.",
        "label": "Debt Instrument, Convertible, Number of Equity Instruments",
        "terseLabel": "Debt convertible to common shares (in shares)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleNumberOfEquityInstruments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Conversion threshold percentage of stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Conversion threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r311",
      "r344",
      "r345",
      "r555",
      "r557",
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r326",
      "r344",
      "r345",
      "r530"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r54",
      "r331",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Effective interest rate during period"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r54",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r56",
      "r130",
      "r138",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r318",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r344",
      "r345",
      "r346",
      "r347",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price, percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r56",
      "r130",
      "r138",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r318",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r337",
      "r344",
      "r345",
      "r346",
      "r347",
      "r358",
      "r360",
      "r361",
      "r362",
      "r554",
      "r555",
      "r557",
      "r558",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r324",
      "r340",
      "r344",
      "r345",
      "r556"
     ],
     "calculation": {
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedLabel": "Unamortized debt issuance costs",
        "terseLabel": "Unamortized debt issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r132",
      "r486",
      "r495"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "verboseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r132",
      "r486",
      "r495"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "verboseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r464",
      "r465"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r117",
      "r132",
      "r486",
      "r495",
      "r496",
      "r497"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total Deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "terseLabel": "Deferred revenue, net of current portion"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r132",
      "r486",
      "r495"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "verboseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r476"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred tax asset before valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r478"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "terseLabel": "Net deferred tax asset",
        "totalLabel": "Net deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails",
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r478"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax asset after valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r483",
      "r484"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "verboseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r483",
      "r484"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r481",
      "r483",
      "r484"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r483",
      "r484"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": {
     "auth_ref": [
      "r483",
      "r484"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other",
        "terseLabel": "Other accruals and reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves": {
     "auth_ref": [
      "r483",
      "r484"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from warranty reserves.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Warranty Reserves",
        "terseLabel": "Accrued warranty"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails",
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": {
     "auth_ref": [
      "r483",
      "r484",
      "r505",
      "r506"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill",
        "negatedLabel": "Goodwill"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r483",
      "r484"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedLabel": "Right of use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Employer 401(k) discretionary contribution"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DefinedContributionPlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r117",
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeCapPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cap rate on a price risk derivative such as a cap or collar. A payment or receipt is triggered if the market rate exceeds the cap rate on the contract.",
        "label": "Derivative, Cap Price",
        "terseLabel": "Cap price (in USD per share)"
       }
      }
     },
     "localname": "DerivativeCapPrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perUnitItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r378",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stockholders' Equity, Stock Plans and Stock-based Compensation Expense"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpense"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r90",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r166",
      "r168",
      "r175",
      "r176",
      "r177",
      "r181",
      "r182",
      "r528",
      "r529",
      "r618",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income (loss) per share, basic (USD per share)",
        "verboseLabel": "Basic (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net income (loss) per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r90",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r168",
      "r175",
      "r176",
      "r177",
      "r181",
      "r182",
      "r528",
      "r529",
      "r618",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (USD per share)",
        "verboseLabel": "Net income (loss) per share, diluted (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Dilutive effect of incremental shares and share equivalents:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r178",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Computation of Net Income (Loss) per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r467"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r134",
      "r467",
      "r499"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. federal statutory income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r467",
      "r499"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign rate differential"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r467",
      "r499"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r467",
      "r499"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r467",
      "r499"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent",
        "terseLabel": "Change in prior year reserves"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r467",
      "r499"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesReconciliationofEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Bonus and payroll-related accruals"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r84",
      "r85",
      "r86",
      "r147",
      "r148",
      "r149",
      "r152",
      "r161",
      "r163",
      "r188",
      "r250",
      "r357",
      "r363",
      "r448",
      "r449",
      "r450",
      "r491",
      "r492",
      "r527",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r643",
      "r644",
      "r645",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r563",
      "r570",
      "r577"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Finance lease cost"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r566",
      "r571"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flow"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r561",
      "r576"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of lease liabilities",
        "totalLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r561"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liabilities, current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Finance Lease, Liability, Fiscal Year Maturity"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r561"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease liabilities, non-current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofFinanceLeasesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r565",
      "r571"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedLabel": "Payments on capital lease obligation",
        "terseLabel": "Financing cash flow"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r560"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails": {
       "order": 2.0,
       "parentTag": "cutr_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance lease"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails",
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": {
     "auth_ref": [
      "r563",
      "r570"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization",
        "terseLabel": "Leased vehicles, accumulated depreciation"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r563",
      "r570",
      "r577"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Finance lease cost"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r574",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r573",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Cloud computing arrangement expected contract renewals"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r270",
      "r271",
      "r274",
      "r275",
      "r602",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r270",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r542",
      "r543",
      "r544",
      "r545"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign currency transaction gains"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r117",
      "r348",
      "r349"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Gain on extinguishment of PPP loan",
        "terseLabel": "Gain on extinguishment of PPP loan"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r263",
      "r265",
      "r589",
      "r608"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r266"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill additions during the year"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r117",
      "r264",
      "r267",
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GranteeStatusAxis": {
     "auth_ref": [
      "r407",
      "r409",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of recipient to whom award is granted.",
        "label": "Grantee Status [Axis]",
        "terseLabel": "Grantee Status [Axis]"
       }
      }
     },
     "localname": "GranteeStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted.",
        "label": "Grantee Status [Domain]",
        "terseLabel": "Grantee Status [Domain]"
       }
      }
     },
     "localname": "GranteeStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r95",
      "r131",
      "r211",
      "r220",
      "r223",
      "r226",
      "r229",
      "r246",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r533"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization": {
     "auth_ref": [
      "r277",
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated amortization of capitalized implementation cost from hosting arrangement that is service contract.",
        "label": "Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, Accumulated Amortization",
        "terseLabel": "Capitalized computing accumulated amortization"
       }
      }
     },
     "localname": "HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization": {
     "auth_ref": [
      "r277",
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of capitalized implementation cost from hosting arrangement that is service contract.",
        "label": "Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, after Accumulated Amortization",
        "terseLabel": "Capitalized computing set-up costs"
       }
      }
     },
     "localname": "HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HostingArrangementServiceContractImplementationCostExpenseAmortization": {
     "auth_ref": [
      "r277",
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for capitalized implementation cost from hosting arrangement that is service contract.",
        "label": "Hosting Arrangement, Service Contract, Implementation Cost, Expense, Amortization",
        "terseLabel": "Capitalized computing amortization expense"
       }
      }
     },
     "localname": "HostingArrangementServiceContractImplementationCostExpenseAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HostingArrangementServiceContractImplementationCostImpairment": {
     "auth_ref": [
      "r277",
      "r283"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss on capitalized implementation cost from hosting arrangement that is service contract.",
        "label": "Hosting Arrangement, Service Contract, Implementation Cost, Impairment",
        "terseLabel": "Capitalized computing impairment loss",
        "verboseLabel": "Impairment of capitalized cloud computing costs"
       }
      }
     },
     "localname": "HostingArrangementServiceContractImplementationCostImpairment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r133",
      "r498"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r87",
      "r211",
      "r220",
      "r223",
      "r226",
      "r229",
      "r607",
      "r615",
      "r619",
      "r634"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r133",
      "r498"
     ],
     "calculation": {
      "http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesIncomeLossBeforeProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r284",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r134",
      "r468",
      "r474",
      "r480",
      "r493",
      "r500",
      "r502",
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r135",
      "r162",
      "r163",
      "r210",
      "r466",
      "r494",
      "r501",
      "r635"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax provision",
        "totalLabel": "Tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r83",
      "r462",
      "r463",
      "r474",
      "r475",
      "r479",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid (refunded) for income taxes, net of (refunds) payments"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Change in deferred tax assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other long-term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Other current assets and prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r169",
      "r170",
      "r171",
      "r177"
     ],
     "calculation": {
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive effect of share-based payment arrangements (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expense [Abstract]",
        "terseLabel": "Interest and other income (expense), net:"
       }
      }
     },
     "localname": "InterestExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r99",
      "r332",
      "r343",
      "r346",
      "r347"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "negatedTerseLabel": "Interest on convertible notes",
        "terseLabel": "Interest on convertible notes"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r111",
      "r114",
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Internal Revenue Service (IRS)"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Demonstration inventories included in finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r34",
      "r258"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r7",
      "r62",
      "r589"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r15",
      "r63",
      "r126",
      "r186",
      "r255",
      "r256",
      "r259",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r36",
      "r258"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r62",
      "r257"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Valuation adjustment for excess and obsolete inventory"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r35",
      "r258"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r576"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorLeasesPolicyTextBlock": {
     "auth_ref": [
      "r579",
      "r581",
      "r582",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.",
        "label": "Lessor, Leases [Policy Text Block]",
        "terseLabel": "Accounting for Leases as a Lessor"
       }
      }
     },
     "localname": "LessorLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r51",
      "r131",
      "r222",
      "r246",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r510",
      "r514",
      "r515",
      "r533",
      "r587",
      "r588"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r31",
      "r131",
      "r246",
      "r533",
      "r589",
      "r612",
      "r628"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r53",
      "r131",
      "r246",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r510",
      "r514",
      "r515",
      "r533",
      "r587",
      "r588",
      "r589"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r49",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Commitment Fee Amount",
        "terseLabel": "Commitment fee amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r49",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r58",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated product liability"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r22",
      "r325",
      "r341",
      "r344",
      "r345",
      "r611",
      "r626"
     ],
     "calculation": {
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Carrying Value"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "PPP loan payable, net of current portion"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r56",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/DebtOutstandingDebtandCarryingValueDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r286",
      "r287",
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Paid, Value",
        "terseLabel": "Arbitration settlement"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r614"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsandRestrictedCashNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r113",
      "r115",
      "r118"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r77",
      "r80",
      "r86",
      "r88",
      "r118",
      "r131",
      "r151",
      "r156",
      "r157",
      "r158",
      "r159",
      "r162",
      "r163",
      "r174",
      "r211",
      "r220",
      "r223",
      "r226",
      "r229",
      "r246",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r529",
      "r533",
      "r616",
      "r631"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r158",
      "r164",
      "r181",
      "r241",
      "r242",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r298",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r489",
      "r490",
      "r491",
      "r492",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r586",
      "r603",
      "r604",
      "r605",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted by the Company"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Non-US"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total interest and other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes Payable, Current",
        "terseLabel": "PPP loan payable"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReduction": {
     "auth_ref": [
      "r122",
      "r123",
      "r124"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of notes retired (or transferred to another entity) in noncash investing or financing transactions.",
        "label": "Notes Reduction",
        "terseLabel": "Gain on extinguishment of PPP loan"
       }
      }
     },
     "localname": "NotesReduction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of countries in which the entity operates as of balance sheet date.",
        "label": "Number of Countries in which Entity Operates",
        "terseLabel": "Number of countries in which entity operates"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r211",
      "r220",
      "r223",
      "r226",
      "r229"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r564"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "auth_ref": [
      "r187",
      "r578",
      "r585"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income",
        "terseLabel": "Operating lease income from equipment rentals"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesOperatingLeaseIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": {
     "auth_ref": [
      "r187",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of income from operating lease.",
        "label": "Operating Lease, Lease Income [Table Text Block]",
        "terseLabel": "Operating Lease, Lease Income"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r561"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total Operating lease liabilities",
        "verboseLabel": "Total Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
      "http://cutera.com/role/CommitmentsandContingenciesMaturitiesofOperatingLeaseLiabilitiesDetails",
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r561"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "negatedLabel": "Operating lease liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails",
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r561"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "negatedLabel": "Operating lease liabilities, net of current portion",
        "terseLabel": "Operating lease liabilities , non-current",
        "verboseLabel": "Operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails",
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r567",
      "r571"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flow"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r560"
     ],
     "calculation": {
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails": {
       "order": 1.0,
       "parentTag": "cutr_LeaseRightOfUseAsset",
       "weight": 1.0
      },
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails",
      "http://cutera.com/role/CommitmentsandContingenciesFinancialStatementInformationDetails",
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r574",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r573",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesLeaseInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforward"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r146",
      "r165",
      "r203",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r52"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Available-for-sale investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax": {
     "auth_ref": [
      "r70",
      "r71"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax",
        "verboseLabel": "Net change in unrealized gain (loss) on available-for-sale investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "auth_ref": [
      "r70",
      "r71",
      "r73"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "totalLabel": "Total change in unrealized gain (loss) on available-for-sale investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r78",
      "r81",
      "r507",
      "r508",
      "r512"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Net change in unrealized gain on available-for-sale investments",
        "totalLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax": {
     "auth_ref": [
      "r73",
      "r75",
      "r76",
      "r244"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax",
        "negatedLabel": "Less: Reclassification adjustment for net losses on investments recognized during the year"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesEffectofAdoptionoftheNewStandardDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForDerivativeInstrumentFinancingActivities": {
     "auth_ref": [
      "r108",
      "r112"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.",
        "label": "Payments for Derivative Instrument, Financing Activities",
        "negatedLabel": "Purchase of capped call",
        "terseLabel": "Purchase of capped call"
       }
      }
     },
     "localname": "PaymentsForDerivativeInstrumentFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Payment of issuance costs of convertible notes",
        "terseLabel": "Payment of issuance costs of convertible notes"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Issuance costs on the public\u00a0offering",
        "terseLabel": "Stock issued, offering cost"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r243"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchase of marketable investments"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Acquisition of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r390",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Defined Contribution Plan"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DefinedContributionPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "PSUs"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r412",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r24",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r9",
      "r40",
      "r41"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Other current assets and prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Other current assets and prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of convertible notes"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from convertible notes, net of unamortized debt issuance costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Gross proceeds from equity offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "verboseLabel": "Loan proceeds"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r105",
      "r443"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from exercise of stock options and employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r101",
      "r102",
      "r243"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from maturities of marketable investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Notes Payable",
        "terseLabel": "Proceeds from PPP loan"
       }
      }
     },
     "localname": "ProceedsFromNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sales of marketable investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Disposal of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Products",
        "verboseLabel": "Total product revenue"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductWarrantiesDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Warranties Disclosures [Abstract]"
       }
      }
     },
     "localname": "ProductWarrantiesDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductWarrantyAccrualClassifiedCurrent": {
     "auth_ref": [
      "r52",
      "r289",
      "r290"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Product Warranty Accrual, Current",
        "terseLabel": "Product warranty"
       }
      }
     },
     "localname": "ProductWarrantyAccrualClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyDisclosureTextBlock": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.",
        "label": "Product Warranty Disclosure [Text Block]",
        "terseLabel": "Product Warranty"
       }
      }
     },
     "localname": "ProductWarrantyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ProductWarranty"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r281",
      "r563",
      "r570"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedLabel": "Less: Accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r65",
      "r282",
      "r570"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r17",
      "r280",
      "r560"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Property, plant, and equipment and finance lease right-of-use asset, before accumulated depreciation and amortization"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r45",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "verboseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails",
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r44",
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r17",
      "r18",
      "r282",
      "r589",
      "r620",
      "r629"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Construction in progress to be depreciated"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r43",
      "r282",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r17",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment",
        "verboseLabel": "Schedule of Property and Equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailTables",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r17",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "verboseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails",
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r92",
      "r254"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r460",
      "r600",
      "r670"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expenditures"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": {
     "auth_ref": [
      "r46",
      "r276",
      "r278",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.",
        "label": "Research, Development, and Computer Software, Policy [Policy Text Block]",
        "terseLabel": "Capitalized Cloud Computing Set-up Cost"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research Tax Credit Carryforward"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r11",
      "r19",
      "r125",
      "r655"
     ],
     "calculation": {
      "http://cutera.com/role/CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      },
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsandRestrictedCashSummaryofCashandCashEquivalentsDetails",
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r363",
      "r451",
      "r589",
      "r627",
      "r647",
      "r652"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r147",
      "r148",
      "r149",
      "r152",
      "r161",
      "r163",
      "r250",
      "r448",
      "r449",
      "r450",
      "r491",
      "r492",
      "r527",
      "r643",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r208",
      "r209",
      "r219",
      "r224",
      "r225",
      "r231",
      "r232",
      "r235",
      "r377",
      "r378",
      "r601"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Total net revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r127",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Deferred revenue balance, amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Deferred revenue balance, recognition period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Deferred revenue balance, percentage"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DeferredRevenueNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Net revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r572",
      "r577"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Assets acquired under finance lease"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r572",
      "r577"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Assets acquired under operating lease"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "auth_ref": [
      "r13",
      "r48"
     ],
     "calculation": {
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales and Excise Tax Payable, Current",
        "terseLabel": "Accrued sales tax"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r198",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived": {
     "auth_ref": [
      "r580"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received",
        "verboseLabel": "Lease receivable"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseRevenue": {
     "auth_ref": [
      "r187",
      "r584"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sales-type lease revenue.",
        "label": "Sales-type Lease, Revenue",
        "terseLabel": "Revenue for sales-type leases"
       }
      }
     },
     "localname": "SalesTypeLeaseRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareAntidilutiveSecuritiesExcludedFromComputationofEarningsPerShareDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments.",
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "terseLabel": "Summary of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CashCashEquivalentsandRestrictedCashTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Cost by Plan"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computation of Basic and Diluted Net Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r168",
      "r172",
      "r175",
      "r177",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r411",
      "r440",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income before Income Tax"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r15",
      "r37",
      "r38",
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r155",
      "r158",
      "r184",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Schedule of Product Warranty Accrual"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ProductWarrantyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r45",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": {
     "auth_ref": [
      "r94",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]",
        "terseLabel": "Schedule of Revenue by Geography"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r412",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r417",
      "r429",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Option, Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r473",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r204",
      "r206",
      "r207",
      "r211",
      "r212",
      "r223",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r234",
      "r235",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information and Revenue by Geography and Products"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProducts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/DeferredRevenueNarrativeDetails",
      "http://cutera.com/role/SegmentInformationandRevenuebyGeographyandProductsSummaryofRevenueDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited(in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Awards granted (in shares)",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding (in shares)",
        "periodStartLabel": "Outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding (in dollars per share)",
        "periodStartLabel": "Outstanding (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant- Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r431"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Grant date fair value of awards vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpensebyDepartmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Additional stock available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Stock reserved for issuance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Additional Disclosures"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r431"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Options cancelled (expired or forfeited) (in shares)",
        "terseLabel": "Options cancelled (expired or forfeited) (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Options cancelled (expired or forfeited) (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average estimated fair value at grant date (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r442"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r419",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance (in dollars per share)",
        "periodStartLabel": "Balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r410",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockbasedCompensationExpenseDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche Two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r412",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]",
        "terseLabel": "Exercise Price Range [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Exercise price, lower range limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Number exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Number outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Exercise price, upper range limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "auth_ref": [
      "r409",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-based Payment Arrangement, Employee [Member]",
        "terseLabel": "Share-based Payment Arrangement, Employee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": {
     "auth_ref": [
      "r407",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-based Payment Arrangement, Nonemployee [Member]",
        "terseLabel": "Share-based Payment Arrangement, Nonemployee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementNonemployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "verboseLabel": "Stock price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding",
        "terseLabel": "Aggregate intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r435",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r442"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Balance"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and expected to vest"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of stock, percent of market value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Exercise price (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseOptionsOutstandingandExercisablePriceRangesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Common stock issued, price (in dollars per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_StandardProductWarrantyAccrual": {
     "auth_ref": [
      "r294"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.",
        "label": "Standard Product Warranty Accrual",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Decrease for Payments",
        "negatedLabel": "Less: Settlements made during the period"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r292"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Add: Accruals for warranties issued during the period"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ProductWarrantySummaryofWarrantiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.",
        "label": "Standard Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Warranty Obligations"
       }
      }
     },
     "localname": "StandardProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r129",
      "r131",
      "r168",
      "r172",
      "r173",
      "r175",
      "r177",
      "r189",
      "r190",
      "r191",
      "r246",
      "r299",
      "r303",
      "r304",
      "r305",
      "r308",
      "r309",
      "r351",
      "r352",
      "r355",
      "r356",
      "r357",
      "r533",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails",
      "http://cutera.com/role/IncomeTaxesNarrativeDetails",
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r60",
      "r84",
      "r85",
      "r86",
      "r147",
      "r148",
      "r149",
      "r152",
      "r161",
      "r163",
      "r188",
      "r250",
      "r357",
      "r363",
      "r448",
      "r449",
      "r450",
      "r491",
      "r492",
      "r527",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r643",
      "r644",
      "r645",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails",
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical",
      "http://cutera.com/role/IncomeTaxesNarrativeDetails",
      "http://cutera.com/role/NetIncomeLossPerShareNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r188",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails",
      "http://cutera.com/role/BalanceSheetDetailPropertyandEquipmentNetDetails",
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical",
      "http://cutera.com/role/IncomeTaxesNarrativeDetails",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseValuationAssumptionsandFairValueofStockOptionandESPPGrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": {
     "auth_ref": [
      "r24",
      "r25",
      "r357",
      "r363",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Ownership Plan",
        "terseLabel": "ESPP stock issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r24",
      "r25",
      "r357",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock for employee purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r24",
      "r25",
      "r357",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock in connection with public offering, net of issuance costs of $2,303 (in shares)",
        "verboseLabel": "Issuance of common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r24",
      "r25",
      "r357",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r24",
      "r25",
      "r357",
      "r363",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised (in shares)",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r24",
      "r25",
      "r357",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock for employee purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r24",
      "r25",
      "r357",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock in connection with public offering, net of issuance\u00a0costs of $2,303"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r357",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of common stock in settlement of restricted and performance stock units, net of shares withheld for employee taxes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r60",
      "r357",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r25",
      "r29",
      "r30",
      "r131",
      "r240",
      "r246",
      "r533",
      "r589"
     ],
     "calculation": {
      "http://cutera.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets",
      "http://cutera.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r590",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "terseLabel": "Summary of Valuation Allowance"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance Sheet Detail"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetail"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r378",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r378",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Transferred over Time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r151",
      "r152",
      "r153",
      "r154",
      "r164",
      "r241",
      "r242",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r298",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r489",
      "r490",
      "r491",
      "r492",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r586",
      "r603",
      "r604",
      "r605",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r461",
      "r470"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r471"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Decreases related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increases related to current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increases related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r192",
      "r193",
      "r195",
      "r196",
      "r200",
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r478"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r143",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "terseLabel": "Deferred tax assets valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r139",
      "r144"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at End of Year",
        "periodStartLabel": "Balance at Beginning of Year"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r142"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r143"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "terseLabel": "Deductions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r143",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r143",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ScheduleIIValuationandQualifyingAccountsSummaryoftheDeferredTaxAssetsValuationAllowanceandAllowanceforDoubtfulAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]",
        "terseLabel": "Vehicles"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/BalanceSheetDetailNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/StockholdersEquityStockPlansandStockbasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r167",
      "r177"
     ],
     "calculation": {
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted average shares of common stock outstanding used in computing net loss per share, diluted (in shares)",
        "verboseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r166",
      "r177"
     ],
     "calculation": {
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares of common stock outstanding used in computing net income (loss) per share, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://cutera.com/role/ConsolidatedStatementsofOperations",
      "http://cutera.com/role/NetIncomeLossPerShareNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3505-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e725-108305"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e765-108305"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=SL77927221-108306"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL49131251-203054"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL49131252-203054"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL49131252-203054"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=118198657&loc=SL118198666-228104"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123377177&loc=d3e11281-110244"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12524-110249"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1),(c)(5)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "http://asc.fasb.org/topic&trid=2155896"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=SL116886442-113899"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4549-113899"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "40",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109244457&loc=d3e16649-113920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.15)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123403335&loc=d3e9972-128506"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123403335&loc=d3e9979-128506"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL77916155-209984"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123420820&loc=SL77919311-209978"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919352-209981"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919391-209981"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL119206284-209981"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL117410129-209981"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r671": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r672": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r673": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r674": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r675": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r676": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r677": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r678": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r679": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r680": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r681": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r682": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r683": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r684": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r685": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r686": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r687": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r688": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r689": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r690": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r691": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r692": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08"
  },
  "r693": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>102
<FILENAME>0001628280-22-004539-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-004539-xbrl.zip
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M[W;ZA]]HG@\[&%XT/_VB_0FO6E-K[9/JZ+1IY_1KUZ7Y,;!IS'A.FQ\/BSV
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M%5'9R"6AD)=@ W=YRXTH@2A"'5DP17H0=.Y.=SSG)(BH\]YZZ(1RG"3QDTX
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MYH*+6@0!&,SF.68=G*0FH*J9&JT9F34^LU\UXJ/RAAH..H&0F@!/&)9ZU+J
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MFL@CE]8$G^N:2BX@$C!! "3J*'=2>5I'>?Q2,%Y MX-H]3OPLF*)G6$^X?D
MT9L_T7BTE=.Q7^$5MQ1#=&057%F0#"P++H)QEJHZ!3-O!OT]M$V]U>A&7U+Y
M%X/^IUB..JX;<X.[DH]\K77L_O*XBE ^#_)<NM]6['<&96LPBL/5XXC=N)!%
M7BTQ@8D8DV$YU9$[XF5DPD>%E%6Q.I7TOLTJN$6$D"F=J_L)2;E!#^6,$QZ)
M5 3E;#+ ZCL1- L(9Y,9I03WEOH8'!%!2ANDT#Y%'V,TAM0I,VKV$,YF&LA&
M-)X2_7*T7%!@UHJJL#)22.H(JU/NTPI>(72ZQSD)8BMZI$>C3ARNG?KN<8CA
M93GHY2'&XU$UPKB1U@#I8W]O^#:6X\&_LYLO<-G-PM%1#,@]NY\/+Z)I5EP[
M'C3Q%'D:Q@W HY8 S,5D.9MLB5,3T[R(0C&;27\T"Z#1W*M(!+,*0%D-+#"%
MA![=0)V,_0(*Q8Q6-W@** U1J;SIMD]&*Z6$M\Y&SKRO50VF^Q2*KP2&"^Y&
M,I>@E(-70F@T$RX%(QA3(#CQH5:K>A=9.&;B3JR6-$%2AE M"!.@%(J'YEX0
MEW,X'MW)7 C'C-P*TREIG7Q,5.098N:M2M% KJP2U:-;&7XC3%W<(F9)1FZ5
M0\J!9D(H-!\R$LI]X%P$Q6M5:V<QQ6(VPU!&^4BU(8)3X4-RFA&NI &6P##I
M'UW)+UE@#7DF,XXCVH&)Y((-8"2QQG,AI=6/3F3XQ6SFKU)M5@3NB!#4AKR#
M6-(V$L-)$,E$F7R]RG,OKFC,IA"<#D&$!"HY(\ $0W@*/ IE%,I!2(_.9 Y$
M8S8.15B%WD-XBLQ3" - J;4^Q+R/='#\T:%\BV<LHAN!$)1 ;J&LUL+E*1*;
M6#">:N7R*M5'-_*+38@;AN* C--YI84";R5$[41B)NK@U..@UNP$8C8N ^F#
MMSQ2$P%#4T- >RE 6V2>-G)5ITU-'T0@?HDU,($'HZ3UDA@J@G5@HR7&DY1+
MN@?&']W&+UB .@:,," F*<$*DZ0+2?,DHPM<.*G)H^OX!<M9&\>L4-I%)94(
M/%D%A$2D%<@NDZ:N!NYC6(Z>7E2R>14'>R4<[7<\="?9$N-%)4_?;RV6C1?2
MR4@2QHK,"6O 6F:59EXDIZ.MQ7XKLT=N)H;880SG24B.(7*YH'6B 0)QFC(M
M8JA#_=69(S<;:YF8=@PH)43G? ('3/F\!ZU!QBV"K@/9OB5RK]\NEK4$%RD$
MP6AD46BMG9<F6<GSIHO2A#H,I,P>N=F,>$CO8_#X-S%"$PI,T!"U"0HC7"KK
M,%P^<^1F8RT]B=8$9Y5%;DF#R%S32!<%."J]"0M@+7,F[LJP ^/0 V.,UW"T
MF%7U3"(*%%56<32CSCGJ8A+"&Y^2!%J'Q51S">9LA@(<5WEG#AZ4$#Q)ZYTQ
M%B,^*45.GET FSH+,&=4LS0J_$\K@P&%P #>!JD-CPF!Y(Q#'28-_P;,?'CM
MN!P<+69!.9KW98S@%>)',9R@T3G/!(:%%#RIPV#MO. W&V-JG4']<IQZ*81B
M& \2BW2',N!$DCK4*IT3_&9C/W6$8*4P/A<(!AH-, ]6:2$9"!6A_O;SHDSG
M1FKOQ^T!7NW"+>9TFIQ9@R</L[]<Z8?%-;72)9N(2$"D$5X1ZQ*AVNED" %F
M:?U-[3Q"/9O5/R TQI@.HQ4O-"<V3VDHSC$$I7EVM/Y6>0ZAGE$*!'@JE/+)
M4I*KA%LN=>(FTB@<\[P.I5HRU&_+03CVHXUR4H3L<KWPLR%*P4*F*CBF)*/6
M:.6\R,$G#08]<M+1&Y&BK(E)GCEXLTEE%BIH1HPDD@MCHR'"LB CIR#!.583
M(SMK\&9C-G.V.4TV*)_7QZH$N4 _0>633*$:UF7J_QO@_0OZX6TG^K@94Z?;
M74C[:214]1&$)T0$;X"C\@&)3#L;0FU&#^8'Q=ELR4ITTB!0^:P6A@:;J)7:
M!\/ <C:>GJRW(7U8%&=$1)U#CTBEHD((E\L,V&"#I$XE"BG599+Y6^[PL-/W
M<.\;>\Q$!UFT!KRW7D8G$EI133TBRD+>N)P&67\=?!CT9C0+$C@GS$F6\H;S
M@MC(T24R8? ?2EA=1O$V\Y80GT==FYU^IW?<6T3BDJ37-G&O<M9;< )X8M$9
M'_,6?$G7)6J_#AB<+BI@W-J\!9LVVD;!B#3<1 ?,YUV]I!O7H:=F'G&Z2!L/
M!\?#43YI^')0MN+)BJ]R;SK]/;2:??SHJ[&V:XG@GUMMC9#%0!F&[X\"]B*^
MKR+L[K'^7!J;FKLKC:T%54ZYD UDKKZ)Y%(! RHXB6!A?N'+>O7BN'?<'>\^
MFE+TH[?5BV^DE3 X^KQSZ:U:7@A!38#32OA(O//26D$2A@<I1*]TDD)$-ME'
M#^WD [+*[^=SE#Q\FK4A*5FK-$JY2#09R;3W##B ")1.$^3%I-^(XF0N)3_;
MGE@>89==VJ:@XG-HQ'JQ7#N-OEK(\N'M2C^\>+EQ_^1<W!I,H@I.[L+YZ&0U
MV, ,AE8<@LWCP]ZB+OB@$S'C32<(GS_K]5C/_XIAS-R%WXUAI(%Z%?)V.)GK
M*PL8:E,TC4:"XBE,-QCE$P;Y*!QS*AS7J2V_-;6](DD_$_J#BH9S&Q(&(CYP
M&T-P)!B,\@,PQ^;?NES,$[_HPG"XD:KU[M>EJ-<;]&^S$+YV$G0OYH4[I6A4
M)G!%10@&"#<6.$.#(QUW-=AWZY>V*O>ROY#7/H'RFJD,%DN6))^"SND&VC//
M'UW.?0C'RTXY'(U;Y,NUR\[>7BP7Q!$=]SMCX0IP=B$KO0C#XS*.^P8/3,^=
M_C[]GD^^>5K0$71<R1%.B8@I0D I!2$H<Q QUGD4U/L0U*V(((1%E=2KJ90&
MA*::8)0M!1 'TGLP&H" (23$^:=,-9*K^[G[9@RQ5XV)C<?(KFW*^<VV?[\'
M_+S0."V\3UR"I#P)=-9&<1(LET*%I-+%1FZ/EO!18NMHARDGC@MO4A!)<!%=
MKC(;E%00F;=$/YP=?D %O^!,Q\. Z*YCZ'OQ=J'S"9_J<LL6RD,)H\&%YDU9
M5&<X$(SJI^^W5K]%L+XX/_^X&ON#7J=_TV4K[>C@,WWKHE?.?W+UT?^.W&'D
M@2%'<D$RE[?>M<83ENOW& !&F9AB3L0<8D[$'1AU(;FS&'2I*NO-"L.D25$[
MSYRFR?H9&/5:6 NOG =&J-/""L:%<0"61R$U90;(--M:$UM,/\RM,^STXT8:
M;Z#\$GRG>[&9\3C7!7_ 5_\ W6X\>P[].QOSNNF.GTL5?QIT/W7Z>U<;W;LK
M?C. _DH_3"J9G:WLE3'>SPSG]9D@71![RYF@RTU_9KF>#MQK C%O[II  U,J
M(J.+-#AN_7A8[E%R'R7WZW[HFC#^S'A@()$KIY+65*1H#04A8DZ4(<(Q[1[M
MZ3Q+Y0<H.X#ARR::HFNU'TMLG7]>( 68O>FVVE#OA2$<U4.#M@PY:X"DB1/(
M1L@T(X.Q8OIA7K7EJWB^A3-\('_XML1HV%?A9YE7;O9>K&RN;:WX!P!6%(S=
M$MC+37]JMQ/FP5,?&&B$5UD2,3:AFEE%#&-FXI,?\?P!3W49HI_P5"Q%@P&C
M=#1:X0,8@]P_2*H$"Y?V4573B&D.LZ'F$:OK(9VZ?4AW1YE1H)VPP02(R#UH
MT%9*'X)A/F@O";@:C6_.R]3Q[./T7,L?3/(0T35"Q#!'>0C6*$4L"7IB4.<Y
M]P")XG%5?GNEVQV<Y"+:0Z0YFW$8RT]Q^.7H]9?M-])J3+%$YM>&TY7A,([N
M8='8%5M[5UD"DB.E,2D7'.4"5'00/4UY7\E("=1B+4K-8)S]Z@@;(_*?*"37
M(*1&_PH\)JN)) 9\DO.?+503J.\EKX?HH&,PFAIF15[VAQZ4!Y=<#(EI7R4
MSN>2O]JB=WWMWT^@AR[1@)*:BD %H\R99#F@[U3*&"'K4)NT9C#.?K4N=QJ[
M'X-.I$8"(QG07BD=HR6*(F.*\[N<J690W\N:IH2FE:*OE(P:88( H8VG#IQ4
M1G%;A\(Q-8-Q]BNTI<#>3SHJSH*@RKB\[)#0A#_1P!A9O)CFHMG+03D9YWT3
M81C?#!#DN@0S,>3*7,AL.=&"JP#<@N$ZF*@$!2D6.)AY:/QF'\4XDG>VCU8D
MKM$H2W 8R43C>5+**>T6+XJ9H8[>7?A" ZJHLEK(: 0J/T*F1$C4>B1&SO/%
M"U]F!]L=QBT>#:D4VB7/<@%+  C<R< S=,8[L<!QRTQ-ZVQV_7(V*>:2)"P)
MH_.^K3+JZ EG/GAC%B]@F:&.WF'9#$[1&>9L.1<$\<0Z;;E.*:%+Y-+8!8Y4
M9JFC#Q"B/.F</BWC<'!<8D>,O^Y'"-7#A\ZG9W_B7],"P\X;C%)XI%H$[FVB
M.D'>"H<(E:3ZF"'_?,YP=-9%<'N=?K$?.WO[HZ>"+6MY-/KCI!-&^T\I(?]G
MJ6KZ[,_A$?2G)_A!=U ^_0>"3U+Z(^%S%@EZG>[9T__;1C2'C58\:6P.>M#_
MO[\/H3\L$+C.I.&P<Q[QPGB/ZNO)Y+Z$_-'M]./T.2@C_^>/_/9%B'Y05L+P
M]+B/[YQ;X3/!W#Q+8[^,Z:^E?_Q]Y^NE9^V<Q=,8I,:+#&Y_-/SS"2 BN7.G
MP'P!3W5KZ';V^D]]S!4VEKZ*!C[Y7?2 OJ$'EIXUWK?6VVNKC:WV2GMMZ^I#
MS^'C;JV]>+^YWEY?VVJLM%8;:_]^\:^5UJNUQHN-9G-]:VM]HS7WK[ -P_U.
M?V\TZ/_>6%U^L=Q@1 K[78\]J@1NTL -2I3: A^_"T?#^'3ZX8_0&1YUX0S=
M3_40U4E_]*#<0\O@!J/1H/<T6X5J:MM#=W*3ZG[CPY\-QC(9&XT16J=1F-YY
M<GBY.O1D%+X\9LVR)5\_3);IQ;$GU;7+:8-)E_&CT5)U'KY5[J"_EOC2M1>?
MO H]&C6&@VXG-#*$?QQ!R)7HGY(&K2[Q^1Y/JHZXR6)>Z1J&73,O(O-R8[/9
M^!,]1'_0KY:#='QCXD@VLYGJ&$Z,U8$$,$$88UV$JHZRXT%RZ<Q-HR2-/F02
M$&+GZ>K 5SD/V0DO3?=P_W#F5@>?WK#-3SN\>1P.UC[MOK('&[W-_9U>4[38
M^],F_FF=;QXV65/N'JSQW=X:VVCOG#=7W['=@_?L#6]U=\Z/#G>V7Q]LK(9N
ML]W"/Y[LKK8.-K9W3EML=[]U<,B:YRNDU=NAK:XY?<-VSW:VO=K8;AWNKG[8
MQ_:G&]OO9&MU1>X<[)TUV^NLN=T\:QTT1?-@]Z#Y:N=3>/5!A'^][NZR[B=W
M,) [;/.PM;V&S[8F=U</27.UV]E873]M'NR<[ISC^>=[9ZU>\V2W:\Y;Y^OR
MH]16,B]B835GA0A$%?B#*Z1-EH9 "->P](R2XG\J/_T9A6=?5=N),(T&1Y62
MS5Z+K5TVDB^\$L^^HW_"7%*R+#B[54]_SS&D?]3^T)G?>EC-EBT5=W[9J@_D
M]TC;UT3K1NGY=E-V=)H;?ZFNUV$?(WY[=["-5\]W&/XP7QU+U/W[@)5^_QBZ
MF_%H4(Z6&FE0]F"$5\?^P!@1WWO0=8"1V<@-3FOI*EYVW*OW"EU"=_=@CS:W
M7W=V#E;PG,/3?$YK]4.G>;!^MM%>$3OGW8.-5^\FYWS >\G^;GMPLK']H;>Q
M^OYTI_>ZTT3WLM%^F=T+:6VOG^&YLKFZC\_<%+LOS<F;]MJHN45.W[371>M@
M_?1C,-)&RUWA&3,%XN0*PP,I*$V)>"L-!W0U__T/JX7ZXZO>9H:2?*?$9BQL
MC;&T-=X>E\-CZ(\:HT%C:YQ!VZ"\,2@;5/X6_IDCK-%^;$P6*W3P,=9._7ZN
M@-M8\:-\F%HNOJ.3OI\<9G]>O=N7_5K]TNGGD9*GS"XS65UZ)G01>RQUAHAQ
MXRQ"V8CX4.$A^.-XJ?O:> 3DBO%XF@O6%CV\YWX^K0AP5N1G*V*_EE;DQPGG
MQNH[O,[A2>M\Y;1Y[L5''@,% Q;M -&%4)05#B@ODG,J)4&8H^Q>+?^+X[)$
M\%Y6$K.#H-P6P$?LHO T!2\+AV%"(8@CA6$"__(N0*+1L9B6GJU&/QX5S:.$
M5RWZ[XV,R(]$%3?&IS,Q0C<-K2T]&Y2_0FR4V:I2]\'8F;E[QLZ7C>)W?EF[
M+,3MKOH@A+T;TY>0#XX6D:NW2WR^3N9)"\_7MYND]6KM)//RUOD>GK/&F[V7
M!SMHC7=?O<?GVD7>CKR\O7:=KZ,5?T=VVBO(R_?X1K;P;8_'6IV-]O/#W7;S
MI-5;/VMM[\CFAQOXNH.\LE#)@D"2A6! "J Q%50$Y37/>2EFPM?%XO/USP*W
M$)Q]AOP\=\KH<V^.9PD;J1ST&A_QO]R=^=^YG\W(97T[PSS3BR$'NNS^<68Z
M3^\SVEBK)G%?XMU:U<UJ:=9^:L2:?(R<@.-1%M;R5 BG0N&\0=L4&$TR&44U
MJR;R"TF4$#]$,!]$9=CMQ.S>Q6DS[G6&62%'>9>#7TZDFB<?B0K&:PB%Q%Y$
MD:(8QFA@!7/,B4"]CD:COK]OKVVN_-Y8;[U8OK54/;RQNCDF^6WM%-#I9.RS
MYRDO,&_ L#$\BCZGN(1&I]_HC(8-=%,E/NL_;QG'U&JB02Q;\V.AR;<NR]0R
MXW<_T\#(,K=W_[34+'-Q#Q,88EF*.YG F$A0Q5^N3(Q]=6[L)ZY3#P)Z[WY@
MO>\'Y=$D(:C:UJ#: :<\>S$(\<OX:IA;')6#3_DZ-1T/&T=8.^<OL?WZZ4[[
M.?Z[<MYZ]?(0(RZRN]T\V=E>/]L]>'G8?/5AO\6NSX@<'331SS0/\/Q7^.]J
MD^QLYXAK$Y__^?[.P>M><_O=R>XVON.5&9$FON][\E'S0)/RL6!1D$(0Q@NP
MD"M4@-/2(I$A)(^A=>$$RO@#(=:C&CV\&K7A='V2,^HK5:HQ57]H_6A>'8&@
M@DDC32BXC:H0WD !CD(AD-=;Z@EP+9:>:5T081E3[$$T9(93[]\UEG>G6O-;
MY0_RV,8 P_>R<7!<=H:A,Q[T&*0_7?GD6>>R_ZB:EGO0[YQ7W__YH^,<]>^Z
M]>7-Y:WEQEKOJ#LXBV755U<M1*,U6/[A#JKG0-"]F^&5$,HX'$[^R346:2U-
M\$^-EM"/'(1)8'GAF$3#Z9,H 'Q5%%/0&((RTB\]XTR0QG,X&^X/RMAXWOT4
MOHAP?[__<:T)5B_PXT;9'IS4DU/^%&#LHP$/!%0JI%6R$$+[P@;B"O1VP5H6
MC15AZ=ES-+\.^E]PPH=#J7((&^5;# #0\"]H?'!7\^7O^4>>(C$Z^0()3"@$
M(Z)PRH="4E!1.H:*BHKX DTS=F2_ ]>1?3!@WPX0N>YNYV@<]OU2J*$&(E)1
M@/3,%IY36@B(B%2*%.&BR1AG4HIFZ9D5A,@Y'@;\"AF9@)S' (]*5-S.$70;
M<;J1+?Z,G"0.;S7P-U=\XK?[S!+*RE%&^"458DU\),'P%%0LJ*2Q$,9&5 AN
M,0R3"21UB"PL/1/T"W7XYWT:K3<#9/=O]P?]7W4N;$U^-):0($@H7$B(!_.N
M ))D$:C2D5FJN7=+SY34A92$U,]:?9Z:^N]_&$;U'\/&*';C449],M_Z>P.M
M6/<XQT4-0"5%&0MQGNW7S?,SE[($QG,SL8RA<713B@'[S5TD%ZSXT=-YG:2Q
M=ED3_2-S-)PO*WF[93??-9E"ESF_^UD/09<UO5TBW"W'CN9J5.-F>6UW1N.%
MOQ'\?L/GO8_O(^5GAB]80F53MLYZ;M#];?@]XS,U>+W69"*X@B].\Y+0O)SL
M=_"7SS;HRFLOCOS>(S&9[BA!F:NTI);$9#SRO]%^3UNOUNGNZOO3W7S.J[7S
M5F^--]O[W=W5-=%D[TAK>_=P]\!?SSV4K?9[LG/PX;#5?MG-9&:GW60[^=ZO
M/APVVWOGNZOOZ&YOL]>B^(SME:LC_UQ:'4$QC)8)4DYG0V&X406E2@FTMB9$
M]PCBG(,HI1)<$5,DSA%$\*EP-OK"JQ0 <<V+P<9I=&AWMD8#?]CX[7_GQ [:
M.(*R\0FZQYG)72>M]Y]HNI!F:>+0QO[L49QO(<[7\J&)#%)ZD(5W7A="4EV8
M_)?+*%# 7]4X2VSS449_TNI.$Z7'"8G71Y8S7:GQH/)#B_'ZI:23=_*CCY*8
M9- ,^\#R:$XHP#E1R!"\E 1MM9%(?S&X;*ULK:Z\FUCF)I2'<?1[X\V;%]\4
M[WF?CKR#\'OO2OC=: WR/,SWC#=,5JG9F:U06^^'//4<&^ZL46W<T\#G/&QT
MQF]U*3FT,VQ XR1VN\5A?W""SQEAB*\;\,#P. ^^P+ 18NKTQ[FCF\<8% HB
M;UC[@%VUW-C!#].N>K E2=4;__<_D#3^\9WWOMMR4P]S\P>WV>/)HVV4D?_)
M(K(UD9#U2D!J::!_:O[HY&.DTGEI9)&,<X6(S!3.255 <HIPK9W1 0/PP9<S
M?#/1C-,%MEW]P0A_^<]Q)UMS-.+5.IVR6KXUO-FZ5^NW+KY=7L?U"QFPFY_@
M_F>@/PRZQ_T1E-4*IW+XZQF/TX\LB@B>Q"(E@NP,N[$ PDT1?*[$J,%RHA^-
MQUT;CY/]6*4U7K,@O]%_-O:1X62S$1K0[5[8CLM&Q<5) [SFCZ\#;00\VM^K
MFAZ5T<=J])FR1E5X8MCX+5<VP3_#8[_?R'E:2%&G:R='^S"Z_NPG,/S2]%4G
M3][AGTC>^J'Q&QN_H\-P"H^[ WR#W+YJBB?EIYA<)Z^['E8/43TD#$<-2QH!
MSH;+]V\;)J4ZQFMO\SC&"$;'OZ")./NHO:3,*EX0P6(A$J3"$HMT@Q'J$Z.>
M&;?T##W5O-F(F3BMUF N'/9"VL=L-]!D]#JC$1J9V$7340[Z>9"J>_9[(WZ*
MY5EC/4?UX*OLHE480>/EF(-=L9^?+W*9E%V.)C?CWG%WG"R]5;0;O^7>U7\P
MSI8OPLU.M6[Q**];O&]C.G[>"QL9A_]\  MXJ2=S1TX,XJ]G <^K2G*4>U%8
M;M$":HL6D+E0D, A1DJ8L>31 CY:P/NW@-7X6!=?)#; >[2 )60KEFU"'ASK
MW_@KAJ7]XH8#PQX:3KQ'.>4X:$1ZV 5H2]%6X<60@>4NVVOLE8.3T?[T\#)R
MRU@]63445Y75J#(\<](4PY?\RO-5A^D?TV9_V^#KSS=MF GEI/%7GG7:<CI8
M2)DKV)0B7^;%R]]50^N*V-1G+;I<UO0^BMXR<[M5V-_UL'19JQ^[[ P>5BZC
MCZC+P]IEKO0O_[#VNPIMSZ(\VNT<C9V/$?EJ#.T%6O.]07EVPR1JU:BR\W[2
MJ-;SJ;OM_0X^$S[+#JM*$J]N=G;8:WR^=V>[JR\/6NWWHM7>(<TORAH?=3=>
MK9_OMKN]UL$.7O<=:;UZ?;#3>W>^NXKG;S=IJ[U'6P?O3L:+E*=9+DW9/&^2
MCTIP*2E1!=-YQ,X'65@A4F$X:"(Q'*=!+#U[<[,/OMM,@;D2\(M"S@OS1BO7
MT6LLT,M=U/%;F#=JW<2R%^C]%@^QK:\%& OTCO?N]ZM.?'X\Q#L/AXM;%O7A
M_+V_5A:5*$F]X85T,A9">5T8E7(:( U*41>E(?=4%G6N!'GMY@!_@=[PWE5U
MVH6OJAY\,>[ 1Y7]>94]O*JR47--@*E"0LPJ&TQA7.*%HLG1E PH K=3V1_.
M;CPX'HXZZ6Q>!CG3-X83\XK*6Z;8Y F@:MH'Z57.M1D-&L?#\5 DON=X\XT;
M2OT.RNI>W;-\\Y,.WAIOV^CCNPVR\__4&59TK0]]WX%NCIIR(;K<..\F&Z ,
MPT:N+-$)7TO2Y+_!/[\YJO@X$GX/<X&3/(D)?\NKR?* ,(Q&,1<#R< @1KF^
M*#X;[%7Y!!?K>B%O;3O,/TUQBRG%:K:K/RE8D,_LY$FP/@I%ML;EH-L8H+>X
M)"N?J6.UH^F%1 @B+BV;W8(R5T\9%ANGW7A6I6'\1F7C_?)6WI52,Y77V/XS
MO_CGMYQD!+LNNH)+$IDZ96\\9WB$]X;<"(6X2H\-U1/#<>B,)L\URP2R>_1F
MZSZ5*_DU!^7*9[!?=F'OZD8JJ7,:0S$JC^NYG.JNJL$<LH_4&4C!0$%52H5@
M1A8V0B@\D39)1V)@HIHWO-D7/<XCUMUZ7I]#'.[';G?J@1N_W9!6?V6F#"W6
M/R?&Y-[CR?QD-W'3B3HGZ Y_-7UNG:^+CU9;9)%1%M1&6P@)H@!K1$%2\EPD
M:2A)7V65L].F[TS9G$?ZFA<GP=X>ZE!6L%ZU,FF\7'2J'^67A4/\>)WI,*]F
M^KV!0ETE;%93\2GG.>*EAE^>GA>XX(^OC_NQP<EXSZK&;^-%\JBXN7$W)T*Z
MR8!+3H>\6F#]X@%Z@V'F 7F=4_=L3(!C)LX8X@WZ8;IMW7^.QZ77&PXR"SX^
MRJP)[^*[@V'F&T<H/=5KCG.7JK59DR:3]5JON@.,%I'Y9&(^6;>5FUQYA]^K
MG"8X0AI]VD&-COA(_WMB2UY6649XQG&_,[8DQ\.P=-6T4&:(\L&P2)/P,8+7
M,GE&O$6;PRGYN%Z9%L7)$EHRC[?H#O]:*M27]N5M1:E>=@=P=1.?I_WC7A$&
MU2[U^?2E1NX?/%7]6L;F;&-UCW]4BMGDO2FHB_^?O2_MCMO&TOXK/.ZW>YSN
M4D4E:_$RT^?(6Z)N._983GIZOLQ!D:@J1"R" 4E)E5__W@4 P5ID*;%3+ OG
MS*0MB0MX<7'W^]Q#$#;C)WM/'D\.]K+QZ'B4GJ3'C[)'#_Y^\N38"1JWB:0]
M]Y_!*<SAIUM55?1(B^))9YP?8OD9V->5+0>\Z7P[^QO=#]W4Y#420!#=_%J.
M#9RR!5/FX(!.Q $=B(TG@%^]= B.)U(<C$=/CH^SR>&3=") IXY/,O'DB3@\
M.A@).@3X?P?A(3C[X?6:\F9:/;5:GM.KWK7+_L2QN$^'81E7\?#_LB,0.@?[
M)WO[^^EH[W"R+_8>'XGCO?W1HR>3\23+Y,G^@[^/'@_VC_<'!\>CE?-QQR/1
M UBLE^]>_/CVU0\?SW$4R;L/[]]]./WXZF7R_-_)AU>O7WUX]<.+5[?]IJ^O
MA=P-B*O:<08R>[Z 9X,#7Z3R([SH>0['[%X?G(M'_P>&B#S(QG+O\/!QMG<H
M'QWLB</L8._X4!Z/Q!/QY.0D?9!(4+HED):<]K^_!]LD.3L[2UJL;V *,*.,
M(V^22E,+'"-3L-"B\5@XVVN#6>9*%B^Q4EM?+Q+"C:4XD.LT(>ELYR6_E9+"
M+B#&25C.=)Y)4PTL;M$5J+FV(8="BTN]-Z@2?$0P&.&%X<M<U!38$MCFS9TM
MB9C@[X(YIFP_W7$"D%6DQ\.3=BSIWPD)?.-]]L <'M ]STK-0=2G1F(=_*5L
MRP_Q0 4WVN+%_?86,:YTWM2KMVQ>2/A??#:?%3%.'V,?FAR='&:/TB>3T<E$
M'#\!*^_P>')T_'\G#]P],]-F>Z9R;VRDN-@C6CX5^140]L&W7;D$0FGIB]<O
M=HVHFDR^F*ABF0^JUL+:/Z6H(EX%:Q*]64LR,R@[_W2K'?I(Y;%P@%Z@V 5)
M^9_?BK6[OP.J\./I\S>ODG>ODQ?O?OB(*O'K T-\,CS>__R3:Q_O#P\//C\6
MXO'P^&1; W&_FK$1)/'>@]C\3-A[ZY+J?@;/'R!8UQW=;0G6.Z[E]H)U!.[W
M^],/']FI/%LC4S\+!__F>35+9L7HD(7@%@[?;YFF<Z=2D9M8^LNZ->L8]PN^
M<85QP1Z]$\\>/_C[&1C;S+-HT_X&IOUL6Q/-N+OMG*OQ^T-VK>/-;!>P:_\/
M/VK[G^>H'6[8J:]%!N[FQCSIR,#3+RH$_TBKZW[(0=B]#ZJZX-U[+=):FR@0
M=^7<'1Q$B=B_G3DXZ$C$YU$B;G\M=]N]'PLCP3.\E!GOX7DM)A/^)T:\-\3\
MHHSLXTD\.HHRLH<[<Q3*R(,H(K>_EKMMWGNC2R2SC))P5\[;T7&4A#W<F<>A
M)'P4)>'VUW*WS7LCIR+GW0.AF$K"RHM2<5?.7I2*?=R91Z-0*AY&J;C]M=QM
M\]["+=9Y%A-9VUKAEZK".OS&1+-Q9X[AIP3D<F+\Z&M,C,=RC\\M(PX[Y1Y?
MK-[C+B4=7R7G1L/C;GQY$AH>1]'PV/Y:[K9YW*_'VS?1AO^QVN[41O-UP?]^
M]4NC:H3BY1NPEMV'_WVA//_B+4(R&/L,4=C+>&*3]00;D\Y$)>TU>A*^PS[5
MU]1'4VA'!,/12?05^[<SA_NAR#Z.(GO[:[G;YGV0\/Y+')4>Y>!.G+:C)U$.
M]G!G'H5R\"3*P>VOY6Z;]W8%U:N-FC749;ED<9X6(E]4:LG(?.W O)R-6V34
MQKAT,TC=)J^7[GU72OZ(:)3NRI$_WH_"N'\[<](Q2D]B670/UG*WW?MO!,54
M-?6*+XE.^%/>^4N0U["2>:R;V@4+VH $EEI'P;HCQ_=D% 5K#W>F8^4^CG)U
M^VNYV^8MF:?G#JYD.9QZWI1E3G_Q4%,XMC&*SQTYI">/HOCLW\[ ,0KEYY,H
M/[>_ECONW@O"7K+B4BV[]6"*BJF1H4A%&"=KEC+NMO!_<E&!4P_(O?2X)6G=
M&KI1#N_*:1^-HB3NY=YT+-DG,430@[7<<?L0 <S WBP)3:H#SV*5XRZ=Q"@E
M>[HW'8R=)U]Q-_4Z:FU+2MZ\ECMNWSN<V&!KI%I4TR@:=^7XC49_#/*./WW;
MV!F4,<F3%RV:=10J?14JCPZ>/#YZ=/CX\1$\\L'?6Y\48>V%(:3ZU]K 6W%H
M@U%5I@BJO.(Y4^^-O$1XY+.B*GFZ5333OAY9="^*^F,[RF?WYIYT^U%B0TIL
M2.F'U#OIPDGM?[T.T%<9)L+M>ZF,)&0]VUWRZEJF35L]\FXR4>EJ/\D+-R&"
M?_P.)W5B,#Z&WG?FW/Y1GE.4J7?<FP[\U.C+(C='F?K992ILWY(,Q0&;LJAB
M9&FGSF"4CSW=FPXHU2CB\_5@+7?</MM>;"OGWET58&#.5-EM]WC!P\;XA^>R
MD&"(^EH/OF?)* U[5);:26[1,1TE\ZZ<_M$HXJ;V<6\>=X"Q1A$OL =KN>/V
M=80NB4U,08!L7I:U'9'ZT<#2>>2J"R,$-7\<7W YUDR"+9S)&"K8H4,=!6Y/
M]^:P(W"_8BC"KS%53-OWWJ@B5:6S:Y=KG5]+N=)[(LVE2F/YWNX<T4^*SWN1
M6XMYX<]NL)UT\L(_Q;1P3 OW0N@]Z?1QC2)280_6<L?M>W4]4V-5.W=N4V.L
M_3&=R:S)HTVR.\=S-(K8\KW<FT[CU2@B!O9@+7?<OM?:^(*H?SJ\@/E<F$44
MC[MR!$>C&V$$OZW%.)?N]_[T_/T_Q^;;I9N"';&+/#P8GH"9_*S4%6&?/344
M9[V4SZY45L\<V8(;^9P^W6]O$>-*YTV]^98>[#Z-33]8(F'P7URMRO[KP2VV
M9/^!NVEFVO,QE7MC(\7%GIC !SX5^9585 ^^[=!AKHJ]);HODRQ*OL^!GO+@
M[Q_Q3"1ZDF#GZ88YE-WS\@68D9[X5-7 ^NDGW7"0U>\^_.OTP\N]-^_>_?/L
MA^^2\X^G'U^]??7#Q_.-IQ@$^128"N0MO79+Y^KC3%7):5$T(D\^R%*;.M$%
M=I;,D]'^WC]!H128R*D2A&L\(+CQ*V&RO5SK"^Q!J0)H&[A@](S[3U1QB;-%
M$Z.JBRH1198T1<HY(40#'R8?9S+!>B91+!P09"+2&I=A&+017MWD69*IR42:
M9 ZO,> WY(MD8O0<WJ(K"7\DU$B9P0OA5S+9O#Q^9?NS^S)W+Y#!\/?3!P@C
MDT+72=F 5%TD\.=:&U23])?-KTD0B,(N9BY%@7\%5C[G)ISDX.04?\2_MMCH
MR6E:$XW\5:-7:ZYZ=9T2*@9=#G\&!7,X2 30;8Z9L&R0:$/WA!<.<2\WK14_
M18/,*T!^PB_41 $UQ@MZ2%/1&;S2)JN2JDEG\*9!,FYJ(DNNYJJ&BVL]<)R!
M2'(8@:[EP+&"_<M8YDI>KOPZ%<7*KS3&K)O52Y$5EG\IJUK-U[QNCNR]<O$U
M]D$M_U:A@%EY\%PLEG]5YJN++8W^><TS*RDO5GXW6_<!B-9?R^G*RVJ0#'+E
MN5<JSU=^AX]UOX/=OQ1P1K@-C/D'-A'.S9R/8 6;E@N3 "W@C%64974\4\@I
MV0[+]\&?U]R6,.&( 1SO+&X\?)_@PD*F\&A8/9RUL< ##<? ;3"O7E15,R_;
M'K=!<C53H"B 9RI8@H%[0(E7NB#U8;G8BAAZ@()WS7UI3_L:N$Z9Y*+05[G,
MX-2PM((GPAJ+S!Y@?-BXJ4!>5+P<560-;.!B0.M7Q0Q64-2P?"_H/OG153-&
M!D(:DIP<=(4DO49C7W&BYBB9X(0E$QY?ST**)60J\*PN"4^\%]<,%+1?8)^<
M4&-@A2_=(%HG38U]ANY)=MN15K20W H)D@DW;OFFI<)S\* ;!=)$XD+H4;P:
M3.@C>Z5YDTF6-TX4AS*'Q7\HM62NK^Q7K]4,E96MM:IAF]T!0K!*MU!WCNS+
M+1,D[P7HA+-!0LVSHU-^$WQ=8W!KYMK ,C]!BZ0JP;P$7@,2"W<TDPS^S/_V
MNF>(LEN6-5YEY"^-,DSK7%P-.OQ,2ZO%!="JT(D>@X$N^/-TTI3T9+SLAB4A
MT\E)COQG.0*W19FTF2/?XRZ0.=Q9*GUGL,>]-VY05>>P7_CQF8>89GEB@:43
M%LZPKR@_B%^ .W^&HT@$17W.UP,;_H*@J,1ORLD-Y$ CZP5N$Q"4.1BI2W3S
MKZQ:MH);'2_M)2$#6AX[@5^OPF0G+4)V\A<Q+Y\E#AD;-\;'51,/A4V+M@#8
M>$D+>SV@/\F\DE<HM;S]L]D,[/M&GWWR"U"VYBB[<5M0^H"OPL+U2E72'38@
MC=_#RFVB%17VZ"VKX!<@PXQ84<PK5DGCY0L2WVGZ52O8747KH#78-R1G1;IY
M'^YC3.#19XD)/(HQ@5V+"5! 8$>_Y.9XQ@:Q&@9M?P:S$ZSM+W[FU@<ZL$X@
M.5L50[<\;,</=NECSSZ^>NL^=1L"+OEC7K[^XT=#SCFL_O?YC^=G/[PZOW5H
M:QL;^MOMA!OU>J"P;Z/R![]!YR^K?.^[HJ.K<X6V>(:^(WB]"CQF>7LSO#\G
MR_DQST5Z,34:9&F?OV$],_$F)5?@JR'@%UOVHR>/'U-,+GD)EM<5.@VI[7%W
M-KG"OTYS/08.+(V^Q. %JK9<P$+8-"^DF2[V.$(A9 4L4ZLTJ185^ ?T-K@1
MZ^3QF6@E7FF39V![R$Y@-<ED!60"HS8#%R_7)?P+OKK!&$)#QFZ&$R/)#;=.
MP9P&.53@:\-WKJX%EILUX#&68%3B-_-:T*<'[Z><@3<"/D@11BY:CZF[XH>P
M2^A\@FF:+P9M2"VXQIZ*;P:P!E#_Z,+!(^=X/C0%+BHQX6B-A!_I40&Q:K#>
M:N_JLJ\&_A/8NO#H(9RL!/.B^*JN9QV0!&4%.,^E,.#>!82#TP?>=(I[:PG2
M#6C#>XP-!M%"JT2*:@$<O(>4<K=T E"!FWHA%RU]GWYI%; QS[&>YV5!G"&Q
ML^/D\!ENC?U%<O[!_NYKUIAW)==U*G,F2_+]!Z!6\/-/2S_^+1*N74YMFO.T
MR<O:4D>]A%.Z]+M)+J\CS=KEG,O4R#IY_^'=-HDRZ"=5/KSN@W1"9=4O\EQ+
MS839*EW($#YX!GHRG5'6<:;@'Z3VX2UW,BQ V9?2H/*\V3XH/7[UP(9FR<!P
M5@,9-F.=+2A8J!L#?QV0WJ?$B %3 *_'IQMY2>3^55AK0M2UQNCZ7%^*?.#^
M@=\UE@4"-I9JBN^ M</G<43V4E0@VP1E1M@L@5_.!!@M_CF4W-! %)4GDZ:8
M-AO2Z*UQAA8*VX"<J1M+M$0PQ]:44R-L_@[L(&\+87Z[+(%U;!81WSG#_Y0*
M,W0#NS/6;"41K,8J5S7E&I(UODUK=*%9#!<L,*-DTU/*&;+IIIH 74PU$AJ(
M+H5).11OS5G:)[S[DA/DI5%S3B%.-+P532M[)3ZA %[UMA?9X7/Z#+N+LIAA
M!)V-S%6:@I\()II"TQ/6#S8B7KG>^A-YI?$;X>S HC!NB%1N/WKUX=:J)F,1
MGHMD I]H"A^;UXB'Q:QK#";UVRH#>Q!2>IK"S;%I^M:&)9<CN*^[4(7 [O!F
MV3>AY&7V=A692":&NY$Q5O ZF:O4@)"1&?DBP%K ML3V5BQTQ0#\ZA_@,PBS
M2 [V1X_[IA=#PWVKLA_H= HG-^\EE;S-"1;HMJGTCR;O*2NA&P,.S+8)]%J.
MC3MO3WIH:WEFBDZ+7PY:$-OFFW\TA22>&22M#Q6<N(-]-KZ$U]3R&@0GI>+)
M'&#V3S*R$FTX!\M#T$@U-4?W\#$4=H)_C#H1IU8-]VMK6H>;[+RM'F]4QJUM
M/M=@>U)948;[17$T*G;R5]3P<JYF G/6Z&NJ(X/-/#P"+5YP<$\G(_]3KT/H
MFXM;EBW)&HUZC.'Z<I.GR8-^<15'S;?O<PX>](TRIVG:?%1E<K2_;V,57WJ!
MNZ0H?!6.SK_+P?>T)+))@DBHC82*I%D7CH^,LXEQEE,\D5";"(7<%,GBE_/]
MA\@QD6/N0I:?(L-$AKD3P_PM<LS-'/,&WO(&?]TE5/+@[>*_G5?AJFW>2V&B
M.?0)@KX_>_$N^4X6LE)5I-4G:&7TO\2E3$Y.]B.I;B;5N<Y]&"12:1.5/L(-
M2WZ(+Z/M5@-%&FZBX1=/81T/CW[3"M<T*6&4=>\1/6\98DA4DEM8/G[IDOP[
MDCERWJ<Y[XME>2+O$>\]:/-6D1TWJERB4:2+7XZOB8PLL[P<47SI9.PN4<,>
M(%\K.NP#PZS+?^9ZJH,:44J')H688W%<FQOE;'[%^.<)ITM%68(WC.E[UPV?
MZ;3A"D,C-Y7ME: H%L/DW>]_VPT03.[][GT6/X)*0WFZ-\*VT""C88)^1<[%
MF*DN+F6AL)=]L/8#@FPQE2:VZ^=.-&/Q76ZQ1/H>JDK436V[YJE('ZOC%O.Q
MSBUX$*-S!$WV#MVC@RA39%B!*JF(#DLDKL1BP G_L' "$7'H7E$!>>N!:]B?
M-'DN*UNE45L8#UO6BFW$RV@:GB &^:O%Q*$?'5I'>#]L9%%I8]^'6#D;*;F#
MA06G6#.<&D58.U3@8JNRUY&,JR M0D]2,3ZENW@B!36:;;J9"W872Q7+U$^'
MW5#5TUL3SX)<[B&BY=/1XSZ1DV3E\9>6E1LE^EK8^"ZY#H>$MMZ/_A'N!0 _
MGTNE]KO=>5Q%+;DAME/FW.*EN0(N9LUA^"O/D/65IB)V";)-IK,"/FZ*)>3N
MY2O5OLC?037PBR]#H\"=N;OS,AH>CFYR7@ZVN:V=;8 =R^'>*E+T]QR4H/)\
MJ2%%9$H#;>4O#>C8Q1(GXVV9E"7\Q\P),0S+Z?!/W!U0"F4<Z%EX-&S/1[7<
M;X.ZT;: H#X4"CZ?54:WF4; DVM%W0NHW^%9:$W0!X"EDDI3@/GR(R-VN3]C
M!ZUA1*;Y6!7<0TV=.:C?P=2 WTO;#3%7A<+OR< 4PO*_8?**%H&5@*)M]\'V
M:]L@A)")9%BY_J)D#IJ"VID%M8M@YPLUOL!32@L@*7*'D8>87;E(I2TX+#UB
M&FT)]@!SXPH(F4;>W@[8KBJ[DQ[9(>5VOVNOUV_>UFNO U4?U&"OKXVV!;YA
M1-&WG,&Q37.Y5]&?\- QC &>6-6V5Q'NPECI/8G  PSFRG<F"#39\)!"U]<3
M]LV!F2&+*;RI&"03!4X/M^(5TDJ_#*100?X-SH1UX(OPI=;Y2X&V) Q;$8@0
ML^"]3%1-B)(Y]JG9]JRECT39?(F2]BT(%[7'<Q!QH>?!HDD"PHT(CV1T/B!X
M2E((]@MG"_0=P8.<,1@F_0SBJU)BF/Q#S\ ;35ZJ*?).\KT4>3TC?(,W=39,
M'JYMZ\,W@2((@!%(:YBI*&P/U#<H!B4L/DN.1OL/+[Y)8"7"(+B@ _&5R8\%
M@3K2)) J>6A##3\.SUV0X1OP,W5&BWYIFFERFJ&D)^Q4_')WQ^N7I_X&Y O[
MW;Z=TCK;P&*/ALD9<4.E<P\/^>/YZ2!Y(0J1B4'R#P&?.O"(F:= I.0]Z->)
M2AU"QL C;+YJT"^''88O"=;SZD>_' OZP1"TOA.3WH[ME\G8:($N*KK AI4<
M[(+KFR2<B*0I==%"0AHYQ9W7X#M1??NE<,S3K\#1_9:ZO>UXH<X E(8(*=3,
M*:@1V#H89T%SL;*<^L#(B<ISF3VPD*#@Z(,E7S3S,?>V!%@K!(K2FE=L$MFS
MMVH4N7Z8@85EC TQN]<0$T,OO]\ZO;]U?NLMTRWWD@9V::>G]$;;M%^RZOYR
MU*;*T6U+:PPHJ-IB,+L00K^(%)EFB6FV2@L/">/2(^!<@8=64%@L$#[LU8R&
M/2/>J\A,O9) %/[ H,2>M<\%)88]EZ&7N@&?*+ C/2]&)/* NH>;D<@CJ'AO
MH;CO.ZAXCSTWA,]2J4((51^(]=%>BL#AOE$&JZ8$565!O3"D25BYC9E*7?0R
M*A;-K#YIQF0FJN1H_\\)CO))2GU%,V]@'5AB4!J9T6@JS0K2)T%%,D6="-<2
MNAIR8RF,F,L:0_7(JA-@1&D&_%@.YJI?2>*TX;+(G3O G1$Q-/)'?Z47#9+#
ML0![-)?+HLBW%74LL:@TI%-%80,01X\.DD(4V@HNE[TJYCY[!7).%O:QE&8<
M[1\?)L4\^2%[^N_3[]HB$:K_<,B@8$C!.W-P,"BJ;P=<RLD$M#KZ$8QE;VLZ
M41YR)0E/TVIE:JJK.<&UWLI-:;%3*;/PWX<.>&MCX&X=I!<6H,)R^L5E\=0M
MGSK/X]MUJQD0UP]WHSC?(!DE\WGR$LU3/)5!<HU.@2MBQ.IM3"H+R[,?:1#G
M5;\HG436ZY/ '[3LTT9E4E%R#9X;&VK%<+;.1>I@8-/T$1<9 @E/A2ADS1K@
M33\L$0M01-T"/7?$\0J<=31K(Q=_@AANTC/7&&@0D[?RP1Y:L,UOOHPWUJ\M
MBBS;*Y:E /IF4]M:UPX!]JLUK%&TMY"W7"SI2XH<NJ<M$L3('75<V,^<,HY*
M>^8&=I9V)Y-.MQ\_8_I,'?0*/3+0>2Y)+[B^?:]L<BQ[0;K[BX;)YCQ%OZ*A
ML>[Z:Y1CZS=ORU#RG:IK#RF_T4%&WZ7:F\!A)"LPB!TLEP3W2UOT@_.<=ACT
ML-RC'Q3J%TVV>S8'/LE5Z&(/<UC4I4!SB%:[&["*W2G>H)(W7:0X-<F7\=HJ
M7FW TX.?Q@O;3=YV<7WVLM[5O@LN/$##7JXVJ#GC" $IK'%DS9A.\B]5)FWF
MU#E>*^I<P^?3L)5<E3I?@)TPL ."9)G4JJH:F<S@(UQG7-N(@<T71%9JSL<F
MM'I1REYZKO&8]NV8MCTY-1B1$@UE'I.*;3T'R=OO?P7K7#1HJ..@WK2I12%U
M ^<@ SY%O !F3<^UW;E,M^B:>?WRE(Z$?P*>5VI$POHP\'9K6Q;V>)B\-PJN
M[-?^]8.GVRR)E:-12>_$Z7^T924M^)"'(\#6*9M-Z@K/JCVA0?\@0PSDHKAH
M>\M<P6?/Z-\/GO2!EUPT13KC2MC39HH]W"#Y#JPE0)(ZC)93\^4(-Y"RA"]!
MVI+% _<<=_V@6PIBL*]L35(4'Y_8*F?>@FV',]'-(C@5V.;?'IG4M]G;\Q%-
MLRB<;Q.EO6MWH_4]7(^C@YG]S"Y1#$/V -OH7I[2]3NWW=FJ/1-9-B*Z58J<
M+8^+W1B0Q4:R6PRFM>W UE%%PQ0?PPAY&!_!9+]8X-^LGJ4H"#NM!.Z@41SB
MX]FWM> 42PZOGWHK.<_$=O @N50"WCG752U\5";58NH *^P[W>4$WJ-^I>7W
M$[^G.SF9/]8#D&E2#GYL<93VVY7V[6SC;1[I(,\2^AB'N]1%[ BY5=&XE&>G
M7+E("#[L2ES*G+!YDH<N??XWSKW/O_F4>]>1JO4,,US!\P@5;?6I\(_CDWU\
M?+^V:A#U><_8ME\T.3L[&VZ5'/WSWOO!)C;315DRDFE4R(+#I"W U<G1?E*J
M5%<2RW 8GM@ZK67EQZ)0R/!*4\W1FBN+RJ?66)S:UU)(R^;7Y@0P1A^.VDC4
MM=8$#WD)JW(AR;8 !RR>#?5"MLXT+<#>2H6I+,[/359MT9:U!NW)D6%V0:YL
M5_5P 5ER6AJ5W\QD_2)<9*;5Y9Q_V#(O);PG)BQUZA>)^L$V9(-3Z![.E2X)
M'CD4W,/D!=Q%OZWJ)L.V!"S]H$+2QH$@5DU)HP1@_9A&:;,K<)S?I;6V5OMC
MSAJ$>J=5+3B'P(-JTJI>J_I7^(U1Z450V)&<G>W]E%S-)(8XX/4,F ER(ISO
ME[S^G^0MQE*2-Q*4V*DQHBU.>?NF!9@,^GGJ6J0SJC6-3G_$4.L-C7 <<W^J
M3!G;=Z<B'_>6F]8O9\O<U);18BA8SE4S!R%,(W#8/2&@((<.C\5]K>@?+'5F
MK)GC@W,@<@T2A7VOI48,=IAXPDE;QYB<'!WA1:>YO(:_&>4[0DBW5*(L9XI5
M7HUM&JG6&)Z/:F*[:N):ZK[(Q8/]_4<[)!*W3;E^4:-/W><LWV3%0[1 @-E>
M*/(4PCXRDDQ6G/$\*VKJHC%;MJ_,!H;Z6&VS;0:D$!T'R0+J!?",A=T/T8*W
M8\5YV9ATAB#N,^Z6)K\A)+^KBG+*##R<IK@2%%%#+3?H>C^^9<]&VP9M$;M/
MQ_+2L-;?V)+$3%5$*<$5\Q/XO@0_TMZ>BVM5+W9P7!D(4I3SM87NX(HQT.A[
M2"YL;\C\G#%F[:HK<['!T-#P 9OJ;8O[E@=,(8EI+()M;:C< <3?S?T<!&ZR
M^-]WR3EN"4]3&(# 3X?>F?S?=\Z7M)L7C"*@Z0,X5:Z=8M&N5N25OFG)+K]=
MZ@KH)L"#+>J%FSZXB]/HPH_7DPG6*V!3N#M@*P.(*IKNP;3@[6;++3QO5!I!
M(X0FJK:S%+D?QB)T5,VXHN84!*!KRBG-\^/KW$-Q<D.649E!^&S;^^+N*07F
M*FF8W5K;,_@,C3VY]9Z$;Z21CO#F<:/RS+XW1&W@E5;='OCN9$1*D58:) ^Q
M _"MH4('JD.^8TG:%GAAO9&)O/"6*VU19/Z@B[USUR-UZNGSWI6*5'W^PD]S
M^UCF"K:J I:^A...71UIK0U7'E*%#HDF]&I8[$US/8;+ID9?U32PL>69 ,#5
M4V<)#(3- IPP4M*%*$FJ@:VGA+=L'L9X'Q%?CR+B:S_6$A%?;T!\C2&$+Q%"
M^ X$+(K=LSF%CDA:@NWV"F2RGH,D?55<*J,+QK=H]=)IBB VBDT5-OM>N9SW
M^[ ;]SE(XGOI:6_FBVU7YZ)>5NUVD\>L22OG3NU*M_TM6 JZU"DW%8*[)8H4
MV\!2HVR_YL'^_LD>_.?Q7_XT.MY_-A.7H-<)QX@*(LAFHU$^.%NZX!J-#GB7
M5>3."T$@6ZYAY5XH7U2!S-KI]Z:18F@L@PRJ)@M;$XPO&2:G-]^%XT%=_BRS
M ^-P<7,-C W6<W:)*3PF$BXHETM3SCP$C0C/ R41G2]<ZMKVS+G4WF9CM9\@
MUJ.#'@HT6-1Z@78*QO!T2^>+*-4?B4/+>2GG&ORW$DY5%<GBEZ,GD1A^.6=%
MUF!TB'H?OO2@NETBS O=H&LJX\GI:H+MF3!,$31AQ)24NBZ#-AS5862P7NSV
M<914S/%G&K:@*FQOP:8C@YDJ'+V=B$NA<H91U!Z[[6#_V5B,%\E88VC+%:AF
MK5!-*CFU&&Y/#D\.GL&ZX$./3O A)T>)L-;1P:B]H'!Q,$2$,?0Z6(R@Q,5"
M-_5LTN08B',E1#X^XE=V:W-JF/R+YXGGN2P*H$N54*3!YH]A#8?[_U$%-I.-
MPTG7MXP/1OP>55R*2H%1MR8.PU$<BN:B/8C#U]\&+[R::0[S-,9P%')I"8]@
M"4%P!GZ+N"(<0?9_)HMRC"AZ0)9<8=8G SO+]GRM717/6B\%+(KCZ3K/+'"?
ML1'.GIIB7ZNW^9SMYN@0^N5\0 \BTL,O9VMV61^)<2XFD3?:Y8!JBM3PRWGE
MDFN1)FW*R2O_2)1^Q1RQ;H=RFQF"\NO2VHU%)SI(-A]N(6,_MK''K"'3%Q/4
M'HG1EI?57#5"YJ&-SU4@-@>)3S[#/T6UV*OU7E-)6R"BK_8P0QU:BQ0%G$BL
MAJP0G)KOKY;04%SDCXQ/ZW6L,[RQ:B(,.'+?F"ON&' A$Q&D$V64!7UZYTZR
M7+%:8%W@<6G^%H9"UY.:&QR"Y"G2P<@4([\+0B: 3\VER&P2UH'0VZBE"ZE&
M@SD:S%O=NIA0BO;R)F*\<!5(D2:]TOYO12&F&(^C.!'HG2EJG8)K>,1"8^N#
MFH\;4W$"&O0G]KRQ[I]K4.(XHL)#XY!&A$M 5:IJAHWAG.2S\2(JFNN&JMHR
M,]+R@9HNA>+H6:9 &6)P"A6WR]0EIU@FRP; @-*0075F2O-=.IJZ:K" LKK-
M,-<!%EDN$EWCI*+.4P;^,=-%(5/WE$'"F[-\L2L(Y6).3Z-!2"_;S4AHGALB
M91CDF\N,# >-$SA<,2VO\)<&^&VBJ  U_&(_"P1N7R6(;S)LYSQU"A1#VV9=
M]#):&W^HM?'!X5=& =HN1]W/IO8-&A:<ID@.OYPRFN;!<GRQ<J1)K\ROEPV6
M.ADT;G >K,\=8G),LJ[V^-U>"W/#!B=.*512DIWBD MG9.6X)]F[2QQ]-X%5
M+R0AY5#[@*AKU/95$+V@XBL<W.4[!LA"<M 'E90775,EF@3;,@G^I;)XG-OE
M8-UK66.\+A(EQB#6<H@36I$FJX9!]"MB-G,]-<Z<51)IXI?S6H.!%.G1ZIGH
MB0=Y$)TM(CE:^3$7L8XJ:I=-1IDOIHU$Z55H OPI;;*@[_MT#D]"H)%SG2I9
M+R@W$_3#VRP*MLICW4+5F$NYL/,!GPR2L4:X*M='CU&%SO#1(/'3#8,0;C L
M 9YR-$S.;[Q^O$B.AP=_IDZU7-[B!7##Z-'PT9^IRPZ^4F%G6&/V,$J"816E
M;ZBKZ$%[_WKV^21B 6T=]Y4ZN++G=DKIM_ 7!!3QV!'M :5-^TA9HC=J#LS<
MR4?TD3SK6?LM(YS4TA0$'(#?;T2)Z*&4!?7-!D@EY:DDD"$JW5(FZ ,($7"J
M4J9J@OG$VC0$U,*Y31N)0W075Q 4\&13*^R, -[\6=KT*C8.C(VM[9]2_(WZ
M$7!>2:8F//(OR619S_QT%4QOJLK#:,M2\6^6:IRZ?0/85XF3442>XX&UOPZ2
MD&V%ORU<HG2AJ!,Y+W.]"*#K."7)4UOVQG3&/#"4XJ0B+!\!)Y(*> CAA9CZ
MLD$6M;-1X)QCVP=_4X51SOE<%^NKN=KL<MXR)6UD)JO4J#$><UCS53\/\ATU
M Q[M,[M#46%&DWM3+K"H08UMK]WV#R%*[TVHMN9YM5EK:=@ZVE5C$%FZD%85
ML,JY%(9L+12%@1P->[*6QIP/6!H/'!(HEXJ 5 5-HAMLO0_L - (\#^5A84+
M!L=Z8#B<(*L[$V0'/#X6:U ,HYS!-U-IS!B_M9GS&\<BO?#3T'%QV$^'GX<C
M(+ <):R//;=P5QXO.X#:PL[!5':IUPZD?DC -SC-R\Z[_<97Y-);2JSW*0AI
MR&&W,FP5J!-$5IA*^L3.Q_/R9@)-US\/$2D)M4]8>LRJ29$-8#0JY+E8^/'.
M8+.*3%^3^35;P JPPD@)?K'=%CL_S5;R%#IK<K03"&&A7I1X;XYSSV#5\+UL
MGJJY])K=J.J"9F,TQD/.!A7$\"^+GH[<X9G#O748 B8_V2%T4#\*%9A07F\7
M%5,D8Z7WJ*;-T%[/FRI%:$O8*-?Y:J?D83OIM+ U\+!-./J)3I(R]KC4>#0Z
MIVS<U+5.+RHWIQE/F1UQ<C#:L&/]VJRDNUM_V_9VM><#IVZYT87.%^R>(#IL
MA'=(1_P:K.,:P?(.C]!6;FJV94?^IZ_"NOQ(PWB^9IOAC@2Q4*F1(OVRJ^"D
MXLS/MI$HN1(+=HYAOZ0=*E4YPX5L+44'UKG9X72JJC/$-*&NFVJ&(T.Z,[*L
M>8*"&,P*<9$P0#MB-!FLG<%!SVB,)$UIH0 NJ+A'I:C:Z1T8T +-[5?83ZGQ
M2>Q(BT6U-+O+3J>_$A68K7F#\%)U\O]&!P=#"SV%6 >VH@G-#OXE#58B>'P,
M?+"*Y!C'_SL8/1GN)^ZN,8ZL/3@>=B.3]J5@*$EATMD =D:7"!0ABRSD"(H0
M.+ZP36M8EXW@R3/-EEBE&3K+=[<-;,@'D?]5W8BZQ4%&&[%%Q'+A$=SV"PEF
MEN%YN'X0_3I*#9.7LBH1T)]"-8Z7"S3(P;(C%K6/Z-P^</$0Y*9<*/0O8,VI
M9$N067OIC<XT%=A@ER"J+U5YX0,D_+L=BO.P NN#>L[ *(6/JFL*C *?'>W_
MV8XK=TBAK07_#=;$7\D\Q__%KZ%#LG:@.7X/ X(1SN@B?+>>X#35T?X:'R$!
M7D]I@EQ#)XU8$EXI+] (AU/VS3#Y'L[C);H^N((<D8OK %*"UM&EBB4Q-R[*
M8/S=\LD?) _1?&!.M*BG"5_ZC3/)C1R#\X7>SEP*W(E)0_$TQG-SKVZ_EKO\
MN/4/640CQMDZDBT-!>ZS>=Z/L5$LU@<;)AV&HG_ 8AE%UFU'%/939-]1BW^/
M0TT^],"X<7,JN L9G%06$)VA*TYV78EKBF=DLE1PNK6%#P(9\"O]O@(Y3/]@
MEXP#! ,7G&[ETYH8=>=]X!P &6LE[<G3!9;GM@LDEK& V"10L3(3DU\8_'=!
M!@Q KUE'V+@3D8X#3CB.2,?]6$M$.KX!Z;BW5OGZC-O"]RN>V9$M[WEDRQNR
MGER'X-G[-ZX=<)B\"H06&N9-U5 HL@1#$RR: 45&0#<65<-=BR#/Y'4)3T<_
M#(5W#D22%(*L*(I%KI=SV:SI"C;F3+.R);%+ABLNRFM=%,E@(5,68TF2(N*L
M_04U8(*& +)1'T,A99;+MF44K"5$A27Y/M%@OF& CL<&<^]JU3X-0749",UU
M3?#3ALDY >R&B[!* 6VTBJ+:2V^H,=P$A!JL3C,6!8=G85<J3+GB/^!W38EM
M'+DJ*93L N9@#TJC&_"H5*5LORIUI\[ #JXZ=N)2BK>S6K1*4]$  \!YG:MJ
M9A.GL*6<;4Y(M[#W96D(5],C6Z"V@3.8\7&POO3"T2#<<S<6@ER 3$YQX#U.
M-1$33&00NV 3JT@7PUN-I[J6VHV1]C-PK!N?K1@+-\\J^GVCBGBZ],Z-%TSB
M4+T_?*A>CTU_+.Z)\4R_G ^=45:1,+T*])ZO&3;6P49P02UJ7VRAEQAZUH1%
M7IV4^7-=ZVM.3H/&QMJJH.X*9,X,I!2/FI8YPD'@L&8"CJ!R+%2$2TGW)?"F
MF^NA@L#.OVR^NPI#78.VWW*F2XI4NB"2&P; $A+M#@H^@;1I,!QIPTDEALZ0
MT&BL43B&;^"($\5#>5V8E&20UBDYSBV%YN!)(F97J0A"UTYSPZHS-"+@/12E
MQ =>@8%VD:.O?)KG;<E66*&%@3PYAU71=#0K[:TM ](1"Q^,+'DB@:V4<R%&
M#O!1.+# ,C>:YUT1(J^%%*&PZ< %X%QMIU,8U!_+E@X(<] 5BK!SX3$MDLAK
M@BD1& H=M/D"])S-N%K#*X-N3ZPSU7#.>.ZF7P5E?))AO&9H!^'RU77P,7,,
MW]JO 3H4<J)<=4&7*?JI>VX\ON^8QVX\PRVB2O?0V:+$E7.'EB>%V]'-JY0A
M_S.LS!@F+[H/0GX5J<K NM>&C&#">O%<B*P %R:"4DAAS>1@_2)L2!E](FN&
M@B%/_&' 4$1894H[5(V9"!O;#6L^@T 2?@SBNG%5 + L'4)[N. T&F/K&7E:
M7"K&8X)P[MCY%"?''4(O@0+ZSH@-:8N2D:Q:V@[B@(&MS,&*2\YT9U*6E \)
M";B#C,? VFB=MZ&\#H9X)KAZ?1UOLI#DW:/]"*U][JUW);"BU3@IK,+6[%B;
MM.6PAK:;76@_U$0X >)MV5Q-)!&JG;-ILSK!3O;+OSC'XHDZ>?_AW79+.]CG
M\Z=Q0AA&E+9[\656=HPM^)^.3:U&;NFP# ]'<#>HA1I9QAX9- XX&'BP59LK
M.!?^$/"A6#)Y2#!2K "O(* ND!\,L)63G8$9=7MS+_GVP^MM5R05("KRD%\_
MO%ZBJXU\4!98556#)HV8NO(R)"U(:S!R!(9YNF5F7(4FO=D'V]':N^02!]6?
MJ2MR#"W"?LK^NWIXKY.W(4E[D>\ZQ9$,%P66K:)^;KT05X;*71&+P1([\'#H
MU6:-3086)ZO@,BPC16.(SBJLRT;Y>"(L <HF,["I0#^Q^:F*!?H#&'8DV-NF
MH%:6Y IKB"L7((7]!V=G83/6UM)Q\MAS8.6MZO^H$G#'&K+L\4' O"+G"6 :
MQW3)95#?%'-V<$-!%;#6D/?=80$O2\[ .1!B),*E$N'A($]IY0AQ):PH&O1-
M#O9'CS>&]Z((6Q/;8VJC*(-C%LBQ=4+,%:_N=TD,NK$MP.PED<&^&6R5S'R>
M;+B#"465#=:\#<,/;L =G,<578(G(!I$=R4^!7.^"DWX1G[5_4"Q#__W()H(
MK'V,!/'+^4FJ"+;:LWS "YN>7S=QGBL*N'PLEZSL)L34R25NI<\68(^.T=Z^
M#@K#/EO8'F$2J4@56Y(+M*V='4U+X<#BVIA^VU,^3,[#A;HP,]K_<&6>+^$]
M<Z<<!IWQ C2JJ=,NDS5\ RS*?H7/M5)A!)<FP]]K6I@SW*G""KQ)]$[PDDNT
MS'.*G9)97C/&-EC?9<7NY5C:>#DA3MHGH\'/%71H@5A<;EN7X0R!H,S"5>L#
M@3">:QT*7%<R%Q<8O:PI :%2#%CB.ZCR@&HHJ&R?*,M?0*W@U6KMA6<(_"!V
M";@& SF&GN#2_+O4%$=I_GLIJM8OYZ>M=YIQJ0%#N^-A'B3@IZ><DZ3C4H!]
MZ))KP%/@B'?==E_IXD,Z#E:"_'[75X"X[GNV!0*'9]X&W-[VF'+I$B4\BAKS
M5VTL6U=S$JZW6G/;+=%/&_G&O7ISD\3OP,<L=3!T:XZL[-F43J!\(M:2<$\^
M@U,HH&T5(/1B[9B^(F^9,X>])N<&!\.3DW-_KYB<SXF<+1#-ZBRP/G[B;^"8
MM1,<,,OF,$_68)U@7Y/@WA_<^YLQ8\+!4:ZHSI74K8S6Z "X5/9]S'"";)X]
M/ZE#9JZ1RDJ63@9_,R?V85MH[O#[SN@+)#GF?>^$2U.YZ218U,A&4:>HL_+G
M?"YS;/!9[2E(9T;/=3G32_OG4\JT%I==Q@MT T:-F//$9! V!J.B5+Q D4H$
M:UC^,)KFBU]7M_GD\#. )0@Y@.H\2FU\/&C=2KCE<8:&E+7:W)\IT"P%W^JZ
MJ&!A..G-1UZG1E_5LV%R.N9PSFKFR%JYK&D"Q*0@7HPGP!<!XR^!*%@*BW'E
M*KSPIO<LU9M@?3)^*;&[C9%C%<E*Y)S:2233',3U3%\E<\RUKM!+59:F&;82
M,3I'4'N+P#SB]U+!8TCA+[F0?=&1"AUJ[)[P/%\55^T1W>!M^?H:47 K?FD4
M>E1<&.H[^Z@O$($WYNCQ5$]C<TU ]Y/87-./M<3FFCLTUZR,C>A-('UG9D2P
M 7XO0P.;4B"7]S14TM^H+ME$<S!\R:7A%AWL"UNJ-Y)S5=L.);)7A;72GVU4
M]5& _&X!0OV"\;SXY;RT* *1)+T3(838A>U^!IO*J%[(ACHIQHF*,*$:.?)Y
M91;EQA>4&^>EKI-S>&P\*'XY.DXD;)=CV\SC"+,P/!+/2Q\52Z8XJ.1C@JQ+
MQE+,739-6%C8-H%'L.Q<90V_>Y8$U48WZYM'QRYBI\#9+NJG>U$#_18-]"\!
MGAX!K<8C%570VI(WYUI&FO1.YOKZ()=!8W-A+J8%Y3:Q&J(VS=R51L]+&F3+
M ,J5-J5/OG>P%:U8[@IR[Q'L8$:ET[ML:97:&;[=&H7Q(@"6M[4C6(RUG$BQ
MR5^?26'8CJ#0S"57A<W=P HX^\F1FTHWACNLUR147>8TR(UV@7,0K8<*R2R&
M8^6SMC9A60$7+'S!!-ZS)I'*Z\%]33%5%"3574)]-=/:Y[W?@-;<PM@@;5Y2
MI9#C[66D%(NPW^>OW(PWN_PQ_2HW\Z"7@X0J\09)T#>2^$:=00"'COMU+;>+
MM.U*S"J/94A'+D0S# $)-M12))LK7SJXI7[O O E@15/7$^%TPI@!<&XBT_"
M,?U3+I*)%'RN-W!]VX1MJW\WYX5OS#X]67LBNF;ZDVBEW]Y*/V(C_2UV^H'N
MBA:87\YIP/>1+"U9''Q#I(E?3@3R"I8C(BV"0")JRDB0EB!D,T2"],K/?XN-
M-1L,M]8XM28>8[*#J;#7,0QY"F5!E5)EIU26<)VH :,[1FWM$$EN;/(F)D]M
M6C.ET_60+97_NSZ)H&K18_AT^P%\P-A";V ; -+;_I&0&9!4MD>L*21B"5F
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M.]8K=^S'<FK N(QA\*X\L[&B2)+>F]O]$OS74MN4??)3M!$Z2ZI-4[63V_N
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MRSF;8[%*Y(^5?):Z5'7$ONY;!F=3ZB:HX.V"EKKNWBN5YSX*UW:83HV^PK&
M(611UW7J1.[&C<JS9&S0@,/&EFEA8WV(&Q6@)W7:>=>"#V,)O;!79ZJJC1HW
MC)0_P\K[W.+H3W3:4'R0@WVNZFNE9BW7X^4'%;*^TN:"L(5;L*HP*"FO2YI=
MZVE#]\H0:S?S8%71THF63J\%U&L\*I$>?CDZ0L^$2CT &(AT\<O!A%(DAU_.
M*^H\5M7LBP=5=HDJ;R4.#;J?O9L;*[RP9C]29!?< VDD%FZMF/H+F@E-XZDW
MV=6A'>_ 9ASX*G6JKTFSK*LILW"M]KF8K4^Q<48A+BN\/T>T"0N!D#0E&.\S
M<4ESR<#POU8\DG?.I]"#IP[(TUFQZE=PC1RXZQH$6HM/RY_73!E PB_7/\DO
MP;TZ.@7;7M1:I^ -[(H1$8XR3-/&TNV;@G^(>9+GT=@)EO-\VUZUU:3)OUQ;
ML$OTN>$>_4KW^;*DP;UDHAO*:2(]_'*V6A'>RUJKR!Q^.;&H>5-MV79%:I@J
M $^%X2"Z>*B<1 D3'[Y4&;06YSZ\]Z"<M6$]ITZQM!NI4?/@9?\8B\J*KD[;
M)3-I:#"T'8YA/:V5M:2B9$2-E9Q.X*(I<I#@.?.$O)%J<[X&(6? 8YQB'[^@
M+W)NE$?PV#B>Q'E^X8,4I5Z=ZVDD?%-A2\&5"0<SKTS86,6\LS1 ?*:Q=#BP
M7!)H05&MZQ9=MEZY;-\Q,T67+5:L;*8(%J1%<OCEG$MS&:.OL:;I!@DR47F.
M]LK]]$DWSE>HFGFDRI+S$8].)T].0*"1('W-:_44+I7FG ^2L)<S^.E>LE,O
MD2A['.O8?A]=ND@MBG'9Y)7,]ABZ#P&2 _A^XXT+GQT>8!8V7S_8!1'U<\*_
MQ^K,4E<<1E%EY:#U;5BE7]O2-IIQ'6HO6O2(_JDW8SS]A\DKT<YA[41PVM!,
MF/<'<I<".\-4B0,5.$C23LBQ$(TNND/]0.OVUD>V?)BG&V:BB!2A1<*'"6-$
M >^NK/="5;9A<4 B%;7UUS-#.#7RVDYIL'=PA:ZPU0BIOI08U<$UTH0%PJJ4
M!2("T'PD^Y1,&1R6, :>Q952' T^G>$F@8VUH357<M,R\1^2@"[;R)HK&]"3
M6 FP[47%L%(,*\6PTN<(*UVH(@4-$TG2>H-6P4:2]-4?=-DH677-E4XG$*75
ME,E(\R]P9D(S 3L"+!T>H(A<'V#<(0P"/-O9!:M7T ]@ <S(3.)V:7[#WLH;
M#!D:E<XSM%J QK+ F\K9H@+S2Q1LB&@+:)31D*5=!$-?/BI]7/GM,=#[Y8S$
M$J--5221(.M=5N^N1@+UKJRD?S&H:ZG;BI/MTH;F:4W(?Y=))G/P[ T-.,I!
MUYIVF,2W<,F'UW:DQ%++<S"RL7+:V8:AN"=@V-:6]EOP]V6:X6!I0#&-0;,&
M4#NJ)PN:S8&\(KD4.&9GL6GP-(U5VZME.BO@@V ;PXVS,:T-MWI3#*-A8.KQ
M2.V569QD6A44#YIK(\-9;P/;<8)!(3<!2P/#;3:]+&GNU>R0)UUJQ-DA.S%Q
MX[[/#NF5:]$.*.*AOCF)JQO@;EU9*7J)W0!_.I/I!9:/ZFOP=DN$62_LLSHZ
MSXZQS(+ /C[&_;B0 F1XH6N9W<K1I(CJ?_+JO4@SL)][0,=<E)5\ZO[Q#',\
MN5@\5051@VYZ9I]EY>":V62T8?SG5B@,]UDPU ;^/W-OMG\>TI^^K;/5OST>
M'NX?;/SK_G#T&_]V]&CS.V^Z\Z:UG@P?CQ[OR%J/AJ/'QSNRUN/A\>&NT/5X
M^.3PMSTUKO6FM3X9/CX^W)&U/AZ.1KM"UZ/AHT>[(E]W20X\'IZ,;D?7;TDE
MLEH$S8L:_+\>/'KTH#7(*2/Z]*"\3D9=>PB3I"NHL*1X/[>)]/A386/2[J>!
MW=*.;;0$:+]MY=/V\<,>K+GT8'0;,K!3U2="8/8M^2 O*3;P*Q'D<Y#C5DS1
M/VK\H M57 H<,?2?8_/MWY_K;$'_0(]&-S@UXJ\=\JP_$KMX(LXIAD(?^WXY
M)O?%.:%OQ%C)*MV_H_!O\-;N\>>_H@@O'8=SJKJZQ[3X7BA#E/@@Y_JR!:2Z
MAZ3X251IDPLFQQM9H?WP><EA0QP45"IKS."K+''?M5.T>O[^C<=^07*]7%3I
MS.BY$O3C7\2\?):\E;FHYN(6-+P58>X5@3_"XAHC!\R,\&<JZJ"?_@6FRD4N
M;\.;D:XKSD%:R.0\%2:2[S>QI8!WZR^G,+X>2KU1I<X7E:KNY%2,17J!$TV+
M;,^N,TVEG$R>_5;"K+.^X2%?C":WST;O+V6C;^**352Y"V?=,\K^D#W]]^EW
MNTK<]>?Y2Y+W1F(>[.\_BJ3\+*1\*+Z)E/PLE+R.=+Q'=/P]+XB;'3?[ZUOD
MVF?<,FA_A]C5YX]^]\A*=$/B3T[VMQSYVZ9M=W1?O_WA^#;&V%?YZ;=1!%]6
M6L1+^W7I;PW-]$T?[IX6.DV;CZI,CO9OHX2V1<.>R:];JJU(K3LHNITYXO=C
MT[;NJ\5GQ&=$#_3+ZGZ"N4O^Y\U]]4- CQ_?UV]_F'XA]S->&B^-OETOY/L;
M>/H;_+DOQES_Q>(M54*D5G3M=G73>N/:15+%9WQ-SXC>Y]WRGU*8;?<\;-/.
M.+FOW_XPBZ[G#FS3%\K2WML/W]E+HP._5169O":P-D2J[XLYVO\S#/KU<:36
MY]7(.W/0OZ9G])]Y>N,D1U)%4O7S$,=0PY;M*%MJ_>9_[JM/<[ _NDT7W5?Y
M[;'2NB^>9+QTZY>NU1Q/OF8GFB9+)#_UQ9[HO]  73&*U+JU=I&]\9W[3ZS>
M6/615)%4D51]<6?C,WZ3>W]7Q,^;9G+\L3;9EYVE?KNC\)<_C8[W_>1#.XNB
M%S;ZKGN=8$ >W%>/^^$D%C?$2[=]]/\8]+W;F!A_:+RA/PJ.@P[??]@=_18-
M9*>[#OMB(_>?6@^G,?BQ>[Y7)%4DU0YXP?$9?U!DX<EM#,V^9WG<4/6'62/R
MY$I<REP6TWIV;W._M[1DOLIO?_BEMGV7+NW_-L7RA%UTZ6-APF=66<G9V1E[
MZP_?OCF-'M5=5%SLUK^]4E2]8:WXC%UCGMZXF9%4D5215'V1=U]M/,%7*"2/
M7MY7+QK,J_L+4A#S^/'2Z/1O)X_?"PUP+E,CZ^3#Z[XHWOX+35 8L>O^]BKF
MY^B/QV?L.!/WTRV)S[AW;IJZSV[:;;3N5_GMT4V+E]YS-^T60\Z_:C^M50&3
M7/;&'.F_Z 2U\212Z_,JFMVT#N,SXC.^XF?T7[C<38?OKJJV4"Q_NZ_>RBU5
M[E?Y[;?#2?DJ/STB:<</CQ_>/__^#[CTGK8_<^YTB\W/R9=]]QW)\?[#N]B'
M?5=3Z2!.)+^]<741HQ/Q&3O.Q-=__6MDXAUX!MDTW]9BG$NGS^ _[EES8::J
MV ,N@FVEFSXK*^$S[ZJ##_;_S&R?R50;@;-4GL*W2H-7/?C[JT*:Z>)<-R:5
MU=.NH@X^S-)B#^VOIT]Z\V4@_,4W7\3:^:VD[A!J=#1\=(C$&NT?'W[A9=Y(
MI2]C$?[F32OFD1A^.3]D3_]]^ETDB%].+N!1SW90%(UW013]I"H%RBORFU^.
M*+)(C58V2V'V5#$QPLA(EW8Y9^ N%%4\-^URWC=Y%5DD6,X;_/<N*JZTWXKK
M"?E?9U$F19D49=)]D4E9OV42&],')T_V([-%OW[=<EZ9I_\^_RXZ]E^!8R_[
M+8O8/GJAYV.X,BJ_=CD3(W]I9)$N]C+=C/-(FV Y1X\.(C6BYHH!L4\M)^9N
MXDF)N9NOW<2;]-G$.QD>G2"Q/HA,Z<AMJ_9=I$FKO+],Y>EN$F,4:>&7\Q<Q
M+Y]%>OCE1/>G7<[;[W^-U&A/RI\>'XQ&\:RTRYGK0N^5.A=F!TV[:9]-.Y=)
MB-&[E>6<'!U%:D2_>]UR3G-Y+8K,J#HFOY><[TB/&,>,<<PH3V,<\U[&,6>[
M8.R^;$0>F<TOIYW7&(D2\]-16T6[+MIU\:1$N^X+$*14J:YDJJ,$^1J,7=5G
M8]<E[3_.C(Q1JFCM1FOW#CI\$*GAEW-\$GM,(F]$5RBZ0M$5BJY0=(6B*[3&
M%?IY%URA6+\<ZY<_:='$^N5V.=$I;)<3:U3#Y;05F<^2P G8(8UUT6>-Y9JJ
MH\:*&BMJK*BQHL;ZW=1XKEA?#6^MJT*X[I^;JE:316_4UU_CSOKE?)S%_%:[
MG!=Z#NM84!/1R;,J4J:ES*M(C%8Y"',1R=$:47FNK^)A:9>CHE79+J>./EC@
M^H/D^$+SI7:3('X(=J1)*SZ*2(R60:*!&BSG56-T*45DD'8Y/Q9*%[&NI%W.
M*;C;!JX5D2:MB1HSY<%R4FEJ$;5,L!P-:B:V7P<<HINB-DI&KR[@D::N5!:M
MD6B;;3!$AN?#2(XVW:BC0 VH$3.-P7*,S)JTCG9[9SECG<74?+N<:B9*54PC
M1:(3$X_+;2SVHM:-@1,3C9!V.6?1R8WF>C37(W/\MD*02!&_G)F(L:!V.4>C
M_2]?!+U+!$ES*8PHTBA$8@0D*I@[1$ B36+=PUJ!JDS:S"?2R"A4.UF8221&
ME*GKXV/C3,]EC"D'RRETL:>*2U&IR\@I[7)R5>I\4:GHTK3+>3@V4EQD^BIJ
MX:AM-N4PH\L;>2-:(K>U1")%8NYR[7)D+B]%';/;'0FBJJJ)0B0@B)R7THBZ
M,9$J,:@:U>XMJ $>3 UZ-Y;:12MU[7(J4+QI'2<U!LN9RTRE<:1/&'G71:8P
M-1.C0\'):=*(^1ZX,Y$WPEQFKF14,U'GKEU.*51,R80*MZG2/%KM@6HI136O
M(HN$A1 I>#)59))8&[(^?:FCQ=ZQV+%6)A>QH2S&W&.H[/;!96V$B27N@8Z9
MET9?RAA C)HW"I%;*9BRC%7_T?F_R3*3>=[DJI:W1X[N TSTZ C6_M>__J1$
M\KV<ZZH6E:IP5D/R0HNI-34W?M%<F*DJ]FI=\LO_2"AL^T4G:[_HQW)J1-:"
M^O1QY>OYZ.-,)DO@S#WC]&NI!XF\!H9/?MJJ $ N[1=I:M-4A/&93')YO57B
M@(&'?3?5(!%&)G 4@+5EEM0Z(1#C) 4NUW-I*OQ5"@=_3TXF,JW5I<P72</G
M!_]6KV'(0E[)JDYJF<X*^*"I@H5KDX!\2T!3 JU(;%3V=F62:E&!'0YL(])9
MHB?)U4S!/] (5;"T\!W)E:IGB4@JW9A4XK4H-?%Q(D^,O)1%<X.(M30X/!B>
M' &=2EW1K4^-1$EV*9]=J:R> 1&11N&-8UT#.9[NM[>(<:7SIMY\2R R4C"D
MI=F2Q!CM=\D1_G=F6N4SE7M4^+PG)K#8IR*_$HOJP;==L0@R<8F&RY^_\2,G
MDR_VD2R>,YF"(T>;TQ29-'@5K$GT9BW)S,C)?SWXD\K$.'U\(D>/Y.CD,'N4
M/IF,3B;B^,GQH_W#X\G1\?^=@* 7XYSX^P6\$,Q*L;-?4M05+7\-%_9+XZ[8
M"G1^7EW7$CX\HXTP(JV3<VDN52K9#CIORE*;>J<M"6"S"8KZ$N7\E3#@R=2+
MI'*?"6):U56H$F9&-],9:'E+&GMIDEH2X26BAA\OI4E*86JF52[&H 8F\/\@
M8>85<K<N2(M,0)PG"_"AJF$2+DSDE7:K\^O1!2B &FBQ!P_=FPMXF((+DS$9
MI_AXUB?\TDS6H%7H-,WPYU))6*F192Y2"G' *S^PXDA(#[ :]&\KI8%'SN&W
M-[\7_L_ 69D6L <9:#!9M+?21U5R$X'Q'S(15:C+6,$1C>"QC4% &Z?@DHG1
M\[6:5Q5@HN<Y+, J>%S<#0IQ%[C3?YRS6<ADD04L7$K#NR4+VN!?&I5>T*Z#
MM:)2!;OK>1-_6_%AI>V 9^!S*B"I07I+X%/84F#:>0E<"7R!M%]'Y-9VZMHK
M*9!IC$PT![[/Z(66S;(N5X^Q3N!2VE/2632;6,"T.?R/P9/I/P!Y#&.5-3#/
MRID<)J>TWI? W/.Q-'_YT^AX_]FCT2 YV#^ _X8FU$QDR>%^\EK)/'/"+)'S
M,M<+*:L=9):S(O$XK7CR8%O#[Z6361HX@ 4>[O$BR50%%X\;/&LDGPH@X2"0
M<,P91)G,BSM\IK]3FV'RLOV!;YG* ID)+&1KNX(@<*>=A"%8622@6";J(E\,
MV*)ET<@+$$:%3[!&-DA:OT#\AI75]-\U_ A7QL14UR&,0Q^6EO/HY3:),>@9
M-2*'K$G$;)E#>AE8.N])8*FUL:M ':HBS9L,+*Y6'Z(:!(]6UDG1H,5"ILY,
MHUD%=A@H<;2."GL96-)*9V20P6I[;:*L]R(_&J&*H,^MCRM?OZ/G(F<WQ#E5
M&!!TAA)'>H'O^(])11<[@RDP3^!*QP.U)07Z4VC$-)5TEK9]"KP![.C6A (#
M217)Z/%^DHD%K:4$YVB&GDWB"(M6'GF+E<XS;\T#ZY&O9-?>-<.]NU:UCA7Z
MINWZ4C8D_6_@E; R].SLVG:0$U_HHFKFZ"Y5R<-W=-!$"J>UTF@^?]/G#_IT
M((,:GZJN:_0?GENL-^T]_R1=I$@&W/6^"O3M*KNHZVZV!,#=E'F._QNR5;\(
M1EY79*(-3+1==R,TEXB=4B^=G4X:W"D;MB%6**]!%>-O@X 1RLU^[<JY3 W8
M@Q]>1VY=1Y?W']Y]Z87=W,#BXJ\S<0FV&K!3SM8;V'FEKHAI:U56CF/GP&L<
M$.4@:$*9Q4128-.W* \3;V'6%"0/C@ ^+9DTAJP46<R$L\B6XUPK;+^#AMEI
MF!I')GQO-%"M,5]+G4HG?K]:<H#[6F+VB%(@Z/]A%@;[E($:6#A@=&F4#=&/
M54&40K9!+W.Z2'+8^7R0 "N".P)+)1J638X,VG *DRP]"MH'[(=+%6.5*W!*
MX97PZ:K$RB;FM.!= 8^B=S&7-86*:>CS6J[L%%'0&^FRL=%8?%2#GUM,26JW
MG;:)N!0J)^9WLIW/&7_D'J9S,NO.])/'[RC;?M#%WED$YEM>SO,XU&/):;5#
M/2)1_')(SHR>;94B_4\Z]2."[FOA%DYAA*J.% 26QL%?PRJ%3(%A4^<+EP.L
M+E1ABQHH/YS,X!U[I;ZB//B'UTX54EX9[(8FQV (A]DR*4NZMRD45B4D,TG(
M6S[VUHS3!CQ%J1NPN5!5$0Y5 O^J0&<(1<H:##%1RJ96:1+ ,I$WH2K_2,R$
MIP)-0U;@G-*N8"M2I[3Q#5@4[:U%2NKG:H[*%M[D2QR\IL8K1"<9BY./VJ)#
M7(G(DRO=P$?"2G)<28DV5%5)Z^^T#ZO%!5;PH%5QK>8<*AP=)?#ZIK:E/?65
MQK+%N3;!C148" NV:G]IE"T_T&.DCR5S1;\5\+DSB72R^[ ^0?OB5?)6F(LU
M5@3;(N9"]BV>T(\#9<G]ZL=!XN<\TZ[9F;X)3;(-Z@+LU%*Z"T?>D"TXH7/B
M9O 10R5VWIK]J1TGQ4]OT<AK126G]N9A<E;X9\<LXOI81Y7PO)#$3\G@B+LN
M$7K'BP_Z'7H#C0&_DBQD#Q3HQ%(@??SU[>FFLAF&.$HLL$]@9(.3T*#$0;\1
M$3LHHR"L:&58 G CL!F??N.ZT)'GJ.,X"?ILA\FI+]K":@Y<QT'R]OM?,;75
M^9K#_22='X3B'2MZ"EP<"3RXS',3OJH#?.^DM 74I'6%F-:)1W).6OQB*V>_
M6;JYCZ&??G#H7%05ENADTE=<%;;$$:2QC<!A$:!K&NWN&-'8MX*18_?IMI\=
M\M4^BKK6.EK@?CD?L-0O(A!$G^2.5))%CC]M&1C9)L4'SIL@>UFEH'%15:+I
MFS6@[()?D=81A?NQ&USCN%Y365U6D[#@:EB1#U85]%@6(.3@\=,Y%V;F8#J3
M=L;7B"0'E6O8Y:EUX8UY#(BR@Q,:RT9.G!O5M\U^?_;B7?(=>&9;'K/P5:B@
M[X6*L+=1 >V, B*G!P,));@+&':I^N8;4JMN9*!6PGR(V>?EAN[M5MG8^&"6
M&5EA\ED99U5P=6B>6RMA46+DKJW)H4MKN/NB"&* _38-MTQM+Z<VAJEM2G8L
MZRNLA$0C;+1_?)@4\V2N,P[&9!BW- .,OIE*TCZP55?W+O#PWNA_B9AZ#);S
MYG]Z4A'5K1&PQW\"=P S76)@A4_XD#ISL3$WU3JWI<"VW0MKC,>ZGG7*TJD(
MH%29-'-T;XRNI0WA]FLCHF;NE6;F#LF*^4EXH?=#]O3?I]^%:D<D)T='^*?3
M7%X#WQE5LU@,5=<P>:,N9 \%XM;5?:A1KD TY[*8UE[_PYO6:!>T$7*FIJ5]
M<">( Q^5L.*#PR_&RH_GN*/M#1S(J U\Q5S5]5(':"7F?=NR%R#W?E+RJB]R
MFRJ7?!T64+]$"3YZG,SG/ANRNDV4FUYSY2HO]#&!T;<]<-*J$F4Y4X;A!9*Y
M%%S&EBZI3.LV;]"+=$"\!TO'@S)X+M1G;.*N:XI'')YP<T:CB,/3C[5$')Z>
MXO#<4>3^)!!-3<1X<."[<0HE4J17\6!2G^L*Q/M%JFV'G@(7JE^$B8[XDN!E
MM"+&^/Q;+\*5UB@5I5/7K4T*[D@FVUZ+MC#S4F*555 5QAWJ>%-%9K"%<()K
M4<W0]38[7<W1U)V(%&L Z?=]"QYM^S [_Z-_ 8XW\/@W^'-?7+4)8Z-B=(-X
MCWB+F"H4B9?6VG%E$D'(PX:@5-7IDJ) O)0EQ3O JI/(P54E\][Q:C]V!,F7
M3-0U]E?Y'K*S]V]6"3TCJ#XTATG:K$8Z]N?S/L8HHAY;TF,QT[O*'Z#1M]IE
MS+6WK,_I2%(16A GY+HP%[!RT4&DYM&C _RG^Q,W4*X]IV@-4&TV=ID<8+01
MC^V!"SM:0M!#1_C+O61T',8D^[EO6ZTN(WEG=X#HAAL3;)M%QZ1(O&^')8#8
M@_VP ;:S-1U=" ^U"HP2@J 1C9(U860N*\=A\AIVBC(UOF?7,M8@*<$PI$X>
M ]H7:^<1V-6",[JT-N+2DJ&GKH/>'PO6B+^$JRX(U3S7!:I6GP_W%W\5]7;G
M%W'L3:?>[I*N_;4S^"(2IA=AEEC<LV/@EM$>[9$]&IFCW\S1@[I4W[825C,W
MM0)]R/VQSD$F$WT0X+K<B(QB8?*[_8S4BJD*A0;@HOUUT(=MF]RSAN#\,RSQ
M'"39HDIG8#DJ,:!:CP0_!4-[/-+09J?!WFJ,M"6);(@R$**/#;8&Z3#Y%V+Y
M-Q4'$Y?*?M@9033V-2\(GA^N)2A3*\ CH9$X%B\>:=5M$)TA2+O' 1!C?(>#
M A@FIQS9"2!4J2?'0NS07?CD>JG[IE(U?+V1I<36T]R"D]L]Q#;[MD.6,'!F
M8.P.D^>+L%-HCM7M]FWP7B8$\0=;Y]V^?: UPL'6.(6ABSN Y0;PG3I-&\-&
M/O!T#K9XD4R-ON+Z'3"*YXV?S6#DS\VE+!Q$CT=%L,QP!>N[R+'<][VS].L%
M=1CG"V_ST\0)+&?M&/C6P:,"0MMKM (<X!_%$ (Y5B425"U"-^239(9/=N ]
MI4C=MUYI/^F"G8<U+D."]C9B6 56)CA1%7BD<'X<&"IVI3*6D@53^(^IP0=-
MN<GH/Y#8<Y4:O4?[XQWCH/VJZ*L;NV4O]FOPV3Y:\1:59Q!A+F3,BK?+B1.Q
MP^7\RRJ,2)+>^?/]HLJVDZJ^.0>#J6%'!)N69 0YZ\=:K/U3\^^E,-MU[/J7
M>=D^3?I%C]?4=8:8.CU)TCLWT)>5A Y=Z.[YXV<]@'[1=?M\UI)TL,G;!7=5
M\"A!3:/L<(P$8T4Y3#CO\=$/( P1+M;ZII@RI.ZO&A,]M33D(6'NSPV<77)-
ML7]LK4/N!F]Q23S\,6,<L,XCV#VTN'MV"3QD;.GKQ!C]5UJ=-LYQZSZ?"PUR
M*2XYUI#:&=LXSL_>0T&/*Y7G[$V#!RYECA,2.97&B+74%H.E3LD$=@UG9@R3
M[S$*X69DM.L$3U(';O@@&&7'N'4.UZCL.)P%/->YZ3B#(X#UP(LG#5='27I0
M4S7D+^-,#S],416KX'NPE$?[#H(O\-YOD:>K9^ !AXX\?.T<6&A&PV> "R[A
MP_OIW=UX7E;!Q?J=X6"H\JC)VHSAZZU64_3/U&G!['MA2H/]+!E%\(/(E$Y>
M(ZZG+-(%1] **3/2#182CN2OJVV<."NE[J"O/B3\OV\"*0OW9&K"J)&HG/9
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M[CFH <WFY+%,@L*:?H%TI C6IH"MG_WFC-*]S2'%KJ[?0X[_!FY2=9RWV/^
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M%:QS6L"V'.RS*O,,D:UG!V"3YX**N][;/[_B/Y]62OB"10X&T(YPH@CO>]/
MIZ/ $,[\Y>H@:U(NND?8?;,'# >I88WWB9(Y+Z7=QT'2&,J4@VE3SL#^S^?V
MQU<_?"0B3.%(I/9WC-Y0+ 4""%>@P"C [NF/0/DE8H[VJ:-Q@-^W05HZ$KL(
M9LNPUKL C9.") ,6@\7]RL* #%(";42J"9/.K/%/!X.8W%IZ?"I:3RPH:T#8
M#3=]P9MK-9R,TEM%-05LZC7Q,;#>N([+?Q5N9XZZJ>$)AVAF@4N+9.+:0YL3
MP)JUL3 @K;AH AYC%A9\03<YLKY$E4C&$?Y1X'L(.=YZ>$[;8MR)Y(3];L6$
M=POU#W3:RR>6E\M*2>79Y1'V8B#PJ9?5*BXR]?GD#5HW-WB[VTSZ&T8&Z.[.
M?I-/FUO.#_>#O,MS;+/UX;CP0V<"+IY2*3$.NN5B!(N.&.Y@IBD:YCW7CFN.
M3.8"1F#&[/E@P#J;AYZ$H!TE:!WPBG'+ATF+FM!9'J:<2'D$089V+KD/ZG&$
M*E^X FO<%MH-;L6V5'>QBDE3,TID>W'0RM@U_S%27R/\!IP_#+G6MJ'\1GL=
MMR\( @3[0@]CQO9"L @-,G;1;..YLG4^-[W+5C, %RAVW\-H$EAC\/1"S.7
M.YF6VY8#H_BA("@QR(JJ>F '1F&-2<5DA?44C>2S9:\;!(Y7ZQQ?S?0@R>RE
M[G2M<:G71R3\Y@]X0)2>NY&^\%3B0#G!-]>A.1G8A"L\/DR\(+V4I! JB@@A
M;[6(*402;D%DIF[A24G]3U712M--NQ'GIW;J,Q[%^HQ^K"769^QB?<:&U,SF
MH)WUIJ@?X!H<2C+E.HY"ZWB1!/[?=U9!3]$<DEVMVGV,"2H,,:HU\-H85S7H
M^B2R*YTM, J)9WAE&V/\WW=>A*Y^U7)T@-7F^]FB JM!%'L8_\0P2=;>2_JN
M<J:3-8MXG6' 8$VDX%5QJ0RZKS\(&Q# 6W%X"/UP;M\PL(:X]8'[[%.L#ZA]
M" W[EZUAW^<O^?3IX!051Z4_Y;I0JL<Z+G:;0WR626OD+J6UV3+'+V\S G-5
M5<O1.<J"PDG@3AL\$=;NH].)79[9IEP36EN!35WK&@PKZNW-V8GMB(247'-5
MS6AQBK-X?'# 9.(XLS?<=+."0X,56],B#'<H+!$(/GJPQG[WR3N?[\*E5@T8
MGFHS[=!HI"@+D)RS%#Z"7<$75Q.N>\5\ /R>;K:1[>Y'^]P-?;OUN7#BE'5(
M&+ 'V*RVCE4W'& DMU!10A$S"/!G5\"&J5:XSR5F>WVX;U\]MO$X"$XH4W2/
M[.P"]\T& GPUBL7$'!LM,G0R)">N<+.1(Y&-* Z!Z:>RUC:*7%#TIM*3^DJX
MJ0TL>LG>981(</T(C;.[P2X*1\F:#8Z#*S!Q^3+@+=@0Z>8A9):SN1PAQ[9J
M6,U476YRIFHIYC[]@S6/E)VA.!]&P*G8_!*UBQ09];H%ZZ6<4I+FNI)M" !C
M&;6-4=H)">ZP#Y8D05/,)08E9,87PNDT-$VMXV%C+K>-X& 8#;ZWUQRZ7OV<
MMN'#"N.O($=<(H(44FBKG#I;I>KS=][^)'+X8+K@L#S*3NZKY+/EIQW7 < -
M34?&M+*B$B,*AE=N/G(P3*\;Y&Y3S<1YP3.8=>'Q*DM*!XOD[[6A62\AK%QL
M&<\BZOF<EL=SY7!OD A555 G3,A/#DL/>]?1][Z06/V1S@2J-AX?V'6N.>Q"
MJ_%$PF3F1.=*KRZ<?&*>_G+6+7P(2KZX" ?ECQU4XN*.GXYW+@>%2,EGGPR5
MN,L&8>2<$CY+K+_>3'<14^KI 85/M2YZM5*F@^0%]*8 (5[%2[,Q&!N7Z[7<
M^+2Q%U#:9<77"75[W(!M-256R0HCHZ0VU&,EN>3'4V>,F7B<5DF&%' H,67#
M8'[!YEFS(M@_'%QIXY3< &2W:-.>JL(>@^508J<RBI -. &&;_ #=6RU?<NC
M%MVWB^96M!G38?)6XC!I6U05?@K<ZI(R06-BX!\%:<O.UW2T\L#69<WHB".R
MA:HN6#P4&FX%PX^+%A@5!32QM+C(;,>V*27J41\C;!OQ^J3)\=/IMQ@R1N!A
MPQ I(L.F1H*B8Q2P]='$ N2"RNC(<[*=C]]$%; B"ELZ6 @K+*M9,L$Z^UX?
MDO7*]6UHQ_=Y^;>IM&XSL-U,$5E8R*"Z\)FBJ@'+M)+S,=;24<43H8'#F01&
MR[1C?+[$A=PE5NE(D1*B4^<5]DP^!RX>BT)B+CY7H 8*);!'17'9)CT2KU0F
MHUS&HK5'@^6W[IV]E=2P[5]WF.D#+N'TT6<O8D"2&%>I[.#/0?"5&*[61KF:
M/4Z.!+L?,'NO&?G3G% VH)8%"F6786HW?]#=^4%GF[,V(8_)/)'D:DZ%[.WD
M-<LIF"(X!0EC<7$_O&X+"$Q(5V:ILUSK3,#ZALF;.D,/6;MR-*XG%X3LP6Z.
M]3=Q$UM_:S7Q,LE!"]GZ01];\*NCZ6PT%)LVNEW_C<=@"=',]@V#!YW.@,UR
MMPS@:PE2SV:M.)D(##@#8:^--0FY1IA>0?4'<%)<+1 0 ;R<I*;MISS@36O"
ME,LEMCX'?;-4$5W".26VM;VYB.1H^5H;,I\(@3=L/9N(,:ZOEOXXVUIH_WX*
M2W3XPY<(.]IV:YG943-DI]HTN2W6=K;I35]G*YQ\0HSJ0%1E&H_22&^E=*5+
M+)&AP3$(JL=LL$Y2L?'-I]\I<S  "SR2Y#.TKFK PM16MTPE"F9,%EP2Z!F*
M(C:8$P[/$@6<<&7L/,/GSE$N4:I;, 9!+A8^B[JL:SORAY*KF4UH=WD=]7@;
M0,@Z+=3M&[BQD/WYA9/0-^QMKZ7<>G7]/JAU>!_  GSTAEB?O^G3DMM(.O.H
MS7#GL++7'00N\T#N*A>46+!UP'/J<_2UOQ4+Y%Q<6=F.E8P8.<IM,1BHSPD?
M#-$J9>5*'U$5 $E8;RY[5/4FF_&F@A/0$Z1O_P&\CEN%A6\'^P<'RUR>)0>/
MX9A7C4U!- 5P/!U):C2R52Z#1#+B@!5^P=\ZT1_^+&IU=9=VHYJ=4%&; V(&
MPUDISAA@E*9%\O#]BX_?K#9&V1Z1"9;OH(@(Y$Q8F..W:L7;#5RKNY/6G8>V
MNY>*4P10>&\!WGE"K<I^HDSPT;ABJI.A4A(NNK&^1L?_()?#D7 -H1TJ5SA%
M!7>1FS,G[;[Q@^QZ[3YC80>.4TTY)V4AT'R8T+DP8^F#'JAI06$JDS;S2P8I
M'"^Z%1"D=M@>!0'LWNB\)&")@EX\QF@0^#DL%IT.0;@M"IM\@N,#SX]U@ LX
M=#^  L&^)/G2UK778//$LH=.V<-A+'OHQUIBV<.NESU0HSPZ5VP/RK9W/U!"
MK<& E6Z?KM*R50$V]><>F$F$6:IP8'>SL;XOI?C@<HC=A1K9ZPIM%XY&UPX#
M("RC1\>+DU2^K[GN6$]8.DY]?+!B]UO\P"Z$02=V80G@%D'D"9L+^H40\8(Z
M>[<)$3'H&45.T^8C3KK!\7;?@3Z7P3__/WOOVMVVD:P+_Q6L.9=)UH84RW8N
MCL_9:VE\23P3)QXKF:SW? /))HD(!#@ *)GSZ]]ZJJIO $A)MC2BQMAKS8Y,
M@D"CN[JZ+D\])3@ LADM<7HJGR3_^*\T<8TBTF2U_7N:,-<I_>?-BU^2'Z3'
M> HGXW=85-]^^XCS[&?33;%N@S^3_&7X+T0ETL1W?[)_OW\M8O_!5,?WVBHK
MCABJO0CT0X6L]*5:EHEC^HAV2; O#DL([+)R11%MD#1A*A5-Y>"K']_?:\?U
MF_@-=^,K_*<XQK$_ZUS<H.XO=%S9!'?0C#2 *41 !P^V8(2]"3U>IJ3!QVE\
M3(4_"D(1855'#XWH\M&(%'&,<J&,X_I*QL9C.9P45:!SD-0YZIRH8;)?3A;3
M/TJC-'@6)Q[FFZYT\<1;BF;.>U^PN1$"3?O9-[Y,G,X9O1QBBP@-SG(U*CA#
MQS_7'PL,T-\^+R64:32L*=EKS!.Y9]))SD]N7C)07V(BSL^SV83<!/?EYUPB
MJ0XL9) ('G3G>@L;/O6\K"X+,]OGM!WL)GH=ZY9@ E%AQ]P)7!R F7G3DE">
MG!XG[]$,Z'4VY7H2CBGG37):EM K[PT0!=B)K]&C^^31T=_2((#2J!1"2EMD
M%##'CQ\]CVYYQ(0XNU05GTM<[6*3^%:R=$=R^,*&8_%^17$UA8"@\G#K-5@F
MNW+3]DMK0S%?@?4AJGCI%M0HTQMMT*K03:F)<.2IE%R[_\K(;BUT/;0K+8>/
M<[KKCMB#WM;FWB72Y9*S03'+,<^])S@^1*D=CO/^@)I\B4*^=_##@WR-G8;*
M\(LI,=19BQ+V@WRA&V.THA*N;KEJ4*'O<:0(V96;E:D!L%WXI4;-_+13VXT-
M\/KEJ=;5<P45MJR[MD] ]VO%^3(I L1YAJ"QYJSM*:>_U>.X"Z$*<;((I&M=
MDX?!RICM\"P0*@T1)BFGUQ@<W,$*%QD0*_@+/5(U9Q80VM72,II./ULOP!>'
M4))4H!QMWNA]4%[ GX->@[3:N3%K_JIF;<U_(LU^[M#*I%_D"XO$TG\%Z!9=
MP\@=3WDQ^G,A18(5Z!;YGAXHV[,85$')K/)Q'9JX^FV ?N8;V#$Y8?-U$S,'
M7N8 .)>GXFU,!\@,V NH>[*Y&%E.F]O@1UZK94Z_!#3^^VOOSS5.V')Q5)AY
M^_TSNV%S-FJ^/Z(/[FF[LO[_YAX)[N.9^?KX:TR%=2DU:=J!#^X^K<99_IA9
M5C4T3NOM3FNDU,?)O=W)A8YNM^.LWNZL6L-CG-=;EE;R:<FD'*?U=J8U-F''
M6;TM8=WO:XSS?#OS'#AF-HXHOMDXP;>J=<<9O0.K:X@H[3D^&6?Z5F:: TL
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M95^<4TM[-F? U/[+/]Z\/#IYEM#X9H;<NW'I;W?I;:T@5ZW;9H -^4*6&T?
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M7=;.@49=;ES]/<@@%.W8N+0N5%:,TX\:.*:^_EM/"TO47SG+.+9 _!G$((W
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MED?()7$VRIV@KFH5!'6F;:5@G*S(HI HH[UKTEE;>>V,;-LE[;UI.#99JR!
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MY@<F+6BU<S''OF:[XH"V;5$:^W:I-?L<)T\:MJ$/88.6K&=<YCM=YIX3%+!
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MQI)<<P=@\83<JUENVEEU*6:-[94<'):6ACD\/_5N_%Y\+\T4DP_-PI_0++:
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MLN%M>4=( $IW2WLYAJP W.*.@O5)B?10]G$>SD,_Q@D'*B@*C(MC,6CCD6@
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M".@*H/H?5'89@? HU,$F-.E-( #:00EO5]!TUQD(A/#7W_H?@)-T^6<+HGQ
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MIT=2H#Y$P'JX_VTX/R:]781>)TD;*:!AX.>P?MN]%/>(BUC%]?C'"F3N:I7
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MZQ*;7]FB\\N2L1JP3#9@01>9]OQH*L!(7:<A?Z3_8TRCG_Z*FR&#CLU@_<L
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ML;IUU"$JEVD#MQ/XJ^=O1[T(57CG,#*MS$EP_D<@.=XZ)U0E$J87)CIAGA2
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M%VLV9GMPL.BB7@@'G^ZR!CD[AN(]0T<>PE,"8#N.6I#4VN@6*\%U[XBW9S[
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M#!%<0\9SHT3:)'030!0QA).+JN(B]!%O5]UR#7\:-X]2YR7T4,+52MG"=F7
M4) 7YT2Y729$Z)>8V>8FS*Z_]6'C3Y)!]^OX^NV/[+(EBPXKRF ->KS"WIGP
MRM:K/XR<\_%13(=Y)W;I8/Q(Y96P\.X[*) @'Q2\#HPBI"_HMY?M]$2=GIF
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MWV#AQ_G4'<BP'/'F\'N&LN>HH*3R-,I,2B(HKNQ;T=CT.[.:K_O]4X)Y?K6
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MP0_W]A:*YW2@HMV.W =F^(9/ 9X1'134O B@+3AK@TR\C=VWFJ4P!3[#^!?
M-J:"DF^W-WB5#=)"AB#!_VCDAW)%A0XPI!@P2-1_]2_#S) H9A4"B2@LL!%
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M\1V</=+\^+&_];'X3U'O/XA_53Z0I2\AZ@F/@(SP-8WPQ2OZ-VPYJH!_;^\
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MHX#LPM!989E,ODNT_(0Y>&(=I.*3H&+M,RS( YDYD%T=]0Z9"\9D_D+LQN:
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M"BKM]IDW37$FH+3:5D6R ^,9>XX;\9'FX,]GZ_Z3!9(UP>,.B\*RU:;MG:P
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M 5R/G+12T)O]UH9X<6RQ#"G/@2<P7/P\J@GRXT'9H9II57.R0Q=&QX%5<^(
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MZBUT6_&0:DJ:5VR%)?IN*%_L=N?A=J?0&#!CVUCCG@GK4.YR J8=S''*E4-
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M5:0FSNA2,H@FB@R9I010[C7NA%'^]7-56\-S(<>G<L@B,70Z$@?_"26@UZ'
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M9$=;="-[I-9CE4W8MF7\1U0<B\KTG"%-$0UL^SS#]$^&M=28!?!O@7ZO!",
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M5&1!.EE2"-7BYL+GC^D9"C-%YF4<HI!,9R)A4<8_+-3&<H#A.L[#,<8CS('
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MFD+!@>G<NCYQJ.+ZP78DA#*LMIB,]W&F1Y>BS@NVOVTM\,\=Q)K2<UY"ISQ
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M.(R%!3IX&"'$!##<.0 ](7%)"$,II!A5J=19CBBN:$1/!N=#P3E?%%DE_-$
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M>)]5J14#^KPJA0U%UA$"&$Y EU$8D8P@H.,6=% YAY!+?:;K3#PX3S(#O;I
MU]0&9"5C. JAS$+IC>&2"9+JF#J.L^JQ8D"?5SV0]\PK'4!@U$750P6@'(3
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MX #"['E:!6DUKU)UDTV68-_Y5=;)#7+K[5@Z2ZIW(>)YTTZ44:$3%@(63UE
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M%"MX_+ HO>!QV:6R2W>?7T*QTM)C;Y1G2FD;3."5$)9Z3KE5A6L^/*ZYVD!
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MGHG*)F+GEWC<'GROI0>AF"S22DHE= V9=,R<3N##<4K0*WZ-.^HPM[ GA[$
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M4&.(XSAL;5>D*_"JGZ($;#\:RKZ3'.X5RB[$>SWB7=(9 (*=!,T 20J: K-
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MJ@S9E :KU1^Z'$S4&W1^'?7&U@P >G:3/68X&O1,%Q8VC,(%, ),J3=E#L$
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M*1@Q6U>\Y]O\_N)[)%4N1A:)UIP9IFP@S M!M34**VDW1R+X*AYDSN13TL+
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MK.XE0:01TVV PS7(\4O);+ DL!.>!':BN_4T:M.,24<YH?994A F*3$D:]&
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M6I#S6>?E+(_'3@<^B28K#[P8$3F+C$M[,"]J<OGS<UF!QBIUI6#1BPOQ;"D
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M%!#0M/+TJRT\%_O%K7S9]MC.)_MSKZX</VO1O=-"11.V49?C;FSE8<8VVMZ
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MN4?G)T5FN6593F04I83)A!$A\-8SLQ%+>):KQ&Z\BK;FX7![H-_[-1'T?41
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M>]L'.[UWN^^/WNV]/MK=<;^?-W5MD5[8[G'K8+Y['DB=&3WM@SNX6.K>GT&
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MS\(0%1%57!8@D*"$&9)W%VD6$RH,+XI49(H+!*F/^3-1QUUL(@<9,X]0]!3
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M)*6H4'GPXST4QO%P%4INN7S-P'A5Z^+F[J@-C/&-D!MK2ID?:O1(.P&PDDQ
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MQ4M5FH,RG;)=V[6<EB&L9H3($I_)W=L%Q@K*;&[_<)I;R#:.N^V6/R_R<',
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M[2F@M-;0S+&UY(D:IWAD6%)M&8D^T#N&W]1[:M[WU.'G/:L5XY(XI&4,B#-
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M55-:ZSP0T1\F2\]M@(Y@\Z,,T/O?T5,.7Q_C58_Q#N+HD]7$,*\T5@Z_\)3
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M'9.;]UK@Q99K*@N\=W ""RR%#2EPI$R5'QG9L $H PAAIIT/4FQL4[Y%IAN
MW+G ^'X+?+\FM66![US@KZ_$9QILP)8RA)-EB-.@D+%&($T=<X2FH)6J;&T]
M^P(3LUEMI?=99*R=D3C@**/DPC,3-?=>"Q4]85&Z:I%U6>39%_GMY6<9*NQP
MI .!10Y, D/[@(SW1CIJ*0ZAZFF!9Z=IHE=2&V*UTX8.0--I5V<P6;6Y0S,=
M^AX;S;9O#0*,9WCJ]$.A':E*C?-F__@XMBKMRL5CVTIC92J>GK4Z%S%_J=/(
M-G(O751O@"W;'_0[7?C+?A]>H-.J#@V[$2SD;F5#]U9RL7GM%GM_J/1^R5[C
MRB;9K/Y.MMD=&3-@?.27>G&\YC;[*GJ-<]O[.:%.Z;M$6A&T2QK4'V&,@XV;
M4\V$Y-XRE0-3B!D%IMS2VUT\52[+0:=O6W,&=LMGR.S[.X>7GQD3FH2H4+#.
M(TZ20]9BV,V=,(H1+(.W&]MB:[IV10,DO@6_K"2PQ3,&]D-;^11@UQW8!V_%
MYTBP(R$E6$/C$! X*&_2,"2L=B)Y3CDUN17/UBT:VRHC6SYC9#\T&:L@N_;(
M/B&?,0;XJL"0E0*V['RPK8FB*!MHR27*;+:XP>">%=BCC^W!2H'E,/P[RU6S
M/:C6^P;T1^+.Z9;*&3[3Z3_GS= _'I_F7?OB*(@(__B*=;U.:]"_^RO73DT\
M"%'L/A&I&#TQ8==^'G=_D.*7B%PWVA-D$PSVA6V=VXO>QB\W3V^:;30QAY./
M?^=#IK0\ZJKF&C#6Z59K_F( 7-X=)FO]V]9F+(WC;F:Z?S2SNJI5)"P24&.8
M-XFH9*61#'.9A/P,$#C(!VC9?/TMD^2_?[$K^R1 H-7P;Y'"":P..5%$( .O
MI9!2<ROA%H$;T/L4#E18+C=^=J"X/)!55WS1!*YO^I_''U>P>Y_]%VAXV'-]
M_[DY#3?(Z^9^J!G6^9PW6-!LM38NVBBHE(X%P833M^Z'$SN@/XYAT(K[Z?H(
M?NOT^K]WNM-[WX^=L?>JU>KXZM/[Z?9]-%^E]^O%'RW;KD3U  ;^*WSIY/GM
M;&1OQ[//UN.H58B(,Q[@!U'( 0J0)41B15G45F\T(B@ 9WEWZ [B$PGR3W>+
MH=A6T2(@CC^6NQ&_Y]^OU+W&1;3=7B,")80[#[*R!5;YPK./I5((X;_4 =DZ
M[S7^V<RJ96< HPV]?[VX4UV_-B^BFI8JM&"BSB1,3\N>]>*+\2\O0[-WUK(7
M+YKMZB&K+[T<76NTF]^2Y%M1WO#MT<YFS);"*F]NHX2)T8U'^]Y6M>]-Q%<,
MWY-@GG!VY]MXB]SYWL\N2_ 6L.N]+OOS]P0K@Y5LM@'-F&1]9T@@$;,D9 _U
MQEJEU1P"[!NO;Z ^I]3<"#1ZZ.1<BY><(T*_YA/WTYRC.9_XV<W<W7V\RLS]
M=.:(F0>9*Y;X=WL0[OMAG-304[.TCE-K&FP]^_.O320V=3(IXX*)E'#)A<,R
M$H,U3=SPD&ZWLWX6DCVRG6*XW7!Z/52DUR4^FAX=_/EU_^#CU]VO'RX/O^[B
M/;I+]@]>Y9AIO+OSX?P0C*BCT[WCHZGXZ*/6WIM=L?=I]V+O8*^Y>_F.'5Y^
M$/"=R_V==^=[![\>[^U\/#VDO[?^NGP[U9#.!QFU)QAEWP#B@7-DJ,%@;S'#
ML-?)![:QK?3T$<'S;D97*.[949R1P5*)=<!><6>\M9@K^%U:$1DUYN\.30O%
M/1+%3;2:<X*+P 5!47F+8'/RR&G)$<,Q<:5ET$IN;#.UJ/2/0G&%XNKTX/,$
M?(E@C:3:A&! ;S,ZAN"(DCH$8HBA?Q?P52CN<2AN;T*+2X9C O\@+))!/)J$
MK&0,"2U<SJ. 72MN;$NZ,EK<&I5?_//]ARD#>CTJ+SY%C>!YB>49Y-8^$NOL
M3MF.+/!H/;;(<IT03Y0A'31#1C/A/3%)\+2Q+389%BM3G^RY /*A$: %D'4
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M 5'=O-EK#"\!E'?<A&MVLU!45^DV8]O#%5*CUX3)L=W1;38;7YK?\MB #'M
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M(@CLX @K[Q%/1"*3@D">&DX-!M/9\X*Z^J%N:?IR0=T24#>I-3.BI0%E!>E
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M3AQ#+F&/B"?,A! XU0 YC:?+*JR 2Z+6V_F;3B><-UNM9Y8-\<3G#]?(9;P
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MX8U&!#H[@X7I=P=Q8_O@.#9"$U:D&]L>A,G%_GF,[48?7O^P]7ZKD2) Q;9
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M1Q+G//7.)DLYC=1%[%ED)$62' W\\]O;##TD)OGERBUEO[_J]6*_-QU!>S-
M#>@/A4X?C2YZQ3IR14GGZ*]C[$\_MNTG,X QGN[N9#)HG>Y>PK</WO&C-Q^/
M]S_!.$^/3O8/@)"^[GT]O'Q[_M?EX?G^N\^6\(2]<2@YJ1 G)B'K@@7-)SKA
M%5/:@]+#\=9T6GP#Q+&5EQFFMY*4LTZW6G80A?QGN#IYM=\;-B\.O&S[C6:_
M$3H@P>U.OQ&_G\'VT.AW&BZ"A $B+F/8:AS UV\5LO9UD:P"W]1+N!)<^OK=
MX.+-MH?+]>!O=S&78#[0%3$MH=,".2FSPQC8M^U7I\"S_2*NMXNKIWOGGR/8
M5U0ECB@3,H=91&0T-H@D'0U-408FLXX^G7YU):VV'>83B(<9=T4@EB80;._5
M9Z:3$3@$Q(S'B%-@,I,3=C0U,4B=')=Q8UMN36L\5P(1!EW012IBR='GO4;,
M#;WOV!,K\<GKO)FCU,^&NFWK8DA9OEJW3#ZWLI?MQASE#KH [.-PVYAY+VM"
M^7.VU?BP]7[K%M;L5?=L-:UKMN"C0W(;5)]I#OGPQTBJ)Q@.9KQO']O>7/).
MHTR@+L*&;#"G'GXQ7I/ @HG$$ZWNO3/_]\<3[,4BU7=(]0G?_?(Y KT$S0/"
MV@/-&:UA5Q8"2=CP3(@1:RFS(C]]RGLEU; )3VZ+8W%J5EMVU;3B*\A^+S2K
M[_8V&^?'37_< *72?HE5$V\76\WX#40NR^XI? FUFB<@[PAV\C;*._C-K;OQ
M!81P*)3#K=V.-8(TZ _@&B">;4!;;R2ZO7AS"#=%=Z14P^WA+J<=D-F1IC&\
MW5"<+L;ZQIWPZ=N3#/!F.\/-^\RIC=-!J]\\:\5&@HGK=.'9 52M01@S 4 *
M/E$IQYTK$[4"XJG] @,9A$KEC<..@_EFP!F#X4-4"E&OW_$GR%4JR/6&A#>?
M$,8$;%,]W_AAX0;P*OPO#\7"O+5:=^E"31C@G4\-3]ELY6>!66_V&KU!2DW?
MS(L:OS5#S)> N_8&9UEM&STS&%P](")X,+A/(S\%V.P3>ATLV=4@8+W^C*VL
M9XV^LYF_9,??V!POS6WC/^\,6F$TSS^(S'?R[([NYL'^@XFXDQ-M)J!*S<N/
MTJP\#-5GLNRUX=4KS12,HTX8W6(X7IB2L46S=67:K8[9UI_)9CNV,$EG9]W.
M=V#5/N!VKIU B*AI8"P*P3E6W%)K/><J*-"$N)QY)QCY>-I?_MOI]7ZSW>X%
MK,NY[89>V01NWP1>\]W+#Y]58#&0R)%VV",>!:@UR>O<8P'LYD!3\&QC6XFM
MZ1;R]]9VE>.6)&:"%(2KY*VG41,KO,3)!S>S75[6?/XUW]MY^SEH[[UD!/9[
MFQ#7WB)C342,1*$4)X0%6QVF3L>17]_Z4PQ5]<>\_+U^[DR5E8'.>%$:K4ZN
M"'E]66[JLYL-^\TV6]F_E:FUDU(VWT=[.#!L]<:0<(<;VGUNV$R5#V  ^U2E
M.YS#^!M?AG4K@:I<_)*WA4YF\V:WRA$%V3-#ONL?=SN#+\?P"LQ%X]6].>ZA
M?J@J?NIN8?_4[!]W!OW7^0FJ#? 9"_A;MK?SA>U=GISO71Z>P_<^RX2)SM&,
MAA.#."8$:6(,2D(QJB*8'"X+N]B:+O)T7=C[G3Y(WE@"_T[N&N=9(QJ*61^D
M[JS3^[&9-H;[*%&5(!];L*C:(P$<:6]S[+S=48VPZEKA1Y6P2D49EF/MW8ZS
M:V#Z#=0-&'J[::NOW30#JUO:RDLPKP,6#(S(* %)#X1'3PR5B5 M0.:-LC',
M2O1@WOU6/<IUN2^.BY\"X7)OQW_FS'$9N$2&<8=XROL\2#\B%FML"";4T.RY
M6.#FSH31P5N#@V#<1IQ=G-8FX@AS0GI2UGR9:W[P^C-U6H>\L3ML%1!>I,AB
MZ9 S7"L7I3#4YZIV=SO;)]U.OX^H8DPGU1YZ^\[))_EDN$]?)Z-;"&_U;*/?
MIU21ECW/FP 8S*? ]A&,7@=O5%VB\G3VNR/OP_A\8:B17+DN;ME1\K5_3-S$
M!C/B92#\(2W#C?-1!<4O.^>PZ_2.FV<C5^%F]3IY"49M-G+A42J?WOLXA#+3
M=&Q!OP48=[.3\,]\V4'>:$*<=O2%"!\[K:Y3G;7 6N:#^2:8_O"\L'N<-D<N
MF:'Y[< V;ED/'[_]T>\Z;9EG.D:.SF%]C\D9Z*V@@.UU;GHDKN_)%8)<C.T?
MYZ7=V!I.%4Q")1=C%]@=\SOVS64I;8:F[>;K]IJ5!QG W1N 1G%U#5O!NS]T
M60]]<<UV)4K-2A>&2[6_@8B/3]5^* O5:K=''I>L?M_Z3!?9W]+QS4I5.@=M
M=N0"^N''@_].L^+=!335<S&K*[X P6\U_8WE5;<N[X?VV.\$^USCCTZO\D?U
M:OEH/Y73Z^0 (@!*9K,'BW=57J=RCPVNGC8O^]GX:1M#S^6(%5KPB'"%L?0,
MCW%[/W,(]^#);>8AT)C;UVYRS4DWOM=PS\I?=5<>P"R/8!X"EV16:U4^5KA!
MPS8$_M]&=<OF<:<3_C][;][45I+TC7X5!<]S[^U^0^6N?7%/$$$;[)>)EFC;
MV![XQU$K" N)T6(,G_YFG2.!D,!&($""T]/CQIRMELQ?+I5+)F07,W--?'!R
MWH!362$!1JD-3KM "O&D](A9X"(8ZOA[A;,U>W>C[9?G03<LS,C<;?5@.8JW
MM0KO;2Q=G+%8KBNSRXL\Z==T9Q<H77BE2TXL-[*0%A<&P86?%C@:\'L0^Q<'
MZ*/%+U?BK%R;8O'S]?(L?G)Q)S<D[ZD= DQ/NKR!)+KMX1CU"\2*A>LP@@J8
M?;H9W@Y*L0"+EYW>L;3@89'+)>GG=*$PN2;E6EXNB0.;*\'@;?]71%5.Z&*K
MSRZW^>*@87@"0P%C:= N3BJFD&<V)&>"84=,PNDK)8"1QDOUN@3J[_'/TU88
M'(X3&28>' 4[X<M'K"O6[>9')L @)TS%WA-A <E1JU=6:.+/P]YX."?V("('
MB_P-V02C?6W;I_:LO_;'5<0#N)M:Q.GYWSC+E!YLEB7RABQWBTU_/01)V,MW
MP9CLTHRE=MC+UMC_M()U7JM(6"2*!^9-(BI9:23#7"8AORK \ ()@/QSR&3\
MUQ]V96?2&?2+X5]#A5/,6MJ&*02C4B1&8["2O;0F1<IX4BE9H1)?6PTAO-'.
M'L"#PRO>H8MCU9& LR'^=VA'"ELAG$,A-UK%.=ZU<JB>=7O0S8:]XC0M6S>
M\N/CUY$4 #403(;\7'<X* 3OQ1D>J&S W_TKPC>,V^=>E:&VZ)75'SUXH3W
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MT-A&)^P,#F/OGVY_T(N#5B\>Q\[@K]B)J37H;[;ZOMWM#Y>I-\ZW$>1U =8
MM#;WSIKOM@#F-C#\C>UL_ONHL?GAV\Z7#RWXDFB>'[8S?%WIC7,4CN!]I\VC
M;;RWVR!P/T"8YXWCQFGSW7NQ_P[><?Z-[;S[!/#UC30.OA)+I=(^(A^U05R"
M@:93"L@HY6/PU%HQ:ML%S!O#1A8<A@L2)%98*\HEC@!YL!,NL2 9#8!P4ZUT
M-K?>;C>W-F=AH:3%*7 HM^'7W[@Z)JK!HN0F$&455Y8[T.F9,LGH$$22_HD:
M]#PIP[W9:>Y^V/[KT^[V3O/%HLX_?V]<3/XG;;QF*? 6%+5<(N?ZQ=_N% V5
M/KWZ^*I>_)251-LYJQW:?FZ7%"^BO>WWK"Z68=Z_9:RF^$^.R6_??J_] [\K
M?D/^_!U>8@>U_PYA<@GTSUI^#>BM*?9Z.2'5MFWOK&9[/=LY*" 7U&100&J@
ML19K.WKCJ.?4=FYCT;'MVH?X/0(SP^A"?%7;@H4K*G^.1]>O'=LS^/^W6/O>
M;8,>FS^2]ZS7<L.+NCOYC1,CK@U/\F]O5-O+?EG3R2;$.4^]L\E23B-U$7L6
M&4F1)$<#_[I]G8<2CZ60'PYZKS=!QG1B>#,QOCR>AOW1.AX>@T*>VW?8@PA*
M^FA^G\>3FGSF0AU'],4)IVT.PDD&F1RC"0F%+>(B&J0I8R@%0\&H(M2HK$[C
MV;"'_V=$8*T>T#BP=;OH20::0<'@]5I_Z(YR7S @CSX83,-!-Q-M>6>[==PJ
MC:C^*R#06M[O>OX3%\W0LK%VE9..;8BU !I%UC.ZG5G2+#E@FCIAA/_[LZZ9
M"_:ABVE%Z08J'9%D;W-R0I,WS6-(RA='N.]QX_0K" X& L.CH&5"/'*&#'&Y
MSP4/7(A@HS*Y4>:L_ZD&(J!=D.A<M'%/+V=%&X]$&\W3K\"R1'@2$':>()XB
M*-M:1,2==T:0%)S$F39F3T7&M%' T#SD<5]75$4>CT,>I+GQU29"/&,111+
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M47BM!3+ ]C/DE6Z1D9NCA-?B7GMRTNL";-5'_HZ)_MKY@5%7[,(',O%4MW<
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M&.8*:4LQXI8'9 (V2#C+B#<T.[S7UBFO$[ZH<G2/8'BLI'VQT6_9>BW^&+%
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M/*X L0+$JACDBP/$*<M588Y]] D%)BWB5&GD<H=Q$JCD6L3<KOJNU2 K0*P
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MV@J#P_%!^,2#HT-*?/F(=;#VP\'-CTR,T6<%N?=$^@3!?&K')OX\[%V&@1P
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MWWQY\K6WS.";HZ'P-=')I>*^+.&Y!81L]*=\]H7%<X$0M^C^_'R7)F0%[JJ
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MA<#; - & (0E!$YO!@WNW!_N',[ACA")(Q(,)DPY)XQ%(8F$PTD<B"3DU/:
M\A7N^!M:*)J @+6AA:T!+=]OX&TP9U/,N<SETZ@N]HM0ISV'.J%@,:>A(&$J
ML+J8XQ(>"I![0ILR:G. ($?918/[:@+5"#2SJ.,U LT#@,O;P3AOL.7^L.7C
M'+8X44RY1T&$<?V8,![[)'*]E#C43AW/24&ND1I;-JRIVD@T:V.+WT@T6P4Z
MV9=&H+E'T/DTKT9YD71=&A*1)EC(V?$)CUE"[(C;,A8L\0(ET$3!UCEZ?P^!
MYO12YI*G(YDW8LT/(DPR'N6KX>5T\$9^X)G8Q?5N .;^ >9LWCY,02WR&*!
MX@0:8,(D=$G@>D$0@](4^S'::5SW\39!4M]F[D[@;3O8#$:\:QSI0W/4_HC$
M\V/>O"<-5IN*0PU*W1]*)7,HE3)JL]2.B9M01E@0IB22#B5)P)TT#@+ *?'L
M-0TWAZG&C74/?(E,\M+*>L/Q2%6:UR5Y?D^!Z?FV@="GOLB*!"-<I#CXFL"M
M.MZE0:3[0Z2+.42B">6>'46$)VY"&),IB0/0TV00I($C4\Z$0,6,N?,U+E\T
M(M.]L>,'0!KL9?&%=\=R93CNAL!O@@)=6 LQ&&.(83F9)D;JWA9HNZ'^ 9!^
M"<8W6'Y_6'X]A^6)[;,T$3Z1L6T3%DF/A+$7$^D[7$3,IG8(.C#U6I%]7TFH
M]\=#]YR,,<D4>!2I&'_+RRR!95/L4OS*O(=Z-9$FWV%!OL/M><PB%CD@'OE!
MA/D.3DA"RAFQ R^&)?=H GRU?KY#G<"OQL4H2V\?Z&#879'(T%*ML_8&/1C7
MK77#"Z"\7B\;H68T&EB]K)_UQKT9(X]JV?5%TW*AKPDX;@ !K.Z@?T% H>I9
M0,PD09KKJHR'M%XAL:CG632I%$TJ19-*T:12;(6:T&@!FVL!"V6+E2D4OX4&
M,+P$"?_VK/?YNMT[L#OOX'_[!]^.3@^<SC]_71^=_@W?;]N=?]JT,YM/W3L
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MZ9ES[G';E@Z3)$T"A[!(."3BDA'NV%[B,<?QJ/?L]4A59K!ZJC3#[,&BJ:(
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M=9=F:\'2WA0L?]#EV(#ESP/+V[+(Z:'7/KTX=Y+4M:,X)EX:2\(\+R01]SS
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M7^3$+J#I!= =;\?@ U-JR%0?J7@:/G8(<H$06>E35\;!>/!%DEP:>A<E6Z_
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M@+&FKL<]ZH)TF8K0=VT1N1[S1>JGCMT(03^5>BYNL "!ESBA[P4QL0/JPJD
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M$R<.:!HEZR<DS^,6#'0/QGDZ&2;JR(O3D1LZU73*.D"G(14NC:E#W( %A'E
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MU3N:\;M*&(Z'=P:PS%8Q QTW"6PN ]=FH.-RQ_>E+2))1>Q&B8Z2-=2TZLC
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M3Q6&,Y%C]G:/#TZLW62DCPBDO#(W#L\/D_VDCF6,OT:J[,$Y/@!-2B7?::%
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M5%(NK]KOSFY 'J&@9'SM?#QG%+8Q2CGQF?"Q&:X@W DI\6U;.GX4!*$;S8H
M:Q[JOP@U%TN>)WM_'NQ_>G]@'1Y:>Y].#XYW6]9A9V^YAV%;!O[W[OM/NZ>'
M1YVM*YWQJU9@M[/_9.?^\=/N^\.W9X>==T]V"7;W]HX^*;UBRSGU>;9]Y6U^
MU=PG'<>W?IO>#O(GO$WRR<[]3/*\>+*S/\" F2<[^V7Q+^C\?+*+ G#]9.?N
MV#2:/JE^MF6ZAW':=36TVQW<8-#)DU8X+\X%!7TS3CQ"'8X-024G410&Q!&A
MY\01=9ETUE0XO>$(KJFF;1,[G^H2!V35Y<-"OBQ_>"6R8MCEMR^SOB(.]= K
M\RYC'$2SUDR3."7#Z,O&XA5%.X&J*USV"#4?-O:P'64/F^EXIZ\Q>#*(EEZV
M=^C2:ZM>2^T=WUU^>=5K5U_S7+<9[.,:K+/6:^_H<%NV4[2QF6+M?2MN7=#"
M58O\#]2P=/$9\,:$O_.1<C*\D<#[F,RA?ANDUIFJ&[6D7?<36)^R$\/RGN5/
M8!'VR]+G3WH5#*LHSN C"Y0):Y"JW^:8Y)[Z96]K^V=#%*G4WE3^M:QQ\Z44
M[#"(3DMV:U#,7<UOY]O;VK4.MVO0V9WK_2/O: ;Y<(-<\]2N-T%V@RWGJ[/Y
M(KY6J:POZ1[]J'K'.ZMZQS^.5N_U,*ZU"B!3EO P3;BT8\9ER@,_X2(*?=^.
M;!&8 /2[6[W/Z\W%;E\<2YC!%UF8\^F1](#_3D5;]X ?7K6_=;+._MNK]G[G
MNGUU8<-S7\]Z9[96NK$;Z^ZWLV_7;GNV!WRO_:WM'-KM?]HW;>?C[1$HY^W]
MM]GGJX_TK/?QIKW_B;5QW*?)S?]].YST@+^Z<-I7!^<VE9Z/)7%<ZC/"O"0F
M<4 YL65D)T[LRMCQGKUVPY;K+.M6M@;I?V_']LTDL@8]'@5Z>&X:V&%*N6 N
MX[Z,N4QH&ODQE=3F#K^K?/J&,+)WR?,+*4X'V!<$_FZ*K#>P<J^P<CL-*SP%
M8 D21N!P< A+?4%"'E/B!9[O<SN- L&?O0Y:GKVLG%&#*@VJ;#&J3$P(#9#<
M)Y!T9N23U!-I$&,9-.J ?)($/HFE(PB- 402-V)^'#Y[[;5<=[ZU2 ,D#9!L
M#B21E#01DGENP)D7\##DKH0#R_;LD">IIQO'-\K--H+'C!3BQV[DQ2$C(O!"
MPCA6%Q:11R(.QP-E09*$(?;^;K'P =#CGHRJC]X*9"]9X[46X'$CZ'I3_&V@
MU0Y$($48T-")&(!L+$3HBCB-I4B=('$06FG40.O606M[SFY$?>:FS D)%VY$
M6!ACUT@AB1\Z+)$.-DO!3BE.R_66U4W[$9ZX7XEM8R] @U"_*4)%M@BY[P64
M"<H<ZL1A&KF<2]OWPY!YCJE(9+3('S9Q-[:I7P%=,U)AFHC0BU.'".8DV.2)
MDIB[E !APU[#EGJA@[:I*/0;Y&J0JT&NQO[UZ\!JUOX5L@245<<E;N Z!*@D
M(9&7<$*E&_+(X9' [MQ.RZ;S?7$:L&K :CO!J@D@>+P -2--B8"[MNW:(#[Q
M"$/]*>%HKX=MC%S7]UU?.-\70/!3$>II15K5\F(:9\2#3V$#H'3C@%*?)Q00
MDL5<\"#Q_4#*R/8I *=4%K.P <JM \J/<Q:SB*5V(EE,[(@*PL)0DHC9@O@!
MB.G,%Z$3HR07M$)_0U&N<64VZ+$0/=(XC2GS7,^A(0L%XRP($QKSV/-#WXV4
M3D@CHQ/^N.&]L6;]"EB9D;^\Q$E26\;$85Y*F.,)$H9A1/Q()BR)W @D;;1F
MN=&&UJP&51I4V094:2Q-/P=(9BU-++$33R0N"03V1Q>>1Z(0M#F'<E>X#@]M
M/T!+4T2;0/ &2)IP@*<-'C-22.P+X:22D9BE'F$\ "G$"1T2^Y&0U ,E5J;?
M%PYP;\:>/U0YB%H-JZ:JQ*.K?= ,MJDJ\8M3Y>VFJL3=Z_/4JTK8356)&59I
MJDH8SBA%4M4U*=$]%KNJ6TY+M8C%0M6FG1X*%DUYB6:037F)IKS$-(H\;KN
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M5U Q/1(%.STYVK'>CG.XG+?J=A=XA,\^T(/-GCH%4UY;/7B;!M@"=-Y$Z]T
MOYG2L$N1+08=-<VTVELMJGIOK)^ N:*^4L99FD,\R^%B 31JO9$)!\8HIY25
M(GBW)H(;;7QZ](5:^9IN!&^8W]_ZDI>K.[NX]7=G<,D(>%D?E9Y$+[?:?2!*
M6,7^;4MS8RQEWQ",1,KH%@-<F-N902VTB%4#A+FE8SPV*IL +GHQ5IM=BCQY
M5ER7^X*"Z/P\>_P6Q@,Z&UZ$0^??\'T<8;6X6D]5WXO'1:;&45DO"H5+%:4)
M>9%+_10J@=GDR%)2>BD%PR,U(1A'@(L!DT!RWT[TV5 AG.!1!2$3\]&L3J@U
MQ8FU[[A4([9R)3;6%6MRB'*%P!D&W(WGI%+)"HS,SHK+4I\K/4;J]Y(>U]>\
M5OF0TBD?4EKW(4W98WY 45VZ94\SCMQ='D?>1(1O;1SU4X\(WQHX72+D;V *
MVZO[/"9'S,EWV,4^[9SL:./8XSN7%NL'*W4#U*304;^6/K#\/-+NQK(>BPY]
M*;M3[5B3<5FQ\B>B1*R_K/Z(QOT\4YK;Y*34)]NL%*'&YKS"/U_D>KMSWI,W
M@_Q:"Z?&K:DF R+R2 MJ)W@:@]()0SW*+WA_UJIPBEX @&/]5*'<R,\=F[HH
MV>K7OZC/8TH3-;.HO&K3\JWL&A)4,0J\6.+MA9'-2<'7\G;A:I=B;15H 2I>
M,L:O&+]XW0]FQ-&)3F)V^5^%VLZZ="_[7[)\T,<7H28W[^7$J HE=\ ;^\FM
M$HM1;>K%,,IRPM5U]=6LOSX9M?0:U32L3/M>*^$$V!:$*BV$:.5D,DK<MY+A
MEQH.M.\,AJT&E?466[R4VHL:9RQ+[1>]X'FESB#)\M*^ 32=/49S0LVWG]4I
MN34ES*)%3 ?D\$44L3A$:.TM-T[!A:2FA,;2F3?QV-=]@K ;EWU8KHO;TAT\
MT?G*,(+#TW=[115(8 ;,D:B4/:K R(U$<1%R2('*W<6$F,?*U5D;2F+,[4N&
M,?EJ]4FCD)>12D.E(:U[XI4<CC%;0)E_<44HX[C(1,;S6]2K0>D=7USJ75P4
MF2 4*9L(!CSR5,3:W5SSK^+N8(+E+OL6NEFU<:Z++E:,<5K^68-8P$M=8U3(
M:P$=!4Q3G=.P(MW;*?I<& 61%364TI:9; 2Z1+&(AA\AY]9C#W$!8GDQ[AO!
M2).+PF$\8TJI*4-W-:[8U$DSSZ@]X OMM1O@,Z ?2D5X\S:5Y<* BO/K28'!
M;4O(<LKU"(0&(])AA'HGIX?+3=OE^M?K[E9CE1P.1O@ [RXF,\. :(CA>5;(
MV<">]9  HU#@1!T5UK01]5\+>/-Q$M;"\+2?(QJV#/5* "405D=:>N,(KD*B
MQP@Y'#8A P!%,^EP#*)A4A=OTBSOJ9@3M<UE1%,&&PFB7S$JPT)P,&702U98
M,P%0>+L6#/2=QF)2(CG:@L.=Q7H%$LH)0+HF5O2M[?,1-]"O%V]UA-U6TLBF
M@> 3X^F<U6_P@U:_AV,$$#]-O&#=.OQCS"#&>6E/^_>8Y^@5F2YE.<T?&K&4
M-;V$-/31*P;%$Q;%[[QFO;NUNMDUBJ2CP?P#K1FX6E]&^_Y\#G^=?(XEJ>E3
MM+Y5V>I6]&9IVO;1Z9\'Q]9AY^W1<7OW]'"2Q_<=##XU:>IJ3^R#I?5\+Q6X
M3A1Z+@M#C]KV;TH/>TOI89+,91T?O-L]WC_LO+. . X.WW6LOSX='Y[L'^XA
MG9Q8IW_NGEH?C@_^/NB< @6=?#C0%WX3"AI9NW!.9@DJ\C\ *=&C2A'[L'L,
M>WEXN.7'W=X"I;:>H_$!SBJ<!@I/ V56 W4P'_2T>)//RS5:YU"2UB ?#K2I
M#L]4=+#>ZD!=J5S,BQ-QE',K4RK*AWSP]78B<U4:Y^PC?=CS4M)J2SDRX;@G
MHT%R?3GH8I2N]1P?-'+=S'M+=;T4$^LI*"JB3BB=*,W0##7.BS'O*P?T,>A>
M7;UBE.U^1YATJ\R%@JVP!+^%"^@?6F9-_6[."9S?$WRIO0)\CP%#CXY/6M;!
M_QWL?3H]_/O .GK[]G#OX%AG9.X='7\X.MX]/;#>'?U]<(RIQX\PZ_9T)E2^
MSKJ*0S/483(,LE?\,[JL.873 ::>*;LR'U81)8LX;(9C6BHT!"BZKE>MY/:7
M-=X;#@I@U,Y@QZ+JKQ3TI8/N)%!LK\M!_3RT]LN(/L.@K?(=;P8\UR%$$U/_
MX6019F^?RTLJ7ZA>86[:G5@::J^JQE?#$JN<0F'2)C]4N2H@LG?FL6C'?.[[
M^=?[3?F7+N7?"=/N';4_''1.-I*HMYH9-^/$^^.\"1L@=\M^H0:YG#B?=& '
MNY<"@4'8% C<_B"*IQX.LMT% D$X7GI*G, A<7QX>F8=_=,!N>[/PP\@XUD@
MXIWN'G:L-P>= Q#X#G??F^M*[FOO=G;?J2)CZM?C@_<@ ^Y;)Z='>__[Y]'[
M_8-CN.7T%&[_+4Z;C46_^SMPC"9T:QW=]$'HNLR&BLF,POE&!4CK]&]U74EC
MDT"+'Y::0OH#4M/6$+^[O$RD(7-%P6@M O(_F:+IT^-=$)RT*:FEKI1JD778
MV3\ L6K_8 .MIZ'SQ71>4O2QU-8 I'1-S<<Z>("@$>76.JVE:/TX=;/?5"=@
M2PG^P_%A9^_P \#YI%"<]?;@0!/]R<'QWZ#=-ZBMJ7DQ&4\9X-96TYV6=<PG
MV?#()8<U-^WQQ$W[0;MI=R=NVK=9WFMTC(4ZAG<O.D88-#K&]DOF3UW'F..Z
M:?\4W7%^A8-JE:?F[^\^BJ.%ODT834)@CM@'XJ6NA7;[ZG%)GT^V#B?U5A@F
M_SQ\<WAZTGJRB].4:3TY!?4*+0A/=P7V_CS8__1^36G;GL&U!RRR\)R_4/&G
M$TFZ3*#0^<7HY%7!@<;O77IUY^+X\(]'>09SY%V-#.C\7J_8C?U@J$X7!S,^
M)!V_7#BBE]:)E-8S5#.^HIOMSCRO9_6ZHG?>O5[PY</MD[-PGZP3+ V'&;\O
M'Q1Y5@[ME2[84 7\6"9HHU9M;JI8ZP#S?6XRE;P_79SP[MP^58(B2;2S&ID9
M/KUNV;^'VUQWQSHPI?T>EO%4S'=99+"+.GRU]E.KFI5<6-U<067+2L=Y7R7M
MM71RU3)K R]41=8J,KI6:G0:D%7F%XX&;U5I8>5JK8VN=Z@;OM)U'VCWS624
M!>7K.A/20U7]W29FCQQT-P)#[O)A(5^6/[S""CI=?OLRZZL/JX=*I</82E#+
MG^DGI]9&7S8&@"C:">P ;0#87&[2K\Z8!W:4>6"FEYVYYNQXKK_TLKU#ES^Z
MXK6AM^/X;*W7JGYX9M@KNFIN5\/,.5JQ:[2BY8O.8 )L=S<-73 ]PPG;-,%]
M621YIDR94W,S>SAC']3:\&;-4M>]]7ZI!OCV@1J4NCOTQZAD^70>PAQHKVL.
MG#*WF'/JU8,/T%C6+D>C8?'RCS]N;FYV8)P[%X,O?^SFR276K/I#B@N>_P%2
M#O\#QDFI[S"?JA^9&P0LHH%-0\\-_Y!?SZ/(LZ.=RQ'PZZXIM:O]3"8):J^J
M6BNUE;X\C6LEE[2Y/L<@UN=:W>%%><1:[HZW+##WHTY;Z=XNR&;Z:!0G^%-G
M\$4%KUH!AJW2P)2,6NU+>[' I-C@P(_A@-/@P&/%@04@X,'/S/<!!%S"- *\
MN>WRFV)-MF;+V'IOG.?:BS?%U"'YWPE/_\7[8\QP#!5+>PU+/PA+L^9H_SU8
MFD8N=3S;LWWXAOT'Z(&,:I8^P1XX<+"KP'9@/!5V7JM%+]?B=B"49=R^,!]Y
M8K^<L'R;PR0LQT..MQN.?RB.;P[QWX+C]2$.G&1[+G-0DJ=!X#J.YOJ:%CS/
MWQ7KUA++%K&\LQ'+6XNXG?HJT\QNN/U!N)W:._3_:_C]]^%W&MFV"\>\XG?7
M8Y&M^5TQH FBZ_4G<76[6%VXRG2M"MJ;.OHS3<<6H0!2T(_(^6]EG"M!WU$Y
MIS1JD."AD,!ID."W0 (CZ\,'F><PE/6I;8Y]&D6AD? _=&$[%O+STF,]-Q*"
M0HY:137#UR>$SNOO5(OSK&'KAV)KMV'KWXFM ]OS0\_3;&W,<HK!#GK#[N!6
MRI*_Q_ ^7L@5C+[40'>'RJY_FI;DS54ESMN-!?[!N)TUS/X;,?O4&>X;&WR>
M%3'O2^MT4@CV \^OK?<2V5W'+NV.+[#QBSY\75WH$#M0CFZP_N&,.0\N:?9]
M!WM>OKZE__1^Y\..T@VT#F !!6"SVH'N;,U'ENLPVWK#;XM+[%3Y9C#NRB\\
M%RVK>I&U!W0$K^AG?#$.^=\G<)B$7$)G\,B('@:1&OGC@1'):Q#I-T(D'_X#
M_X^(%$6E"T&.1KHF:<V>L!QK *VZ,,?<:DN!FSH!,E7$_;"?[!@4^VO<EYJ-
M,2$0V-A? "!1M*D%0K\RG!-D)I_SS=<:T'@@T/ ;T/A=0<.8(CJ#/CGXFG3'
M!;S 9%OSD>[XG,A^(>\9058"R%*31P,@CQ1 @L;J\3LAB.<XGE=:/2B==FI\
MD+G*[\"8_T]]X.C=&ZS6-Y%%%KLMEDH-R\(.*PO(QQF^+P,0S0VLB6!X6.8/
M&^;_+9A_XM,,73?Z(QF/<G01VLR)SH5,*>.E_9-&UL&_QUCY"0Y_;,SQ9<[P
MN3M4;<&_6KMKU $>JN(F\SX.K+I;L?WN,,],)J;EVHW[\F&9/FIX_G?@>?TC
MU103_8'G_3DU"0AOL[R TQW3$!17 A]O8 TUI[..,[ 7V43+$MSX]S?M8S)O
MUK3>O]_#>MKZ7<58=? 9Y"3K$]7B0I:?&0U6FE1U?XR!R>:V *D$;!GF-FYN
M:ETBWD0_2[PQZ]< W4-%;-F->/-;0)T1;WS;]>U00QUQ3,"6;G-4EF_"CCFJ
M^Y/$+IJHY\P;6O]7?L$B$COX0+^,X;HS<!OC/>Q[0XHIH%4X\2A-('^H+.8%
M.=*_LFK<PFI.VU-*SI_9KMI_?T)1N%6+LGP)'KQBW$-!UB\J(_<;3&_CVG)-
M;82'K(WPL()7$RO_&PM>]'L%KV-LX2*LOW:L$Y"QLFXW6U_TNC\;]&\B>OTF
M2-'$TO_&2.$L=S_IV-OUG5#.4L]S P"/&@":J/O?"@ "^-ECH0$ ]WM%A;\X
M3O<86+ 8(1^N+2>X]Q2@,A4:2YMR.0^,$DVT_N\%$M2-5*X]@H0)U]=^J%.9
M][+^;,YM&:/6-1QI^88C[XS7MTX.+2=LH3MJ"6(L#:K_(<&BJ;#UT)#1A-/_
MOI 1E/'TR0#X:\K/77=GKP<8ZSBS/RP!CZ !C]\2/)JP^M\(/&9K^U!_<90,
MLML__$N&';TT5[\?\+[154R_Q%F99#KD0V??T/ NF/E'=KN%]9;G%P/K#>]?
MMZS.SN[.IE[GIGK0(T*4H$&4WQA1E@DD&E+@A1M 2JU,@$7+8C\; LHJ/-D.
MU_0#[1!]TK-O3I+?X"1IDC9^)U:E$6BV@>TK5F615U:OT%5JU+%PE (_@6([
M H5R0<*WL_B(V!O#[=PD>>*%?1!MX709W.2W]U*?;GER9ZEU/PFL7;:!U'[2
MTV^R?![XF(B:8^)W9K-H4]?JG$DTO*]SX]Z* CSM<R-ZVN=&U)P;VW!N.$W2
MU&_&9HY+;:K8S ?IK$R;&O2+<7>$31WGHV_FCH"W[]^IKKM]F1<M2X(^DJCL
M[QGK=V6M^IGJQ4R29=@ Q@,#1M/YYK? "UU !GB)NIX3_2$BRAS&L(Z,"?BO
M"N56@-$JT\:QOD-E&FRMDBA;NBQ5-I0Y9@&(+OS[W[PW? 6HL&,M H[[P@T]
MR/_7WI5UIXUDX;]2IY^2:5I&8G6?F3Y' 1(3V\ !TIGTRYRR*$)UA$1+HF/W
MKY][J\1F([9(EA#U8@Q::KU?W?W*[/FGZR^7>_*W?S]X5PI,X@83550GWV!2
M"<&D.^-.6%/G,[=]K*<%' G\1CZX[LCCUB2$A;[K0[\*I.>Y8^;['&.(  E6
MI3-?0D9%0<8E049)048>(&-EN:R7:])R63=JE3"$ ,A_RC&#S!,(  ';8#P6
M!%J(%F &W.864/3OU+;9DS21)RFDA!TK*^3(,G*HJ()\(8=>*NDU@1S7Q6I]
MH2%?QX)="?#H6M5N;U&UFXHBOFAN#2OT&,6W"5M/L:F: HXL X>*+<@9<%2*
M):DBO2Z5KQ<!2=&>>@O%QP(=["=R_4SY0:>N\_6YZL,G#Z[GN=^95XAB2\1=
M-B*1E[B7!M%+RILK92A1D09YAI+0[W(XX=[6.*5]MO?(>*0"V9I3DVRDT22B
M*%'2-OL?1A'%K20+,2K%?]XPIE:LAW).O;C F'T.HT"H1LBD[(6=OCN!-1VP
M8+(=/2["0R5JHB\FA&#KZ&/2C\FR>S\HYJJSX8?/!A5,D&NBK9_N)1K?:1$3
MKQD/9F26V52YE'?039A+N?9LN50NY0QAF\JEK'(IJUS*L7-HJEQ/+ABTT"-*
M+XIL1E<CO52N5O41>RR''E%M:,4)YA[;-"[(L&O)BND[/!P^:0,M#/T7O:8V
M,7W?M;CX)JP*@0?\$V-;F+1R7%:%M=P%89>5;)<6<I2*"CERC1QZ<:]GMD2/
M\E[T& 1\S.P"Z7"8*3KWES[9 @S$C4L"%ECBL9G'?&A)B" (5 @>OI H;2*J
M \+G+.R8YQ.'3AD" 1E8$S:: R/3QD<\!KB3I)TS/D3*K.28$[A2<21YAZMG
M^> ;=#8#ZFM0VR9##X8!4X >W2#TC;DWC7+OCD^C]$K8L&O_)4I5BVAJ!52Q
M I6*4<D[4(5.YRN'C8ZK$3V"J=J?V*VPKE8_0*L>Z1Q&WFR%PYB2WI\*ATIZ
M2P)E5&&,?,!,:)D#84VO76-AC/\9Y7I]4;YTP&8T#&03IC1FLPU!;J_Q[2/%
MX+D^!ZDJV;1>]W11#L-0<E26@:.L@",7P+'@3_2:4:[4@3\!U"B5UO4^NUV^
M@&")OCC(]\*(1IK4X<P6P3"!_SI08E04E&092BH*2O(.)<9I'D(_!BX):W44
MNIP%NJC0EUR RTK J>A%X7IH5.IZK9),^*W^"N&WV7 X2FG!+J0^0,3H+\2Y
M/V+TRF4CY2-158G)!955C;I1+R*55?5B]8KJ_[A3-L)% =*RQ(E(!4,MR>Z/
M+KF7EP7IR2-SC>6NH.\['IZE(\^^$ZO0R6IY"@A2!(*Z H(\ H'QC^M_X\Z$
M43N8T(5YT=#I$@@&<)G<B.MK >- B[LA(%)V5A!PKA"@'+]S"0&E[1!0^7,?
M!%2P*KTDRN.\ %80\+H8H/1GB0)$6?EWYQ(@REL!0B_O PB]C-JK'0!15@!Q
M60"A/*HS!Q @_'N_(,WH1DE_9(^/>G$1 +:DY/4*&W#D W$^$9GBUA#>ADWN
M!QY_F NOH>>&N9 RA;(<$S-M&N76W LW<40JZ'?Q\2H^?<?:A_'I]6>3I^+3
M,T2?*CX]GOAT%8B>5B"ZG);$T:VVE:$(&4G)"'9<+7[>(M7A-9EO>7R&9+,Q
M,L6!GLJ!&B5-_UEQH)GG0.%C51,.&4DXUS 9P8R)C 0@$GX%AA.$N!'IS1]L
M;A'3LMRY(XK'O>?>5&E_XZ:<LI:8Z);&>'J8\1JWE0D [SGL22%L+/,*A%M2
M")M]A"WI84!A R=Z#%,=A+6O&A/.QJ3UR. 9%/>[8[@*M#*;>_Z<RDS1 R;#
MHDM%8Y%G84 ]3/#L_])]Q-! TQ*@;12+AL+B^&FLK&CL'&BLO)/&WG.'.A8F
M)5$TECD:,Y2D<!8T9NA'GF/"G>T ^M/K(H%90UM2HEZJ%$6F(3IR9ZC8WD:N
MU\6J(M<43$NZUNX,\B2AM(6.DOSW7?\.9%\_$#%/3=>:HV5%22NQ;9M!XR:O
MVV9('UW'G3X!"@;,P4*U(M79E*I]%/\^:IAW%[2/&M2VYK8\;.^X\^T!4T2H
M717[KFJVWE_0KFJRL<C3B/^JO13W7KHSWUW07KJC#\Q6V)3@?NKU6Q>TGWK+
MY++JR$MP6R56 #N-X31<Z KIT:\,1#AT=I,>=$T:4/*>VYCWW,6LHF%<^?H.
M1#6%!0U0^$4D*5YYS>IO7^ZV2%>XM9(-V.F4_-#^)7TT7OZ]IP[,CG 6Q-'B
M#!'7@_^G,Z [&KC>$YG9U(GPTGWM<?P<-8[WP@T9?8R_\V#RHK>$C_[STWY'
M)_VZ]-.>-31>80U?N*.(L;>'K7NB5S7ROMN'?XJ_W)+!I_M[L__EY7 SM?DZ
MKL-.7Y'J 2L2Z>\9D7LW#3_5[+BD7F_SXDO,)36[7J>I]R4V!]/S&LG1M8YV
MDOAKP_"@_:%C#C_U6X.#8/=9U_^<^P$?[_#%3I3V>VL&$[20>.RO.??$\2^R
MZJPL+<@$Z)4WH[=+8XI,8<P9Q@]9,C58:%'!LM:%\'WH%^9A"Q/@IT:8W-BB
M<Q^.YF#"18D(#"6"UA\8\6$^9.@0A]8?V(3:8PP/PA>)G17>($I"S!UX2+R/
MSH.)Z\&@1P5DR_!N"Y,'04=65:X'F"M()I2W.?!X#J<%; GOUH,)&=&G924=
M&4:A';*:*17=T@WC%%_G<D6K2"_I6'V=2UJY9L3^UG)-JQG1CY[@01TIRU7/
MS1M9T&[CT[#5-PNDW6EH!TB[U02EW?@%XR->GZVUVHZS[YY^3= 7/H-,Y95_
MM5E9(J%.B#?^R@,8LG5 MYKF[^TFN='(???S<S$IH>V9X$Y.==VW@U*3_LU'
M8H+=[]Y3Y!&:E>X*OY.$M^C.#4E>I_'MHU_ZXESL#(1^1D?'LV95%HGVHC]H
M!%Q$<_QJU%)3#=UVNI^)>7='[EL=8G::Y',7_WOWA0QO6H,6Z8&8U>H,!RA>
MT( P:DW(#"0#8.6_3UQ?"A$42V02K!Q%/10D;/<[*C-!T KF ?055;EPU>4H
MY6PB5N%9M7+Y730CY9ZI<#A#V04$(A!$L&(F$S?9]/MX;LM3CX;3[\.4PD19
M84B<:/@K"E<%@FI) @_89+98-'_^(/NX*/7@L8V?QM@DGRY:EAD5UON"!?0*
MJ)ZUF.RX'S JQ2+JR 3,6$C+HC-J2=$-A"B<L8W+RWP2OA0+X?VFX\RI'97Y
MX;:P&AX\@1D@9*D_T1TQT-!OT5_6\\-[7?Q"1J'%QL=NPC(YH<P9+)2WX2OP
MC:*"Z9KDB6]92I\-=SKEOB]*F7Y%F1.#CX2<Z%,^.GAA7B[XVBJ)&Z7 "2(F
MBJ!R*+ 'T7(@'Q1O@$,;IA0$8C$K$^R+D*Y]'LC] N-DOH^!^U+\';D.6Q\T
M;#-L6%S&98'=*F9)-#?W9K#;?5&R%:MZ3)&&I*)^;H^P5S"9DC *0@N.:38H
M:AJP(Z$M RNHB:_P=D%.1\\3;IMPFK!Q^.3>:ALS_&WU#9Z9@I@MZ03&!9W$
M#J,Z8'T*H*=_<R\ JL)^N^.#!/$L8=@^I<J!VI.5>@15)P^8H"%4@$A$"S4C
M8]>&;[B,<KE]),]0>1(VMJ:%"3%#*$E6*""(4?Z*&2*0$C'59,!&T9-_D:IR
MHZA4Y=GHBU*5'Z8J3T5#6=.JU>(I&DJCHL%X3](E[KY6*==CUU!6REJY=-IK
M7[^S>D4KUJ(OQY.00H)SIK2D@X4\<(3^[<=4-AF<A"$/[(N>@"8-V $Z\NL=
M.O(0-06S.0-6V;5!;%ST/!F]X%DT>4:>;D<JBZ_\*Q*A,$Y#[9N*U]Q*2QH1
MN=<$R<8"69&\Z7G<L?B,VB_O?)LR]J0W=;(.<#%,S;<-@GZ($@_<.E,^&MDL
MI2F(, DD9V),U'!YQ(F1S7&DYL2\;K;*$,3GV?9QY&STNS=FAPQ:PYLM!I%+
M.^Y>!J.OG7"KBW@&KN6ZRLB!EZJS@SSS+OG(6]F/U'%W/K?F6Y+! JMFI]VZ
M([T[LS,\)C5#GL!])9LT)I1[\+Z%E>2=2[T1?EF(-/Z%2RV7C.#/RQ$K'#^?
M6_.-XQ_ZK0_=_A=B:N2=V>^WAL,+1?(%3"N43A.ETQO^!X]]Q6A4) 3J>2P(
M%$B?SZWY!NF/W4&K=T-:&OE\TQX.6_U+9;<52%\V2']T?3:;"$*8\ !61G'2
M9W1KOD%ZV+Y'K4@WK'$WN&F9"J452E\@2L/+-BAAPJB"Z?.Y-=\P?6L.;UK]
M=J=%!AKYP^QTA\.VPFF%TQ>(T[<4XX,P)1F2 G7<(. Y ^JZ NI,[,,3@!H8
MZ/:=B?JXFV[O]KCL[PJE%4KG!:6!?>8V%73@SKYQ)V\J#P71V=B$I^BES4YK
M2.XT\KG=O#<["J 50%\@0'^D#@L$%?#1E#H*GL_GUIS#\Z>[-B T&6JD9_9O
M%3PK>+Y$>)[;'!!:4 'UOITW/+]((:7R4$<FU] WYV/C[X,[>H*/23"U?_L_
M4$L#!!0    ( .>$851J]M61>1<  #H) 0 1    8W5T<BTR,#(Q,3(S,2YX
M<V3M7?]SHSBR_WW_"EY^>?NJUA-CDZ^U,U>>9+*;J\PX+\[LW/MI"X.P=8/!
M*R")[Z]_W1+8V( 0V!YSAZ_V:F)0=TOZM%HM=4O\^K>WF:N]$!90WWM_HK_K
MGFC$LWR;>I/W)U^?[SJ7)W_[\--/O_Y7I_./CT\/VJUO13/BA=H-(V9(;.V5
MAE/MFTV"[YK#_)GVS6??Z8O9Z7S@1#?^?,'H9!IJO6ZOM_F67>MD3*ZZ_;/.
MA:.?=0SCRNF,+R\O.F?$/-,=0^^95\XOD^M+8G;[Y^=G'?/\\JIC7%UU.Y?=
MWE7GRK![YXYI=(WN!6?Z%EP'UI3,3 T:Y@77;\'[DVD8SJ]/3U]?7]^]]M_Y
M;'+:ZW;UTW]\?ACQHB=Q69=ZW]=*OXV9FY3OG^+KL1F0I+@5A6Q9''X09KZS
M_!D4[NEZKZ\GY9 +E?"E7A":GK7D:X>L$R[F),BG@=>G^!KE=#M=O=-;DV2'
M2[*TF+-3\?)$,\.0T3%4]\YGLUOBF)$+))'W5V2ZU*'$!@UP"6*\5B#U.C39
MA(1?S!D)YJ9%I'WPX2=-0U#H;.ZS4/,R1(X9C'DE Q9R,FP2=IZ \<&WS)#K
M)I8/DE9EJ$Z)&P;XJ[/B\>XML$].U6L0!9V):<YKU")-*6H2/ZE>FY26ZE=7
M5Z=OJ';Y]<C5)EZ^@W]V]%XUL45JJ2X;?G42NEW4837DJM4AH=NR#KE#K4@C
MRBCY[T"Q&OE#5[$3$@)L_5D5@0&QWDW\EU/+C[R0+;@ZEPR!/)+D!U?^.O)M
M0CFCOPQ%Z2L"_+,C_ER7;'J>'W(>^"1^-I]3S_'% WB$:G.=Z,X3<1*SFID8
M<@8H_^?:9!;SW9+1?#IG_IRPD)(@/:EP!E-&G/<G.+5T$AOZIVN.WT%-DB(9
M >L# %^? @EQ'U8M26A1!]^?! "#2T3?-+GA<T:J-AQ( IBZ.-#_]NVW3+=J
M^X'$BMS_C.;;Q*G:?""A'JW1>J1^AO<:M=^?W/C@$9]H^.SKTWV>?\.%B6()
MGX33J@H?NN!FPG]:9^4V=S1.]>OI9MD-+E% [*'W@?^]J=,Q<5Q$0KBA#,IT
MZ[V82Q8_3+I-TIF#R*;A/9A9-N,U*>_7#(6\BP']WGH7<P9:BD.+NOO&]P+?
MI38NSCZ:+GIBHRDA8:"BST6D$@!TKN-]Z/41=!E9*OF*E1;ST@2S(Q9A\&@R
M:-64A!3JN04PZWSD*,$P,=11TGY>X_T_+45MV5N![PQA[N)5JSB4"GC(T>J#
MZRY#:\54\QUMQ?:(DW/CSZ!A4^(%](7<>X )>?"#+4 K8BA'T.AVS]417).A
M"2':SRCF./1\9Q3ZUO>I[]J$!9_^BFBXJ(]F#B\YD&?=[H4ZD&GV_ZT) 4<$
M<WI]BSFP"F,YMN?=[N5VV!XGRJR]-(/IG>N_;F-RERSD^%UTNU<5C"QPU3C;
M%J$TBF8SDRU@I-")1QU04B\<6'R+CGJ31^@J"Q;DY5 I\I'@U=.[NBZ6PS2P
M7#^(&$'P!&,^P%:LM15O+6%^1&VCMW>-GA**&,C;!D6PF/%?;3*6:@ \FV-W
M=W#&W&1@]KO]_G9@"B%'*#<[_XO)<$WV0FY):%)W9Z!F^,K@-;J&L16\'6TI
M3_LYEGC$.F,WQ<;VPO1L] KGZ''L&':9"+D&G!EB?[2V!B2B-9"M+86W4AW0
M@\3_8R^\F"XZEM I3R0(&;7 X<1W"EZO"A>Y(W6N9T%%LE^$DYOBS%%;\>;O
MCXBM];7JK%N!EWS.O>AO@UX;YUR5KE\:4OP!;S?**QOD'<J26^9+@P=.ZJK!
MFAGG3[!4AO1HI_,AK.Z@U>(J5X$K@T=EZJM N]VS=#1,-+\<Q1P:Z5RK=_7L
M,%V+EFF"3:O[774.+:24SIBZWE?#H(US8[9+[[T7:([/P']7-FY*7*3&3,?%
MAA)('2W%^VBX>//S%GA?B/HRLC)'.99]@X<O5;#,7Q_^HH&L([:\^;"N9A&Q
M'Z@YIBX-MQN6Q<SDB!H&CV.J(!J+T%(RCDCRYE=W&A5XR'$[,WB,4@6W=CN#
M8(?LR J_82=X*BD"FP1R-_!<S[KJ,0<M8='>WE;U__+)Y,[?1;^\Y]OH^&WT
MY7)/(GY099I19R4W5I<&#\C+H5K;N%A):*71NB4.88S83P0<XHB4([5)(#=:
M5WK6)4\X:#&+]O:VJM'*)Y,:K5ZW7][S;31:&WU9W:$J8R U4#W=T+NEL+3=
MDRKIXC_UK5'Z4S_BM'.<EK-V\GQ$V NUR(WOA<RTPKA8W9%6D;T<7_ 5,GD)
M.?BF'(7EVUBLELA=6=,6JD V_Y4_>83U(08G^ \\!V=CACF!9RCWTQO^J>!L
M;,5=ZIF 6Y_=8,I+L/U%/-6X3+[%Q']WN%@M+5>+!1_15\)'.==L>QER3\GH
M[TL3VNA?;0-7C9RU74J3SQAGAI[-8]J-FK3=C]@&1?YR.,<G PMZ$(A_B/9(
MY,KUZ-S0,Z'$G>F1(!'5TI)Z'76J(K:B_X)A%.)=,G@9%<:PW@BS:( &_9&!
M__=D>I,*.UP_N#YR';PP],R.YLYT,*ZMEJJN",VM*JSQ&FNBRD?UK*@.JRP<
M7NPK5"KXH;9/I0)R!;PT],SNU,X4,)6E)*AY!8_F<*NIKNCECYMLRVH@U[@K
M0]^7E]]16 @<56YW@(_!R,Q-%E8[YO C:R-5Q7[7T#.9$#].%<<+;57AHV)6
M5(4_3#?BOP=!$,V$IP,T=R9E^(K$)\*%#X1>VNCQ\3<,,/X83W'[ZLE55S?T
M3#+(SE1W67DM57M.C/7GK\GR''RRR.&>);1"$\UHI4*+^SJ>S3>5_;1T8>D6
M:;^G9S.VXJM!.'D[>UAUWS)+(MV&A/_)>[N-FXFI/EQ=?/.1.#Z#-:__0O':
M:/B1*J9L9>NSEEM(P] S&2AK,';6K]?1A$QM*52#GQO M]ND+?]<=E%]D/.X
MR/$\,WJ90' ^GO SA6++04NBI? #)G-2P?U182*'[-SH96*[&Y M@[D(FN#=
M=L2>B.5[%G4IKY+O?'(<@CLF^/;)#-47^C5XRO&\,'J9R,L&GNN"T$E<BN(0
MH["V UP]NB8CED-V:?0R08X-R-H=\DIU[5>/@?9.//HO;ND^$@\$U3.8):SD
MF%T9O4Q08 .S-'\^KA()K<3P"PE7KN,C8:.IR1226O+)I$LQHZMG#V'@^:9U
M5Q*8:9Q;VT%07:/)B*6K-4/O5P*DC8NWW,Z%A^F?RD:N"C.IF3,PE:,*<N(M
M/DW#>31WHL\'7DAMZD8XD8^(%3%^6N_3F^5&-K'OF#_#S;XH3!Q DWG4F^P(
M_QT)E^M+W^AE D=R?4E72UO52TLJIF'-M%35N+\:5^ZH9#GCO++GJL9&#CR8
MBLR&7(FA:+5+>XO,,"KAB2]\ 5?<_E?*\\XEE+M$9WKVJ%?,24NSXC&((PRU
M#KHH,9*/HG.CEW&4"F%J_1@:D0F&95/?#N$W_/#S!>/%;\2?,',^Q2L5XE.-
M*O'$ZCSE(^]"SYZ-B86DOWH2WQ@DSD:,%]I2$G^1R#J"*P%".4>^+F?Y(N>R
MGS6QM8%NXQ*H.BXU4N"WER&WX%=&;X=:<+3P5>%:GGNK>GYN=Z*D"G+6-?J[
MFP_6#]VU^6@=+!!GE&=I80H/^DJP/B2>VH7K,F+I['ZFZ]F3D2ENXI+'-+\C
M)%6N3B]G(9V3S_#@8B5XVCCO2CJYQK6;%9C)#67?Z%<;6JV?+25]+P*\OC.P
M_;G8WPNGY MY'>&9$Y/9N\!7588<=L/H9Z];+H%=2,8I,)&-?X-T#<1KB?RC
M3JSC=4?!Q;&HZ2X_O)/R/W:A$$H"Y-IP9O2SMRZ7:,-2;.I30VG/ZJ@&:SWV
MV0SC/??E)P^]R0,Q U+G"L1="9*KQ;G1S][$7*(6*_&IKS!Z$XW7H/6W)^X(
M-Y7;9G8GZJ@DC50288 )[[-@CT:D3(Y</2Z,?B:T74T]8OE".8*C=NP$M1U:
MD'))1PUIBH;P'MJQ_UG$4X[ZI='/I#"4H2ZFAZ.360C%^F0ND@)V ;&,KQSF
M*Z.?25@H@WG3'TB2&UJ(]2T9ARI1<2@EW4$][^K9FX*0K&5]J7Z[Z;*L=.OS
M7._GW=DW#MNXPXGMKI/2D4,E-2KGF,R?V^EMWYK$3DA=<8,_^8>X&%O 3WY8
MN1(NBKSD:/6-?DY2%$<K?1T/?R2^UB5$Q(>KVXCC*!H'Y*\(&O )OPFC],7,
M#0KY=&#H.1=^+5EH@D>;.MR:$CMRR?W]\L _J.+_1J9+'=3%^"N@*D"H<I(#
M=*;GW(85L];N[]=N)L!!LQ*0?+'T"%^VTY5SEZKQD[L(Y_V<2QJK0=E&;T(5
M@V5^2#@EF<.YJ[M'7-=_Q4T"X+'\&]:1MWXT#IW(3;@]$8O0%^QL]926AE14
M/@M?&$8V(::B%JZEP6#<+^_(<NK&E*3ZG.'J%UXFD#1GQ7S5H/_T*?_7T[?@
MVIS/J>?X^$3\]CQ?U)T_@B?$%4$U' R@<^Q/GM+_<?.6G0%^*V3"BWY<K(H\
MF@M\-'@UF<V?!H,7Z%/LWSN?\8MI[KU'PJAO_\;\ /3<' ?\[O#W)X[IXDW8
MGCDC, [W*]6C+G_]_B1D^*V/MS%SZ?6<%\$N>W]B1XR+/-$"\%!"&O+<;""/
MYN]/1'$:DMF)%O+BXDG A=_#<V1R<EK8J0_^PG3#Q6<R&Q.6[@11'=$'&X5V
M7F<[9!W\*[BV_9E)/85Z+\^2+X_:XGGR]3/GGPD .?#L3QY8+!A1'K* WK?@
MGT*\MV>\Q^Z9"QDJ_2-N]DS=0WHFQUA"T 2\:P_#+Q$V8NC\00+<4WL& C#[
M>QCOA8+V-,0I*-^$,(6^>W[UGZ=^A-N:7ZA'0D(\<248J#@4!%W'@QYR]:C&
MHPD:$X]'<T*&CIB;"S'/*UK>!.KAXCW<XR >!-04)Q1!H?YNSLM *B[?!$"R
M%J9?U23U&]4>A9D"=W4^O:$]B&@PW=7\(^':B,EG!!6%^H(K[)+%1]/[+L>Y
ML'@34'X@8!!(?IK(XMG_2!Y-:@\<< 3^CYCL#H KA+8.JPIF2+P:B^^ 0NUA
M84)5K9-X,O/!LL/Z1J%;;GSO!7P?"E4;$8_Z[(L?DN V(KUN[UP.MQ)I$Z"'
M$<@0HULB_KWW"K.%"C&OQ*-*HS?0MLEX?V +Q>7U?2(>>37=9\)F)7J>+;XG
M1R@A4M':*<XB]U[RG:AO-)S>1$$(AI8M1^*3[[JP6D.?KE"%*_/9USHO9*!)
M"BW'*>,>+ 6+4M,%=WBR.S6KK8A"B.NR:X)7=0O27GB0[,:<<]_BD9$9C69#
M,$OB7E_^L&2BKLJF"4V7FMX1^ABV*(+W)3XS.H$%QA;&O(1C$VP\N%'$LS,?
MKA,W&>.B1V;HU(@/;_;65'4.*UOPM'!]&D!EL:903:A[0"Q^/PJ\X1%/<U$\
MK6W!\>#+8;#)8*9A<2$J]\?C '3T;BC7\Q*B)JAR:E-]+0U1/$V4<V#!LCW@
MV[8W?B!9%-=EUU2/]3%BUA1<DJ&S4MGB'8'<PEOX9_MM&T['-_X+\:!;80)F
ML(1P%Y^I1V?1;/D9:<E47DK;V):G?$UP-'"DX-Z;HG>Z27%X2[V,$@5@<$:F
MBU4,(^;A;O-F".S1AV7SXIF\A1]=\#8*&[P5SST:MC"1HC)-CQX?2S:+4B6:
M8(U5]G$^O0$H07J?>1>[0Q*NC=@=2@_ <NTM*-T0O52(%J0#!:FO=/'+\C:#
M@SR0$'^L#9XY!&J-043\M-R<BO8$201QFQ#&'BMUZ(BFU"D?>J2^1[\D/OP\
ML?)*5I<9EBS4)!1-L)>Y'[#S;- J?MP!IB^NG?RYO*5U.#6A!Y( (J\U'W1@
MQ&%2)C:,ND^PA!:!1SXFB3UD-]@4EQ3;@?H,#SV&O\(89*^@I# :'Z,Q^"1#
MF/APJTL.?3E=$X#FDYF-X=,YOBC)O<@OW(1VU Z5#VR;KQA--TZ2B<*IS_ &
M\]5.XNX#]&I2&^$B0;6M*<$=1#\D?$<%_IHP<W8S>/HT&E@E.J-,W@0MRD9Y
M2^)'$H(FM&=3S6 Z F>"%.6#%2_;JO(YM-'.^]#=(/6ANV'Z0W?<?0SF<_&)
M.)[>6[X6V*&$AJP?5L% 'Y9L>/+#$1&C $-*?A2N7.S"7JG$H_[NW%XCC,FV
M8KSAQ+<288D;X;/2'<I\HJ8&4Z4QPR1</+!?L"KQ]!6'T"1=L1W3QN[NP:*%
MAGBS#XRFS4F[N"^D1+L.PU4TDK&NBHOPLY@!5")["]/0X#_<?8^]DZ'S[$.S
M8@;%^_8[E- (7^B)!M_1EG\%?>/)MKAR%?N4JCN@55@T9&(0 >0X"E&>GEE8
MO D>4=9A,ZIZ>$:3VC/"7)X0]$G\ ;YU"3B%Y1O1FKKKJ<3-VO1$%?)G]BOS
M\+DV<T8LL1D/J ]F/@OIOY*]>6%]:X1CMV':5&<H.]+UJJ9!;])@@K%M$6('
M./LF51TZRV@RUUX>@D,^?&NG. 1=@U5C89[-77]!2,59K92L"9"OI\(-/(]B
MMA/TRQTA,$HC:0I9.6E#%VRI\R!W?L2V.4]20M\$C$7X47K3J.(61@U.3?%(
M:\_9\1;\]E%+-?Z'C\X)>Z7HM#=,U?-AR.G[N\AU%WC8+8ZSB0 3]\9N0:F7
MFW(5 =]*4E-SSY++H>,O*GS#6WJ\<('1Y%L*;EW()_+BGE(DWY/FAW1&5!JY
M (1F)<'9C4)-T'CIWEER;@.]L.47.,2V8[W-."G#QF[$R3.=IXQLD5:1(F^
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M!LY&#QI=B2(Q+M/#K*IC(G8/>JQ_3D8=+;*S$JH>LI'OS&/A",D5!\I;"X[
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M2J+,$H17-&;-,X3B!,@LK./*.S3^\%O5);['29J&.FJ0,W[7PG8%),K"E?.
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MN/.DOEC&<[V[X+">4]0TDEB"!Q><9XH[+5*;DE";9TYT<_[/=<I!U\2[$(D
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MA<$V0;2'$DCMG@_;B/P@@52K$AGRP@.K"4BJ* Z!G$+@U9'1BDFNVA3O.-E
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M1"=&G ;U,@Z[5KS'JGKZ]<O1<#H.:7H1!A]Q?"YZ7!N>!9($L&:R9LD@6(>
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M>.M$+;G.%#HRMIAJ0I0-P#TFKG2MBP9%47[!(8[#@!"^R.<DZLET3*/_@C=
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M)Y>3'!WRH(ZW;<O5$_@(?HY?.(^S\8^50-;%E=XIT(*CP6UPAY"\])9)B=A
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MAR<JE/[B%E\&#9XX8RC:R$[A6]&;!;H)P;E8';U(N,=;38W9#3]66?2+;S.
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MF3JYCDZPA[JE>%KJ#:?9EW#3\<W-]<U5TU)CZ7TM;W7?9Q2:,)#!W3D+ETB
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M H^>4!\T=5';6.F2U08PYT&&KE+>H/F>(YK-O&AE,OK24!(\V3:A5>(B_A&
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MGC^@SBN_]6DGZ!BR3X//CL%]HCKT8L/JX_)'0*+_[__V_P%02P,$%     @
MYX1A5#G1&&30VP$ Q"@" !0   !C=71R+3(P,C$Q,C,Q7V<Q+FIP9^R[9U03
MW=\V&@0,14!Z$R*"%"E1J@(2%&DB1E&I0FY%NA!I$C42!>E-X!84E"BB" A1
MJE(2.BHB37I+@HI29((81C,)9_@_YWW/>M=Z/YQSUOETUC.L/0M6,GO_VOY=
MUS4S;(YOTA$[C]LYVB'XMO$A_H%_$)L_$>)'+N$O^B'\$/#!MSF%L$%LX]LZ
MML[;M@X!_JVSH(  O\!VP>W;_S.0PD+P0&[?+B0J)"RR=<"_[1 5V;'UQ]8D
M_W7I-D%^?D$1Y':DR/_C8[,5(2G$7R+PBI]O#V*;)!^_)-]F)P(%VRCX'_/X
M$/_GP;>-7T!P.Q(V0Q3^0MU.V'Q^?MAH0=AB^-.;\.<( 4E!*;4#1[9+G[Z
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MNK"M:"]POD'ZB%A1_(O@7_VR']W"'P@E.35:>:3G>%M;1KXGM37  ?*BI*
M5SP?= 3 K^@$,)HDDGG"GRM_,N([KKIX3LU^'Q-^K>%>DF>'WL7Z4+W_\L7
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M6.+)LS#+7)83=LSX!KAA&XW7?$)O_1#^H8AQ>\=+?AV!;8@#6[L! [CADDB
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MP-R\V%S"?8+F)_<H3H7@4%0%)^0^-*'R\'C#-UO?VN5+.U(_M%/OLS8R+=%
M3VOC6"=E5_#@>"!5=2@L^O#%OV?6O#S;I)WT,I9?I&.'JMP#"PSNQ=P@/?LA
M5S^\&+-GP:5@=N;TSV^2]D(Y1[=?"I<Y;:=8?;4[;= :94!J"[$2C(7;?AT*
MDB[MP=5@E[V>_:@!FWI2\$]GL>5+HGZR]?^N(9LMQG=V.]QM:WCSQG?R%D;'
M!"8Z*$A%>=[K#^0'Y/*$KY5A$DRN%6QTP-UAV^_>G*@_CC<N^CO&?2 ^QSZR
M%OM\)82MS!..88FR1\"W'!G0B5D*R8BVFY.2K#0)=\[[!!<I#J_KU*XN%T8:
M5=9*=1AG+AU(<;'?<>2,P=#V61*9IL@;( -1^=#.GQLGP0R.#8'<H[1Z.[3J
M8F)0<T!%#W-58EKSZ+/F!B>]ZHFP@^=40YN3%'P.4F8DQI_R1-4YJKS/J%?X
M.$P8.@TE3U0!R"=9MA\;3SX)F*?)3_P8F%@Z%28O=[H_@O6R1\COQ(4"3==]
MI;L1-\\P+9Q#3@V@+Q/-7O:4!DM[.N29WZF/BZZ_7R:LEES]Y[87,HSQT%>]
M,E8H=IH$7)&'Y/AYPEN5J[2)2-S/+8M&)[C&2F=UFA.3>AIC.M+J0VABYS\]
MY;B(1KZX4.+0/# 8MMM9(/NG10QJ8A.1  ,H9AP]WY 9:J4 [>0V6$D2>CL;
MXSZ,JJH"I9V/T*>I;R6[AQQ\XV9CLMN+C>IE&&=S;PE3XFCT)1RHB81,R<M6
MI&")1"M5CGTG.FX 6P9CKE&P)S]B;'0ZHGMW\0^CAT+/SRGFW<*<>.DW4I>5
M,# =2-NY'(8.J]U[ R=KXY_CY:1^5&16[PC;^%+V[E/@[OFKAR@P8:<7XF0P
M]*>8NJ0X8@"+QNSO(?'UT/5M.J\_?P3 (8I5=L)'5@6Y;CB+45OVY_&L7Y\7
MFBB^(U%D6+TJLJC[*X8GM*6_)4"81PJJ<Q-JT:"ZR_FE_2&3A]N&FT/FQU7N
MCA.-TG7RM!>0NC?4HH8N(OS4'ODC]Q=P%P!:HJ4%/6O'C]D=0&)*Z/,?YK9W
M3#U]'OD)92I[!=ZUWW7Z!>/TZ7/6NQ"(QQ+M+2B>*$R"!$/'8*NK8S" X[M8
M=4BM)B56TX?@*K&+UCY5-FXO?_]]Q&C\66OW\AV/_T4X=NR*A&4O#" ]L"KU
M61VO84>Q[%<4 5]V BC&<AEN4W):Y&D/*#-DV5DO;)YWOQR:;H]W>^M(K'-4
MN?= V.%AU3=EB?G9.F:6 HCFB8^.69X!-A&,1POI=87H2>3I7"S037XQY>G\
MXOW7#Y8E!8L.C'1Z;G[TKFC*) [4*%V18/6P)[B/8?Y<2)Y"LJ_FM\;4J^H,
M$O6VA, /WQ93)9>@G)7$(,1:E6NX94W>B<ZER+6\$P<0G"6[IKQ-A'TM]:'8
MKRE[]95=EUYHH1X1+\ A@",0]]J3U+87XW=8F=D=_VQB<1;-,DM?-IZ3"'0+
M[>JKC=3XFYY^\+^DS\Q_I _'4[LX;F^<T(BDS+X]Z8+\CV5!,CS51VXZ$;L5
M56X!U2IV<G9GP=KB%%VN9!+=5BAZS;VC;#)P%0WM=2M_JJOUZ,I0:T*$^W?)
ME?_H&AL&J@LK0(P W1BT#-3_(FMR2]CY^U\.6EE(91I:J.K.DT!TP$H&YQ*I
MS8+D&XIE?^3>M[S&0&E9CQA/Z=NWS^X#[N2G1328J1[)LTC^61PX;IS]Z)G[
MSLJ!@C]XWHX%V-U;I/9?W(SH3<1X3(_27"$3?<=L$Q$,K/5I^MS<QK:+/@>K
M&N]K_U/5P)L.>1$FS])4-=+X>\8JUWQJ  GS:($L;BV-7HT#SL(SY9_B5D)J
M'!M(")BMD$]!KWMCVLU7VRJ/,V%1,Y\PZHA^/#K(=#/ZASE[]$EDXB=!/*B1
M!.UR8Z'85=R&.I@?D%86 )0U@.ZJ1)\=B>K#G (2/O:<:/D<-8R>TO/4F;5/
M&/D?HH:F,T6;[P?5YB"Y7/H&).7+$QHM6.A>G>A@%M$"*HBNH_\,U*V*?6>'
MEIR?JZNLJ7R8[S*C;J,YWKNKNR=P+__*/V88^@P*U)+OHDQ%LM=','0J3@DZ
MS7B$L1XAAC*]0ZR!Y["F:8(US258TU3)VO_5.Z4_7%V1K<O[FBH0^I&/N\WM
M$PTXDP7JE"[#BDZ@BEM810K$9C7$R+N</W\SK7U6;M@C=JIJ[I[>JV/*=VP1
MM3D-O4KIT,?3RM_+>3AXV_VBI/N8L6(@F9IV$M+$Z7U^!T\<O!!DE77I(Y%6
M.SL]?;BO%34;G3AK>%,?[D4N&#IY;A=\W1L2< Z7E#=7]W6A"YN$J<&W<XG-
M5'[@*[ECGND<X%JSXUQ8F$;3FQ3UC&0+C7,VN[W;][K:A_7/)ZW *1<\S\TD
M!?;'D1"Q1@1[1G]6LQ@+R\R[Q^@&AQF'-9>.OWGE=O>]_J-O]_3&#O18LNSW
M](3OXOG(8;-1@91:C/^<$(SI&\LK=#0?P7#V8.U-Z;;KWHGW9'8+. 6&[LG<
M_699TK6AV9>.01*/U%0/0T&,I5 [%0NWVA$]*4;D%Q_/CS5'S+/?7<J6O?TW
M_J[#;A3<-X%P+"0+<V!=.(ZWP4? 'QZ20&-\HS%H*:9_FT<+8I(AB0-OAPH^
M.)TZ\RF5=>Q#;XR"0/%=W\L+EC?_P->,@_$<1XC 38M5Y0V2:S&=E?QG1GD:
MD-4@Y"A(3FK6NZQ?FWLSL,%IIT2XKG.=?X;CQ;<'<A!BMT%8 2)[2>](;%B-
M4C#RFXCOUTUBNV 6HD7Z*@<C/;<0YKJD]9X :U5OSF'(<4O$@C#O.LVR9P>"
M]^#+&=RYCM7$6!6@^^V.R8".E- Z9Y_#WJM'IRSJ.#W(?&YAQ'-;.WVJJ4AS
M*DCCB6;#&8B$9]D28[JQ9OU/(+51JA)AN)5%"+ ?P=<YN[5*=\4\>_]B)OCJ
M0 ?ZWLWZ8S//'3G3NS^^2XB,FR/R^C%K^;C)*YN(D7T@7$5/F\_Y>'#">.]\
MI+@MF)"Y+'*U6WKSO_'=I&ITXLIEM*9S>S?7TH8I?/GGZ[D/;S,5]YLO]UQ'
M_*: ZC"YD!OFB83  >0!V!7':RH9M!2#"[DG6-V/2G7<7_XN])^X4O[L?K'#
MCLCBO(OJ;]*E3CH38:J+E"2U728%DT'-2G;\8UXW50G(*_X;,#[%M"IE/C+T
M>O/RTN<NQE"ENOOSK,O5FOEEQSDI:E+2Z0>UZ&C0!,G^VL2]0[N,34,!6/QD
MEINJXM#O&Z%'>>YU05<ULRC?4W2H&4T&'(<PT:*(RQ=/C[98\,1E@*3DWRAP
MCW@*QYWH,/BMFA730YG$GV112X,(;\@GA_T'?KM'A1[Z]:'PIH&R1A1=.'T!
M\?JQQ" .W..V<HX33FJSVT3\<].,W0XNL&ZT_86);MKS$?VHP^H=/OR!S&&Q
MRJ7)E)(@_*[I _L=KHK%2Z$/G2?'\^3@-,7 >^YET6$X:?TT2"KK%*NTW5VO
MDJ<;'"M+[MX)F;\U?!]RZ5?>&W?QIW67"(\/NG3J8ESYR34D^@CJSY&-=C)'
M!(2CALT?^2/-.43Z,*^4Q7V(2Z6MNSZQ1@UANLC"O,$-N"S(MJ 1*]=FJ#DR
M]'*_.*V*X+22YQ8I-!?L&)POJ3#X\,G>2^]$PA^.W2:UF5(U8F=@0KH!2<^W
MD6LI75E9LSN&("^6?$?]W]%[J@G CXS,K!U-DP=G#Z&=9@[8*/I2+7?=YL[_
M7B8O3G&'<3"IE>1# 0[DB7YU7I!!UB:B9,D:]0 %',>!: E(%L\3D85-TD*]
M*LV <$!I1T'TK5&-49,97<;OC\/O\OANN[LX >7>[>GU5^-."BM09KP-1)>\
M#6>GSM+DW0ZTIH5'O4KN'!+D>[A;*^SD2</PAVYKG$W$]GX81CJ*U.'-AE4D
M??]&6=2\)0)J\41-X,5> F:05"DSH#4+$1P^Z?U^?A.A8L<S<SQR==A2%_4S
MK&KDR+N[3L9854)XJ"'7ZM?;MPTU#3D_?T:E:M]MKG[7=DYF1XXC'6$Q]HL&
MSP9Q4RUQG*NQ[7_[(3B+)Y7N;#C-9U 5AB;(?K2._>T]SF_<WW8X1X@_=_@A
M]_+/;GMKU #WV4PE]Z7;J-F!/H'!EW?[I!,==Z8GNAS<G7E$EH7J1*5@ ->Y
M#!1P.BL9A]A$^,VI$O4!LW8,7Z"Y[@Q8TVTET#2*KXJVF/*UF#HBXS;:J]G%
M-U[SO$W#]YM^CS#L?LM_W5%L(-'O3R+C+;TJN:7=9.07K##AEI.F7\$G[;;A
MJBRBR2OW-.F\G-$SN.(!]_')_L-]E0]/OX_<?>.!>OKV>W%W=G3>9,J>B[BA
MK?*"'T@Z#A?F=WC>\R884"\$YC%P3PHFHIQIDII  Z0%=]>RL$_$V@ .=IQ4
MQUGIR5]@D5MPL2"*:0;)CC',(!F;=AA$5G18ZHR8-*H\8:.M<:4[89Z,A#"-
M0Q1]DQ#MI]%QS-D03L+)O5+:XNVV]HHNSVGRS?J;"-T,F,8'2%_;1!3OI2R*
MW%#6+4P.^WF9F>/EKX_7[18]UG4\IV2MI$P]LS,5 <&6Q263_FL_85[#.O,J
M%M1"WK$, ,A>KYM9VV_[EA *7<"8R%WO5<M4:G3R-#Z;UAP;$SPYQ'_GD_S5
MP8U\2 XYGP3)S+-EN'>B49,U[$O@/7J60C!5(-."O"O(<[5C0L;'W;A)H[EA
MYVR\Q%T5Q>R&>*EW4[?/F\VC('D<S_7NP"9B.0K<LGA]D??(,H:>)0(Y U8U
MP%S/=3WSO"2FV+YYY]&HI82/,:XUG8-.TN*+[Y9+QP>0WV#JJYSQ'P!]1J*_
MG!-KCF9)L)/!+/IW$XH@(=5"E"( XMJQP:X?;OC=\!I[D[/H:O'5Z0U; '&3
M7#;3 ^OM-G>>$:QMMT%F=(NY<1P3&4=B[&/U=XJAVY7,XHD!#!V\.K7H2[_&
MQE&F\OU9C;A)Q3"-/[N$*DL..U#:5\&]21G$<W"[5H%!*;&./,'/K*HSMMK)
MDDB^!%A57B-<?=:7L)S=5[SH/'@V+\0NX'MV_\%^3RX 1I"!SW/ :;PT=+%P
M@R?!):__(2HSI$<MR#)S76+==03J\\F!"?>GD74+GZ7CLZU5X6XGF,,M(]$?
MSP'.6:#69;C9C'50,F/YQZ C#*VA%<O3%\HALQP+9T^GBI'ZH,IVW&K=9$"6
M4)^!J]$OOVI+$D]HGA,.N^RU]: $5RW>Q'$U6\$!OHRA[T4F+0,HNT80%5-F
MMX0/"H@(\US@7)70DXPZ2\D+_[H0/G/[!P:()D-/1)GYW$3+0YN(TB9S*!TN
MGQN\"7+=PC(L0+9/0)' :BMN NG)DD@B.K*0GD/-MBR?N?,U'*W$?ZA#Z[U>
M<:/'OZW,7+R0$J=WH/9[]]%33Q#<"FY"K#FI[:P>AO[8QXI[ET1_DL2H+WT2
M1)/0AYSI:%G(8B#L,G.D^,9JC17+<DWARU$A@L.'G!(C75U4P^*_1;L :%8M
MJ6OH>UYE^=2$8\#VXG]P5A;75%28$AEMBL49J0L"Q47M50/(!;-67.K6\[NY
M26E&3V?6I)$;. 4'8"QN'2=-R$/Q!9F1A2G1&4YGAZ.F>N^K%T68>%VZY1#Z
MSE4Y38(<N.,Q= _.-7;K=C,<1V\,_35I%]R+75!I, 1356@)1#7NFX(TXIZF
MD80)SMG]0L=)E[W^D)9B\--S,<K7WG$?@G,7?)\3$:Q'>84!LLTZ#'WLI?UV
MDFZF0[FW#N[*(2GQ8#Y(?X_[8P6#(8[ML(G8T FP1M60@)/X3!)P*A0[;]:#
MOXT!3O^!MN&ME,]_;_"18:'BC,N6]:*]]_Q5?FLUWLX,$F%4/E"0LFQ(/=>+
M4(#:8(PW(*\HP@5DNR4U@E&O5B$I= =5>@A29-P(HEB&L,9Z"L[^3;_X2<=5
MLQ#[*C50MN'#A[M_JJ6U+W[=<U8?YTAJ:YTU8:';::!ZPXK@_%Q2+_NF_T(K
M\,-H=NJ%1\:CD6737 /6)SGEIKA#\S<DTPL@6,3%*T-F3S.4V=FL\ 0E:(;@
MV7=I=UCFSL:*NX?Y#RC^7NMYAKCY%K9*C_L"0R^? QQI<3\XESP)2ZTTE)7R
M=S?V*\@&^%1*?SY@<M-\,DAN;U-M8^V;G#V);L<N:(C[_N*_,!:./0GT0[*E
MC+$5;S@U&>!6.Y#GII0ZM7BU;R+$?\\<G>MH_$HIM+I7-3[N>$7/@)'1%K'K
MV)6,%/5LQ9,*;O"&$,P8B*)(;C%,6I *QCU%58$G3"CXP9]I.6X\L9#,/9;]
M1)7N-H^&%%'S:*E9R!OD /Y_K,88H4[MUUV?W?"-H%[:MFB1\AAWK]J*\/RN
MV<:=D(<K"@B.&WN*6XZA-Y)>:4'26JY<*M4"B@05J'L'_QE"G0+]GD%[6QZ$
MSOYESWYN_YLR\OE:]LVG^O7;7=Z=<X]3?4VC9\\U8&$YQ1.9X<B"I>Q2,(9S
MC"@&Y-4](0QQ.@KP=WYGQ6_\FL(Y"68\&NK=NW[]3:!L'_VH8',"L67.]&H6
MK!#CRVA?D2AYTK(:@\;%_/C-I %^^5 QI7N.[5.'YQI]K^7;*(6D>N8;5M0Y
M#K$=5%FPC(,#0YP&J9I6KYDJ6MV>KAF! UZ>/D&-/Y\\KPW,T+CSCZ>VUC7!
M:GL!D;5^T* !DHT=XPGK<C1_8.2-Q0QZ75E)*9:^%YX3\$>;\7G?!.X%?%:Y
M]65W7:9#?%:3?J?6)'6HYG7U\!/3OS<?GK(;>J^K<2!!<*:WZ9^8 /^+UW,Z
MBYQC=4EM$31?E/06AF(")++FZG%W-)L;Z[GDU2E;\,"%4-UKYB5*-N^(;H1R
M0XU? 4'Z=ZN<3.,*"5NZ'4W?1'21^*$8$,N@9)!WU"5\MK1@SFP?=A]8/</S
M\IQNK^X<7S[^YMURA(7;?^Z;8"8WV)WPSK@>VS4YM_*$LQ_DM#NA$BFUO=XV
M6^(];?;9Y(QWY>MLK?\\D716;',54-LEG;V6!"G"$PC"Q"-ACJ,")K$56=T-
MW\ DALK&E*5IKF,^V;HE^^&^A;PU@_1RK*U3LLP5W5D:?0G_YR@*7I C1H"%
M!]8UB@_'$_NRM35Y,QC@G,3$@B>W A.$@M4P=F@]2V6&<'6NG2H'G+][N#6Q
M>S32,M]PYIV;_M7'>TI5'=]; +02V3\P &W'D3YH0VXP"^J%3\.NV;@J8X0;
MHQ^23^*)/H+MM(:7L(T=OXY9AKW>Z$;M:/8J)J2UCLYJO&H>M>2S-#,M=FIJ
M\F\@&7 NWS<M[+CU5LH7WYO+R<!]Q$.J,%KJ&(#X3<0E ]AIK'D+(K:,U&:_
MB0A"@_I82#J$?8;&?;6.22'S61T@Q+2WSY(4ON>C1$QP$G,= <;OY<G\/57G
M2YJ4CLW<;3H3>:&>V9+%$]J$@R?H#6A!<OQLAV9PA(X1=Z3/R7YO& KDZ0*_
M.]M945L+7\H,) LOM"XR/K\Z<R\*$QD.P5PT[C>I[28D.[]Z:U8'_NLT9,4M
MH.XF6##M,X9/#$;#[#9U=%3I<&:V7[B&]+5BV\9_#^8<KOAVP"%;(TCT46'(
M2C]HEL435F%N(D"-L>6L"M"+N9JV/H/K*;(:G1^U=# ^5."E;W60(3DU::LN
M:"1[1KWYEJ"^SKD/CZ\BP*3_J&/!:7CE"EX7"CCW&FY WX"Q3*K,DI(?[^UC
MCQ^S.C00'U'3(?>\_HOQW>?%LI/JAW89)@E)O&_B7T5/IK73 !]: DK4A*3
M^T2NP[?B4E35A];?XRLAE1>0''4PS$0CV6^^(3NZXO%0D2R_H*L_HG'!!"R%
MX49X;O&Z&[2K[D)Y8*-,X[.O]6_ICJ'&[[0RM9KO7:S6%6E.."UZ5\9HY^.'
M.=N=8[MBV^?J5F'9!7/3MDM6^@1Y]CUN?AWNCBE/ #1Z?H2!%UE2JFN!QJY,
M+[HX&CQE%[H&:DC5AJCNB3G',1WJZKC%5\HJ9,.P%Y<(-O"$2SEZT 7NW>;#
M](JL]#E5O*5Z:%D74W_?U2&][B>/IQ?=-E0]CVND:MLVO8L-\,LT15A<I'K
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MDG-#JJ7S<T)B1WLUMOA#[O.*DB7YTUV^>SXDQ)?$#'67GYV77S.]HLOV3T5
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M^KO_Y':JJG*?-WMP']RLPTX&[.GUD"MK^9ACWEU^J^D*4G9#5H8/RH7$P3]
M#4\(+C'D]N!)2ALM99*43)7XH;H_W^[S;PGQQ8[3<7B114>9V=,%IJ1:)_^]
M"?>W[RU]M?L7K$M00-3&"IYC &[PA$8JP,A64JU9W.\9F^[&T?@8AI.*<N=H
MPYG@^O>QU2:=PM(UCCO=]WZ\%2HHI&7IMK357.!5M\]".MQ,#/TQ#K#IAY']
M(.\08=[ZS4C=JFJ(E!.CK=RZ\=-#YY:2^L9'M3MF_7VC9JL%M4^<S,AN"?G2
M#^Z=6[G!ZN");;UA^QRDL!6Y-3\7TAA9R=&$E]"9B.PFS_;*KJ04??F<BX$?
M4HY"W7L^M+X/>X%Y<5V;'YCC22ASRS81_N0T,H"%2T5U&XB%Z5<;57O4(%9W
M,F3_C]E=+/W*]5*LM_HI7%UHPGARRMMX<0+>Y,K)D!&X..-Q*)Y," 8(I4'[
M2 *0]Z ?J^>.E3*!YQW0,:KT&3=9X&&>61&^JW];0Z'2<F-]N":"N_C/EU1N
M^ O*Y9=U%CJU*W9#NFDWD@L.T8OV_]BSOT-7AQXG+* J9,P'X"!I>9ZH"L<T
M=I1<;9] U.7X$6J.@^&L@Z#=K(0BK(_J^]0YT99WL\H\*GF=+35O<;/^ASF6
M[5D3A0S*> A/> IP@SGBKM*;'!]2FZFQ<@AV8H%QKZ7KVULF7KS*$A/.%'UD
M>,-QO6^/'W>:]2=_F[V[D^U.CU.R9Z3(TWAYR!) =JJ8'E;NF=T^^+OWX'E+
MTX+N![(?'3J>"F8[(*=%!H>-6XQLAQE#4:'FHDY>A':O*:^CKWND,E/+'POR
M#YQ"_OJ/+.R D^/#&YQ[E03):G60 "^)"6F&5=D\5M!^_I%9%]5BH!D3/.P=
MI)31/-C"R#$6Y/5>3?XYC#@6X:1],]57_V\+3"($&^!97+UC/ZFSBU'U&[?4
M@0VV_13Y9&ZGZ[R[34W,Q,E'M!5,<'_O%Z&-A<?J!7^?O\T#=8!0Z-PF0G@8
MV@N\'^V$-4/]R7@\NV7BTZJ%/[3P\-LMC!"&GDH"3I FE6&N R_CSC*#Y/K9
MKT"G<A#=ZCP/JU8Y(F8 L@T>F F1'_JP\H^+&1^U+T@QHQ/2R^G8Z;ST398K
MQGV*H3_91+R6B*/185(J8*4*EK)+@,-Y3TH@718ON]*8M[?>W;CEZ!JG(\?+
MT_LXSJ]Y3<P $/JR;R+#SG!18D[F%/(.J>TH[1_*+1QPIG\"X\DMX!E[V9L^
M>FG=$*O"$BO0R_T^MIBT_#>A)D P/_R=@+!ZS-&K;RE].-!$EZT)+L#+LKG/
M-Q&7<1,A[/@!JYZJ0#-58=.-NQ7*WJY]GZC_4.LCMH-^I^]>+]N1+COX;^S
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M/*/ BA)N^'XO=?7 J9YP4:1NPT9\ 33.;:+*@?,\86'88+T?F(8%6(H)A.@
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MQPD1@_$9:BK@[1JPJF?')]I;,WII_>MNM:=R1:0\]8@,NU>C#ET"209)))C
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MZ738K-NB8OWZ]-11P4OF3]SJW[0V"X2\J-V["V9D"\-NMO$HI+1LP JN,U;
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MKUH]^N#Q:W<3B)\"IQ%3%+ZH&$N!+RK%,>!_PP&G*.#>E1PKF+64^J]2(Y_
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M.;O]!0PF !/^@Z)%L<7YN$(6C!B:"P;)P*^:4688BOFVRS[.UHX9^\O_^:?
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MMW6L_)VK#V *+\QVUX+CU@D#\L\K7GB,+=M%[\H94>KN<;7;VVJ\OGV'@'_
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MCE&K  M%SY!/=TVO&5T0"<0=U10YMKP%NX"ZI2)GKQZ1O6%<^6:\#%P?[A$
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MMS)X/AT2O-#WC:>8UD5Y2TE#C4XD:DG%]$YF^\>F>NW[@U]D["D^79ET[CT
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M":5#>X.!Z5.&EI<:1;3 7[V5>=T34UKP6&I]!&TN?7>1[#41I#X"=))%&7)
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MW*I.2"-\01FRHXLM^D-=6QO7:.(IA*S L709KLPE3.]>,?FPW]=%^A24:'4
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M48K >UQM_T(:";]3^2WQS ^;;\*3)Y\'HC[_^WG#J NT"H@[)OP 5%ZSMDJ
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MR3F!:B,V^$XRPDEJ(*0\\/!!D_$LE.OG&_;@C:8UZ%?V8+D64_'KKVL:+!E
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M.K CHN ?(Y4A=8;F;.ZQ0;L1..F.1BWSRH1"[*S"B3N_4]J=[71/Q?*CXC*
M.$S)X^M\"R^"&^'SI=0>AJB14NODQ)V*^U!N+O5(>*8GK,S(EKT^"'1[$.0_
MSKNK$BE/9R/_&&FGJ_Y"&E*#]\^[Q>&G@LY-*_U>.'Z?DU?9EYWPH:ZAV]F
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MC]WEU#W0K'Y7='E_4U\[ZKA+AW7E\MVBGB-_JS6(F?\@GY2(WTHB9L$HEV&
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MPTG;[B?H)&8KCB-+8(M;M.4PPB>>*\7OK7RE:T)_.:[J8P>0VHBE(M3-DZ?
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M>47FW 1ONGX PUE^X*O[-_&7EBR>%IU9"!623A3@9B\I[M:0OW/[R<^' P#
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MBI[]BON1Z7G0\.+W2_>".WBIV-8Q+<CW!W+.5S#5.7M46*;,[%>%9D&,>$]
M_!A'ZQVMKA9_R2JX..#.YH[TZ3A%NP?JFMJ'[#Z\N0%W!VN@T(&"+O?E"(!/
M"S@*8 _;%Z/%:'^Z;'_EI*/)(,;11V @J]+[8%%2A:NYV372?%.#<#.QDCY/
MFR ^5F"]AF@;>&N2^K4TD\T3Q]%>V%KLZ34T4VS[\^*<F).<A7A\ >$OG%I#
MZX1H6 B3WE8XZL@3EH(^A#,[P,DV^8,- QQ7IN;X1"!1KK5E-?U^U]_J9Q7V
MN<?/EA_S*JT0DSVS8][8MYP/HTSQ80EX00X<NG:5F\2'N=!_-E^MB*;TM*@,
M-/3>^E[R.YF\:MI'*;/0M__MHOC^TNMDO':ZYX%KF-J44XA*]*:-!&;#.-;+
MQA\/<(^1,@]08N@97<9U+P>GHK^&G:$/TQ_HB?@>L3^K*7K%J0[QJLC/.07]
M%,^X!D\\L3I?P8<)HGA?&H\SY)KM\N.,Q-\$GW&NJ394:"C[435ZX7.[<J+<
MY1[91_()6V_?C\.-G("0_4=D#+)R]3,\TEG!5PAS%BS(FY%)/IU<]>I7O*S"
M_>+/1C(PZG^P'!MMP2'V68X8^(DY3FF-;D8_E;E;IH-/E"YQJ0@\?)PA<>6^
MX+7]M@,2,"O3?[7_H&U:@\0J8,YM %S'Q3C[N24;E<>(E5'Y5!^I%C*"U'7&
M!@S+!^LZ8I'B9GK1F1/2=Q)ZOOH]],66;&Y=>K-+,X$4 X[SMB>Q#::!4AQ'
MHA B1URVHA?V,!.8KZ(B(IP?U&1NKGZ7V5C];'A6Y)WG0JY:GK]WC=7C"UJ:
M#^/$J]?T$"/(.$"0MY<3##XLY!P!290LQ*[@4*?^N\=T+#5YQXH&E\[VGG\3
M)2UT[N:G[3=?/H'KU.3,R+@]SG/T"%&-#QP,O*>H6\THV7/D!^R#X&O8#ABG
MD]G.D:C@;2^ )O>%^]3(B='>&C*0-UAGG/1P#XXQV4J^:!7<T6.SZ/@EY4)5
M0E[RWZG@*\1;GOZKBI1RVU8BXRH25.##:*H,=]YV [:*EUZV5 -3,![I-I=%
M,VLG&V<:]QOC\^>DD'?K1DIK,JOOM_L(/^^(L$TQW%6%Y<UD[V1@XXI&@^/.
M,;(S/-^C@7;:2G&$7Y??^%3 )CSS<.7[+4P75B%H_AH@61,I?W##(Q/M\UT3
M889M>%$>'&/PG8.:!*3!0)K:,DTW-,S:ZL>Q8OG@KZC*BW^_Q?@3;^<Q(^Y@
M^P=.BC>3!:.*]Z$8?Z/=\S\O5A8+I):?C1RA:^R ?5T(R?QT2L!U=FP[P[DA
M.$#$OTG&B4:Z_"ZTP=A ]O'WNZY*D@40:UAB7P213<X(D,JXX"381 Z(,Y\L
MV)K@[B)K^JCFEE;E3LH2^LP_4ZCL7^U_:MVW?[5_B?-?XOS?O4FBKPX\:!"T
M^#2DTW5!V%!%)2A[<6'6-?'(P8TR/!J;KMKL-M>'[?9J]8/@,9+4I<1Z"FZ:
MQ ^ST0,E#]APN6!#:\8*C8M?G_/P]5&L?BB.;"L\>G-! (;Y %!J !$CJV+0
MUPZ49"MBG$$<!2'NX:PX4$F0#[:VZ&?-7LM4[4JH&NV*POL%2=)^"Q^:OM)T
M*)!L%+.P*1#WW5B?#R-=!VX1'O%AI?*OH%BHP$0D$@B-<MZL-#K5ZF;>^=JH
M3WX&?B*O&BIYC@_G75*4V:>+[LZ3;*JP^S#*W#=$7R*HZ\CJ!/T96;P=0A05
M.@*SCS&8->&C0BTI>'W]W,$P0YO:_GSBQ_X_ 0*O%"NKDXK<;Q_I;Y0^6Z@0
MHL>1$V#64*);X<-XEE(*Z]0/U3SPS"1^%QC7XG#!<W9FRX6*F9_6^Y;$<\:=
M<\Z>6OQ9"ZL+? 0?&O\?J\JBPLCA":=,(G:!<)YH%/=I%7T'2C$HQ1%$H9ZW
MW.OR"9H(9=L/37_O4<[^>9@8, U[&[O(A\6.27"+5@"IDQO%,F)Y4GW:UINW
ME@]4*GU\<5ZPNY4D*_[]LJ >VP[X>@>$N(C++^+ZQ8&%5":29D'I&0E$2G/T
M^NF-6N ))RR]);F=:@'6&S%;;S[\+?ZW(S_H1=U]C?"A/"\^K.G%1LYBH'<2
M<PSZ<(H/6SP)"XLVQ3SDPW:X\(2M^#"S! :$H84@H/ME&?A7]__?=U]I]RB%
M5K)+%2&!/$[21WH#T2K V^E!<L0JG+*\*'?XEJ3MKKN_-+K/G3RRA7Y!9;('
MM$8P''#K1KZ1>/ \@F>6PY-HY^S)X>'V4=UYNR&_GC2]9?[$OSK^%^I8XCVY
M9Z-FQ7,0R6AW #.*L4. 2'Y5;U%7"V,X^"1FZ/*I)GJ-<';H=\%1"=LV>3D0
M"NL";YCPZ'D=MN^(,#7$+,Q=LL5;*<+X1LGC1_HU;?="K_Z[45[#2Z<)."3U
M(D#R0DXS&_< U/W FCSN7_W^"_1[PCO4#.D\$?29H&\/MK#A%O-DN_3BJM+Z
MY[.'2#/E2F+IHX>GM6JV@ ]+VO\+F/R_.OY/<AV&% R284=/:!3[Q+P;SG;D
M&-1$C=C7]8^JU\L_[B0=.'>S?+-NLCY][A0BQ HM_Q]%)P3C'9)2A5@.'A=&
M,IXA.;A3B)N]_^KZ_]&NSA9L*<QE,)KI3OF5O1_,*7!P]MX3LK* ]_-W]3J0
M:+(U:XN G-830&;EP__MD0V5).YK;=^8; 40/ND+QQSXD=G9FLX3^U',40].
M-S8/MPJUWT,V46)(/G\S.B)-<PJ0V+0&9_L[\P:1-2?;'R/=^3"R.$_(>Z(:
M3"WD]2#$C)"AK\>\UG>2Q;UMKX >9PH=9@]RTPR]'U*EI _<=3'<HY][P]*5
M]X/(N(ML)8AMO(=E#,>VC0MC7'+GD-(\0:]T8\4^]\S?S2Z%3F._>OR!=Z;'
MZLZ>=[XM=H&Z1:<HE%.FH(EMLSJ%>$'.G]_$)/)V2$%NM11$_^,5J@'&/D?0
ME<&F$)L[#4_JG6(F_(G/?%<SH?B1^-%:-C!(O"AP<-%9X6%WQ^W0>V+VU\MY
M+WO_C2L^%*0A*&BIX(J)]B9+W^;,G:N!F8AXQ=J!_(C-U:4OI,_4G-1J#>'^
M\Y7I_]&<32CCF\':9E8_,[]%N&M;\++3&=)Z0'':V\\/[W?M*WL@NP(;(O3^
MYS;*'[;3@J@H,7"*Y<G$16 4<BV  O0T3?+52YA4ZNI1LM9X['+(D2T(ZDK"
M6#I%#G[QARKY*&TYU"/_Z7I.T05IU,?]L3__DV=[%N%DY.=&-:9[*RXB<SQ:
M6WJ!IHW<:QY0B-HNX'/SN&;TW1#WV)7U_VP!AG#6489Z7","H_2C$B7CH34S
MY!_<;%.;*/QHB[;F)7M$^/=$4TCH_^DGY[\19:C'&"<&FVJ<]S:XWP1_J2ZK
M32;OQ[WK,.DWR?>_<.0C[JL,3?^36V@D,#T7I#LPG%:BFU$RCL& @X?=3Z_T
MS/.-44=A^N-"#\8^M9T*T)\V<QA[=QUHK\<O(/Z<0L0#C--\&*B2SI',X@G+
M\F&2Q>D3[:2>K6B,046?6_]$+6@=^M[1"Q7*ZBUWRJR'[RZH0F=8(%Z^E+W!
M%>##MFYD&9X.+IRLH7V:H(.'\FETAK\9&,0<:4JO"61I!;NMVU>B=G-?&4VQ
MC^"U3G7Y\E)DZO23Y;H^[;V#W#C3GP L:O'Z^+ 5*E6="[<KL69U]%7AY:%O
MIN5W]6-%"CL+?@;/D9;F"+<TS^J2=7)71V+FJ\_/CCW:%2)V"M&;NI"3/Y-4
M1$Y=UIU>/.;1W[%+JZSIO5*!TB/#'P.@)2-N4C .2<G#,QR D7W4H';UX6K?
M^#1C6*^.[V:,(>/J0D&^J2LU;B\!C_KT8W_TY52QNX>3CXR6'-QV<VK77K7O
M^H2- V/M*%"9OG$04(3%4)I_PT:!;70S,'("&;-J+)G>&H)ZFL9BUA^2+'0R
M$R1/^'0J:+#UQD99P3OD]VEOXFX9]JIUR^T__*K Y)[/'XWN_1G7V[B!U?".
M,)Q.$M/"GAD=C=T+XEH0\ ?Z52>QS2;U'[\O#R^5+S /!$9!OJWYO.0E Q+A
M::,()!:91CG,84CJR9R3T-]X7BMQKX_1%L8$/)+I@54 ;U)?"=RJ9%Z_U>=!
M4\O+-)#<]R>3?,59Z3[+8Z3B@,IJ VRCS,W6C<H-T=@A/HQQ&0"5SI6Q+_-^
MR OUKR!WCX!TF_YZ0Q]JJ'X1LJKH1M1PRI]LJ]VU/8=:#./>CVSOMML]YL^&
M0W?B"7@3R#4\X8>3.%!)KQ7U:$P&?$C%1X])#?QIZ)M?T?HP*Q54O31<9'UR
M>AB1YO+R8Z+^\P30[8[?NA!;"]N%WH&\#43H$K<T"DT3\L' SJL_5H2][64U
MS'T)4XTO;F]:?'I7]DC;:8'K+]V(TD3**\3B1W?:(3[L5AO$;#_&PK@6_U:1
MZR(/8KDDM4:8>AL0KSM$[BXL'$_0(AGOZ+U'CHZI.BSM&&S2_4-6ZOF37;M@
M[K?-AKA)JD1?Q#Z/:H04\0Y=+!C=E!Z22B#O!RTI">I=<>?,I8X*\/+N]9VD
M-6W6TZEU/"MW?K/IOJQ%)9YPKV\A!\N'A3]'WL8/X]K'#@Y4$H4<9]8%NE,/
M9P7\[I0<&*P(=/OT^,N!0VX55;A T9W",\YY;"GLC_&JH7EO/DSP %C!$]*9
M1)#/M",EL!)@W86L*XQFC-E0WD"5B%AB K<H/MW?[7+LE5"GR.KR%S\3FK4W
ML;7^+SRXX!21(WMF(YT!EX"DI!/+LZ/9-KQOSDJ,HG%O9A4^N@HN"A8VPX/V
M'6,-^8>]-7#Y^#3I<<U5\IG-^XS$>@2#V*&0^- ;-2.V?F#D<R1]F].)@MA#
MGGKRVZJ8OHG&,LA'*R('UWLN>K2D:]I[B<WZFQV(U#O?Y.C'K@R4WG_@+Q]&
M64*NG>U^S(>YYIOQ8?W8 N=AMJ27\<;KCA0R07BV42,XW;R:FZJ6]^-;^V_V
MB>E^:3WWZE_?!6L DBK4YQT24B'EPT:R['2:"N-6]Y1%FN%0/\::&G;:-7GJ
M[(^<LT$U09>WOK_:._D<)B>[^STI"1MC:89*6[?4-)QV^'MDX$^-O4F2Q-1.
MV_>"@H)DX@LZJ#<UV=-._)G/$Q)F!_)^XD5:&"(JE@P:+MPW-_I;[+B#;[6)
M:I/*YCR*(_OH^?WA,:L[[X5-LFYQTY$^=+(U3RB%K8&%8, E/FSXZQN02J7'
M2!FK,1'MJOYMZ[=MG8\_75"?^%&LKJ15-=IAKNEXNO?Z4;3:SX*]G_<CB">B
M(,>D>]_K1/&R[B!3;<;]X_.#^U>.!4L>NZ_XOKR%FOI(N>/^]A5)<* (X]6+
M],6!)_1:D:6KM)NY#M[$G8U[.>IU50QD,RWD$/[2I\'#_?/N'QO3AI=DA^0M
M1RGFVP\I1&G6G3_<2('6@!ZD/UWC P#I&-(M#,WR8.)HR/>8BWT]\6I5"*&&
MA<S!SK>>?8KGT_P*+=0V>8Q=VW%U2\>(C6O&(Z-FGNB1#5_ &P88EN/#P&?D
M'J0+>N=T.CD_!JM$]I IJAU\/O1AMZ/WTULU=JE#V]RC;V)^BTKMI$;70Z-"
MRKZ#2D27"<X'3/B2K:D]\_U2.!WX#O"6#]JI,J7UN"?+ 7/O;8;]JV9+W>_?
M)O0GUP8/"_3&1BW3R>HL+]"*;0VJ6S"DVN0DZ0^X^]ID])[>N:*WXPK[(C&*
M-6ZP5<(]PNS@Y-]$<RF%0#/<1ME?XI_=R,H@;A(MB \[__NUJ!EO^QDVAN,%
M3>(Y[W,:L<JW?41N=X_3@-'-0K(J+KHH6]C"T>.PD(1'N>&GIA4W-\55&EK4
M&\&PZ@%/X"81,?4FS#,L2^YC(W%_!F2 C@V?&-L*)IQ.D#LFILYH?;E3(NLT
M6VI(KUD<_[8X<%WN,\PTE,"1.;9I(U4[& S!0ZW!!CXL;S/TAR><SCX=G,6"
MUM,3K^"%3FJ,&Y/88N7-X,.HW)<BU8X)CO;/[5['L)(.)GNFC\G OD(==_)^
MHJNE:$RV@#UO8+SZ)"Y*-4!=/#CK,DK8$;2]$&HGFGIGXN=YTM_G=57?;.UN
MG'YNL]\_A97PD#Z?SCX9[,*ZR'V!@3Q$L/:!_GIAZCZ1/=))NMPWKQ];32FP
M^_0]]ZZZ'V[8\=]%#EM>WO-F=K(V@'TM0++ B@$D?\[&VQ>9#*"%'JU*[9%
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MXXR([))[)9-V@<(S>@??V$N"9J:984*?<H)*=1*H%TJ"J;?PD%[%BA?3!2O
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MF7.+NJB+YE$*_/GR/Y>8.MS'5_1E(X[.Y ASV$\YID#G^8-X2'NE@B4IV%6
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M4^E"-X9_M_^R6(:G>P DQA1E!7QIWPUE=Y#!LV12'.?P]2)],*<O/CQRI>W
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M7<2L4^IF,T@".G2 HVK!?K2%^#G0%K6%B&4:@"7_Y4YU(&<O&KF%^"1$ +6
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MA)Z'C!5F-00Q2O<>>,Q<9[Q]5#9Z,G="_'YHL]HND?[OAB][\J4()P-!;XY
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M5_I[Z]Z.KE6BZ]"+$Z,FD[I5>_LW:M]/=:A?0 P.OGS%+?0E>,^/LTN0>WX
MM@8U$6GFSB\<0>+\B6,5 4=Z&\/>_:*VA^EGWM5YPJ^>#@Y<_?U$Z$,(M(!^
MB01#8,/G0C-E2<DP>/(H%9T8<0_72'(71Z>>CGY051W<EFBLTQIX]Y%PR<"(
M"CA[ZNSP=JN,4&?=#IY2"!8!KQE4QE3'*C9#&TPW3L<E,W B[MRL7+C([J7-
MX"82=N3*Y81SZ?S.R^OO!Y"%LD625TW?-Y_C1KBYH"AO+L&F.,8:\K"$6=<
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M+GSWM6@(:?;DJQQ!9")-L2N[8I].*2G"I7X-\Q)U!'7#$3K,P[@%3PL -]F
MJOFQ C!-L2?!PEEZ;7-&3XT%/@J6YC7/_L\:Q>:/LP_$N1\^49WW761?QW%+
MOB4TC"1;:MF/ -\A;T832";JV=,,XNI$1.RJ%]%@PN+M:Q='LI!'J_<8]6=^
MC-']\+O]5.KK7]L@F,]PRRR]@+B;%;[0 KV/4I':/E0&M=I!QRAFJPFX_?X1
M=B7741CZ9:*HJ7'=M+-&:KC3JYW0O,Y&&E,(UMUS%OLY/?BW$2O[X(9TX/YG
M]D0\6W(WZ*J6"4 +K?[-OWD#HV#7K%-2EY"D]V-&K?:A>,6@V O?7%&"9>2/
M-0 <[N9HT_'WZU8EH GJ[(\'?W4FS0?P(M=EWG@Z^MA1U;)FYU0F>V\;(<X8
M!@X9#T_W4?@2MA 8)4$._S1 4R*(PN0Z81VG5]>@V^[:$$^]ZFKT)+_0:O!9
M:/?MUWW/AU]&DGMQ,E H90A-0Z8;/S\X*W-LY)>QDO?9YALV@8$[@G3?-B^_
M3!YT?%K]G7O$T8R[0-C(D&._(?@-0P:CA:Z!*%'CSI>!14KM-U.>RLZ6OOE4
MVL&>S#MQJR['.L(A,')#^3*"9].:CDIJ0U$(PM<M#M"#:X,J MP=4B=:BIY%
M::4K>$0^;,MJ599REGJ4W8$HV#A/&69)\?41ZBJZPIAG.1_Q;_ 9YEY@>L!K
M0@W6)K JH&'S8VL0QHBH_BTWV[S_]_%+AV^K9?68W]\Y:>=[?LG"Z"T$*Q2O
M-#LVO!#9R3',0O%A@Z'SX8%77D]K&9[PK@P8EA^4.33WPN*4!''?^3G"-@MA
MS@P*=%N%3'BZ0W"#Z'K-#C+DV,X[O22A?_\@Y\IH:;J=O$V0IG.:XQ3IN/N)
MP)#4"[5(;<-O[_E6<JO@[SH'ZA+ ,]P*;'CB:HR%#EWFONX-XWLV3J/B]H%Z
MYP2%+1AWW?SV>[Z/C=@T>W]55\FR5S#TT@GF : 3J#,@33"N36PA;F!B8.=[
M9CA=>0\40?5R_W&&OKOB*2'A%Z9*O3%&,"EYTJ1"J7NQQM.ZNRL]Y,PV4F@.
MO9)1QLY!W<!#INCYQK[5R452H '_$EG8W.]N5,F<S=NETU]^.7SY_@QS)/AR
MUKWR[V[[7SF]>OG^MN%$-CP_\]"_DS&RP%3X%\+::,DGOI\VRYKPV^QF9W'C
M+%&['L^;+N?13R%% \9'J]IKKAP4Q@"E,U(S>UL:'_(E)?(%WDS?IC6X,_ S
MQPCK"1IT&#R ;3:5CG+U0A&+1#\%_TT+_DOXEE/5YJ#[8/>/ZT]VEU)V.P!'
M">"Q68PSNQ"@_,C( &IMN@S'.?QC++OY*N5UVP;:G(*'\)F &].7*0<=1),\
MWN1W4--P#4"G*TYXB0PZI?$2*+ES_/3"WCAD"A;Y/#*[C_2EY/+DI&65=';P
MU^V6S5]2#3.W$'IZ:Y63T(PPXIX$4Q,W0MC-E?!4=2>J7J8K)3?;DMZ74/77
M0_;;99\&0X-5O:_3';G[>+HI(<HF2I5/V,VP&E5/17#X!T"+^?GU%1>ZV,&C
M4IK2I/!2T?S5<(^W9;FD<=Z-LH?1CK[.O(4YQZYLP-9\)Y8SV:X+5N%['"&U
MQC[ [ S=AI@6O.H*SN5@H5S2@5!&T,7NW;$?6G]_(QG:M3Q:<Z>CH,- 3\%Z
M+P 9_%A>8!IA;7-M0),B\WW"#3D6#FVQYR;D#/Q(D1HGTP\]6I?N-W/B6])O
MYB;>AIA4@ZDVSE2[P;^;!0ZUD)]TEO'CSS*)=4E8>]_2&W^$UTB63X*<4\0/
M'@_3UJ>]-RE8'YX29/3 H@\FWR] KT@Q#5@V]72#N+_'/Z<D.I<4C% 1?_1>
MJX0H\V>'S*1N(^H(5>H@;<;6ALS<1O4/!KGWZZ38-RDK/ YX:&BOL.^B-=_S
M/0]MW@'F:/":2[>(7*0-8YS]%'7MG<+9IL>=:=3,EQNZWXK3&</G[%V]PKIJ
MB6%[U&YVJ0_/R"+8-/:+]B/7X>'OP(NS(NN@*\^AAN$N=[VYZE<![E9_VV30
MW@WW?^33F">*S7A3J8+;[X;U8*>Y5;;AUQV.-.4(?*%62T%D1C@['^M=YM\N
MUBP=0<I(_JMGL>WHDN6H#4;^Q,%780]X)WG1^Q6?B!Z=Y@@(;R$TQ.@$S@>^
M)&!M(@R=@@;]'7LQ)!$J?KF,[GT&,F,J!^+%@_1Q>ST^1#Q?N&0P<O!+W4/7
MWAVG\R;$:K/V3_\C]M&H ,'\0T6S%'DHW!TPT(E]GL.?0@4FR31%M,2MH%.<
MX?,R+0U9!5BD3U)9KO>1V0/^_5HZ]?9*BR:Q3W"QJ?.9Z(_5+ G';@MM.IJE
MM$X7Z<8= GF'X\(#!S(D[ #JT@"D7_8FFWGPFDGN;-&^791OLNEW)N!WET=1
MJEH:>T4@W8146$6?Y!+J;5A:J_$$ 7-^O=5$EE\Y:=+N!92"?NB6N.*=Q9FC
M'=KSX%*P=DU"1/U#&2VJ)=^BE]2&,?,@T.F)HCQ'*G%CV6"(Q3%D&;'S?]#[
M5F3 ]5XDF')"B1"OEJQW?:I O&#Y-O^;_I.&[5<2OAE:M6FE/NK+9]ER>3MG
M ODVCR5EP+@(B?@R71;1HG5 ZAL(L($^@Z.]3OXR,A;"$_6"37I^#3+R5H6$
MJ5]Z:?T'HG/E,K[S^IQ&W!NFKW($C<%*!O=LSR,(=EH)=!F*8ZI-LH6:E6\H
M-4/"S=%7(U^]:K!1M'28236\ZN'VZ84#64MU3RSZ;.3P/(IHD, Y"@(PNI:&
M&DBCW<H68_K+;9IE!S2"CGMX'*[6%WB^XT'Z+J_\CY+25IJW$D7F95A29,[%
M(3;,&I=/PXR+4U1/^MI^. !5+]*= 9E-6T('9%;R:?>T_YP&WZVU"]-WR"L7
MAI@;^X52ERJ;=5=N_+J2-?E"Z'-=>IKJK[E!UWT(9!FZ+H(E[4VU6>Z$U5(#
MBN+6BX:20*->\<@,VLV%WQ"Z1UK"S:Z\329L*/BMK5"7/V,(H_UV65-@U_LK
M:!\7"IXE/7T2>L'-$**&ZU56 &W2EC7I#W#\X&P5/@EK58ZYO[JS_N7>MB+2
M9#?R^V"\+,G8^_?.5,6,9RC*8Q3H!$S7PM8GAH[EID(XQQDCU[E"5=0T/N+O
MQ79%.N]JW(V#K:W[QG4$<ZP\M#Z?MM;IL[XX^^=D:MG-SFB4N\X\.H-[="E&
MF8]=N86@QJ!\R0]P>M JO6A'Q#A6D\(3J%04G=0X&&1_MB77[*Y7ZS_[!_ZY
M=B'D57_%[!8B&$C!Z4*\3 G696B)HH4=BN@$!.O9$58G9$."5PXN_$C0OI-&
M?VUSA\7=4=8P-RN!,KK0=2Y]CJ(S[67SPB[=+5;E)2_GWOLV^Y^.<!'JM1Z0
MT!TQ.CP\Z'TNK,Z)[^<6H@</:<<3F/LUXY91@=63&33-F-=M ;0T4^*<XMC:
MP"S*X[/?&";8NS%]SF/:;H#4]$>0PY'],FXB5I<JD/&Z\@E4"99T /)M<IK1
M%FK^9Q>/>!;$Y:Q/?54+:JIK2?Y%<K*Q3H]4>8B\($7G6W%CGN),5\-C*3^!
M0T#K[G3-#OQ4MC7DCWD*;10+*VNM&C>?]% M6'5N;(J3\OIZ7V_OR:8 ;Q?=
MS^V?MFWR6N'<8-_:2 ;/HTBC'(%[3&7L!7!]91]=UVX>A5@** \@B-8%R7^<
M^^VO'S1+R[4/XW'/+X[$"UTA]5\PE!8:^DWFDO=-6%BQL'Z^ =YJ]G@945Q6
MG"GW>'HM1.G214%M&!K /]DQ(>8@@5P>\&EX&WGU4+J;3U.NG.RU7:/^$;<0
M;+"8 $-.[MZ<=E\/@1_HM.>( YU:+#^F?0!A]].1=J7.*A86JBEU=:_Z^ QF
M!7X'*[TK!)O4XT?V^8B]'Y$]_5B35'3VN,<X@9((,SH@?0M1_VVUSR :7Z>^
MTI=8+Q*+%KLVPC*@'U@S?N,H]U-\9K;/%WM.:_[^MVG_P>'MQ88._"1^]6@+
MQG\*I_X/U_;R=T_]+^W[_,O\*.V>].C9-ZT9OE_2V&^'A ;8$S:\KG?%/ &6
MX<2_X08_*"B6FBX!^A)QZ^(87>IGY?&@.R8/1NX^T?POGT"" ^A:)%L!'PT;
M[X=OMQ#SSK.?7?[.^+%8>7-;B$'/FN40_'_Y#,R(]'"#P%HPCF<+T75\8 N1
MYA)AA?3J!88_W%ME$7./IDMPY +_C5X( Y$<<6DTZWH&Y%L]E<%)&^X (%LW
M@/[RU\^2I:;AC0T#F# _NME7T_5?6X7)FE#]OU$,S9#(%H)?T(!C[#4K>2]"
M;@N!4E\G_-GMRCC$%F1$03S4H*OD;@LY2('"/L(9<6 TCBO+U<?[>S#?+\CZ
M6E FKEA)Y9RJO][ZT6&S-4VM :7&A75HT(I PE.W$"S)]7\C.E&0>GM.<>"<
MR6BX:S4V%*QU^^(]2FB8\7ALGU#7G"WZK+G.+]GJ8?F$AK.?GY;%>]AJKA"9
ME['G/GG#?Q+QD#JAFRP<V4+;JSB!EC2>%7$$&7D'9 T=POV L/ P\<8]'J36
M)B75CS9C_UST1AU$4>8-( TR]R0R+_S6,6CH!!7=.7]E/B.IG9<>G%\=>)&1
MV5.NW^X]^JM*GS2^KVR?H)S^R0&)4R&)[^6F@U=SMQ!!R$D_CL!?YC7N6GW>
MBAT?2^+UO-6G]EUI.Z ,XCSM3*Q&%7(R7- L)5_I6EO\WN^ZPE][TY>W7SNO
M@,K%M]QRXOLFPY*NY/"/,H.Q_U93Q0T X%G\E!_%A:6K9T2]75*>(1UYG-Q=
M@"M\;IG;4C$=H3/GH*BOY'.KOS7(9T=:14@W_-@HK.FF!$H)( %<7XU&@2[H
MR4HJ+J.*Y0QY>P<$T@CQGY8^!_W>TU;P2RTY:E#GUN/@7T$5VF<G#>L"/_!O
MTJT06")8/<^W0J8S*7PIG+VL0';R-0@3:AK[^@;+#'R-DEW8+&^L1'^0VQF@
MG](9$"BZ<>[0G.50NTWV "D1=Q$V$AY;B"LBTX[<=S%EG83DF+Z<CQ$<X3'C
M:H6T"+LQD:1;]ZS'OTO7-C0>X/&^>S!IC[];NX\SR5JV2.>O<C*"5<9N(?BB
M(9V\;A%(OYJ()YWO1-7^2.#HLG:"UOF2[;L_M3G.+]W3L?X4;EJ;M2]<\)%M
M[K6VY&^#'[3=/_9(JQ]_E9_!C<K7YAY;!"BON"0&*<J9BH4A/M98N75^VF8,
M)PV5K_<P,LJO%_14,"K=BJ=[5_?'!!A<N>JW7])Y;_KR?>8!I^NW'9\O-,IC
M(_Z0ZD#SP/#K'?;\OJIWI'?LE'O_7E7UV5.1.!3E ;F>CR59,H^_;Z&#A=E*
M3 ETIFN49@I/907WA>Q%>>Q%[;=E<X6\F].VMQB!%W.U?NU5ZSTF>$0G;;'[
M)]#9A:Q=73%E7N4F@&D+8*IR^O&U<]7S& FH=\DV,&HE?%:E:^2#7KA]X >A
M82"*QZ>LV4G5Y4/XQYVVFZM4S4YR L#3IH:5 4<MF<)/&D?)EP:,Q_)D3">R
MFZ->OP[6N)9+BU+,&GD_N-)[!L%3\51DL!K2F%AN9-[ ?01 2[0HKA,MM87P
M)HN[LNQ'L<*T%<W3(WOIC@E^":Y-7X*KOS;^#E8=&PQ]F3)F*)?J*F8Q^\,?
MDXD3 #HU8<3&/8<;>]-B/]S[@S"WGWSLBDY6W@_5>%?Z7SP;^8/H$* 7W3P2
M?.EV$V>4]!A5ZYOZ;&/ @=^IW^< 9_VS)1(&>W48EI@!HYI= QN#N6'8P]1P
MJL!)R&@>Z'3QJ#(CWOG>6C&P\R4]);&\T:/2/NFI5<&^+_,1X=T/7Q)R7WG>
MN\(]C0.18>6-HA.(CKPL13;<DROW3*D#D4;V*6?HZ&Z'B%[&Q%LH38_Z^R$I
M8#RNP"QI5UII@5M;9I*<U/JNT5_)6CPT-*2.3@$H=1:J,&5L@1WE?0I&>.&2
M<!U=P* KJ2[41^CAQNBJJW!M[8>@KXFR1S]JS$Q^,/MB0?H_<H,:=7/X0;^T
MI\D3O3BQD;^13V^"?2\F;4)J:F353R:'A,Y<+)1\XJU^+4ZK]_J(BPT\5P1$
M*&BV&(8?H!Z&L58O#"SB^$ #3F+C P+X!'Z)^?#QLVY, 61_^U?OOS=,?QLT
M*^)96JC[P)I5F_H6XL$W&!0HE' DD1V$394Y<=ABWX1Y>]J$FY5R5\+OZF:^
M+V_([]N_W@3 IQQ>V(!+@WD<B5P"*S@#<@*V;R%^ID3:PQ9] ,TQ]?*5O/OO
M%R$O$@$59N8'N+%82&8+<=*C"PV=<=]"T%M0U&/<>(%B/:H!2U,/@&;#_SF[
MK 5H,Q_>\Q!FI?SZ7[S2DB,1N1NG#&E$!;?)41P4;'-O\1\LN)8GU6K[].O.
M \_5_&JJ"O;UIFFU/B_[K7U0Z]C< ;M-E82DOVDG+#_IUQ?J=$ULS@ZU>5!'
M;C7KC=!@"84*#]:<%&'^UIJOPFXAX+$?0-8IQX%FYT$N?=2/3* VO&ZWH%^J
M%7)O)Y1<%YV9OH[;,V9\: >FG.PINB1%4TVXL.US0ZZLYL]-G1/G_^@S.;LP
M%5CNUO ?%I>Y%G$&[O#6XV/#/[!@#"MH3\S]IN*@>J[YL\&\@S7O^T%3"=M*
MM<#^T]3H?7O%[LKTHA[ QO8&$M)R2(C;0L N5C-\"Y%HL3U2E2CC%.GH0M=X
M06UEFSG1A8<&[?4K38K"=S:YTNH2>X)[);1D3#U*SBUEU#U_*@)CRD.!G%UZ
MK[!1X 3QGC>'_QB3=X'DE\8R?36X^;&$TIK&0QPWFCP5EU P.N?Q?GW_L)"&
M84V.8.@^<F;R)D"3YD+$>"B!:01[<(F#J"F3HSKS (PO/6:PSF US,;*- I?
M36K<?S%%=E2:S>GI4HO0.Q)U+!ZJR#)\?^[HCS6N]9V$1? .BX"XE/X^.SL(
M\''<#72B6,Y40&$.2CC3%-M'$/>P329VV"D-.D;=S#/)JWTW;[?]0[!*O3C_
MCNDGY9V78,C M_W?K"(H;NHZV  ;<?C93'[.T)WU]+V08T19"93+[-Z4+L2H
MYZ2G;V(OL]]R]KE?FRNE'2WQQLX:;;*M$#@/UH5_USI=H75N) 6(88E/4U'+
M)^Z"$]TN*,&#*!Z(2=/LSE#^*5PZY>[A=BSHSGCH@LS$A(O%S6YZAJ'LFZSL
MM$F>293/ZJ11+]P)*QA9K&PA.@B3=ZF[G]'S:/_ >'1,7UEGULS>P:-;1O2&
M1S.)LRA+?9O2'X/2\_KV^],5MWQ2^\_B: M=]F-N@>^:G-7EJF<.S!-<@\<R
MC9@? TE ER\R=4V8QVG">-:U0_GW=X_W^NHQ;J_UY2_^D0_G?9+]QALI"'3N
M(%#P*- 9@-1E5F;IJL2Y/>S4-CN#Y3_TW9R['O8;;5'4?$S=6&/+/PL%J0SZ
M8FHWN\A.-5]E9@OQ;@?F=Q=^NE^+YW<* ^YTS$G<9U3-#Y;42!]'$$9F.U9
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MBI8:Q3+ZB&@>3?B:C%1!22^U_'R3]L_BG/I8VK>_'_S\]'2[A7_HW>_89HE
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MCNT4X\M<QI58I]CRD%['D("!H<\+L77O"@V.+KJ2WX4OBMUU&I-/)HTET0T
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M%,M5B>GJ[W*U>[.N5L4#+S_FF.2+?/5\*^_RRZ*@O\]I$B0L9!XD(4D@XCB
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MC ,6BD@N)FD:&(>>GQMM:AS9E1?4 H-68HMHZ;,@GR8 Y] -3 BG4#MO@_:
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M3-* IBD5?BB,3IM,!IL:B<C1$&AE!EKH;2-8);:%P7H.9P-WP"%Z S/)6>#
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MP<$0"(]T7O!A*0WBAWJ+1_4I;;N?%W6SH1KU?(.ZZFH$,"L>FUIYZDN_%*I
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M1AD*(@0C*J39Q%(&T]"+8"0\ZA%!219;.9[GAYP:1Y[LX R^*+F!%MPRS,
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MB<]#Z,<L03YC >%6.T9GQIO:TO2V[:#'=3\#13&Y2K=2TZ/Z8-1TH[:W]8^
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MAVF? "^X4]_T3*5COLCUJB?I=EG*3^Z6JOK)+?[Z"U]RD:^J=VVH=GWTIAI
MK>JLH=OBW5>L$MK5UV_X:ETNJYM.BTR!64A\%$,_TA7&_0QB$A(8LY@PQ+(
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M)(X%49F]+WT@(:?&F6T>,VPK 'R53S1?&E?,G@;@MURYI+,--<,67OX)S-O
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MJ:>&Y[MX2_JT*M;Y__B(GSV/OQUO#8/JP,QU,M:U%5S_9$2O@-X*/V#HZD7
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M8+]>8(8=S-UI\&&Y-ILA(?275II]T5UQO_JQG&=492+(]):#\!BB&(>0QIC
M!"M,>!03B:V*MW2,,35>K\4$C9SZFS>_K0I@9+5W+)P#]+*/P0-, S-H+X2<
MG \7,.CMASCWW-%<$A<4V_=.7+JTGP'Y*]7&J#F[E.7=\L-/0T*;O'PT3'.G
MWDNVUF-+F<HT@TA)!1'.$&18)5#&G*HX%D*$3BUB+XXX-0(P @.]Y,L#6:O^
M\E^^@,7*MMZC ^2,!P(S!N-$<RO*2 PQD@)&7 J$E5(LYFT8Y/W8R!_&/=[_
M7SD!=I:QUS=Y8(ZN,/S%"/LG ^6'(RB-O/XL56MHO%J=ET<=U8*T!N&U-6A_
M8]\SY#/MU7XOI=HL?LN5G"<HB2*4*ICBP%3]1@RR1!-1HL*,<B8QBIRJ?EN,
M.37B_Z!M\J=J.[>I9 0++:3K0?)EI&U/E+WB-_C1\D%+QL..C#-0RPQ^Z\*S
MQS&S-4*>SYLOCSORP;,U$,<GT/:W]FP#UQQQW].?-YK@UJ7^H?U;T[2VK3>N
MQZ\JD])%676YG:=9%-$D2F$D!(9()A02&<0P#&5(21JAB"0NG'2%+%/CJKI1
M,VU$K+ZWXE*-?>_S8\=D(Z$^,,.U$@,M/:CUF%4_;__A0]MCO-6FFI56GQFH
M-/+8O>]Z6/VV[KM"GG'[]ET/W%'3/@^/])7_O:M!ETD6B1!#S&FB=Y5Z2T^)
M25^.DY!D@B4T5DZ! V>'FAHY[DMZF GN6&&N UW+@WPOF U]$&^?DCM(I;C+
M( V<I?LVE=\NJWTY:]=3);?/J[4LO] 7,]FW=7+I/(GBE 1$04Z("1V,*:1)
M+&!(HD 1(K(X<3*^3HPQ-=YHW4O@N1;3L1SE"1#M6.)*: :FATHZT(@W XV
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M8J>W>_M&M;OUOXB^:;]^V67:V@60XB1A*)44IGF@^"H26&V"@PB*E,6<9&'
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MFCTNCEGCX_D6V?5^1[Y29@W$Z?TR^U?=.)Z+8GZWX84:PT]-]JEY&J<LEDD
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MP!XPS50'@R2$NH*$UYE_J:]19_\5A8\9X-KC/GW;/XMJ3EB6\9 &,(CT/=P
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MAH;OVZL7^QO[[NHUQ<_<7+WZ2D]/]*H4Q</RK;8\RI<VS1NB2499!N-,*,9
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M+G[^O^)E'D;*RB "0X3R0&TS,84$T02F.:."X"0+8JN:"A=[F-KDKX4$C93
MB F4G/8^IO- 7O<QW0S/P#/>&1DG'U.G]KU]3.=;'<W'U*G4OH^I^T%?:0?$
MDCT^D?+/=ZLG4BSG. UX$(H($IQE$$G&(:4<0<%2)'BHMQ9.-XFO=3BUJ7[F
M,OU68O!'+?/->0B.,+=;_7TB.3 KW :BA\0$YY$9.#O!4:>OG*+@/ 37\Q1<
M>*\?W7PJEN*+?%L*7JP_$&9R5GX2BLK*EFY8BC.61C 2.JL1CB3$22!@R'$F
M*1$,L<R%;JYU.#6ZT?)J>[F6&+0BST M=$_&N0J['>/X!'-@QKD91V?2L07'
M*^E<[714TK&%X)ATK-_K><=9V4V\6&QTSL;O@ND$N86HWO]DBPT7O+Y3K:-Q
MFBK)[TFY5%NEZJLHC:-72_=Q+9ZJN60TR=)$P)P334Y(0IHA4\(XB3'E(DZL
M4J[Y%FQJ)+:O%]@I!EK-VM0"6]U,TM5&.WTL4Q_)@#_,+#8J.A*>MR&W(\;7
M&,B!"734,72_MNT9<+^WNGT)-^ZE;\^0GMP)]]W^R,5$OSSK!_<OVGQ;+18?
M5J7^XYQ(G/(X(C!@/(0H#5)(>:IS[R2$2T1YDCG9K<.(.;6%8N<?KH]41RHQ
MVCV4EL$1KSY 0T=,W%YVM%'UX,H@^$.K"QI]?>9+'W1 IE&/M%O4?X_*I%9P
M>ZM1:M=;OZ7$)A'\=[6>B;LE_Z2^W\7V.9V<),!!AE &(YVF$0F:09Q'NBA0
M&H=A2G)FE[[9AS!36Q:,G#I*#I36@;M>!L6.^L>">NBC&LLJ%S-0CX<.>S3J
M[#VOP^:4A<:\1H?XP-<K7]\DT*BL[ .Z8^[UTF8_AGTGI"A+'6!WKOGF^L0;
ML12R6,^%"#"*$@HI%<KPCM0_*"%$F> T39BD)""16\86E^Y=)O8X&5R,U&[D
MZ82W'5D.A>' Y-B*W<%][>TO\$LC_N4P;F<*[(.:5\IS$F!4BNL#S3&E]6JC
M=PCOLRC7+U_5Y[567;W_YZ9XUN;IKLZ6%#C@>1I PB6&B$L$J20<"BXE2<-8
ME[EWC-Z]TN7D#+Z]XENM]&;.;45W#N6]!GJ429J2E$&:HUBM$3B#-,D0%'G
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MPQ3#--#UPDD6PIRJ?3#.HRC#*"=9[&3Q=/8VM3G?^)5V)DXK;L^0SVZH[<C
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MEH\EGTL=)]&=W$#([Y7D92VX6T0]8&[L N*PB =>REOAFW2W.U#+#Y<*:@U
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M]GK95*<K/76F5;JV7F#5MH4QA&+=M)JN@7\]EOS1<(RM2M':OXZVNKWJD:X
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MXV#6;X=I)"/^Y=&T-VI0JG-&#&U8\SZ9-VQ>Z^'+IO:CTFM!+]PZGKWLE_W
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M"B-.$,1ISJ$.9@L8<XD)5PEEA+K6G0R497H>;B?9X/#7<3*<(^0  +] $'U
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M#FBDK<M&C;S@4*4[T$W5\77[BM79S-SKD9I/O+W:52^"C6IV?4)Y;)6]/GM
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M*H_<Z$]7\"&$3Y/-K;SJN+TN+Z9S>MB4_/K%MO/,.7@B+6ZC68*H774*N8#
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MDP,;:IHGTV80N ]@6%"2\8+%MZJEN)6HL0/9AT/84>KH$5G5.!,;K&1ODG2
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M'0!D)X<=\44HX3FC5<)J'SWFJR^?<KTCRTD>,OE&,\8ND3%..KH=0 Z7<0\
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MEKR-HB[370]A4@]62P_6\ (?3Q?DHB_74V)CT\2!R23K8 / Q!P% =I"C"Q
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M0''=>ZR/5U^_AL6/>;DCX,.+-7?_\&$]VZY<G-+;Y1P%+\F#70T:4"5"1*V
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MCQJ<\]0'W][[W%SYJ!11H2H0.-&I4K+D5W,=/64+9QBC*_$EB.SQ?>-F 2V
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M!P*2.^!DOCY&#<%8X0*9771MIO8=2?BX%T$GQ.I#'WQ*A??WGG",USI\<,T
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MU6X=][M^X[A)T5#8:"+?CD#S^W2&EXBS[8QQ)9632=+96B(HKR49 D<H0ON
M,5#,MMMK]S[?.FY@T@ \P\IY= !]P3=?5Z^AF_K&^O0C&/?;V4N.)?2%0^92
M@A+5/B*Y5U&LB<+PF![VHFR#T=[?/6X)W6!@:BOSL2%U4YJT.HPWN>0=7IQE
MTC@>0)(I@$I9@=>4\+D8C=/!)29W<T,O?-&X56)#@65(:7:0YZQ3/?K+JZ!>
MH?2R7BWI7+,]FSQX@7342L,,*SR@W&EUY-YISCTRQO4J?>3.A^NE U =+KA;
MMF?Y@<6BY5XI*RCX"Y0[))DAU+)(IDIAQKA<'M8&#O4<VH";<=.[(\#U\-%T
M;$UW@/:GNE ^?/SC.N5EK!05+%BED+*70,PP7R!IQS6S1K)FJ]2?(6OD-]G1
M4?-H@/90*AP[V'NR)6HVNPH7J_+<ZY0ZB%20,$/$UUHQ3!3X9$%QD%>)V^#P
M86G)EI!OIZ\;>_3I8+J=-Q5TC]#Y'?_]OZ>+Z\5T0LF0F:@Y=!T/+XV $$4&
M[J.5A<PLE'(P;.Y]U=@+@4X&F<,%W,')=V?D_+JS^3H'TA0U9&NA%IZ"TJ@A
M6N'!*2L9QV!T:!.J;2%HY"J2WDZ[(=36 ?I6?K8FXN'R:KE^DR)OFK/G8*0B
M&[+$1>"4WJ,K40F7I0YM^L$?D3+N74<?*>QQ^ND-8!N[B]R3*1@%*4M+SI\.
M].B* A%"O0!,6;DV9>%/$#-N7'6D>I\#RP&R[@ NSW5._SZ?X>;B\/H&6?H<
MC,^02ZC"RG7G"BKRYU8D68.(TFAVQ3YD=@2Q0T"Q];9B: UU#K^W#SA+24O/
M OER2UF)KS.?)4J(G,5JI)ACH]%#.],X;LAV2N =H9L.4/=?E--,9Y]7_I_Y
M.LM!4G10ZH!&:3AX2[_S%)%J9>H[?9N&E3M$C-NOW4?@=:A.^H'3QN2DESYJ
M$D*T6M8:,PXN6P,N>*L5\Y2 MYE'<X^,<<_ @Y7Y-"@.D&P'L-AB32MS(8LB
MJWLWNW:@+FI)H:<#+-R#,C$3D\J#T$I$[HH7K,U*RSV([ )2AT!AM^>?H_5R
M%I#[]._Y=9M78KY@W<MMF:[5(/7.A)B4.C/%LF&ZM*D.WH/(<0.J4T+N,+WT
M"[G;F&%;R/#WFTV>+C-MO2V4I"2L;[DDV?J@*SV%CL6KP$*CKO6C:=\)H/9U
M1VXG1D 'F"<^OVX&"+\/BW>+CZOBN]60H?>X'D8W,=YQD54$&^M==TB9/(6-
M4&3 8HN3JA&H=R"N\X?T@?'R:*O*L,H;^P7TY_!M>ADN5@P]'-4[<<*FI#0#
MEARG^"61R&(NH%C,4=-A(M0#%&Y;9O;,MW3^4M4&3L/*OB^G]H@5RM)*%G4Z
M!=867HD>@DD6;$C!8T;"2IN<]AFB1FY6[,:)':6L'G'WVW)Y53>Q&\TTXQE8
M3!1O2VG :PI.9%%6,,^<DZW6TSY)T,@%OIWA[0 E]8BU=U>7R\LPRY3F3:PJ
MQJ&)D'-Q=;MIA."C!UZX3<BCX:)- <AS5(W\)M\9Z@Y5U\'0^XZ+.!^J\.CZ
MFY]VVTH7;8438(AX4,H5"$P6*,0,3\4'F=NLO'^>KI'?)L8%X( JZ\#[W>=F
M:_)3*%K(FDLPB@M0J2AP6F70S".758"BS;*CW>@;^<JE)T .HL+N@'DOP$C9
M9JE(1+&@J\/(% 6S$B&BTABTDJK1=H?M-.T$0/>7 .#!JNH4='?CBTS^VV(T
MP)RN2;M6X)G2(%(=@^>%3[N-D1L$>?M&A/XO!+]#E=8!!E=<K,WGEZLZ@G&]
M5F'-U^_X[]4?+2=D03%SCV"B2\15,A"T8""D4EI8[[5KL[AQ-_IVNTYFKQ22
M#7381;IRU[>O=KK=1A=)V>PM&9E857N) "$7"<B$259&C[[1+IAM).V&P-?Z
MHC&,ICIPA^\7\X28E[^2A"L[M=EC-5;^^A9@4HAL5X@-8DB#XLR2%15.5B2$
M+M(Z^7!6XF"'\@ND[0;!U_8*TD9S/4!QLZE@,X7YFJ?5/H.)L]Q;52R43!Y<
ML<PAJ"#K&X]RAA7M=*-AC<]0M1L 7^N#R&#ZZ@![!XOR]ZM:0;2I!KE[4<5B
M*I;"#$BLIF8Q%'!.1! V*?2&AV0;[:\>FI7=4/Y:GV'&1<;8E0XW3*Q6)U2V
MENNAPOG7^>(MQ;YKYM=]$/G=XN?J 2[J*Y4*P7)>F:1C1Z6L(;K(@,L<M&;)
M"[/;L*A#*=@-M:_M&>=T2GL-3OM-SM/Z3\+%(R.UR:!(/%+LY (H)3)X0V$\
M=RD)39+(YJ35X4,PM9M)O-:'I5[0<LZ&L_IE4Z.]OG/A$\4,>DV1GE,E@7*.
MG$8F[1@;G-0FQ:)+7Y;R!!>[F<9K?>(:#0]CAS<',_ZNE&DB&HCI.O0S?,9/
M\Y_P?^-%/6+?_&,ZFWZ]^OJNO)OA_\&PF&BLA1,^@S:J#GNLVZVCKN\T.H?$
M#0M\MSE*)R)X-W-X;0]NW4*B3S-Y0A"_7EU<_*C^8/-:M X^5X'F+^$2;_8"
M3XA#YI,E)U$DJ^K)M5T>03+T3!F6Q,/.\KT,X@C2=H/^:WOLZT#-YQP770^
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M>EU^(4+,SN5:R*5(!CY0E,A+HC L2N$\EUZ--)/J &[&A?@1X!IL\>9 FNX
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MDRQM$I\7"!LW\QD;A4-HJX/<9WO\84)T3$.VOF[#P0*!%5:7+@6*S9W$))J
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M=^)X!_'9%[(1;\X7R_7\/S?RF97D=/9>@ @Y@PK6@7=!@73HBTW*6=.FP\=
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MO+A[DY_/),LV2(YD):9<;Q\&B#+7,0I<&1\5_>\85ZB>IW 8_DXJ?-]$.!V
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ME]M<_AKO!!^])6QO&-Q'5@>>X#]?Y"%IRNT']9](WM?__F__'U!+ P04
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M2Q +0\[5 UU+\ [5+W>P06PDZH"O)DQ'+E88(]4R=$H&U90QG[HI")P071X
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M[:@8?<UR3"#Z\8&NZ9."S:]-XQR6W0V/'_]N.0;W!+OUW)['!RP%."PM4EA
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MGN1)/#XS2#@>XE]<&\9J58/:<7TOC,.+< :PKP2M@#0-)]I]*&$<X7'D_QS
MUWY<_FVS_[H?3D\R9+Q;X7SQ%M[=OAC Y>7UMX_\EF#?Z;8B#%7?]Z/TL.,>
MS>&C71J,<G3>*#</%JY#=_S!C'2T/(X3GTS("GL8^^]1DX8PAEWF=Q-3X6=!
M^O<;Y0LC6K^Z:;&;6V=_ %!+ P04    " #GA&%4!?"N9DX(  #7)0  &
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MB4PFW*:]E Z+>W554"$?9XF<<?1.1]+S'WT$5\#KN]0$P39!]_$U[H14] Z
M-JXJ6.F$9IJWYG^<@J:SA,Y:(G7KY0:=%KH&TA@YMNI.)Y;K4284+T-=QO3=
MQ9O[DY/@J'9D7]X;A?_9?.+BO7[@WNM7#5OO:QP')[7GNVM!^&S?=U);=29[
ML[$P&OGI3>FP-!]0X*95SQY(^/@EO872T[7QR_+C-YASM@/0NJ1#/E(%S@K+
M[@N/!6J*I?@Z+_VK[Q_MI]/8$@:S15MX_FHO?%T[?;77P'YROZ1S\4>OX]XH
M7WVZ^?QH";:,>(VX(^;?+5NQL1S79E@&>W=&YO[OW)H^]Y%!@9W5-_#VRYOV
M2/"8=!]XE-L3++DJRKS]:W^3 69:ZSQ87^BJ8Y45SGKVXYX5/GOR?5 F_0=2
M+7^5.>%K7PPM(^)8J[8<0@<(2V[6AWSA(Z/BUW_RY#Z^.O\O4$L#!!0    (
M .>$8509/():2@@  -TE   8    8W5T<BTR,#(Q,3(S,7AE>'@S,30N:'1M
MW5IM<QHY$OY^OT)+ZK)V%0P,AN!@QU4$XS)U6=MED\KMIRLQTH#*PVA6TH#9
M7W^/I.'%!F_()IO@;-42C]1J=:L?/=W2S.DOY]?=P>\W/3(VDX3<?'S_H=\E
MI4JU^NFH6ZV>#\[)Y>"W#Z01U$(R4#35P@B9TJ1:[5V52&EL3-:N5F>S63 [
M"J0:50>W5:NJ44VDU#Q@AI7.3FT+?CEE9_\Z_:52(><RRB<\-212G!K.2*Y%
M.B*?&-?WI%(II+HRFRLQ&AM2K]7KY)-4]V)*?;\1)N%G"SVG5?]\6G63G XE
MFY^=,C$E@KTKB6&+MFJ-F$7'#=:@0TZCVO$PKKUI\K 5OV'1_T(8686X'Z/-
M/.'O2A.15L;<SM]NU(-6,S,G,\',N!W6:O\N.=&STUBF!O,IC/=_>C6;RJ@:
M09^163NL0Y/A#Z9"$S%*V\[%DE>U$(]D(E7[5<W]=V)[*C&=B&3>_G4@)ER3
M*SXCMW)"TU_+&F&I:*Y$[ 6U^)/#1DSB'F?>A1;T)"+E"Y?"NG6B]S 60V'(
M41@T'GNPF^T1%I^K'V1\MW<[Z%_TNYU!__J*7%^0[F6_=T$N^E>=JVZ_\P%-
MZ.W=/NO8OCAR\_'V[F/G:D &UR1LDH_!7= -R%VOZQQKU1MAF73N]MZ-SOGU
MS:!W3M;=63AQ5*O;" TN>^2N<_N^<]6[JUS_]T/O=]+I#FQ/O5:K[XK ?]R_
MQE;_^F5H&=.4W'$S+I.(*R/B.3%C:EZ_:AZ?[+R!,LH8^*Z2\-BTZ_6@N=A4
M(F4(8+OBVWZ0FV&P<.3[S_YX:4*W"'TRIE-.%)\*/D.N,&.A"4W3G"9HS*0R
M1*;D0JH)"6N5_Q 9DVZ.74#+I)]&P<\4FOJ>A>8]U0@(5G\R)_>IG"6<C7C9
M1Z@(#9,P()5(]=!/18K(S4F>&I5SV(_D[^H Q(R2"9Z40%1C&J%)$3E!:C+2
MRVT(I#SB6E,UMR(3>L\Q[YI.C38&8S!EXHH(S&$%(J%0-$ LQ7!8PK@BL[&(
MQD3G]F<U?L85+Y18!R9")Z@N;*$R$V8,!W7&(V>@U9O!-,G@YA3#&!G.UY<!
M('S[LX#PZ*6 D)-8I BS1<PJK&4@$.+H5FO](HU!(-16M_@[2G(&G8#.6@S+
M@)U0R9QDB+P%K05SDJQ060!"/YD:P&>N;"Y;B3R! * H@1<WG7;V1%2/29S(
MF5[@5/&1T 8UMR'4-GJ[865Y#6YZ8<R&M3\3XAI[AKC!H_"\?G5<#ULGNL!4
M4198FI!Q+/#H M<G5'$'$81<#!-N0TDX<#E,A!Y;<2LV 45:FK3/3.@HD3K'
M.$N>2B8>*YF2$6=HUN0 T& <6//Q[SU$J$]&G'3 2[=Y HGPB%;"Y@$_=$/#
M)O-/_E'8:C'U&+7ZB26O->AZ*%E;=IXH7DU$W..A<_0IHB%BL_I7)^<?A,@#
M>K@OD*P'C="NPSG7. $@/"Z-?1X[99MA(YKKW8?85#?DP$$QDT^>-K1=.<F0
MV)=;0>?@IZG0CO4PBJ=.KRV55WRYSKF*)]0!K<BF*ZR4"SZVG0+<"=NT3 1S
M]P8Z'VK!!%7".B1\SG=9(%UH*DRS"=EM4.VRMR-+J3DL,R!G.SJC@'J4)]1R
M//QUUJP2.T;X,F%+_8F&(;?R8&.HX>RKV?='X7JX-[@.@^/&)JYW9JP->._.
M=7\;Y=@I4\$L>*F6*;4D3S6 ;TM-BVBJV )4P+N@0Y$(,[<)?YL9=N\Y_#E,
M^6WR2'2M5'6YY*%P,,M5!FAK5Z!$D53,&>"*UA%/47<D0#AZ>&;WD!5!0>[A
MB[TF,M#YBP5PM#< 7A!S;TJ3W+&5C2:/8]2(8HHXZ"VUWA);.["Q?]Q>_FW%
M*Q2!2;4O.H<R-\];M$O^H$MI;BOJ^//'(#)<U.IN2W*_,K#'P<U.\!(AQ_8&
M<DO.]-';1(5-A$7EYGJV0N\+F-+F<QE%N;*Q7LN96[1.I#9HMS>4T*4C*/HC
M1\J%ZH-GAL0R5^"L)]*%X3@Q<7=OD#Y.QH?>JC'5RTK#LIT#.6<N+;CU*"AZ
M3A)QSY/B$N&)?/FKE^B; 'N/CF+-G^(HYBX4V6*3E%>TM(TUUX&[8BP+O2\H
M1C;*VJ5ZBM+62*67^=XU0.5D(HSA_"]RQ%"BHK#]3, ^I^0 \ 8%:TOQ^-<6
MV(L]R?_(!<QW^R]/(W?W</A2#V#[<_YJ!BW'N9T$%1DJ1@&@V2.N/2U'@@,)
M1:I>GGMFG-[;7.LK-)=M7:WIKCP7UT)?A*_B9.)O&+80&V48J/F2UY[%8E&1
M8@@ A<*Q[!.^1K;7^01PP"(Y9XI\LO4"[24G\_TY_S2#L.5PA90=*Y!"&5'F
MCM> $W<A70"J[#.>2*<RF7*;]E(Z*N[554&%?)(E<L[1.QM+SW_T$5P!KV]2
M$P2[!-W'U[@34M$[!-JXJF"E$YIIWE[\<0*:SA(Z;XO4K9<;=%+H&DICY,2J
M.YE:KD>94+P(=1G3=Q=O[=^^#5JUEGUQ;Q3^9XN)BW?Z@7NG7S5LLZ]Q'+RM
M/=]="\)G^[Z1VJHSV9N-A='(3^]*1Z7%@ (W[7KV0,+'+^@ME)ZNC5^6[[_!
MG+/G *U+.N0WJL!98=E]W;%$3;$47^:E?^W]O?UT&MO"8+9H!\]?OPK?U$Y>
MOVI@/[E?<GM]V;DB=[W!Y2/W=XQVC;CCY5\M6;&I',]F6 )[;T86ON_=>C[W
M<8%;O=6;=_NU37<L>$PNEO1S791W!S?^!@--JTZ;B3"FL[KG*,0/-Y>]ZOAE
MC;V>_<1GC=F>?"642?^95-M?:D[YQG=#J_@X_JJMAM A@I2;S2&?^=2H^/4?
M/KE/L,[^#U!+ P04    " #GA&%4QU_R2DL%   $%@  &    &-U='(M,C R
M,3$R,S%X97AX,S(Q+FAT;>U86V_;-A1^WZ\X=; V :RK[<2W!G!M!3&6V(&M
M-.W30$N4350F-8J.X_WZ'5)R;DZV!-C: &L>A%B'/#=^YSM'[+X;C/OAUXL
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M>[>%S/"0<!I\[8UD^2SN1\U-[?%?4$L! A0#%     @ YX1A5 $%Q[-,<00
M?,TM !$              ( !     &-U='(M,C R,3$R,S$N:'1M4$L! A0#
M%     @ YX1A5&KVU9%Y%P  .@D! !$              ( !>W$$ &-U='(M
M,C R,3$R,S$N>'-D4$L! A0#%     @ YX1A5#4_7E%O*@  8+$! !4
M         ( !(XD$ &-U='(M,C R,3$R,S%?8V%L+GAM;%!+ 0(4 Q0    (
M .>$8527H^:2>7$  %$+!0 5              "  <6S! !C=71R+3(P,C$Q
M,C,Q7V1E9BYX;6Q02P$"% ,4    " #GA&%4.=$89-#; 0#$* ( %
M        @ %Q)04 8W5T<BTR,#(Q,3(S,5]G,2YJ<&=02P$"% ,4    " #G
MA&%4%P.*--92 0!P[@T %0              @ %S 0< 8W5T<BTR,#(Q,3(S
M,5]L86(N>&UL4$L! A0#%     @ YX1A5";R<I]QQ0  G20) !4
M     ( !?%0( &-U='(M,C R,3$R,S%?<')E+GAM;%!+ 0(4 Q0    ( .>$
M851B3X4FB"<  (_% @ 9              "  2 :"0!C=71R+3(P,C$Q,C,Q
M>&5X>#$P-#$N:'1M4$L! A0#%     @ YX1A5*#"B:UA P  $@L  !@
M         ( !WT$) &-U='(M,C R,3$R,S%X97AX,C,Q+FAT;5!+ 0(4 Q0
M   ( .>$850%\*YF3@@  -<E   8              "  79%"0!C=71R+3(P
M,C$Q,C,Q>&5X>#,Q,RYH=&U02P$"% ,4    " #GA&%4&3R"6DH(  #=)0
M&               @ 'Z30D 8W5T<BTR,#(Q,3(S,7AE>'@S,30N:'1M4$L!
M A0#%     @ YX1A5,=?\DI+!0  !!8  !@              ( !>E8) &-U
L='(M,C R,3$R,S%X97AX,S(Q+FAT;5!+!08     #  , "L#  #[6PD    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
